4	4	0.07428 0.0303026 0.0183647 0.0315285 0.0256586 0.0147039 0.0466852 0.0694485 0.0589304 0.0832588 0.0860927 0.0154797 0.0197741 0.0366053 0.0218462 0.0702406 0.0591806 0.118787 0.118833	Drug-Drug Interactions : The pharmacokinetic and pharmacodynamic interactions between DRUG1 capsules and other DRUG2 have not been determined .
1	1	0.0346105 0.0151713 0.0395199 0.0388135 0.0317762 0.0379998 0.022205 0.0846355 0.108303 0.0476312 0.0486599 0.0548871 0.0454285 0.0534014 0.0753262 0.0642772 0.0254245 0.0727918 0.0991379	However , interactions may be expected and DRUG1 capsules should NOT be used in combination with other DRUG2 .
4	4	0.0802164 0.0714172 0.0826324 0.0709896 0.129461 0.0368502 0.0723077 0.108194 0.113251 0.13101 0.10367	The pharmacokinetic interaction between DRUG1 and DRUG2 capsules was investigated .
1	1	0.0575426 0.0364859 0.0855981 0.103004 0.0384563 0.0458112 0.0438178 0.0531117 0.0400201 0.0445564 0.0573804 0.0712891 0.046799 0.0137906 0.0484977 0.0144953 0.0095247 0.0292716 0.0170649 0.0397443 0.0334708 0.0702672	Therefore , DRUG1 capsules should be used with caution in combination with DRUG2 , particularly at doses higher than 0.4 mg .
4	4	0.0451998 0.0245347 0.0164716 0.0161814 0.012555 0.0122297 0.0321893 0.0707246 0.0650051 0.0662735 0.0732582 0.0687898 0.14248 0.0474408 0.0756316 0.0603826 0.0618765 0.108776	Results from limited in vitro and in vivo drug-drug interaction studies between DRUG1 and DRUG2 are inconclusive .
1	1	0.0373397 0.0151065 0.0350845 0.0428247 0.0549474 0.0544556 0.0692767 0.0413839 0.0493103 0.0618189 0.123619 0.0564753 0.106877 0.106422 0.145058	Therefore , caution should be exercised with concomitant administration of DRUG1 and DRUG2 capsules .
4	4	0.0703862 0.0622683 0.052037 0.0307171 0.0333826 0.0352377 0.0335547 0.0351094 0.0556627 0.0539523 0.0565548 0.0334808 0.0196681 0.0438886 0.0242457 0.0136283 0.0372209 0.0164356 0.0120408 0.0251495 0.0105546 0.0220877 0.0186393 0.0218302 0.0264688 0.0362995 0.0314664 0.0272837 0.0607487	Acromegalic patients with diabetes mellitus being treated with DRUG1 and/or oral DRUG2 agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUG0 .
2	1	0.0573148 0.0502014 0.040805 0.0266011 0.0310194 0.0373017 0.0367326 0.0384823 0.0331567 0.0164876 0.0184481 0.0143681 0.0183019 0.0585824 0.0285376 0.0159934 0.0472842 0.032435 0.0255118 0.0425568 0.0239733 0.0345915 0.0336647 0.0274194 0.0433287 0.0383118 0.0468374 0.0372801 0.0444711	Acromegalic patients with diabetes mellitus being treated with DRUG1 and/or oral DRUG0 agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUG2 .
2	1	0.0295688 0.0264342 0.0245492 0.0194586 0.0226092 0.0316349 0.0370336 0.0277167 0.033201 0.0483528 0.050228 0.0569814 0.0177043 0.0649854 0.0239683 0.0139885 0.0425454 0.0304877 0.0257074 0.0405776 0.0237165 0.0350631 0.0343924 0.0274342 0.0435285 0.038692 0.0474924 0.037624 0.0443239	Acromegalic patients with diabetes mellitus being treated with DRUG0 and/or oral DRUG1 agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUG2 .
4	3	0.0324882 0.0226002 0.0180762 0.00980938 0.0350636 0.0378701 0.0509647 0.0302947 0.0310668 0.108424 0.106314 0.0544026 0.0422255 0.0228488 0.0478198 0.0357404 0.0358724 0.0354622 0.026115 0.0243571 0.021331 0.0312404 0.0360272 0.0356142 0.0679711	In clinical studies , patients on DRUG1 often needed higher serum DRUG2 concentrations to achieve appropriate IGF-I suppression compared with patients not receiving DRUG0 .
4	4	0.0122553 0.00751254 0.00552195 0.00286702 0.00961423 0.00863378 0.0166886 0.0230475 0.0252128 0.0847745 0.0716993 0.0768347 0.0557181 0.0296252 0.0499785 0.0461619 0.0756734 0.0885474 0.0555342 0.04439 0.024817 0.0467128 0.0479675 0.0404588 0.049753	In clinical studies , patients on DRUG0 often needed higher serum DRUG1 concentrations to achieve appropriate IGF-I suppression compared with patients not receiving DRUG2 .
4	4	0.0923884 0.153321 0.0892928 0.0718854 0.118091 0.0350508 0.0746627 0.065417 0.10216 0.0975289 0.100202	Distinct synergistic action of DRUG1 and DRUG2 against Pseudomonas aeruginosa .
4	4	0.0312265 0.0253327 0.0203402 0.0392189 0.064173 0.064314 0.10298 0.029023 0.0201981 0.0145047 0.0124705 0.016532 0.024086 0.0176967 0.0271395 0.00862162 0.0065864 0.0293049 0.0102215 0.0185293 0.0295179 0.0598401 0.061973 0.0558609 0.032883 0.0672716 0.0250341 0.0335567 0.0515626	Results revealed that the strains were resistant to many drugs at high levels , only DRUG0 , DRUG1 , DRUG0 and DRUG2 showed resistances at comparatively lower levels .
4	4	0.0262161 0.0209804 0.0166038 0.0316579 0.0520715 0.0538065 0.0822324 0.0197878 0.0122094 0.00836076 0.00778127 0.010778 0.017542 0.0118841 0.0253113 0.00708417 0.00471037 0.0124791 0.0207234 0.124431 0.0388231 0.0647476 0.0643246 0.059372 0.0332641 0.0679976 0.0244015 0.0316706 0.0487477	Results revealed that the strains were resistant to many drugs at high levels , only DRUG0 , DRUG0 , DRUG1 and DRUG2 showed resistances at comparatively lower levels .
4	2	0.0283684 0.0138499 0.0553772 0.0530203 0.0671092 0.0496219 0.068021 0.0537885 0.0969918 0.0297119 0.059089 0.0451755 0.0800917 0.10591 0.0537833 0.0286856 0.0225968 0.0137872 0.00868495 0.0165087 0.0167307 0.0330968	Distinct and statistically significant synergism was observed between DRUG1 and DRUG2 by disc diffusion tests when compared with their individual effects .
2	2	0.158301 0.0969846 0.0832293 0.0821719 0.0849167 0.0756122 0.0707429 0.089885 0.0902637 0.0392366 0.0115379 0.0252844 0.0918337	Synergism was also noted when DRUG1 was combined with DRUG2 and DRUG0 .
2	2	0.173368 0.0991153 0.0780355 0.0699758 0.0702046 0.0653409 0.0584539 0.0839744 0.059725 0.0317139 0.0323437 0.0778324 0.0999163	Synergism was also noted when DRUG1 was combined with DRUG0 and DRUG2 .
4	4	0.119963 0.0555428 0.0424035 0.0293103 0.0410648 0.0482309 0.0610668 0.101972 0.1233 0.134237 0.0356675 0.0953855 0.111856	Synergism was also noted when DRUG0 was combined with DRUG1 and DRUG2 .
2	3	0.0278774 0.021877 0.0220417 0.0189435 0.0225901 0.0219047 0.0232536 0.0388287 0.0492673 0.0277948 0.035106 0.0288247 0.0539969 0.0199435 0.0274006 0.0465169 0.040361 0.0373403 0.0448162 0.0484779 0.0484663 0.03364 0.0361707 0.0416154 0.0266753 0.0108777 0.0182088 0.0166965 0.0125672 0.0214566 0.0192244 0.0239676 0.0332709	In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving DRUG1 , treatment with DRUG2 once weekly for 4 weeks was associated with a mean increase of 16% in DRUG0 AUC;
4	4	0.0193632 0.012655 0.0128084 0.00982681 0.00863199 0.00850234 0.00784398 0.0130077 0.0172059 0.0146374 0.0224276 0.0198332 0.0158697 0.019495 0.0468431 0.0828222 0.0732138 0.0478436 0.0253116 0.0259334 0.0362472 0.0304585 0.0326686 0.0512456 0.0385915 0.0214592 0.037752 0.0293696 0.0327433 0.0495111 0.0520196 0.0470087 0.0368492	In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving DRUG0 , treatment with DRUG1 once weekly for 4 weeks was associated with a mean increase of 16% in DRUG2 AUC;
2	2	0.158402 0.0788565 0.0978066 0.0796881 0.0842134 0.104927 0.158149 0.136913 0.101045	DRUG1 competitively inhibits the intracellular phosphorylation of DRUG2 .
1	1	0.0742261 0.0491553 0.0661846 0.099148 0.077657 0.124053 0.0878367 0.117275 0.0743914 0.0393576 0.0473463 0.052114 0.0912543	Therefore , use of DRUG1 in combination with DRUG2 should be avoided .
3	2	0.0449896 0.0290452 0.0399956 0.0298184 0.0226283 0.0521219 0.0867637 0.0624098 0.0629378 0.0361943 0.0404814 0.0996389 0.0555482 0.0686469 0.0714832 0.071361 0.0395043 0.00997453 0.0163756 0.0600813	In vitro data indicate that the phosphorylation of DRUG1 is also inhibited at relevant concentrations by DRUG2 and DRUG0 .
3	2	0.0463182 0.0297662 0.0410442 0.0306075 0.0226617 0.052356 0.0877012 0.0643854 0.0643988 0.0359662 0.0421328 0.104147 0.0544309 0.0530564 0.0563792 0.0402897 0.0199926 0.0219545 0.0560427 0.0763687	In vitro data indicate that the phosphorylation of DRUG1 is also inhibited at relevant concentrations by DRUG0 and DRUG2 .
4	4	0.0178937 0.00941735 0.0118967 0.0112725 0.00558298 0.0096607 0.0238038 0.0118894 0.0248941 0.0330625 0.0510605 0.125848 0.0569829 0.0880763 0.0900281 0.0884528 0.13856 0.0296325 0.0777615 0.0942244	In vitro data indicate that the phosphorylation of DRUG0 is also inhibited at relevant concentrations by DRUG1 and DRUG2 .
2	4	0.0109999 0.0100255 0.0110884 0.00702054 0.00870022 0.0354791 0.0240806 0.0442936 0.014142 0.00744903 0.0166437 0.0272628 0.0343161 0.0417725 0.0324077 0.0358647 0.0158867 0.059671 0.0134307 0.0470262 0.0306862 0.0121966 0.0361437 0.0711929 0.0304438 0.0235288 0.0207444 0.036782 0.0298426 0.0194747 0.0197616 0.0177336 0.0220601 0.0285812 0.0147189 0.0292465 0.0280335 0.0312677	In the present study , we tested whether the highly specific metabotropic glutamate receptor 5 antagonist , DRUG1 , reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of DRUG2 .
4	4	0.0451984 0.0544291 0.0448043 0.0325865 0.0292552 0.0300069 0.0326275 0.0341645 0.0159791 0.0337712 0.0309862 0.0269879 0.0331438 0.0322031 0.03991 0.019438 0.00964645 0.0129204 0.00510104 0.011572 0.0135727 0.0236876 0.0368726 0.0343427 0.0151823 0.0207305 0.0336829 0.0146405 0.0104435 0.0103882 0.00793327 0.0068663 0.00533315 0.00750775 0.00822689 0.0033662 0.00574544 0.00514494 0.0143672 0.0247992 0.0282304 0.0422493 0.0519545	Weekly intramuscular DRUG1 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG2 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG0 / DRUG0 versus DRUG0 /vehicle) .
4	4	0.0338454 0.0421713 0.0315882 0.0218208 0.0166089 0.0163017 0.0160379 0.0135324 0.00573134 0.01344 0.0131632 0.0132943 0.0171733 0.0156483 0.0111851 0.00646965 0.00277206 0.0116193 0.0037701 0.00997825 0.0148787 0.0266783 0.0423361 0.0454595 0.0229727 0.0298793 0.0594367 0.0281852 0.0172166 0.0168055 0.0169152 0.0173476 0.0194551 0.0335072 0.0272764 0.00869279 0.00946992 0.0139269 0.0260078 0.0331392 0.0386961 0.0697158 0.0658502	Weekly intramuscular DRUG1 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG0 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG0 / DRUG2 versus DRUG0 /vehicle) .
4	4	0.0313303 0.0493538 0.0411096 0.0520425 0.0426305 0.0225008 0.0129964 0.0108245 0.00502763 0.0101577 0.0132805 0.0147811 0.0170009 0.0133399 0.0134538 0.0123267 0.00820939 0.0162959 0.00630395 0.0134002 0.0138744 0.0188745 0.0309248 0.0288555 0.022489 0.0295565 0.0534506 0.0252852 0.0196021 0.0190699 0.0177 0.0176429 0.0193018 0.0403415 0.0363351 0.0112422 0.0141228 0.00635084 0.0114697 0.0273647 0.0289687 0.0479245 0.0528866	Weekly intramuscular DRUG0 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG1 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG2 / DRUG0 versus DRUG0 /vehicle) .
4	4	0.0326211 0.0513758 0.0427684 0.0540607 0.0442082 0.0233105 0.0134657 0.0112307 0.00522396 0.0105367 0.0137594 0.0152973 0.0175507 0.0137387 0.0138168 0.0126312 0.00833657 0.0162723 0.00633427 0.0129104 0.01296 0.0182686 0.0291755 0.0267585 0.0176791 0.0241855 0.0407614 0.0180372 0.0139201 0.0136877 0.0101927 0.00901183 0.00697367 0.0107958 0.0130808 0.00516704 0.00796841 0.0105445 0.060763 0.0841508 0.0539514 0.0421325 0.0503844	Weekly intramuscular DRUG0 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG1 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG0 / DRUG0 versus DRUG2 /vehicle) .
4	4	0.0277831 0.0424259 0.034167 0.0385738 0.0278745 0.0141144 0.00823363 0.00655425 0.00290583 0.00602333 0.00746407 0.00761342 0.0119016 0.0103905 0.00711991 0.00466574 0.00196933 0.00810419 0.00288233 0.00776297 0.0120192 0.0221183 0.0356547 0.039534 0.0204855 0.0269925 0.0555625 0.0256498 0.0155693 0.0158809 0.0149708 0.0145349 0.016255 0.0376205 0.032496 0.0189657 0.0479865 0.0353426 0.0265274 0.039917 0.0390191 0.0702174 0.0581503	Weekly intramuscular DRUG0 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG0 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG1 / DRUG2 versus DRUG0 /vehicle) .
4	4	0.0291034 0.0443665 0.0356599 0.04003 0.0288268 0.014645 0.00858234 0.00684152 0.00304581 0.00629143 0.00781555 0.00793812 0.0123538 0.0107822 0.00735029 0.00486043 0.00201781 0.00820953 0.00287386 0.00748025 0.011066 0.0205302 0.0316384 0.0361509 0.0169202 0.0231744 0.0484342 0.0231094 0.0150244 0.0172754 0.0145575 0.0126746 0.0121097 0.0201578 0.0204022 0.0129558 0.0183109 0.0365079 0.0974648 0.0770711 0.0543167 0.0438099 0.0472631	Weekly intramuscular DRUG0 injections (0.2-0.5 mg/kg body weight) , in combination with daily administration of DRUG0 or vehicle , were performed until the development of parkinsonian motor symptoms in either of the two experimental groups ( DRUG0 / DRUG1 versus DRUG2 /vehicle) .
4	4	0.0517223 0.0381768 0.0372986 0.045825 0.055607 0.0243893 0.0103381 0.0264161 0.0296606 0.0528136 0.0414344 0.0417029 0.0317714 0.0278226 0.0146514 0.0458082 0.0319832 0.0328584 0.0286626 0.019586 0.0257091 0.0358218 0.0294993 0.0332718 0.0382501 0.0601875 0.0393102 0.0494217	After 21 weeks of DRUG1 treatment , all DRUG0 /vehicle-treated animals displayed parkinsonian symptoms , whereas none of the DRUG0 / DRUG2 -treated monkeys were significantly affected .
4	4	0.0301701 0.0147825 0.0221766 0.0189782 0.0192187 0.0350371 0.0511197 0.0909802 0.0989375 0.0448298 0.0276029 0.0300691 0.0224224 0.0203152 0.0123267 0.0392761 0.0303943 0.0317032 0.027511 0.0183862 0.0249012 0.0343424 0.0295048 0.0337806 0.0392081 0.0620454 0.0401313 0.0498489	After 21 weeks of DRUG0 treatment , all DRUG1 /vehicle-treated animals displayed parkinsonian symptoms , whereas none of the DRUG0 / DRUG2 -treated monkeys were significantly affected .
4	2	0.0231737 0.0101402 0.0126825 0.00900499 0.0115144 0.0108352 0.00443712 0.0101893 0.0225855 0.0447712 0.0369051 0.0425733 0.0301094 0.0256922 0.0123298 0.0433822 0.035888 0.0427546 0.0522433 0.0698942 0.074136 0.0452314 0.0425104 0.0393274 0.0475096 0.0864312 0.0519366 0.0618109	After 21 weeks of DRUG0 treatment , all DRUG0 /vehicle-treated animals displayed parkinsonian symptoms , whereas none of the DRUG1 / DRUG2 -treated monkeys were significantly affected .
4	2	0.00847623 0.0169432 0.0266001 0.0166169 0.0204368 0.014814 0.00783722 0.0114111 0.0128618 0.0135172 0.0147667 0.029146 0.0247955 0.0175062 0.00955587 0.00269421 0.00402361 0.0104126 0.00495009 0.00608505 0.0101007 0.00532772 0.00839721 0.0120184 0.00825829 0.00265056 0.00403497 0.0099949 0.00471972 0.0164168 0.0231444 0.0213493 0.0112476 0.0176109 0.0164503 0.00592774 0.0102696 0.0103589 0.0154637 0.00858071 0.0184951 0.0123168 0.0130421 0.0349185 0.0565803 0.0452186 0.0700244 0.056807 0.029128 0.017603 0.0135437 0.00983979 0.0133871 0.0165842 0.0301447 0.0210922 0.0455012	These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post-mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in DRUG1 / DRUG2 -treated animals than in DRUG0 /vehicle-treated monkeys .
4	4	0.00851633 0.0170238 0.0267281 0.0166954 0.0205345 0.014885 0.00787412 0.0114653 0.0129247 0.0135842 0.0148369 0.0292879 0.0249126 0.0175938 0.00960916 0.00271041 0.00405139 0.0104851 0.00498184 0.00612261 0.0101797 0.00535883 0.00845599 0.0121114 0.00833577 0.00267125 0.00406894 0.0100793 0.00474488 0.0165497 0.0234739 0.0219024 0.0116062 0.0182645 0.0171928 0.00625205 0.0111221 0.0116422 0.0175679 0.0115972 0.0270312 0.0160451 0.0124646 0.0212681 0.0229683 0.0184289 0.0222224 0.0230662 0.0458608 0.0325277 0.0282258 0.0274142 0.0529467 0.0343534 0.0311158 0.0273466 0.0487141	These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post-mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in DRUG0 / DRUG1 -treated animals than in DRUG2 /vehicle-treated monkeys .
2	2	0.046891 0.0436693 0.016548 0.0262025 0.030777 0.0300517 0.0419463 0.0351518 0.0471777 0.0611424 0.0545604 0.0651994 0.0594024 0.0315322 0.0441083 0.0374561 0.0258071 0.0239216 0.025293 0.0238617 0.00751856 0.0264513 0.0218852 0.00729247 0.0171359 0.0270768 0.0484844 0.0321743 0.0412812	The DRUG1 treatment also had a significant effect on the DRUG2 -induced loss of norepinephrine neurons in the locus coeruleus and adjoining A5 and A7 noradrenaline cell groups .
4	4	0.0342516 0.0412048 0.0177565 0.0142315 0.0076983 0.0201284 0.0292688 0.0215773 0.0132989 0.0202099 0.0225248 0.0358815 0.0372245 0.0193452 0.0136531 0.00922623 0.0147603 0.0124261 0.0163844 0.0294276 0.0183522 0.00618743 0.0182896 0.0191997 0.0210807 0.0244155 0.0646445 0.0455984 0.0217366 0.0128286 0.0176507 0.0669443 0.0420878 0.0276418 0.0139729 0.0134798 0.0132667 0.0178553 0.0256735 0.0183331 0.0198713 0.0404098	In DRUG1 /vehicle-treated animals , almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than 15% of control values in DRUG0 / DRUG2 -treated monkeys .
4	2	0.0117318 0.0129364 0.0131289 0.00809358 0.00509302 0.0209889 0.0374464 0.0306831 0.0123599 0.0154744 0.0172904 0.0334718 0.0339769 0.0169569 0.0139845 0.00909832 0.0158558 0.0134052 0.0173195 0.030676 0.0190946 0.00648272 0.0192334 0.019687 0.0214929 0.0246669 0.0623324 0.0439198 0.0191113 0.00978909 0.00949369 0.0414837 0.0318197 0.0278701 0.0267846 0.0322878 0.0484472 0.0433831 0.0294786 0.0253488 0.0235226 0.0442981	In DRUG0 /vehicle-treated animals , almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than 15% of control values in DRUG1 / DRUG2 -treated monkeys .
2	2	0.0364174 0.0300052 0.049043 0.0142163 0.0117524 0.0131466 0.0168195 0.017494 0.0226373 0.0394964 0.0557393 0.0393809 0.042167 0.0175894 0.0831015 0.0269207 0.052067 0.0717634 0.0425556 0.0346952 0.0763214 0.0410229 0.0134099 0.0263805 0.0489463 0.0209836 0.00873416 0.00801568 0.0105277 0.0286497	Our data demonstrate that chronic treatment with the metabotropic glutamate receptor 5 antagonist , DRUG1 , significantly reduces DRUG2 toxicity towards dopaminergic and noradrenergic cell groups in non-human primates .
4	4	0.0385191 0.017761 0.047612 0.0403106 0.0372205 0.0502093 0.0251185 0.0432183 0.0355693 0.0251394 0.0438622 0.0231955 0.0132856 0.00649408 0.00547271 0.0106825 0.0051795 0.00734186 0.00653161 0.0107075 0.00851377 0.00449207 0.00229728 0.00487117 0.00578097 0.00951813 0.01278 0.00870086 0.0069034 0.0129007 0.018919 0.0180955 0.00837354 0.0147504 0.0180799 0.02186 0.0417586 0.0268259 0.0291985 0.00518024 0.0132121 0.00596587 0.00671365 0.0192991 0.00401262 0.00678788 0.00916842 0.0144051 0.0127755 0.0146023 0.0147497 0.0231936 0.0171396 0.0207666 0.0439772	DRUG1 : Absorption of a single dose of DRUG2 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG0 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.0362389 0.0089096 0.0206456 0.0117421 0.0104225 0.0258498 0.00955705 0.0154209 0.0188499 0.0210214 0.0397408 0.0206558 0.0205499 0.0118414 0.012271 0.0240983 0.017329 0.0292421 0.0247814 0.0501004 0.0404602 0.0157181 0.00581485 0.00546227 0.00889473 0.0124033 0.0167024 0.0101331 0.00765109 0.0137204 0.0206703 0.0212024 0.00914494 0.0160247 0.0191363 0.0234328 0.0434272 0.0271059 0.028117 0.00505301 0.0128117 0.00580624 0.00647921 0.0188229 0.00389251 0.00656513 0.00888034 0.0139723 0.0124236 0.0142284 0.0143649 0.0225809 0.0166927 0.0202099 0.0427265	DRUG1 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG2 - DRUG0 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.0354021 0.00870617 0.0202199 0.0115054 0.010229 0.0254197 0.00937723 0.0151933 0.0186711 0.0210146 0.0402639 0.020906 0.0209812 0.0123138 0.0129841 0.0255021 0.0180149 0.0275644 0.0201314 0.0445132 0.0251237 0.0131504 0.0169856 0.0185791 0.0157927 0.014489 0.0200332 0.0122536 0.00880456 0.0141029 0.0203925 0.0202728 0.00888815 0.0155377 0.0185558 0.0226216 0.0419667 0.0261124 0.0274481 0.0049169 0.0125605 0.00567057 0.00633024 0.0183988 0.00379716 0.00640399 0.00864977 0.013602 0.012108 0.0138681 0.0140076 0.0220204 0.0162782 0.0197067 0.041657	DRUG1 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG2 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.0330728 0.00762175 0.0172535 0.00958606 0.00833351 0.020192 0.00716505 0.0110476 0.0135201 0.0136421 0.0236583 0.0103275 0.00913959 0.0049823 0.00452245 0.00790723 0.00399052 0.00552682 0.00426567 0.00857178 0.00678862 0.00391622 0.00206006 0.00434199 0.00530558 0.00864923 0.0115617 0.00799077 0.00650022 0.0131893 0.0196674 0.0184354 0.0086372 0.0165059 0.0218703 0.0285841 0.0546752 0.0353923 0.0438591 0.00870887 0.0296825 0.0125706 0.0141736 0.0525287 0.0156574 0.0345814 0.0591381 0.0353669 0.0259534 0.0244974 0.034901 0.0269416 0.0249133 0.0225123 0.0356158	DRUG1 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG0 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG2 was administered alone under fasting conditions .
3	3	0.0108328 0.0115504 0.0205801 0.0191817 0.0214981 0.0376274 0.021535 0.0292501 0.0308592 0.0216389 0.0501638 0.0169834 0.016495 0.0137319 0.0134482 0.0264665 0.0189319 0.0314398 0.0213677 0.0431003 0.0408501 0.0130783 0.00536181 0.0064738 0.00980209 0.0128227 0.0155045 0.0091576 0.00691393 0.0119691 0.018011 0.0184045 0.00807285 0.0138966 0.0162062 0.0198983 0.0375021 0.0248597 0.0263142 0.00467624 0.0118406 0.00535056 0.00601529 0.0172758 0.00359918 0.006082 0.0082511 0.0130024 0.0114778 0.0131326 0.0132396 0.0208139 0.0153693 0.0186279 0.0394643	DRUG0 : Absorption of a single dose of DRUG1 was decreased when administered to 12 stable renal transplant patients also taking DRUG2 - DRUG0 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
3	3	0.0106847 0.0111327 0.0197338 0.0182354 0.0202544 0.0353381 0.019987 0.0271102 0.0281627 0.0202413 0.0462622 0.0157403 0.0152372 0.0124507 0.0124949 0.0237826 0.0179405 0.0262519 0.0190793 0.0418295 0.0302313 0.0156508 0.0184058 0.0191304 0.0159255 0.015155 0.0190609 0.0115977 0.0082824 0.012952 0.0188343 0.0186775 0.00825389 0.0141606 0.0164962 0.0201377 0.0376058 0.0246868 0.026255 0.00465057 0.0118207 0.00532577 0.00598751 0.0171684 0.00357296 0.00603832 0.00818222 0.0128802 0.0113744 0.0130123 0.0131211 0.0206255 0.0152296 0.0184583 0.0391032	DRUG0 : Absorption of a single dose of DRUG1 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG2 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
3	4	0.0105886 0.0107795 0.0189899 0.0174413 0.0193333 0.0339016 0.0189489 0.0255777 0.025809 0.0191187 0.0423397 0.0146476 0.0140811 0.0114427 0.0115424 0.0212729 0.0161981 0.0232057 0.0185961 0.0390394 0.0277453 0.0122203 0.0085904 0.0181901 0.0353715 0.0305829 0.0252884 0.0124331 0.0090232 0.0132105 0.0190808 0.0192514 0.00820282 0.0141125 0.016568 0.020542 0.0381394 0.0251683 0.0262457 0.00466514 0.0118032 0.00534242 0.0059882 0.0172302 0.00358721 0.0060537 0.00820979 0.012922 0.0114204 0.0130638 0.0131694 0.0206985 0.0152858 0.0185208 0.0392186	DRUG0 : Absorption of a single dose of DRUG1 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG0 containing DRUG2 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.00854105 0.00658138 0.0113171 0.00731138 0.00762868 0.0201995 0.00813993 0.0133734 0.0162006 0.018323 0.0392301 0.0203079 0.0208133 0.0119534 0.0124267 0.0228028 0.013679 0.020887 0.0179338 0.0325445 0.0263186 0.030121 0.0160966 0.0240228 0.0509401 0.0330422 0.0256067 0.0128463 0.0100272 0.0160076 0.0230344 0.0214829 0.00876798 0.0151082 0.0184217 0.0228673 0.0426568 0.0267064 0.0273638 0.00491191 0.0123928 0.00563602 0.00627621 0.0182474 0.00377463 0.00635944 0.0086024 0.0135286 0.0120321 0.0137785 0.0139035 0.0218608 0.0161559 0.019559 0.0413474	DRUG0 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG1 - DRUG0 containing DRUG2 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.00692486 0.00528725 0.00896223 0.00571942 0.00589688 0.0153859 0.00610319 0.00974262 0.0119197 0.0128696 0.0265096 0.0131398 0.012877 0.00711772 0.00713838 0.0134374 0.00755898 0.0122245 0.0115893 0.0226431 0.0219396 0.0179959 0.00821034 0.00670523 0.014811 0.0179244 0.027293 0.012715 0.00843378 0.0142505 0.0205448 0.0193346 0.0083729 0.0155338 0.019764 0.0261972 0.048074 0.0315043 0.0378922 0.00757426 0.0257735 0.0109566 0.0123362 0.0456464 0.0136647 0.0301474 0.051552 0.0308087 0.0227536 0.0214963 0.0305775 0.0235821 0.0217867 0.019684 0.0311161	DRUG0 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG1 - DRUG0 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG2 was administered alone under fasting conditions .
4	4	0.00794237 0.0060815 0.0104316 0.0066748 0.00689632 0.0181646 0.00720562 0.0115696 0.0142805 0.0158446 0.034086 0.0173714 0.0180906 0.0103398 0.0108213 0.0219081 0.0140753 0.0239484 0.0215126 0.0409511 0.0294813 0.0195858 0.0188658 0.0430604 0.076363 0.0317039 0.0235416 0.0119313 0.00993507 0.0164918 0.0232222 0.0206225 0.00832839 0.0142804 0.0174215 0.0215511 0.0400782 0.0249515 0.0255477 0.00459497 0.0116084 0.0052868 0.00588325 0.0171217 0.00353977 0.00596419 0.00806746 0.0126848 0.0112897 0.0129297 0.013048 0.0205123 0.0151628 0.0183546 0.0387918	DRUG0 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG1 containing DRUG2 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG0 was administered alone under fasting conditions .
4	4	0.00673051 0.00515141 0.00877774 0.00560869 0.0057811 0.0151477 0.00598567 0.0095878 0.0118847 0.0131788 0.0276783 0.0138085 0.0139768 0.00788849 0.00811275 0.0157727 0.00937657 0.0149368 0.0132737 0.0279908 0.0184221 0.00959241 0.00901469 0.0186509 0.020312 0.0158323 0.0275245 0.0124161 0.0087879 0.0150077 0.0208582 0.0186925 0.00797927 0.0146445 0.0184898 0.0246627 0.0450871 0.0301153 0.0365065 0.00727768 0.0249812 0.0106023 0.0119432 0.0441811 0.0132401 0.029206 0.0499035 0.0298223 0.0220501 0.0208216 0.0296111 0.0228313 0.021095 0.0190602 0.0301273	DRUG0 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG1 containing DRUG0 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG2 was administered alone under fasting conditions .
4	4	0.00655744 0.00505658 0.0085615 0.0055007 0.00569412 0.0149285 0.00590336 0.0094496 0.0114435 0.0124989 0.0262359 0.0131111 0.0132988 0.00749431 0.00779594 0.0152771 0.00904843 0.0147712 0.0137816 0.0272017 0.0185936 0.0108431 0.00831586 0.017678 0.0293865 0.0385511 0.0258175 0.00909645 0.0078978 0.0150957 0.0214479 0.0176364 0.00751589 0.0132508 0.0167672 0.0224588 0.0429098 0.0293233 0.0358085 0.00715094 0.0242428 0.0103336 0.0116685 0.0431646 0.0129468 0.0285801 0.0488298 0.0291794 0.0215506 0.020347 0.028942 0.0223234 0.0206291 0.0186388 0.0294682	DRUG0 : Absorption of a single dose of DRUG0 was decreased when administered to 12 stable renal transplant patients also taking DRUG0 - DRUG0 containing DRUG1 (30 mL) : the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower , respectively , than when DRUG2 was administered alone under fasting conditions .
1	1	0.0711948 0.0706679 0.0539754 0.0626534 0.141567 0.0505703 0.0831822 0.0839929 0.0737408 0.0576117 0.106278 0.144566	It is recommended that DRUG1 and DRUG2 not be administered simultaneously .
4	4	0.0584309 0.0165944 0.0635882 0.0384778 0.0136715 0.0124837 0.0068745 0.00807959 0.00574151 0.00422056 0.0114754 0.0128843 0.0703543 0.0859474 0.0650717 0.0369937 0.0500909 0.0344723 0.0570636 0.062804 0.0596424 0.0732579 0.0715747 0.0802046	DRUG1 : When studied in stable renal transplant patients , DRUG0 , USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of DRUG2 .
4	4	0.015678 0.0186231 0.0573213 0.0363255 0.0205727 0.0270473 0.0260727 0.0465631 0.0327308 0.0140503 0.06964 0.0176797 0.0453771 0.0518093 0.0410159 0.0418877 0.0632904 0.0448381 0.051446 0.0501089 0.048176 0.065291 0.0570332 0.057422	DRUG0 : When studied in stable renal transplant patients , DRUG1 , USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of DRUG2 .
4	4	0.202437 0.12985 0.0993666 0.0572955 0.109019 0.0978535 0.146248 0.0652948 0.0529236 0.0397129	DRUG1 / DRUG2 : may be taken with DRUG0 ;
4	4	0.110429 0.0484349 0.0272787 0.0471349 0.163663 0.139856 0.170302 0.159242 0.0981178 0.0355408	DRUG1 / DRUG0 : may be taken with DRUG2 ;
4	4	0.0407557 0.0375079 0.0938657 0.0474044 0.170876 0.139929 0.176506 0.159057 0.0987637 0.0353345	DRUG0 / DRUG1 : may be taken with DRUG2 ;
4	4	0.0977478 0.0703841 0.0444769 0.02839 0.00695409 0.0153015 0.0332987 0.0232733 0.050557 0.0301676 0.0232543 0.0208697 0.0213054 0.0183899 0.0278791 0.00785231 0.0223461 0.082461 0.0606337 0.0507952 0.0202782 0.0186505 0.0120372 0.00834043 0.0291616 0.0349772 0.0170274 0.0144935 0.0179849 0.01309 0.0121735 0.015382 0.050066	Both DRUG1 / DRUG2 and DRUG0 concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
4	4	0.073013 0.0534014 0.0350698 0.0167469 0.0205058 0.0406074 0.0494505 0.0322013 0.0651154 0.040688 0.0275152 0.0215649 0.0228533 0.0182551 0.0261903 0.00727278 0.0202097 0.0749003 0.0558344 0.0473595 0.0191015 0.0176 0.0113941 0.00797405 0.0278043 0.0335441 0.0161798 0.0137378 0.0170848 0.0124465 0.0115541 0.0146991 0.048125	Both DRUG1 / DRUG0 and DRUG2 concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
4	4	0.061868 0.0516108 0.0638012 0.124211 0.0288829 0.044115 0.0430324 0.0278039 0.0537809 0.0323435 0.0218814 0.0171416 0.0178537 0.0143357 0.021238 0.00584686 0.016123 0.0608548 0.0452504 0.0388284 0.015758 0.0145307 0.00942163 0.00664979 0.0231276 0.0280372 0.013445 0.0113999 0.0142041 0.0103547 0.00960153 0.0122738 0.0403927	Both DRUG0 / DRUG1 and DRUG2 concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
4	4	0.119998 0.0756997 0.0731059 0.049465 0.123809 0.0317763 0.0338755 0.0165406 0.0382063 0.0669224 0.0284918 0.0385996 0.0129637 0.0127138 0.0109137 0.0145479 0.00851177 0.0102164 0.0143471 0.0123371 0.014591 0.0204122 0.0206328 0.0157981 0.00972926 0.0319766 0.093819	DRUG1 / DRUG2 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.0639785 0.0353411 0.0201288 0.0406938 0.20727 0.0770448 0.0551221 0.0506644 0.0830976 0.051998 0.0384864 0.0456868 0.0120927 0.0105506 0.00815261 0.0101091 0.00732303 0.00782385 0.0109493 0.00959976 0.011228 0.0155544 0.0153939 0.011643 0.00713019 0.023241 0.0696959	DRUG1 / DRUG0 : Given that DRUG0 and DRUG2 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.0427002 0.0174411 0.0128514 0.0215406 0.0820242 0.0223839 0.0253624 0.0135601 0.0375863 0.0781644 0.0455266 0.0582386 0.024477 0.0331412 0.0353604 0.0323891 0.0412635 0.0302907 0.0301461 0.037526 0.0410561 0.0519579 0.0327001 0.0160804 0.00986823 0.0310398 0.0953233	DRUG1 / DRUG0 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG2 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.04555 0.0181774 0.0133961 0.022453 0.0825423 0.0221062 0.026189 0.0137677 0.0376964 0.0739849 0.0391685 0.0479335 0.0189425 0.0180854 0.0136196 0.0171494 0.0108293 0.0176812 0.0319256 0.0411841 0.0592949 0.0647315 0.0631945 0.0246408 0.0257463 0.0584436 0.0915663	DRUG1 / DRUG0 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG2 .
4	4	0.0220393 0.0257051 0.0536637 0.0409265 0.284109 0.114572 0.0682222 0.0170012 0.0244877 0.0474685 0.0306468 0.0411106 0.0112916 0.0105696 0.0086569 0.010497 0.007138 0.00779926 0.0107866 0.00948432 0.0110435 0.0153341 0.015244 0.011615 0.0071472 0.0233726 0.0700674	DRUG0 / DRUG1 : Given that DRUG2 and DRUG0 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.0218414 0.0196525 0.0460728 0.0232268 0.0850856 0.0227461 0.0257891 0.0137065 0.0368984 0.0724934 0.0408396 0.0553457 0.0234587 0.0320546 0.0344413 0.0323228 0.0411424 0.0302023 0.0297312 0.036921 0.0404359 0.0512837 0.0324494 0.0160254 0.00985265 0.0309667 0.0950141	DRUG0 / DRUG1 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG2 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.0211233 0.0186169 0.0439626 0.0215876 0.0776776 0.0201884 0.0237214 0.0121577 0.0324934 0.0599137 0.0296935 0.0401366 0.0163732 0.0169501 0.0142057 0.0183221 0.0126773 0.0202001 0.0387898 0.0503369 0.0728332 0.0712182 0.107396 0.0455731 0.0206206 0.0198901 0.0733412	DRUG0 / DRUG1 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG2 or DRUG0 .
3	4	0.014022 0.00990927 0.013352 0.0302742 0.156165 0.071839 0.141683 0.0366443 0.0835698 0.0676815 0.0508288 0.0504019 0.0148255 0.0140968 0.0104573 0.0127187 0.0102624 0.0101422 0.0134559 0.0116231 0.0134782 0.0182971 0.0180459 0.0135416 0.00808179 0.0263285 0.0782751	DRUG0 / DRUG0 : Given that DRUG1 and DRUG2 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.00683881 0.00440414 0.00984843 0.022066 0.168488 0.0834675 0.0832844 0.0199359 0.0383448 0.0720422 0.0351585 0.0382243 0.015387 0.0191269 0.0225811 0.0232856 0.0327044 0.0248329 0.0288126 0.0337745 0.035362 0.0423573 0.0258189 0.0121344 0.0072534 0.0230724 0.0713941	DRUG0 / DRUG0 : Given that DRUG1 and DRUG0 inhibit purine metabolism , it is recommended that DRUG2 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.0071173 0.00454698 0.010176 0.0227234 0.173731 0.0850123 0.0846925 0.020122 0.0382749 0.0733756 0.0360003 0.0357596 0.0135153 0.0152815 0.0120045 0.0142851 0.0117646 0.0134855 0.0260566 0.0331227 0.0458144 0.0482579 0.0438641 0.0172592 0.0174523 0.0381179 0.0581863	DRUG0 / DRUG0 : Given that DRUG1 and DRUG0 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG0 or DRUG2 .
4	4	0.00746887 0.00469313 0.0101167 0.0204082 0.112346 0.0564066 0.0454483 0.0302846 0.0793205 0.0951991 0.0398245 0.043702 0.0170794 0.0210928 0.0249382 0.0263654 0.0354396 0.026309 0.0306188 0.0360793 0.0380339 0.0459154 0.028134 0.0133835 0.00801496 0.0252416 0.0781358	DRUG0 / DRUG0 : Given that DRUG0 and DRUG1 inhibit purine metabolism , it is recommended that DRUG2 not be administered concomitantly with DRUG0 or DRUG0 .
4	4	0.00709306 0.00443571 0.00965352 0.0195891 0.108527 0.0538034 0.0432574 0.0285707 0.0752647 0.0871003 0.0375205 0.0379016 0.0141045 0.0158541 0.0133367 0.0170704 0.0138973 0.0166915 0.0333352 0.0438333 0.061491 0.0588268 0.0820089 0.0335653 0.0152688 0.0145452 0.0534545	DRUG0 / DRUG0 : Given that DRUG0 and DRUG1 inhibit purine metabolism , it is recommended that DRUG0 not be administered concomitantly with DRUG2 or DRUG0 .
1	1	0.00704423 0.00371179 0.00695851 0.0125203 0.0477465 0.0139301 0.0168319 0.00941475 0.0262252 0.0512668 0.0285384 0.0419922 0.0204028 0.0404099 0.0455141 0.0372314 0.0422934 0.0676591 0.063587 0.0449889 0.0537353 0.0667749 0.0828958 0.0386165 0.0189878 0.0252599 0.0854625	DRUG0 / DRUG0 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG1 not be administered concomitantly with DRUG2 or DRUG0 .
1	1	0.00824552 0.00435818 0.00817419 0.0147193 0.0559735 0.0164975 0.019904 0.0112342 0.0312817 0.0609495 0.0339908 0.0494241 0.0230896 0.0422472 0.0445139 0.035417 0.0393842 0.0667263 0.0523383 0.0382492 0.0420551 0.0590126 0.0607236 0.0253335 0.024033 0.0555121 0.0766118	DRUG0 / DRUG0 : Given that DRUG0 and DRUG0 inhibit purine metabolism , it is recommended that DRUG1 not be administered concomitantly with DRUG0 or DRUG2 .
4	4	0.0978202 0.0110691 0.0218784 0.0207992 0.0443825 0.0442478 0.020311 0.0123861 0.0212709 0.0258665 0.0440967 0.0444731 0.0453171 0.0394211 0.0839405 0.0534384 0.0755775 0.0584384 0.092583 0.0492505 0.0341563 0.0592756	DRUG1 and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUG2 exposure when coadministered with DRUG0 .
4	4	0.118584 0.0130318 0.0246394 0.0235789 0.0502747 0.0484007 0.0200542 0.00951809 0.0127783 0.0140357 0.0250359 0.0208389 0.0161247 0.00967023 0.0224068 0.0395229 0.0932654 0.081378 0.104027 0.0962079 0.0771064 0.0795198	DRUG1 and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUG0 exposure when coadministered with DRUG2 .
4	4	0.0147424 0.00983396 0.0255043 0.0286184 0.0643226 0.0641128 0.0248726 0.0114264 0.0135861 0.0160679 0.0365497 0.0427514 0.0501322 0.0420902 0.0758009 0.0769484 0.0878669 0.0512243 0.0611593 0.0774753 0.0663889 0.058525	DRUG0 and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUG1 exposure when coadministered with DRUG2 .
1	1	0.0447675 0.0228746 0.0323271 0.0637379 0.0490376 0.110996 0.0700306 0.0271506 0.00991539 0.00688595 0.0110766 0.0125367 0.0500981 0.0345587 0.0201775 0.0117329 0.00835928 0.00433785 0.00699103 0.0085065 0.0308662 0.0263964 0.028377 0.0163796 0.00515563 0.00774578 0.00987676 0.0130184 0.00985155 0.00795602 0.00369103 0.00518011 0.00766695 0.00545888 0.0118071 0.00935701 0.00992372 0.0132051 0.00763078 0.0175899 0.0116982 0.0182827 0.0225411 0.0265565 0.0676895	Therefore , do not administer DRUG1 with DRUG2 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral DRUG0 , because of the potential to reduce the efficacy of DRUG0 .
4	1	0.0202731 0.0134485 0.035438 0.0537861 0.0738413 0.105533 0.0402794 0.0122089 0.00414362 0.00390775 0.00734443 0.00935191 0.0276058 0.0201444 0.0125487 0.00922726 0.00676804 0.00338837 0.0064685 0.00837984 0.0283833 0.0270555 0.0320321 0.0198438 0.00666272 0.0136672 0.0215656 0.0465387 0.0349428 0.0357241 0.0176905 0.0303715 0.0188948 0.00496638 0.00985162 0.00849099 0.00812574 0.00889299 0.00583554 0.0143988 0.0104859 0.0157764 0.0201954 0.0228415 0.062679	Therefore , do not administer DRUG1 with DRUG0 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral DRUG2 , because of the potential to reduce the efficacy of DRUG0 .
4	4	0.0183277 0.0127259 0.0378577 0.0446209 0.0610365 0.081888 0.0722226 0.0239821 0.00600071 0.00434387 0.00841762 0.0103857 0.047596 0.0240263 0.0128076 0.00779828 0.0055164 0.00314102 0.0054977 0.00755998 0.0279559 0.0256534 0.0299058 0.0186772 0.00620218 0.0129801 0.0204073 0.0441993 0.033266 0.0339728 0.0168278 0.0289098 0.0179755 0.00477555 0.00951925 0.00822691 0.00789422 0.00864432 0.00567446 0.0139941 0.0102023 0.015362 0.019675 0.02227 0.0610758	Therefore , do not administer DRUG0 with DRUG1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral DRUG2 , because of the potential to reduce the efficacy of DRUG0 .
4	4	0.0182825 0.0126957 0.0376929 0.0444092 0.0607085 0.0815402 0.0718406 0.0238073 0.00592183 0.0042837 0.00824986 0.0101566 0.0468291 0.023476 0.0124507 0.00752963 0.00529937 0.00294637 0.00502064 0.00648282 0.0238703 0.0204321 0.0227448 0.0134671 0.00411709 0.00641327 0.00823708 0.0113006 0.00861807 0.00685532 0.00282113 0.00416109 0.0068804 0.00599823 0.0140985 0.0143279 0.0171083 0.0210216 0.0136158 0.0323127 0.0474734 0.0348482 0.0564827 0.0537662 0.0594046	Therefore , do not administer DRUG0 with DRUG1 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral DRUG0 , because of the potential to reduce the efficacy of DRUG2 .
4	4	0.00932427 0.00495984 0.0158236 0.0188904 0.0266411 0.0264849 0.0172165 0.00606427 0.00185225 0.00182512 0.00348439 0.00506103 0.0187223 0.0145992 0.00908909 0.00644253 0.00545766 0.00289334 0.00564279 0.00719332 0.0256823 0.0263955 0.0310275 0.0187484 0.00557225 0.0117895 0.0229349 0.0629881 0.0517864 0.0429944 0.0285077 0.0433713 0.0569852 0.0127912 0.016494 0.019543 0.0242399 0.019581 0.0175172 0.0320304 0.0421552 0.0294944 0.0563379 0.0494903 0.043874	Therefore , do not administer DRUG0 with DRUG0 or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral DRUG1 , because of the potential to reduce the efficacy of DRUG2 .
4	4	0.0363559 0.0491676 0.0261478 0.118474 0.0913204 0.0561622 0.0925968 0.0748823 0.0285027 0.00572619 0.00682131 0.00617027 0.00641896 0.0329976 0.0326627 0.0412389 0.0475406 0.0164976 0.020343 0.0513777 0.0273098 0.0232739 0.0190014 0.0263547 0.0626559	Oral DRUG1 : Given the different metabolism of DRUG2 and oral DRUG0 , no drug interaction between these two classes of drug is expected .
4	4	0.013712 0.0108102 0.0175349 0.083953 0.0748307 0.0417212 0.0847676 0.056283 0.106748 0.0200016 0.0563711 0.03237 0.0102954 0.0416139 0.041073 0.0441433 0.045424 0.0158714 0.0199061 0.0459353 0.0243398 0.0208635 0.0173238 0.0225794 0.0515278	Oral DRUG0 : Given the different metabolism of DRUG1 and oral DRUG2 , no drug interaction between these two classes of drug is expected .
3	3	0.0213316 0.00670778 0.0127863 0.0175159 0.0355517 0.0287419 0.0308857 0.0306912 0.0611201 0.0705942 0.0833505 0.0531688 0.0685065 0.0444654 0.0954854 0.0583848 0.075978 0.0820405 0.0651422 0.0575517	However , in a drug-drug interaction study , mean DRUG1 AUC was decreased by 15% when coadministered with DRUG2 .
1	1	0.0379649 0.020079 0.0353037 0.0454147 0.037981 0.0506583 0.0413977 0.0688292 0.0429179 0.0762815 0.0539861 0.079835 0.0636652 0.0485802 0.0399542 0.0165505 0.0314213 0.0328851 0.0308782 0.0287701 0.0261165 0.033829 0.0567009	Therefore , it is recommended that oral DRUG1 are co- administered with DRUG2 with caution and additional birth control methods be considered .
4	4	0.0897654 0.0387821 0.116717 0.0917174 0.0917655 0.0320669 0.00608977 0.0116531 0.0170534 0.0167017 0.025482 0.0297812 0.0214613 0.0218242 0.00808027 0.0123231 0.0218582 0.0216638 0.025975 0.0121616 0.0249521 0.0355834 0.0289981 0.0396759 0.0626882 0.0951793	DRUG1 : During treatment with DRUG2 , the use of DRUG0 should be avoided and patients should be advised that vaccinations may be less effective .
4	4	0.0666797 0.0189956 0.0503521 0.0461781 0.0324737 0.0264845 0.0272276 0.0994352 0.0726494 0.0807676 0.0555046 0.0232317 0.0250764 0.0237303 0.00655126 0.0104623 0.017052 0.018033 0.0222797 0.0108465 0.0221567 0.0332904 0.0279591 0.0374456 0.0580268 0.0871101	DRUG1 : During treatment with DRUG0 , the use of DRUG2 should be avoided and patients should be advised that vaccinations may be less effective .
1	1	0.0219413 0.0253338 0.0528779 0.046277 0.0712223 0.0979836 0.0229986 0.0842712 0.0495127 0.0896985 0.0535674 0.0258976 0.0272332 0.0247906 0.00638496 0.00986124 0.0156547 0.0161606 0.0190679 0.00923669 0.0188053 0.0285863 0.0235653 0.0320202 0.0499328 0.0771186	DRUG0 : During treatment with DRUG1 , the use of DRUG2 should be avoided and patients should be advised that vaccinations may be less effective .
3	4	0.105198 0.0882128 0.0969308 0.0656746 0.120773 0.0503947 0.0581093 0.0819226 0.0766772 0.0688973 0.0543057 0.0697701 0.0631345	Interference of DRUG1 hydrolysis may lead to less DRUG2 available for absorption .
2	2	0.207358 0.134449 0.0939395 0.105802 0.0971045 0.125297 0.131445 0.104605	DRUG1 may decrease arterial responsiveness to DRUG2 .
2	2	0.170015 0.180774 0.0738372 0.110005 0.0772115 0.155958 0.135824 0.0963749	DRUG1 may increase the responsiveness of DRUG2 .
3	3	0.138983 0.0452479 0.0913265 0.0636052 0.132811 0.11252 0.057574 0.0134864 0.0373631 0.0367742 0.0317667 0.0260329 0.0358268 0.0607972 0.115886	DRUG1 renal clearance is reduced by DRUG2 , increasing the risk of DRUG0 toxicity .
4	4	0.0236654 0.0364415 0.095501 0.0974337 0.13954 0.0814 0.0956722 0.017001 0.0462903 0.077154 0.0351163 0.0788513 0.0595448 0.038007 0.0783814	DRUG0 renal clearance is reduced by DRUG1 , increasing the risk of DRUG2 toxicity .
2	2	0.142366 0.142706 0.100776 0.0508679 0.0487321 0.0734589 0.0763506 0.0549269 0.0663243 0.0362242 0.0941852 0.113083	DRUG1 may add to or potentiate the action of other DRUG2 .
4	4	0.07958 0.0346045 0.0556526 0.115447 0.0528158 0.0512088 0.0326442 0.0238406 0.0308636 0.0411654 0.0205715 0.0367714 0.0495354 0.0623457 0.0384596 0.0072222 0.0226034 0.0198613 0.0290972 0.0548049 0.0326845 0.0339036 0.0743172	DRUG1 : DRUG0 causes a 60% reduction in the absorption and enterohepatic cycling of DRUG2 and should not be coadministered with DRUG0 .
4	4	0.0768807 0.0304431 0.0469245 0.0932706 0.0379306 0.0320048 0.018067 0.0103054 0.0100185 0.0184212 0.00631401 0.0096465 0.0103945 0.00835133 0.0124661 0.013967 0.0447529 0.0407311 0.0636214 0.115012 0.108149 0.0888648 0.103463	DRUG1 : DRUG0 causes a 60% reduction in the absorption and enterohepatic cycling of DRUG0 and should not be coadministered with DRUG2 .
3	3	0.0325588 0.0449677 0.118829 0.107548 0.0454402 0.0368993 0.0416958 0.0384183 0.0356568 0.0414815 0.0193054 0.0359265 0.040345 0.050683 0.0274233 0.00628412 0.0222051 0.0199929 0.0295172 0.0558264 0.0342718 0.0348926 0.0798308	DRUG0 : DRUG1 causes a 60% reduction in the absorption and enterohepatic cycling of DRUG2 and should not be coadministered with DRUG0 .
1	1	0.0292422 0.0390481 0.100128 0.100463 0.0405058 0.0251492 0.0235862 0.0229326 0.0173488 0.0240306 0.00670094 0.00911853 0.00971661 0.0086163 0.0116184 0.0122994 0.0404165 0.0369049 0.0568932 0.10715 0.100116 0.0807985 0.0972166	DRUG0 : DRUG1 causes a 60% reduction in the absorption and enterohepatic cycling of DRUG0 and should not be coadministered with DRUG2 .
1	4	0.0190452 0.0216785 0.03287 0.0612301 0.0277146 0.0278092 0.0198492 0.0156169 0.0186383 0.0265793 0.0151012 0.0419144 0.0582108 0.0621729 0.120188 0.0214948 0.0226168 0.0367787 0.0403678 0.0774231 0.0863389 0.0744028 0.0719581	DRUG0 : DRUG0 causes a 60% reduction in the absorption and enterohepatic cycling of DRUG1 and should not be coadministered with DRUG2 .
4	4	0.0840572 0.0288983 0.0648738 0.0787981 0.099984 0.0410703 0.00830143 0.0167724 0.0324102 0.0804758 0.0595372 0.0795776 0.0842172 0.0443041 0.0630453 0.133677	DRUG1 : The coadministration of DRUG2 and DRUG0 has not been assessed under chronic conditions .
4	4	0.0241524 0.0378794 0.0559809 0.0662376 0.0546324 0.0903999 0.0280665 0.0607496 0.0501686 0.0869114 0.085853 0.0904038 0.0868148 0.0465122 0.0513883 0.0838492	DRUG0 : The coadministration of DRUG1 and DRUG2 has not been assessed under chronic conditions .
1	1	0.12468 0.147072 0.0841616 0.0848217 0.120983 0.124782 0.0593447 0.0149649 0.0286438 0.0257821 0.0312024 0.0324686 0.0378704 0.0832227	If DRUG1 is given concurrently with DRUG2 , prothrombin time should be monitored .
4	4	0.0380856 0.0210642 0.0129557 0.0667646 0.0646016 0.0845086 0.0929781 0.127203 0.170468 0.124985 0.047265 0.00734046 0.00652316 0.00518107 0.00981187 0.0260148 0.0942489	In vitro , DRUG1 did not affect the binding of DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0439268 0.0246153 0.0148315 0.0723061 0.0665447 0.0910195 0.0989287 0.131399 0.178715 0.0666742 0.0207432 0.0122559 0.0290777 0.00690491 0.0119078 0.0265746 0.103576	In vitro , DRUG1 did not affect the binding of DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0432566 0.0238451 0.0145485 0.0701426 0.0645783 0.0861538 0.0979394 0.127429 0.150535 0.0604669 0.0152517 0.00621967 0.0086056 0.0119733 0.0291763 0.0693046 0.120573	In vitro , DRUG1 did not affect the binding of DRUG0 , DRUG0 , or DRUG2 .
1	1	0.0605832 0.0469719 0.0494043 0.0571134 0.0606834 0.102908 0.0878875 0.0908576 0.0756235 0.0295091 0.0472717 0.0924109 0.0217682 0.00578675 0.00657667 0.0076031 0.0136065 0.00289032 0.00329711 0.00257442 0.0034308 0.00264726 0.0037138 0.00292991 0.00465485 0.00338946 0.00589928 0.0214312 0.0865761	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
1	1	0.0615666 0.0478438 0.0502783 0.0583077 0.0619269 0.10659 0.0895512 0.0945475 0.0796867 0.0303877 0.0471814 0.088501 0.0178559 0.00443377 0.00425908 0.00279569 0.00429442 0.00443595 0.011531 0.00253933 0.00316225 0.00248356 0.0034843 0.00275574 0.00439789 0.00321986 0.0055346 0.0209605 0.0854875	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
1	1	0.0616364 0.0478768 0.0503623 0.0584643 0.0620971 0.107296 0.0896955 0.0953072 0.0802614 0.0303939 0.0472467 0.0869503 0.0167346 0.00412595 0.00383709 0.00239969 0.00319263 0.00242106 0.00421951 0.00457867 0.0118834 0.00265023 0.00350176 0.00279302 0.00439362 0.00325446 0.00543303 0.0207932 0.0862002	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
1	1	0.0616469 0.0478808 0.050396 0.0585381 0.0621683 0.107677 0.0897625 0.0955962 0.08055 0.0304431 0.0473526 0.0862438 0.016327 0.00400848 0.00370354 0.00231709 0.00306494 0.0021487 0.00321063 0.00253102 0.00443546 0.00477168 0.0129503 0.00298123 0.00440047 0.00336362 0.00532483 0.0202907 0.0859152	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
1	1	0.0617086 0.0479037 0.0504907 0.0586667 0.0623012 0.108086 0.0900014 0.0958457 0.0807054 0.030445 0.0474129 0.0859816 0.0163168 0.00398862 0.00369457 0.00230613 0.00303661 0.00212985 0.0031508 0.00227596 0.00343674 0.00261866 0.00458346 0.00508842 0.0156165 0.00388294 0.00512093 0.019207 0.0839969	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
1	1	0.0590334 0.0458688 0.0484328 0.0560778 0.0594957 0.104414 0.0866608 0.0919262 0.0794079 0.0300628 0.0448362 0.0762427 0.0157637 0.00357308 0.00353785 0.0021188 0.00254831 0.0018677 0.00255575 0.00196398 0.00273055 0.00209042 0.00300232 0.00250546 0.00426753 0.0055268 0.0146352 0.0533452 0.0955088	Caution should be used when DRUG1 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0372785 0.0262966 0.0282598 0.025842 0.0335903 0.0625331 0.0989437 0.0953638 0.0585565 0.0108982 0.0231175 0.0487674 0.0103159 0.00370773 0.00390173 0.00248958 0.00345298 0.00248288 0.00424332 0.00304037 0.00582986 0.00486036 0.0115349 0.014644 0.0890444 0.0225796 0.0294836 0.0961161 0.142825	Caution should be used when DRUG0 is coadministered with other highly protein-bound drugs , such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
2	4	0.0858853 0.0568542 0.0716879 0.0225631 0.0592473 0.0552947 0.0659651 0.0580609 0.0797651 0.06035 0.015791 0.0345897 0.0346882 0.0564684 0.0573188 0.0666818 0.0572192 0.0615692	DRUG1 locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with DRUG2 .
4	4	0.0398616 0.0400614 0.0231932 0.017206 0.0455436 0.043688 0.0342183 0.0361995 0.0564805 0.0767061 0.0225506 0.0261534 0.0316267 0.0429162 0.0338709 0.0320166 0.0442163 0.0389282 0.031021 0.0453017 0.0549398 0.0170627 0.0303308 0.0321783 0.0450077 0.0214532 0.0372679	The objective was to analyze the effects of neonatal DRUG1 treatment on effects of DRUG2 in adolescent rats using locomotor sensitization and conditioned place preference procedures .
4	2	0.0492474 0.0537343 0.0396599 0.022201 0.0780835 0.120484 0.0508777 0.133815 0.0574186 0.0464321 0.0538938 0.0351841 0.0284217 0.0282004 0.0299055 0.0204024 0.0288421 0.0172633 0.0304785 0.0754552	In female rats , neonatal DRUG1 treatment enhanced DRUG2 locomotor sensitization compared with DRUG0 -free controls sensitized to DRUG0 .
4	4	0.0367853 0.0365322 0.0291064 0.0173643 0.0611485 0.0461438 0.014733 0.0388351 0.0180299 0.0215114 0.0308651 0.0189779 0.0201279 0.0423207 0.0795175 0.0889087 0.11731 0.0911184 0.0912012 0.0994629	In female rats , neonatal DRUG1 treatment enhanced DRUG0 locomotor sensitization compared with DRUG0 -free controls sensitized to DRUG2 .
4	4	0.0138766 0.0120692 0.00739593 0.00373071 0.017373 0.0294074 0.0553702 0.122369 0.136826 0.0686144 0.0677342 0.0559534 0.0696754 0.0487748 0.0466586 0.0418989 0.0501985 0.0299997 0.0347266 0.0873477	In female rats , neonatal DRUG0 treatment enhanced DRUG1 locomotor sensitization compared with DRUG2 -free controls sensitized to DRUG0 .
4	4	0.0128202 0.0101168 0.00653531 0.00313901 0.0091858 0.0104085 0.0130889 0.0226848 0.027747 0.0481321 0.0961196 0.0684862 0.0909896 0.107436 0.0952507 0.0679265 0.0736301 0.0880479 0.0830289 0.0652263	In female rats , neonatal DRUG0 treatment enhanced DRUG0 locomotor sensitization compared with DRUG1 -free controls sensitized to DRUG2 .
4	4	0.0383055 0.0444765 0.0509779 0.109025 0.0722017 0.0963412 0.0177707 0.0530747 0.0349734 0.0177104 0.0134347 0.0145303 0.0111816 0.0115669 0.00839864 0.0029843 0.00569796 0.0226665 0.0756034 0.0852849 0.0891036 0.0624911 0.0621991	Male rats demonstrated sensitization to DRUG1 , although this was muted compared with female rats , and were unaffected by neonatal DRUG2 .
2	4	0.0545216 0.0541089 0.0553562 0.0406133 0.0795354 0.0837249 0.0297801 0.0503973 0.0409005 0.0590509 0.0408707 0.0273577 0.0180747 0.0106868 0.00807301 0.0113448 0.0119336 0.00802971 0.0135782 0.00619523 0.00482377 0.00289638 0.0038465 0.0109768 0.00757602 0.00781 0.012721 0.00645375 0.0136802 0.0232028 0.0133031 0.0102931 0.00819731 0.0119885 0.0223639 0.0300796 0.0156635 0.0171044 0.011204 0.0212409 0.0404408	Rats treated with neonatal DRUG1 enhanced time spent in the DRUG2 -paired context compared with DRUG0 -free controls conditioned with DRUG0 , but only female controls conditioned with DRUG0 spent more time in the drug-paired context compared with saline-treated controls .
4	4	0.0411609 0.040677 0.0395402 0.0320551 0.0642247 0.0476055 0.0160086 0.0171082 0.0159559 0.0135855 0.0157615 0.0251943 0.0214145 0.011489 0.0115092 0.0220085 0.0486394 0.0567339 0.0989262 0.06352 0.0260919 0.0052442 0.00550384 0.00958205 0.00812725 0.00859751 0.0132697 0.00724298 0.0148911 0.022711 0.0124462 0.00893475 0.00682081 0.0103757 0.019275 0.025959 0.013428 0.0147806 0.00965762 0.0185392 0.0354037	Rats treated with neonatal DRUG1 enhanced time spent in the DRUG0 -paired context compared with DRUG0 -free controls conditioned with DRUG2 , but only female controls conditioned with DRUG0 spent more time in the drug-paired context compared with saline-treated controls .
2	4	0.0425798 0.0420487 0.0409105 0.0332097 0.0655361 0.04572 0.0148826 0.0159509 0.0154152 0.0130723 0.0141034 0.0220167 0.0155598 0.00773351 0.00696946 0.0112694 0.0142398 0.0106064 0.0182259 0.00784933 0.0054212 0.00454411 0.0114244 0.031662 0.0354073 0.0362322 0.0469819 0.0461336 0.0409229 0.0373651 0.0329384 0.0165461 0.0158932 0.0162203 0.0283428 0.0331724 0.0198825 0.0161718 0.0110978 0.0201283 0.0356118	Rats treated with neonatal DRUG1 enhanced time spent in the DRUG0 -paired context compared with DRUG0 -free controls conditioned with DRUG0 , but only female controls conditioned with DRUG2 spent more time in the drug-paired context compared with saline-treated controls .
4	4	0.0148564 0.0160217 0.0156573 0.0215652 0.0365786 0.0681725 0.0316634 0.0638461 0.041119 0.0411817 0.0546213 0.0455466 0.0367423 0.0414302 0.0515772 0.0340154 0.0293726 0.0203427 0.0281373 0.01137 0.00687137 0.00336425 0.00458479 0.0124817 0.00838001 0.00808591 0.0129778 0.00655982 0.0143511 0.0232232 0.0132166 0.0101258 0.0080638 0.0118693 0.0218696 0.0292686 0.0152217 0.0165959 0.010751 0.0201627 0.0381576	Rats treated with neonatal DRUG0 enhanced time spent in the DRUG1 -paired context compared with DRUG2 -free controls conditioned with DRUG0 , but only female controls conditioned with DRUG0 spent more time in the drug-paired context compared with saline-treated controls .
4	4	0.00984505 0.00960916 0.00905591 0.010923 0.0191108 0.0334003 0.0110402 0.0156118 0.00782648 0.00806866 0.014865 0.0351231 0.0563336 0.0416868 0.0607827 0.0753263 0.0980432 0.0550502 0.0986767 0.0610474 0.0221166 0.00498497 0.00594518 0.0102943 0.00842024 0.00861019 0.0125139 0.00667107 0.013587 0.0202135 0.0111557 0.00797397 0.00607344 0.00928798 0.0170991 0.023043 0.0118744 0.0131227 0.00847896 0.0161859 0.0309218	Rats treated with neonatal DRUG0 enhanced time spent in the DRUG0 -paired context compared with DRUG1 -free controls conditioned with DRUG2 , but only female controls conditioned with DRUG0 spent more time in the drug-paired context compared with saline-treated controls .
4	4	0.0103506 0.0101166 0.00965192 0.0117363 0.0212261 0.037594 0.0123659 0.0160871 0.00778019 0.00743634 0.0137598 0.0303003 0.0467007 0.0405361 0.0729697 0.0602046 0.0308089 0.0181693 0.0273959 0.0115844 0.0057483 0.00387133 0.0110736 0.0331963 0.0359398 0.0354668 0.0456991 0.045402 0.0386842 0.0353868 0.0307794 0.0153496 0.0146912 0.0147055 0.0245595 0.0278734 0.0166303 0.0134806 0.00917356 0.0165118 0.029002	Rats treated with neonatal DRUG0 enhanced time spent in the DRUG0 -paired context compared with DRUG1 -free controls conditioned with DRUG0 , but only female controls conditioned with DRUG2 spent more time in the drug-paired context compared with saline-treated controls .
3	3	0.0459907 0.0390969 0.0447675 0.0438401 0.0279518 0.0269263 0.0323784 0.022301 0.0237373 0.00859455 0.00927358 0.0592349 0.0201625 0.0712726 0.0518027 0.0475759 0.0456537 0.0765315 0.0789533 0.0873767 0.0749077 0.0616704	Concomitant administration of substances that are also tubularly secreted (e.g. , DRUG1 ) could potentially result in delayed clearance of DRUG2 .
4	4	0.0200985 0.0440873 0.0227569 0.0219172 0.0259496 0.0480678 0.0239685 0.0334858 0.04386 0.0474114 0.0585821 0.0483219 0.0363286 0.0213967 0.00999603 0.0157989 0.0202489 0.0249807 0.0136505 0.00799866 0.00651646 0.00854387 0.00421772 0.00165053 0.00460937 0.00565527 0.00620099 0.00488449 0.00678913 0.0129373 0.00877146 0.00945985 0.0071864 0.01151 0.0128545 0.0137742 0.0235459 0.0275897 0.0166754 0.0438579 0.0161962 0.0289047 0.0179333 0.018406 0.00865415 0.00826303 0.00615951 0.01308 0.021014 0.0352527	Although DRUG1 (400 mg qid) can be administered with DRUG2 in patients with normal renal function (creatinine clearance    80 mL/min) , caution should be used when administering DRUG0 concurrently with DRUG0 to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min) .
4	4	0.0140037 0.0252143 0.0102853 0.00920647 0.0200138 0.0357819 0.0226376 0.0191726 0.0172029 0.0170751 0.0193392 0.0252136 0.0274143 0.014034 0.00803711 0.0145752 0.0176621 0.0239347 0.0127737 0.00731006 0.00621794 0.00907015 0.00448431 0.00190501 0.00692178 0.00968399 0.0127194 0.0115412 0.0156384 0.0277351 0.0367844 0.0562837 0.0598262 0.0348331 0.0190635 0.0227794 0.026873 0.0398642 0.0237555 0.0478088 0.0178474 0.0294269 0.0175944 0.0178013 0.00826236 0.00743253 0.00548375 0.011574 0.0186353 0.0312656	Although DRUG1 (400 mg qid) can be administered with DRUG0 in patients with normal renal function (creatinine clearance    80 mL/min) , caution should be used when administering DRUG0 concurrently with DRUG2 to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min) .
4	4	0.00454197 0.00627716 0.0111214 0.00973185 0.0523839 0.064618 0.0380932 0.0352157 0.0356346 0.0382461 0.0497612 0.0261832 0.0209149 0.0145826 0.00707757 0.0118107 0.0162868 0.0237937 0.0143973 0.00974148 0.00887182 0.0112508 0.00577636 0.00210087 0.00664841 0.00862881 0.0108653 0.0120292 0.0155929 0.0302405 0.0158997 0.0233648 0.0166617 0.0161096 0.0167324 0.0187506 0.0270455 0.0302399 0.0178457 0.0444774 0.0164545 0.0297709 0.0187065 0.0182847 0.00855627 0.00794521 0.00586187 0.0122942 0.0197172 0.0328631	Although DRUG0 (400 mg qid) can be administered with DRUG1 in patients with normal renal function (creatinine clearance    80 mL/min) , caution should be used when administering DRUG2 concurrently with DRUG0 to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min) .
2	1	0.00394716 0.00433903 0.00630068 0.00532474 0.0260832 0.0256337 0.0111075 0.0115451 0.00908964 0.0127724 0.0116541 0.0162156 0.0207478 0.0113664 0.00729793 0.0146113 0.0192563 0.0281492 0.0162775 0.0103728 0.00956006 0.0130037 0.00648091 0.00245387 0.00942106 0.0120488 0.0147036 0.0136138 0.0162502 0.0180874 0.0362688 0.0335244 0.0422324 0.0412471 0.0297458 0.0353518 0.039757 0.0587467 0.0382618 0.0634594 0.0214282 0.0351516 0.0205467 0.0206172 0.00970134 0.00856113 0.00631662 0.0134815 0.021673 0.036212	Although DRUG0 (400 mg qid) can be administered with DRUG0 in patients with normal renal function (creatinine clearance    80 mL/min) , caution should be used when administering DRUG1 concurrently with DRUG2 to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min) .
1	1	0.0384502 0.0330375 0.0425008 0.02775 0.0370933 0.0105157 0.0207163 0.0143322 0.0388045 0.03104 0.059837 0.025738 0.020374 0.0272736 0.0286744 0.0256869 0.0180081 0.0155424 0.0195512 0.0191735 0.0202593 0.0283635 0.0155345 0.0385113 0.0327262 0.0168652 0.00586842 0.00947718 0.0387552 0.0335385 0.0376062 0.0306478 0.0470656 0.04324 0.0474416	Patients with mild to moderate renal insufficiency should avoid taking DRUG1 with short elimination half-lives for a period of 2 days before , the day of , and 2 days following administration of DRUG2 .
4	4	0.0319084 0.0352778 0.0382538 0.0365273 0.0367601 0.067831 0.0492803 0.0576636 0.0511851 0.102135 0.0343649 0.0454712 0.0300843 0.0178704 0.0103364 0.00382509 0.00492645 0.00436248 0.00577657 0.00601504 0.0161507 0.0247366 0.0344729 0.0167522 0.00805137 0.00532907 0.0132806 0.0147166 0.0109922 0.0123881 0.006858 0.0119441 0.00969909 0.00419964 0.00179192 0.00319342 0.0135965 0.0109074 0.00944013 0.00943007 0.0204127 0.0718021	In the absence of data regarding potential interaction between DRUG1 and DRUG2 with longer half-lives , all patients taking these DRUG0 should interrupt dosing for at least 5 days before , the day of , and 2 days following DRUG0 administration .
4	4	0.0148267 0.0150917 0.018771 0.0134817 0.0209909 0.0494492 0.0495398 0.0625236 0.0791962 0.0760205 0.0201345 0.0320687 0.0570831 0.0386757 0.0362979 0.0208659 0.0340923 0.022156 0.0272709 0.0392346 0.0332191 0.0140496 0.0250262 0.0167216 0.00942546 0.00579742 0.0100879 0.0118494 0.00904507 0.0101828 0.00499899 0.00978611 0.00714136 0.00326017 0.00129464 0.00236165 0.010432 0.00847384 0.00689435 0.00680973 0.0147903 0.0505816	In the absence of data regarding potential interaction between DRUG1 and DRUG0 with longer half-lives , all patients taking these DRUG2 should interrupt dosing for at least 5 days before , the day of , and 2 days following DRUG0 administration .
4	4	0.0152548 0.0150412 0.0185129 0.0134161 0.021249 0.051528 0.0471366 0.0514992 0.0505974 0.0278596 0.0224518 0.0735259 0.0324935 0.0150779 0.00825358 0.0030525 0.00444287 0.00399786 0.00529709 0.00562214 0.0141599 0.0225591 0.0340946 0.0177143 0.00900687 0.00638598 0.0182291 0.0225488 0.0177245 0.0203631 0.0151954 0.0285869 0.0230679 0.00971042 0.00383458 0.00866808 0.0362509 0.0342155 0.0407626 0.0370965 0.0290784 0.0644368	In the absence of data regarding potential interaction between DRUG0 and DRUG1 with longer half-lives , all patients taking these DRUG0 should interrupt dosing for at least 5 days before , the day of , and 2 days following DRUG2 administration .
1	1	0.0115027 0.0101877 0.0126619 0.00740862 0.0089372 0.0188797 0.0161272 0.0128729 0.0119691 0.00697004 0.00397756 0.0142576 0.0260647 0.0153539 0.0124892 0.00812275 0.0215661 0.0204977 0.0271948 0.030499 0.0921362 0.0200792 0.0346341 0.023912 0.0201293 0.0125883 0.0169574 0.0258052 0.0231974 0.0300558 0.0154991 0.0346848 0.0309779 0.0165187 0.00652178 0.0118392 0.0455203 0.0429187 0.0487984 0.0420808 0.0344444 0.0731606	In the absence of data regarding potential interaction between DRUG0 and DRUG0 with longer half-lives , all patients taking these DRUG1 should interrupt dosing for at least 5 days before , the day of , and 2 days following DRUG2 administration .
4	4	0.048713 0.0220818 0.0215172 0.0347842 0.0445201 0.0389554 0.027609 0.0144994 0.0176073 0.0295539 0.0776815 0.0738306 0.0430577 0.0121252 0.0283563 0.0306933 0.0309705 0.0414265 0.0785032 0.0156727 0.014169 0.0133211 0.00988805 0.0114691 0.00915427 0.00917751 0.00552194 0.0249358 0.0465677 0.0304699 0.0359591 0.0572078	Drug Interactions : The use of DRUG1 ( DRUG0 ) Injection before DRUG2 , for the purpose of attenuating some of the side effects of DRUG0 , has not been studied .
4	4	0.0354053 0.0144183 0.0114695 0.0188569 0.02651 0.0248527 0.0169749 0.00620756 0.00736839 0.0099944 0.0722362 0.043598 0.0196579 0.0131825 0.0329489 0.0465478 0.0425416 0.0558809 0.0839577 0.0271749 0.0321533 0.0349579 0.0329011 0.0439993 0.052575 0.0259955 0.00535423 0.0146253 0.0312024 0.0250756 0.033739 0.057637	Drug Interactions : The use of DRUG1 ( DRUG0 ) Injection before DRUG0 , for the purpose of attenuating some of the side effects of DRUG2 , has not been studied .
4	4	0.0536711 0.0263174 0.0289666 0.0412303 0.0481154 0.0463122 0.0298134 0.0238874 0.0404013 0.0302637 0.0694101 0.0642591 0.0359025 0.0100772 0.0240163 0.0261754 0.027559 0.0370014 0.0747251 0.0146653 0.0130207 0.0121703 0.00907542 0.010502 0.0083647 0.00844035 0.00508578 0.0229393 0.0430921 0.0281563 0.0333261 0.0530567	Drug Interactions : The use of DRUG0 ( DRUG1 ) Injection before DRUG2 , for the purpose of attenuating some of the side effects of DRUG0 , has not been studied .
4	4	0.0407117 0.016698 0.0138811 0.0230584 0.031332 0.027424 0.0169657 0.0119804 0.0188721 0.0120666 0.0640213 0.0374498 0.0175526 0.0110717 0.0300931 0.0432346 0.0412215 0.0538335 0.0831558 0.0262867 0.0307578 0.0331555 0.0313296 0.0425468 0.0506318 0.0251508 0.0052332 0.0143183 0.0307059 0.0246749 0.0333583 0.0572266	Drug Interactions : The use of DRUG0 ( DRUG1 ) Injection before DRUG0 , for the purpose of attenuating some of the side effects of DRUG2 , has not been studied .
1	1	0.0641951 0.0763854 0.058471 0.045155 0.052763 0.0479269 0.0886563 0.050336 0.0155847 0.0635768 0.0350656 0.0146338 0.0117007 0.0112429 0.0338459 0.0664636 0.0404293 0.0414927 0.0314017 0.0285833 0.0530471 0.0690433	If DRUG1 is administered following administration of DRUG2 , it should not be given until recovery from DRUG0 has been observed .
4	4	0.0780655 0.0464578 0.0313284 0.0258448 0.0208112 0.0319736 0.0380121 0.0206272 0.0196558 0.0784059 0.0387602 0.0264203 0.018344 0.0184666 0.0405828 0.0870913 0.0929139 0.0689696 0.0493203 0.045712 0.0502724 0.0719646	If DRUG1 is administered following administration of DRUG0 , it should not be given until recovery from DRUG2 has been observed .
2	4	0.0377622 0.0480308 0.0444083 0.039292 0.0289063 0.0275526 0.0368985 0.0328537 0.0227804 0.0186461 0.032015 0.0246834 0.0243036 0.0375722 0.0210948 0.0483848 0.034219 0.0248546 0.0265859 0.029278 0.0359596 0.0223507 0.0240684 0.0289744 0.0260506 0.0181961 0.0203769 0.0173326 0.0237953 0.0132072 0.00626206 0.0322133 0.0459145 0.0451761	The median duration of action of DRUG1 0.6 mg/kg administered after a 1 mg/kg dose of DRUG2 when T 1 returned to 75% of control was 36 minutes (range 14-57 , n=12) vs .
4	4	0.0304249 0.0369328 0.0590736 0.0944772 0.0583154 0.0629238 0.0788555 0.0610133 0.0636279 0.0746353 0.0588425 0.034338 0.0760658 0.0332058 0.0786934 0.0985748	There are no controlled studies documenting the use of DRUG1 before or after other DRUG2 .
4	4	0.113604 0.0429053 0.0648129 0.174467 0.0878371 0.1927 0.101177 0.0241646 0.0340853 0.0340138 0.0665391 0.0636946	DRUG1 is not known to interact with other drugs including DRUG2 supplements;
1	1	0.0738329 0.0739931 0.0784939 0.0843059 0.0610663 0.0263571 0.0813985 0.0474962 0.0173892 0.0270705 0.0318067 0.0747788 0.0804449 0.0833986 0.036921 0.121247	Concomitant administration of DRUG1 with other chelation therapy , such as DRUG2 is not recommended .
0	0	0.0799422 0.0595303 0.0515584 0.0423856 0.0447998 0.0453298 0.0296518 0.0105266 0.0141446 0.00263557 0.00148349 0.00199385 0.00244125 0.00183793 0.00288166 0.00336065 0.00136362 0.00394162 0.00773398 0.00311014 0.00276219 0.00642344 0.00715875 0.0128597 0.00598703 0.0019068 0.00078832 0.00176729 0.00265759 0.00530086 0.00517352 0.00404257 0.00164176 0.0059642 0.010856 0.00588576 0.00501638 0.00602942 0.00308996 0.00299931 0.00183594 0.00568333 0.00872246 0.00553994 0.00914096 0.00727459 0.0253805 0.0336501 0.0164973 0.00713439 0.00396058 0.00312528 0.0038972 0.0017668 0.00389784 0.00358378 0.00971565 0.0602879 0.0204707 0.0100063 0.00768787 0.00713501 0.0154656 0.0102353 0.00458492 0.00948008 0.0131015 0.00808752 0.00327217 0.00267257 0.0031931 0.00121988 0.00145583 0.00428198 0.00704535 0.00399592 0.00419191 0.0024407 0.00958306 0.0157488 0.0102875 0.00852968 0.00722179 0.00897122 0.0102706 0.0100667 0.00711098 0.0087942 0.0433327	DRUG1 may interact with the following drugs : DRUG2 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
0	0	0.0783136 0.0605618 0.0510387 0.0442179 0.0453273 0.0468772 0.0263009 0.0131229 0.00699302 0.00447877 0.00458977 0.00910814 0.00456202 0.00255254 0.00383559 0.00467515 0.00177054 0.00476387 0.0097528 0.00405575 0.00348762 0.00752632 0.00832558 0.0139682 0.00625812 0.00202534 0.000822019 0.00181208 0.00278395 0.00547532 0.00525259 0.00414708 0.00167605 0.00601149 0.0109235 0.00588164 0.00499185 0.00598258 0.00306664 0.00297262 0.00181074 0.00556958 0.00852179 0.00539665 0.00888523 0.00706265 0.0244117 0.0323411 0.0158141 0.00684469 0.00380692 0.00300616 0.0037488 0.00170135 0.00374684 0.00344361 0.0093237 0.0574848 0.0195147 0.00954309 0.00733387 0.00680976 0.0147532 0.00975513 0.00436819 0.00903073 0.0124808 0.00770669 0.00311808 0.00254672 0.00304248 0.00116232 0.00138713 0.00407984 0.00671391 0.00380761 0.00399425 0.00232566 0.00913057 0.015005 0.00980218 0.00812772 0.00688263 0.00854906 0.00978754 0.00959309 0.00677566 0.00837894 0.0412842	DRUG1 may interact with the following drugs : DRUG0 and other DRUG2 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
2	0	0.0734724 0.0533376 0.0473492 0.0373293 0.0413266 0.0386675 0.0153684 0.00720848 0.00405939 0.00175348 0.00123131 0.00345027 0.00696511 0.00431101 0.00713415 0.0196465 0.00574094 0.0157428 0.0154241 0.00956808 0.00982885 0.0147757 0.0152184 0.0195374 0.00860817 0.00275053 0.00104618 0.0022213 0.00340634 0.0064183 0.00597373 0.00483958 0.00195987 0.00691033 0.0122855 0.00653476 0.00550013 0.00648441 0.00327418 0.00312152 0.00187834 0.00571897 0.00868042 0.00546135 0.00898827 0.00713628 0.024077 0.0317375 0.0153458 0.00665692 0.00370797 0.00292898 0.00364664 0.00165551 0.00363665 0.00333972 0.00902785 0.0547283 0.0185532 0.00908088 0.0069811 0.00648621 0.0140194 0.00920278 0.00411366 0.0085017 0.0117546 0.00726925 0.00294088 0.00240164 0.00286726 0.00109487 0.00130652 0.00384357 0.00633 0.0035892 0.00376413 0.00219168 0.00860404 0.0141366 0.00923525 0.00766233 0.0064936 0.00805562 0.00922358 0.00903988 0.00638068 0.00788756 0.0388539	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG2 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	0	0.0732684 0.0480224 0.0452274 0.0290302 0.0374278 0.0240212 0.00879013 0.00449281 0.0036175 0.00131621 0.00102252 0.00269534 0.00348897 0.00251821 0.00385514 0.00404317 0.00152713 0.00550442 0.0110831 0.00615481 0.00593023 0.0141341 0.0238583 0.0516253 0.0332895 0.0188454 0.0054421 0.0124431 0.0051092 0.00909286 0.00782349 0.005897 0.00225715 0.00694628 0.012835 0.00667639 0.00547103 0.00637109 0.00329841 0.00311027 0.00188071 0.00567193 0.00864512 0.00541861 0.00885724 0.00703334 0.0236342 0.0309963 0.0150293 0.00654382 0.00363834 0.00287765 0.00357536 0.00162489 0.00356215 0.00327185 0.00882887 0.0537191 0.0182057 0.0089371 0.00686939 0.00639782 0.0137792 0.00906029 0.00404268 0.00835359 0.0115298 0.00714766 0.00289171 0.00236251 0.00281867 0.00107606 0.00128417 0.00377686 0.00623334 0.00353222 0.00370201 0.00215578 0.00845966 0.0139017 0.00908212 0.0075355 0.00639582 0.00793047 0.00908001 0.00889882 0.00627276 0.00775071 0.0381641	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	0	0.0744676 0.0482183 0.0452195 0.0288563 0.0366579 0.0229032 0.00843718 0.00440681 0.00356313 0.00129931 0.00103475 0.00266331 0.00337691 0.00245434 0.0037106 0.00388638 0.00154645 0.0051341 0.00988951 0.00507776 0.00504079 0.0121538 0.0172865 0.0283573 0.0136661 0.0044155 0.00140338 0.0034771 0.00689924 0.0108765 0.0116677 0.0297343 0.00873339 0.0195327 0.0123812 0.00822362 0.0073947 0.00780178 0.00448095 0.00365496 0.00226033 0.00642691 0.00943024 0.00602406 0.00980576 0.00775767 0.026168 0.0331806 0.01601 0.0070137 0.00388423 0.00308245 0.00382527 0.00173732 0.00380539 0.00349665 0.00942134 0.0570467 0.0193684 0.0095517 0.00735251 0.00686014 0.0146721 0.00950569 0.00421916 0.0086999 0.0120257 0.00747863 0.00302478 0.00246907 0.00294215 0.00112235 0.00133906 0.0039405 0.00650837 0.00368653 0.00386329 0.00224979 0.00882552 0.0144933 0.00947311 0.00787166 0.00669002 0.00827437 0.00947759 0.00928729 0.00654125 0.00807608 0.0397485	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	0	0.0712787 0.0452879 0.041743 0.0265757 0.0327597 0.019404 0.00730059 0.00394096 0.00323816 0.00117833 0.000962955 0.00237502 0.00293563 0.0021614 0.00320256 0.0033054 0.00137163 0.00412188 0.0074216 0.00348042 0.00316971 0.00698507 0.00798209 0.0143494 0.00671836 0.00220689 0.000878608 0.0020219 0.00324411 0.00625872 0.00571092 0.00521965 0.00239153 0.0115633 0.0272304 0.017071 0.0160444 0.026221 0.0180938 0.0226208 0.00832594 0.0138788 0.010773 0.00987239 0.0141198 0.011714 0.0328684 0.0409345 0.0189567 0.00810733 0.00421693 0.00327268 0.00388228 0.00180049 0.00386914 0.00359356 0.00952087 0.05723 0.0192165 0.00944523 0.00725243 0.00683149 0.0143411 0.00941285 0.00414652 0.00856909 0.0117242 0.0072751 0.00294344 0.00240236 0.00284618 0.00108649 0.00129661 0.00381519 0.00631696 0.00357548 0.00374175 0.00217874 0.00855182 0.0140499 0.00917882 0.0076191 0.00648057 0.00801197 0.00917498 0.00899198 0.00632333 0.00780662 0.0384293	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0652522 0.0414516 0.0383135 0.0242752 0.0299529 0.0177657 0.00673705 0.00357465 0.00298572 0.001099 0.000893768 0.0021981 0.00267294 0.00198314 0.00294822 0.0030107 0.001269 0.00376992 0.00661322 0.00306265 0.00278036 0.00620415 0.00667685 0.0123485 0.0056511 0.00189898 0.000788659 0.00174623 0.00266565 0.00510393 0.00471753 0.0039566 0.00171999 0.00680106 0.0146311 0.00784385 0.0063959 0.00840335 0.0042314 0.00347071 0.00211047 0.00846188 0.0238664 0.0231506 0.0502642 0.0704777 0.0527934 0.041017 0.0216329 0.00967557 0.00461134 0.00333433 0.00382009 0.00179608 0.00382888 0.00354708 0.00933735 0.0573138 0.0192895 0.0093992 0.0071534 0.00672516 0.0138443 0.00899553 0.00393801 0.00814433 0.0111427 0.00688906 0.0027862 0.00226792 0.00267505 0.00102207 0.00121972 0.0035925 0.00593312 0.00335986 0.00351821 0.00204806 0.00804485 0.0132078 0.00863091 0.00717037 0.00608927 0.00751809 0.00861295 0.0084416 0.00594432 0.00734011 0.0361518	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	0	0.0732589 0.0467124 0.0432246 0.0274163 0.0338329 0.0198768 0.00752103 0.00398179 0.00336211 0.00123483 0.00100102 0.00245923 0.00297773 0.00221933 0.00331364 0.00333624 0.00141707 0.00419875 0.00729563 0.00337749 0.00307974 0.00687785 0.00729892 0.0134376 0.00604891 0.00205787 0.000863237 0.00189855 0.00281514 0.00536161 0.00509027 0.0040219 0.00170507 0.0062263 0.0114205 0.006124 0.0051932 0.0063359 0.00313144 0.003173 0.00185079 0.00610872 0.00992098 0.00614549 0.0107029 0.00915243 0.0358491 0.0578681 0.0363013 0.0243111 0.0187158 0.0180842 0.0312318 0.00649836 0.0139595 0.00321111 0.00595537 0.0447262 0.0158347 0.00787194 0.00772303 0.00763497 0.0169516 0.0105226 0.00460338 0.00961293 0.0131123 0.00797373 0.00320547 0.00260519 0.00295472 0.00114825 0.00137151 0.00404403 0.00670954 0.0037793 0.00394507 0.002299 0.00903368 0.0148436 0.00970263 0.00804818 0.0068553 0.00842354 0.00966281 0.00948203 0.00664175 0.00819223 0.0404392	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
2	0	0.072637 0.0462863 0.0427814 0.0272375 0.033393 0.0195902 0.00741849 0.00391438 0.00329789 0.0012119 0.000987555 0.00241914 0.00292826 0.00218166 0.00324545 0.00328739 0.001396 0.00412545 0.00714513 0.0033114 0.00301385 0.00674602 0.00713787 0.0131574 0.00590448 0.0020111 0.000848972 0.0018548 0.00275003 0.00524042 0.00496345 0.00393944 0.00165579 0.0059542 0.0106823 0.00571758 0.00486024 0.00587632 0.00299122 0.00293432 0.00178387 0.00548393 0.00842862 0.00532088 0.00879126 0.00701199 0.0238806 0.0321399 0.0158206 0.00688676 0.0038508 0.00300008 0.00377894 0.00169901 0.00382383 0.00357527 0.00973173 0.0594384 0.0229532 0.0123946 0.00978307 0.00959437 0.0225819 0.0177929 0.00963043 0.0229907 0.0285271 0.0167022 0.0150339 0.0163204 0.0143809 0.00327781 0.00509861 0.00980871 0.00831692 0.00565918 0.00496144 0.00289906 0.0109093 0.0189628 0.0133921 0.0097838 0.00783935 0.00917184 0.0110255 0.0108021 0.00692147 0.00869761 0.0423048	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
2	4	0.0748126 0.0476865 0.0440828 0.0280738 0.0344162 0.0201867 0.00764179 0.00403178 0.00339664 0.00124818 0.00101714 0.00249164 0.00301607 0.0022473 0.00334296 0.00338599 0.00143803 0.00424989 0.00736036 0.00341141 0.0031056 0.00694972 0.00735307 0.0135548 0.00608045 0.00207158 0.000874469 0.00191035 0.0028322 0.00539922 0.00511223 0.00405743 0.00170545 0.00613197 0.0109962 0.00588634 0.00500465 0.00605031 0.00308075 0.00302134 0.00183782 0.00564526 0.00867243 0.00547462 0.00903742 0.00719831 0.0245116 0.0328927 0.016155 0.00703039 0.00393204 0.00307962 0.00386381 0.00174292 0.00388405 0.00361294 0.00984712 0.0603046 0.0222563 0.0116106 0.00886625 0.00838443 0.0195599 0.0149412 0.00784309 0.0172511 0.0207704 0.0130406 0.0061849 0.00489635 0.00426804 0.00131939 0.00167167 0.00732985 0.0209323 0.0111377 0.00822132 0.0107931 0.0242001 0.0178363 0.0144545 0.0113129 0.0087139 0.00987739 0.0127505 0.0119869 0.00711525 0.00942507 0.0436102	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0716971 0.0457178 0.0422717 0.0269285 0.0330123 0.0193584 0.00732515 0.0038644 0.00325557 0.00119632 0.000974823 0.00238811 0.00289085 0.00215425 0.00320451 0.00324524 0.00137847 0.00407424 0.00705607 0.00327074 0.00297844 0.00666307 0.00704946 0.0129958 0.00582669 0.00198581 0.000838198 0.00183097 0.00271423 0.00517705 0.00489965 0.0038885 0.0016347 0.00587682 0.0105316 0.00563809 0.00479384 0.00579508 0.00295069 0.00289345 0.00176116 0.00540605 0.00830103 0.00523691 0.00864089 0.00687143 0.023393 0.0312735 0.0153114 0.00664379 0.00371874 0.00292033 0.00365899 0.00165871 0.00368993 0.00340346 0.00921723 0.0563442 0.0198685 0.00999425 0.00765069 0.00716822 0.015843 0.0109974 0.00504712 0.010812 0.0146824 0.00979736 0.00387197 0.00300098 0.00382604 0.00132908 0.00170974 0.00545527 0.010942 0.00613379 0.00678225 0.00383816 0.017578 0.0304841 0.0212444 0.0202311 0.0202978 0.0179534 0.0198155 0.0309067 0.0271383 0.0152718 0.0406511	DRUG1 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0370529 0.0614246 0.0658551 0.0422663 0.0371267 0.027841 0.0138953 0.0157494 0.0364233 0.00533258 0.00978589 0.0110397 0.00518953 0.00272492 0.00391482 0.00569492 0.00219297 0.00578115 0.0118699 0.00497281 0.00445307 0.00921958 0.0104305 0.015929 0.00747756 0.00249716 0.00102602 0.00224057 0.00344067 0.00661641 0.00650975 0.00521412 0.00209357 0.00726183 0.0128328 0.00700542 0.00608844 0.00711677 0.00352005 0.00325479 0.0019345 0.00599601 0.00916844 0.005766 0.00948194 0.00760714 0.0253911 0.0331187 0.0158528 0.00700795 0.00389596 0.00306232 0.00379955 0.00170105 0.00375769 0.00343842 0.00932644 0.0577622 0.0195975 0.00971445 0.00746078 0.00696338 0.0148169 0.00952477 0.00421884 0.00870991 0.0120059 0.00754227 0.00305002 0.00249266 0.00296411 0.0011279 0.00134575 0.00396087 0.00659056 0.00372843 0.00389697 0.00226966 0.00890058 0.0146117 0.00954791 0.00794492 0.00679117 0.00836108 0.00957452 0.00938155 0.00657291 0.00809917 0.0398029	DRUG0 may interact with the following drugs : DRUG1 and other DRUG2 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0340092 0.059599 0.0628534 0.0413726 0.0333926 0.0240963 0.0118185 0.0122875 0.0209944 0.00310024 0.0048531 0.0121097 0.031011 0.0309295 0.0161128 0.00812284 0.00328257 0.0087423 0.016223 0.00746071 0.00644939 0.0111814 0.0120279 0.0167199 0.00742204 0.00238168 0.000952364 0.00204079 0.00319029 0.00609365 0.00581469 0.00468155 0.00188411 0.00659412 0.0117889 0.00633866 0.00536655 0.00630207 0.00317047 0.00297928 0.00178849 0.00546794 0.00829769 0.00523232 0.00860957 0.00685723 0.0232058 0.0304718 0.0147111 0.00641387 0.00356965 0.00281611 0.00349922 0.0015814 0.00347958 0.00319292 0.00864782 0.0529954 0.0179852 0.0088354 0.0067866 0.00631422 0.0135845 0.00888202 0.00396117 0.00818531 0.0113015 0.00702443 0.00284146 0.0023217 0.00276889 0.00105631 0.00126051 0.00370793 0.00612873 0.00347211 0.00363712 0.00211803 0.00831111 0.0136553 0.00892049 0.00740611 0.006294 0.00779327 0.00892299 0.00874469 0.00615713 0.00760409 0.0374282	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG2 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0332449 0.0567697 0.0601216 0.0393689 0.0336693 0.0248735 0.0120017 0.0131666 0.0277267 0.00233535 0.00245235 0.004879 0.0137272 0.00630511 0.00727509 0.0309857 0.00639794 0.0161081 0.0172794 0.0115092 0.0122625 0.0167282 0.0160271 0.0191127 0.00872986 0.00281905 0.00105348 0.00222434 0.00345169 0.00646953 0.00616175 0.00499164 0.00200597 0.00693033 0.0122694 0.00661569 0.00567411 0.00661194 0.00327998 0.00304051 0.00180454 0.0055436 0.00846444 0.00531409 0.00872513 0.00698121 0.0233115 0.0305111 0.0146388 0.00644045 0.00358768 0.00282583 0.00350726 0.00157664 0.00347309 0.00318061 0.00861483 0.0530292 0.0180012 0.008897 0.00683285 0.00637273 0.0136119 0.00881234 0.00391293 0.00808044 0.0111429 0.00697465 0.00282079 0.00230551 0.00274471 0.00104551 0.00124755 0.00367051 0.00609428 0.00344898 0.00360764 0.00210116 0.00824038 0.0135338 0.00884276 0.00735109 0.00627112 0.0077391 0.00886167 0.00868353 0.00609424 0.00751561 0.0369538	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG2 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0313601 0.0553432 0.0574167 0.0376952 0.0305091 0.0225524 0.0112501 0.0116119 0.0224052 0.00202181 0.00206518 0.0034205 0.0072288 0.0038983 0.00388337 0.00760764 0.00364116 0.0136668 0.0337604 0.0327517 0.0319018 0.0327197 0.0181348 0.0205238 0.00822344 0.00315854 0.00118432 0.00256234 0.00394014 0.00662637 0.00635564 0.00505466 0.00197924 0.00679989 0.0120972 0.00648719 0.00538537 0.00621152 0.00312133 0.00290574 0.00174269 0.00532061 0.00808367 0.00509249 0.00835662 0.00666704 0.0224715 0.029441 0.0142197 0.00621708 0.00345831 0.00272724 0.00338641 0.0015288 0.00336386 0.00308554 0.00835512 0.0513594 0.0174183 0.00857248 0.00658348 0.00613204 0.0131632 0.00859984 0.00383092 0.00791625 0.0109191 0.00680096 0.00275102 0.00224847 0.00268009 0.00102204 0.00121965 0.00358746 0.00593943 0.00336356 0.00352149 0.00205082 0.00804582 0.0132197 0.00863583 0.00717102 0.00610173 0.00754964 0.00864372 0.00847076 0.00595764 0.00735478 0.0361893	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG2 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0292618 0.0519048 0.0536227 0.0351386 0.028567 0.0209955 0.0102786 0.0107691 0.0204939 0.00171692 0.00167481 0.00259458 0.0046922 0.00246665 0.00320967 0.00552965 0.00201354 0.00691674 0.0200752 0.0116009 0.0130772 0.0195349 0.0336916 0.0637198 0.0395861 0.024137 0.00652626 0.0140431 0.00582839 0.00923778 0.00800419 0.00598738 0.00225561 0.00676302 0.0123131 0.0064675 0.00530461 0.00604662 0.00303909 0.00277833 0.001662 0.00504649 0.00771205 0.00482769 0.00788914 0.00629921 0.0209966 0.027363 0.0131786 0.00578628 0.00321064 0.00253333 0.00313903 0.00141721 0.00311346 0.0028553 0.00771577 0.0473237 0.0160365 0.00791756 0.00608236 0.00567729 0.0121337 0.00789213 0.00350564 0.00723968 0.00997873 0.00623169 0.00252063 0.00206017 0.00245329 0.000935069 0.00111583 0.00328241 0.00544355 0.0030813 0.00322428 0.00187785 0.0073652 0.0120992 0.00790505 0.00656776 0.00559672 0.00691521 0.00791803 0.0077591 0.00545039 0.00672463 0.0330753	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0297859 0.0528162 0.0544096 0.035586 0.028732 0.0211156 0.0103606 0.0108631 0.0204606 0.00175158 0.00168883 0.00254304 0.00459902 0.00241551 0.00312956 0.00538212 0.00203912 0.00603068 0.0164434 0.00790845 0.00800991 0.0126989 0.0170742 0.0257964 0.0131386 0.00475935 0.00226261 0.0092181 0.0281891 0.0594813 0.0286304 0.0111589 0.00399996 0.00919977 0.0165072 0.0088984 0.00658994 0.00690135 0.00353541 0.00302987 0.00178936 0.0054085 0.00836239 0.00524639 0.00847155 0.00680088 0.0225892 0.0289954 0.0139482 0.0060872 0.00333538 0.0026277 0.00322359 0.00145996 0.00320233 0.0029414 0.00794362 0.0486507 0.016514 0.00815508 0.00626471 0.00585275 0.0124812 0.00811213 0.00359925 0.00743251 0.010241 0.00639412 0.00258629 0.00211329 0.00251498 0.000958664 0.00114395 0.00336535 0.00558074 0.00315876 0.00330537 0.00192506 0.00755052 0.0124028 0.00810389 0.00673351 0.0057379 0.00708858 0.00811698 0.00795409 0.0055875 0.00689361 0.033907	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG2 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0308022 0.0546479 0.0562615 0.0367811 0.0296744 0.0218382 0.0107353 0.0112192 0.021082 0.00179857 0.00174184 0.00263341 0.0047233 0.00250027 0.00320964 0.0054487 0.00205769 0.0062758 0.0172664 0.00933348 0.0105737 0.0178033 0.0263095 0.03523 0.0161312 0.00575006 0.00169526 0.0038445 0.00780736 0.0118896 0.0129094 0.0310797 0.00913366 0.0198465 0.0123201 0.00819975 0.00708437 0.00723554 0.00406394 0.00323793 0.00200406 0.00567628 0.00832213 0.00532615 0.00867207 0.00687856 0.0231008 0.0292422 0.0140957 0.00622516 0.00345066 0.0027366 0.00339383 0.00153684 0.00336871 0.00309163 0.00832885 0.050944 0.0173003 0.00857005 0.00659685 0.00616827 0.013123 0.00846764 0.00374795 0.00772826 0.0106618 0.00666716 0.00269632 0.00220215 0.00262035 0.000998441 0.00119125 0.00350549 0.00581347 0.00329 0.00344307 0.00200531 0.00786334 0.0129116 0.00843937 0.00701785 0.0059834 0.0073831 0.0084564 0.00828606 0.00581955 0.0071771 0.0352943	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0301029 0.0533325 0.0546621 0.0356631 0.0284955 0.0209528 0.0102932 0.0106671 0.0197042 0.00171913 0.00163715 0.00234749 0.00420563 0.00223882 0.00286866 0.00477357 0.00181801 0.00501615 0.0129074 0.00606427 0.00595099 0.00996976 0.0125047 0.0177244 0.00804656 0.00271701 0.000991262 0.00214606 0.00374268 0.0068524 0.00642312 0.00586349 0.00267787 0.0117665 0.0266055 0.017142 0.0161491 0.0261201 0.0177586 0.0213561 0.00783699 0.0129654 0.0103346 0.00934227 0.0134446 0.0111068 0.0306751 0.0378002 0.0174459 0.00748937 0.0038687 0.00299867 0.00354223 0.00163631 0.00351729 0.00326201 0.00862908 0.0522746 0.0175655 0.00866873 0.00665853 0.00628118 0.0131124 0.00853705 0.00374995 0.00774526 0.0105908 0.00660305 0.00267136 0.00218085 0.00258074 0.000984138 0.00117442 0.00345604 0.00573966 0.00324651 0.00339413 0.00197649 0.00775544 0.0127383 0.00832283 0.00691443 0.00589623 0.00727322 0.00832928 0.00816254 0.00572749 0.00706422 0.0347512	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0297339 0.0526515 0.0539366 0.0351329 0.0280782 0.0206412 0.0101194 0.0105098 0.0193598 0.00169723 0.00160758 0.00231034 0.00410544 0.00215984 0.00277387 0.00458221 0.00175133 0.00479566 0.012107 0.00560311 0.00542422 0.00931234 0.0111735 0.0163819 0.00731136 0.0024921 0.000939529 0.00199846 0.00336601 0.00618143 0.0057855 0.00496232 0.00217045 0.00857184 0.0195289 0.0110797 0.00945974 0.0134376 0.00678839 0.00608573 0.00352773 0.0157496 0.0512874 0.0510391 0.0259797 0.0116395 0.0216592 0.0333365 0.0156491 0.00688184 0.00379624 0.00293288 0.00357862 0.0016169 0.003464 0.0032043 0.00855137 0.0525448 0.0176213 0.00865309 0.00660739 0.00623539 0.0129669 0.00846363 0.00371056 0.00766907 0.0104763 0.0065268 0.00264008 0.00215388 0.00254572 0.000971331 0.00115929 0.00341193 0.00566507 0.00320418 0.00334983 0.00195059 0.00765499 0.0125738 0.00821573 0.00682453 0.0058175 0.00717646 0.00821903 0.00805477 0.00565289 0.00697306 0.0343082	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0285121 0.0505116 0.0517466 0.0336859 0.0269138 0.0197757 0.00969092 0.0100813 0.018546 0.00162584 0.00153763 0.0022097 0.00391838 0.00205275 0.0026394 0.00435448 0.00166547 0.0045472 0.0114064 0.00524725 0.00505497 0.00874203 0.0103804 0.0153325 0.00683189 0.00232691 0.000891271 0.00187713 0.00313159 0.00573639 0.00536101 0.00450407 0.00193406 0.0071031 0.0149953 0.0081551 0.00681193 0.00877843 0.00448428 0.00344306 0.00206744 0.00806444 0.0223415 0.0217358 0.04632 0.0644485 0.0485288 0.0382933 0.0201404 0.00902683 0.00426086 0.00307574 0.00349325 0.00163917 0.00348666 0.00322336 0.00846308 0.0527197 0.0177903 0.00870506 0.00663032 0.00624316 0.0127931 0.00827385 0.00361479 0.00747601 0.0102205 0.00634664 0.00256683 0.00209026 0.00246312 0.000940281 0.0011221 0.00330488 0.00547487 0.00309813 0.00324098 0.00188688 0.00740892 0.0121627 0.00794839 0.00660757 0.00562525 0.00693293 0.00794263 0.00778421 0.00546973 0.0067482 0.033215	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0318748 0.0564114 0.0577467 0.0375878 0.0300291 0.0220602 0.0108018 0.0112212 0.020629 0.00180845 0.00170497 0.00243635 0.00431089 0.00225422 0.00291337 0.00479269 0.00182753 0.00496604 0.0123663 0.00566389 0.00545163 0.00957416 0.0112093 0.0166157 0.00726882 0.00248857 0.000964534 0.00202242 0.00326747 0.00598768 0.00573172 0.00454396 0.00188759 0.00648702 0.0118693 0.00638043 0.00548088 0.00656072 0.00321799 0.00308816 0.00178722 0.00583141 0.00929485 0.00576087 0.00999891 0.00857599 0.0330706 0.0528463 0.0328955 0.022201 0.0171756 0.0166443 0.0284285 0.00592964 0.0127859 0.00293168 0.00542512 0.0410448 0.0145404 0.00729878 0.0071548 0.00709982 0.015675 0.00967062 0.00421433 0.0087872 0.0119651 0.00732963 0.00294703 0.00239701 0.00271553 0.00105397 0.00125873 0.00371158 0.006184 0.00347992 0.00362767 0.0021142 0.00830442 0.0136431 0.00891948 0.00740433 0.0063289 0.00775696 0.00889769 0.00873065 0.00609713 0.00751091 0.0370484	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0317301 0.0561625 0.0574924 0.0374037 0.029878 0.0219397 0.0107378 0.0111729 0.0205276 0.00179814 0.00169362 0.00242134 0.00429026 0.0022351 0.0028762 0.00473432 0.00180533 0.00489772 0.0121786 0.00556695 0.00533238 0.00938458 0.0109722 0.0162861 0.007096 0.00243327 0.000949863 0.00197757 0.00319907 0.00587091 0.00559467 0.00445633 0.00183369 0.00621393 0.0111286 0.00596946 0.00513097 0.00607129 0.00308377 0.00286959 0.0017209 0.00523062 0.00789315 0.00498543 0.00819564 0.00656017 0.0220763 0.0293728 0.0143972 0.00633863 0.00354994 0.00276459 0.00346962 0.00154948 0.00348576 0.00325234 0.00886112 0.0546882 0.0211627 0.0115187 0.00907658 0.00893598 0.0208256 0.0162887 0.00878471 0.020865 0.0258174 0.0152231 0.0136844 0.0148655 0.0130897 0.00299362 0.00464995 0.00895513 0.00762895 0.00518801 0.00455278 0.00265751 0.00999162 0.0173689 0.0123054 0.00898896 0.00722446 0.00843918 0.0101423 0.00993294 0.00634804 0.00796735 0.0387385	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0314318 0.0556286 0.0569438 0.0370476 0.0295948 0.0217326 0.0106363 0.011066 0.0203334 0.00178146 0.00167806 0.00239917 0.00425079 0.00221486 0.00284992 0.00469031 0.00178857 0.00485254 0.0120667 0.00551656 0.00528534 0.00930046 0.0108737 0.0161414 0.00702926 0.00241101 0.000941159 0.0019594 0.00316941 0.00581955 0.005544 0.00441519 0.00181682 0.00615676 0.0110205 0.00591256 0.00508422 0.00601844 0.003058 0.00284452 0.00170635 0.00518324 0.00782158 0.00493994 0.00811406 0.00649209 0.0218519 0.0290223 0.0142158 0.00625416 0.00350275 0.00273529 0.00341983 0.00152976 0.00343022 0.00319876 0.00872297 0.0535383 0.0200888 0.0106297 0.00816095 0.00794777 0.0178015 0.0134988 0.00642823 0.0142616 0.017934 0.0118936 0.00554159 0.00447539 0.00486209 0.00158548 0.00236069 0.00991694 0.0399009 0.0375211 0.0178474 0.00310914 0.00626772 0.0142082 0.0109607 0.00808719 0.00609731 0.007933 0.00989789 0.00982795 0.00602771 0.00780387 0.0381381	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0325824 0.0576671 0.0590311 0.0384053 0.0306786 0.0225283 0.0110258 0.0114715 0.0210772 0.00184658 0.00173934 0.00248669 0.00440602 0.00229569 0.00295366 0.0048612 0.00185384 0.00502923 0.0125056 0.00571701 0.00547667 0.00963707 0.011268 0.0167258 0.00728463 0.00249848 0.000975388 0.0020305 0.00328458 0.00603006 0.00574467 0.00457578 0.00188283 0.00637966 0.0114209 0.00612712 0.005267 0.00623188 0.00316645 0.00294583 0.00176752 0.00536801 0.00809673 0.0051138 0.00839919 0.0067139 0.0225904 0.0299698 0.0146566 0.00645102 0.00361371 0.00282925 0.00353696 0.00158486 0.00353027 0.00327665 0.00893727 0.0553221 0.0204552 0.0107558 0.00820012 0.00778425 0.0179799 0.013632 0.00712613 0.015608 0.0187509 0.0118797 0.0056302 0.00446229 0.00388933 0.00120392 0.00152325 0.00667277 0.019189 0.0102043 0.00751608 0.00987449 0.022155 0.0163562 0.0132796 0.0103841 0.00801403 0.00905983 0.0116887 0.0109816 0.00649889 0.00859768 0.0397733	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0313441 0.0554704 0.0567804 0.0369418 0.0295101 0.0216714 0.0106063 0.0110337 0.0202737 0.00177658 0.00167351 0.0023925 0.00423899 0.00220909 0.00284189 0.00467648 0.00178353 0.00483842 0.0120315 0.00550111 0.00527082 0.00927308 0.0108433 0.0160958 0.00700648 0.00240372 0.000938444 0.00195337 0.00315958 0.00580333 0.00552646 0.00440184 0.00181143 0.00613691 0.01098 0.00589114 0.00506395 0.00599149 0.00304422 0.0028319 0.00170021 0.00516019 0.00777992 0.00491062 0.00806155 0.00643379 0.0216426 0.0286044 0.0139441 0.00611994 0.00343109 0.00269343 0.00336321 0.00151452 0.00336785 0.00309899 0.00839854 0.0518828 0.0183267 0.00929536 0.007107 0.00668434 0.0146334 0.0100769 0.00460283 0.0098417 0.0133361 0.00898595 0.00355116 0.00275509 0.00350625 0.00121675 0.00156446 0.00499084 0.0100791 0.0056421 0.00622642 0.00352436 0.0161345 0.0279758 0.0194588 0.0184851 0.0186379 0.0165014 0.0182192 0.0283832 0.0249481 0.0140409 0.0371378	DRUG0 may interact with the following drugs : DRUG1 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0276407 0.0480805 0.04871 0.0303285 0.0252413 0.0197589 0.00927395 0.0107728 0.00614952 0.00391215 0.00709659 0.0225125 0.0395463 0.0364951 0.0179232 0.00953846 0.0038481 0.0098741 0.0177355 0.00819079 0.00703988 0.0120687 0.0128632 0.0177618 0.00792342 0.00253831 0.00100536 0.00215922 0.00339493 0.00649791 0.00622932 0.00500429 0.00200406 0.00701126 0.0125632 0.00678625 0.00574951 0.0067381 0.00338577 0.00317232 0.00190369 0.00583419 0.00886898 0.00559562 0.00920456 0.00734204 0.0248796 0.0326273 0.0157484 0.00687655 0.00382402 0.00301478 0.00374384 0.00168945 0.00371997 0.00341286 0.00924946 0.0569031 0.0193125 0.00949799 0.00729369 0.00678886 0.0145837 0.00952213 0.00424337 0.00876811 0.012101 0.00753259 0.00304691 0.0024899 0.0029684 0.00113208 0.00135093 0.00397393 0.00657532 0.00372424 0.00389986 0.00227112 0.00891084 0.0146402 0.00956384 0.00794194 0.00675495 0.00835877 0.0095704 0.00937898 0.00659889 0.00814732 0.0400931	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG2 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0302691 0.0525466 0.0517398 0.0314339 0.0275178 0.0209566 0.00889353 0.00861765 0.00492485 0.00280224 0.0051302 0.0185969 0.0190807 0.00860793 0.00891582 0.0346111 0.00681682 0.0171793 0.01985 0.01293 0.0135854 0.0182699 0.0170957 0.0199828 0.0091559 0.00295963 0.00110719 0.00234302 0.00362838 0.00678864 0.00649162 0.00525495 0.0021088 0.00728154 0.0128786 0.00695884 0.00597557 0.00695112 0.00343905 0.00318039 0.00188527 0.00580882 0.00888295 0.00557686 0.00915484 0.00733406 0.0244507 0.0319629 0.0153125 0.00674935 0.00375625 0.00295617 0.00366697 0.0016462 0.00362907 0.00332265 0.00900327 0.0555293 0.0188463 0.00932508 0.00716132 0.00668162 0.0142479 0.00919966 0.00408078 0.00842665 0.0116173 0.00728242 0.00294513 0.00240713 0.00286426 0.00109061 0.00130134 0.00382922 0.00636375 0.00360086 0.00376525 0.00219297 0.00860011 0.0141225 0.00922764 0.00767376 0.00655179 0.00807808 0.00924999 0.00906386 0.00635658 0.00783652 0.0385237	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG2 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0293949 0.0511545 0.0501383 0.0302584 0.0262311 0.0201163 0.00835596 0.00767214 0.00455397 0.00236736 0.00357048 0.0141738 0.0109073 0.00545569 0.00451139 0.00893784 0.0041671 0.0156722 0.0393624 0.0370722 0.0350364 0.0354345 0.0196488 0.0214997 0.00857737 0.0032612 0.00122241 0.00262398 0.00401711 0.00677699 0.00651075 0.00517929 0.00202757 0.00695743 0.0123719 0.00663971 0.00552276 0.00636719 0.00319373 0.00296986 0.00177976 0.00543814 0.00826974 0.00520812 0.00854486 0.00682099 0.0229739 0.030095 0.0145282 0.00635858 0.00353757 0.00278926 0.00346294 0.00156237 0.00343821 0.00315302 0.00853843 0.0525514 0.0178248 0.00877853 0.00674124 0.00628069 0.0134717 0.0087943 0.00391589 0.0080915 0.0111587 0.00695599 0.00281367 0.00229984 0.00274083 0.00104504 0.0012471 0.00366818 0.00607653 0.00344074 0.00360163 0.00209754 0.0082285 0.0135196 0.00883185 0.00733462 0.00624379 0.0077229 0.00884207 0.00866502 0.00609186 0.00751928 0.0369941	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG2 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0284204 0.0498737 0.048661 0.0293811 0.0253378 0.0191943 0.00791657 0.00676862 0.00437188 0.0022366 0.00325365 0.013365 0.00762743 0.00367144 0.00382346 0.00659822 0.00228519 0.00771717 0.0218841 0.0122707 0.0137357 0.0210268 0.035884 0.0656686 0.0405272 0.0240833 0.00654856 0.0143403 0.00594753 0.00950785 0.00824976 0.00617688 0.00232533 0.00695347 0.0126479 0.00664754 0.00546272 0.00621778 0.00311624 0.00284344 0.00169936 0.0051643 0.00789791 0.00494271 0.00807482 0.00645157 0.0214878 0.0279962 0.0134789 0.00592527 0.00328815 0.00259391 0.00321386 0.00144992 0.00318608 0.00292104 0.00789345 0.0484891 0.0164341 0.00812063 0.00623824 0.00582464 0.0124373 0.00808096 0.00358764 0.00740848 0.0102095 0.00638177 0.00258128 0.00210986 0.00251192 0.000957232 0.00114228 0.00336025 0.00557604 0.00315584 0.00330164 0.00192295 0.00754148 0.0123882 0.00809412 0.00672584 0.00573435 0.0070824 0.00810951 0.00794661 0.0055797 0.00688287 0.0338488	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0291033 0.0510942 0.0497809 0.0300695 0.0258891 0.0196414 0.00812432 0.00706057 0.00450113 0.00230229 0.00336167 0.0136516 0.00754168 0.00360109 0.00372888 0.00645828 0.00232171 0.00675836 0.0180244 0.00840439 0.00841497 0.0136134 0.0181255 0.0264415 0.0135301 0.00480114 0.00227076 0.00930677 0.0287513 0.0604735 0.0291747 0.0114376 0.00408242 0.0093772 0.0168197 0.00907862 0.00674781 0.00707356 0.00361656 0.0030968 0.00182828 0.00552953 0.0085533 0.00536573 0.00866309 0.00695752 0.0230964 0.029649 0.0142605 0.00622944 0.00341397 0.00268927 0.003299 0.00149344 0.00327614 0.00300859 0.008125 0.0498245 0.0169139 0.00835708 0.00641973 0.00599895 0.0127852 0.00830515 0.00368373 0.00760686 0.0104794 0.00654723 0.00264819 0.00216401 0.00257495 0.000981394 0.00117108 0.00344515 0.0057157 0.00323482 0.00338444 0.00197114 0.00773087 0.0126988 0.00829739 0.00689486 0.00587755 0.00725921 0.00831233 0.00814545 0.0057201 0.0070563 0.0347038	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG2 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0299952 0.0526248 0.0513034 0.030971 0.0266196 0.020188 0.00833351 0.00721331 0.00461571 0.00234622 0.00342276 0.0139718 0.00771537 0.003741 0.00383225 0.00654986 0.00234914 0.0070245 0.018895 0.00987838 0.0111057 0.0191142 0.0280522 0.0361488 0.0165052 0.00575982 0.00170283 0.00388005 0.00794484 0.0122139 0.0132896 0.0318397 0.00934491 0.020448 0.0127428 0.00846358 0.0073008 0.00743709 0.00416255 0.0033133 0.0020488 0.00580079 0.00850901 0.0054466 0.00886845 0.00703748 0.0236167 0.0299042 0.0144127 0.00637048 0.00353182 0.00280051 0.00347316 0.00157213 0.00344649 0.00316245 0.00851948 0.0521711 0.0177177 0.00878133 0.00675955 0.00632179 0.0134421 0.00866871 0.00383575 0.00790922 0.0109095 0.00682625 0.00276063 0.00225478 0.00268255 0.00102201 0.00121937 0.00358827 0.0059533 0.00336882 0.00352506 0.00205309 0.00805033 0.0132183 0.00863994 0.00718528 0.00612828 0.0075598 0.00865877 0.00848429 0.00595696 0.00734565 0.0361198	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0293206 0.0513628 0.0499859 0.0301767 0.0258495 0.0195813 0.00806389 0.00715922 0.00447478 0.00227355 0.00329129 0.0131821 0.00685301 0.0033314 0.00342669 0.00576705 0.00207243 0.00562501 0.0141153 0.00641025 0.00621034 0.0106346 0.0132109 0.0181252 0.00827842 0.0027504 0.001006 0.00219528 0.00378984 0.0069989 0.00658198 0.00601291 0.0027279 0.0120518 0.0273965 0.0176788 0.016671 0.0268355 0.0182392 0.0218826 0.00802134 0.0132932 0.0105979 0.00956329 0.0137624 0.0113708 0.0313952 0.0387061 0.0178562 0.00766729 0.00395737 0.00306668 0.00362097 0.00167151 0.0035935 0.00333217 0.00881465 0.0534353 0.0179562 0.00886572 0.0068106 0.00642552 0.0134041 0.00871416 0.00382614 0.00790177 0.0108052 0.00674049 0.00272694 0.00222619 0.00263395 0.00100429 0.00119844 0.00352691 0.00585917 0.00331391 0.00346422 0.00201731 0.00791546 0.0130003 0.0084942 0.00705785 0.00602029 0.00742368 0.00850173 0.00833145 0.00584458 0.00720774 0.0354546	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0290902 0.0510022 0.0496123 0.0299363 0.0256304 0.0194077 0.00800392 0.0070562 0.00443399 0.00223179 0.0032396 0.0129653 0.0066716 0.00320766 0.00330463 0.00554391 0.00199617 0.00537853 0.0132334 0.00592518 0.00566178 0.00994791 0.0118104 0.0167593 0.00752718 0.0025256 0.000954698 0.00204733 0.00340836 0.00631553 0.0059339 0.00508886 0.00220894 0.00876498 0.0199996 0.0113622 0.00970996 0.0137076 0.0068845 0.00617569 0.00357697 0.0160451 0.0524088 0.0520974 0.0265663 0.0119078 0.0221709 0.034107 0.0160076 0.00704105 0.00388137 0.00299762 0.00365508 0.00164991 0.00353553 0.00326981 0.00872512 0.0536701 0.0179998 0.00884437 0.00675417 0.00637529 0.0132455 0.00863108 0.00378209 0.00781576 0.0106767 0.00665654 0.00269253 0.00219668 0.00259582 0.000990281 0.00118189 0.00347861 0.00577817 0.00326786 0.00341594 0.00198911 0.00780582 0.0128207 0.00837728 0.00695989 0.00593513 0.00731864 0.008382 0.00821439 0.00576307 0.00710788 0.0349681	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0279081 0.0489683 0.0476447 0.0287399 0.0246044 0.0186293 0.00768659 0.00675564 0.00425381 0.00213674 0.00310102 0.0124185 0.00636627 0.00304474 0.00314155 0.0052681 0.00189778 0.00509891 0.0124598 0.00554696 0.00527618 0.00933797 0.0109694 0.0156795 0.00703279 0.00235738 0.000905893 0.00192344 0.00316991 0.00585934 0.00549908 0.00461913 0.00196875 0.00726193 0.0153337 0.00835747 0.00698714 0.00895785 0.00454402 0.00349093 0.00209567 0.00820469 0.0227959 0.0221544 0.0472231 0.0656632 0.0494629 0.0391177 0.0205635 0.00921784 0.00434549 0.00313625 0.00355906 0.00166936 0.00354999 0.00328123 0.00861372 0.053745 0.0181391 0.00887922 0.0067638 0.00636959 0.013046 0.00843078 0.00368248 0.0076159 0.0104118 0.00646838 0.00261606 0.00213041 0.00251018 0.000958148 0.00114341 0.00336771 0.00558057 0.00315774 0.00330304 0.00192302 0.00755061 0.0123949 0.00810028 0.00673444 0.00573468 0.00706621 0.00809537 0.00793385 0.00557371 0.00687582 0.033841	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0312901 0.0548452 0.0533236 0.0321632 0.0275264 0.0208191 0.00858519 0.00755855 0.00475846 0.00238968 0.00346029 0.0138112 0.00700454 0.00334853 0.00347892 0.00582157 0.00208818 0.00558842 0.0135426 0.00600298 0.00570649 0.010259 0.0118758 0.0170321 0.00750414 0.00253083 0.000983871 0.00208081 0.00332144 0.00613881 0.00590426 0.00467814 0.00192881 0.00665874 0.0121471 0.00654429 0.00563352 0.00672399 0.00328101 0.00315086 0.00181979 0.00595539 0.00952255 0.00589568 0.0102303 0.00878515 0.0338151 0.0540117 0.0335863 0.0226821 0.0175558 0.0170195 0.0290245 0.00605328 0.0130569 0.00299264 0.00553711 0.0419479 0.0148611 0.00746905 0.00732067 0.00726772 0.0160299 0.00987395 0.0043002 0.00896379 0.012205 0.00748291 0.00300872 0.00244729 0.00277203 0.00107571 0.00128466 0.00378822 0.00631421 0.00355291 0.00370327 0.00215826 0.00847734 0.0139262 0.00910489 0.00755941 0.00646387 0.00791924 0.00908392 0.00891332 0.00622277 0.00766448 0.0378029	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0311699 0.0546603 0.0531355 0.0320432 0.0274164 0.0207318 0.00855328 0.00751489 0.00473387 0.00237391 0.00344519 0.0137744 0.00697637 0.00332102 0.0034322 0.00574742 0.00206263 0.00550868 0.0133315 0.00589904 0.00557961 0.0100522 0.0116226 0.0166918 0.00732624 0.00247402 0.000968938 0.00203488 0.0032515 0.00601867 0.00576311 0.00458788 0.00187393 0.00637841 0.0113873 0.00612132 0.00527271 0.00622297 0.00314258 0.00292585 0.00175193 0.00533926 0.00808357 0.00509956 0.00838105 0.00671546 0.0225625 0.0300144 0.014699 0.00648091 0.00362909 0.00282505 0.00354582 0.00158171 0.00355971 0.00332052 0.00904755 0.0559134 0.0216328 0.0117859 0.00928615 0.009146 0.021288 0.0166243 0.00896027 0.0212682 0.0263125 0.0155271 0.0139553 0.0151613 0.0133493 0.00305381 0.00474292 0.00913562 0.00778614 0.00529433 0.00464645 0.0027118 0.0101951 0.0177213 0.0125586 0.00917435 0.00737604 0.00861368 0.0103519 0.0101377 0.00647719 0.00812825 0.0395191	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0308726 0.054134 0.0526206 0.0317332 0.0271509 0.0205305 0.00847015 0.00744315 0.00468847 0.00235082 0.00341202 0.013639 0.00690919 0.00329017 0.00339998 0.00569266 0.00204294 0.00545644 0.0132058 0.00584421 0.00552906 0.00995965 0.0115154 0.0165395 0.00725544 0.00245079 0.000959817 0.00201569 0.00322054 0.00596459 0.0057095 0.00454437 0.00185622 0.00631814 0.0112737 0.00606133 0.0052233 0.00616714 0.00311547 0.00289948 0.00173665 0.00528944 0.00800811 0.00505165 0.00829536 0.00664395 0.022327 0.0296482 0.0145098 0.00639278 0.00357985 0.00279434 0.00349402 0.00156118 0.00350207 0.00326494 0.00890396 0.0547226 0.0205292 0.0108732 0.00834735 0.00813238 0.0181917 0.0137726 0.00655438 0.0145339 0.018276 0.012132 0.00565253 0.00456542 0.00495908 0.00161713 0.00240735 0.0101123 0.0407149 0.038278 0.0182108 0.00317264 0.00639492 0.0144951 0.0111856 0.00825298 0.00622388 0.00809477 0.0100997 0.0100276 0.00614824 0.00795869 0.0388938	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0320247 0.056156 0.0545873 0.0329192 0.0281656 0.0212982 0.00878685 0.00772135 0.00486347 0.00243864 0.00353954 0.0141497 0.00716734 0.00341281 0.00352631 0.00590435 0.00211907 0.00565928 0.0136963 0.00606103 0.00573343 0.0103277 0.0119418 0.017151 0.00752465 0.00254158 0.000995462 0.00209038 0.00334004 0.0061849 0.00592053 0.00471314 0.00192509 0.00655173 0.011692 0.00628599 0.00541513 0.00639067 0.00322838 0.00300503 0.00180026 0.00548213 0.00829604 0.00523337 0.00859332 0.00687613 0.0230989 0.0306393 0.0149709 0.00659899 0.00369605 0.00289251 0.00361644 0.00161864 0.00360696 0.00334696 0.00912946 0.0565901 0.0209193 0.0110103 0.00839322 0.00797074 0.0183873 0.0139188 0.00727123 0.015917 0.0191209 0.0121258 0.0057464 0.00455491 0.0039698 0.00122895 0.00155465 0.00680972 0.0195963 0.0104209 0.00767385 0.0100817 0.0226221 0.0167039 0.0135651 0.010607 0.00818781 0.00925193 0.0119362 0.0112131 0.00663386 0.00877476 0.0405905	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0307853 0.0539782 0.0524679 0.0316417 0.0270721 0.0204712 0.00844546 0.00742317 0.00467499 0.00234385 0.00340233 0.0135985 0.006889 0.0032815 0.00339017 0.00567559 0.00203706 0.00544019 0.0131667 0.00582757 0.0055136 0.00992977 0.0114825 0.016492 0.00723154 0.00244327 0.000956996 0.00200939 0.00321039 0.00594769 0.00569113 0.00453037 0.00185061 0.00629745 0.0112317 0.00603902 0.00520224 0.00613928 0.00310131 0.00288652 0.00173033 0.00526572 0.0079651 0.00502144 0.00824132 0.00658404 0.0221122 0.0292202 0.0142317 0.00625538 0.00350651 0.00275149 0.0034362 0.00154563 0.00343842 0.00316304 0.00857238 0.0530297 0.0187272 0.00950797 0.00726903 0.00683951 0.0149551 0.0102814 0.00469287 0.0100313 0.0135915 0.00916783 0.00362303 0.00281099 0.00357652 0.00124095 0.00159548 0.00508993 0.010286 0.00575727 0.00635231 0.00359567 0.01646 0.0285383 0.019847 0.0188503 0.019016 0.0168366 0.0185894 0.0289561 0.0254545 0.0143263 0.0378635	DRUG0 may interact with the following drugs : DRUG0 and other DRUG1 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0209627 0.0345626 0.0345912 0.0200899 0.0148665 0.0114699 0.00569676 0.00571664 0.00370867 0.00154323 0.00247954 0.0105965 0.0231288 0.0293151 0.0510367 0.0564063 0.0155019 0.026355 0.0222708 0.014902 0.0151306 0.0195596 0.0176875 0.0200383 0.00900233 0.00287507 0.00108158 0.00227808 0.00355225 0.006642 0.00636346 0.00514677 0.00206367 0.00712525 0.0125858 0.00678863 0.00581159 0.00675552 0.00334684 0.00309048 0.00183376 0.00563945 0.00859485 0.00540089 0.00886946 0.00709819 0.0236848 0.0309427 0.0148264 0.00652589 0.00362993 0.00285737 0.00354397 0.00159229 0.00350932 0.00321448 0.00871122 0.0536186 0.0181918 0.00899183 0.00690548 0.00644038 0.0137463 0.00888346 0.00394257 0.00814184 0.0112273 0.0070302 0.0028432 0.00232363 0.00276548 0.00105321 0.0012567 0.00369791 0.00614113 0.00347548 0.00363496 0.00211702 0.00830317 0.0136355 0.00890902 0.00740774 0.00632086 0.00779656 0.00892763 0.00874814 0.00613823 0.00756896 0.0372145	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG2 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0194144 0.0329301 0.0316649 0.0181656 0.0132672 0.0100327 0.00479802 0.00401188 0.00300887 0.0011913 0.00165902 0.00857336 0.0209848 0.0313908 0.0457864 0.0184344 0.00540027 0.0136553 0.0278923 0.0180809 0.0198581 0.0226908 0.0389801 0.0685237 0.0421683 0.0260758 0.00680918 0.0140959 0.00585324 0.00882909 0.00764814 0.00568044 0.0021318 0.00638316 0.0116074 0.00609591 0.00497239 0.00563131 0.00282661 0.0025774 0.00154371 0.00469284 0.00717462 0.00449556 0.00734474 0.00586904 0.0195584 0.0254596 0.0122517 0.00538034 0.00298042 0.00235014 0.00290968 0.00131344 0.00288638 0.00264794 0.00715905 0.0439502 0.0148809 0.00734542 0.00564205 0.00526636 0.0112502 0.00731446 0.00324843 0.0067099 0.00924592 0.00577532 0.00233604 0.00190937 0.00227317 0.000866315 0.00103379 0.00304121 0.00504497 0.00285565 0.00298774 0.00174005 0.00682528 0.0112119 0.00732493 0.00608611 0.00518721 0.00640749 0.00733651 0.00718929 0.00504902 0.00622902 0.0306368	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0207993 0.0352914 0.0339282 0.0194522 0.0141999 0.0107441 0.00514843 0.00430678 0.003233 0.00127755 0.00178352 0.00920471 0.0224369 0.0333522 0.0484906 0.018785 0.00567505 0.013077 0.0247311 0.0149614 0.0163553 0.021581 0.0313781 0.0393264 0.0176194 0.0064391 0.00175216 0.00387036 0.0078316 0.0116878 0.0126373 0.030025 0.0088406 0.0189574 0.0117263 0.00779386 0.00671257 0.00681376 0.00381765 0.00303131 0.00187629 0.00531401 0.00779092 0.00498693 0.00811495 0.00643963 0.0216011 0.0273354 0.0131731 0.00582327 0.00322695 0.00255854 0.00317207 0.0014362 0.00314818 0.00288915 0.00778368 0.0476882 0.016189 0.00802216 0.00617462 0.005775 0.0122792 0.0079235 0.00350632 0.00723105 0.00997182 0.00623948 0.00252337 0.00206114 0.00245205 0.000934191 0.00111461 0.00327992 0.00544241 0.00307969 0.00322232 0.00187676 0.00735913 0.0120838 0.00789806 0.00656788 0.00560195 0.00691076 0.00791513 0.00775569 0.00544499 0.00671436 0.0330157	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0208103 0.0352605 0.0338738 0.0194029 0.0141315 0.0107019 0.00513293 0.00431983 0.00323743 0.00127681 0.0017802 0.00921237 0.0222605 0.0327349 0.0470974 0.0170917 0.00516226 0.0108692 0.018902 0.00970497 0.00941048 0.0128964 0.0160039 0.0201374 0.00880883 0.00300558 0.00101352 0.00215779 0.00383914 0.00679064 0.00634753 0.00577741 0.00260782 0.0113781 0.0258052 0.0166116 0.0155102 0.0249458 0.0169153 0.0203121 0.00745744 0.0123204 0.00983616 0.008893 0.0128141 0.0105944 0.0292416 0.0360485 0.0166442 0.00715042 0.003692 0.00286125 0.00337936 0.00156143 0.00335606 0.00311218 0.00822904 0.0499266 0.0167718 0.00827897 0.00635849 0.00599961 0.0125219 0.00815857 0.00358354 0.00740273 0.0101182 0.00631069 0.00255313 0.0020846 0.0024666 0.000940554 0.00112244 0.0033029 0.00548759 0.00310368 0.00324432 0.00188928 0.00741304 0.0121765 0.00795551 0.00660891 0.00563716 0.00695328 0.00796259 0.00780318 0.00547392 0.00675105 0.0332088	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0198861 0.0337102 0.0323627 0.0185246 0.0134782 0.0102027 0.00489909 0.00411445 0.00309594 0.0012192 0.00170373 0.0087753 0.021103 0.0308359 0.0441824 0.0157609 0.00471692 0.00993119 0.0168686 0.00838082 0.00799014 0.0113418 0.0134025 0.0174488 0.0075047 0.00257101 0.000912612 0.00189713 0.00323419 0.00572219 0.0053297 0.00446524 0.00189508 0.00691744 0.0146497 0.00796905 0.00660634 0.00845046 0.00431557 0.00330037 0.00198202 0.00773745 0.021478 0.0208777 0.0444035 0.0617675 0.0465062 0.0367594 0.0193314 0.0086749 0.00409469 0.00295474 0.00335363 0.00157403 0.00334721 0.00309408 0.00812151 0.05068 0.0170973 0.00836806 0.006373 0.0060023 0.0122958 0.00795588 0.00347548 0.0071894 0.0098245 0.00610358 0.00246855 0.00201047 0.00236871 0.000904148 0.001079 0.00317785 0.00526703 0.00298025 0.0031171 0.00181477 0.0071257 0.011698 0.00764447 0.00635488 0.00541191 0.00666892 0.00763991 0.00748754 0.00525955 0.00648828 0.0319334	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0221793 0.0375755 0.0360167 0.0206056 0.0149808 0.0113367 0.00544222 0.00457535 0.0034475 0.00135719 0.00189656 0.00978925 0.0235117 0.0344054 0.0491496 0.0173148 0.00515538 0.0108494 0.0182767 0.00899556 0.00856098 0.0123985 0.0144551 0.0188535 0.00795685 0.00273289 0.00098303 0.0020379 0.00336143 0.00595409 0.00567944 0.00448614 0.00184117 0.006296 0.0115496 0.00621058 0.0052979 0.00630473 0.00309031 0.00295387 0.00171101 0.00559172 0.00892209 0.00553063 0.00957552 0.00822887 0.0316201 0.0504865 0.0313918 0.0212109 0.0164019 0.0158929 0.0270717 0.00565435 0.0121946 0.00279396 0.00516854 0.0392141 0.0138846 0.00697327 0.00683702 0.00678673 0.0149879 0.00926224 0.0040359 0.00841605 0.0114502 0.00702038 0.00282276 0.00229648 0.0026012 0.00100946 0.0012056 0.00355464 0.0059271 0.00333481 0.00347548 0.00202553 0.0079558 0.0130711 0.00854533 0.00709326 0.00606618 0.00743373 0.00852636 0.00836626 0.00583971 0.00719272 0.0354756	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0220844 0.0374223 0.035876 0.0205265 0.0149226 0.0112929 0.00542332 0.00455902 0.00343547 0.00135211 0.00189379 0.00976661 0.0234518 0.0342649 0.0490202 0.0171631 0.00509577 0.0107055 0.0180255 0.0088446 0.00837377 0.0121501 0.0141441 0.0184644 0.00776215 0.00267064 0.000967442 0.00199172 0.00329024 0.00583605 0.00554122 0.0043972 0.00178743 0.00602861 0.0108233 0.00580736 0.00495709 0.00583225 0.00296089 0.00274482 0.00164728 0.00501464 0.00757497 0.00478488 0.00784603 0.00629211 0.0211003 0.0280638 0.0137492 0.00606638 0.00339348 0.0026406 0.00331149 0.00147808 0.00332558 0.00310336 0.00845529 0.0523942 0.020244 0.0110251 0.00868361 0.00855443 0.0199138 0.015588 0.00840512 0.0199594 0.0246709 0.0145612 0.0130886 0.0142186 0.0125177 0.00286492 0.00444897 0.00856858 0.00730344 0.00496652 0.00435906 0.00254419 0.00956598 0.0166313 0.011786 0.00860918 0.00692183 0.00808413 0.00971463 0.00951419 0.00607759 0.00762675 0.0370835	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0226498 0.0383796 0.0367912 0.0210499 0.0153028 0.0115805 0.00556129 0.00467552 0.00352312 0.00138654 0.00194224 0.0100162 0.0240495 0.0351379 0.0502714 0.0176034 0.00522615 0.0109788 0.0184863 0.00907156 0.00858925 0.0124614 0.0145072 0.0189388 0.00795833 0.00273867 0.000992163 0.0020424 0.00337385 0.00598654 0.00568248 0.00450924 0.00183296 0.00618141 0.0110933 0.00595306 0.00508195 0.00597883 0.00303637 0.00281414 0.00168973 0.00513975 0.00776036 0.00490178 0.00803056 0.00643128 0.0215638 0.0285976 0.013979 0.00616607 0.00345 0.0026989 0.0033715 0.00150994 0.00336383 0.00312254 0.00851696 0.0529342 0.0195422 0.0102819 0.00783553 0.00744299 0.0171711 0.0130284 0.00680848 0.0149109 0.0178934 0.0113514 0.0053798 0.00426488 0.00371723 0.00115102 0.00145602 0.00637764 0.0183595 0.00976193 0.00718747 0.00944546 0.021192 0.0156497 0.0127078 0.00993562 0.00766948 0.00866806 0.0111816 0.0105059 0.00621369 0.00821928 0.0380255	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0218283 0.0369863 0.0354525 0.0202836 0.0147453 0.0111585 0.0053584 0.0045056 0.00339492 0.001336 0.00187166 0.00965212 0.0231733 0.0338583 0.0484415 0.016966 0.00503669 0.0105803 0.0178164 0.00874417 0.00828043 0.0120119 0.0139849 0.0182572 0.00766777 0.00263931 0.00095623 0.00196822 0.00325104 0.00577137 0.00547606 0.00434529 0.00176647 0.00595643 0.0106835 0.00573363 0.00489444 0.00575811 0.00292421 0.00270997 0.00162819 0.00494929 0.00746956 0.00471513 0.00772103 0.00617359 0.0206947 0.027342 0.0133224 0.00585983 0.00328134 0.00257378 0.00321152 0.00144548 0.00321471 0.00295832 0.00801748 0.0497273 0.0175391 0.00890156 0.00680362 0.00640346 0.0140002 0.00964735 0.00440472 0.00942035 0.0127516 0.00860354 0.00340023 0.00263886 0.00335693 0.00116476 0.00149753 0.00477723 0.00966014 0.00540654 0.0059637 0.00337571 0.0154565 0.0267984 0.0186305 0.017688 0.0178476 0.0158068 0.0174522 0.0271831 0.0238958 0.013448 0.0355438	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG1 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0235841 0.0411795 0.0389512 0.0212255 0.0155903 0.0114101 0.00531237 0.00397191 0.00272602 0.00107877 0.00105086 0.00317394 0.00480559 0.00487281 0.0120447 0.0256866 0.00798115 0.0341168 0.0338446 0.0324759 0.0339282 0.0324289 0.0193983 0.0270176 0.0102554 0.00389666 0.00142682 0.00301007 0.00452021 0.00746151 0.00717992 0.00569831 0.00221406 0.00764269 0.0135932 0.00727183 0.00601762 0.00692427 0.0034765 0.00323664 0.0019414 0.00592906 0.00900839 0.00567672 0.00932128 0.00743206 0.025121 0.0328783 0.0158721 0.00693056 0.00385113 0.00303672 0.00376871 0.00170171 0.00374479 0.00343613 0.00930765 0.0571807 0.0194041 0.00954458 0.00733002 0.00682473 0.0146543 0.00956756 0.00426238 0.00880704 0.0121534 0.00756508 0.00306006 0.00250058 0.00298082 0.00113683 0.00135659 0.00399058 0.00660303 0.00373984 0.00391618 0.00228062 0.00894803 0.0147012 0.00960386 0.00797521 0.00678338 0.00839375 0.00961054 0.00941829 0.00662645 0.00818126 0.04026	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG2 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0248623 0.0444446 0.0429843 0.0241468 0.0194907 0.0137428 0.00598614 0.00371587 0.00247602 0.000971605 0.000827303 0.00281293 0.00402011 0.00349044 0.00817521 0.016532 0.00434817 0.022338 0.023692 0.0169109 0.0197971 0.0212971 0.040792 0.0731575 0.0443105 0.0254836 0.00652691 0.0139324 0.00600202 0.00928086 0.00821114 0.00618883 0.00233028 0.00699577 0.0127039 0.00670899 0.00550404 0.00620922 0.00310963 0.00282384 0.00168522 0.00513396 0.00786003 0.00492776 0.00806607 0.00644976 0.0215379 0.0279406 0.0134235 0.00589673 0.00326167 0.00257016 0.0031806 0.00143292 0.00315278 0.00289172 0.0078236 0.047964 0.0162541 0.00803213 0.00617121 0.0057597 0.0122852 0.00794127 0.00352183 0.00726959 0.010026 0.00626773 0.00253497 0.00207107 0.00246486 0.000939051 0.00112044 0.00329717 0.00546918 0.00309577 0.00323911 0.0018864 0.00739928 0.0121508 0.0079395 0.00660099 0.00562761 0.00694431 0.00795243 0.00779259 0.00547204 0.00674923 0.0331919	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0251973 0.0451391 0.0436118 0.0245062 0.0196166 0.0138859 0.00610866 0.00383226 0.00255127 0.00100094 0.000854604 0.00289412 0.00415213 0.0037109 0.00894663 0.0184317 0.00510552 0.0243842 0.0194471 0.0113243 0.0125675 0.0156425 0.0235988 0.0326884 0.0163116 0.0058964 0.00243694 0.00966256 0.030437 0.0619015 0.0297133 0.0116052 0.00411654 0.00941171 0.0168564 0.00908634 0.00672445 0.00700298 0.00356969 0.00304512 0.0017941 0.00542309 0.00838688 0.00526297 0.0085037 0.00682855 0.0226832 0.0290804 0.0139755 0.00610233 0.00334192 0.00263211 0.00322798 0.00146071 0.00320535 0.00294377 0.00795199 0.0486916 0.0165332 0.0081695 0.00627647 0.00586414 0.012495 0.00810166 0.00359227 0.00741624 0.0102211 0.00638538 0.00258266 0.00211005 0.00251064 0.00095684 0.00114173 0.00335918 0.00557149 0.00315339 0.00329957 0.00192168 0.00753709 0.0123792 0.0080889 0.00672286 0.00573031 0.00707574 0.00810273 0.00794 0.00557657 0.00687912 0.033833	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG2 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0261267 0.0467744 0.0452739 0.0254628 0.0205491 0.0145139 0.00633996 0.00395092 0.00262323 0.00102833 0.000876685 0.00297265 0.00425175 0.00372386 0.00877046 0.0177208 0.00472076 0.0235602 0.021245 0.0140651 0.0167331 0.0211596 0.0350254 0.0448429 0.020011 0.0070741 0.00182493 0.00402474 0.00821394 0.0124963 0.0136495 0.0318892 0.00940946 0.0204108 0.0126882 0.00842614 0.00721782 0.00730876 0.00408122 0.00324278 0.00200221 0.00565171 0.008286 0.0053066 0.00865292 0.00686449 0.0230615 0.0291769 0.0140523 0.00620815 0.0034393 0.00272682 0.00338123 0.00153011 0.00335548 0.00307948 0.00829869 0.0507278 0.01723 0.0085384 0.00657357 0.00614629 0.0130674 0.00841148 0.00372089 0.0076708 0.0105857 0.006622 0.00267795 0.00218676 0.00260155 0.000991117 0.00118245 0.0034801 0.00577142 0.00326622 0.00341816 0.00199078 0.00780645 0.0128164 0.00837753 0.00696839 0.00594207 0.00732852 0.00839441 0.00822522 0.00577632 0.00712298 0.0350265	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0256318 0.0458929 0.0443211 0.0249397 0.0200109 0.0141393 0.00618792 0.00393242 0.00258724 0.00101154 0.000864672 0.00291216 0.00417325 0.00367362 0.00856819 0.0169539 0.00457943 0.0215913 0.0154437 0.00870535 0.00948372 0.0129761 0.0181155 0.0230347 0.0103116 0.00346127 0.00111836 0.00233424 0.00401217 0.00719893 0.00674508 0.00622024 0.00277064 0.0123666 0.0280887 0.0181344 0.0170785 0.0274254 0.0184757 0.0220859 0.00807341 0.0133966 0.0106302 0.00955055 0.0137213 0.0113195 0.0312579 0.0384745 0.0177005 0.00759453 0.00391219 0.00303028 0.00357382 0.0016476 0.00354342 0.0032862 0.00870121 0.0526737 0.017701 0.00874199 0.00671788 0.00633704 0.0132047 0.00855015 0.00375123 0.00774415 0.0105962 0.00661274 0.00267511 0.00218333 0.00258262 0.000984514 0.00117475 0.00345791 0.00574409 0.00324896 0.00339638 0.00197775 0.00776064 0.0127434 0.00832682 0.00692143 0.00590463 0.00727635 0.00833371 0.00816671 0.00572867 0.00706386 0.0347455	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0255185 0.0457121 0.0441574 0.0248513 0.0199423 0.0140893 0.00616186 0.00388345 0.0025578 0.00100254 0.000854858 0.0028767 0.00411022 0.00361768 0.00844151 0.0165917 0.00445291 0.0209658 0.0144641 0.00800474 0.00867887 0.0121522 0.0162916 0.0213215 0.00942601 0.00317682 0.00106451 0.0021891 0.00362554 0.00653923 0.00611205 0.00530055 0.00226172 0.00902833 0.0205243 0.0116553 0.00990512 0.013883 0.00691004 0.006196 0.00358656 0.0160713 0.0526363 0.0522783 0.0266938 0.0119713 0.022239 0.0340922 0.0159557 0.00700929 0.00385508 0.00297699 0.00362579 0.00163472 0.00350474 0.00324152 0.00865605 0.0531045 0.0178129 0.00875393 0.00668722 0.0063106 0.013092 0.00849099 0.00371756 0.00767842 0.010498 0.00654656 0.00264789 0.00215954 0.00255135 0.000973148 0.00116132 0.00341892 0.00567727 0.00321106 0.00335689 0.00195465 0.00767113 0.0125965 0.00823142 0.00684161 0.00583416 0.00718951 0.00823501 0.00807023 0.00566239 0.006983 0.0343534	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0245289 0.0439839 0.042505 0.0239098 0.01919 0.0135612 0.00593519 0.00373237 0.00245841 0.000964414 0.000822014 0.00276219 0.0039443 0.00346533 0.00808537 0.0158789 0.00425086 0.0200047 0.0136206 0.0074766 0.00807155 0.0114304 0.0151698 0.0199737 0.00882653 0.00296859 0.00101267 0.0020632 0.00338181 0.00608921 0.00568146 0.00483045 0.00202483 0.00750753 0.0157877 0.00860718 0.00714825 0.0090846 0.00456617 0.00350585 0.00209923 0.00823366 0.0229878 0.0223139 0.0473479 0.0657043 0.0494876 0.0391714 0.0205336 0.00919015 0.00431325 0.00311041 0.00352257 0.00165076 0.00351025 0.00324496 0.00852243 0.0531212 0.0179273 0.00877516 0.00668685 0.00629593 0.0128863 0.00830591 0.00362644 0.00749769 0.0102561 0.0063717 0.00257692 0.00209814 0.00247201 0.000943521 0.0011259 0.00331656 0.00549433 0.00310912 0.00325248 0.00189355 0.00743512 0.0122039 0.00797581 0.00663234 0.00564727 0.00695655 0.00797021 0.00781113 0.00548813 0.00677005 0.0333207	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0275508 0.0493134 0.0476329 0.0268213 0.0215232 0.0151832 0.00663184 0.00417074 0.00275163 0.00107896 0.0009171 0.00308943 0.00440248 0.00387678 0.00903684 0.0176313 0.0047202 0.0220715 0.0146865 0.00801731 0.00867388 0.0126134 0.0165107 0.0217463 0.00942931 0.00318166 0.00109942 0.00223564 0.00355082 0.00639543 0.00610997 0.00490018 0.00198649 0.00689781 0.0125343 0.00674071 0.00576534 0.00681012 0.00330465 0.00317234 0.00182378 0.00597772 0.00959427 0.00593029 0.0102946 0.00884091 0.0339884 0.0541862 0.0336484 0.0226917 0.017546 0.0170141 0.0290016 0.0060279 0.0129991 0.00298043 0.00551867 0.0416903 0.0147711 0.00743223 0.00727902 0.00722782 0.0158921 0.00972666 0.00423083 0.00881376 0.0120133 0.00736637 0.00296184 0.00240836 0.0027274 0.00105819 0.00126359 0.00372713 0.00620953 0.00349447 0.00364287 0.00212295 0.00833958 0.0136962 0.00895523 0.00743849 0.00635974 0.00778661 0.00893283 0.00876503 0.00612031 0.00753774 0.0371783	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.027498 0.049257 0.0475642 0.0267679 0.0214799 0.0151567 0.00662214 0.00415625 0.00273913 0.00107401 0.000914834 0.00307806 0.00438883 0.00385948 0.00899552 0.0175832 0.00469241 0.0219944 0.0145687 0.00792764 0.00853277 0.0124039 0.0162041 0.0213577 0.0092339 0.00311951 0.00108646 0.00219505 0.00348898 0.00629362 0.00598475 0.00482252 0.00193692 0.00663208 0.0117969 0.00632788 0.00541408 0.00632151 0.00317375 0.00295348 0.00176027 0.00537132 0.00816711 0.0051422 0.00845451 0.00677556 0.02275 0.0301707 0.0147421 0.00649217 0.00362794 0.00282275 0.0035415 0.00157876 0.00355415 0.00331609 0.00903853 0.0555825 0.0215084 0.0117208 0.00923809 0.0090981 0.0211476 0.0164395 0.0088511 0.0209961 0.0260038 0.0153408 0.0137855 0.0149788 0.0131886 0.00301485 0.00468334 0.00902259 0.00768732 0.00522582 0.00458562 0.00267591 0.0100601 0.0174797 0.0123851 0.00904991 0.00727628 0.00849271 0.0102075 0.00999597 0.00638787 0.00801577 0.03897	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0272504 0.0488055 0.0471253 0.0265229 0.0212827 0.0150161 0.00655943 0.00411665 0.00271323 0.00106384 0.000906092 0.00304913 0.00434722 0.00382392 0.00891265 0.0174173 0.0046485 0.0217877 0.0144352 0.00785661 0.00845761 0.0122937 0.0160599 0.0211698 0.00914737 0.00309089 0.00107647 0.00217485 0.00345654 0.00623845 0.00593041 0.0047778 0.00191902 0.00657079 0.0116817 0.00626712 0.00536444 0.00626602 0.00314699 0.00292745 0.00174525 0.00532222 0.00809249 0.00509487 0.00836962 0.00670468 0.0225168 0.0298082 0.014555 0.00640503 0.00357934 0.00279261 0.00349045 0.00155859 0.00349729 0.00326129 0.00889689 0.0544094 0.0204161 0.0108156 0.00830654 0.0080917 0.018076 0.0136196 0.00647406 0.0143489 0.0180646 0.0119876 0.00558475 0.00450958 0.00489654 0.00159631 0.00237643 0.00998051 0.0401636 0.037769 0.0179692 0.00313083 0.00631122 0.0143018 0.0110352 0.00814352 0.00614123 0.00798394 0.0099632 0.00989212 0.00606667 0.00785244 0.0383735	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0282501 0.0505996 0.0488586 0.0274975 0.0220651 0.015569 0.00680144 0.00426882 0.00281326 0.00110307 0.000939586 0.00316153 0.00450778 0.00396468 0.00924033 0.0180595 0.00481967 0.022591 0.0149655 0.00814462 0.00876665 0.0127423 0.0166466 0.0219415 0.00948232 0.00320399 0.00111595 0.00225446 0.00358324 0.00646606 0.00614691 0.00495307 0.00198934 0.00681075 0.0121099 0.00649661 0.00555906 0.00649034 0.00325965 0.00303271 0.0018084 0.00551372 0.00837982 0.00527585 0.00866649 0.00693597 0.0232853 0.0307913 0.015011 0.00660873 0.00369388 0.00288946 0.00361114 0.00161525 0.00360046 0.00334186 0.00911797 0.0562448 0.0207945 0.0109461 0.00834662 0.00792565 0.0182603 0.0137603 0.00718102 0.0157105 0.0188953 0.0119769 0.00567536 0.00449796 0.00391835 0.00121258 0.00153389 0.00671922 0.0193263 0.0102802 0.00757113 0.00994167 0.022311 0.0164726 0.0133794 0.0104649 0.00807814 0.00912114 0.0117695 0.0110545 0.00654192 0.00865223 0.0400172	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0271747 0.0486671 0.0469902 0.0264478 0.0212222 0.0149733 0.00654021 0.00410511 0.00270532 0.00106073 0.000903498 0.00304036 0.00433489 0.00381341 0.00888724 0.017366 0.00463491 0.0217245 0.0143936 0.00783499 0.00843417 0.0122583 0.0160153 0.0211098 0.00911762 0.00308142 0.00107332 0.00216812 0.00344575 0.00622094 0.00591144 0.00476311 0.00191323 0.00654935 0.0116384 0.00624414 0.00534293 0.0062378 0.00313278 0.00291446 0.00173893 0.00529844 0.00804918 0.00506444 0.00831518 0.00664429 0.0223008 0.0293779 0.0142763 0.00626738 0.00350605 0.00274988 0.00343283 0.00154316 0.00343393 0.00315988 0.00856554 0.0527341 0.0186245 0.00945723 0.0072323 0.00680381 0.0148627 0.0101709 0.00463753 0.00990709 0.0134372 0.00906027 0.00358023 0.00277651 0.0035319 0.00122531 0.00157528 0.00502661 0.0101501 0.00568214 0.00627112 0.00354956 0.016246 0.0281634 0.0195945 0.0186219 0.0187804 0.0166193 0.0183476 0.0285813 0.0251245 0.0141421 0.0373657	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG1 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0205309 0.03517 0.0328493 0.0177054 0.0130319 0.00934987 0.00426564 0.00328486 0.00227756 0.00092982 0.000902843 0.00255341 0.00336144 0.00290203 0.00479573 0.00619693 0.00303844 0.0129682 0.0336525 0.0273116 0.0192979 0.0333738 0.0275872 0.060456 0.0274303 0.0328997 0.0102838 0.0170587 0.00779462 0.011699 0.0105374 0.00786873 0.00288104 0.00852008 0.0152479 0.00793987 0.00633113 0.00708187 0.00355426 0.0032245 0.00193546 0.00584731 0.00884986 0.00555949 0.00912215 0.00725225 0.0244762 0.0316594 0.0152588 0.00663878 0.00366358 0.00289086 0.0035797 0.00161915 0.00356065 0.00327161 0.00885202 0.0537239 0.0182172 0.00895413 0.00688189 0.00640564 0.0137487 0.0089234 0.00396999 0.0081931 0.0113298 0.00703286 0.00284473 0.00232214 0.00276838 0.00105618 0.00126011 0.00370857 0.00611863 0.00346744 0.00363447 0.0021163 0.00830555 0.0136398 0.0089128 0.00740424 0.00628646 0.00777896 0.00890907 0.00873073 0.00615348 0.00760022 0.0374175	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG2 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0195855 0.0333545 0.0311152 0.0166731 0.0122109 0.00876486 0.00403023 0.00306417 0.0021394 0.000882607 0.000847493 0.00236166 0.00306118 0.0026418 0.0044585 0.00553949 0.00272835 0.011965 0.0305336 0.0252853 0.0175817 0.029551 0.0232906 0.049369 0.0193664 0.0126061 0.00355244 0.00687022 0.0143682 0.0179395 0.0197346 0.0435868 0.012944 0.0250423 0.0152701 0.0102116 0.00838348 0.00820805 0.00454785 0.0035258 0.00216822 0.00606195 0.00879828 0.00563674 0.00918543 0.0072707 0.0244852 0.0307655 0.0147863 0.00649942 0.0035878 0.00284494 0.00352277 0.00159683 0.00350128 0.00321719 0.00867388 0.0525862 0.0178562 0.00882475 0.0067952 0.0063448 0.0135193 0.00869747 0.00385094 0.00793726 0.0109703 0.00683994 0.00276611 0.00225745 0.00268723 0.00102433 0.00122197 0.00359712 0.00594968 0.00336908 0.00352885 0.00205503 0.008061 0.0132332 0.00865013 0.00719411 0.00612254 0.00755801 0.00865809 0.00848386 0.00596843 0.00736432 0.0362318	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0201111 0.0345505 0.0319848 0.0170338 0.0125071 0.00884117 0.00408458 0.00286231 0.00209117 0.000844435 0.000779907 0.0022354 0.00290508 0.00241097 0.00425354 0.00505576 0.00240663 0.0116355 0.0271008 0.021518 0.0152526 0.0200757 0.0155702 0.0318501 0.0108552 0.00551954 0.00169674 0.00369434 0.00701381 0.00998848 0.0095286 0.00863582 0.00366886 0.01532 0.0332899 0.0210214 0.0188565 0.0302847 0.0202806 0.0234794 0.00844215 0.0138328 0.0110315 0.00990548 0.0143536 0.0117948 0.0324207 0.0394095 0.0180135 0.00771176 0.0039557 0.00306084 0.00360215 0.00166145 0.00357375 0.00331797 0.00880264 0.0530883 0.0178227 0.00879049 0.00675563 0.00636805 0.013269 0.00857137 0.00376007 0.00776158 0.0106273 0.00662569 0.00268024 0.00218677 0.00258648 0.000986016 0.00117644 0.00346369 0.00574863 0.00325235 0.00340073 0.00198014 0.00777182 0.0127599 0.0083373 0.00693144 0.00590969 0.00728128 0.00833989 0.00817289 0.00573587 0.00707366 0.0347993	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0193714 0.0333208 0.0308177 0.0164 0.012043 0.00849689 0.00392943 0.00272677 0.00200058 0.000807063 0.000741981 0.00213617 0.00277465 0.00229492 0.0040592 0.00480238 0.00226556 0.0110974 0.0256881 0.0200614 0.0141579 0.0178349 0.0137743 0.0265276 0.0090788 0.00447319 0.00148779 0.0031936 0.00583962 0.00835769 0.00787949 0.00669319 0.00268692 0.00949103 0.0199317 0.0107324 0.00828976 0.0102503 0.00526365 0.00382517 0.00226836 0.00876959 0.0241618 0.0235641 0.0493775 0.0680289 0.0511842 0.0404691 0.0211194 0.00944895 0.00439994 0.00316208 0.00356142 0.00166931 0.00355071 0.00328542 0.00864108 0.0536331 0.0180738 0.00883679 0.00673372 0.00633756 0.0129676 0.00834468 0.00364268 0.00753035 0.0103035 0.00639621 0.00258683 0.00210574 0.00248058 0.000946808 0.00112977 0.00332843 0.00551071 0.00311894 0.00326321 0.0018997 0.00746055 0.0122444 0.00800203 0.00665474 0.00566394 0.00697636 0.00799313 0.00783367 0.00550584 0.00679259 0.0334356	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0218313 0.0375658 0.0347369 0.0184827 0.0135707 0.00956918 0.00442853 0.00306326 0.00225333 0.000908203 0.000833787 0.00240467 0.00312434 0.00258263 0.00457953 0.00540482 0.00254656 0.0125475 0.0290211 0.0226072 0.0159353 0.0199156 0.0151677 0.0286966 0.00965863 0.00469766 0.00159466 0.00341671 0.00605396 0.00874707 0.00841868 0.00675034 0.0026037 0.00867868 0.016051 0.00854589 0.00670194 0.00766448 0.00375015 0.00342407 0.00197287 0.00640804 0.010088 0.00626362 0.0108578 0.00930836 0.0356684 0.0563552 0.0349538 0.0235191 0.0181172 0.0175563 0.0298654 0.00619345 0.0133435 0.00306307 0.00568456 0.042761 0.0151254 0.0076 0.00743786 0.00738024 0.0161966 0.00988562 0.00429881 0.00895559 0.0122098 0.00747888 0.003007 0.00244443 0.00276776 0.00107383 0.00128219 0.00378257 0.00629765 0.00354479 0.00369591 0.00215373 0.00846213 0.0138959 0.00908528 0.0075474 0.00644972 0.0078959 0.00905856 0.00888851 0.00620898 0.00764791 0.0377262	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0218872 0.0376591 0.034819 0.0185242 0.0136012 0.00959005 0.00443856 0.00306997 0.0022577 0.000910084 0.000835566 0.00240974 0.00313108 0.0025878 0.00458731 0.00541555 0.0025506 0.0125633 0.0290047 0.0225409 0.0158679 0.0197593 0.0151832 0.0285395 0.00956909 0.00462472 0.00157967 0.00336963 0.00596707 0.00862744 0.00826107 0.00665656 0.00253795 0.00836719 0.0151686 0.00805509 0.00631029 0.00712318 0.00361388 0.00320681 0.00190933 0.0057756 0.00861248 0.00544787 0.00893939 0.00715978 0.0239739 0.0314133 0.0153627 0.00674155 0.00374209 0.00290942 0.00363647 0.00162333 0.00365601 0.00341503 0.00931691 0.0569397 0.0219821 0.0119579 0.00942712 0.00927955 0.0215809 0.0167609 0.00902429 0.0214261 0.0265476 0.015641 0.0140579 0.0152728 0.0134471 0.00307174 0.00477298 0.0091941 0.00782425 0.0053184 0.00466544 0.00272274 0.01024 0.0177897 0.012594 0.00920423 0.00739699 0.00863183 0.0103749 0.010161 0.00649558 0.00815217 0.0396379	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.022493 0.0387014 0.0357827 0.0190368 0.0139777 0.00985562 0.00456144 0.00315506 0.00232019 0.000935289 0.000858728 0.0024765 0.00321785 0.00265958 0.00471461 0.00556595 0.00262147 0.0129119 0.029808 0.0231641 0.0163063 0.0203041 0.0156072 0.0293395 0.00983609 0.00475322 0.00162381 0.00346338 0.00613265 0.00886963 0.00849089 0.00684167 0.0026084 0.00859858 0.015583 0.00827628 0.00648389 0.00731885 0.00371457 0.0032955 0.00196306 0.00593337 0.00884372 0.00559386 0.00917061 0.00733494 0.0245575 0.032084 0.0156558 0.00686788 0.00381298 0.00298051 0.00371076 0.00166216 0.00370655 0.00344444 0.00940653 0.057665 0.0212708 0.0111768 0.00852425 0.00809003 0.0186499 0.0140414 0.00732869 0.0160461 0.0193026 0.0122145 0.00578886 0.004587 0.00399438 0.00123568 0.00156324 0.00684954 0.0196749 0.0104679 0.00771153 0.0101238 0.0227161 0.0167679 0.0136143 0.0106521 0.00821964 0.00928016 0.0119761 0.0112504 0.00666045 0.00881047 0.0407513	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0216124 0.0371863 0.034382 0.0182916 0.0134305 0.00946994 0.00438294 0.0030317 0.0022294 0.000898702 0.000825158 0.00237965 0.00309205 0.00255566 0.00453048 0.0053487 0.0025192 0.012408 0.0286435 0.0222585 0.0156686 0.0195096 0.015001 0.0282041 0.00945388 0.00456813 0.00156087 0.00332872 0.00589365 0.00852759 0.00816068 0.00657535 0.00250702 0.00826337 0.0149679 0.00795046 0.00622815 0.0070301 0.00356797 0.00316529 0.00188664 0.00569871 0.00849055 0.00536706 0.00879439 0.00702287 0.0235077 0.0305956 0.014883 0.00651005 0.00361733 0.00283523 0.00352586 0.00158725 0.0035335 0.00325555 0.00883279 0.0540458 0.0190457 0.00965338 0.00738352 0.00694235 0.0151746 0.010375 0.00473124 0.0101115 0.0137156 0.00923096 0.00364783 0.00282814 0.00359677 0.00124775 0.0016041 0.00511963 0.0103261 0.00578259 0.00638335 0.00361276 0.0165399 0.0286677 0.0199497 0.0189703 0.0191156 0.0169106 0.0186653 0.0290818 0.0255584 0.0143862 0.038043	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG1 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0220831 0.0383699 0.034303 0.0177757 0.012809 0.00863101 0.00409438 0.00248298 0.00204822 0.000832208 0.000708681 0.00190262 0.0022655 0.00191777 0.00328828 0.00338032 0.00139298 0.00511341 0.0100399 0.00540237 0.00554105 0.0138269 0.0217389 0.0411857 0.0277681 0.0150339 0.00698852 0.0342544 0.032418 0.0869392 0.030538 0.0128034 0.00472019 0.012255 0.0201612 0.0103648 0.00729486 0.00730232 0.00378565 0.00320512 0.00191038 0.00573618 0.00881233 0.00554135 0.00898329 0.00719626 0.0239873 0.0306001 0.014699 0.00642138 0.0035122 0.00276797 0.00339426 0.00153587 0.00337187 0.00309791 0.00837081 0.0511513 0.0173664 0.00858062 0.00659402 0.00615957 0.0131178 0.00848357 0.00375966 0.00775971 0.0106997 0.00668299 0.00270294 0.00220774 0.00262654 0.00100092 0.00119424 0.00351433 0.00582643 0.00329803 0.00345133 0.00200999 0.00788416 0.0129472 0.00846034 0.00703341 0.00599393 0.00739851 0.00847298 0.00830278 0.00583246 0.00719467 0.0353865	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG2 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0244299 0.0426754 0.0383441 0.0199712 0.0145307 0.00980325 0.00461682 0.00279966 0.00228077 0.000923985 0.000785478 0.00212114 0.00254685 0.00214621 0.00370014 0.00384259 0.00156826 0.00588018 0.01145 0.00621276 0.00632303 0.0153036 0.0240035 0.0436848 0.0263424 0.0139627 0.00564258 0.0237296 0.0153936 0.0201078 0.0155584 0.0359456 0.0112979 0.0223951 0.0142796 0.00990255 0.00896678 0.0091154 0.00503152 0.00383578 0.00235644 0.0065008 0.00946486 0.00607522 0.00989368 0.00785109 0.0262231 0.0329455 0.0158373 0.00703219 0.00388303 0.00307702 0.00380608 0.00172008 0.00377479 0.00346291 0.00932732 0.0572434 0.0194525 0.00967082 0.00744993 0.00697585 0.0147624 0.00944218 0.00416505 0.00858378 0.0118371 0.00743076 0.00300472 0.0024533 0.00291478 0.0011094 0.00132345 0.00389631 0.00647566 0.00366314 0.00383067 0.00223106 0.00874755 0.0143557 0.00938498 0.00781348 0.00667588 0.00821505 0.00941074 0.00922062 0.00646449 0.00796499 0.0391473	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0228199 0.0401809 0.0362823 0.0190903 0.0140075 0.00940892 0.0043674 0.00259653 0.0021017 0.000851758 0.000711608 0.0019595 0.00235602 0.001976 0.00345977 0.00356895 0.00144361 0.00552824 0.0107482 0.00578748 0.00563563 0.013127 0.020562 0.0377964 0.022859 0.0108185 0.00357887 0.0158769 0.00577407 0.011015 0.0076252 0.00932809 0.0046706 0.0158041 0.0334846 0.0216414 0.0191969 0.0299002 0.0207692 0.0232246 0.00804192 0.0132382 0.0110235 0.00979736 0.0145017 0.0117968 0.0322791 0.0390253 0.0178587 0.00770848 0.00396091 0.00307149 0.0036139 0.0016668 0.00358405 0.00332514 0.00880703 0.0533558 0.0179343 0.00887125 0.00682416 0.00643906 0.0133675 0.00858366 0.00375774 0.00775258 0.0106147 0.00663578 0.00268416 0.00218984 0.00258815 0.000986018 0.00117636 0.00346414 0.00575799 0.00325654 0.0034035 0.00198181 0.00777702 0.0127648 0.00834179 0.00693986 0.00592536 0.00728927 0.00834977 0.00818219 0.00573573 0.00706921 0.0347645	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0224852 0.0396481 0.0358298 0.0188573 0.0138498 0.00931006 0.00431759 0.00255794 0.0020676 0.0008393 0.000700509 0.00192921 0.00231718 0.00194507 0.003408 0.0035212 0.00142408 0.00543255 0.0105494 0.00566004 0.00549686 0.0128101 0.0199479 0.0365699 0.0220522 0.0102737 0.00336096 0.0148872 0.00522447 0.00976248 0.00652696 0.00765995 0.00366385 0.0113828 0.025323 0.0146225 0.0115889 0.015384 0.00821012 0.00663639 0.00386267 0.0164051 0.0554163 0.0549578 0.0278844 0.0126872 0.0232807 0.0347483 0.0161576 0.00709708 0.00388344 0.00300861 0.00364959 0.00164768 0.00353642 0.00327005 0.00871912 0.0534799 0.0179549 0.00884198 0.00675797 0.00638144 0.0131769 0.00848423 0.00370644 0.00765042 0.0104617 0.00653602 0.00264349 0.0021553 0.002544 0.000969785 0.00115717 0.00340777 0.00566355 0.00320273 0.00334717 0.00194895 0.00764865 0.0125551 0.00820535 0.00682498 0.0058256 0.0071678 0.00821116 0.00804659 0.00564145 0.00695383 0.0342015	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.02169 0.0382618 0.0345796 0.0181913 0.0133615 0.0089837 0.00416859 0.00246757 0.00199414 0.000809759 0.000676023 0.00186087 0.0022344 0.00187579 0.00328658 0.00339814 0.00137387 0.00523084 0.0101577 0.0054407 0.00527821 0.0123287 0.0191575 0.03507 0.0211305 0.00980692 0.00319494 0.0141318 0.00492399 0.00911033 0.00599632 0.00685869 0.00319653 0.00944981 0.0198942 0.0109264 0.00844023 0.0100473 0.00539692 0.00379825 0.00226614 0.00869129 0.0247525 0.0239673 0.0489072 0.067021 0.0503756 0.0405216 0.0210804 0.00946649 0.00439422 0.0031577 0.0035361 0.00166176 0.00353092 0.00326284 0.00855123 0.0534481 0.018051 0.00884389 0.00674218 0.00634923 0.0129509 0.00830763 0.00362209 0.00748593 0.0102407 0.00636846 0.00257561 0.00209664 0.00246844 0.000941847 0.00112382 0.00331106 0.00548803 0.00310517 0.00324772 0.00189077 0.00742412 0.0121832 0.00796282 0.00662457 0.00564391 0.00694577 0.00795849 0.0077995 0.00547741 0.00675488 0.0332411	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0245016 0.043182 0.0389895 0.0205209 0.0150584 0.0101078 0.00468388 0.00276989 0.00224401 0.000910878 0.000759273 0.00209149 0.00250754 0.00210794 0.00369657 0.00380738 0.00154085 0.00586329 0.0113582 0.00608573 0.00591939 0.0138534 0.0214977 0.039211 0.0235329 0.0108839 0.00352699 0.0154921 0.00521624 0.00961486 0.00635014 0.00702845 0.0030275 0.00865199 0.0160798 0.0086364 0.00682378 0.00756851 0.0038653 0.00339251 0.00198286 0.00637627 0.0101521 0.00628384 0.0109082 0.00931254 0.0355411 0.055713 0.0345825 0.0233727 0.0180562 0.0175659 0.0294632 0.00609849 0.0131503 0.0030155 0.00559327 0.0422869 0.0149832 0.00757598 0.00740553 0.00736379 0.0161259 0.00981853 0.00426116 0.00886438 0.0120741 0.00742121 0.00298413 0.00242635 0.00274594 0.00106478 0.00127128 0.00375053 0.00625496 0.00351927 0.00366743 0.0021372 0.00839544 0.0137843 0.00901397 0.00749107 0.00641128 0.00783983 0.00899436 0.00882522 0.00615716 0.00757964 0.0373773	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0245269 0.0432413 0.0390338 0.0205359 0.0150704 0.0101171 0.00468944 0.00276969 0.00224347 0.000910597 0.000759567 0.00209201 0.00250779 0.0021084 0.00369777 0.00381119 0.00154202 0.00586888 0.0113654 0.0060878 0.00591855 0.0138697 0.0214972 0.0391799 0.0234964 0.0108847 0.00352545 0.0155137 0.00520115 0.00955002 0.00625699 0.00692493 0.00294595 0.00833475 0.0152163 0.00814887 0.0064372 0.00704913 0.00372693 0.00319467 0.00192041 0.00574152 0.00867097 0.00546809 0.008946 0.00716747 0.0238718 0.0310588 0.015217 0.0067211 0.00371904 0.00289756 0.00360708 0.00161074 0.0036208 0.00337981 0.00919224 0.0564053 0.0218285 0.0119419 0.00941362 0.00929711 0.0214798 0.0166267 0.00892833 0.0211262 0.0261356 0.0154493 0.0138761 0.0150819 0.0132707 0.00303487 0.00471263 0.00908404 0.00774976 0.00526624 0.00462212 0.00269575 0.0101321 0.0175996 0.0124792 0.00912043 0.00734013 0.00855892 0.010287 0.0100726 0.00643246 0.00806825 0.0392206	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0243002 0.0428386 0.0386683 0.020345 0.0149297 0.0100216 0.00464454 0.00274302 0.00222206 0.000901884 0.000752229 0.00207201 0.00248368 0.00208827 0.00366268 0.00377426 0.00152716 0.00581315 0.0112569 0.00602993 0.00586325 0.0137387 0.0212946 0.0388115 0.0232732 0.0107822 0.00349259 0.0153682 0.00515208 0.00946329 0.0061987 0.0068596 0.0029179 0.00825484 0.0150651 0.00806973 0.00637638 0.00698613 0.0036954 0.00316683 0.00190389 0.00568856 0.00859087 0.00541715 0.00885458 0.00709168 0.0236232 0.0306814 0.0150228 0.00663022 0.00366872 0.0028665 0.003555 0.00159027 0.00356293 0.00332421 0.00904815 0.0552111 0.0207194 0.0110185 0.00846546 0.00826919 0.0183626 0.0137721 0.00652765 0.0144393 0.0181628 0.0120838 0.00562916 0.00454645 0.00493064 0.00160753 0.00239185 0.0100416 0.0404893 0.0380527 0.0181128 0.00315648 0.00636027 0.0144075 0.011126 0.00821055 0.00619614 0.00804627 0.0100415 0.00996792 0.00610832 0.00790268 0.0386167	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0252008 0.0444277 0.0401035 0.0210995 0.0154837 0.0103941 0.00481742 0.00284522 0.00230471 0.00093544 0.000780266 0.00214911 0.00257619 0.00216599 0.00379884 0.00391502 0.00158409 0.00602945 0.011676 0.00625434 0.00608107 0.0142495 0.022086 0.0402529 0.0241381 0.0111827 0.00362221 0.0159394 0.00534341 0.00981306 0.00642789 0.00711367 0.0030259 0.00855972 0.0156224 0.0083674 0.00660993 0.00723818 0.00382847 0.00328126 0.00197325 0.00589458 0.00889807 0.00561086 0.0091705 0.0073377 0.024435 0.0317003 0.0154967 0.00684227 0.00378659 0.00296645 0.00367829 0.00164846 0.00366885 0.00340723 0.00927495 0.0570962 0.0211087 0.0111533 0.00850599 0.00809962 0.0185505 0.0139174 0.00724248 0.0158118 0.0189983 0.0120725 0.00571913 0.00453426 0.00394608 0.00122145 0.00154431 0.006763 0.0194916 0.0103688 0.00763087 0.0100168 0.0224865 0.0166109 0.0135018 0.010561 0.00815709 0.00919617 0.0118659 0.0111417 0.00658838 0.00870925 0.0402736	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0242346 0.0427219 0.0385623 0.0202898 0.0148891 0.00999425 0.00463158 0.00273545 0.00221587 0.000899367 0.000750138 0.00206624 0.0024768 0.00208253 0.00365253 0.00376377 0.00152297 0.00579736 0.0112261 0.00601361 0.00584786 0.0137016 0.0212374 0.0387059 0.0232081 0.0107525 0.00348311 0.0153269 0.00513733 0.00943743 0.00618031 0.00683971 0.00290906 0.0082283 0.0150104 0.0080402 0.00635071 0.0069542 0.00367835 0.00315254 0.00189686 0.00566267 0.00854486 0.00538461 0.00879585 0.00702684 0.0233938 0.0302354 0.0147346 0.00648693 0.00359277 0.0028225 0.00349607 0.00157475 0.00349884 0.00322125 0.00871182 0.0535187 0.0189005 0.00963447 0.00737186 0.00695464 0.0151075 0.0102901 0.00467656 0.00997966 0.0135218 0.0091413 0.00361222 0.00280115 0.00355862 0.00123406 0.00158619 0.00506212 0.0102392 0.00573005 0.00632081 0.00357774 0.0163718 0.0283752 0.0197365 0.0187485 0.0189341 0.0167544 0.0184962 0.0288035 0.0253273 0.0142577 0.037587	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG1 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0222495 0.0383909 0.0342843 0.017762 0.0127905 0.00869731 0.00412553 0.00256887 0.00204689 0.000855328 0.000740793 0.00188061 0.00220129 0.00190313 0.00308885 0.00328902 0.00144726 0.00448437 0.008195 0.00394001 0.00359472 0.00698629 0.00714148 0.0144417 0.00811602 0.00333774 0.00258239 0.00946858 0.0250784 0.0526557 0.0713393 0.0523446 0.0225441 0.0330434 0.0186509 0.012478 0.0107403 0.00996045 0.0052993 0.00388901 0.0023884 0.00642287 0.00922264 0.0058997 0.00958739 0.0075728 0.025198 0.0315549 0.0151873 0.00675208 0.00372672 0.00295728 0.00365591 0.00165535 0.00362991 0.0033319 0.00897028 0.0550765 0.0187174 0.00929975 0.00716364 0.00670858 0.0141975 0.00909656 0.00401403 0.00827465 0.011407 0.00715815 0.00289457 0.00236364 0.00280822 0.001069 0.0012753 0.00375424 0.0062395 0.00352955 0.00369091 0.00214966 0.00842867 0.0138339 0.00904325 0.00752735 0.00643057 0.00791585 0.00906751 0.00888446 0.00622916 0.00767579 0.0377278	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG2 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0187146 0.03256 0.0292543 0.0152748 0.0111127 0.00757487 0.00358209 0.00220213 0.00175191 0.000726417 0.000618595 0.00162538 0.0019477 0.00164585 0.00275672 0.00290923 0.00121917 0.00408905 0.00790294 0.00373807 0.00337874 0.00741846 0.00859788 0.0156998 0.00940167 0.00309031 0.00211751 0.00844049 0.0283186 0.0671116 0.0725901 0.0170068 0.00704283 0.0182216 0.0354394 0.0239524 0.0194918 0.0295349 0.020041 0.0212174 0.00724933 0.0118695 0.0100689 0.00894586 0.013491 0.0108767 0.0295505 0.0351889 0.016026 0.00692976 0.00356191 0.00276475 0.00325162 0.00149946 0.00322474 0.00299228 0.00792769 0.0479997 0.016135 0.00798626 0.00614685 0.00580025 0.0120211 0.00768626 0.00336141 0.00693215 0.009496 0.00593989 0.00240254 0.00195955 0.00231514 0.000881768 0.00105189 0.00309833 0.00515017 0.00291281 0.00304417 0.00177252 0.00695608 0.0114146 0.00745999 0.00620907 0.00530269 0.00651796 0.00746695 0.00731699 0.00512841 0.0063195 0.0310755	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0181484 0.0315927 0.0283759 0.0148012 0.0107552 0.00733228 0.00346755 0.00212476 0.00169116 0.000703343 0.00059847 0.0015709 0.00187516 0.00158963 0.00265985 0.0028041 0.00117648 0.00391806 0.00754037 0.00354126 0.00320703 0.00706699 0.00811133 0.0148048 0.00880173 0.00286972 0.00197205 0.00782616 0.0260819 0.0607777 0.0622736 0.0124076 0.00505639 0.011894 0.0228173 0.0131316 0.00923087 0.01027 0.00574544 0.0037279 0.00221985 0.00824881 0.0237132 0.0230002 0.0456983 0.0622544 0.0466015 0.0378257 0.0194786 0.00875826 0.00403829 0.00289663 0.00322823 0.00151856 0.00322525 0.00298008 0.00780498 0.0488764 0.0165007 0.00808701 0.00616763 0.00580881 0.0118275 0.00756353 0.00329484 0.00680861 0.00931484 0.00579663 0.00234434 0.00190817 0.00224557 0.000856603 0.00102206 0.00301168 0.00499371 0.00282531 0.00295456 0.00172007 0.00675405 0.011082 0.00724324 0.00602775 0.00513749 0.00631823 0.00723974 0.00709506 0.00498099 0.00614148 0.0302198	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0202608 0.0352445 0.0316312 0.0164892 0.0119742 0.00815883 0.0038602 0.00236496 0.00188651 0.000784045 0.000667136 0.0017505 0.00208861 0.00177056 0.00296405 0.00311889 0.00130972 0.00435926 0.00837324 0.00392945 0.00354921 0.00779259 0.00887709 0.0162651 0.00963777 0.00317425 0.00222066 0.00885498 0.0294756 0.0689297 0.070686 0.0126701 0.00474101 0.0108776 0.0185595 0.0103662 0.00744272 0.00752034 0.00400352 0.00324585 0.00192441 0.0060583 0.00954294 0.00594856 0.0102598 0.00872399 0.0330813 0.0513247 0.0317307 0.0214782 0.0165477 0.0161146 0.0268615 0.00554448 0.0119609 0.00274066 0.00508581 0.0385651 0.013655 0.00692304 0.00676205 0.00672994 0.014692 0.00891012 0.00386062 0.00802581 0.0109262 0.00672827 0.00270561 0.00219992 0.00248822 0.000964377 0.00115129 0.00339716 0.00567105 0.00319025 0.00332339 0.00193665 0.00760798 0.0124887 0.00816722 0.00679016 0.00581664 0.00710482 0.00815125 0.00799789 0.00557562 0.00686107 0.0338283	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0203623 0.0354204 0.0317798 0.0165628 0.0120241 0.00819111 0.0038753 0.00237231 0.00189247 0.000786834 0.000669571 0.00175653 0.00209467 0.00177666 0.00297357 0.00312892 0.0013145 0.00437133 0.00839099 0.0039341 0.00355453 0.00780281 0.00886863 0.0162622 0.00961719 0.00317013 0.00222444 0.00885513 0.0294916 0.0689461 0.0706793 0.01252 0.00462982 0.0105248 0.0177155 0.00987081 0.00705777 0.00702076 0.00386942 0.00308053 0.00186907 0.00548323 0.00819659 0.0051983 0.00842527 0.00674329 0.022326 0.0286419 0.0139747 0.00618889 0.00340207 0.00264965 0.0032863 0.00146828 0.00329993 0.00308314 0.00838476 0.0516242 0.019959 0.0109378 0.00862243 0.00852788 0.0196182 0.015127 0.00810943 0.0191635 0.0236892 0.0140271 0.0125938 0.013691 0.0120412 0.00275517 0.00427721 0.00824784 0.0070413 0.00478302 0.00419845 0.00244765 0.00919992 0.0159764 0.0113324 0.00828421 0.00667278 0.00777272 0.00934147 0.00914632 0.00583692 0.00731844 0.0355748	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0208656 0.0362955 0.0325645 0.0169719 0.012321 0.00839322 0.00397085 0.00243079 0.00193914 0.000806233 0.000686073 0.00179983 0.0021463 0.00182047 0.0030469 0.003206 0.0013469 0.00447904 0.00859763 0.00403094 0.00364211 0.00799478 0.00908651 0.016662 0.00985309 0.00324807 0.00227925 0.00907331 0.030218 0.0706454 0.072428 0.0128292 0.00474337 0.0107809 0.0181438 0.0101105 0.00722844 0.00719053 0.00396471 0.00315632 0.00191568 0.00561546 0.00839044 0.00532069 0.00861465 0.00688608 0.0227951 0.0291589 0.0141953 0.00628426 0.00345481 0.00270575 0.00334266 0.001499 0.00333541 0.00310058 0.00843867 0.0521296 0.0192541 0.0101898 0.0077717 0.00741094 0.0169006 0.0126293 0.00656013 0.0143079 0.0171781 0.0109393 0.00518137 0.00410909 0.00357345 0.00110631 0.00139806 0.00612161 0.0176707 0.00940104 0.00691421 0.00907486 0.0203757 0.0150587 0.0122465 0.00958004 0.00740289 0.00833337 0.0107519 0.0100944 0.00596415 0.00788069 0.0364392	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.020137 0.0350275 0.0314263 0.0163789 0.0118904 0.0080997 0.00383189 0.00234571 0.0018713 0.00077802 0.000662054 0.00173684 0.00207117 0.00175677 0.00294029 0.00309372 0.00129974 0.00432223 0.00829653 0.00388974 0.0035146 0.00771465 0.00876788 0.016078 0.00950724 0.00313428 0.00219953 0.00875616 0.0291619 0.0681776 0.0699019 0.0123804 0.00457664 0.0104008 0.0175005 0.0097522 0.0069707 0.00693374 0.00382324 0.00304404 0.00184844 0.00541501 0.0080882 0.00512558 0.00829389 0.00661927 0.0219063 0.0279155 0.013548 0.00598036 0.00329027 0.00258427 0.00318938 0.00143757 0.00319322 0.00294261 0.00795666 0.0490497 0.0173063 0.00883672 0.00676367 0.00638993 0.0138238 0.00937646 0.00425207 0.00907119 0.0122803 0.00832093 0.00328801 0.00254976 0.00323531 0.00112142 0.00144115 0.00460031 0.00932039 0.00521487 0.00574917 0.0032541 0.0148919 0.0258021 0.0179392 0.0170343 0.0172237 0.015241 0.0168231 0.0261902 0.0230342 0.0129676 0.0341206	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG1 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.022773 0.0396943 0.0355605 0.0184536 0.0133929 0.00902878 0.00427054 0.00256481 0.0020613 0.000860931 0.000721765 0.001862 0.0022203 0.00188003 0.00308798 0.0032539 0.00136759 0.00428854 0.0078587 0.00368121 0.00329246 0.00717266 0.00779358 0.0146221 0.00783818 0.00261968 0.00111725 0.00358778 0.00646416 0.0146724 0.0207178 0.0380926 0.0118098 0.048887 0.0261453 0.0222696 0.0184666 0.0279165 0.0188923 0.0187621 0.0062405 0.0116069 0.0109146 0.00958289 0.0152888 0.0121295 0.0336706 0.040082 0.0184575 0.00809967 0.00420038 0.00328205 0.00387297 0.00178962 0.00384912 0.00357011 0.00943663 0.0572925 0.0193251 0.00959447 0.00739927 0.00698613 0.0144183 0.00914206 0.00398888 0.00821774 0.0112681 0.00706129 0.00285579 0.00232789 0.0027484 0.00104618 0.00124777 0.0036768 0.00611386 0.0034573 0.00361302 0.00210374 0.00825474 0.013539 0.00885113 0.00737411 0.00630281 0.00773461 0.00886288 0.00868447 0.00608401 0.00749323 0.0368381	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG2 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0218619 0.0381494 0.0342323 0.0178093 0.0129354 0.0087294 0.00412304 0.00247472 0.00198283 0.000829904 0.000694565 0.00179645 0.00214376 0.00181552 0.00298433 0.00315159 0.00132436 0.00417897 0.00768547 0.00362597 0.00326615 0.0071819 0.0079329 0.0146707 0.00783407 0.00258423 0.00107868 0.00339901 0.00609454 0.013645 0.0182281 0.0331652 0.0106489 0.0449787 0.0197459 0.0140104 0.0103612 0.013593 0.00837104 0.00622175 0.00390021 0.0141576 0.0559046 0.0559095 0.0291955 0.0141369 0.0254451 0.0361112 0.0164439 0.0072049 0.00396012 0.00312533 0.00381228 0.00173531 0.00373517 0.00345274 0.00916237 0.0561409 0.0189395 0.00935746 0.00716284 0.00676559 0.0138552 0.00879484 0.00382829 0.00788992 0.0108108 0.00676627 0.00273618 0.00222855 0.00262755 0.00100096 0.00119401 0.0035188 0.0058471 0.00330637 0.0034559 0.00201218 0.00789626 0.0129516 0.00846805 0.00705391 0.00602517 0.0073959 0.00847575 0.0083054 0.00582131 0.00717124 0.0352626	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0208528 0.0363958 0.0326665 0.017009 0.0123606 0.00834136 0.00393352 0.00236145 0.00188982 0.000791182 0.000661798 0.00171365 0.00204484 0.00173278 0.00285084 0.00301119 0.001265 0.00400206 0.00737488 0.00348736 0.0031578 0.00698202 0.00779919 0.0142868 0.0076279 0.00249688 0.00103528 0.00324011 0.00580087 0.0128675 0.0165516 0.0296593 0.00983725 0.0415528 0.0165895 0.0109201 0.00785943 0.00964815 0.00591697 0.00392911 0.0024297 0.00873172 0.0268932 0.0263021 0.0506342 0.0682185 0.0505257 0.0422827 0.0213392 0.00960761 0.00443878 0.003212 0.00359199 0.00170197 0.00361819 0.00334308 0.00872954 0.054947 0.018577 0.00910385 0.00694703 0.00653767 0.0132704 0.00843761 0.00367161 0.00758168 0.0103851 0.00646123 0.00261307 0.00212577 0.00250089 0.000953979 0.00113815 0.00335463 0.00555828 0.00314498 0.0032898 0.00191519 0.0075201 0.0123357 0.0080641 0.00671401 0.00572096 0.0070321 0.0080591 0.00789789 0.00554664 0.00683856 0.0336508	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0230173 0.0402106 0.0361125 0.018836 0.0136995 0.00924287 0.00434695 0.00260606 0.0020879 0.000872646 0.000728827 0.00189566 0.00226067 0.00191645 0.00316758 0.00333853 0.00140001 0.00446543 0.00825782 0.00392659 0.00358493 0.00801674 0.009157 0.016456 0.00882662 0.00284192 0.00116386 0.00364773 0.00646859 0.0140862 0.0171791 0.030579 0.0105233 0.0441823 0.0151835 0.00871118 0.00655793 0.00761421 0.0045315 0.00348739 0.00217205 0.00641177 0.0104937 0.00680087 0.0120776 0.0100492 0.0391579 0.0588377 0.0364851 0.024755 0.0189262 0.0185681 0.030644 0.00619901 0.0133829 0.0030707 0.00571834 0.0432248 0.0153395 0.00781446 0.00761004 0.0075805 0.0164343 0.00982769 0.00424487 0.00880441 0.0120089 0.00739842 0.00297506 0.00241676 0.00273215 0.00105851 0.0012633 0.00373017 0.00621956 0.00349976 0.0036473 0.00212518 0.00834999 0.0136977 0.00896036 0.00745789 0.00638685 0.00778908 0.00893918 0.00877091 0.00611751 0.00752643 0.0371096	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0232368 0.040584 0.0364426 0.0190144 0.0138293 0.0093295 0.0043854 0.00263069 0.0021064 0.000880311 0.000735452 0.00191284 0.00228135 0.00193462 0.00319656 0.00337015 0.00141353 0.00450941 0.00834302 0.00396962 0.00363092 0.00812416 0.00930201 0.0166738 0.00893672 0.00287441 0.00117679 0.00367365 0.0065281 0.0142016 0.0171575 0.0303388 0.0104523 0.0439978 0.0149727 0.00852109 0.00636723 0.00732584 0.0044654 0.00338362 0.0021296 0.0058941 0.00920998 0.00599829 0.00988717 0.00786394 0.0265241 0.032717 0.0159499 0.00708285 0.00385224 0.0030164 0.00372248 0.00167492 0.00374899 0.00351481 0.00951527 0.0578852 0.0224047 0.0122994 0.00972391 0.00964705 0.022034 0.0168239 0.0089845 0.0211727 0.0262081 0.0155115 0.013919 0.0151388 0.013304 0.0030377 0.00471736 0.00910349 0.0077719 0.0052762 0.00463068 0.00269796 0.0101375 0.0175868 0.0124724 0.00912318 0.0073497 0.00855049 0.0102795 0.0100633 0.00642585 0.00805561 0.0391511	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0230215 0.0402081 0.0361052 0.0188383 0.0137013 0.00924317 0.00434481 0.00260635 0.00208689 0.000872161 0.000728646 0.00189513 0.00226023 0.00191672 0.00316698 0.00333899 0.00140046 0.00446771 0.0082659 0.00393295 0.00359746 0.0080495 0.00921688 0.0165204 0.00885453 0.00284789 0.00116592 0.00363942 0.00646744 0.014069 0.016995 0.0300474 0.0103505 0.0435716 0.0148284 0.00844265 0.00630859 0.00726275 0.00442958 0.00335703 0.00211249 0.00584355 0.00913107 0.00594553 0.00978936 0.00778504 0.0262574 0.0323302 0.0157515 0.00698927 0.00380105 0.00298545 0.00367047 0.00165466 0.00369091 0.00345941 0.0093707 0.0566799 0.0212786 0.0113515 0.00875283 0.00858698 0.0188551 0.0139322 0.00656352 0.0144773 0.0182273 0.0121467 0.00565634 0.00456729 0.00493845 0.00160968 0.0023944 0.0100428 0.0405277 0.0380906 0.018139 0.00316232 0.00637069 0.0144156 0.0111371 0.00822307 0.00620948 0.00804604 0.0100464 0.00997195 0.00611001 0.00789958 0.038598	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0238823 0.0417114 0.037455 0.0195427 0.0142136 0.00958873 0.00450723 0.00270379 0.00216492 0.000904766 0.000755885 0.00196599 0.00234474 0.00198838 0.00328539 0.00346381 0.00145282 0.00463475 0.00857495 0.00408001 0.00373196 0.00835035 0.00956132 0.0171379 0.00918544 0.00295435 0.00120951 0.00377557 0.00670933 0.0145954 0.0176312 0.0311726 0.0107387 0.0452056 0.0153834 0.00875584 0.00654146 0.00752629 0.00458988 0.00347834 0.0021895 0.00605531 0.00945806 0.00615838 0.010138 0.00805494 0.0271591 0.0334028 0.0162467 0.00721189 0.00392215 0.00308918 0.00379673 0.00171519 0.00380031 0.00354623 0.00960494 0.058632 0.0216798 0.011488 0.00878696 0.00840468 0.0190389 0.0140854 0.00728913 0.0158604 0.0190723 0.0121335 0.00574457 0.00455527 0.00395227 0.0012229 0.00154537 0.00676684 0.0195222 0.0103937 0.00764457 0.0100156 0.0225 0.0166276 0.0135318 0.0105942 0.00818709 0.00919839 0.0118739 0.011141 0.00658798 0.00870202 0.0402166	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0229596 0.0400997 0.0360079 0.0187877 0.0136645 0.00921834 0.00433311 0.00259938 0.00208129 0.000869817 0.000726693 0.00189005 0.00225418 0.00191159 0.00315848 0.00333004 0.00139671 0.00445577 0.00824382 0.00392249 0.00358794 0.00802809 0.00919251 0.0164765 0.00883087 0.0028403 0.00116282 0.00362971 0.00645022 0.0140317 0.016949 0.029964 0.0103213 0.043448 0.0147828 0.0084142 0.00628413 0.00722897 0.00440994 0.00334295 0.00210469 0.0058175 0.00908457 0.00591092 0.00972323 0.00771365 0.0259981 0.0318524 0.0154452 0.00683607 0.00372045 0.00293944 0.00360911 0.00163884 0.00362461 0.00335294 0.00902204 0.0549571 0.0194093 0.00992198 0.00762144 0.00722103 0.0155332 0.0104271 0.00470812 0.010025 0.0135936 0.00920173 0.00363493 0.0028152 0.00356764 0.00123668 0.00158914 0.00507536 0.0102626 0.00574357 0.00633669 0.0035864 0.0164019 0.0284118 0.01978 0.0188091 0.0190061 0.0167944 0.0185347 0.0288605 0.0253826 0.0142941 0.0375762	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG1 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0211431 0.0363588 0.0323675 0.0166665 0.0120327 0.0081353 0.00392258 0.00239689 0.00192635 0.000806655 0.000689102 0.0017263 0.00206425 0.00174673 0.00278079 0.00297021 0.00126474 0.00378925 0.0067063 0.00318357 0.00285901 0.00629707 0.00679012 0.0121561 0.00607245 0.00201106 0.000812655 0.00190148 0.00303055 0.00585044 0.00553421 0.00493696 0.00229713 0.0118184 0.0312434 0.0194932 0.0190026 0.0302455 0.0186136 0.0250674 0.0108206 0.0503606 0.0489808 0.0349348 0.0209906 0.0156075 0.0346988 0.0432964 0.0178135 0.0074875 0.0040412 0.00323671 0.00395202 0.00182357 0.00391683 0.00366607 0.00966918 0.0595461 0.019987 0.00982004 0.00751835 0.00712957 0.0144668 0.00917757 0.0039846 0.0082196 0.0112316 0.00702676 0.00284181 0.0023137 0.00272076 0.00103679 0.00123686 0.00364629 0.00606337 0.00342816 0.00358129 0.00208495 0.0081857 0.0134255 0.00877585 0.0073105 0.00624608 0.00765958 0.00877769 0.008602 0.00602538 0.00742188 0.0365002	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG2 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0200163 0.0345227 0.0307522 0.0158484 0.01145 0.00774893 0.00372258 0.00225168 0.00180914 0.000761185 0.00064653 0.00162666 0.00193874 0.00164511 0.00263006 0.00280446 0.00119479 0.00360468 0.00636976 0.00302413 0.0027269 0.00605961 0.0065509 0.0117367 0.00584818 0.00192637 0.000773827 0.00181311 0.00287679 0.00558114 0.00520382 0.00459618 0.00203366 0.00963182 0.0244326 0.0147624 0.0141744 0.0238586 0.017756 0.020582 0.00568926 0.0214796 0.0162315 0.0140455 0.0145184 0.0185869 0.050068 0.0815324 0.0462506 0.0292084 0.0205014 0.0194606 0.0284899 0.00575774 0.0121904 0.00282463 0.00529752 0.0407712 0.0143793 0.00733945 0.0070949 0.00705983 0.0152766 0.00919286 0.00396638 0.00820669 0.0111323 0.00684877 0.00275425 0.00223719 0.00252494 0.000978587 0.00116771 0.00344687 0.0057493 0.00323458 0.00336987 0.00196344 0.0077164 0.0126617 0.00828006 0.0068863 0.00589604 0.00719515 0.00825594 0.00810098 0.00564935 0.00695198 0.0342848	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0208705 0.0360059 0.0320671 0.0165246 0.0119333 0.00807257 0.00387796 0.00234143 0.00188375 0.0007926 0.000672647 0.00169353 0.0020169 0.00171187 0.00273988 0.00291764 0.00124329 0.00375368 0.00662942 0.00314605 0.00283661 0.00631267 0.00681697 0.0122202 0.00608698 0.00200476 0.00080543 0.00188706 0.00298912 0.00579832 0.00540741 0.00476171 0.00209887 0.00989048 0.0248993 0.0149507 0.0142737 0.024008 0.0177642 0.0202218 0.00555023 0.0205393 0.0141446 0.0117108 0.0126587 0.0163775 0.0379614 0.0510373 0.0221166 0.00902062 0.00420168 0.00311978 0.00351196 0.00164902 0.00360583 0.00345166 0.00927462 0.0561609 0.0213828 0.0116684 0.00922697 0.00926846 0.0209606 0.016377 0.00873687 0.0206141 0.0252252 0.014871 0.013361 0.0145197 0.0126985 0.00289771 0.00449494 0.00867225 0.00739821 0.00502502 0.00441109 0.00256967 0.00966002 0.016783 0.0118765 0.00868345 0.00698223 0.00813428 0.00977611 0.00957667 0.00611818 0.00767527 0.0373335	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0207027 0.0357166 0.0318089 0.0163915 0.011837 0.00800719 0.0038465 0.00232225 0.00186844 0.000786153 0.000667146 0.00167974 0.00200042 0.00169791 0.00271768 0.00289381 0.00123313 0.00372318 0.0065755 0.0031204 0.0028135 0.00626153 0.00676155 0.0121209 0.00603748 0.00198846 0.000798865 0.00187174 0.00296471 0.00575105 0.00536353 0.0047227 0.00208169 0.00980932 0.0246932 0.0148267 0.0141552 0.0238111 0.0176179 0.0200543 0.00550361 0.0203679 0.0140277 0.0116078 0.0125381 0.0162194 0.0375736 0.0504161 0.0218571 0.00890521 0.00414774 0.00309136 0.00346558 0.00163117 0.00355381 0.00340353 0.0091466 0.0550616 0.0203369 0.0107749 0.00832146 0.00826852 0.0179958 0.0135873 0.00638984 0.014122 0.0175287 0.0116365 0.00542205 0.0043816 0.00470776 0.00153786 0.00228888 0.00960028 0.0387262 0.0363891 0.0173017 0.00301395 0.00607684 0.0137608 0.0106016 0.00782721 0.00590216 0.00765892 0.00955849 0.00949499 0.00581989 0.00753056 0.0368175	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0214476 0.0370021 0.0329538 0.0169814 0.0122629 0.00829529 0.00398491 0.00240572 0.00193564 0.000814427 0.000691131 0.00174016 0.00207234 0.00175895 0.00281546 0.00299787 0.00127747 0.00385711 0.00681198 0.0032326 0.00291463 0.00648686 0.00700481 0.012557 0.00625479 0.00206 0.000827597 0.00193909 0.00307136 0.00595786 0.00555654 0.0048926 0.00215656 0.0101625 0.0255832 0.0153609 0.0146648 0.0246657 0.01825 0.0207717 0.00570059 0.02109 0.0144963 0.0119875 0.0129622 0.0167393 0.0388155 0.0520068 0.0225176 0.0091687 0.00426969 0.00319216 0.0035751 0.0016882 0.00365358 0.00348524 0.00936736 0.0568933 0.0207086 0.0108957 0.00833909 0.00807984 0.0181288 0.0137071 0.00708631 0.0154521 0.0183226 0.0116078 0.00549777 0.00436324 0.00376004 0.00116561 0.00147354 0.00645211 0.0186168 0.00990908 0.00728002 0.0095336 0.0213992 0.0158206 0.0128593 0.0100719 0.00777065 0.00875273 0.0112954 0.010613 0.00627569 0.00829722 0.0383781	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0206899 0.0356952 0.0317893 0.0163813 0.0118293 0.00800169 0.0038438 0.00232029 0.00186705 0.000785562 0.000666597 0.00167847 0.00199881 0.00169656 0.00271578 0.00289149 0.00123214 0.00372046 0.00657055 0.00311797 0.00281129 0.00625727 0.0067567 0.0121124 0.00603324 0.00198702 0.000798251 0.0018704 0.00296245 0.00574671 0.00535983 0.00471913 0.00208018 0.0098032 0.0246786 0.0148177 0.0141454 0.0237918 0.0176014 0.0200298 0.00549571 0.0203295 0.0139445 0.011519 0.012462 0.0160569 0.0372365 0.0496822 0.0214854 0.00870964 0.0040551 0.00304456 0.00340395 0.00161657 0.00349248 0.00330272 0.00882419 0.053443 0.0185874 0.00942676 0.00726705 0.00697816 0.0148649 0.0101954 0.00458481 0.00978859 0.01311 0.00881824 0.00348467 0.00269928 0.00340031 0.00118067 0.00151753 0.00484599 0.00979941 0.00548324 0.00604375 0.00342015 0.0156689 0.0271473 0.0188875 0.0179308 0.0180885 0.0159984 0.0176517 0.0275012 0.024168 0.0136022 0.0359004	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG1 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	2	0.0184478 0.0315348 0.0282596 0.0145572 0.0105337 0.00719452 0.00350558 0.00221305 0.00174216 0.00074034 0.000640464 0.00156941 0.00187973 0.00159873 0.00248345 0.00269717 0.0011633 0.00338102 0.0059106 0.00280268 0.00253774 0.0055573 0.00592967 0.0105313 0.00510309 0.00169588 0.000723868 0.00158393 0.00242897 0.0045523 0.00427514 0.00355598 0.00144415 0.00525567 0.0108202 0.00627439 0.00596561 0.00812801 0.00573302 0.00553298 0.00395087 0.0130439 0.0528911 0.0550969 0.074665 0.0614286 0.0605351 0.0570202 0.0317873 0.0172189 0.00713082 0.00486894 0.00440273 0.00213665 0.00434874 0.00396591 0.00991032 0.059202 0.0198865 0.00964562 0.00740627 0.00697818 0.0140769 0.00888891 0.0038485 0.00794593 0.0108505 0.00668998 0.00270499 0.00219657 0.00256984 0.000981872 0.0011712 0.00345281 0.0056992 0.00322627 0.00337795 0.0019662 0.00772547 0.0126701 0.00828219 0.00689254 0.00585653 0.00720547 0.00825929 0.0080949 0.00569816 0.00703143 0.034631	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG1 with DRUG2 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0185735 0.0318179 0.0283469 0.0146528 0.0105615 0.00716697 0.0034527 0.0021364 0.00170279 0.000721315 0.000615327 0.00153002 0.00182525 0.00155726 0.00245432 0.0026248 0.00113182 0.0033539 0.00588281 0.00278719 0.00253993 0.00555017 0.00588674 0.0105931 0.00515027 0.00172062 0.00071598 0.00160132 0.00247363 0.00477939 0.00439949 0.00369178 0.00157343 0.00620971 0.0137009 0.00757176 0.0068267 0.00997542 0.00604103 0.00615605 0.00387549 0.0181591 0.0529905 0.0438275 0.0453392 0.0276691 0.0418884 0.0781348 0.0467505 0.0337844 0.0230286 0.020605 0.0272777 0.00560033 0.011939 0.00281297 0.00535958 0.0407002 0.0142069 0.00723042 0.00695447 0.00691236 0.0149183 0.00885414 0.0038074 0.00784683 0.0106302 0.00652842 0.00262398 0.00212927 0.00240121 0.000930305 0.0011096 0.00327699 0.00545711 0.00307185 0.0032016 0.00186509 0.00733303 0.0120268 0.00786432 0.00654446 0.00559841 0.00682623 0.0078337 0.00768667 0.0053647 0.00660262 0.0325676	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG1 with DRUG0 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0187914 0.0321941 0.0286953 0.014825 0.0106908 0.00726051 0.00350107 0.00216889 0.00172572 0.000731386 0.000624924 0.00155229 0.0018522 0.00157985 0.00248666 0.00266473 0.00114881 0.00340013 0.00596285 0.00282541 0.00257178 0.00562118 0.00596237 0.0107293 0.00522146 0.00174301 0.000727171 0.00162456 0.00251161 0.00484786 0.00445856 0.00374874 0.00159376 0.00626996 0.0137419 0.00758381 0.00683306 0.00997876 0.00617725 0.00619655 0.00397455 0.0176292 0.0540069 0.0452913 0.0480103 0.0268693 0.0371126 0.0609046 0.0258657 0.0114691 0.00476768 0.00325414 0.00328492 0.00151169 0.00337883 0.00320465 0.0087188 0.050276 0.0192098 0.0104847 0.00834262 0.00834231 0.0193092 0.0149894 0.00802543 0.018963 0.023325 0.0137251 0.0123415 0.0134064 0.0117541 0.00268062 0.00416153 0.008027 0.00684079 0.00464782 0.0040766 0.00237657 0.00893694 0.0155252 0.0109781 0.00802558 0.00644783 0.00751788 0.00903522 0.00885093 0.00565821 0.00710114 0.0345386	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG1 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0192689 0.0330137 0.0294254 0.0152017 0.0109622 0.00744459 0.00358987 0.00222337 0.00176933 0.000749869 0.000640663 0.00159152 0.00189888 0.00161969 0.00254971 0.00273199 0.00117779 0.00348624 0.00611369 0.00289677 0.00263661 0.00576398 0.00611345 0.0110012 0.00535405 0.00178716 0.000745546 0.00166575 0.00257514 0.0049703 0.00457188 0.00384359 0.00163409 0.00642943 0.0140905 0.00777543 0.00700503 0.0102275 0.00633007 0.00634914 0.00407278 0.0180618 0.0553207 0.046375 0.0491515 0.0274488 0.0379417 0.062014 0.0263205 0.0116342 0.00483849 0.00332168 0.00333652 0.00154394 0.00341732 0.00322799 0.00879256 0.0508441 0.0185577 0.00977727 0.00752734 0.00725533 0.0166567 0.0125279 0.00650523 0.0141846 0.0169124 0.0106894 0.00506828 0.00401937 0.00347892 0.00107725 0.00136175 0.00596387 0.0171471 0.00912671 0.00671575 0.00880248 0.0197464 0.0145863 0.0118433 0.00927401 0.00715244 0.00806808 0.0104121 0.00978465 0.00579122 0.00766044 0.0354364	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG1 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0186362 0.0319312 0.0284601 0.0147027 0.010602 0.00719974 0.00347179 0.00214976 0.001711 0.000725146 0.000619487 0.00153905 0.00183615 0.0015662 0.00246583 0.00264182 0.0011389 0.00337147 0.00591224 0.00280122 0.00254956 0.00557464 0.00591226 0.0106392 0.00517801 0.00172832 0.000720959 0.00161094 0.00249024 0.00480634 0.00442163 0.00371689 0.00158026 0.00621846 0.0136275 0.0075194 0.00677368 0.00988764 0.00611864 0.00613657 0.00393693 0.0174579 0.0534585 0.044785 0.0474441 0.0264425 0.0365493 0.0594884 0.0252178 0.0110762 0.00460603 0.00317398 0.00318297 0.00148188 0.00327565 0.00306888 0.008309 0.0479406 0.0167195 0.00849456 0.00657143 0.00627655 0.0136791 0.00934335 0.00423026 0.0090172 0.0121254 0.00813587 0.00321701 0.00249259 0.00315194 0.00109348 0.00140506 0.00448488 0.00904698 0.00506548 0.00558855 0.00316244 0.0144884 0.0251001 0.0174647 0.0166014 0.0167245 0.0147928 0.0163218 0.0254335 0.0223449 0.0125757 0.0332618	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG1 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0189137 0.0325681 0.0290042 0.0149327 0.0107028 0.00723193 0.00350126 0.0021124 0.00172212 0.000730008 0.000615269 0.00154167 0.00181929 0.00155516 0.00249418 0.00261721 0.00112936 0.00336609 0.00585451 0.00275033 0.00249774 0.00560287 0.00586049 0.0104806 0.00509336 0.001693 0.000710636 0.0015775 0.00238037 0.00451207 0.00428979 0.00347925 0.00145224 0.00538078 0.0106733 0.00575311 0.00513293 0.00671103 0.00396956 0.00368809 0.00222981 0.00852661 0.0197733 0.0234097 0.0373317 0.0570483 0.0995335 0.0791844 0.0471524 0.0306971 0.0212355 0.022116 0.0285195 0.00568476 0.0115946 0.00275737 0.00517474 0.0404761 0.0142695 0.00731725 0.00703147 0.00700661 0.0149973 0.00889725 0.00382387 0.00787331 0.0106793 0.00655687 0.00263629 0.00213892 0.00241296 0.000935432 0.00111566 0.00329531 0.00547981 0.00308518 0.00321763 0.00187456 0.00736853 0.0120839 0.00790314 0.00657813 0.00562295 0.00685801 0.00787155 0.00772378 0.00539532 0.00664137 0.0327627	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG1 can inhibit ovarian function in women) , DRUG2 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0186912 0.0321946 0.0286877 0.0147611 0.0105844 0.00715836 0.00347011 0.00209477 0.00170532 0.000723415 0.000610599 0.00152791 0.0018033 0.00154107 0.00246784 0.00259479 0.00111986 0.003333 0.00579088 0.00272246 0.00247028 0.00554957 0.00580401 0.0103731 0.00503496 0.00167287 0.000703852 0.00155713 0.00234742 0.00444256 0.00422649 0.00343035 0.00142657 0.00524307 0.0102643 0.00552788 0.0049327 0.00643057 0.00383548 0.00353301 0.00219189 0.00814135 0.0195044 0.0240832 0.0372825 0.0604707 0.101539 0.0652437 0.0233789 0.00981807 0.00403559 0.00287437 0.00309654 0.00152568 0.00340302 0.00322188 0.0086191 0.0522955 0.019755 0.0107287 0.00856265 0.00855643 0.0195184 0.0149814 0.00800374 0.0189058 0.0232635 0.0136816 0.0122862 0.0133568 0.0116796 0.00266035 0.00412987 0.00796584 0.00677923 0.0046014 0.00403518 0.00235023 0.0088377 0.015338 0.0108426 0.00793334 0.0063779 0.00741978 0.00891966 0.00873742 0.00558603 0.00700758 0.034084	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG1 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0185601 0.0319688 0.0284869 0.0146576 0.0105103 0.00710846 0.003446 0.00208031 0.00169347 0.000718398 0.000606388 0.00151732 0.00179082 0.00153039 0.00245064 0.00257685 0.00111212 0.00330981 0.00575055 0.00270351 0.00245305 0.00551083 0.00576353 0.0103007 0.00499984 0.00166118 0.000698972 0.00154627 0.00233104 0.00441146 0.00419689 0.00340646 0.00141662 0.00520605 0.0101912 0.00548864 0.00489756 0.0063842 0.00380867 0.0035079 0.00217708 0.00808241 0.019371 0.0239197 0.0370098 0.0600263 0.100748 0.0645323 0.0231191 0.00970185 0.00398668 0.00285243 0.00306116 0.00151238 0.00336036 0.00318242 0.00851713 0.051377 0.0188255 0.00992377 0.00773485 0.00764353 0.0167756 0.0124334 0.00585458 0.0129618 0.0161847 0.0107027 0.00498557 0.00402806 0.00431938 0.0014095 0.00209817 0.0087984 0.0353977 0.0332932 0.0158285 0.00275798 0.00556587 0.0125965 0.00969589 0.00716214 0.00539878 0.00699877 0.00873846 0.00868134 0.0053261 0.00689121 0.0336912	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG1 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0191677 0.033016 0.02942 0.0151377 0.0108545 0.00734111 0.00355879 0.00214822 0.00174884 0.000741885 0.000626188 0.00156693 0.00184933 0.00158039 0.00253084 0.00266106 0.00114845 0.00341811 0.00593867 0.00279192 0.00253322 0.00569132 0.0059522 0.010638 0.00516376 0.00171561 0.000721836 0.00159695 0.00240744 0.00455606 0.00433459 0.00351814 0.0014631 0.0053776 0.0105276 0.00566948 0.00505855 0.00659421 0.00393365 0.00362259 0.00224792 0.00834721 0.0200019 0.0246994 0.0382359 0.062023 0.103999 0.0664414 0.0237265 0.00994858 0.00408758 0.00293458 0.00314654 0.00156029 0.00344308 0.0032467 0.00868638 0.0528717 0.0190831 0.00999216 0.00772196 0.00743822 0.0168434 0.0125074 0.00647878 0.0141438 0.0168674 0.0106462 0.00504142 0.00400083 0.00344103 0.00106527 0.0013466 0.00589787 0.0169722 0.00904195 0.00664774 0.00869526 0.0195229 0.0144265 0.011726 0.00919159 0.00709013 0.00797201 0.010293 0.00966771 0.00572271 0.00756521 0.0349797	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG1 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0185439 0.031942 0.0284632 0.0146452 0.0105013 0.00710231 0.00344309 0.00207831 0.00169194 0.000717753 0.000605819 0.00151597 0.00178917 0.00152896 0.00244852 0.0025745 0.00111108 0.00330694 0.00574544 0.00270108 0.00245071 0.00550625 0.00575859 0.0102921 0.00499594 0.00165983 0.000698367 0.00154506 0.00232921 0.00440794 0.0041937 0.00340383 0.00141557 0.00520313 0.0101861 0.00548547 0.00489395 0.00637944 0.0038061 0.00350464 0.00217521 0.00807534 0.0193572 0.0239004 0.0369922 0.0600067 0.100422 0.0637684 0.0226862 0.00946404 0.003884 0.00280266 0.00300465 0.00149887 0.00330213 0.00308722 0.00820674 0.0498319 0.0171851 0.00867687 0.00674851 0.00643911 0.0138535 0.00933019 0.00420089 0.00897924 0.0120997 0.00810721 0.00320214 0.0024783 0.00311754 0.00108232 0.00139098 0.00444434 0.00895932 0.00501734 0.00553553 0.0031322 0.0143471 0.0248442 0.0173048 0.0164633 0.0165864 0.0146488 0.0161564 0.0251796 0.0221227 0.0124543 0.0328734	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG1 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0226165 0.038866 0.0343443 0.0176637 0.0125951 0.00844831 0.00408 0.00242254 0.0020019 0.000845303 0.000710403 0.00178444 0.00209466 0.00179721 0.00289989 0.00300869 0.00130283 0.00389846 0.00670518 0.00315485 0.00287189 0.00647657 0.006694 0.0119777 0.00571289 0.00192551 0.000805326 0.0017854 0.00262815 0.00500284 0.00484203 0.00380859 0.00159664 0.00577826 0.0104836 0.00570673 0.00492546 0.00593664 0.00294827 0.00292715 0.00170165 0.0056742 0.00913997 0.00581416 0.0102145 0.008518 0.0330687 0.0529129 0.0338345 0.0206203 0.0152815 0.0148706 0.0275885 0.00859448 0.0390714 0.00670765 0.0127179 0.0348321 0.0123674 0.00726433 0.00933413 0.0127019 0.0255524 0.0179884 0.00957981 0.0228733 0.0282095 0.0168585 0.0158947 0.0175667 0.0146264 0.00324623 0.00492492 0.0095576 0.00834309 0.00563939 0.00492226 0.00282708 0.0104898 0.0181807 0.012755 0.00934515 0.00749134 0.00868487 0.0104395 0.0102411 0.00655619 0.00822453 0.040077	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG1 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG2 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.022417 0.0385225 0.0340388 0.0175059 0.0124828 0.008373 0.00404368 0.00240094 0.00198389 0.00083765 0.000704086 0.00176845 0.00207596 0.00178115 0.00287371 0.00298197 0.00129122 0.00386355 0.00664509 0.00312673 0.00284615 0.00641835 0.0066341 0.0118703 0.00566149 0.0019082 0.000798108 0.0017693 0.00260462 0.00495815 0.00479861 0.00377487 0.00158239 0.00572648 0.0103915 0.00565673 0.00488157 0.00588311 0.00292208 0.00290135 0.00168643 0.00562508 0.00906195 0.00576265 0.010126 0.00844502 0.0327755 0.0523413 0.0333776 0.0202789 0.0150899 0.0146972 0.0273051 0.00852013 0.0386889 0.00657818 0.0124878 0.0340699 0.0117091 0.00657257 0.00833955 0.0112598 0.0224217 0.0143282 0.0069306 0.016606 0.0211036 0.0139915 0.0068522 0.00557801 0.00533378 0.00175101 0.00257179 0.0104808 0.0427442 0.0398868 0.0187901 0.003268 0.00653335 0.0147034 0.0112251 0.00832543 0.00626012 0.0080984 0.0101198 0.0101032 0.00620149 0.00801854 0.0392688	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG1 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	4	0.023254 0.039961 0.0353095 0.018159 0.0129487 0.00868563 0.00419468 0.00249055 0.00205782 0.000868873 0.000730373 0.00183442 0.0021534 0.00184761 0.00298079 0.0030933 0.00133942 0.00400772 0.00689286 0.00324339 0.0029523 0.00665783 0.00688158 0.0123134 0.00587258 0.00197937 0.00082789 0.00183523 0.00270173 0.00514315 0.0049774 0.00391582 0.00164142 0.00593989 0.0107787 0.00586719 0.00506246 0.00610023 0.00302988 0.0030078 0.00174878 0.00583041 0.00938855 0.00597107 0.0104904 0.00874576 0.0339504 0.054171 0.0344987 0.0209434 0.0156263 0.0152216 0.0282891 0.00885257 0.0402552 0.00688264 0.0130536 0.0360452 0.0122596 0.00669995 0.00826623 0.0110528 0.0224525 0.0148027 0.00782448 0.0181237 0.0220918 0.0137971 0.00686114 0.0055576 0.00428006 0.00132839 0.00164904 0.00707971 0.0207912 0.0111369 0.00798826 0.0101547 0.0227453 0.0168936 0.0138094 0.0109083 0.00836393 0.00936655 0.0120993 0.011383 0.00673047 0.00889472 0.041104	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG1 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0223778 0.0384549 0.0339783 0.0174746 0.0124607 0.0083582 0.00403648 0.00239663 0.00198022 0.000836099 0.000702828 0.00176524 0.00207219 0.00177795 0.00286841 0.00297666 0.00128892 0.00385661 0.00663302 0.00312111 0.00284109 0.0064068 0.00662222 0.0118491 0.00565109 0.00190472 0.000796672 0.00176601 0.00259982 0.00494925 0.00478993 0.00376827 0.00157966 0.00571653 0.0103737 0.00564679 0.00487216 0.0058702 0.00291582 0.00289467 0.00168285 0.00561009 0.00903263 0.00574472 0.010094 0.00841037 0.0326094 0.0519743 0.0330435 0.0200137 0.0149139 0.0145288 0.026956 0.00840855 0.0381813 0.00637327 0.0122424 0.0335924 0.010926 0.00582359 0.00736887 0.00975244 0.0193125 0.0114312 0.00512873 0.0119102 0.0163485 0.0107157 0.00442442 0.00334814 0.00369179 0.00128669 0.00164227 0.00523834 0.0106612 0.00593234 0.00649282 0.00366838 0.016862 0.0292555 0.0205037 0.019243 0.0193141 0.0169872 0.0187185 0.0292147 0.0256138 0.0144065 0.0381333	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG1 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG0 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.0245121 0.0421578 0.0371986 0.0190851 0.0136009 0.00911286 0.0044105 0.002606 0.00215531 0.00090935 0.000766186 0.0019237 0.00225698 0.00193427 0.00311981 0.00324175 0.00140301 0.00419825 0.00720076 0.00339194 0.00307385 0.00697597 0.00718801 0.0128766 0.006129 0.00206664 0.000868018 0.00191897 0.00282343 0.00536872 0.00518183 0.00408721 0.00170188 0.00609702 0.010874 0.00589397 0.00505245 0.00604628 0.00303229 0.00292678 0.00176028 0.00543642 0.00844177 0.00531056 0.00875226 0.00701688 0.0237469 0.0319296 0.0157032 0.00691689 0.00388671 0.00304317 0.00381616 0.00171339 0.00383709 0.00357763 0.0099049 0.0627538 0.0249615 0.0134049 0.01026 0.00991175 0.0236073 0.0192241 0.0102563 0.0253201 0.0319948 0.0213419 0.0145921 0.015377 0.0174172 0.00488298 0.00722017 0.0369072 0.0379149 0.0241787 0.0126685 0.00281746 0.00751037 0.0161016 0.0120575 0.0092913 0.00698086 0.00882076 0.0110176 0.0115165 0.00698676 0.00882616 0.0437161	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG1 (coadministration of DRUG2 and DRUG0 may interfere with the efficacy of the DRUG0 ) .
4	2	0.0228146 0.0392244 0.0346078 0.0177617 0.0126584 0.00848167 0.00410339 0.00242703 0.00200639 0.000846535 0.000713359 0.00179058 0.0021014 0.00180123 0.00290351 0.0030177 0.00130642 0.00390783 0.00670428 0.00315886 0.00286445 0.00649239 0.00669086 0.0119854 0.0057008 0.00192337 0.000808034 0.00178553 0.00262734 0.00499954 0.00482054 0.00380373 0.00158457 0.00567232 0.0101108 0.00548331 0.00470316 0.00563157 0.00282573 0.00272766 0.00164052 0.00506758 0.00787735 0.00494313 0.00813652 0.0065199 0.0220284 0.0295129 0.0143766 0.00632999 0.00355871 0.00279162 0.00347834 0.00155348 0.00345092 0.00319427 0.00872463 0.0546027 0.0204029 0.0105237 0.00813819 0.00800501 0.0173909 0.0127017 0.00539276 0.0117998 0.0160342 0.0110144 0.00515158 0.00505968 0.00588737 0.00242224 0.00391577 0.0156171 0.0456252 0.0428742 0.0739636 0.0186792 0.0363909 0.0266707 0.0207591 0.0153476 0.0118834 0.0118273 0.0141133 0.0136077 0.00729916 0.0090482 0.0390871	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG1 and DRUG2 may interfere with the efficacy of the DRUG0 ) .
4	4	0.0221171 0.0380266 0.0335577 0.0172222 0.0122759 0.00822781 0.00398126 0.00235595 0.00194678 0.000821522 0.000692457 0.00173766 0.00203954 0.0017481 0.00281685 0.00292898 0.00126801 0.00379173 0.00650514 0.00306526 0.00277937 0.00629845 0.00649154 0.0116281 0.00553176 0.00186615 0.000784188 0.00173249 0.00254958 0.00485055 0.00467641 0.00369139 0.00153771 0.00550241 0.00980971 0.00532093 0.00456352 0.00546379 0.00274216 0.00264759 0.0015924 0.00491987 0.00764791 0.00479724 0.00789434 0.00632413 0.0213553 0.0285936 0.0138884 0.00612262 0.00344079 0.00270589 0.00336466 0.00150077 0.0033059 0.00304968 0.00832778 0.0522702 0.0192954 0.00994428 0.00767152 0.00750372 0.0165459 0.0124264 0.0057213 0.0126514 0.0163406 0.0112995 0.00494488 0.0044609 0.00544122 0.00197312 0.00331073 0.0155856 0.0565126 0.0485723 0.0454321 0.00997555 0.0192441 0.0367641 0.0246196 0.0147801 0.0179335 0.01846 0.017867 0.0281261 0.0238177 0.0131381 0.0309449	DRUG0 may interact with the following drugs : DRUG0 and other DRUG0 (may lower DRUG0 levels) , DRUG0 (bioavailability of oral DRUG0 is increased with coadministration) , DRUG0 (may decrease DRUG0 levels) , DRUG0 (reports of psychotic episodes when coadministered) , DRUG0 (coadministration of DRUG0 with DRUG0 can inhibit ovarian function in women) , DRUG0 and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects) , and DRUG0 (coadministration of DRUG1 and DRUG0 may interfere with the efficacy of the DRUG2 ) .
4	4	0.124236 0.0456323 0.11034 0.168884 0.0479455 0.0115081 0.0507476 0.0510538 0.0330584 0.0368346 0.0231029 0.0168828 0.0209943 0.0184999 0.0541265 0.0234672 0.0183212 0.0107223 0.0151532 0.0179087 0.0155235 0.0266428 0.0584137	DRUG1 , a bacteriostatic DRUG2 , may antagonize the bactericidal effect of DRUG0 and concurrent use of these drugs should be avoided .
2	2	0.0701011 0.00984247 0.0228283 0.0538772 0.0220563 0.0265348 0.127487 0.0765668 0.0670019 0.0717966 0.0683332 0.0890801 0.0561026 0.0146633 0.0449753 0.0268176 0.0185771 0.0111741 0.0123053 0.015424 0.015775 0.0253879 0.053292	DRUG1 , a bacteriostatic DRUG0 , may antagonize the bactericidal effect of DRUG2 and concurrent use of these drugs should be avoided .
4	4	0.0210444 0.0183007 0.0809853 0.184242 0.184746 0.0332806 0.0733856 0.0484807 0.0436527 0.038238 0.0369893 0.0492796 0.0347819 0.00971884 0.030426 0.0181696 0.0124494 0.00741278 0.00792343 0.0095156 0.00960216 0.0153488 0.0320273	DRUG0 , a bacteriostatic DRUG1 , may antagonize the bactericidal effect of DRUG2 and concurrent use of these drugs should be avoided .
3	0	0.141977 0.109559 0.0970782 0.10936 0.0527544 0.0264862 0.032131 0.0934469 0.0955747 0.0434575 0.0210844 0.0342845 0.0199955 0.0324613 0.0401862 0.0501641	DRUG1 may interact with DRUG2 or DRUG0 (causing too great a decrease in adrenal function) .
3	0	0.142855 0.102186 0.0993033 0.0809325 0.0357932 0.0390823 0.071321 0.0653359 0.0871259 0.0479835 0.0256701 0.0396498 0.0249295 0.0371329 0.045252 0.0554476	DRUG1 may interact with DRUG0 or DRUG2 (causing too great a decrease in adrenal function) .
4	4	0.0282185 0.0248204 0.0197678 0.0196917 0.0181653 0.0337832 0.0298647 0.0596897 0.0171895 0.0194815 0.0199473 0.0202797 0.0198082 0.0128819 0.0108655 0.00910462 0.00509789 0.00502079 0.00251624 0.00786211 0.0169361 0.00526841 0.00992089 0.0106075 0.0161172 0.0217577 0.00781608 0.00406975 0.0068649 0.00885531 0.0161965 0.0194604 0.0152899 0.00870657 0.0103972 0.0215955 0.00875223 0.00323262 0.0073398 0.00646513 0.011699 0.0300695 0.0163568 0.0104596 0.0164349 0.0118156 0.0129084 0.00526611 0.013509 0.0161696 0.0156574 0.0273049 0.0193063 0.0122592 0.00505175 0.00174432 0.00491648 0.00602186 0.0044463 0.00425879 0.0134652 0.0104033 0.022856 0.0146741 0.0213556 0.0265298 0.0353537	While in vitro studies have shown that DRUG1 is not a potent inhibitor of any of these enzymes , an indication that DRUG0 is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes , the concomitant use of DRUG2 with most other drugs metabolized by these enzymes has not been formally studied .
4	4	0.00915685 0.00694763 0.00416733 0.00485716 0.00300474 0.00599483 0.00399414 0.0119727 0.0149692 0.0205057 0.0119646 0.0135664 0.0179517 0.012615 0.0127119 0.010952 0.00673036 0.00811844 0.00617084 0.0317922 0.0659402 0.0393562 0.053132 0.0165098 0.0196425 0.0279042 0.00946681 0.00724474 0.0117863 0.0141179 0.0203657 0.025278 0.0185714 0.0148154 0.016272 0.0241744 0.0107813 0.00369294 0.00717729 0.00708845 0.0134115 0.0293426 0.0164651 0.0103257 0.0161105 0.0114602 0.0118937 0.00479333 0.0123725 0.0147243 0.0142371 0.0249102 0.0175868 0.0112199 0.00462365 0.00160733 0.00453239 0.00548398 0.00404382 0.00386621 0.0122997 0.00953308 0.0209594 0.0134895 0.0200671 0.0251535 0.0340253	While in vitro studies have shown that DRUG0 is not a potent inhibitor of any of these enzymes , an indication that DRUG1 is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes , the concomitant use of DRUG2 with most other drugs metabolized by these enzymes has not been formally studied .
4	4	0.0378064 0.0153818 0.0344153 0.0534806 0.0515415 0.0305093 0.0369019 0.0316386 0.0426553 0.0182247 0.0099546 0.0138765 0.0410682 0.0336512 0.0241359 0.0662509 0.060002 0.0650641 0.0549492 0.0349563 0.0362416 0.0327596 0.0340364 0.0286572 0.0370694 0.0242801 0.0504913	DRUG1 : Concomitant administration of DRUG0 (equivalent to 60 g) had a minimal effect on plasma levels of DRUG2 (15 mg) in 6 healthy male subjects .
3	3	0.0153381 0.0186873 0.0289448 0.0361953 0.0373314 0.0401755 0.0315835 0.0242345 0.036192 0.0203045 0.0196119 0.0242743 0.0568713 0.0497113 0.0427847 0.0565946 0.0481979 0.0564715 0.043797 0.0325775 0.0366279 0.0358132 0.040369 0.0346135 0.0442978 0.0294703 0.0589297	DRUG0 : Concomitant administration of DRUG1 (equivalent to 60 g) had a minimal effect on plasma levels of DRUG2 (15 mg) in 6 healthy male subjects .
4	2	0.023408 0.013441 0.0320825 0.0411557 0.0237338 0.0226134 0.011503 0.0560013 0.0584904 0.0594092 0.0468778 0.0565176 0.0314336 0.0337722 0.0292924 0.0482291 0.102549 0.0373861 0.0252114 0.0524155 0.0767978 0.0617274 0.0559524	However , the impairment of cognitive and motor skills produced by DRUG1 were shown to be additive with those produced by DRUG2 .
4	1	0.0267172 0.00710706 0.0121415 0.0105172 0.0107295 0.0141334 0.0231098 0.04254 0.0759496 0.0638838 0.0599142 0.0397917 0.0184855 0.0157127 0.0211235 0.0351775 0.0513749 0.0611358 0.0410374 0.0537904 0.0277581 0.0118244 0.0152826 0.0289965 0.0246485 0.0101672 0.0184785 0.0142833 0.0108455 0.0158754 0.0263315 0.0177182 0.00941266 0.0104002 0.0140777 0.0128196 0.0467074	Accordingly , patients should be advised to avoid DRUG1 while taking DRUG2 . DRUG0 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG0 (15 mg) in 12 healthy subjects .
4	4	0.0239381 0.00610946 0.0100123 0.00869739 0.00888195 0.0131812 0.0245916 0.0433758 0.0708107 0.0633132 0.0320674 0.0211936 0.0434363 0.038611 0.0285331 0.045428 0.064774 0.0695969 0.038913 0.0485741 0.0259223 0.01135 0.0143409 0.0269814 0.0228171 0.00957077 0.0175647 0.0135685 0.0102411 0.0148592 0.0247931 0.016744 0.00889767 0.00976159 0.0132201 0.0120466 0.0432821	Accordingly , patients should be advised to avoid DRUG1 while taking DRUG0 . DRUG2 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG0 (15 mg) in 12 healthy subjects .
1	4	0.0267676 0.00684108 0.0112029 0.00993121 0.00950658 0.0144605 0.0265559 0.0472283 0.0708448 0.0555932 0.029318 0.0173287 0.0216217 0.0152633 0.0218119 0.0398171 0.0352515 0.047972 0.049324 0.0411663 0.0438484 0.0250197 0.0267907 0.0545573 0.0329007 0.0159592 0.020547 0.015893 0.0132252 0.0157906 0.0259338 0.0178429 0.00950071 0.0103576 0.0141317 0.0129825 0.0469126	Accordingly , patients should be advised to avoid DRUG1 while taking DRUG0 . DRUG0 : Concomitant administration of DRUG2 (15 mg) had a minimal effect on plasma levels of DRUG0 (15 mg) in 12 healthy subjects .
4	4	0.0232592 0.00603377 0.00993111 0.0088096 0.00767258 0.0120613 0.0228652 0.0434775 0.0584229 0.0473573 0.021698 0.0104495 0.0113408 0.0106435 0.0121156 0.024391 0.0390883 0.0427174 0.0300336 0.0470398 0.0253382 0.0110303 0.0134767 0.0298945 0.0285526 0.0192143 0.0588605 0.0529495 0.0575002 0.048495 0.0298988 0.0289977 0.0206014 0.0140395 0.0163679 0.0161999 0.039175	Accordingly , patients should be advised to avoid DRUG1 while taking DRUG0 . DRUG0 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG2 (15 mg) in 12 healthy subjects .
4	4	0.0163385 0.00469104 0.00820527 0.00855622 0.00791011 0.0105632 0.0127521 0.0347273 0.0487027 0.0640928 0.0643224 0.0873747 0.0640569 0.03981 0.0291879 0.0416292 0.0536183 0.0582657 0.035113 0.0455575 0.0242216 0.0107368 0.0131223 0.024126 0.0203818 0.00865697 0.0157687 0.0120914 0.00904355 0.0131029 0.0219861 0.0148575 0.00795021 0.00866904 0.0117609 0.0107397 0.0373099	Accordingly , patients should be advised to avoid DRUG0 while taking DRUG1 . DRUG2 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG0 (15 mg) in 12 healthy subjects .
4	4	0.0212041 0.00613847 0.0105817 0.0107968 0.0100359 0.0127618 0.0150186 0.0391337 0.0505618 0.0674343 0.0567525 0.0640272 0.0384479 0.0132101 0.0203699 0.0340176 0.0277855 0.0392081 0.0423176 0.0394208 0.0426735 0.0232695 0.0247672 0.0502938 0.0310123 0.0150636 0.0196435 0.0151481 0.0125977 0.0150817 0.0248213 0.0170818 0.00908404 0.00988947 0.0134908 0.0123835 0.0444737	Accordingly , patients should be advised to avoid DRUG0 while taking DRUG1 . DRUG0 : Concomitant administration of DRUG2 (15 mg) had a minimal effect on plasma levels of DRUG0 (15 mg) in 12 healthy subjects .
4	4	0.0179604 0.0051716 0.00899419 0.00931763 0.00864385 0.0112581 0.013269 0.0366004 0.0466985 0.0646639 0.0579625 0.0511854 0.0189529 0.00896224 0.0120962 0.0218599 0.0334589 0.0386338 0.0278384 0.0448759 0.0250236 0.0111692 0.0133757 0.028339 0.0273266 0.0179695 0.0531306 0.0471131 0.0502569 0.0423152 0.0264554 0.025628 0.018151 0.0123387 0.0143753 0.0142483 0.0343802	Accordingly , patients should be advised to avoid DRUG0 while taking DRUG1 . DRUG0 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG2 (15 mg) in 12 healthy subjects .
4	4	0.0189701 0.00525486 0.00907732 0.00853315 0.0065773 0.00743837 0.00656642 0.0170596 0.0235234 0.028135 0.014994 0.0145446 0.0204125 0.0273439 0.0150276 0.0316022 0.0501972 0.0509708 0.0330005 0.0532894 0.0293388 0.0132767 0.0156848 0.033391 0.0319573 0.021386 0.0636307 0.0574792 0.0612336 0.051665 0.0326442 0.0316955 0.0224495 0.0151707 0.0175877 0.0173896 0.0415014	Accordingly , patients should be advised to avoid DRUG0 while taking DRUG0 . DRUG1 : Concomitant administration of DRUG0 (15 mg) had a minimal effect on plasma levels of DRUG2 (15 mg) in 12 healthy subjects .
3	3	0.0217376 0.00605844 0.0106857 0.0103691 0.00773205 0.00873033 0.00665087 0.0150831 0.0214571 0.0230598 0.0117826 0.00909365 0.0080846 0.00792893 0.0105249 0.0233516 0.0334831 0.0358723 0.0533541 0.0332348 0.0283191 0.0210406 0.0239555 0.0539779 0.050897 0.0424494 0.0558295 0.0468042 0.0547115 0.0421571 0.0334536 0.0367986 0.0288273 0.0203656 0.0242942 0.0246364 0.0532078	Accordingly , patients should be advised to avoid DRUG0 while taking DRUG0 . DRUG0 : Concomitant administration of DRUG1 (15 mg) had a minimal effect on plasma levels of DRUG2 (15 mg) in 12 healthy subjects .
2	2	0.0249946 0.0142371 0.0382481 0.0484608 0.0345751 0.0557641 0.0561411 0.0616642 0.0677557 0.0875334 0.0243549 0.0223609 0.0239822 0.0183765 0.0300613 0.0811465 0.0320921 0.0248228 0.0557482 0.0800032 0.064723 0.0529541	However , the impairment of motor skills produced by DRUG1 has been shown to be additive with those caused by DRUG2 .
1	1	0.0548809 0.0154321 0.0282207 0.0258806 0.0269028 0.0403304 0.0758114 0.130382 0.137956 0.0185315 0.0163169 0.0552359 0.0408391 0.0545696 0.0898949 0.0899255 0.0988897	Accordingly , patients should be advised to avoid DRUG1 and other similar drugs while taking DRUG2 .
4	4	0.0341702 0.0313397 0.0386511 0.052328 0.0352741 0.0392008 0.0223705 0.0231549 0.0330814 0.019564 0.00657218 0.0114852 0.0579944 0.0641991 0.0445873 0.0482758 0.0493134 0.0225469 0.0236232 0.050068 0.0314723 0.0294039 0.0492614 0.0402879 0.050856 0.0408709 0.0500472	We elucidated the expression of HB-EGF in T-ALL cell lines , and evaluated the effect of DRUG1 on these cells alone or in combination with DRUG2 .
4	4	0.0327436 0.0379188 0.0190545 0.00586943 0.00697149 0.0286766 0.01433 0.0509533 0.0468508 0.0623592 0.0830773 0.117039 0.0916917 0.0843762 0.0687623 0.0243643 0.0196871 0.0325282 0.062564 0.0475342 0.0626481	DRUG1 induced apoptosis , and furthermore , the combination of DRUG0 plus DRUG2 enhanced cytotoxicity in a T-ALL cell line .
2	2	0.0200915 0.0244994 0.0190356 0.00463826 0.00595619 0.0421292 0.0221134 0.0628599 0.0370168 0.053185 0.0671488 0.120227 0.0789391 0.0911383 0.0692688 0.0286629 0.0254805 0.0384393 0.0679464 0.0527347 0.0684884	DRUG0 induced apoptosis , and furthermore , the combination of DRUG1 plus DRUG2 enhanced cytotoxicity in a T-ALL cell line .
3	3	0.0506618 0.0347076 0.0232798 0.0280116 0.0398398 0.0547036 0.0416936 0.0948505 0.097755 0.0523252 0.0437149 0.0401888 0.0555498 0.0422514 0.0582894 0.0619078 0.065502 0.0591913 0.0555762	A study published in 2002 found that DRUG1 causes a statistically significant increase in plasma clearance of DRUG2 .
2	3	0.0230974 0.0151072 0.00656994 0.0261687 0.0135402 0.00522249 0.0177361 0.0166893 0.0284325 0.0186915 0.0193816 0.0291499 0.0459016 0.0275236 0.0326251 0.0634935 0.0795752 0.0571442 0.0573356 0.0385947 0.04116 0.0615872 0.0518686 0.0240777 0.0233125 0.0378131 0.0298376 0.0432843 0.065079	In 1984 , Drs Rimmer and Richens at the University of Wales reported that administering DRUG1 with DRUG2 lowered the serum DRUG0 concentration in patients with treatment-resistant epilepsy .
4	4	0.0146914 0.00956713 0.0041893 0.0166549 0.00838952 0.00286749 0.00800659 0.00757429 0.0109875 0.00821453 0.0106715 0.0220555 0.0350013 0.0320823 0.0551603 0.0634796 0.0393329 0.0436971 0.0746614 0.0899315 0.105671 0.0754424 0.0610396 0.0343275 0.0294541 0.030074 0.0282246 0.0319554 0.0465953	In 1984 , Drs Rimmer and Richens at the University of Wales reported that administering DRUG1 with DRUG0 lowered the serum DRUG2 concentration in patients with treatment-resistant epilepsy .
2	4	0.0696648 0.0333088 0.155831 0.0612638 0.0262058 0.0186515 0.0202662 0.0522157 0.0327019 0.0387884 0.0267375 0.0255833 0.0542434 0.0545927 0.0614164 0.0533065 0.0485752 0.0718313 0.0948155	DRUG1 : Excessive reductions in blood pressure may occur in patients on diuretic therapy when DRUG2 are started .
4	4	0.0271516 0.0307614 0.030066 0.0358432 0.0484186 0.0458759 0.0595725 0.0473477 0.0278194 0.0538594 0.0296204 0.0250985 0.0333186 0.0194369 0.0240236 0.0223923 0.00821732 0.00419268 0.0116668 0.0175798 0.0132556 0.00807334 0.00850243 0.0074403 0.006597 0.00950853 0.00811868 0.00802302 0.0170329 0.0190521 0.0194222 0.0158235 0.0200924 0.0233601 0.00969547 0.0231849 0.0258171 0.0158013 0.0297592 0.0221053 0.00957186 0.0117577 0.0285754 0.0371669	The possibility of hypotensive effects with DRUG1 can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with DRUG0 . If this is not possible , the starting dose of DRUG2 should be reduced. .
1	4	0.0110687 0.0108357 0.00664488 0.00783239 0.00704612 0.00725693 0.0186607 0.0264259 0.0150882 0.0448401 0.0188462 0.0215592 0.0319014 0.0197984 0.0251552 0.0293447 0.0119132 0.00790628 0.0222997 0.0416357 0.0369031 0.022235 0.019505 0.0236112 0.0237204 0.0201836 0.0285009 0.032896 0.0351851 0.0260337 0.0346687 0.0190893 0.025087 0.0278333 0.0116893 0.0233713 0.0279402 0.0181594 0.0361006 0.0241005 0.0119363 0.01444 0.0310024 0.0397487	The possibility of hypotensive effects with DRUG0 can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with DRUG1 . If this is not possible , the starting dose of DRUG2 should be reduced. .
4	4	0.115025 0.108098 0.0249914 0.0494497 0.0404654 0.0563218 0.112063 0.0364752 0.0245314 0.0722557 0.0279277 0.0324319 0.108975 0.0587825 0.0493661 0.0828393	DRUG1 Supplements and DRUG2 : DRUG0 can increase serum potassium because it decreases aldosterone secretion .
4	4	0.103624 0.0864343 0.0208671 0.0281471 0.042609 0.0954011 0.118873 0.0365205 0.0359926 0.0970773 0.0307288 0.027052 0.0966299 0.0572982 0.0518537 0.0708916	DRUG1 Supplements and DRUG0 : DRUG2 can increase serum potassium because it decreases aldosterone secretion .
4	4	0.0400034 0.0712656 0.0282989 0.0769124 0.052885 0.101281 0.119852 0.0373706 0.0366629 0.0971216 0.0309946 0.0269197 0.0972432 0.0583258 0.0527516 0.0721124	DRUG0 Supplements and DRUG1 : DRUG2 can increase serum potassium because it decreases aldosterone secretion .
2	2	0.0268706 0.0278204 0.02032 0.0096904 0.00398827 0.00307953 0.00436286 0.00469395 0.00669623 0.00968551 0.0178907 0.0315125 0.0699384 0.0993387 0.144222 0.113461 0.111482 0.0588917 0.0747248 0.0356742 0.0226024 0.030498 0.0725564	Use of DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 supplements concomitantly with DRUG2 can increase the risk of hyperkalemia .
2	2	0.0297399 0.0274935 0.0167103 0.0115703 0.0209702 0.00446003 0.00486628 0.00531185 0.00705926 0.00994324 0.0202755 0.0314167 0.0657391 0.0855937 0.134984 0.106581 0.115921 0.0587356 0.0754233 0.036094 0.0228884 0.0314652 0.0767571	Use of DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) or DRUG0 supplements concomitantly with DRUG2 can increase the risk of hyperkalemia .
2	2	0.0220483 0.0174028 0.00853257 0.0044319 0.00740423 0.00487278 0.0190641 0.00521197 0.00791246 0.0112456 0.0203822 0.0345976 0.0726815 0.096958 0.1387 0.108556 0.116378 0.0582308 0.0735426 0.0367651 0.0229723 0.0318598 0.0802485	Use of DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) or DRUG0 supplements concomitantly with DRUG2 can increase the risk of hyperkalemia .
2	2	0.0181027 0.0134903 0.0067874 0.00306669 0.00449308 0.00252383 0.00656765 0.00568733 0.0261011 0.0131516 0.0209989 0.0355949 0.0806214 0.106399 0.144546 0.110168 0.111729 0.0557772 0.0698002 0.0351083 0.0219029 0.0304689 0.0769126	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) or DRUG0 supplements concomitantly with DRUG2 can increase the risk of hyperkalemia .
2	2	0.0220039 0.0161532 0.00621903 0.00353631 0.00405571 0.00299401 0.00553863 0.005946 0.0138142 0.0205958 0.0167714 0.110848 0.0569473 0.0671741 0.123104 0.0988327 0.118332 0.0645254 0.0800509 0.0353926 0.0228264 0.0308849 0.0734536	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG1 supplements concomitantly with DRUG2 can increase the risk of hyperkalemia .
4	4	0.0340376 0.0461664 0.0269027 0.0837088 0.0832006 0.0759003 0.0656192 0.0687643 0.0327576 0.0469046 0.0380151 0.029703 0.0472195 0.0290272 0.0186228 0.0203258 0.0152258 0.0225438 0.0136641 0.00945783 0.00844912 0.00450314 0.0109505 0.0319035 0.0427833 0.0422474 0.0513961	Oral DRUG1 : Interaction studies with DRUG2 failed to identify any clinically important effect on the serum concentrations of the DRUG0 or on its DRUG0 effect .
4	4	0.0385949 0.044558 0.0115986 0.0235059 0.0175266 0.0183295 0.0320585 0.0484293 0.0183562 0.0233554 0.0258456 0.0238314 0.0529911 0.0366821 0.0316706 0.0512432 0.0456252 0.0645517 0.0567467 0.0676989 0.0349727 0.0133667 0.0172269 0.0500117 0.0491243 0.0416408 0.0604575	Oral DRUG1 : Interaction studies with DRUG0 failed to identify any clinically important effect on the serum concentrations of the DRUG2 or on its DRUG0 effect .
4	4	0.0147801 0.0119767 0.0179655 0.0540794 0.0654284 0.0843249 0.0896732 0.0501711 0.0236552 0.0333332 0.0308738 0.0254129 0.0447113 0.0310625 0.030329 0.0436505 0.036918 0.0435675 0.0390003 0.0470129 0.0237402 0.00920914 0.0118193 0.0329756 0.0338472 0.0277409 0.0427414	Oral DRUG0 : Interaction studies with DRUG1 failed to identify any clinically important effect on the serum concentrations of the DRUG2 or on its DRUG0 effect .
4	4	0.0599136 0.0225425 0.0928321 0.0346473 0.0321614 0.0216291 0.0111352 0.0163823 0.0131499 0.0249462 0.0386127 0.0181187 0.026937 0.0592192 0.0512769 0.0443889 0.0618028 0.0519039 0.0649085 0.0664543 0.0561936 0.0441602 0.0866838	DRUG1 : Increased serum DRUG0 levels and symptoms of DRUG0 toxicity have been reported in patients receiving DRUG2 during therapy with DRUG0 .
4	4	0.0207663 0.0274021 0.130886 0.101061 0.0565959 0.0278126 0.00862181 0.0187864 0.0197232 0.0281042 0.0344082 0.0183971 0.0267848 0.0471212 0.0442571 0.0400678 0.0528096 0.0432097 0.0528011 0.0536325 0.0449894 0.0347748 0.0669868	DRUG0 : Increased serum DRUG1 levels and symptoms of DRUG0 toxicity have been reported in patients receiving DRUG2 during therapy with DRUG0 .
4	4	0.0142603 0.0161304 0.0599506 0.0353864 0.0377132 0.02991 0.0228803 0.0434453 0.049086 0.058553 0.0441833 0.0238828 0.031464 0.0466613 0.0351652 0.0393024 0.0583331 0.0510822 0.0638681 0.0607583 0.0543164 0.0437051 0.0799623	DRUG0 : Increased serum DRUG0 levels and symptoms of DRUG1 toxicity have been reported in patients receiving DRUG2 during therapy with DRUG0 .
2	2	0.016529 0.0192571 0.0581611 0.0312866 0.0337871 0.0260958 0.0152508 0.0234518 0.0215736 0.0323907 0.0479975 0.0278861 0.0396715 0.0692364 0.0524011 0.0391457 0.0347099 0.0819573 0.0650911 0.0537379 0.0818534 0.0714456 0.0570829	DRUG0 : Increased serum DRUG0 levels and symptoms of DRUG0 toxicity have been reported in patients receiving DRUG1 during therapy with DRUG2 .
2	2	0.067687 0.0777608 0.0646234 0.0485265 0.0527227 0.0460317 0.0283876 0.0782837 0.0530317 0.100581 0.0627547 0.0416773 0.0645156 0.0520254 0.086287 0.0751041	If a DRUG1 is also used , the risk of DRUG2 toxicity may be increased .
4	4	0.0112778 0.0143458 0.0253959 0.0868353 0.0507207 0.0739241 0.0541777 0.0807109 0.0973384 0.0712204 0.0759166 0.0522492 0.0436117 0.057316 0.0642247 0.0239719 0.00529023 0.00545908 0.00445165 0.00810457 0.0207368 0.0727206	Other Agents : No clinically important pharmacokinetic interactions occurred when DRUG1 was administered concomitantly with DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0122015 0.0154921 0.0273844 0.0932039 0.0542949 0.0783075 0.0562459 0.0792683 0.0930734 0.0692056 0.068192 0.0486222 0.0403205 0.0605176 0.0564177 0.0133718 0.00773414 0.0177682 0.00493144 0.00859656 0.0193405 0.0755096	Other Agents : No clinically important pharmacokinetic interactions occurred when DRUG1 was administered concomitantly with DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0120206 0.0152516 0.026944 0.0910838 0.0530546 0.0765779 0.0554847 0.079791 0.0915768 0.0675848 0.0712195 0.0471578 0.0383513 0.0531441 0.0494391 0.010535 0.00415005 0.00600213 0.00769267 0.0170394 0.0476279 0.0782712	Other Agents : No clinically important pharmacokinetic interactions occurred when DRUG1 was administered concomitantly with DRUG0 , DRUG0 , or DRUG2 .
4	4	0.149939 0.0556381 0.0571443 0.0441943 0.053748 0.047751 0.0916957 0.11628 0.0884137 0.0267868 0.00446587 0.00411664 0.00316618 0.00402583 0.00333444 0.0050818 0.00407992 0.00947088 0.00987791 0.00582562 0.009151 0.0594161 0.028582 0.117815	DRUG1 has been used in clinical trials concomitantly with DRUG2 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , and cholesterol-lowering agents .
4	4	0.15532 0.0562381 0.0518972 0.0428603 0.0578401 0.049019 0.0912728 0.100649 0.0627741 0.0133701 0.00898159 0.0161494 0.00301625 0.00375131 0.00308144 0.00490276 0.00378474 0.00827502 0.0107031 0.00609866 0.0104627 0.0643818 0.0332658 0.141905	DRUG1 has been used in clinical trials concomitantly with DRUG0 , DRUG2 , DRUG0 , DRUG0 , oral DRUG0 , and cholesterol-lowering agents .
4	4	0.158271 0.0567697 0.0524667 0.042938 0.0573699 0.0481928 0.0890873 0.0963273 0.0572641 0.0103379 0.00407222 0.00692272 0.00871377 0.0170844 0.00327029 0.00469882 0.00394591 0.00865972 0.0111041 0.00619918 0.0106086 0.0665306 0.0343086 0.144856	DRUG1 has been used in clinical trials concomitantly with DRUG0 , DRUG0 , DRUG2 , DRUG0 , oral DRUG0 , and cholesterol-lowering agents .
4	4	0.157006 0.0562581 0.0516729 0.0424125 0.0563968 0.0472786 0.0875719 0.0954202 0.0554529 0.0099147 0.00367016 0.00539475 0.00363915 0.00703737 0.00790346 0.0187397 0.00442363 0.00900005 0.011049 0.00639173 0.0108877 0.0677316 0.0356189 0.149128	DRUG1 has been used in clinical trials concomitantly with DRUG0 , DRUG0 , DRUG0 , DRUG2 , oral DRUG0 , and cholesterol-lowering agents .
4	4	0.13666 0.0483048 0.0424497 0.0369839 0.051994 0.0446 0.0808567 0.0814057 0.0471603 0.0087616 0.00327669 0.00501412 0.00338116 0.00622773 0.00442764 0.0106247 0.0181505 0.0833871 0.0470459 0.00764619 0.00990417 0.0546567 0.0319129 0.135168	DRUG1 has been used in clinical trials concomitantly with DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG2 , and cholesterol-lowering agents .
4	4	0.0497832 0.0705451 0.0731676 0.0524601 0.0391786 0.0441729 0.0811583 0.0906236 0.0905191 0.0444808 0.00845132 0.00578952 0.00567718 0.00521729 0.00665365 0.00833918 0.0176215 0.0602586 0.0267324 0.00593502 0.00895171 0.0505637 0.0298602 0.123859	DRUG0 has been used in clinical trials concomitantly with DRUG1 , DRUG0 , DRUG0 , DRUG0 , oral DRUG2 , and cholesterol-lowering agents .
4	4	0.0506791 0.0591868 0.0556803 0.0394697 0.0303829 0.0335117 0.0645329 0.0885816 0.0597731 0.0199896 0.0130776 0.0438858 0.0092935 0.00736498 0.00860947 0.0105845 0.0217388 0.0743572 0.0319814 0.00719515 0.0112192 0.0639634 0.0376738 0.157267	DRUG0 has been used in clinical trials concomitantly with DRUG0 , DRUG1 , DRUG0 , DRUG0 , oral DRUG2 , and cholesterol-lowering agents .
4	4	0.0520598 0.0566942 0.051034 0.0351038 0.0263399 0.0267008 0.0507562 0.0711792 0.0464688 0.0130581 0.00603749 0.0133561 0.0133072 0.0481115 0.0118753 0.0141187 0.0275186 0.0910282 0.038617 0.00820593 0.0125536 0.0701512 0.0412645 0.17446	DRUG0 has been used in clinical trials concomitantly with DRUG0 , DRUG0 , DRUG1 , DRUG0 , oral DRUG2 , and cholesterol-lowering agents .
4	4	0.0469059 0.0466508 0.0408824 0.0281561 0.0210652 0.0207543 0.0390315 0.0576853 0.0379145 0.0119712 0.00490549 0.00992898 0.00714716 0.0209193 0.0234349 0.108548 0.0268877 0.0995309 0.0441284 0.00901696 0.0133384 0.0700106 0.0408841 0.170302	DRUG0 has been used in clinical trials concomitantly with DRUG0 , DRUG0 , DRUG0 , DRUG1 , oral DRUG2 , and cholesterol-lowering agents .
4	2	0.0325478 0.0352947 0.0997033 0.0848029 0.0736546 0.113313 0.107914 0.0864271 0.0686243 0.00941362 0.0130103 0.0124896 0.0211489 0.00547919 0.00984281 0.0108776 0.0300759 0.0311968 0.0212996 0.0207239 0.0222737 0.0898873	Drugs which may potentiate the myeloproliferative effects of DRUG1 , such as DRUG2 and DRUG0 , should be used with caution .
4	2	0.0350738 0.0377828 0.10606 0.086971 0.0726688 0.102873 0.0891753 0.0710246 0.0610364 0.00835979 0.0133069 0.013888 0.0151222 0.0231146 0.0424177 0.0117271 0.0273776 0.029807 0.0218304 0.0201497 0.0216783 0.0885545	Drugs which may potentiate the myeloproliferative effects of DRUG1 , such as DRUG0 and DRUG2 , should be used with caution .
4	4	0.0278302 0.0306468 0.0873116 0.071789 0.0587298 0.0793935 0.078068 0.0466652 0.0209574 0.0116248 0.0236439 0.0281803 0.114607 0.0244493 0.0433994 0.0113836 0.0315313 0.0335101 0.0244206 0.0225969 0.0251438 0.104117	Drugs which may potentiate the myeloproliferative effects of DRUG0 , such as DRUG1 and DRUG2 , should be used with caution .
2	2	0.0305593 0.0250348 0.0151669 0.0298739 0.0385573 0.0538703 0.0348525 0.0341081 0.0631144 0.0380012 0.0833377 0.0567173 0.0401626 0.0341707 0.032307 0.0192502 0.0272057 0.0502102 0.023448 0.0657161 0.0634585 0.0216192 0.00591703 0.00300938 0.00323993 0.00226991 0.00327928 0.00225373 0.00314352 0.00781769 0.0126224 0.0757051	The induction dose requirements of DRUG1 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG2 (eg , DRUG0 , DRUG0 , and DRUG0 , etc.)
2	2	0.0319647 0.0259381 0.015301 0.029772 0.0384664 0.0527859 0.0338594 0.0326382 0.0609466 0.0367767 0.0802241 0.0535954 0.0376322 0.0318059 0.0277315 0.0176783 0.0253269 0.0506298 0.0255524 0.0974442 0.0561638 0.0142049 0.00856598 0.00538789 0.0106737 0.00223522 0.00274653 0.00199532 0.00261794 0.00698804 0.0102121 0.0721388	The induction dose requirements of DRUG1 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG0 (eg , DRUG2 , DRUG0 , and DRUG0 , etc.)
2	2	0.0322757 0.0262171 0.0155076 0.0302295 0.0390639 0.0538044 0.0344451 0.0332628 0.0618843 0.0373092 0.0813579 0.0546244 0.0383543 0.032387 0.0281271 0.0177961 0.0252775 0.050273 0.0251279 0.0958854 0.0533287 0.0127322 0.00610533 0.00234067 0.00369111 0.00421914 0.0101754 0.00245155 0.002573 0.00655986 0.00999484 0.0726177	The induction dose requirements of DRUG1 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG0 (eg , DRUG0 , DRUG2 , and DRUG0 , etc.)
2	2	0.0323103 0.0263657 0.0157931 0.0310153 0.0401026 0.0558968 0.0359808 0.0350297 0.0646133 0.0389501 0.0848859 0.0579088 0.0408679 0.0346823 0.0304165 0.0188017 0.0253439 0.0499102 0.0252297 0.0800384 0.0476451 0.0109702 0.00574033 0.00206076 0.00270932 0.00203639 0.00355651 0.00362453 0.00848094 0.0198337 0.00833648 0.0608625	The induction dose requirements of DRUG1 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG0 (eg , DRUG0 , DRUG0 , and DRUG2 , etc.)
4	4	0.0258281 0.021026 0.00665617 0.0140268 0.0157958 0.0278398 0.0530844 0.0334804 0.0424945 0.0321854 0.0709999 0.0357648 0.0278953 0.0275922 0.0255764 0.0139759 0.0290545 0.04785 0.0322786 0.0846096 0.0858318 0.0592823 0.0202533 0.0116938 0.0180387 0.00424324 0.00462485 0.00337133 0.00414077 0.0100709 0.0151336 0.0953008	The induction dose requirements of DRUG0 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG1 (eg , DRUG2 , DRUG0 , and DRUG0 , etc.)
4	4	0.0257938 0.0210457 0.00667408 0.0140872 0.0158804 0.0279862 0.0534642 0.0337237 0.0430582 0.0328052 0.0720083 0.0368147 0.028598 0.0283062 0.0253291 0.0136706 0.0282942 0.0455023 0.0305356 0.0784213 0.0785233 0.0621617 0.0174593 0.0113833 0.00938882 0.00944402 0.0195585 0.00478946 0.00450165 0.00971044 0.0151947 0.0958856	The induction dose requirements of DRUG0 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG1 (eg , DRUG0 , DRUG2 , and DRUG0 , etc.)
4	4	0.0272303 0.0221715 0.00703449 0.0148267 0.0166988 0.0294041 0.0559385 0.0352654 0.0449433 0.0343552 0.0751135 0.0383716 0.0292589 0.0282224 0.024177 0.0122304 0.0257307 0.0417235 0.0282109 0.0633538 0.0636567 0.0568427 0.0198776 0.0116112 0.00715841 0.00725135 0.0076604 0.0123524 0.0177114 0.0368185 0.0155507 0.0892476	The induction dose requirements of DRUG0 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG1 (eg , DRUG0 , DRUG0 , and DRUG2 , etc.)
4	4	0.0272906 0.0222157 0.00698014 0.0146057 0.0165565 0.0288887 0.0548032 0.0344264 0.0429536 0.031755 0.0684261 0.0326366 0.0243511 0.0214714 0.0168156 0.00763509 0.0177896 0.0308824 0.0316316 0.12468 0.0636855 0.0186471 0.0076256 0.00399469 0.00897945 0.0105571 0.0523417 0.0139189 0.0178928 0.0387986 0.0147092 0.0920542	The induction dose requirements of DRUG0 Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUG0 (eg , DRUG0 , DRUG1 , and DRUG2 , etc.)
4	4	0.0531214 0.2019 0.133096 0.182572 0.033595 0.0318769 0.0112057 0.00554124 0.00561868 0.00401336 0.00532198 0.00424342 0.00650966 0.00623576 0.0150525 0.0242321 0.146721 0.129142	and combinations of DRUG1 and DRUG2 (eg , DRUG0 , DRUG0 , DRUG0 , DRUG0 , etc.) .
4	4	0.0615654 0.231549 0.147266 0.153972 0.0271293 0.0203218 0.026 0.011558 0.0183953 0.00431929 0.00480002 0.00368661 0.00545448 0.00516559 0.0123255 0.0180488 0.128036 0.120406	and combinations of DRUG1 and DRUG0 (eg , DRUG2 , DRUG0 , DRUG0 , DRUG0 , etc.) .
4	4	0.060357 0.227105 0.145966 0.153198 0.0266175 0.0182343 0.0207151 0.0101449 0.00930529 0.0100491 0.0192807 0.00457688 0.0061283 0.00532717 0.0122715 0.0188498 0.132315 0.119559	and combinations of DRUG1 and DRUG0 (eg , DRUG0 , DRUG2 , DRUG0 , DRUG0 , etc.) .
4	4	0.0597645 0.224477 0.144771 0.152438 0.0259611 0.0177001 0.0203376 0.00959716 0.00732012 0.00676325 0.00811648 0.0100821 0.0217873 0.00621118 0.0121841 0.018839 0.133329 0.12032	and combinations of DRUG1 and DRUG0 (eg , DRUG0 , DRUG0 , DRUG2 , DRUG0 , etc.) .
4	4	0.0611885 0.204394 0.132472 0.152491 0.0267658 0.0171927 0.0251247 0.0109682 0.00722501 0.00724414 0.00645075 0.00738157 0.00861882 0.016609 0.0489787 0.017827 0.117474 0.131595	and combinations of DRUG1 and DRUG0 (eg , DRUG0 , DRUG0 , DRUG0 , DRUG2 , etc.) .
4	4	0.0628442 0.243448 0.103209 0.0547433 0.0265206 0.056814 0.0235229 0.0128522 0.0217829 0.00499806 0.00623935 0.00494078 0.00754975 0.00696771 0.0165898 0.0222418 0.160022 0.164714	and combinations of DRUG0 and DRUG1 (eg , DRUG2 , DRUG0 , DRUG0 , DRUG0 , etc.) .
4	4	0.0632942 0.242023 0.104988 0.0553489 0.0269127 0.0563453 0.0174744 0.00952373 0.0104972 0.0109133 0.0226447 0.00512934 0.00747158 0.00662762 0.0155701 0.021588 0.160217 0.16343	and combinations of DRUG0 and DRUG1 (eg , DRUG0 , DRUG2 , DRUG0 , DRUG0 , etc.) .
4	4	0.0625072 0.238318 0.105014 0.0556567 0.026945 0.0555867 0.016735 0.00848616 0.00813192 0.00652794 0.00941332 0.0110825 0.0256953 0.00691783 0.0150274 0.0212709 0.160701 0.165984	and combinations of DRUG0 and DRUG1 (eg , DRUG0 , DRUG0 , DRUG2 , DRUG0 , etc.) .
4	4	0.065505 0.226081 0.10012 0.0521689 0.0251775 0.0558334 0.0175484 0.00869642 0.00749111 0.00600477 0.00709856 0.0065291 0.00960771 0.0157309 0.0520522 0.0189089 0.143651 0.181796	and combinations of DRUG0 and DRUG1 (eg , DRUG0 , DRUG0 , DRUG0 , DRUG2 , etc.) .
1	1	0.0281822 0.0319988 0.0225372 0.0214637 0.00900799 0.0203665 0.0269218 0.0614836 0.0527301 0.0404444 0.0491432 0.0268942 0.0237066 0.0225367 0.0111958 0.0128616 0.0232909 0.0197491 0.0131473 0.0164183 0.0146486 0.0149177 0.0104202 0.0110503 0.00572388 0.0143387 0.00928894 0.0417883 0.0337218 0.0519884 0.0285125 0.0279468 0.0261571 0.0339704 0.0411226 0.0163747 0.00455573 0.00244649 0.00320315 0.00329727 0.00601416 0.0102799 0.0541522	During maintenance of anesthesia or sedation , the rate of DRUG1 Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental DRUG2 (eg , DRUG0 or DRUG0 ) .
1	1	0.0305376 0.0346718 0.0244192 0.023257 0.00976021 0.0220689 0.0291667 0.0666235 0.0571377 0.0438144 0.0532505 0.0291194 0.0256556 0.0243784 0.0121036 0.0139208 0.0251507 0.0212209 0.0141155 0.0177614 0.0160217 0.0165677 0.0113774 0.0115787 0.00580012 0.0148165 0.00873746 0.03645 0.02946 0.0440449 0.0248201 0.0218081 0.0196409 0.0256217 0.02559 0.00824355 0.00593758 0.00394037 0.0111182 0.00480462 0.00602869 0.0111287 0.0583289	During maintenance of anesthesia or sedation , the rate of DRUG1 Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental DRUG0 (eg , DRUG2 or DRUG0 ) .
1	1	0.0307614 0.0349255 0.0245975 0.0234255 0.00983017 0.0222237 0.0293746 0.0670837 0.0575189 0.0441044 0.0535675 0.0292897 0.0257946 0.0244903 0.0121555 0.013966 0.0252245 0.0213046 0.014165 0.0177926 0.0160101 0.0165176 0.0113454 0.0115569 0.00582032 0.0148191 0.00874009 0.0364624 0.0293718 0.0438684 0.0243383 0.0216141 0.0191843 0.0245572 0.0243034 0.00696666 0.00431234 0.00181736 0.00391381 0.0064287 0.0182021 0.012163 0.0560905	During maintenance of anesthesia or sedation , the rate of DRUG1 Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental DRUG0 (eg , DRUG0 or DRUG2 ) .
4	4	0.0275992 0.0274997 0.0171724 0.0154163 0.00682968 0.0144098 0.0120493 0.0386598 0.045836 0.0263049 0.0259692 0.0370552 0.0255175 0.0187535 0.016104 0.0158266 0.0316381 0.0259743 0.0134568 0.0167856 0.0157097 0.0161367 0.0106381 0.0121642 0.00634362 0.0173033 0.0091304 0.0345879 0.0304395 0.043454 0.022181 0.0196986 0.0201855 0.0273525 0.0421733 0.0383215 0.0203008 0.0114338 0.0219662 0.0108006 0.011033 0.0201392 0.0796487	During maintenance of anesthesia or sedation , the rate of DRUG0 Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental DRUG1 (eg , DRUG2 or DRUG0 ) .
4	4	0.0272849 0.0271854 0.0169757 0.0152394 0.00675093 0.0142426 0.0119097 0.0382079 0.0452952 0.0259903 0.0256573 0.0366134 0.0252169 0.0185384 0.0159242 0.0156448 0.0312819 0.0256908 0.0133077 0.0166111 0.0155499 0.0160039 0.0106096 0.0121051 0.00638993 0.0173707 0.00901509 0.0343256 0.0301114 0.0430451 0.0215098 0.0190543 0.0190012 0.0254647 0.0395123 0.0404181 0.0177929 0.00870561 0.0105267 0.017077 0.0372117 0.0226261 0.0730048	During maintenance of anesthesia or sedation , the rate of DRUG0 Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental DRUG1 (eg , DRUG0 or DRUG2 ) .
4	4	0.0358071 0.0415097 0.0258371 0.0255714 0.0384546 0.0342413 0.0117303 0.00848081 0.00562735 0.0229574 0.00490942 0.00455644 0.00502884 0.00687836 0.0105581 0.0211624 0.0352928 0.0493433 0.0709728 0.0643116 0.0709973 0.0868917 0.0569137 0.0590789 0.0516727 0.0431204 0.044854 0.0632403	The concurrent administration of potent inhalational agents (eg , DRUG1 , DRUG0 , and DRUG0 ) during maintenance with DRUG2 Injectable Emulsion has not been extensively evaluated .
4	4	0.0432421 0.0481574 0.030094 0.0307328 0.0485071 0.0435905 0.0149738 0.00946357 0.00673979 0.0103931 0.00996752 0.0532017 0.0101144 0.0145891 0.029938 0.013313 0.046757 0.0720658 0.0417753 0.0468134 0.0583423 0.0431521 0.0263388 0.053303 0.0344145 0.0372775 0.046487 0.0762555	The concurrent administration of potent inhalational agents (eg , DRUG0 , DRUG1 , and DRUG2 ) during maintenance with DRUG0 Injectable Emulsion has not been extensively evaluated .
4	4	0.0347641 0.0389643 0.0239635 0.0235789 0.0357851 0.0305045 0.00950702 0.00581095 0.00374035 0.00516044 0.00457302 0.0223242 0.00520468 0.00650537 0.0108586 0.022297 0.0379468 0.0530824 0.072599 0.0654013 0.074815 0.0911044 0.0586998 0.0606337 0.0512923 0.0429268 0.0444273 0.0635291	The concurrent administration of potent inhalational agents (eg , DRUG0 , DRUG1 , and DRUG0 ) during maintenance with DRUG2 Injectable Emulsion has not been extensively evaluated .
4	4	0.0320499 0.0374454 0.023222 0.0227673 0.0355243 0.0307407 0.00907012 0.00531754 0.00305846 0.00375061 0.00305985 0.00541737 0.00515052 0.00816722 0.0387201 0.0225214 0.0408264 0.0579541 0.079308 0.0666256 0.0747818 0.0902365 0.0565338 0.0569163 0.0480625 0.040321 0.0422853 0.060166	The concurrent administration of potent inhalational agents (eg , DRUG0 , DRUG0 , and DRUG1 ) during maintenance with DRUG2 Injectable Emulsion has not been extensively evaluated .
4	4	0.0628801 0.0493449 0.0486397 0.0346814 0.0399058 0.0430462 0.0341526 0.0429113 0.0463317 0.0368508 0.0361601 0.0687558 0.0174305 0.0288039 0.006088 0.012438 0.0410312 0.0277909 0.0287472 0.0352918 0.0438548 0.0589949 0.0459877 0.0190397 0.00533785 0.00286476 0.00354571 0.00294914 0.00650555 0.0118532 0.0577849	DRUG1 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG2 (eg , DRUG0 and DRUG0 ) .
4	4	0.0707166 0.0555431 0.0548461 0.0392489 0.0452244 0.048916 0.039016 0.0490453 0.0530714 0.0425604 0.0413603 0.0797249 0.0202973 0.0332939 0.00650895 0.0120891 0.0380926 0.025661 0.0270674 0.0263107 0.0281423 0.0359606 0.0142247 0.00606789 0.00498379 0.00340179 0.0112753 0.00277595 0.00609577 0.0116363 0.0668412	DRUG1 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG0 (eg , DRUG2 and DRUG0 ) .
4	4	0.0696011 0.0546383 0.053901 0.0385308 0.0442894 0.0477535 0.038045 0.0478149 0.0516686 0.0413597 0.0402316 0.0773114 0.0195968 0.0319499 0.00622984 0.0115176 0.0364954 0.0242775 0.0261312 0.0256428 0.02764 0.0348191 0.0134513 0.00535417 0.00366921 0.00189414 0.00441178 0.00777978 0.0249189 0.0167641 0.0723115	DRUG1 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG0 (eg , DRUG0 and DRUG2 ) .
4	4	0.0350787 0.067818 0.0601563 0.0300984 0.0407063 0.041976 0.0293107 0.0373188 0.0455841 0.0335238 0.0323119 0.0650557 0.0170416 0.028404 0.0060607 0.0124691 0.0450541 0.0263188 0.0265014 0.0299092 0.035127 0.0460096 0.0431064 0.0349507 0.0144204 0.0082217 0.0159057 0.00399918 0.00709891 0.013969 0.066494	DRUG0 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG1 (eg , DRUG2 and DRUG0 ) .
4	4	0.0332919 0.0644396 0.0572737 0.0287412 0.0389168 0.0401526 0.0281845 0.0358783 0.0438803 0.0323888 0.0311921 0.0632041 0.0167723 0.0281615 0.0059422 0.0122308 0.0440495 0.026218 0.0267889 0.0301874 0.0350246 0.0451256 0.0415394 0.0363507 0.0123496 0.00796768 0.00931021 0.0118627 0.0314291 0.0197159 0.06143	DRUG0 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG1 (eg , DRUG0 and DRUG2 ) .
4	4	0.035272 0.0681175 0.0602376 0.0300164 0.0403942 0.0414857 0.0289346 0.0368952 0.0448781 0.032673 0.0314302 0.0632262 0.0163861 0.0265422 0.00553055 0.0101518 0.0370668 0.0257583 0.0279779 0.0228889 0.0216277 0.0284122 0.0187097 0.0148739 0.0154073 0.011209 0.0649536 0.0147343 0.0331907 0.0197856 0.0712327	DRUG0 Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUG0 (eg , DRUG1 and DRUG2 ) .
4	4	0.0776369 0.0653856 0.0401566 0.0677188 0.042659 0.0256066 0.020653 0.0254107 0.0094693 0.019087 0.0197409 0.0353672 0.0278243 0.0161943 0.0339325 0.0292172 0.0419957 0.0410033 0.0383591 0.0664029 0.0158032 0.0298006 0.0141274 0.00827848 0.0120385 0.00296034 0.00279247 0.00543523 0.00488203 0.00773504 0.011963 0.0218347 0.0522955 0.0662325	No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of DRUG1 , inhalational agents , DRUG2 , and local DRUG0 ) have been observed .
4	4	0.0742758 0.0625685 0.0384674 0.0650811 0.0410594 0.0247371 0.0200294 0.0246476 0.0091852 0.018468 0.0190316 0.034127 0.0267407 0.0158742 0.032909 0.0299614 0.0432706 0.0427413 0.0410024 0.0694525 0.0132673 0.0236241 0.012454 0.00822961 0.00493435 0.00418503 0.00560482 0.0196796 0.0222428 0.0102437 0.0118305 0.0209786 0.0434936 0.0656018	No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of DRUG1 , inhalational agents , DRUG0 , and local DRUG2 ) have been observed .
4	4	0.0881705 0.0721484 0.0428982 0.0665034 0.0401225 0.0216729 0.0158127 0.0191194 0.00615346 0.0108819 0.00995419 0.0199116 0.0173066 0.00784759 0.02056 0.0124298 0.0210914 0.0333569 0.0236602 0.0185655 0.0178752 0.0490963 0.023671 0.0121514 0.0498682 0.0112281 0.0118989 0.0355759 0.0285408 0.0123172 0.0144607 0.0262783 0.0594777 0.0793932	No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of DRUG0 , inhalational agents , DRUG1 , and local DRUG2 ) have been observed .
2	2	0.149266 0.16748 0.0821999 0.0930209 0.091771 0.103662 0.0884246 0.0298338 0.00969652 0.00621813 0.0038443 0.00456759 0.00357854 0.00479713 0.0035341 0.00506136 0.00383299 0.00611453 0.00407677 0.00690443 0.0285955 0.10352	DRUG1 may enhance the sedative effects of DRUG2 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.144314 0.153005 0.0833986 0.0830229 0.0994142 0.0995147 0.0732882 0.0263909 0.0182761 0.0247062 0.00462378 0.00464815 0.00341233 0.00464866 0.00350235 0.00498407 0.00385093 0.00615578 0.00432847 0.0074544 0.0296136 0.117446	DRUG1 may enhance the sedative effects of DRUG0 including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.150907 0.153705 0.0816697 0.0818971 0.099892 0.0940541 0.0774375 0.0217432 0.011233 0.00953025 0.00955219 0.0203014 0.00394933 0.00460567 0.00348967 0.00490469 0.0038128 0.00607186 0.00434654 0.00736957 0.029439 0.120088	DRUG1 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.149687 0.149725 0.0807937 0.0806442 0.0996034 0.092553 0.0747615 0.0207631 0.00971503 0.00747819 0.00488111 0.00843792 0.00972847 0.0214117 0.00422607 0.00531046 0.00409272 0.00637441 0.00461626 0.00760111 0.0307197 0.126876	DRUG1 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.14931 0.147897 0.0803057 0.0800245 0.0992612 0.0917428 0.073461 0.0202435 0.00936596 0.00716433 0.00442137 0.00657241 0.00496397 0.00906496 0.00999319 0.0231925 0.00476945 0.00663953 0.00488772 0.00758869 0.0306215 0.128509	DRUG1 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
2	2	0.14958 0.147934 0.0804496 0.0804741 0.099546 0.0925102 0.073434 0.0200946 0.00935547 0.00707581 0.00434628 0.00630128 0.00446754 0.00702333 0.00501914 0.00936146 0.0102059 0.0268538 0.00603877 0.00744367 0.0287808 0.123704	DRUG1 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
2	2	0.147373 0.139981 0.0759165 0.0737547 0.0882752 0.0752694 0.0661182 0.0172151 0.00899592 0.00638758 0.00411304 0.00548149 0.00420907 0.00592522 0.00450499 0.00653799 0.00531712 0.00894273 0.0115233 0.0308337 0.0844956 0.128829	DRUG1 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.067075 0.0988433 0.0863147 0.0929713 0.186049 0.126313 0.0805141 0.054259 0.0208745 0.0200279 0.00434904 0.00429873 0.00332872 0.00422693 0.00339288 0.0045587 0.00371919 0.00559053 0.00423909 0.0069535 0.0249556 0.0971446	DRUG0 may enhance the sedative effects of DRUG1 including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0734607 0.111469 0.0878589 0.0916642 0.164318 0.105402 0.0676716 0.0654912 0.0317292 0.0104802 0.00969695 0.0194525 0.00392116 0.00434858 0.00336574 0.00439557 0.00363595 0.0053889 0.00425269 0.00705979 0.0243675 0.100569	DRUG0 may enhance the sedative effects of DRUG1 including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0735911 0.111824 0.0877333 0.0918742 0.163733 0.104252 0.0671363 0.064011 0.0282518 0.00838905 0.00682665 0.00842451 0.00930449 0.0189818 0.00405268 0.00481996 0.00376766 0.00548983 0.00439451 0.00703893 0.0248204 0.101282	DRUG0 may enhance the sedative effects of DRUG1 including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0732879 0.111386 0.0872196 0.0915135 0.16282 0.103177 0.0666476 0.0640661 0.0278063 0.00816001 0.00633934 0.00660462 0.0064383 0.0079491 0.00899322 0.01967 0.0044166 0.00585517 0.004544 0.0069024 0.0246624 0.10154	DRUG0 may enhance the sedative effects of DRUG1 including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0731442 0.11117 0.0869639 0.0913158 0.162721 0.102654 0.066142 0.0633541 0.0275182 0.00808241 0.00653934 0.00651233 0.00613054 0.0062997 0.00606794 0.00771585 0.00912128 0.0226065 0.00556266 0.00687223 0.0233779 0.100129	DRUG0 may enhance the sedative effects of DRUG1 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0714303 0.106254 0.0832419 0.0871939 0.149107 0.0885227 0.0563125 0.0569201 0.0263088 0.00740679 0.00650672 0.00562036 0.00622885 0.00540675 0.00593109 0.00563579 0.00684206 0.00804562 0.0129381 0.0216363 0.0704185 0.112091	DRUG0 may enhance the sedative effects of DRUG1 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.05482 0.0776021 0.0638615 0.0621482 0.124021 0.0879317 0.0406116 0.0145517 0.00688328 0.00643594 0.00379815 0.00694228 0.00480514 0.00962421 0.00764121 0.0172187 0.0208879 0.0933445 0.0250901 0.0316044 0.0987721 0.141404	DRUG0 may enhance the sedative effects of DRUG0 including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.125078 0.110486 0.0861345 0.0647763 0.0098308 0.0153546 0.0150286 0.0250805 0.00610108 0.0156462 0.0530071 0.0588748 0.0836102 0.0296505 0.0253941 0.0248987 0.0513594 0.059315 0.0418414 0.0985332	The effects of DRUG1 , such as DRUG2 and DRUG0 may be enhanced by the concomitant administration of DRUG0 .
4	4	0.108033 0.0891604 0.0667026 0.0500021 0.00694711 0.0108747 0.00957301 0.0110802 0.0162427 0.0484906 0.0750975 0.0810635 0.0847287 0.0358689 0.0300292 0.0259639 0.0514559 0.0616499 0.0412267 0.0958096	The effects of DRUG1 , such as DRUG0 and DRUG2 may be enhanced by the concomitant administration of DRUG0 .
2	2	0.10123 0.0834117 0.0629782 0.0384184 0.00501011 0.00697762 0.00661683 0.0101432 0.0107446 0.0219714 0.0825153 0.0412204 0.0837283 0.0420174 0.0520289 0.0390665 0.053573 0.0858648 0.0909324 0.0815508	The effects of DRUG1 , such as DRUG0 and DRUG0 may be enhanced by the concomitant administration of DRUG2 .
4	4	0.0704508 0.0589404 0.0346592 0.0170336 0.00813326 0.0170809 0.0240543 0.108644 0.0177905 0.0484518 0.0772191 0.0917379 0.0931316 0.0359688 0.028271 0.0247599 0.0503178 0.0592818 0.0401938 0.09388	The effects of DRUG0 , such as DRUG1 and DRUG2 may be enhanced by the concomitant administration of DRUG0 .
2	2	0.0673057 0.0570742 0.0351443 0.017762 0.00685946 0.0106499 0.0136632 0.0534974 0.011665 0.0241898 0.0949716 0.0484545 0.0886201 0.0439551 0.054544 0.0407479 0.0569404 0.0913168 0.0968718 0.0857669	The effects of DRUG0 , such as DRUG1 and DRUG0 may be enhanced by the concomitant administration of DRUG2 .
2	2	0.0524914 0.0413355 0.0292464 0.0145823 0.0050604 0.00728528 0.0063643 0.0136087 0.0168879 0.0793411 0.094158 0.0532366 0.0986148 0.050763 0.0614553 0.0442357 0.0596591 0.0941462 0.0954968 0.0820313	The effects of DRUG0 , such as DRUG0 and DRUG1 may be enhanced by the concomitant administration of DRUG2 .
4	4	0.0299289 0.0211001 0.0390361 0.0473742 0.0363068 0.0469986 0.0430993 0.0380336 0.0308008 0.0478195 0.0260637 0.0486029 0.134708 0.080353 0.118721 0.0826345 0.0307763 0.00520904 0.00410439 0.00266054 0.00364714 0.00271913 0.0040879 0.0146985 0.0605163	In vitro studies with human liver microsomes showed that DRUG1 does not inhibit the metabolism of DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0361048 0.0255679 0.0473941 0.0575278 0.0436069 0.056759 0.0512275 0.0438252 0.0345766 0.0505261 0.0230535 0.0441187 0.12054 0.062939 0.100954 0.047231 0.0159093 0.00926063 0.0188134 0.00357846 0.00423389 0.00313966 0.00476012 0.0177183 0.0766348	In vitro studies with human liver microsomes showed that DRUG1 does not inhibit the metabolism of DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.03693 0.026159 0.0484407 0.0588 0.044587 0.0579176 0.0521126 0.0445824 0.0353573 0.0516142 0.023399 0.0445817 0.119834 0.0625715 0.0955663 0.0431849 0.0117544 0.00427746 0.00655021 0.00751793 0.0191856 0.00436737 0.00501143 0.01769 0.078007	In vitro studies with human liver microsomes showed that DRUG1 does not inhibit the metabolism of DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0365359 0.0259154 0.0478471 0.0577359 0.0440297 0.0568336 0.0505393 0.0428719 0.0338896 0.0492738 0.0227195 0.0438253 0.115107 0.0595597 0.0845435 0.0392085 0.0104852 0.00378552 0.00454354 0.00365828 0.00598023 0.00766137 0.0211408 0.0533365 0.0789729	In vitro studies with human liver microsomes showed that DRUG1 does not inhibit the metabolism of DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0418364 0.0258692 0.0451235 0.0550297 0.0366138 0.0411316 0.0255509 0.0192149 0.010263 0.0172492 0.0256459 0.056937 0.087795 0.0524023 0.0614799 0.0261635 0.0124013 0.00620033 0.0120564 0.0143974 0.073817 0.0209317 0.0261724 0.0836555 0.122062	In vitro studies with human liver microsomes showed that DRUG0 does not inhibit the metabolism of DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0152322 0.0242361 0.0166545 0.0157006 0.019879 0.0703865 0.0475423 0.0599687 0.0492089 0.0254581 0.0213209 0.0200913 0.00811836 0.00577602 0.0144785 0.019203 0.076801 0.0248769 0.0539932 0.041437 0.0403714 0.0262207 0.00783577 0.00833842 0.00277208 0.00302548 0.00212493 0.00183443 0.00276502 0.00875716 0.00925227 0.0337273 0.0308795 0.0096248 0.0116355 0.0176333 0.0484384 0.0422168 0.0621837	This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUG1 ,    -blockers , DRUG2 ( DRUG0 ) , and DRUG0 , if they have a narrow therapeutic window .
4	4	0.0152562 0.0242774 0.0166855 0.0157259 0.0199283 0.0706486 0.0476695 0.0599698 0.0489873 0.0253836 0.0212335 0.0200122 0.00814993 0.00583003 0.0144076 0.0189522 0.0752291 0.0240126 0.052331 0.0374618 0.034908 0.0221222 0.0071709 0.00708756 0.0082155 0.00949509 0.00296921 0.00207597 0.00272745 0.00813381 0.00929664 0.0377135 0.032534 0.010129 0.0120221 0.018037 0.0491566 0.0419557 0.0620974	This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUG1 ,    -blockers , DRUG0 ( DRUG2 ) , and DRUG0 , if they have a narrow therapeutic window .
4	4	0.0150552 0.0239233 0.0164465 0.0154711 0.019518 0.0688988 0.045634 0.0563311 0.0453771 0.024135 0.0201596 0.0184951 0.00801452 0.00592784 0.014595 0.0190721 0.0745608 0.0266848 0.062106 0.048061 0.043853 0.0237196 0.00737949 0.00586456 0.00681938 0.00589976 0.00607458 0.00464639 0.00889466 0.0155626 0.00619471 0.0276019 0.0302827 0.00984614 0.0114686 0.0162662 0.0435341 0.0396849 0.0579398	This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUG1 ,    -blockers , DRUG0 ( DRUG0 ) , and DRUG2 , if they have a narrow therapeutic window .
4	4	0.0190562 0.0290385 0.0193115 0.01782 0.022391 0.0719318 0.0399904 0.0444494 0.0258913 0.0109642 0.00698985 0.00877584 0.00376061 0.00248129 0.00342972 0.00339091 0.0104323 0.0163103 0.0566086 0.0464723 0.0370738 0.024568 0.00786453 0.00929248 0.0144143 0.0518169 0.0199659 0.0146691 0.016704 0.0283064 0.010719 0.0386786 0.0391686 0.0127297 0.0147533 0.0208682 0.0541011 0.0504508 0.0743592	This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUG0 ,    -blockers , DRUG0 ( DRUG1 ) , and DRUG2 , if they have a narrow therapeutic window .
4	4	0.0275642 0.0365787 0.0535537 0.0466243 0.034831 0.0278302 0.0198184 0.0286505 0.0247082 0.0328374 0.0427967 0.0335664 0.0568278 0.0353846 0.0519446 0.0525635 0.0648083 0.097041 0.081676 0.0437201 0.0198396 0.0194323 0.0674024	In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that DRUG1 does not affect the clearance of DRUG2 or DRUG0 .
4	4	0.0307396 0.0408549 0.0598207 0.0522963 0.039338 0.0312339 0.0222852 0.0317614 0.0270518 0.0351251 0.0444427 0.0343821 0.0555585 0.032106 0.0491875 0.048601 0.0522363 0.0783532 0.0499681 0.0293139 0.0319243 0.0560661 0.0673535	In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that DRUG1 does not affect the clearance of DRUG0 or DRUG2 .
3	3	0.133505 0.161761 0.0898031 0.105777 0.125777 0.1054 0.0740884 0.10063 0.103259	DRUG1 decreases the clearance of DRUG2 by 19% .
3	3	0.160441 0.132335 0.0803029 0.112138 0.126813 0.108829 0.0789304 0.0972993 0.102911	DRUG1 increases the clearance of DRUG2 by 15% .
2	2	0.0253304 0.0218005 0.0356736 0.119136 0.0435457 0.0220608 0.0245972 0.0171081 0.0762636 0.0424152 0.0406826 0.0392759 0.0306741 0.0200479 0.0224199 0.0290149 0.0215657 0.044957 0.0147447 0.0165061 0.00447897 0.0073281 0.00308682 0.00814346 0.0292978 0.0354902 0.0115449 0.0110495 0.010713 0.00460409 0.0109039 0.0334348 0.0134958 0.0213263 0.0157664 0.0321099 0.0394064	There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUG1 and DRUG2 , however , a causal relationship between DRUG0 Tablets and these changes has not been established .
2	4	0.0199919 0.0170182 0.0285054 0.0910715 0.0291753 0.0123725 0.0130849 0.00754916 0.0403704 0.0181147 0.0198365 0.0228265 0.0202523 0.0173048 0.0275073 0.0329713 0.0342399 0.0361791 0.0080346 0.00713411 0.00629458 0.0219056 0.00828443 0.0182888 0.0477867 0.0466895 0.0568811 0.0416294 0.0226173 0.00719732 0.0190161 0.0438468 0.0230213 0.0278036 0.0209086 0.038963 0.0453256	There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUG1 and DRUG0 , however , a causal relationship between DRUG2 Tablets and these changes has not been established .
2	4	0.0199311 0.0170114 0.0284404 0.0923698 0.0304389 0.0130485 0.0142495 0.00823711 0.0435129 0.0190856 0.0201662 0.0218807 0.0199976 0.0179803 0.0318721 0.0365664 0.0276262 0.0182659 0.0111772 0.0259939 0.00532861 0.0169402 0.00828194 0.0172862 0.0498879 0.0470236 0.0555392 0.0373724 0.0206767 0.0066846 0.0180128 0.0433878 0.0225242 0.0278187 0.0207554 0.0389633 0.0456648	There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUG0 and DRUG1 , however , a causal relationship between DRUG2 Tablets and these changes has not been established .
3	3	0.078051 0.0708478 0.0563443 0.0951457 0.110462 0.122286 0.0511092 0.010907 0.0198769 0.0196774 0.0105916 0.0129855 0.00402753 0.006352 0.044907 0.0369907 0.016071 0.013774 0.00860349 0.027201 0.033201 0.0200524 0.0524601 0.0780763	DRUG1 clearance is increased 100% by DRUG2 , a CyP450 enzyme inducer , and decreased 33% by DRUG0 , a CyP450 enzyme inhibitor .
3	3	0.0648617 0.0637529 0.0402343 0.0745016 0.0635414 0.0279376 0.0141101 0.00949431 0.0285873 0.0293857 0.015585 0.0252938 0.0128631 0.0220247 0.0916895 0.0829192 0.0845701 0.0415649 0.0103141 0.024303 0.0336684 0.0240947 0.0481763 0.0665264	DRUG1 clearance is increased 100% by DRUG0 , a CyP450 enzyme inducer , and decreased 33% by DRUG2 , a CyP450 enzyme inhibitor .
4	4	0.0375173 0.0695635 0.0602274 0.0950015 0.10481 0.0885795 0.0827221 0.0144145 0.0293002 0.0181193 0.0136703 0.0186517 0.00873951 0.0137932 0.0638287 0.0445787 0.0583156 0.027901 0.0068848 0.018023 0.0244257 0.0170215 0.0349794 0.0489321	DRUG0 clearance is increased 100% by DRUG1 , a CyP450 enzyme inducer , and decreased 33% by DRUG2 , a CyP450 enzyme inhibitor .
3	4	0.121062 0.12602 0.0909941 0.149995 0.218652 0.156589 0.136688	DRUG1 clearance is unaffected by DRUG2 .
4	4	0.0176713 0.0235595 0.0325321 0.0475989 0.0347452 0.0269661 0.0521965 0.0595957 0.0513718 0.0468363 0.0488367 0.0490233 0.0421367 0.0600736 0.0357734 0.0184887 0.026475 0.0425328 0.0635139 0.0208459 0.0304878 0.0329196 0.0229809 0.00646767 0.00888973 0.00225203 0.002285 0.00171566 0.00224931 0.00175271 0.00245686 0.00194621 0.00306224 0.00222723 0.00384736 0.01444 0.0592467	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0174133 0.0232204 0.0320501 0.0468872 0.0341756 0.0264504 0.0510782 0.0580308 0.0500653 0.0457085 0.0477329 0.0481367 0.0413855 0.0598541 0.0360517 0.018556 0.027196 0.042641 0.0671095 0.0225766 0.031247 0.033833 0.0203148 0.00704555 0.00463687 0.00383488 0.00922113 0.00193941 0.00226383 0.00172897 0.00238048 0.00189707 0.00298042 0.00221905 0.00385014 0.0142817 0.0600059	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0174743 0.0233006 0.032154 0.0470327 0.0342614 0.0265012 0.0511665 0.0580329 0.0500688 0.0457225 0.0477802 0.0481509 0.0413589 0.0598134 0.0359956 0.0184838 0.0271404 0.0423633 0.066939 0.0224128 0.0307778 0.0333674 0.0191198 0.00609235 0.00344508 0.0021542 0.00347244 0.00385031 0.00945503 0.00204165 0.00257833 0.0019804 0.00306025 0.00229753 0.00384981 0.0145232 0.0617812	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0174766 0.0233029 0.0321539 0.0470297 0.0342496 0.026484 0.0511313 0.0579465 0.0499869 0.0456514 0.0477235 0.0480881 0.0412933 0.0597402 0.0359611 0.0184512 0.0271101 0.0422622 0.0669889 0.0224333 0.0307567 0.0332728 0.0187697 0.00601506 0.00329692 0.00191341 0.00260435 0.00223174 0.00357834 0.0038728 0.00998002 0.00228593 0.00322524 0.00238484 0.00377001 0.0143228 0.0622545	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0175015 0.0233353 0.0321972 0.0470917 0.0342895 0.0265098 0.0511793 0.0579818 0.0500075 0.0456712 0.0477475 0.0481028 0.0412859 0.0597298 0.0359667 0.0184431 0.0271074 0.0422466 0.0670181 0.0224451 0.0307259 0.0332159 0.0186581 0.00605115 0.00326283 0.00190655 0.00254234 0.00200891 0.00272317 0.00223455 0.00363532 0.00405525 0.0117646 0.00295563 0.0037095 0.0135924 0.0611002	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0171158 0.0228224 0.0314892 0.0460556 0.0335392 0.0259428 0.0500429 0.0567253 0.0488988 0.0446233 0.0465501 0.0466042 0.0397382 0.0568164 0.0343091 0.0176473 0.0257933 0.0400404 0.0627947 0.0223087 0.0296361 0.0319507 0.0169589 0.00556119 0.00282709 0.00172734 0.00211318 0.00179162 0.00221006 0.00184262 0.00239848 0.00234205 0.00359485 0.00517794 0.0112097 0.0389137 0.0698868	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG1 , hormone replacement therapies , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0204579 0.0269176 0.0369586 0.0537832 0.0393192 0.0297967 0.0563203 0.0628058 0.0508245 0.0441184 0.0434591 0.0396781 0.0322053 0.0542966 0.0258553 0.0164346 0.0112912 0.0111271 0.0112593 0.00738567 0.017649 0.0152714 0.0150928 0.00354536 0.00348725 0.00187296 0.00345718 0.00230902 0.00479899 0.00375342 0.00864593 0.00966931 0.0510318 0.0141255 0.018658 0.0601137 0.0922237	There is no information available from adequate drug-drug interaction studies with the following classes of drugs : oral DRUG0 , hormone replacement therapies , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0328792 0.0245087 0.0398255 0.0115482 0.0179137 0.0256129 0.0418687 0.0565603 0.0951292 0.0394651 0.0329156 0.0295582 0.0237376 0.017258 0.00850693 0.00991323 0.0167036 0.0310798 0.0228233 0.0375667 0.0464914 0.0531394 0.0628182 0.0600935 0.0527836 0.0332967 0.0230384 0.0529642	Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DRUG1 or DRUG0 to warrant dosage adjustment when DRUG2 is administered with these drugs .
4	4	0.0282508 0.0210125 0.0354453 0.0101937 0.0159406 0.0233616 0.0389803 0.0548328 0.0942482 0.0441644 0.037577 0.032217 0.0275983 0.0172933 0.0154138 0.0400375 0.0169222 0.0280283 0.0220433 0.0346924 0.0453844 0.0514984 0.0582945 0.0544663 0.0483189 0.0315816 0.0219447 0.0502582	Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DRUG0 or DRUG1 to warrant dosage adjustment when DRUG2 is administered with these drugs .
3	3	0.0536996 0.0512907 0.0510649 0.0412785 0.0305038 0.0448355 0.0434605 0.0775102 0.0295814 0.0612093 0.10204 0.0446212 0.0352473 0.0439492 0.0472438 0.0224143 0.0168095 0.0132595 0.01163 0.0101087 0.00929353 0.0155709 0.0055539 0.0102849 0.0110101 0.0143724 0.0166027 0.0216038 0.0639496	A pharmacokinetic study demonstrated that coadministration of DRUG1 and DRUG2 results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of DRUG0 .
4	4	0.0338815 0.0269824 0.026666 0.0205451 0.0216384 0.0561064 0.0713587 0.0786422 0.0214824 0.0396233 0.0790418 0.0315893 0.0266505 0.0401424 0.0405492 0.0200336 0.0176032 0.0145542 0.0148816 0.0136705 0.0125679 0.0193748 0.0100911 0.0324842 0.0359849 0.0359738 0.0600256 0.0514054 0.0464497	A pharmacokinetic study demonstrated that coadministration of DRUG1 and DRUG0 results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of DRUG2 .
1	1	0.0586791 0.0508233 0.0419669 0.0654831 0.0464234 0.0654506 0.118485 0.0383559 0.0405416 0.0664412 0.0504572 0.0845332 0.101661 0.0901324 0.0805669	Administration of a higher dose of DRUG1 should be considered when coadministering with DRUG2 .
4	4	0.0664421 0.0529207 0.0462546 0.0362067 0.00670595 0.00621519 0.0093006 0.0178527 0.0462261 0.0914068 0.0815576 0.0881482 0.0752693 0.0801033 0.100334 0.0943611 0.100695	The effects of DRUG1 , DRUG0 or DRUG0 on the pharmacokinetics of DRUG2 were not studied .
4	4	0.0413256 0.0324127 0.0223618 0.0137413 0.00647421 0.0262121 0.012859 0.0232738 0.0602591 0.108071 0.0903623 0.0946434 0.0772986 0.0814017 0.104617 0.0972494 0.107437	The effects of DRUG0 , DRUG1 or DRUG0 on the pharmacokinetics of DRUG2 were not studied .
4	4	0.0379558 0.0266241 0.0208501 0.00953806 0.0054436 0.0110607 0.0155508 0.0526819 0.061061 0.101489 0.086769 0.092818 0.0771869 0.084589 0.104044 0.101502 0.110836	The effects of DRUG0 , DRUG0 or DRUG1 on the pharmacokinetics of DRUG2 were not studied .
4	4	0.140699 0.164561 0.103049 0.0258131 0.0174872 0.028389 0.0233472 0.0873682 0.0383272 0.1499 0.10839 0.112668	These include DRUG1 , DRUG0 , and oral and inhaled DRUG2 .
4	4	0.117555 0.116538 0.0282691 0.0208269 0.0909592 0.0246404 0.0244531 0.0972736 0.0449705 0.178773 0.120729 0.135012	These include DRUG0 , DRUG1 , and oral and inhaled DRUG2 .
4	1	0.030465 0.0210079 0.0542623 0.0774638 0.0919186 0.0709001 0.054657 0.0546868 0.0561969 0.0555726 0.0291136 0.0301863 0.0212534 0.00769344 0.00458082 0.00359913 0.00678172 0.011028 0.0316493 0.0454258 0.0330622 0.0308204 0.00683652 0.0206583 0.0335176 0.0269829 0.01931 0.0703698	However , the co   administration of DRUG1 with other DRUG2 containing drugs (e.g. , DRUG0 ) has not been studied and is therefore not recommended .
4	1	0.0323075 0.0225009 0.0578452 0.0833935 0.0969309 0.0758783 0.0680042 0.0621012 0.0784634 0.0414516 0.0185539 0.0227622 0.0552153 0.0162976 0.00533209 0.00623332 0.0174576 0.00787425 0.0171818 0.030474 0.0192442 0.0226061 0.00496272 0.017267 0.0272229 0.0217944 0.0156068 0.055037	However , the co   administration of DRUG1 with other DRUG0 containing drugs (e.g. , DRUG2 ) has not been studied and is therefore not recommended .
4	4	0.0195314 0.0127376 0.0363668 0.0528003 0.0651831 0.0606834 0.0966267 0.104562 0.065496 0.0638339 0.0178298 0.0489578 0.0600275 0.0139993 0.00440749 0.00529042 0.0155222 0.00662705 0.0155502 0.0298798 0.019476 0.0246114 0.00567034 0.0193737 0.0310927 0.0249072 0.0174607 0.061495	However , the co   administration of DRUG0 with other DRUG1 containing drugs (e.g. , DRUG2 ) has not been studied and is therefore not recommended .
3	3	0.0996706 0.068228 0.0599335 0.0921026 0.0921037 0.123106 0.0855662 0.0772369 0.0438165 0.0363646 0.0472098 0.0389139 0.0389419 0.0968054	DRUG1 administered concomitantly with DRUG2 may significantly decrease the serum concentrations of DRUG0 .
4	4	0.0532707 0.0287879 0.0370728 0.0438789 0.0585228 0.100417 0.0797365 0.0940117 0.0994216 0.0773995 0.0825002 0.083576 0.0820416 0.0793626	DRUG1 administered concomitantly with DRUG0 may significantly decrease the serum concentrations of DRUG2 .
4	4	0.0301078 0.047084 0.0440795 0.0924165 0.1063 0.0985435 0.0804124 0.0735516 0.0832227 0.0699624 0.0729325 0.0755605 0.0671198 0.0587072	DRUG0 administered concomitantly with DRUG1 may significantly decrease the serum concentrations of DRUG2 .
4	4	0.180762 0.0707684 0.176438 0.0449395 0.0119003 0.0546736 0.0356086 0.0352977 0.0131988 0.0157344 0.0128561 0.0109815 0.0175199 0.00862255 0.0218211 0.021412 0.0146684 0.0115431 0.0333271 0.0302476 0.0230277 0.0125211 0.00856098 0.025445 0.0166539 0.0239968 0.067474	DRUG1 , particularly DRUG2 , may cause serious cardiac arrhythmias during DRUG0 anesthesia and therefore should be used only with great caution or not at all .
2	2	0.0834717 0.0129494 0.0476128 0.0235953 0.028021 0.134928 0.0648968 0.0636033 0.0455627 0.0517946 0.0783456 0.0685129 0.0465925 0.012066 0.0254298 0.0161855 0.0119954 0.00972347 0.0252474 0.0217927 0.0181069 0.00941167 0.00680727 0.0185726 0.0123049 0.0169245 0.0455455	DRUG1 , particularly DRUG0 , may cause serious cardiac arrhythmias during DRUG2 anesthesia and therefore should be used only with great caution or not at all .
4	2	0.0266654 0.0333867 0.168194 0.195468 0.0363853 0.0798864 0.0466466 0.0436239 0.0316093 0.034714 0.0555964 0.0481902 0.0318442 0.00827957 0.0177724 0.0110648 0.00817719 0.00658499 0.0169576 0.0145974 0.0120908 0.00623967 0.00450702 0.0122581 0.00812616 0.01116 0.0299738	DRUG0 , particularly DRUG1 , may cause serious cardiac arrhythmias during DRUG2 anesthesia and therefore should be used only with great caution or not at all .
4	4	0.0745015 0.0260533 0.0530521 0.0545611 0.0476388 0.0658488 0.0591987 0.0570673 0.140052 0.0724821 0.0641184 0.0500234 0.0483864 0.0188831 0.00989198 0.0201391 0.024571 0.113531	DRUG1 - The pressor effect of DRUG2 is markedly potentiated in patients receiving DRUG0 ( DRUG0 ) .
4	4	0.0486385 0.0154376 0.0263424 0.0351546 0.0323249 0.036141 0.0451707 0.0691383 0.176585 0.104221 0.0718243 0.065859 0.0912335 0.0379639 0.0161985 0.0122246 0.0175136 0.0980283	DRUG1 - The pressor effect of DRUG0 is markedly potentiated in patients receiving DRUG2 ( DRUG0 ) .
4	4	0.0535935 0.0173764 0.0300809 0.037748 0.0342368 0.0384912 0.0465404 0.0686967 0.165323 0.0961864 0.0723866 0.0637029 0.0532826 0.0261941 0.026767 0.0450175 0.0269124 0.097463	DRUG1 - The pressor effect of DRUG0 is markedly potentiated in patients receiving DRUG0 ( DRUG2 ) .
2	2	0.0178136 0.0158536 0.0301863 0.0710182 0.0815943 0.0687725 0.0812954 0.0429545 0.134518 0.0743173 0.052611 0.0507634 0.0768219 0.0379952 0.0183054 0.0177762 0.0251638 0.102239	DRUG0 - The pressor effect of DRUG1 is markedly potentiated in patients receiving DRUG2 ( DRUG0 ) .
2	2	0.020343 0.0181945 0.0335565 0.0729943 0.08195 0.0636321 0.0774195 0.036954 0.112435 0.0644722 0.0460566 0.0527257 0.06426 0.0324352 0.0360125 0.0545621 0.0354909 0.0965063	DRUG0 - The pressor effect of DRUG1 is markedly potentiated in patients receiving DRUG0 ( DRUG2 ) .
2	2	0.0814965 0.111758 0.0745814 0.0708512 0.118714 0.108165 0.0461523 0.0480452 0.0609828 0.095528 0.100273 0.083452	The pressor response of DRUG1 may also be potentiated by DRUG2 .
4	4	0.163455 0.0685944 0.189803 0.0476296 0.0117583 0.0292198 0.0364039 0.0503508 0.0581611 0.040655 0.0478013 0.0903123 0.0740641 0.0917921	DRUG1 , an DRUG2 , is the standard hormone treatment for breast cancer .
3	4	0.1682 0.0499489 0.10507 0.113962 0.0653333 0.0684302 0.0607158 0.0382394 0.0367344 0.0289679 0.0494326 0.105287 0.109678	DRUG1 and DRUG2 reduce the plasma concentration of DRUG0 by about 50% .
3	3	0.104264 0.0270364 0.0564259 0.0919252 0.0636949 0.0872263 0.0804051 0.101651 0.0816418 0.0515303 0.0606622 0.0930311 0.100505	DRUG1 and DRUG0 reduce the plasma concentration of DRUG2 by about 50% .
3	3	0.0334037 0.024597 0.121529 0.106208 0.0679529 0.0974788 0.0875626 0.100906 0.0734409 0.0451144 0.0565389 0.0890759 0.0961923	DRUG0 and DRUG1 reduce the plasma concentration of DRUG2 by about 50% .
2	1	0.0308691 0.0360421 0.0780579 0.0351672 0.0507086 0.0378403 0.0175642 0.0193441 0.017957 0.0125822 0.0228716 0.0653574 0.0515134 0.0531513 0.0545307 0.0565136 0.0475757 0.0763254 0.0399095 0.0632471 0.0226005 0.00864165 0.00502728 0.00619427 0.00568309 0.0203783 0.0643464	It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with DRUG1 for breast cancer , especially DRUG2 such as DRUG0 and DRUG0 .
2	1	0.0356469 0.0415905 0.0899311 0.040736 0.0581507 0.0436991 0.0201865 0.0211227 0.0186203 0.0126193 0.0232722 0.066957 0.0519494 0.0535913 0.0538119 0.0590482 0.0531183 0.0732458 0.0219045 0.0305181 0.00732308 0.00591263 0.00807169 0.0180859 0.00525013 0.0169087 0.0687281	It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with DRUG1 for breast cancer , especially DRUG0 such as DRUG2 and DRUG0 .
2	1	0.0350286 0.0408526 0.088482 0.0399488 0.0572998 0.0428573 0.0198279 0.0211708 0.0189344 0.0127755 0.0230913 0.0651471 0.0500664 0.0519645 0.05269 0.0566927 0.0472357 0.067382 0.0218947 0.0255767 0.00584897 0.00438436 0.00332741 0.00657444 0.0132064 0.0465339 0.0812058	It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with DRUG1 for breast cancer , especially DRUG0 such as DRUG0 and DRUG2 .
4	4	0.0366333 0.0415656 0.0844989 0.0339772 0.0502815 0.0327898 0.0115214 0.0110486 0.00979851 0.00562184 0.0126706 0.0390608 0.0389437 0.0344866 0.0374269 0.0359825 0.0679497 0.0635176 0.0216344 0.0444228 0.0431764 0.0169549 0.0136854 0.0156652 0.0230731 0.0723341 0.101279	It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with DRUG0 for breast cancer , especially DRUG1 such as DRUG0 and DRUG2 .
4	4	0.0376188 0.0428064 0.0872251 0.0353944 0.0522575 0.0343963 0.0122356 0.0117217 0.0102107 0.00563631 0.0122258 0.0375413 0.0353614 0.0295972 0.0341153 0.0307819 0.055231 0.0469192 0.0117011 0.0211505 0.0125646 0.0147311 0.0237542 0.114028 0.0225873 0.0683075 0.0998999	It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with DRUG0 for breast cancer , especially DRUG0 such as DRUG1 and DRUG2 .
4	4	0.0229365 0.0211416 0.0301614 0.0527969 0.0550742 0.066215 0.0419928 0.0213742 0.0199951 0.0378222 0.0227253 0.0543822 0.109448 0.106093 0.0914117 0.0293773 0.0215687 0.0330145 0.0412446 0.0182316 0.0247938 0.0282653 0.0499337	Depression does not always require DRUG1 therapy , and DRUG2 have no proven preventive impact on hot flushes linked to the menopause .
4	1	0.0347119 0.018632 0.0149694 0.0412141 0.0218087 0.0540407 0.0541832 0.0374066 0.0394375 0.0236683 0.00874551 0.0184822 0.0596442 0.0478889 0.0606811 0.0703752 0.134875 0.0612116 0.0499545 0.0467631 0.101306	If in certain cases , an DRUG1 is considered necessary , it may be advisable to replace DRUG2 with DRUG0 .
1	4	0.0326767 0.0173603 0.014069 0.0392521 0.0208364 0.0531138 0.0535667 0.0348978 0.0347264 0.0231024 0.0101218 0.0236085 0.0660654 0.0506103 0.0548586 0.0539669 0.0630707 0.0827874 0.107795 0.0782468 0.0852672	If in certain cases , an DRUG1 is considered necessary , it may be advisable to replace DRUG0 with DRUG2 .
1	4	0.02308 0.010243 0.00720853 0.0149108 0.00634037 0.0223557 0.0373103 0.0552096 0.0632989 0.0174938 0.00655215 0.0208661 0.0493403 0.0389653 0.0451114 0.0507612 0.0691106 0.123287 0.137641 0.115223 0.0856909	If in certain cases , an DRUG0 is considered necessary , it may be advisable to replace DRUG1 with DRUG2 .
3	4	0.0699528 0.0622208 0.0245502 0.0216031 0.0336102 0.0306743 0.0377674 0.0575554 0.0859285 0.044688 0.0228806 0.00748074 0.0159043 0.0102834 0.00654704 0.0226928 0.00929174 0.0332311 0.0213421 0.0188866 0.0175899 0.0120916 0.0152495 0.0211839 0.0159771 0.0341001 0.0350422 0.0533253 0.0425047 0.0380052 0.0319687 0.0458707	Since DRUG1 is a substrate for the metabolic pathways involving CYP2D6 and CYP1A2 enzymes , inhibition or induction of either of these enzymes would be expected to alter DRUG2 plasma concentrations .
3	3	0.0176842 0.0103085 0.0155436 0.00996093 0.0428404 0.0258681 0.0218168 0.0183465 0.0162742 0.0268592 0.0302339 0.0375522 0.0498862 0.0328263 0.0413825 0.0246958 0.0614868 0.0299565 0.0498769 0.0261663 0.0313854 0.030165 0.0498483 0.0391614 0.0144547 0.0586725 0.0497148 0.0368637 0.0433169 0.0568517	In a formal , single-dose interaction study (n = 6 males) the clearance of DRUG1 was decreased by 38% following the coadministration of DRUG2 , an inhibitor of CYP1A2 .
4	4	0.0200689 0.0271521 0.0205164 0.0159947 0.0136376 0.0157409 0.0217619 0.0250653 0.00608006 0.0110887 0.0132447 0.0218067 0.0241928 0.00685877 0.00605618 0.00663851 0.00440841 0.0194828 0.0240546 0.0237654 0.0253526 0.0302984 0.0443897 0.052874 0.0852127 0.0784216 0.0640783 0.0573622 0.0488637 0.0433413 0.0284298 0.035331 0.032624 0.0458053	In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6) , coadministration of DRUG1 did not alter the kinetics of DRUG2 in the poor CYP2D6 metabolizer group .
4	4	0.0248264 0.0251234 0.0176969 0.0307927 0.0256425 0.0168084 0.0137137 0.0388848 0.0582187 0.0452392 0.0414834 0.0343207 0.0462304 0.0490801 0.047533 0.10484 0.0571642 0.0649239 0.0525102 0.078401 0.0672716 0.0592948	In this crossover steady state study , the pharmacokinetics of DRUG1 were unaffected in either phenotype by the coadministration of DRUG2 .
4	4	0.089647 0.0742244 0.0773693 0.0742533 0.0576579 0.0724021 0.0728733 0.0689064 0.0395958 0.0735424 0.0360778 0.0325783 0.0366233 0.0140519 0.0100186 0.00334592 0.00547044 0.00423987 0.0112526 0.00277207 0.0037176 0.0161585 0.015843 0.00885839 0.0125397 0.0237421 0.0622382	Addition of DRUG1 to DRUG2 did not lead to further electrocardiographic parameters changes of QRS , QTc , RR , and PR intervals than DRUG0 alone .
4	4	0.0876648 0.0811679 0.0696261 0.0331974 0.0210701 0.0400415 0.0511752 0.0597833 0.0310878 0.0600544 0.0323995 0.0331935 0.0385031 0.0163521 0.0121408 0.00403317 0.00664055 0.00470745 0.0146394 0.00552108 0.0116932 0.0592854 0.0592226 0.0283213 0.0323238 0.0332128 0.0729418	Addition of DRUG1 to DRUG0 did not lead to further electrocardiographic parameters changes of QRS , QTc , RR , and PR intervals than DRUG2 alone .
4	4	0.0312861 0.0196245 0.0352928 0.0327743 0.0348979 0.0563064 0.0718838 0.0379076 0.0314234 0.0262397 0.0321855 0.0288857 0.0387062 0.0734559 0.0459708 0.0129071 0.0156052 0.00480337 0.0053044 0.020737 0.0682606 0.110258 0.077643 0.0876401	In a large compassionate use program DRUG1 has been used concurrently with commonly employed antianginal , DRUG2 , and DRUG0 without observed interactions .
4	4	0.0305068 0.0187463 0.0325841 0.0299168 0.0319902 0.0532475 0.0676503 0.0361352 0.0298101 0.024646 0.0282261 0.0278953 0.0395829 0.0613697 0.035188 0.0107274 0.00901515 0.00745334 0.0166067 0.0408843 0.0884907 0.111367 0.0753036 0.0926559	In a large compassionate use program DRUG1 has been used concurrently with commonly employed antianginal , DRUG0 , and DRUG2 without observed interactions .
4	4	0.0185364 0.0115254 0.0239863 0.020369 0.0277299 0.0429714 0.0298701 0.0365114 0.0448446 0.045808 0.0611189 0.0448156 0.032456 0.049658 0.0413863 0.0155839 0.0565519 0.0207716 0.0226123 0.0469598 0.0744292 0.105113 0.0592393 0.0671513	In a large compassionate use program DRUG0 has been used concurrently with commonly employed antianginal , DRUG1 , and DRUG2 without observed interactions .
4	4	0.0817555 0.101841 0.072871 0.0561481 0.0214687 0.0159673 0.0145427 0.0255611 0.0374632 0.0412336 0.0397135 0.0278795 0.0151522 0.100196 0.0743982 0.0917703 0.0395141 0.0205173 0.022437 0.034291 0.0652787	A variety of DRUG1 such as DRUG0 or DRUG2 were also added , sometimes with improved control of ventricular ectopy .
4	4	0.105312 0.0673114 0.0267901 0.0220519 0.0370495 0.0258103 0.0312181 0.0128292 0.0134777 0.0248476 0.00470865 0.00857831 0.00874873 0.0157501 0.0380822 0.0346534 0.0199872 0.0231522 0.013187 0.0581564 0.0462594 0.0730673 0.0485843 0.0262332 0.0335887 0.0811526 0.0994127	When DRUG1 or other hepatic enzyme inducers such as DRUG2 and DRUG0 have been taken concurrently with DRUG0 , lowered DRUG0 plasma levels have been reported .
4	4	0.100678 0.0637873 0.0244986 0.0196189 0.0309352 0.0203623 0.0231301 0.00906732 0.00581443 0.00952483 0.0129684 0.028494 0.0147986 0.0241747 0.0540931 0.0512204 0.0252426 0.0247063 0.0133173 0.0573583 0.0450541 0.0692112 0.046366 0.0250828 0.031798 0.0765031 0.0921939	When DRUG1 or other hepatic enzyme inducers such as DRUG0 and DRUG2 have been taken concurrently with DRUG0 , lowered DRUG0 plasma levels have been reported .
3	3	0.0739781 0.0416579 0.0128671 0.0100279 0.0130381 0.00879955 0.0103447 0.00515591 0.00412117 0.00632557 0.00675946 0.0160172 0.0318658 0.0591758 0.14044 0.132851 0.114953 0.0530011 0.0124937 0.0363162 0.0274536 0.0373433 0.0246063 0.0139643 0.0167029 0.0376091 0.0521311	When DRUG1 or other hepatic enzyme inducers such as DRUG0 and DRUG0 have been taken concurrently with DRUG2 , lowered DRUG0 plasma levels have been reported .
4	4	0.0866617 0.0471176 0.0115505 0.00892628 0.0110706 0.0079273 0.00925474 0.0044856 0.00327034 0.00421454 0.00355008 0.00743351 0.00789498 0.0183843 0.0553622 0.0512525 0.0368549 0.0433905 0.0540676 0.164804 0.0868565 0.0626562 0.0467207 0.0274215 0.0298539 0.0437476 0.0652702	When DRUG1 or other hepatic enzyme inducers such as DRUG0 and DRUG0 have been taken concurrently with DRUG0 , lowered DRUG2 plasma levels have been reported .
4	4	0.0789679 0.0228491 0.0103214 0.0100375 0.0211848 0.0212633 0.041424 0.0215156 0.0273988 0.108777 0.0184233 0.0306772 0.0131139 0.0217429 0.0517796 0.044906 0.022952 0.0233624 0.0119589 0.0510429 0.0400763 0.0616463 0.041162 0.0224227 0.0286963 0.0694044 0.082894	When DRUG0 or other hepatic enzyme inducers such as DRUG1 and DRUG2 have been taken concurrently with DRUG0 , lowered DRUG0 plasma levels have been reported .
3	3	0.0595579 0.0153652 0.0069654 0.00651632 0.0136824 0.012504 0.0244914 0.0122592 0.0154392 0.059615 0.0130178 0.0169432 0.040464 0.0479136 0.0773156 0.102344 0.0976688 0.0510752 0.0140513 0.0483581 0.0383251 0.0488075 0.03125 0.0174617 0.0205416 0.0461035 0.0619631	When DRUG0 or other hepatic enzyme inducers such as DRUG1 and DRUG0 have been taken concurrently with DRUG2 , lowered DRUG0 plasma levels have been reported .
4	4	0.0525761 0.0138536 0.00599933 0.00523943 0.0112006 0.0103653 0.0215371 0.0102412 0.0124494 0.0401048 0.0055156 0.00736718 0.0103797 0.0188705 0.0672387 0.0570405 0.0474779 0.0469673 0.0493992 0.172128 0.0877538 0.0537437 0.0414338 0.0246017 0.0275483 0.040274 0.0586931	When DRUG0 or other hepatic enzyme inducers such as DRUG1 and DRUG0 have been taken concurrently with DRUG0 , lowered DRUG2 plasma levels have been reported .
3	3	0.0564441 0.014344 0.00617569 0.00517501 0.00994601 0.00816692 0.0144361 0.00655375 0.00538179 0.0119516 0.0155217 0.0678086 0.0415121 0.0521896 0.0956746 0.112501 0.103297 0.0513673 0.0140253 0.0472233 0.0373065 0.0476216 0.0306357 0.0171498 0.0202505 0.0456918 0.0616485	When DRUG0 or other hepatic enzyme inducers such as DRUG0 and DRUG1 have been taken concurrently with DRUG2 , lowered DRUG0 plasma levels have been reported .
4	4	0.0506436 0.0125853 0.00542742 0.00434358 0.00832194 0.0067369 0.0128308 0.00512491 0.0037414 0.00824747 0.00774459 0.0311201 0.0121114 0.0218478 0.0805444 0.0658278 0.0506682 0.0506155 0.0523948 0.173274 0.0873606 0.0551353 0.0418258 0.0246922 0.0274259 0.0404765 0.0589313	When DRUG0 or other hepatic enzyme inducers such as DRUG0 and DRUG1 have been taken concurrently with DRUG0 , lowered DRUG2 plasma levels have been reported .
4	4	0.0373952 0.0243676 0.0402878 0.0306375 0.0114828 0.0483527 0.0500367 0.0814212 0.0903968 0.0870345 0.113598 0.0911629 0.0925121 0.0796396 0.121674	In a formal study , DRUG1 were shown not to affect DRUG2 plasma concentrations .
4	4	0.023971 0.0330598 0.0149048 0.00458092 0.00650041 0.00426623 0.0106634 0.0867461 0.0651499 0.0891339 0.107767 0.0878844 0.127112 0.112945 0.0282636 0.0241006 0.00689574 0.00838706 0.00660409 0.0125194 0.0329999 0.105545	ECG intervals (PR , QRS , and QT) were not affected by concurrent DRUG1 and DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0221353 0.0307521 0.0139413 0.00431501 0.0061847 0.00420136 0.010671 0.0893997 0.0692502 0.0930284 0.114322 0.0888786 0.121422 0.0993543 0.03027 0.017121 0.0138224 0.0278149 0.00864897 0.0149452 0.0277492 0.0917727	ECG intervals (PR , QRS , and QT) were not affected by concurrent DRUG1 and DRUG0 , DRUG2 , or DRUG0 .
3	3	0.0913066 0.0768393 0.0744102 0.103683 0.0382249 0.0758907 0.0526034 0.0667208 0.0576356 0.0154514 0.0172418 0.00835112 0.0219303 0.00747175 0.0118376 0.043185 0.0368281 0.0503644 0.0767735 0.0732509	Concurrent administration of DRUG1 and DRUG2 has been reported to increase , decrease , or leave unchanged DRUG0 plasma levels;
4	4	0.0671838 0.0881702 0.100238 0.103453 0.0253172 0.0303377 0.0500027 0.0788122 0.0488839 0.0186704 0.0229918 0.0116639 0.0335204 0.0134155 0.0222858 0.044206 0.0537868 0.0520445 0.0710071 0.0640092	Concurrent administration of DRUG1 and DRUG0 has been reported to increase , decrease , or leave unchanged DRUG2 plasma levels;
4	4	0.0879071 0.0526483 0.0825007 0.131328 0.139583 0.0630506 0.0429018 0.0158134 0.0161841 0.00923161 0.029799 0.0223745 0.011709 0.0149706 0.0271105 0.0155168 0.0190139 0.00613032 0.00624618 0.00339147 0.00801079 0.0115293 0.0298744 0.00862635 0.00881151 0.0146531 0.0223733 0.0341484 0.0645622	DRUG1 does not alter serum DRUG2 levels but DRUG0 , when used to treat gastrointestinal symptoms due to DRUG0 , has been reported to lower serum DRUG0 levels .
4	4	0.117235 0.0562652 0.0661089 0.0840628 0.0586431 0.0466472 0.0681409 0.0423579 0.0347231 0.00773689 0.0220186 0.0178031 0.0101769 0.0150459 0.0283435 0.0210989 0.0223052 0.00778637 0.00774338 0.00415361 0.00989137 0.0144727 0.0381437 0.0108178 0.0112769 0.0187847 0.0286931 0.0443969 0.0851267	DRUG1 does not alter serum DRUG0 levels but DRUG2 , when used to treat gastrointestinal symptoms due to DRUG0 , has been reported to lower serum DRUG0 levels .
4	4	0.077716 0.0388739 0.0341264 0.0290287 0.0160031 0.0181518 0.0213954 0.00653373 0.0113973 0.00958482 0.0284461 0.022504 0.0144355 0.0186652 0.0351706 0.0223554 0.0330824 0.00927455 0.00913217 0.00560562 0.0188714 0.031094 0.063935 0.0364684 0.0526113 0.0796681 0.0699787 0.08583 0.10006	DRUG1 does not alter serum DRUG0 levels but DRUG0 , when used to treat gastrointestinal symptoms due to DRUG0 , has been reported to lower serum DRUG2 levels .
4	4	0.0287572 0.0403831 0.0825038 0.0973442 0.0802219 0.0632309 0.0699324 0.0425634 0.0313218 0.00876094 0.0263185 0.02179 0.0122777 0.0172419 0.032034 0.0235457 0.0241835 0.0084423 0.00822047 0.00441359 0.010707 0.015716 0.0404835 0.0115679 0.0119018 0.0198376 0.0304651 0.0469626 0.0888714	DRUG0 does not alter serum DRUG1 levels but DRUG2 , when used to treat gastrointestinal symptoms due to DRUG0 , has been reported to lower serum DRUG0 levels .
4	4	0.0247219 0.038397 0.0689586 0.0719436 0.0484265 0.0339881 0.0218846 0.0101601 0.00965962 0.00803291 0.0393034 0.033341 0.0210705 0.0344088 0.0906726 0.0597294 0.0838947 0.0537098 0.0351845 0.00715485 0.010922 0.0135733 0.034092 0.00924652 0.00801624 0.0139594 0.0216666 0.0333756 0.0605059	DRUG0 does not alter serum DRUG1 levels but DRUG0 , when used to treat gastrointestinal symptoms due to DRUG2 , has been reported to lower serum DRUG0 levels .
3	4	0.0261232 0.0325392 0.0477478 0.0393815 0.0280797 0.036852 0.0524217 0.0382806 0.0933139 0.0197658 0.0319931 0.0190133 0.0199233 0.0210653 0.0522076 0.0379801 0.0581508 0.054104 0.0333533 0.0083295 0.015224 0.0199486 0.0457745 0.0116612 0.00995618 0.0166053 0.0250868 0.0374726 0.0676451	DRUG0 does not alter serum DRUG0 levels but DRUG1 , when used to treat gastrointestinal symptoms due to DRUG2 , has been reported to lower serum DRUG0 levels .
4	3	0.020083 0.025404 0.0371645 0.0304574 0.0219625 0.0284825 0.0413009 0.029958 0.0702463 0.0133338 0.0186922 0.0129681 0.0125664 0.0146556 0.0314171 0.0314717 0.039267 0.0145041 0.00928079 0.00532114 0.023586 0.0425149 0.0618832 0.0333605 0.0449819 0.0751137 0.0627302 0.0696441 0.0776485	DRUG0 does not alter serum DRUG0 levels but DRUG1 , when used to treat gastrointestinal symptoms due to DRUG0 , has been reported to lower serum DRUG2 levels .
4	4	0.0110438 0.0107953 0.0134716 0.012152 0.00676957 0.00928087 0.01131 0.00401564 0.00782511 0.00767626 0.0274881 0.0251259 0.0172684 0.0248085 0.0660536 0.0612685 0.0916417 0.0649904 0.0797899 0.0111197 0.0220664 0.0305517 0.049434 0.0265983 0.0367424 0.0693455 0.0571149 0.0659767 0.0782752	DRUG0 does not alter serum DRUG0 levels but DRUG0 , when used to treat gastrointestinal symptoms due to DRUG1 , has been reported to lower serum DRUG2 levels .
3	3	0.094465 0.0737039 0.0644587 0.106395 0.0327501 0.0916383 0.13398 0.0758816 0.0418973 0.05149 0.0460003 0.0597399 0.0525913 0.0750087	Concurrent use of DRUG1 and DRUG2 may lead to increased plasma DRUG0 levels .
4	4	0.0714917 0.0904464 0.101446 0.0963823 0.0262798 0.0423927 0.0793863 0.0574784 0.0636826 0.0919924 0.0776466 0.058091 0.066288 0.0769963	Concurrent use of DRUG1 and DRUG0 may lead to increased plasma DRUG2 levels .
4	4	0.0149024 0.024043 0.0140045 0.0143913 0.00637114 0.00917942 0.0181639 0.0120093 0.0337788 0.0182248 0.0152319 0.018274 0.0254854 0.0237987 0.0363402 0.0319436 0.058134 0.0850298 0.0393479 0.0319181 0.0243493 0.0148105 0.0092903 0.0150592 0.0136139 0.00951866 0.0108397 0.00957977 0.00733452 0.0115747 0.0111715 0.0121787 0.0135441 0.0101957 0.00529342 0.00261777 0.006994 0.00494075 0.00349277 0.00455924 0.00320861 0.00436163 0.00231379 0.00802722 0.00957338 0.0112762 0.0113529 0.00892141 0.00897803 0.0042268 0.011668 0.00728906 0.00667569 0.00859362 0.00916055 0.0307773 0.0681034 0.0539613	This increase was observed at the first test point which was the second day after starting DRUG1 . DRUG2 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0128759 0.0207338 0.0121029 0.0125226 0.00546384 0.00778942 0.0155891 0.00996399 0.0294046 0.0161578 0.014115 0.017621 0.0262556 0.0271574 0.0431903 0.0404014 0.0432245 0.0192699 0.011767 0.0152194 0.0112151 0.00943345 0.00677559 0.0157557 0.0156617 0.0169632 0.0197912 0.0216939 0.0175988 0.0259056 0.0235056 0.0215588 0.0420221 0.0251626 0.0132157 0.0158722 0.0165437 0.00607555 0.00479756 0.00715857 0.00456341 0.00549035 0.00260534 0.00917187 0.011586 0.0137281 0.0113694 0.00942077 0.00878033 0.00399516 0.0110923 0.00703839 0.00640501 0.00790652 0.00840326 0.0289145 0.0632279 0.0487696	This increase was observed at the first test point which was the second day after starting DRUG1 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG2 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0137459 0.0221274 0.0129141 0.013348 0.00582562 0.00829837 0.0166004 0.0105947 0.0312294 0.0170426 0.0147513 0.0182995 0.0272644 0.0280985 0.044903 0.0417452 0.0438821 0.0194828 0.0114391 0.0147367 0.0107411 0.00820206 0.0058797 0.0128741 0.0124784 0.0108354 0.012718 0.0117758 0.0089451 0.0150963 0.015118 0.0157787 0.0206898 0.0150531 0.00728229 0.00357907 0.0140703 0.014619 0.0117567 0.0191549 0.023091 0.0260686 0.0107943 0.0267551 0.00967932 0.0172892 0.0100201 0.0111346 0.0105059 0.00443158 0.0114772 0.00788231 0.00741363 0.00837547 0.00865157 0.0302424 0.0637736 0.0494371	This increase was observed at the first test point which was the second day after starting DRUG1 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG2 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0101337 0.0162016 0.00928508 0.00930632 0.00413305 0.00572475 0.0110998 0.00655862 0.0176743 0.00917689 0.00788543 0.0097985 0.0173857 0.0198492 0.0347569 0.0357337 0.0327136 0.0637501 0.0658887 0.0629549 0.0368243 0.0314518 0.0288782 0.0537756 0.0243815 0.0170455 0.0172676 0.0174731 0.0152678 0.0218292 0.0168714 0.0124004 0.0136775 0.00966533 0.00506428 0.00238477 0.00606609 0.00419148 0.00293984 0.00370178 0.00257272 0.00350228 0.00184214 0.00648251 0.00771206 0.00907904 0.0090198 0.00706508 0.00702752 0.00329478 0.00911701 0.00567504 0.00518665 0.00666744 0.00711321 0.0238624 0.0527963 0.0408157	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG1 plasma levels returned to pre- DRUG2 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	3	0.0097359 0.0156119 0.00902959 0.00917462 0.0040103 0.00559834 0.010892 0.00649414 0.0179688 0.00920408 0.00786656 0.00973962 0.0166729 0.0186922 0.0326645 0.0294839 0.0244913 0.041453 0.0416717 0.0316892 0.0220483 0.018503 0.0133063 0.0275527 0.0187804 0.0238018 0.0285637 0.0370623 0.0319678 0.0525912 0.0637157 0.0329232 0.0225398 0.0193432 0.00726953 0.00343073 0.00646827 0.00525908 0.00347607 0.00433693 0.0029404 0.00389844 0.00196898 0.00699994 0.0085528 0.0100053 0.00894639 0.00719381 0.00687222 0.00317176 0.00880289 0.00552825 0.00504314 0.00634997 0.0067604 0.0229286 0.0503941 0.038558	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG1 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG2 . If DRUG0 and DRUG0 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0100162 0.0160591 0.00926806 0.00940272 0.00411384 0.0057376 0.0111502 0.00662704 0.0183282 0.00935153 0.0079086 0.00972574 0.0165506 0.0185102 0.0328614 0.0301054 0.025398 0.0405405 0.0397989 0.0259943 0.0155627 0.0110673 0.00763398 0.0150103 0.0132877 0.0132185 0.0159841 0.0178181 0.0157757 0.0230509 0.0286645 0.0455061 0.104594 0.0748237 0.0243281 0.00422883 0.00463356 0.00369881 0.00307205 0.00423928 0.00291938 0.00369156 0.00191438 0.00686652 0.0088428 0.0107333 0.0091594 0.00752533 0.00697177 0.0031682 0.00877615 0.00557618 0.00509866 0.00629785 0.00668556 0.0229878 0.0502259 0.0389124	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG1 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG2 and DRUG0 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0124388 0.0199397 0.0115137 0.0116802 0.00510775 0.00712623 0.0138479 0.0082261 0.0227431 0.0115548 0.00976188 0.0120004 0.0204204 0.0228564 0.0407929 0.0369125 0.0308674 0.0485425 0.0472468 0.0282238 0.0163495 0.0109072 0.0075637 0.0137743 0.0116705 0.00943513 0.0102755 0.00891512 0.00668076 0.0104977 0.0099964 0.0105372 0.0121715 0.00896254 0.00452443 0.00222725 0.00590408 0.00433487 0.00305497 0.0040302 0.00284301 0.00388122 0.00208561 0.00772908 0.0103377 0.0131573 0.0126757 0.0108656 0.0124516 0.00968861 0.0364352 0.0232798 0.0405483 0.0348396 0.015638 0.0262655 0.0756773 0.0679848	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG1 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG2 dose is changed .
4	4	0.0107312 0.0170389 0.00934437 0.00934509 0.00409408 0.00570903 0.010917 0.00597593 0.0159869 0.00754396 0.00559671 0.00666299 0.00913548 0.00685883 0.0141117 0.0131058 0.0105098 0.0144315 0.0153081 0.0277732 0.0207619 0.0277722 0.0375176 0.0630785 0.055608 0.0388944 0.0179488 0.0210604 0.0194914 0.0316337 0.0269266 0.0225546 0.0433831 0.02943 0.0155106 0.0172737 0.0177673 0.0068641 0.00517235 0.00744087 0.00458371 0.00548433 0.00258235 0.0091325 0.0115425 0.0136776 0.0110944 0.00923096 0.00850352 0.00385534 0.0107032 0.00679336 0.00617553 0.00759181 0.00805686 0.0277564 0.0606721 0.0462928	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG1 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG2 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0110736 0.017585 0.00964509 0.00964888 0.00422487 0.00588926 0.0112436 0.00615829 0.0164539 0.00778067 0.00578275 0.00688923 0.00947761 0.00714048 0.014624 0.0136122 0.0110064 0.0151725 0.0160833 0.0295276 0.0226515 0.0307387 0.0411457 0.0735451 0.0419116 0.0233418 0.0126235 0.0162086 0.0158386 0.0274867 0.0230753 0.0164333 0.0247886 0.0180783 0.00883985 0.00413471 0.0151142 0.014478 0.0117476 0.0186702 0.0224584 0.0249048 0.010541 0.0252455 0.00908685 0.0160543 0.00909449 0.0102506 0.00961853 0.00404787 0.0104269 0.00717134 0.00674368 0.00758176 0.00781524 0.0272993 0.0574439 0.0443439	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG1 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG2 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0121345 0.0192026 0.0105403 0.0103194 0.00463209 0.00644121 0.0121484 0.00662276 0.01733 0.00804359 0.00603586 0.00698119 0.00928729 0.00701712 0.0142898 0.012124 0.00937397 0.0119747 0.0112632 0.0192813 0.0125845 0.0111088 0.00619913 0.015791 0.0162513 0.0201675 0.0287227 0.0304792 0.0250644 0.0330487 0.0378078 0.0507719 0.0680646 0.0377673 0.0156729 0.013968 0.0182653 0.00955658 0.00756209 0.00977713 0.00602615 0.00714699 0.00353306 0.0122251 0.014918 0.0176208 0.0137923 0.0115225 0.0105183 0.004741 0.0132001 0.00841515 0.0076525 0.00937615 0.00993817 0.0342826 0.0749345 0.0564824	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG1 . If DRUG0 and DRUG2 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0109826 0.0173966 0.00954066 0.00938465 0.00419115 0.00583001 0.0109965 0.00599129 0.0157294 0.00733788 0.00549104 0.00636973 0.00847655 0.00640149 0.0129861 0.011042 0.00865133 0.011084 0.0105155 0.0178948 0.011514 0.0100638 0.00552851 0.0138053 0.0143151 0.0180312 0.0285914 0.0335449 0.0300515 0.0438831 0.0500297 0.0518501 0.0489242 0.0304881 0.00935284 0.00562999 0.014144 0.0162783 0.0130312 0.0225617 0.0248566 0.0257861 0.0113049 0.0252722 0.00989603 0.0170077 0.00991483 0.0114513 0.0106019 0.00445631 0.0114148 0.00786788 0.00738031 0.00823664 0.0084299 0.0293733 0.0617569 0.0470803	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG1 . If DRUG0 and DRUG0 are to be used concurrently , DRUG2 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	1	0.0106556 0.0167756 0.00922744 0.00886031 0.00404943 0.00561597 0.0104671 0.0056823 0.0145392 0.00664172 0.00499236 0.00568973 0.00729568 0.00543057 0.0107434 0.00892185 0.00716907 0.00898874 0.00886257 0.0157253 0.0101183 0.00773571 0.00452354 0.0103433 0.0113456 0.0116062 0.0197089 0.0213364 0.0190148 0.0253441 0.036094 0.0408038 0.0895436 0.0542455 0.10168 0.0365641 0.0321403 0.0140781 0.0100673 0.00973941 0.00586104 0.00639739 0.00314705 0.0109041 0.0127904 0.0144457 0.0114143 0.00951774 0.00858935 0.00381558 0.0103932 0.0066151 0.00602664 0.00739142 0.00786266 0.0271824 0.0590823 0.0461971	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG1 and DRUG2 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.00908356 0.0143228 0.00787328 0.00763134 0.00344976 0.00478774 0.00897535 0.00487121 0.0126126 0.00577659 0.00431621 0.00493403 0.00639227 0.00476771 0.00955116 0.00803658 0.0064183 0.00806019 0.00786667 0.0136729 0.00866644 0.00671284 0.00367594 0.00860539 0.0090027 0.00845169 0.0137996 0.0147713 0.0140666 0.0227626 0.0319487 0.0457444 0.101602 0.106126 0.0877144 0.0132063 0.0193558 0.0204135 0.0132408 0.0164243 0.0186533 0.0214456 0.0114034 0.0237405 0.00960646 0.0153856 0.00847112 0.0100103 0.0090149 0.00374792 0.0094507 0.00651503 0.00609963 0.00673512 0.00688895 0.0240543 0.0503736 0.0387113	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG1 and DRUG0 are to be used concurrently , DRUG2 blood levels should be monitored , particularly when the DRUG0 dose is changed .
4	4	0.0107414 0.0169816 0.0093137 0.00912105 0.00407962 0.00566873 0.0106566 0.00578137 0.0151003 0.00695489 0.00515632 0.00592127 0.00770373 0.00572806 0.0115618 0.00971926 0.00780955 0.00966299 0.00916304 0.015779 0.00997684 0.00778893 0.00420422 0.00969831 0.00995027 0.00890059 0.0138581 0.0143387 0.0135775 0.0224477 0.0270267 0.0285974 0.0565811 0.0436779 0.0192807 0.0107808 0.0199942 0.00941474 0.00623863 0.00930883 0.00564703 0.00636857 0.00323945 0.0120969 0.0173879 0.0217612 0.0156721 0.0140075 0.0147522 0.0111638 0.0426157 0.0263402 0.0456716 0.0381901 0.0175471 0.0291595 0.0813145 0.0688181	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG1 are to be used concurrently , DRUG0 blood levels should be monitored , particularly when the DRUG2 dose is changed .
4	4	0.0112709 0.0177871 0.00973956 0.00948542 0.00425979 0.00591963 0.0110971 0.00599275 0.015533 0.00707156 0.00520912 0.0059431 0.00762867 0.00560137 0.0112923 0.00946675 0.00767115 0.00923353 0.00878234 0.0152188 0.00960874 0.00714931 0.00392547 0.00875841 0.00899654 0.00745007 0.0104683 0.00968006 0.0078909 0.0133506 0.0137907 0.0146239 0.0180758 0.0140944 0.00734116 0.00359352 0.0143963 0.01521 0.0148409 0.0236387 0.0222915 0.0289846 0.0135514 0.0624068 0.0143085 0.0188779 0.010061 0.0132531 0.016778 0.0124861 0.036052 0.0242322 0.0505302 0.0403456 0.0199986 0.0349643 0.0940852 0.0757053	This increase was observed at the first test point which was the second day after starting DRUG0 . DRUG0 plasma levels returned to pre- DRUG0 values within 48 hours after discontinuing DRUG0 . If DRUG0 and DRUG0 are to be used concurrently , DRUG1 blood levels should be monitored , particularly when the DRUG2 dose is changed .
3	3	0.0342644 0.00803792 0.0161945 0.0258898 0.0283176 0.0164298 0.0119128 0.0150803 0.0191118 0.0104616 0.0057269 0.0195476 0.0171275 0.0129236 0.0372172 0.0614431 0.0407815 0.0531162 0.03838 0.0797356 0.0733886 0.0412535 0.0565395 0.05241 0.0899816 0.078227 0.0565	Additionally , in one controlled study in five normal subjects and seven patients , the clearance of DRUG1 was decreased 50% following the administration of DRUG2 .
1	1	0.0629092 0.0699935 0.0303134 0.0340742 0.034893 0.0204235 0.0248934 0.0426309 0.0291984 0.0160376 0.0157087 0.031283 0.0473672 0.0385823 0.0399025 0.0439049 0.0302483 0.068053 0.0415241 0.0869182 0.0430864 0.017809 0.0164059 0.0194927 0.0262881 0.0680584	Because DRUG1 have been shown to depress plasma prothrombin activity , patients who are on DRUG2 therapy may require downward adjustment of their DRUG0 dosage .
4	4	0.0588831 0.0636565 0.0263444 0.0287465 0.0278876 0.0126469 0.0131586 0.0217946 0.0121385 0.00587618 0.00492919 0.0124958 0.0186768 0.0104948 0.0126712 0.0205342 0.0251092 0.0502503 0.0330893 0.0855943 0.0904407 0.08212 0.0870518 0.0628097 0.0427982 0.0898017	Because DRUG1 have been shown to depress plasma prothrombin activity , patients who are on DRUG0 therapy may require downward adjustment of their DRUG2 dosage .
4	4	0.076859 0.0690809 0.0417659 0.0453611 0.0332837 0.0286271 0.0270672 0.0437532 0.0461723 0.0431105 0.0579781 0.00982028 0.013961 0.0149714 0.0181376 0.027003 0.0559589 0.0662251 0.0347363 0.0386559 0.0569057 0.0420863 0.0352734 0.073206	Since bacteriostatic drugs may interfere with the bactericidal action of DRUG1 , it is advisable to avoid giving DRUG2 in conjunction with DRUG0 .
1	1	0.0675932 0.0407594 0.0178262 0.0225727 0.0134769 0.0105022 0.00659696 0.0095444 0.00975528 0.00825891 0.0096869 0.00870191 0.0377058 0.0266453 0.0391693 0.0385565 0.0782938 0.0789231 0.0812482 0.0974498 0.0663006 0.0871083 0.0757379 0.0675864	Since bacteriostatic drugs may interfere with the bactericidal action of DRUG0 , it is advisable to avoid giving DRUG1 in conjunction with DRUG2 .
4	4	0.0803852 0.077934 0.0743131 0.0783845 0.14834 0.133171 0.0503577 0.0245781 0.0115979 0.00431791 0.00637884 0.00411577 0.00643747 0.00389301 0.00588373 0.020797 0.0462917 0.0968713 0.125952	Absorption of DRUG1 is impaired by DRUG2 containing DRUG0 , DRUG0 or DRUG0 , and DRUG0 -containing preparations .
3	3	0.0789392 0.0772316 0.0706827 0.0668331 0.14024 0.0958982 0.0507838 0.068402 0.0384978 0.00707957 0.00731499 0.00554767 0.00618564 0.0047918 0.00606225 0.0185493 0.0449737 0.0847381 0.127249	Absorption of DRUG1 is impaired by DRUG0 containing DRUG2 , DRUG0 or DRUG0 , and DRUG0 -containing preparations .
3	3	0.0834586 0.0804861 0.0751078 0.0709172 0.159408 0.10966 0.0312437 0.0380328 0.0143033 0.00969115 0.0203852 0.00713544 0.00617355 0.00427152 0.00552916 0.0178466 0.039012 0.0931306 0.134207	Absorption of DRUG1 is impaired by DRUG0 containing DRUG0 , DRUG2 or DRUG0 , and DRUG0 -containing preparations .
3	3	0.0863281 0.0834429 0.078239 0.073247 0.160491 0.109533 0.02864 0.0356122 0.0120246 0.00526971 0.0122965 0.0101624 0.0232692 0.00503646 0.00569262 0.0161812 0.0439516 0.0804589 0.130124	Absorption of DRUG1 is impaired by DRUG0 containing DRUG0 , DRUG0 or DRUG2 , and DRUG0 -containing preparations .
3	3	0.0790474 0.0760034 0.0719579 0.0678688 0.137705 0.0999347 0.0272812 0.0335446 0.0112268 0.00472348 0.00754491 0.00641661 0.00876596 0.0100152 0.0259661 0.0526494 0.0532514 0.0878237 0.138274	Absorption of DRUG1 is impaired by DRUG0 containing DRUG0 , DRUG0 or DRUG0 , and DRUG2 -containing preparations .
4	4	0.0366113 0.0403987 0.0613323 0.0977749 0.190213 0.131991 0.104842 0.0845119 0.0364329 0.00579481 0.00495947 0.00361006 0.00401311 0.00314569 0.00399597 0.0122967 0.0274201 0.0584766 0.0921794	Absorption of DRUG0 is impaired by DRUG1 containing DRUG2 , DRUG0 or DRUG0 , and DRUG0 -containing preparations .
4	4	0.0451396 0.0488036 0.0688848 0.104629 0.182168 0.118186 0.120946 0.0673414 0.0118727 0.00736172 0.0157523 0.00523049 0.00435006 0.00308386 0.00393875 0.0121603 0.0256946 0.0606348 0.0938226	Absorption of DRUG0 is impaired by DRUG1 containing DRUG0 , DRUG2 or DRUG0 , and DRUG0 -containing preparations .
4	4	0.0450984 0.0493097 0.0711214 0.106842 0.184601 0.122349 0.127069 0.0618322 0.00959747 0.00395867 0.00858755 0.00698045 0.016498 0.00348384 0.00387622 0.0106608 0.0276578 0.0510969 0.08938	Absorption of DRUG0 is impaired by DRUG1 containing DRUG0 , DRUG0 or DRUG2 , and DRUG0 -containing preparations .
4	4	0.0462202 0.0491443 0.0684183 0.100404 0.165043 0.107264 0.116006 0.0618692 0.00949764 0.00376917 0.00590615 0.00478632 0.00623445 0.00681034 0.0156901 0.0346052 0.0346263 0.0608094 0.102896	Absorption of DRUG0 is impaired by DRUG1 containing DRUG0 , DRUG0 or DRUG0 , and DRUG2 -containing preparations .
4	4	0.054297 0.049743 0.0594295 0.0721053 0.113968 0.0460378 0.0262942 0.0299127 0.0155553 0.0095934 0.0248762 0.0281077 0.0984555 0.0269984 0.0363661 0.0643797 0.0540909 0.0720897 0.1177	Absorption of DRUG0 is impaired by DRUG0 containing DRUG0 , DRUG0 or DRUG1 , and DRUG2 -containing preparations .
2	2	0.0700263 0.0792583 0.0637669 0.0526729 0.0804463 0.0283437 0.0592489 0.0484978 0.0687591 0.08295 0.0372024 0.0496311 0.0574636 0.0841099 0.0271506 0.0423962 0.0680759	The concurrent use of DRUG1 and DRUG2 has been reported to result in fatal renal toxicity .
2	2	0.0635341 0.0447643 0.0481627 0.0592981 0.0725323 0.0875755 0.0836063 0.0851593 0.0809841 0.0624654 0.0706237 0.070317 0.0639253 0.107052	Concurrent use of DRUG1 with oral DRUG2 may render oral DRUG0 less effective .
4	4	0.0601371 0.0720699 0.083235 0.0835797 0.0401163 0.0548449 0.0674423 0.0810174 0.0968187 0.108109 0.0908404 0.0362077 0.0446577 0.080924	Concurrent use of DRUG1 with oral DRUG0 may render oral DRUG2 less effective .
2	2	0.0669071 0.048518 0.0819254 0.0547581 0.081663 0.0743373 0.0645423 0.109689 0.0790842 0.0897244 0.0347581 0.0270759 0.0126558 0.00783085 0.037653 0.069293 0.0595839	Interaction of DRUG1 with different DRUG2 is antagonistic in breast but not in other cancer cells .
4	4	0.0258779 0.0273125 0.0660918 0.0742903 0.0629259 0.0576646 0.0635912 0.0340688 0.0612564 0.068275 0.0383305 0.0500488 0.0603068 0.0571057 0.10628 0.0759033 0.0706711	This study investigates the ability of DRUG1 to sensitize cells from different origins to several DRUG2 .
4	4	0.0250073 0.0205858 0.00690991 0.0185413 0.0152031 0.00830864 0.0337968 0.0144666 0.0488584 0.0521701 0.0201767 0.0215497 0.0359878 0.0187394 0.0228745 0.0272398 0.0167384 0.00842746 0.0230522 0.00935502 0.0246262 0.0104479 0.0267985 0.00975192 0.0260699 0.00844312 0.00503888 0.00311831 0.0139601 0.00364723 0.00400775 0.0041819 0.0224842 0.0126214 0.0417142 0.0837004 0.0595033 0.0597776 0.0450586 0.0469129 0.0401471	The sensitivity , cell cycle , apoptosis and DNA damage of five different cancer cell lines (HeLa , HCT116 , HepG2 , MCF7 and U251) to DRUG0 , DRUG1 , DRUG0 and DRUG2 DRUG0 following different incubation schedules were analyzed .
4	4	0.0262954 0.0216436 0.00726463 0.0194879 0.0159746 0.00872723 0.0354721 0.015187 0.0512527 0.0547376 0.0211938 0.0225383 0.0373538 0.0193647 0.0234091 0.0275677 0.0166492 0.00815559 0.0218259 0.00847728 0.0213717 0.00852856 0.0205251 0.00720721 0.0185575 0.00531326 0.00318355 0.00168838 0.00436349 0.00419221 0.0280629 0.00561233 0.0225526 0.0126815 0.044311 0.081159 0.0575386 0.0612714 0.0440734 0.0452613 0.0399669	The sensitivity , cell cycle , apoptosis and DNA damage of five different cancer cell lines (HeLa , HCT116 , HepG2 , MCF7 and U251) to DRUG0 , DRUG0 , DRUG1 and DRUG2 DRUG0 following different incubation schedules were analyzed .
4	4	0.0264952 0.0218087 0.00731994 0.0196342 0.0160902 0.00878542 0.0357059 0.0152865 0.0516057 0.0550545 0.0212347 0.0227269 0.0378418 0.0195284 0.0236127 0.0278685 0.0169089 0.00832628 0.0221093 0.00874829 0.0219001 0.00906239 0.0218085 0.00808397 0.0188825 0.0056575 0.00309956 0.00187857 0.00449598 0.00547916 0.0290224 0.00652487 0.00830123 0.0300118 0.019737 0.0740373 0.0624358 0.0613162 0.0475924 0.0505913 0.0433896	The sensitivity , cell cycle , apoptosis and DNA damage of five different cancer cell lines (HeLa , HCT116 , HepG2 , MCF7 and U251) to DRUG0 , DRUG0 , DRUG1 and DRUG0 DRUG2 following different incubation schedules were analyzed .
2	4	0.0262767 0.0328392 0.0723293 0.0470792 0.071631 0.00876233 0.0261245 0.0278497 0.0129827 0.0162227 0.0222595 0.0274075 0.0354633 0.0468922 0.0453131 0.027795 0.0205295 0.0269579 0.0317346 0.0178915 0.0237403 0.00835675 0.00944783 0.0146233 0.0104038 0.0107613 0.0294663 0.0556971 0.0278787 0.0158226 0.013602 0.0261284 0.016429 0.0282558 0.0346183 0.0304272	We found antagonism between DRUG1 and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between DRUG0 and DRUG2 in all cell lines except for two combinations in HCT116 cells .
4	2	0.012672 0.0114369 0.0233622 0.0133683 0.0104698 0.00826294 0.0195433 0.0198002 0.0158143 0.00942312 0.0163612 0.0237703 0.0381813 0.0625384 0.0485405 0.0269738 0.0208865 0.0299532 0.0404648 0.0248531 0.0283485 0.0633497 0.0232656 0.0283808 0.0208119 0.0146569 0.0395712 0.0691034 0.0329541 0.020609 0.0174476 0.0308591 0.0201047 0.0347611 0.0423451 0.0367555	We found antagonism between DRUG0 and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between DRUG1 and DRUG2 in all cell lines except for two combinations in HCT116 cells .
4	4	0.0119456 0.0184007 0.00480868 0.0109783 0.041715 0.033896 0.017311 0.0428811 0.0347319 0.0600109 0.0217252 0.028303 0.0367838 0.0540166 0.0715081 0.0720002 0.0720246 0.087065 0.0472256 0.0660783 0.0325026 0.0185905 0.00828554 0.0499902 0.0572215	These results , if confirmed in-vivo , indicate that DRUG1 is not a suitable chemosensitizer for breast cancer or with DRUG2 for other cancers .
1	1	0.0447978 0.0608691 0.0646074 0.0888479 0.0579078 0.0570844 0.0392325 0.10523 0.0319305 0.0398306 0.0246563 0.00617565 0.007553 0.018805 0.0061258 0.0116787 0.00514532 0.0100654 0.00508093 0.0120944 0.00627375 0.0205104 0.00898628 0.0112411 0.0247415 0.0129654 0.0102517 0.0195576 0.0203649 0.0201881 0.0144416 0.00852895 0.0307776 0.0934525	Caution is advised for patients receiving high-dose DRUG1 and DRUG2 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DRUG0 and DRUG0 .
4	4	0.0205493 0.0317826 0.0378988 0.0656597 0.0455782 0.0473054 0.0602906 0.0759956 0.0145551 0.0199557 0.0258978 0.00607277 0.00861724 0.0361526 0.00947282 0.0240686 0.00821174 0.0204975 0.00935503 0.0309659 0.0119189 0.0367668 0.0175293 0.0236306 0.041524 0.0201412 0.0179626 0.0216091 0.0254281 0.0228206 0.0179924 0.0212314 0.0491044 0.0734577	Caution is advised for patients receiving high-dose DRUG1 and DRUG0 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DRUG0 and DRUG2 .
4	4	0.0217684 0.0354139 0.0418001 0.069288 0.0501414 0.0584114 0.0563715 0.039687 0.0242976 0.0492183 0.0279614 0.00540701 0.00687787 0.0270034 0.00793306 0.0184181 0.00715981 0.0164505 0.00806699 0.0252193 0.0109868 0.0361515 0.0158363 0.0212146 0.0405021 0.0191981 0.0171469 0.0290216 0.0338702 0.0524069 0.0243353 0.0086233 0.0208477 0.0729636	Caution is advised for patients receiving high-dose DRUG0 and DRUG1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DRUG2 and DRUG0 .
4	4	0.0215289 0.0350503 0.041404 0.0686441 0.0497093 0.0579521 0.055953 0.0395844 0.0242895 0.0494544 0.0284993 0.00555137 0.00733882 0.0296045 0.00865737 0.0207008 0.00775472 0.0187036 0.00897348 0.0291628 0.0115355 0.0354431 0.0167323 0.0225971 0.0406351 0.0195775 0.017441 0.021159 0.0248131 0.022263 0.0175787 0.0207777 0.0483116 0.0726184	Caution is advised for patients receiving high-dose DRUG0 and DRUG1 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DRUG0 and DRUG2 .
2	2	0.0172045 0.0210023 0.0218797 0.0302845 0.0188901 0.0224983 0.0168781 0.0102735 0.00549123 0.0126199 0.0138211 0.00509891 0.00677071 0.0282413 0.00883024 0.0224913 0.00833064 0.0235744 0.0115247 0.04261 0.0180427 0.0594884 0.0267599 0.0383338 0.0635603 0.0328119 0.0267454 0.0278811 0.0492246 0.037935 0.100067 0.0305506 0.0679757 0.0723081	Caution is advised for patients receiving high-dose DRUG0 and DRUG0 concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high-dose DRUG1 and DRUG2 .
3	3	0.0801696 0.162127 0.0932011 0.13207 0.0759228 0.161531 0.175101 0.0873556 0.0325223	The metabolism of DRUG1 is accelerated by DRUG2 ;
3	3	0.134129 0.130505 0.0847351 0.0794255 0.125279 0.063302 0.0159089 0.0440134 0.0324699 0.0506639 0.0570018 0.0666781 0.115888	DRUG1 inhibits the glucuronidation of DRUG2 and could possibly potentiate DRUG0 toxicity .
4	2	0.0673843 0.0941076 0.0424135 0.033575 0.0352842 0.0297379 0.0227967 0.112022 0.135236 0.16107 0.0948367 0.0590281 0.112508	DRUG1 inhibits the glucuronidation of DRUG0 and could possibly potentiate DRUG2 toxicity .
0	4	0.216102 0.128841 0.25339 0.0698955 0.110629 0.0678017 0.153342	[Interaction between DRUG1 and DRUG2 ] .
4	4	0.0770268 0.0708856 0.0768008 0.0609475 0.109083 0.033019 0.0587387 0.0376142 0.0418172 0.0513663 0.0437715 0.036587 0.0657219 0.0405423 0.0364071 0.0517275 0.0404136 0.0675301	The drug interaction between DRUG1 and DRUG2 has been the subject of much study in recent years .
4	4	0.0484464 0.0783685 0.070503 0.0785823 0.0503734 0.0435275 0.0394815 0.0124338 0.00748019 0.0110387 0.00452561 0.0119651 0.0270895 0.0849846 0.0676452 0.0519687 0.0629568 0.0435279 0.0205912 0.0296709 0.0496618 0.0259423 0.0292636 0.0499715	Contradictory results regarding the effect of DRUG1 on platelet reactivity and on clinical outcome in DRUG2 -treated patients have been reported in literature .
3	3	0.0488191 0.0413833 0.0359242 0.0600123 0.0193026 0.0381595 0.0364783 0.0329701 0.0195476 0.0412452 0.025132 0.0291885 0.0260213 0.0186043 0.030857 0.0345069 0.0320519 0.0353172 0.0312727 0.00532896 0.00466202 0.00999101 0.0166005 0.00647292 0.00712249 0.00217951 0.00280777 0.00742752 0.0166559 0.0204074 0.035879 0.0150696 0.0176449 0.0212774 0.0193966 0.00924085 0.0211332 0.0238943 0.016067 0.0214641 0.0137235 0.0487596	Concomitant use of DRUG1 and DRUG2 was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity , as a result of inhibition by DRUG0 of CYP2C19 , a cytochrome P450 (CYP) enzyme .
4	4	0.0361253 0.0550421 0.0532587 0.0299225 0.0149935 0.0288475 0.0221493 0.0208243 0.0108484 0.0311339 0.017836 0.0206266 0.0208408 0.0150949 0.0276295 0.0305096 0.0263582 0.0305101 0.029499 0.00525838 0.00513172 0.0113758 0.0184676 0.00716043 0.0082029 0.0024391 0.00392073 0.0120567 0.0226133 0.0313933 0.0520889 0.0453101 0.0405264 0.0339849 0.0351989 0.0104042 0.0197923 0.0274348 0.0186514 0.0183801 0.0120967 0.0360615	Concomitant use of DRUG0 and DRUG1 was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity , as a result of inhibition by DRUG2 of CYP2C19 , a cytochrome P450 (CYP) enzyme .
4	3	0.0870994 0.045346 0.0473925 0.0699556 0.118861 0.0833248 0.104462 0.110487 0.0964475 0.0410355 0.0118597 0.0149563 0.0137962 0.0286445 0.0238816 0.0160824 0.0228106 0.0635577	DRUG1 has a much weaker effect on DRUG2 's pharmacokinetics and on platelet reactivity during concomitant use .
4	4	0.0466565 0.0594888 0.033469 0.0264416 0.0124279 0.0476133 0.0312204 0.020664 0.0390845 0.053895 0.0507315 0.0361995 0.0668469 0.101057 0.065261 0.0799135 0.0622836 0.0553562 0.0431903 0.0247377 0.0434617	The influence of the other DRUG1 when used simultaneously with DRUG2 has not yet been investigated in adequately randomized studies .
1	1	0.100778 0.0593724 0.0678025 0.0444038 0.0843969 0.0703031 0.0732504 0.121416 0.0204117 0.0683257 0.0405623 0.0153073 0.0192105 0.00538456 0.0130878 0.0324673 0.0341384 0.0456158 0.083765	Regulatory agencies state that the combination of DRUG1 and the CYP2C19 inhibitors DRUG2 and DRUG0 should be avoided .
1	1	0.0937941 0.054998 0.0627724 0.0423162 0.0788993 0.0653119 0.0666013 0.114589 0.0171691 0.0524939 0.0433221 0.0197017 0.0152463 0.0221688 0.0499359 0.0352056 0.039819 0.0476128 0.0780428	Regulatory agencies state that the combination of DRUG1 and the CYP2C19 inhibitors DRUG0 and DRUG2 should be avoided .
4	4	0.0651347 0.0372431 0.0344961 0.0229987 0.0418296 0.0501307 0.0442868 0.0315865 0.026844 0.0665348 0.0683566 0.036905 0.17151 0.0502315 0.0650463 0.0323512 0.037166 0.0441483 0.0731995	Regulatory agencies state that the combination of DRUG0 and the CYP2C19 inhibitors DRUG1 and DRUG2 should be avoided .
4	4	0.0429784 0.0201996 0.00522084 0.0151341 0.0272235 0.0356294 0.0747956 0.0648829 0.0514012 0.0490342 0.0968349 0.0781303 0.068238 0.0507245 0.0518449 0.0555883 0.0701882 0.0233243 0.055797 0.0628299	To date , there is no conclusive evidence of a clinically-relevant interaction between any of the DRUG1 and DRUG2 .
4	1	0.0402438 0.0176223 0.0118073 0.0176672 0.0147751 0.0166572 0.00772702 0.00799334 0.017572 0.0200633 0.0289472 0.0388414 0.0466595 0.0388657 0.0385905 0.0486142 0.0472165 0.0215289 0.0145622 0.0208806 0.0517229 0.0276611 0.0567371 0.0275179 0.0260514 0.0184077 0.0216359 0.00693493 0.00716923 0.00481484 0.00354373 0.0157996 0.0193885 0.0175775 0.0191309 0.0202707 0.0324323 0.0290381 0.0114182 0.00213444 0.00188933 0.0012857 0.00177674 0.00131349 0.001753 0.00393666 0.00675831 0.0450644	Drug Interactions : Inhibitors of CYP3A4 Isozymes : Caution is advised when DRUG1 is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie , some drugs in the drug classes of DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) .
4	1	0.0415179 0.018183 0.0121861 0.0182335 0.0152539 0.017198 0.00798326 0.00827103 0.0181851 0.0207725 0.0299675 0.0402003 0.0482867 0.040217 0.039933 0.0502748 0.0489151 0.0223138 0.0150347 0.0215655 0.0536762 0.0287135 0.0591202 0.0289884 0.0273457 0.0195879 0.0230542 0.00746692 0.00759939 0.00509222 0.00349285 0.0146961 0.0170481 0.0159979 0.015932 0.0166954 0.0301423 0.0153719 0.00503045 0.00324023 0.00683308 0.00136928 0.00166584 0.00128633 0.00168438 0.0038189 0.0069569 0.0436005	Drug Interactions : Inhibitors of CYP3A4 Isozymes : Caution is advised when DRUG1 is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie , some drugs in the drug classes of DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) .
4	1	0.0419292 0.0183624 0.0123054 0.0184114 0.0154017 0.017364 0.00805889 0.00834791 0.0183528 0.0209612 0.0302397 0.0405688 0.0487253 0.040578 0.0402874 0.0507164 0.0493139 0.0224895 0.0151515 0.0217311 0.0540388 0.0289109 0.0595112 0.0291354 0.0274855 0.0196452 0.0230767 0.00745709 0.00757079 0.00509085 0.00348987 0.0146648 0.0168175 0.0156097 0.0153219 0.0159503 0.0278309 0.0138804 0.00402204 0.00158859 0.00246258 0.00273252 0.00739486 0.00155382 0.00169975 0.00358834 0.00714734 0.0430256	Drug Interactions : Inhibitors of CYP3A4 Isozymes : Caution is advised when DRUG1 is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie , some drugs in the drug classes of DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) .
4	1	0.0411756 0.0180314 0.0120825 0.0180774 0.0151209 0.0170471 0.0079101 0.00819152 0.018006 0.0205629 0.0296655 0.039804 0.0477999 0.0398145 0.0395283 0.0497566 0.0483608 0.0220561 0.0148649 0.0213192 0.0529787 0.0283483 0.0583146 0.0284866 0.026879 0.0191541 0.0223949 0.00718137 0.00723708 0.00484321 0.0032881 0.0137189 0.016096 0.0149815 0.0148469 0.01531 0.0262917 0.0132668 0.00389978 0.00147478 0.00199594 0.00143248 0.00253965 0.00235728 0.00580932 0.0165154 0.0112947 0.0498875	Drug Interactions : Inhibitors of CYP3A4 Isozymes : Caution is advised when DRUG1 is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie , some drugs in the drug classes of DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) .
4	4	0.0447486 0.0181178 0.0110434 0.0160833 0.0129368 0.016499 0.00696662 0.0045193 0.00875383 0.00898205 0.0141642 0.0127744 0.0175279 0.0214072 0.0248651 0.0239652 0.0407176 0.0208397 0.0129599 0.0171768 0.0583878 0.0276984 0.0583398 0.0292296 0.0230617 0.0191167 0.026674 0.00756906 0.00890823 0.00608095 0.00367242 0.0150024 0.0172504 0.0163935 0.0173867 0.0249059 0.0516838 0.0267568 0.00977602 0.0042407 0.00889969 0.00956124 0.0376553 0.0100821 0.0126858 0.0300552 0.0175442 0.0663329	Drug Interactions : Inhibitors of CYP3A4 Isozymes : Caution is advised when DRUG0 is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie , some drugs in the drug classes of DRUG0 , DRUG0 , DRUG1 , and DRUG2 ) .
4	3	0.0174984 0.0114143 0.0104917 0.0271675 0.00502537 0.005077 0.00459362 0.00515225 0.00494272 0.00575334 0.00600389 0.00867185 0.0100272 0.0183216 0.0302808 0.0586087 0.0243493 0.0507293 0.0386411 0.0282196 0.0261078 0.0279406 0.0246581 0.0967895 0.0742764 0.098711 0.10033 0.0861944 0.094023	Drugs such as DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
4	3	0.0132588 0.00700772 0.00442896 0.00787616 0.00580724 0.0232446 0.0044084 0.00530707 0.004693 0.00580324 0.00583566 0.00860954 0.00979416 0.0184892 0.0300671 0.0606888 0.0241771 0.0495141 0.0370992 0.0269418 0.024601 0.0269698 0.0248889 0.100591 0.0776025 0.102449 0.103757 0.089405 0.0966841	Drugs such as DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 and DRUG0 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
4	3	0.0121502 0.0061287 0.00354486 0.00494054 0.00350077 0.00860322 0.00615254 0.0249417 0.0048175 0.00616699 0.00588479 0.00896281 0.0101525 0.0189968 0.03016 0.0591867 0.0236016 0.0487128 0.0365695 0.0264142 0.0242297 0.0268509 0.0249416 0.101198 0.0780702 0.103119 0.104425 0.0900657 0.0975105	Drugs such as DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 and DRUG0 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
4	4	0.0156702 0.00730216 0.00393387 0.00517744 0.00350581 0.00640598 0.00499413 0.0123131 0.0116752 0.0545895 0.0145378 0.0223676 0.0289136 0.0649729 0.0804288 0.0898084 0.0306161 0.0600533 0.0434666 0.025907 0.0273172 0.0209575 0.0162689 0.0618081 0.0301033 0.0482469 0.0450642 0.0591196 0.104475	Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 and DRUG2 were shown to significantly increase the C max and AUC of orally administered DRUG0 .
4	3	0.0116524 0.0057451 0.00325352 0.00437118 0.00286254 0.00523951 0.00372764 0.00921896 0.00645747 0.0282042 0.00576196 0.00940224 0.0103601 0.019787 0.0308338 0.0579649 0.0229611 0.0482122 0.0361641 0.0258796 0.0238516 0.0266491 0.0249215 0.101504 0.0782975 0.103516 0.104808 0.0904674 0.0979261	Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 and DRUG0 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
4	4	0.0151475 0.00718311 0.00409351 0.00515616 0.00347506 0.00620428 0.00423576 0.00876951 0.00768399 0.0197803 0.0295708 0.165596 0.0317839 0.061173 0.0711507 0.0752127 0.0259769 0.052347 0.0379493 0.0219451 0.023226 0.0176972 0.0137347 0.0509384 0.0250134 0.0399616 0.0374847 0.0492575 0.0882519	Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 and DRUG2 were shown to significantly increase the C max and AUC of orally administered DRUG0 .
4	3	0.0108341 0.00522464 0.00297754 0.00388283 0.00258093 0.00444068 0.00286161 0.00533045 0.00380951 0.0101845 0.00909576 0.051545 0.00973629 0.0189484 0.032217 0.0557892 0.021853 0.0472206 0.0352988 0.0247799 0.0229977 0.0258373 0.0244477 0.0995874 0.0765942 0.10194 0.10328 0.0893109 0.0973937	Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 and DRUG0 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
4	3	0.00994368 0.00491032 0.00275786 0.00327957 0.00231739 0.00366283 0.00250721 0.00421608 0.00286794 0.00546191 0.00458689 0.0120094 0.0136231 0.0577434 0.0445404 0.0648697 0.0254359 0.0515678 0.0374863 0.026133 0.023788 0.0261846 0.0236801 0.0968559 0.0739248 0.0983914 0.0994731 0.0858206 0.0919609	Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG1 were shown to significantly increase the C max and AUC of orally administered DRUG2 .
3	4	0.0134539 0.0294015 0.047087 0.0179194 0.040621 0.0408697 0.0447087 0.0392463 0.0421745 0.0180704 0.0772839 0.0224128 0.0460865 0.0768587 0.044781 0.03037 0.0191943 0.0607911 0.0340595 0.0126187 0.0199345 0.0288803 0.0271827 0.0088772 0.00810823 0.0181364 0.0113646 0.0206 0.0235497 0.0175398 0.0179927 0.0398251	Although not studied , the potent cytochrome P450 3A4 inhibitors DRUG1 and DRUG2 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUG0 .
3	3	0.0106924 0.0222969 0.0366113 0.0138713 0.0315252 0.0274342 0.0319882 0.0247666 0.0295885 0.0164711 0.0427459 0.0101918 0.0224807 0.0554343 0.0325483 0.0248971 0.0164174 0.0566321 0.0338925 0.0103053 0.0173654 0.0281151 0.0316675 0.0162515 0.0186641 0.046686 0.0316253 0.0530262 0.0581222 0.0502662 0.0513371 0.0460822	Although not studied , the potent cytochrome P450 3A4 inhibitors DRUG1 and DRUG0 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUG2 .
3	3	0.0105006 0.0220135 0.0351482 0.012966 0.0296765 0.0234239 0.0274717 0.021904 0.0261395 0.0131055 0.0123944 0.012364 0.0650382 0.0605682 0.0345006 0.0252109 0.016773 0.0541488 0.0320522 0.0103991 0.0161827 0.0270846 0.0324074 0.0161853 0.0184579 0.0477282 0.0323221 0.0544246 0.059436 0.0510374 0.0523544 0.0465808	Although not studied , the potent cytochrome P450 3A4 inhibitors DRUG0 and DRUG1 may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUG2 .
3	3	0.059283 0.0392103 0.0442742 0.0206186 0.00859354 0.0168803 0.0127125 0.00965748 0.00344883 0.00439867 0.0046339 0.0155259 0.00300293 0.00320953 0.00289609 0.00471618 0.00953851 0.0163506 0.0474109 0.0308608 0.0199931 0.045118 0.0247968 0.0406074 0.0446097 0.0341784 0.0354334 0.0260726 0.0605933 0.04623 0.0408364 0.0534207 0.0503341 0.045996 0.0290479 0.0455095	Inducers of CYP3A4 Isozymes : Cytochrome P450 inducers , such as DRUG1 , DRUG0 , and DRUG0 , induce metabolism and caused a markedly decreased C max and AUC of oral DRUG2 in adult studies .
4	4	0.07868 0.0527017 0.0591853 0.0291965 0.0127536 0.025685 0.0193638 0.0133689 0.0040875 0.0046629 0.0036909 0.00633159 0.00783982 0.0438363 0.0112985 0.0146977 0.032266 0.0139377 0.0648151 0.0647953 0.0360244 0.0572441 0.0221643 0.0358413 0.036034 0.0225069 0.0149405 0.0101254 0.0251646 0.0105797 0.0111802 0.0170858 0.0192441 0.0427594 0.0263285 0.049583	Inducers of CYP3A4 Isozymes : Cytochrome P450 inducers , such as DRUG0 , DRUG1 , and DRUG2 , induce metabolism and caused a markedly decreased C max and AUC of oral DRUG0 in adult studies .
3	3	0.0608924 0.0406206 0.0454053 0.0212176 0.00866124 0.0165481 0.0119142 0.00840322 0.00284514 0.003052 0.00217866 0.00385064 0.00332978 0.0161152 0.00325669 0.00459614 0.0098824 0.0161501 0.0472294 0.0309757 0.0198507 0.0453259 0.0245226 0.0405249 0.0444332 0.0338309 0.0351934 0.026065 0.0605695 0.0462476 0.0408628 0.0534826 0.0504025 0.0462942 0.0293093 0.0459605	Inducers of CYP3A4 Isozymes : Cytochrome P450 inducers , such as DRUG0 , DRUG1 , and DRUG0 , induce metabolism and caused a markedly decreased C max and AUC of oral DRUG2 in adult studies .
3	3	0.054278 0.0357942 0.0399174 0.0189001 0.0083551 0.016775 0.0129583 0.00885458 0.00273745 0.00311352 0.00205313 0.00292138 0.00238303 0.00520395 0.00523522 0.00927552 0.0560877 0.0165573 0.0468512 0.0353622 0.022077 0.0483477 0.0252475 0.040073 0.0429908 0.0321021 0.033271 0.0248922 0.0567021 0.0432193 0.0378877 0.0499252 0.0468839 0.042878 0.0271123 0.0427759	Inducers of CYP3A4 Isozymes : Cytochrome P450 inducers , such as DRUG0 , DRUG0 , and DRUG1 , induce metabolism and caused a markedly decreased C max and AUC of oral DRUG2 in adult studies .
2	4	0.0355452 0.0357727 0.0199829 0.0286778 0.0222864 0.0234119 0.0380405 0.0135116 0.0199453 0.0265476 0.0263048 0.0263915 0.0367847 0.0432429 0.0333572 0.0388534 0.0826413 0.0272873 0.0185717 0.0239958 0.0282155 0.0360243 0.0293612 0.0167761 0.054227 0.0435542 0.0608692 0.0586042 0.0512154	The difficulty in achieving adequate sedation may have been the result of decreased absorption of the DRUG1 due to both the gastrointestinal effects and stimulant effects of DRUG2 .
2	2	0.0481801 0.0867825 0.0684167 0.0485901 0.0504501 0.0282524 0.0426656 0.0271133 0.0322341 0.029317 0.0293543 0.0186236 0.0203981 0.0574911 0.0463581 0.0423628 0.041868 0.0490876 0.0326755 0.0736243 0.0179772 0.00519714 0.00239146 0.00228187 0.00169519 0.00234413 0.00171724 0.00242069 0.00163366 0.00139207 0.00200739 0.00151458 0.00224495 0.00166784 0.00261116 0.00209795 0.00431004 0.00388816 0.0138463 0.0529158	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG2 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.0526071 0.0953692 0.0758564 0.05396 0.0558994 0.0315511 0.0477484 0.0303208 0.0360578 0.0329831 0.0334286 0.0214078 0.023079 0.0641666 0.0497507 0.0448956 0.042514 0.0410208 0.0168406 0.0250696 0.00616086 0.00466447 0.00304571 0.00732084 0.00156271 0.00200099 0.00153779 0.00226074 0.00161056 0.00138763 0.00200094 0.00151947 0.00225412 0.00169677 0.00268648 0.00217954 0.00459844 0.00425135 0.0149947 0.0577392	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG2 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.0534944 0.0968219 0.0767142 0.0545104 0.0563987 0.0318415 0.0480549 0.0305233 0.0361852 0.0330541 0.0334245 0.0212842 0.0229273 0.0638878 0.049482 0.0445047 0.0422116 0.0400493 0.0159408 0.0235935 0.0053171 0.00324915 0.0015335 0.00278873 0.0030268 0.00809957 0.0015631 0.00220714 0.00166142 0.00138595 0.00200797 0.00151782 0.0022554 0.00169518 0.00270636 0.0021854 0.00464424 0.00420734 0.015071 0.0579724	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG2 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.0538963 0.0974454 0.0765532 0.0542227 0.0558444 0.0317496 0.0477941 0.030516 0.0358922 0.0330288 0.0331619 0.0209217 0.0225501 0.0625823 0.0484102 0.0431771 0.0409308 0.0354172 0.0140428 0.0212202 0.0051146 0.00304777 0.00139907 0.00225551 0.00176565 0.00399688 0.00512075 0.00874124 0.00241306 0.00158295 0.00226853 0.00165561 0.00258546 0.00186193 0.00312641 0.00244448 0.0053769 0.00447506 0.0171436 0.0642671	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.0536868 0.0972348 0.0768002 0.0545375 0.0562889 0.0318392 0.047968 0.0305445 0.0361473 0.0330452 0.0334041 0.0212555 0.0228933 0.0636969 0.0492745 0.0440216 0.0417173 0.0380479 0.0147186 0.0211257 0.00476107 0.00284849 0.00127915 0.00199438 0.00146016 0.00278876 0.00189127 0.00329971 0.00277361 0.00311179 0.00790081 0.0017017 0.00227404 0.00176859 0.00268173 0.00216434 0.00440838 0.0040938 0.0154069 0.0631436	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.053708 0.0972872 0.0768279 0.0545481 0.0562908 0.0318452 0.0479727 0.0305506 0.0361513 0.0330454 0.0334107 0.0212597 0.0228916 0.0636801 0.049262 0.043975 0.0416651 0.0379686 0.0146477 0.0208352 0.0046558 0.00279427 0.00125754 0.00194937 0.00142147 0.00269169 0.00180803 0.00291833 0.00211631 0.00172896 0.00310072 0.00329196 0.00876571 0.00186262 0.00272041 0.00221928 0.00432743 0.00402381 0.0152169 0.0633067	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.0535129 0.0969642 0.0765989 0.0544115 0.0561479 0.0317591 0.0478437 0.0304663 0.036064 0.0329404 0.0333269 0.0212288 0.0228588 0.0636344 0.0492721 0.0440186 0.0417027 0.0383434 0.0148163 0.0208856 0.00460597 0.00278099 0.0012465 0.00193093 0.00140212 0.00264327 0.00178639 0.00277876 0.00199336 0.00152177 0.00236179 0.00171046 0.00318732 0.0034354 0.00983535 0.00230643 0.00428291 0.00394454 0.0151295 0.0643197	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 and DRUG0 .
2	2	0.0539668 0.0977737 0.0771533 0.0547593 0.0564806 0.0319871 0.0481836 0.0307017 0.0362978 0.0332017 0.0335534 0.0213377 0.022988 0.0639384 0.0495024 0.0441561 0.0418891 0.0380412 0.0147798 0.0207187 0.00460617 0.00276034 0.00124589 0.00193266 0.0014029 0.00265701 0.00178127 0.00275408 0.00197104 0.00149342 0.00229667 0.00154165 0.00244059 0.00174511 0.00321738 0.00367621 0.0135017 0.00387625 0.0140735 0.0596159	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 and DRUG0 .
2	2	0.0513115 0.093161 0.0732955 0.05237 0.0537385 0.0305718 0.0459063 0.0294544 0.0347039 0.0317443 0.0319984 0.0204916 0.0222795 0.0626456 0.048632 0.0436581 0.0405765 0.0410153 0.0169353 0.0199582 0.00394266 0.00249455 0.00109969 0.00161267 0.00122112 0.0021738 0.00158313 0.00229835 0.0017461 0.00130954 0.0018598 0.00133215 0.00194954 0.00143435 0.00221986 0.00196923 0.00536622 0.0110865 0.0405357 0.0683174	The sedative effect of DRUG1 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG2 .
4	4	0.0282348 0.0417855 0.0266848 0.0310116 0.0379853 0.0547467 0.0794021 0.0396123 0.0466016 0.0351594 0.0246416 0.013612 0.0222826 0.0679294 0.050069 0.0419795 0.029896 0.0284547 0.0239785 0.0811895 0.0522794 0.0158289 0.00770276 0.0104975 0.00265073 0.00269604 0.00202082 0.00272271 0.0021237 0.00177326 0.002396 0.00188242 0.00259811 0.00203631 0.00299181 0.00251287 0.00494543 0.00480077 0.0147759 0.0555076	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG2 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0277642 0.0411286 0.026272 0.03055 0.0374127 0.0539508 0.0783819 0.0391992 0.0461941 0.0348486 0.024496 0.0135687 0.0221236 0.0680271 0.0504313 0.0420253 0.0307477 0.0286574 0.0232336 0.0800719 0.0550907 0.0135922 0.00832487 0.00556241 0.005572 0.0118533 0.00223167 0.00273822 0.00219425 0.00175259 0.0023363 0.0018292 0.00251472 0.00197378 0.00290311 0.00244694 0.00483483 0.00470722 0.014449 0.0540077	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG2 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0276922 0.040983 0.0261563 0.0304018 0.0372378 0.0536493 0.0778636 0.0388784 0.0457509 0.0345047 0.0242273 0.0133892 0.021846 0.0670181 0.0495504 0.0412368 0.0299806 0.0282284 0.0225967 0.0786529 0.0513255 0.0128229 0.00792095 0.00476187 0.00551048 0.0066408 0.00685071 0.0106833 0.00319093 0.00206061 0.00254637 0.00187278 0.00265992 0.00203737 0.0030989 0.00256915 0.00522879 0.00479112 0.0158225 0.0577609	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0277658 0.0410769 0.0262036 0.0304572 0.0373234 0.0537401 0.0779686 0.0388992 0.0457151 0.0344692 0.0241795 0.013345 0.0218052 0.0668852 0.0493035 0.0408195 0.0293502 0.0276791 0.0225161 0.0773488 0.0521937 0.0122607 0.00746346 0.00445992 0.00549561 0.0060374 0.00616856 0.00438495 0.00479786 0.00456697 0.00881698 0.00226677 0.00278709 0.00213625 0.00308335 0.00256493 0.00485314 0.00475453 0.0154645 0.0585919	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0276894 0.0409594 0.0261273 0.0303692 0.0372122 0.0535752 0.0777182 0.0387683 0.0455554 0.0343474 0.0240928 0.0132936 0.0217227 0.0666025 0.0490857 0.0406369 0.0292185 0.027613 0.0223974 0.0763107 0.0510173 0.0119055 0.0072299 0.00431227 0.00540919 0.00604779 0.00609413 0.00398078 0.00436643 0.00428289 0.00441851 0.00460596 0.0109423 0.00241564 0.00320385 0.00256289 0.00470162 0.00461471 0.0151376 0.0594547	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0277101 0.0409868 0.0261433 0.0303883 0.0372367 0.0536053 0.0777504 0.0387756 0.0455558 0.0343466 0.0240871 0.0132861 0.0217146 0.0665757 0.0490355 0.0405564 0.0290987 0.0275305 0.0223427 0.0757329 0.050899 0.0119065 0.00720525 0.0042815 0.00542193 0.00601937 0.00604027 0.003816 0.00404899 0.00388067 0.00343228 0.00272344 0.00400294 0.00441964 0.0117657 0.00290193 0.00481762 0.00443629 0.0149876 0.0605338	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 and DRUG0 .
4	4	0.0278943 0.0412598 0.0263177 0.0305899 0.0374831 0.0539634 0.078269 0.0390365 0.0458717 0.0345871 0.0242583 0.0133859 0.0218758 0.0670226 0.0493699 0.0408179 0.0292847 0.027716 0.0223669 0.0755877 0.0500766 0.0116847 0.00708937 0.00422967 0.00530022 0.00591139 0.00589001 0.00375389 0.00399978 0.00386919 0.00335381 0.00245213 0.00310374 0.00252294 0.00388428 0.00465622 0.0156045 0.00458426 0.0138626 0.0572125	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 and DRUG0 .
4	4	0.0278199 0.0411589 0.02626 0.0305331 0.0374327 0.053908 0.0781949 0.039006 0.0458443 0.0345673 0.024255 0.0133848 0.0218514 0.0666203 0.0486459 0.0394731 0.027891 0.0257919 0.0207043 0.0605539 0.0442199 0.0116184 0.00655256 0.00374012 0.00517037 0.00564285 0.00581133 0.00336248 0.00393635 0.00356219 0.00276713 0.00214425 0.00251104 0.00223551 0.00298305 0.00348039 0.00705544 0.0118021 0.0408502 0.0666579	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG1 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG2 .
4	4	0.0307535 0.0454061 0.0289016 0.0335247 0.0414471 0.0597317 0.0869224 0.0436683 0.0513853 0.0387439 0.0276191 0.0154904 0.0251282 0.0746427 0.0550773 0.0468467 0.0353733 0.0257521 0.0119488 0.0280617 0.0105919 0.00817992 0.00589079 0.0280382 0.00718039 0.00766284 0.0065521 0.0101278 0.00265423 0.00185249 0.0025127 0.00185763 0.00267253 0.00206219 0.00311538 0.0026489 0.00542479 0.00518464 0.0164014 0.0629643	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG1 , DRUG0 and DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0312708 0.046117 0.0293386 0.0339671 0.0421228 0.06058 0.087784 0.0436513 0.0508876 0.0382205 0.0268798 0.0148741 0.0240566 0.0702204 0.0502002 0.0425624 0.0279592 0.0194909 0.00941275 0.0251047 0.00910949 0.00478844 0.00326869 0.00899756 0.0103394 0.0570052 0.00801413 0.0110315 0.00312565 0.00204626 0.00270751 0.00202204 0.00291602 0.00222169 0.00339012 0.00282193 0.00571933 0.00517615 0.0171027 0.0634956	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG1 and DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0320929 0.0471918 0.0299393 0.0346515 0.0431182 0.061912 0.0896319 0.0446015 0.0518035 0.0387501 0.0274206 0.0152085 0.0246203 0.0712438 0.0496669 0.0399586 0.0275225 0.0190173 0.00861675 0.0142293 0.00437404 0.0023353 0.00120366 0.00184986 0.00136988 0.00258194 0.00166308 0.00267973 0.00198025 0.00159066 0.00280661 0.00234266 0.00489715 0.00531499 0.0248969 0.00739868 0.0107687 0.0161133 0.0544958 0.0781394	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 and DRUG2 .
4	4	0.029644 0.0435859 0.0276318 0.0319538 0.0398204 0.0570337 0.0823594 0.0406093 0.0468478 0.0349591 0.0244938 0.0134166 0.0218217 0.0631327 0.0433576 0.0351464 0.0222175 0.0147328 0.00694375 0.0142044 0.00502672 0.00255372 0.00132855 0.0020707 0.00150367 0.0028405 0.0018333 0.00308882 0.00213669 0.00169529 0.0030223 0.00222597 0.00435556 0.00394626 0.00938837 0.0148008 0.0904701 0.0199275 0.0580674 0.0758053	The sedative effect of DRUG0 is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly DRUG0 (eg , DRUG0 , DRUG0 and DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 and DRUG2 .
4	4	0.118689 0.116325 0.0772182 0.124804 0.0793233 0.0523043 0.0496023 0.0227818 0.0131133 0.0354635 0.00745311 0.00471118 0.00528795 0.00414241 0.00519287 0.00418204 0.00529523 0.0045969 0.00450226 0.00482018 0.00866786 0.0131368 0.00465535 0.00512665 0.00656366 0.0106828 0.0183417 0.0319554 0.0725698 0.088491	No significant adverse interactions with common premedications (such as DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and other DRUG2 ) or local DRUG0 have been observed .
4	4	0.118046 0.115539 0.0762184 0.123203 0.0773249 0.0506677 0.04552 0.0206607 0.0121034 0.0338428 0.0074768 0.00448104 0.00517491 0.0038461 0.00506398 0.00381558 0.00504874 0.00391749 0.00385676 0.00343263 0.0060806 0.0059793 0.0102258 0.0105684 0.0257456 0.0284754 0.0168733 0.0276496 0.0634177 0.0857446	No significant adverse interactions with common premedications (such as DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and other DRUG0 ) or local DRUG2 have been observed .
4	4	0.129568 0.119888 0.0789341 0.110379 0.0602026 0.0363509 0.0302599 0.0109177 0.00570524 0.00775813 0.00768272 0.0386834 0.00737813 0.00556723 0.00604615 0.00514219 0.0062121 0.00555546 0.0053871 0.00578347 0.00992933 0.0151173 0.0054562 0.00617424 0.00801071 0.013105 0.0223666 0.0392778 0.0896788 0.107483	No significant adverse interactions with common premedications (such as DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and other DRUG2 ) or local DRUG0 have been observed .
4	4	0.12707 0.117871 0.0774359 0.10941 0.0594348 0.0361548 0.0290236 0.0104957 0.00538 0.00699398 0.00735695 0.0370055 0.00713021 0.00515968 0.00573862 0.00462335 0.00578283 0.00467265 0.00454302 0.00407463 0.00704142 0.00702186 0.0118364 0.0123232 0.0303137 0.0337795 0.0200291 0.0332451 0.0771144 0.101939	No significant adverse interactions with common premedications (such as DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and other DRUG0 ) or local DRUG2 have been observed .
4	4	0.131347 0.119445 0.0776627 0.103385 0.0539066 0.0309236 0.0255245 0.00860409 0.00418305 0.00520397 0.00362596 0.00885662 0.00916838 0.0437201 0.00835971 0.00639834 0.00719345 0.00636218 0.00629309 0.00658046 0.0111294 0.0166707 0.00591481 0.00667283 0.00860966 0.0139831 0.0236876 0.0413564 0.0937218 0.11151	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and other DRUG2 ) or local DRUG0 have been observed .
4	4	0.128668 0.11721 0.0761088 0.102145 0.0530828 0.0306546 0.0244142 0.00825108 0.00391059 0.00475646 0.00340892 0.00795157 0.00882915 0.0418312 0.00806304 0.00586926 0.00672428 0.00537927 0.00531806 0.0045927 0.00802147 0.00782979 0.0130048 0.0132673 0.0323083 0.0357302 0.0211001 0.0349277 0.0807361 0.105906	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and other DRUG0 ) or local DRUG2 have been observed .
4	4	0.131911 0.119101 0.0768775 0.100529 0.051637 0.0291527 0.0235899 0.00766597 0.00361401 0.00437222 0.00268095 0.0054105 0.00427816 0.00996249 0.00991861 0.04745 0.00949714 0.00755655 0.00703979 0.00737288 0.0120371 0.0183527 0.00627241 0.00702762 0.00897601 0.0144046 0.0241438 0.0419007 0.0948183 0.112449	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and other DRUG2 ) or local DRUG0 have been observed .
4	4	0.128541 0.116146 0.074914 0.0987973 0.0507417 0.0288961 0.0226796 0.0073908 0.00338061 0.00402877 0.00251495 0.0049477 0.00407966 0.00913548 0.00984715 0.0465411 0.00900636 0.00654661 0.00599973 0.00509433 0.00898907 0.00854855 0.013989 0.0139819 0.0333744 0.0366054 0.0213997 0.0353234 0.0818821 0.106678	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and other DRUG0 ) or local DRUG2 have been observed .
4	4	0.131576 0.117262 0.0750772 0.0961565 0.0495211 0.0278182 0.0230174 0.00733994 0.0034844 0.00424268 0.00248918 0.00469348 0.00311904 0.00643617 0.00496392 0.0118795 0.0110481 0.0560548 0.00906582 0.00860753 0.0135706 0.0202088 0.00679471 0.00753771 0.00950191 0.014764 0.024411 0.0418325 0.0953251 0.1122	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and other DRUG2 ) or local DRUG0 have been observed .
4	4	0.127045 0.113698 0.0729836 0.0947278 0.0488322 0.027687 0.0221938 0.00710713 0.00324499 0.00388062 0.00230825 0.00425914 0.00294577 0.00595727 0.0048709 0.0110267 0.0111145 0.0536294 0.00783889 0.00594723 0.0105826 0.0095613 0.0155919 0.0150932 0.0343082 0.0373117 0.0215237 0.0353919 0.0829849 0.106352	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and other DRUG0 ) or local DRUG2 have been observed .
4	4	0.123278 0.110572 0.0702643 0.0925626 0.0471882 0.0263983 0.0193502 0.0058857 0.00277363 0.00325626 0.00197205 0.0032986 0.00218411 0.00375471 0.00246417 0.00446422 0.00323931 0.00631183 0.00446045 0.00682028 0.0148389 0.0689033 0.0262318 0.018925 0.0376443 0.040353 0.0235591 0.0374395 0.0849568 0.106649	No significant adverse interactions with common premedications (such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and other DRUG1 ) or local DRUG2 have been observed .
2	2	0.037694 0.0855417 0.0800708 0.0223112 0.0148437 0.00941922 0.00987834 0.0260147 0.00969703 0.00451228 0.00495459 0.00415168 0.00476162 0.00497622 0.00570328 0.00568361 0.0107118 0.020139 0.112644 0.0750086 0.089418 0.0548393 0.0960791 0.0768161 0.0506039 0.0835268	Other eye drops or medications such as DRUG1 ( DRUG0 ) and DRUG0 ( DRUG0 , DRUG0 ) may decrease the effects of DRUG2 ophthalmic .
4	4	0.0424882 0.0934768 0.0795581 0.02121 0.0145837 0.010958 0.00881039 0.0164772 0.0260252 0.0788534 0.0291412 0.0148798 0.0171075 0.0046392 0.00465915 0.00384433 0.00880422 0.0114085 0.0733909 0.0583089 0.0541739 0.0386161 0.0452597 0.0518815 0.0714425 0.120001	Other eye drops or medications such as DRUG0 ( DRUG1 ) and DRUG2 ( DRUG0 , DRUG0 ) may decrease the effects of DRUG0 ophthalmic .
2	2	0.0316471 0.07311 0.0653861 0.0161429 0.0105498 0.00621078 0.00500588 0.0110655 0.0140505 0.0357232 0.00897132 0.00488191 0.00470693 0.00490552 0.00574981 0.00555871 0.0108124 0.0204177 0.116343 0.0740999 0.0940133 0.0601584 0.102523 0.079041 0.0513602 0.0875649	Other eye drops or medications such as DRUG0 ( DRUG1 ) and DRUG0 ( DRUG0 , DRUG0 ) may decrease the effects of DRUG2 ophthalmic .
2	2	0.0332057 0.077398 0.0677818 0.0166548 0.0101734 0.00559385 0.003859 0.00584812 0.00581819 0.007929 0.00672178 0.00696451 0.0209742 0.00792388 0.00649806 0.00644313 0.0119703 0.0226075 0.122609 0.0745064 0.0919182 0.0583807 0.102391 0.0807925 0.0535798 0.0914571	Other eye drops or medications such as DRUG0 ( DRUG0 ) and DRUG1 ( DRUG0 , DRUG0 ) may decrease the effects of DRUG2 ophthalmic .
2	2	0.0295965 0.0704429 0.0638571 0.0155777 0.00923563 0.00528043 0.00359641 0.00544766 0.00524496 0.00713435 0.00581272 0.00576506 0.0155946 0.0215364 0.0545088 0.0112118 0.0149755 0.0259824 0.130838 0.0576407 0.0804891 0.0525059 0.0975974 0.0743407 0.0485512 0.0872366	Other eye drops or medications such as DRUG0 ( DRUG0 ) and DRUG0 ( DRUG1 , DRUG0 ) may decrease the effects of DRUG2 ophthalmic .
2	2	0.0276236 0.0641393 0.0574261 0.0133103 0.00813359 0.00460019 0.00312691 0.00459636 0.00419093 0.00541625 0.00400776 0.00366853 0.00670247 0.00572219 0.008977 0.0107408 0.056002 0.0266266 0.126452 0.074729 0.0940783 0.0609503 0.106854 0.0802148 0.0515243 0.090186	Other eye drops or medications such as DRUG0 ( DRUG0 ) and DRUG0 ( DRUG0 , DRUG1 ) may decrease the effects of DRUG2 ophthalmic .
2	2	0.0554094 0.0956111 0.0401133 0.046617 0.0443442 0.0285763 0.0448524 0.0431996 0.0482013 0.0909914 0.0781458 0.032573 0.00888299 0.0175716 0.0235537 0.0886142 0.0288938 0.0205619 0.0331973 0.0220283 0.0209872 0.02042 0.0666539	Oral DRUG1 has been reported to potentiate the anticoagulant effect of DRUG2 and DRUG0 , resulting in a prolongation of prothrombin time .
2	2	0.0593408 0.102149 0.0418805 0.04527 0.0454912 0.0265445 0.0418221 0.0344764 0.0368807 0.0592744 0.0470376 0.0288262 0.0301343 0.043197 0.0169632 0.0814526 0.0334357 0.0249838 0.0412612 0.0288442 0.026422 0.0254515 0.0788613	Oral DRUG1 has been reported to potentiate the anticoagulant effect of DRUG0 and DRUG2 , resulting in a prolongation of prothrombin time .
4	4	0.0270766 0.026612 0.0274357 0.0379197 0.0664655 0.0387175 0.0655393 0.0527053 0.0610839 0.0839145 0.0529444 0.0945577 0.0304867 0.0476348 0.0199653 0.074515 0.0304086 0.019921 0.0285044 0.020291 0.0185183 0.0183026 0.0564801	Oral DRUG0 has been reported to potentiate the anticoagulant effect of DRUG1 and DRUG2 , resulting in a prolongation of prothrombin time .
4	4	0.0207553 0.0138456 0.0117064 0.0128234 0.0185749 0.0196681 0.0348663 0.0358282 0.0336069 0.0174974 0.0182371 0.0449337 0.011857 0.0419426 0.0258129 0.0300671 0.02752 0.0198892 0.0171432 0.0136978 0.0171574 0.0239597 0.0183859 0.0167439 0.0538218 0.0235134 0.0120127 0.0192394 0.03642 0.0157887 0.0218275 0.0367535 0.0329596 0.0269849 0.0196005 0.0166206 0.0208308 0.0331928 0.0449613 0.0389524	Drug interactions should be kept in mind when DRUG1 ( DRUG0 gel) , 1% is prescribed for patients who are receiving anticoagulant treatment , although they are less likely to occur with topical DRUG2 administration because of low absorption .
4	4	0.102046 0.0543919 0.0445673 0.023656 0.0208556 0.0141763 0.0272885 0.0421689 0.0827877 0.089979 0.0471671 0.0589957 0.0299655 0.037262 0.0283015 0.034366 0.0361762 0.0492909 0.045185 0.131373	DRUG1 / DRUG2 : DRUG0 / DRUG0 does not influence the pharmacokinetics of DRUG0 in healthy volunteers (N= 10) .
4	4	0.0774021 0.0487007 0.0181661 0.0240291 0.0265806 0.0463094 0.0711444 0.0683439 0.0772857 0.0880957 0.0509877 0.0645893 0.0359402 0.03469 0.0259855 0.030785 0.0324279 0.0429227 0.0385482 0.0970658	DRUG1 / DRUG0 : DRUG0 / DRUG2 does not influence the pharmacokinetics of DRUG0 in healthy volunteers (N= 10) .
4	4	0.0370767 0.012348 0.00763432 0.00841942 0.0105311 0.00887045 0.0180866 0.031105 0.0680245 0.100192 0.117304 0.108278 0.0996551 0.0780305 0.0558069 0.0405959 0.0353246 0.041351 0.0352746 0.0860909	DRUG1 / DRUG0 : DRUG0 / DRUG0 does not influence the pharmacokinetics of DRUG2 in healthy volunteers (N= 10) .
4	4	0.0424999 0.0317113 0.0733486 0.0261385 0.0395171 0.0135803 0.0218961 0.0479612 0.0810503 0.092386 0.0550147 0.0733296 0.0382804 0.0394708 0.0285982 0.0358487 0.0377435 0.0505166 0.0461314 0.124977	DRUG0 / DRUG1 : DRUG2 / DRUG0 does not influence the pharmacokinetics of DRUG0 in healthy volunteers (N= 10) .
4	4	0.0239884 0.0145533 0.0294379 0.00895654 0.010146 0.00760524 0.016118 0.0286766 0.0653428 0.100184 0.118013 0.106971 0.0998733 0.0776781 0.0550312 0.0399828 0.034974 0.0411883 0.035269 0.0860118	DRUG0 / DRUG1 : DRUG0 / DRUG0 does not influence the pharmacokinetics of DRUG2 in healthy volunteers (N= 10) .
4	4	0.0225753 0.0128247 0.0179288 0.0263969 0.0743186 0.0676681 0.0511806 0.063184 0.0761671 0.104496 0.0590133 0.0693631 0.0397628 0.0365253 0.0269016 0.0326673 0.0335518 0.0445545 0.040166 0.100754	DRUG0 / DRUG0 : DRUG1 / DRUG2 does not influence the pharmacokinetics of DRUG0 in healthy volunteers (N= 10) .
4	4	0.0202909 0.0108154 0.0142944 0.0157445 0.0314041 0.0149752 0.0128715 0.0357022 0.0531397 0.0917783 0.0954072 0.093584 0.0932675 0.0717819 0.0590998 0.0488351 0.0463001 0.0521785 0.0424912 0.0960385	DRUG0 / DRUG0 : DRUG1 / DRUG0 does not influence the pharmacokinetics of DRUG2 in healthy volunteers (N= 10) .
4	4	0.0165992 0.00854644 0.0123297 0.0173421 0.0226049 0.0225038 0.0497581 0.0416398 0.0532363 0.0874653 0.086505 0.0879371 0.0887396 0.0683035 0.0565499 0.0467867 0.0448774 0.0515271 0.042112 0.0946361	DRUG0 / DRUG0 : DRUG0 / DRUG1 does not influence the pharmacokinetics of DRUG2 in healthy volunteers (N= 10) .
4	4	0.0609811 0.0106952 0.0197872 0.0140447 0.0110842 0.0118054 0.00764582 0.00410557 0.0133795 0.035277 0.0763265 0.121138 0.140938 0.132323 0.110484 0.107342 0.122642	DRUG1 : In healthy volunteers (N= 11) , DRUG0 did not influence the pharmacokinetics of DRUG2 .
4	4	0.0165047 0.0146412 0.0213676 0.0178329 0.0193204 0.0319045 0.0280627 0.00855699 0.0437722 0.0435277 0.0621588 0.116641 0.123522 0.127167 0.115593 0.100244 0.109185	DRUG0 : In healthy volunteers (N= 11) , DRUG1 did not influence the pharmacokinetics of DRUG2 .
4	4	0.0428532 0.0107259 0.0211942 0.0162602 0.0180922 0.0213348 0.00990197 0.028245 0.0358224 0.052269 0.0367006 0.0672395 0.0754786 0.0546722 0.127323 0.0976269 0.0741028 0.0583427 0.062749 0.0890658	DRUG1 : Population pharmacokinetic analysis suggests that DRUG0 is unlikely to alter the oral clearance of DRUG2 (N= 54) .
3	4	0.0130718 0.0131427 0.0219323 0.0218232 0.0419754 0.0699225 0.0447474 0.0698678 0.0359763 0.0373134 0.0337437 0.0525669 0.0689989 0.04741 0.085851 0.0879465 0.0675073 0.0529557 0.0582583 0.0749887	DRUG0 : Population pharmacokinetic analysis suggests that DRUG1 is unlikely to alter the oral clearance of DRUG2 (N= 54) .
4	4	0.0360198 0.011305 0.0183194 0.0128721 0.034143 0.058889 0.0348742 0.0251608 0.012699 0.0271922 0.02141 0.0159195 0.0129689 0.0152436 0.0179313 0.0181929 0.0282243 0.0239803 0.0132312 0.0142378 0.0644503 0.0356407 0.0573533 0.053844 0.0517415 0.0515271 0.0300708 0.0115931 0.0125175 0.0179754 0.0269786 0.0197621 0.0296629 0.0218254 0.0273088 0.0349341	DRUG1 : DRUG0 , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a 50% increase in DRUG2 AUC and a 40% increase in half-life (N= 12) .
3	3	0.0178974 0.0218895 0.05099 0.0138249 0.0270951 0.0411976 0.0307265 0.0292262 0.0139637 0.0222808 0.0197669 0.0154588 0.0134477 0.016393 0.0184746 0.0190262 0.0272794 0.0228576 0.0126012 0.0134796 0.0625143 0.0346175 0.0554914 0.0512481 0.0504358 0.0491597 0.028817 0.0111428 0.0122201 0.0180728 0.0278812 0.0205849 0.0323053 0.0247941 0.0319164 0.0409218	DRUG0 : DRUG1 , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a 50% increase in DRUG2 AUC and a 40% increase in half-life (N= 12) .
4	4	0.0478317 0.01468 0.0237089 0.0164417 0.0424043 0.0722836 0.0427089 0.0301069 0.0141335 0.0276004 0.0203128 0.0134675 0.0109239 0.0165062 0.0161189 0.0117416 0.0119311 0.0105684 0.00535601 0.0206274 0.0387989 0.0778558 0.0991891 0.0641507 0.0677408 0.0523166 0.0568838 0.0736103	DRUG1 : DRUG0 , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DRUG2 pharmacokinetics (N= 12) .
4	4	0.0213039 0.0256199 0.0595435 0.0161012 0.0314841 0.0468198 0.0353198 0.032853 0.0151104 0.0217953 0.0179881 0.0128103 0.0112531 0.0175822 0.0177082 0.0134696 0.0130077 0.0113125 0.00553197 0.0208203 0.0378115 0.0765448 0.102484 0.0662579 0.0709895 0.0564323 0.0619081 0.0801367	DRUG0 : DRUG1 , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DRUG2 pharmacokinetics (N= 12) .
3	3	0.0136913 0.0246199 0.043126 0.0200646 0.00567175 0.00763169 0.00569783 0.0106953 0.00985729 0.0159564 0.0233956 0.0104429 0.0177661 0.0217555 0.0146069 0.00945897 0.0108157 0.0367145 0.0226707 0.0204933 0.0238228 0.0174953 0.00562844 0.0024462 0.00232844 0.0115488 0.0021977 0.00186524 0.00172466 0.0017598 0.00171329 0.00178705 0.00177215 0.00198338 0.00210244 0.00263326 0.00279966 0.00413182 0.00789042 0.0155794 0.0554812 0.0373265 0.0195943 0.0302054 0.0396314 0.0335962 0.0203113 0.0243764 0.0339555 0.0155701 0.0223041 0.00707307 0.0164247 0.00672937 0.00535275 0.00475681 0.00465362 0.00148424 0.000710534 0.000613825 0.000804851 0.000617774 0.000873014 0.000645553 0.000947557 0.000698696 0.0011496 0.000741046 0.000970005 0.00225049 0.00257831 0.00839859 0.0214663 0.00564159 0.00360249 0.0113497 0.0116019 0.00787693 0.00829919 0.00605801 0.0156359 0.0104612 0.0112803 0.0275571	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0131139 0.0235829 0.0413028 0.0192056 0.00542991 0.00730119 0.00545221 0.0102264 0.00941833 0.0152253 0.0222604 0.00992181 0.0167935 0.0204894 0.0136922 0.00877131 0.0100042 0.0334795 0.0202442 0.0179623 0.0202658 0.0145897 0.00453579 0.00201899 0.00194037 0.00946861 0.00164641 0.0014626 0.00130168 0.00135683 0.00127127 0.00134022 0.00125908 0.0013826 0.00132494 0.00161649 0.00160951 0.00233245 0.00466209 0.00936277 0.0424347 0.0152949 0.0107901 0.0148178 0.0161536 0.0161982 0.0171342 0.0221343 0.0362605 0.0165922 0.0266832 0.0124406 0.0430646 0.0273054 0.0276971 0.0326761 0.0272099 0.00795711 0.00218416 0.0019793 0.00492032 0.000908577 0.000922396 0.000740053 0.000923638 0.000751741 0.00104055 0.000779228 0.00090808 0.00200034 0.0028326 0.00793198 0.0244367 0.00586947 0.00418533 0.0128068 0.0117251 0.00857435 0.00830733 0.00637119 0.0161177 0.011171 0.011865 0.0282767	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0131982 0.0237344 0.0415682 0.0193289 0.00546481 0.00734807 0.00548725 0.0102921 0.00947876 0.0153228 0.022402 0.00998487 0.0168991 0.020617 0.0137767 0.00882388 0.0100631 0.0336701 0.0203523 0.0180568 0.0203694 0.0146667 0.00455762 0.00203021 0.00195116 0.00951975 0.00165485 0.00147029 0.00130847 0.00136399 0.00127786 0.00134722 0.00126549 0.00138962 0.00133135 0.00162359 0.00161524 0.00233818 0.00466947 0.0093813 0.0425967 0.0153554 0.0108438 0.0148946 0.0163052 0.0164244 0.01739 0.0226645 0.0373935 0.017182 0.0276001 0.0130597 0.0448602 0.0278414 0.0260096 0.0313076 0.0231695 0.00503617 0.0013933 0.000965422 0.0013625 0.00136981 0.00376815 0.000773734 0.000888109 0.000736902 0.00101206 0.00075681 0.000880788 0.00193346 0.0027766 0.0081681 0.0250968 0.00602161 0.00430983 0.013186 0.0119766 0.0087457 0.00842076 0.00646133 0.0162177 0.0112913 0.0119745 0.0285765	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0132205 0.0237746 0.0416386 0.0193617 0.00547406 0.00736051 0.00549654 0.0103095 0.00949478 0.0153486 0.0224395 0.0100016 0.016927 0.0206507 0.013799 0.00883766 0.0100785 0.0337191 0.0203799 0.0180812 0.0203962 0.0146866 0.0045634 0.00203316 0.001954 0.00953309 0.00165698 0.00147232 0.00131023 0.00136588 0.00127958 0.00134907 0.00126716 0.00139147 0.00133302 0.00162544 0.00161665 0.00233947 0.00467033 0.00938303 0.042621 0.015361 0.0108518 0.0149106 0.0163337 0.0164706 0.0174293 0.0227539 0.0375669 0.0172631 0.0276777 0.0131031 0.0450184 0.0278304 0.0255446 0.0309348 0.0221995 0.0046065 0.00128526 0.00085178 0.00105765 0.000727725 0.00130874 0.00139517 0.00376803 0.00078963 0.00101325 0.000789629 0.000892257 0.00192616 0.00285365 0.00825998 0.025146 0.00606359 0.00439732 0.0134766 0.0120565 0.00880557 0.00841539 0.00646448 0.0162212 0.0113131 0.0119919 0.0286319	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0132473 0.0238228 0.0417228 0.0194008 0.00548514 0.0073754 0.00550766 0.0103303 0.00951397 0.0153796 0.0224847 0.0100217 0.0169608 0.0206917 0.0138263 0.00885487 0.0100979 0.0337833 0.0204173 0.018114 0.0204326 0.0147131 0.00457132 0.00203689 0.0019576 0.0095505 0.0016598 0.00147491 0.00131251 0.0013683 0.00128181 0.00135145 0.00126937 0.0013939 0.00133532 0.00162816 0.00161919 0.00234283 0.00467598 0.00939457 0.0426708 0.0153731 0.0108622 0.0149262 0.0163602 0.016506 0.0174501 0.0227819 0.0375974 0.0172957 0.0277132 0.0131699 0.0452297 0.0280412 0.0256041 0.0310333 0.0220026 0.00449418 0.00125031 0.000819592 0.00100756 0.000673454 0.00102114 0.000735194 0.00134206 0.00139921 0.004199 0.000880938 0.000898617 0.00181696 0.00291828 0.00783959 0.0246528 0.00603683 0.0044781 0.0136876 0.0119677 0.00876788 0.00823233 0.00632855 0.0159743 0.0112029 0.0119165 0.0284326	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.013141 0.0236317 0.0413882 0.0192452 0.00544115 0.00731624 0.00546349 0.0102475 0.00943767 0.0152563 0.0223045 0.00994136 0.016825 0.0205261 0.0137157 0.00878422 0.0100176 0.0335157 0.020256 0.0179704 0.02027 0.0145954 0.00453465 0.00202043 0.0019418 0.00947379 0.00164647 0.00146292 0.00130189 0.00135717 0.00127144 0.00134046 0.00125909 0.00138258 0.00132454 0.00161506 0.00160634 0.00232449 0.00463985 0.0093201 0.0423037 0.015238 0.0107617 0.0147811 0.0161868 0.016337 0.0172523 0.0224866 0.0370731 0.0170615 0.0272583 0.0128643 0.04404 0.02739 0.0250629 0.0300634 0.0211488 0.00439286 0.00123515 0.000798641 0.00098477 0.000652443 0.000982361 0.000678216 0.00105655 0.000744077 0.00133458 0.00118189 0.00273872 0.0072665 0.0034362 0.00931643 0.0251272 0.00641262 0.00492796 0.0150809 0.0124612 0.00903087 0.00851794 0.00659073 0.0164098 0.0114532 0.012016 0.0287496	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0127961 0.0230115 0.0403019 0.01874 0.00529832 0.00712415 0.00531999 0.0099782 0.00918955 0.0148548 0.0217171 0.00967995 0.0163823 0.019985 0.0133537 0.0085527 0.00975526 0.0326414 0.0197309 0.0175028 0.0197355 0.0142068 0.0044191 0.00196913 0.00189299 0.00923809 0.00160078 0.0014242 0.00126721 0.00132127 0.00123796 0.00130542 0.00122682 0.00134752 0.0012924 0.00157735 0.00157255 0.00227611 0.00452826 0.0090535 0.040663 0.0144714 0.010212 0.0139986 0.0148083 0.0147268 0.0148298 0.0180895 0.0276831 0.0125154 0.0170741 0.00578774 0.0170274 0.00613494 0.00499311 0.00529281 0.00498044 0.00157557 0.000734575 0.000616495 0.000820269 0.000613619 0.000904065 0.00064877 0.000992557 0.00071372 0.00122785 0.000765487 0.00104324 0.00251282 0.00290853 0.00981692 0.0266473 0.0079777 0.00574736 0.0186971 0.0196649 0.0207315 0.0315188 0.0226631 0.0563655 0.0412826 0.0390726 0.04204	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
3	3	0.0139028 0.0249984 0.0437892 0.0203692 0.0057553 0.00774047 0.00577265 0.010833 0.00998213 0.0161367 0.0236373 0.0105058 0.0178164 0.0216107 0.0144897 0.00935297 0.0107269 0.0364226 0.021669 0.0188737 0.0209579 0.0150349 0.00419388 0.00173703 0.0013785 0.00220328 0.0019538 0.00888718 0.00169377 0.0017879 0.00160936 0.00177227 0.00169699 0.00195712 0.00200471 0.00261589 0.00271427 0.00394777 0.00770672 0.0151986 0.0611682 0.0389063 0.0201747 0.0316506 0.0396003 0.0339178 0.0204769 0.0243604 0.0340559 0.015571 0.0222235 0.00707383 0.016612 0.00680716 0.00542546 0.00482954 0.00472386 0.0015067 0.000721238 0.000623085 0.000816871 0.000626939 0.000886165 0.000655188 0.000961958 0.000709226 0.00116726 0.000752317 0.00098483 0.00228511 0.00261685 0.00852873 0.0218113 0.00573525 0.00366127 0.0115353 0.0117955 0.00800817 0.0084388 0.00615776 0.0158924 0.0106331 0.0114678 0.0280066	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0134878 0.0242533 0.0424771 0.0197453 0.00558001 0.00749874 0.00559404 0.0104881 0.00965775 0.0155938 0.0227735 0.0101142 0.017077 0.0206825 0.0138074 0.00882108 0.0100917 0.0336094 0.0195193 0.0165762 0.0177173 0.0124949 0.0033517 0.00141998 0.00110127 0.00176081 0.00162655 0.00719125 0.00131619 0.00141016 0.00122222 0.00135956 0.00123187 0.00140218 0.00129967 0.0016562 0.00157879 0.002265 0.00460215 0.00899036 0.045793 0.0159764 0.0111636 0.0147634 0.0152858 0.0160777 0.0165167 0.0202421 0.0341486 0.0160419 0.0263937 0.0123437 0.0439139 0.0276519 0.0280309 0.0335312 0.0277996 0.00817475 0.00224893 0.00204428 0.00509059 0.000936346 0.000949233 0.000761529 0.00095102 0.00077371 0.00107146 0.00080214 0.000934941 0.0020607 0.00291754 0.00815797 0.0251463 0.00602187 0.00429406 0.0132033 0.012068 0.00881538 0.00854025 0.00655094 0.0165902 0.0114872 0.0121986 0.0290886	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135758 0.0244116 0.0427543 0.0198741 0.00561642 0.00754764 0.00563054 0.0105565 0.00972067 0.0156952 0.0229209 0.0101796 0.0171865 0.0208144 0.0138949 0.00887558 0.010153 0.0338058 0.0196279 0.0166674 0.0178121 0.0125635 0.00336837 0.00142793 0.00110693 0.0017692 0.0016358 0.00723109 0.0013234 0.0014179 0.00122888 0.00136698 0.00123844 0.00140962 0.00130624 0.00166389 0.001585 0.00227182 0.0046128 0.00901216 0.04598 0.0160497 0.0112298 0.0148582 0.0154454 0.016311 0.0167628 0.0207355 0.035232 0.0166114 0.0273257 0.0129851 0.0457739 0.0281805 0.0263168 0.0321164 0.0236643 0.00518171 0.00143924 0.000998374 0.00140673 0.0014138 0.00388526 0.000796552 0.000915533 0.000759645 0.00104377 0.000780268 0.000908071 0.00199459 0.00286454 0.0084123 0.0258494 0.00618432 0.00442687 0.0136067 0.0123356 0.00899819 0.00866342 0.0066482 0.0167033 0.0116172 0.0123183 0.0294084	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135991 0.0244535 0.0428276 0.0199081 0.00562605 0.00756056 0.00564019 0.0105746 0.00973729 0.015722 0.0229597 0.0101969 0.0172153 0.0208492 0.0139179 0.00888982 0.0101689 0.0338563 0.0196557 0.016691 0.0178368 0.0125813 0.00337288 0.00143006 0.00110844 0.00177149 0.00163823 0.00724139 0.00132525 0.00141992 0.0012306 0.00136891 0.00124013 0.00141155 0.00130793 0.00166585 0.00158647 0.0022733 0.00461431 0.00901409 0.0460071 0.0160577 0.011241 0.014879 0.0154768 0.0163598 0.0168024 0.0208185 0.0353982 0.0166904 0.027409 0.0130338 0.0459395 0.0281659 0.0258476 0.0317327 0.0226697 0.00474023 0.00132837 0.00088085 0.00109093 0.000750712 0.00134997 0.00143849 0.00388163 0.000812937 0.00104501 0.00081422 0.000920052 0.00198738 0.0029443 0.00850755 0.0259013 0.00622835 0.00451766 0.0139071 0.0124173 0.00906027 0.00865849 0.00665171 0.0167057 0.0116397 0.0123368 0.0294649	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0136268 0.0245033 0.0429147 0.0199486 0.0056375 0.00757593 0.00565167 0.0105961 0.00975709 0.0157539 0.0230062 0.0102175 0.01725 0.020891 0.0139457 0.00890733 0.0101888 0.0339213 0.0196922 0.0167217 0.0178688 0.0126039 0.00337873 0.00143266 0.0011104 0.00177451 0.00164124 0.0072545 0.00132758 0.00142242 0.00123277 0.00137132 0.0012423 0.00141401 0.0013102 0.00166864 0.00158901 0.00227673 0.00462026 0.00902537 0.0460617 0.0160714 0.0112539 0.0148989 0.0155073 0.0163996 0.0168258 0.0208479 0.0354333 0.0167245 0.0274493 0.0131036 0.0461603 0.0283824 0.0259127 0.0318351 0.0224675 0.00462443 0.00129222 0.000847474 0.00103915 0.000694704 0.00105325 0.000757993 0.00138392 0.00144272 0.00432583 0.000907192 0.000926515 0.00187541 0.0030114 0.00807904 0.0253926 0.00620124 0.0046007 0.0141226 0.0123231 0.00902084 0.00846971 0.0065113 0.0164475 0.0115255 0.0122586 0.0292572	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135146 0.0243017 0.0425617 0.0197845 0.00559111 0.0075136 0.00560517 0.0105089 0.00967683 0.0156244 0.022817 0.0101335 0.0171082 0.0207193 0.0138312 0.00883429 0.0101055 0.033645 0.0195317 0.0165846 0.0177215 0.0124994 0.0033505 0.00142065 0.0011011 0.00175961 0.00162753 0.00719437 0.0013165 0.00141048 0.00122246 0.00135981 0.00123193 0.00140217 0.00129931 0.00165484 0.00157607 0.00225849 0.00458345 0.00895217 0.0456555 0.0159263 0.0111477 0.0147536 0.0153432 0.0162323 0.0166356 0.0205773 0.0349396 0.0164984 0.0269964 0.0127965 0.0449462 0.027724 0.0253678 0.0308345 0.021588 0.00451654 0.00127614 0.000825493 0.0010154 0.000672851 0.00101295 0.000699099 0.00108916 0.000766933 0.0013754 0.00121846 0.00282218 0.00748479 0.00353333 0.00957284 0.0258349 0.00658175 0.00506025 0.015533 0.0128166 0.00928284 0.00875753 0.00677689 0.0168815 0.0117756 0.0123538 0.0295657	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0131097 0.0235736 0.0412864 0.0191915 0.0054236 0.00728842 0.00543715 0.0101938 0.00938644 0.015155 0.0221308 0.00982879 0.0165925 0.0200926 0.0134123 0.00856654 0.00980091 0.0326361 0.0189464 0.0160859 0.0171818 0.0121181 0.00325367 0.0013792 0.00106995 0.00170898 0.00158013 0.00698255 0.00127582 0.00136657 0.00118508 0.00131784 0.00119498 0.00135997 0.00126226 0.00160829 0.00153529 0.00219974 0.00444622 0.00863764 0.0436869 0.0150454 0.0105177 0.0138755 0.0139453 0.0145523 0.0142882 0.0164172 0.0257881 0.0120251 0.0167512 0.00569952 0.0172118 0.00617492 0.00505315 0.00541258 0.00509235 0.00161658 0.000752678 0.000630627 0.000839353 0.000628096 0.000926638 0.000664429 0.00101768 0.000731191 0.00125933 0.00078451 0.00106946 0.00257855 0.00298252 0.0100403 0.0273262 0.00816862 0.00588778 0.0192148 0.0201946 0.0212593 0.0323577 0.0232587 0.0578584 0.0423628 0.040096 0.0431533	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
3	3	0.0140895 0.025333 0.0443754 0.0206353 0.00582915 0.00783811 0.00584254 0.0109589 0.0100951 0.0163049 0.0238686 0.0105793 0.017913 0.0216511 0.0144947 0.0093305 0.0107391 0.0363265 0.0211179 0.0179606 0.0192263 0.0133078 0.00356033 0.00149358 0.00110555 0.00152775 0.00123102 0.00253142 0.00214257 0.00907188 0.00175817 0.00193646 0.00178037 0.00206136 0.00209495 0.00270177 0.00280056 0.00404272 0.00793359 0.0153918 0.0610586 0.0389481 0.020186 0.031936 0.0396268 0.0336162 0.0202996 0.024246 0.0340332 0.0155616 0.0222404 0.00709539 0.0167824 0.00687743 0.0054836 0.00488849 0.00478856 0.00152775 0.000731206 0.000631633 0.000828028 0.000635452 0.00089827 0.000664058 0.000975093 0.000718839 0.00118321 0.00076252 0.000998213 0.00231602 0.0026521 0.00864495 0.0221138 0.00581749 0.00371341 0.0116988 0.0119649 0.00812408 0.00856168 0.0062462 0.0161194 0.0107851 0.0116333 0.028403	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0136931 0.0246218 0.0431231 0.0200384 0.00566166 0.00760686 0.00567175 0.0106292 0.00978587 0.0157899 0.02305 0.0102171 0.0172374 0.0208247 0.0138876 0.00885489 0.0101639 0.033713 0.0191482 0.0158679 0.0163512 0.0111639 0.00284413 0.00124033 0.000908689 0.00122721 0.000990108 0.00201264 0.00175749 0.00730082 0.00135079 0.00149774 0.00131165 0.00149599 0.00138795 0.00173374 0.00165391 0.00233493 0.00478055 0.00906467 0.0453015 0.0156858 0.0110316 0.014636 0.0149627 0.016008 0.0162799 0.0196341 0.0334361 0.0158814 0.0262982 0.0123404 0.0441706 0.0278209 0.028187 0.0337802 0.0280052 0.00824922 0.00227172 0.00206632 0.00515499 0.000948937 0.000962078 0.000771752 0.000963794 0.000784033 0.00108575 0.000812822 0.000947406 0.00208814 0.00295653 0.00826565 0.0254928 0.00610499 0.00435336 0.0133885 0.0122403 0.00894134 0.00866219 0.00664545 0.0168328 0.0116559 0.0123768 0.0295222	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.013783 0.0247835 0.0434062 0.0201699 0.00569883 0.00765675 0.00570898 0.010699 0.00985001 0.0158932 0.0232002 0.0102837 0.017349 0.0209591 0.0139767 0.00891044 0.0102266 0.0339136 0.0192578 0.0159583 0.0164428 0.011228 0.00285871 0.00124758 0.000913805 0.0012336 0.000995302 0.00202224 0.00176739 0.00734164 0.0013582 0.00150594 0.00131873 0.00150401 0.00139512 0.00174203 0.00166085 0.00234245 0.00479245 0.00908881 0.0454929 0.0157606 0.0110997 0.014736 0.0151246 0.0162439 0.0165234 0.020116 0.0345041 0.0164464 0.0272302 0.0129854 0.0460405 0.0283465 0.0264604 0.0323531 0.0238361 0.00522946 0.00145466 0.0010105 0.00142592 0.00143344 0.00393885 0.000807439 0.000928066 0.00076998 0.00105796 0.000790841 0.000920371 0.00202163 0.00290363 0.00852554 0.0262091 0.00627075 0.00448884 0.0138003 0.012514 0.00912857 0.00878889 0.00674532 0.0169504 0.0117897 0.0125005 0.0298509	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0138065 0.0248258 0.0434803 0.0202043 0.00570855 0.0076698 0.00571872 0.0107172 0.00986677 0.0159202 0.0232393 0.0103011 0.017378 0.0209941 0.0139999 0.0089248 0.0102428 0.0339647 0.0192855 0.0159815 0.0164664 0.0112445 0.00286262 0.0012495 0.000915168 0.00123534 0.000996681 0.00202481 0.00176996 0.00735204 0.00136006 0.00150803 0.00132053 0.00150606 0.00139693 0.0017441 0.00166247 0.00234404 0.00479407 0.009091 0.0455195 0.0157685 0.0111111 0.0147579 0.0151564 0.0162932 0.0165629 0.020197 0.0346679 0.0165248 0.0273139 0.0130348 0.046207 0.0283307 0.0259884 0.0319663 0.0228331 0.00478375 0.00134268 0.000891676 0.00110584 0.00076119 0.00136874 0.00145843 0.00393538 0.000824082 0.00105931 0.000825307 0.000932571 0.00201438 0.00298454 0.00862221 0.0262621 0.00631557 0.0045811 0.0141056 0.0125976 0.009192 0.00878433 0.00674919 0.0169535 0.011813 0.0125198 0.029909	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0138346 0.0248763 0.0435687 0.0202454 0.00572015 0.00768538 0.00573034 0.010739 0.0098868 0.0159525 0.0232863 0.0103219 0.017413 0.0210362 0.0140279 0.00894242 0.0102628 0.0340301 0.0193215 0.016011 0.0164962 0.011265 0.0028676 0.00125181 0.00091684 0.00123751 0.000998443 0.00202824 0.00177318 0.00736537 0.00136244 0.00151066 0.00132283 0.00150868 0.00139935 0.00174704 0.00166516 0.00234761 0.0048003 0.00910257 0.0455738 0.0157821 0.0111242 0.0147787 0.0151875 0.0163339 0.0165869 0.0202267 0.0347044 0.0165593 0.0273555 0.0131055 0.0464305 0.0285492 0.0260549 0.0320703 0.0226297 0.00466686 0.00130613 0.000857887 0.00105336 0.000704405 0.00106791 0.000768527 0.00140307 0.00146269 0.00438573 0.000919636 0.000939189 0.00190096 0.00305258 0.00818828 0.0257467 0.00628815 0.00466537 0.0143247 0.0125026 0.00915246 0.00859333 0.0066071 0.0166923 0.0116976 0.012441 0.0296993	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0137185 0.0246674 0.0432029 0.0200754 0.00567213 0.00762086 0.00568223 0.0106488 0.00980383 0.0158186 0.023091 0.0102353 0.017267 0.0208598 0.0139103 0.00886757 0.0101771 0.033747 0.0191605 0.0158768 0.0163569 0.0111693 0.00284307 0.00124108 0.000908984 0.00122686 0.000989903 0.00201085 0.00175808 0.00730313 0.00135086 0.00149775 0.00131157 0.0014958 0.00138748 0.00173228 0.00165128 0.0023284 0.00476131 0.00902733 0.0451658 0.0156374 0.0110178 0.0146325 0.0150248 0.0161652 0.016397 0.0199612 0.0342151 0.0163328 0.0268992 0.0127956 0.0452021 0.0278829 0.025504 0.0310574 0.0217401 0.00455718 0.00128969 0.000835484 0.00102911 0.000682125 0.00102685 0.000708681 0.00110402 0.000777409 0.00139407 0.00123501 0.0028605 0.00758631 0.00358105 0.00969981 0.0261926 0.00667333 0.00513091 0.0157533 0.0130014 0.00941658 0.00888378 0.00687543 0.0171295 0.0119489 0.0125348 0.0300063	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0132782 0.0238759 0.0418164 0.019431 0.00549011 0.00737622 0.0054998 0.0103067 0.00948868 0.0153095 0.0223468 0.00990535 0.0167088 0.0201828 0.0134584 0.00857903 0.00984775 0.0326595 0.0185413 0.0153608 0.0158181 0.0108025 0.00275477 0.00120208 0.000881192 0.00118947 0.000959861 0.00194846 0.00170363 0.00707351 0.00130654 0.00144824 0.00126927 0.00144741 0.0013444 0.00167927 0.00160384 0.0022617 0.00460651 0.0086877 0.0430997 0.0147309 0.0103645 0.0137138 0.0136085 0.014451 0.0140677 0.015881 0.025152 0.0118644 0.0166345 0.0056796 0.0172762 0.00620178 0.00508006 0.00545547 0.0051425 0.0016348 0.000761034 0.000637499 0.000848497 0.000634962 0.000936816 0.000671688 0.00102887 0.000739198 0.00127326 0.000793144 0.00108122 0.00260712 0.00301535 0.0101488 0.0276397 0.00826391 0.00595602 0.0194426 0.020438 0.0215153 0.0327513 0.0235435 0.0585824 0.0428946 0.0405974 0.0437083	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
3	3	0.0141999 0.0255315 0.0447231 0.0207902 0.00587199 0.00789445 0.00588263 0.0110306 0.0101596 0.0164003 0.0240021 0.0106181 0.0179652 0.0216802 0.0145034 0.00932461 0.010757 0.036294 0.0209244 0.0176273 0.0185521 0.0125552 0.00324788 0.00138321 0.00100726 0.00134716 0.00101759 0.0016941 0.00133865 0.00273421 0.00228721 0.00962363 0.00192592 0.00222227 0.00214417 0.00282082 0.00289655 0.00417055 0.00821115 0.0156275 0.0609094 0.0389241 0.0201147 0.0319906 0.0394952 0.0331671 0.0200129 0.0240131 0.0338327 0.0154806 0.0221591 0.00708392 0.0168674 0.00691212 0.00551219 0.00492087 0.00482727 0.00154046 0.000737194 0.000636741 0.000834696 0.000640528 0.000905501 0.000669336 0.000982933 0.000724561 0.00119273 0.000768591 0.00100619 0.00233436 0.00267306 0.00871445 0.0222963 0.00586796 0.00374533 0.0117985 0.0120687 0.00819556 0.0086376 0.00630057 0.0162585 0.0108784 0.0117351 0.028645	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0138172 0.0248451 0.0435149 0.0202138 0.00571043 0.00767135 0.00571802 0.010713 0.0098624 0.0159075 0.0232193 0.0102775 0.0173365 0.0209264 0.0139513 0.00889216 0.0102254 0.0338418 0.0190743 0.0156602 0.0159004 0.0106783 0.00262931 0.00116304 0.000840147 0.00109117 0.000839874 0.00135557 0.0010671 0.00217568 0.00184538 0.00767147 0.00144203 0.0016426 0.00146594 0.00182665 0.00174672 0.0024208 0.00500729 0.00923076 0.0451175 0.0154544 0.0108713 0.0144736 0.0146469 0.0158652 0.0159815 0.0191297 0.0327905 0.0157065 0.0261269 0.0122932 0.0441852 0.0278492 0.0281976 0.0338219 0.028046 0.00827053 0.00227961 0.00207443 0.00518496 0.000955723 0.000969175 0.000777357 0.000970753 0.000789646 0.00109346 0.000818594 0.000954131 0.00210276 0.00297739 0.00832289 0.0256826 0.00615231 0.00438723 0.0134902 0.0123378 0.00901354 0.0087321 0.00670004 0.0169733 0.0117546 0.0124809 0.0297781	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139081 0.0250087 0.0438013 0.0203467 0.00574801 0.00772179 0.00575564 0.0107835 0.00992721 0.0160119 0.0233711 0.0103447 0.0174493 0.0210622 0.0140414 0.00894844 0.0102891 0.0340455 0.0191854 0.0157513 0.0159921 0.0107416 0.00264332 0.00117 0.000845019 0.00109702 0.000844619 0.00136265 0.00107258 0.0021861 0.00185563 0.00771447 0.00144979 0.00165137 0.0014736 0.00183548 0.0017544 0.00242885 0.00502022 0.00925694 0.0453126 0.0155295 0.0109397 0.0145765 0.014809 0.0161012 0.0162208 0.0196011 0.033842 0.0162655 0.0270535 0.0129375 0.0460524 0.0283704 0.0264671 0.0323902 0.0238671 0.00524264 0.00146015 0.00101586 0.00143613 0.00144406 0.0039678 0.000813415 0.000934865 0.000775558 0.00106557 0.000796517 0.000926971 0.00203599 0.00292449 0.00858575 0.0264054 0.00631974 0.00452408 0.0139066 0.0126153 0.00920346 0.00886097 0.00680148 0.0170936 0.0118909 0.0126073 0.0301126	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139317 0.025051 0.0438754 0.0203811 0.00575773 0.00773484 0.00576537 0.0108017 0.00994397 0.0160388 0.0234103 0.0103621 0.0174783 0.0210972 0.0140646 0.00896284 0.0103053 0.0340968 0.0192132 0.0157744 0.0160155 0.0107577 0.00264703 0.00117182 0.000846299 0.00109858 0.000845866 0.00136454 0.00107401 0.00218886 0.00185825 0.0077253 0.00145171 0.00165357 0.0014755 0.00183766 0.00175616 0.00243049 0.00502192 0.00925932 0.0453385 0.015537 0.0109509 0.0145987 0.0148406 0.0161504 0.0162597 0.0196801 0.034003 0.016343 0.0271366 0.012987 0.0462184 0.0283537 0.0259946 0.0320025 0.0228617 0.0047955 0.00134776 0.000896542 0.00111386 0.000766938 0.00137903 0.00146933 0.00396486 0.000830208 0.001067 0.000831265 0.000939298 0.00202871 0.003006 0.00868316 0.0264591 0.006365 0.00461715 0.0142149 0.0127001 0.00926779 0.00885675 0.00680565 0.0170974 0.0119147 0.012627 0.0301718	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139599 0.0251017 0.0439642 0.0204224 0.00576939 0.00775049 0.00577704 0.0108236 0.00996408 0.0160712 0.0234575 0.010383 0.0175134 0.0211394 0.0140927 0.00898052 0.0103255 0.0341624 0.0192491 0.0158036 0.0160445 0.0107774 0.00265166 0.00117399 0.000847857 0.00110053 0.000847407 0.00136693 0.00107588 0.00219254 0.0018616 0.00773929 0.00145423 0.00165642 0.00147804 0.00184075 0.00175902 0.00243419 0.00502844 0.0092712 0.0453924 0.0155501 0.0109639 0.0146198 0.0148717 0.0161915 0.0162837 0.0197098 0.0340401 0.0163775 0.0271787 0.0130579 0.0464428 0.0285726 0.0260615 0.0321071 0.0226583 0.0046783 0.00131106 0.000862569 0.001061 0.000709725 0.00107593 0.000774327 0.00141355 0.00147359 0.00441856 0.00092645 0.000946019 0.00191448 0.00307451 0.0082461 0.0259401 0.00633741 0.00470217 0.0144365 0.0126052 0.00922844 0.00866472 0.00666281 0.0168353 0.0117989 0.0125483 0.0299617	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.013841 0.024888 0.0435898 0.0202485 0.00572025 0.00768449 0.00572785 0.0107314 0.00987926 0.0159345 0.0232579 0.0102946 0.0173644 0.0209595 0.0139728 0.00890423 0.010238 0.0338739 0.0190861 0.015669 0.0159068 0.0106844 0.00262861 0.00116378 0.000840484 0.00109091 0.000840039 0.001355 0.00106654 0.00217347 0.00184556 0.00767302 0.00144171 0.0016421 0.00146533 0.00182498 0.00174412 0.00241399 0.00498703 0.0091935 0.0449819 0.0154062 0.0108581 0.0144736 0.0147109 0.0160225 0.0160955 0.0194488 0.0335557 0.0161513 0.0267217 0.0127473 0.0452086 0.0279026 0.0255082 0.0310897 0.0217651 0.00456794 0.00129443 0.000839935 0.00103645 0.00068718 0.00103442 0.000713918 0.00111209 0.000783125 0.00140419 0.00124393 0.00288111 0.00764113 0.00360727 0.00976838 0.0263921 0.00672571 0.00517134 0.0158768 0.0131077 0.009494 0.00895671 0.00693271 0.0172743 0.0120507 0.0126409 0.0302672	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0133729 0.0240462 0.0421153 0.0195634 0.00552678 0.0074245 0.00553404 0.010368 0.00954455 0.0153939 0.0224677 0.0099448 0.0167725 0.0202423 0.013494 0.00859854 0.00988842 0.0327215 0.0184334 0.0151291 0.0153501 0.0103116 0.00254149 0.00112498 0.000813194 0.00105577 0.000813075 0.00131155 0.00103249 0.0021025 0.00178603 0.00742143 0.00139282 0.00158612 0.00141712 0.00176572 0.00169002 0.00233979 0.00481504 0.00882969 0.0428252 0.0144797 0.0101908 0.0135282 0.0132884 0.0142915 0.0137953 0.0154426 0.0245979 0.011702 0.0164843 0.00564405 0.0172639 0.00620191 0.00508109 0.00546757 0.00516479 0.00164366 0.000765071 0.000640813 0.000852884 0.000638266 0.000941615 0.000675147 0.00103411 0.000742999 0.00127976 0.000797233 0.00108676 0.00262041 0.00303107 0.0102016 0.0277934 0.00831264 0.00599075 0.0195555 0.020561 0.0216482 0.0329521 0.0236909 0.0589634 0.0431767 0.0408626 0.0440093	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
3	3	0.0142309 0.0255876 0.0448216 0.0208314 0.00588311 0.0079087 0.00589201 0.0110465 0.0101743 0.0164206 0.0240339 0.0106209 0.0179646 0.0216659 0.0144894 0.00931077 0.0107589 0.0362561 0.0208387 0.0174786 0.0182559 0.012214 0.0030934 0.00132249 0.000953359 0.00124827 0.000940607 0.00148819 0.00108784 0.00183379 0.00139609 0.00285846 0.00252133 0.010892 0.00228586 0.00300592 0.00296286 0.00430821 0.00858395 0.0160574 0.06135 0.0392054 0.0201285 0.0319701 0.0393813 0.0327307 0.0197119 0.0237479 0.0335343 0.0153611 0.0219965 0.0070415 0.0168641 0.00690976 0.0055101 0.0049255 0.00483874 0.00154446 0.00073905 0.000638285 0.000836732 0.00064206 0.000907733 0.000670923 0.00098535 0.000726287 0.00119567 0.000770422 0.00100861 0.00233988 0.00267938 0.00873577 0.0223543 0.00588517 0.00375611 0.0118322 0.0121045 0.00822063 0.00866449 0.00631929 0.0163058 0.0109101 0.0117704 0.0287248	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0138612 0.0249247 0.043655 0.0202748 0.00572722 0.00769351 0.00573335 0.0107406 0.00988836 0.0159481 0.023285 0.010297 0.0173729 0.020968 0.0139821 0.0089163 0.0102662 0.0339583 0.0191081 0.0156339 0.0157932 0.0105446 0.00255317 0.00112689 0.000809264 0.00103153 0.000787612 0.001208 0.00089071 0.00146544 0.00111437 0.00228223 0.00197115 0.00840947 0.00161585 0.00197361 0.00185348 0.00251943 0.00533026 0.00961885 0.0458717 0.0154648 0.0107996 0.0143784 0.0144322 0.0157224 0.0156633 0.0187215 0.0322117 0.015528 0.025902 0.0122081 0.0440081 0.0277577 0.028084 0.0336914 0.0279426 0.00824591 0.00227478 0.00207093 0.00518713 0.000957886 0.000971616 0.000779211 0.00097305 0.000791447 0.00109592 0.000820387 0.000956205 0.00210707 0.00298364 0.00833914 0.0257389 0.00616876 0.00439932 0.013523 0.0123715 0.00903965 0.00875762 0.00671988 0.0170243 0.0117909 0.0125196 0.0298708	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139522 0.0250884 0.0439417 0.0204078 0.00576482 0.00774398 0.00577098 0.0108111 0.0099532 0.0160526 0.0234371 0.0103642 0.0174858 0.0211041 0.0140725 0.00897291 0.0103303 0.0341636 0.0192204 0.0157259 0.0158858 0.0106081 0.00256712 0.0011337 0.000814031 0.0010372 0.000792136 0.00121444 0.000895666 0.00147306 0.00112003 0.00229321 0.00198185 0.00845631 0.00162422 0.00198319 0.00186191 0.00252788 0.00534406 0.00964692 0.0460716 0.0155395 0.0108675 0.0144823 0.0145937 0.0159574 0.0158972 0.0191831 0.0332454 0.0160798 0.0268193 0.0128483 0.0458629 0.0282732 0.0263567 0.032261 0.0237746 0.00522624 0.00145733 0.00101578 0.00143917 0.00144741 0.00397657 0.000815381 0.000937032 0.000777283 0.00106792 0.000798231 0.00092896 0.00204018 0.00293073 0.00860307 0.0264636 0.00633684 0.00453668 0.0139415 0.0126509 0.00923104 0.00888771 0.00682215 0.0171463 0.0119285 0.0126473 0.0302083	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139756 0.0251305 0.0440154 0.020442 0.00577449 0.00775696 0.00578066 0.0108292 0.00996986 0.0160794 0.023476 0.0103815 0.0175147 0.021139 0.0140956 0.00898733 0.0103466 0.0342151 0.0192485 0.0157491 0.0159092 0.0106242 0.00257078 0.00113547 0.000815272 0.0010387 0.000793313 0.00121615 0.000896958 0.00147509 0.0011215 0.00229611 0.00198456 0.00846805 0.00162625 0.00198551 0.00186382 0.00252954 0.00534577 0.0096494 0.0460966 0.0155462 0.0108783 0.0145046 0.0146248 0.0160062 0.0159352 0.0192604 0.0334037 0.0161561 0.0269013 0.0128975 0.0460272 0.0282557 0.0258856 0.0318739 0.0227718 0.00478013 0.00134513 0.000896601 0.00111631 0.000768855 0.00138254 0.00147289 0.00397433 0.000832227 0.0010694 0.000833074 0.000941344 0.00203292 0.00301242 0.00870071 0.0265179 0.00638234 0.00463009 0.014251 0.0127365 0.00929585 0.00888372 0.0068265 0.0171505 0.0119526 0.0126674 0.0302681	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0140038 0.0251811 0.044104 0.0204832 0.00578612 0.00777257 0.0057923 0.010851 0.00998992 0.0161117 0.0235231 0.0104023 0.0175497 0.0211811 0.0141237 0.00900501 0.0103667 0.0342808 0.0192844 0.0157782 0.0159382 0.0106437 0.00257531 0.00113757 0.000816776 0.00104055 0.000794761 0.00121829 0.000898571 0.00147766 0.00112343 0.00229997 0.00198812 0.00848345 0.00162903 0.00198883 0.00186686 0.00253335 0.00535265 0.00966172 0.0461507 0.0155589 0.010891 0.0145255 0.0146557 0.0160472 0.0159589 0.0192898 0.0334408 0.0161903 0.0269435 0.0129682 0.0462512 0.028474 0.0259525 0.0319787 0.0225694 0.00466324 0.00130848 0.000862621 0.00106333 0.00071148 0.00107863 0.000776277 0.0014171 0.00147712 0.00442906 0.000928663 0.000948111 0.00191844 0.00308099 0.00826252 0.0259982 0.00635476 0.00471544 0.014474 0.0126422 0.00925671 0.00869143 0.00668348 0.0168884 0.0118368 0.0125887 0.0300581	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0138835 0.0249648 0.0437251 0.0203072 0.0057364 0.00770579 0.00574253 0.0107577 0.00990411 0.0159733 0.0233212 0.010313 0.017399 0.0209992 0.0140024 0.00892778 0.010278 0.0339884 0.0191195 0.0156424 0.0158 0.010551 0.0025527 0.00112759 0.000809612 0.00103138 0.000787791 0.00120755 0.00089069 0.00146463 0.00111359 0.00227977 0.00197089 0.00841028 0.00161495 0.00197167 0.00185089 0.00251215 0.00530821 0.00958007 0.045731 0.0154143 0.0107854 0.0143791 0.014496 0.0158785 0.0157732 0.019033 0.0329622 0.0159655 0.0264882 0.0126587 0.0450191 0.0278043 0.0254004 0.0309637 0.0216782 0.00455305 0.00129179 0.000839903 0.00103862 0.000688813 0.00103689 0.000715623 0.00111472 0.000784975 0.00140746 0.00124668 0.00288719 0.00765747 0.00361586 0.00978894 0.0264575 0.0067449 0.00518633 0.0159201 0.0131464 0.00952296 0.00898392 0.00695389 0.017328 0.0120883 0.0126803 0.030362	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.013395 0.0240864 0.0421864 0.0195924 0.00553456 0.00743457 0.0055404 0.0103788 0.00955506 0.0154097 0.0224969 0.00994856 0.0167823 0.0202519 0.0135032 0.00860885 0.00991302 0.032785 0.0184382 0.0150801 0.0152222 0.0101663 0.00246397 0.00108836 0.000782114 0.00099659 0.000761331 0.00116712 0.000861101 0.00141612 0.00107682 0.0022031 0.00190626 0.00812997 0.00155972 0.00190471 0.00179008 0.00243049 0.00511703 0.00918718 0.0434522 0.0144598 0.0101046 0.013412 0.013067 0.0141381 0.0135085 0.0150924 0.0241204 0.0115455 0.0163128 0.00559509 0.0171934 0.00618028 0.0050608 0.00545551 0.00516542 0.00164526 0.000765728 0.000641272 0.000853497 0.000638743 0.000942252 0.000675612 0.00103478 0.000743502 0.00128056 0.000797759 0.00108746 0.00262192 0.00303378 0.0102115 0.0278216 0.00832426 0.00599909 0.0195796 0.0205883 0.0216824 0.0329975 0.0237255 0.05905 0.0432415 0.0409246 0.0440766	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	4	0.0147969 0.0266099 0.0466043 0.021666 0.0061235 0.00822981 0.00613825 0.0114989 0.0106089 0.0171486 0.0252824 0.0110625 0.0187221 0.0227281 0.0152163 0.00993298 0.0115767 0.03872 0.024481 0.0210582 0.0220039 0.0140598 0.00340048 0.00128245 0.00086825 0.00115037 0.000820015 0.00129723 0.000911834 0.00154832 0.00108488 0.00204017 0.00161506 0.00365412 0.00420793 0.0270558 0.00683184 0.00951845 0.0234513 0.0145525 0.0970621 0.0352805 0.0191761 0.0215733 0.0122695 0.0128546 0.0100723 0.0108948 0.019171 0.01014 0.0145824 0.00532665 0.0170715 0.00637415 0.0051271 0.00533247 0.00529966 0.00169695 0.000800149 0.000680294 0.000880984 0.000674502 0.000963256 0.000707195 0.00104949 0.000768057 0.0012776 0.000817438 0.00107175 0.0025047 0.00282271 0.0092005 0.0238132 0.00624952 0.00398777 0.012835 0.0131127 0.0087831 0.00932062 0.00674269 0.0174935 0.0115755 0.0125498 0.0304529	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
3	3	0.0142623 0.0256443 0.0449229 0.0208733 0.00589409 0.00792327 0.0059015 0.0110624 0.0101875 0.016434 0.024065 0.0106138 0.0179659 0.0216732 0.0144884 0.00932161 0.0107938 0.0363316 0.0209487 0.0175613 0.0182328 0.0119768 0.00297635 0.00125753 0.000905459 0.00117803 0.000879032 0.00134922 0.000975904 0.00157085 0.00110772 0.00189495 0.0014268 0.00293621 0.00291468 0.0140625 0.00308135 0.0042129 0.00888103 0.016509 0.0620213 0.0396404 0.0201262 0.0319906 0.0393504 0.0319677 0.0191763 0.023258 0.0328788 0.015095 0.0216087 0.00694213 0.0168313 0.00689188 0.00549267 0.00492192 0.00484786 0.00154786 0.000740536 0.00063945 0.000838221 0.00064315 0.000909357 0.000672033 0.000987107 0.000727516 0.00119783 0.000771736 0.00101038 0.00234365 0.00268395 0.00875302 0.0224085 0.00590413 0.00376772 0.0118667 0.0121431 0.008249 0.00869529 0.00634003 0.0163567 0.010945 0.01181 0.0288091	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139394 0.0250656 0.0439041 0.0203872 0.00575836 0.00773592 0.00576402 0.010796 0.00993805 0.0160228 0.0234072 0.0103277 0.0174453 0.0210736 0.0140564 0.00898687 0.0103587 0.0342389 0.0193477 0.0158435 0.0159444 0.0105463 0.00252163 0.00109197 0.000786616 0.00100435 0.000755423 0.00113491 0.000821858 0.0012946 0.000911498 0.00153645 0.00115561 0.0023825 0.00217239 0.0104473 0.00207679 0.00261085 0.00569647 0.0102326 0.0476666 0.0156378 0.010606 0.0141177 0.013889 0.0152614 0.0148856 0.0179776 0.0311032 0.0151648 0.0253838 0.0120106 0.0434889 0.0275065 0.0277936 0.0333213 0.0276555 0.00817085 0.00225781 0.0020558 0.00517179 0.00095933 0.000973869 0.000780755 0.00097482 0.000792784 0.00109759 0.000821588 0.000957558 0.00210925 0.00298742 0.00834908 0.025796 0.00619307 0.00441738 0.0135573 0.012417 0.00907835 0.0087957 0.00674971 0.0170997 0.0118477 0.0125802 0.030016	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0140307 0.0252297 0.0441915 0.0205206 0.00579606 0.00778653 0.00580175 0.0108667 0.010003 0.0161275 0.0235598 0.010395 0.0175585 0.0212103 0.0141474 0.0090441 0.0104235 0.0344467 0.0194622 0.0159375 0.0160391 0.010611 0.00253581 0.00109862 0.000791293 0.00100998 0.000759833 0.00114117 0.000826549 0.00130154 0.00091658 0.00154461 0.00116156 0.00239438 0.00218416 0.0105074 0.00208664 0.00262058 0.00571087 0.0102631 0.0478702 0.0157121 0.0106718 0.0142215 0.0140459 0.0154902 0.0151059 0.0184198 0.0321017 0.0157013 0.0262776 0.0126391 0.0453092 0.0280095 0.0260772 0.031896 0.0235207 0.00517612 0.00144641 0.0010116 0.0014405 0.00144966 0.00398285 0.000817169 0.000938712 0.000778488 0.00106942 0.000799296 0.00093019 0.00204226 0.00293448 0.008614 0.0265216 0.00636186 0.0045553 0.0139787 0.0126999 0.00927248 0.00892812 0.00685354 0.0172247 0.0119879 0.0127111 0.03036	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0140538 0.0252712 0.0442642 0.0205544 0.00580559 0.00779932 0.00581129 0.0108845 0.0100195 0.0161539 0.0235982 0.010412 0.017587 0.0212447 0.0141703 0.00905843 0.0104397 0.0344979 0.0194902 0.0159606 0.0160625 0.010627 0.00253944 0.00110031 0.000792479 0.00101144 0.000760949 0.00114279 0.000827736 0.00130334 0.000917869 0.00154673 0.00116306 0.00239743 0.00218707 0.010522 0.00208881 0.00262241 0.0057124 0.0102655 0.0478913 0.0157172 0.0106815 0.0142431 0.0140753 0.0155373 0.0151414 0.0184935 0.0322541 0.0157747 0.0263565 0.012687 0.0454698 0.027991 0.0256096 0.0315114 0.0225264 0.00473344 0.0013349 0.000893202 0.00111777 0.000770423 0.00138549 0.00147591 0.00398313 0.000834135 0.00107109 0.000834257 0.000942682 0.00203506 0.00301631 0.00871184 0.0265775 0.0064078 0.00464924 0.0142904 0.0127876 0.00933841 0.00892481 0.00685843 0.0172307 0.0120129 0.0127319 0.0304217	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0140817 0.0253215 0.0443522 0.0205952 0.00581714 0.00781483 0.00582285 0.0109062 0.0100394 0.016186 0.023645 0.0104326 0.0176218 0.0212866 0.0141982 0.00907608 0.0104598 0.0345634 0.0195263 0.0159899 0.0160915 0.0106466 0.00254393 0.00110233 0.00079393 0.00101324 0.000762331 0.00114481 0.000829221 0.00130561 0.000919498 0.00154942 0.00116504 0.00240147 0.00219099 0.0105412 0.00209224 0.00262634 0.00571957 0.0102784 0.0479448 0.0157289 0.0106934 0.0142632 0.0141047 0.0155771 0.0151635 0.0185218 0.0322905 0.0158079 0.0263982 0.0127568 0.0456916 0.0282071 0.0256759 0.0316158 0.0223264 0.00461758 0.00129848 0.000859351 0.00106474 0.0007129 0.00108086 0.000777983 0.00142012 0.0014801 0.0044389 0.000930697 0.000949596 0.00192036 0.00308476 0.00827181 0.0260579 0.0063803 0.00473521 0.0145166 0.0126955 0.00930021 0.00873267 0.00671564 0.0169706 0.0118977 0.0126539 0.0302136	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0139582 0.0250994 0.0439633 0.0204146 0.00576613 0.00774631 0.0057718 0.0108105 0.00995137 0.0160441 0.0234378 0.0103411 0.0174674 0.0211001 0.0140738 0.00899665 0.0103685 0.0342626 0.019356 0.0158498 0.0159496 0.0105521 0.00252121 0.00109249 0.000786843 0.00100415 0.000755526 0.00113453 0.000821816 0.00129388 0.000911281 0.00153549 0.00115463 0.00237996 0.00217166 0.0104485 0.00207398 0.00260379 0.00567118 0.0101901 0.047505 0.0155814 0.0105885 0.0141169 0.0139488 0.0154106 0.0149841 0.0182718 0.0318214 0.0155853 0.0259469 0.0124501 0.0444662 0.0275385 0.0251262 0.0306088 0.0214419 0.00450822 0.00128173 0.000836561 0.00103975 0.000690035 0.00103877 0.000716981 0.00111674 0.000786446 0.00140994 0.00124861 0.00289147 0.00767036 0.00362477 0.00980701 0.0265398 0.00677447 0.00520936 0.0159765 0.0132051 0.00956869 0.00902647 0.00698714 0.0174124 0.012149 0.0127438 0.0305149	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0134296 0.0241489 0.0422981 0.0196412 0.00554774 0.00745284 0.00555313 0.0104007 0.00957391 0.0154349 0.0225462 0.00994816 0.0168014 0.0202927 0.0135338 0.00865079 0.00997209 0.0329543 0.0186113 0.0152337 0.0153184 0.0101351 0.00242578 0.00105137 0.000757932 0.000967452 0.000727983 0.00109315 0.000792001 0.00124703 0.000878558 0.00148054 0.00111342 0.00229398 0.00209539 0.0100667 0.00199842 0.00250916 0.00545142 0.00975039 0.0449883 0.0145667 0.00988967 0.0131199 0.0125251 0.0136745 0.0128074 0.014454 0.0232119 0.0112263 0.0159309 0.00548549 0.0169991 0.00612394 0.00500782 0.00541256 0.00515204 0.00164352 0.000764717 0.000640431 0.000852351 0.000637934 0.000940648 0.000674604 0.00103287 0.000742343 0.00127811 0.000796458 0.00108555 0.00261638 0.00303029 0.0102065 0.0278072 0.0083324 0.00600399 0.0195769 0.0205956 0.0217113 0.0330184 0.0237481 0.0591092 0.043292 0.0409736 0.0441332	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
3	3	0.0132389 0.0238031 0.0417027 0.0193841 0.00547113 0.00735209 0.00546744 0.0102575 0.00945249 0.0152519 0.0224215 0.00985765 0.0166591 0.0199766 0.0134104 0.0085631 0.010012 0.0342676 0.0199791 0.0168826 0.0178035 0.0120738 0.00307502 0.00128526 0.000887682 0.00113283 0.000850856 0.00128205 0.000935796 0.00145474 0.00104467 0.00170255 0.00125072 0.00214288 0.00175836 0.00321612 0.0031064 0.00541112 0.0279985 0.0154847 0.0721755 0.0465948 0.0248135 0.0387439 0.0429536 0.0339033 0.0203297 0.0232645 0.0317974 0.0145791 0.0204069 0.00653041 0.0157565 0.00645164 0.00513874 0.00458919 0.00451758 0.00144221 0.000689585 0.000595315 0.000780256 0.000598672 0.000846888 0.00062566 0.000919545 0.000677447 0.00111606 0.000718724 0.000941113 0.00218329 0.00249982 0.0081621 0.0208994 0.00551155 0.0035159 0.0110682 0.0113292 0.00769845 0.00811657 0.00591299 0.0152462 0.0102027 0.0110146 0.0268328	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG2 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0134405 0.0241675 0.0423349 0.0196701 0.00555367 0.00745899 0.00554963 0.0104031 0.00958491 0.0154641 0.0226934 0.00997561 0.016836 0.0202464 0.0135885 0.00864082 0.0100378 0.0337378 0.0193815 0.0160498 0.0164918 0.0114787 0.00282636 0.00119633 0.000821207 0.00103497 0.00077866 0.00115913 0.000841938 0.00128815 0.000915715 0.0014644 0.00105689 0.00179632 0.00145438 0.00274007 0.00234021 0.0043846 0.0224918 0.00993498 0.0542901 0.0196779 0.0133949 0.0172564 0.0157105 0.0169008 0.0156895 0.0173468 0.0294476 0.0145326 0.0239604 0.0114126 0.0410792 0.0262293 0.0264153 0.0311423 0.0259425 0.00763006 0.0021128 0.00192174 0.00486273 0.000918857 0.000938066 0.000752398 0.000939331 0.000763918 0.00105673 0.000790998 0.000921364 0.00202638 0.00286757 0.00799972 0.0246524 0.00593239 0.00423348 0.0129384 0.0118673 0.00868368 0.00841098 0.00646096 0.0163707 0.0113547 0.0120507 0.0288012	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135284 0.0243255 0.0426117 0.0197987 0.00558998 0.00750776 0.00558596 0.0104712 0.00964757 0.0155652 0.0228412 0.0100405 0.0169455 0.0203786 0.0136769 0.00869678 0.0101015 0.0339452 0.0194985 0.0161466 0.0165897 0.0115456 0.0028413 0.00120293 0.000825687 0.0010404 0.000782832 0.00116507 0.000846314 0.00129452 0.000920233 0.0014712 0.00106165 0.00180397 0.00146014 0.0027508 0.0023473 0.00439567 0.0225521 0.00996328 0.0545216 0.0197813 0.0134888 0.0173974 0.0158987 0.0171452 0.0159047 0.0177533 0.0303754 0.0150351 0.0247489 0.0119759 0.0427227 0.0266933 0.0247578 0.0297941 0.0220521 0.0048197 0.00134913 0.000952002 0.00137613 0.00138463 0.0037996 0.000783615 0.00090066 0.000747103 0.00102608 0.000767063 0.000892584 0.00195738 0.00280914 0.00823656 0.0252995 0.00608231 0.00435612 0.013322 0.012127 0.00886095 0.00852982 0.00655468 0.0164799 0.0114833 0.0121696 0.0291235	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135506 0.0243654 0.0426816 0.0198311 0.00559915 0.00752008 0.00559514 0.0104884 0.00966339 0.0155907 0.0228785 0.0100569 0.0169731 0.020412 0.0136992 0.00871093 0.0101175 0.0339966 0.0195275 0.0161707 0.0166141 0.0115623 0.00284507 0.00120455 0.000826794 0.00104177 0.000783857 0.00116657 0.000847382 0.0012961 0.00092132 0.00147287 0.00106276 0.00180578 0.00146143 0.00275327 0.00234862 0.00439746 0.0225614 0.00996495 0.0545439 0.0197911 0.0135037 0.0174257 0.01593 0.0171896 0.0159331 0.0178154 0.0305117 0.0150996 0.0248084 0.0120125 0.04286 0.0266729 0.0243059 0.0294313 0.0211173 0.00440436 0.00124397 0.000841309 0.00106941 0.000737902 0.00132867 0.00141367 0.00381127 0.000800114 0.00102654 0.000799914 0.000903981 0.00194959 0.00288644 0.00832885 0.0253491 0.00612475 0.00444465 0.0136191 0.0122122 0.00892426 0.00852711 0.00655984 0.0164887 0.0115083 0.0121906 0.0291863	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0135762 0.0244116 0.0427624 0.0198686 0.00560975 0.00753431 0.00560574 0.0105082 0.00968168 0.0156201 0.0229217 0.0100758 0.017005 0.0204505 0.013725 0.00872726 0.0101363 0.0340586 0.0195624 0.0161994 0.0166432 0.0115826 0.00284986 0.00120661 0.000828203 0.00104352 0.000785183 0.00116851 0.000848797 0.00129824 0.000922827 0.00147523 0.00106444 0.0018086 0.00146367 0.0027575 0.00235196 0.00440341 0.0225917 0.00997664 0.0546034 0.0198073 0.0135191 0.01745 0.0159614 0.0172283 0.0159508 0.0178371 0.0305397 0.0151265 0.0248403 0.0120748 0.0430603 0.0268739 0.024363 0.0295276 0.0209303 0.00429603 0.00120991 0.000809514 0.0010188 0.000682803 0.00103662 0.000746393 0.00136236 0.00141789 0.00424884 0.00089236 0.000909923 0.00183819 0.00295105 0.00790435 0.0248548 0.00609879 0.00452766 0.0138389 0.0121287 0.00889023 0.00834601 0.00642528 0.0162465 0.0114007 0.0121191 0.0289933	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.01346 0.0242025 0.0423963 0.0196985 0.00556171 0.00746979 0.00555773 0.0104183 0.00959879 0.0154864 0.0227255 0.00998956 0.0168594 0.0202752 0.0136074 0.00865242 0.0100496 0.0337683 0.0193952 0.0160605 0.0164999 0.0114828 0.00282532 0.00119625 0.000821087 0.00103451 0.000778438 0.00115844 0.000841514 0.00128705 0.00091493 0.00146257 0.00105538 0.00179316 0.00145127 0.00273409 0.00233248 0.0043672 0.022404 0.00989482 0.0541324 0.0196297 0.0133901 0.017276 0.0157861 0.0170462 0.0157653 0.0175997 0.0300929 0.0149123 0.024421 0.0117857 0.0419032 0.0262348 0.0238418 0.0285947 0.0201084 0.00419839 0.00119442 0.000788221 0.000994961 0.000661032 0.000996408 0.000687918 0.00107155 0.000754644 0.0013529 0.00119615 0.0027665 0.00734067 0.00347684 0.00939757 0.0253779 0.00648526 0.00498525 0.0152579 0.0126288 0.00915393 0.00863054 0.00668742 0.0166794 0.0116454 0.0122085 0.029293	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0129503 0.0232861 0.0407906 0.0189524 0.00535109 0.00718682 0.00534712 0.0100233 0.00923478 0.0148988 0.0218622 0.00961085 0.016218 0.019501 0.013087 0.0083207 0.00966666 0.0324849 0.0186564 0.015445 0.0158643 0.0110505 0.00272338 0.00115287 0.000791634 0.000997883 0.000750736 0.00111769 0.000811825 0.00124233 0.000883235 0.001413 0.00102004 0.0017345 0.00140449 0.00264644 0.00225769 0.00422563 0.0216468 0.00948363 0.0512802 0.0183644 0.0124711 0.0160099 0.0141065 0.0151018 0.0135068 0.0140028 0.0220167 0.0107235 0.0150703 0.00520444 0.0162554 0.00588271 0.00475955 0.00510453 0.00493982 0.00157627 0.000736321 0.000618464 0.000823308 0.000615929 0.000906273 0.000650479 0.000993945 0.000715035 0.00122877 0.000766436 0.00104404 0.00251311 0.00291313 0.00980654 0.0266096 0.00796391 0.00574105 0.0186906 0.0196618 0.0207467 0.0315152 0.022691 0.0565671 0.0414479 0.0392144 0.0423495	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	4	0.0115663 0.0208222 0.0364621 0.0167892 0.00474695 0.00634377 0.00472235 0.00876105 0.0079777 0.0125781 0.0176837 0.00756284 0.0122491 0.0138795 0.00891596 0.00511933 0.0056091 0.0161507 0.00695031 0.00625082 0.00645663 0.00522427 0.00166004 0.000789755 0.000667931 0.00090134 0.000653634 0.000975709 0.000681776 0.00105613 0.000711189 0.00113529 0.000754636 0.00124483 0.000897022 0.00169457 0.000988979 0.0017123 0.00629397 0.0145399 0.0882884 0.0533573 0.0361531 0.0501138 0.0401054 0.0467401 0.0215781 0.0214311 0.0237503 0.01161 0.0243178 0.0111977 0.0309662 0.0220627 0.0256325 0.0265706 0.0213598 0.00606984 0.00165808 0.00150264 0.0037786 0.000777335 0.000814291 0.000655211 0.000818687 0.000666879 0.000920048 0.000689255 0.000801875 0.00175875 0.0025002 0.00703323 0.0216494 0.00535674 0.00382899 0.0112059 0.0104434 0.00773128 0.0074818 0.00573399 0.0143974 0.0100873 0.0107265 0.0254965	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG1 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0116638 0.0209977 0.0367695 0.0169308 0.00478697 0.00639726 0.00476216 0.00883496 0.008045 0.0126842 0.0178331 0.00762674 0.0123525 0.0139963 0.00899134 0.00516279 0.00565696 0.0162902 0.00701072 0.00630476 0.0065119 0.00526909 0.00167397 0.000796568 0.000673629 0.000908789 0.000659201 0.000983762 0.000687591 0.00106485 0.000717281 0.00114477 0.000761206 0.00125558 0.000905116 0.00170944 0.000998187 0.00172821 0.00635111 0.0146743 0.0890568 0.0538453 0.0364652 0.0505819 0.0405273 0.0473018 0.0218206 0.0218045 0.0242841 0.0119141 0.0246794 0.0113414 0.0314747 0.0222632 0.0240639 0.0257414 0.018254 0.00385233 0.00104721 0.000761045 0.00114163 0.00114561 0.00316502 0.000672828 0.000775035 0.000642585 0.000881213 0.000660205 0.000768245 0.00168111 0.00242341 0.00715335 0.0219497 0.00542503 0.00389072 0.0114068 0.0105628 0.00780928 0.00750871 0.00576543 0.0143779 0.0101318 0.0107491 0.0256595	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG1 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0116874 0.0210402 0.0368439 0.016965 0.00479664 0.00641016 0.00477177 0.00885274 0.00806117 0.0127096 0.0178687 0.00764187 0.0123769 0.0140235 0.00900869 0.00517256 0.00566751 0.0163201 0.00702332 0.00631625 0.00652388 0.00527919 0.00167721 0.000798194 0.000675007 0.000910574 0.000660547 0.000985699 0.000688993 0.00106695 0.000718744 0.00114702 0.000762761 0.00125807 0.00090695 0.00171271 0.00100017 0.00173151 0.0063622 0.014699 0.0892185 0.053943 0.0365307 0.0506718 0.0405954 0.0473904 0.0218284 0.0218241 0.0243239 0.0119254 0.0246554 0.0113026 0.0314473 0.0222219 0.0236023 0.0254407 0.0174769 0.00351946 0.000962675 0.000673933 0.00089109 0.000619641 0.00112742 0.00120557 0.00327127 0.000692956 0.000880844 0.000686813 0.000776087 0.00166949 0.00248747 0.00722712 0.0219748 0.00545491 0.00396174 0.0116504 0.0106364 0.00785648 0.00749492 0.00576351 0.0143843 0.0101458 0.0107552 0.0257082	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG1 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0117136 0.0210873 0.0369264 0.017003 0.00480738 0.00642452 0.00478246 0.00887258 0.00807925 0.0127382 0.0179088 0.00765909 0.0124048 0.0140552 0.00902912 0.00518436 0.0056805 0.0163577 0.00703966 0.00633087 0.00653895 0.00529135 0.00168108 0.00080003 0.000676554 0.000912673 0.000662061 0.000987972 0.000690573 0.00106941 0.000720393 0.00114968 0.000764513 0.00126101 0.000909058 0.00171679 0.00100254 0.00173569 0.0063776 0.0147321 0.0893976 0.054046 0.0365917 0.050745 0.0406538 0.0474335 0.021811 0.0218098 0.0242666 0.0119047 0.0246244 0.0113257 0.0315089 0.0223256 0.0236001 0.0255078 0.0173029 0.00343319 0.000936645 0.000649725 0.000850448 0.000572911 0.000878165 0.000640741 0.00117062 0.00121939 0.00367628 0.000774672 0.000782328 0.00156719 0.00253806 0.00683228 0.0215682 0.00543371 0.00403627 0.011865 0.0105985 0.0078358 0.00734245 0.00565168 0.0142104 0.0100579 0.0106967 0.0255607	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG1 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG0 .
4	4	0.0116152 0.0209102 0.0366163 0.0168603 0.00476706 0.00637067 0.00474238 0.0087983 0.00801163 0.0126317 0.0177595 0.00759552 0.0123022 0.0139398 0.00895528 0.00514245 0.00563499 0.0162279 0.00698467 0.00628093 0.00648709 0.0052486 0.00166745 0.000793406 0.000670939 0.000905222 0.000656567 0.000979908 0.000684847 0.00106069 0.000714413 0.00114028 0.000758139 0.00125062 0.000901419 0.00170263 0.000994194 0.00172154 0.00632657 0.0146094 0.0885839 0.0535361 0.0362287 0.0502146 0.0402147 0.0468204 0.0214916 0.0214723 0.0237693 0.0116523 0.0241249 0.01109 0.03074 0.0218662 0.0231148 0.0247202 0.0166664 0.00337311 0.000925503 0.000634413 0.000830199 0.000554774 0.000844891 0.000589778 0.000919985 0.000652556 0.00116977 0.0010331 0.00239342 0.00638983 0.00308931 0.0082812 0.0223623 0.00583203 0.00447931 0.0133158 0.0111529 0.0081377 0.00763121 0.00590623 0.0146967 0.0103195 0.0108219 0.0259349	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG1 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	3	0.0134096 0.0241328 0.0422521 0.0194303 0.00549383 0.00733305 0.00545595 0.0100997 0.00918102 0.0144146 0.0201976 0.00856918 0.0138418 0.0156251 0.0100185 0.00572517 0.00627994 0.0176786 0.00755511 0.0067997 0.00688125 0.00537593 0.00166915 0.000829865 0.000709777 0.000905143 0.000690419 0.000961487 0.000712238 0.00102466 0.000737948 0.00108616 0.000777142 0.00117349 0.000873302 0.00147002 0.000985703 0.00165056 0.00551614 0.011796 0.0654012 0.0263251 0.0107785 0.0153926 0.00770913 0.0103363 0.010581 0.0102275 0.0225688 0.0127356 0.0214579 0.00947548 0.0349377 0.017822 0.0149975 0.0182341 0.0157895 0.0052796 0.00235783 0.00228206 0.0110472 0.00192716 0.00173985 0.00158207 0.00168747 0.0016383 0.0018407 0.00176955 0.00211891 0.00319859 0.00519722 0.0104964 0.0225775 0.0074839 0.00826331 0.0220731 0.0206817 0.0250557 0.0338318 0.0221843 0.0453084 0.0377041 0.0337488 0.032835	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	3	0.0136321 0.0245332 0.0429531 0.0197526 0.005585 0.00745469 0.00554638 0.0102671 0.00933328 0.0146536 0.0205322 0.00871087 0.0140704 0.015881 0.0101813 0.00581731 0.006381 0.0179617 0.00767445 0.00690777 0.00699132 0.00546391 0.00169567 0.000843282 0.000721217 0.000919419 0.000701516 0.000976577 0.000723635 0.00104065 0.000749715 0.00110304 0.000789495 0.00119168 0.00088705 0.00149247 0.00100135 0.00167649 0.00559955 0.011967 0.0663823 0.0266954 0.0109252 0.0156125 0.00779476 0.0104496 0.0106772 0.0102961 0.0226516 0.0127423 0.0212856 0.00933461 0.0342721 0.0168849 0.0135605 0.0156131 0.0133037 0.00383525 0.00158058 0.00121824 0.00207879 0.00185926 0.0083364 0.0015139 0.00168963 0.00151089 0.00180022 0.00168114 0.00200342 0.00312351 0.00498746 0.0103299 0.0237838 0.0075805 0.00820462 0.0223295 0.0215681 0.0259865 0.0343738 0.0227016 0.0464718 0.0381695 0.0345055 0.0339308	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	3	0.0137401 0.0247276 0.0432935 0.0199088 0.00562919 0.00751358 0.00559013 0.0103479 0.00940667 0.0147686 0.0206926 0.00877822 0.0141789 0.0160018 0.0102579 0.00585994 0.00642669 0.0180872 0.00772634 0.00695586 0.00704118 0.005505 0.00170866 0.000849943 0.000726964 0.000926651 0.000707095 0.000984237 0.000729364 0.00104878 0.000755633 0.00111163 0.000795715 0.00120094 0.000893989 0.00150392 0.00100908 0.00168899 0.00563878 0.012044 0.0668589 0.0268797 0.0109961 0.0157193 0.0078416 0.0105157 0.0107321 0.0103403 0.0227145 0.0127679 0.0212832 0.00933798 0.0341755 0.016515 0.0129464 0.014439 0.0119946 0.00330219 0.00137521 0.000989393 0.00140997 0.0010879 0.00242302 0.00206383 0.00881152 0.00162596 0.00193736 0.00176922 0.00206977 0.00321179 0.00510076 0.0104304 0.0235893 0.00742735 0.00816295 0.0225213 0.0217078 0.0260781 0.034288 0.0226667 0.0465065 0.038093 0.0345093 0.0340218	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	4	0.0150464 0.0270784 0.0474087 0.021802 0.00616459 0.00822842 0.00612194 0.0113324 0.0103021 0.0161748 0.0226644 0.00961526 0.0155295 0.0175246 0.011232 0.00641592 0.00703754 0.019809 0.00846105 0.00761523 0.00770643 0.00602367 0.00186769 0.000929251 0.000794382 0.00101183 0.000772473 0.00107449 0.000796574 0.00114464 0.000825007 0.00121284 0.000868438 0.00130969 0.000974948 0.00163855 0.00110035 0.0018412 0.00613858 0.0131002 0.0728466 0.0293181 0.0119935 0.0171865 0.00857197 0.011524 0.011778 0.0114337 0.0252782 0.0141907 0.0239707 0.0109894 0.0404673 0.0212616 0.0169617 0.018733 0.0144507 0.00391217 0.0014715 0.000998098 0.00151776 0.00101716 0.0020646 0.00154191 0.00393292 0.0040104 0.024355 0.00526144 0.00707124 0.0140631 0.0063213 0.0139956 0.0384396 0.00980074 0.00775065 0.0195544 0.0153282 0.011208 0.0102611 0.00777091 0.019192 0.013476 0.0145404 0.0334927	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 ) are likely to have little effect on the oral clearance of DRUG0 .
4	3	0.0138405 0.0249084 0.0436101 0.0200541 0.00567028 0.00756834 0.00563081 0.010423 0.00947492 0.0148755 0.0208416 0.00884085 0.0142799 0.0161143 0.0103292 0.00589956 0.00646911 0.0182035 0.00777376 0.00699968 0.00708648 0.005542 0.00172047 0.000856059 0.000732246 0.000933293 0.000712225 0.000991267 0.000734624 0.00105624 0.000761058 0.0011195 0.0008014 0.00120939 0.000900318 0.00151435 0.00101607 0.00170026 0.00567411 0.0121138 0.0672933 0.0270376 0.0110532 0.0158088 0.00788571 0.0105828 0.0107891 0.0103962 0.0228127 0.0128232 0.0213513 0.00939556 0.0343022 0.0164832 0.0127678 0.013955 0.0113766 0.00301579 0.00125606 0.000889633 0.00123203 0.000895214 0.00157626 0.00118531 0.00268498 0.00227939 0.0108335 0.0019515 0.00216213 0.00328227 0.00529116 0.0106082 0.0237387 0.00713927 0.00803047 0.0225038 0.0213855 0.0257874 0.033862 0.0223705 0.0458251 0.0374677 0.0340035 0.0336458	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) are likely to have little effect on the oral clearance of DRUG2 .
4	3	0.0135396 0.0243669 0.0426618 0.0196181 0.00554692 0.00740376 0.00550825 0.0101961 0.00926862 0.0145513 0.0203873 0.00864681 0.0139652 0.0157561 0.0100982 0.00576607 0.00632167 0.0177879 0.00759317 0.00683797 0.00692209 0.00541511 0.00168054 0.000836164 0.000715119 0.000911024 0.000695472 0.000967428 0.000717237 0.00103066 0.000742941 0.00109219 0.000782196 0.00117967 0.000878375 0.0014762 0.00099123 0.00165794 0.00552489 0.0117817 0.0654942 0.02629 0.0107314 0.0153813 0.00764249 0.0102587 0.0104397 0.0100271 0.0219305 0.0123204 0.0204737 0.00896004 0.0327249 0.0157144 0.0122408 0.0132354 0.0109088 0.00289954 0.00118351 0.000817602 0.00110937 0.000792027 0.00130344 0.000902496 0.00159462 0.00119014 0.00245806 0.00164673 0.00290451 0.0140878 0.00601408 0.012378 0.0312202 0.00906648 0.0100626 0.0264643 0.0237578 0.0275977 0.0332305 0.0222824 0.0452595 0.0365648 0.0334196 0.0331984	Other drugs eliminated via renal secretion : Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) decreases the oral clearance of DRUG0 by about 20% , while those secreted by the anionic transport system (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) are likely to have little effect on the oral clearance of DRUG2 .
4	4	0.107268 0.0697115 0.267987 0.0694088 0.02658 0.0130456 0.0147609 0.00870629 0.0216836 0.0115537 0.0182544 0.00584512 0.00474969 0.00228156 0.00270931 0.00258882 0.00412552 0.00374802 0.00213072 0.00315895 0.00183257 0.00313076 0.00229112 0.0044398 0.00256997 0.00341766 0.0080262 0.00754357 0.039548 0.032412 0.0306741 0.0383772 0.0288548 0.0418743 0.0947109	DRUG1 : Since DRUG2 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0865763 0.0505418 0.175713 0.093263 0.105505 0.108284 0.048289 0.00805095 0.0126086 0.00716414 0.0101565 0.00318069 0.0030924 0.00174875 0.00231889 0.0021782 0.00334611 0.00295353 0.00181857 0.0024854 0.00157638 0.00255965 0.00195095 0.00361134 0.00210568 0.00287146 0.00638537 0.0061034 0.0322947 0.0251686 0.0237037 0.0297835 0.0226226 0.0329193 0.0770689	DRUG1 : Since DRUG0 is a DRUG2 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.104606 0.0455554 0.120261 0.0367376 0.0251022 0.0153704 0.0226526 0.028387 0.0676575 0.0391946 0.0466096 0.0164147 0.00756549 0.00476472 0.00478919 0.00673368 0.0509558 0.0205982 0.00358812 0.00305814 0.00212516 0.00305362 0.00238503 0.00402882 0.00244317 0.00334591 0.00695621 0.00630155 0.0364319 0.030299 0.0288247 0.0373608 0.0287375 0.0404829 0.0966227	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.105252 0.0460314 0.122058 0.0371686 0.0254666 0.0157159 0.0229272 0.0291332 0.0715109 0.0443089 0.0489308 0.0162114 0.0066288 0.00422689 0.00419805 0.00453465 0.0122372 0.00765226 0.00816871 0.0130317 0.00228274 0.00268251 0.00214295 0.00318232 0.0025498 0.0031234 0.0061167 0.00598378 0.0418322 0.0343604 0.0295967 0.0374162 0.0306934 0.0417922 0.110851	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.106426 0.0467319 0.124163 0.0378552 0.0259192 0.0160541 0.0234323 0.0300064 0.0739132 0.0456412 0.0493428 0.0162788 0.00660125 0.00418921 0.00411194 0.00403096 0.00827781 0.00461221 0.00261671 0.00374265 0.00397294 0.0107476 0.00221595 0.00313497 0.00262973 0.00321044 0.00617997 0.00597212 0.0410286 0.0337859 0.0297505 0.0378162 0.0309194 0.0423106 0.112378	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.106445 0.0467567 0.122889 0.0375964 0.0255424 0.0156976 0.0230724 0.0284948 0.0672069 0.041375 0.0461692 0.0150627 0.00636591 0.00390931 0.00381391 0.00368021 0.00686092 0.00431173 0.00227092 0.00301856 0.00180583 0.00373697 0.00391293 0.0124102 0.00374924 0.00410335 0.00809717 0.00750377 0.0426768 0.0372935 0.0348013 0.0438023 0.0333664 0.0454006 0.1068	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0993335 0.0443997 0.119032 0.0361945 0.0247761 0.0154584 0.0223806 0.0289942 0.0731301 0.0460291 0.0485788 0.0161349 0.00631209 0.0040132 0.00392886 0.00377956 0.00735928 0.0037165 0.00206897 0.00255178 0.00157492 0.00260527 0.00194089 0.00474743 0.00642633 0.0054738 0.0191543 0.00508992 0.0416819 0.0388944 0.034448 0.0374356 0.0341163 0.0427476 0.115492	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG2 , may diminish the effectiveness of DRUG0 .
4	4	0.0854832 0.0307811 0.0720668 0.0240615 0.0149751 0.00805716 0.012887 0.00934615 0.0159338 0.00885631 0.0145576 0.00521802 0.00434178 0.00229331 0.00238161 0.00235716 0.00388004 0.00396817 0.0020552 0.00327993 0.00177659 0.00329752 0.00233561 0.00482083 0.00303142 0.00411985 0.00986145 0.00917522 0.0542396 0.0620914 0.120144 0.0939802 0.0961054 0.0990233 0.109217	DRUG1 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
4	4	0.0315615 0.0562051 0.133895 0.0943568 0.102997 0.132356 0.0454017 0.0095354 0.0183852 0.00978412 0.0134191 0.0039648 0.00367379 0.00202893 0.00275248 0.00255664 0.00392331 0.00339668 0.00208321 0.00279867 0.00180312 0.00288387 0.00223233 0.00411232 0.00240443 0.00328875 0.00734614 0.00709074 0.0392187 0.0309803 0.0287036 0.0353773 0.027011 0.0391703 0.0933019	DRUG0 : Since DRUG1 is a DRUG2 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0271424 0.0528214 0.172372 0.0591709 0.0326064 0.0280648 0.0226236 0.0270076 0.100966 0.0572197 0.0768841 0.045937 0.0220339 0.00442033 0.00370696 0.00298715 0.00409478 0.00300675 0.00199808 0.00222184 0.00153388 0.00211397 0.00178277 0.00287949 0.00192921 0.0025133 0.00511523 0.00525031 0.0329997 0.0265319 0.0224652 0.026574 0.020776 0.0280303 0.0722194	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG2 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0280868 0.0550483 0.178936 0.0607787 0.0322755 0.028263 0.0232901 0.0289203 0.093136 0.0587165 0.0603221 0.0189878 0.00646634 0.00353736 0.00377903 0.00554526 0.0460917 0.0182983 0.0030806 0.00243133 0.00169091 0.00236677 0.00189369 0.00310045 0.00191511 0.00261447 0.00535895 0.00487994 0.0296195 0.0235391 0.0213934 0.0263909 0.0204464 0.0282835 0.0705163	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0283805 0.0550608 0.180651 0.0622176 0.0344087 0.0300582 0.0244092 0.0292252 0.0968562 0.0608598 0.0652143 0.0195675 0.00577195 0.00316749 0.00327133 0.00367937 0.0115291 0.00633595 0.00659853 0.0102412 0.00182622 0.00213558 0.00172443 0.00251691 0.00205387 0.00250726 0.00480319 0.00475235 0.0342578 0.0268413 0.0220158 0.026197 0.021642 0.0292721 0.0799501	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0286737 0.0555859 0.182488 0.0630297 0.035125 0.0306405 0.0248928 0.0297887 0.0991051 0.0618801 0.065645 0.0196974 0.00580218 0.00317273 0.00325237 0.00338149 0.00806704 0.00384515 0.00218796 0.00297936 0.00314871 0.00857966 0.0017444 0.00240858 0.00207462 0.0025364 0.0047759 0.00466752 0.0333847 0.0263164 0.0221152 0.026486 0.0218558 0.0296168 0.0810494	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0290325 0.0564466 0.184858 0.0623687 0.0332344 0.0291746 0.0239937 0.0290001 0.0926185 0.0609441 0.0632187 0.0184616 0.00556517 0.00294548 0.00304453 0.00311777 0.006725 0.00359179 0.00189564 0.00238617 0.00146045 0.00302017 0.00313532 0.0101185 0.00301082 0.00320987 0.00621761 0.00584395 0.0344151 0.0283553 0.0253299 0.0305746 0.0235221 0.031766 0.0773975	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0272172 0.0524815 0.172973 0.0603213 0.0347075 0.030024 0.0242061 0.0285254 0.0950467 0.0580006 0.0625816 0.0196774 0.00566064 0.00306827 0.00314731 0.00322565 0.00720765 0.00313811 0.00175359 0.00205036 0.00128486 0.0021025 0.00159733 0.00408177 0.0053729 0.00466079 0.0157826 0.00426536 0.0360134 0.0316075 0.0268779 0.0276725 0.025439 0.0315183 0.0867097	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG2 , may diminish the effectiveness of DRUG0 .
4	4	0.0281673 0.0569916 0.183792 0.0535906 0.0162075 0.0132972 0.0128584 0.00860126 0.0285444 0.0139196 0.0151655 0.00472494 0.00360698 0.00181313 0.00212579 0.00204122 0.00341381 0.00311434 0.00168337 0.00253806 0.0014058 0.00250401 0.00184479 0.00370136 0.0023926 0.00337982 0.00776022 0.00739345 0.0451044 0.0555255 0.0978827 0.0739835 0.0772369 0.0778689 0.085819	DRUG0 : Since DRUG1 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
4	4	0.0191567 0.0297536 0.102104 0.0768079 0.0908002 0.113949 0.132291 0.0251712 0.0522271 0.0367761 0.0631087 0.0291885 0.0133217 0.00288727 0.00281318 0.00236467 0.00324754 0.0024655 0.00166204 0.00181691 0.001295 0.00179385 0.00150688 0.00249696 0.00165702 0.00211718 0.00444346 0.00461875 0.0267027 0.0206016 0.0173959 0.020235 0.0157214 0.0214844 0.0560175	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG2 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0182242 0.0281211 0.0982772 0.0766854 0.0945613 0.121445 0.142632 0.0249743 0.0447421 0.0338953 0.0449667 0.012402 0.00409127 0.00243097 0.00335662 0.00519059 0.036868 0.0147682 0.00247321 0.00193745 0.00138511 0.00195512 0.00157252 0.0025844 0.00160934 0.00215939 0.00448522 0.00413921 0.0245202 0.0185173 0.0163879 0.0196434 0.0152209 0.020973 0.0528034	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0186614 0.0290688 0.100499 0.0775578 0.0967403 0.123064 0.144721 0.0257536 0.0466721 0.0356267 0.0507822 0.0128377 0.00365517 0.00213028 0.0026651 0.00336305 0.00928028 0.00473755 0.00504527 0.00760656 0.0014383 0.00171824 0.00141396 0.00208719 0.00171317 0.00204587 0.00407533 0.00400441 0.0279893 0.0208541 0.0166707 0.0193238 0.0159001 0.0214167 0.0588816	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0187505 0.0292387 0.100977 0.0778188 0.0972501 0.123625 0.145769 0.0262452 0.04772 0.0362391 0.0513736 0.0130052 0.00368899 0.00215121 0.00264306 0.00313262 0.0068245 0.00303792 0.00182477 0.0024058 0.00247736 0.00672937 0.00139516 0.00196589 0.00172987 0.00206802 0.00399358 0.00388105 0.0274897 0.0207125 0.0168543 0.0195415 0.0161624 0.0216662 0.0596118	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0187767 0.0291414 0.10137 0.0784825 0.0974089 0.124665 0.145272 0.0250319 0.0441419 0.0350337 0.0480705 0.0122812 0.0035446 0.00200852 0.00248065 0.00288054 0.00569365 0.0028383 0.00156349 0.00190635 0.00119032 0.00245009 0.00251167 0.00807205 0.00244293 0.00257746 0.00503252 0.00471238 0.0282295 0.0219943 0.0190082 0.0222479 0.0171881 0.0230018 0.0567497	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0184664 0.0288851 0.098874 0.0757211 0.0939091 0.118295 0.140652 0.0260239 0.0471428 0.034966 0.0494902 0.0132101 0.00366531 0.00212437 0.00267149 0.00309808 0.00627559 0.00251807 0.00148671 0.00166114 0.00105719 0.00170513 0.00133316 0.00326693 0.00431593 0.00378044 0.0125625 0.0035555 0.0297932 0.0250022 0.0204906 0.020174 0.0185982 0.0226127 0.0626162	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG2 , may diminish the effectiveness of DRUG0 .
4	4	0.0196598 0.0301663 0.104356 0.076679 0.0845831 0.109736 0.102749 0.0110211 0.0175353 0.0109355 0.00998427 0.00358261 0.00242692 0.00137429 0.00171899 0.0016926 0.0026484 0.002371 0.00139544 0.00195482 0.00114038 0.00191637 0.0014832 0.0028211 0.0019258 0.00279199 0.00597503 0.00587575 0.0369887 0.0451919 0.0734839 0.0520623 0.0561218 0.0555241 0.0601264	DRUG0 : Since DRUG0 is a DRUG1 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
4	4	0.0191077 0.0318733 0.0668962 0.0230801 0.0154011 0.010352 0.0150357 0.0184944 0.072766 0.0610378 0.0771533 0.0451876 0.0620816 0.0112087 0.0200844 0.0228397 0.0771459 0.0219911 0.00454702 0.00314497 0.00217842 0.0028891 0.00241214 0.00366531 0.00258181 0.00335913 0.00694827 0.00658361 0.044258 0.0337952 0.0282758 0.0331013 0.0262319 0.034533 0.0897584	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0195777 0.0327909 0.0684705 0.0232506 0.0155483 0.0104155 0.0147976 0.0181833 0.0711963 0.0625892 0.0772459 0.0485352 0.0723913 0.0119142 0.0248623 0.0236899 0.0436763 0.0121362 0.0131972 0.0138122 0.00263473 0.00279373 0.00219985 0.00308941 0.0027043 0.00319697 0.00636389 0.00622234 0.0448357 0.0336986 0.0267134 0.0315029 0.0264036 0.0345779 0.0947819	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0193023 0.0323601 0.0676962 0.0229054 0.0153193 0.0102837 0.0145682 0.0181362 0.0709563 0.0626038 0.0769848 0.0489048 0.0735317 0.0118896 0.0254597 0.0232465 0.0375497 0.00949687 0.00997911 0.00651142 0.00666561 0.0137978 0.00263316 0.00315563 0.00294954 0.00341208 0.00622906 0.00609595 0.0465897 0.0348628 0.027214 0.0313644 0.0271774 0.0347287 0.0954385	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.0195943 0.0328637 0.0686853 0.0231789 0.0154569 0.0103693 0.0147181 0.0180502 0.0704238 0.0628168 0.0765825 0.0488969 0.070751 0.0110697 0.0224426 0.0213775 0.0338388 0.00842073 0.0084842 0.00494164 0.00340554 0.0053578 0.00588553 0.0146943 0.00452502 0.00440202 0.00746479 0.00685379 0.0446595 0.0352613 0.0300996 0.035576 0.0285236 0.0367409 0.0935876	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) or DRUG0 , may diminish the effectiveness of DRUG0 .
4	4	0.019259 0.0322227 0.0672703 0.0227798 0.0152593 0.0102214 0.0144523 0.0177143 0.0683786 0.0600748 0.0720531 0.045462 0.0697592 0.0117923 0.026992 0.0221752 0.0321168 0.00886901 0.00878717 0.00486739 0.00362737 0.00410354 0.00390892 0.00654165 0.0093662 0.00846413 0.0190166 0.00546645 0.0436373 0.0378723 0.0315083 0.0317188 0.0298169 0.0357982 0.0986468	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG2 , may diminish the effectiveness of DRUG0 .
4	2	0.0170234 0.0285916 0.059073 0.0208046 0.0137708 0.00909972 0.0136285 0.0150779 0.0616013 0.0515626 0.0677976 0.0378275 0.0372737 0.00424083 0.00552076 0.00532999 0.00984097 0.00380737 0.00292248 0.00312117 0.00194334 0.00277225 0.00234892 0.00352709 0.003581 0.00480997 0.00808594 0.00917623 0.0647304 0.053717 0.0853353 0.0543912 0.0852534 0.0793633 0.0730487	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
4	2	0.0198022 0.033443 0.0688754 0.0218952 0.0145922 0.00905764 0.0131037 0.0146759 0.0394785 0.0287146 0.0436611 0.0161545 0.00814765 0.00392736 0.00496803 0.0087264 0.0286807 0.0170609 0.0057667 0.00349057 0.00245529 0.00327794 0.00285032 0.00395856 0.00377504 0.00546476 0.00877854 0.0105616 0.0781574 0.0625043 0.0890779 0.0576084 0.0954787 0.0905365 0.0812924	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
2	2	0.0213828 0.036407 0.0743567 0.023322 0.0155731 0.00963105 0.0135309 0.0146245 0.0378073 0.0282766 0.0406725 0.0143145 0.0075498 0.00370563 0.00474555 0.0059867 0.014108 0.0145792 0.0127257 0.025301 0.00405086 0.00413899 0.00385618 0.00462695 0.00458166 0.00683259 0.00992784 0.0134175 0.0943276 0.0460622 0.0762064 0.0470305 0.0976652 0.0929083 0.0757665	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
2	2	0.0225794 0.0382944 0.0782217 0.0243777 0.0163403 0.0100265 0.0140116 0.0152111 0.0376752 0.0266996 0.0373495 0.0125052 0.00656643 0.00322153 0.00377573 0.00398905 0.00760663 0.00683822 0.00404727 0.00693955 0.00487048 0.0192494 0.00376443 0.00483727 0.00502318 0.00702892 0.0105494 0.0135513 0.0908824 0.0528956 0.0820732 0.0517923 0.0997999 0.0966272 0.0807783	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
2	2	0.0221221 0.0370419 0.0744459 0.0232378 0.0157001 0.00974938 0.0137224 0.0150844 0.0355404 0.0222937 0.0305596 0.0101717 0.00537629 0.00276309 0.00304514 0.00305931 0.00543599 0.00490095 0.00262792 0.0039482 0.00226521 0.00591907 0.00454825 0.019092 0.00572558 0.00700048 0.0106051 0.0141054 0.0931755 0.0588491 0.0916228 0.0570116 0.104463 0.100399 0.0843909	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) or DRUG0 , may diminish the effectiveness of DRUG2 .
2	2	0.0186008 0.0318092 0.0652173 0.0207421 0.013832 0.00854683 0.0117701 0.0121806 0.0328436 0.0253525 0.0333458 0.0118051 0.00599991 0.00275637 0.00345861 0.00366116 0.00696706 0.00523337 0.00325439 0.00406607 0.00246941 0.00512384 0.00481051 0.0118195 0.0167092 0.0185606 0.0908053 0.0198172 0.104353 0.0360686 0.075943 0.0411867 0.0976269 0.0872133 0.0660498	DRUG0 : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG1 , may diminish the effectiveness of DRUG2 .
4	4	0.259157 0.0826903 0.09149 0.0578543 0.0872198 0.0593842 0.0771663 0.109052 0.175985	DRUG1 and DRUG2 are incompatible with DRUG0 solution .
4	0	0.105655 0.0267075 0.0433328 0.0994104 0.192501 0.189382 0.130563 0.0760454 0.136404	DRUG1 and DRUG0 are incompatible with DRUG2 solution .
0	0	0.0387861 0.0255818 0.110872 0.0987949 0.215021 0.175703 0.120276 0.0786147 0.136351	DRUG0 and DRUG1 are incompatible with DRUG2 solution .
4	4	0.0456565 0.0336623 0.0411829 0.0416766 0.0408136 0.0790644 0.103847 0.100799 0.0465776 0.0242203 0.0224835 0.022162 0.00958448 0.0261686 0.0729821 0.0814207 0.0328746 0.0263207 0.0306616 0.0574503 0.0603915	The addition of DRUG1 to parenteral solutions containing DRUG2 should be avoided , except where compatibility has been previously established .
2	2	0.0953044 0.0734793 0.0540486 0.0423762 0.0759369 0.0523582 0.0162155 0.0617962 0.0396312 0.0167187 0.027602 0.0190802 0.00706306 0.0114377 0.0565668 0.0318705 0.0413803 0.0332899 0.0302303 0.0909007 0.0661887 0.0565249	DRUG1 decreased the toxicity of DRUG2 , increased exposure to parent compound , and decreased metabolite levels in a dose-dependent manner .
4	4	0.023847 0.027092 0.0244407 0.0113971 0.0085227 0.0464542 0.028875 0.0298443 0.0237096 0.0280363 0.0333824 0.0341526 0.036042 0.0537028 0.031323 0.0785455 0.0438945 0.0399772 0.0551468 0.0439781 0.0196846 0.0477581 0.0347697 0.034848 0.0160314 0.0168091 0.0149831 0.00457943 0.0100654 0.00297098 0.00584171 0.00300798 0.00522828 0.0326933 0.0483651	Of the isoform-specific CYP inhibitors tested for an effect on the DRUG1 metabolite profile , only DRUG2 was noticeably effective , indicating a role of CYPs 2A6 , 2C9 , 2Cl9 , and 2E1 .
4	4	0.027047 0.0356561 0.0130134 0.0201217 0.0265949 0.0530366 0.0466435 0.0239969 0.0240345 0.0568854 0.0644153 0.0751936 0.143994 0.125527 0.0385753 0.0242438 0.0258807 0.0409672 0.045461 0.088713	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG1 > DRUG2 ~ DRUG0 > DRUG0 .
4	4	0.0266073 0.0350934 0.0125038 0.0191923 0.0248661 0.050808 0.0451158 0.025449 0.029226 0.0715162 0.0729399 0.0711756 0.0740264 0.0573754 0.0394591 0.10756 0.0569136 0.0381623 0.0461223 0.0958874	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG1 > DRUG0 ~ DRUG2 > DRUG0 .
4	4	0.026143 0.0342186 0.0122173 0.0188811 0.0244227 0.0512181 0.0456615 0.0245492 0.0282501 0.0713495 0.0736782 0.0734496 0.0605684 0.0406476 0.0192266 0.0357026 0.077803 0.130335 0.0872966 0.064381	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG1 > DRUG0 ~ DRUG0 > DRUG2 .
4	4	0.0199487 0.0249927 0.00930374 0.0145589 0.0184365 0.0370832 0.0318896 0.0127686 0.0112815 0.0224337 0.0301839 0.0347418 0.0728473 0.123326 0.189321 0.118254 0.0559801 0.0401979 0.0437715 0.0886784	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG0 > DRUG1 ~ DRUG2 > DRUG0 .
4	4	0.0273107 0.035084 0.012889 0.0198003 0.0249405 0.0471289 0.0431843 0.0204157 0.0206003 0.0420406 0.0501005 0.0385359 0.057094 0.0891413 0.0784281 0.0470878 0.067118 0.132116 0.0843036 0.0626806	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG0 > DRUG1 ~ DRUG0 > DRUG2 .
4	4	0.0242223 0.0301494 0.0114168 0.0179446 0.0225751 0.0440458 0.0349467 0.012359 0.00975021 0.0183154 0.0230012 0.0169367 0.0266133 0.0288991 0.060311 0.10653 0.159211 0.176851 0.106606 0.0693152	With respect to toxicity , the order of CYP inhibitor effectiveness was DRUG0 > DRUG0 ~ DRUG1 > DRUG2 .
4	4	0.213377 0.0498282 0.0745908 0.0495457 0.0597232 0.0507325 0.0143403 0.0203139 0.0334473 0.0484725 0.0244686 0.0718895 0.0768333 0.0833961 0.129041	DRUG1 and DRUG2 had no effect , while DRUG0 appeared to augment DRUG0 toxicity .
4	4	0.0885369 0.0127508 0.019727 0.054462 0.0556472 0.0893011 0.0554345 0.114838 0.0609187 0.0582241 0.0404674 0.103115 0.0776804 0.0722672 0.0966298	DRUG1 and DRUG0 had no effect , while DRUG2 appeared to augment DRUG0 toxicity .
4	4	0.0753345 0.00959852 0.0134688 0.0252776 0.0218732 0.0244235 0.0069701 0.0158486 0.0468483 0.119969 0.11548 0.223306 0.0971563 0.0652453 0.139201	DRUG1 and DRUG0 had no effect , while DRUG0 appeared to augment DRUG2 toxicity .
4	4	0.0212444 0.012585 0.0595111 0.0582727 0.063396 0.0944734 0.0557466 0.118637 0.0626333 0.0621134 0.0424392 0.104599 0.0780399 0.0712586 0.0950503	DRUG0 and DRUG1 had no effect , while DRUG2 appeared to augment DRUG0 toxicity .
4	4	0.0189437 0.00960637 0.035144 0.0249167 0.0260481 0.0267562 0.00750106 0.0176141 0.051845 0.129646 0.122603 0.228169 0.099856 0.0652511 0.1361	DRUG0 and DRUG1 had no effect , while DRUG0 appeared to augment DRUG2 toxicity .
2	2	0.00769726 0.00393425 0.0125715 0.0258524 0.0325612 0.0471904 0.0306149 0.0837317 0.149062 0.113049 0.0701888 0.156277 0.0938445 0.0680122 0.105413	DRUG0 and DRUG0 had no effect , while DRUG1 appeared to augment DRUG2 toxicity .
2	2	0.115023 0.0296467 0.0146308 0.015026 0.0719339 0.0288002 0.107274 0.0377436 0.0683043 0.084457 0.0830956 0.0564519 0.0606742 0.0900603 0.076349 0.0605294	Catecholamine-depleting drugs (e.g. , DRUG1 ) may have an additive effect when given with DRUG2 .
1	1	0.0904962 0.0649163 0.119447 0.0567533 0.0748938 0.051941 0.0324835 0.0668311 0.107182 0.0724 0.0487025 0.0603326 0.0580693 0.0955513	patients receiving DRUG1 and DRUG2 should have more frequent monitoring of neutrophil counts .
2	2	0.101353 0.108014 0.0684128 0.0671203 0.0594627 0.0270274 0.0499844 0.0158882 0.0621548 0.0611487 0.0945758 0.0725584 0.0633641 0.0416673 0.107267	When DRUG1 is used with other DRUG2 , potentiation of antihypertensive effect may occur .
2	1	0.0491594 0.122634 0.062765 0.104947 0.065118 0.074182 0.131338 0.0730797 0.109932 0.111145 0.0957002	Patients may require reduced doses of DRUG1 when on DRUG2 .
1	1	0.10882 0.149108 0.0581486 0.0698956 0.0486252 0.0569909 0.0521621 0.0446891 0.0284437 0.0222477 0.0264446 0.0432148 0.0320158 0.0237177 0.0248137 0.0248423 0.0351171 0.0515966 0.0991061	When DRUG1 and DRUG2 are given concomitantly the patient should be carefully monitored for symptoms of DRUG0 toxicity .
4	4	0.169726 0.119789 0.0203205 0.0357773 0.0381176 0.0275085 0.0279303 0.0264964 0.0177653 0.0154921 0.0204322 0.0406278 0.0413478 0.0588534 0.0597678 0.0760255 0.060686 0.04755 0.0957866	When DRUG1 and DRUG0 are given concomitantly the patient should be carefully monitored for symptoms of DRUG2 toxicity .
3	3	0.0496797 0.0410101 0.0654441 0.0358828 0.0794625 0.0543276 0.0581604 0.0750355 0.047632 0.0915967 0.0406657 0.039768 0.0350995 0.0746427 0.0693028 0.034821 0.0173282 0.0217692 0.0683716	Several studies demonstrate a decrease in the bioavailability of DRUG1 when it is ingested with DRUG2 or DRUG0 .
3	3	0.0570606 0.0476701 0.0759259 0.0402174 0.0847779 0.058047 0.060796 0.0793607 0.0500557 0.0945084 0.0346544 0.0295394 0.0279994 0.0652578 0.0484873 0.0198298 0.0188574 0.0475718 0.059383	Several studies demonstrate a decrease in the bioavailability of DRUG1 when it is ingested with DRUG0 or DRUG2 .
1	1	0.1207 0.0864914 0.121258 0.121002 0.0571349 0.0290023 0.0425298 0.103725 0.101223 0.0463665 0.170567	Coadministration of DRUG1 with DRUG2 or DRUG0 is not recommended .
1	1	0.120561 0.0950527 0.125437 0.103713 0.0452134 0.053997 0.094871 0.0840529 0.0874077 0.0421416 0.147553	Coadministration of DRUG1 with DRUG0 or DRUG2 is not recommended .
4	4	0.0991029 0.0559019 0.074583 0.120295 0.0802024 0.091152 0.0871907 0.0328636 0.00718468 0.00520101 0.00386727 0.00414924 0.0122679 0.0225588 0.0214024 0.0238096 0.0069432 0.0104326 0.0103164 0.0330343 0.0128023 0.0192247 0.0196852 0.0177823 0.0360731 0.0919734	DRUG1 does not interfere with measurement of DRUG2 ( DRUG0 ) , a test for pheochromocytoma , by those methods which convert DRUG0 to DRUG0 .
4	4	0.109415 0.0540796 0.0674287 0.103157 0.077654 0.0903927 0.0462843 0.0242219 0.0221232 0.0290562 0.00659993 0.0048 0.012672 0.0221392 0.0211223 0.0242415 0.00740298 0.0112688 0.0114655 0.0361616 0.0140213 0.0213423 0.0218012 0.0196122 0.0397599 0.101776	DRUG1 does not interfere with measurement of DRUG0 ( DRUG2 ) , a test for pheochromocytoma , by those methods which convert DRUG0 to DRUG0 .
4	4	0.0662026 0.0339249 0.0301686 0.0289273 0.0278645 0.0340206 0.0123812 0.00771438 0.00352128 0.00696222 0.00523681 0.00591766 0.01883 0.0361346 0.0366694 0.0488745 0.0152311 0.0278775 0.0294229 0.124263 0.0614086 0.10912 0.0653082 0.0345402 0.0311013 0.0983764	DRUG1 does not interfere with measurement of DRUG0 ( DRUG0 ) , a test for pheochromocytoma , by those methods which convert DRUG2 to DRUG0 .
4	4	0.0733325 0.0372213 0.0327716 0.0307603 0.029586 0.0360709 0.0130129 0.00830367 0.00378572 0.00744163 0.00550819 0.00594994 0.0180367 0.0338247 0.0318791 0.043731 0.013264 0.0224505 0.0262167 0.0949548 0.0334483 0.0414621 0.0636174 0.0935744 0.0897472 0.110048	DRUG1 does not interfere with measurement of DRUG0 ( DRUG0 ) , a test for pheochromocytoma , by those methods which convert DRUG0 to DRUG2 .
4	4	0.0251827 0.0320234 0.0555571 0.062656 0.0565996 0.0515329 0.0410043 0.0314335 0.0115647 0.00565647 0.00728235 0.00914518 0.0297735 0.037701 0.0402887 0.0398438 0.00981948 0.0216748 0.0279806 0.078221 0.0283567 0.0312288 0.0469895 0.070634 0.0668086 0.0810413	DRUG0 does not interfere with measurement of DRUG1 ( DRUG0 ) , a test for pheochromocytoma , by those methods which convert DRUG0 to DRUG2 .
4	4	0.0217253 0.0261678 0.0419892 0.0421369 0.0369387 0.0339164 0.0246601 0.02033 0.0220453 0.0516913 0.0147769 0.0118874 0.0333552 0.0354592 0.0411014 0.0400714 0.0107034 0.0255869 0.0286596 0.101752 0.0494831 0.0853549 0.0500051 0.0271923 0.0296601 0.0933502	DRUG0 does not interfere with measurement of DRUG0 ( DRUG1 ) , a test for pheochromocytoma , by those methods which convert DRUG2 to DRUG0 .
4	4	0.0233833 0.0280561 0.0449831 0.0451293 0.0395835 0.0368714 0.0269015 0.022462 0.0234729 0.0545856 0.0142434 0.0116165 0.0312972 0.0335788 0.037201 0.0342638 0.00947181 0.0215471 0.0287776 0.0816374 0.0299221 0.0332804 0.0502212 0.0762092 0.0727248 0.088579	DRUG0 does not interfere with measurement of DRUG0 ( DRUG1 ) , a test for pheochromocytoma , by those methods which convert DRUG0 to DRUG2 .
1	4	0.019202 0.0202858 0.0250116 0.0229598 0.0191177 0.0188254 0.00811249 0.0066738 0.00337 0.00629774 0.00453997 0.00506272 0.0162995 0.0326909 0.0310204 0.0405386 0.0128078 0.0206897 0.0190151 0.0761159 0.0482998 0.0911369 0.131075 0.121931 0.109587 0.0893338	DRUG0 does not interfere with measurement of DRUG0 ( DRUG0 ) , a test for pheochromocytoma , by those methods which convert DRUG1 to DRUG2 .
4	4	0.0480157 0.0422496 0.0298071 0.0545428 0.0899932 0.0640469 0.107787 0.0198094 0.025676 0.00521033 0.00769948 0.00482635 0.00918694 0.00425324 0.00398802 0.002456 0.00185658 0.00241942 0.001839 0.0027854 0.00195407 0.00235403 0.00548052 0.00643478 0.0389473 0.0304372 0.042543 0.0283724 0.010893 0.0138512 0.0191856 0.0231282 0.0399585 0.0138402 0.0136014 0.034522 0.0331884 0.0368247 0.0760351	In addition to bleeding associated with DRUG1 and DRUG2 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
4	4	0.0428445 0.046297 0.0242196 0.040782 0.0894315 0.0774321 0.05093 0.00866564 0.0103879 0.0144835 0.0244022 0.0154073 0.0298809 0.0122242 0.0142776 0.0088522 0.00637972 0.00993663 0.00211288 0.00273365 0.00213807 0.00234319 0.00531521 0.00693045 0.0435193 0.0335104 0.0461831 0.0295139 0.0108192 0.0148024 0.0196348 0.0229427 0.0377362 0.0129933 0.0127588 0.0322023 0.0306723 0.0339949 0.0703087	In addition to bleeding associated with DRUG1 and DRUG0 , drugs that alter platelet function (such as DRUG2 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
4	4	0.0434602 0.0470419 0.0244893 0.0412593 0.0902389 0.0790192 0.0520506 0.00873948 0.0106965 0.014911 0.0246873 0.015357 0.0271043 0.00992835 0.00866034 0.00464122 0.00277456 0.00362898 0.00373459 0.0108932 0.00223696 0.00220842 0.00478504 0.00697884 0.0452743 0.0348527 0.0493844 0.0299589 0.0109141 0.0150179 0.0196935 0.0230565 0.0376641 0.0130303 0.0128196 0.0323874 0.0309045 0.0342808 0.0712354	In addition to bleeding associated with DRUG1 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG2 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
4	4	0.0431334 0.0467847 0.0242545 0.040851 0.0894245 0.0786895 0.0518013 0.00872964 0.0107381 0.0150582 0.0251281 0.0157434 0.0275004 0.00989913 0.0085694 0.00455232 0.00248643 0.00276243 0.00195706 0.0032047 0.00317635 0.00678633 0.0173051 0.00885364 0.0413819 0.0362573 0.0447643 0.0262495 0.010508 0.0149427 0.0202638 0.0234603 0.0381831 0.0132035 0.0130286 0.0329242 0.0312083 0.0346021 0.0716327	In addition to bleeding associated with DRUG1 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG2 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
2	2	0.0352126 0.0377417 0.0196934 0.0335596 0.0718577 0.0644682 0.0417197 0.00596421 0.00658831 0.0073789 0.00895656 0.00475949 0.00805744 0.00397458 0.00380185 0.00234485 0.00175924 0.00209852 0.00179678 0.00257602 0.00214604 0.002955 0.00633288 0.011403 0.0606363 0.0433527 0.0737681 0.0328932 0.0210444 0.0253056 0.0298861 0.0266072 0.0441442 0.0315824 0.029106 0.0592013 0.0388504 0.0328372 0.0636384	In addition to bleeding associated with DRUG1 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG2 therapy .
4	4	0.0332501 0.0350018 0.0167851 0.0298187 0.0526914 0.0486076 0.0313006 0.0246792 0.0716956 0.014865 0.0265892 0.0159958 0.0313604 0.0122905 0.0146085 0.00889079 0.00664049 0.0103973 0.00223221 0.0029295 0.0022855 0.00250521 0.0057535 0.00747461 0.0468489 0.0359087 0.0494094 0.0318264 0.0116634 0.016115 0.0214136 0.02503 0.0413026 0.0142255 0.0139839 0.0353304 0.0336694 0.0373322 0.077292	In addition to bleeding associated with DRUG0 and DRUG1 , drugs that alter platelet function (such as DRUG2 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
4	4	0.0338266 0.0356255 0.0170714 0.0303626 0.0537177 0.0499448 0.0324893 0.0255592 0.0743925 0.0153068 0.0267335 0.0158315 0.0283229 0.00989028 0.0088559 0.00472796 0.00282861 0.00379439 0.00392374 0.0115519 0.00237367 0.00236454 0.00517325 0.00749105 0.0485158 0.037032 0.0523696 0.0320918 0.0116853 0.0162463 0.0213514 0.0250072 0.0409969 0.0141857 0.0139718 0.0353346 0.0337388 0.0374397 0.0778735	In addition to bleeding associated with DRUG0 and DRUG1 , drugs that alter platelet function (such as DRUG0 , DRUG2 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
4	4	0.0336005 0.0354019 0.016939 0.0301074 0.0532616 0.0495915 0.0322717 0.0253978 0.074148 0.0153753 0.0271287 0.0162044 0.0288299 0.00986157 0.00876996 0.00463407 0.00254749 0.00290498 0.00205121 0.00339254 0.00335511 0.00721412 0.0182586 0.00937631 0.0443756 0.0384507 0.0475772 0.028184 0.0112704 0.0161399 0.0219183 0.0254308 0.0415314 0.0143712 0.014195 0.0358823 0.0340305 0.0377543 0.0782646	In addition to bleeding associated with DRUG0 and DRUG1 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG2 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
2	2	0.0297338 0.030032 0.0151583 0.027076 0.0476481 0.039946 0.0225691 0.0166828 0.0494362 0.00842452 0.00927771 0.0049256 0.00829929 0.00404034 0.00389849 0.00242161 0.00180728 0.00216107 0.00185029 0.00267399 0.00221356 0.00307165 0.00662589 0.0118746 0.0629037 0.0447147 0.0758623 0.0343194 0.0219412 0.0266236 0.0316925 0.0284071 0.0473506 0.0338392 0.0312661 0.0636074 0.0417976 0.035303 0.0685234	In addition to bleeding associated with DRUG0 and DRUG1 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG2 therapy .
2	2	0.0228668 0.0199425 0.00871814 0.0122952 0.0197476 0.0140395 0.00755712 0.00407125 0.00977571 0.0118295 0.0310173 0.0164339 0.0238058 0.0111343 0.0172619 0.00990145 0.00879449 0.0261346 0.00411187 0.00413104 0.00405026 0.00509723 0.00823752 0.0144292 0.0742538 0.0384347 0.051937 0.0208847 0.0193836 0.0263986 0.0295143 0.0304505 0.0552925 0.0439314 0.0350315 0.0803686 0.0507569 0.0444869 0.0834907	In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as DRUG1 , DRUG0 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG2 therapy .
4	4	0.0276425 0.0248903 0.0108694 0.01534 0.0241178 0.0167123 0.00840304 0.00447736 0.0111245 0.013822 0.0325782 0.0153251 0.0194369 0.00842859 0.00969953 0.00577416 0.00392618 0.00744298 0.00812932 0.0458772 0.00953725 0.0132718 0.0274638 0.0124636 0.0658195 0.0548683 0.0734866 0.0374939 0.014432 0.01916 0.0252909 0.0296869 0.048777 0.0168875 0.0166037 0.0423599 0.0405043 0.0449378 0.0929381	In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG1 , and DRUG2 ) may increase the risk of bleeding if administered prior to or after DRUG0 therapy .
2	2	0.023697 0.0203726 0.00895542 0.0126574 0.020334 0.0139621 0.00743492 0.00401007 0.00951812 0.0111883 0.026713 0.0125659 0.0166555 0.00734332 0.00881059 0.00502045 0.00354535 0.00589105 0.00540351 0.0277385 0.00462073 0.00517417 0.00857661 0.0149876 0.0775976 0.0402804 0.0561018 0.0219369 0.0200276 0.0272885 0.0307499 0.0317373 0.0574998 0.045321 0.0365979 0.083289 0.0527352 0.0462829 0.0873781	In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG1 , and DRUG0 ) may increase the risk of bleeding if administered prior to or after DRUG2 therapy .
2	2	0.0215229 0.0184557 0.00806764 0.0113456 0.0178528 0.012116 0.00654183 0.00350679 0.00815982 0.00910434 0.0215402 0.00971027 0.0133711 0.00574111 0.00694946 0.00392625 0.00246697 0.00335326 0.00255445 0.00496503 0.00438414 0.00771396 0.0386638 0.0184914 0.0869574 0.0476855 0.0698988 0.0280643 0.0242801 0.0316412 0.0354445 0.0332708 0.0552047 0.0420978 0.0358966 0.0765732 0.0488254 0.0426054 0.0810494	In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as DRUG0 , DRUG0 , and DRUG1 ) may increase the risk of bleeding if administered prior to or after DRUG2 therapy .
2	2	0.180329 0.123384 0.0860083 0.0945045 0.0791351 0.0903463 0.133548 0.120488 0.0922567	DRUG1 may decrease the hypotensive effect of DRUG2 .
3	3	0.091017 0.082362 0.0561402 0.0461285 0.0553318 0.0403603 0.115109 0.101941 0.0847358 0.0702497 0.0668049 0.051248 0.0166464 0.00323489 0.00306117 0.00209463 0.0020521 0.00149165 0.00188751 0.00156143 0.00212622 0.00156054 0.00138536 0.0019437 0.00139864 0.00150062 0.00221438 0.00173394 0.00200994 0.00162321 0.00266345 0.00251951 0.00656391 0.0111023 0.0661966	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG2 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0941507 0.0840937 0.0543075 0.0435517 0.051659 0.0397849 0.0981389 0.0988627 0.0868486 0.0632399 0.0644011 0.0358981 0.0107733 0.00629553 0.0123853 0.00291123 0.00267081 0.00177632 0.00237138 0.00181806 0.00269518 0.00183871 0.00164325 0.00243041 0.00162971 0.00180095 0.00276199 0.00195799 0.00257571 0.00186558 0.00332829 0.00304249 0.00877545 0.0142149 0.0935004	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0953501 0.0852762 0.0548541 0.0437242 0.0515395 0.0393857 0.0988844 0.0957916 0.0830828 0.0604462 0.0619021 0.0340944 0.00938445 0.00389928 0.00711026 0.0117004 0.014835 0.00277182 0.00289805 0.00216271 0.0029294 0.00216997 0.00184297 0.00258144 0.00183974 0.00193028 0.00289897 0.0022305 0.00260049 0.00205283 0.003367 0.00325006 0.00863891 0.0145578 0.0880162	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0966866 0.0865319 0.0554399 0.044029 0.0520401 0.0400001 0.0996006 0.0967722 0.0837849 0.060706 0.0629073 0.0336771 0.00920666 0.00347029 0.00500401 0.00624791 0.00542026 0.00547337 0.0117831 0.00232447 0.00274205 0.00216055 0.00176578 0.00240948 0.00174278 0.00183063 0.00273723 0.00209964 0.0024404 0.00198292 0.0032493 0.00316981 0.00846433 0.0143159 0.0877831	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.093546 0.0833279 0.052613 0.0414921 0.0495575 0.0392614 0.0918902 0.0947621 0.08111 0.0598634 0.0627586 0.0331853 0.0092024 0.00329089 0.00478635 0.00526292 0.00439155 0.00297125 0.00498492 0.00541251 0.0143246 0.0034651 0.00217604 0.00279651 0.00191699 0.00203302 0.00310399 0.00230579 0.00298211 0.00212113 0.00377091 0.00349285 0.0101669 0.0168561 0.104817	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0961166 0.0859598 0.0547606 0.043283 0.0512775 0.039772 0.0974938 0.0958527 0.0824337 0.0602297 0.0626882 0.0330078 0.00903244 0.00329221 0.00459139 0.00509683 0.00416211 0.00261535 0.00379816 0.00298985 0.00556476 0.005511 0.00550304 0.012259 0.00251305 0.0020115 0.00285325 0.00234755 0.00257271 0.00214992 0.0033771 0.0033745 0.00866839 0.0149374 0.0879028	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG2 , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0935623 0.0835804 0.0532392 0.0421347 0.0500384 0.0390696 0.0943325 0.0944773 0.0812713 0.0601323 0.061884 0.0326062 0.00896507 0.00324453 0.0046087 0.0050617 0.00419008 0.00263034 0.00384216 0.00288503 0.004831 0.00400544 0.00310984 0.00459175 0.00368525 0.00709716 0.0107027 0.00271089 0.00284632 0.00216891 0.00360712 0.00346433 0.00970868 0.0160712 0.0996439	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0939217 0.0839586 0.0535114 0.042338 0.0501335 0.0389389 0.0951428 0.0939718 0.0805075 0.0592152 0.0608667 0.0319204 0.00871572 0.003156 0.00439628 0.00485106 0.00400611 0.0025168 0.00364047 0.00271783 0.00441362 0.00367699 0.00277103 0.00404686 0.00264374 0.00381499 0.00694211 0.0101408 0.0146257 0.00313562 0.00415519 0.0037346 0.00908902 0.016577 0.0918056	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) .
3	3	0.0955708 0.0854433 0.0545828 0.0432373 0.0511081 0.0395469 0.0971972 0.0954235 0.0817865 0.0602195 0.0617345 0.0322683 0.00882363 0.00320964 0.00445294 0.00491317 0.00406828 0.00255913 0.00369044 0.00275707 0.00445019 0.00369044 0.00277571 0.00397346 0.0025178 0.00327964 0.00475903 0.00526554 0.00498752 0.00474535 0.0139048 0.0036203 0.00797887 0.0158774 0.0855812	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) .
3	3	0.093056 0.082999 0.0528903 0.041812 0.0495136 0.0386832 0.0932005 0.0933076 0.0793663 0.0584508 0.0589137 0.0310581 0.00862504 0.00311274 0.00431388 0.00476512 0.00395551 0.00247543 0.00356433 0.00266841 0.0043163 0.00362703 0.00269917 0.00381267 0.0024114 0.00309768 0.00442433 0.00459136 0.00390083 0.00267289 0.00464145 0.00754463 0.0342348 0.0224304 0.0888636	Human pharmacologic studies have shown that DRUG1 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , and DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.123721 0.0926424 0.0330365 0.0151022 0.0248656 0.0233608 0.0665954 0.10767 0.0654775 0.0353061 0.049962 0.0161421 0.00798456 0.00319188 0.0054489 0.00397441 0.00520761 0.00301441 0.00623881 0.00453801 0.0111278 0.0114513 0.0121341 0.0533334 0.0114819 0.0123584 0.0180573 0.00432317 0.00395407 0.00312941 0.00480828 0.00480568 0.0118816 0.0208681 0.122806	Human pharmacologic studies have shown that DRUG0 may inhibit the metabolism of DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , and DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0560247 0.0660195 0.072654 0.0555385 0.0545083 0.0811951 0.066631 0.0611427 0.0254043 0.0109253 0.00714915 0.0252019 0.0561313 0.0375969 0.0375096 0.0531553 0.0413379 0.0714791 0.0535292 0.0668665	The safety of using DRUG1 in combination with DRUG2 or other centrally acting DRUG0 has not been systemically evaluated .
4	4	0.0383034 0.0517106 0.0508519 0.0443525 0.0320478 0.0549528 0.0419395 0.0280454 0.0127448 0.00845722 0.0169817 0.0692425 0.135521 0.0618312 0.0443058 0.0604018 0.0482321 0.0717843 0.0589201 0.069374	The safety of using DRUG1 in combination with DRUG0 or other centrally acting DRUG2 has not been systemically evaluated .
4	4	0.0337098 0.0409785 0.0246449 0.0297846 0.0398051 0.0539392 0.0722503 0.0617424 0.0254044 0.0171268 0.0198071 0.0651183 0.120875 0.0494662 0.0349623 0.061625 0.050731 0.0719195 0.0571816 0.0689279	The safety of using DRUG0 in combination with DRUG1 or other centrally acting DRUG2 has not been systemically evaluated .
3	3	0.0379099 0.0366106 0.0580181 0.0602484 0.0464869 0.0817594 0.0251654 0.0691332 0.0511153 0.043054 0.070579 0.120006 0.0883767 0.0742333 0.0418126 0.0321055 0.0633858	Limited published data indicate that DRUG1 treatment increases cytochrome P450 (CP450) mediated DRUG2 clearance in man .
3	3	0.0271091 0.0410592 0.0311409 0.0360158 0.0661899 0.0311399 0.0615091 0.0303447 0.0324855 0.0385309 0.040196 0.0537651 0.0676368 0.0322299 0.0372575 0.0343026 0.0489435 0.0727813 0.0653088 0.0237932 0.00515915 0.00442169 0.0105677 0.00230016 0.00250361 0.00207673 0.00304842 0.00291755 0.00717509 0.0127988 0.0752915	These data suggest that DRUG1 administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) .
3	3	0.0278628 0.0421748 0.0320186 0.037156 0.06839 0.0321888 0.0640768 0.0315441 0.0338034 0.040253 0.0419025 0.0559221 0.0705411 0.0335968 0.0377313 0.0343386 0.0485705 0.0698093 0.0570289 0.0168553 0.00344698 0.00242983 0.00315052 0.00309408 0.00912082 0.00213583 0.00292963 0.00282992 0.00682024 0.0125264 0.0757511	These data suggest that DRUG1 administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) .
3	3	0.0280111 0.042388 0.0321788 0.037358 0.0687808 0.0323636 0.0645359 0.0317377 0.0340179 0.0405341 0.0421355 0.0561122 0.0706744 0.0335827 0.0374989 0.0341252 0.0483942 0.069447 0.0549829 0.015935 0.003183 0.00216088 0.00249606 0.00176494 0.00294471 0.003407 0.0111282 0.00289732 0.0065965 0.0131501 0.0754774	These data suggest that DRUG1 administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) .
3	3	0.0277875 0.0420185 0.0318459 0.0368668 0.0678131 0.0319286 0.0635739 0.031279 0.033528 0.0398329 0.0413165 0.054968 0.0690596 0.0328055 0.0368174 0.0334468 0.0469957 0.0678626 0.0524221 0.0154483 0.00307143 0.00209341 0.00235895 0.00162337 0.00235664 0.0018793 0.00316784 0.0049993 0.0246776 0.0169227 0.0792326	These data suggest that DRUG1 administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) .
1	1	0.0443732 0.181448 0.0457876 0.0607977 0.0468994 0.0454776 0.0764141 0.0924529 0.0584012 0.0490753 0.0436887 0.053659 0.0333964 0.0603429 0.0440132 0.0637727	Other DRUG1 should not be used concomitantly with DRUG2 because they may have additive effects .
1	1	0.0292118 0.013765 0.0219948 0.0204585 0.0165539 0.0232325 0.0262109 0.0113481 0.0586619 0.0351078 0.0218016 0.0208101 0.0242891 0.0412263 0.0542027 0.0425752 0.0409928 0.0330609 0.0225301 0.0419667 0.0367118 0.0135502 0.00356566 0.00372514 0.0083818 0.00289611 0.00174062 0.00250047 0.00320627 0.00348716 0.010353 0.0151657 0.119667 0.0569845 0.0267194 0.018527 0.00674129 0.00666636 0.00205612 0.00173285 0.00382879 0.00757013 0.0442216	Due to its effects on gastric emptying , DRUG1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g. , DRUG2 such as DRUG0 ) and agents that slow the intestinal absorption of nutrients (e.g. , DRUG0 ) .
1	1	0.0299319 0.0141132 0.0225636 0.0209655 0.0168703 0.0236243 0.0265915 0.0114945 0.059466 0.0351277 0.0218481 0.0207951 0.0243142 0.0414771 0.0546914 0.042261 0.0405265 0.0310555 0.0210689 0.0374171 0.0287594 0.00818768 0.00212745 0.00168555 0.00263689 0.00276918 0.0037917 0.0109336 0.00438131 0.00386223 0.0107904 0.0166983 0.12012 0.061063 0.0294194 0.0204244 0.00722368 0.00704226 0.0021046 0.00177003 0.00392755 0.007791 0.0462865	Due to its effects on gastric emptying , DRUG1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g. , DRUG0 such as DRUG2 ) and agents that slow the intestinal absorption of nutrients (e.g. , DRUG0 ) .
1	1	0.0330025 0.0156956 0.0251801 0.0232238 0.0175215 0.0237816 0.0259693 0.0110364 0.0593454 0.0325613 0.019984 0.0186654 0.0214032 0.0341537 0.0413104 0.0269308 0.031763 0.0174605 0.0083637 0.0119256 0.00999166 0.00366748 0.00132875 0.00121509 0.00244158 0.0019181 0.00145261 0.00259488 0.00282568 0.00380019 0.0101463 0.0193238 0.125837 0.0733501 0.0489265 0.0411804 0.0252298 0.0220748 0.00661301 0.00720564 0.0259062 0.0162663 0.0474263	Due to its effects on gastric emptying , DRUG1 therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g. , DRUG0 such as DRUG0 ) and agents that slow the intestinal absorption of nutrients (e.g. , DRUG2 ) .
1	4	0.0261452 0.00822655 0.0138259 0.0121721 0.00680674 0.00616998 0.00648125 0.00388581 0.0123979 0.0303074 0.0288524 0.0203957 0.0252252 0.0518202 0.055242 0.041389 0.0438566 0.0371122 0.0247344 0.0347897 0.0255667 0.0094617 0.0037815 0.0031192 0.0141124 0.00476111 0.00357586 0.00379957 0.00627259 0.00434696 0.0111534 0.0160306 0.109484 0.0530025 0.0431842 0.0378081 0.0280336 0.0255399 0.00691844 0.00737347 0.0249846 0.0173138 0.0505397	Due to its effects on gastric emptying , DRUG0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g. , DRUG1 such as DRUG0 ) and agents that slow the intestinal absorption of nutrients (e.g. , DRUG2 ) .
3	4	0.0255425 0.00803516 0.0134867 0.0118895 0.00666199 0.00604368 0.00634571 0.00381901 0.0120656 0.029651 0.0281264 0.0197971 0.024501 0.0500466 0.0527499 0.0392543 0.0422584 0.03621 0.0228966 0.0295393 0.0207737 0.00710031 0.00253647 0.00218279 0.00436418 0.00454792 0.00639497 0.0253101 0.00776607 0.00420119 0.00997503 0.01507 0.115786 0.0560903 0.0462857 0.0390817 0.0288582 0.0264371 0.00719818 0.00759285 0.0255684 0.0176325 0.0503261	Due to its effects on gastric emptying , DRUG0 therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g. , DRUG0 such as DRUG1 ) and agents that slow the intestinal absorption of nutrients (e.g. , DRUG2 ) .
4	1	0.0259902 0.0272783 0.0516225 0.0353541 0.0192432 0.0171323 0.0165942 0.030278 0.0211663 0.0396541 0.0267461 0.0208241 0.0455121 0.0627088 0.0403308 0.0280961 0.0112882 0.0085675 0.0232494 0.0068626 0.00645596 0.0192796 0.024164 0.00991939 0.01048 0.0100042 0.00819271 0.0124615 0.0131157 0.0267575 0.0420655 0.0223229 0.0159108 0.0219268 0.026376 0.0448105 0.0371669 0.0353044 0.0547865	When the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness (such as DRUG1 ) , the agent should be administered at least 1 hour prior to or 2 hours after DRUG2 injection .
4	4	0.0202151 0.0143173 0.0153905 0.00560776 0.0124521 0.0153 0.0254883 0.0245852 0.024879 0.0148306 0.0172214 0.0404026 0.051466 0.0710217 0.0583309 0.0476912 0.127357 0.104982 0.115721 0.100743 0.091998	In clinical trials , the concomitant use of DRUG1 or DRUG0 did not alter the adverse event profile of DRUG2 .
4	4	0.0192669 0.013684 0.0146056 0.00558547 0.0140178 0.0184014 0.0355688 0.0269915 0.0139404 0.0118761 0.0341651 0.0417006 0.0513816 0.0766316 0.0629725 0.0514394 0.123895 0.0989065 0.108497 0.0932032 0.0832694	In clinical trials , the concomitant use of DRUG0 or DRUG1 did not alter the adverse event profile of DRUG2 .
4	4	0.0523224 0.0436251 0.0390415 0.0269348 0.0116577 0.0145725 0.012292 0.0164302 0.064678 0.0574663 0.0396399 0.0368546 0.0365513 0.0272815 0.0522666 0.110719 0.0914525 0.102315 0.0968271 0.0670718	No formal interaction studies have been performed to assess the effect of DRUG1 on the kinetics of oral DRUG2 .
4	4	0.0869008 0.119241 0.0382725 0.0473798 0.0407564 0.0309851 0.0231863 0.0175447 0.0235293 0.0260605 0.0530221 0.0300461 0.0631032 0.0197016 0.00956576 0.00400497 0.00779911 0.00367151 0.00537536 0.0207511 0.016271 0.0155425 0.0103521 0.0199983 0.0373387 0.0567291 0.0566429 0.0225379 0.0311485 0.0625421	Mixing DRUG1 and DRUG2 The pharmacokinetic parameters of DRUG0 were altered when mixed with regular , NPH , and 70/30 premixed formulations of recombinant DRUG0 immediately prior to injection .
4	4	0.0887342 0.0721255 0.0109118 0.0187834 0.0330662 0.0178418 0.0138916 0.0107487 0.0149074 0.0165949 0.0328889 0.0192865 0.0428706 0.0137801 0.00698896 0.00290303 0.00635053 0.0038374 0.00866842 0.0463896 0.0487526 0.044391 0.0388641 0.057425 0.0529882 0.0622652 0.0696586 0.0375782 0.0428507 0.0636571	Mixing DRUG1 and DRUG0 The pharmacokinetic parameters of DRUG0 were altered when mixed with regular , NPH , and 70/30 premixed formulations of recombinant DRUG2 immediately prior to injection .
4	4	0.0434417 0.0233578 0.0150645 0.0600095 0.0659917 0.065758 0.0577253 0.0636126 0.0458612 0.0449357 0.0558058 0.0409673 0.0745559 0.0190046 0.0109968 0.00372711 0.00814375 0.00363194 0.00534409 0.0198941 0.0141696 0.0128993 0.00879934 0.0166692 0.0309856 0.0475191 0.0466592 0.0185963 0.0254983 0.050375	Mixing DRUG0 and DRUG1 The pharmacokinetic parameters of DRUG2 were altered when mixed with regular , NPH , and 70/30 premixed formulations of recombinant DRUG0 immediately prior to injection .
4	4	0.0430554 0.0214553 0.0133965 0.0473255 0.0337559 0.0214415 0.0177512 0.0137363 0.0183583 0.0204157 0.0391687 0.0219191 0.049311 0.0161255 0.00789538 0.00321112 0.0069655 0.00414671 0.00954307 0.0531282 0.0546294 0.0487355 0.0426378 0.0603419 0.0556109 0.0647512 0.0701339 0.0375709 0.0418783 0.0616045	Mixing DRUG0 and DRUG1 The pharmacokinetic parameters of DRUG0 were altered when mixed with regular , NPH , and 70/30 premixed formulations of recombinant DRUG2 immediately prior to injection .
4	3	0.014755 0.00909296 0.0048716 0.0219269 0.0330856 0.0248397 0.0284844 0.0311738 0.0324653 0.0253182 0.0424718 0.0311982 0.0763768 0.0213764 0.0133565 0.00398319 0.00888992 0.00514798 0.0111624 0.0564868 0.0498752 0.044 0.0399206 0.0572213 0.05195 0.0604249 0.0659441 0.0353267 0.0398744 0.0589991	Mixing DRUG0 and DRUG0 The pharmacokinetic parameters of DRUG1 were altered when mixed with regular , NPH , and 70/30 premixed formulations of recombinant DRUG2 immediately prior to injection .
1	4	0.102033 0.0429613 0.204227 0.0601319 0.0764706 0.0430198 0.0338561 0.0397247 0.0911392 0.02637 0.0404967 0.0324672 0.0355441 0.077563 0.0939947	Thus , DRUG1 and DRUG2 should not be mixed and must be administered separately .
4	4	0.0281104 0.0195786 0.0225042 0.0323194 0.0593013 0.0775134 0.0676266 0.0914236 0.0285722 0.00986762 0.0106396 0.00825778 0.0213656 0.0211685 0.0204569 0.0291897 0.0478479 0.038623 0.0301842 0.0304205 0.0321193 0.0395674 0.0301821 0.00985937 0.0111103 0.00176541 0.00160564 0.00109178 0.00144322 0.00104066 0.00153709 0.00114139 0.00220534 0.00181765 0.00490643 0.0103991 0.0100623 0.0047054 0.00202397 0.00103188 0.00151086 0.000954772 0.000832728 0.00125984 0.000865393 0.00132455 0.000893427 0.00137933 0.000931773 0.00148357 0.00100956 0.00180979 0.00137377 0.00380963 0.00291133 0.0140733 0.00431841 0.00270314 0.00123454 0.00275049 0.00143585 0.00167984 0.00100256 0.000814925 0.00133768 0.000863519 0.00144694 0.000900443 0.00148499 0.000931108 0.00153483 0.000973979 0.00161724 0.00103794 0.00175154 0.00127401 0.00246878 0.00153617 0.00306704 0.0134181 0.0474054	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281275 0.0195736 0.0225092 0.0323084 0.0593237 0.0775535 0.0676976 0.0915308 0.0284692 0.00983507 0.0106447 0.00827073 0.0214174 0.0213673 0.0208941 0.0294231 0.0479024 0.0389531 0.0297942 0.030315 0.032682 0.0363745 0.028117 0.0106731 0.00523146 0.00324947 0.00641842 0.00118184 0.00137802 0.00101513 0.00146931 0.00109232 0.00212109 0.00174961 0.00478485 0.0107291 0.0110105 0.00522547 0.0021944 0.00107574 0.00154124 0.000966016 0.000842971 0.00126345 0.000876315 0.0013272 0.000903616 0.0013798 0.000941132 0.0014826 0.00101877 0.00180771 0.00138957 0.00381283 0.00296806 0.0144223 0.00435178 0.00269464 0.00124104 0.00274766 0.00144559 0.00167415 0.000999901 0.000815281 0.00133229 0.000865443 0.00144177 0.000902536 0.00147886 0.000933028 0.00152812 0.000975905 0.00161034 0.00103993 0.00174525 0.00127703 0.00246139 0.00154248 0.00308605 0.0134498 0.0477317	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284783 0.0198159 0.0227881 0.0327113 0.0600683 0.0784985 0.0684831 0.0925363 0.028742 0.00991388 0.0106995 0.00828819 0.0212573 0.0210566 0.0203952 0.0288165 0.0467231 0.0373642 0.0288536 0.0295889 0.0320322 0.035669 0.0267342 0.00931614 0.00412509 0.00160154 0.00245927 0.0026684 0.00604252 0.001144 0.0014844 0.0011117 0.00210937 0.0017613 0.00503709 0.0114626 0.0118136 0.00547464 0.00231615 0.00111815 0.00158632 0.000993475 0.00086586 0.00129553 0.000898469 0.00135978 0.00092534 0.00141339 0.000963041 0.00151853 0.0010422 0.00185375 0.00142195 0.00391477 0.00304669 0.0148067 0.0044952 0.00277268 0.00127216 0.0028171 0.00148049 0.00171266 0.00102103 0.000831254 0.00135957 0.000882133 0.00147157 0.000919834 0.00150932 0.000950874 0.00155951 0.000994601 0.00164333 0.00105984 0.00178075 0.00130174 0.00251189 0.00157262 0.00314888 0.013743 0.0487219	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0285831 0.0198885 0.0228674 0.0328184 0.0602537 0.0787556 0.0686881 0.0928007 0.0288582 0.00996188 0.0107511 0.00832125 0.0212999 0.0210515 0.0202965 0.0285715 0.0463401 0.0368442 0.0284328 0.0293388 0.031575 0.0355067 0.0261011 0.00887361 0.0038582 0.00147599 0.00190724 0.00125219 0.00238528 0.00263196 0.00626942 0.00121769 0.00199743 0.00171342 0.00499303 0.0112745 0.0121426 0.00554893 0.0023994 0.00114663 0.00161551 0.00101032 0.00088036 0.00131583 0.000912884 0.00138024 0.000939417 0.00143434 0.000977088 0.00154077 0.00105702 0.00188214 0.00144163 0.00396701 0.0030848 0.0149636 0.00456936 0.00281929 0.00129019 0.00285669 0.00149889 0.00173401 0.00103214 0.000840293 0.0013752 0.000891639 0.00148823 0.00092966 0.00152612 0.000960983 0.00157669 0.00100516 0.00166124 0.00107105 0.00179991 0.00131537 0.0025376 0.00158896 0.00318076 0.0138873 0.0491667	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284615 0.0198039 0.0227722 0.0326858 0.0600198 0.0784577 0.0684379 0.0924523 0.0287622 0.00993435 0.0107281 0.00830662 0.0213034 0.0210711 0.0203391 0.0285157 0.0462446 0.0367729 0.0282618 0.0292537 0.0311793 0.0353327 0.0259442 0.00877739 0.00378999 0.00145285 0.00179095 0.00116346 0.00184486 0.00121756 0.00244501 0.00273982 0.00821377 0.0016667 0.00466948 0.0102313 0.0126185 0.00558112 0.00259476 0.00122345 0.0016971 0.00105148 0.000916172 0.00136666 0.000947741 0.0014298 0.000972083 0.00148265 0.00100815 0.00158919 0.00108801 0.0019394 0.00147844 0.00404778 0.00313652 0.0150269 0.00466261 0.00289573 0.00131904 0.00291711 0.00152361 0.0017667 0.00104853 0.000854707 0.00140141 0.000906653 0.00151479 0.00094491 0.00155211 0.000976507 0.00160271 0.00102122 0.00168763 0.00108776 0.00182693 0.00133426 0.00256857 0.00160987 0.00321639 0.0140263 0.0494945	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267719 0.0186295 0.0214464 0.0308301 0.056703 0.0740493 0.064662 0.0872334 0.0270275 0.00929607 0.0100015 0.00774619 0.019884 0.0196528 0.019061 0.0267685 0.0432517 0.0344739 0.0265324 0.0275594 0.0288713 0.0328385 0.02471 0.00868982 0.00370907 0.00142661 0.00176975 0.00113948 0.00177522 0.00116837 0.0020044 0.00140974 0.00302659 0.00535572 0.0184882 0.0179254 0.019774 0.00877659 0.00382317 0.00162947 0.00207699 0.0013034 0.00111564 0.00161117 0.0011173 0.00166569 0.00112831 0.00172453 0.00115923 0.00184591 0.00124499 0.00227772 0.00168977 0.00482991 0.00372394 0.0173842 0.00567454 0.00334001 0.00150395 0.00328847 0.00172443 0.00198279 0.00118074 0.000938396 0.00154604 0.000988059 0.00167196 0.0010276 0.00171438 0.00106023 0.00176978 0.00110741 0.00186211 0.00117863 0.00201398 0.00144626 0.002836 0.00173155 0.00350388 0.0153894 0.0537284	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0301036 0.0208721 0.024264 0.0351799 0.0656767 0.0847352 0.074325 0.098875 0.028594 0.00955295 0.00994098 0.00776993 0.018422 0.0168961 0.0146517 0.0230638 0.0361085 0.022873 0.0136536 0.0212874 0.0216954 0.0227708 0.0153087 0.0061611 0.00366691 0.00138344 0.00212513 0.00127898 0.00236896 0.00136874 0.00290492 0.00183755 0.00523082 0.0037201 0.0132653 0.0286605 0.0284512 0.0184598 0.00868726 0.00490728 0.00750953 0.00175485 0.00109218 0.00126538 0.00092381 0.0012574 0.000905506 0.00129333 0.000918552 0.00138202 0.000981765 0.00171166 0.00131777 0.00353757 0.00276035 0.0137124 0.00457553 0.002844 0.00132791 0.00291776 0.00155044 0.00177037 0.00104936 0.000855688 0.00138483 0.000907015 0.0015043 0.000944204 0.00154116 0.000975598 0.00159367 0.00102167 0.00168338 0.00109078 0.00183192 0.00134468 0.00258692 0.00164048 0.00328323 0.0143984 0.0519545	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0308582 0.0213924 0.0248256 0.0359069 0.0668745 0.0864269 0.0757161 0.100896 0.0294272 0.00987707 0.0103011 0.00804122 0.0191694 0.0176697 0.0154016 0.0240222 0.0376669 0.0242174 0.014893 0.0223311 0.0228912 0.024281 0.0161827 0.00635493 0.00374507 0.00138275 0.00213981 0.00126519 0.002374 0.00134812 0.00293213 0.00182457 0.00552278 0.00385724 0.0129365 0.0265432 0.0228233 0.0122596 0.00515191 0.00210475 0.00272248 0.00251132 0.00276589 0.00540002 0.00104803 0.00116874 0.000886589 0.00116271 0.000882078 0.00122462 0.000929006 0.00144769 0.00117548 0.00282413 0.0026361 0.014122 0.00377029 0.00231734 0.00125279 0.002531 0.00151197 0.00164247 0.00101531 0.000852227 0.00132807 0.000915565 0.00143633 0.000953298 0.00146953 0.000982682 0.0015188 0.00102661 0.00160563 0.00109492 0.00175787 0.00134247 0.00249414 0.00165527 0.00332294 0.0140021 0.0514575	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.030709 0.0212877 0.0247155 0.035768 0.0666588 0.0861112 0.0754764 0.100532 0.0292539 0.00980783 0.0102173 0.00797749 0.0189984 0.0174815 0.015256 0.0238677 0.0374094 0.0240474 0.0146539 0.0221681 0.0227237 0.0240561 0.0161018 0.00632919 0.00375488 0.00138291 0.00215346 0.00126818 0.00239664 0.00135831 0.00298379 0.0018519 0.00570312 0.00399841 0.0133459 0.0272438 0.0233348 0.0123375 0.00505043 0.00191714 0.00225727 0.00168514 0.00127941 0.00217663 0.00261547 0.00558154 0.00104511 0.00121216 0.00092569 0.00125476 0.000951028 0.00146365 0.00118438 0.00282995 0.00270237 0.0147094 0.0038965 0.0023611 0.00127456 0.00257581 0.00154219 0.00166019 0.00102389 0.000857005 0.00133695 0.000920378 0.00144651 0.000958088 0.00147965 0.000987408 0.00152915 0.00103162 0.00161695 0.00110037 0.00177043 0.00135144 0.00251662 0.00166896 0.00335531 0.0141728 0.0520031	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0306326 0.0212342 0.0246603 0.0357005 0.0665591 0.0859601 0.0753641 0.100356 0.0291626 0.00977074 0.0101729 0.0079441 0.0189056 0.0173783 0.0151687 0.0237721 0.0372511 0.0239304 0.014507 0.0220826 0.0226448 0.0239486 0.0160572 0.00632059 0.00376684 0.00138566 0.00216597 0.00127262 0.00241475 0.00136665 0.00301635 0.00186811 0.00578481 0.00405844 0.0135081 0.0275039 0.0235375 0.0123701 0.00503231 0.00189685 0.0021512 0.00158836 0.00115376 0.00167499 0.00120282 0.00219044 0.0026003 0.00562869 0.00106322 0.00129493 0.000986514 0.0014758 0.00118492 0.00276751 0.00270343 0.0147782 0.00393004 0.00238631 0.00128747 0.00259329 0.0015593 0.00166927 0.00102906 0.000860493 0.00134226 0.000923861 0.00145247 0.000961484 0.00148563 0.00099077 0.00153539 0.00103518 0.00162398 0.0011044 0.00177907 0.00135789 0.00253148 0.0016798 0.00337964 0.0142932 0.0523304	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0305767 0.0211952 0.0246182 0.0356456 0.0664692 0.0858336 0.0752631 0.100209 0.0291016 0.00974742 0.0101461 0.00792388 0.0188517 0.0173207 0.0151194 0.0237155 0.0371621 0.0238673 0.0144366 0.0220518 0.0226259 0.0239169 0.0160439 0.00631968 0.00377553 0.00138763 0.00217399 0.00127554 0.00242618 0.00137195 0.00303657 0.0018782 0.00583278 0.00409371 0.0136083 0.0277064 0.0236802 0.0124036 0.00503646 0.00189793 0.00212553 0.00156835 0.00113408 0.00160825 0.00110496 0.00169569 0.00119041 0.00217813 0.00257408 0.0057142 0.00109869 0.00148732 0.00119475 0.00262785 0.00266685 0.0145844 0.00393297 0.00240739 0.0013025 0.00260005 0.00157732 0.00167775 0.00103452 0.000865098 0.00134707 0.000928284 0.00145715 0.000965603 0.00148998 0.000994687 0.00153984 0.00103919 0.00162915 0.00110894 0.00178638 0.00136463 0.00254397 0.00169228 0.00340607 0.0144074 0.0526021	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0305016 0.0211432 0.0245557 0.035551 0.0662848 0.0856031 0.0750559 0.0999422 0.0290373 0.00972826 0.010128 0.0079094 0.0188218 0.0172986 0.0150997 0.0236747 0.0371091 0.0238509 0.0144584 0.0220737 0.0226699 0.0239998 0.0160873 0.00633759 0.00378125 0.0013883 0.00217699 0.00127643 0.00243099 0.00137396 0.00304494 0.00188218 0.00585404 0.0041088 0.0136984 0.0278645 0.023884 0.012507 0.00506707 0.00191152 0.0021228 0.00156927 0.00113122 0.00158995 0.00109179 0.00163175 0.00109815 0.00170306 0.00117774 0.00218438 0.00256496 0.00620318 0.00126149 0.00236381 0.00261525 0.014001 0.00397062 0.00246728 0.00133498 0.00262709 0.00160938 0.00170244 0.00104807 0.000876129 0.00136099 0.000938175 0.00146967 0.000974362 0.00150086 0.00100272 0.00155008 0.00104705 0.00163972 0.00111727 0.00179913 0.00137585 0.00256197 0.00170987 0.00344118 0.0145532 0.0528397	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0302363 0.0209614 0.0243216 0.0351702 0.0654869 0.0846517 0.0741639 0.0988514 0.028864 0.00969315 0.010111 0.00789151 0.0188293 0.0173709 0.0151791 0.0237032 0.037238 0.0240783 0.0148359 0.0223021 0.0229328 0.0244829 0.0163593 0.00644311 0.00376713 0.00138371 0.00214943 0.00126971 0.00240284 0.00136773 0.00301271 0.00187894 0.0058384 0.00413486 0.0138907 0.0282515 0.0247434 0.0129857 0.0052078 0.00191207 0.00209158 0.00159412 0.00111079 0.00150489 0.00106051 0.00152113 0.00105435 0.00153469 0.00106312 0.00159588 0.00117884 0.00202291 0.0028576 0.0109645 0.00256626 0.0126138 0.00406752 0.00252598 0.00138701 0.00255963 0.00164695 0.00170246 0.00105001 0.000879793 0.00134802 0.000942158 0.0014516 0.00097536 0.00147837 0.00100174 0.00152542 0.00104504 0.00161412 0.00111535 0.00177695 0.00137406 0.00252445 0.0017212 0.00345764 0.0143624 0.0517774	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0287438 0.0199203 0.0231819 0.0336452 0.0629091 0.0810874 0.0712129 0.0946256 0.0272124 0.00907428 0.00941333 0.00736011 0.017444 0.0159305 0.0138728 0.0218496 0.0340845 0.0215147 0.0126838 0.0198168 0.020009 0.0203849 0.0136761 0.00539206 0.00331532 0.00124831 0.00193333 0.00114946 0.00213679 0.00122117 0.00261464 0.00163506 0.00477385 0.00333748 0.010458 0.0216806 0.0166273 0.00874655 0.00365933 0.00145306 0.00191601 0.00132329 0.00096498 0.00149458 0.000960984 0.00157622 0.00098172 0.00164358 0.00101847 0.00177475 0.00112407 0.00226029 0.00176581 0.00632639 0.0113369 0.0552236 0.0261336 0.0144779 0.00261097 0.00265842 0.00172011 0.00173141 0.0011134 0.000921461 0.0013678 0.000949807 0.00143548 0.000964022 0.00144464 0.000976327 0.00147993 0.00100911 0.00155677 0.00106802 0.00169935 0.00130289 0.00239959 0.00159963 0.00318881 0.0135195 0.049944	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0292983 0.0203057 0.0236155 0.0342477 0.0639793 0.0825177 0.0724334 0.0963164 0.0277895 0.00928128 0.00963888 0.00753367 0.0178763 0.0163566 0.0142624 0.0224468 0.0350671 0.0222945 0.013239 0.0205444 0.0209094 0.0215692 0.0144575 0.00569793 0.00348048 0.00129689 0.00202147 0.00119365 0.00224341 0.00127532 0.00277614 0.00172661 0.0051896 0.00363592 0.0115164 0.0238581 0.0189207 0.00974411 0.0040161 0.00153817 0.00191476 0.00134437 0.000978087 0.00146019 0.000956044 0.00151471 0.000960719 0.00155569 0.000978155 0.00164167 0.00104631 0.00199449 0.00152438 0.00557597 0.00921038 0.0409626 0.0129141 0.00692833 0.00751206 0.0089495 0.00212111 0.00180298 0.00126626 0.000999016 0.00136619 0.00103732 0.00143633 0.00104312 0.00144844 0.00105219 0.00148963 0.00108607 0.00157655 0.0011535 0.00175181 0.00138371 0.00244843 0.00175557 0.00343031 0.0138395 0.0504783	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.030394 0.0210621 0.0245287 0.0356336 0.066697 0.0859084 0.0754886 0.100223 0.0287055 0.00955592 0.00990193 0.00774577 0.0183156 0.0166768 0.0144755 0.0228008 0.0354778 0.0222439 0.0129754 0.0204606 0.0205931 0.0207417 0.0138965 0.00550766 0.00345161 0.00130979 0.00203027 0.00120956 0.00224452 0.00128541 0.00273985 0.00171745 0.00494866 0.00344264 0.0105417 0.0217056 0.0162983 0.00848038 0.00353122 0.00141291 0.0018864 0.00129869 0.000956147 0.00147541 0.000950002 0.00154675 0.000964776 0.00159749 0.000994204 0.00169583 0.00107348 0.00210614 0.00161127 0.00610153 0.00823964 0.0302132 0.00957407 0.00413358 0.0025831 0.00563187 0.00716653 0.00863741 0.00179135 0.00109964 0.00140645 0.00100335 0.00145917 0.00100308 0.00148433 0.00100703 0.00152042 0.00103437 0.00159627 0.00109195 0.00174739 0.00133544 0.00248163 0.00169696 0.0033693 0.0141937 0.0528806	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0307861 0.0213354 0.024827 0.0360291 0.0673591 0.0868306 0.076256 0.101342 0.0291504 0.00972306 0.0100873 0.00788594 0.0186861 0.0170632 0.0148666 0.0234284 0.0365353 0.0231136 0.0135988 0.0212404 0.0215282 0.0219931 0.0147819 0.00583433 0.00360409 0.0013513 0.0021061 0.0012471 0.00233672 0.00133305 0.00288397 0.00179998 0.00533554 0.00373961 0.0117111 0.0242259 0.019027 0.00976324 0.00402385 0.00154906 0.00196315 0.00137198 0.000999882 0.00150094 0.000977479 0.00155718 0.000982139 0.00159816 0.00100105 0.00168645 0.00107075 0.00206818 0.00155297 0.00563377 0.00761537 0.0255132 0.00794391 0.00343287 0.00191455 0.00318321 0.00232859 0.00237024 0.00220702 0.00232798 0.0052178 0.00101157 0.00123192 0.000945027 0.00126156 0.00094817 0.00130413 0.000980878 0.00138376 0.00104491 0.00153956 0.00123915 0.00216803 0.00168534 0.00322467 0.0127058 0.0489875	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0307889 0.0213371 0.0248302 0.0360357 0.067376 0.0868488 0.0762753 0.101363 0.0291499 0.00972218 0.0100858 0.00788508 0.018683 0.0170579 0.0148617 0.0234235 0.0365218 0.0230922 0.0135736 0.0212183 0.0214976 0.0219259 0.0147283 0.00581313 0.00359789 0.00134968 0.00210414 0.00124599 0.00233446 0.00133192 0.00287985 0.00179755 0.00531935 0.00372589 0.0116542 0.0240969 0.0188759 0.00970124 0.00400087 0.0015415 0.00196234 0.00136947 0.000998187 0.00150249 0.000976572 0.00156021 0.000981933 0.00160231 0.00100183 0.0016924 0.00107311 0.00208458 0.00156848 0.00572633 0.00776608 0.0252661 0.00786098 0.00341034 0.00186157 0.00310529 0.00210646 0.00199886 0.00154317 0.00112531 0.00201069 0.00236876 0.00547936 0.0010323 0.00127812 0.000987333 0.00132707 0.000999635 0.00139866 0.0010558 0.00155136 0.00124485 0.00218218 0.00169673 0.00324899 0.0127967 0.0495451	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0307464 0.0213075 0.0247962 0.035987 0.0672866 0.0867327 0.0761746 0.101228 0.0291089 0.00970846 0.0100714 0.00787406 0.0186564 0.0170326 0.0148386 0.0233871 0.0364649 0.0230561 0.0135514 0.0211974 0.0214843 0.021915 0.0147124 0.00580807 0.00359861 0.00134942 0.00210565 0.00124603 0.00233653 0.00133231 0.00288292 0.00179827 0.00532402 0.00372647 0.0116599 0.024096 0.018857 0.00969679 0.00399831 0.00154211 0.00196462 0.00137 0.00099886 0.00150579 0.00097742 0.00156421 0.000983056 0.00160694 0.0010034 0.00169801 0.00107545 0.00209503 0.00157728 0.00577239 0.00782795 0.0250894 0.00780203 0.00339389 0.0018473 0.00306668 0.00206565 0.00188147 0.00144404 0.0010127 0.00156483 0.00111485 0.00210721 0.00237772 0.00560009 0.00106686 0.00134814 0.00103822 0.00142254 0.00107523 0.00156646 0.00125351 0.00219495 0.00171172 0.00327525 0.0128803 0.0501014	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0307086 0.0212812 0.0247659 0.0359435 0.0672067 0.086629 0.0760849 0.101108 0.0290733 0.0096966 0.010059 0.00786462 0.0186342 0.0170118 0.0148203 0.0233591 0.0364233 0.0230318 0.0135372 0.0211904 0.0214876 0.0219216 0.0147089 0.00580742 0.00360183 0.00134982 0.00210856 0.00124672 0.00234031 0.00133354 0.00288854 0.00180035 0.00533522 0.00373183 0.0116841 0.0241327 0.0188709 0.00970686 0.00400064 0.00154449 0.00196762 0.0013713 0.00100004 0.00150929 0.000978627 0.0015682 0.00098439 0.00161143 0.00100499 0.00170335 0.00107763 0.0021044 0.00158435 0.00580961 0.0078739 0.0250199 0.00778507 0.00339297 0.00184706 0.00306221 0.00206053 0.00184723 0.00141687 0.000985748 0.00148635 0.00101774 0.00164457 0.00113112 0.00212973 0.00237224 0.00572958 0.00110967 0.00143608 0.00111167 0.00158341 0.00126569 0.00219582 0.00173323 0.00330883 0.0128541 0.0502925	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0306601 0.0212475 0.0247269 0.035887 0.0671017 0.0864938 0.0759673 0.100951 0.0290286 0.00968193 0.0100438 0.00785297 0.0186073 0.0169872 0.0147993 0.0233274 0.0363784 0.0230088 0.0135263 0.0211899 0.0215021 0.0219449 0.0147164 0.00581113 0.00360728 0.0013506 0.00211271 0.00124781 0.00234573 0.00133544 0.0028969 0.00180371 0.00535395 0.00374246 0.0117304 0.0242144 0.0189297 0.00974098 0.00401202 0.00155012 0.00197246 0.00137412 0.00100217 0.00151403 0.000980592 0.00157332 0.000986363 0.00161713 0.00100712 0.00171016 0.00108035 0.00211592 0.00159265 0.0058561 0.00794018 0.0250286 0.00779573 0.00340118 0.00185595 0.00306887 0.00206884 0.00183615 0.00140791 0.000977916 0.0014629 0.00099687 0.00156707 0.00103422 0.00166874 0.00114274 0.00216799 0.00238262 0.00592416 0.0011879 0.0016085 0.0013023 0.00219661 0.00177466 0.00337972 0.012741 0.0502816	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0305943 0.0212018 0.0246736 0.0358091 0.0669556 0.0863068 0.0758038 0.100735 0.0289693 0.00966273 0.0100241 0.00783777 0.0185729 0.0169567 0.0147742 0.0232897 0.0363278 0.0229885 0.0135211 0.0211974 0.0215329 0.0219936 0.0147411 0.00582164 0.00361612 0.00135203 0.00211878 0.0012496 0.00235379 0.00133851 0.00290995 0.00180937 0.00538554 0.00376264 0.0118157 0.0243784 0.0190784 0.00982247 0.00404131 0.00156191 0.00198079 0.00137988 0.00100624 0.00152087 0.000984015 0.00158019 0.000989513 0.00162459 0.00101019 0.00171902 0.00108404 0.00213057 0.0016033 0.00591542 0.00804729 0.025113 0.0078362 0.00341817 0.00187636 0.00308261 0.0020909 0.00183459 0.00140757 0.000978766 0.0014584 0.000992479 0.00154552 0.00101588 0.00159384 0.00104751 0.00170942 0.00116756 0.0022311 0.00241537 0.00634872 0.00138671 0.00220216 0.00187363 0.00358152 0.0124369 0.0498925	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0305114 0.0211442 0.0246093 0.0357211 0.0668023 0.0861004 0.0756316 0.100493 0.0288857 0.00963237 0.00999055 0.00781251 0.0185094 0.0168935 0.014715 0.0232054 0.0362072 0.0229153 0.0134778 0.021191 0.0215497 0.02202 0.0147656 0.00583805 0.00363195 0.00135545 0.0021301 0.00125375 0.00236849 0.00134489 0.0029329 0.00182026 0.00543753 0.00379717 0.0119313 0.0246026 0.0192776 0.00995827 0.00409412 0.00158203 0.00199565 0.0013891 0.00101242 0.00153197 0.000989434 0.00159155 0.000994565 0.00163684 0.0010153 0.00173323 0.00108999 0.00215325 0.00162297 0.00607631 0.00832894 0.0257055 0.00803308 0.00349557 0.00192292 0.00313131 0.00215124 0.00184615 0.00141323 0.000985016 0.00146695 0.000996209 0.00154757 0.0010141 0.00157934 0.0010315 0.00164263 0.00107407 0.00178306 0.00121045 0.00233417 0.00256433 0.00800443 0.00213763 0.00400354 0.0118059 0.0478191	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0298305 0.0206721 0.0240629 0.0349325 0.0653385 0.0842052 0.0739792 0.0982773 0.0282396 0.00941304 0.00975926 0.00763228 0.0180867 0.0165112 0.0143768 0.022658 0.0354002 0.0224153 0.0132296 0.0208253 0.0211564 0.0216246 0.014545 0.00576774 0.00353934 0.00132435 0.00206817 0.00122464 0.00229958 0.0013133 0.00284657 0.00177526 0.00527461 0.00373062 0.0117172 0.0244064 0.0192188 0.00995302 0.00406815 0.00156152 0.00195694 0.00135888 0.000990825 0.00148587 0.000964232 0.00153376 0.000966918 0.0015696 0.000985392 0.00165436 0.00105675 0.00204929 0.00162614 0.00604811 0.00898017 0.0254014 0.00792373 0.00323915 0.00193614 0.00270101 0.00204875 0.00169389 0.00139242 0.000943895 0.00132661 0.00094513 0.00137453 0.000953271 0.00138913 0.000961665 0.00142187 0.000987382 0.00148984 0.00105319 0.00165085 0.00123647 0.0021579 0.00311536 0.00770167 0.0279614 0.054505	Based on studies evaluating possible interactions of DRUG1 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0258165 0.0150882 0.015022 0.0163532 0.0264501 0.0262581 0.0107308 0.0107334 0.00980195 0.00241557 0.00411833 0.00321806 0.016911 0.0265869 0.0190013 0.0239992 0.0420818 0.0327267 0.0252846 0.0416735 0.0475926 0.0483732 0.0382164 0.0208002 0.0271307 0.00446931 0.00403738 0.00318483 0.00370149 0.00319011 0.00409668 0.00391859 0.00728321 0.00901817 0.0222494 0.061866 0.0351737 0.02282 0.0148744 0.00542411 0.00848269 0.0028128 0.0017863 0.00207145 0.00154795 0.00204951 0.00152463 0.00207773 0.00152104 0.00217589 0.00158836 0.00262068 0.00207063 0.00529792 0.00438987 0.0220566 0.00716428 0.00420061 0.00196732 0.00422135 0.00226941 0.00253214 0.00151755 0.00124713 0.0019933 0.00132473 0.0021502 0.00137921 0.00220053 0.00142322 0.00227289 0.00148775 0.00239707 0.00158626 0.00261187 0.00194546 0.00365699 0.00235542 0.00473257 0.0205624 0.0750345	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0263469 0.0154044 0.0153393 0.0167031 0.0270322 0.0268346 0.0109627 0.0109617 0.0100129 0.00246709 0.00420769 0.00329203 0.017339 0.0272938 0.0195545 0.0247453 0.0432996 0.0337354 0.0261513 0.0425854 0.0485476 0.0494122 0.039111 0.0215166 0.028279 0.00460234 0.00412976 0.00326904 0.00376755 0.00326491 0.00417792 0.00401149 0.00757259 0.00941745 0.0237255 0.0617011 0.0300557 0.0159076 0.0115171 0.00540423 0.0045312 0.00347019 0.00374057 0.0078659 0.00166601 0.00189622 0.0014338 0.0018856 0.00142719 0.00197006 0.0014838 0.00230747 0.00185552 0.00443546 0.00412299 0.0221801 0.00606799 0.00356612 0.0018823 0.00377018 0.00224178 0.00239919 0.00147514 0.00123467 0.0019149 0.00132237 0.00206106 0.00137591 0.00210737 0.00141577 0.00217517 0.00147636 0.00229656 0.00157348 0.00251818 0.00192714 0.00357319 0.0023821 0.00482099 0.0202377 0.0742529	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.026197 0.0153135 0.0152478 0.0166023 0.0268633 0.0266692 0.0108959 0.0108949 0.00995184 0.00245182 0.00418037 0.00327113 0.017219 0.0270979 0.0194018 0.024541 0.042954 0.0334384 0.0258996 0.0424059 0.0483658 0.0490597 0.0389003 0.0213365 0.028012 0.00456995 0.0041082 0.00325384 0.00374799 0.00325348 0.00417223 0.00401672 0.00762164 0.00950385 0.024267 0.0626684 0.0302726 0.0160285 0.0112633 0.00498538 0.00378443 0.0024545 0.00204063 0.00346418 0.00343183 0.00800016 0.00162591 0.00191565 0.00145124 0.00197195 0.00148992 0.00229684 0.00184407 0.00438782 0.0041559 0.0230818 0.00627452 0.00362418 0.00191302 0.00383078 0.00227932 0.00241993 0.00148766 0.00124036 0.00192593 0.00132653 0.00207216 0.00137996 0.00211837 0.00141946 0.00218606 0.00147997 0.00230777 0.00157706 0.00252948 0.00193447 0.00359625 0.00239251 0.00485983 0.0204348 0.0750889	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0261058 0.0152584 0.0151923 0.016541 0.0267607 0.0265684 0.0108554 0.0108545 0.00991469 0.00244261 0.00416399 0.00325825 0.0171445 0.0269753 0.0193053 0.0244114 0.042738 0.0332585 0.025733 0.0422739 0.0482418 0.0488624 0.0387858 0.021246 0.0278773 0.00455598 0.00410125 0.00324868 0.00374297 0.00325078 0.00417408 0.00401937 0.00763113 0.00950864 0.0243105 0.0629956 0.0302691 0.0160236 0.0112041 0.004889 0.00359619 0.00232187 0.00179639 0.00258347 0.00186171 0.00328911 0.00336166 0.00790881 0.0016572 0.00204963 0.00153703 0.00232412 0.00185528 0.00433965 0.00421711 0.0236531 0.00640595 0.0036722 0.0019357 0.0038704 0.00230962 0.00243752 0.0014997 0.00124716 0.00193802 0.001333 0.00208539 0.00138632 0.00213155 0.00142564 0.00219937 0.0014863 0.00232182 0.00158378 0.00254492 0.00194434 0.00362013 0.0024051 0.00489191 0.0206083 0.0756695	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0260544 0.0152274 0.0151611 0.0165067 0.0267036 0.0265122 0.0108328 0.010832 0.00989394 0.00243748 0.00415493 0.00325109 0.0171037 0.0269084 0.0192531 0.0243415 0.0426211 0.0331619 0.0256431 0.0421954 0.0481669 0.0487518 0.0387157 0.0211949 0.0278032 0.00454845 0.00409695 0.00324567 0.00373973 0.00324903 0.00417479 0.00402157 0.00763494 0.00951173 0.0243223 0.0632671 0.0303161 0.0160419 0.0112009 0.00487145 0.00355224 0.00230215 0.0017865 0.00253291 0.00169214 0.00250153 0.00184372 0.00325629 0.0033457 0.00806423 0.00172481 0.00236668 0.00186353 0.00413687 0.00418564 0.0235308 0.00643451 0.00369822 0.00195537 0.00388011 0.0023356 0.00244824 0.00150763 0.00125308 0.00194481 0.00133816 0.00209171 0.00139077 0.00213714 0.00142952 0.00220472 0.00149006 0.00232785 0.00158796 0.00255327 0.00195117 0.00363532 0.0024191 0.0049235 0.0207295 0.0759761	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0260271 0.0152119 0.0151459 0.0164903 0.0266778 0.0264863 0.010822 0.0108211 0.00988413 0.00243506 0.00415098 0.00324818 0.0170905 0.0268898 0.0192423 0.0243298 0.0425966 0.0331442 0.025641 0.0421642 0.0481211 0.0487035 0.0386676 0.0211792 0.0277892 0.00454647 0.00409261 0.00324271 0.00373504 0.0032453 0.00416795 0.00401456 0.00762347 0.00949431 0.0243049 0.0631458 0.0303184 0.0160595 0.0112606 0.00489412 0.00355211 0.00230587 0.00178945 0.00252189 0.00169216 0.00246802 0.00168802 0.00250086 0.00182271 0.00325459 0.00341747 0.00893022 0.00201729 0.00376946 0.00409591 0.0227768 0.00651199 0.00377344 0.00199591 0.00390471 0.00237775 0.00247521 0.00152311 0.00126525 0.00195899 0.00134758 0.00210295 0.0013979 0.00214546 0.00143509 0.00221161 0.00149495 0.00233473 0.00159302 0.00256244 0.00195919 0.00364963 0.00243594 0.0049578 0.0208345 0.0760427	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0261315 0.0152785 0.015214 0.0165671 0.0268111 0.0266148 0.0108719 0.0108701 0.00992945 0.00244615 0.00417151 0.00326583 0.0172067 0.0270936 0.0194146 0.0245744 0.0429709 0.0334519 0.0260121 0.0423849 0.0482047 0.0488006 0.0386392 0.0213238 0.0280403 0.00458338 0.00409152 0.00325345 0.00372932 0.00324665 0.00414533 0.00399953 0.00763011 0.00944819 0.0244156 0.0611873 0.0296233 0.015924 0.0113907 0.00476929 0.00341882 0.0022656 0.00174041 0.00230718 0.00162577 0.00222391 0.00160625 0.00221473 0.00158855 0.00225773 0.00172605 0.00293278 0.00413794 0.0166106 0.00424383 0.0200327 0.00668145 0.00386504 0.00206189 0.00378795 0.00242719 0.00247982 0.00152217 0.0012686 0.00194044 0.00134774 0.0020747 0.00139124 0.00210781 0.00142451 0.00216948 0.00148242 0.0022907 0.00158012 0.00252174 0.00194531 0.00358249 0.00243902 0.00494217 0.0203605 0.0736454	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0221812 0.0129552 0.0128961 0.0140367 0.022695 0.0225387 0.0092142 0.00921577 0.00841684 0.00207387 0.00353338 0.00276157 0.0144951 0.0227757 0.016261 0.020527 0.0360382 0.0280567 0.0215526 0.0359739 0.0412659 0.0418413 0.0334796 0.0181955 0.0237148 0.00391391 0.00359112 0.00285356 0.00330536 0.0028711 0.0036967 0.00354144 0.00647082 0.00795769 0.0186776 0.0482055 0.021863 0.0109705 0.00714656 0.00330019 0.0026719 0.00172315 0.00140004 0.00202746 0.00136459 0.0020397 0.00138285 0.00209404 0.00141479 0.00223912 0.00156763 0.0029343 0.00290199 0.0087021 0.017112 0.0963564 0.0488675 0.0245337 0.00491681 0.00452047 0.0027034 0.00260885 0.00167559 0.00136958 0.00198097 0.0013827 0.00204036 0.00138476 0.00202822 0.0013859 0.00205809 0.00141885 0.00214641 0.00149038 0.00232899 0.00179437 0.00323513 0.00216082 0.00430347 0.018049 0.0666224	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0232089 0.0135579 0.0134966 0.0146915 0.023757 0.0235911 0.00964271 0.0096433 0.00880721 0.00216987 0.0036971 0.0028909 0.0151843 0.0238664 0.0170508 0.0215351 0.03777 0.0293904 0.0226334 0.0376154 0.0430813 0.043612 0.0347504 0.0188839 0.0246658 0.00404168 0.00368303 0.00292164 0.00337869 0.00293593 0.00378355 0.00363586 0.0067515 0.00834622 0.0202562 0.0524474 0.0237655 0.0119123 0.00801864 0.00360261 0.00274923 0.00176414 0.0014234 0.00201499 0.00136069 0.00199296 0.00136046 0.00202016 0.00136981 0.00211327 0.00147421 0.00265726 0.00256397 0.00801837 0.0148081 0.0795323 0.0285825 0.0118128 0.0120701 0.0136748 0.00340643 0.00275767 0.00191199 0.00149543 0.00201457 0.00151971 0.00208197 0.0015088 0.00207578 0.0015048 0.00211373 0.00153847 0.00221731 0.00162153 0.00244541 0.00192872 0.00338963 0.00243608 0.00471183 0.0185939 0.0666885	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0241974 0.0141285 0.0140619 0.0153034 0.0247354 0.0245669 0.0100447 0.0100458 0.009173 0.00226 0.00384809 0.00300718 0.0157664 0.0247506 0.0176487 0.0222501 0.0390699 0.0303677 0.0232847 0.0390334 0.0448327 0.0454308 0.0362639 0.0194935 0.0253965 0.00410672 0.00377125 0.00298737 0.00347073 0.00300669 0.00387542 0.00369228 0.00673505 0.0082514 0.0188039 0.048657 0.0211072 0.0103181 0.00636144 0.00289457 0.00258534 0.00169506 0.0013815 0.00198945 0.0013572 0.00200081 0.00137199 0.00204783 0.00139835 0.00216287 0.00151107 0.00276136 0.00252719 0.00837789 0.0136235 0.0669142 0.024308 0.00757686 0.00491992 0.00904278 0.0119658 0.013697 0.0029586 0.00172117 0.0020708 0.00146952 0.00209371 0.00145305 0.00211067 0.00144349 0.00214223 0.00146808 0.00222898 0.00153657 0.00242235 0.00185697 0.00340253 0.00232505 0.00461628 0.0193306 0.0711334	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0248124 0.0144914 0.0144246 0.0157001 0.0253824 0.0252072 0.0103045 0.0103051 0.00941082 0.0023185 0.00394886 0.00308729 0.0162025 0.0254524 0.0181667 0.0229242 0.0402214 0.0312689 0.0240308 0.0400957 0.0459743 0.0465104 0.0370681 0.0200833 0.0262315 0.00425584 0.00388472 0.00308521 0.00356777 0.00310389 0.00399511 0.00383529 0.00707694 0.00874227 0.0208465 0.0543194 0.0242102 0.0119348 0.00780496 0.00352446 0.00282028 0.00181629 0.00147343 0.00208594 0.00141464 0.00206853 0.00141677 0.00209917 0.00142937 0.00219499 0.00153095 0.00274853 0.00252162 0.00798574 0.0131643 0.0607276 0.021094 0.00651933 0.00376475 0.00556278 0.00421102 0.00388001 0.00362828 0.0037634 0.00795745 0.00156255 0.00185447 0.0014031 0.00186314 0.00139789 0.00191057 0.00143488 0.00201259 0.00151906 0.00222739 0.0017909 0.00310693 0.00242655 0.00461911 0.0178653 0.067316	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0248309 0.0145019 0.014435 0.0157112 0.0254 0.025225 0.0103119 0.0103125 0.0094176 0.00232018 0.00395166 0.00308939 0.0162127 0.0254675 0.0181764 0.0229341 0.0402407 0.0312832 0.0240367 0.0401182 0.0460082 0.0465481 0.0370996 0.0200907 0.0262484 0.00425539 0.00388612 0.00308593 0.00356959 0.00310515 0.00399739 0.00383636 0.00707029 0.00873143 0.0207568 0.0541529 0.0240889 0.0118579 0.0077173 0.00349028 0.00281694 0.00181397 0.00147192 0.00208981 0.0014143 0.0020742 0.00141741 0.00210674 0.00143123 0.00220528 0.00153452 0.0027728 0.00254408 0.00812458 0.0134006 0.0604545 0.0209789 0.00647291 0.00367111 0.00544441 0.00379258 0.00327524 0.00245031 0.00187874 0.00322536 0.00360804 0.00826577 0.00154289 0.00187542 0.00144245 0.00192076 0.00145187 0.0020135 0.00152649 0.00222592 0.00178981 0.00310293 0.00244736 0.00467432 0.0179338 0.0677426	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0247964 0.0144816 0.0144148 0.0156892 0.0253642 0.0251896 0.0102974 0.0102982 0.00940445 0.00231696 0.00394616 0.00308505 0.0161896 0.025431 0.0181501 0.0229003 0.0401826 0.0312384 0.0240002 0.0400639 0.0459506 0.0464919 0.037056 0.0200592 0.0262097 0.00424855 0.00388081 0.00308116 0.00356488 0.00310061 0.00399251 0.00383121 0.007059 0.00871719 0.0207 0.0540396 0.0240225 0.0118194 0.00768019 0.00347693 0.00281509 0.00181223 0.00147079 0.00209098 0.00141354 0.00207601 0.00141698 0.00210915 0.00143126 0.00220843 0.00153495 0.00277975 0.00255224 0.00817652 0.0134823 0.0599943 0.020786 0.00642513 0.00363972 0.00537359 0.00369148 0.00308287 0.00228241 0.00164812 0.00245989 0.00176484 0.00325744 0.003572 0.00831924 0.00158547 0.00197745 0.00151409 0.00206068 0.001563 0.00226046 0.00181269 0.00313523 0.00247614 0.00472396 0.018101 0.0687007	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0247664 0.014464 0.0143972 0.01567 0.0253331 0.0251588 0.0102849 0.0102856 0.009393 0.00231414 0.00394135 0.00308128 0.0161696 0.0253995 0.0181275 0.0228715 0.0401326 0.0311998 0.0239699 0.0400182 0.0459013 0.0464421 0.0370166 0.0200313 0.0261748 0.0042425 0.00387581 0.00307676 0.00356042 0.0030964 0.00398801 0.0038267 0.00705017 0.00870702 0.0206628 0.0539748 0.0239777 0.011793 0.00765338 0.00346586 0.0028127 0.0018105 0.00146948 0.00209098 0.00141255 0.00207642 0.0014162 0.00211 0.0014308 0.00220986 0.00153473 0.00278316 0.00255566 0.00820418 0.0135321 0.0596996 0.0206751 0.00640796 0.00363236 0.00536202 0.00367163 0.00302646 0.0022393 0.00160479 0.00234856 0.00158562 0.00250688 0.00178281 0.00327131 0.00355356 0.00848535 0.00164916 0.00210988 0.00162321 0.00229939 0.00184138 0.00315304 0.00252088 0.00479983 0.018103 0.0691018	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.024725 0.0144398 0.0143731 0.0156438 0.0252906 0.0251167 0.0102677 0.0102684 0.00937732 0.00231028 0.00393479 0.00307615 0.0161427 0.0253573 0.0180975 0.0228335 0.0400666 0.0311489 0.0239311 0.0399577 0.0458339 0.0463724 0.0369614 0.0199953 0.0261293 0.00423574 0.00386991 0.00307163 0.00355507 0.00309143 0.00398275 0.00382186 0.00704229 0.00869951 0.020648 0.0539689 0.0239727 0.0117934 0.0076516 0.0034641 0.00281295 0.00181005 0.00146863 0.00209175 0.00141158 0.00207723 0.00141527 0.00211111 0.00143 0.00221135 0.00153409 0.00278637 0.00256036 0.00823486 0.0136091 0.0595876 0.0206319 0.0064079 0.0036394 0.0053656 0.00367445 0.00300352 0.002223 0.00159123 0.00231384 0.00155441 0.00240602 0.00160642 0.00252874 0.00179821 0.00332611 0.00357036 0.00878163 0.00176844 0.002367 0.00190264 0.00317007 0.00259455 0.00493814 0.0179632 0.0692011	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.024666 0.0144053 0.0143388 0.0156064 0.0252303 0.0250569 0.0102432 0.010244 0.00935504 0.00230479 0.00392548 0.00306892 0.016105 0.0252987 0.0180562 0.0227819 0.0399763 0.0310794 0.0238797 0.0398747 0.0457392 0.0462711 0.0368808 0.0199478 0.0260696 0.00422834 0.003863 0.00306588 0.00354869 0.00308587 0.00397689 0.00381749 0.00703741 0.00869865 0.0206787 0.0540845 0.0240539 0.0118488 0.00770289 0.00348412 0.00282022 0.00181293 0.00146986 0.00209512 0.00141154 0.00207962 0.00141484 0.0021133 0.00142927 0.00221341 0.00153346 0.00279045 0.00257018 0.00827819 0.0137483 0.0597318 0.0206761 0.00642904 0.00367228 0.00538221 0.00370272 0.00299497 0.00221975 0.00159056 0.00230449 0.00154643 0.00237635 0.00157915 0.00243113 0.00162312 0.0025824 0.00183206 0.00341114 0.00361687 0.00940995 0.00206449 0.00321165 0.00274919 0.00526866 0.0174907 0.0687417	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0245813 0.0143552 0.0142886 0.0155516 0.0251403 0.0249679 0.0102071 0.0102078 0.00932185 0.00229656 0.00391115 0.00305776 0.0160438 0.0252007 0.0179831 0.0226862 0.0398132 0.0309464 0.0237722 0.0397376 0.0455847 0.0460953 0.0367534 0.0198543 0.025941 0.00421376 0.00384978 0.0030551 0.0035371 0.0030755 0.00396647 0.00380946 0.00702665 0.00869123 0.0207115 0.0541255 0.0241215 0.0119648 0.00780422 0.00351612 0.00282831 0.00181632 0.00146975 0.00209639 0.00141016 0.0020798 0.00141296 0.0021137 0.00142736 0.00221424 0.00153175 0.00279672 0.00259431 0.00844956 0.0141803 0.0610418 0.0211853 0.0065692 0.00376356 0.00546791 0.00380798 0.00301241 0.0022289 0.00159886 0.00231419 0.00154854 0.00237724 0.00157419 0.00241196 0.00159854 0.00249541 0.00165737 0.00267701 0.00188106 0.00351069 0.00377614 0.0118641 0.00320268 0.00592509 0.0164273 0.0658932	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0238218 0.0139112 0.0138468 0.0150706 0.0243623 0.0241957 0.0098915 0.00989221 0.00903396 0.0022255 0.00378991 0.0029632 0.0155456 0.0244185 0.017424 0.0219851 0.0385927 0.0299954 0.0230454 0.0385714 0.0442238 0.0446782 0.0356672 0.0192562 0.0250947 0.00410578 0.00374273 0.00297902 0.00344059 0.00299791 0.00385836 0.00372047 0.00686503 0.00854124 0.0206174 0.0534359 0.0241058 0.0121603 0.00815353 0.00364709 0.00278286 0.00177083 0.00143188 0.0020217 0.00136096 0.00199129 0.0013584 0.0020122 0.00136843 0.00209367 0.00147853 0.00270839 0.00269462 0.00872666 0.0149288 0.058417 0.0200685 0.00611135 0.0038769 0.00470108 0.00368871 0.00270661 0.00219043 0.00152321 0.00205295 0.00145261 0.00206857 0.00145803 0.00207677 0.00146826 0.00211821 0.00150268 0.0022036 0.00159019 0.00240794 0.00185106 0.00319077 0.00453764 0.0114731 0.0397502 0.0729102	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0273957 0.0160059 0.0159197 0.0173143 0.0279239 0.0276485 0.0113134 0.0113094 0.0103021 0.00254455 0.0043359 0.00331615 0.0172924 0.0268588 0.0185112 0.0224728 0.0392629 0.0284105 0.0207032 0.0385855 0.047192 0.0492586 0.0366086 0.0195446 0.0122876 0.00521344 0.0171805 0.00315742 0.00373693 0.0028623 0.00391194 0.00348261 0.0068229 0.00817958 0.02195 0.0656724 0.0383089 0.0236685 0.0150456 0.00557841 0.00870444 0.0028458 0.00180513 0.00208963 0.00155763 0.00206244 0.00152718 0.00208638 0.00152152 0.00218526 0.00159026 0.00264133 0.0020798 0.00536934 0.00440247 0.022114 0.00719313 0.00426211 0.0020014 0.00431666 0.00231826 0.00259823 0.00155578 0.00127728 0.00204482 0.00135663 0.00220795 0.00141242 0.00226006 0.00145795 0.00233515 0.00152467 0.00246379 0.00162619 0.00268493 0.00199605 0.00376318 0.00241902 0.00485903 0.021193 0.0772004	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0280736 0.0164052 0.016318 0.01775 0.0286386 0.0283566 0.0116004 0.0115929 0.0105614 0.00260793 0.00444367 0.00340079 0.0177486 0.0275752 0.019024 0.0231262 0.0403616 0.0292842 0.0213823 0.039738 0.0487606 0.0509242 0.0379586 0.0202959 0.0128045 0.00546996 0.0181879 0.00327197 0.00383353 0.00293923 0.00400038 0.00356232 0.00707546 0.00855872 0.0235727 0.066512 0.0329053 0.0163237 0.0113111 0.00514228 0.00450134 0.00353343 0.00374767 0.00795136 0.00165502 0.00187108 0.00141755 0.0018639 0.00140989 0.00194807 0.00146822 0.00228757 0.00184029 0.00442429 0.00407624 0.0218523 0.00597534 0.00355991 0.00189203 0.00380604 0.00226458 0.00243256 0.00149629 0.00125411 0.00194568 0.00134462 0.00209751 0.00139967 0.0021455 0.00144122 0.00221591 0.00150388 0.00234123 0.00160356 0.00256807 0.0019652 0.00364591 0.00242953 0.00491001 0.0206903 0.0758237	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0279059 0.0163047 0.016217 0.017639 0.0284542 0.028175 0.011527 0.0115198 0.0104944 0.0025912 0.00441416 0.00337888 0.0176265 0.0273783 0.0188804 0.0229522 0.0400579 0.0290381 0.0211498 0.0394644 0.0483935 0.0503884 0.0376191 0.0201298 0.0127459 0.00543049 0.0180803 0.00326025 0.00382405 0.00293439 0.00400276 0.00357348 0.00714119 0.00867484 0.0242475 0.0679669 0.0330461 0.0163997 0.0110683 0.00474075 0.00371899 0.00246951 0.00198802 0.00342055 0.0034397 0.00804731 0.00161349 0.00189224 0.00143808 0.0019539 0.00147701 0.00228039 0.00183228 0.0043856 0.00412385 0.0227928 0.00618491 0.00361464 0.00192189 0.00386734 0.00230268 0.00245223 0.00150806 0.00125876 0.00195514 0.00134799 0.00210752 0.001403 0.0021554 0.00144422 0.00222573 0.00150686 0.00235139 0.00160648 0.00257817 0.00197171 0.00366668 0.00243801 0.00494309 0.0208818 0.0765961	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0278068 0.0162455 0.0161575 0.0175736 0.028346 0.0280681 0.011484 0.0114771 0.0104551 0.00258146 0.0043971 0.00336592 0.0175544 0.0272618 0.0187958 0.0228488 0.0398781 0.0288945 0.0210088 0.0392867 0.0481749 0.0501052 0.0374448 0.02005 0.0127243 0.00541495 0.0180364 0.00325793 0.00382574 0.00293612 0.00401026 0.00358104 0.0071645 0.0087007 0.0243381 0.0684095 0.0329984 0.0163745 0.0110143 0.0046392 0.00353176 0.00233932 0.00175638 0.0025666 0.00183458 0.0032685 0.00338343 0.00795802 0.00164365 0.00202615 0.00152611 0.00230798 0.00184291 0.0043359 0.00417816 0.0233136 0.00630504 0.00366147 0.00194409 0.0039069 0.00233232 0.00246932 0.0015193 0.00126492 0.00196663 0.0013539 0.00212042 0.00140884 0.00216829 0.00144993 0.00223881 0.00151276 0.00236527 0.00161281 0.00259349 0.00198131 0.00369059 0.00245048 0.00497444 0.0210554 0.0771523	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0277482 0.0162106 0.0161226 0.0175353 0.0282829 0.0280056 0.0114588 0.0114519 0.010432 0.00257574 0.00438711 0.00335831 0.0175127 0.0271949 0.0187476 0.0227897 0.0397755 0.0288128 0.0209309 0.039182 0.0480493 0.0499463 0.0373409 0.020001 0.0127077 0.00540528 0.0180053 0.00325575 0.00382511 0.00293607 0.00401303 0.00358486 0.0071739 0.00871345 0.0243803 0.0687597 0.0330281 0.0163849 0.0110164 0.00462518 0.0034876 0.00231741 0.00174266 0.00251169 0.00167231 0.0025027 0.00181943 0.00324279 0.00337267 0.00811379 0.00170978 0.00234122 0.00185259 0.00413206 0.0041459 0.0231769 0.0063242 0.00368689 0.00196409 0.00391603 0.00235827 0.00247978 0.00152695 0.00127068 0.00197311 0.00135901 0.00212659 0.00141331 0.00217379 0.00145388 0.00224415 0.00151664 0.00237137 0.00161715 0.00260203 0.00198839 0.0037061 0.00246494 0.00500662 0.0211824 0.0774644	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0277171 0.0161928 0.0161049 0.0175163 0.0282526 0.0279755 0.0114462 0.0114392 0.0104205 0.00257287 0.00438227 0.00335475 0.0174954 0.0271692 0.0187306 0.022769 0.0397386 0.028789 0.0209264 0.0391617 0.0480211 0.0499098 0.0373052 0.0199903 0.0126906 0.00539958 0.0179886 0.00325142 0.00381816 0.00293097 0.00400448 0.00357703 0.00715998 0.00869444 0.0243628 0.068646 0.0330115 0.016396 0.0110744 0.00465336 0.00348643 0.00232072 0.0017439 0.0024989 0.00166921 0.00246378 0.00167032 0.00250714 0.00180388 0.00324757 0.00343546 0.00896534 0.00199204 0.00374474 0.00406233 0.0224111 0.00638869 0.00376231 0.00200607 0.00394197 0.00240138 0.00250798 0.00154317 0.00128358 0.00198846 0.00136935 0.00213921 0.0014215 0.00218362 0.00146061 0.00225267 0.00152279 0.00238001 0.00162358 0.0026132 0.00199808 0.00372305 0.00248377 0.00504481 0.0213073 0.0775895	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0278361 0.0162662 0.0161794 0.0175994 0.0283932 0.0281123 0.0114995 0.0114906 0.0104676 0.00258427 0.00440213 0.00337124 0.0175958 0.0273388 0.0188578 0.0229276 0.0399969 0.0290054 0.0212449 0.0395513 0.048398 0.0502665 0.0374176 0.0202145 0.0126566 0.00542129 0.0180314 0.00325502 0.003797 0.00292222 0.00397349 0.00355956 0.007151 0.00865244 0.0244687 0.0662906 0.0321277 0.0162118 0.0111937 0.00456249 0.00337084 0.00228812 0.00170174 0.00229149 0.00160758 0.00222484 0.00159189 0.00222109 0.00157984 0.0022645 0.00172203 0.00292195 0.0041364 0.0166189 0.00415051 0.0196941 0.00652046 0.00384907 0.00207504 0.00382676 0.00245329 0.00251341 0.00154421 0.00128859 0.00197206 0.00137201 0.00211346 0.00141782 0.00214914 0.00145331 0.00221413 0.00151374 0.00233988 0.00161443 0.00257703 0.00198875 0.00366236 0.00249314 0.0050461 0.0208883 0.0754356	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0235968 0.01378 0.0137041 0.0149025 0.0240301 0.0238009 0.00974352 0.00974277 0.00887662 0.00219263 0.00373647 0.00285736 0.0148879 0.0231171 0.0159433 0.0193906 0.0338994 0.02458 0.0177718 0.033428 0.0410699 0.0429068 0.0324959 0.0174057 0.0111645 0.00470641 0.0156813 0.00286422 0.00339532 0.00261102 0.00356321 0.00316565 0.00609503 0.00727685 0.0185923 0.0515094 0.0242566 0.0113877 0.00705105 0.00310863 0.00268404 0.00175158 0.00137696 0.00203781 0.00136046 0.00206228 0.00138086 0.00211968 0.001418 0.00226821 0.00157032 0.00294283 0.00283335 0.00861393 0.0169766 0.0962012 0.048218 0.0244349 0.00477969 0.0044249 0.00267868 0.0026049 0.00167074 0.00136711 0.00198477 0.00138403 0.0020502 0.00138869 0.00204196 0.00139268 0.00207579 0.00142841 0.00216861 0.00150265 0.00235601 0.00181343 0.00328207 0.00218857 0.00436554 0.018453 0.0680569	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0247617 0.0144616 0.0143818 0.0156401 0.0252204 0.0249768 0.010223 0.0102196 0.00930955 0.00229907 0.00391631 0.00299607 0.0156135 0.0242388 0.0167111 0.0203228 0.0355011 0.0257148 0.0185947 0.0349392 0.0428921 0.0446844 0.033618 0.017908 0.0114967 0.00485641 0.0161857 0.0029413 0.00347779 0.00267198 0.00365438 0.00325591 0.00637362 0.00767081 0.0203207 0.056745 0.0262151 0.0122745 0.00790648 0.00340472 0.00274933 0.0017951 0.00140039 0.00202571 0.00135748 0.00201705 0.00135988 0.00204834 0.00137466 0.00214556 0.00147899 0.00266795 0.00249276 0.00790371 0.0146725 0.078744 0.0274268 0.0115914 0.0120128 0.0136416 0.00333252 0.00273094 0.00189595 0.00148768 0.00201176 0.0015193 0.0020868 0.00151242 0.00208566 0.00151213 0.0021285 0.00154922 0.00223728 0.00163553 0.00247138 0.00194961 0.00343406 0.00246302 0.00478178 0.019094 0.0685789	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0259208 0.0151347 0.01505 0.0163643 0.0263822 0.0261304 0.0106975 0.0106967 0.00974391 0.00240659 0.0040993 0.00313425 0.0163147 0.0253097 0.0174371 0.0211944 0.0370119 0.0267499 0.0192266 0.0362084 0.0443808 0.0463146 0.0348614 0.0183832 0.0119461 0.00502094 0.0166712 0.00302245 0.0035937 0.00275893 0.00376963 0.00333378 0.00640302 0.00757635 0.0186311 0.0514844 0.0234821 0.0107113 0.00626656 0.00271377 0.00262435 0.00173902 0.00137427 0.00201994 0.00136788 0.00204395 0.00138514 0.00209412 0.001417 0.00221449 0.00153356 0.0028127 0.00251438 0.00837881 0.0135173 0.0654814 0.0232031 0.0073837 0.0048047 0.00898166 0.0118917 0.0136627 0.00292274 0.00171467 0.00208545 0.00148339 0.0021191 0.00146905 0.00213963 0.001462 0.00217576 0.00148975 0.0022684 0.00156205 0.00246955 0.00189234 0.0034774 0.00237434 0.00471998 0.0199131 0.0732764	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265552 0.0155072 0.0154209 0.0167689 0.027037 0.026777 0.0109607 0.010958 0.00998174 0.00246507 0.00419842 0.00321138 0.016726 0.0259553 0.0178833 0.0217405 0.0379677 0.0274549 0.019782 0.0372404 0.0457037 0.0475786 0.0357725 0.0189679 0.0122419 0.00517003 0.0172008 0.0031193 0.00368986 0.00284018 0.00387853 0.00345402 0.00671783 0.00805432 0.0208983 0.0586391 0.0268504 0.0123413 0.00771121 0.00331989 0.00283723 0.0018566 0.00145609 0.00210658 0.00141712 0.00210264 0.00142172 0.00213718 0.00144015 0.00223862 0.00154519 0.00278597 0.00249161 0.00795087 0.0130357 0.0589132 0.0199784 0.00631491 0.0036492 0.0054657 0.00412392 0.00385968 0.00362308 0.00375903 0.00797259 0.00156083 0.00185821 0.00140981 0.00187346 0.00140688 0.00192442 0.0014467 0.00203077 0.00153387 0.00225071 0.00181098 0.00314665 0.00245341 0.00467798 0.0183247 0.0690662	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265745 0.0155184 0.015432 0.0167808 0.0270562 0.0267962 0.0109687 0.0109661 0.00998917 0.00246694 0.00420168 0.00321373 0.0167375 0.0259725 0.0178947 0.0217537 0.0379893 0.0274686 0.0197828 0.0372471 0.0457158 0.0475963 0.0357894 0.0189679 0.0122519 0.00517343 0.0172122 0.00311992 0.00369181 0.00284158 0.00388091 0.00345531 0.00671205 0.00804189 0.0207972 0.0584213 0.026735 0.0122685 0.00762417 0.00328463 0.00283512 0.00185468 0.0014546 0.00211075 0.00141687 0.00210873 0.0014224 0.00214519 0.00144207 0.00224955 0.00154891 0.0028116 0.00251465 0.00809206 0.0132733 0.0585616 0.0198495 0.00627657 0.0035633 0.00535187 0.00372009 0.00326576 0.0024605 0.00186624 0.00321913 0.00362624 0.0082888 0.00154917 0.00188748 0.00145389 0.00193876 0.00146557 0.00203515 0.00154272 0.00225232 0.00181128 0.00314663 0.00247315 0.004728 0.0184133 0.0695806	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265361 0.015496 0.0154097 0.0167566 0.027017 0.0267574 0.0109529 0.0109504 0.00997488 0.00246342 0.00419574 0.00320913 0.0167133 0.0259348 0.0178686 0.0217221 0.0379339 0.0274288 0.0197495 0.0371872 0.0456443 0.0475257 0.0357395 0.0189343 0.0122366 0.0051656 0.0171878 0.00311489 0.00368682 0.00283735 0.00387607 0.00345062 0.00670131 0.00802803 0.0207381 0.0582925 0.0266671 0.012232 0.00758701 0.00327151 0.00283382 0.00185317 0.00145359 0.00211231 0.00141625 0.00211096 0.00142212 0.00214803 0.00144224 0.00225319 0.00154954 0.00281943 0.00252312 0.00814521 0.0133541 0.0580826 0.019664 0.00623432 0.0035357 0.00528656 0.00362746 0.00307807 0.00229497 0.00164409 0.00246829 0.00176452 0.00326887 0.003595 0.00835689 0.00159402 0.00199133 0.00152735 0.00208098 0.00157824 0.00228504 0.00183263 0.00317696 0.0025005 0.0047747 0.0185848 0.0705606	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265044 0.0154774 0.0153912 0.0167365 0.0269847 0.0267255 0.0109398 0.0109374 0.00996305 0.00246051 0.00419082 0.00320532 0.0166933 0.0259036 0.0178473 0.0216964 0.0378887 0.0273964 0.0197226 0.0371387 0.0455851 0.0474657 0.0356953 0.018904 0.0122223 0.00515848 0.0171656 0.00311046 0.00368238 0.00283361 0.0038719 0.00344678 0.00669335 0.00801872 0.020701 0.0582227 0.0266219 0.0122069 0.00756035 0.00326089 0.00283204 0.00185175 0.00145252 0.00211279 0.00141545 0.00211186 0.00142153 0.00214939 0.00144197 0.00225518 0.00154954 0.00282379 0.00252713 0.00817483 0.0134032 0.0577831 0.0195609 0.00622117 0.00353097 0.00527815 0.00361112 0.0030238 0.00225297 0.00160188 0.00235799 0.0015911 0.00252714 0.00178354 0.00328505 0.00357712 0.0085272 0.00165832 0.00212467 0.00163753 0.00232176 0.00185951 0.00319162 0.0025429 0.00484455 0.0185874 0.0709646	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0264606 0.0154518 0.0153657 0.0167088 0.0269399 0.0266812 0.0109217 0.0109193 0.00994663 0.00245646 0.00418395 0.00320006 0.0166658 0.025861 0.0178181 0.0216614 0.0378276 0.0273529 0.0196885 0.0370772 0.0455096 0.0473869 0.0356371 0.0188676 0.0122032 0.00514927 0.0171372 0.00310518 0.00367691 0.00282905 0.00386689 0.00344253 0.00668616 0.00801238 0.0206898 0.0582304 0.0266176 0.0122086 0.00755871 0.00325955 0.00283262 0.00185168 0.00145184 0.00211404 0.00141467 0.00211318 0.00142079 0.00215105 0.00144136 0.00225732 0.00154912 0.00282796 0.00253206 0.00820714 0.0134795 0.0576677 0.0195231 0.00622381 0.00354002 0.00528402 0.00361634 0.00300233 0.0022374 0.0015888 0.00232408 0.00156063 0.00242607 0.00161233 0.00255035 0.00179924 0.00334028 0.0035934 0.0088232 0.00177776 0.00238304 0.00191934 0.00320551 0.0026147 0.00497551 0.0184479 0.0710554	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0263965 0.0154143 0.0153285 0.0166683 0.0268748 0.0266167 0.0108953 0.0108929 0.00992264 0.00245054 0.0041739 0.0031924 0.0166262 0.0257998 0.0177763 0.0216112 0.0377406 0.0272917 0.0196435 0.0369959 0.0454104 0.0472787 0.035557 0.0188239 0.012177 0.0051372 0.0171007 0.00309891 0.00367002 0.00282358 0.00386095 0.0034384 0.00668149 0.00801325 0.0207327 0.0584033 0.0267039 0.0122656 0.0076101 0.00327974 0.00283942 0.00185485 0.001453 0.00211765 0.00141462 0.00211587 0.00142038 0.00215366 0.00144068 0.00225995 0.00154851 0.00283257 0.00254092 0.00825023 0.0136184 0.0578039 0.0195669 0.00624437 0.00357246 0.00530088 0.00364523 0.00299435 0.0022343 0.00158821 0.00231492 0.00155283 0.00239642 0.00158549 0.00245213 0.00162905 0.00260456 0.00183353 0.00342616 0.00363952 0.00945298 0.00207497 0.00323877 0.00276876 0.00530005 0.0179753 0.0705643	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0263121 0.0153646 0.0152789 0.016614 0.0267862 0.0265292 0.0108596 0.0108573 0.00989001 0.00244244 0.00415987 0.00318178 0.016569 0.0257098 0.0177126 0.0215321 0.0376036 0.0271868 0.0195567 0.036853 0.0452172 0.0470635 0.0353997 0.0187362 0.0121284 0.0051139 0.0170218 0.00308795 0.00365936 0.002815 0.00385272 0.00343303 0.00667553 0.0080134 0.0207894 0.058475 0.0267702 0.012389 0.00771366 0.00331407 0.0028492 0.00185997 0.00145382 0.00212095 0.0014144 0.0021183 0.00141976 0.00215652 0.00144006 0.00226355 0.00154799 0.00284155 0.0025642 0.00842399 0.0140517 0.0591125 0.0200673 0.0063847 0.00366347 0.00538821 0.00375038 0.00301318 0.00224434 0.00159732 0.00232567 0.00155608 0.00239859 0.00158175 0.00243425 0.00160594 0.0025186 0.00166475 0.00270237 0.00188566 0.00353011 0.003806 0.011925 0.00321405 0.00595286 0.0168895 0.0675928	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0254476 0.014859 0.0147762 0.0160673 0.0259034 0.0256562 0.0105024 0.0105 0.00956517 0.0023621 0.00402291 0.00307771 0.0160286 0.0248766 0.017142 0.020844 0.0364206 0.0263386 0.0189696 0.0357491 0.043794 0.0455405 0.034294 0.0181672 0.0117256 0.00493833 0.0164359 0.00299875 0.00354781 0.00273563 0.00373812 0.00334496 0.00650537 0.00786509 0.0207382 0.0577745 0.0266392 0.0125747 0.00805154 0.00346085 0.00279272 0.00180611 0.00141212 0.0020387 0.00136153 0.00202092 0.00136165 0.00204572 0.0013776 0.00213279 0.00148709 0.00272431 0.00263433 0.00863519 0.0147911 0.0569941 0.0190967 0.00591448 0.00374989 0.00461694 0.00361346 0.00270192 0.00219806 0.00151855 0.00205885 0.00145655 0.00208244 0.00146281 0.00209233 0.00147353 0.00213506 0.0015086 0.00222233 0.00159734 0.00242934 0.00185859 0.00320171 0.00456976 0.011545 0.0404411 0.0748596	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0277576 0.016207 0.0161176 0.0175255 0.0282506 0.0279663 0.0114529 0.0114547 0.0104349 0.00257899 0.00440092 0.0033427 0.0174178 0.0270262 0.0186631 0.0227786 0.0396293 0.0282021 0.0199302 0.0370209 0.0438498 0.0453908 0.032907 0.0146232 0.0087722 0.00302223 0.00687168 0.00528431 0.0191738 0.00346362 0.00450317 0.00382175 0.00756118 0.00913817 0.0244605 0.0700494 0.0393078 0.0236606 0.0148613 0.00562223 0.00885879 0.00286381 0.00182141 0.00211879 0.00157877 0.0020962 0.00154884 0.00212195 0.00154377 0.00222283 0.00161371 0.00268707 0.00211129 0.0054579 0.00444468 0.0222218 0.00722705 0.00431507 0.00202601 0.00437675 0.00234647 0.00263804 0.00157685 0.00129547 0.00207683 0.00137625 0.00224248 0.0014326 0.00229503 0.00147871 0.00237112 0.0015464 0.00250169 0.00164937 0.00272583 0.00202499 0.00382167 0.00245605 0.0049294 0.0214759 0.0779798	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284485 0.0166124 0.0165216 0.0179666 0.0289714 0.0286805 0.0117435 0.0117425 0.0106979 0.0026435 0.00451101 0.00342718 0.0178694 0.027735 0.0191694 0.0234241 0.0407211 0.0290426 0.0205878 0.0381817 0.0453845 0.046978 0.034108 0.0151239 0.00911501 0.00313025 0.00716107 0.00556128 0.0204587 0.00360363 0.00463576 0.00394273 0.0078944 0.00967539 0.0265687 0.0710736 0.0337566 0.0160979 0.0110253 0.00504074 0.00451285 0.00356689 0.00375797 0.00802202 0.00167065 0.00189155 0.00143473 0.00188841 0.00142735 0.00197445 0.00148655 0.00231937 0.001863 0.00449109 0.0041112 0.0220055 0.00601987 0.00360404 0.00191415 0.0038576 0.00229338 0.00246764 0.00151663 0.0012714 0.00197368 0.00136353 0.00212789 0.00141919 0.00217653 0.00146133 0.00224806 0.00152495 0.0023754 0.0016261 0.0026056 0.00199309 0.00369987 0.00246442 0.00497673 0.0209865 0.0765757	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0282468 0.016492 0.0164009 0.0178342 0.0287526 0.0284653 0.0116564 0.0116557 0.0106187 0.00262371 0.00447624 0.00340176 0.0177307 0.0275147 0.0190121 0.0232382 0.0404027 0.0287924 0.0203641 0.0379154 0.0450313 0.0464767 0.0338084 0.0150071 0.00907027 0.00311293 0.00714243 0.00552525 0.0203536 0.00359391 0.00463846 0.00395382 0.00797067 0.00981673 0.0273901 0.0725425 0.0339533 0.0161811 0.010812 0.00464715 0.00372631 0.00249145 0.00199305 0.00343803 0.00346061 0.00810027 0.00162679 0.0019119 0.00145495 0.00197887 0.00149473 0.00231066 0.00185383 0.00444801 0.00415728 0.0229413 0.006229 0.00365731 0.00194339 0.00391785 0.00233109 0.00248609 0.00152753 0.00127511 0.00198182 0.00136594 0.00213656 0.0014215 0.00218503 0.00146326 0.00225641 0.00152679 0.00238399 0.00162781 0.00261393 0.00199817 0.00371825 0.002471 0.00500606 0.021167 0.0772989	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.028136 0.0164261 0.0163347 0.0177616 0.0286329 0.0283472 0.0116088 0.0116083 0.0105753 0.00261292 0.00445739 0.00338773 0.0176541 0.0273925 0.0189249 0.0231341 0.0402244 0.0286518 0.0202333 0.0377513 0.0448305 0.0462152 0.0336539 0.0149506 0.00905267 0.00310614 0.00713746 0.00551205 0.0203136 0.0035923 0.00464605 0.00396027 0.00799612 0.00984704 0.0275158 0.0729907 0.0339337 0.0161646 0.0107675 0.00454347 0.00353734 0.00236143 0.00176146 0.00257857 0.00184173 0.00328588 0.00340776 0.00802011 0.00165603 0.00204577 0.00154327 0.00233641 0.00186335 0.00439326 0.00420966 0.0234444 0.00634412 0.00370311 0.00196505 0.00395601 0.00236001 0.00250236 0.00153808 0.00128071 0.00199249 0.00137123 0.00214863 0.00142668 0.00219705 0.00146829 0.00226858 0.00153199 0.00239693 0.00163337 0.00262823 0.00200691 0.00374093 0.00248264 0.00503552 0.0213319 0.0778178	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0280717 0.0163879 0.0162965 0.0177198 0.0285641 0.0282792 0.0115813 0.0115809 0.0105501 0.00260666 0.00444649 0.00337959 0.0176102 0.0273228 0.0188753 0.0230743 0.0401217 0.0285706 0.0201604 0.0376529 0.0447131 0.0460654 0.0335602 0.0149157 0.00903923 0.00310136 0.00713086 0.00550331 0.020281 0.0035903 0.00464839 0.00396339 0.00800607 0.00986143 0.027573 0.0733517 0.0339824 0.0161804 0.0107754 0.00453086 0.003493 0.00233882 0.00174678 0.00252253 0.0016794 0.00251598 0.00182518 0.00325995 0.00339725 0.00817972 0.00172172 0.00236345 0.00187259 0.0041837 0.0041779 0.0233029 0.0063617 0.00372865 0.00198535 0.00396479 0.00238604 0.00251271 0.00154563 0.00128636 0.00199875 0.00137618 0.00215454 0.00143095 0.00220223 0.00147201 0.00227356 0.00153561 0.00240264 0.00163744 0.00263635 0.00201366 0.00375585 0.00249674 0.00506691 0.0214547 0.0781135	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0280439 0.0163719 0.0162807 0.0177027 0.028537 0.0282521 0.0115699 0.0115694 0.0105396 0.00260406 0.00444206 0.00337632 0.017594 0.0272982 0.0188582 0.0230524 0.0400823 0.028545 0.0201531 0.0376297 0.0446838 0.0460318 0.0335276 0.0149058 0.00902721 0.00309732 0.00712223 0.00549789 0.0202657 0.00358603 0.00464001 0.00395619 0.00799313 0.00984117 0.0275576 0.0732289 0.0339673 0.016194 0.0108399 0.00456305 0.00349251 0.00234236 0.00174789 0.00250979 0.00167573 0.00247627 0.00167633 0.00252046 0.00180985 0.00326511 0.00345898 0.0090353 0.00200376 0.00378582 0.00409843 0.0225351 0.00642532 0.0038051 0.00202816 0.00399131 0.00242969 0.00254148 0.00156222 0.00129953 0.00201446 0.00138674 0.00216745 0.00143931 0.00221226 0.00147886 0.00228223 0.00154184 0.00241138 0.00164392 0.00264758 0.00202338 0.00377276 0.00251551 0.00510501 0.0215781 0.0782334	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281868 0.0164591 0.0163686 0.0178001 0.0286999 0.0284106 0.0116324 0.01163 0.0105947 0.00261748 0.00446513 0.00339453 0.0176989 0.027469 0.0189807 0.0231961 0.0403124 0.0287394 0.0204266 0.0379619 0.0450154 0.0463874 0.0336479 0.0150385 0.00899814 0.00309851 0.00708589 0.00551373 0.0202967 0.00358705 0.00460715 0.00394237 0.00799228 0.00980136 0.0276919 0.0707465 0.0330366 0.0160406 0.011021 0.00449745 0.00338366 0.0023117 0.00170769 0.00230514 0.00161594 0.0022404 0.00159964 0.00223635 0.00158847 0.00227923 0.00173335 0.00293975 0.0041631 0.0167308 0.00416651 0.0198409 0.00655452 0.00389366 0.00210096 0.00387806 0.00248512 0.00254891 0.00156505 0.00130609 0.0019999 0.00139116 0.00214344 0.00143739 0.00217944 0.00147326 0.00224528 0.00153446 0.00237282 0.00163648 0.0026132 0.002016 0.00371415 0.0025274 0.00511235 0.0211744 0.0761631	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0239475 0.0139759 0.0138976 0.0151094 0.024352 0.0241159 0.00988015 0.00988497 0.00900711 0.00222632 0.00380002 0.00288558 0.0150275 0.0233186 0.0161201 0.019723 0.0343423 0.0244719 0.0171958 0.0322255 0.0383153 0.0396167 0.0291823 0.0129825 0.00796319 0.00272036 0.00626347 0.00477803 0.0175568 0.00314017 0.00409941 0.00347699 0.00676648 0.00820552 0.0209511 0.0553538 0.02498 0.0112486 0.00685236 0.00304718 0.00270892 0.00177799 0.00138901 0.00206552 0.00137509 0.00209269 0.00139572 0.0021517 0.00143345 0.00230169 0.0015843 0.00297153 0.00282706 0.00867464 0.0168961 0.0960031 0.0480465 0.0244543 0.00476457 0.00444214 0.00270125 0.00263508 0.00168869 0.00138217 0.00201018 0.00140114 0.00207753 0.0014062 0.00206939 0.00141036 0.0021036 0.00144652 0.00219753 0.00152151 0.00238677 0.0018366 0.00332695 0.00221743 0.0044208 0.0186984 0.0686986	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0251047 0.0146521 0.0145696 0.0158405 0.0255304 0.0252796 0.0103555 0.010358 0.00943655 0.00233197 0.00397874 0.00302254 0.0157433 0.0244247 0.0168793 0.0206514 0.0359364 0.025585 0.0179784 0.0336712 0.0400019 0.0412443 0.0302075 0.0133794 0.00819198 0.00280296 0.00645001 0.00494002 0.0181867 0.00323604 0.00421773 0.0035883 0.00709886 0.00867911 0.0229776 0.0608963 0.0270584 0.012144 0.00769654 0.00333259 0.0027698 0.00182042 0.00141097 0.00204905 0.00137055 0.00204308 0.001373 0.00207578 0.00138837 0.002174 0.00149196 0.00269259 0.0024795 0.00793229 0.0145891 0.078296 0.0270861 0.0116086 0.0120649 0.0137016 0.0033442 0.00275275 0.00191231 0.00150184 0.00203382 0.00153682 0.00211199 0.00153104 0.00211191 0.00153134 0.00215582 0.00156916 0.00226621 0.00165655 0.00250327 0.00197481 0.00347908 0.00249421 0.00484038 0.0193521 0.0692624	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.026304 0.0153494 0.0152624 0.0165918 0.0267375 0.0264781 0.0108479 0.0108535 0.00988813 0.00244388 0.00417024 0.00316602 0.016477 0.0255516 0.0176548 0.021608 0.0375982 0.0267242 0.0186592 0.0350099 0.0415386 0.0428954 0.0314139 0.0138024 0.00854494 0.00292159 0.00669233 0.0050993 0.0186944 0.00331369 0.00433125 0.00365911 0.00710708 0.0085421 0.0210158 0.0553358 0.0241509 0.0105654 0.00609098 0.00266346 0.00265144 0.00176691 0.00138812 0.00204965 0.00138425 0.00207616 0.00140174 0.00212772 0.00143432 0.00224947 0.0015513 0.00284983 0.00252273 0.00845479 0.0134474 0.0647959 0.0228145 0.00736327 0.0047805 0.00900751 0.0118787 0.0136908 0.0029235 0.00172429 0.00210783 0.00150084 0.00214648 0.00148813 0.00216898 0.00148208 0.00220666 0.00151085 0.00230126 0.00158448 0.00250546 0.00191999 0.00352912 0.00240952 0.0047874 0.0202065 0.0740552	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.026943 0.0157236 0.0156346 0.0169975 0.0273923 0.0271247 0.0111119 0.0111157 0.0101267 0.00250257 0.00426959 0.00324303 0.0168854 0.0261899 0.0180941 0.0221424 0.0385277 0.0273947 0.019178 0.035974 0.0427183 0.0440033 0.0322223 0.014219 0.00874483 0.0029937 0.00687302 0.00526318 0.0193533 0.0034343 0.0044742 0.00380626 0.00747972 0.00911175 0.0236295 0.0629877 0.0277086 0.0121997 0.00748822 0.00324611 0.00286089 0.00188464 0.0014687 0.00213313 0.00143238 0.00213219 0.00143711 0.00216837 0.00145635 0.00227137 0.00156202 0.0028209 0.00249653 0.00802139 0.0129668 0.0580276 0.0195582 0.00628294 0.00361536 0.00545537 0.00410049 0.00386852 0.00362814 0.00377079 0.00801802 0.00157097 0.0018759 0.00142519 0.00189514 0.00142345 0.00194778 0.00146433 0.00205586 0.00155273 0.00227851 0.00183337 0.00318636 0.0024829 0.00473182 0.0185675 0.0697416	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.026962 0.0157347 0.0156456 0.0170094 0.0274115 0.0271438 0.0111198 0.0111238 0.0101342 0.00250445 0.00427292 0.0032454 0.0168973 0.026208 0.0181065 0.0221578 0.0385533 0.0274111 0.0191809 0.0359839 0.0427329 0.0440223 0.0322383 0.0142218 0.00875408 0.0029962 0.00687971 0.00526653 0.0193662 0.00343488 0.00447634 0.00380725 0.00747276 0.00909659 0.0235127 0.0627544 0.0275844 0.0121243 0.00740052 0.00321099 0.00285867 0.00188266 0.00146718 0.00213736 0.00143214 0.00213837 0.00143783 0.00217651 0.00145833 0.00228249 0.00156583 0.00284703 0.00252013 0.0081648 0.013203 0.0576468 0.0194201 0.0062461 0.00352997 0.005341 0.00369949 0.00327505 0.00247044 0.00186917 0.00323398 0.00365108 0.0083305 0.00156074 0.00190744 0.00147042 0.00196272 0.00148354 0.00206133 0.00156213 0.00228143 0.00183444 0.00318828 0.00250289 0.00478187 0.0186648 0.0702923	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0269226 0.0157117 0.0156228 0.0169846 0.0273715 0.0271043 0.0111037 0.0111077 0.0101196 0.00250086 0.00426684 0.00324073 0.0168728 0.0261699 0.0180802 0.0221259 0.0384975 0.0273717 0.0191492 0.0359273 0.0426671 0.0439577 0.0321922 0.014198 0.0087438 0.0029921 0.00687197 0.00525863 0.0193392 0.00342948 0.00447068 0.00380199 0.007461 0.00908088 0.0234461 0.0626163 0.0275139 0.0120878 0.00736383 0.00319814 0.00285759 0.00188123 0.00146626 0.00213915 0.00143161 0.00214086 0.00143766 0.00217967 0.00145864 0.0022865 0.00156661 0.00285538 0.00252889 0.00821936 0.0132829 0.0571609 0.0192347 0.00620485 0.00350284 0.00527601 0.0036094 0.00308684 0.00230546 0.00164879 0.002481 0.00177323 0.00328773 0.00362153 0.00840501 0.00160616 0.00201206 0.00154466 0.00210621 0.00159733 0.00231374 0.00185557 0.00321853 0.00253055 0.00482882 0.0188379 0.0712757	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268897 0.0156925 0.0156037 0.0169638 0.027338 0.0270712 0.0110902 0.0110943 0.0101074 0.00249784 0.00426174 0.00323681 0.0168523 0.0261381 0.0180584 0.0220997 0.0384517 0.0273393 0.0191234 0.0358811 0.0426126 0.0439025 0.0321514 0.0141764 0.00873389 0.00298831 0.00686445 0.00525136 0.0193145 0.00342475 0.00446579 0.00379767 0.00745249 0.00907076 0.0234055 0.0625416 0.0274684 0.0120632 0.00733769 0.00318779 0.00285601 0.00187991 0.00146525 0.00213984 0.00143089 0.00214199 0.00143716 0.00218128 0.00145846 0.00228876 0.00156673 0.00286016 0.00253321 0.00825009 0.0133311 0.0568602 0.0191329 0.0061925 0.00349848 0.00526773 0.00359373 0.00303243 0.00226336 0.00160642 0.0023697 0.00160014 0.00254256 0.00179251 0.003305 0.00360429 0.00857887 0.00167104 0.00214655 0.00165599 0.00234939 0.00188198 0.00323257 0.00257305 0.00489829 0.0188412 0.0716854	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268441 0.0156659 0.0155772 0.016935 0.0272917 0.0270253 0.0110714 0.0110755 0.0100903 0.00249363 0.00425459 0.00323137 0.016824 0.0260943 0.0180283 0.0220633 0.0383884 0.0272949 0.0190902 0.0358213 0.0425415 0.0438289 0.0320973 0.0141499 0.00872022 0.00298323 0.00685444 0.00524208 0.0192834 0.00341925 0.00446012 0.00379304 0.00744522 0.00906455 0.0233955 0.0625492 0.0274672 0.0120659 0.00733631 0.00318652 0.00285679 0.00187997 0.00146465 0.00214132 0.00143018 0.00214356 0.0014365 0.00218322 0.00145794 0.00229123 0.00156643 0.00286479 0.00253838 0.00828362 0.0134068 0.0567447 0.0190965 0.00619577 0.00350792 0.0052739 0.00359947 0.00301111 0.00224779 0.00159328 0.00233553 0.00156939 0.00244021 0.00162154 0.00256648 0.0018086 0.00336088 0.00362095 0.00887699 0.0017913 0.00240723 0.00194097 0.00324474 0.00264473 0.00502828 0.0187009 0.0717808	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267775 0.015627 0.0155385 0.0168929 0.0272239 0.0269583 0.0110439 0.0110481 0.0100653 0.00248746 0.00424408 0.00322344 0.0167829 0.0260308 0.0179847 0.0220102 0.0382964 0.0272307 0.0190451 0.0357402 0.0424453 0.0437255 0.0320222 0.014117 0.00870108 0.00297627 0.00684125 0.00523024 0.0192441 0.00341306 0.00445378 0.00378879 0.00744136 0.00906735 0.0234485 0.0627324 0.0275626 0.0121246 0.00738725 0.0032063 0.00286379 0.00188334 0.00146587 0.00214514 0.00143018 0.00214648 0.00143615 0.00218611 0.00145735 0.00229422 0.00156594 0.00286984 0.00254726 0.00832785 0.0135459 0.0568788 0.019141 0.0062162 0.0035402 0.00529081 0.00362851 0.0030033 0.0022447 0.00159268 0.0023264 0.00156152 0.00241022 0.00159441 0.00246701 0.00163862 0.00262125 0.00184344 0.00344772 0.00366771 0.00951095 0.00209078 0.00327353 0.00279852 0.00535185 0.0182232 0.071291	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0266856 0.0155728 0.0154845 0.016834 0.0271279 0.0268635 0.0110053 0.0110093 0.0100299 0.00247866 0.00422882 0.00321203 0.016722 0.0259354 0.0179175 0.021927 0.0381535 0.0271243 0.0189624 0.0356032 0.0422664 0.0435318 0.0318848 0.014056 0.00866698 0.00296441 0.0068145 0.00520644 0.0191529 0.00340126 0.00444337 0.00378191 0.00743589 0.00907135 0.023521 0.0628118 0.0276456 0.0122523 0.00749069 0.00324 0.00287401 0.00188876 0.00146678 0.00214891 0.00143003 0.00214937 0.00143562 0.00218949 0.00145687 0.00229842 0.00156559 0.00287944 0.00257007 0.00850248 0.0139741 0.0581778 0.0196346 0.00635594 0.00363013 0.00537776 0.00373291 0.00302203 0.00225439 0.00160159 0.0023373 0.00156472 0.00241241 0.0015905 0.00244876 0.00161508 0.00253399 0.0016747 0.00271993 0.00189648 0.00355352 0.00383805 0.0119971 0.00323618 0.00600299 0.0171283 0.0683155	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0257824 0.0150448 0.0149595 0.0162631 0.0262064 0.0259524 0.0106322 0.0106359 0.00969023 0.00239456 0.00408504 0.0031037 0.0161592 0.0250675 0.0173204 0.0211978 0.0369021 0.0262437 0.0183719 0.0344876 0.040881 0.0420717 0.0308574 0.0136136 0.00836589 0.00286366 0.00657541 0.00502047 0.0184548 0.00329933 0.00430431 0.00367977 0.00723881 0.00890277 0.0234503 0.0620756 0.0275412 0.0124522 0.00783652 0.00338867 0.0028145 0.00183161 0.00142353 0.00206311 0.00137535 0.00204809 0.00137572 0.00207449 0.00139263 0.00216315 0.00150167 0.0027515 0.00262854 0.00868524 0.0147182 0.056248 0.0187334 0.00587252 0.00370929 0.00459991 0.00358407 0.0027082 0.00220248 0.00151993 0.0020673 0.00146236 0.00209264 0.00146885 0.0021031 0.00147983 0.00214624 0.0015154 0.00223432 0.00160543 0.00244354 0.0018686 0.00321948 0.00460594 0.0116127 0.0408603 0.0758152	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0277413 0.0161918 0.0161029 0.0175093 0.0282341 0.0279499 0.0114539 0.0114568 0.0104375 0.00258134 0.00441316 0.00332894 0.0173579 0.0269679 0.0186951 0.0229872 0.0399132 0.0279922 0.0191191 0.0355055 0.0416053 0.042936 0.0305778 0.0124517 0.007444 0.00246786 0.0044453 0.00271676 0.00735935 0.00551465 0.021275 0.0043078 0.0082397 0.00976896 0.0264432 0.0743847 0.0412527 0.0242126 0.0150058 0.00568541 0.0089195 0.00288345 0.00183369 0.00213445 0.00158914 0.00211374 0.00156005 0.0021412 0.00155547 0.00224288 0.0016255 0.00271002 0.00212572 0.00549543 0.00445806 0.0222264 0.00722838 0.00433319 0.00203008 0.00438904 0.00234989 0.0026458 0.00157893 0.00129826 0.00208296 0.00137955 0.00224894 0.00143583 0.00230132 0.00148194 0.00237743 0.00154976 0.00250827 0.00165297 0.0027328 0.00202969 0.00383176 0.00246316 0.00493884 0.0215171 0.0779655	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0283833 0.0165678 0.0164773 0.0179177 0.0289002 0.0286115 0.0117236 0.0117246 0.0106823 0.00264149 0.00451613 0.00340731 0.0177749 0.0276252 0.0191661 0.0235951 0.0409575 0.0287877 0.0197524 0.0366577 0.0431148 0.0444696 0.0317259 0.0128679 0.00774186 0.00254996 0.00462025 0.00281568 0.00768444 0.00583663 0.022894 0.00449045 0.00862786 0.010454 0.0290479 0.0754827 0.035683 0.0164707 0.0110951 0.00501375 0.0045296 0.0035761 0.00375955 0.00805237 0.00168338 0.00190455 0.00144492 0.00190267 0.00143725 0.00198929 0.00149615 0.00233605 0.00187342 0.00451979 0.004124 0.0220588 0.00603706 0.00362204 0.00191863 0.00386995 0.00229905 0.00247573 0.00152006 0.00127468 0.00197975 0.00136743 0.00213447 0.0014231 0.0021831 0.00146527 0.00225476 0.00152905 0.00238247 0.00163048 0.00261333 0.00199859 0.00371065 0.00247151 0.00498619 0.0210459 0.0765629	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281492 0.0164281 0.0163374 0.0177642 0.0286474 0.0283633 0.0116232 0.0116246 0.0105912 0.00261874 0.0044763 0.00337822 0.0176174 0.0273771 0.0189911 0.0233883 0.0406119 0.0285252 0.019536 0.0364087 0.0427991 0.0440255 0.0314814 0.0127835 0.00771642 0.00253707 0.00460847 0.00280407 0.00767583 0.00580587 0.0228067 0.00448784 0.00870378 0.0106234 0.0299982 0.0769293 0.0359794 0.0165825 0.0108962 0.00462376 0.00374019 0.00250235 0.00199442 0.00345122 0.00346757 0.00811849 0.00163527 0.00192146 0.00146293 0.00199034 0.00150239 0.00232388 0.00186167 0.00446911 0.0041641 0.0229676 0.00624234 0.00367334 0.00194678 0.00392779 0.00233569 0.00249262 0.00152995 0.00127753 0.00198656 0.00136897 0.00214178 0.0014245 0.00219019 0.00146625 0.00226165 0.0015299 0.00238951 0.00163113 0.00261996 0.00200238 0.00372665 0.00247646 0.00501219 0.0212132 0.0772338	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0280299 0.0163571 0.0162662 0.0176861 0.0285186 0.0282366 0.011572 0.0115738 0.0105447 0.00260718 0.00445612 0.00336334 0.0175367 0.0272492 0.0189007 0.0232806 0.0404307 0.0283856 0.0194164 0.036265 0.042627 0.043798 0.0313565 0.0127445 0.00770707 0.00253226 0.00460542 0.00280019 0.00767618 0.00579474 0.0227776 0.00448653 0.00872794 0.0106569 0.030149 0.0773195 0.0359833 0.0165784 0.010857 0.00451822 0.00355021 0.00237312 0.00176463 0.00258985 0.00184406 0.00329474 0.00341277 0.00803089 0.00166183 0.00205374 0.00155011 0.00234801 0.00187041 0.0044117 0.00421562 0.0234624 0.00635597 0.00371859 0.00196799 0.00396508 0.00236405 0.00250834 0.00154005 0.00128277 0.00199673 0.00137388 0.00215333 0.00142928 0.00220167 0.00147086 0.00227323 0.00153465 0.00240185 0.00163622 0.0026336 0.00201056 0.00374846 0.00248754 0.0050404 0.0213717 0.0777263	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0279624 0.016317 0.016226 0.0176421 0.0284463 0.0281653 0.0115432 0.011545 0.0105184 0.00260063 0.00444469 0.00335488 0.0174913 0.0271776 0.01885 0.0232194 0.0403272 0.0283053 0.019349 0.0361766 0.0425234 0.0436633 0.0312771 0.0127185 0.0076979 0.00252861 0.00460116 0.00279695 0.00767183 0.00578688 0.0227503 0.00448522 0.00873729 0.0106726 0.0302178 0.0776595 0.0360471 0.0166008 0.0108694 0.00450635 0.00350592 0.0023504 0.00174949 0.00253239 0.00168307 0.00252436 0.00182561 0.00326569 0.0033989 0.00818458 0.00172571 0.002371 0.00187894 0.00419926 0.00418363 0.0233163 0.00637334 0.00374379 0.00198819 0.00397347 0.00238993 0.00251852 0.00154747 0.00128828 0.00200279 0.00137866 0.00215902 0.00143337 0.00220659 0.00147438 0.00227794 0.00153805 0.00240723 0.00164004 0.00264135 0.002017 0.00376283 0.00250123 0.00507098 0.02149 0.0780061	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0279381 0.016303 0.0162122 0.0176273 0.0284227 0.0281415 0.0115332 0.0115349 0.0105091 0.00259832 0.00444073 0.00335193 0.0174765 0.0271547 0.0188337 0.0231982 0.0402886 0.0282798 0.0193385 0.0361484 0.0424881 0.0436253 0.0312401 0.0127043 0.00768605 0.00252474 0.00459453 0.00279297 0.00766263 0.00578076 0.0227308 0.00447934 0.00872456 0.0106518 0.0302116 0.0775627 0.03604 0.0166163 0.0109399 0.0045406 0.00350565 0.00235403 0.00175051 0.00251967 0.00167904 0.00248368 0.00167825 0.00252668 0.00180896 0.00326868 0.00345732 0.00903662 0.00200616 0.00379687 0.00410511 0.0225502 0.00643606 0.00381943 0.00203084 0.0039995 0.00243337 0.00254714 0.001564 0.00130136 0.00201834 0.00138909 0.00217172 0.00144156 0.00221637 0.00148104 0.0022863 0.00154405 0.00241561 0.00164625 0.00265214 0.00202635 0.003779 0.00251946 0.0051081 0.0216075 0.0781096	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281073 0.0164056 0.0163151 0.0177409 0.0286117 0.028325 0.0116062 0.0116057 0.010573 0.00261395 0.00446739 0.00337214 0.0175894 0.0273337 0.0189594 0.0233462 0.0405212 0.0284679 0.0195594 0.0363969 0.0427219 0.0438957 0.0312858 0.0127566 0.0076405 0.00252177 0.00456268 0.0027873 0.00761198 0.00579202 0.0227316 0.00448012 0.00872305 0.0106101 0.0304001 0.0752466 0.0350764 0.0164642 0.0111664 0.00448825 0.00340042 0.0023237 0.00171106 0.00231712 0.00162012 0.00224992 0.00160225 0.00224381 0.00159002 0.00228435 0.00173426 0.00294261 0.00415656 0.0167145 0.0041705 0.0199011 0.0065715 0.00390949 0.0021056 0.00388882 0.00249107 0.00255625 0.00156812 0.00130887 0.00200501 0.00139447 0.00214883 0.00144053 0.00218458 0.00147627 0.00225031 0.00153746 0.00237797 0.00163957 0.00261871 0.00201978 0.00372152 0.00253222 0.00511781 0.0212105 0.0760813	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0239132 0.0139506 0.013873 0.0150822 0.0243156 0.0240824 0.00987268 0.0098794 0.00900333 0.00222683 0.00380828 0.00287289 0.0149728 0.0232697 0.016152 0.019911 0.0346206 0.0243218 0.0165884 0.031072 0.0365465 0.0376288 0.0272422 0.0111068 0.00678733 0.00222161 0.0040649 0.00245705 0.00672045 0.00500794 0.0196629 0.0038965 0.00738258 0.00884866 0.0228628 0.0586332 0.0264465 0.0115387 0.00689157 0.00303256 0.00273192 0.00179418 0.00139677 0.00208353 0.00138359 0.00210948 0.00140352 0.00216792 0.00144046 0.00231705 0.00158908 0.0029804 0.00281653 0.0086756 0.0168159 0.0958237 0.0480518 0.0245026 0.00477623 0.004466 0.00271242 0.00264853 0.00169582 0.0013883 0.00202044 0.00140805 0.00208837 0.00141294 0.00207974 0.00141674 0.0021135 0.00145263 0.00220727 0.00152748 0.00239656 0.00184366 0.00334071 0.00222598 0.0044329 0.018767 0.0687263	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.025037 0.0146065 0.0145247 0.0157909 0.0254574 0.0252105 0.0103342 0.0103387 0.00942025 0.00232948 0.00398221 0.00300504 0.0156635 0.0243389 0.0168889 0.0208205 0.0361876 0.0253993 0.0173198 0.0324499 0.038147 0.0391686 0.0282122 0.01146 0.00698962 0.00229079 0.00417736 0.00253032 0.00692884 0.00518919 0.0204255 0.00403446 0.00774862 0.00938391 0.0251195 0.0644451 0.0287077 0.0124681 0.00773557 0.00331162 0.00278974 0.00183502 0.00141726 0.00206413 0.00137747 0.00205669 0.00137901 0.0020885 0.00139368 0.00218575 0.00149614 0.0027005 0.00246945 0.00792482 0.0145319 0.0782325 0.02704 0.011645 0.0120588 0.0136918 0.00334885 0.00275919 0.00191626 0.00150584 0.00204018 0.00154234 0.0021198 0.00153687 0.00211993 0.00153712 0.00216382 0.00157482 0.00227423 0.00166215 0.0025116 0.00198112 0.00349019 0.00250152 0.00484881 0.0194043 0.0692037	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0262527 0.015314 0.0152281 0.0165541 0.0266854 0.0264296 0.0108345 0.0108424 0.00987969 0.00244338 0.00417775 0.0031512 0.0164154 0.0254994 0.0176949 0.0218233 0.0379306 0.0265998 0.0180613 0.0338752 0.0397903 0.0409384 0.0294948 0.0119292 0.00732045 0.00240103 0.00435982 0.00263457 0.00716187 0.00533547 0.0209445 0.00409369 0.00774381 0.00919881 0.0229235 0.0584723 0.0255325 0.0108312 0.00613296 0.00265427 0.00267481 0.00178311 0.0013965 0.00206772 0.00139339 0.00209287 0.00141028 0.00214385 0.00144244 0.00226519 0.00155891 0.00286469 0.00252408 0.00847067 0.0134001 0.0647088 0.0227389 0.00737325 0.0047635 0.00901547 0.0118447 0.0136732 0.00292132 0.00172685 0.00211316 0.00150546 0.002154 0.00149373 0.00217774 0.00148829 0.00221611 0.00151743 0.00231124 0.00159136 0.00251609 0.00192829 0.00354391 0.00241985 0.00480224 0.0202832 0.0740972	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268765 0.0156786 0.0155905 0.0169488 0.0273219 0.0270584 0.011092 0.0110982 0.0101124 0.00250068 0.0042749 0.00322557 0.0168088 0.0261144 0.0181188 0.0223442 0.0388358 0.0272322 0.0185174 0.0347408 0.040831 0.0418915 0.0301794 0.012235 0.00747801 0.00245383 0.00446311 0.00270264 0.00737812 0.00552476 0.0217512 0.00427497 0.00816435 0.00984677 0.0258162 0.0665977 0.0293741 0.0125148 0.00751806 0.0032246 0.00288253 0.0019003 0.00147593 0.00214951 0.00144039 0.0021473 0.00144437 0.00218278 0.00146311 0.00228515 0.00156823 0.00283323 0.00249473 0.00803194 0.0129153 0.0578593 0.0194632 0.00628646 0.00359617 0.00544967 0.00408207 0.00386384 0.00361399 0.0037638 0.00801239 0.00157227 0.00187903 0.00142866 0.00190019 0.00142752 0.00195351 0.00146867 0.00206196 0.00155722 0.00228499 0.00183842 0.00319533 0.00248908 0.00473884 0.0186079 0.0696797	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268965 0.0156903 0.0156021 0.0169615 0.0273424 0.0270788 0.0111004 0.0111068 0.0101203 0.00250269 0.00427847 0.00322816 0.016822 0.0261347 0.018133 0.022362 0.0388657 0.0272525 0.0185251 0.0347578 0.0408539 0.0419197 0.0302022 0.0122423 0.00748755 0.00245633 0.00446895 0.00270513 0.00738509 0.00552763 0.0217672 0.0042751 0.00815736 0.00982979 0.0256868 0.0663414 0.0292393 0.0124364 0.00742917 0.00318964 0.00288032 0.00189832 0.00147443 0.00215382 0.00144021 0.00215359 0.00144518 0.00219108 0.00146519 0.00229648 0.00157216 0.0028597 0.00251863 0.00817647 0.0131509 0.057474 0.0193227 0.00625014 0.00351126 0.00533489 0.00368319 0.00327195 0.00246506 0.00186387 0.00323091 0.00364822 0.0083152 0.00156114 0.00191034 0.00147343 0.00196767 0.00148731 0.00206714 0.00156631 0.00228788 0.00183935 0.00319751 0.00250857 0.00478784 0.018706 0.0702295	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268575 0.0156675 0.0155796 0.0169369 0.0273029 0.0270397 0.0110844 0.0110909 0.0101059 0.00249913 0.00427245 0.00322358 0.016798 0.0260974 0.0181072 0.0223305 0.0388108 0.0272144 0.0184964 0.0347062 0.0407949 0.0418626 0.0301624 0.0122242 0.00747981 0.00245314 0.00446443 0.00270165 0.00737718 0.00551932 0.0217381 0.00426864 0.00814492 0.00981305 0.025614 0.0661908 0.0291647 0.0123995 0.0073923 0.00317695 0.00287932 0.00189693 0.00147353 0.00215572 0.00143972 0.00215623 0.00144506 0.00219441 0.00146556 0.0023007 0.00157303 0.00286832 0.00252751 0.00823164 0.01323 0.0569871 0.0191368 0.00620913 0.00348434 0.00526996 0.0035943 0.00308375 0.00230109 0.00164515 0.0024793 0.00177042 0.00328501 0.00361849 0.00838911 0.00160622 0.0020147 0.0015476 0.00211111 0.00160114 0.00231981 0.00186035 0.00322771 0.00253643 0.00483498 0.0188793 0.0712055	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0268244 0.0156482 0.0155604 0.0169161 0.0272693 0.0270065 0.0110708 0.0110774 0.0100936 0.0024961 0.00426732 0.00321968 0.0167776 0.0260658 0.0180856 0.0223043 0.0387652 0.027183 0.018473 0.0346643 0.0407464 0.0418142 0.0301274 0.0122079 0.00747239 0.00245021 0.00445987 0.00269836 0.00736938 0.00551173 0.0217119 0.00426321 0.00813591 0.00980268 0.02557 0.0661064 0.0291176 0.0123749 0.00736602 0.00316674 0.00287776 0.00189562 0.00147252 0.00215648 0.00143901 0.00215745 0.00144458 0.00219613 0.00146541 0.00230309 0.00157318 0.00287327 0.00253192 0.00826272 0.0132773 0.0566861 0.0190351 0.006197 0.00348011 0.00526165 0.00357888 0.00302932 0.00225913 0.00160286 0.0023678 0.00159837 0.00254114 0.00178955 0.00330222 0.00360132 0.00856314 0.00167098 0.0021491 0.00165898 0.00235451 0.00188633 0.00324133 0.0025789 0.00490423 0.0188827 0.0716107	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267783 0.0156213 0.0155336 0.0168869 0.0272223 0.0269601 0.0110518 0.0110584 0.0100763 0.00249184 0.00426007 0.00321422 0.0167491 0.0260217 0.0180552 0.0222672 0.038701 0.0271387 0.0184415 0.034608 0.0406807 0.0417467 0.0300788 0.0121865 0.00746164 0.00244609 0.00445342 0.00269395 0.00735926 0.00550224 0.0216788 0.00425736 0.00812833 0.00979717 0.0255601 0.0661096 0.0291188 0.0123786 0.00736459 0.0031655 0.00287856 0.00189571 0.00147192 0.00215803 0.00143829 0.00215908 0.00144391 0.00219816 0.00146489 0.00230566 0.00157288 0.00287803 0.0025371 0.00829652 0.0133522 0.0565698 0.0189989 0.00620048 0.00348967 0.00526786 0.00358477 0.00300804 0.0022436 0.00158972 0.00233359 0.00156764 0.00243856 0.00161964 0.002565 0.00180567 0.00335801 0.00361796 0.00886082 0.00179107 0.00240979 0.00194433 0.00325227 0.00265014 0.00503327 0.0187416 0.0717013	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267105 0.0155817 0.0154942 0.0168441 0.0271534 0.0268919 0.0110239 0.0110305 0.0100509 0.00248556 0.00424935 0.00320617 0.0167073 0.025957 0.0180105 0.0222123 0.0386062 0.0270732 0.0183966 0.0345279 0.0405869 0.0416467 0.0300075 0.0121574 0.00744574 0.00244015 0.00444441 0.00268804 0.00734663 0.00549065 0.0216378 0.00425181 0.00812475 0.00980253 0.0256206 0.0663015 0.0292253 0.0124403 0.00741556 0.00318503 0.00288555 0.00189911 0.00147312 0.00216189 0.00143825 0.00216204 0.00144352 0.00220111 0.00146425 0.00230873 0.00157234 0.00288316 0.00254577 0.00834078 0.0134907 0.0567004 0.0190434 0.00622088 0.00352181 0.00528474 0.00361374 0.00300026 0.00224046 0.00158906 0.00232443 0.00155973 0.0024085 0.0015925 0.00246533 0.00163673 0.00261969 0.0018406 0.00344482 0.00366463 0.00949394 0.00209038 0.00327792 0.00280267 0.00535448 0.0182604 0.0712058	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0266141 0.0155249 0.0154376 0.0167823 0.0270528 0.0267926 0.0109834 0.0109899 0.0100139 0.00247635 0.00423338 0.00319429 0.0166441 0.0258582 0.0179409 0.0221255 0.0384583 0.0269659 0.0183178 0.0343981 0.0404223 0.0414727 0.0298873 0.0121092 0.00741925 0.00243083 0.00442774 0.00267755 0.00731837 0.00546534 0.0215331 0.00423953 0.00811688 0.00981013 0.025702 0.0663854 0.0293219 0.0125743 0.00752037 0.00321862 0.00289578 0.00190454 0.00147397 0.00216575 0.00143798 0.00216492 0.00144284 0.00220445 0.00146361 0.00231288 0.00157182 0.00289262 0.00256787 0.00851416 0.0139148 0.0579893 0.0195345 0.00636048 0.00361091 0.00537117 0.00371737 0.00301864 0.00224972 0.00159771 0.00233515 0.00156275 0.00241046 0.00158839 0.00244678 0.00161302 0.00253202 0.00167272 0.00271817 0.00189378 0.0035508 0.00383567 0.0119755 0.00323411 0.00600088 0.0171579 0.0682369	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.025705 0.0149934 0.014909 0.0162076 0.0261247 0.0258749 0.0106075 0.0106134 0.00967129 0.00239151 0.00408799 0.00308523 0.0160766 0.0249811 0.0173339 0.0213766 0.0371739 0.0260706 0.0177268 0.0332853 0.0390621 0.0400461 0.0288945 0.0117119 0.00715699 0.00234638 0.00426884 0.00258535 0.00705992 0.00526875 0.0207182 0.0041181 0.00789711 0.0096378 0.0256276 0.0657522 0.0292449 0.0127844 0.00787753 0.00336923 0.00283493 0.00184584 0.00143011 0.0020783 0.00138247 0.00206191 0.00138207 0.00208759 0.00139846 0.00217563 0.00150638 0.00275978 0.0026202 0.00868325 0.0146622 0.0560583 0.0186518 0.00586898 0.00368724 0.00459005 0.00356302 0.00270462 0.00219577 0.00151517 0.00206481 0.00145956 0.0020904 0.00146596 0.00210086 0.00147698 0.00214401 0.00151263 0.00223214 0.00160283 0.00244152 0.00186562 0.00321524 0.00460095 0.0115896 0.0408765 0.075792	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0265875 0.0154791 0.015391 0.016719 0.0269275 0.0267263 0.0109626 0.0109808 0.0100139 0.00247517 0.00423278 0.0031971 0.0166355 0.0259074 0.0180141 0.0223419 0.0390838 0.0271961 0.0180757 0.0343146 0.0399266 0.0404787 0.029645 0.011816 0.00705076 0.00232384 0.00389979 0.00222219 0.00488481 0.00302843 0.00900119 0.00766504 0.0379981 0.00922496 0.0270284 0.0818246 0.0452368 0.0250655 0.0152639 0.00574455 0.008846 0.00284846 0.00180428 0.00208914 0.0015539 0.00206973 0.0015275 0.00209992 0.00152391 0.00219969 0.00159151 0.00265561 0.00207804 0.00537373 0.00434372 0.0215851 0.00703673 0.00422411 0.00196831 0.00425787 0.00227677 0.00256473 0.00152802 0.00125724 0.00201833 0.001336 0.00217883 0.00139018 0.00222936 0.00143464 0.00230288 0.00150022 0.00242953 0.00160017 0.00264688 0.00196523 0.00371196 0.00238607 0.00477894 0.02084 0.0753559	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0270103 0.015721 0.0156315 0.0169785 0.0273448 0.0271519 0.0111366 0.0111566 0.0101761 0.00251481 0.0043006 0.00324993 0.0169045 0.0263353 0.0183175 0.0227547 0.0398419 0.0277601 0.0185163 0.0353275 0.0412467 0.0416464 0.0306707 0.0122083 0.00735213 0.0024046 0.00407835 0.00231342 0.00515423 0.0032066 0.00961034 0.00845533 0.0429891 0.0099923 0.0302394 0.0829182 0.0394658 0.0171375 0.0111908 0.00493616 0.00449951 0.00351408 0.00369394 0.00788978 0.00165517 0.00186544 0.00141428 0.0018617 0.00140585 0.00194589 0.001462 0.00228225 0.00182687 0.00440203 0.0040143 0.0214384 0.00587493 0.00352444 0.00185742 0.00374714 0.00222503 0.00239722 0.00147024 0.00123326 0.00191674 0.00132332 0.00206622 0.00137687 0.00211294 0.00141744 0.002182 0.00147902 0.00230536 0.00157708 0.00252846 0.00193312 0.0035893 0.00239041 0.00481634 0.0203462 0.0737912	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267586 0.0155704 0.0154805 0.016813 0.0270721 0.0268854 0.0110292 0.0110496 0.0100787 0.00249058 0.00425828 0.00321911 0.0167375 0.0260741 0.0181358 0.0225354 0.0394772 0.0274949 0.0183154 0.0350807 0.0409617 0.0412542 0.0304611 0.012137 0.00733654 0.00239535 0.00407609 0.00230691 0.0051497 0.0031991 0.0096167 0.00843084 0.0430379 0.0101093 0.0313289 0.0842997 0.0398759 0.0173138 0.0110134 0.00456022 0.00370844 0.00246299 0.00195221 0.00339041 0.00339914 0.00792313 0.0016006 0.00187552 0.00142782 0.00194204 0.00146518 0.00226587 0.00181194 0.00434408 0.0040449 0.0222761 0.00606761 0.00357271 0.00188325 0.0038004 0.00225929 0.00241209 0.00147878 0.00123533 0.00192225 0.00132414 0.00207222 0.00137754 0.00211874 0.00141768 0.00218756 0.0014791 0.00231103 0.00157691 0.00253364 0.00193578 0.0036031 0.00239398 0.00483861 0.0204968 0.0743905	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0266458 0.0155029 0.0154128 0.0167388 0.0269498 0.0267655 0.010981 0.0110018 0.0100351 0.00247976 0.00423947 0.00320527 0.0166625 0.0259561 0.0180539 0.0224359 0.0393098 0.0273715 0.0182178 0.0349568 0.0408241 0.041074 0.0303623 0.0121061 0.00733227 0.00239216 0.00407651 0.00230448 0.00514757 0.00319355 0.00961666 0.00840475 0.0429326 0.0101251 0.0315101 0.0845436 0.0398876 0.0173341 0.0109826 0.00445443 0.00351993 0.00233812 0.00173158 0.00254385 0.00180461 0.00323099 0.00333918 0.00781702 0.00162163 0.00200087 0.00151038 0.00228761 0.00182002 0.004288 0.00409593 0.0227568 0.00618086 0.00361806 0.00190407 0.00383736 0.00228721 0.00242779 0.00148874 0.00124059 0.00193235 0.00132909 0.00208369 0.00138235 0.00213012 0.00142231 0.00219905 0.00148387 0.00232325 0.00158201 0.00254716 0.00194392 0.00362477 0.00240508 0.00486663 0.0206529 0.0748734	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265822 0.015465 0.0153748 0.0166971 0.0268813 0.026698 0.0109538 0.0109747 0.0100103 0.00247362 0.00422878 0.00319739 0.0166202 0.0258894 0.0180073 0.0223788 0.0392127 0.0272983 0.0181608 0.0348777 0.0407353 0.0409607 0.0302944 0.0120841 0.0073255 0.00238926 0.00407414 0.00230214 0.00514378 0.00318936 0.00961128 0.00838919 0.0428644 0.0101317 0.0315979 0.084829 0.0399622 0.0173694 0.0110011 0.00444335 0.00347672 0.00231622 0.00171602 0.00248429 0.00164889 0.00247449 0.00178358 0.00319854 0.0033187 0.0079524 0.00168063 0.00230665 0.00182721 0.00408001 0.00406496 0.0226123 0.00619962 0.00364283 0.0019237 0.0038459 0.00231246 0.00243793 0.00149604 0.001246 0.00193837 0.00133378 0.00208934 0.00138636 0.002135 0.00142574 0.00220367 0.00148715 0.0023285 0.00158567 0.00255465 0.00195008 0.00363859 0.00241817 0.004896 0.0207655 0.0751369	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265631 0.0154542 0.0153641 0.0166857 0.0268633 0.0266797 0.010946 0.0109667 0.0100029 0.00247175 0.0042255 0.00319494 0.0166081 0.0258706 0.0179936 0.0223605 0.0391795 0.0272766 0.0181516 0.0348537 0.0407056 0.0409299 0.0302602 0.0120699 0.00731427 0.00238547 0.00406797 0.00229851 0.00513671 0.00318476 0.00959771 0.00837527 0.0427672 0.0101092 0.0315943 0.0847853 0.0399679 0.0173867 0.011076 0.00447823 0.00347685 0.00231992 0.00171686 0.00247178 0.00164393 0.00243167 0.00164103 0.00247424 0.0017647 0.00319872 0.0033688 0.00877153 0.00195073 0.00368691 0.00398739 0.0218748 0.00625987 0.00371461 0.00196444 0.0038704 0.00235405 0.00246537 0.00151188 0.00125847 0.00195314 0.00134364 0.00210128 0.001394 0.00214402 0.00143185 0.00221124 0.00149257 0.00233598 0.00159123 0.00256434 0.00195851 0.00365299 0.00243489 0.00493031 0.0208695 0.0752086	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267481 0.0155658 0.0154758 0.0168087 0.0270676 0.0268775 0.0110249 0.0110425 0.0100709 0.00248823 0.00425299 0.0032159 0.0167243 0.0260522 0.0181175 0.0225066 0.0394169 0.0274575 0.0183393 0.0350958 0.0409267 0.0411776 0.030299 0.0121115 0.00726816 0.00238215 0.00403794 0.00229383 0.0051064 0.00318795 0.00953334 0.00839137 0.0424756 0.0100258 0.0317656 0.0828226 0.038962 0.0172028 0.0113173 0.00443026 0.00338041 0.00228991 0.00167804 0.0022774 0.00158669 0.00220651 0.00156621 0.00219787 0.00155221 0.00223557 0.00169087 0.00287264 0.00403305 0.0162086 0.00406515 0.0193897 0.00640448 0.0038033 0.00203849 0.00376525 0.00241178 0.00247508 0.00151662 0.0012662 0.00194062 0.00134923 0.0020792 0.00139322 0.00211308 0.00142729 0.00217602 0.0014861 0.00229897 0.00158455 0.00253123 0.00195168 0.00359602 0.00244645 0.0049381 0.0204759 0.0732332	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0228962 0.0133185 0.0132413 0.0143791 0.0231461 0.0229927 0.00943528 0.00945827 0.00862917 0.00213307 0.00364901 0.00275733 0.0143298 0.0223258 0.0155413 0.0193299 0.0338788 0.0235929 0.0156678 0.0300538 0.0350747 0.0353528 0.026363 0.0105222 0.00642365 0.00208969 0.00357019 0.00201364 0.00449774 0.00276064 0.00830828 0.00721075 0.0370083 0.00856921 0.0239873 0.0641894 0.0295097 0.0121556 0.00701054 0.00300536 0.00273782 0.00178524 0.00138359 0.00206623 0.00136715 0.00208963 0.00138531 0.00214737 0.00142001 0.00229381 0.00156364 0.00294161 0.00275165 0.00854278 0.0163691 0.0935737 0.0473977 0.0242087 0.00471375 0.00441077 0.00265961 0.00259404 0.00165945 0.00135892 0.00197785 0.00137795 0.00204405 0.0013819 0.00203441 0.0013845 0.00206589 0.00141845 0.00215606 0.0014905 0.00233943 0.00179844 0.00326043 0.00217063 0.00431473 0.0182857 0.0666987	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0238969 0.0138994 0.013818 0.0150051 0.024152 0.0239914 0.00984483 0.00986663 0.00900031 0.00222436 0.00380349 0.00287522 0.0149422 0.023277 0.016198 0.0201466 0.0353124 0.0245737 0.0163206 0.0313619 0.036604 0.0367876 0.0273433 0.0108959 0.0066454 0.00216298 0.00369259 0.00208304 0.00465269 0.00286726 0.0086462 0.00753317 0.0387302 0.00903078 0.0263438 0.0703195 0.0319692 0.0131064 0.00783834 0.00327094 0.0027883 0.00182109 0.00140011 0.00204057 0.00135768 0.00203039 0.0013574 0.00206129 0.00137012 0.00215631 0.00146857 0.00265733 0.00240637 0.00777248 0.0141687 0.0765233 0.0267092 0.0115759 0.0118689 0.0134056 0.00328339 0.00269457 0.00186844 0.00146962 0.00199009 0.00150565 0.00206865 0.00150005 0.00206823 0.00149953 0.00210998 0.00153532 0.00221633 0.00161937 0.00244619 0.00192881 0.00339697 0.00243391 0.00470546 0.01883 0.0668563	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0251125 0.0146076 0.0145227 0.01577 0.0253835 0.0252143 0.0103463 0.010372 0.00946183 0.00233887 0.00400075 0.00302246 0.0157049 0.0244602 0.017027 0.0211873 0.0371185 0.0258261 0.0171017 0.0328086 0.0382783 0.038582 0.0286649 0.0113801 0.00696675 0.00226884 0.00385532 0.00217091 0.00481122 0.00294743 0.00884598 0.00766551 0.0394179 0.00893467 0.0240414 0.0636732 0.0284542 0.0114069 0.00624692 0.00263167 0.00267784 0.00177158 0.00138232 0.00204648 0.00137523 0.00206863 0.00139028 0.00211857 0.00142044 0.00223745 0.00153347 0.00282539 0.00247362 0.00834989 0.0131187 0.0633354 0.0223871 0.00728623 0.00467209 0.0088847 0.0115747 0.0133415 0.00284989 0.00168586 0.00205903 0.0014674 0.00210052 0.00145697 0.0021253 0.00145227 0.00216307 0.0014807 0.00225555 0.00155247 0.00245464 0.00188074 0.0034564 0.00235968 0.00467289 0.019748 0.071876	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0256456 0.0149162 0.0148288 0.0161024 0.0259168 0.025745 0.0105646 0.0105893 0.00965968 0.00238745 0.0040827 0.00308577 0.016035 0.024977 0.0173822 0.0216262 0.0379004 0.0263599 0.0174706 0.0335805 0.0391971 0.0393873 0.0292839 0.0116502 0.00711809 0.00231837 0.00394963 0.00222662 0.00495628 0.00304865 0.00918436 0.00798544 0.0411222 0.0095041 0.0270622 0.0725116 0.0327001 0.013147 0.00761676 0.00318227 0.0028807 0.00188511 0.0014576 0.00212396 0.00141898 0.00211909 0.00142118 0.00215372 0.00143797 0.00225391 0.00153939 0.00278953 0.00243786 0.00789875 0.0126028 0.0564321 0.0191042 0.0061992 0.00351768 0.00535206 0.00399315 0.00376709 0.00350913 0.0036613 0.00778454 0.0015291 0.00182626 0.00138971 0.00184806 0.00138881 0.00190019 0.00142862 0.00200519 0.00151417 0.00222112 0.00178658 0.00310437 0.00241787 0.00459383 0.0180213 0.0672757	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0256692 0.0149301 0.0148428 0.0161175 0.0259414 0.0257695 0.0105746 0.0105996 0.00966916 0.00238985 0.00408697 0.00308886 0.016051 0.025002 0.0173999 0.0216487 0.0379378 0.0263865 0.0174842 0.0336043 0.0392291 0.0394267 0.0293142 0.0116603 0.00712811 0.0023209 0.00395494 0.00222871 0.00496142 0.00304969 0.00918947 0.00798585 0.0411416 0.00949463 0.0269285 0.072219 0.0325544 0.0130666 0.00752805 0.00314804 0.00287864 0.00188321 0.00145629 0.00212824 0.00141895 0.0021254 0.00142217 0.00216207 0.00144024 0.00226527 0.00154354 0.00281605 0.00246182 0.0080434 0.0128354 0.056059 0.0189627 0.00616271 0.00343334 0.00523654 0.00360034 0.00318602 0.00239516 0.00180856 0.00314141 0.00354545 0.0080603 0.00151501 0.00185454 0.00143136 0.00191207 0.00144546 0.0020093 0.00152225 0.00222351 0.00178707 0.00310643 0.00243595 0.00463987 0.0181152 0.0678059	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0256344 0.0149099 0.0148227 0.0160957 0.0259065 0.0257348 0.0105604 0.0105854 0.00965632 0.00238669 0.00408166 0.0030848 0.0160299 0.0249691 0.0173772 0.0216207 0.0378884 0.0263531 0.0174604 0.0335592 0.039179 0.0393803 0.0292808 0.0116453 0.00712176 0.00231815 0.00395146 0.00222603 0.00495654 0.00304546 0.00917962 0.00797365 0.0410893 0.00948073 0.0268547 0.0720488 0.0324741 0.0130299 0.00749146 0.00313573 0.00287775 0.00188195 0.00145552 0.00213027 0.00141858 0.00212818 0.00142218 0.00216557 0.00144075 0.0022697 0.00154457 0.00282496 0.00247084 0.00809917 0.0129135 0.0555874 0.0187797 0.0061229 0.00340695 0.0051723 0.00351358 0.00300155 0.00223569 0.00159723 0.00240877 0.00171905 0.00319205 0.00351466 0.00812672 0.0015576 0.00195487 0.00150283 0.00205067 0.0015556 0.00225413 0.00180743 0.00313593 0.00246345 0.00468637 0.0182845 0.0687442	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.025604 0.0148923 0.0148052 0.0160767 0.0258759 0.0257045 0.010548 0.0105731 0.00964511 0.00238394 0.00407701 0.00308126 0.0160114 0.0249405 0.0173576 0.0215967 0.0378465 0.026325 0.0174406 0.0335225 0.0391382 0.0393412 0.0292518 0.0116321 0.00711594 0.00231569 0.00394819 0.00222361 0.00495191 0.00304173 0.00917083 0.00796338 0.0410491 0.00947172 0.0268105 0.0719467 0.032424 0.0130059 0.0074653 0.00312577 0.00287623 0.00188071 0.00145459 0.00213109 0.00141793 0.00212947 0.00142176 0.00216737 0.00144067 0.00227218 0.00154482 0.00283011 0.00247538 0.00813076 0.0129599 0.0552961 0.0186797 0.00611144 0.00340292 0.00516397 0.00349856 0.00294815 0.00219466 0.00155578 0.00229881 0.00155241 0.00246788 0.0017369 0.00320787 0.00349697 0.00829379 0.00161999 0.00208484 0.00161071 0.00228659 0.00183224 0.00314886 0.00250484 0.00475403 0.0182882 0.0691296	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0255603 0.0148668 0.0147799 0.0160492 0.0258317 0.0256607 0.01053 0.0105552 0.00962883 0.00237993 0.0040702 0.00307611 0.0159846 0.024899 0.017329 0.0215613 0.037785 0.0262833 0.0174124 0.0334711 0.0390799 0.0392831 0.029209 0.0116138 0.00710692 0.00231211 0.00394331 0.00222025 0.00494561 0.00303708 0.00915991 0.00795099 0.0409999 0.00946574 0.026802 0.0719389 0.0324271 0.0130113 0.00746397 0.00312459 0.002877 0.00188084 0.00145404 0.00213267 0.00141726 0.00213115 0.00142115 0.00216945 0.00144021 0.00227483 0.0015446 0.00283506 0.00248057 0.00816477 0.0130329 0.0551828 0.0186444 0.0061154 0.00341256 0.00517023 0.00350457 0.00292732 0.00217946 0.0015429 0.00226502 0.00152219 0.00236667 0.00157256 0.00249069 0.00175212 0.00326146 0.00351225 0.0085808 0.00173612 0.00233732 0.00188735 0.00315791 0.00257347 0.0048788 0.0181503 0.0692089	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0254946 0.0148285 0.0147418 0.0160078 0.025765 0.0255947 0.010503 0.0105281 0.00960423 0.00237385 0.00405982 0.00306832 0.015944 0.024836 0.0172853 0.0215069 0.0376909 0.0262189 0.0173696 0.0333943 0.0389921 0.0391919 0.0291424 0.0115871 0.00709264 0.00230673 0.003936 0.00221551 0.00493723 0.00303139 0.00914714 0.00793645 0.0409403 0.0094673 0.0268683 0.0721391 0.032547 0.0130773 0.00751498 0.00314374 0.00288388 0.00188427 0.00145523 0.00213651 0.00141725 0.00213411 0.00142078 0.00217242 0.00143961 0.00227799 0.00154412 0.00284038 0.00248896 0.00820848 0.0131674 0.0553055 0.0186889 0.00613605 0.00344437 0.00518728 0.00353324 0.00291976 0.00217633 0.00154223 0.0022559 0.00151439 0.0023369 0.00154584 0.00239228 0.00158884 0.00254357 0.00178575 0.00334551 0.00355641 0.00919151 0.00202575 0.00317902 0.00271963 0.00518795 0.0176786 0.0687166	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0254023 0.0147742 0.0146877 0.0159488 0.0256692 0.0255 0.0104645 0.0104895 0.00956894 0.0023651 0.00404469 0.00305704 0.0158842 0.0247426 0.0172199 0.021424 0.0375485 0.0261184 0.0173005 0.0332758 0.0388474 0.0390446 0.0290367 0.011546 0.00706988 0.00229863 0.00392323 0.00220752 0.00491906 0.00301917 0.00910905 0.00789507 0.0407546 0.00946172 0.0269544 0.0722103 0.0326604 0.0132224 0.00762211 0.00317763 0.00289439 0.00188977 0.00145623 0.00214051 0.00141705 0.00213698 0.00142011 0.0021757 0.00143898 0.00228214 0.00154365 0.00284981 0.00251011 0.00837807 0.0135799 0.0565479 0.0191697 0.00627451 0.00353205 0.00527332 0.00363547 0.00293778 0.00218514 0.00155063 0.00226621 0.00151728 0.00233849 0.00154171 0.0023736 0.00156542 0.00245673 0.0016236 0.00263934 0.00183749 0.00344989 0.0037216 0.0115898 0.00313252 0.00580825 0.0166028 0.0658494	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0245458 0.0142742 0.0141903 0.0154083 0.0247969 0.0246356 0.0101104 0.0101342 0.00924515 0.00228492 0.00390707 0.00295379 0.0153468 0.0239089 0.0166399 0.0207002 0.0362958 0.0252448 0.0167311 0.0321906 0.0375289 0.0376854 0.0280563 0.0111613 0.00681819 0.00221875 0.00378337 0.00213253 0.00474815 0.00292051 0.00879003 0.00762396 0.0393753 0.0092672 0.0269102 0.07178 0.0326247 0.0134502 0.00799013 0.00333263 0.0028352 0.0018318 0.0014135 0.00205497 0.00136309 0.00203613 0.00136094 0.00206117 0.0013755 0.00214748 0.00147934 0.00271629 0.00255608 0.00852475 0.0143137 0.0546755 0.0183451 0.00578603 0.00360618 0.00450768 0.00348048 0.00263507 0.0021346 0.00147098 0.00200617 0.00141776 0.00203031 0.00142329 0.00204002 0.00143358 0.00208184 0.00146811 0.00216802 0.0015561 0.00237333 0.0018105 0.00312224 0.00446081 0.0112246 0.039637 0.0732919	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0252473 0.0144174 0.0142762 0.015401 0.0244195 0.0245372 0.0101414 0.0102216 0.00933694 0.00229599 0.00386745 0.00299026 0.0150307 0.0233741 0.0162693 0.0195602 0.0351309 0.0235933 0.0153932 0.0315196 0.0322952 0.0317623 0.0264124 0.0107992 0.00641158 0.0022144 0.00375634 0.00216475 0.00459402 0.00270079 0.00684999 0.00428862 0.0152864 0.0198567 0.0629273 0.0973478 0.0559695 0.0295096 0.0179643 0.0066019 0.00962041 0.00310242 0.00192536 0.00218025 0.00161308 0.00213552 0.00157934 0.00216511 0.00157244 0.00226505 0.0016384 0.00272485 0.0021319 0.00548563 0.00445205 0.0220812 0.00722605 0.00431799 0.00200006 0.00431796 0.00230657 0.00259793 0.00154675 0.00127323 0.00204512 0.00135205 0.00220608 0.00140654 0.00225742 0.00145132 0.00233161 0.00151752 0.00245938 0.00161858 0.00267878 0.00198782 0.00375588 0.00241259 0.00483668 0.020918 0.0757687	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0258018 0.0147254 0.0145795 0.0157263 0.0249283 0.0250574 0.0103618 0.010446 0.00954556 0.00234693 0.00395266 0.00305804 0.0153555 0.023893 0.0166511 0.02001 0.0360129 0.0242135 0.0156761 0.0322761 0.0330147 0.0326497 0.027546 0.0112609 0.00675637 0.00232007 0.00396369 0.00227019 0.00483601 0.00282547 0.00725816 0.00451335 0.0163902 0.021813 0.0628415 0.0997473 0.0492399 0.0209573 0.0139678 0.00611806 0.00517172 0.00389578 0.00409977 0.00850752 0.00180609 0.00202113 0.0015249 0.00199781 0.00151018 0.00208192 0.00156431 0.00242862 0.00194415 0.00462903 0.00427782 0.0227747 0.00625388 0.00371398 0.00194639 0.00390486 0.0023236 0.00250206 0.00153434 0.0012859 0.00200123 0.00137877 0.00215454 0.00143366 0.0022027 0.00147511 0.00227375 0.00153859 0.0024012 0.00164025 0.00263279 0.00200986 0.00373594 0.00248652 0.00501805 0.0209588 0.0760505	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0256456 0.0146248 0.0144769 0.0156131 0.0247337 0.0248732 0.0102903 0.0103742 0.00948174 0.00233072 0.00392254 0.00303893 0.0152427 0.023718 0.016533 0.0198338 0.035729 0.0239906 0.0154847 0.031999 0.0326223 0.0322248 0.0273301 0.0112072 0.00672563 0.00231843 0.00395483 0.00227413 0.004826 0.00283112 0.00724462 0.00452034 0.0164302 0.0220373 0.0622329 0.101723 0.0494702 0.021074 0.0137425 0.00560744 0.00426174 0.00273328 0.00220041 0.00379407 0.00379132 0.00863445 0.00174605 0.00202364 0.00153398 0.00207716 0.00156799 0.00241203 0.001929 0.00456609 0.00430849 0.0236532 0.00645718 0.00377294 0.00197606 0.00396383 0.00236227 0.00252224 0.00154623 0.00129094 0.00201135 0.00138258 0.00216522 0.00143737 0.00221335 0.00147842 0.00228432 0.00154182 0.00241217 0.00164342 0.0026438 0.00201665 0.00375914 0.00249592 0.00505258 0.0211639 0.0768402	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.025566 0.014574 0.0144253 0.0155563 0.024637 0.0247811 0.0102543 0.0103381 0.00944939 0.00232256 0.0039075 0.00302907 0.0151857 0.0236286 0.0164716 0.0197429 0.0355803 0.0238751 0.0153917 0.0318655 0.0324428 0.0320268 0.0272149 0.0111768 0.00671066 0.00231734 0.00395057 0.00227589 0.00482152 0.00283359 0.0072371 0.00452044 0.0164345 0.0220637 0.0619445 0.102074 0.0493354 0.0210483 0.0137077 0.00547273 0.00403387 0.00259221 0.00194371 0.00281536 0.00202022 0.00358517 0.00370366 0.00847125 0.00175602 0.00214752 0.00161552 0.00243543 0.00193897 0.00450934 0.00436816 0.024189 0.00658894 0.00382706 0.00200009 0.0040056 0.00239396 0.0025409 0.00155823 0.00129775 0.00202356 0.00138904 0.00217865 0.0014436 0.00222664 0.00148439 0.00229765 0.00154789 0.00242625 0.00164984 0.00265927 0.00202635 0.00378385 0.00250886 0.00508475 0.0213411 0.077399	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0255134 0.0145409 0.0143917 0.0155195 0.0245745 0.0247211 0.0102307 0.0103143 0.00942802 0.00231719 0.00389768 0.00302252 0.0151484 0.0235699 0.0164306 0.0196827 0.0354803 0.0237971 0.0153306 0.0317719 0.0323229 0.0318926 0.0271308 0.0111528 0.00669802 0.00231555 0.00394621 0.00227618 0.00481776 0.00283468 0.00723163 0.00452024 0.016431 0.0220867 0.0618612 0.102415 0.0493507 0.0210703 0.0137301 0.00545352 0.0039823 0.00256857 0.0019262 0.00274458 0.00183657 0.0027112 0.00198515 0.00352949 0.00365468 0.00857097 0.00180977 0.00246632 0.0019489 0.00429348 0.00433869 0.0240484 0.00662355 0.00385934 0.00202263 0.00401765 0.00242217 0.00255354 0.00156711 0.00130434 0.00203118 0.00139476 0.00218565 0.00144846 0.00223262 0.00148854 0.00230322 0.00155182 0.00243236 0.00165411 0.00266761 0.00203324 0.00379879 0.00252284 0.00511597 0.021458 0.0776742	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0255006 0.0145336 0.0143844 0.0155115 0.0245618 0.024708 0.0102253 0.0103085 0.00942253 0.0023158 0.00389513 0.00302073 0.0151396 0.0235557 0.0164202 0.01967 0.0354567 0.0237793 0.015321 0.031754 0.0323002 0.0318619 0.0270963 0.0111404 0.00668813 0.00231245 0.00394073 0.00227324 0.00481175 0.00283105 0.00722084 0.00451342 0.0164046 0.0220239 0.0616605 0.102295 0.0493469 0.0210899 0.0138153 0.00548974 0.00398391 0.00257385 0.00192842 0.00273243 0.00183108 0.00266135 0.00181805 0.00269903 0.00195067 0.0035172 0.00369204 0.00942358 0.0020989 0.00389924 0.00425706 0.0232966 0.00670852 0.00394237 0.00206762 0.00404733 0.00246797 0.00258506 0.00158523 0.00131851 0.00204815 0.00140598 0.00219921 0.00145711 0.00224271 0.00149539 0.00231152 0.00155781 0.00244036 0.00166013 0.00267766 0.00204216 0.00381325 0.00254008 0.00515081 0.0215569 0.077714	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0257105 0.014665 0.0145164 0.015657 0.0248072 0.0249405 0.0103174 0.0103984 0.00950192 0.00233542 0.00392945 0.00304481 0.0152815 0.0237757 0.0165748 0.0199015 0.0358297 0.0240611 0.0155626 0.0321423 0.0327321 0.0322699 0.0272496 0.0111987 0.00667803 0.00230793 0.00392284 0.00226145 0.00479011 0.00281405 0.00717595 0.00450192 0.0163872 0.0214973 0.0601976 0.100036 0.048278 0.0209535 0.0140919 0.0054397 0.00389382 0.00254678 0.00188616 0.00253222 0.00177109 0.00242979 0.00173815 0.00240737 0.00170998 0.00244232 0.00185384 0.00314329 0.00437037 0.0173285 0.00439663 0.0208233 0.00692413 0.00406967 0.00216041 0.0039603 0.00254315 0.00260997 0.00159853 0.00133342 0.00204472 0.0014183 0.00218526 0.00146212 0.0022184 0.00149594 0.00228209 0.00155609 0.00240879 0.00165814 0.00265038 0.00204069 0.00376236 0.00255823 0.00516575 0.0211692 0.0757134	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0216368 0.0123395 0.0122163 0.0131749 0.0208705 0.0209898 0.00868265 0.00875697 0.00800506 0.00196829 0.00331472 0.00256484 0.0128627 0.0200147 0.0139488 0.0167305 0.0301343 0.0202412 0.0130789 0.0269728 0.0275286 0.0272892 0.0232981 0.00953731 0.00577587 0.00197754 0.0033933 0.00194132 0.00413318 0.002413 0.00620117 0.00380781 0.0137191 0.0184416 0.0525861 0.077928 0.0368656 0.0147403 0.0086981 0.00364783 0.00306932 0.0019404 0.00152694 0.00223242 0.00148345 0.0022351 0.00149138 0.00228999 0.00151722 0.00244147 0.00166064 0.00312331 0.002936 0.00915172 0.0173452 0.0996094 0.0512534 0.0261155 0.00515271 0.00468698 0.00277213 0.00268602 0.00172106 0.00141095 0.00204875 0.00142628 0.00211177 0.00142678 0.00209723 0.00142568 0.00212494 0.00145716 0.00221317 0.00152815 0.00239731 0.00184055 0.00333509 0.00221917 0.00440567 0.0184276 0.0672348	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0226381 0.0129003 0.0127684 0.013768 0.0217965 0.0219296 0.00907518 0.00915147 0.00836578 0.0020563 0.00345931 0.00268156 0.0134354 0.0209049 0.0145706 0.0174439 0.0314564 0.0210928 0.013579 0.0281312 0.0286111 0.0282673 0.0241622 0.00991173 0.00599129 0.00206253 0.00352825 0.00202969 0.0043052 0.00252725 0.00647704 0.00400553 0.0145343 0.019583 0.0546464 0.0848192 0.0394053 0.0158019 0.00969012 0.00396553 0.00313622 0.00198243 0.00155089 0.00221116 0.00148344 0.002178 0.00147219 0.0022038 0.00147463 0.00230124 0.00157068 0.0028318 0.00258828 0.00837929 0.0153032 0.0829367 0.0297157 0.012803 0.0129496 0.0143624 0.00353282 0.0028477 0.00197069 0.00154813 0.00208795 0.0015793 0.00216563 0.00156961 0.0021604 0.00156489 0.00219873 0.00159815 0.00230417 0.00168197 0.00253816 0.00199813 0.00351548 0.00252098 0.00485146 0.0190811 0.0677207	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0237811 0.0135688 0.0134346 0.0144899 0.0229609 0.023085 0.0095461 0.00962752 0.00879919 0.00216375 0.00364505 0.00281723 0.0141364 0.021991 0.0153243 0.0184103 0.0331307 0.0222588 0.0143674 0.0295797 0.0302239 0.029964 0.0254044 0.0103398 0.00626558 0.00214382 0.00365866 0.00208756 0.00441778 0.00257847 0.00663141 0.00406463 0.0147125 0.0197345 0.0571006 0.0786032 0.0358754 0.0139428 0.00778996 0.00319179 0.00299264 0.00192121 0.00152225 0.00219957 0.00148744 0.00220004 0.00149141 0.00224618 0.00151277 0.00236782 0.00162457 0.00298452 0.00263844 0.00897432 0.0142845 0.0686227 0.0246604 0.00793463 0.0050722 0.00951042 0.0122931 0.0139765 0.00299452 0.00176289 0.00213657 0.0015188 0.00217437 0.00150738 0.00219913 0.0015009 0.00223515 0.00152801 0.00232698 0.00159972 0.00252851 0.0019351 0.00355517 0.00242657 0.00479852 0.0200339 0.0728718	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.02442 0.0139156 0.0137732 0.0148512 0.0235104 0.0236546 0.00978867 0.00987178 0.00902401 0.00221816 0.00373173 0.00289183 0.0144864 0.0225369 0.015707 0.0188076 0.0339075 0.0227208 0.0146102 0.0302689 0.0307833 0.0304093 0.0259836 0.0106348 0.00643997 0.00221761 0.00378775 0.00217697 0.00460615 0.00270442 0.00693215 0.0042807 0.0155253 0.0208796 0.0584421 0.0884644 0.040647 0.0159651 0.00949422 0.0038844 0.00324819 0.00205822 0.00161882 0.00230719 0.00155291 0.00227887 0.0015439 0.00230918 0.00155064 0.00241264 0.00165022 0.00298112 0.0026298 0.00857072 0.0137649 0.061606 0.0211906 0.0067862 0.00384534 0.00578435 0.00436524 0.00399357 0.00371198 0.00385315 0.00816024 0.00160277 0.00191299 0.0014542 0.00193357 0.00145156 0.00198533 0.00149043 0.00209079 0.00157667 0.0023117 0.00185642 0.00322384 0.00251605 0.00476769 0.018357 0.0687402	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0244481 0.0139321 0.0137897 0.014869 0.0235394 0.0236833 0.00980036 0.00988376 0.00903497 0.0022209 0.00373655 0.00289524 0.0145039 0.0225639 0.0157258 0.0188317 0.0339486 0.0227498 0.0146288 0.030302 0.0308215 0.0304526 0.0260155 0.0106444 0.00644825 0.00221952 0.00379177 0.00217811 0.00460887 0.00270482 0.00693536 0.00427965 0.0155245 0.0208727 0.0584816 0.0882064 0.0404919 0.0158733 0.00938811 0.00384437 0.00324509 0.00205579 0.00161768 0.00231111 0.00155277 0.00228486 0.00154485 0.00231734 0.00155304 0.00242393 0.00165471 0.0030086 0.00265598 0.00872913 0.0140213 0.0611975 0.0210273 0.00673666 0.00374337 0.00564742 0.00391942 0.00335546 0.00251766 0.0019055 0.00331115 0.00372253 0.00843175 0.0015792 0.00193557 0.00149289 0.00199408 0.00150638 0.0020933 0.00158455 0.00231313 0.00185667 0.0032241 0.00253612 0.00481974 0.0184367 0.0692644	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.024416 0.0139139 0.0137717 0.0148496 0.0235087 0.0236525 0.00978759 0.00987098 0.00902332 0.00221805 0.00373182 0.0028915 0.0144851 0.0225347 0.0157055 0.0188077 0.0339052 0.0227217 0.0146096 0.0302622 0.0307818 0.030416 0.0259834 0.0106306 0.00644122 0.00221671 0.00378752 0.00217525 0.00460315 0.00270102 0.00692652 0.00427304 0.0155036 0.0208485 0.0584296 0.0880221 0.0403913 0.0158282 0.00934335 0.00382931 0.00324328 0.00205403 0.0016167 0.00231265 0.00155216 0.00228721 0.00154467 0.0023205 0.00155344 0.00242809 0.00165573 0.00301766 0.00266585 0.00879024 0.0141071 0.0606912 0.0208226 0.0066895 0.00371048 0.00557081 0.00381694 0.00315328 0.00234591 0.00167784 0.00252064 0.00180716 0.00335016 0.00368588 0.00848055 0.00162007 0.00203731 0.00156497 0.00213578 0.00161929 0.00234615 0.00187886 0.00325644 0.0025662 0.00487084 0.0186078 0.0702242	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0243858 0.0138966 0.0137547 0.0148312 0.0234796 0.0236233 0.00977555 0.00985892 0.00901235 0.00221536 0.00372734 0.002888 0.0144675 0.0225074 0.0156867 0.0187854 0.0338651 0.0226955 0.0145915 0.0302257 0.0307446 0.0303808 0.0259529 0.0106176 0.00643441 0.00221404 0.00378344 0.00217259 0.00459779 0.00269756 0.00691864 0.00426722 0.015488 0.020832 0.0583933 0.0879204 0.0403228 0.0157979 0.00931123 0.00381679 0.00324056 0.00205216 0.00161536 0.00231273 0.00155113 0.00228779 0.0015439 0.00232163 0.00155307 0.00242996 0.00165576 0.00302239 0.00267054 0.00882389 0.0141572 0.0603742 0.0207083 0.00667411 0.00370365 0.00555786 0.00379698 0.0030938 0.0023005 0.00163199 0.00239948 0.00162713 0.00257431 0.00182436 0.00336296 0.00366367 0.00864715 0.00168405 0.00217162 0.00167651 0.00238042 0.00190588 0.0032722 0.00261175 0.00494698 0.0186105 0.0706244	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0243421 0.0138715 0.0137298 0.0148044 0.0234369 0.0235806 0.00975798 0.00984128 0.00899631 0.00221142 0.0037207 0.00288293 0.0144417 0.0224675 0.0156592 0.018752 0.0338058 0.0226563 0.0145647 0.0301725 0.030689 0.0303264 0.0259077 0.0105996 0.0064243 0.00221035 0.0037777 0.00216916 0.00459092 0.00269338 0.00690861 0.00426052 0.01547 0.0208152 0.0583438 0.0879186 0.0403108 0.015801 0.00930917 0.00381482 0.00324042 0.0020517 0.00161441 0.00231363 0.00155013 0.0022888 0.00154298 0.00232304 0.00155234 0.00243201 0.00165533 0.00302698 0.00267605 0.00885993 0.0142346 0.0602415 0.0206654 0.00667627 0.00371259 0.00556206 0.00380143 0.00306998 0.0022832 0.00161761 0.00236156 0.00159352 0.00246325 0.00164758 0.00259649 0.00183893 0.0034167 0.00367595 0.00894139 0.00180459 0.00243427 0.00196384 0.0032824 0.00268457 0.00508315 0.0184677 0.0707149	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0242779 0.0138344 0.0136929 0.0147644 0.023373 0.023517 0.00973191 0.00981504 0.00897247 0.00220554 0.0037107 0.00287543 0.0144033 0.022408 0.0156181 0.0187007 0.0337156 0.0225952 0.0145228 0.0300924 0.030603 0.0302397 0.0258396 0.0105744 0.00640947 0.0022054 0.00376999 0.00216507 0.00458285 0.00268891 0.00689673 0.00425393 0.0154515 0.020803 0.0582655 0.0881264 0.0404203 0.0158713 0.00936987 0.00383732 0.00324741 0.00205488 0.00161545 0.00231725 0.00155012 0.00229151 0.00154263 0.00232575 0.00155176 0.00243499 0.00165492 0.00303257 0.00268568 0.00890725 0.0143772 0.0603568 0.0207133 0.0066988 0.00374734 0.00558023 0.00383221 0.00306128 0.00227934 0.00161674 0.00235108 0.00158478 0.0024301 0.00161796 0.00248878 0.00166383 0.00265065 0.00187287 0.0035028 0.00371724 0.00957143 0.00210533 0.00330617 0.00283595 0.00540935 0.0179839 0.0702312	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0241828 0.0137797 0.0136387 0.014706 0.0232797 0.0234236 0.00969346 0.00977622 0.00893717 0.00219684 0.00369595 0.00286423 0.0143468 0.0223204 0.0155571 0.0186253 0.03358 0.0225037 0.0144644 0.0299695 0.0304665 0.0300996 0.0257153 0.0105274 0.00637747 0.00219492 0.00375052 0.00215487 0.00455913 0.0026762 0.00685973 0.00423357 0.015378 0.0207209 0.0581036 0.0882742 0.0405346 0.0160351 0.00949953 0.00387821 0.00325703 0.00205856 0.0016152 0.00231876 0.00154858 0.00229161 0.0015405 0.00232602 0.00154967 0.00243609 0.00165307 0.00303924 0.00270686 0.00908173 0.0148126 0.0615772 0.0212151 0.00684686 0.00384127 0.00567028 0.00394172 0.00307806 0.00228689 0.00162459 0.00235998 0.00158663 0.00242912 0.00161203 0.00246539 0.00163665 0.00255302 0.0016983 0.00274755 0.00192429 0.00361194 0.00388044 0.0120535 0.00325713 0.00604582 0.0169122 0.0673279	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0233491 0.0133023 0.0131659 0.0141959 0.0224683 0.0226099 0.00935745 0.0094373 0.00862813 0.00212078 0.00356755 0.00276611 0.0138529 0.0215544 0.0150225 0.0179782 0.0324167 0.0217139 0.0139592 0.0289148 0.0293605 0.0289665 0.0247771 0.0101611 0.0061393 0.0021164 0.00361332 0.00208222 0.00440428 0.00259181 0.00662593 0.00410351 0.0148602 0.0201574 0.0566561 0.0876167 0.040472 0.0162848 0.00991088 0.00404841 0.00319068 0.00199366 0.00156496 0.00222335 0.00148785 0.00218156 0.00147444 0.00220146 0.00147876 0.00228965 0.00158111 0.00289448 0.00275214 0.00920344 0.0155286 0.0591322 0.0202812 0.0063117 0.00392255 0.00484497 0.00377054 0.00276216 0.00223404 0.00153758 0.00208852 0.00147893 0.00210785 0.00148318 0.00211605 0.00149266 0.00215865 0.00152822 0.00224887 0.00162044 0.00246645 0.00188468 0.00325554 0.00462682 0.0116519 0.0406839 0.0749345	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0235243 0.0135782 0.0134791 0.0146044 0.0233174 0.0232123 0.00953336 0.00959308 0.00880815 0.00217125 0.00366984 0.00279205 0.0142288 0.0217815 0.0151266 0.0180519 0.0304163 0.0218327 0.0135317 0.0237099 0.024802 0.0260647 0.0185556 0.00769821 0.00437315 0.00157031 0.00250636 0.00142648 0.00282545 0.00154325 0.00357124 0.00211162 0.00686712 0.00469592 0.0195226 0.0421027 0.0404777 0.0281355 0.0145946 0.00764387 0.0245152 0.00498973 0.00405238 0.00302874 0.00232439 0.00258665 0.00211742 0.00245177 0.0019752 0.00247354 0.00217019 0.00341355 0.00467622 0.00961382 0.0243491 0.12295 0.0470106 0.0214288 0.00525973 0.00453614 0.00286507 0.00272051 0.001817 0.00149019 0.00210571 0.00150475 0.00216007 0.00150231 0.00214499 0.00149888 0.00217789 0.00153224 0.00227535 0.00161191 0.00248805 0.00193398 0.00342973 0.00235497 0.00471021 0.0201754 0.0735268	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0236263 0.0136389 0.0135402 0.0146713 0.0234312 0.0233239 0.00957902 0.00963878 0.00885046 0.00218148 0.0036874 0.00280553 0.0142989 0.0218895 0.0152076 0.0181522 0.030567 0.021982 0.0136137 0.0237682 0.0248774 0.0262174 0.0187329 0.00780599 0.00440198 0.00158072 0.00252074 0.00143814 0.00285584 0.00156425 0.00363541 0.00215833 0.00707573 0.004905 0.0205949 0.0441606 0.0426004 0.0294294 0.0154876 0.00811 0.025882 0.00542738 0.00433814 0.0030519 0.00238864 0.00253418 0.00210205 0.00234189 0.00188852 0.00231439 0.00218974 0.00341231 0.00487554 0.00973166 0.0214726 0.114107 0.0369211 0.0121286 0.012734 0.0140915 0.00371623 0.00293591 0.0020981 0.00160047 0.00214085 0.00162307 0.00219307 0.00159771 0.0021726 0.00158237 0.00220322 0.00161102 0.00230529 0.00169569 0.00254401 0.00201094 0.00350919 0.00257369 0.0050088 0.0203044 0.0720338	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0245517 0.0141655 0.0140601 0.0152316 0.0243036 0.0241964 0.00993918 0.0100032 0.00918432 0.00226417 0.0038257 0.00291153 0.0148232 0.0226777 0.0157296 0.0187463 0.0315837 0.0225997 0.0139657 0.024604 0.0256876 0.0268844 0.0190962 0.00792747 0.0045439 0.00163366 0.00261332 0.00148499 0.00294272 0.00160406 0.0037117 0.00218707 0.00709464 0.00479791 0.0197053 0.0424416 0.0404107 0.0277822 0.0143237 0.00743065 0.023841 0.004376 0.0035811 0.00280999 0.00211042 0.00240168 0.00192934 0.00227061 0.00180747 0.0022722 0.0019693 0.00316325 0.00424273 0.00956542 0.0203292 0.104065 0.0335217 0.00946369 0.00721328 0.0100855 0.0148871 0.0144962 0.00323487 0.00185124 0.00218616 0.00157075 0.00219464 0.00154403 0.00219758 0.00152169 0.00221947 0.0015386 0.00230112 0.00160503 0.00250075 0.00192752 0.00348755 0.00241584 0.00483896 0.0207152 0.0760756	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0249882 0.0144199 0.0143136 0.0155068 0.0247528 0.0246433 0.0101226 0.0101881 0.00935479 0.00230583 0.00389627 0.0029652 0.0150999 0.0231047 0.0160451 0.0191404 0.0322333 0.023145 0.014299 0.0250574 0.0261862 0.0275262 0.0196598 0.00819767 0.00465226 0.00167296 0.00267248 0.0015242 0.00302767 0.00165804 0.00385138 0.0022843 0.00745904 0.00515299 0.0215215 0.0461685 0.0445697 0.030839 0.0161936 0.00839831 0.0268917 0.00533974 0.00431541 0.00309571 0.00239445 0.00257751 0.00212233 0.00239056 0.00192143 0.00233985 0.00205613 0.00317121 0.00436514 0.0092422 0.0194622 0.09914 0.0293513 0.00816407 0.00604013 0.00653154 0.00621589 0.00447086 0.00433021 0.00421944 0.00819533 0.00169046 0.00198722 0.00149613 0.00197722 0.00149251 0.00202372 0.00152731 0.00212553 0.00161273 0.00234656 0.00189599 0.00324314 0.00257309 0.0049265 0.0195654 0.0723743	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0250608 0.0144611 0.0143543 0.0155506 0.0248211 0.0247118 0.010151 0.010217 0.00938134 0.0023124 0.00390728 0.00297362 0.015141 0.0231662 0.0160865 0.0191868 0.0323122 0.0231967 0.0143241 0.0251149 0.0262437 0.0275803 0.0196918 0.00821 0.00466558 0.00167758 0.00268128 0.00152848 0.00303688 0.00166235 0.00386175 0.00228889 0.00747127 0.00515344 0.0215063 0.046157 0.0445621 0.0308632 0.0161981 0.00840926 0.0269318 0.0053035 0.004297 0.0031008 0.00238905 0.00258465 0.0021215 0.00240021 0.00192512 0.00235193 0.00205892 0.00319268 0.00438277 0.00937225 0.0198037 0.0992473 0.0292576 0.00807199 0.00593157 0.00645325 0.00574148 0.00378541 0.00293027 0.00232528 0.00367543 0.00383269 0.00870839 0.00163621 0.00195678 0.00151051 0.0019861 0.0015156 0.00207897 0.0015914 0.00229911 0.00186139 0.0031825 0.00257823 0.00497327 0.0193062 0.0714673	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0250455 0.014452 0.0143452 0.0155406 0.0248046 0.0246955 0.0101444 0.0102105 0.00937535 0.00231094 0.00390477 0.00297172 0.0151306 0.0231497 0.0160747 0.019172 0.0322872 0.0231771 0.0143096 0.0250945 0.0262212 0.0275537 0.0196703 0.00820107 0.00466277 0.00167649 0.0026801 0.00152753 0.00303536 0.00166123 0.00385952 0.00228696 0.00746481 0.00514621 0.0214704 0.0460885 0.0444936 0.0308235 0.0161763 0.00840239 0.0269084 0.00528647 0.00428588 0.0030986 0.00238376 0.00258315 0.00211767 0.00239928 0.00192284 0.00235132 0.00205592 0.00319325 0.00438219 0.00939963 0.0198839 0.0985719 0.0289366 0.00798489 0.00585975 0.00635481 0.00553737 0.00357157 0.00268513 0.00198768 0.00282852 0.0020189 0.00356884 0.0037277 0.0086593 0.00167421 0.00205874 0.0015782 0.0021253 0.00162654 0.00233148 0.00188336 0.00321095 0.00260409 0.00502181 0.0195035 0.0725382	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0250267 0.014441 0.0143342 0.0155286 0.0247851 0.0246764 0.0101366 0.0102028 0.00936824 0.00230919 0.00390181 0.00296948 0.0151188 0.0231313 0.0160618 0.0191561 0.0322611 0.0231577 0.0142957 0.0250739 0.0261991 0.0275293 0.0196519 0.00819334 0.00465989 0.00167531 0.00267872 0.00152648 0.00303372 0.00166011 0.0038574 0.00228523 0.00745994 0.00514123 0.0214473 0.046042 0.0444458 0.0307946 0.0161611 0.00839853 0.0268908 0.00527171 0.00427499 0.00309515 0.00237862 0.00258039 0.00211365 0.00239695 0.00192003 0.00234911 0.00205144 0.00318871 0.00437298 0.00940234 0.0199253 0.098082 0.0287282 0.00793914 0.00582227 0.00632744 0.00548739 0.00350575 0.00263587 0.00194389 0.0027259 0.00179639 0.00277915 0.00202384 0.00354522 0.0036817 0.00875174 0.00173408 0.00218953 0.00168472 0.00236645 0.00190767 0.00321935 0.0026421 0.00509301 0.01949 0.0729078	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0249917 0.0144206 0.014314 0.0155066 0.0247499 0.0246415 0.0101224 0.0101885 0.00935518 0.00230598 0.00389637 0.00296535 0.0150974 0.0230985 0.016039 0.0191286 0.0322156 0.0231256 0.0142739 0.0250381 0.0261618 0.0274911 0.0196254 0.00818249 0.00465454 0.00167318 0.00267582 0.00152459 0.00303055 0.0016582 0.00385373 0.00228269 0.00745354 0.00513646 0.0214304 0.0460081 0.0444156 0.0307802 0.0161584 0.008402 0.0268956 0.00526882 0.00427197 0.00309418 0.00237601 0.00257871 0.00211081 0.00239486 0.00191709 0.00234637 0.00204789 0.00318652 0.00437311 0.00941665 0.0200071 0.0977942 0.0285878 0.0079124 0.00580007 0.00631068 0.00546151 0.00347152 0.00261426 0.00192917 0.00269112 0.00176879 0.00269591 0.00180794 0.00277464 0.00202691 0.00358258 0.00368984 0.00903721 0.00185634 0.00245362 0.00196945 0.00323136 0.00271096 0.00523199 0.0193159 0.0729149	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0249349 0.0143876 0.0142813 0.0154711 0.0246932 0.0245854 0.0100994 0.0101655 0.00933408 0.00230077 0.00388756 0.00295867 0.015063 0.023046 0.016003 0.0190852 0.0321435 0.0230763 0.014241 0.0249797 0.026101 0.0274315 0.0195876 0.0081679 0.0046458 0.00166983 0.00267087 0.00152171 0.0030256 0.00165557 0.00384867 0.00227983 0.00744722 0.00513508 0.021437 0.0460241 0.0444487 0.0308164 0.0161926 0.00842511 0.0269669 0.00529716 0.00429142 0.00310132 0.00238192 0.00258157 0.00211306 0.00239521 0.00191614 0.00234448 0.00204918 0.00319286 0.00439903 0.0094638 0.0201734 0.0978177 0.0285264 0.00791546 0.00582041 0.00630595 0.00547703 0.00344911 0.00260554 0.00192523 0.0026749 0.0017583 0.00266692 0.00178448 0.00269507 0.00181344 0.00281324 0.00204949 0.00365199 0.00373842 0.0096838 0.00216399 0.00329656 0.00286848 0.00557478 0.0187826 0.0722042	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0248621 0.0143447 0.0142384 0.0154243 0.0246173 0.0245107 0.0100691 0.0101352 0.00930636 0.00229391 0.00387584 0.00294989 0.0150161 0.0229739 0.0159519 0.0190209 0.0320404 0.0230001 0.0141886 0.0249045 0.0260184 0.0273444 0.0195317 0.00814635 0.00463558 0.00166537 0.00266509 0.00151767 0.00301928 0.00165143 0.00384154 0.00227437 0.00743595 0.005125 0.021403 0.0459949 0.0444662 0.0308535 0.0162153 0.00843513 0.0270275 0.00532042 0.00429953 0.00310098 0.00238092 0.00257775 0.00210862 0.00238891 0.00190933 0.00233693 0.00205031 0.00320901 0.00445852 0.0096581 0.0207087 0.0991522 0.0290434 0.00805897 0.00592057 0.00637684 0.00560171 0.00345597 0.00261599 0.00193274 0.00267573 0.00175589 0.00266137 0.0017781 0.00267834 0.00179531 0.0027478 0.00184156 0.00289659 0.00208328 0.0037256 0.00391006 0.0122467 0.00337812 0.00626986 0.0174188 0.0684786	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0244509 0.0141089 0.0140061 0.0151746 0.0242253 0.0241209 0.00990739 0.00996995 0.00915646 0.00225665 0.00381336 0.00290252 0.0147853 0.0226367 0.0157164 0.0187299 0.0315636 0.0226777 0.0140129 0.0245087 0.025607 0.0269608 0.0193179 0.00804532 0.00454783 0.00163328 0.00260739 0.00148821 0.00295551 0.00162057 0.00376039 0.00223229 0.00728157 0.00505224 0.0211354 0.0455705 0.0439865 0.0303872 0.0158338 0.00825847 0.0262698 0.00545838 0.00438606 0.00308423 0.00239537 0.00255239 0.00209918 0.00234743 0.00188204 0.00229615 0.00213246 0.00338731 0.00486992 0.0103241 0.0221517 0.0907484 0.0269509 0.0079328 0.0059973 0.00567591 0.00568514 0.00311078 0.00270167 0.00191138 0.00236536 0.00166788 0.00231196 0.0016704 0.0023074 0.00167803 0.00234424 0.00170724 0.00241902 0.00177684 0.00259136 0.00208292 0.0034888 0.00479716 0.0119215 0.0397908 0.0717221	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0268511 0.0154955 0.0153792 0.0166649 0.0265799 0.0264558 0.010858 0.0109107 0.0100098 0.00246625 0.00416121 0.00317227 0.016209 0.024827 0.0171791 0.0205192 0.0345779 0.0244226 0.015123 0.0263526 0.0272044 0.0279096 0.0198034 0.00794615 0.00451073 0.00164558 0.00253428 0.00146847 0.00277123 0.00153592 0.00335023 0.00202938 0.00619384 0.00416069 0.0140623 0.0301493 0.0252406 0.0149803 0.00667135 0.003032 0.00477524 0.00437763 0.00422119 0.018349 0.00364071 0.00319007 0.00270216 0.0028294 0.00249223 0.00281161 0.00261249 0.00373098 0.00519801 0.0104419 0.0269068 0.118689 0.0434225 0.0185182 0.00497521 0.00468875 0.00320373 0.00304009 0.00203221 0.00168276 0.00237953 0.00170887 0.00244569 0.00171025 0.00243364 0.00170925 0.00247598 0.00174994 0.00259341 0.00184494 0.00284913 0.002219 0.00394375 0.00273132 0.0054553 0.0235283 0.0842749	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0267632 0.0154467 0.0153319 0.0166161 0.0265084 0.0263802 0.0108259 0.0108755 0.00997937 0.00245829 0.00414793 0.00316304 0.0161636 0.024763 0.0171262 0.0204466 0.0344038 0.0243012 0.0151133 0.0262375 0.0270635 0.0277413 0.0197478 0.00796512 0.00448202 0.00163482 0.00251024 0.00145666 0.00274534 0.00152268 0.00332364 0.00201341 0.00618228 0.00416805 0.0141184 0.0304292 0.0256393 0.0150903 0.00676494 0.00314352 0.00479016 0.0045056 0.00446995 0.0196247 0.0038007 0.0031318 0.0027015 0.00270148 0.00240482 0.00267427 0.00277604 0.00396047 0.00574707 0.0108791 0.0239339 0.112169 0.0356994 0.0116224 0.0123594 0.0143342 0.00400444 0.00333279 0.0024044 0.0018492 0.00250379 0.00189449 0.00257509 0.00186803 0.00255278 0.00185113 0.00258993 0.00188567 0.00271209 0.00198603 0.00299684 0.00235823 0.00413821 0.0030155 0.00588448 0.024095 0.0844212	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0274468 0.0158331 0.0157124 0.0170255 0.0271372 0.0270089 0.0110863 0.0111393 0.010221 0.00251807 0.00424677 0.00324013 0.0165395 0.0253187 0.0174801 0.0208414 0.035061 0.0246503 0.0152788 0.0267085 0.0274367 0.0279113 0.0197945 0.00799938 0.004545 0.00166792 0.00256012 0.00149045 0.00280188 0.00155936 0.00338613 0.00205779 0.00622353 0.0041888 0.0139751 0.0299754 0.0250847 0.0147536 0.00656208 0.00296688 0.00464629 0.00421381 0.00398669 0.017109 0.00324515 0.00293764 0.00242855 0.0026047 0.0022594 0.00260586 0.00247086 0.00367004 0.00506029 0.0105356 0.0223384 0.0981471 0.032172 0.00946334 0.00777698 0.0109093 0.0159313 0.0155127 0.00356615 0.00209654 0.00253398 0.00182818 0.00256494 0.00180429 0.00257364 0.00178203 0.00260372 0.00180441 0.00270336 0.00188451 0.00294271 0.0022648 0.00410339 0.00284015 0.00568487 0.0243871 0.0885718	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281585 0.0162462 0.0161233 0.0174712 0.0278569 0.0277256 0.0113799 0.0114345 0.010492 0.00258464 0.00435952 0.00332546 0.01698 0.0259997 0.0179707 0.0214472 0.0360813 0.0254376 0.0157904 0.027505 0.0283264 0.0289208 0.0205656 0.00830835 0.00470329 0.00171948 0.00264367 0.00153476 0.00289336 0.00160554 0.00350243 0.00212211 0.00648439 0.00436397 0.0147072 0.0315957 0.0266811 0.0157315 0.00705633 0.00323085 0.00498458 0.00466108 0.00456178 0.0200778 0.00381878 0.00317579 0.00272388 0.00275116 0.00243813 0.00269301 0.00262105 0.00371223 0.0052618 0.0103641 0.0219152 0.0971591 0.0289682 0.00839006 0.00664258 0.00708582 0.00673124 0.00497996 0.00473499 0.00461512 0.00903139 0.00194539 0.00232719 0.00174791 0.00233618 0.00175384 0.00239796 0.00179819 0.0025217 0.00190096 0.00278516 0.00223799 0.0038514 0.00301425 0.00575997 0.0232593 0.0851976	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0282575 0.0163026 0.0161789 0.0175311 0.0279505 0.0278192 0.0114186 0.0114739 0.0105282 0.00259357 0.00437443 0.00333693 0.0170364 0.0260839 0.0180271 0.0215116 0.0361888 0.0255071 0.0158247 0.0275791 0.0283959 0.0289815 0.0206006 0.00832388 0.00471767 0.00172499 0.00265323 0.00154005 0.00290405 0.00161128 0.003515 0.0021294 0.00650137 0.00437241 0.0147241 0.0316253 0.0267005 0.0157589 0.00706352 0.00323392 0.00500232 0.00466425 0.00455998 0.0200569 0.00381243 0.00318508 0.00272339 0.00276209 0.00244183 0.00270444 0.00262155 0.00373056 0.0052769 0.0104761 0.0222303 0.0972382 0.0289507 0.00834036 0.00658326 0.00706093 0.0063552 0.00426738 0.00330963 0.00262623 0.00419354 0.00427506 0.00960117 0.00187932 0.00228091 0.0017535 0.00233711 0.00176843 0.00245313 0.00185966 0.00271526 0.00217882 0.00376469 0.00299159 0.0057544 0.0227915 0.0838205	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0282313 0.0162872 0.0161635 0.0175142 0.0279228 0.0277918 0.0114075 0.0114628 0.010518 0.00259106 0.00437011 0.00333369 0.017019 0.0260561 0.0180073 0.0214869 0.0361461 0.025475 0.0158021 0.0275441 0.028356 0.0289384 0.0205668 0.00831101 0.00471221 0.00172318 0.00265069 0.00153854 0.00290133 0.00160974 0.0035116 0.00212726 0.00649296 0.00436594 0.0146971 0.031569 0.0266492 0.0157341 0.00705015 0.00322865 0.00499852 0.00465524 0.00455053 0.0200104 0.0038018 0.00318162 0.00271643 0.0027595 0.00243676 0.00270155 0.00261467 0.00372651 0.00526929 0.0104882 0.0222913 0.0965343 0.0286489 0.00825808 0.00651294 0.00696166 0.00615003 0.0040374 0.00303898 0.00224887 0.00324707 0.00226256 0.00407276 0.00417056 0.0095534 0.00192484 0.00240098 0.00183347 0.00250164 0.00189893 0.00275073 0.00220258 0.00379768 0.00301985 0.00580123 0.0230215 0.0850822	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0282056 0.0162721 0.0161485 0.0174979 0.0278964 0.0277657 0.0113968 0.0114522 0.0105082 0.00258867 0.00436605 0.00333062 0.0170028 0.0260308 0.0179897 0.0214654 0.03611 0.0254491 0.0157834 0.0275147 0.0283241 0.0289055 0.0205415 0.00830085 0.00470781 0.00172154 0.00264852 0.00153715 0.00289899 0.00160833 0.00350875 0.00212539 0.00648693 0.00436133 0.0146791 0.0315313 0.0266123 0.0157145 0.00703922 0.00322441 0.0049945 0.00464799 0.00454401 0.0199774 0.00379247 0.00317756 0.00271002 0.00275611 0.00243175 0.00269771 0.00260704 0.00371879 0.00525537 0.0104809 0.0223187 0.0960407 0.02846 0.00821406 0.00647496 0.00693378 0.00610039 0.00396664 0.00299015 0.0022078 0.00314296 0.00202703 0.0031971 0.00227359 0.00404635 0.00413015 0.00967065 0.00199444 0.00255325 0.00195644 0.00278341 0.00222639 0.0038044 0.00305998 0.00586758 0.0230084 0.0855067	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281668 0.0162496 0.0161262 0.0174736 0.0278575 0.0277273 0.0113811 0.0114365 0.0104938 0.00258513 0.00436007 0.00332606 0.0169792 0.0259945 0.0179648 0.0214352 0.0360601 0.0254147 0.0157595 0.027475 0.0282828 0.0288656 0.0205128 0.00828896 0.00470205 0.00171924 0.0026454 0.0015351 0.00289558 0.00160624 0.00350472 0.00212269 0.00647969 0.00435597 0.0146612 0.0314974 0.0265789 0.0156974 0.0070295 0.00322187 0.0049913 0.00464275 0.00454228 0.0199676 0.00378795 0.0031752 0.0027055 0.00275315 0.00242709 0.00269373 0.00260142 0.00371468 0.00525287 0.0104911 0.0224019 0.0957985 0.0283462 0.0081919 0.00645134 0.00691736 0.00607283 0.00393019 0.00296872 0.00219436 0.00310764 0.0020023 0.0031159 0.00204515 0.00319255 0.00227979 0.00409187 0.00415313 0.0100124 0.00213474 0.00285933 0.00228489 0.00380962 0.0031355 0.00600712 0.0228064 0.0854722	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0281186 0.0162218 0.0160986 0.0174436 0.0278098 0.0276801 0.0113618 0.0114172 0.0104761 0.00258077 0.00435273 0.00332045 0.0169503 0.0259505 0.017935 0.0213994 0.036001 0.0253759 0.0157329 0.027428 0.0282359 0.028824 0.0204851 0.00827734 0.00469587 0.00171657 0.00264183 0.00153268 0.00289168 0.00160379 0.00350028 0.00211961 0.00647311 0.00435122 0.0146494 0.031483 0.0265667 0.0156951 0.00702765 0.00322475 0.00499363 0.00464596 0.00455459 0.0200293 0.00379957 0.00317942 0.00270907 0.00275361 0.00242655 0.0026919 0.00260383 0.00372167 0.00528038 0.0105454 0.0226017 0.0959542 0.0283209 0.00820677 0.00647231 0.00691523 0.00608906 0.00390732 0.00296114 0.00219164 0.00309168 0.00199255 0.00308859 0.00202571 0.0031175 0.00205359 0.00323802 0.00230815 0.00417545 0.00422835 0.0107701 0.00248985 0.00385909 0.00330638 0.00637148 0.022158 0.0845199	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0280789 0.0161979 0.0160747 0.0174173 0.0277667 0.0276382 0.0113449 0.0114005 0.0104609 0.00257702 0.00434625 0.00331562 0.0169231 0.025908 0.0179045 0.0213589 0.0359379 0.0253302 0.0156972 0.0273811 0.0281828 0.0287764 0.0204555 0.00826641 0.00469158 0.00171425 0.00263947 0.00153061 0.00288915 0.00160179 0.00349749 0.00211705 0.00646745 0.00434629 0.0146291 0.0314547 0.0265551 0.0157053 0.00702914 0.00323176 0.00499773 0.00464203 0.00455664 0.0200395 0.00380014 0.00317974 0.00270559 0.00274983 0.00242069 0.00268798 0.00261029 0.00374611 0.00535216 0.0107646 0.0231781 0.0973061 0.0289243 0.00838143 0.00657774 0.00700095 0.00622034 0.00391739 0.00297655 0.00220262 0.00309665 0.00199215 0.00308718 0.00202231 0.00310682 0.00204212 0.00318277 0.00208894 0.00333729 0.00235283 0.00426493 0.00446813 0.013743 0.00387956 0.00716689 0.0204612 0.0799275	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0275406 0.0158907 0.0157719 0.0170924 0.0272578 0.0271288 0.0111335 0.0111844 0.0102645 0.00252834 0.00426492 0.00325365 0.0166183 0.0254564 0.0175869 0.0209618 0.0352582 0.0248677 0.015466 0.0268528 0.0276285 0.0282631 0.0201269 0.00812588 0.00457431 0.00167296 0.00256505 0.00149181 0.002806 0.00155973 0.00339454 0.0020598 0.00627565 0.00423641 0.0142457 0.0308035 0.0259766 0.0153596 0.00687263 0.00318449 0.00484087 0.00449323 0.0044141 0.0193477 0.00378643 0.00311993 0.00268028 0.00268303 0.00238481 0.00263696 0.00270164 0.00390304 0.00572272 0.0114667 0.024474 0.0885394 0.0266077 0.00827637 0.00655089 0.00621666 0.00628992 0.00350614 0.00307017 0.0021836 0.002718 0.0018818 0.00266447 0.00189026 0.00266095 0.00190113 0.00270386 0.00193377 0.00278574 0.00200578 0.00296355 0.0023697 0.00400647 0.00545907 0.0132989 0.0469653 0.0842923	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0272225 0.0157017 0.0155818 0.0168813 0.0268973 0.0267813 0.0109904 0.0110453 0.0101335 0.00249667 0.00421002 0.00321252 0.0164124 0.0251304 0.0173604 0.0207341 0.0349267 0.0244953 0.0150671 0.0262448 0.0268576 0.0272394 0.0193357 0.00771033 0.00439409 0.00162596 0.0024744 0.00145253 0.00269783 0.00151517 0.00323424 0.00198661 0.00582917 0.00393499 0.0127592 0.0270761 0.0218836 0.0126674 0.00553722 0.00225173 0.00353209 0.00253469 0.00222413 0.00530769 0.00432723 0.0185266 0.00358293 0.0034228 0.00286192 0.00316369 0.00294911 0.00403042 0.00562618 0.0112021 0.028681 0.121726 0.0445274 0.0186364 0.00503525 0.00475582 0.00326408 0.00309769 0.00207019 0.00171663 0.00243007 0.00174484 0.00249798 0.00174685 0.00248624 0.00174604 0.00252976 0.0017877 0.00265003 0.00188493 0.0029121 0.00226808 0.0040334 0.00279451 0.00557571 0.024101 0.0860198	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0271816 0.0156802 0.0155616 0.0168627 0.0268725 0.0267503 0.0109761 0.0110273 0.0101191 0.00249265 0.0042034 0.00320872 0.0163941 0.0251068 0.0173245 0.0206755 0.0347611 0.0243526 0.015064 0.0261488 0.0267167 0.0270137 0.019223 0.00771172 0.00435508 0.00161396 0.00244592 0.00144012 0.00266703 0.00150145 0.00320003 0.00196876 0.00578265 0.0039173 0.0126443 0.0270246 0.0218656 0.0125089 0.0054757 0.00224293 0.0034695 0.00251866 0.00224498 0.0052533 0.00446315 0.019431 0.00365439 0.00328798 0.00278879 0.00302231 0.00316285 0.00432771 0.00632196 0.0118061 0.0258021 0.115732 0.0365439 0.0118392 0.0126066 0.0145417 0.00407839 0.00340656 0.00245552 0.00189351 0.00257126 0.00194437 0.00264669 0.0019178 0.00262401 0.00190042 0.00266199 0.0019357 0.00278733 0.00203838 0.00307953 0.00242123 0.00425418 0.00309238 0.00603323 0.0247856 0.0865712	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0277856 0.0160204 0.0158961 0.0172223 0.0274225 0.027301 0.011205 0.0112596 0.0103322 0.00254534 0.00429014 0.00327666 0.0167217 0.0255876 0.0176302 0.0210137 0.0353206 0.0246465 0.0151914 0.0265342 0.0270109 0.0271402 0.0192609 0.00774937 0.00441165 0.001644 0.00249024 0.00147042 0.00271747 0.00153424 0.00325728 0.00200903 0.00583714 0.00395501 0.0126554 0.0268552 0.0217836 0.0124914 0.00546815 0.00222045 0.00346611 0.00248949 0.0021792 0.00513343 0.00410306 0.017152 0.00315125 0.0031269 0.00259395 0.00292552 0.00280906 0.00400841 0.00555238 0.0113543 0.023972 0.100441 0.0329402 0.00961248 0.00791067 0.011222 0.0162739 0.0158143 0.00364253 0.0021472 0.00260019 0.00187671 0.00263473 0.00185285 0.00264498 0.00183059 0.00267667 0.00185388 0.00277948 0.00193625 0.00302544 0.00232763 0.00422005 0.00291831 0.00583218 0.0250628 0.0907412	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286196 0.0165036 0.0163765 0.0177431 0.0282589 0.0281342 0.0115459 0.0116023 0.0106467 0.00262266 0.00442093 0.00337597 0.0172342 0.0263784 0.0181907 0.0217027 0.0364794 0.0255044 0.0157454 0.0274206 0.0279673 0.0281586 0.0200182 0.00804619 0.00457014 0.00169806 0.00257583 0.00151764 0.00281064 0.00158339 0.00337172 0.00207534 0.00606616 0.00410507 0.0132002 0.0280718 0.0228122 0.0130821 0.00574404 0.00232958 0.00362722 0.00262727 0.00233155 0.00548468 0.00458308 0.0199746 0.00366009 0.00333419 0.00281535 0.00304081 0.00299731 0.00407273 0.00580273 0.0112537 0.0236928 0.100046 0.0297886 0.00854391 0.00673938 0.00727194 0.00683416 0.00509591 0.00483922 0.00472665 0.00926603 0.00200196 0.00239877 0.00180178 0.00241203 0.00180882 0.00247666 0.00185477 0.00260451 0.00196067 0.00287578 0.00230871 0.00397872 0.00310315 0.0059224 0.0239942 0.0877369	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0287213 0.0165615 0.0164336 0.0178046 0.0283549 0.0282302 0.0115857 0.0116428 0.0106838 0.00263183 0.00443623 0.00338775 0.017292 0.0264645 0.0182486 0.021769 0.0365895 0.0255757 0.0157799 0.0274942 0.0280358 0.028219 0.0200537 0.00806212 0.00458469 0.00170366 0.00258542 0.00152299 0.00282133 0.00158915 0.0033842 0.00208263 0.00608343 0.0041144 0.0132254 0.0281141 0.0228519 0.0131221 0.00575973 0.0023378 0.00364557 0.00263489 0.00233769 0.00551134 0.00458696 0.0199679 0.00365517 0.00334596 0.00281848 0.00305253 0.00299742 0.00409155 0.00581936 0.0113704 0.0239961 0.100073 0.0297965 0.00850058 0.00668229 0.00725038 0.00645767 0.00436751 0.00338716 0.00267697 0.00429794 0.00440369 0.00983541 0.0019332 0.00235048 0.00180622 0.00241275 0.00182256 0.00253326 0.00191655 0.00280325 0.00224601 0.00388903 0.00307579 0.00590662 0.023494 0.0863082	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286923 0.0165445 0.0164167 0.017786 0.0283245 0.0282001 0.0115735 0.0116306 0.0106726 0.00262907 0.00443148 0.00338418 0.0172728 0.026434 0.0182269 0.021742 0.0365428 0.0255413 0.0157558 0.0274562 0.0279932 0.0281749 0.0200191 0.00804908 0.00457908 0.00170176 0.00258279 0.00152139 0.00281851 0.00158751 0.00338068 0.00208037 0.00607512 0.00410818 0.013202 0.0280641 0.0228104 0.0131045 0.00575075 0.0023354 0.00364399 0.00263129 0.00233432 0.00550849 0.004578 0.0199196 0.00364418 0.00334226 0.00281189 0.00304877 0.00298884 0.00408632 0.00580975 0.0113811 0.0240504 0.0993319 0.0295003 0.00841879 0.00661066 0.00714855 0.00624841 0.00413221 0.00311439 0.00229395 0.00332241 0.00231398 0.00418071 0.00430075 0.00979264 0.00197992 0.0024737 0.00188878 0.00258225 0.001957 0.00283966 0.00227033 0.00392361 0.00310503 0.00595418 0.0237341 0.0876063	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286649 0.0165286 0.0164008 0.0177687 0.0282966 0.0281725 0.0115622 0.0116194 0.0106623 0.00262654 0.00442717 0.00338092 0.0172557 0.0264072 0.0182084 0.0217193 0.0365046 0.0255142 0.0157365 0.0274252 0.0279599 0.0281416 0.0199934 0.00803879 0.00457457 0.00170008 0.00258053 0.00151995 0.00281607 0.00158603 0.00337771 0.00207842 0.00606906 0.00410366 0.0131858 0.028031 0.0227796 0.0130896 0.00574272 0.00233306 0.0036416 0.00262788 0.00233141 0.00550502 0.00457161 0.0198844 0.00363484 0.00333799 0.0028057 0.00304419 0.0029798 0.0040775 0.00579398 0.0113719 0.024074 0.0988147 0.0293156 0.00837578 0.00657315 0.0071209 0.00619836 0.00406018 0.0030643 0.0022515 0.00321421 0.00207459 0.00327763 0.00232565 0.00415441 0.00426033 0.00991863 0.00205156 0.00263047 0.00201554 0.00287242 0.0022949 0.00393129 0.00314685 0.00602148 0.0237267 0.088044	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286256 0.0165057 0.0163781 0.0177441 0.0282573 0.0281335 0.0115462 0.0116034 0.0106477 0.00262295 0.00442112 0.00337629 0.0172317 0.0263704 0.0181831 0.0216888 0.036454 0.0254796 0.0157126 0.0273852 0.0279186 0.0281024 0.0199648 0.0080269 0.00456885 0.00169777 0.00257741 0.0015179 0.00281266 0.00158394 0.00337365 0.00207571 0.00606175 0.00409827 0.0131683 0.0279997 0.0227483 0.0130745 0.00573415 0.00233093 0.00363911 0.00262449 0.00232874 0.00550246 0.00456887 0.0198705 0.00362969 0.00333503 0.00280049 0.00303995 0.00297343 0.00407304 0.0057913 0.0113833 0.0241592 0.0985654 0.0292064 0.00835495 0.00655043 0.0071053 0.00617196 0.00402356 0.00304266 0.00223773 0.00317803 0.00204893 0.00319308 0.00209344 0.00327382 0.00233223 0.004202 0.00428491 0.0102719 0.00219545 0.00294499 0.00235384 0.00393586 0.00322505 0.00616252 0.0235245 0.0879974	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0285793 0.016479 0.0163516 0.0177153 0.0282117 0.0280884 0.0115277 0.0115849 0.0106307 0.00261877 0.00441409 0.00337091 0.0172041 0.0263283 0.0181546 0.0216545 0.0363975 0.0254427 0.0156875 0.0273407 0.0278743 0.0280633 0.0199381 0.00801541 0.00456293 0.0016952 0.00257399 0.00151556 0.00280891 0.00158156 0.00336927 0.00207271 0.00605473 0.00409302 0.0131531 0.0279803 0.0227259 0.0130658 0.00572834 0.0023304 0.00363864 0.00262285 0.00232829 0.00550555 0.00457675 0.0199217 0.0036385 0.00333748 0.00280089 0.00303894 0.00297675 0.00408128 0.00582241 0.0114457 0.0243719 0.098744 0.0291878 0.00837213 0.00657342 0.00710453 0.00619029 0.00400103 0.00303529 0.00223515 0.00316221 0.00203915 0.00316529 0.00207328 0.00319595 0.00210226 0.00332152 0.00236218 0.00428959 0.00436308 0.0110528 0.00256092 0.00398124 0.00340046 0.00653212 0.0228609 0.0870007	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0285413 0.016456 0.0163286 0.01769 0.0281698 0.0280478 0.0115114 0.0115687 0.010616 0.00261512 0.00440775 0.00336621 0.0171774 0.0262865 0.0181242 0.0216136 0.0363336 0.0253954 0.01565 0.0272906 0.0278161 0.02801 0.0199052 0.00800299 0.00455781 0.00169279 0.00257112 0.00151341 0.00280578 0.00157947 0.00336567 0.00207002 0.00604729 0.00408754 0.013129 0.027946 0.0227076 0.0130699 0.0057269 0.0023321 0.00364001 0.00262132 0.00232856 0.00551074 0.00457538 0.0199277 0.00363927 0.00333779 0.00279826 0.00303757 0.00298654 0.00411112 0.00590521 0.0116913 0.024973 0.100122 0.0298262 0.00855434 0.0066836 0.00719409 0.00632544 0.00401185 0.00305112 0.00224671 0.00316805 0.00203927 0.00316449 0.00207015 0.00318523 0.00209035 0.00326404 0.00213905 0.00342503 0.00241016 0.00438451 0.00461372 0.0141142 0.00398451 0.00734781 0.0211055 0.082268	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0279675 0.0161288 0.0160061 0.0173439 0.0276282 0.0275052 0.0112863 0.0113383 0.0104065 0.00256318 0.0043209 0.00330002 0.0168518 0.0258039 0.0177871 0.021193 0.0356118 0.0249104 0.0154146 0.0267508 0.0272531 0.027499 0.0195813 0.00786518 0.00443899 0.0016507 0.00249587 0.00147379 0.00272168 0.00153649 0.00326277 0.00201178 0.0058627 0.00398215 0.0127732 0.0273427 0.022185 0.0127505 0.0055791 0.00228312 0.00352611 0.0025494 0.00226103 0.00526119 0.004372 0.0190305 0.00358494 0.00324568 0.00275126 0.00297462 0.00308035 0.00427556 0.00630358 0.0124552 0.0262028 0.0910735 0.027403 0.00843041 0.00666156 0.0063606 0.00639719 0.00358168 0.00312974 0.00221759 0.00277536 0.00192084 0.00272629 0.00192958 0.00272341 0.0019407 0.00276804 0.00197482 0.00285314 0.00205079 0.0030378 0.00242386 0.00410867 0.0056293 0.0137295 0.0486677 0.0869434	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0272363 0.0157046 0.0155833 0.0168802 0.0268803 0.0267699 0.0109866 0.0110452 0.0101334 0.00249686 0.00420943 0.00321274 0.0164032 0.0251036 0.0173329 0.0206968 0.0348565 0.024384 0.0149328 0.0260636 0.0265796 0.0268642 0.0190625 0.00759371 0.00435292 0.00161978 0.00246006 0.0014498 0.00268111 0.00151251 0.00320579 0.00197867 0.00570955 0.00386541 0.0123463 0.0259263 0.0207043 0.0118966 0.00517206 0.00206366 0.0031732 0.00218592 0.00160989 0.00324067 0.00231113 0.00582819 0.00435527 0.0184583 0.00369243 0.00370302 0.00327907 0.00431044 0.00593707 0.0117015 0.0303071 0.123002 0.0454325 0.0186261 0.00502343 0.00473302 0.00328154 0.00310942 0.00208147 0.00172923 0.00244945 0.00176095 0.00252021 0.00176444 0.0025097 0.00176418 0.00255426 0.00180656 0.00267624 0.00190524 0.00294233 0.00229292 0.00407693 0.00282962 0.00564384 0.0244436 0.086991	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0272431 0.0157115 0.0155915 0.0168934 0.0269065 0.0267872 0.0109919 0.0110458 0.0101371 0.00249728 0.00421047 0.00321501 0.0164149 0.0251251 0.0173204 0.020657 0.0347002 0.0242361 0.014959 0.0260111 0.0264751 0.0266533 0.0189527 0.00760901 0.00431504 0.00160993 0.00243284 0.00143961 0.00265208 0.00150119 0.00317378 0.00196348 0.00566125 0.00384878 0.012217 0.0258432 0.0206591 0.0117076 0.00509126 0.00203425 0.0030838 0.00214827 0.00159907 0.00320377 0.00231262 0.00569345 0.00438645 0.0187916 0.00364684 0.00355368 0.00352357 0.00463124 0.00675263 0.0124613 0.0274287 0.116465 0.0371524 0.0119139 0.0127901 0.0147182 0.00413467 0.00344379 0.00248348 0.00191383 0.00260228 0.00196727 0.00267967 0.00194091 0.00265715 0.00192346 0.00269571 0.00195922 0.00282267 0.00206321 0.00311889 0.00245111 0.00430928 0.00313188 0.00611527 0.0251744 0.0876603	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.027768 0.0160048 0.0158791 0.0172015 0.0273725 0.0272557 0.0111875 0.0112451 0.0103198 0.00254244 0.00428424 0.00327329 0.016691 0.0255261 0.0175703 0.0209286 0.0351543 0.0244515 0.0150244 0.0262928 0.0266571 0.0266615 0.0189249 0.00762011 0.00435761 0.00163483 0.00246907 0.00146522 0.00269369 0.00152911 0.00322027 0.00199715 0.00569643 0.00387409 0.0121964 0.0256048 0.02056 0.0117064 0.00510307 0.00203267 0.00311255 0.00215457 0.00159414 0.00317816 0.00226478 0.00563016 0.00412368 0.0170858 0.00324325 0.00340555 0.00313118 0.00430653 0.00595106 0.011911 0.025373 0.100975 0.0337509 0.00967112 0.00803601 0.0114791 0.0166694 0.016062 0.00369838 0.00217563 0.00263359 0.00190151 0.00267095 0.001879 0.00268294 0.00185711 0.00271574 0.00188094 0.00282024 0.00196457 0.00307015 0.00236171 0.00428218 0.00296099 0.00591807 0.0254749 0.0919655	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286472 0.0165147 0.0163861 0.0177515 0.0282554 0.0281343 0.0115468 0.0116062 0.0106512 0.00262395 0.0044222 0.00337804 0.0172318 0.0263595 0.0181595 0.0216535 0.0363642 0.0253407 0.0156091 0.0272335 0.0276632 0.0277153 0.0196895 0.00792167 0.00451866 0.0016908 0.00255685 0.00151435 0.00278903 0.00158011 0.00333651 0.00206553 0.00592344 0.00402389 0.0127235 0.0267636 0.0215019 0.0122223 0.00533673 0.00211671 0.00322561 0.00224338 0.00166808 0.00334172 0.00240208 0.00595529 0.00451422 0.0194472 0.00365068 0.00356072 0.00335761 0.00438765 0.00624273 0.0118637 0.0251866 0.100825 0.0304951 0.00858655 0.00684593 0.00741765 0.0070175 0.00518735 0.00493157 0.00481554 0.00941951 0.00203676 0.00244141 0.0018334 0.0024558 0.00184126 0.00252215 0.00188813 0.00265246 0.00199599 0.00292876 0.00235031 0.00405109 0.00315855 0.00602896 0.0244763 0.0892269	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0287479 0.016572 0.0164425 0.0178122 0.02835 0.028229 0.011586 0.0116461 0.0106879 0.00263301 0.00443727 0.00338967 0.0172887 0.026444 0.0182163 0.0217188 0.0364728 0.0254103 0.0156414 0.0273033 0.027727 0.0277697 0.019721 0.0079358 0.00453245 0.00169621 0.00256604 0.00151952 0.00279927 0.00158567 0.00334831 0.00207251 0.00593903 0.00403232 0.0127456 0.0267968 0.0215353 0.0122597 0.0053522 0.00212519 0.00324436 0.00225196 0.00167367 0.00335917 0.00240883 0.00598913 0.00452389 0.0194645 0.00364967 0.00357235 0.00335787 0.00440734 0.00626207 0.0119826 0.0254676 0.100824 0.0305362 0.00854763 0.00678942 0.00739833 0.00663332 0.00444518 0.00345724 0.00273164 0.00438035 0.00449616 0.0100193 0.00196836 0.00239384 0.00183906 0.00245755 0.00185576 0.00258048 0.00195143 0.00285557 0.00228685 0.00396071 0.00313177 0.00601572 0.0239618 0.087778	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0287162 0.0165534 0.0164239 0.0177919 0.0283169 0.0281961 0.0115727 0.0116328 0.0106756 0.00262999 0.00443207 0.00338576 0.0172678 0.0264108 0.0181928 0.0216896 0.0364227 0.0253734 0.0156155 0.0272621 0.0276813 0.0277222 0.019684 0.00792166 0.00452628 0.00169412 0.00256309 0.00151775 0.00279609 0.00158383 0.00334432 0.00206996 0.00592983 0.00402553 0.0127207 0.0267429 0.0214914 0.0122413 0.00534331 0.00212302 0.00324332 0.00224933 0.00167143 0.00335755 0.00240492 0.00598663 0.00451574 0.0194193 0.00363906 0.00356716 0.00334783 0.00440116 0.00625081 0.0119903 0.0255085 0.100065 0.0302525 0.00846783 0.00671744 0.00729543 0.00641712 0.00420527 0.00317753 0.00233935 0.00338342 0.0023594 0.00426137 0.00439267 0.00998079 0.0020168 0.00252031 0.00192362 0.00263091 0.00199319 0.00289345 0.00231227 0.0039971 0.00316243 0.00606553 0.0242119 0.0891197	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286875 0.0165367 0.0164073 0.0177738 0.0282876 0.0281672 0.0115609 0.011621 0.0106648 0.00262734 0.00442756 0.00338233 0.0172498 0.0263828 0.0181734 0.0216659 0.0363829 0.0253451 0.0155953 0.0272293 0.0276461 0.027687 0.019657 0.00791072 0.00452142 0.00169232 0.00256062 0.00151619 0.00279341 0.00158224 0.00334104 0.00206785 0.0059232 0.00402069 0.0127036 0.0267079 0.0214597 0.0122262 0.0053355 0.00212084 0.00324128 0.00224662 0.00166933 0.00335535 0.00240154 0.00598267 0.00450932 0.0193836 0.00362979 0.00356144 0.00333774 0.00439168 0.00623394 0.011979 0.0255241 0.0995339 0.0300744 0.008426 0.00668015 0.00726833 0.0063658 0.00413216 0.00312654 0.00229612 0.00327316 0.00211459 0.00333757 0.00237155 0.00423466 0.00435192 0.0101124 0.00209028 0.00268042 0.00205295 0.00292685 0.00233752 0.0040053 0.00320543 0.00613476 0.0242059 0.089572	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286478 0.0165137 0.0163845 0.017749 0.0282481 0.028128 0.0115448 0.011605 0.0106501 0.00262372 0.00442145 0.00337766 0.0172257 0.0263457 0.018148 0.0216353 0.0363319 0.0253103 0.0155712 0.0271888 0.0276043 0.0276472 0.0196279 0.00789856 0.00451552 0.00168996 0.00255739 0.00151409 0.00278987 0.00158008 0.0033368 0.00206507 0.00591559 0.00401515 0.0126856 0.0266761 0.0214282 0.012211 0.0053271 0.00211866 0.00323895 0.00224369 0.00166702 0.00335366 0.0023983 0.0059791 0.00450549 0.0193624 0.00362345 0.0035569 0.00333097 0.00438709 0.00623114 0.011991 0.0256059 0.0992717 0.0299684 0.00840581 0.00665738 0.00725329 0.00633885 0.00409515 0.00310463 0.00228232 0.00323645 0.00208851 0.00325135 0.00213387 0.00333346 0.00237782 0.00428327 0.00437764 0.0104758 0.00223741 0.00300129 0.00239775 0.00400989 0.00328531 0.00627886 0.0239992 0.0895244	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0286031 0.0164879 0.0163589 0.0177213 0.0282041 0.0280844 0.0115269 0.0115871 0.0106337 0.00261968 0.00441467 0.00337247 0.0171991 0.0263053 0.0181206 0.0216023 0.0362774 0.0252748 0.0155475 0.0271463 0.0275621 0.0276102 0.0196022 0.00788745 0.00450973 0.00168745 0.00255402 0.00151181 0.00278617 0.00157775 0.00333247 0.00206212 0.00590863 0.00400999 0.0126706 0.026657 0.0214055 0.0122016 0.00532075 0.00211748 0.00323776 0.00224156 0.0016654 0.00335462 0.00239693 0.00598007 0.00450961 0.0193906 0.00362797 0.00355736 0.00333539 0.00439614 0.0062642 0.0120594 0.0258225 0.0994392 0.0299511 0.00842321 0.00668054 0.00725358 0.0063582 0.0040727 0.00309741 0.00227999 0.00322069 0.00207871 0.00322323 0.00211336 0.00325405 0.00214246 0.00338202 0.00240811 0.0043727 0.00445815 0.011276 0.00261041 0.00405701 0.00346424 0.00665587 0.0233199 0.088505	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0285679 0.0164665 0.0163375 0.0176976 0.0281649 0.0280465 0.0115117 0.011572 0.0106199 0.00261626 0.00440869 0.00336807 0.017174 0.0262659 0.0180915 0.0215625 0.0362152 0.025228 0.01551 0.0270952 0.0275019 0.0275541 0.0195682 0.00787451 0.00450414 0.00168504 0.00255085 0.00150964 0.00278271 0.00157565 0.00332845 0.00205942 0.00590043 0.00400442 0.0126452 0.0266197 0.021386 0.0122041 0.00531866 0.00211762 0.00323815 0.00224003 0.00166378 0.00335733 0.00239576 0.00598355 0.00450574 0.0193774 0.00362807 0.00356083 0.00334934 0.00443057 0.00635449 0.012324 0.0264241 0.100768 0.0306159 0.00860631 0.00679206 0.00734744 0.00649949 0.00408488 0.00311423 0.00229225 0.00322735 0.00207914 0.00322308 0.00211043 0.00324365 0.00213046 0.00332369 0.00217988 0.0034878 0.0024568 0.00446972 0.00471663 0.014406 0.0040618 0.00749099 0.0215242 0.0837034	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0279957 0.0161405 0.0160163 0.0173532 0.0276268 0.0275069 0.0112877 0.0113424 0.0104113 0.00256453 0.00432225 0.00330215 0.0168506 0.0257877 0.0177584 0.0211467 0.0355013 0.0247527 0.0152877 0.0265786 0.0269683 0.0270789 0.0192688 0.00774744 0.00438989 0.00164434 0.0024781 0.00147126 0.00270144 0.00153404 0.0032296 0.00200319 0.00572633 0.00390528 0.0123177 0.026079 0.0209058 0.0119063 0.0051773 0.00206976 0.003137 0.00217837 0.00161979 0.00323069 0.00231534 0.00568343 0.00428943 0.0183665 0.00356108 0.00348643 0.00343768 0.00459088 0.00675576 0.0131449 0.0275911 0.0915238 0.0280991 0.00846541 0.00675294 0.00647457 0.00656486 0.00364302 0.00319309 0.00226073 0.00282448 0.00195581 0.00277396 0.00196456 0.00277063 0.00197532 0.00281576 0.0020097 0.00290219 0.00208696 0.00309051 0.0024685 0.00418791 0.00575375 0.0140599 0.0495959 0.0882618	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0270275 0.0155796 0.0154581 0.0167418 0.0266487 0.0265461 0.010896 0.0109577 0.010053 0.00247728 0.00417582 0.00318732 0.0162664 0.0248873 0.0171866 0.0205253 0.0345847 0.024172 0.0147277 0.0257599 0.0262241 0.0264744 0.0187995 0.00747079 0.00431056 0.00160694 0.0024431 0.00144067 0.00266245 0.00150435 0.00318088 0.0019679 0.00563802 0.00382512 0.0121403 0.0253569 0.0200687 0.0114815 0.00497413 0.0019806 0.00302114 0.002053 0.00145862 0.00272776 0.0016883 0.00349005 0.00235491 0.00590573 0.00434419 0.0183908 0.00408075 0.00478445 0.0061495 0.0122098 0.0323236 0.125899 0.0471525 0.0189121 0.00504906 0.00471779 0.00327984 0.00310702 0.00208198 0.00173275 0.00245628 0.00176685 0.00252943 0.00177175 0.00252005 0.001772 0.00256516 0.00181473 0.00268777 0.00191399 0.00295553 0.00230377 0.00409642 0.00284572 0.00567312 0.0246041 0.087399	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0270734 0.0156101 0.0154898 0.0167812 0.0267183 0.0266039 0.010918 0.0109748 0.0100727 0.00248162 0.00418377 0.00319469 0.0163004 0.0249395 0.0171899 0.0204937 0.0344194 0.0240169 0.01478 0.0257479 0.0261684 0.0263283 0.0187245 0.00751299 0.0042852 0.00160228 0.00242428 0.00143552 0.00264311 0.00149845 0.00316062 0.00195947 0.00560633 0.00381839 0.0120399 0.0253017 0.020037 0.0112858 0.0048904 0.00194929 0.00292589 0.00201114 0.00143514 0.00265636 0.0016726 0.00343563 0.0023489 0.00571669 0.00434538 0.0188085 0.00432196 0.00509771 0.00709331 0.0131367 0.0294548 0.118891 0.0383704 0.0121091 0.012969 0.014801 0.00415511 0.00344448 0.00248451 0.00191498 0.00260697 0.00197048 0.00268632 0.00194514 0.00266481 0.00192821 0.00270398 0.00196429 0.00283147 0.00206863 0.00312877 0.00245775 0.00432317 0.00314088 0.00613577 0.0252984 0.087883	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0275281 0.015861 0.0157352 0.0170432 0.0271075 0.0269978 0.0110832 0.0111433 0.0102272 0.00251975 0.00424524 0.00324433 0.0165318 0.0252735 0.0173891 0.0207042 0.0347745 0.0241466 0.0147854 0.0259221 0.0262115 0.0261565 0.0186038 0.00749031 0.00430344 0.00161951 0.00244545 0.00145407 0.00266827 0.00151901 0.00318734 0.0019831 0.00560508 0.00382413 0.011942 0.0249538 0.0199115 0.011298 0.00491636 0.00195453 0.00296531 0.0020278 0.00144936 0.00268397 0.00168073 0.0034421 0.00232471 0.00571393 0.00416406 0.017444 0.00377632 0.00476946 0.00625439 0.0124967 0.0271794 0.103657 0.0352615 0.00981797 0.00814172 0.0116762 0.0169321 0.0161701 0.00372746 0.00218728 0.00264355 0.00190923 0.00268293 0.00188859 0.00269689 0.00186738 0.00273066 0.0018915 0.00283594 0.00197555 0.00308758 0.00237466 0.00430595 0.0029769 0.00594891 0.0256411 0.0922882	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284367 0.0163886 0.0162597 0.0176123 0.0280214 0.0279063 0.0114548 0.0115169 0.0105702 0.00260418 0.00438824 0.00335272 0.0170906 0.0261329 0.0179975 0.0214528 0.0360181 0.0250625 0.0153964 0.0269152 0.0272783 0.0272759 0.0193941 0.00780306 0.00447376 0.00167883 0.00253981 0.00150648 0.00277075 0.00157345 0.0033117 0.00205595 0.00584386 0.00398066 0.0124919 0.0261239 0.020819 0.0117742 0.00512654 0.00202926 0.00306004 0.00210022 0.00150152 0.00277413 0.00174691 0.0035925 0.00244021 0.00597175 0.00447272 0.0193708 0.00417125 0.00488626 0.00661931 0.0124959 0.0270419 0.10354 0.031779 0.0086912 0.00693389 0.00752114 0.00716933 0.00524389 0.00498755 0.00487074 0.00949282 0.00205555 0.00246307 0.00184939 0.00247808 0.00185802 0.00254551 0.00190531 0.00267707 0.00201403 0.00295587 0.00237117 0.00408718 0.00318576 0.00607948 0.0247168 0.0898527	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0285354 0.0164445 0.0163148 0.0176715 0.0281132 0.0279985 0.011493 0.0115559 0.0106059 0.002613 0.00440288 0.00336404 0.0171459 0.026215 0.0180528 0.0215165 0.0361254 0.0251303 0.0154259 0.0269808 0.0273366 0.0273227 0.0194219 0.00781519 0.00448662 0.00168395 0.00254845 0.0015114 0.00278037 0.00157876 0.0033227 0.00206257 0.00585781 0.00398828 0.0125104 0.0261499 0.0208486 0.0118112 0.00514245 0.00203785 0.00307939 0.00210946 0.00150771 0.00279253 0.00175336 0.00361454 0.00244791 0.00601041 0.00448656 0.0193986 0.0041706 0.00490383 0.00663949 0.0126157 0.0273008 0.103538 0.0318579 0.00865592 0.00687729 0.00750273 0.00677628 0.00448991 0.00350076 0.00276607 0.00442898 0.00455599 0.0101171 0.00198748 0.00241626 0.00185605 0.00248064 0.00187293 0.00260476 0.00196928 0.00288232 0.00230727 0.00399648 0.00315927 0.00606739 0.0241893 0.0883899	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0285027 0.0164253 0.0162956 0.0176505 0.0280789 0.0279645 0.0114792 0.0115421 0.0105933 0.00260988 0.0043975 0.00336 0.0171244 0.0261809 0.0180287 0.0214868 0.0360744 0.0250926 0.0153993 0.0269384 0.0272892 0.0272729 0.0193836 0.00780038 0.00448007 0.00168175 0.00254528 0.00150952 0.00277693 0.0015768 0.00331837 0.00205987 0.00584794 0.00398114 0.0124843 0.0260934 0.0208037 0.011793 0.00513395 0.00203583 0.00307878 0.00210735 0.00150603 0.00279237 0.00175103 0.0036136 0.00244395 0.00600895 0.00447919 0.0193506 0.00415764 0.00489556 0.00662619 0.0126201 0.0273266 0.102754 0.031581 0.0085771 0.00680482 0.00739936 0.00655371 0.00424657 0.003216 0.00236731 0.00341636 0.00238674 0.00430971 0.00445261 0.0100808 0.00203708 0.0025447 0.00194183 0.00265625 0.00201206 0.00292141 0.00233371 0.00403445 0.00319118 0.00611915 0.0244476 0.0897636	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284741 0.0164087 0.016279 0.0176325 0.0280497 0.0279356 0.0114674 0.0115304 0.0105824 0.00260722 0.00439297 0.00335657 0.0171064 0.0261529 0.0180092 0.0214631 0.0360348 0.0250642 0.0153788 0.0269051 0.0272532 0.0272363 0.019356 0.00778914 0.00447497 0.0016799 0.00254265 0.00150791 0.00277408 0.00157515 0.00331489 0.00205768 0.0058409 0.00397613 0.0124665 0.0260572 0.020772 0.0117783 0.00512654 0.00203376 0.00307702 0.00210501 0.00150427 0.00279109 0.00174874 0.00361142 0.00244037 0.00600505 0.00447261 0.0193087 0.00414528 0.00488494 0.00660824 0.0126066 0.0273331 0.102204 0.0314048 0.00853591 0.00676774 0.00737315 0.00650149 0.0041728 0.0031643 0.00232329 0.00330417 0.00213843 0.00337001 0.00239931 0.00428259 0.00441121 0.0102169 0.00211174 0.00270657 0.00207253 0.00295517 0.00235951 0.00404313 0.00323512 0.00618993 0.0244428 0.0902268	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0284355 0.0163863 0.0162568 0.0176083 0.028011 0.0278973 0.0114517 0.0115147 0.0105681 0.00260368 0.00438699 0.00335201 0.0170829 0.0261167 0.0179844 0.021433 0.035985 0.0250301 0.0153551 0.0268651 0.0272117 0.0271968 0.0193272 0.00777706 0.00446908 0.00167756 0.00253941 0.00150583 0.00277053 0.00157301 0.00331063 0.00205492 0.00583327 0.00397066 0.0124487 0.0260258 0.0207415 0.0117638 0.00511854 0.00203163 0.0030749 0.00210242 0.00150207 0.00278972 0.00174612 0.00360944 0.00243675 0.006001 0.00446773 0.0192769 0.00413751 0.00487963 0.00660471 0.0126186 0.0274102 0.10192 0.0312969 0.00851571 0.00674497 0.00735882 0.00647435 0.00413558 0.00314223 0.00230944 0.00326695 0.00211192 0.00328206 0.002158 0.00336555 0.00240496 0.00433175 0.00443736 0.0105877 0.00226086 0.00303072 0.00242057 0.00404776 0.00331615 0.00633611 0.0242334 0.0901805	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0283929 0.0163617 0.0162324 0.0175819 0.0279693 0.0278559 0.0114347 0.0114977 0.0105525 0.00259984 0.00438055 0.00334707 0.0170575 0.0260782 0.0179584 0.0214017 0.0359332 0.0249967 0.0153329 0.0268253 0.0271726 0.0271637 0.0193039 0.00776682 0.00446386 0.00167525 0.00253638 0.00150373 0.00276719 0.00157086 0.00330673 0.00205222 0.00582714 0.00396605 0.0124357 0.0260097 0.0207205 0.0117548 0.00511227 0.00203037 0.00307371 0.00210043 0.00150007 0.00278947 0.00174399 0.00360964 0.00243449 0.00600003 0.00446882 0.0192845 0.00414481 0.0048884 0.00663806 0.0126909 0.0276272 0.102061 0.031274 0.00853256 0.00676814 0.00735999 0.00649477 0.00411326 0.00313512 0.00230728 0.00325114 0.00210203 0.00325348 0.00213704 0.00328447 0.00216599 0.00341455 0.00243509 0.00442221 0.00451888 0.0114005 0.00263811 0.0040959 0.00349719 0.00671733 0.0235444 0.0891507	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0283594 0.0163413 0.016212 0.0175593 0.0279317 0.0278196 0.0114201 0.0114832 0.0105393 0.00259656 0.00437479 0.00334285 0.0170333 0.0260402 0.0179301 0.0213626 0.035872 0.0249501 0.0152948 0.0267723 0.0271095 0.0271043 0.0192689 0.00775332 0.0044578 0.00167278 0.00253292 0.00150152 0.0027634 0.00156872 0.00330233 0.00204947 0.0058183 0.00396042 0.0124091 0.0259701 0.0207004 0.0117567 0.00511016 0.00203001 0.00307373 0.00209906 0.00149769 0.00279048 0.00174158 0.00361113 0.00243224 0.00600128 0.00446463 0.0192674 0.00415821 0.00492547 0.00673082 0.0129692 0.0282227 0.103361 0.0319728 0.00871787 0.00688115 0.00745686 0.00664112 0.00412626 0.00315238 0.00231977 0.00325796 0.0021024 0.00325334 0.00213394 0.00327371 0.00215348 0.00335471 0.00220326 0.00352135 0.00248366 0.00452007 0.00478185 0.0145704 0.00410433 0.00756287 0.0217214 0.0843108	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0278049 0.0160257 0.0159012 0.0172261 0.0274126 0.0272989 0.0112039 0.0112616 0.0103377 0.00254658 0.00429137 0.00327901 0.0167207 0.0255786 0.0176112 0.0209651 0.0351933 0.0245076 0.0150907 0.0262937 0.0266269 0.0266998 0.019015 0.00764309 0.00435463 0.00163528 0.00246635 0.00146599 0.00268896 0.00153023 0.00321234 0.00199783 0.00566378 0.00387279 0.0121272 0.02552 0.0202785 0.0114887 0.00497998 0.00198686 0.0029839 0.00204466 0.00146068 0.00269759 0.00169255 0.00346544 0.00234998 0.00569707 0.00425678 0.0183197 0.00420903 0.00504738 0.00709787 0.0138217 0.0293145 0.0935558 0.0292495 0.00855734 0.00682631 0.00655161 0.00669647 0.00367736 0.00323192 0.00228693 0.00284987 0.0019756 0.0027984 0.00198432 0.00279472 0.00199451 0.00284022 0.00202889 0.00292772 0.00210693 0.00311878 0.00249348 0.00423449 0.00583225 0.014277 0.0501286 0.0887177	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0261604 0.0150665 0.0149464 0.0161808 0.0257375 0.0256577 0.0105354 0.010601 0.00972543 0.00239645 0.00403788 0.0030831 0.0157115 0.024036 0.0166101 0.0198369 0.0335135 0.0234131 0.0141477 0.0249223 0.0253101 0.025561 0.0182737 0.00724558 0.00422144 0.00156836 0.00239623 0.0014081 0.00261179 0.00147391 0.00312357 0.00193229 0.00554266 0.00376287 0.0119193 0.0249915 0.0197965 0.0113898 0.00491816 0.0019493 0.00297097 0.00200851 0.00140562 0.00257438 0.00155735 0.00303821 0.00177474 0.00366999 0.00245265 0.0062928 0.0050328 0.0236849 0.00681315 0.012809 0.0343669 0.132298 0.0509463 0.0198745 0.00515436 0.00473317 0.00324908 0.00308426 0.0020662 0.00172373 0.00244682 0.00175812 0.00252249 0.00176448 0.00251422 0.00176486 0.00255871 0.00180684 0.00267974 0.00190476 0.00294477 0.00229257 0.00408082 0.00282904 0.00563878 0.024472 0.0867237	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0261379 0.0150566 0.0149374 0.0161757 0.0257363 0.0256436 0.010529 0.0105903 0.00971965 0.00239438 0.00403462 0.00308195 0.015692 0.0239972 0.0165463 0.0197185 0.0331863 0.02314 0.0141212 0.0247834 0.025112 0.0252994 0.01812 0.00727274 0.00418563 0.00156132 0.00237158 0.00140096 0.0025862 0.00146585 0.0030957 0.0019205 0.00549183 0.0037461 0.0117764 0.0248352 0.0197432 0.0111877 0.00483679 0.00191874 0.00287297 0.0019653 0.00138191 0.00248365 0.00153308 0.00294655 0.00177401 0.00362853 0.0024755 0.0061043 0.00548261 0.027923 0.00788346 0.0140092 0.0317492 0.125784 0.0413021 0.0126622 0.013334 0.0147936 0.00411836 0.00338142 0.00243898 0.00188253 0.0025657 0.00194008 0.00264707 0.00191703 0.00262779 0.00190106 0.002667 0.00193656 0.00279232 0.00203889 0.0030845 0.00242133 0.00425887 0.0030917 0.00603681 0.0248889 0.0861238	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0265002 0.0152526 0.0151282 0.0163793 0.0260287 0.0259426 0.0106551 0.0107178 0.0098376 0.00242338 0.00408033 0.00312086 0.0158704 0.0242564 0.0166849 0.0198532 0.0334116 0.0231567 0.0140823 0.0248659 0.0250255 0.0249254 0.0179044 0.00722096 0.00417325 0.00156916 0.0023733 0.00141097 0.00259035 0.00147777 0.00309791 0.00193248 0.0054475 0.0037311 0.0115887 0.0243845 0.0196337 0.0112374 0.00488672 0.00192907 0.00291744 0.00198932 0.00140051 0.00252357 0.00155619 0.00299758 0.00179143 0.00365904 0.00246753 0.0061122 0.00520916 0.025665 0.00687242 0.0132416 0.0293693 0.11204 0.0387709 0.0102379 0.00829621 0.0119128 0.0171635 0.0160918 0.00370685 0.00216477 0.00260315 0.0018814 0.00264516 0.0018648 0.0026628 0.00184506 0.00269743 0.00186876 0.00280136 0.00195114 0.00304992 0.00234391 0.00425126 0.00293669 0.00586494 0.0252875 0.0904996	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0273849 0.0157653 0.0156376 0.0169312 0.026914 0.0268237 0.0110161 0.0110817 0.0101717 0.00250558 0.00421937 0.00322611 0.0164087 0.0250815 0.0172722 0.0205738 0.0346124 0.0240466 0.0146674 0.0258393 0.0260714 0.0260455 0.0186922 0.00753372 0.00434998 0.00163007 0.00247262 0.00146517 0.00269828 0.00153428 0.0032284 0.00200807 0.00569392 0.00389128 0.0121571 0.0255716 0.0205319 0.0117192 0.00509534 0.00200392 0.00301434 0.00206026 0.00144982 0.00260121 0.00160907 0.00309467 0.0018586 0.00380878 0.0025788 0.00636569 0.00558409 0.0282013 0.00748343 0.0132996 0.0292402 0.111663 0.0347718 0.00900513 0.00707725 0.00765036 0.00741334 0.00528727 0.00501711 0.00489347 0.00943008 0.00204268 0.00244251 0.00183547 0.00245794 0.00184524 0.00252548 0.00189168 0.00265554 0.00199869 0.00293138 0.00235097 0.00404823 0.00315709 0.0060157 0.0244363 0.0883335	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0274755 0.0158163 0.0156878 0.0169849 0.0269968 0.0269074 0.0110509 0.0111173 0.0102043 0.00251363 0.00423267 0.00323646 0.0164591 0.0251566 0.0173231 0.0206327 0.0347145 0.024111 0.0146936 0.0259007 0.0261242 0.026086 0.0187201 0.00754502 0.00436235 0.00163488 0.00248082 0.0014698 0.00270739 0.00153935 0.00323891 0.00201449 0.00570788 0.00389919 0.012177 0.0256053 0.0205731 0.0117661 0.00511569 0.0020135 0.00303502 0.00207059 0.00145666 0.00262103 0.00161668 0.00311851 0.00186677 0.00383524 0.00258851 0.00641205 0.00559957 0.0282333 0.00750145 0.0134236 0.0294905 0.111709 0.0349005 0.00897243 0.00701695 0.00762682 0.00699202 0.00450797 0.0035201 0.00278069 0.00443478 0.00457033 0.0100725 0.00197376 0.00239576 0.00184202 0.00245961 0.00185891 0.00258256 0.00195373 0.00285701 0.00228676 0.00395657 0.00313043 0.00600269 0.0238895 0.0868407	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0274442 0.0157979 0.0156694 0.0169648 0.0269638 0.0268748 0.0110377 0.0111041 0.0101921 0.00251063 0.0042275 0.0032326 0.0164386 0.0251242 0.0173003 0.0206046 0.0346671 0.0240759 0.0146686 0.0258613 0.0260797 0.0260384 0.0186846 0.00753119 0.00435616 0.00163279 0.00247777 0.00146802 0.0027041 0.00153752 0.0032348 0.00201196 0.00569862 0.00389259 0.0121528 0.0255537 0.0205346 0.0117525 0.00510932 0.00201212 0.00303529 0.00206922 0.00145556 0.00262213 0.00161537 0.00311982 0.00186496 0.00383547 0.00258506 0.00641211 0.00558916 0.0281561 0.00748598 0.0134255 0.0295042 0.110885 0.0346165 0.00889237 0.00694236 0.00752191 0.00675654 0.00425949 0.00322946 0.00237701 0.00340968 0.00239328 0.00431446 0.00446656 0.0100282 0.00202279 0.00252295 0.00192677 0.00263363 0.00199671 0.00289666 0.00231418 0.00399589 0.00316333 0.00605597 0.0241538 0.088225	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0274177 0.0157823 0.0156539 0.0169479 0.0269364 0.0268477 0.0110267 0.0110931 0.010182 0.00250814 0.00422324 0.0032294 0.0164219 0.0250983 0.0172822 0.0205825 0.0346305 0.0240494 0.0146496 0.0258306 0.0260459 0.0260032 0.0186591 0.00752082 0.00435132 0.00163105 0.00247525 0.00146651 0.00270136 0.00153597 0.00323147 0.0020099 0.00569192 0.00388797 0.0121361 0.0255209 0.0205077 0.0117413 0.00510362 0.00201062 0.00303432 0.00206754 0.00145427 0.00262191 0.00161384 0.00311947 0.00186303 0.00383412 0.00258186 0.00640923 0.00557939 0.0280824 0.00746682 0.0134107 0.0295043 0.110302 0.0344307 0.00885074 0.0069048 0.00749666 0.00670217 0.00418446 0.00317618 0.00233081 0.00329309 0.00214281 0.00336131 0.00240617 0.00428562 0.00442133 0.0101601 0.00209677 0.00268274 0.00205589 0.00292936 0.0023399 0.00400455 0.00320762 0.00612775 0.0241487 0.0886894	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.027381 0.015761 0.0156327 0.0169249 0.0268996 0.0268114 0.0110118 0.0110782 0.0101683 0.00250478 0.00421756 0.00322507 0.0163995 0.025064 0.0172587 0.020554 0.0345836 0.0240173 0.0146275 0.0257933 0.026007 0.0259663 0.0186329 0.00750973 0.00434589 0.00162888 0.00247225 0.00146457 0.00269806 0.00153399 0.00322753 0.00200734 0.00568492 0.00388297 0.0121201 0.0254936 0.0204818 0.01173 0.00509709 0.00200905 0.00303295 0.00206556 0.0014525 0.00262153 0.00161179 0.00311884 0.00186074 0.00383295 0.00257863 0.00640668 0.00557414 0.0280442 0.00746188 0.0134226 0.0295765 0.10997 0.0343056 0.00882887 0.00688137 0.00748267 0.00667426 0.00414638 0.00315344 0.00231645 0.00325431 0.00211481 0.00326891 0.00216236 0.00335564 0.00240976 0.00433307 0.00444389 0.0105278 0.00224488 0.00300333 0.00239988 0.0040079 0.00328807 0.00627396 0.0239362 0.0886466	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0273396 0.0157371 0.015609 0.0168992 0.026859 0.0267712 0.0109953 0.0110618 0.0101532 0.00250106 0.00421132 0.00322026 0.0163747 0.0250263 0.0172336 0.0205238 0.0345341 0.0239863 0.0146064 0.025756 0.0259713 0.0259386 0.0186133 0.00750072 0.00434158 0.00162682 0.00246974 0.0014627 0.00269528 0.00153208 0.0032243 0.00200498 0.00568014 0.00387915 0.0121106 0.025484 0.0204652 0.0117236 0.00509185 0.00200826 0.00303238 0.00206403 0.00145079 0.00262189 0.0016098 0.00311904 0.00185886 0.00383366 0.00257662 0.00640744 0.00558093 0.0280988 0.00749554 0.0134972 0.0297886 0.110045 0.0342562 0.00884248 0.0069035 0.00748366 0.00669565 0.00412327 0.00314576 0.00231388 0.00323728 0.00210406 0.00323826 0.00213956 0.00326967 0.00216811 0.00340328 0.0024377 0.00442168 0.0045205 0.0113329 0.00261853 0.00405335 0.00346663 0.00665123 0.0232413 0.0876278	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0273018 0.0157143 0.0155862 0.0168741 0.0268177 0.0267311 0.0109792 0.0110457 0.0101385 0.00249742 0.00420498 0.00321557 0.0163483 0.0249851 0.0172037 0.0204831 0.0344705 0.0239392 0.0145684 0.0257009 0.0259071 0.0258796 0.0185782 0.00748686 0.00433523 0.00162422 0.00246602 0.00146036 0.00269124 0.00152981 0.00321969 0.0020021 0.00567143 0.00387351 0.012085 0.0254469 0.020448 0.0117255 0.00509 0.00200799 0.00303215 0.00206274 0.00144839 0.00262272 0.00160711 0.00311975 0.00185662 0.00383462 0.00257393 0.00640506 0.00559133 0.0282236 0.00757413 0.0137795 0.0303631 0.111305 0.0349973 0.00903347 0.00701916 0.00758234 0.00684825 0.00413537 0.00316188 0.00232525 0.00324156 0.00210281 0.00323525 0.00213453 0.00325523 0.00215278 0.00333701 0.00220246 0.00350743 0.00248315 0.00451696 0.00477504 0.0144694 0.00407035 0.00747851 0.0213982 0.0828019	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0268322 0.0154482 0.0153244 0.0165933 0.0263839 0.0262957 0.0107981 0.0108601 0.0099692 0.0024554 0.004135 0.0031615 0.0160861 0.0245994 0.0169432 0.020163 0.0339341 0.0236095 0.0144075 0.0253118 0.0255356 0.0256185 0.0184123 0.00740386 0.00425412 0.00159333 0.00241163 0.0014306 0.00262995 0.00149741 0.00314624 0.00195945 0.00555331 0.00380802 0.0118872 0.0251584 0.0201221 0.0114898 0.00496826 0.00196868 0.00294839 0.00201139 0.00141467 0.00253914 0.00156536 0.00300574 0.001805 0.00367469 0.00249025 0.00608219 0.00543771 0.0276479 0.00784887 0.0146486 0.0313646 0.100138 0.0317496 0.00882925 0.00693945 0.00664755 0.00688175 0.00368645 0.00324704 0.00229545 0.00283832 0.00197551 0.00278467 0.00198427 0.00278052 0.00199316 0.00282598 0.00202689 0.00291463 0.00210513 0.00310885 0.00248932 0.00422641 0.00582274 0.0142896 0.0497493 0.0870255	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0222095 0.0127365 0.0126215 0.0136363 0.0216276 0.0216183 0.00889973 0.00898485 0.00823851 0.00203003 0.00341611 0.00260966 0.0131464 0.0200494 0.0138674 0.0164488 0.0280341 0.0195104 0.0114991 0.0210064 0.020892 0.0212472 0.0155449 0.0062555 0.00380006 0.00140997 0.00218399 0.00127578 0.00238788 0.00134363 0.00284993 0.00175337 0.00490084 0.00327676 0.0102384 0.021099 0.0180987 0.0112496 0.00507162 0.0019985 0.00319373 0.00210269 0.00143885 0.00273625 0.00162058 0.00321166 0.0018677 0.00391033 0.00246632 0.00572621 0.00434254 0.0118704 0.0197969 0.117589 0.0283811 0.122691 0.0553786 0.0206233 0.00506655 0.00441088 0.00298016 0.00281676 0.00188263 0.00157361 0.0022219 0.00159545 0.00227741 0.00159102 0.00225731 0.00158232 0.00228657 0.00161296 0.00238672 0.00169567 0.00261818 0.00203873 0.00362827 0.00252399 0.00502388 0.0217231 0.0761906	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG2 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0219242 0.0125759 0.0124638 0.0134702 0.0213684 0.021352 0.00878847 0.0088673 0.00813383 0.00200386 0.00337228 0.00257766 0.0129938 0.0198254 0.0136837 0.0162184 0.0275931 0.0191692 0.0113468 0.0206397 0.0204946 0.0207371 0.0152121 0.00616264 0.00369293 0.0013772 0.0021135 0.00124498 0.00231155 0.00131078 0.00276042 0.00170855 0.00474164 0.00319704 0.00995254 0.0206872 0.01785 0.0110394 0.00496975 0.00194618 0.00307957 0.00203663 0.00140498 0.00261832 0.00158707 0.00309378 0.00186894 0.00384145 0.00251056 0.00556989 0.00460438 0.0122136 0.0219206 0.126631 0.0258926 0.120149 0.0460974 0.0131788 0.0132601 0.0139756 0.00386288 0.00304351 0.00219464 0.0016962 0.00229485 0.00174016 0.00235517 0.0017065 0.00232196 0.00167955 0.00234216 0.00170048 0.00244001 0.00178242 0.0026859 0.00210895 0.00369536 0.00269177 0.00523717 0.0214443 0.0735636	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG2 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0221813 0.0127171 0.0126022 0.0136179 0.0215891 0.021577 0.00888219 0.00896279 0.00822161 0.00202543 0.00340701 0.0026054 0.0131214 0.0200113 0.0137976 0.0163282 0.0277832 0.019254 0.0113679 0.0207328 0.0205327 0.020713 0.0152299 0.00616975 0.00371436 0.00138939 0.00213155 0.00125765 0.00233201 0.00132512 0.00278401 0.00172704 0.00476575 0.00321618 0.00993431 0.0205251 0.0177662 0.0110248 0.00499128 0.00194071 0.0030906 0.00204635 0.00140301 0.00261651 0.00157731 0.00307261 0.00182992 0.00376828 0.00242742 0.00548139 0.0043697 0.011764 0.0213682 0.127923 0.0236438 0.105919 0.0430433 0.010369 0.00838565 0.0113053 0.0158828 0.0144045 0.00335415 0.00194011 0.00229422 0.00166321 0.00232283 0.00164377 0.00233068 0.0016191 0.00235171 0.0016325 0.00243295 0.00169804 0.00264149 0.00203218 0.00367034 0.00254335 0.00505828 0.0217212 0.0771015	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0226554 0.0129883 0.0128706 0.0139063 0.0220464 0.0220373 0.00907259 0.00915774 0.00839964 0.00206943 0.0034814 0.00266163 0.0134025 0.0204395 0.0141096 0.016716 0.0284583 0.0197486 0.011658 0.0212853 0.0210824 0.0212863 0.0156318 0.00633143 0.00382127 0.00142757 0.00219505 0.0012926 0.00240145 0.00136168 0.00286519 0.00177355 0.00489709 0.00329718 0.0102358 0.0210589 0.0182893 0.0114104 0.00517454 0.00201712 0.00321991 0.00212409 0.00146403 0.00272922 0.00165026 0.00322186 0.00193267 0.00399472 0.00259025 0.00585087 0.00475623 0.0129696 0.0236602 0.136951 0.0235411 0.104589 0.0380648 0.00899762 0.00714049 0.00721105 0.00734587 0.00477747 0.00448687 0.00434417 0.00824128 0.00181503 0.00215053 0.00161832 0.00215509 0.00162229 0.00220544 0.00165488 0.00230914 0.00174089 0.00253994 0.0020396 0.00349316 0.00273585 0.00518757 0.0209129 0.07495	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0227141 0.0130211 0.0129029 0.0139408 0.0220995 0.0220915 0.0090952 0.0091812 0.00842123 0.0020748 0.00349042 0.00266857 0.0134357 0.0204893 0.0141437 0.0167547 0.0285273 0.0197936 0.0116776 0.0213305 0.0211179 0.0213142 0.0156534 0.00634011 0.00383073 0.00143127 0.00220144 0.00129624 0.00240855 0.00136565 0.00287305 0.00177831 0.00490576 0.00330156 0.0102457 0.0210605 0.018303 0.0114393 0.0051908 0.00202581 0.00323834 0.00213265 0.00147072 0.00274555 0.00165754 0.00324082 0.00194096 0.00401789 0.00260237 0.00589419 0.00477853 0.0130993 0.0238807 0.138185 0.0235856 0.104355 0.0381063 0.00895213 0.00707592 0.00717466 0.00691172 0.00405051 0.00315939 0.00252904 0.00393033 0.00402572 0.0087544 0.00172749 0.00208392 0.00160511 0.00213318 0.00161579 0.00223333 0.00169265 0.00246372 0.00197419 0.00340003 0.00270408 0.00516373 0.0203469 0.0734228	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0226923 0.0130083 0.0128901 0.0139269 0.0220767 0.0220691 0.0090861 0.00917221 0.008413 0.00207279 0.00348701 0.002666 0.0134219 0.0204677 0.0141287 0.0167361 0.0284959 0.0197711 0.011662 0.0213056 0.0210894 0.0212832 0.0156304 0.00633137 0.003827 0.00143 0.00219972 0.0012952 0.00240672 0.00136459 0.00287067 0.00177676 0.00489972 0.003297 0.0102293 0.0210205 0.0182712 0.0114259 0.00518502 0.00202511 0.00323874 0.00213154 0.00147039 0.00274648 0.0016571 0.00324195 0.00194057 0.00401961 0.00260237 0.00589967 0.00477859 0.0131234 0.023918 0.138359 0.023562 0.103576 0.0377614 0.00886548 0.00699642 0.00706969 0.00666072 0.00381396 0.00287921 0.00214686 0.00299798 0.002128 0.00378103 0.00390682 0.00864578 0.00175707 0.00218275 0.00166922 0.0022739 0.00172781 0.00249661 0.00199735 0.00343363 0.00273221 0.00520881 0.0205679 0.0746254	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0226763 0.012999 0.0128808 0.0139168 0.0220604 0.022053 0.00907953 0.00916571 0.00840708 0.00207134 0.00348459 0.00266415 0.0134122 0.0204527 0.0141182 0.0167231 0.0284739 0.0197556 0.0116513 0.0212874 0.0210695 0.0212626 0.0156153 0.00632515 0.00382426 0.00142899 0.00219838 0.00129435 0.00240527 0.00136372 0.00286881 0.00177554 0.00489552 0.00329382 0.0102181 0.0209956 0.0182484 0.0114152 0.00518015 0.00202428 0.0032383 0.00213033 0.00146978 0.00274656 0.00165629 0.00324188 0.00193953 0.00401935 0.0026012 0.00590115 0.00477534 0.0131285 0.0239216 0.138381 0.0235473 0.103006 0.0375242 0.00881739 0.00695459 0.00704188 0.00659853 0.00374158 0.00282858 0.00210322 0.00288994 0.00190119 0.00292432 0.0021277 0.00373405 0.00384756 0.00872317 0.00181255 0.0023123 0.0017744 0.00252149 0.0020179 0.00343962 0.00277021 0.0052711 0.0205523 0.0750306	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.022651 0.0129843 0.0128663 0.013901 0.0220353 0.0220282 0.00906932 0.00915551 0.00839781 0.00206907 0.0034808 0.00266127 0.0133974 0.0204301 0.0141024 0.0167035 0.0284406 0.0197325 0.0116364 0.0212608 0.0210414 0.0212339 0.0155947 0.00631678 0.00381986 0.00142732 0.00219599 0.00129288 0.00240265 0.00136219 0.00286554 0.00177345 0.004889 0.00328913 0.0102027 0.020966 0.0182203 0.0114012 0.00517343 0.002023 0.00323684 0.00212842 0.00146862 0.00274593 0.00165489 0.00324104 0.00193806 0.00401844 0.00259964 0.00590102 0.00477346 0.0131384 0.0239456 0.138462 0.0235823 0.102674 0.0373505 0.00878825 0.00692608 0.00702486 0.00656401 0.00370376 0.00280618 0.00208953 0.00285289 0.00187551 0.00283947 0.0019084 0.0029039 0.00211857 0.0037607 0.0038539 0.00902159 0.00193486 0.00258235 0.00206622 0.0034396 0.0028386 0.00539793 0.0203533 0.0749953	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0226155 0.0129639 0.0128461 0.0138792 0.0220005 0.0219935 0.00905512 0.00914126 0.0083849 0.0020659 0.00347552 0.00265726 0.0133769 0.0203989 0.0140804 0.0166767 0.0283945 0.0197004 0.0116171 0.0212252 0.0210039 0.0211942 0.0155664 0.00630604 0.00381343 0.00142495 0.00219232 0.00129078 0.00239865 0.00135999 0.00286057 0.00177039 0.0048791 0.00328237 0.0101812 0.0209257 0.0181854 0.011384 0.00516507 0.00202148 0.00323471 0.00212586 0.00146731 0.00274486 0.00165349 0.0032402 0.00193742 0.00401899 0.00259993 0.00590254 0.00478041 0.0131767 0.0240417 0.138813 0.0237094 0.102739 0.0372568 0.00879284 0.00693862 0.00702197 0.00657921 0.00368016 0.00279745 0.00208626 0.00283523 0.00186446 0.00280958 0.00188722 0.00282502 0.00190217 0.00293391 0.00213277 0.00382622 0.00391013 0.00970489 0.00225307 0.0034762 0.00298826 0.00571957 0.0197267 0.0741116	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0226061 0.0129581 0.0128404 0.0138732 0.0219903 0.0219838 0.00905115 0.00913729 0.00838173 0.00206513 0.00347432 0.00265646 0.0133722 0.0203923 0.014073 0.0166636 0.0283713 0.0196812 0.0116032 0.0211978 0.0209694 0.0211527 0.0155408 0.00629694 0.00380742 0.00142304 0.00218879 0.00128913 0.00239488 0.00135834 0.00285583 0.00176788 0.00486782 0.0032753 0.0101531 0.0208787 0.018149 0.0113685 0.00515747 0.00202103 0.00323281 0.00212295 0.00146598 0.00274357 0.00165157 0.00323818 0.00193619 0.00401658 0.00259898 0.00589631 0.00478362 0.0132006 0.0241256 0.139161 0.0240075 0.103606 0.0379313 0.0089734 0.00704588 0.00711956 0.00672797 0.00369041 0.00281176 0.00209579 0.00283638 0.00186157 0.00280438 0.00188137 0.00280989 0.00188815 0.00287332 0.00192386 0.00301614 0.00216449 0.00390164 0.00412611 0.0123974 0.00350286 0.00642669 0.0181159 0.0699978	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0223849 0.0128326 0.0127172 0.0137431 0.0217849 0.021775 0.008964 0.00904532 0.00830001 0.00204478 0.00344015 0.00263171 0.0132542 0.0202202 0.0139326 0.0164853 0.0280372 0.0194225 0.0114879 0.0209226 0.0206539 0.0207597 0.0152862 0.00621631 0.00372059 0.00139746 0.00213311 0.00126516 0.00233371 0.00133212 0.00278149 0.00173069 0.00472538 0.00320033 0.00987007 0.0203576 0.0177605 0.0110859 0.00502203 0.00197787 0.00314103 0.00206343 0.00143939 0.00265731 0.00162148 0.00313903 0.00191348 0.00390796 0.00256785 0.00568375 0.00476435 0.013002 0.0237319 0.134379 0.0247067 0.0969202 0.0351247 0.00881955 0.00691449 0.00628481 0.00678313 0.00333208 0.00294873 0.00210344 0.0025113 0.00176179 0.00243785 0.00176084 0.00242289 0.0017597 0.00245521 0.00178184 0.00252697 0.00184289 0.00269131 0.00217904 0.00368129 0.00506166 0.0124363 0.0431514 0.074552	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , an oral DRUG0 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0236589 0.0135741 0.0134516 0.0145497 0.0230202 0.0229704 0.00944976 0.00952597 0.00875577 0.00215739 0.00362447 0.00278096 0.0139881 0.0212517 0.0144959 0.017079 0.0285185 0.019493 0.0116343 0.0207792 0.0202754 0.0197644 0.0143406 0.00597473 0.00352045 0.00137944 0.00205725 0.00125606 0.00225696 0.00131963 0.0026809 0.0017039 0.00444676 0.00309107 0.00919333 0.0184835 0.0148268 0.00888057 0.00398873 0.00163151 0.00249086 0.00165434 0.00120657 0.00208773 0.00128104 0.00235036 0.0013805 0.00262292 0.00157825 0.00326439 0.00216381 0.0054342 0.00445046 0.0173939 0.035827 0.120442 0.0616462 0.0682817 0.0223936 0.0181625 0.0245297 0.0198575 0.00479307 0.00256743 0.00263009 0.00185964 0.00248613 0.00176804 0.00244072 0.00170937 0.00242738 0.00170394 0.00248613 0.00175961 0.00268255 0.00209316 0.00369725 0.00262128 0.00516537 0.0212366 0.0775421	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.023054 0.0132213 0.0131017 0.0141685 0.0224087 0.0223708 0.00920387 0.00928048 0.00853055 0.0021018 0.00353028 0.00270924 0.0136277 0.0207128 0.0141421 0.016659 0.0278701 0.0190849 0.0113523 0.0202961 0.0197969 0.0193252 0.0140972 0.00586105 0.00346448 0.0013528 0.00202565 0.00123358 0.00222387 0.00129788 0.00264206 0.00167589 0.0043766 0.00303832 0.00908887 0.0182996 0.0146766 0.00887379 0.00398544 0.00163691 0.00251457 0.00165974 0.00121236 0.00210662 0.00129252 0.00238583 0.00141157 0.00271025 0.00167292 0.00348556 0.00236338 0.00579908 0.00495642 0.0190007 0.0387292 0.126545 0.0655214 0.0761022 0.0198501 0.0145747 0.017719 0.00801798 0.00833678 0.00762894 0.0113082 0.0024248 0.00256657 0.00186311 0.00230361 0.00177912 0.00229467 0.00178092 0.00236846 0.00185015 0.00257961 0.00213016 0.00346751 0.00290898 0.00542363 0.0195904 0.0713644	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0230874 0.0132407 0.0131209 0.0141888 0.022442 0.0224043 0.00921762 0.00929508 0.00854357 0.00210504 0.00353589 0.0027131 0.0136467 0.0207402 0.0141638 0.0166842 0.0279158 0.0191229 0.0113629 0.0203129 0.0198194 0.0193716 0.014121 0.00586361 0.00347218 0.00135471 0.00203049 0.00123525 0.00222887 0.0012995 0.0026474 0.00167809 0.00438593 0.0030413 0.00910519 0.0183247 0.0146679 0.00887705 0.00398546 0.00164072 0.00252476 0.00166462 0.00121459 0.00211741 0.00129443 0.00239637 0.00141201 0.00271653 0.00166922 0.00348808 0.00235791 0.00582514 0.00494645 0.0191287 0.0389006 0.126925 0.0654204 0.0760245 0.0196813 0.0145047 0.0165895 0.00668487 0.00608002 0.00491509 0.00560467 0.0062852 0.0117144 0.00218558 0.0024023 0.00179532 0.00224685 0.00174918 0.00230176 0.00180788 0.00250695 0.00207646 0.00338892 0.00290806 0.0054833 0.0190706 0.0709958	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0230599 0.0132247 0.013105 0.0141714 0.0224141 0.0223767 0.00920641 0.0092842 0.00853341 0.00210256 0.00353172 0.00270979 0.0136287 0.0207115 0.0141449 0.0166609 0.0278778 0.0190977 0.0113415 0.0202788 0.0197849 0.0193445 0.0140972 0.00585215 0.00346866 0.00135319 0.00202888 0.00123392 0.002227 0.00129803 0.00264473 0.00167603 0.0043799 0.00303584 0.00908923 0.0182801 0.0146279 0.00885941 0.00397748 0.0016397 0.00252571 0.00166404 0.0012142 0.00211918 0.00129391 0.0023981 0.00141095 0.0027166 0.00166659 0.00348685 0.00235461 0.00583402 0.00493769 0.019159 0.0389153 0.126813 0.065145 0.0754833 0.0195305 0.0143804 0.0162072 0.00633691 0.00558342 0.00444514 0.00437165 0.00330665 0.00500215 0.00562564 0.0108745 0.00211766 0.0024333 0.00181973 0.00235706 0.00183972 0.00254392 0.00209587 0.00341408 0.00292197 0.00551467 0.0193586 0.0724207	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.023012 0.0131969 0.0130774 0.0141413 0.0223661 0.0223292 0.00918699 0.00926491 0.00851561 0.00209819 0.00352437 0.00270408 0.013599 0.0206655 0.0141137 0.0166233 0.027816 0.0190552 0.0113107 0.0202275 0.0197334 0.0192972 0.0140602 0.00583557 0.00346137 0.00135028 0.00202497 0.00123131 0.00222264 0.00129529 0.00263929 0.00167243 0.00437003 0.00302832 0.00906614 0.0182261 0.0145801 0.00883346 0.00396539 0.00163622 0.00252206 0.00166076 0.00121188 0.00211676 0.00129132 0.00239511 0.00140759 0.00271153 0.0016611 0.00347872 0.00234688 0.00583005 0.00491946 0.0191292 0.038874 0.126598 0.0649298 0.0750025 0.0194096 0.0143213 0.0160847 0.00623346 0.0055627 0.00447164 0.00426166 0.00300188 0.00394601 0.00313708 0.00470877 0.00526207 0.0105013 0.00210528 0.00252363 0.00190548 0.00259044 0.00211983 0.00342189 0.00295532 0.00559298 0.019363 0.0730755	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0229394 0.013155 0.0130358 0.0140961 0.0222943 0.022258 0.00915777 0.0092357 0.00848873 0.00209158 0.00351325 0.00269553 0.0135552 0.0205983 0.0140681 0.0165688 0.0277264 0.018994 0.0112696 0.0201577 0.0196643 0.0192316 0.0140118 0.00581454 0.00345113 0.00134609 0.00201923 0.00122756 0.00221633 0.00129139 0.00263168 0.00166739 0.00435691 0.00301855 0.00903692 0.0181651 0.0145277 0.00880493 0.00395196 0.00163201 0.002517 0.00165663 0.00120868 0.0021134 0.00128795 0.00239144 0.00140383 0.00270689 0.00165633 0.00347277 0.00234082 0.00582697 0.00490736 0.0191148 0.0388577 0.126402 0.0647969 0.0747117 0.0193342 0.0142712 0.0159716 0.00616628 0.00552023 0.00447633 0.00421481 0.00298887 0.00386501 0.00285369 0.00372742 0.00299907 0.00457186 0.00508141 0.0105648 0.00219196 0.00277856 0.00219079 0.00344388 0.00302369 0.00575936 0.0192098 0.0734556	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0228337 0.013094 0.0129753 0.0140305 0.02219 0.0221545 0.00911529 0.0091931 0.0084496 0.00208195 0.00349706 0.00268312 0.0134923 0.0205027 0.0140033 0.0164917 0.0276 0.018909 0.011215 0.0200631 0.0195712 0.0191423 0.013949 0.00578773 0.00343711 0.00134026 0.0020112 0.00122234 0.00220758 0.00128601 0.00262126 0.00166047 0.00433932 0.00300563 0.00899984 0.0180935 0.0144678 0.00877374 0.00393728 0.00162718 0.00251085 0.00165175 0.00120478 0.00210922 0.00128406 0.00238744 0.00140033 0.00270401 0.00165428 0.00347257 0.00234004 0.00582893 0.00491059 0.0191459 0.0388904 0.126243 0.064753 0.0747617 0.0193194 0.014277 0.0159624 0.0061307 0.00549924 0.00447864 0.00418187 0.00297591 0.00383005 0.0028477 0.0036575 0.0027282 0.00362624 0.00292292 0.00453021 0.00501503 0.0111773 0.00250007 0.00361185 0.00318576 0.00615422 0.0187143 0.0733646	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0227086 0.0130207 0.0129024 0.0139512 0.0220617 0.0220277 0.00906371 0.00914136 0.00840232 0.0020703 0.00347722 0.00266824 0.0134137 0.0203817 0.013918 0.0163871 0.0274274 0.0187847 0.0111366 0.0199408 0.0194433 0.0190055 0.0138598 0.00575448 0.0034199 0.00133342 0.00200173 0.00121637 0.00219743 0.00128005 0.00260925 0.00165266 0.00431725 0.00298983 0.00894816 0.0179926 0.0144091 0.00875185 0.00392744 0.00162398 0.00250674 0.0016483 0.00120122 0.00210759 0.00128081 0.00238696 0.00139794 0.00270592 0.00165433 0.00347858 0.00234172 0.00583428 0.00491725 0.0191786 0.0389196 0.126485 0.0650948 0.0753527 0.0195541 0.0145161 0.0163151 0.00618187 0.0055396 0.00451482 0.00417844 0.00297363 0.00381986 0.00284798 0.00364733 0.00273861 0.00358638 0.00267558 0.00362476 0.00288908 0.00454052 0.00513407 0.0140768 0.00387582 0.00709539 0.0173069 0.0702545	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0228685 0.0131173 0.0130009 0.0140611 0.0222488 0.0222123 0.00913692 0.0092114 0.00846827 0.00208634 0.0035058 0.00268981 0.0135453 0.0206082 0.0140771 0.0165815 0.0277657 0.0190491 0.0113239 0.0201737 0.0196843 0.0192751 0.0141022 0.00584318 0.00343644 0.00133891 0.00200256 0.00121987 0.00219801 0.00128363 0.00261267 0.00165811 0.00433787 0.00301585 0.00903284 0.0183587 0.0146982 0.00887397 0.00396966 0.00163158 0.00250082 0.00165166 0.0012022 0.00209794 0.00128444 0.00237924 0.00141287 0.00272188 0.00170057 0.00352557 0.00241437 0.00584563 0.00508747 0.0196739 0.0381217 0.115313 0.0584586 0.0679554 0.0176427 0.0136492 0.0158123 0.00605232 0.00632751 0.00496323 0.00394778 0.00310231 0.00352111 0.00294841 0.00334065 0.00281871 0.00326087 0.00271695 0.00323853 0.00265199 0.00332834 0.00297446 0.00443656 0.00617601 0.0141521 0.043293 0.0719923	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG1 ( DRUG0 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.026784 0.0153847 0.0152503 0.0164823 0.0261639 0.0261166 0.0107444 0.0108528 0.00995517 0.00245419 0.00413363 0.00315149 0.0158683 0.0241286 0.0166622 0.0197264 0.0332876 0.0231835 0.0135867 0.024369 0.0243459 0.024975 0.0179445 0.00719794 0.00442842 0.00165493 0.00257518 0.00150024 0.00281765 0.00157718 0.0033594 0.00206363 0.00577193 0.00384772 0.011903 0.0241075 0.0188742 0.011262 0.0049754 0.00202454 0.00314346 0.00209015 0.00146642 0.00268276 0.00156842 0.0030022 0.00166838 0.00323852 0.00179521 0.00362998 0.00208899 0.0052851 0.00367634 0.0155832 0.0222331 0.087202 0.03853 0.0247157 0.0187763 0.0439982 0.0262611 0.0174104 0.00460782 0.00249086 0.00286766 0.00211745 0.00283067 0.00205778 0.00277839 0.00199242 0.0027507 0.00197822 0.00280044 0.00203234 0.00301307 0.00239531 0.00410943 0.00302782 0.00590768 0.0228892 0.0818152	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG2 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0261079 0.0150011 0.0148723 0.0160823 0.0255243 0.0254718 0.0104748 0.0105699 0.00970255 0.00239139 0.00402731 0.00307554 0.0155197 0.0236284 0.0162733 0.0192994 0.0324726 0.022534 0.0133396 0.023785 0.0237126 0.0239164 0.0172186 0.00695685 0.00419628 0.00157865 0.00242973 0.00143081 0.00265916 0.00150563 0.00317457 0.00196964 0.00546489 0.00369574 0.0114027 0.0234698 0.018265 0.0107886 0.00475305 0.00194014 0.00296136 0.00197541 0.00139237 0.00251702 0.00148041 0.00281294 0.00157479 0.00304365 0.00170161 0.00345187 0.00203656 0.00532694 0.0038288 0.016729 0.0269606 0.0891845 0.0395537 0.0258026 0.0214185 0.043087 0.0281178 0.0087479 0.00889251 0.00733267 0.01138 0.00243599 0.00269179 0.00205664 0.0025447 0.00199992 0.00254833 0.00199553 0.00261825 0.00205878 0.00284049 0.00235205 0.00381027 0.0032867 0.00616673 0.021502 0.077099	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0254568 0.0146226 0.0144959 0.0156724 0.0248683 0.0248228 0.0102097 0.010305 0.00945831 0.00233119 0.0039252 0.0029976 0.0151165 0.0230097 0.0158556 0.0188006 0.0316629 0.0219772 0.0129699 0.0231863 0.0230917 0.0233144 0.0168146 0.00678891 0.00411409 0.00154494 0.00238457 0.00140102 0.00261039 0.00147545 0.00311758 0.00193146 0.00536898 0.00362566 0.0111988 0.0230377 0.0179514 0.0106556 0.00469626 0.00191636 0.00293603 0.00195261 0.00137303 0.00249823 0.00146204 0.00279574 0.00155725 0.0030284 0.00168538 0.00344059 0.00202622 0.00534262 0.00384643 0.0170052 0.0273992 0.0899485 0.0407007 0.0273334 0.0233513 0.045828 0.0272681 0.00774686 0.00757603 0.00688627 0.00617704 0.00642764 0.0122788 0.00228997 0.00259216 0.00198184 0.00249025 0.00195389 0.00254879 0.00200569 0.00275977 0.002283 0.00370907 0.00322973 0.00613031 0.0209892 0.0763802	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0253417 0.014555 0.0144283 0.0155982 0.0247484 0.0247051 0.010162 0.0102581 0.00941474 0.00232048 0.00390692 0.00298352 0.0150411 0.0228918 0.0157784 0.0187077 0.0315167 0.0218792 0.0128947 0.0230762 0.0229734 0.0232093 0.0167408 0.00675691 0.00410393 0.00154032 0.00238017 0.00139714 0.00260571 0.00147159 0.00311191 0.00192656 0.00535765 0.00361494 0.0111706 0.0229535 0.0178906 0.0106371 0.00468882 0.00191469 0.00293876 0.00195193 0.00137219 0.00250219 0.00146176 0.0028018 0.00155756 0.00303613 0.00168634 0.00345048 0.00202867 0.00536064 0.00385101 0.017041 0.0272904 0.0896957 0.0408324 0.0277017 0.0236701 0.0460509 0.0268996 0.00733208 0.00697604 0.00628926 0.00485588 0.00397772 0.00525376 0.00566769 0.011213 0.00221732 0.00262407 0.00199417 0.00259001 0.0020331 0.00279515 0.00230193 0.00373373 0.00325224 0.00618185 0.0212698 0.0776059	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0252746 0.0145157 0.0143891 0.0155552 0.0246792 0.0246369 0.0101343 0.0102307 0.0093894 0.00231425 0.00389632 0.00297538 0.014998 0.0228245 0.0157335 0.0186534 0.0314288 0.0218185 0.0128497 0.0230058 0.0228969 0.0231355 0.0166872 0.00673453 0.00409463 0.00153676 0.00237553 0.00139406 0.00260068 0.0014684 0.00310566 0.00192231 0.00534519 0.00360543 0.0111414 0.0228801 0.0178353 0.0106111 0.00467753 0.00191127 0.0029359 0.00194867 0.00137004 0.00250055 0.00145962 0.00280067 0.00155548 0.00303536 0.00168427 0.0034499 0.00202647 0.00536077 0.00384406 0.0170054 0.0271317 0.0891959 0.0406952 0.0277257 0.0236953 0.0458946 0.0267206 0.00721677 0.00699702 0.00636823 0.00474861 0.00366926 0.00417609 0.00362889 0.00484926 0.0052684 0.0107864 0.00220352 0.00271525 0.00207257 0.00282955 0.00232172 0.0037374 0.00328919 0.00627622 0.02128 0.0782666	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0252115 0.014479 0.0143526 0.0155155 0.0246154 0.0245738 0.0101085 0.0102051 0.00936576 0.00230844 0.00388648 0.00296784 0.0149588 0.0227641 0.0156928 0.0186044 0.0313488 0.0217636 0.0128112 0.0229424 0.0228304 0.0230709 0.0166402 0.00671467 0.0040854 0.00153318 0.00237064 0.00139089 0.00259534 0.00146511 0.00309915 0.00191797 0.00533311 0.00359643 0.0111142 0.022819 0.0177861 0.0105857 0.00466582 0.0019078 0.00293168 0.0019449 0.00136733 0.00249789 0.00145677 0.00279821 0.00155255 0.00303307 0.00168122 0.00344759 0.00202312 0.00535901 0.00383549 0.0169715 0.0270073 0.0887344 0.0405285 0.0276812 0.0236555 0.0456604 0.0265525 0.00713476 0.00694988 0.00637508 0.0046934 0.00370692 0.00409457 0.00335278 0.00387355 0.00336874 0.00463949 0.00507934 0.0108959 0.00229619 0.00298862 0.00237069 0.0037482 0.00335634 0.0064575 0.0211475 0.0787522	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0251131 0.0144221 0.0142961 0.015454 0.0245176 0.0244769 0.0100688 0.0101654 0.00932918 0.00229943 0.0038713 0.00295618 0.0148992 0.022673 0.0156315 0.0185314 0.0312293 0.0216831 0.0127575 0.0228508 0.0227377 0.022983 0.0165771 0.00668769 0.00407177 0.00152768 0.00236305 0.00138597 0.00258706 0.00146001 0.00308928 0.00191139 0.00531619 0.00358398 0.0110786 0.022746 0.0177253 0.0105532 0.00465035 0.00190287 0.00292482 0.00193937 0.00136314 0.00249305 0.00145235 0.00279325 0.001548 0.00302816 0.00167652 0.00344273 0.0020186 0.00535574 0.00382764 0.0169472 0.0269264 0.0884042 0.0404381 0.0276886 0.0237019 0.0456139 0.0265251 0.00709406 0.00692407 0.0063755 0.00464868 0.00370871 0.00405102 0.00338608 0.00379962 0.00310325 0.00370227 0.00319101 0.00453769 0.00505058 0.0116729 0.00262897 0.0038923 0.0034917 0.00684685 0.0207358 0.0788862	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0250294 0.0143729 0.0142471 0.0154005 0.024431 0.0243916 0.0100342 0.010131 0.00929765 0.00229166 0.00385808 0.00294621 0.014846 0.0225907 0.0155747 0.0184613 0.0311156 0.0216026 0.0127035 0.0227684 0.0226476 0.0228906 0.016517 0.00666449 0.00406128 0.00152333 0.00235752 0.00138221 0.00258116 0.00145632 0.00308239 0.00190659 0.00530334 0.00357413 0.0110467 0.0226856 0.0176881 0.0105421 0.0046449 0.00190201 0.00292292 0.0019372 0.00136053 0.0024933 0.00144955 0.00279423 0.00154516 0.00302999 0.00167375 0.0034459 0.002017 0.00536498 0.00382238 0.0169291 0.0268115 0.0881647 0.0405019 0.0278104 0.023871 0.0458061 0.0270052 0.00715787 0.00696967 0.00641199 0.00463405 0.00371116 0.00402852 0.00339807 0.00378006 0.00314587 0.0036584 0.00295697 0.00364361 0.00307725 0.00451879 0.00535958 0.0150372 0.00414888 0.00784278 0.0192538 0.0759569	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.024943 0.0143318 0.01421 0.0153666 0.0243936 0.0243462 0.0100112 0.0101 0.00927168 0.00228492 0.00384818 0.00293908 0.0148408 0.0226109 0.0155767 0.0184682 0.0311073 0.0216044 0.0127541 0.0226994 0.0225896 0.0228247 0.0164994 0.00665289 0.00398799 0.00150046 0.0022998 0.00135843 0.00251635 0.00142996 0.00300812 0.00187225 0.00519582 0.00353403 0.0108895 0.0226404 0.0176507 0.0103874 0.00455929 0.00185682 0.00282492 0.00188445 0.00132374 0.00239249 0.00140709 0.00266893 0.00149768 0.00288762 0.00162281 0.00328886 0.00197206 0.00515358 0.00382067 0.0166046 0.0268958 0.0844545 0.037466 0.0251627 0.0213724 0.0421417 0.025822 0.00727014 0.00748247 0.00643232 0.00434211 0.00385353 0.00364005 0.00347749 0.00337804 0.0031699 0.00323175 0.00291497 0.0031601 0.00276652 0.00326894 0.00317887 0.00457245 0.00638528 0.0142153 0.0449181 0.0767153	Based on studies evaluating possible interactions of DRUG0 with other drugs , no dosage adjustment is needed with concomitant use of the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (and its active metabolite , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , an oral DRUG0 ( DRUG1 / DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
2	4	0.037954 0.0195929 0.0282956 0.0388303 0.0424763 0.0530738 0.0966228 0.063721 0.0219388 0.0481246 0.0469426 0.0537359 0.0495844 0.0539073 0.0582265 0.0152629 0.0264148 0.0223872 0.00584462 0.00631919 0.0214566 0.0591407 0.130147	There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUG1 , including DRUG2 , and DRUG0 concomitantly .
2	2	0.0379556 0.0200351 0.0292277 0.0411109 0.045967 0.0580623 0.101142 0.0641899 0.0214663 0.0447584 0.0414498 0.0463133 0.0398995 0.0377969 0.0435255 0.0123103 0.0275109 0.0128705 0.0201164 0.0258959 0.0554345 0.0647004 0.108261	There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUG1 , including DRUG0 , and DRUG2 concomitantly .
2	2	0.0335854 0.0172739 0.024901 0.0340894 0.0376029 0.0470654 0.0808494 0.0518463 0.0186515 0.0466465 0.0476521 0.0654745 0.0586813 0.0537879 0.0170854 0.0109085 0.0219756 0.0788612 0.0279844 0.0299291 0.0546838 0.0475793 0.092885	There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUG0 , including DRUG1 , and DRUG2 concomitantly .
1	1	0.0825491 0.0851841 0.0661841 0.12196 0.0490814 0.0673651 0.0624233 0.0316384 0.0338429 0.0377937 0.0452258 0.0790888 0.0560079 0.0512092 0.0128775 0.0239872 0.0230211 0.0705607	Patients treated with DRUG1 and DRUG2 concomitantly should be monitored for increases in INR and prothrombin time .
3	3	0.043299 0.0294917 0.0315021 0.00694069 0.013315 0.0382732 0.0558511 0.0312385 0.0324238 0.0303491 0.0303768 0.0175287 0.0744182 0.0474271 0.0339985 0.0225361 0.0290665 0.0245975 0.0161462 0.0172417 0.0263095 0.0196693 0.0180974 0.0276937 0.0288289 0.0633676 0.0298938 0.0210694 0.0244613 0.00628372 0.00390221 0.00892865 0.0017518 0.00258188 0.00435876 0.00165268 0.00211881 0.00802507 0.0309903 0.0439936	Because of profound and long lasting inhibition of gastric acid secretion , DRUG1 may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg , DRUG2 , DRUG0 esters , and DRUG0 salts) .
3	3	0.0426535 0.029064 0.0310442 0.0068394 0.0131231 0.0377213 0.0550606 0.0307881 0.0319652 0.0299327 0.0299876 0.0173055 0.0737613 0.0469706 0.0338044 0.0223839 0.0288542 0.024576 0.0162024 0.0175274 0.0272323 0.0202339 0.0187493 0.0273766 0.0277117 0.0577409 0.0268811 0.0188297 0.0192446 0.00443683 0.00194825 0.00227555 0.00302738 0.00990736 0.00814067 0.0025912 0.00306098 0.0105496 0.0416415 0.0488553	Because of profound and long lasting inhibition of gastric acid secretion , DRUG1 may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg , DRUG0 , DRUG2 esters , and DRUG0 salts) .
3	3	0.0430636 0.0293209 0.0313277 0.00689512 0.0132027 0.0379959 0.0553454 0.0308202 0.0319623 0.0298765 0.0298012 0.0172475 0.0732752 0.0470617 0.0336674 0.0224126 0.02862 0.0241944 0.0160355 0.0173021 0.0267952 0.0202568 0.0191993 0.0280195 0.0283395 0.059015 0.0218124 0.0145148 0.0134824 0.00313027 0.001572 0.00196924 0.00142932 0.00443655 0.0141475 0.00452047 0.00873342 0.0242821 0.0328663 0.05205	Because of profound and long lasting inhibition of gastric acid secretion , DRUG1 may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg , DRUG0 , DRUG0 esters , and DRUG2 salts) .
4	4	0.0335284 0.0188661 0.0203173 0.00447081 0.00674974 0.0202926 0.0321679 0.0110479 0.0101787 0.00851608 0.00660005 0.00695774 0.0263176 0.0524819 0.0378547 0.0275316 0.0205424 0.0134259 0.0137385 0.0202064 0.0317746 0.0236069 0.0228696 0.0363503 0.0436316 0.0787815 0.0370367 0.024638 0.0283701 0.0100081 0.00774735 0.0298264 0.0060658 0.0104588 0.0549164 0.0126589 0.0160355 0.0378181 0.0406348 0.0549781	Because of profound and long lasting inhibition of gastric acid secretion , DRUG0 may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg , DRUG1 , DRUG0 esters , and DRUG2 salts) .
4	4	0.0347035 0.0195392 0.0210364 0.00462787 0.00698894 0.020981 0.0331163 0.0113922 0.0104664 0.00872604 0.00675751 0.00707378 0.026438 0.0526109 0.0379459 0.0273931 0.020644 0.0131991 0.0133635 0.0196715 0.0307262 0.0235619 0.0231922 0.0373002 0.0470328 0.079979 0.0300461 0.0188695 0.0203109 0.00616416 0.0040766 0.00608412 0.00716472 0.036108 0.0548961 0.0135476 0.0171675 0.0381931 0.0464294 0.0624746	Because of profound and long lasting inhibition of gastric acid secretion , DRUG0 may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg , DRUG0 , DRUG1 esters , and DRUG2 salts) .
4	4	0.0397466 0.0568432 0.024728 0.0118616 0.0163034 0.0209214 0.0153006 0.0305479 0.0650148 0.0738807 0.0777203 0.0853911 0.0754301 0.0289223 0.0184062 0.0255024 0.0625548 0.0352645 0.0452066 0.0576459 0.0218927 0.00612538 0.00877384 0.0201716 0.0758439	Laboratory Tests There have been reports of false-positive urine screening tests for DRUG1 ( DRUG0 ) in patients receiving most DRUG2 , including DRUG0 .
4	4	0.0420149 0.0604464 0.0263918 0.0126549 0.0174343 0.0223047 0.0161152 0.0315679 0.0664249 0.0748976 0.0781179 0.0858229 0.0755379 0.0273833 0.017543 0.0228457 0.0554641 0.0305964 0.0387144 0.035537 0.0102548 0.00732877 0.0210506 0.05032 0.0732308	Laboratory Tests There have been reports of false-positive urine screening tests for DRUG1 ( DRUG0 ) in patients receiving most DRUG0 , including DRUG2 .
4	4	0.0391186 0.0552662 0.0235647 0.011361 0.0149129 0.0182567 0.0139135 0.0291385 0.0651312 0.0795827 0.0801551 0.0618326 0.034772 0.0372602 0.0949774 0.0267498 0.0550924 0.0300089 0.0385547 0.0546444 0.020981 0.00604905 0.00897167 0.0212344 0.0784701	Laboratory Tests There have been reports of false-positive urine screening tests for DRUG0 ( DRUG1 ) in patients receiving most DRUG2 , including DRUG0 .
4	4	0.0397498 0.055943 0.0239054 0.011751 0.0153749 0.0186604 0.0146031 0.030467 0.06773 0.08245 0.0819695 0.0643155 0.0358557 0.0384327 0.0962451 0.0235836 0.048358 0.0240269 0.0330956 0.0316484 0.0093426 0.00711308 0.021197 0.0500311 0.0741507	Laboratory Tests There have been reports of false-positive urine screening tests for DRUG0 ( DRUG1 ) in patients receiving most DRUG0 , including DRUG2 .
4	4	0.050235 0.0705399 0.0297365 0.0131231 0.0169809 0.0220028 0.0129905 0.0230185 0.0496412 0.0510135 0.0490359 0.0253129 0.0142836 0.00958281 0.0239977 0.030579 0.0546826 0.0519966 0.0527023 0.0495203 0.0756675 0.0203499 0.0430869 0.0654874 0.0944325	Laboratory Tests There have been reports of false-positive urine screening tests for DRUG0 ( DRUG0 ) in patients receiving most DRUG1 , including DRUG2 .
4	4	0.0568588 0.0154258 0.0383734 0.0301028 0.0371343 0.025512 0.0200405 0.0290816 0.0354916 0.0398053 0.0244445 0.0124249 0.0336375 0.0472538 0.0245805 0.00493101 0.0099219 0.011221 0.00552458 0.0053262 0.00225356 0.00361372 0.0174469 0.0373737 0.0299359 0.017528 0.0266546 0.0195728 0.0178944 0.00994645 0.00862088 0.0174946 0.00897967 0.00859386 0.0136388 0.00657401 0.0171207 0.0356404 0.0302332 0.0163774 0.00602091 0.0026512 0.00398591 0.0110874 0.0311739 0.0169735 0.0240349 0.0514868	DRUG1 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG2 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.050276 0.0110579 0.0251751 0.0163834 0.0206823 0.0122985 0.00841219 0.0110163 0.0107588 0.00931591 0.00421948 0.002878 0.00881967 0.0067881 0.00717462 0.00484577 0.00992936 0.0119437 0.00600238 0.00590425 0.00253052 0.00419524 0.0170356 0.032917 0.0313344 0.0198859 0.0356185 0.0268356 0.0252831 0.0170117 0.0172574 0.0340031 0.0262992 0.0313645 0.0463887 0.0257364 0.0483815 0.0558665 0.053945 0.0338781 0.0122184 0.00402429 0.00573865 0.0128502 0.0346831 0.0189187 0.0257265 0.0561904	DRUG1 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG2 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.058217 0.0127225 0.0288025 0.0186147 0.0233611 0.013849 0.00947284 0.0123626 0.012024 0.0103426 0.00470652 0.0032412 0.00966226 0.00745382 0.00804923 0.00518007 0.0105593 0.0129218 0.00658712 0.00671509 0.00278858 0.00437924 0.0160133 0.0311467 0.0289225 0.0169229 0.0289524 0.0189057 0.0179548 0.0111332 0.00998413 0.0217091 0.010973 0.011044 0.0180009 0.00929221 0.0266014 0.0611762 0.0579763 0.0340109 0.0149281 0.00614852 0.0118818 0.0281698 0.0621634 0.0558172 0.0540595 0.0540989	DRUG1 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG2 .
3	4	0.0104726 0.00985332 0.0182701 0.0177051 0.027892 0.0188162 0.0150427 0.0264573 0.0338636 0.0382903 0.0236647 0.011211 0.0340496 0.0362161 0.0625109 0.0159272 0.0390295 0.0448731 0.0513028 0.0188462 0.00512812 0.00497668 0.0211244 0.0353167 0.0283915 0.0179482 0.0261088 0.0196745 0.0180107 0.00923616 0.00732632 0.0141613 0.00753733 0.0072105 0.011328 0.00546121 0.0143102 0.0295846 0.0251863 0.0136223 0.00506637 0.00223465 0.0033548 0.00932691 0.0261222 0.0143086 0.0201861 0.0434624	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG1 and 40 grams of DRUG2 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.00781634 0.00725214 0.0132017 0.0124642 0.0196177 0.0130247 0.0101452 0.017838 0.0220986 0.0243365 0.0139941 0.00688441 0.0207942 0.0235509 0.0390749 0.00599036 0.0174977 0.0164177 0.0122497 0.00499577 0.00269212 0.00553738 0.0352188 0.0394985 0.0326999 0.0269097 0.0388503 0.0353971 0.0368273 0.0325524 0.0313311 0.0500363 0.0497019 0.0353584 0.025817 0.0102729 0.0189826 0.0348699 0.0297223 0.0163247 0.00539006 0.00205297 0.00310102 0.0074474 0.0209785 0.0112736 0.0157953 0.0361159	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG1 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG2 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.00917624 0.00848852 0.0153953 0.0144905 0.0229203 0.0151926 0.0118446 0.0208897 0.0258618 0.0284486 0.0164785 0.00812062 0.0247055 0.0278255 0.0447378 0.00677089 0.0187495 0.0172609 0.0124634 0.00534294 0.00267806 0.00488053 0.0297559 0.0353819 0.0287853 0.0236248 0.0334667 0.028023 0.0255992 0.0153964 0.0146803 0.0251358 0.0210343 0.0248608 0.0343635 0.0195277 0.0364059 0.0413322 0.0403716 0.0258639 0.009443 0.00313635 0.00447068 0.0100415 0.0271759 0.0148659 0.0202672 0.0442681	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG1 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG2 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.0103683 0.00956137 0.0172808 0.0162117 0.025773 0.0170618 0.0133223 0.0235653 0.0291572 0.0320451 0.0187559 0.00928355 0.0284234 0.0318811 0.0499807 0.00741394 0.0192008 0.0171763 0.0124827 0.0058 0.00287294 0.00496041 0.0284317 0.0344845 0.0267612 0.020434 0.027291 0.0207386 0.0183995 0.00988613 0.00807113 0.0156971 0.00868785 0.0085952 0.0134451 0.00692446 0.0199836 0.0450719 0.0431142 0.0253323 0.0111974 0.00462423 0.00887912 0.0210314 0.0466414 0.0420001 0.0407451 0.0409532	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG1 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG2 .
4	4	0.00873317 0.00733543 0.0129665 0.0111459 0.0175548 0.0110324 0.00806635 0.0122269 0.0136367 0.0138145 0.00689938 0.00468571 0.0223574 0.0224346 0.0175203 0.0161667 0.0484638 0.0503231 0.0408397 0.0344 0.00571134 0.00867073 0.0215419 0.0182015 0.0150632 0.014899 0.0257944 0.0250307 0.0246707 0.0152269 0.0142472 0.02646 0.022244 0.0271656 0.0367834 0.020948 0.0391205 0.0439077 0.0429481 0.027605 0.0101174 0.00336088 0.00479488 0.010759 0.0291268 0.0159305 0.0216933 0.0473737	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG1 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG2 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.00971353 0.00816292 0.0144087 0.0123651 0.019439 0.0122037 0.008927 0.0135068 0.0150388 0.0152065 0.00760043 0.00516039 0.024466 0.024573 0.0190296 0.0174424 0.0532009 0.0559463 0.0456493 0.0382572 0.00602176 0.00887337 0.0210238 0.0177817 0.0137367 0.0121795 0.020228 0.0188116 0.0181556 0.00993662 0.0079232 0.0164756 0.0091846 0.0091654 0.014173 0.00729606 0.0211038 0.0475484 0.0456544 0.0269045 0.0118914 0.004897 0.00942488 0.0221565 0.0490449 0.0442006 0.0428319 0.0430777	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG1 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG0 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG2 .
4	4	0.00848448 0.00688366 0.0112562 0.00884927 0.0137414 0.00813231 0.00585915 0.00798848 0.00788832 0.00723959 0.00335149 0.0023349 0.00727431 0.00561386 0.00560942 0.00401499 0.00843129 0.0100742 0.0052131 0.00511263 0.00239468 0.00441044 0.0200014 0.0372784 0.0361024 0.0253364 0.0410672 0.0318862 0.0274458 0.0274692 0.0289684 0.0634736 0.0466252 0.0504777 0.0365878 0.0235101 0.0400164 0.0535343 0.0599196 0.0375404 0.0141768 0.00442334 0.00620283 0.0123275 0.0330406 0.018023 0.0232533 0.051154	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG1 pharmacokinetics , DRUG2 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG0 .
4	4	0.0079156 0.00636689 0.0104945 0.00826677 0.0128219 0.00763899 0.00546119 0.00752972 0.00743307 0.00681941 0.0031469 0.00218897 0.00681856 0.00524976 0.00525591 0.00378534 0.00789871 0.00930603 0.00476444 0.00460829 0.00215113 0.00392453 0.0176012 0.0336842 0.032995 0.023481 0.0408282 0.032664 0.0290887 0.0257453 0.0284641 0.0651927 0.0393906 0.0396911 0.0225818 0.0132442 0.0362769 0.0691648 0.0581763 0.0351942 0.0147589 0.0050521 0.0104142 0.0216059 0.0460621 0.0414927 0.0386533 0.0386499	DRUG0 : In a multiple-dose study in 30 normal weight subjects , coadministration of DRUG0 and 40 grams of DRUG0 (e.g. , approximately 3 glasses of wine) did not result in alteration of DRUG1 pharmacokinetics , DRUG0 pharmacodynamics (fecal fat excretion) , or systemic exposure to DRUG2 .
4	4	0.0784109 0.0308751 0.142138 0.115863 0.062936 0.062721 0.0401857 0.00639537 0.0102355 0.0253494 0.0219952 0.023167 0.0314953 0.011862 0.0128269 0.0123202 0.014977 0.0360462 0.0277801 0.0143632 0.0218628 0.0199356 0.0358645 0.0276119 0.037929 0.0748532	DRUG1 : Preliminary data from a DRUG2 and DRUG0 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG0 was coadministered with DRUG0 .
4	4	0.0508707 0.0126116 0.0351767 0.0254757 0.0151686 0.00784666 0.0086333 0.00522346 0.0173902 0.0329494 0.0311814 0.0257209 0.0354423 0.015893 0.0138432 0.0156027 0.0232183 0.0765654 0.0804303 0.0874237 0.0626187 0.0511595 0.0847483 0.0503562 0.0433322 0.0911177	DRUG1 : Preliminary data from a DRUG0 and DRUG0 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG2 was coadministered with DRUG0 .
4	4	0.0241715 0.0281387 0.0879608 0.0820033 0.0614002 0.0642171 0.12785 0.0343821 0.0522155 0.0380495 0.0302955 0.0406898 0.0426642 0.0166635 0.0136465 0.0114295 0.013195 0.0279859 0.0208902 0.0111556 0.0168285 0.0153786 0.0275218 0.0217826 0.0287781 0.0607061	DRUG0 : Preliminary data from a DRUG1 and DRUG2 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG0 was coadministered with DRUG0 .
4	4	0.0153621 0.0177921 0.070231 0.0731756 0.0540711 0.0505692 0.0679486 0.0121028 0.0189848 0.0452404 0.0335637 0.0380241 0.0622859 0.0431389 0.0503188 0.061336 0.04874 0.0360149 0.0320466 0.0182321 0.0191371 0.0151909 0.0257302 0.0189421 0.0242828 0.0475379	DRUG0 : Preliminary data from a DRUG1 and DRUG0 drug interaction study indicate a reduction in DRUG2 plasma levels when DRUG0 was coadministered with DRUG0 .
4	4	0.0135941 0.0153528 0.0611794 0.0653196 0.0496336 0.0472039 0.0596666 0.00893897 0.0147481 0.0279548 0.0201268 0.0254846 0.0306782 0.011816 0.014189 0.0132173 0.0177602 0.0347695 0.0250258 0.0193657 0.0461387 0.0613379 0.0807934 0.0965862 0.067428 0.0716908	DRUG0 : Preliminary data from a DRUG1 and DRUG0 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG0 was coadministered with DRUG2 .
4	4	0.0126162 0.0143087 0.0444614 0.0478218 0.0332471 0.0255185 0.0225469 0.0200897 0.0655115 0.0385988 0.0263306 0.0316934 0.0389472 0.0145707 0.0155373 0.0198956 0.0257679 0.0698283 0.0650624 0.0698649 0.0474528 0.0383221 0.0643238 0.0398451 0.0340317 0.0738056	DRUG0 : Preliminary data from a DRUG0 and DRUG1 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG2 was coadministered with DRUG0 .
4	4	0.0105358 0.00938648 0.020751 0.0176164 0.0114853 0.00649229 0.00754164 0.00467922 0.0198326 0.0415767 0.0409614 0.0373371 0.0558962 0.0278873 0.0329316 0.0421698 0.0582519 0.075527 0.0533635 0.0525801 0.0375242 0.0571988 0.0971545 0.0521821 0.0421039 0.087033	DRUG0 : Preliminary data from a DRUG0 and DRUG0 drug interaction study indicate a reduction in DRUG1 plasma levels when DRUG2 was coadministered with DRUG0 .
3	3	0.011688 0.0106453 0.0219452 0.0187376 0.012213 0.00712675 0.0078987 0.00499711 0.0166679 0.0287752 0.0282606 0.0239634 0.0364643 0.0161839 0.017592 0.0196935 0.0249762 0.0687304 0.0547485 0.0415705 0.0914029 0.0778308 0.0832313 0.113806 0.0865088 0.074342	DRUG0 : Preliminary data from a DRUG0 and DRUG0 drug interaction study indicate a reduction in DRUG0 plasma levels when DRUG1 was coadministered with DRUG2 .
4	4	0.0723985 0.0225849 0.0481131 0.0456312 0.0843486 0.0903875 0.0742562 0.0390683 0.0173345 0.0157891 0.0281254 0.0305989 0.0164581 0.0173702 0.0149643 0.0174491 0.00747848 0.00348876 0.00899658 0.019932 0.0345433 0.030636 0.0242804 0.0331111 0.0146922 0.013741 0.0344383 0.0133202 0.0273145 0.0294588 0.0696904	DRUG1 : In 12 normal-weight subjects receiving DRUG2 120 mg three times a day for 6 days , DRUG0 did not alter the pharmacokinetics of a single dose of DRUG0 .
4	4	0.0555881 0.0126008 0.0271482 0.0178783 0.0305255 0.0339732 0.0408277 0.0244435 0.0271802 0.0193122 0.0339103 0.0430263 0.0315671 0.0418206 0.0351674 0.0497176 0.0255666 0.0107474 0.0384217 0.0433405 0.0418923 0.0380465 0.0314699 0.0402943 0.0182029 0.0160441 0.0377327 0.0148456 0.0280216 0.027261 0.0634259	DRUG1 : In 12 normal-weight subjects receiving DRUG0 120 mg three times a day for 6 days , DRUG2 did not alter the pharmacokinetics of a single dose of DRUG0 .
4	4	0.0134361 0.011155 0.0149757 0.0119111 0.0339426 0.040031 0.0336934 0.0286537 0.0167528 0.0102006 0.0123818 0.0153416 0.0112119 0.0125609 0.0136612 0.016552 0.0071808 0.0034895 0.0102929 0.026422 0.0537147 0.0595243 0.0601365 0.0608641 0.0451325 0.0454526 0.0749171 0.0391261 0.0709559 0.0683719 0.0779574	DRUG0 : In 12 normal-weight subjects receiving DRUG1 120 mg three times a day for 6 days , DRUG0 did not alter the pharmacokinetics of a single dose of DRUG2 .
4	4	0.010869 0.00823587 0.0124631 0.00968726 0.0196165 0.0231322 0.0279551 0.0165939 0.0174476 0.012108 0.021253 0.025465 0.0170186 0.0189205 0.0149181 0.0220478 0.0128274 0.00553239 0.0271806 0.0259177 0.0373553 0.0656306 0.0614541 0.0665147 0.0525941 0.0489017 0.0754331 0.0377782 0.0710634 0.0650852 0.0690002	DRUG0 : In 12 normal-weight subjects receiving DRUG0 120 mg three times a day for 6 days , DRUG1 did not alter the pharmacokinetics of a single dose of DRUG2 .
4	4	0.0861405 0.0124323 0.0305517 0.0218254 0.0629066 0.0467735 0.040908 0.0437589 0.0503259 0.0368832 0.0511655 0.0510161 0.0657325 0.0477184 0.0412508 0.0873279 0.0362807 0.038394 0.0360137 0.0311718 0.0262533 0.0551693	DRUG1 and Analogues : A pharmacokinetic interaction study showed a 30% reduction in DRUG2 supplement absorption when concomitantly administered with DRUG0 .
4	4	0.079809 0.0114559 0.0272023 0.0170425 0.0459582 0.0293647 0.0222757 0.0216765 0.0255146 0.0167503 0.0179305 0.0191378 0.0248781 0.0393714 0.0791862 0.0818025 0.0466275 0.0610159 0.0849991 0.0957524 0.0724345 0.0798145	DRUG1 and Analogues : A pharmacokinetic interaction study showed a 30% reduction in DRUG0 supplement absorption when concomitantly administered with DRUG2 .
3	3	0.00925514 0.0057607 0.0153933 0.0144777 0.0456675 0.0381419 0.0354998 0.0394372 0.0488042 0.0412359 0.0789476 0.0849643 0.0756972 0.102587 0.0321807 0.0504357 0.034305 0.0332717 0.049345 0.0589116 0.0518153 0.0538655	DRUG0 and Analogues : A pharmacokinetic interaction study showed a 30% reduction in DRUG1 supplement absorption when concomitantly administered with DRUG2 .
3	3	0.173194 0.124182 0.0703009 0.0785633 0.110797 0.101038 0.110721 0.0498147 0.0474512 0.0569071 0.0770309	DRUG1 inhibited absorption of a DRUG2 supplement by approximately 60% .
4	4	0.0745432 0.0626987 0.0658333 0.0556327 0.0477994 0.0806409 0.108704 0.0873901 0.103803 0.0264095 0.00424951 0.00370579 0.00243922 0.00354813 0.0171296 0.0184799 0.0207869 0.0276854 0.0475676 0.0143437 0.023277 0.0225294 0.0808029	The effect of DRUG1 on the absorption of supplemental DRUG2 , DRUG0 , and nutritionally-derived DRUG0 is not known at this time .
4	4	0.0838617 0.0704639 0.0727772 0.0593565 0.048245 0.0786768 0.111595 0.0781847 0.049658 0.0106203 0.00767505 0.0159514 0.00301442 0.00390314 0.01672 0.0187386 0.022785 0.0317069 0.0550871 0.0168645 0.026536 0.0261815 0.0913976	The effect of DRUG1 on the absorption of supplemental DRUG0 , DRUG2 , and nutritionally-derived DRUG0 is not known at this time .
4	4	0.0742094 0.0633187 0.0626887 0.0513866 0.0311692 0.0405263 0.0460653 0.027488 0.0209519 0.00643211 0.00319844 0.00859839 0.0118619 0.0345715 0.167472 0.0718876 0.0410738 0.0475113 0.0524239 0.0174757 0.0258124 0.0220414 0.0718355	The effect of DRUG1 on the absorption of supplemental DRUG0 , DRUG0 , and nutritionally-derived DRUG2 is not known at this time .
4	4	0.0317614 0.028491 0.0203981 0.030172 0.0307116 0.0487544 0.0716847 0.051319 0.0685557 0.0433815 0.0118953 0.0149564 0.0271393 0.0375075 0.152147 0.0546664 0.0379645 0.0488826 0.0573987 0.0189574 0.0262318 0.0210415 0.0659821	The effect of DRUG0 on the absorption of supplemental DRUG1 , DRUG0 , and nutritionally-derived DRUG2 is not known at this time .
4	4	0.0330567 0.0272751 0.0199339 0.0234665 0.023647 0.0342043 0.0479983 0.0296115 0.0322616 0.0143469 0.0121706 0.0577783 0.026579 0.0384097 0.193606 0.0604845 0.0428516 0.0561103 0.0686087 0.0224861 0.0311668 0.0249573 0.0789891	The effect of DRUG0 on the absorption of supplemental DRUG0 , DRUG1 , and nutritionally-derived DRUG2 is not known at this time .
4	4	0.063538 0.0197087 0.0411978 0.0362434 0.0725716 0.0869577 0.0683934 0.0533992 0.0307822 0.0172063 0.0263968 0.0281893 0.0133876 0.0131082 0.00952288 0.00934726 0.00589804 0.00300315 0.00805836 0.0180621 0.0322101 0.0281815 0.0192216 0.0287697 0.0127083 0.0502248 0.0266464 0.0252234 0.0318008 0.0346697 0.0853718	DRUG1 : In 12 normal-weight subjects receiving DRUG2 80 mg three times a day for 5 days , DRUG0 did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of DRUG0 .
4	4	0.0452522 0.0100035 0.0220282 0.0135755 0.0210859 0.0233661 0.0346408 0.0395649 0.0519112 0.0212442 0.0287091 0.0377569 0.0282402 0.0362601 0.0274023 0.0344062 0.0214787 0.00958122 0.0348783 0.0391249 0.0379796 0.0344492 0.0250539 0.0396414 0.0176116 0.0648318 0.0340746 0.0294483 0.0327623 0.0318343 0.0718023	DRUG1 : In 12 normal-weight subjects receiving DRUG0 80 mg three times a day for 5 days , DRUG2 did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of DRUG0 .
4	4	0.0128278 0.0116597 0.0163828 0.0128769 0.0324197 0.0351701 0.0320785 0.0498304 0.0278521 0.0118754 0.0121927 0.0139766 0.0108675 0.0110748 0.0103216 0.0100668 0.00622825 0.00315589 0.00930163 0.0245372 0.0455506 0.0456182 0.0388786 0.0419997 0.0244385 0.0786773 0.0681588 0.056298 0.0935241 0.0785694 0.0735904	DRUG0 : In 12 normal-weight subjects receiving DRUG1 80 mg three times a day for 5 days , DRUG0 did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of DRUG2 .
4	4	0.0100139 0.0071192 0.0108853 0.00791562 0.014244 0.0165253 0.0249741 0.0288575 0.039396 0.0146881 0.0200683 0.0253132 0.0173517 0.017606 0.0126802 0.016586 0.0118611 0.00535589 0.0256619 0.0239489 0.0335909 0.053463 0.0452757 0.052116 0.0283743 0.0803673 0.0663151 0.0528674 0.0945418 0.0755083 0.0665282	DRUG0 : In 12 normal-weight subjects receiving DRUG0 80 mg three times a day for 5 days , DRUG1 did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of DRUG2 .
4	4	0.076515 0.076438 0.0343059 0.0194893 0.0375527 0.0448426 0.0619234 0.06774 0.0583335 0.0320565 0.0142224 0.0129393 0.0224187 0.0260492 0.0140554 0.0149969 0.0129891 0.0158179 0.00674004 0.00317911 0.00999296 0.0236441 0.0443172 0.0410821 0.0251978 0.033673 0.0167621 0.0215361 0.0302651 0.0375223 0.0634022	DRUG1 (extended-release tablets) : In 17 normal-weight subjects receiving DRUG2 120 mg three times a day for 6 days , DRUG0 did not alter the bioavailability of DRUG0 (extended-release tablets) .
4	4	0.0587027 0.0563157 0.0246568 0.0116259 0.0239064 0.0205964 0.0207184 0.0240899 0.0317924 0.019314 0.0219184 0.0157116 0.0280468 0.0357564 0.0265726 0.0353573 0.030453 0.0433987 0.0234222 0.0103836 0.0371725 0.0455537 0.0495238 0.0477935 0.0330646 0.0464213 0.0232805 0.0241637 0.0331495 0.0383019 0.0588356	DRUG1 (extended-release tablets) : In 17 normal-weight subjects receiving DRUG0 120 mg three times a day for 6 days , DRUG2 did not alter the bioavailability of DRUG0 (extended-release tablets) .
4	4	0.0277658 0.0493924 0.0312411 0.0127104 0.0156626 0.0141714 0.026608 0.0302251 0.0252336 0.0216421 0.0131293 0.00811651 0.00977692 0.0122925 0.00908969 0.0104877 0.0115809 0.014707 0.00636533 0.00295944 0.00970046 0.0244347 0.0487366 0.0706664 0.0884733 0.107946 0.0821986 0.0533296 0.0465419 0.047404 0.0674102	DRUG0 (extended-release tablets) : In 17 normal-weight subjects receiving DRUG1 120 mg three times a day for 6 days , DRUG0 did not alter the bioavailability of DRUG2 (extended-release tablets) .
4	4	0.0246571 0.0416772 0.0271555 0.0102228 0.0135428 0.0127153 0.016606 0.0199379 0.0223559 0.0134104 0.0137187 0.00937353 0.0164193 0.0199038 0.0131112 0.0147466 0.0114986 0.0183654 0.0106271 0.0048993 0.0266295 0.0297082 0.0378949 0.0749809 0.0796366 0.108876 0.0854164 0.0573333 0.0504238 0.0485222 0.0656331	DRUG0 (extended-release tablets) : In 17 normal-weight subjects receiving DRUG0 120 mg three times a day for 6 days , DRUG1 did not alter the bioavailability of DRUG2 (extended-release tablets) .
4	4	0.0441222 0.053439 0.0134138 0.034612 0.0428415 0.0386169 0.0402206 0.0205887 0.0161804 0.0418568 0.0284925 0.041805 0.0262025 0.0155123 0.0155165 0.0293551 0.039716 0.0256963 0.028988 0.0169027 0.0149096 0.0130962 0.0247812 0.0220768 0.0279944 0.038654 0.0191462 0.0162004 0.0222031 0.0238357 0.0227349 0.0283755 0.0342897 0.0776236	Oral DRUG1 : In 20 normal-weight female subjects , the treatment of DRUG2 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral DRUG0 .
4	4	0.0155306 0.00998855 0.0080127 0.0167519 0.0229643 0.0235863 0.024953 0.0127994 0.00953346 0.0234715 0.0181429 0.0231528 0.0244769 0.0156221 0.0098224 0.0126944 0.019014 0.019664 0.0217903 0.021665 0.0210976 0.0195896 0.0442119 0.0373502 0.0437282 0.0714762 0.0500164 0.0444489 0.0447288 0.037389 0.0513744 0.0585528 0.060161 0.0622386	Oral DRUG0 : In 20 normal-weight female subjects , the treatment of DRUG1 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral DRUG2 .
4	4	0.0724018 0.0224862 0.0479378 0.0453971 0.0841287 0.0899184 0.0736496 0.0396199 0.0173904 0.0159047 0.02833 0.03234 0.0166487 0.0156073 0.0105314 0.00969739 0.00649197 0.00313981 0.00822526 0.0193848 0.034038 0.0305558 0.0244465 0.0326604 0.0143353 0.012992 0.0302423 0.0193689 0.0122202 0.0258795 0.0305973 0.0734325	DRUG1 : In 12 normal-weight subjects receiving DRUG2 120 mg three times a day for 7 days , DRUG0 did not alter the pharmacokinetics of a single 300-mg dose of DRUG0 .
4	4	0.0572967 0.0132499 0.028436 0.0190075 0.0329189 0.0370884 0.0440753 0.0254551 0.0286013 0.020805 0.0369047 0.0478328 0.0344248 0.0406768 0.0282438 0.0240928 0.0213771 0.00936684 0.0332441 0.0388643 0.0399496 0.0377546 0.0317305 0.0417204 0.0182187 0.0152541 0.0340922 0.022001 0.0137933 0.0268498 0.0287044 0.0679694	DRUG1 : In 12 normal-weight subjects receiving DRUG0 120 mg three times a day for 7 days , DRUG2 did not alter the pharmacokinetics of a single 300-mg dose of DRUG0 .
4	4	0.0135394 0.0112884 0.0151885 0.0119849 0.0340465 0.0399633 0.0333057 0.0283901 0.0164845 0.0101915 0.0123273 0.0158221 0.01135 0.0111292 0.00936184 0.0091511 0.00602432 0.00307444 0.00930057 0.024643 0.0475121 0.0521579 0.0515963 0.0555338 0.0416339 0.0411036 0.067751 0.0580743 0.0357021 0.0749949 0.0711213 0.0762522	DRUG0 : In 12 normal-weight subjects receiving DRUG1 120 mg three times a day for 7 days , DRUG0 did not alter the pharmacokinetics of a single 300-mg dose of DRUG2 .
4	4	0.0106341 0.00810886 0.0123301 0.00970424 0.020009 0.0238985 0.0290505 0.0168998 0.0184246 0.0130935 0.0235505 0.0280176 0.0179393 0.0165767 0.0106916 0.0112782 0.0108556 0.00474497 0.0246838 0.0223552 0.0320106 0.0579011 0.0542456 0.0609736 0.0489564 0.0462343 0.0665748 0.0585233 0.0342104 0.0742828 0.0673994 0.0658409	DRUG0 : In 12 normal-weight subjects receiving DRUG0 120 mg three times a day for 7 days , DRUG1 did not alter the pharmacokinetics of a single 300-mg dose of DRUG2 .
4	4	0.0574079 0.0151979 0.0345347 0.0233959 0.0322916 0.0311374 0.0285707 0.0291147 0.0325085 0.0286296 0.0177021 0.0618286 0.0634032 0.0579223 0.0649837 0.0327107 0.0151909 0.0133745 0.0212732 0.0229363 0.0131297 0.0138801 0.0127754 0.015145 0.00676562 0.00307035 0.00852772 0.0203787 0.0323538 0.0233135 0.0223535 0.0380006 0.0249234 0.0267929 0.0544753	DRUG1 : In a 2-way crossover study of 24 normal-weight , mildly hypercholesterolemic patients receiving DRUG2 120 mg three times a day for 6 days , DRUG0 did not affect the pharmacokinetics of DRUG0 .
4	4	0.0541723 0.0126138 0.0276321 0.0171386 0.0212484 0.0176363 0.0137259 0.0123212 0.0138699 0.0115302 0.00627759 0.0219517 0.029201 0.0267843 0.0296733 0.0202242 0.022651 0.0169145 0.0318129 0.040629 0.0283966 0.0375682 0.0299619 0.0423828 0.0211422 0.010225 0.0372153 0.0446116 0.0430146 0.0320152 0.0353507 0.0554958 0.0378293 0.034673 0.0621097	DRUG1 : In a 2-way crossover study of 24 normal-weight , mildly hypercholesterolemic patients receiving DRUG0 120 mg three times a day for 6 days , DRUG2 did not affect the pharmacokinetics of DRUG0 .
4	4	0.012341 0.0103857 0.0164207 0.0121545 0.018906 0.0193305 0.0170352 0.0171547 0.0194099 0.016323 0.00770697 0.0279441 0.0420956 0.0322075 0.032406 0.0280637 0.015907 0.00988619 0.0123788 0.0150698 0.0113656 0.0127761 0.0144341 0.0169325 0.00764717 0.00369344 0.0107314 0.0282817 0.0499495 0.0585605 0.0937801 0.0855947 0.0747949 0.0682527 0.0800785	DRUG0 : In a 2-way crossover study of 24 normal-weight , mildly hypercholesterolemic patients receiving DRUG1 120 mg three times a day for 6 days , DRUG0 did not affect the pharmacokinetics of DRUG2 .
4	4	0.0123904 0.00985505 0.0152379 0.0107703 0.0156053 0.0147236 0.0119654 0.0109838 0.0123837 0.0104318 0.00579985 0.0201736 0.0269442 0.0252038 0.0286089 0.0188684 0.0184265 0.0133095 0.0241001 0.029523 0.0186689 0.0215651 0.0172634 0.0276175 0.0156552 0.00676685 0.0343784 0.0359654 0.0412215 0.0514037 0.0862378 0.0857682 0.0808618 0.0663234 0.0749975	DRUG0 : In a 2-way crossover study of 24 normal-weight , mildly hypercholesterolemic patients receiving DRUG0 120 mg three times a day for 6 days , DRUG1 did not affect the pharmacokinetics of DRUG2 .
4	4	0.0457849 0.0141741 0.0277629 0.0217441 0.0362204 0.0291036 0.0121316 0.0263581 0.0398605 0.0258027 0.0145177 0.0134642 0.0248663 0.0321121 0.0184056 0.0213775 0.0142526 0.0125275 0.0188243 0.0186922 0.0205015 0.0145826 0.011575 0.0142356 0.0155921 0.0108159 0.0130934 0.0187025 0.0251306 0.0261568 0.0231964 0.00954129 0.0244862 0.0200475 0.0746635 0.0455403 0.0235419 0.00955895 0.0137593 0.0287111 0.0322236 0.0563611	DRUG1 : In 12 normal-weight subjects , administration of DRUG2 120 mg three times a day for 16 days did not result in any change in either DRUG0 pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII) .
4	4	0.00840205 0.00713239 0.00966828 0.00769836 0.0167114 0.0102952 0.00495937 0.015177 0.0176317 0.0199178 0.0137175 0.00865446 0.00998615 0.0147397 0.0145248 0.0163943 0.0187091 0.0194091 0.0271975 0.0309293 0.033355 0.0322372 0.0271711 0.0266096 0.0365902 0.0351226 0.0432916 0.0411627 0.0450839 0.0516996 0.0351922 0.0102814 0.0258705 0.0208421 0.0572983 0.0407466 0.023287 0.00927847 0.013496 0.0255931 0.0274268 0.0465084	DRUG0 : In 12 normal-weight subjects , administration of DRUG1 120 mg three times a day for 16 days did not result in any change in either DRUG2 pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII) .
3	3	0.0261082 0.0188929 0.0251786 0.0628314 0.105262 0.106918 0.0447694 0.120824 0.0761198 0.033929 0.00777548 0.0181409 0.00763686 0.00749662 0.00724118 0.00606703 0.00670416 0.0110247 0.0135688 0.00575099 0.0105151 0.0174729 0.0197045 0.0145823 0.0193551 0.0137909 0.0313218 0.0485919 0.0145718 0.0138469 0.0224199 0.0615871	Therefore , as DRUG1 absorption may be decreased with DRUG2 , patients on chronic stable doses of DRUG0 who are prescribed DRUG0 should be monitored closely for changes in coagulation parameters .
4	4	0.0229257 0.013857 0.0207783 0.0540083 0.0571542 0.0325174 0.0156619 0.0331788 0.0172348 0.016391 0.0140231 0.0360461 0.0226823 0.0319237 0.0694651 0.0477001 0.0631842 0.0369116 0.0159829 0.0131096 0.0234147 0.0269424 0.0258082 0.0210066 0.024536 0.0182928 0.0396201 0.0570237 0.0180054 0.016693 0.0259235 0.0679978	Therefore , as DRUG1 absorption may be decreased with DRUG0 , patients on chronic stable doses of DRUG2 who are prescribed DRUG0 should be monitored closely for changes in coagulation parameters .
4	4	0.0214651 0.0129133 0.019139 0.0497339 0.0518697 0.029427 0.0137884 0.0293159 0.0140733 0.0150831 0.0126976 0.0246103 0.0120516 0.0108095 0.0140067 0.0130507 0.0217302 0.0425913 0.0807571 0.059001 0.0977311 0.0598373 0.0200834 0.0178248 0.0231547 0.0209469 0.0432502 0.0539951 0.0190864 0.0169024 0.0234452 0.0556278	Therefore , as DRUG1 absorption may be decreased with DRUG0 , patients on chronic stable doses of DRUG0 who are prescribed DRUG2 should be monitored closely for changes in coagulation parameters .
4	4	0.00781995 0.00336731 0.00512451 0.0208832 0.0663675 0.0525909 0.0375478 0.135112 0.100816 0.107663 0.01761 0.0206002 0.0156579 0.0226431 0.0415215 0.0281869 0.0422201 0.0233671 0.010578 0.00875895 0.0148631 0.0176813 0.0164758 0.0134882 0.0154572 0.0115547 0.0250629 0.0356379 0.0113638 0.01048 0.0163106 0.0431885	Therefore , as DRUG0 absorption may be decreased with DRUG1 , patients on chronic stable doses of DRUG2 who are prescribed DRUG0 should be monitored closely for changes in coagulation parameters .
1	1	0.0103929 0.00389431 0.00470391 0.0139636 0.0297413 0.0204888 0.00767971 0.0208806 0.0107587 0.0129154 0.0131974 0.0310626 0.0169721 0.0240885 0.0447804 0.031143 0.0411913 0.0780896 0.0474507 0.0505087 0.105722 0.049732 0.0262631 0.024279 0.0268128 0.0243719 0.0483871 0.058254 0.0210092 0.0181628 0.0248957 0.0582069	Therefore , as DRUG0 absorption may be decreased with DRUG0 , patients on chronic stable doses of DRUG1 who are prescribed DRUG2 should be monitored closely for changes in coagulation parameters .
4	4	0.0655518 0.0312605 0.0922562 0.0880029 0.10345 0.0478368 0.0115654 0.0257172 0.0491465 0.0208409 0.0145236 0.0317296 0.017448 0.0339013 0.0500847 0.04715 0.0578153 0.0232715 0.0345046 0.0262471 0.0388728 0.0888232	DRUG1 : Concurrent use of DRUG2 and DRUG0 may result in increased systemic toxicity since DRUG0 inhibit the breakdown of DRUG0 .
4	4	0.0577348 0.0278594 0.0709793 0.0819782 0.0601492 0.0429576 0.038401 0.0736439 0.0540818 0.0214268 0.0188931 0.0316847 0.0179075 0.0335007 0.0488103 0.0458418 0.0588701 0.0238114 0.0354491 0.0270155 0.0393443 0.0896595	DRUG1 : Concurrent use of DRUG0 and DRUG2 may result in increased systemic toxicity since DRUG0 inhibit the breakdown of DRUG0 .
4	4	0.036459 0.00997744 0.0252072 0.0329357 0.0232204 0.0156723 0.00746661 0.0224213 0.0356341 0.0184601 0.00959017 0.0258027 0.0117371 0.0209593 0.047369 0.0731548 0.103183 0.0861583 0.101081 0.103806 0.092484 0.0972205	DRUG1 : Concurrent use of DRUG0 and DRUG0 may result in increased systemic toxicity since DRUG0 inhibit the breakdown of DRUG2 .
2	2	0.0208601 0.0313526 0.0586195 0.0568124 0.0471148 0.0858052 0.0294655 0.0590865 0.0826854 0.0387257 0.032662 0.0380194 0.0265941 0.0506365 0.0599669 0.0453696 0.0542189 0.0218069 0.029576 0.0223916 0.0331964 0.0750339	DRUG0 : Concurrent use of DRUG1 and DRUG2 may result in increased systemic toxicity since DRUG0 inhibit the breakdown of DRUG0 .
4	4	0.0118636 0.0159608 0.0436977 0.0746874 0.0851472 0.0821976 0.0225836 0.044647 0.0727562 0.040227 0.0349763 0.0359918 0.0291128 0.0503646 0.0458147 0.0409172 0.0422397 0.0282563 0.0423388 0.0360543 0.0355403 0.0846251	DRUG0 : Concurrent use of DRUG1 and DRUG0 may result in increased systemic toxicity since DRUG2 inhibit the breakdown of DRUG0 .
4	4	0.0118653 0.0158454 0.0391772 0.0696192 0.070468 0.0383086 0.0283574 0.095634 0.077984 0.0341049 0.0281472 0.0373987 0.0297302 0.05481 0.0516406 0.0420058 0.0418569 0.0284417 0.0432201 0.0368097 0.0364996 0.0880756	DRUG0 : Concurrent use of DRUG0 and DRUG1 may result in increased systemic toxicity since DRUG2 inhibit the breakdown of DRUG0 .
4	4	0.0107607 0.0142187 0.0358923 0.0636042 0.0595667 0.0341316 0.0233296 0.0667451 0.0519369 0.0211166 0.015935 0.0231704 0.0142442 0.0284995 0.0521753 0.0555643 0.0835792 0.0654224 0.0729902 0.0755005 0.0647958 0.0668207	DRUG0 : Concurrent use of DRUG0 and DRUG1 may result in increased systemic toxicity since DRUG0 inhibit the breakdown of DRUG2 .
3	3	0.0115354 0.0107909 0.0235428 0.0360923 0.0292404 0.0183747 0.00979596 0.0325181 0.0534513 0.0311754 0.0194652 0.0428988 0.023803 0.0409572 0.0479766 0.0813376 0.0852163 0.0615051 0.0693098 0.120153 0.0863685 0.0644913	DRUG0 : Concurrent use of DRUG0 and DRUG0 may result in increased systemic toxicity since DRUG1 inhibit the breakdown of DRUG2 .
4	4	0.198576 0.0353131 0.0344709 0.0888759 0.101849 0.123543 0.0616996 0.0158099 0.0360897 0.0676258 0.028134 0.021403 0.045917 0.0429682 0.0369056 0.0608195	DRUG1 medications : Concurrent use of DRUG2 and DRUG0 may result in additive depressant effects .
4	4	0.167788 0.0301727 0.028111 0.0666867 0.0925274 0.0828242 0.0603241 0.0585898 0.104441 0.0799488 0.0291394 0.026469 0.0441572 0.0417071 0.0335874 0.053526	DRUG1 medications : Concurrent use of DRUG0 and DRUG2 may result in additive depressant effects .
2	2	0.0234983 0.0311255 0.0382534 0.0736337 0.0763706 0.0600802 0.106049 0.0416052 0.090843 0.125284 0.0519434 0.0500085 0.0621133 0.0568292 0.0498846 0.0624784	DRUG0 medications : Concurrent use of DRUG1 and DRUG2 may result in additive depressant effects .
4	4	0.0561109 0.0255907 0.0419405 0.0541479 0.0346691 0.0537207 0.0866216 0.0929711 0.0738257 0.0495127 0.0141221 0.04748 0.0195388 0.0155226 0.0362928 0.0196054 0.0256683 0.0551373 0.0100362 0.0119353 0.0283927 0.0282745 0.0186917 0.0179616 0.0331685 0.0490615	DRUG1 : DRUG0 may increase the diffusion rate of DRUG2 , resulting in a decreased time of onset , but an increase in systemic toxicity .
2	3	0.0210807 0.0307266 0.0749936 0.0702448 0.0322678 0.0424884 0.0448507 0.0549713 0.0696156 0.0505543 0.021006 0.0669459 0.0304358 0.0219501 0.0382494 0.0212887 0.0282436 0.0648125 0.0115248 0.0136367 0.030514 0.0301615 0.019703 0.0192635 0.0363164 0.0541546	DRUG0 : DRUG1 may increase the diffusion rate of DRUG2 , resulting in a decreased time of onset , but an increase in systemic toxicity .
4	4	0.0722494 0.0399105 0.024409 0.0381155 0.0182829 0.0210049 0.0598661 0.0810481 0.0557674 0.0330779 0.0156282 0.0466304 0.0694934 0.0374676 0.0160781 0.023217 0.0159515 0.0883771 0.0366039 0.027644 0.0227905 0.0653259 0.0910608	DRUG1 (such as DRUG2 ) : Concurrent use of DRUG0 and DRUG0 may result in prolongation or enhancement of the neuromuscular blockade .
4	4	0.0531729 0.0159664 0.00994973 0.0107833 0.0172092 0.024303 0.097269 0.0919787 0.110224 0.0526701 0.0138684 0.0344569 0.0669783 0.0290294 0.0162858 0.019026 0.0155515 0.0842164 0.039716 0.0305333 0.0222755 0.0598308 0.0847049	DRUG1 (such as DRUG0 ) : Concurrent use of DRUG2 and DRUG0 may result in prolongation or enhancement of the neuromuscular blockade .
4	4	0.0234754 0.0157346 0.0133621 0.0601231 0.0202563 0.0229969 0.093014 0.0916333 0.10702 0.0506018 0.0134074 0.0339671 0.0649475 0.0281929 0.0157127 0.0186235 0.0150736 0.0819355 0.0385235 0.0295365 0.0216037 0.0580057 0.0822527	DRUG0 (such as DRUG1 ) : Concurrent use of DRUG2 and DRUG0 may result in prolongation or enhancement of the neuromuscular blockade .
4	4	0.0227004 0.0151276 0.0125129 0.0525431 0.0175501 0.0201296 0.0693155 0.088681 0.0661091 0.0480959 0.0475052 0.0905947 0.0733983 0.0274704 0.01888 0.0190623 0.0162615 0.0782272 0.0368272 0.0278489 0.0197757 0.0540573 0.0773261	DRUG0 (such as DRUG1 ) : Concurrent use of DRUG0 and DRUG2 may result in prolongation or enhancement of the neuromuscular blockade .
2	2	0.01068 0.00497466 0.00398704 0.00730088 0.0124859 0.0214686 0.0716318 0.0673132 0.0523915 0.0949018 0.0342325 0.0802062 0.105906 0.0430543 0.0312245 0.0245761 0.0242868 0.0841441 0.0417511 0.0337226 0.0223599 0.0526223 0.0747779	DRUG0 (such as DRUG0 ) : Concurrent use of DRUG1 and DRUG2 may result in prolongation or enhancement of the neuromuscular blockade .
4	4	0.0718982 0.0352002 0.1025 0.0983774 0.115831 0.0541648 0.0133876 0.0305389 0.0552043 0.0237402 0.0115215 0.00963282 0.0177428 0.0213626 0.0238166 0.0484608 0.0334726 0.0375167 0.0431588 0.0422569 0.110215	DRUG1 : Concurrent use of DRUG2 and DRUG0 may result in a reduction of the antibacterial action of the DRUG0 .
4	4	0.0446656 0.0140016 0.0373322 0.0513336 0.0386337 0.0244787 0.0124422 0.0383469 0.0574018 0.03498 0.0145486 0.0159787 0.0254885 0.0384402 0.0488229 0.0817809 0.0606871 0.0722692 0.0963818 0.093312 0.0986739	DRUG1 : Concurrent use of DRUG0 and DRUG0 may result in a reduction of the antibacterial action of the DRUG2 .
2	2	0.0234169 0.0354384 0.066384 0.0642139 0.0535583 0.0978646 0.0348634 0.0751214 0.0955629 0.0403595 0.0258561 0.01776 0.0248369 0.0265864 0.0260005 0.0423049 0.0323495 0.0369076 0.0435379 0.0374869 0.0995904	DRUG0 : Concurrent use of DRUG1 and DRUG2 may result in a reduction of the antibacterial action of the DRUG0 .
4	4	0.0123376 0.0164889 0.0457188 0.0770145 0.0900128 0.0895362 0.0245936 0.0491388 0.078937 0.0412988 0.0277243 0.0219519 0.029334 0.039295 0.0417009 0.0595661 0.0425722 0.0452982 0.0627939 0.0539946 0.0506915	DRUG0 : Concurrent use of DRUG1 and DRUG0 may result in a reduction of the antibacterial action of the DRUG2 .
4	4	0.0132018 0.0176555 0.0442756 0.0797941 0.0814597 0.0464574 0.0348005 0.112358 0.0853176 0.0353034 0.0204047 0.0157457 0.0238461 0.0344163 0.0381561 0.0574748 0.0410829 0.0462343 0.0630109 0.0549723 0.0540326	DRUG0 : Concurrent use of DRUG0 and DRUG1 may result in a reduction of the antibacterial action of the DRUG2 .
4	4	0.0735054 0.0361526 0.0901674 0.105898 0.0819902 0.0569002 0.0500801 0.0926289 0.083093 0.0573337 0.0255016 0.0371894 0.0424221 0.0342787 0.040454 0.0924048	DRUG1 : Concurrent use of DRUG0 and DRUG2 may extend the plasma half-life of DRUG0 .
4	4	0.0405566 0.0150463 0.0400622 0.0524663 0.0458441 0.0254806 0.0149694 0.0424144 0.0740552 0.0651393 0.0650674 0.084248 0.115693 0.112609 0.102678 0.103671	DRUG1 : Concurrent use of DRUG0 and DRUG0 may extend the plasma half-life of DRUG2 .
3	3	0.0250176 0.0358901 0.0657835 0.0631118 0.0502286 0.0920413 0.0312662 0.0848248 0.123866 0.0763991 0.0473643 0.0485939 0.0491728 0.0526912 0.0519538 0.101794	DRUG0 : Concurrent use of DRUG1 and DRUG2 may extend the plasma half-life of DRUG0 .
4	4	0.0136133 0.0182441 0.0480752 0.0816078 0.0897607 0.086804 0.0249986 0.0422765 0.0799011 0.0598722 0.0730705 0.0669546 0.0682893 0.0922364 0.0842454 0.07005	DRUG0 : Concurrent use of DRUG1 and DRUG0 may extend the plasma half-life of DRUG2 .
4	4	0.0164382 0.0222384 0.0497654 0.077278 0.0765539 0.0366631 0.026794 0.0880077 0.0972717 0.0592544 0.0630969 0.0658665 0.076686 0.0904958 0.0796403 0.0739498	DRUG0 : Concurrent use of DRUG0 and DRUG1 may extend the plasma half-life of DRUG2 .
2	0	0.0766415 0.0642843 0.0462546 0.0768136 0.0279008 0.0460594 0.0332948 0.0591939 0.0919304 0.051043 0.0515425 0.0524825 0.0682182 0.0704185 0.0366351 0.0290449 0.0275013 0.0401619 0.0505786	Synergistic interaction between DRUG1 and DRUG2 is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation .
4	4	0.0172194 0.0183638 0.0170862 0.0225493 0.0141314 0.0516444 0.0348835 0.0255276 0.0322348 0.0414407 0.0290856 0.024105 0.0430495 0.0060677 0.0100432 0.0185876 0.0272544 0.0214412 0.0344217 0.0352029 0.0324182 0.0226152 0.0210256 0.0300756 0.0234119 0.0311565 0.0547215 0.039469 0.0150288 0.0176891 0.0468557 0.0199813 0.0460914 0.034967 0.040153	This study was aimed to investigate the efficacy of single use of DRUG1 and that of concurrent or sequential administration of DRUG0 and DRUG2 in NSCLC cell lines that are resistant to EGFR TKIs .
2	4	0.0127242 0.0126631 0.0102695 0.0127529 0.0081643 0.0298701 0.0156935 0.0121785 0.0197696 0.0361697 0.0284724 0.0194486 0.0103658 0.00747786 0.0158244 0.0259155 0.0296804 0.0173932 0.0505031 0.0352666 0.0324423 0.05607 0.0243899 0.0432749 0.0420718 0.0330881 0.0619192 0.0443853 0.0193917 0.0258738 0.0511724 0.0228697 0.0501678 0.0384348 0.0438451	This study was aimed to investigate the efficacy of single use of DRUG0 and that of concurrent or sequential administration of DRUG1 and DRUG2 in NSCLC cell lines that are resistant to EGFR TKIs .
2	4	0.0474305 0.0390742 0.057317 0.051345 0.0474167 0.0336932 0.0342235 0.0570213 0.0531629 0.016035 0.038601 0.0361689 0.0309465 0.0201927 0.0339873 0.0588415 0.0282629 0.0650058 0.0431915 0.0365937 0.024726 0.0406658 0.0540899 0.0520073	DRUG1 exhibited dose-dependent growth inhibition in NSCLC cell lines and arrested cell cycle at G1 phase , whereas DRUG2 arrested at S phase .
2	2	0.0279845 0.0584551 0.0363913 0.0619934 0.046156 0.0385454 0.0715654 0.023246 0.0446472 0.0256057 0.0276092 0.0786154 0.0467396 0.0216191 0.0352835 0.0405335 0.0352105 0.0337226 0.0305841 0.0228459 0.0401166 0.0499705 0.0307311 0.0145742 0.0572541	Although single or concurrent use of DRUG1 and DRUG2 has some anti-proliferative effects , the sequential administrations of both drugs remarkably enhanced anti-tumor activity .
4	2	0.0621728 0.0859171 0.0596539 0.0590125 0.0427986 0.0953589 0.0925243 0.0951641 0.0511848 0.01602 0.130902 0.0691556 0.0675255 0.0726095	When cells were exposed to DRUG1 followed by DRUG2 , synergism was observed .
4	2	0.0233181 0.0190638 0.0152326 0.00963971 0.0127046 0.0360396 0.0160699 0.0153598 0.0315915 0.0502534 0.053919 0.0163983 0.0207683 0.0412036 0.0738677 0.0548844 0.0396393 0.0376981 0.0291703 0.0509164 0.0615543 0.031186 0.0436231 0.0349376 0.050097 0.0475882 0.0426958 0.0405798	The molecular basis of this synergism is that the signaling pathways that were initially activated by DRUG1 exposure were efficiently suppressed by the subsequent exposure to DRUG2 .
2	4	0.0584982 0.0106266 0.0230613 0.0314389 0.0249101 0.0357261 0.0602611 0.0339473 0.0195399 0.0139953 0.0127367 0.01765 0.0328412 0.0431754 0.0282771 0.0399215 0.0314589 0.00656021 0.0151548 0.0247652 0.015219 0.0305714 0.0298117 0.0233953 0.0338892 0.0282 0.026448 0.0139253 0.0148431 0.0120655 0.0133743 0.00794979 0.0161586 0.0262979 0.00951584 0.0114058 0.0110098 0.0350084 0.0216711 0.0546941	DRUG1 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG2 followed by DRUG0 is superior to DRUG0 followed by DRUG0 and concurrent administration .
4	4	0.0593141 0.0104228 0.0227319 0.031097 0.0251582 0.0379735 0.0636018 0.0346375 0.017431 0.0125906 0.0103711 0.0145063 0.0266052 0.0338637 0.0225206 0.0301216 0.0205528 0.00525254 0.0100748 0.0154121 0.00721908 0.0111698 0.0153217 0.013556 0.0144543 0.0140546 0.025166 0.0101918 0.0137112 0.0118694 0.0153689 0.0134923 0.0360592 0.0775692 0.0587561 0.0354443 0.00930127 0.0319485 0.0228769 0.0582303	DRUG1 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG0 followed by DRUG0 is superior to DRUG0 followed by DRUG2 and concurrent administration .
2	2	0.0106921 0.00660081 0.0218569 0.0454255 0.0363862 0.0365456 0.0614204 0.0319696 0.0134771 0.0113895 0.00905707 0.0145998 0.0287029 0.0368978 0.0243921 0.0334591 0.0263919 0.00648846 0.0181349 0.0306395 0.0185086 0.0323159 0.0271501 0.0207147 0.0194735 0.0266188 0.0360367 0.0411904 0.0229778 0.013615 0.0161177 0.0122247 0.0214609 0.0326174 0.0132555 0.0130505 0.0118549 0.0362762 0.0227396 0.0572739	DRUG0 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG1 followed by DRUG2 is superior to DRUG0 followed by DRUG0 and concurrent administration .
4	4	0.00746078 0.00459203 0.0152164 0.0318723 0.025593 0.0257869 0.0435562 0.0226587 0.00947892 0.00812972 0.00654324 0.0107075 0.0214495 0.0279637 0.0188705 0.0277785 0.0221038 0.00452059 0.0106031 0.0174245 0.0122155 0.0247872 0.0262621 0.0241216 0.0261309 0.0321965 0.0333059 0.0292096 0.027413 0.0438469 0.0819185 0.0649129 0.0434075 0.0305347 0.0163916 0.0140778 0.0108964 0.0330188 0.0196288 0.0434136	DRUG0 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG1 followed by DRUG0 is superior to DRUG2 followed by DRUG0 and concurrent administration .
4	4	0.0088632 0.00529114 0.0171531 0.03633 0.0293556 0.0298998 0.0505411 0.0261914 0.0100006 0.00867524 0.00637995 0.0105697 0.0203272 0.0261085 0.0176054 0.0243192 0.0173022 0.0045462 0.0104163 0.0176003 0.010199 0.0174695 0.0289526 0.0312177 0.0359553 0.0290971 0.0583337 0.0502217 0.030306 0.0174227 0.0162737 0.0138428 0.0280013 0.0709685 0.0537589 0.0314942 0.00825159 0.0260094 0.0187874 0.0459607	DRUG0 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG0 followed by DRUG1 is superior to DRUG0 followed by DRUG2 and concurrent administration .
4	4	0.0103873 0.00607969 0.0194339 0.0417367 0.0338452 0.034346 0.0576762 0.029358 0.0109856 0.0093483 0.00693656 0.0112753 0.0214815 0.0270211 0.0180056 0.0241592 0.0159939 0.00414574 0.00804101 0.0124207 0.00631436 0.00982118 0.0143358 0.012515 0.0141785 0.0131139 0.0220885 0.0131418 0.0215024 0.0248568 0.0369036 0.0356546 0.0670478 0.0597356 0.065862 0.0344357 0.00997854 0.0420168 0.0295816 0.0642384	DRUG0 as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of DRUG0 followed by DRUG0 is superior to DRUG1 followed by DRUG2 and concurrent administration .
4	4	0.0443499 0.0639872 0.0742353 0.0316432 0.0529916 0.0408905 0.0746722 0.0373729 0.0264864 0.0317812 0.025825 0.017729 0.0296627 0.0377315 0.0611109 0.0520556 0.0659232 0.0365855 0.0191869 0.0115302 0.0115798 0.0135558 0.0137431 0.0254324 0.0190684 0.0284567 0.0524127	Potential for DRUG1 to Affect Other Drugs DRUG2 is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome P450 isozymes .
4	1	0.108499 0.0749916 0.0785637 0.103672 0.0887335 0.0692048 0.0605625 0.0115871 0.014062 0.0194306 0.0253794 0.0195537 0.0227417 0.0292016 0.051285 0.0672902 0.0347024 0.00968908 0.0217764 0.00634168 0.0165199 0.0662118	Given the primary CNS effects of DRUG1 , DRUG0 should be used with caution in combination with other DRUG2 and DRUG0 .
2	1	0.108681 0.0743737 0.0770602 0.101771 0.0877582 0.069056 0.0608873 0.0117314 0.0157494 0.0208806 0.0301756 0.0232713 0.0238246 0.024401 0.0388715 0.0486606 0.0287903 0.00737685 0.00840437 0.0132206 0.0456668 0.0793876	Given the primary CNS effects of DRUG1 , DRUG0 should be used with caution in combination with other DRUG0 and DRUG2 .
4	1	0.08946 0.059821 0.0546115 0.0559147 0.0463481 0.04254 0.0276652 0.0266006 0.132582 0.0246761 0.0288674 0.0252767 0.0301023 0.0363735 0.0594824 0.080176 0.0420065 0.0116542 0.0258003 0.0074459 0.0183053 0.0742902	Given the primary CNS effects of DRUG0 , DRUG1 should be used with caution in combination with other DRUG2 and DRUG0 .
1	1	0.0885419 0.059659 0.0544242 0.0556534 0.0468417 0.0440598 0.0282389 0.0293648 0.141961 0.0264787 0.0332619 0.0285694 0.0295632 0.02851 0.0433104 0.0558476 0.0336392 0.00861644 0.00960433 0.0148142 0.0502624 0.0887778	Given the primary CNS effects of DRUG0 , DRUG1 should be used with caution in combination with other DRUG0 and DRUG2 .
4	4	0.0455126 0.0214658 0.0180341 0.0144539 0.0130372 0.00928278 0.0103664 0.00607209 0.0217452 0.0353561 0.0279046 0.0287961 0.0547857 0.0496937 0.0826996 0.100052 0.070858 0.0294509 0.129851 0.0277723 0.0851639 0.117646	Given the primary CNS effects of DRUG0 , DRUG0 should be used with caution in combination with other DRUG1 and DRUG2 .
2	2	0.162346 0.185455 0.105409 0.127948 0.101535 0.11029 0.0553346 0.0131464 0.0119432 0.0271676 0.0994241	DRUG1 may antagonize the effect of DRUG2 and other DRUG0 .
2	2	0.155892 0.161367 0.0974492 0.114722 0.0920319 0.088809 0.0363189 0.0190903 0.0324515 0.0940824 0.107786	DRUG1 may antagonize the effect of DRUG0 and other DRUG2 .
4	4	0.0621875 0.106706 0.130995 0.144879 0.0994039 0.0942465 0.119855 0.0252034 0.0389294 0.0808202 0.0967745	DRUG0 may antagonize the effect of DRUG1 and other DRUG2 .
2	4	0.0955186 0.104951 0.150546 0.037387 0.0688879 0.0668415 0.0943534 0.101766 0.0548835 0.0433363 0.0540927 0.0482162 0.0792196	[Influence of DRUG1 and DRUG2 on MPTP-evoked behavior violations in C57BL/6 mice] .
4	4	0.0466857 0.101959 0.0185189 0.0295893 0.029293 0.0151261 0.0479194 0.0465065 0.0357137 0.0124344 0.0220449 0.0379528 0.0109942 0.0190478 0.037389 0.0640651 0.0220421 0.00941315 0.0115976 0.0187835 0.0676416 0.0728836 0.051692 0.0303226 0.0104953 0.0286576 0.0541626 0.0470683	and/or DRUG1 DRUG0 (100 mg/kg , p . o.) , as well as that of neurotoxin DRUG2 ( DRUG0 ) (4 x 20 mg/kg , i . p.)
4	4	0.0494558 0.107404 0.0196215 0.0312113 0.0308965 0.0162326 0.0506988 0.0489787 0.0374306 0.0126471 0.0225197 0.0356272 0.0102533 0.0147449 0.0253125 0.0272956 0.0162481 0.0257889 0.0346564 0.0214443 0.0508904 0.0680491 0.0564709 0.0369365 0.0126694 0.0323098 0.0562406 0.0479653	and/or DRUG1 DRUG0 (100 mg/kg , p . o.) , as well as that of neurotoxin DRUG0 ( DRUG2 ) (4 x 20 mg/kg , i . p.)
4	4	0.0305332 0.0314662 0.0543784 0.0358951 0.030615 0.0145767 0.0505433 0.0494115 0.0356129 0.011759 0.0220176 0.0402118 0.0111089 0.0194254 0.03897 0.0679418 0.0233567 0.00984361 0.0120605 0.0196911 0.0725156 0.0780179 0.0554374 0.0325546 0.0112998 0.0310535 0.0588157 0.0508867	and/or DRUG0 DRUG1 (100 mg/kg , p . o.) , as well as that of neurotoxin DRUG2 ( DRUG0 ) (4 x 20 mg/kg , i . p.)
4	4	0.0326163 0.0336414 0.0576017 0.038247 0.0326159 0.0158646 0.0541599 0.052425 0.0377163 0.0121917 0.0228479 0.0380996 0.0104463 0.0150616 0.0263671 0.0283977 0.016519 0.0268794 0.0365247 0.0225053 0.0549378 0.0733605 0.0607747 0.0395234 0.013549 0.0346656 0.0607811 0.0516795	and/or DRUG0 DRUG1 (100 mg/kg , p . o.) , as well as that of neurotoxin DRUG0 ( DRUG2 ) (4 x 20 mg/kg , i . p.)
4	4	0.17381 0.118092 0.0787883 0.14043 0.0292116 0.039057 0.0193967 0.0237352 0.055705 0.0275228 0.0194431 0.0223009 0.0298181 0.0316781 0.0433828 0.0376404 0.0334702 0.0765183	Reduced absorption of DRUG1 and DRUG2 have been reported when those agents were administered concomitantly with DRUG0 .
3	3	0.13035 0.103839 0.0728645 0.0791134 0.0106018 0.0136823 0.0221488 0.0440594 0.0738934 0.0420756 0.0352919 0.0288496 0.0414232 0.0504485 0.058109 0.0764148 0.053288 0.0635463	Reduced absorption of DRUG1 and DRUG0 have been reported when those agents were administered concomitantly with DRUG2 .
3	3	0.0925007 0.0709471 0.0455281 0.0249881 0.0126758 0.0411736 0.0244922 0.0478389 0.102511 0.0530678 0.0418199 0.0350262 0.0497142 0.061935 0.069837 0.0890046 0.0622597 0.0746804	Reduced absorption of DRUG0 and DRUG1 have been reported when those agents were administered concomitantly with DRUG2 .
4	4	0.0455983 0.0336463 0.0229058 0.0289093 0.0396376 0.0331162 0.0417244 0.0176298 0.0369208 0.0278976 0.0549941 0.0405103 0.0306462 0.0294532 0.0334491 0.044283 0.0207951 0.0187508 0.0230521 0.0263603 0.01536 0.0118986 0.0114841 0.0190142 0.011211 0.0114323 0.00589628 0.0135133 0.0150641 0.0345728 0.0182962 0.0153134 0.0110055 0.0186343 0.0368951 0.0488618 0.0512663	When daily doses of DRUG1 2 g and weekly doses of DRUG2 7.5 mg were coadministered to 15 rheumatoid arthritis patients in a drug-drug interaction study , the pharmacokinetic disposition of the drugs was not altered .
4	4	0.0458822 0.0242443 0.0277807 0.0321698 0.0256169 0.0242392 0.0347771 0.0341257 0.0404421 0.0164255 0.0338792 0.0235321 0.0457979 0.033476 0.0216733 0.0233979 0.0485643 0.0403919 0.0403913 0.0307455 0.0224395 0.0222347 0.0150601 0.0286354 0.0184451 0.0117047 0.023362 0.0228245 0.0267467 0.0146761 0.0113571 0.014603 0.026868 0.0275484 0.0184132 0.016671 0.0308578	Daily doses of DRUG1 2 g (maximum 3 g) and weekly doses of DRUG2 7.5 mg (maximum 15 mg) were administered alone or in combination to 310 rheumatoid arthritis patients in two controlled 52-week clinical studies .
1	1	0.168007 0.036672 0.0438514 0.0396774 0.0402566 0.0317054 0.0347412 0.0393052 0.0433177 0.0138 0.0163483 0.0170906 0.00656285 0.0074568 0.0110091 0.00609731 0.00451813 0.00752752 0.00853949 0.0465968 0.0388178 0.0866824 0.0501503 0.0238345 0.016495 0.0172616 0.0177593 0.0497637 0.0761542	DRUG1 should be used with caution in patients receiving other local DRUG2 or agents structurally related to DRUG0 , since the toxic effects of these drugs are additive .
1	4	0.150587 0.0301705 0.0358837 0.0343543 0.0345979 0.0238178 0.0295051 0.0298267 0.0263413 0.00640208 0.00814453 0.0068061 0.00698951 0.0181845 0.0388042 0.0370569 0.0441205 0.0275322 0.00748801 0.0357348 0.0418166 0.0993672 0.0454744 0.0203356 0.0153815 0.0146027 0.0165202 0.0472067 0.0669476	DRUG1 should be used with caution in patients receiving other local DRUG0 or agents structurally related to DRUG2 , since the toxic effects of these drugs are additive .
4	4	0.0265208 0.0295387 0.0299856 0.026941 0.0447829 0.035216 0.0470677 0.0449557 0.0337782 0.00938787 0.0128298 0.028484 0.0120728 0.0148419 0.0295853 0.0313522 0.0398742 0.0270072 0.00763294 0.0422618 0.0507811 0.118516 0.0517436 0.022682 0.0172266 0.01643 0.0189993 0.0542859 0.0752193	DRUG0 should be used with caution in patients receiving other local DRUG1 or agents structurally related to DRUG2 , since the toxic effects of these drugs are additive .
3	3	0.0170166 0.0174597 0.00874219 0.0198871 0.0378482 0.0415247 0.0312839 0.0505748 0.0237913 0.0533455 0.031149 0.0346162 0.0348948 0.0262585 0.041914 0.0378724 0.0240929 0.0265322 0.0417754 0.0474385 0.0332854 0.0213755 0.0122795 0.0403638 0.0968817 0.0189435 0.027138 0.0321828 0.0266681 0.0428637	In vivo , the plasma clearance of DRUG1 was reduced by 70% during coadministration of DRUG2 (25 mg bid for 2 days) , a selective and potent CYP1A2 inhibitor .
4	0	0.0350063 0.0288237 0.0127906 0.018806 0.0282449 0.0208931 0.00627606 0.0132406 0.0159484 0.0654378 0.016525 0.0402662 0.0242942 0.038913 0.0376963 0.0564122 0.0519045 0.031008 0.125638 0.0501678 0.0230667 0.0262617 0.0229037 0.0138549 0.0277583 0.0222876 0.0450342 0.0384371 0.0621032	Thus strong inhibitors of cytochrome P4501A2 , such as DRUG1 , given concomitantly during administration of DRUG2 , can interact with DRUG0 leading to increased DRUG0 plasma levels .
4	4	0.028736 0.0229257 0.0101017 0.014334 0.0216507 0.0167327 0.00535392 0.00976505 0.010551 0.0393843 0.00683697 0.01622 0.0191332 0.0260243 0.0367436 0.043826 0.0422367 0.0409929 0.0896718 0.120354 0.102092 0.0623405 0.0351513 0.0181337 0.027269 0.0229787 0.0345534 0.0295869 0.04632	Thus strong inhibitors of cytochrome P4501A2 , such as DRUG1 , given concomitantly during administration of DRUG0 , can interact with DRUG2 leading to increased DRUG0 plasma levels .
4	4	0.026392 0.0209575 0.00920198 0.0129223 0.0197595 0.0153849 0.00497359 0.00888637 0.00955474 0.0348647 0.00589578 0.0119449 0.0125068 0.0151715 0.0217044 0.0282298 0.0235068 0.0325686 0.0863452 0.0455993 0.0256102 0.0359645 0.0571536 0.0783768 0.116302 0.0711281 0.0578875 0.0470969 0.0641103	Thus strong inhibitors of cytochrome P4501A2 , such as DRUG1 , given concomitantly during administration of DRUG0 , can interact with DRUG0 leading to increased DRUG2 plasma levels .
4	4	0.109479 0.0604958 0.0342004 0.0213732 0.0218237 0.00981685 0.0160596 0.0164362 0.0218593 0.0601446 0.0548645 0.0638021 0.0591829 0.023297 0.0238923 0.0917056 0.0230354 0.0570977 0.0948196 0.0416297 0.0294253 0.0655593	Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as DRUG1 and DRUG2 may also occur .
3	4	0.0409334 0.0373415 0.0309338 0.057477 0.0140861 0.0196056 0.0209932 0.0148851 0.0167101 0.00710406 0.0302485 0.0139156 0.012789 0.0184116 0.0214413 0.0197603 0.0237492 0.0316261 0.0263928 0.0314264 0.0267175 0.0332034 0.0414608 0.044871 0.0314033 0.0430247 0.0897259 0.0448179 0.0385081 0.0167452 0.0112663 0.0126547 0.0137868 0.0154762 0.0104478 0.0107422 0.0253173	Coadministration of a selective and potent inhibitor of CYP3A4 , DRUG1 (100 mg bid for 2 days with DRUG2 infusion administered 1 hour after DRUG0 ) caused a 15% reduction in in-vivo plasma clearance of DRUG0 .
4	3	0.0413289 0.0381658 0.0316379 0.0584259 0.0149306 0.0217075 0.0223449 0.0136686 0.0166366 0.00630677 0.02342 0.00665575 0.00509686 0.00801688 0.00799964 0.0080468 0.00791755 0.00782051 0.00836644 0.0133845 0.0110677 0.0107949 0.0208653 0.0156992 0.0181031 0.0262591 0.0883266 0.0351906 0.0401926 0.0268425 0.0248629 0.0458231 0.0532663 0.0635888 0.0532608 0.0527523 0.0512256	Coadministration of a selective and potent inhibitor of CYP3A4 , DRUG1 (100 mg bid for 2 days with DRUG0 infusion administered 1 hour after DRUG0 ) caused a 15% reduction in in-vivo plasma clearance of DRUG2 .
3	4	0.0360234 0.0309959 0.0280445 0.0511105 0.00869555 0.010745 0.0101454 0.00545452 0.00673183 0.0029039 0.00743683 0.0136153 0.0188582 0.0561131 0.0478515 0.0396454 0.0371993 0.0359683 0.0352251 0.022189 0.0195352 0.0224455 0.0273098 0.053825 0.0455788 0.0271592 0.0718527 0.0423587 0.0392625 0.0186958 0.0154625 0.0146514 0.0180577 0.0200223 0.0146657 0.0134847 0.0306801	Coadministration of a selective and potent inhibitor of CYP3A4 , DRUG0 (100 mg bid for 2 days with DRUG1 infusion administered 1 hour after DRUG2 ) caused a 15% reduction in in-vivo plasma clearance of DRUG0 .
4	4	0.0320639 0.0274213 0.0251125 0.0454347 0.00766267 0.00902978 0.00833073 0.00433508 0.0058053 0.00215914 0.0052204 0.00568459 0.00784524 0.0234844 0.0151908 0.0117291 0.00958244 0.0109358 0.0162162 0.0233606 0.0238875 0.0277254 0.0589026 0.0600997 0.0685922 0.0230914 0.0594925 0.029667 0.0355507 0.0284109 0.0291143 0.0406143 0.0440525 0.0485215 0.0454384 0.0420778 0.0381564	Coadministration of a selective and potent inhibitor of CYP3A4 , DRUG0 (100 mg bid for 2 days with DRUG0 infusion administered 1 hour after DRUG1 ) caused a 15% reduction in in-vivo plasma clearance of DRUG2 .
3	3	0.0493726 0.0549152 0.0357071 0.059111 0.0397977 0.0718821 0.059323 0.0659749 0.0285561 0.0204351 0.0389027 0.0443063 0.0283123 0.0349953 0.041828 0.0132787 0.010844 0.0153765 0.0251657 0.0136048 0.00618043 0.00557277 0.00713525 0.0199386 0.024838 0.0148089 0.0193062 0.0220906 0.0291511 0.018301 0.0152162 0.0194935 0.0462784	Administration of DRUG1 in combination with DRUG2 resulted in a two-fold decrease in DRUG0 clearance in a non-human primate study and in a 1.5-fold increase in DRUG0 serum levels in clinical studies .
4	4	0.0319479 0.0338376 0.026305 0.0345466 0.0315545 0.0321184 0.0461635 0.0656248 0.0268852 0.0320795 0.0911384 0.0957801 0.0761645 0.0748852 0.0430201 0.0201202 0.0142455 0.01902 0.0276207 0.0137423 0.0042542 0.00391408 0.00466224 0.0128363 0.0164184 0.0104552 0.0134573 0.014812 0.0189398 0.0119531 0.00991618 0.0123082 0.0292728	Administration of DRUG1 in combination with DRUG0 resulted in a two-fold decrease in DRUG2 clearance in a non-human primate study and in a 1.5-fold increase in DRUG0 serum levels in clinical studies .
4	4	0.0323982 0.0335718 0.0252805 0.0318489 0.0282174 0.0269774 0.0352155 0.0411036 0.0138541 0.0135293 0.0268613 0.0298837 0.0138706 0.0207038 0.0325883 0.0110388 0.0108721 0.0169324 0.0316112 0.021033 0.0105103 0.0128211 0.0207648 0.0610592 0.0727075 0.0628972 0.0548102 0.0409374 0.0538362 0.0358855 0.0236534 0.0182064 0.0345191	Administration of DRUG1 in combination with DRUG0 resulted in a two-fold decrease in DRUG0 clearance in a non-human primate study and in a 1.5-fold increase in DRUG2 serum levels in clinical studies .
4	4	0.0815277 0.0635789 0.0751815 0.0773789 0.0629551 0.0863825 0.062871 0.0584069 0.0629795 0.0536569 0.0238965 0.00590587 0.00480172 0.00367777 0.00520949 0.0290704 0.0567419 0.0425517 0.0526294 0.0905963	Effect of DRUG1 -mediated CYP3A4 inhibition on clinical pharmacokinetics of DRUG2 ( DRUG0 ) , an orally active DRUG0 .
4	4	0.0824976 0.0642404 0.0758797 0.0754357 0.0603434 0.0807134 0.0562105 0.049352 0.0621169 0.0405921 0.025065 0.0150766 0.0220519 0.00643635 0.00591612 0.0275245 0.0545345 0.0441153 0.0556071 0.096291	Effect of DRUG1 -mediated CYP3A4 inhibition on clinical pharmacokinetics of DRUG0 ( DRUG2 ) , an orally active DRUG0 .
4	4	0.0604137 0.0488802 0.0543324 0.0540838 0.0441331 0.0574783 0.0346727 0.0333413 0.0499922 0.0247353 0.0140218 0.00560738 0.0102845 0.0102885 0.0222995 0.079704 0.115758 0.108139 0.0854533 0.0863805	Effect of DRUG1 -mediated CYP3A4 inhibition on clinical pharmacokinetics of DRUG0 ( DRUG0 ) , an orally active DRUG2 .
4	4	0.0235186 0.0267202 0.0376414 0.0723964 0.057441 0.0654118 0.0359631 0.038346 0.0641286 0.0429513 0.0335626 0.0154382 0.0110166 0.0177655 0.0235365 0.0913276 0.0732766 0.115921 0.0885443 0.0650924	Effect of DRUG0 -mediated CYP3A4 inhibition on clinical pharmacokinetics of DRUG1 ( DRUG0 ) , an orally active DRUG2 .
4	4	0.0276878 0.0313875 0.041237 0.0757983 0.0570811 0.0622168 0.0338651 0.0335232 0.058573 0.0347553 0.0256261 0.0201938 0.0390373 0.0254279 0.0265154 0.0818722 0.0641869 0.109387 0.0849915 0.0666368	Effect of DRUG0 -mediated CYP3A4 inhibition on clinical pharmacokinetics of DRUG0 ( DRUG1 ) , an orally active DRUG2 .
4	4	0.0387284 0.0388962 0.0445117 0.0655554 0.0472868 0.0306252 0.0192773 0.0308387 0.0481245 0.0365352 0.0131362 0.0584193 0.0118029 0.0272013 0.0578186 0.0546034 0.0434536 0.0868125 0.090492 0.0745345 0.0813464	This study evaluated the effect of a potent CYP3A inhibitor , DRUG1 , on the pharmacokinetics and safety of DRUG2 .
4	4	0.0510531 0.0457245 0.0404179 0.0254907 0.0787721 0.158901 0.151043 0.0329712 0.0624646 0.0832958 0.109102 0.0841392 0.0766255	On day 8 , a single DRUG1 dose was co-administered with DRUG2 .
3	3	0.0451148 0.0443454 0.0371804 0.0428421 0.0547234 0.0135363 0.0281236 0.0262603 0.0356399 0.0164433 0.059019 0.0540968 0.0435253 0.0481465 0.0586337 0.0279388 0.0853024 0.067645 0.0438189 0.0133614 0.070537 0.0837657	In the presence of DRUG1 , there was 1.6- and 1.8-fold increase in C (max) and AUC of DRUG2 , respectively .
0	1	0.106485 0.0557816 0.0268635 0.0224006 0.0411616 0.134498 0.0953242 0.0630601 0.0669437 0.0647549 0.0491757 0.00869095 0.0122325 0.00823438 0.00976967 0.0055889 0.00356879 0.00270259 0.00305456 0.00646388 0.00464586 0.00478584 0.00777399 0.0228889 0.0347459 0.0182549 0.00861377 0.0114667 0.01075 0.0054322 0.00403306 0.00235435 0.00536639 0.00922776 0.0629053	Since DRUG1 ( DRUG0 ) may interact with concurrently administered DRUG2 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG0 and DRUG0 ) .
4	4	0.138249 0.0553076 0.0166812 0.0138599 0.0194964 0.0959443 0.0447161 0.0290305 0.031932 0.0206721 0.0196463 0.0182484 0.0293053 0.0185256 0.0240124 0.0170396 0.00998165 0.00706292 0.0102525 0.0201395 0.014941 0.0202503 0.028136 0.0489591 0.0422463 0.026059 0.0164168 0.0218446 0.0200142 0.00993546 0.00586528 0.00328372 0.0070727 0.0127317 0.0821403	Since DRUG1 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG2 may increase the plasma concentrations of DRUG0 and DRUG0 ) .
4	4	0.133261 0.0529263 0.015814 0.013236 0.0182102 0.0898453 0.0407752 0.0261148 0.0273406 0.0171922 0.0167507 0.0127904 0.0171367 0.0111389 0.0142762 0.00915266 0.005014 0.0035615 0.00473397 0.0100996 0.00694894 0.00805295 0.0143838 0.0430015 0.0700827 0.0463926 0.0374565 0.0452785 0.0409749 0.0448985 0.0260687 0.00502895 0.00622504 0.0108737 0.0549629	Since DRUG1 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG2 and DRUG0 ) .
4	4	0.143456 0.0571313 0.0171324 0.0143252 0.0198175 0.0975984 0.0444483 0.0285129 0.0301107 0.0191044 0.018471 0.0144371 0.0195708 0.0125476 0.0159947 0.0102477 0.00556182 0.00394477 0.00529439 0.0115105 0.00779715 0.00901759 0.0156715 0.0423691 0.0666455 0.0384705 0.0252156 0.0285673 0.0258991 0.0155855 0.00909726 0.0103219 0.0277453 0.0174585 0.0709203	Since DRUG1 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG0 and DRUG2 ) .
0	1	0.0970726 0.0312765 0.0230596 0.0435705 0.0369884 0.131439 0.0884523 0.0652858 0.0683762 0.0680053 0.0509982 0.00865887 0.01302 0.00895175 0.0106881 0.00608882 0.00388288 0.00292994 0.00330706 0.00699432 0.00504922 0.00519245 0.0084341 0.0248126 0.0376688 0.0197918 0.00934028 0.0124135 0.0116296 0.0058794 0.00436296 0.0025459 0.00580407 0.00998004 0.0680488	Since DRUG0 ( DRUG1 ) may interact with concurrently administered DRUG2 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG0 and DRUG0 ) .
4	4	0.0891943 0.0294253 0.018565 0.0429027 0.0203554 0.0963324 0.0373437 0.0279114 0.0272544 0.0178807 0.0174782 0.0130926 0.0177073 0.0112888 0.0142343 0.00936592 0.00516639 0.00368301 0.00493704 0.0105459 0.00722364 0.00840721 0.0150718 0.0453449 0.0738362 0.0488803 0.0394493 0.0477453 0.0431778 0.0473116 0.0274577 0.00530368 0.00658239 0.0114928 0.0580508	Since DRUG0 ( DRUG1 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG2 and DRUG0 ) .
4	4	0.0964052 0.0317801 0.0201425 0.0465898 0.0222295 0.105196 0.0409192 0.0305982 0.0301406 0.0199433 0.0193604 0.0148627 0.0202923 0.0127645 0.0160006 0.0105247 0.00575237 0.00409466 0.00554434 0.0120619 0.00813201 0.00945299 0.016495 0.044774 0.0704176 0.0406871 0.0266043 0.0302242 0.0274087 0.0164825 0.00964858 0.0109727 0.0295127 0.0185552 0.0754298	Since DRUG0 ( DRUG1 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG0 and DRUG2 ) .
4	4	0.0459834 0.0104299 0.00615906 0.0141311 0.0311113 0.116081 0.0927493 0.0620168 0.049085 0.0550109 0.0952956 0.0191422 0.0267668 0.0210791 0.0158196 0.0119322 0.00912383 0.00753691 0.0083248 0.0176868 0.0128481 0.016795 0.02072 0.0364009 0.0333449 0.0199077 0.013192 0.0175292 0.0160976 0.00804636 0.00472337 0.00265739 0.00576851 0.0103489 0.0661541	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG1 , periodic serum level determinations of these drugs may be necessary (eg DRUG2 may increase the plasma concentrations of DRUG0 and DRUG0 ) .
4	4	0.0428381 0.00978891 0.00584803 0.0134316 0.0297379 0.110803 0.08812 0.0586813 0.0469304 0.0547509 0.0889809 0.015953 0.0214048 0.0127024 0.00922877 0.00602733 0.00414747 0.00328053 0.00391022 0.0103394 0.00743047 0.00762655 0.0126573 0.0342667 0.0551004 0.0369087 0.0294441 0.0343131 0.0316587 0.03406 0.0202108 0.0040517 0.00495248 0.00852077 0.0418933	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG1 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG2 and DRUG0 ) .
4	4	0.0457005 0.0104321 0.00622196 0.0142865 0.0315951 0.117655 0.0935298 0.0622878 0.0496919 0.0575861 0.0945301 0.0172575 0.0232486 0.0141006 0.0102365 0.00667112 0.00452683 0.00355254 0.00427645 0.0116597 0.00831879 0.00842561 0.0136678 0.0339586 0.052056 0.0299571 0.0201535 0.0215669 0.0196177 0.0118665 0.00676132 0.00762422 0.0206405 0.0136093 0.0527299	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG1 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG0 and DRUG2 ) .
3	3	0.0469566 0.00913294 0.00424078 0.00871311 0.00917828 0.039723 0.0334342 0.0171023 0.0155842 0.0104831 0.0127736 0.0138262 0.0222863 0.0154677 0.0234368 0.0170727 0.00949728 0.00730988 0.00989935 0.0204704 0.0183397 0.0202937 0.0317464 0.0850017 0.0828213 0.0670859 0.0566235 0.0501931 0.0484836 0.0551825 0.0308779 0.00719735 0.0100337 0.0169157 0.0726153	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG1 may increase the plasma concentrations of DRUG2 and DRUG0 ) .
3	3	0.0475576 0.00923036 0.00429267 0.00879371 0.00926617 0.040117 0.0336417 0.0172086 0.015658 0.0105049 0.0127783 0.0136912 0.0218898 0.0151732 0.0229941 0.0166657 0.00919752 0.00702355 0.00943397 0.0194811 0.0174155 0.0199503 0.0331274 0.0879061 0.0790702 0.063427 0.0497184 0.0423799 0.0449514 0.0365467 0.0171484 0.0156917 0.0379186 0.0266487 0.0835007	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG1 may increase the plasma concentrations of DRUG0 and DRUG2 ) .
4	4	0.0374499 0.00739617 0.00337496 0.00711338 0.00732892 0.0318712 0.0256365 0.0127211 0.0109851 0.00738455 0.00924672 0.00852218 0.0117377 0.0084538 0.0123366 0.00839243 0.00471256 0.00341078 0.00485127 0.0102117 0.00768513 0.00938461 0.0184013 0.0577619 0.0920915 0.0614726 0.0452416 0.0596521 0.0593841 0.0581812 0.106636 0.0261367 0.051816 0.0323431 0.0806754	Since DRUG0 ( DRUG0 ) may interact with concurrently administered DRUG0 , periodic serum level determinations of these drugs may be necessary (eg DRUG0 may increase the plasma concentrations of DRUG1 and DRUG2 ) .
2	2	0.0272276 0.0107112 0.0346204 0.0417708 0.0410302 0.0413391 0.0682261 0.0775849 0.0727748 0.0308705 0.0385375 0.0266309 0.0397767 0.0332572 0.0485167 0.0399529 0.0573769 0.0582878 0.0609835 0.0686152 0.081909	however , in patients with Paget's Disease prior DRUG1 use appears to reduce the anti-resorptive response to DRUG2 nasal spray .
3	3	0.0683675 0.117721 0.0697742 0.141744 0.116119 0.0735266 0.084559 0.0689129 0.061796 0.0919199 0.0306615 0.0498467 0.0250516	Mutual inhibition of metabolism occurs with concurrent use of DRUG1 and DRUG2 ;
2	2	0.105393 0.0536482 0.0811261 0.118192 0.0744948 0.0851287 0.0675449 0.0714399 0.119023 0.0394425 0.0898324 0.0947343	convulsions have been reported with concurrent use of DRUG1 and DRUG2 .
3	3	0.042816 0.0413309 0.0617228 0.0223432 0.0248321 0.0116175 0.0111629 0.0344144 0.00652532 0.00712847 0.00765995 0.0136309 0.0329147 0.090345 0.0468376 0.0518028 0.0532888 0.0631603 0.0403367 0.0111997 0.0316192 0.0236064 0.0251654 0.0101665 0.00904233 0.00626022 0.0132915 0.0364922 0.0337655 0.0376002 0.0372231 0.0606976	Drugs that induce hepatic enzymes such as DRUG1 , DRUG0 , and DRUG0 may increase the clearance of DRUG2 and may require increased in DRUG0 dose to achieve the desired response .
1	1	0.0383678 0.0375373 0.0548291 0.0183736 0.0194658 0.0081854 0.00820938 0.0245701 0.00431883 0.00434301 0.00444868 0.00730322 0.0179342 0.0525585 0.0240174 0.0183693 0.020793 0.0240443 0.0196571 0.0179839 0.05943 0.0472027 0.0839043 0.0572239 0.0513174 0.019715 0.0209535 0.0438641 0.0474046 0.0474007 0.0381818 0.0580922	Drugs that induce hepatic enzymes such as DRUG1 , DRUG0 , and DRUG0 may increase the clearance of DRUG0 and may require increased in DRUG2 dose to achieve the desired response .
4	4	0.0505406 0.0506853 0.0593859 0.0193169 0.017635 0.00649363 0.00481728 0.00803917 0.0100379 0.0588118 0.0170711 0.0253064 0.0537272 0.0833557 0.0428568 0.0345241 0.0354071 0.0192009 0.0179438 0.0144547 0.0437762 0.0241047 0.0262798 0.00978971 0.0106119 0.00815701 0.0153026 0.0406094 0.0386125 0.0438278 0.0439955 0.0653219	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 , and DRUG2 may increase the clearance of DRUG0 and may require increased in DRUG0 dose to achieve the desired response .
3	3	0.0445935 0.0430025 0.0582162 0.0181464 0.0160093 0.00688801 0.00438983 0.00647918 0.0078193 0.0409665 0.00832677 0.01347 0.0342368 0.0911923 0.0476696 0.053103 0.0541384 0.0637062 0.0403836 0.0110181 0.0319693 0.0242291 0.0259601 0.0105175 0.00936899 0.00649664 0.0138032 0.0379125 0.035085 0.0390879 0.0387122 0.0631017	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 , and DRUG0 may increase the clearance of DRUG2 and may require increased in DRUG0 dose to achieve the desired response .
1	1	0.0397588 0.0390712 0.0511549 0.0151317 0.0134417 0.00504914 0.00339549 0.00536363 0.00555722 0.0291044 0.00505092 0.00732593 0.0191366 0.0538763 0.024504 0.0182992 0.0207106 0.0232672 0.0199267 0.0182832 0.0591407 0.0481478 0.0848651 0.0566341 0.0510805 0.0193982 0.0207755 0.0452064 0.0488932 0.0488675 0.0394635 0.0601187	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 , and DRUG0 may increase the clearance of DRUG0 and may require increased in DRUG2 dose to achieve the desired response .
3	3	0.0348289 0.031867 0.04523 0.0164687 0.0158614 0.00756726 0.00496037 0.00622951 0.00569021 0.0110229 0.0120766 0.02088 0.0962708 0.111989 0.0580502 0.0544236 0.0550277 0.060012 0.0369547 0.00953866 0.0293256 0.022232 0.0237303 0.00963307 0.00847584 0.00585069 0.0124168 0.0343749 0.0318152 0.0353 0.0351275 0.0567682	Drugs that induce hepatic enzymes such as DRUG0 , DRUG0 , and DRUG1 may increase the clearance of DRUG2 and may require increased in DRUG0 dose to achieve the desired response .
1	1	0.0288423 0.0269919 0.0367765 0.0121715 0.0116719 0.00484591 0.00310156 0.00406728 0.00341043 0.00798272 0.0080136 0.0181966 0.0869801 0.0640687 0.0329779 0.0239399 0.02535 0.025878 0.0209753 0.0178132 0.0572821 0.0464905 0.0812934 0.0518988 0.046825 0.0172229 0.0182512 0.0405692 0.0439072 0.0435747 0.0351881 0.0534414	Drugs that induce hepatic enzymes such as DRUG0 , DRUG0 , and DRUG1 may increase the clearance of DRUG0 and may require increased in DRUG2 dose to achieve the desired response .
4	4	0.0369074 0.0321648 0.0325643 0.12611 0.0301554 0.0702945 0.105615 0.0671885 0.035068 0.0484108 0.0239258 0.0238704 0.0153246 0.0429028 0.0834874 0.0623693 0.0723361 0.0913052	Drugs such as DRUG1 and DRUG2 may inhibit the metabolism of DRUG0 and thus decrease its clearance .
3	3	0.026591 0.0226616 0.0226049 0.0812753 0.02117 0.0486082 0.125396 0.0870762 0.0755712 0.0892925 0.0864343 0.0493108 0.0124832 0.0267976 0.0482829 0.0478913 0.0543497 0.0742033	Drugs such as DRUG1 and DRUG0 may inhibit the metabolism of DRUG2 and thus decrease its clearance .
3	3	0.0259402 0.0172094 0.0132129 0.021252 0.0244856 0.124127 0.139795 0.10094 0.0797248 0.0910442 0.0810736 0.0436116 0.0100193 0.0234402 0.0441395 0.043601 0.0490231 0.0673603	Drugs such as DRUG0 and DRUG1 may inhibit the metabolism of DRUG2 and thus decrease its clearance .
3	3	0.166837 0.138228 0.0793567 0.0786687 0.0732308 0.0531594 0.0565338 0.0564717 0.071579 0.109785 0.11615	DRUG1 may increase the clearance of chronic high dose DRUG2 .
4	4	0.0321526 0.0587758 0.0609016 0.0554195 0.104901 0.0918146 0.0206379 0.0142394 0.00809557 0.0206432 0.0195084 0.0230995 0.0254931 0.0554771 0.0865384 0.0756686 0.0784761 0.0546487 0.0440281 0.0694807	This could lead to decreased DRUG1 serum levels or increase the risk of DRUG0 toxicity when DRUG2 is withdrawn .
2	2	0.0326525 0.0550026 0.0411195 0.0121733 0.020667 0.0204433 0.0185589 0.0155787 0.0097679 0.0372925 0.0676413 0.0412916 0.0417568 0.109553 0.0732496 0.0852288 0.0859108 0.0705113 0.0684541 0.093147	This could lead to decreased DRUG0 serum levels or increase the risk of DRUG1 toxicity when DRUG2 is withdrawn .
1	1	0.163847 0.035412 0.0441656 0.0366122 0.0634811 0.0587406 0.0630512 0.0837179 0.0707947 0.0692208 0.046261 0.0571123 0.0544617 0.0536209 0.0995006	DRUG1 should be used cautiously in conjunction with DRUG2 in patients suffering from hypoprothrombinemia .
2	4	0.0856177 0.0703225 0.0764414 0.0669891 0.080328 0.0958906 0.0860905 0.0741497 0.197154 0.167016	The effect of DRUG1 on oral DRUG2 is variable .
2	2	0.0302469 0.0195244 0.023966 0.0365997 0.0587784 0.0175661 0.0372441 0.026091 0.125438 0.0807646 0.0656425 0.126683 0.0411668 0.045157 0.0604827 0.0730951 0.0693793 0.0621744	There are reports of enhanced as well as diminished effects of DRUG1 when given concurrently with DRUG2 .
2	2	0.179691 0.146463 0.0664017 0.0767652 0.0957477 0.0599846 0.134738 0.125208 0.115001	DRUG1 may reverse the analgesic activity of DRUG2 .
4	4	0.0898197 0.0895595 0.0717741 0.0424111 0.0222089 0.0213348 0.00529948 0.00616189 0.00443457 0.00536459 0.0162252 0.042628 0.0932577 0.101951 0.0919663 0.0464563 0.0453029 0.0657232 0.0495056 0.0886151	Concurrent use with DRUG1 including DRUG2 , DRUG0 , and DRUG0 (e.g . smoking) may result in enhanced vasoconstriction .
4	4	0.0778579 0.0731509 0.0596735 0.0545628 0.0323763 0.0136346 0.0136311 0.0291515 0.00663494 0.00634757 0.015111 0.0418075 0.0902757 0.0980512 0.0872169 0.0461942 0.045538 0.067451 0.050652 0.0906814	Concurrent use with DRUG1 including DRUG0 , DRUG2 , and DRUG0 (e.g . smoking) may result in enhanced vasoconstriction .
4	4	0.0698682 0.0606912 0.0501396 0.0448411 0.0283855 0.0110297 0.00937711 0.0108962 0.0181299 0.0266031 0.0518303 0.0567004 0.0891512 0.0996177 0.0854171 0.0471701 0.0474994 0.0614396 0.0467775 0.084435	Concurrent use with DRUG1 including DRUG0 , DRUG0 , and DRUG2 (e.g . smoking) may result in enhanced vasoconstriction .
4	4	0.0955604 0.126687 0.0786084 0.020419 0.00890121 0.0133012 0.013327 0.0554458 0.016792 0.0231262 0.0442425 0.0395493 0.0826313 0.0777014 0.0662657 0.0370699 0.0377664 0.0527319 0.0389872 0.0708861	Concurrent use with DRUG0 including DRUG0 , DRUG1 , and DRUG2 (e.g . smoking) may result in enhanced vasoconstriction .
2	2	0.0488799 0.037049 0.0361954 0.0381338 0.0552029 0.0418814 0.0211741 0.0278563 0.016789 0.0204936 0.00546662 0.0102903 0.0189431 0.0399403 0.0468037 0.0557589 0.0166115 0.0332106 0.0180392 0.0547789 0.0251842 0.00752732 0.00750123 0.00488024 0.0252522 0.0226656 0.0255571 0.0207781 0.0237171 0.0335942 0.0218541 0.0545466 0.0148952 0.0112183 0.0172345 0.0400954	The concomitant use of DRUG1 with other DRUG2 or with other agents which produce dry mouth , constipation , somnolence (drowsiness) , and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects .
4	4	0.105074 0.0625064 0.0580097 0.0407233 0.0266776 0.0290406 0.0315935 0.0475436 0.0840296 0.072229 0.0360663 0.030066 0.0360302 0.0261755 0.022229 0.0246824 0.0586388 0.0500298 0.0499836 0.041135 0.0675361	Mean DRUG1 plasma concentrations were approximately 2 fold higher when DRUG2 was administered with DRUG0 , a potent CYP3A4 inhibitor .
4	4	0.10615 0.058563 0.0495035 0.0354491 0.0222389 0.0230831 0.0239433 0.0347932 0.0605356 0.0517122 0.0542559 0.0699332 0.0703766 0.0729288 0.0376565 0.00898229 0.027037 0.0375935 0.0487749 0.0390066 0.0674832	Mean DRUG1 plasma concentrations were approximately 2 fold higher when DRUG0 was administered with DRUG2 , a potent CYP3A4 inhibitor .
3	3	0.0437888 0.0367853 0.0485051 0.0353726 0.0209003 0.0294429 0.0362511 0.0522061 0.0826352 0.0470533 0.0786166 0.0491377 0.0434827 0.0630585 0.04665 0.0166052 0.0496636 0.0515322 0.0554228 0.0445313 0.0683588	Mean DRUG0 plasma concentrations were approximately 2 fold higher when DRUG1 was administered with DRUG2 , a potent CYP3A4 inhibitor .
4	4	0.0278367 0.0221199 0.0536298 0.0567421 0.0617103 0.0487037 0.0558304 0.0227562 0.0155325 0.00517051 0.00717263 0.00840786 0.0319573 0.00919535 0.00913249 0.0154149 0.00308066 0.0042229 0.00360496 0.00368161 0.00486608 0.00323857 0.0028358 0.0044658 0.00352443 0.00569294 0.0042858 0.00586406 0.0435414 0.0426369 0.0652635 0.0671297 0.026073 0.0178631 0.00910045 0.00861889 0.0333204 0.0145021 0.0511032 0.120171	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG2 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0260903 0.0208193 0.050818 0.053787 0.0587443 0.0464655 0.0530252 0.0213154 0.014271 0.00469641 0.00683402 0.00798951 0.0299133 0.00685681 0.00851986 0.00964172 0.0101103 0.0162314 0.00470337 0.00438607 0.00523763 0.00322574 0.00283465 0.00466041 0.00370349 0.00591949 0.00448549 0.00645409 0.0441152 0.0468194 0.069204 0.0709037 0.0280867 0.0191713 0.00931295 0.00856801 0.0320724 0.0140751 0.0495535 0.116378	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG0 and DRUG2 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0260476 0.0208444 0.050963 0.0536804 0.0586524 0.046202 0.0522684 0.0207562 0.0138868 0.00464655 0.00678654 0.00798792 0.0303723 0.00699226 0.00904724 0.00987542 0.0092436 0.00776501 0.00702109 0.00753003 0.0122816 0.00404485 0.00306887 0.00451465 0.00358979 0.00582457 0.00459492 0.00584307 0.0473275 0.0452323 0.0678032 0.0695981 0.0264607 0.0174593 0.00903075 0.00859457 0.0332321 0.0143178 0.0500036 0.116609	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG0 and DRUG0 ) or DRUG2 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.02571 0.0205709 0.0503679 0.0532726 0.0581827 0.0459727 0.0521848 0.0208245 0.0138643 0.00451481 0.00660336 0.00770703 0.0292046 0.00655372 0.0085611 0.00926524 0.00830963 0.00629508 0.00563081 0.00776267 0.00691653 0.00527076 0.00651899 0.0171455 0.00333783 0.00530619 0.00448023 0.00523617 0.046753 0.0452731 0.0680969 0.070197 0.0267038 0.0175231 0.00916675 0.00866552 0.0331415 0.0143069 0.0496246 0.114977	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG2 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.025047 0.0200341 0.0489603 0.0516243 0.0563882 0.0444961 0.0503902 0.0201138 0.0133457 0.00438965 0.00644906 0.00748153 0.0278926 0.00627907 0.00801086 0.00867236 0.00764994 0.00566954 0.00507722 0.0068319 0.00561735 0.00396423 0.00479149 0.00886655 0.0100247 0.0200403 0.00628192 0.0059813 0.0460893 0.0459707 0.0691687 0.0699213 0.0272497 0.0181327 0.00952923 0.00891243 0.0338165 0.0147801 0.0503197 0.115738	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG2 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.0196524 0.0153824 0.0360028 0.0370724 0.0397774 0.0301837 0.0327032 0.0123685 0.00763985 0.00317658 0.00464982 0.0047493 0.0169694 0.00404938 0.00401957 0.00392984 0.00366319 0.00349799 0.00365082 0.00413992 0.00376757 0.00380438 0.0043461 0.00707827 0.00715327 0.0109534 0.0232711 0.0419316 0.0905523 0.103739 0.0962224 0.0793396 0.0419076 0.0273359 0.0122675 0.00900318 0.0254111 0.0112017 0.0352687 0.0781662	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG1 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0247354 0.0195432 0.047121 0.0489456 0.0534011 0.0413458 0.0465163 0.0180614 0.0114731 0.00399476 0.00522717 0.00465748 0.0111702 0.0106714 0.013667 0.0877979 0.0131134 0.0171204 0.00517506 0.00472427 0.00538967 0.00334431 0.0029248 0.00476646 0.00382043 0.00601698 0.00454446 0.00653121 0.0433477 0.0446615 0.0650363 0.0661319 0.0260419 0.0176684 0.00857918 0.00786015 0.0293429 0.0129404 0.0455121 0.107077	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG1 and DRUG2 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0239751 0.019126 0.0467889 0.049058 0.0535468 0.0418095 0.0469544 0.0181965 0.0114782 0.00396241 0.00540233 0.00465017 0.0100903 0.0114955 0.0133238 0.0721435 0.0130446 0.00760485 0.00618201 0.00855307 0.00729393 0.00565879 0.00695512 0.0167953 0.00332762 0.00516227 0.00443583 0.0052112 0.046542 0.0446351 0.0663416 0.0678263 0.0254259 0.0163302 0.00851226 0.00800425 0.0302567 0.0131592 0.0454469 0.105293	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG1 and DRUG0 ) or DRUG0 (e.g. , DRUG2 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0234697 0.0187184 0.0457754 0.0479587 0.0523887 0.0409162 0.0459213 0.0178294 0.0111869 0.00384307 0.00525149 0.00451498 0.0098601 0.0110701 0.0126911 0.0685349 0.0118364 0.00687374 0.00554632 0.00744494 0.00584295 0.00426568 0.00587538 0.00924075 0.0106019 0.019772 0.006198 0.00591888 0.0455389 0.0450299 0.0670621 0.0671205 0.0257989 0.0168171 0.00880587 0.00820628 0.0307682 0.0135438 0.0460219 0.105939	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG1 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG2 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.0200245 0.015524 0.0365768 0.0375445 0.040417 0.0301619 0.032155 0.0117101 0.00661379 0.00265411 0.00342115 0.0025874 0.00475977 0.00475084 0.00545789 0.0315909 0.00549573 0.00401227 0.00408394 0.00454164 0.00400381 0.00411362 0.00485097 0.00741342 0.0077009 0.0109047 0.0235842 0.040738 0.0866974 0.0931828 0.0916746 0.0777146 0.0412511 0.0275366 0.0124739 0.00921642 0.0260297 0.0114312 0.0359402 0.0794587	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG1 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0266515 0.0209715 0.0503059 0.0518754 0.0569559 0.0427775 0.0466132 0.0149189 0.00866428 0.00308353 0.00362328 0.00261265 0.00539507 0.00334019 0.0033352 0.00940641 0.00900165 0.0476126 0.00888661 0.0104569 0.00850045 0.00610964 0.0074373 0.0189259 0.00364525 0.00563538 0.00476712 0.00558033 0.0488756 0.0462373 0.0686919 0.0703089 0.0267391 0.0176516 0.0092813 0.00878565 0.0336161 0.014597 0.0505275 0.117599	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG1 ) or DRUG0 (e.g. , DRUG2 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0258921 0.0203655 0.048751 0.0501114 0.0550134 0.0412672 0.0448396 0.0144235 0.00837087 0.00299648 0.00354785 0.00256362 0.00525121 0.00327325 0.00326842 0.00917865 0.00882494 0.0444946 0.00803979 0.00907954 0.0068556 0.00459075 0.00563223 0.0101907 0.0115448 0.0214768 0.00677629 0.0064152 0.0482882 0.0472882 0.0698459 0.0697173 0.0272701 0.0182418 0.00962234 0.00900154 0.0341015 0.0149876 0.0509159 0.117684	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG1 ) or DRUG0 (e.g. , DRUG0 and DRUG2 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.0199069 0.0154462 0.0361058 0.036887 0.0398565 0.0292382 0.030708 0.010339 0.00561319 0.00235606 0.00303355 0.00221284 0.00371712 0.00273556 0.00243428 0.00491118 0.00448548 0.0191702 0.00526786 0.00494671 0.00431469 0.00410156 0.00464264 0.00752207 0.00762765 0.0113285 0.0237702 0.041806 0.0889278 0.100619 0.0967745 0.0798738 0.0428682 0.0283865 0.0127995 0.00941317 0.0264396 0.0116427 0.0366196 0.0811506	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG1 ) or DRUG0 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0245144 0.0191689 0.0455809 0.0465925 0.0510683 0.0385313 0.0418673 0.0135345 0.00777397 0.00274602 0.00333595 0.00231282 0.00463458 0.00283257 0.00240057 0.0054214 0.0037615 0.00765734 0.00852646 0.0111064 0.0405023 0.0124512 0.0127077 0.0210854 0.00407977 0.00588455 0.00526474 0.00628774 0.0572528 0.056459 0.0806948 0.0822672 0.0297428 0.0180141 0.00924734 0.00866111 0.0324154 0.014184 0.0482381 0.111192	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG1 (e.g. , DRUG2 and DRUG0 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0228796 0.0179937 0.0431683 0.0443281 0.0486544 0.0368866 0.0398944 0.0129835 0.00742341 0.00258832 0.0031545 0.0021599 0.00421462 0.00264002 0.00224928 0.00487741 0.00356311 0.00694236 0.00886135 0.0118972 0.0435699 0.0107762 0.0134382 0.0141046 0.0162232 0.0255982 0.0074607 0.00702416 0.0556995 0.0571305 0.0798166 0.0803194 0.0293371 0.0178089 0.00907546 0.00844186 0.0310832 0.0137563 0.0461226 0.105853	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG1 (e.g. , DRUG0 and DRUG2 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.0193812 0.0150274 0.0350246 0.0354858 0.0382927 0.027978 0.028915 0.00954968 0.00519622 0.00225774 0.00290747 0.00206655 0.00338477 0.0024763 0.00202276 0.00345055 0.00270898 0.00497978 0.00601695 0.00818928 0.0265146 0.00760245 0.00786331 0.00857799 0.00979814 0.0120386 0.029996 0.0489799 0.0866015 0.106697 0.091348 0.074817 0.0385728 0.0248143 0.0114038 0.00860167 0.0255992 0.0111091 0.0355386 0.078214	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG1 (e.g. , DRUG0 and DRUG0 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.022835 0.0178934 0.0422666 0.0426882 0.0465407 0.034804 0.037584 0.0124285 0.00738543 0.0027017 0.00327703 0.00237359 0.0048447 0.00289421 0.00241724 0.00534317 0.00373399 0.00669323 0.00555464 0.00634448 0.0116781 0.0113499 0.0148159 0.103405 0.0182596 0.0263605 0.00791975 0.00711689 0.0530025 0.050375 0.069616 0.0691442 0.0255035 0.0161192 0.00841073 0.00788414 0.0295006 0.0130487 0.0440539 0.101832	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG1 and DRUG2 ) , may alter DRUG0 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.0190921 0.0148024 0.034631 0.0348295 0.0375165 0.027196 0.0277473 0.00902939 0.00483921 0.00208745 0.00267387 0.0018981 0.00309708 0.00226037 0.0018496 0.00315716 0.00247181 0.00385159 0.00328455 0.00351437 0.00602926 0.00684759 0.00850501 0.0493894 0.0116048 0.0124411 0.0294284 0.0457267 0.090979 0.109438 0.0900524 0.0719499 0.0365075 0.0233084 0.0108082 0.0082944 0.0251131 0.0109822 0.0351352 0.0776297	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG1 and DRUG0 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
3	3	0.019143 0.0148778 0.034851 0.0351569 0.0379759 0.0275824 0.0281061 0.00878539 0.00461149 0.00200694 0.00260088 0.00181605 0.00293242 0.00216257 0.00174029 0.00290446 0.0022936 0.00346262 0.00275785 0.00281872 0.00420828 0.00340588 0.00354893 0.00821138 0.00953411 0.0403152 0.0323785 0.040988 0.107034 0.11964 0.0938035 0.0706498 0.0361559 0.0226229 0.0106119 0.00821737 0.0251666 0.0110787 0.0353843 0.0784581	Other inhibitors of the cytochrome P450 3A4 enzyme system , such as DRUG0 (e.g. , DRUG0 and DRUG0 ) or DRUG0 (e.g. , DRUG0 and DRUG1 ) , may alter DRUG2 mean pharmacokinetic parameters (i.e. , Cmax and AUC) .
4	4	0.0499559 0.083019 0.0560181 0.0552102 0.0626234 0.0543571 0.047952 0.0392911 0.0425965 0.0274011 0.00488542 0.0045254 0.00347705 0.00368642 0.00712035 0.0170557 0.0408005 0.058401 0.0768598 0.037573 0.0251226 0.0368391 0.0210583 0.0155939 0.0110935 0.0288667 0.088617	Concurrent ingestion of DRUG1 (20 mL of DRUG0 containing DRUG2 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0540129 0.0885922 0.0609095 0.0591472 0.0650595 0.0604572 0.0560254 0.0238412 0.0243903 0.0105939 0.0067952 0.0177319 0.00377478 0.00327788 0.0062026 0.0161387 0.0393623 0.0592538 0.0775046 0.0377862 0.0251684 0.0374113 0.0211995 0.0156409 0.0111753 0.0289849 0.0895627	Concurrent ingestion of DRUG1 (20 mL of DRUG0 containing DRUG0 , DRUG2 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0471419 0.0775755 0.0525077 0.0517867 0.0563865 0.052955 0.0456208 0.0191365 0.0202311 0.00782127 0.00329152 0.00515632 0.00471139 0.0107077 0.0337861 0.0210292 0.054465 0.0638295 0.0846331 0.0411551 0.0277787 0.0417244 0.0236536 0.0165904 0.0118305 0.030072 0.0944223	Concurrent ingestion of DRUG1 (20 mL of DRUG0 containing DRUG0 , DRUG0 , and DRUG2 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0333977 0.0635166 0.0444964 0.0340815 0.0343686 0.0325725 0.0231328 0.0141388 0.0125004 0.00497012 0.00241077 0.00326396 0.00257127 0.00345615 0.00898516 0.0162652 0.0376187 0.0665298 0.101985 0.0762142 0.0740226 0.0872507 0.0829383 0.0442473 0.0196301 0.0170996 0.0583361	Concurrent ingestion of DRUG1 (20 mL of DRUG0 containing DRUG0 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG2 or DRUG0 .
4	4	0.0376203 0.0713564 0.0497989 0.0381688 0.0384011 0.0363147 0.0258583 0.0158529 0.0139944 0.00550142 0.00271254 0.00364257 0.00286974 0.00381123 0.00974675 0.016579 0.0380298 0.0677167 0.0935707 0.0716237 0.0631756 0.0723524 0.0429413 0.0241799 0.0292954 0.0558947 0.068991	Concurrent ingestion of DRUG1 (20 mL of DRUG0 containing DRUG0 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG2 .
4	4	0.0546593 0.107492 0.0740236 0.0564414 0.0745821 0.0957933 0.079729 0.0454721 0.0473903 0.0222948 0.00350425 0.00245919 0.00195158 0.00205791 0.00424361 0.0103694 0.0250092 0.0390941 0.0605013 0.0286752 0.0181921 0.0267846 0.0151287 0.0112594 0.00808683 0.0210551 0.0637495	Concurrent ingestion of DRUG0 (20 mL of DRUG1 containing DRUG2 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0518851 0.105141 0.0757981 0.0645946 0.0810521 0.0928906 0.0756884 0.0559149 0.0391224 0.0087001 0.00479281 0.0120774 0.00231274 0.00206165 0.00390769 0.0101792 0.0236258 0.0370815 0.0599046 0.0283024 0.0183567 0.0271882 0.0154061 0.0113302 0.00810446 0.0209983 0.0635827	Concurrent ingestion of DRUG0 (20 mL of DRUG1 containing DRUG0 , DRUG2 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0490931 0.0993108 0.072022 0.0624864 0.0787922 0.0890887 0.0720383 0.0530303 0.0328928 0.00602252 0.00229557 0.00363175 0.00311631 0.00655706 0.0214905 0.0122505 0.0316783 0.0398189 0.0613867 0.0293651 0.0196533 0.029578 0.0167306 0.0117849 0.00844169 0.0214186 0.0660251	Concurrent ingestion of DRUG0 (20 mL of DRUG1 containing DRUG0 , DRUG0 , and DRUG2 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.039467 0.0831101 0.0590283 0.0479063 0.065047 0.0729717 0.0426904 0.0234473 0.0144541 0.00437314 0.00206759 0.00265809 0.00215613 0.00281753 0.00603188 0.0115299 0.027262 0.0472214 0.0852763 0.0592362 0.0573492 0.0687157 0.0656545 0.0346413 0.0153597 0.0136972 0.0458303	Concurrent ingestion of DRUG0 (20 mL of DRUG1 containing DRUG0 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG2 or DRUG0 .
4	4	0.0435203 0.0913911 0.0646835 0.0524953 0.0710282 0.0792385 0.0461903 0.0252295 0.0154721 0.00471025 0.00227801 0.00290163 0.00235052 0.00302103 0.00629248 0.0113299 0.0266244 0.0465892 0.0753729 0.0536635 0.0478381 0.056208 0.0343911 0.0192498 0.0227185 0.0431561 0.0520558	Concurrent ingestion of DRUG0 (20 mL of DRUG1 containing DRUG0 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG2 .
4	4	0.0370671 0.0791045 0.0520427 0.0472159 0.0591728 0.0689484 0.0354283 0.0330232 0.0309723 0.0223376 0.00348863 0.00335869 0.00351164 0.00423641 0.00520129 0.00892451 0.0174595 0.0332961 0.0758914 0.0525687 0.0624217 0.0701416 0.0705416 0.0368197 0.0159574 0.0157887 0.05508	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG1 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG2 or DRUG0 .
4	4	0.0419131 0.0892443 0.0587187 0.0528363 0.0660283 0.076456 0.0390892 0.036186 0.0340004 0.0244483 0.00378281 0.00363295 0.00371331 0.00435204 0.00527607 0.00860956 0.0162762 0.0315746 0.0648941 0.0455383 0.0505916 0.0581198 0.040431 0.0205702 0.0225893 0.0443973 0.0567303	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG1 , DRUG0 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG2 .
4	4	0.0504278 0.105504 0.0617428 0.0478037 0.0585446 0.0677571 0.0320425 0.0219736 0.0194082 0.0128309 0.0088891 0.0407385 0.00875655 0.0117549 0.0305086 0.014572 0.0365642 0.0475054 0.0788405 0.0354611 0.0235926 0.0343945 0.0195853 0.0141375 0.0100804 0.0261365 0.0804469	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG0 , DRUG1 , and DRUG2 ) did not significantly affect the exposure of DRUG0 or DRUG0 .
4	4	0.0386796 0.0781594 0.0440148 0.034647 0.0421771 0.051104 0.0236043 0.0176433 0.0159254 0.0102859 0.00550697 0.0236263 0.00409182 0.00484093 0.00625552 0.0108208 0.0216395 0.0387937 0.091651 0.0616635 0.071824 0.0809679 0.0809706 0.0425636 0.0185563 0.0178543 0.0621325	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG0 , DRUG1 , and DRUG0 ) did not significantly affect the exposure of DRUG2 or DRUG0 .
4	4	0.0440748 0.0888216 0.0501959 0.0393824 0.0480128 0.0578398 0.0267306 0.0198392 0.0181123 0.0115905 0.00612084 0.0259019 0.00441002 0.00505428 0.00645835 0.0105951 0.0205426 0.0373286 0.0799622 0.0545273 0.0598088 0.0686889 0.0465483 0.0243407 0.0268826 0.0519037 0.0663259	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG0 , DRUG1 , and DRUG0 ) did not significantly affect the exposure of DRUG0 or DRUG2 .
4	4	0.0368985 0.0716847 0.0358657 0.0262228 0.0313678 0.0389188 0.0158467 0.0117228 0.0102538 0.00534554 0.00236172 0.00469971 0.00340255 0.00650911 0.0350415 0.0141487 0.0296505 0.0455393 0.108893 0.0709444 0.0757793 0.0890123 0.0849829 0.0449448 0.0195328 0.0180259 0.0624044	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG0 , DRUG0 , and DRUG1 ) did not significantly affect the exposure of DRUG2 or DRUG0 .
4	4	0.0418436 0.0810268 0.0405525 0.0295247 0.035399 0.0437019 0.017851 0.0131481 0.0116055 0.0060305 0.00267615 0.00527179 0.00380438 0.00710075 0.0367946 0.0142624 0.0294197 0.0457062 0.0985195 0.0656829 0.0652584 0.0768978 0.0481676 0.0256649 0.0291423 0.0553418 0.0696054	Concurrent ingestion of DRUG0 (20 mL of DRUG0 containing DRUG0 , DRUG0 , and DRUG1 ) did not significantly affect the exposure of DRUG0 or DRUG2 .
0	4	0.226298 0.163138 0.143818 0.119919 0.0400467 0.0104609 0.0102324 0.0103203 0.00266038 0.0035722 0.00213344 0.00186626 0.00258451 0.00197982 0.00275506 0.00196809 0.00274323 0.0019336 0.00273937 0.00192804 0.00281219 0.00197862 0.00288079 0.00217878 0.00179383 0.00265756 0.00186692 0.00286521 0.00199953 0.00335681 0.00199114 0.00175803 0.00271106 0.00218006 0.00175356 0.00176374 0.00270162 0.00221089 0.00511198 0.00641104 0.0020563 0.00294204 0.00203406 0.00366031 0.00207945 0.00190589 0.00417847 0.00330938 0.00326976 0.00220674 0.00197703 0.00367925 0.0020913 0.00208255 0.00385861 0.00350442 0.010321 0.0172256 0.121538	DRUG1 may interact with DRUG2 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.191971 0.13732 0.127748 0.104844 0.0456913 0.0592315 0.0464581 0.0157209 0.00380953 0.00463257 0.0025803 0.00217823 0.00288732 0.00217774 0.00295516 0.00215505 0.00293419 0.00210358 0.00291752 0.00208174 0.00297305 0.00212531 0.00307608 0.00226967 0.00186107 0.00273896 0.00192098 0.00292057 0.00204823 0.00343934 0.00203563 0.00176835 0.00272315 0.00218794 0.00174958 0.0017474 0.00265142 0.00219486 0.00499682 0.00625083 0.00200964 0.0028501 0.001995 0.00358436 0.00204074 0.00185788 0.00406984 0.00323618 0.00314514 0.00213173 0.00190307 0.00355277 0.00201614 0.00200105 0.00368019 0.00336422 0.00984494 0.0163928 0.114247	DRUG1 may interact with DRUG0 ( DRUG2 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.212839 0.153835 0.139498 0.096676 0.0248763 0.0185454 0.0246344 0.0420241 0.0122181 0.0170635 0.00350728 0.00223608 0.00254229 0.00197969 0.00256145 0.00192355 0.00254898 0.00186969 0.00251963 0.0018396 0.0025377 0.00187631 0.00266952 0.00194846 0.0016812 0.0023864 0.00175099 0.0025257 0.00186446 0.00315314 0.0018624 0.00165356 0.00247002 0.00192017 0.00167203 0.00166247 0.00249897 0.00204832 0.00452934 0.00531223 0.00187705 0.00263695 0.00192197 0.00348124 0.00196983 0.0018079 0.00395516 0.00294271 0.00298806 0.00204906 0.00189175 0.00360822 0.00203783 0.00200214 0.00368324 0.00337964 0.0101261 0.0164361 0.117445	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.220093 0.15911 0.144352 0.101984 0.0252896 0.0196302 0.0226392 0.0277657 0.00592061 0.00674788 0.00555313 0.00607419 0.0113501 0.00209594 0.00235523 0.00180728 0.00237104 0.00177547 0.00237375 0.00176573 0.00241457 0.00181684 0.00259533 0.00191808 0.00165326 0.00231577 0.00171438 0.00244723 0.00182939 0.003102 0.00185015 0.0016361 0.00242445 0.00190945 0.00164245 0.00163538 0.00244741 0.00201277 0.00446326 0.00527348 0.00184235 0.00257903 0.00188527 0.00344313 0.00193582 0.00176591 0.00387686 0.00290696 0.00292948 0.00199833 0.00183521 0.00352365 0.00198151 0.0019416 0.00357042 0.00328359 0.00992643 0.0160719 0.114548	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.220149 0.160588 0.144518 0.102256 0.0252309 0.0195404 0.0222296 0.0265857 0.00535899 0.00560346 0.00357823 0.00304458 0.00467738 0.00591595 0.0118366 0.00207291 0.00236292 0.00182663 0.00239398 0.00179394 0.00242151 0.00183605 0.00261161 0.00193763 0.00166914 0.00232453 0.00172704 0.00245012 0.00184061 0.00309884 0.00186707 0.00164329 0.00242274 0.00191216 0.00164809 0.00165247 0.00243184 0.00202142 0.00444795 0.00530854 0.00184512 0.00257275 0.00188499 0.00342203 0.00194017 0.00176449 0.00386782 0.00294803 0.0029177 0.00199504 0.00182597 0.00349501 0.00197711 0.00193317 0.00354475 0.00326826 0.00984605 0.0160212 0.114094	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.219869 0.160672 0.144258 0.10175 0.0250729 0.0193365 0.0220054 0.0259474 0.00515408 0.00524368 0.00333095 0.00269157 0.00369009 0.00306705 0.00475274 0.00596906 0.0118468 0.00208148 0.00241876 0.00185335 0.00247185 0.00186928 0.0026526 0.00197469 0.00169105 0.00235599 0.00174757 0.0024792 0.00185813 0.00312688 0.00188199 0.00165249 0.0024393 0.00192669 0.00165575 0.00166291 0.00243912 0.00203144 0.00447159 0.00535748 0.00185099 0.00258274 0.00188915 0.00342635 0.00194386 0.00176588 0.00387632 0.00297149 0.00292274 0.00199661 0.00182403 0.00348854 0.00197483 0.00193058 0.00354144 0.00326507 0.00982751 0.0160295 0.114136	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.219561 0.160561 0.144012 0.101357 0.0249663 0.0192144 0.0218639 0.0256098 0.0050677 0.00511176 0.00324922 0.00260693 0.00349229 0.00273599 0.00374898 0.00309947 0.00475597 0.00592201 0.0118993 0.00208441 0.00247331 0.00192195 0.00270274 0.00201967 0.0017182 0.00237612 0.00176856 0.00249124 0.00187223 0.00314712 0.00189687 0.00166115 0.00244465 0.00193153 0.00166285 0.00167203 0.00243694 0.00203635 0.00446796 0.00536328 0.00185182 0.00257882 0.00188992 0.00342274 0.001946 0.00176599 0.00387427 0.0029824 0.00291817 0.0019947 0.00182162 0.00348119 0.00197397 0.00192815 0.00353431 0.00326152 0.00981242 0.0160267 0.113951	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.219122 0.160287 0.143658 0.101089 0.0249205 0.0191824 0.0217669 0.0254383 0.00502608 0.0050473 0.00321309 0.00257566 0.00341945 0.00266425 0.00355963 0.00277648 0.00375252 0.00308141 0.00474314 0.00592679 0.0122448 0.00212928 0.00272673 0.00211601 0.00176859 0.00239713 0.00179964 0.00249324 0.0018893 0.00316383 0.00191634 0.00167305 0.00244438 0.00193039 0.00167134 0.00168361 0.00242768 0.00203985 0.00444599 0.00534255 0.00184975 0.00256454 0.00188885 0.00341167 0.00194814 0.00176549 0.00386508 0.00299055 0.00290556 0.00198989 0.00181777 0.00346966 0.00197378 0.00192477 0.00352146 0.00325607 0.00979095 0.0160111 0.113502	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.217134 0.157054 0.141304 0.0968275 0.0239058 0.0177854 0.0209031 0.0235557 0.00462795 0.00481215 0.00299627 0.00242441 0.00330993 0.00252733 0.00343502 0.00260736 0.0035297 0.00268866 0.00375805 0.00305052 0.00491573 0.00617666 0.0153053 0.00294011 0.00193424 0.00262626 0.00190703 0.00279301 0.00199095 0.00333712 0.00190019 0.00169906 0.00260833 0.00208767 0.00166167 0.00166386 0.00259679 0.00207398 0.00494525 0.00598096 0.00190383 0.0027518 0.00192109 0.00355148 0.00191487 0.00177844 0.00403361 0.0030218 0.00312523 0.00204328 0.00186306 0.00356995 0.00194013 0.00194099 0.00368953 0.00333486 0.010235 0.0167236 0.121276	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.218407 0.159974 0.143185 0.099961 0.0245554 0.0187485 0.0213729 0.0246923 0.00488252 0.00490474 0.00311321 0.0025086 0.00332193 0.00257955 0.00341401 0.00262744 0.003447 0.0026346 0.0035036 0.00268811 0.00371803 0.00311994 0.00535752 0.00614677 0.0056394 0.0106604 0.00204426 0.00243468 0.00191939 0.0032501 0.00201035 0.00173272 0.00246271 0.00196925 0.00172807 0.00173721 0.00243579 0.00207998 0.00444379 0.0053882 0.0018623 0.00254823 0.00190173 0.00341093 0.00197 0.00177855 0.00386544 0.00302447 0.00289143 0.00199191 0.00181724 0.00345531 0.00198199 0.00192611 0.00349894 0.00325221 0.0097505 0.0159585 0.112314	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.218613 0.159984 0.143321 0.100046 0.0245239 0.0187042 0.021326 0.024587 0.0048852 0.00489991 0.0031144 0.00250914 0.0033219 0.00257992 0.00341454 0.00262838 0.00344792 0.00263495 0.00349906 0.0026823 0.0036765 0.00292638 0.00451304 0.00389014 0.00312458 0.00461101 0.00544972 0.0119414 0.0020604 0.00318401 0.00211431 0.00179603 0.00245449 0.00195943 0.00175416 0.00177661 0.00239358 0.00207337 0.0043176 0.00522243 0.00184654 0.00250345 0.00188837 0.00336276 0.00197007 0.00177539 0.00383168 0.00303797 0.00285737 0.00198208 0.00181142 0.00343453 0.00198694 0.00192215 0.0034755 0.00324136 0.00969964 0.0158994 0.111512	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.220526 0.160845 0.144231 0.0987492 0.0239805 0.0177844 0.0208275 0.0233095 0.00471282 0.00476512 0.00300695 0.00244309 0.00327511 0.0025259 0.00337367 0.00257788 0.00340808 0.0025835 0.00345532 0.00262178 0.00360349 0.00281642 0.00423032 0.00341872 0.00264168 0.00351269 0.00264224 0.00424757 0.00527563 0.0113903 0.00249293 0.00193422 0.00255204 0.00205155 0.00183968 0.00184657 0.00243844 0.00210458 0.0043105 0.00515486 0.00183652 0.00248924 0.00189353 0.00336142 0.00197363 0.0017807 0.00385319 0.00302049 0.0028656 0.00199681 0.00183594 0.00347203 0.00201206 0.00194809 0.00353674 0.00329358 0.00986524 0.0162022 0.113256	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.217358 0.157915 0.141785 0.0961812 0.0234957 0.0172011 0.0204342 0.0225388 0.00450542 0.00465215 0.00290589 0.00236052 0.00321382 0.00245076 0.00331629 0.00250129 0.00335216 0.00250665 0.00340026 0.0025441 0.00355071 0.00272484 0.00413052 0.00331056 0.00256168 0.00344353 0.00249629 0.00369765 0.00286126 0.00519494 0.00428496 0.00500095 0.013467 0.00273485 0.00189004 0.00179063 0.00247748 0.00207856 0.00450847 0.00565834 0.001862 0.00266152 0.00191438 0.00348212 0.00190442 0.00177543 0.00399235 0.00296579 0.00305775 0.00200602 0.00185569 0.00353576 0.00193046 0.00192735 0.00365578 0.00331783 0.0101795 0.0166072 0.118887	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.218772 0.160414 0.143257 0.0976582 0.0233908 0.0172528 0.0202811 0.0226519 0.00467372 0.0047125 0.00298702 0.00242465 0.0032441 0.00250722 0.00334137 0.00255996 0.00337519 0.00256693 0.00341961 0.00259901 0.00355422 0.00277244 0.00409738 0.00329625 0.00260258 0.00340111 0.00248465 0.00351927 0.00270721 0.00435374 0.00302664 0.00256401 0.00446591 0.00444227 0.0039733 0.00631542 0.0113228 0.00224134 0.00391145 0.00498796 0.00185218 0.00242055 0.0019051 0.00340333 0.0020422 0.00181827 0.00389478 0.0031848 0.00289127 0.00201011 0.00182442 0.00346563 0.00201368 0.00193139 0.00347685 0.00326564 0.00984399 0.0161012 0.110526	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.211869 0.154472 0.138582 0.0964138 0.0235166 0.0178455 0.0203714 0.0235674 0.0047308 0.00466192 0.00300012 0.00240695 0.0031629 0.0024691 0.00324146 0.0025137 0.00326784 0.00251635 0.00330588 0.0025473 0.0034379 0.00272831 0.00400295 0.00334894 0.00255281 0.0032711 0.00241588 0.0033441 0.00258935 0.00399726 0.00282172 0.00239196 0.00386316 0.00353812 0.0026142 0.00270159 0.00388084 0.00566138 0.0212022 0.00556851 0.00199768 0.00277497 0.00203474 0.00370944 0.00203816 0.00185076 0.00413909 0.00326166 0.00317789 0.00207629 0.00188761 0.00359166 0.00195959 0.00194193 0.00364941 0.00335272 0.0101841 0.0168393 0.119138	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.21073 0.154633 0.137924 0.094193 0.0227056 0.0167944 0.0195915 0.0218944 0.00445534 0.00451349 0.00285327 0.00232344 0.00310294 0.00240552 0.00320128 0.00245654 0.00323542 0.00246503 0.00327846 0.00250053 0.0034053 0.0026728 0.00390003 0.00317016 0.002494 0.00323841 0.00237555 0.00334554 0.00256956 0.00403782 0.00274793 0.00234648 0.00365373 0.0032135 0.00249708 0.00243088 0.00331437 0.00311465 0.00746523 0.0278183 0.00733691 0.013047 0.00250933 0.00360598 0.00246892 0.0021133 0.00410676 0.00368469 0.00297524 0.00211655 0.00189125 0.00349722 0.00210436 0.00197936 0.0034933 0.00330679 0.00976836 0.0162311 0.108695	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.21572 0.157834 0.140811 0.0945016 0.0227491 0.016393 0.0196061 0.0213437 0.00438592 0.00449537 0.00282203 0.00230962 0.00312351 0.00240004 0.00322652 0.00245288 0.00326211 0.00246092 0.00330669 0.00249472 0.00343575 0.00266374 0.00393093 0.00313963 0.00248554 0.00327251 0.00237615 0.00338669 0.00257562 0.00407421 0.00276012 0.0023297 0.00366976 0.00316566 0.00245324 0.00233419 0.00336931 0.00299067 0.00692073 0.0151377 0.00309332 0.00411486 0.00480305 0.0112544 0.00275578 0.00219884 0.00417746 0.00373166 0.0029897 0.00219815 0.00195581 0.00360674 0.00219529 0.00204978 0.00363588 0.00343968 0.0101872 0.0169713 0.11247	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.211138 0.155387 0.138794 0.0945918 0.0227014 0.0166876 0.019658 0.0218526 0.00448881 0.00450771 0.00286441 0.00232539 0.00310506 0.0024056 0.00320228 0.00245763 0.0032372 0.00246572 0.00328154 0.00249879 0.00340934 0.00266999 0.00391392 0.00315465 0.00249698 0.00325239 0.00237819 0.00335978 0.00257628 0.00404978 0.00277796 0.00233482 0.00366219 0.00318144 0.00247346 0.00236431 0.00340418 0.00303277 0.00696074 0.0143738 0.002899 0.0034814 0.00247364 0.004592 0.00346239 0.00433633 0.0109981 0.00374219 0.00306039 0.00232391 0.00197946 0.00370419 0.00210717 0.00202259 0.00372477 0.00343228 0.0105571 0.0172573 0.120368	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.209669 0.153506 0.136174 0.0885145 0.021501 0.0147786 0.0185637 0.0192754 0.00396238 0.00425279 0.00263511 0.00215684 0.00300869 0.00225756 0.00311759 0.0023069 0.00315336 0.00231244 0.00319658 0.00234133 0.003323 0.00248656 0.00377263 0.00295809 0.00231422 0.00315812 0.00223484 0.00327967 0.00241247 0.00391549 0.00260634 0.00215256 0.00348287 0.00294869 0.00222119 0.00210182 0.00327244 0.00275695 0.00672283 0.0119547 0.00264403 0.00339129 0.00239176 0.00428592 0.00277275 0.00267009 0.00892897 0.0187818 0.0164866 0.00390493 0.00240592 0.00385406 0.00231928 0.00221642 0.00387626 0.00367315 0.0106739 0.0176325 0.12033	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.214932 0.157513 0.1404 0.0933027 0.02238 0.0159289 0.019278 0.0207356 0.00430375 0.00442762 0.0027771 0.00227538 0.00309099 0.00236808 0.00319449 0.00242116 0.00322984 0.00242886 0.00327394 0.00246035 0.00340075 0.00262142 0.00388568 0.00307698 0.0024511 0.00324382 0.0023483 0.00336031 0.0025469 0.00403726 0.00273675 0.00229072 0.00362523 0.00309343 0.00240344 0.00226507 0.00339602 0.00294048 0.00691923 0.0130263 0.00280913 0.0033766 0.00240236 0.00406591 0.00266809 0.00234771 0.00632671 0.00758518 0.00479755 0.00427676 0.00434229 0.0109733 0.00308942 0.00253107 0.00385481 0.00369956 0.0100393 0.0176491 0.108773	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
0	0	0.215327 0.15845 0.140964 0.0948054 0.0226354 0.0164005 0.0194682 0.0213483 0.00441457 0.00449196 0.0028373 0.00231502 0.00311362 0.0024006 0.00321268 0.00245103 0.00324476 0.0024567 0.00328504 0.00248625 0.00340647 0.00264609 0.00388271 0.00311006 0.00247295 0.00324454 0.00236181 0.00335309 0.00255673 0.00402511 0.00274439 0.00230335 0.00360552 0.00312093 0.00242337 0.00230645 0.00337669 0.00296354 0.00680327 0.0131504 0.00279365 0.00333116 0.00238279 0.00393732 0.00260556 0.00228485 0.00572898 0.00691666 0.00390537 0.00312608 0.00231568 0.00456848 0.00313457 0.0041574 0.0138729 0.00355803 0.00878907 0.0176589 0.104966	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
0	0	0.209248 0.153494 0.136622 0.092089 0.0221037 0.0160517 0.0189337 0.0208061 0.00426775 0.00432266 0.00272566 0.0022292 0.00298893 0.00230998 0.0030822 0.00235794 0.00311227 0.00236314 0.00315057 0.00239224 0.00326791 0.00254923 0.00373021 0.00299551 0.00237909 0.0031085 0.00227148 0.00320775 0.00245599 0.00383593 0.0026272 0.00221017 0.00345144 0.00299309 0.00230727 0.0022147 0.00322406 0.00285488 0.00652501 0.0129546 0.00268021 0.00317042 0.00227362 0.00369121 0.00245915 0.00218163 0.00540472 0.0067494 0.00372527 0.00297158 0.00218308 0.00389707 0.00227229 0.00220944 0.00397937 0.00673571 0.0338492 0.0221119 0.11164	DRUG1 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.107672 0.163004 0.202357 0.114772 0.0712908 0.0274231 0.0206085 0.0526244 0.00807794 0.0126084 0.00296585 0.00192432 0.00213146 0.00163157 0.0020706 0.00153534 0.0020253 0.00147392 0.00199457 0.00144814 0.00201131 0.00148541 0.00212658 0.00154574 0.0013637 0.00191833 0.00140198 0.00202941 0.00149905 0.0025661 0.00150278 0.00135514 0.00201213 0.00155978 0.00137549 0.0013595 0.0020627 0.0016751 0.00373387 0.0043845 0.00154053 0.00218873 0.0015798 0.00292044 0.00162391 0.00150703 0.00331739 0.00244711 0.00251076 0.00171182 0.00159814 0.00306141 0.00171442 0.00169998 0.00310649 0.00286483 0.00866918 0.0143983 0.102932	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107409 0.163207 0.205452 0.119131 0.0778149 0.0297062 0.0199429 0.03391 0.00501437 0.00600565 0.00456933 0.00478254 0.00963669 0.00188659 0.00205238 0.00155944 0.00199363 0.00149812 0.00198148 0.00147877 0.00201046 0.00152378 0.00216458 0.00160476 0.00140197 0.00193773 0.00143273 0.00204452 0.00153369 0.00260853 0.00155546 0.00138613 0.00203771 0.00160504 0.00139569 0.00138221 0.00207668 0.0017025 0.00378766 0.00450763 0.00156137 0.00220517 0.00159644 0.00296133 0.00164359 0.00151384 0.00334025 0.00250551 0.00252716 0.00171474 0.00158712 0.00305235 0.00170567 0.0016887 0.00308785 0.0028512 0.00865733 0.0144024 0.102666	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107199 0.163487 0.205961 0.119729 0.0781952 0.0293326 0.0196582 0.0324389 0.00461335 0.00495338 0.00304926 0.00284621 0.00417171 0.00465063 0.00953018 0.00179595 0.00200601 0.00153339 0.00198602 0.00149311 0.00200561 0.00152984 0.00216515 0.00161561 0.00140954 0.00193911 0.00143994 0.00204196 0.00154 0.00260585 0.00156697 0.00139174 0.00203405 0.00160831 0.00140342 0.00139499 0.00206953 0.0017132 0.00378533 0.00455021 0.00156839 0.00219909 0.00160017 0.00295253 0.00165115 0.00151821 0.00334308 0.00253628 0.00252385 0.00171699 0.00158632 0.00304333 0.00170879 0.00168926 0.00308196 0.0028532 0.00864967 0.0144356 0.102902	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107203 0.163761 0.206116 0.119696 0.0776557 0.0289776 0.0194299 0.0316378 0.00445977 0.00466223 0.00283 0.00249786 0.00322685 0.00266172 0.0040382 0.00461767 0.00907825 0.00175692 0.00202419 0.00153977 0.00203757 0.00155298 0.0021905 0.00164202 0.0014222 0.00195869 0.00145343 0.00205938 0.00155169 0.00262519 0.00157837 0.00139804 0.0020439 0.00161913 0.00141105 0.00140439 0.00207553 0.00172371 0.00380511 0.0045973 0.00157578 0.00220634 0.00160637 0.00295918 0.00165785 0.00152264 0.00335471 0.00256027 0.0025305 0.00172141 0.00158798 0.00304323 0.0017112 0.001691 0.00308498 0.00285783 0.00865696 0.0144819 0.103169	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107191 0.163831 0.206064 0.119519 0.0772686 0.0287545 0.0192861 0.0312313 0.00440308 0.00456061 0.00276591 0.00244372 0.00308697 0.00237191 0.00314759 0.00262497 0.00395208 0.00452762 0.00892145 0.00173442 0.0020574 0.00159339 0.00222781 0.00167965 0.00143969 0.00197378 0.00146707 0.00206661 0.00155957 0.00263868 0.00158797 0.00140203 0.00204564 0.00162109 0.00141586 0.00141096 0.00207209 0.00172696 0.00380207 0.00460093 0.00157697 0.00220292 0.00160767 0.00295777 0.00166095 0.00152341 0.00335515 0.00257195 0.0025278 0.00172096 0.00158678 0.00303937 0.00171203 0.00169002 0.00308138 0.002857 0.00865255 0.0144917 0.103109	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107109 0.163648 0.205758 0.119232 0.0770645 0.0286393 0.019199 0.0310502 0.00437537 0.00450408 0.00273475 0.0024224 0.00302913 0.00233367 0.00302416 0.00235156 0.0030932 0.00256025 0.0039042 0.00451779 0.00912305 0.00176523 0.00226249 0.0017716 0.0014806 0.0019951 0.00149338 0.00207037 0.00157271 0.00265189 0.00160247 0.00140924 0.00204472 0.00161968 0.00142172 0.00141932 0.0020634 0.00172911 0.00378623 0.0045851 0.00157606 0.00219225 0.0016076 0.00295073 0.00166388 0.00152345 0.00335044 0.00258177 0.00251899 0.00171813 0.00158409 0.00303197 0.00171268 0.0016877 0.00307303 0.00285383 0.00864104 0.0144872 0.102826	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106559 0.164308 0.205135 0.117892 0.0720713 0.0260746 0.01751 0.0273876 0.00400982 0.0042917 0.00257576 0.00228229 0.00291113 0.00221522 0.00291828 0.00222753 0.00294628 0.00223443 0.00308506 0.00251487 0.00404769 0.00474047 0.0114355 0.0023511 0.00159966 0.00217459 0.00156443 0.00230106 0.0016339 0.00277648 0.00156623 0.0014152 0.00215962 0.0017243 0.00140306 0.00139489 0.00219049 0.00174502 0.00414615 0.00507917 0.00162204 0.0023689 0.00163889 0.00308057 0.00164102 0.00154238 0.00349091 0.0026126 0.00272274 0.00177815 0.00164014 0.00314374 0.0017046 0.00172225 0.00323954 0.00295235 0.00904141 0.0152133 0.110245	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107163 0.163947 0.205679 0.118723 0.0756885 0.0277312 0.0186534 0.0298969 0.00425659 0.00436856 0.00265021 0.00236716 0.00293043 0.002276 0.00290927 0.00227127 0.00289852 0.00224265 0.00293359 0.00228008 0.0031211 0.00271335 0.00428946 0.00494779 0.00431788 0.00801938 0.00169583 0.0020333 0.00159369 0.00270237 0.00167405 0.00144627 0.00204784 0.00164583 0.00146446 0.00146073 0.00206033 0.00175914 0.00377538 0.00462948 0.00158984 0.00217811 0.00162212 0.00295063 0.00168909 0.00153769 0.00335806 0.00263002 0.002511 0.00172587 0.00158665 0.00302423 0.0017259 0.00169262 0.00305986 0.00285688 0.00861525 0.0144711 0.101911	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107196 0.16407 0.205821 0.118786 0.0757149 0.0277767 0.0186875 0.0297386 0.00423292 0.00434871 0.00263422 0.00235146 0.00291813 0.00226057 0.00289456 0.00225564 0.00288331 0.00222991 0.00291803 0.00228055 0.00309544 0.00255338 0.00363694 0.00316226 0.00270475 0.00385753 0.00423553 0.00924462 0.00172047 0.00267361 0.00177261 0.00150182 0.00204288 0.00163691 0.00147717 0.00148349 0.00201358 0.00173792 0.00365748 0.00444613 0.00156612 0.00212816 0.00159876 0.00289976 0.00167703 0.00152441 0.00331416 0.00261618 0.00247153 0.00170671 0.00157309 0.00299852 0.0017194 0.00167928 0.00302872 0.00283241 0.00855783 0.0143549 0.101099	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.108053 0.166584 0.207973 0.119219 0.0733783 0.0262871 0.0178782 0.027444 0.00404157 0.00425345 0.00255207 0.00228559 0.00288321 0.00221111 0.00287334 0.00221244 0.00286992 0.00219138 0.00290739 0.00223787 0.00306334 0.00246567 0.00345207 0.0027469 0.00224197 0.00291826 0.00215064 0.00351697 0.00416052 0.00876141 0.00212417 0.00162587 0.00212876 0.00170367 0.00152539 0.00152229 0.00203424 0.00174168 0.00362806 0.0043615 0.00154974 0.00211878 0.00159394 0.00289013 0.0016696 0.00152385 0.00332265 0.00259153 0.00248149 0.00171743 0.00159508 0.00303195 0.00174001 0.0017024 0.0030822 0.00287811 0.00869407 0.0146176 0.102989	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106972 0.165475 0.206093 0.117853 0.0708607 0.0251876 0.0170897 0.0259677 0.00386314 0.00412564 0.00246908 0.00220519 0.00280081 0.0021388 0.00279985 0.0021393 0.00279998 0.00211877 0.00283754 0.00216049 0.00298916 0.00236053 0.00332955 0.00264713 0.002181 0.00288142 0.00203729 0.00308046 0.00235057 0.00423311 0.00335869 0.00384525 0.0105977 0.00222818 0.00159348 0.00150431 0.00207305 0.00173063 0.00377594 0.00474703 0.00157103 0.00227775 0.00162022 0.00300907 0.00162246 0.00152712 0.00344603 0.0025642 0.00265798 0.00174098 0.00162498 0.00311053 0.00168994 0.00170217 0.0032055 0.00292688 0.00897999 0.0150846 0.108137	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.10731 0.165708 0.207241 0.118886 0.0728193 0.025968 0.0177115 0.0266908 0.00396428 0.00417385 0.00250599 0.00223805 0.00283373 0.00216664 0.00282075 0.00216583 0.00281538 0.00214325 0.00284882 0.00217998 0.00298916 0.00237971 0.00331644 0.00263272 0.00218955 0.00284733 0.00201933 0.00293824 0.00222083 0.00352447 0.00237486 0.00209023 0.00366344 0.00359646 0.00314753 0.0048064 0.00913002 0.00188867 0.00334227 0.00428354 0.00157897 0.00206628 0.00161045 0.00291569 0.00173589 0.00155708 0.00335431 0.00275984 0.00249498 0.00173134 0.00158249 0.00301808 0.00174313 0.0016864 0.00302896 0.00285313 0.00865733 0.0145372 0.100516	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104022 0.159688 0.200397 0.115434 0.0727663 0.0266794 0.0179301 0.0284557 0.00403995 0.00411649 0.00252313 0.00223539 0.00276178 0.00214227 0.00273047 0.00213149 0.00271266 0.00210197 0.00273605 0.00213738 0.00287466 0.00234874 0.00323276 0.0027201 0.0021767 0.00272779 0.00196754 0.00278054 0.00213034 0.00322765 0.00221377 0.00195696 0.00316476 0.00282152 0.00213436 0.0023357 0.00326693 0.00473192 0.0173066 0.00451049 0.00168135 0.00235832 0.00171136 0.00318876 0.00172861 0.00158383 0.00357045 0.00281041 0.00276662 0.00180404 0.0016569 0.0031777 0.00172093 0.00172218 0.00321887 0.00297366 0.00903418 0.0153725 0.109547	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104517 0.161069 0.200929 0.115028 0.0704967 0.0248723 0.0170885 0.0261192 0.00386378 0.00403394 0.00242531 0.00218648 0.00272538 0.00211372 0.00271599 0.00211288 0.00271065 0.00209157 0.00274092 0.00213119 0.00287181 0.00232367 0.00315124 0.00255369 0.0021344 0.00270878 0.00195585 0.00279265 0.00213895 0.00325589 0.0021585 0.00192962 0.00297576 0.0025501 0.00204437 0.00214299 0.00279195 0.00277354 0.00655749 0.0233842 0.00564578 0.0104529 0.00210723 0.00307413 0.00209487 0.00179475 0.00351203 0.00313098 0.00252283 0.00179973 0.00161883 0.0030103 0.00180134 0.00171091 0.00301274 0.00286969 0.00854787 0.0146025 0.0995234	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106439 0.16496 0.205052 0.116738 0.0695455 0.0241688 0.0166761 0.0246987 0.00374978 0.00400225 0.0023868 0.00215049 0.00272517 0.00208841 0.00272488 0.00209059 0.0027247 0.00207132 0.00275834 0.00210826 0.00288932 0.00229288 0.00316186 0.0025041 0.00210205 0.00273274 0.00194745 0.00282693 0.00213651 0.00328477 0.00216559 0.00191489 0.0029964 0.00252541 0.00200945 0.00206107 0.00285512 0.00265141 0.00595466 0.0125727 0.00254945 0.00355292 0.00402134 0.00949599 0.00238946 0.00189199 0.00359962 0.00317085 0.00255493 0.00187184 0.0016739 0.00311002 0.00187274 0.00176499 0.00312847 0.00297093 0.00888718 0.0151831 0.102866	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104252 0.161327 0.201268 0.115049 0.0700741 0.0248151 0.0170504 0.0257667 0.00382504 0.00399628 0.00240733 0.00215678 0.0027102 0.00208608 0.00270127 0.00208648 0.00269805 0.00206623 0.0027307 0.00210355 0.00286174 0.00229655 0.00315119 0.00252552 0.00210912 0.00271054 0.00193822 0.00279605 0.00212615 0.00326132 0.00217514 0.00191074 0.00299013 0.00253698 0.00201605 0.00209143 0.00288591 0.00269186 0.00598159 0.0119621 0.00237443 0.00300099 0.0021 0.00394591 0.00291007 0.00363429 0.00938087 0.00322059 0.00268723 0.00201336 0.00171484 0.00323558 0.00182684 0.00176542 0.00323608 0.00300149 0.00929314 0.0156246 0.110846	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104283 0.162985 0.201671 0.113801 0.0640999 0.0218683 0.0151593 0.0213296 0.00337934 0.00378446 0.00223133 0.00199551 0.00260245 0.00195512 0.00262136 0.00195992 0.00262994 0.00194323 0.00266568 0.00197344 0.00279084 0.00212161 0.0030134 0.00232514 0.00193712 0.00263518 0.00183392 0.00274035 0.00199731 0.00314146 0.00203712 0.00176381 0.00281996 0.00234021 0.00180338 0.00180644 0.00274722 0.00240363 0.00563259 0.0097987 0.00219197 0.00293138 0.00203585 0.0036333 0.00230105 0.00229355 0.00738076 0.0163551 0.0138058 0.00331038 0.00207654 0.00337102 0.00198933 0.00190785 0.00333077 0.00315751 0.00922534 0.0157782 0.110295	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106111 0.164871 0.204829 0.116376 0.0684224 0.023625 0.0163279 0.0237292 0.00365154 0.00393297 0.00233876 0.00210214 0.00268723 0.00204534 0.00268974 0.00204816 0.00269095 0.00202915 0.00272466 0.00206254 0.00285219 0.00223712 0.00311551 0.00243573 0.00204823 0.00269846 0.00190824 0.00279538 0.00209383 0.00324215 0.0021357 0.00186631 0.00294523 0.00245843 0.00193836 0.00196024 0.00285901 0.00257746 0.00585951 0.0107904 0.0023134 0.00293006 0.00205574 0.00348797 0.0022282 0.00205055 0.00556528 0.00715364 0.00411066 0.00368649 0.00372251 0.00952878 0.00269598 0.00220212 0.00337014 0.0031831 0.00871399 0.0156053 0.0992837	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106261 0.164446 0.204913 0.116943 0.0701253 0.0244351 0.0168254 0.0248392 0.00375055 0.00397553 0.00237827 0.00213378 0.00270337 0.00206902 0.00269744 0.00206828 0.00269347 0.00204608 0.00272312 0.0020785 0.00284798 0.00225491 0.00311004 0.00245885 0.0020646 0.00268893 0.00191071 0.00277752 0.00209331 0.00322318 0.00213232 0.00186782 0.00291997 0.00246819 0.00194847 0.00199794 0.00283298 0.00259308 0.00576434 0.010876 0.00228755 0.00287584 0.0020317 0.00336749 0.00216898 0.00198505 0.00506068 0.00657073 0.00331823 0.00266198 0.00199344 0.00394134 0.00270353 0.00358239 0.012142 0.00308717 0.00769422 0.0156741 0.0959163	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.103248 0.159799 0.198829 0.113294 0.0678427 0.0236185 0.0162661 0.024197 0.00362554 0.00381358 0.00228436 0.00205486 0.00258667 0.00198683 0.00257843 0.00198412 0.00257269 0.00196155 0.00259973 0.00199268 0.00271978 0.00216408 0.00297291 0.00236426 0.00198145 0.00256283 0.00182962 0.00264391 0.00200115 0.00305593 0.00203132 0.00178554 0.00278014 0.0023586 0.0018523 0.00191676 0.00269092 0.00249051 0.00551849 0.0107108 0.00218766 0.0027245 0.00193265 0.00314347 0.00204 0.00188979 0.00473426 0.00640051 0.00315659 0.00252348 0.00186404 0.00330979 0.00192073 0.00188839 0.00345146 0.00581138 0.029841 0.0191544 0.10646	DRUG0 may interact with DRUG1 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.104747 0.157537 0.169668 0.0945624 0.0465614 0.0418536 0.0878444 0.0691438 0.00947127 0.0114623 0.00284921 0.00186549 0.00209825 0.00164034 0.00204543 0.00154964 0.00199421 0.00147887 0.00195126 0.00144346 0.00195458 0.00147581 0.00207105 0.00151665 0.00133492 0.00184641 0.00136867 0.00194776 0.00146416 0.00246822 0.00147202 0.00131554 0.00192933 0.00150614 0.00133087 0.00131312 0.00197037 0.00162026 0.00355596 0.00421622 0.00148351 0.00208736 0.00152295 0.00278837 0.0015659 0.00144866 0.00315363 0.00234979 0.00237891 0.00163066 0.00152266 0.00289582 0.00163194 0.00161822 0.00293552 0.00272028 0.0081258 0.0135456 0.0951496	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104316 0.155628 0.163957 0.0940415 0.0484105 0.0459471 0.0913742 0.0571681 0.0102575 0.0072925 0.00555936 0.00534862 0.00940668 0.00194642 0.00215241 0.00164108 0.0020375 0.00156062 0.00199843 0.00151959 0.00200267 0.0015512 0.00215271 0.00159813 0.00140095 0.00190136 0.00141553 0.00198261 0.00150907 0.00252277 0.00153261 0.00135222 0.00196404 0.0015491 0.00135181 0.00134188 0.00197659 0.00164738 0.00360668 0.00433877 0.00150045 0.00210061 0.00153287 0.00281767 0.00158035 0.00145012 0.0031764 0.00241705 0.00239134 0.0016279 0.00150366 0.00287378 0.00161503 0.00159895 0.00290739 0.00269561 0.00807934 0.0134985 0.0943712	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104244 0.155272 0.162607 0.0932721 0.0483314 0.0452982 0.0897081 0.0561537 0.00967355 0.0061093 0.00383831 0.00429396 0.0046656 0.0049359 0.009494 0.0018739 0.00213042 0.00162882 0.00204678 0.00157322 0.00204129 0.00159695 0.00219837 0.00164965 0.00144512 0.00194987 0.00145823 0.00202281 0.00155105 0.00257048 0.00158049 0.00139106 0.00200433 0.00158772 0.00139087 0.00138635 0.00201184 0.00169699 0.00368233 0.00448902 0.00154142 0.00213609 0.00156872 0.00286338 0.00162173 0.00148587 0.00324599 0.00250401 0.00243632 0.00166377 0.0015331 0.00292128 0.00165094 0.00163215 0.00295973 0.00275326 0.00823827 0.0138107 0.0965781	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104373 0.155308 0.162192 0.0929813 0.0482697 0.0449544 0.0887966 0.0550233 0.00938195 0.00579784 0.00357736 0.00398733 0.00376216 0.0034339 0.00418446 0.00470839 0.0088789 0.00181624 0.00212202 0.00162349 0.00207796 0.00163142 0.00222771 0.00168919 0.00146907 0.00197899 0.00148347 0.00204638 0.00157417 0.00259633 0.00160486 0.00140914 0.00202385 0.00160814 0.00141094 0.00140915 0.0020297 0.00172345 0.00372181 0.00457764 0.00156141 0.00215239 0.0015867 0.00288328 0.00164255 0.00150301 0.00328071 0.00255271 0.00245646 0.00168071 0.00154595 0.00293959 0.00166734 0.00164667 0.00298192 0.00277923 0.00830291 0.0139591 0.0974121	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104388 0.15521 0.161827 0.0926999 0.048132 0.0446653 0.0881288 0.0543261 0.00924954 0.00568137 0.0035042 0.00394852 0.00361525 0.003188 0.00340489 0.00325418 0.0040266 0.0045713 0.00870409 0.00178797 0.00214247 0.00167473 0.00226982 0.00174188 0.00149497 0.00200313 0.00150472 0.00205942 0.00158895 0.00261591 0.00162203 0.00141985 0.002032 0.001616 0.00142247 0.00142275 0.00203272 0.00173421 0.0037297 0.00460145 0.00156838 0.00215322 0.00159335 0.00288911 0.00165233 0.00150958 0.0032929 0.00257665 0.00246021 0.00168591 0.00154978 0.00294504 0.0016748 0.00165146 0.00298746 0.00278825 0.00832826 0.0140192 0.0976324	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104321 0.154983 0.161402 0.0923977 0.0479547 0.0443785 0.0875402 0.0539269 0.00917953 0.00561476 0.00346471 0.00392162 0.00355114 0.00318112 0.00329548 0.00302842 0.00327601 0.00307941 0.00395174 0.00455722 0.00892889 0.00182661 0.00235258 0.00185658 0.00154365 0.0020392 0.00154071 0.00207418 0.0016103 0.00263892 0.00164393 0.00143323 0.00203933 0.00162172 0.00143351 0.00143584 0.00203032 0.00174139 0.00372496 0.00460308 0.00157105 0.00214701 0.00159625 0.00288792 0.00165887 0.00151261 0.00329606 0.00259407 0.00245622 0.00168627 0.00154951 0.00294307 0.00167843 0.00165178 0.00298427 0.0027896 0.00833197 0.0140392 0.0975013	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103543 0.154747 0.161667 0.0920532 0.0476276 0.0438813 0.0856449 0.0474352 0.00830077 0.00527555 0.00321209 0.00357029 0.00335191 0.00292572 0.0031288 0.0028303 0.00310306 0.00275341 0.00321659 0.00297024 0.00408977 0.00488463 0.0109578 0.00239318 0.0016173 0.00216611 0.00157213 0.0022539 0.00163207 0.00272611 0.00157052 0.00140277 0.00210114 0.00168822 0.00138995 0.00138083 0.00211691 0.00172765 0.00395726 0.00494976 0.0015909 0.00227396 0.00160284 0.00296226 0.00161278 0.00151025 0.00336314 0.00256112 0.00259767 0.00172049 0.00158582 0.00301105 0.00165618 0.00166851 0.00309529 0.00285072 0.00859401 0.0145456 0.103381	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104304 0.154886 0.160865 0.09179 0.0474785 0.0435708 0.0858329 0.0518499 0.00885155 0.00543561 0.00334856 0.00378286 0.00341334 0.00308508 0.00315465 0.00295994 0.00308556 0.0028438 0.00310612 0.00286598 0.00329944 0.00337828 0.00433752 0.00544428 0.00446953 0.00758752 0.00172259 0.0020579 0.00163047 0.00267385 0.0017173 0.00146549 0.00203421 0.00164941 0.0014797 0.00148125 0.00203411 0.00177934 0.00372646 0.00468873 0.00158937 0.00213467 0.00161723 0.00289053 0.00169295 0.0015343 0.00332202 0.00266418 0.0024572 0.00170408 0.00156069 0.00294915 0.0017052 0.0016678 0.00298923 0.00281247 0.00835146 0.0141142 0.0970747	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104121 0.154556 0.160388 0.0915322 0.0473967 0.0435206 0.0857437 0.0517177 0.00881626 0.00541516 0.003319 0.00374338 0.00339535 0.00304912 0.00313493 0.00292983 0.0030672 0.00283751 0.00309746 0.00293403 0.00329682 0.00337745 0.00378553 0.00384167 0.00351091 0.00406029 0.00438565 0.00921852 0.00178226 0.00275854 0.00185584 0.00155132 0.00207742 0.00167347 0.00150892 0.00151383 0.00200378 0.00176144 0.00363212 0.00449841 0.00156703 0.00209304 0.00159197 0.00285516 0.00167794 0.00151751 0.00327661 0.00263926 0.00241847 0.0016788 0.00154131 0.00292316 0.00168959 0.00164615 0.00294963 0.00277409 0.00829 0.0139495 0.0961113	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104878 0.156293 0.162037 0.0920924 0.0475066 0.0435512 0.0852583 0.0481846 0.0083815 0.00528068 0.00318675 0.00355532 0.00332903 0.00291614 0.00308978 0.00281139 0.00303412 0.00273395 0.00307052 0.00282479 0.00324935 0.00319528 0.00358717 0.00316441 0.00285477 0.00308608 0.00237091 0.0035572 0.00423853 0.00866651 0.00223633 0.00166462 0.00214978 0.00173406 0.0015443 0.00153922 0.0020156 0.00175422 0.00356816 0.00435187 0.00154256 0.00207442 0.00157948 0.00283091 0.00165975 0.00151085 0.0032617 0.0025866 0.00241929 0.00168529 0.00156243 0.00295292 0.00170897 0.00166909 0.00299837 0.00281647 0.00841291 0.0141773 0.0980069	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103749 0.155025 0.161005 0.0912923 0.0471187 0.0430653 0.083869 0.0454664 0.00795895 0.00508877 0.00306731 0.00337178 0.00320804 0.00276841 0.00298057 0.00266592 0.0029278 0.00259096 0.00296253 0.00267112 0.00313697 0.00301044 0.00345034 0.0030281 0.00281072 0.00304879 0.00227619 0.00315265 0.00258048 0.00431483 0.00354996 0.0039956 0.0103308 0.00225916 0.00161556 0.00151293 0.00205211 0.00173165 0.00369069 0.0046697 0.00155222 0.00221933 0.0015961 0.00293997 0.00160324 0.00150058 0.00335111 0.00252304 0.00256728 0.00169664 0.00158093 0.00301147 0.00165096 0.00165845 0.00309431 0.00284537 0.00862419 0.0145305 0.102383	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.10393 0.15509 0.16046 0.0910599 0.0472266 0.0433936 0.0845706 0.0476811 0.00822821 0.00519414 0.00312432 0.00346547 0.00327744 0.00284506 0.00303876 0.00273381 0.00297693 0.00264618 0.00300109 0.00270911 0.00315582 0.00302525 0.00343879 0.00299096 0.00278888 0.00300953 0.00224656 0.00299986 0.00242765 0.00356431 0.00247884 0.00232861 0.00376784 0.00366651 0.00324324 0.00486516 0.00895929 0.00192367 0.00342272 0.00440698 0.00159544 0.00206582 0.00161752 0.00290012 0.00174794 0.00155989 0.00334697 0.00279411 0.00246277 0.00171527 0.00156223 0.00296986 0.00172586 0.0016651 0.00297633 0.00281376 0.00845191 0.0142106 0.096456	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101019 0.150295 0.156053 0.0888297 0.0461089 0.0422421 0.0829309 0.0498403 0.00842041 0.00514688 0.00318534 0.00354292 0.00321562 0.00286851 0.00295926 0.00274359 0.00288427 0.00264548 0.00290013 0.00271845 0.00305875 0.00307909 0.0033868 0.00324111 0.00287588 0.00289299 0.00219289 0.00283938 0.00232984 0.00328104 0.00234971 0.00219599 0.00324392 0.00288036 0.00226615 0.00271281 0.0033268 0.00488369 0.0171211 0.00445254 0.0016704 0.00231927 0.00169679 0.00313058 0.00172436 0.00157406 0.00351073 0.0027994 0.00269399 0.00177238 0.00162494 0.00310181 0.00169403 0.00168943 0.00312618 0.00290987 0.00872774 0.0148957 0.104178	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101366 0.150858 0.155753 0.0881953 0.0453428 0.0412526 0.0804839 0.0458225 0.00795837 0.00501448 0.00303047 0.00337644 0.00314782 0.00277873 0.00291585 0.00267112 0.00285434 0.00258796 0.00287513 0.00265378 0.00301696 0.00294465 0.00325704 0.00291604 0.00273329 0.00284654 0.00216238 0.00282755 0.00231905 0.00326191 0.00225142 0.002131 0.00301385 0.00256933 0.00214826 0.0025091 0.00284392 0.00304312 0.00678641 0.0247442 0.00561917 0.0103543 0.00215496 0.00314595 0.00217556 0.00184642 0.00360329 0.00326525 0.0025304 0.00181579 0.0016206 0.00299792 0.00180637 0.0017066 0.00298232 0.0028533 0.0084072 0.0143478 0.0955024	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103113 0.15403 0.159066 0.0898346 0.0460963 0.0419601 0.0814395 0.0436845 0.00770924 0.00495511 0.00295886 0.00325244 0.00312597 0.00269144 0.00290676 0.00259184 0.00285295 0.00251584 0.00287806 0.00257583 0.00302146 0.00285474 0.00325366 0.00279448 0.00263596 0.00286243 0.00214687 0.00285852 0.00231103 0.00328374 0.00224371 0.00210461 0.0030276 0.00254174 0.00211885 0.00243881 0.00291954 0.00293143 0.00619963 0.0132535 0.0026656 0.00359562 0.00400794 0.00953692 0.00247184 0.0019308 0.00366108 0.00325888 0.00254961 0.00187925 0.00166965 0.00308517 0.00186681 0.00175234 0.00308298 0.00293676 0.00869508 0.0148231 0.0984891	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101203 0.150956 0.155795 0.0881054 0.0453709 0.0413105 0.0805295 0.0458385 0.00793295 0.00499445 0.00301501 0.0033393 0.00314272 0.00274647 0.00291461 0.0026404 0.00285581 0.00255794 0.00287847 0.00261929 0.00302043 0.00291299 0.00326655 0.00287843 0.00269422 0.00285648 0.00215164 0.00284377 0.00231312 0.0032776 0.00226203 0.00211256 0.00303427 0.00257143 0.00213666 0.00250568 0.00296912 0.00300506 0.00625216 0.0127093 0.00249083 0.00305271 0.00218386 0.00401445 0.0029806 0.00365769 0.00939301 0.00330404 0.00268531 0.00202234 0.00171906 0.00322482 0.00182837 0.00176192 0.00320553 0.0029786 0.00911208 0.0152831 0.106583	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.100485 0.151283 0.156763 0.0880387 0.0451543 0.0411681 0.0787695 0.0380435 0.0068496 0.00461545 0.0027171 0.00289015 0.00293741 0.00242661 0.00274943 0.00234241 0.00270892 0.00227857 0.00273623 0.00232036 0.00286969 0.00253663 0.00306306 0.00247743 0.00232715 0.00273219 0.0019936 0.00274153 0.00212967 0.00310947 0.00207768 0.00189708 0.00281583 0.00231494 0.00187131 0.00204526 0.00275968 0.00259434 0.00570218 0.0101347 0.00226201 0.00291896 0.00208632 0.00359897 0.00232647 0.00234817 0.00727085 0.0167206 0.0135352 0.00328869 0.00205199 0.00335557 0.00198737 0.00189957 0.00330196 0.00313478 0.00908525 0.015514 0.105843	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102522 0.153542 0.158608 0.0894451 0.0459255 0.0419356 0.0810438 0.04229 0.00747947 0.00484629 0.00287687 0.00314027 0.00306898 0.00260649 0.00285807 0.00251041 0.00280652 0.00243608 0.00283018 0.00248684 0.00296705 0.00274566 0.0031863 0.00266672 0.00252159 0.00280845 0.00208757 0.00281021 0.0022448 0.00321691 0.00218214 0.00202285 0.00294485 0.00244791 0.00201557 0.00226522 0.00288502 0.00280696 0.00598312 0.0112632 0.00239138 0.00293212 0.00210896 0.0034634 0.0022492 0.00212276 0.00570992 0.00781713 0.00412016 0.0036245 0.00366505 0.0094124 0.0027143 0.00220244 0.00336546 0.00318652 0.00861839 0.0153672 0.0955976	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102702 0.153506 0.158421 0.0894674 0.0460203 0.0420321 0.0814807 0.0443964 0.00771156 0.00491996 0.00294069 0.00323671 0.00310617 0.00267356 0.00288388 0.00256984 0.00282518 0.00248768 0.00284378 0.00253819 0.00297706 0.00279965 0.00319287 0.00272338 0.00257528 0.00280761 0.00209698 0.00279994 0.00225034 0.00320588 0.00218506 0.00203061 0.00292891 0.00246396 0.0020316 0.00232972 0.00286599 0.00283467 0.00591477 0.011338 0.002364 0.00288109 0.00208529 0.00334653 0.00219143 0.00205265 0.00520916 0.00720074 0.00332169 0.0026405 0.00201028 0.00395945 0.00270244 0.00355755 0.0120892 0.00309069 0.00765853 0.0155576 0.0929661	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.100098 0.149442 0.154193 0.0871216 0.0447614 0.040794 0.0791606 0.0431355 0.00748924 0.00474592 0.00284513 0.00313288 0.00298535 0.00257841 0.00276672 0.00247447 0.00270722 0.00239333 0.00272354 0.00244377 0.00285349 0.00270249 0.00306467 0.00263572 0.00248356 0.00268016 0.00201017 0.00266846 0.002153 0.00304678 0.00208967 0.0019443 0.00279241 0.00235675 0.00193699 0.00223897 0.00272499 0.00272743 0.00567527 0.0111998 0.00226301 0.00272839 0.0019838 0.00312795 0.00206662 0.00195293 0.00487233 0.00703766 0.00315711 0.00249566 0.00187453 0.00330764 0.00193045 0.00189292 0.00345695 0.0057711 0.0294518 0.0190542 0.101598	DRUG0 may interact with DRUG0 ( DRUG1 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.120068 0.172356 0.158634 0.059118 0.0228524 0.0137333 0.0262154 0.0358683 0.012596 0.0371576 0.00908907 0.00793217 0.0128373 0.00276718 0.00314734 0.00244889 0.00301588 0.00232889 0.00297125 0.00227179 0.0029926 0.00233214 0.00323444 0.00238176 0.00211601 0.00287239 0.00213219 0.00298259 0.00228014 0.0037813 0.00231394 0.00204468 0.00297252 0.00232206 0.00203342 0.00203501 0.00298139 0.00248545 0.00540314 0.00645664 0.00227441 0.00321566 0.00234124 0.00427557 0.00240946 0.00221872 0.00485217 0.00367508 0.00367845 0.00250971 0.00233204 0.00442536 0.00248793 0.00246611 0.00450397 0.0041682 0.0124975 0.0211175 0.148989	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.120392 0.178507 0.162445 0.0607313 0.0225365 0.0138543 0.025359 0.0339724 0.0115087 0.0337151 0.00654896 0.00698997 0.00633227 0.00654976 0.0127776 0.00254892 0.00292371 0.00228122 0.00282944 0.00221038 0.00284562 0.00225691 0.00307904 0.00231174 0.00205847 0.00276731 0.00207628 0.00285916 0.00221666 0.00360027 0.00225861 0.00199404 0.00286371 0.00225536 0.00198365 0.00200133 0.00287649 0.00244003 0.00522299 0.00637828 0.00222408 0.00310307 0.00227979 0.0041021 0.0023541 0.00216775 0.00471718 0.00365024 0.00356583 0.00244618 0.00226589 0.00426538 0.00242141 0.00239933 0.00436629 0.00406127 0.0121198 0.0206581 0.145472	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.119795 0.177539 0.161132 0.0603296 0.0225523 0.0139233 0.0254996 0.0337964 0.011354 0.0330022 0.00630269 0.00682389 0.00554203 0.00542639 0.00555048 0.00614905 0.0118551 0.00249003 0.00289441 0.00225616 0.00284565 0.00227976 0.00307303 0.00234377 0.00206973 0.0027728 0.00209168 0.00285675 0.00222943 0.00359064 0.00227594 0.00200398 0.00286092 0.00226563 0.00199732 0.00202166 0.00287774 0.0024635 0.00523005 0.00646388 0.00223704 0.00309807 0.00228936 0.00408928 0.00237029 0.00217941 0.00473324 0.00370771 0.00356712 0.00245647 0.00226959 0.0042564 0.00243185 0.00240662 0.00436965 0.00407623 0.0121316 0.0207722 0.14573	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.119181 0.176223 0.159616 0.0597462 0.0224996 0.0139176 0.0255505 0.0337453 0.0112806 0.0327565 0.00625139 0.00681194 0.00542775 0.0054625 0.00487741 0.00499498 0.00533154 0.00590367 0.0115783 0.00246037 0.00291781 0.00232116 0.00309577 0.00240554 0.0020924 0.00278934 0.0021115 0.00286067 0.00224249 0.00360317 0.00229447 0.00201384 0.00286156 0.00227215 0.00200956 0.00203778 0.00287517 0.00247562 0.00522763 0.00648962 0.00224263 0.00308958 0.00229419 0.00408548 0.00238103 0.00218509 0.00474146 0.00374106 0.00356317 0.00245976 0.00227013 0.00425394 0.00243954 0.00240967 0.00436917 0.00408311 0.012146 0.0208347 0.145797	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.118616 0.175149 0.15847 0.0592591 0.022387 0.0138595 0.025447 0.0335194 0.0111722 0.0324333 0.00618222 0.00674563 0.00533995 0.00551886 0.00479618 0.00503466 0.00465358 0.00461081 0.00520883 0.0058601 0.0118618 0.00251396 0.00319073 0.00255528 0.0021437 0.00282242 0.00215226 0.00287097 0.0022662 0.00362607 0.00232061 0.00202871 0.00286517 0.00227899 0.002023 0.00205459 0.00286908 0.00248504 0.00521568 0.00649302 0.00224451 0.00307532 0.00229596 0.00407758 0.0023889 0.00218733 0.00474129 0.00376708 0.00355186 0.00245796 0.00226652 0.00424559 0.0024433 0.00240788 0.00435978 0.00408165 0.012139 0.0208509 0.145517	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.116547 0.171765 0.155295 0.0579241 0.021963 0.0134286 0.0246975 0.0320326 0.0105817 0.030715 0.00568949 0.00624907 0.00505569 0.00514869 0.00457625 0.00482741 0.00447842 0.00447563 0.00450679 0.00433531 0.00534694 0.00624219 0.0141898 0.00323307 0.00225573 0.00300289 0.00219279 0.00311138 0.00229726 0.00375123 0.00222049 0.00198628 0.00295698 0.00237035 0.00197408 0.00198621 0.0029992 0.00248005 0.00558195 0.00707675 0.00228851 0.00326458 0.00231876 0.00420807 0.00234099 0.00219685 0.0048572 0.00373172 0.00376384 0.00251785 0.00232665 0.00435774 0.00242347 0.00243846 0.00451315 0.00417131 0.0125124 0.0214989 0.152722	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.11735 0.172789 0.155922 0.0580947 0.0221168 0.0136802 0.0251414 0.032786 0.010813 0.0313868 0.00594185 0.00645714 0.00508559 0.00530924 0.00456813 0.00498285 0.00444609 0.00471184 0.00443572 0.00463299 0.00462622 0.00511363 0.00571844 0.00754951 0.00593979 0.00989914 0.00237776 0.00280691 0.00225246 0.00363291 0.00240128 0.00205141 0.00282026 0.00231123 0.00208598 0.00211933 0.00286216 0.0025394 0.00519401 0.00662599 0.00226913 0.00303847 0.00232407 0.00407361 0.00244456 0.00221911 0.00477293 0.00388224 0.00353765 0.00248373 0.00227853 0.00424888 0.00248964 0.00243188 0.00435578 0.00411283 0.0121432 0.0209239 0.14439	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.116858 0.171901 0.154825 0.0576005 0.0220055 0.0135917 0.02507 0.0326219 0.0107713 0.0311518 0.00586078 0.00638553 0.00504912 0.00524135 0.00453045 0.00492432 0.00440933 0.00469918 0.00441885 0.00478075 0.00463625 0.00533269 0.00510874 0.0059833 0.00557639 0.00556378 0.00587783 0.0122691 0.00248597 0.0037865 0.00256618 0.00214987 0.00287853 0.00234008 0.00210979 0.00214409 0.00282688 0.00250749 0.00509073 0.00637771 0.00223398 0.0029866 0.00228395 0.00402918 0.0024103 0.00218583 0.00469969 0.00382618 0.00347971 0.00243722 0.00224231 0.00420345 0.00245291 0.00238989 0.00428653 0.00404131 0.0120215 0.0206221 0.142859	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.117366 0.172039 0.15421 0.0572015 0.0220901 0.013527 0.025155 0.0322609 0.0106383 0.0305348 0.00561302 0.00616945 0.00498431 0.00506783 0.00449073 0.00475731 0.00437894 0.00454362 0.0043978 0.00463717 0.00460353 0.00513518 0.00487925 0.00507468 0.00480001 0.00439142 0.00333954 0.00482498 0.00564944 0.0114715 0.00315696 0.0023373 0.00301787 0.00245136 0.002168 0.0021891 0.0028619 0.00251439 0.0050574 0.00627753 0.00222175 0.00298678 0.00228541 0.00403643 0.00240605 0.00219328 0.00472463 0.00378757 0.00351007 0.00246311 0.0022834 0.00427392 0.00249352 0.00243419 0.00437502 0.0041204 0.0122553 0.0210191 0.145866	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.115404 0.169365 0.15193 0.056253 0.0216859 0.0132224 0.0245212 0.0312621 0.0102481 0.0294114 0.00537204 0.00588028 0.00478264 0.00481295 0.00431293 0.00450513 0.00420392 0.00429221 0.00422208 0.00437655 0.00442561 0.00483169 0.00467406 0.00490549 0.00482903 0.00439362 0.00333079 0.00440572 0.003606 0.00563523 0.00486309 0.00554874 0.0139254 0.00316873 0.002302 0.00214929 0.00289785 0.00247097 0.00518646 0.00668744 0.00222359 0.00316447 0.00229561 0.00415968 0.00232084 0.00217061 0.00481349 0.00368397 0.00370155 0.00247547 0.00230395 0.00433838 0.00240831 0.00241175 0.00447819 0.00414062 0.0124818 0.0213767 0.15075	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.116061 0.170644 0.152002 0.0561146 0.0216434 0.0131979 0.0246482 0.0315799 0.0104662 0.0297458 0.00545596 0.00601589 0.0048842 0.00494046 0.00440013 0.00462337 0.00428205 0.00439469 0.00428835 0.00445696 0.00447128 0.00487374 0.00466497 0.0048718 0.00483223 0.00436562 0.00332081 0.00425548 0.0034581 0.00472006 0.00338169 0.00356594 0.00523088 0.00518814 0.0045491 0.00666904 0.0120663 0.0027439 0.00485671 0.00626888 0.00226284 0.00294248 0.00231787 0.00410286 0.00250609 0.00224438 0.00480428 0.0040694 0.00354686 0.00248843 0.00226771 0.00427092 0.00250399 0.00241416 0.00431793 0.00409306 0.0122282 0.0209537 0.143464	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111686 0.165224 0.149035 0.0552794 0.0208 0.0127562 0.0233523 0.0302235 0.010015 0.0290646 0.00550643 0.00597199 0.00468971 0.00488215 0.0041969 0.00456764 0.00407163 0.00434205 0.00406688 0.00441061 0.00424784 0.00487133 0.00452301 0.00527057 0.00495799 0.00413189 0.00322764 0.0039592 0.00327608 0.00428256 0.00324652 0.00346794 0.00453226 0.00416001 0.00325477 0.00455662 0.0046851 0.00714853 0.0242837 0.00621381 0.00232845 0.00322606 0.00237605 0.00431986 0.00242902 0.00222155 0.00492441 0.00399443 0.0038142 0.00253737 0.00232365 0.00438752 0.00242358 0.00241309 0.00444779 0.00415905 0.0124306 0.02156 0.151243	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.11044 0.161957 0.144588 0.0533524 0.020615 0.012621 0.023453 0.0298606 0.0097625 0.0280721 0.00518266 0.0056393 0.00452062 0.00463079 0.0040641 0.00432436 0.00394792 0.00410962 0.0039457 0.00416569 0.00409911 0.00450364 0.00423109 0.00457468 0.00450201 0.00395971 0.00310855 0.00384384 0.00318388 0.00411551 0.00301109 0.00318833 0.00404463 0.00360339 0.00302287 0.00433377 0.00418059 0.0052453 0.010638 0.0367444 0.0075906 0.0137274 0.0030066 0.0043899 0.00304048 0.00258457 0.00506319 0.0046412 0.00357149 0.00258639 0.00230788 0.00423012 0.00258182 0.00243837 0.00426149 0.00409517 0.0119784 0.0208267 0.139692	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112947 0.165336 0.147052 0.0541747 0.0210252 0.0127798 0.0238572 0.0300441 0.00985131 0.0280542 0.00508006 0.00557427 0.00457061 0.00456638 0.00412478 0.00426499 0.00401423 0.00405196 0.0040196 0.00410771 0.00418111 0.00445398 0.0043034 0.00440399 0.00440508 0.00404244 0.00310383 0.00395038 0.00321586 0.00422663 0.00302767 0.00318055 0.00414593 0.00357537 0.00302399 0.00429818 0.004315 0.00496808 0.0094949 0.0207963 0.00380943 0.00521289 0.00568234 0.0132564 0.00355678 0.00275125 0.00521192 0.00466987 0.00362982 0.00269179 0.00238727 0.0043855 0.00267576 0.00250913 0.0044136 0.0042193 0.0124438 0.0215427 0.144342	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.11043 0.162114 0.144385 0.0532944 0.0205853 0.0125597 0.0234315 0.0297151 0.00978904 0.0277915 0.00513342 0.00562611 0.00455728 0.00461791 0.00410329 0.00431695 0.0039899 0.00410357 0.00399193 0.00415975 0.00414963 0.004518 0.00429034 0.00455189 0.00449982 0.0040114 0.00310169 0.00390442 0.00319725 0.00419029 0.00302157 0.00318679 0.00412532 0.00359915 0.00302444 0.00438753 0.00434764 0.00507043 0.00945447 0.0200308 0.00356524 0.00444395 0.00313509 0.00552592 0.00424991 0.00528869 0.0131353 0.00480506 0.00386706 0.00290596 0.00245408 0.00455725 0.00260954 0.00250773 0.00453856 0.00423618 0.0129341 0.0219776 0.153904	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.109351 0.160397 0.14194 0.0518756 0.0202003 0.0121109 0.0227439 0.028221 0.00924832 0.0259602 0.00459151 0.00502778 0.00426941 0.00409129 0.00387747 0.00381994 0.00378053 0.00362019 0.00379094 0.00365534 0.00394285 0.00392726 0.00401429 0.00376795 0.00383269 0.00381242 0.00282238 0.00375083 0.00292764 0.00396582 0.00276354 0.00276181 0.00381143 0.00311548 0.00262824 0.00349504 0.00396606 0.00400824 0.00826831 0.0152293 0.0032274 0.00423996 0.00299723 0.00491922 0.00328325 0.00342085 0.00974339 0.0236782 0.0188243 0.00466576 0.00292142 0.00472986 0.00283227 0.00270475 0.0046921 0.0044885 0.0129677 0.022401 0.153879	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112104 0.164264 0.145634 0.0535634 0.0207851 0.0125882 0.0235629 0.0295837 0.00972687 0.0273942 0.00490281 0.00541018 0.00449564 0.00442617 0.0040643 0.00413433 0.00395622 0.00392361 0.00396158 0.00397001 0.00411726 0.00429863 0.00422165 0.00415998 0.00421275 0.003968 0.00299948 0.00388859 0.0031155 0.00415151 0.00291193 0.00301559 0.00402285 0.00336267 0.00284168 0.00394501 0.00419129 0.00451521 0.00887557 0.0174523 0.00344218 0.00432539 0.00308082 0.00484818 0.00320023 0.00315828 0.00787404 0.012378 0.00614342 0.00547386 0.00547491 0.0134262 0.00393238 0.00316856 0.00483234 0.00456211 0.0122189 0.022094 0.139648	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112591 0.165452 0.146788 0.0539926 0.0208829 0.0126888 0.0237225 0.0300416 0.00986936 0.0278025 0.00500763 0.00551128 0.00453235 0.00451705 0.00408622 0.00421656 0.003971 0.00399903 0.00396926 0.00404262 0.0041196 0.00436666 0.00422162 0.00425997 0.00429489 0.00396161 0.00301708 0.00386902 0.0031191 0.00412712 0.00290948 0.00303169 0.00399154 0.00339391 0.00285943 0.00404938 0.00415999 0.00462378 0.00882112 0.0177036 0.00340142 0.00425672 0.00304824 0.0046989 0.00311225 0.00305144 0.00721541 0.0115204 0.00498333 0.0039233 0.00297242 0.00574351 0.00392637 0.00507233 0.0171112 0.00441966 0.0108764 0.0221616 0.13592	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.108275 0.159091 0.141484 0.0521195 0.0200787 0.0122087 0.0227167 0.0286826 0.00938951 0.0265234 0.00477469 0.00524741 0.00429463 0.00428792 0.00386423 0.00399652 0.00375114 0.00378758 0.00374736 0.00383156 0.00389259 0.00414902 0.00399492 0.00406374 0.00407535 0.00372583 0.00284971 0.00363252 0.00293925 0.00386372 0.00275295 0.00286379 0.003753 0.00320201 0.00269486 0.00383909 0.00391112 0.00443941 0.00842405 0.0174299 0.00321728 0.00396511 0.00285636 0.00432257 0.00291067 0.00286575 0.00663376 0.0110356 0.00468922 0.00371036 0.00272234 0.0046877 0.00274751 0.00271718 0.00507483 0.0081537 0.0419034 0.0268753 0.146264	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.111614 0.163305 0.143713 0.0495106 0.0193144 0.0104053 0.0194691 0.0165151 0.00455956 0.00829536 0.00702703 0.00866814 0.0457593 0.00906306 0.00618883 0.00669246 0.00532452 0.00640838 0.00515992 0.00638744 0.00525577 0.00681492 0.00548851 0.00725484 0.00755172 0.00550142 0.00505291 0.00520925 0.00474284 0.00623491 0.0057635 0.00659507 0.0140848 0.00326165 0.00237044 0.00219766 0.00293266 0.0025411 0.00524515 0.00691558 0.00225263 0.00315817 0.00231245 0.00411579 0.00234766 0.00219003 0.00482551 0.00377596 0.00370739 0.00250007 0.0023076 0.00430365 0.00241747 0.00241722 0.00446095 0.00414838 0.0124326 0.0214461 0.150485	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111473 0.163293 0.143089 0.0493532 0.0192041 0.0103359 0.0194335 0.0163971 0.00457076 0.00837194 0.00711423 0.00888511 0.0467699 0.00924193 0.00626766 0.00681149 0.00539339 0.00649725 0.00521398 0.00642657 0.00527352 0.00675126 0.00541119 0.00724424 0.00748376 0.00543207 0.00506192 0.00507567 0.00468431 0.00524002 0.00411236 0.00525612 0.00596545 0.00650244 0.0052234 0.0076393 0.0119739 0.00281731 0.00496709 0.00650165 0.00228067 0.00293573 0.00233659 0.00405093 0.00252142 0.00225922 0.00483249 0.0041811 0.00355141 0.00249866 0.00225965 0.00422439 0.00249802 0.0024081 0.00429751 0.00409087 0.0121257 0.0209604 0.142928	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106872 0.157306 0.139358 0.0482823 0.0184314 0.00999948 0.0185239 0.0159778 0.00439609 0.00794652 0.006862 0.00863372 0.0452616 0.00919176 0.00605785 0.00672066 0.00515043 0.00644849 0.00496433 0.00638606 0.00503005 0.00684505 0.00530853 0.00745776 0.00752195 0.00526957 0.00514165 0.00479523 0.0045689 0.00479603 0.00413983 0.00529744 0.00523964 0.00539724 0.00380521 0.00592203 0.00522605 0.00822087 0.0258984 0.00639129 0.00234411 0.00321696 0.00237799 0.00425152 0.00243657 0.00222363 0.00490011 0.00406465 0.00379037 0.00253893 0.00230268 0.00431201 0.00240632 0.00239195 0.00438376 0.00412041 0.0122579 0.0214042 0.149233	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104617 0.152927 0.134083 0.0460261 0.017929 0.0096819 0.0181067 0.015241 0.00421824 0.00772897 0.00657058 0.00820496 0.0430954 0.00859557 0.00571323 0.00629057 0.00489577 0.00597285 0.00471483 0.00588136 0.00474283 0.00609883 0.00481699 0.00658712 0.00678838 0.00484727 0.00462495 0.00449232 0.00419189 0.00446209 0.00360778 0.00452738 0.00453957 0.00467071 0.00364917 0.00600037 0.0051482 0.0077376 0.0132273 0.0464393 0.0083207 0.0133779 0.00299062 0.00432156 0.00302062 0.00256486 0.00502652 0.0047022 0.00351881 0.00255882 0.00226418 0.00412015 0.00254158 0.00239589 0.00417688 0.00403102 0.0117025 0.0204933 0.136178	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107262 0.156642 0.13682 0.0469091 0.0183429 0.0098435 0.0185039 0.0154571 0.00429093 0.00785452 0.00661251 0.008165 0.0431192 0.00844988 0.00577722 0.00621463 0.00498417 0.00589278 0.00481342 0.00582283 0.0048607 0.00604833 0.00491477 0.00644253 0.00670336 0.00493061 0.00455206 0.00462099 0.00420897 0.0046066 0.00358684 0.00453619 0.00469008 0.00453879 0.00359407 0.00592102 0.00521157 0.00748953 0.0118316 0.0289492 0.0045256 0.00570457 0.0062389 0.0134883 0.0035704 0.00273671 0.00518 0.00470199 0.00357066 0.0026581 0.00234265 0.00427582 0.00262816 0.00245941 0.00430867 0.00413248 0.0121197 0.0210588 0.140283	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104565 0.153002 0.133854 0.0460258 0.0179119 0.00963416 0.0180958 0.0151769 0.0042157 0.00772566 0.00653867 0.00814436 0.0428702 0.00852738 0.00575674 0.0062601 0.00494983 0.00595237 0.00477726 0.00588018 0.00481965 0.00613111 0.00489838 0.00658556 0.00679072 0.00490434 0.00461076 0.00456965 0.00422173 0.00456541 0.00362501 0.00457132 0.00466746 0.00461328 0.00361456 0.00599575 0.0052727 0.00758233 0.0117231 0.0285557 0.00432421 0.00485263 0.00344604 0.0058028 0.00467528 0.0057525 0.0131294 0.00485984 0.00382057 0.0028774 0.00241342 0.00444356 0.00255978 0.00245752 0.00442201 0.00413836 0.0126051 0.0214541 0.149783	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104139 0.152033 0.132392 0.0451692 0.0178012 0.00946868 0.0178891 0.014857 0.00412015 0.0075017 0.00623781 0.00750343 0.0397978 0.00760029 0.00543264 0.00565143 0.00473396 0.00534686 0.00458504 0.00528038 0.00464503 0.00542872 0.00462718 0.00560772 0.00593639 0.00465392 0.00402133 0.0044168 0.00375947 0.00436574 0.00318613 0.00390624 0.00435186 0.00368556 0.00302913 0.00490356 0.00465032 0.00560882 0.00988148 0.0206736 0.0038086 0.00463835 0.00327184 0.00509928 0.00351781 0.00375375 0.00983695 0.0256814 0.0185084 0.00462778 0.0028791 0.00461716 0.00278648 0.00266648 0.00462177 0.00443331 0.0128247 0.0221163 0.151432	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106401 0.155467 0.135552 0.046492 0.0181798 0.00972795 0.0183141 0.0152513 0.00425044 0.00775939 0.00651048 0.00798979 0.0422235 0.00817272 0.0056798 0.00603269 0.00491832 0.00571495 0.0047538 0.00564351 0.00480304 0.00585497 0.00483585 0.00615085 0.00643748 0.00482729 0.00436103 0.0045516 0.00406338 0.00454107 0.00341208 0.00430671 0.00457045 0.00411966 0.00330592 0.00544078 0.00493742 0.00652475 0.0107268 0.0244048 0.00410807 0.00471563 0.00337729 0.00503816 0.00344919 0.00354968 0.00804043 0.0140268 0.00660512 0.00586066 0.00569797 0.0132248 0.00387348 0.00310826 0.00473317 0.00447033 0.0118828 0.0215662 0.135461	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106689 0.156202 0.136381 0.0468183 0.0182449 0.00978247 0.0183997 0.0153833 0.00427956 0.00783595 0.006606 0.0081744 0.0429897 0.00835584 0.00573471 0.00614792 0.00494679 0.00582113 0.00476996 0.00573361 0.00480327 0.00592967 0.00483321 0.0062962 0.00656151 0.00484102 0.00443758 0.00454162 0.00410039 0.00452019 0.00343509 0.00434234 0.00454583 0.00422603 0.00335028 0.00554797 0.00493152 0.0067891 0.0107677 0.025149 0.00410147 0.00465893 0.00335149 0.00490129 0.00335416 0.0034306 0.00737411 0.0130566 0.00533204 0.00418411 0.00311199 0.00588195 0.00402554 0.00506218 0.0166609 0.00432339 0.0105828 0.0215864 0.131774	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.102671 0.150379 0.131583 0.0452382 0.0175614 0.00942608 0.0176689 0.0147872 0.00410906 0.00749936 0.00631976 0.007803 0.041038 0.00797628 0.00545467 0.00584809 0.00469222 0.00553138 0.00451951 0.00545256 0.00455501 0.00566169 0.00459512 0.00598936 0.00623517 0.00457746 0.00420782 0.00428345 0.00387216 0.0042489 0.00325413 0.00410793 0.00428646 0.00397863 0.00316024 0.00526302 0.00469199 0.00660407 0.0104053 0.0248265 0.00390907 0.00434634 0.00314059 0.00451734 0.00315094 0.00324483 0.00680073 0.0124861 0.00504488 0.00401199 0.00284769 0.00477105 0.00279178 0.00276483 0.00515176 0.00819052 0.041127 0.0261798 0.14116	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.112074 0.16255 0.141942 0.0462305 0.0179377 0.00888566 0.0173383 0.0135516 0.00362914 0.00616356 0.00374606 0.00360193 0.00930577 0.0106141 0.0492573 0.00914395 0.00659472 0.00708161 0.00577193 0.00700241 0.00570716 0.00735215 0.0058469 0.00746417 0.00777403 0.00568829 0.00512851 0.00539105 0.00485301 0.00648876 0.00585982 0.00677675 0.0143443 0.00334766 0.00243522 0.00226114 0.00302643 0.00261356 0.00541143 0.00709919 0.00231449 0.00325772 0.00237889 0.00425007 0.00241185 0.00225044 0.00496921 0.00386761 0.00382146 0.0025725 0.00237679 0.00444025 0.00248756 0.00248815 0.00459982 0.00426945 0.0128156 0.0220726 0.155065	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112014 0.162717 0.14142 0.0461119 0.01782 0.00881267 0.0172693 0.0133885 0.00363122 0.0061699 0.00375031 0.00361073 0.00948777 0.0109435 0.0505115 0.00931372 0.0066702 0.0071917 0.00583429 0.00705481 0.00573247 0.00730057 0.00577549 0.0074537 0.0076982 0.00561577 0.00514242 0.00525052 0.00478522 0.00546294 0.00416501 0.00527002 0.00611415 0.00658053 0.00533286 0.00775495 0.0122114 0.00287955 0.00508371 0.00664383 0.00233752 0.00302267 0.00239907 0.00418 0.00258489 0.00231588 0.00496517 0.0042639 0.00365712 0.00256928 0.00232624 0.00435822 0.0025693 0.0024778 0.0044284 0.00420897 0.0124984 0.0215685 0.147292	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107327 0.156875 0.137785 0.0450831 0.0171009 0.00852476 0.0164474 0.0130518 0.00348211 0.00588652 0.0036056 0.00349122 0.00895245 0.0107132 0.0493085 0.00926338 0.00643759 0.00709933 0.00556603 0.00701144 0.00547515 0.00739196 0.00564751 0.00767197 0.00775938 0.00543571 0.00521573 0.00495047 0.00466071 0.00498754 0.00415543 0.00530892 0.00535407 0.00542649 0.00384043 0.00590939 0.0053002 0.00830059 0.0260597 0.00650474 0.00239932 0.00330876 0.00243971 0.0043854 0.00249326 0.00227507 0.00502799 0.00413446 0.00389966 0.00260416 0.0023655 0.00444054 0.00246795 0.00245541 0.00451297 0.00423005 0.0126142 0.0219686 0.153609	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105057 0.152235 0.132363 0.0428229 0.0165964 0.00822149 0.0160874 0.0124536 0.00334075 0.00572221 0.00345116 0.00338304 0.00876196 0.0101205 0.0466767 0.00867876 0.00609438 0.00664854 0.00530052 0.00648925 0.00517556 0.00661476 0.00515179 0.00681119 0.00703474 0.00503802 0.00473495 0.00467591 0.00432157 0.00468563 0.00366711 0.00459721 0.00468601 0.00471023 0.00366812 0.00597 0.0051657 0.00771594 0.0134112 0.0462381 0.00850812 0.0136733 0.00305953 0.00443125 0.00308215 0.00261968 0.00514253 0.0047638 0.00362192 0.00262676 0.00232944 0.00425187 0.00261159 0.00246449 0.00430502 0.00414624 0.012067 0.0210828 0.140635	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107844 0.156044 0.135192 0.0437633 0.0170235 0.008395 0.0164875 0.0126865 0.00342434 0.00583971 0.00352587 0.00339992 0.00885764 0.0100092 0.0464092 0.00853828 0.00616906 0.00657079 0.00540405 0.00642129 0.00529901 0.00656714 0.00526778 0.00666831 0.00693918 0.00512887 0.00466208 0.00481295 0.004343 0.00484155 0.0036568 0.00460472 0.00484328 0.00459946 0.00362843 0.00589856 0.00523381 0.00734738 0.0118685 0.0283456 0.00450013 0.00581015 0.00638891 0.0137176 0.00362942 0.00279531 0.00529509 0.00477619 0.00367741 0.00273088 0.00241215 0.00441546 0.00270531 0.00253369 0.00444888 0.00425938 0.0125214 0.0217197 0.145101	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105094 0.152451 0.13226 0.0429381 0.0166066 0.00820249 0.0160892 0.0124079 0.00335354 0.00571385 0.00345928 0.00334381 0.0087635 0.0100361 0.0463395 0.00860683 0.00614066 0.00661726 0.00536216 0.00647574 0.00525302 0.00664962 0.00524346 0.00680602 0.00702465 0.00509209 0.0047137 0.00475153 0.00434791 0.00479047 0.00368754 0.00463361 0.00481375 0.00466414 0.00364241 0.00596978 0.00528775 0.00743705 0.0117493 0.0277261 0.00425344 0.00492782 0.00348633 0.00594719 0.00472797 0.00585071 0.0134007 0.00493864 0.00393257 0.00295622 0.00248371 0.00458715 0.00263462 0.00253047 0.00456502 0.00426597 0.013016 0.0221373 0.154813	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104459 0.151008 0.130512 0.0421372 0.0165383 0.00810815 0.0159821 0.0122687 0.00331352 0.00561711 0.00339702 0.00319967 0.00832977 0.00909821 0.0422799 0.00766488 0.00580077 0.00595389 0.0051319 0.00581331 0.00504996 0.00588754 0.00496128 0.00579712 0.00612113 0.00484179 0.00411311 0.00460196 0.00387853 0.00458961 0.00326186 0.00395428 0.00449804 0.00377041 0.00308251 0.00489039 0.00471679 0.00548819 0.00995628 0.0202511 0.0037863 0.00473238 0.0033225 0.00526553 0.00357386 0.00378967 0.0101281 0.0260133 0.0190865 0.00476152 0.00297011 0.00476856 0.00287317 0.00275011 0.00477129 0.00457137 0.0132261 0.0227855 0.156498	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106962 0.154815 0.133902 0.0434188 0.0168828 0.00830974 0.0163283 0.012524 0.00340445 0.00577395 0.00349744 0.00333395 0.00872839 0.00976778 0.0452693 0.00825208 0.00606285 0.00636961 0.00533117 0.00621804 0.00523219 0.00635597 0.00518869 0.00636604 0.00665284 0.00502217 0.00446422 0.00474137 0.00419199 0.00477403 0.00348967 0.00436638 0.00472288 0.00420325 0.00336181 0.00544083 0.00499777 0.00639322 0.0107978 0.0238103 0.00407211 0.00481088 0.00343248 0.00520659 0.00350758 0.00356329 0.0082457 0.0139505 0.00673824 0.00598089 0.00583138 0.0136159 0.003972 0.00319703 0.00487284 0.00460019 0.0122711 0.0222252 0.140181	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107308 0.155694 0.134824 0.0437332 0.0169398 0.00834897 0.0163907 0.0125997 0.00341845 0.00580953 0.00351866 0.00337701 0.00886059 0.0100488 0.0463344 0.00844331 0.00612221 0.00649583 0.00535983 0.0063272 0.00524193 0.00644605 0.00518826 0.00652079 0.00678898 0.00503763 0.00454608 0.00473157 0.00423132 0.00475161 0.00351228 0.00440648 0.00469688 0.00430746 0.00340318 0.00555333 0.00498507 0.00665755 0.0108282 0.0244978 0.00405562 0.00475129 0.00340611 0.00506537 0.00341338 0.00344884 0.00757018 0.0129667 0.00542728 0.00426396 0.00315736 0.00601395 0.00411406 0.00520047 0.0171192 0.00443754 0.0108986 0.0221995 0.136205	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.103034 0.149567 0.129811 0.0421627 0.0162663 0.00802695 0.0157058 0.0120916 0.00327644 0.00555877 0.00336878 0.00323068 0.00842639 0.00955512 0.0441445 0.00804574 0.00581184 0.00616895 0.00507574 0.0060119 0.00496648 0.00614854 0.00492645 0.00620251 0.00645001 0.00475821 0.00430811 0.0044571 0.00399284 0.00446014 0.00332189 0.0041663 0.00442257 0.00404957 0.00320258 0.0052586 0.00472804 0.006478 0.0104495 0.0241874 0.00385651 0.00442663 0.00318917 0.00466376 0.00319612 0.00325403 0.00696513 0.0123827 0.00512759 0.00407384 0.00288771 0.00488472 0.00285016 0.00281822 0.00525185 0.00840437 0.0421927 0.0268889 0.146412	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.111699 0.16135 0.139644 0.0443794 0.0172317 0.00823379 0.0162104 0.0123473 0.00325965 0.00544686 0.00325162 0.00264937 0.00549849 0.00437608 0.0107014 0.0112971 0.0520318 0.00984128 0.00705746 0.00779633 0.00629352 0.00811722 0.00627789 0.00799996 0.00834585 0.00599349 0.00552292 0.00561853 0.00514358 0.0067304 0.00607347 0.00704712 0.0145135 0.00340642 0.00248105 0.00230186 0.00307472 0.00265927 0.00549332 0.00720564 0.00234593 0.0032969 0.00240986 0.00429855 0.00244389 0.00227948 0.00503117 0.00392306 0.0038662 0.00260515 0.00240529 0.00448972 0.00251805 0.00251815 0.00465226 0.00432005 0.0129583 0.0223346 0.1567	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111525 0.161365 0.139006 0.0442352 0.0171022 0.00815796 0.0161319 0.0121823 0.00326106 0.00545357 0.00326141 0.00264575 0.00556122 0.00439504 0.0109271 0.011676 0.0534264 0.00999272 0.00711631 0.00786264 0.00632179 0.00806515 0.00620027 0.0079922 0.00824676 0.00590529 0.00551655 0.0054597 0.00506518 0.00563321 0.00431163 0.00556406 0.00629184 0.00681024 0.00549407 0.00800585 0.0123414 0.00292094 0.00515155 0.00673709 0.00236737 0.00305607 0.00242888 0.00422237 0.00261728 0.00234479 0.00502743 0.00432574 0.0037 0.00260138 0.00235398 0.00440728 0.00260079 0.00250775 0.00448064 0.00426008 0.0126406 0.0218325 0.148906	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106872 0.155637 0.135397 0.0431867 0.0164008 0.00788558 0.0153551 0.0118712 0.00311851 0.00518064 0.00311389 0.002534 0.00523921 0.00423593 0.0102443 0.0113685 0.0520147 0.00995295 0.0068753 0.00777587 0.00605532 0.00816331 0.00607772 0.0082334 0.00832132 0.00573311 0.00560467 0.00516079 0.0049489 0.00514817 0.00432182 0.00560747 0.00550994 0.0056275 0.00396102 0.00612295 0.00542714 0.00853273 0.0264513 0.00658389 0.00242977 0.00334826 0.0024694 0.0044334 0.00252355 0.00230225 0.00508587 0.00418695 0.00394265 0.00263481 0.00239211 0.0044878 0.00249592 0.00248288 0.00456089 0.00427641 0.0127461 0.0222075 0.155142	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104357 0.150569 0.129733 0.0409164 0.0158722 0.00757558 0.0149791 0.0113055 0.00299552 0.00505301 0.00299565 0.00246266 0.00513117 0.00411765 0.0100885 0.0107507 0.0491445 0.00928846 0.00647345 0.00723768 0.00570375 0.00729798 0.00552268 0.00729163 0.00753129 0.00529385 0.0050649 0.00485702 0.00456093 0.0048246 0.00379542 0.00484212 0.00481553 0.00488641 0.00379035 0.00619269 0.00532041 0.00799572 0.0137509 0.0477293 0.00869062 0.0137976 0.00309556 0.00447728 0.00311828 0.00264964 0.00520127 0.00482535 0.00365996 0.00265582 0.00235374 0.00429458 0.00263973 0.00249033 0.00434892 0.00418955 0.0121873 0.0213011 0.141909	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107175 0.154398 0.132586 0.0418651 0.0162952 0.00774599 0.0153651 0.0115245 0.00307534 0.00516869 0.00307319 0.00250499 0.00522661 0.00412747 0.0102007 0.0106488 0.0489104 0.00913071 0.00655795 0.00716982 0.00582983 0.00724803 0.00564359 0.00712892 0.00742123 0.00538479 0.00498798 0.00499799 0.00458335 0.00498528 0.00377932 0.00485274 0.00497923 0.00477038 0.0037471 0.00612391 0.00539079 0.00765654 0.0122106 0.029391 0.004631 0.00592137 0.00653472 0.0138995 0.00367562 0.00282838 0.00535531 0.00483468 0.00371621 0.00276074 0.00243736 0.00446017 0.0027337 0.00255966 0.00449298 0.00430209 0.0126435 0.021933 0.146418	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104408 0.150819 0.129674 0.0410592 0.0158886 0.00756483 0.0149864 0.0112638 0.00300863 0.00504905 0.0030098 0.0024487 0.00513272 0.00406311 0.0100856 0.0106721 0.0488151 0.00920848 0.0065283 0.00721327 0.00578293 0.00733102 0.00561865 0.00727644 0.00750768 0.00534428 0.00503913 0.00493191 0.00458766 0.00493028 0.00381304 0.00487964 0.00494569 0.00483865 0.0037617 0.00619265 0.00544653 0.00774159 0.0120803 0.0287844 0.00438851 0.00502262 0.00355998 0.00605327 0.00482186 0.00597084 0.0135599 0.0050021 0.0039735 0.00298835 0.00250946 0.00463311 0.00266165 0.00255575 0.00460869 0.00430695 0.0131386 0.0223457 0.156166	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103792 0.149367 0.128011 0.0403498 0.0158402 0.00749212 0.0149007 0.0111468 0.00297859 0.00497902 0.00296746 0.00240115 0.00497705 0.00386051 0.00957678 0.00967074 0.0445495 0.0081628 0.00616017 0.00649174 0.00553682 0.00650966 0.00530898 0.00618721 0.00653593 0.00507693 0.00440009 0.00477585 0.00408741 0.00472484 0.00336024 0.00417588 0.00462654 0.00389186 0.00317425 0.00509504 0.0048468 0.00571337 0.0102179 0.0209704 0.00389517 0.00482186 0.00338954 0.00535205 0.00363497 0.00386202 0.0102838 0.0265233 0.0192921 0.00481341 0.00299971 0.00481531 0.00290243 0.00277767 0.00481871 0.00461671 0.0133594 0.0230102 0.157941	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106272 0.153138 0.131303 0.0415458 0.0161618 0.00766991 0.0152178 0.011374 0.00305866 0.00511586 0.00305407 0.00247356 0.00516733 0.0040392 0.010048 0.0103972 0.0477168 0.00880627 0.00644042 0.00694167 0.00574959 0.00701706 0.00555789 0.00680113 0.00710744 0.00526876 0.00477506 0.00492182 0.00442278 0.00491504 0.00360137 0.00460481 0.00485683 0.00435353 0.00346681 0.0056557 0.0051387 0.00666051 0.0110918 0.0247032 0.00419581 0.00490143 0.00350387 0.00529363 0.00357096 0.00364128 0.00838184 0.0142479 0.00684519 0.00607243 0.00591502 0.0137657 0.00401348 0.00322954 0.0049208 0.00464586 0.012388 0.0224354 0.14142	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.10661 0.154013 0.132193 0.0418304 0.016211 0.00770197 0.015272 0.0114382 0.00306989 0.00514239 0.00306875 0.00248952 0.00521932 0.00409939 0.0102032 0.0106974 0.0488436 0.00901146 0.00649854 0.0070655 0.00576929 0.00711809 0.00556171 0.00697509 0.00725911 0.00528852 0.00486381 0.00491347 0.00446644 0.00489295 0.00362877 0.00464658 0.00483123 0.0044675 0.00351231 0.00576897 0.00512907 0.0069385 0.01113 0.0254358 0.00418323 0.0048422 0.00347778 0.00515099 0.00347516 0.00352401 0.00769354 0.0132356 0.00551014 0.0043275 0.00320178 0.00609591 0.00416746 0.00526343 0.0172976 0.00448067 0.0109994 0.0224086 0.137389	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.10231 0.147874 0.127204 0.0402917 0.0155546 0.00739835 0.0146247 0.0109723 0.00294132 0.00492008 0.00293804 0.00238309 0.00497531 0.00391531 0.00968858 0.0101578 0.046486 0.00858513 0.00616867 0.00671722 0.00547107 0.00679217 0.00528472 0.00663613 0.00689986 0.00499885 0.00461222 0.00463173 0.00421731 0.00459599 0.00343371 0.00439557 0.00455105 0.00419875 0.00330565 0.00546343 0.00486931 0.0067525 0.0107464 0.0251154 0.00398069 0.00451192 0.00325629 0.00474364 0.00325462 0.00332616 0.00707927 0.0126411 0.00520666 0.00413605 0.00292815 0.00495055 0.00288582 0.00285164 0.00531233 0.00850246 0.0425962 0.0271331 0.147626	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.111589 0.160956 0.138458 0.0435379 0.0169425 0.00797707 0.0157236 0.0118726 0.00308425 0.00504968 0.00299826 0.00233438 0.00443286 0.00305241 0.00619726 0.00473098 0.011243 0.0117626 0.0546863 0.0106658 0.00762619 0.00890289 0.00688177 0.00864881 0.00893239 0.00631768 0.00596427 0.0058418 0.00544266 0.00695528 0.00626907 0.00727002 0.0146017 0.00344739 0.00251498 0.00233091 0.00310381 0.0026888 0.00553206 0.00724948 0.00236014 0.00331062 0.00242322 0.00431355 0.00245849 0.00229211 0.00505365 0.00394865 0.00388027 0.00261817 0.00241644 0.00450534 0.0025305 0.00253004 0.00466967 0.00433927 0.0129998 0.0224285 0.157105	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111315 0.16085 0.137716 0.0433674 0.0168019 0.00789685 0.0156349 0.0117044 0.00308119 0.00504915 0.00300581 0.00232672 0.00446253 0.00304594 0.00626952 0.00475349 0.0114886 0.0121614 0.0561863 0.0107586 0.00763291 0.00887238 0.00679811 0.00863698 0.00880824 0.00621806 0.00594046 0.00566485 0.00535795 0.0057847 0.00444186 0.00584586 0.00643317 0.00698386 0.00561402 0.00818313 0.0123863 0.00294422 0.00518222 0.00677579 0.00238122 0.00306692 0.00244181 0.00423258 0.00263223 0.00235782 0.00505195 0.00435719 0.00371432 0.00261487 0.00236538 0.00442393 0.00261464 0.00252046 0.00450078 0.00428171 0.0126899 0.0219438 0.149427	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106765 0.155317 0.134196 0.0423078 0.0161072 0.00763125 0.0148728 0.0114055 0.00294208 0.00478116 0.00285943 0.00221741 0.00418698 0.00291016 0.00586373 0.00455577 0.0106841 0.0117584 0.0543802 0.0107276 0.00742086 0.00891787 0.00667529 0.00893433 0.00892528 0.0060506 0.00603948 0.00536971 0.00525158 0.00529433 0.00447865 0.00589902 0.00563543 0.0057844 0.00406302 0.00631007 0.00552074 0.0087146 0.0266536 0.00660736 0.00244415 0.00336527 0.00248342 0.00445102 0.00253819 0.00231501 0.00510815 0.00421088 0.0039576 0.00264769 0.00240348 0.00450511 0.00250822 0.00249465 0.00457844 0.00429537 0.0127899 0.0222979 0.15559	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104034 0.149868 0.128308 0.0400162 0.0155559 0.00730765 0.014475 0.0108341 0.00282274 0.00466522 0.00275331 0.00215804 0.00410689 0.00283601 0.00579296 0.00444442 0.0105912 0.0111572 0.051421 0.00996202 0.00688928 0.00803619 0.0060423 0.0078774 0.00804681 0.00556957 0.00543434 0.00503327 0.00480604 0.00494557 0.00391054 0.00507376 0.00491282 0.00501315 0.00388787 0.00636976 0.00543558 0.00821734 0.0139529 0.0487073 0.00878176 0.0138068 0.00311157 0.00449491 0.00313648 0.0026636 0.00522734 0.00485754 0.00367385 0.00266877 0.00236395 0.00431035 0.00265252 0.00250142 0.00436602 0.00420805 0.0122318 0.0213917 0.14228	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106809 0.153606 0.131111 0.0409589 0.0159753 0.00747699 0.0148582 0.0110483 0.00290216 0.00478357 0.00283186 0.00220591 0.00421098 0.00288008 0.00589731 0.00445756 0.0107305 0.0110804 0.0513325 0.00980712 0.00699205 0.00799424 0.00616987 0.00766542 0.00790095 0.0056576 0.00535209 0.00517434 0.00482788 0.00510664 0.00388622 0.0050852 0.00507849 0.00489289 0.00384198 0.00630807 0.00551106 0.00792614 0.0124438 0.0301633 0.00472925 0.00598394 0.00662149 0.0139714 0.0037006 0.00284342 0.00538039 0.00486185 0.00372973 0.0027725 0.00244666 0.00447472 0.00274429 0.00256887 0.00450681 0.00431652 0.0126788 0.0220011 0.146726	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104055 0.150076 0.128232 0.0401605 0.0155733 0.0073007 0.0144873 0.0107965 0.00283652 0.0046663 0.00276992 0.00215128 0.00411612 0.00281478 0.00578508 0.00438568 0.0105928 0.0110867 0.0511515 0.00988619 0.00696229 0.00806345 0.00614628 0.00784128 0.00800085 0.00561605 0.00540499 0.0051068 0.00483374 0.00505081 0.00392362 0.00511226 0.00504307 0.00496616 0.00385819 0.00637716 0.00557056 0.00801023 0.0123094 0.0296096 0.00450096 0.00507944 0.00360881 0.00610789 0.00487983 0.00604502 0.0136267 0.00503607 0.00398931 0.00300254 0.0025202 0.00464942 0.00267284 0.00256559 0.00462269 0.00432132 0.0131731 0.0224106 0.156457	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103409 0.148503 0.12658 0.0395049 0.0155393 0.00724152 0.0144254 0.0106939 0.00281799 0.0046243 0.00274325 0.00213022 0.00405326 0.00275328 0.00560624 0.00416277 0.0100825 0.0100637 0.0468692 0.00874167 0.00656733 0.00720891 0.00579769 0.00659906 0.00692898 0.0053284 0.00472672 0.00494041 0.00430405 0.00483807 0.00344712 0.00439065 0.00472109 0.00398122 0.00324835 0.00527306 0.00494216 0.005917 0.0103925 0.0215141 0.00398184 0.00487286 0.00343373 0.00539074 0.00366987 0.00390887 0.0103486 0.0267984 0.0193402 0.00483258 0.00300967 0.00483174 0.00291367 0.0027876 0.00483453 0.00463278 0.0134036 0.0230897 0.158307	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.10587 0.152276 0.129802 0.0406448 0.0158445 0.00740474 0.0147187 0.0109039 0.00288778 0.00474045 0.00281782 0.00218396 0.00417666 0.00283994 0.00582573 0.00436161 0.0105761 0.0108234 0.0501327 0.00944005 0.00686264 0.00774643 0.00607388 0.0072876 0.00754802 0.00553222 0.00512467 0.00509356 0.00465906 0.00503361 0.00369742 0.0048307 0.00495463 0.00446203 0.00354944 0.00583499 0.0052429 0.00689825 0.0112895 0.0253907 0.00429597 0.00495241 0.00355064 0.005333 0.00360747 0.00369722 0.00844938 0.0144474 0.00689289 0.00611334 0.00595418 0.0138194 0.00403109 0.00324178 0.00493774 0.00466248 0.0124228 0.0225008 0.141707	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106214 0.153177 0.130678 0.0409102 0.0158879 0.00743215 0.0147645 0.0109615 0.00289559 0.00475803 0.00282753 0.00219228 0.0041999 0.00285972 0.00588482 0.00442596 0.010728 0.0111228 0.0512404 0.00964652 0.00691133 0.00785724 0.00608501 0.00749554 0.00772192 0.00555743 0.00522069 0.00508769 0.00470698 0.00501278 0.00372926 0.00487362 0.00493012 0.00458314 0.00359861 0.0059472 0.00523752 0.00718905 0.0113368 0.0261668 0.00428907 0.00489427 0.00352512 0.00519035 0.003511 0.00357783 0.00775404 0.0134179 0.0055482 0.00435679 0.00322346 0.00613172 0.00419101 0.00529033 0.0173621 0.00449665 0.0110305 0.0224758 0.137678	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.101915 0.147046 0.125719 0.039387 0.0152385 0.00713519 0.0141325 0.010512 0.00277323 0.0045512 0.00270675 0.00209844 0.00400771 0.00273556 0.00560308 0.00422447 0.0101798 0.0105581 0.0487527 0.00920275 0.00657122 0.00749832 0.00578694 0.00713584 0.00734456 0.00525688 0.00495336 0.0047997 0.0044474 0.0047124 0.00353176 0.00461324 0.00464662 0.00430744 0.00338857 0.00563434 0.0049776 0.00699617 0.0109515 0.0258391 0.00408533 0.00456149 0.00330097 0.00478107 0.00329022 0.00337895 0.00713687 0.0128197 0.00524376 0.00416623 0.002948 0.00497805 0.0029013 0.00286616 0.00534041 0.00854123 0.0427244 0.0272072 0.147857	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.110884 0.159341 0.137168 0.0431499 0.0168718 0.00786495 0.0156642 0.0117068 0.00303436 0.00494521 0.00292376 0.00223019 0.0040833 0.00269702 0.00507289 0.00330872 0.00678437 0.00517426 0.0122974 0.0131421 0.0606184 0.0119119 0.00845802 0.00974257 0.00954793 0.00675454 0.00654235 0.0061184 0.00579373 0.00721493 0.0064703 0.00744826 0.0146534 0.00347189 0.00253317 0.00234287 0.0031058 0.0026942 0.00550646 0.00719598 0.00234509 0.0032826 0.00240565 0.00427211 0.00244094 0.00227511 0.00500603 0.00391873 0.00384169 0.0025961 0.00239646 0.00446098 0.00250955 0.00250902 0.00462432 0.00430103 0.0128585 0.0222128 0.155274	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.11048 0.158979 0.136236 0.0429443 0.0167239 0.00778243 0.0155756 0.0115379 0.00302934 0.00494195 0.00292881 0.00222047 0.00410756 0.00268746 0.0051096 0.00330606 0.00688044 0.00519993 0.0126051 0.0136006 0.0623432 0.0119351 0.00833235 0.00973884 0.00940501 0.00665221 0.00651479 0.00592228 0.00570307 0.00595684 0.00456777 0.00610452 0.00653361 0.00707896 0.00567415 0.00825145 0.0123204 0.00293635 0.00514834 0.00672018 0.00236632 0.00303883 0.00242417 0.00418738 0.00261423 0.00234106 0.00500745 0.00432945 0.00367741 0.00259357 0.00234611 0.00438139 0.00259462 0.00250051 0.00446057 0.00424681 0.0125647 0.021757 0.147851	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106128 0.153867 0.132936 0.0418721 0.0160362 0.00752166 0.0148155 0.0112413 0.00288832 0.0046692 0.00277974 0.00211149 0.003839 0.00255324 0.0047575 0.00313859 0.00636818 0.00493506 0.0115744 0.012976 0.0598803 0.012012 0.00831917 0.0101393 0.00962647 0.00648159 0.00662745 0.00563571 0.00561244 0.00546651 0.00463917 0.00617906 0.00572779 0.00587958 0.00413408 0.0064466 0.00556192 0.00880609 0.026558 0.00654126 0.00243084 0.00334504 0.00247016 0.00441825 0.00252403 0.00230132 0.0050675 0.00418115 0.00392384 0.00262834 0.00238676 0.00446852 0.00249073 0.0024771 0.00454058 0.00426296 0.0126718 0.0221079 0.154019	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103319 0.148173 0.126967 0.0396243 0.0154852 0.00719516 0.0144225 0.0106778 0.00277274 0.00456335 0.0026791 0.0020561 0.00377238 0.00249368 0.00471862 0.00307933 0.006367 0.00486431 0.0116267 0.0124216 0.0565978 0.0108825 0.00739846 0.00892057 0.00863046 0.00595424 0.00594168 0.00525754 0.00509665 0.00508566 0.00402594 0.00529103 0.00497727 0.00507347 0.00394457 0.00646969 0.00547756 0.00832893 0.013939 0.0488729 0.00873663 0.0136389 0.00309039 0.00445959 0.00311893 0.0026468 0.00519117 0.00483064 0.00364405 0.002651 0.00234758 0.00427665 0.00263535 0.00248433 0.00433258 0.00417848 0.0121323 0.0212302 0.14093	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105993 0.151735 0.129668 0.0405588 0.0158939 0.00736159 0.0147964 0.0108865 0.0028523 0.00468329 0.00275916 0.00210559 0.00388032 0.0025466 0.00483457 0.00312721 0.00648969 0.00489235 0.0118293 0.0124393 0.0569232 0.0107492 0.00749461 0.00859208 0.00840433 0.00603579 0.00584296 0.00539236 0.00511146 0.00523992 0.00398865 0.00529571 0.00513671 0.00494774 0.00389688 0.00641536 0.00555812 0.00808949 0.0124777 0.0304094 0.0047611 0.00596179 0.00660812 0.0138537 0.00367995 0.00282306 0.00533748 0.00482614 0.00369681 0.00274999 0.00242623 0.00443422 0.00272112 0.00254677 0.00446482 0.00427776 0.0125536 0.0217922 0.14515	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103265 0.148258 0.12681 0.0397578 0.015495 0.00718865 0.0144289 0.0106395 0.0027868 0.00456587 0.00269695 0.00205186 0.00378773 0.00248351 0.00472075 0.00305574 0.00636087 0.00480666 0.0116588 0.0124211 0.0566933 0.0108728 0.00750488 0.0088328 0.00853962 0.00599788 0.00590512 0.005328 0.00512285 0.00518739 0.00403065 0.00532596 0.00510187 0.00502688 0.00391495 0.00648705 0.00562141 0.00817385 0.0123433 0.0299261 0.00455417 0.00506535 0.00360994 0.00607823 0.00487089 0.00603299 0.0135205 0.0050049 0.00395611 0.00298102 0.00250151 0.00461045 0.00265263 0.00254536 0.00458127 0.00428441 0.0130432 0.022199 0.154733	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102687 0.146747 0.125272 0.0391657 0.015468 0.00713779 0.0143714 0.0105441 0.00277412 0.0045367 0.0026793 0.00204067 0.00375198 0.00245577 0.00464665 0.00298174 0.00615957 0.00456589 0.0111454 0.0113502 0.0523046 0.00953456 0.00695881 0.00727552 0.00730923 0.00567762 0.00516182 0.00514265 0.00456031 0.00496233 0.00353381 0.00459068 0.00477859 0.00402757 0.00329536 0.00539425 0.00497666 0.00605037 0.010413 0.0217064 0.00401868 0.00485666 0.00343533 0.0053561 0.00365837 0.00390617 0.0102755 0.0266853 0.0191354 0.00479229 0.0029841 0.0047936 0.00289171 0.00276567 0.0047945 0.00459588 0.0132879 0.0229009 0.15673	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.10503 0.15034 0.128321 0.040246 0.0157607 0.00729119 0.0146552 0.0107437 0.00283898 0.00464353 0.00274721 0.00208682 0.00385574 0.00251936 0.00479103 0.0030827 0.00641286 0.0047887 0.0116811 0.0121927 0.0558248 0.0103557 0.00733803 0.0081102 0.00798908 0.005899 0.0055935 0.00530467 0.00493265 0.00516219 0.00378796 0.0050353 0.00501069 0.00451139 0.00359628 0.0059441 0.00527778 0.00704442 0.0113085 0.025638 0.00433897 0.00493149 0.00354986 0.00529562 0.0035947 0.00370428 0.00840465 0.0144395 0.00683368 0.00606404 0.00590976 0.0136976 0.00399983 0.00321474 0.00489521 0.00462313 0.012307 0.0222888 0.140214	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105353 0.151196 0.129144 0.0404867 0.0158018 0.00731626 0.0146985 0.0107979 0.00284482 0.00465641 0.00275376 0.00209228 0.0038695 0.00252943 0.00481664 0.00310441 0.00647354 0.00485214 0.0118182 0.0124711 0.0567946 0.0105639 0.00738808 0.00839316 0.00820129 0.00593478 0.00570562 0.00530547 0.00498854 0.00514597 0.00382575 0.005082 0.00499019 0.00463806 0.00364936 0.00605626 0.00527916 0.00734794 0.0113678 0.0264516 0.00434005 0.00487684 0.00352635 0.00515653 0.00350013 0.00358522 0.00771315 0.0134132 0.0055033 0.00432365 0.00320181 0.00608593 0.00416087 0.00525141 0.0172183 0.00445968 0.0109315 0.0222743 0.136293	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.101138 0.14521 0.1243 0.0389901 0.0151611 0.0070251 0.0140748 0.0103576 0.00272502 0.00445588 0.00263707 0.00200348 0.00369572 0.00242144 0.00459649 0.00297122 0.00616676 0.00463863 0.0112299 0.0118701 0.0541616 0.0101083 0.00704301 0.00799511 0.00780766 0.00561901 0.00541663 0.00501041 0.00471749 0.00484293 0.00362809 0.00481467 0.00470645 0.00436091 0.00343961 0.00574178 0.0050223 0.00714943 0.0109858 0.0261274 0.00413865 0.004547 0.00330306 0.00475158 0.00328327 0.00338844 0.0071021 0.0128233 0.00520261 0.00413645 0.00292869 0.00493926 0.00288086 0.00284544 0.00530418 0.00847007 0.0423279 0.0269511 0.146309	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.114343 0.168201 0.141144 0.0434576 0.0163709 0.0078977 0.0150277 0.0117165 0.00301075 0.00471089 0.00286509 0.00215771 0.00368986 0.00244464 0.00418596 0.0026728 0.00475288 0.00316146 0.0061945 0.00490501 0.0113405 0.0125628 0.0595125 0.0124621 0.0091512 0.00663983 0.00615125 0.00598004 0.00555936 0.00716905 0.0060534 0.00708065 0.0147561 0.00349236 0.00253413 0.00235108 0.00313867 0.00270425 0.00555864 0.00721947 0.00235878 0.00331785 0.00241769 0.00431817 0.00244226 0.00228293 0.00502482 0.00389779 0.00387305 0.00260653 0.00241264 0.00450322 0.00251779 0.00252165 0.00465716 0.00432109 0.0129546 0.0223079 0.156937	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.114812 0.170371 0.141716 0.0435939 0.0162366 0.00786968 0.0149317 0.0116554 0.00300968 0.00467819 0.00285716 0.00213796 0.00366754 0.00241484 0.0041475 0.00263537 0.00469861 0.00310338 0.0061317 0.00480445 0.0113416 0.0127218 0.0601888 0.0125221 0.00902232 0.00652672 0.00612882 0.00576017 0.00540864 0.0058587 0.00424239 0.00553304 0.00631638 0.00664875 0.00543823 0.00792627 0.0124193 0.00291481 0.00510257 0.00665908 0.00236165 0.00304294 0.00241891 0.00419979 0.00260013 0.00233377 0.00498172 0.00427019 0.00367819 0.00258951 0.00234829 0.00439176 0.00258954 0.00249985 0.00445828 0.0042389 0.012581 0.0216963 0.148566	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.110289 0.164509 0.138078 0.0425392 0.0155716 0.00762463 0.0142054 0.0113799 0.00287267 0.00443595 0.0027218 0.00203902 0.00344803 0.00230403 0.00389248 0.00251391 0.00440406 0.00296884 0.0057089 0.0045968 0.0103661 0.012218 0.0578651 0.0129506 0.00922906 0.00636078 0.00618891 0.00549026 0.00530573 0.00537827 0.00419573 0.00552676 0.00551588 0.00546635 0.00390106 0.00606375 0.00539915 0.0084456 0.0263911 0.0065862 0.0024485 0.00337252 0.00248442 0.00446311 0.00253186 0.00231116 0.00509219 0.00417684 0.00395362 0.00264223 0.00240302 0.00450755 0.00250232 0.00249101 0.00457196 0.00428633 0.0127685 0.0222383 0.155806	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107514 0.158848 0.132362 0.0404919 0.0151127 0.00730597 0.0138889 0.0108159 0.00276194 0.00433969 0.00262456 0.00198273 0.00338106 0.00224107 0.00383731 0.00245137 0.00436563 0.00291104 0.00572668 0.00455099 0.0105767 0.0117391 0.0549435 0.0115755 0.00835741 0.00586912 0.00563736 0.00514428 0.00488619 0.00504068 0.0037376 0.00485454 0.00484153 0.00471294 0.00367459 0.00598426 0.00514355 0.0076242 0.0133642 0.046646 0.00865525 0.0139565 0.00310337 0.00446728 0.00311364 0.00264767 0.00517669 0.00479261 0.00365496 0.00265375 0.0023565 0.00429871 0.0026377 0.00249046 0.00434177 0.00418234 0.0121748 0.0212447 0.142185	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.110043 0.161661 0.134653 0.0412635 0.0155543 0.00746625 0.0142963 0.0110075 0.00284899 0.00447532 0.00271287 0.00204188 0.00350111 0.00230743 0.00397082 0.0025203 0.0045073 0.00297349 0.005886 0.00460029 0.0108707 0.0118046 0.0555501 0.0112398 0.00819501 0.00597158 0.00557159 0.00529611 0.00491744 0.00521337 0.00374392 0.00487776 0.00500903 0.00463163 0.00366797 0.00595803 0.00525615 0.00719932 0.0117856 0.0277669 0.00450422 0.00583616 0.00647344 0.0139467 0.00368963 0.00284211 0.00535928 0.00483829 0.00373061 0.0027719 0.00245102 0.00448464 0.00274509 0.00257219 0.0045109 0.00431898 0.0126931 0.0220125 0.147402	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107633 0.159168 0.132544 0.0406956 0.0151828 0.00732629 0.0139565 0.0108214 0.00278747 0.0043549 0.00264888 0.00198658 0.00340594 0.00224499 0.00386027 0.00245278 0.00438283 0.00289605 0.00573539 0.00449679 0.0106286 0.0117252 0.0550399 0.0115055 0.0082833 0.00592423 0.00560627 0.00521942 0.0049079 0.00514275 0.00375048 0.00487651 0.00495445 0.00467846 0.00366342 0.00600768 0.00528539 0.00727106 0.0116191 0.0269095 0.00422014 0.00492377 0.00350071 0.00601888 0.00471252 0.00589615 0.0136485 0.00500092 0.00397553 0.0029905 0.00251629 0.00464921 0.00266645 0.00256088 0.00461886 0.00431429 0.0131526 0.022369 0.156685	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106078 0.155076 0.129099 0.0394664 0.0150879 0.00718551 0.0138473 0.0105673 0.002762 0.00434097 0.00262902 0.00198113 0.00339744 0.00223485 0.00384433 0.0024271 0.00433239 0.00281803 0.00556914 0.00423349 0.0102019 0.010632 0.0512335 0.00957301 0.00718909 0.00558755 0.00490816 0.00503431 0.00438248 0.00493624 0.00336431 0.0042087 0.00465011 0.00383709 0.00314766 0.00496653 0.00478539 0.00543042 0.0100076 0.0198238 0.00379507 0.0047512 0.00335695 0.00536178 0.00360057 0.00381692 0.0104547 0.0266781 0.0196839 0.00488126 0.00303154 0.00486872 0.0029305 0.00280081 0.00485361 0.00464906 0.0134227 0.0231356 0.159049	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.108995 0.16006 0.133112 0.0408305 0.0154154 0.00738334 0.0141572 0.0108463 0.00283548 0.00443989 0.0026989 0.00202604 0.00348141 0.0022877 0.00394369 0.00249482 0.00446607 0.0029265 0.00581035 0.00448429 0.0107323 0.0115229 0.0545383 0.0106655 0.00782176 0.00583743 0.00533507 0.00520868 0.00474132 0.00513484 0.00358277 0.00462887 0.00487864 0.00425791 0.00342256 0.00551332 0.00504953 0.00629089 0.0107899 0.0231571 0.00406275 0.00481763 0.00345507 0.00527673 0.00351996 0.00355658 0.00843239 0.0139704 0.00675623 0.00600941 0.00589277 0.0139417 0.00404446 0.00325383 0.00494683 0.00467664 0.0124636 0.0225721 0.142547	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.109688 0.162167 0.134632 0.0412339 0.0154364 0.00742467 0.0141713 0.0109347 0.00283911 0.00443689 0.00269828 0.00202508 0.00347558 0.00228606 0.0039365 0.00249414 0.0044621 0.00293311 0.00582311 0.00452215 0.010768 0.0117415 0.0552527 0.0109931 0.00798545 0.00586066 0.00543095 0.00519519 0.00478382 0.00509983 0.00359679 0.004659 0.00484148 0.00435019 0.00345284 0.00561599 0.00501932 0.00652586 0.0107596 0.0237071 0.00402728 0.00474168 0.00341778 0.00511465 0.00341506 0.00343231 0.00770716 0.0129087 0.00542422 0.00425324 0.00316309 0.00607129 0.00413277 0.00528146 0.0174883 0.0045024 0.0110352 0.0225036 0.13812	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.105033 0.155047 0.129179 0.0396128 0.0148045 0.00711755 0.0135666 0.0104704 0.00271519 0.0042459 0.0025829 0.00193829 0.00332161 0.00218903 0.00376329 0.00239028 0.00426809 0.00281537 0.00556565 0.00434181 0.0102557 0.011196 0.0525936 0.0104918 0.00760904 0.00555672 0.00515983 0.00491264 0.0045293 0.00480501 0.0034116 0.00441644 0.00456964 0.00409419 0.00325318 0.00532754 0.00475981 0.00635174 0.0103792 0.0234956 0.00383123 0.00442604 0.0032056 0.00471969 0.00319748 0.00323697 0.00709947 0.0123544 0.00512622 0.00405299 0.0028978 0.00494834 0.0028751 0.00283826 0.00529827 0.00853654 0.0429416 0.0273659 0.148912	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.112411 0.164586 0.13844 0.0426404 0.0162982 0.00771025 0.0148991 0.011414 0.00289191 0.00449694 0.00271367 0.00206342 0.00352628 0.00233728 0.00395129 0.00248214 0.00424495 0.00267246 0.00474491 0.00314782 0.00600705 0.00457849 0.0100568 0.011854 0.0128497 0.0617496 0.0130867 0.00815087 0.00843803 0.00890989 0.00821743 0.00944622 0.0157344 0.00374454 0.00273261 0.00249772 0.0032466 0.00285021 0.00575113 0.00749287 0.00242948 0.00335421 0.00247918 0.00434549 0.00251601 0.00233642 0.00511197 0.00408214 0.00389158 0.00264353 0.0024258 0.00449108 0.00254303 0.00253815 0.00465177 0.004349 0.0129058 0.0224221 0.155416	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111007 0.162862 0.136363 0.0420786 0.0160007 0.00756373 0.0146822 0.0111548 0.00285778 0.00444679 0.00268701 0.00202952 0.00349632 0.0022973 0.00391739 0.00244221 0.00421546 0.00263335 0.00472601 0.0031101 0.0060174 0.00456628 0.0102783 0.0120923 0.0134 0.0638244 0.0128878 0.0078655 0.0082054 0.00715484 0.00558598 0.00803872 0.00761064 0.00872244 0.0067048 0.00998008 0.012825 0.00309643 0.00536022 0.00701912 0.00246139 0.00308655 0.00249747 0.00420725 0.0027017 0.00242028 0.00514695 0.00457406 0.00373155 0.00265006 0.00238311 0.00441775 0.00264403 0.0025432 0.00451925 0.0043218 0.0126946 0.0221639 0.149028	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106459 0.156943 0.132858 0.0411161 0.0153636 0.00733418 0.0139737 0.0109052 0.00273356 0.00420608 0.0025576 0.00193475 0.00328153 0.00218995 0.00366601 0.00232548 0.00393583 0.00250701 0.00440227 0.00296426 0.00558376 0.00436695 0.00954464 0.011856 0.0127156 0.0614579 0.0130516 0.00769415 0.0081243 0.00657957 0.00583481 0.00817597 0.00662231 0.00725701 0.00493164 0.00792761 0.00634885 0.0106956 0.0288334 0.00673549 0.0025146 0.00340944 0.00252895 0.00444638 0.00259113 0.002361 0.00515649 0.00434467 0.00396193 0.00267691 0.00241787 0.00449211 0.00252923 0.00251078 0.00456512 0.00431484 0.0127207 0.0223397 0.154123	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102344 0.149494 0.125081 0.0382054 0.0145435 0.00686934 0.0133117 0.0101185 0.00256362 0.00401515 0.002406 0.0018416 0.00313154 0.00208303 0.00351615 0.00221422 0.00378946 0.00239578 0.00426162 0.00285319 0.00543294 0.00416233 0.00915527 0.0108555 0.0118402 0.0558452 0.0114855 0.00680736 0.00707555 0.00596594 0.00487226 0.00679685 0.0056308 0.00619845 0.00476823 0.00782431 0.00648156 0.0101604 0.0159198 0.0611026 0.00968857 0.0135305 0.00315839 0.0044793 0.00320044 0.00270735 0.00528451 0.00503853 0.00364729 0.00267899 0.00235531 0.00425822 0.00265777 0.00249598 0.00433184 0.00420003 0.0121061 0.0213252 0.139436	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104572 0.15251 0.127202 0.0388894 0.0148712 0.00699084 0.0136263 0.0102765 0.0026274 0.0041156 0.00247072 0.00188239 0.00322028 0.00212718 0.00361186 0.00225903 0.00388716 0.00243685 0.00435903 0.00288224 0.00553611 0.00418148 0.00928581 0.0107214 0.0118486 0.0558234 0.0112484 0.00690484 0.00708043 0.00612308 0.00476754 0.00678818 0.00581189 0.00606898 0.00474729 0.00790651 0.00674445 0.0107197 0.0151197 0.0406391 0.00621138 0.0065293 0.00755538 0.0144806 0.00383495 0.00289292 0.00543235 0.00499483 0.00370653 0.0027761 0.00243495 0.00441904 0.00273415 0.00255214 0.00444772 0.00427976 0.0124812 0.0217634 0.143587	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101742 0.148822 0.124282 0.0380716 0.0144711 0.00681902 0.013258 0.0100323 0.0025599 0.00399831 0.00240638 0.00182788 0.00312866 0.00206587 0.00350734 0.00219442 0.00377513 0.00236799 0.00423578 0.00280336 0.00538783 0.00408546 0.0091041 0.0106139 0.0117309 0.0553494 0.0113571 0.00686493 0.00710038 0.00607633 0.00485324 0.006816 0.00577241 0.00622479 0.00482829 0.00803943 0.00688866 0.0108133 0.0149258 0.0407137 0.00639655 0.00557754 0.00412794 0.00651895 0.00547277 0.00682246 0.0138877 0.00523494 0.00396897 0.00301305 0.00251328 0.0045897 0.00266422 0.00254955 0.00454904 0.00427361 0.0129366 0.0220871 0.152901	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101182 0.147276 0.122695 0.037493 0.0144745 0.00676921 0.0132522 0.00994297 0.00256018 0.00400293 0.00240966 0.0018313 0.00313862 0.00206706 0.00351521 0.00219086 0.00377235 0.00234996 0.00420563 0.0027408 0.00529274 0.0039095 0.0087429 0.00963116 0.010798 0.0510423 0.00981215 0.00644738 0.00633022 0.00574957 0.00411802 0.00595828 0.00540431 0.00477883 0.00386483 0.00662665 0.0058098 0.00836893 0.0125331 0.0300977 0.00540748 0.00529323 0.00387129 0.00561578 0.00396577 0.00441347 0.0107782 0.0295613 0.0191676 0.00485432 0.0029829 0.00476389 0.00288915 0.00275852 0.00476601 0.00457714 0.0132404 0.0228292 0.155078	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103292 0.150676 0.125468 0.0384143 0.0147025 0.00689532 0.0134674 0.0101113 0.00260648 0.00407284 0.00245368 0.00186098 0.00319551 0.00210137 0.00358029 0.00223024 0.00384921 0.00240013 0.00430785 0.00282206 0.00545634 0.00407639 0.00914168 0.0103349 0.0115585 0.0544223 0.0107012 0.00674461 0.00683375 0.00601887 0.00447805 0.00649254 0.00568168 0.0054632 0.00428989 0.00727208 0.00626024 0.00956468 0.0136838 0.0353866 0.00593938 0.00537478 0.00401725 0.00556107 0.00395354 0.00437821 0.00894424 0.0166204 0.00729141 0.00645974 0.00625314 0.0138487 0.00404294 0.00322278 0.00488268 0.00462104 0.0121746 0.0221754 0.13787	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.103576 0.151522 0.126259 0.0386367 0.014724 0.00691511 0.0134842 0.010155 0.00260744 0.00407235 0.00245351 0.00186034 0.00319309 0.00210102 0.00357796 0.00223056 0.00384892 0.00240299 0.00431355 0.00283349 0.00547836 0.00411402 0.0092297 0.010576 0.0117814 0.0554322 0.0109603 0.00678942 0.00691673 0.00601788 0.00455962 0.00655637 0.00567072 0.00567077 0.00440473 0.00743608 0.00633826 0.00993206 0.0138088 0.0364116 0.00602533 0.00533152 0.00400133 0.00542052 0.00384772 0.00422378 0.00817893 0.0153895 0.0058589 0.00460691 0.00340438 0.00633393 0.00432734 0.00539718 0.0173286 0.00447115 0.0108364 0.0221952 0.13397	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.0994486 0.145499 0.12154 0.0372278 0.0141398 0.00664615 0.012921 0.00975181 0.00250022 0.00389979 0.0023519 0.00178318 0.00305398 0.00201342 0.00342037 0.00213733 0.00367833 0.00230298 0.0041208 0.00271664 0.00522632 0.00393941 0.00878269 0.0100924 0.0112054 0.0528026 0.0104901 0.00646481 0.00659416 0.00570939 0.00435698 0.0062493 0.00538208 0.00535932 0.00418744 0.0071208 0.00610469 0.00963028 0.0133605 0.0356728 0.00579443 0.00499401 0.00375893 0.00501423 0.00364235 0.00403248 0.00757954 0.0147867 0.00556645 0.00445541 0.00312045 0.00512926 0.00298023 0.00293894 0.00544013 0.00867987 0.0424093 0.0268886 0.142904	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.116204 0.16985 0.142409 0.0435915 0.016957 0.00788819 0.0155345 0.0117696 0.00302195 0.00472287 0.00285958 0.00215212 0.00372144 0.00242311 0.00414031 0.00253982 0.00435116 0.00263396 0.00459919 0.00279982 0.00516206 0.00328418 0.00671963 0.00505823 0.00499322 0.011164 0.0119511 0.0571893 0.0100282 0.010025 0.00844558 0.009091 0.0168328 0.0038807 0.00281682 0.00258056 0.00336692 0.00290441 0.00584924 0.00733339 0.00243035 0.00339929 0.00248784 0.00441251 0.00250644 0.00233435 0.00512036 0.00398403 0.00391115 0.0026389 0.00244585 0.00455525 0.00255185 0.00255149 0.00470463 0.00437156 0.0130587 0.0225096 0.157181	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.114211 0.166805 0.139654 0.0429845 0.0166668 0.00774945 0.0153753 0.0115463 0.00299444 0.00470068 0.00284126 0.00212727 0.00371183 0.00239664 0.00413449 0.00251585 0.0043534 0.00261246 0.00461459 0.0027837 0.00520291 0.0032966 0.00689608 0.00507304 0.00524269 0.012131 0.0133486 0.0613839 0.00990495 0.00824537 0.0056657 0.00768392 0.00772973 0.00830419 0.00653771 0.00949723 0.012925 0.0031369 0.0053947 0.00693313 0.00247534 0.00312904 0.002513 0.00426047 0.0027115 0.00242751 0.00514742 0.00450773 0.00374455 0.00265778 0.00240418 0.00446178 0.00266175 0.00256226 0.00456473 0.00435164 0.0128339 0.0223488 0.150924	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.11029 0.162421 0.136987 0.0421304 0.016044 0.00752175 0.0146751 0.0113118 0.00286402 0.00444907 0.00270527 0.00202675 0.00348729 0.00228276 0.00387197 0.00239274 0.0040671 0.00248273 0.00430174 0.00264459 0.00484538 0.00313082 0.00645245 0.00497362 0.00498496 0.0110804 0.0128296 0.059269 0.00969743 0.00768958 0.0058076 0.00769436 0.00667271 0.00683312 0.00480335 0.00775061 0.00620266 0.010164 0.0277865 0.00654079 0.00251445 0.00344611 0.00255361 0.00450683 0.00260298 0.00237023 0.00516171 0.00426971 0.00397296 0.00267651 0.00243605 0.00453584 0.00254178 0.00252639 0.00460937 0.00433907 0.0128321 0.0224167 0.155521	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105944 0.153984 0.128902 0.0392828 0.0152628 0.00708407 0.0140804 0.0105691 0.00270425 0.00429094 0.00256306 0.00194431 0.00335655 0.0021881 0.003745 0.00229315 0.00394068 0.00238008 0.00417497 0.00253944 0.00471438 0.00300535 0.00619777 0.0046342 0.004884 0.0110788 0.0121428 0.0549205 0.00875804 0.00699405 0.00495061 0.0066142 0.00575941 0.00577438 0.00454621 0.00754897 0.00619245 0.00976735 0.0151486 0.05494 0.00906737 0.0132526 0.00314952 0.00451387 0.00320351 0.00270978 0.00529692 0.00496386 0.00369051 0.00270561 0.00239263 0.00433786 0.00269402 0.00253503 0.0044144 0.00426619 0.0123599 0.0217013 0.142943	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.108044 0.156647 0.130895 0.0399768 0.0155945 0.00721215 0.0143894 0.0107262 0.00277185 0.00439337 0.00263159 0.00198763 0.00344761 0.00223557 0.00384395 0.00234288 0.00404406 0.00243037 0.00428259 0.00258942 0.00482733 0.00305867 0.00633649 0.00466603 0.0048974 0.0112566 0.0121118 0.0551398 0.00873471 0.00712845 0.00487568 0.00662143 0.00591907 0.00565661 0.00452781 0.00756784 0.00637914 0.0100563 0.0140727 0.0358433 0.00563031 0.00627552 0.00708281 0.0139997 0.00380711 0.0028952 0.00545126 0.0049512 0.00375825 0.0028051 0.00247155 0.00450093 0.00277214 0.00259214 0.00453557 0.0043504 0.0127451 0.0221713 0.147042	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105383 0.153309 0.128165 0.039212 0.0152054 0.00704742 0.0140336 0.010493 0.00270682 0.00427709 0.00256867 0.00193434 0.00335768 0.00217596 0.00374179 0.0022808 0.00393676 0.00236608 0.00417017 0.00252117 0.00470315 0.00298218 0.00620265 0.00457355 0.00479535 0.0110618 0.0120495 0.0547152 0.00876469 0.00709748 0.00493621 0.00663663 0.00587871 0.00577272 0.00456427 0.00767762 0.00647458 0.0101426 0.0139002 0.0357367 0.00567601 0.00538176 0.00392613 0.0063083 0.00519651 0.00645319 0.0136535 0.00517707 0.00402493 0.00305512 0.0025575 0.00468394 0.00271294 0.00259753 0.004649 0.00435916 0.0132118 0.0225434 0.156281	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.104219 0.150555 0.12585 0.0384101 0.01513 0.00697529 0.0139273 0.0103456 0.00269081 0.00425478 0.00255438 0.00193013 0.00333971 0.00216873 0.00372097 0.00227131 0.00391114 0.00235304 0.00413416 0.00249962 0.00464097 0.00293379 0.00603677 0.00439123 0.00450956 0.0104416 0.0107319 0.049757 0.00773934 0.00666545 0.00432195 0.00589087 0.00552637 0.00465821 0.00382748 0.00644976 0.0056313 0.00771304 0.0117171 0.0262022 0.00490872 0.00515459 0.00373644 0.00551779 0.00386162 0.00424255 0.010507 0.0278901 0.0190596 0.00486602 0.00303146 0.00487909 0.00295515 0.00281982 0.00487929 0.00468374 0.0135485 0.0233794 0.159051	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.106687 0.154534 0.129028 0.0394938 0.0154162 0.00712106 0.01421 0.0105515 0.00275123 0.0043467 0.00261336 0.00196699 0.00341857 0.00221096 0.00380885 0.00231708 0.00400641 0.00240232 0.00424143 0.00255649 0.00477422 0.00301577 0.00626554 0.00455381 0.00475625 0.0110433 0.0117297 0.053597 0.00841243 0.00698458 0.00461972 0.00636026 0.00578943 0.00518493 0.00417017 0.00702831 0.00600214 0.00887291 0.0127447 0.0309342 0.00536828 0.00522444 0.00386867 0.00546455 0.00382178 0.00415592 0.00871942 0.015582 0.007003 0.0062241 0.00609092 0.0138756 0.00409007 0.0032749 0.00498076 0.00470659 0.012484 0.0226475 0.141896	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.107146 0.155692 0.130008 0.0397648 0.0154599 0.00714856 0.014254 0.0106128 0.00275609 0.00435338 0.00261688 0.00196911 0.00342272 0.00221372 0.00381373 0.00232013 0.00401219 0.00240599 0.0042493 0.00256184 0.0047879 0.00302597 0.00629793 0.00459434 0.00481387 0.0111666 0.012018 0.0544822 0.00853981 0.0069979 0.00467741 0.00640916 0.0057769 0.00532711 0.00424474 0.00715492 0.00604158 0.00925398 0.0128502 0.0318986 0.00543368 0.00517688 0.00385009 0.00532633 0.00372252 0.00402166 0.00799852 0.0144787 0.00565713 0.0044484 0.00331054 0.00621283 0.00425789 0.00536947 0.0174354 0.00454044 0.0110847 0.0225992 0.137936	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.102842 0.14948 0.125102 0.0382808 0.0148304 0.00686196 0.0136465 0.0101783 0.00263766 0.00416292 0.00250377 0.00188403 0.0032671 0.00211709 0.00363767 0.00221786 0.00382456 0.00229921 0.00404835 0.00244787 0.00455938 0.00289119 0.0059953 0.00439546 0.00460004 0.0105892 0.0114198 0.0519822 0.00812168 0.00663055 0.00446927 0.00609111 0.00546381 0.0050205 0.00401571 0.00681675 0.00577054 0.00895907 0.0124116 0.0313433 0.00520879 0.00483114 0.00360582 0.0049096 0.00350938 0.00381915 0.0073795 0.0138718 0.00535147 0.00427288 0.00302612 0.00502583 0.00293909 0.00291226 0.00544129 0.00862431 0.042787 0.0272255 0.147442	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.121885 0.180106 0.149298 0.0449379 0.0174813 0.00820386 0.0159392 0.0121703 0.00312399 0.00481314 0.00295412 0.00221771 0.00377454 0.00246773 0.00415607 0.00256159 0.00431827 0.00261994 0.00447379 0.00270784 0.00479553 0.00295097 0.00554945 0.00405133 0.00300962 0.00577605 0.00397995 0.00917256 0.00909008 0.0397509 0.0100583 0.00997673 0.0185448 0.00415045 0.00301209 0.00276898 0.00356094 0.00303137 0.00608725 0.00727935 0.00248917 0.00351351 0.00256803 0.00462834 0.0025767 0.00239352 0.00527352 0.00400466 0.00399991 0.00269065 0.00251397 0.0047348 0.0026266 0.00261873 0.00484941 0.00448354 0.0134837 0.0229906 0.160754	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG2 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.121305 0.182121 0.149287 0.0450649 0.0170154 0.00819327 0.0154793 0.0120801 0.00310169 0.00466583 0.00289084 0.00215984 0.00363108 0.00238711 0.00397147 0.0024722 0.00411812 0.00252376 0.0042662 0.00260584 0.00457373 0.0028441 0.0053624 0.0038845 0.00297889 0.0056735 0.00398315 0.00920514 0.00912723 0.0379166 0.00707517 0.00849165 0.00825377 0.00815614 0.0066871 0.00959474 0.014116 0.00325089 0.00555895 0.00699221 0.00257363 0.00322088 0.00259079 0.00439676 0.00280983 0.00250792 0.00528718 0.00462202 0.00381526 0.00272077 0.00246755 0.00459532 0.00274063 0.00262526 0.00468099 0.00445099 0.0132314 0.0229034 0.154694	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.117454 0.177684 0.147028 0.0444725 0.0163743 0.00797449 0.0147365 0.0118856 0.00296305 0.00438657 0.00273781 0.00204457 0.00338717 0.00225585 0.00368925 0.00233018 0.00381354 0.00237511 0.00393842 0.00245 0.0042107 0.00266777 0.00491231 0.00371373 0.00277798 0.00512709 0.00367641 0.00806549 0.00842926 0.0361493 0.00725264 0.00843248 0.00710705 0.0067163 0.00489771 0.00786103 0.00625897 0.0104556 0.0282728 0.00653203 0.00257934 0.00354211 0.00263001 0.00465667 0.00267848 0.00243645 0.00531287 0.00434612 0.0040527 0.00273224 0.00250165 0.00467986 0.0026138 0.00259205 0.00473992 0.00445438 0.0132209 0.0229842 0.159749	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112579 0.168121 0.13818 0.0415781 0.0156883 0.00755905 0.0142748 0.0111493 0.00282013 0.004296 0.00262911 0.0019858 0.00331661 0.00219417 0.00363503 0.00226976 0.00376769 0.00231662 0.00389897 0.00239374 0.00417917 0.00260927 0.00484842 0.00355312 0.0027633 0.00521178 0.00373344 0.00857913 0.00835838 0.0344233 0.00632735 0.00729996 0.00614279 0.00566103 0.00452918 0.00734357 0.00584938 0.00902236 0.0142633 0.052384 0.00882825 0.0137204 0.0032387 0.00464891 0.00333391 0.00281054 0.00548336 0.00514628 0.00378781 0.00279713 0.00247514 0.00449235 0.00279515 0.00261956 0.00456065 0.00440587 0.0128234 0.022466 0.14783	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.114427 0.170027 0.139595 0.0420637 0.0160379 0.00767299 0.0146117 0.0112833 0.00289218 0.00441219 0.00270628 0.00203727 0.00342103 0.00225206 0.00375065 0.00233141 0.0038897 0.00238012 0.00402774 0.00245918 0.00431889 0.00268391 0.00502745 0.00364277 0.0028383 0.00540094 0.00383318 0.0088915 0.00853296 0.0347575 0.00625374 0.00732697 0.00628829 0.00559866 0.00455849 0.00739136 0.0060762 0.00924457 0.0131944 0.032831 0.00536679 0.00616219 0.00697861 0.0144088 0.00395569 0.00300088 0.0056478 0.00512376 0.00388545 0.00290709 0.00256292 0.00467874 0.00287777 0.00268699 0.00471195 0.00451303 0.0132856 0.0230842 0.153191	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.111996 0.167282 0.137378 0.0414394 0.0156503 0.00752269 0.0142466 0.0110749 0.00282621 0.0042858 0.00263706 0.00197981 0.00331917 0.00218771 0.00363537 0.00226425 0.00376888 0.00231072 0.00390215 0.00238649 0.0041837 0.00260474 0.00488394 0.00354504 0.0027516 0.0052311 0.00371459 0.00862094 0.00838751 0.0341827 0.00628929 0.00734087 0.00624773 0.0056873 0.00456282 0.00752687 0.00613168 0.00938501 0.0130586 0.0327233 0.00534008 0.00528621 0.00389424 0.00631208 0.00525375 0.00645987 0.0141133 0.0053332 0.00413588 0.00315481 0.00264345 0.00485793 0.00281292 0.00268668 0.00481912 0.00451358 0.0137136 0.0233909 0.162125	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.110073 0.163122 0.133481 0.0400614 0.0154578 0.00734346 0.0140786 0.010777 0.00279072 0.00426282 0.00261501 0.00197186 0.00331119 0.00217911 0.00363081 0.0022562 0.00376549 0.00230284 0.00389819 0.00237741 0.00417603 0.00259161 0.00485269 0.00350078 0.0027132 0.0051659 0.00362433 0.00836502 0.0078221 0.0312678 0.00546556 0.00646726 0.00575523 0.00467611 0.00391371 0.00623193 0.00545275 0.00710445 0.0111195 0.0235736 0.00466772 0.00502208 0.00370813 0.0054853 0.00389451 0.00423374 0.0106761 0.0278249 0.0194773 0.00497869 0.00311048 0.0050557 0.00305636 0.00290384 0.00502989 0.00482197 0.0139941 0.0242136 0.164249	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.112976 0.167799 0.137404 0.0413901 0.0158107 0.00754463 0.0143967 0.0110542 0.00286219 0.00435632 0.00267892 0.00201279 0.00338415 0.00222379 0.00370842 0.00230242 0.00384566 0.0023496 0.00398223 0.0024257 0.00426828 0.00264713 0.00498167 0.00357719 0.00278913 0.0053324 0.0037521 0.00875008 0.00833695 0.0335633 0.00589422 0.00700482 0.00609711 0.00515497 0.00423792 0.00685649 0.00578878 0.00816821 0.0120635 0.027955 0.00509343 0.00511966 0.00384249 0.0054476 0.00384039 0.00415337 0.00898959 0.0158136 0.00688465 0.0061545 0.00614279 0.0143849 0.00425745 0.00340365 0.0051744 0.00489185 0.0130177 0.0236142 0.148047	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.113799 0.169959 0.138997 0.041779 0.0158405 0.00758442 0.0144082 0.0111324 0.00286198 0.00434388 0.00267112 0.00200744 0.00336809 0.0022159 0.00368791 0.00229254 0.00382227 0.00233811 0.00395598 0.00241243 0.00423786 0.00262955 0.00493909 0.00356076 0.00276981 0.00529445 0.00373104 0.00871711 0.00839292 0.0339995 0.0059641 0.00704702 0.00607652 0.00525978 0.00428725 0.00698126 0.0057914 0.00850191 0.0120925 0.0287882 0.00512617 0.00505916 0.00380986 0.00529021 0.00372975 0.00400085 0.00821877 0.0146757 0.00556868 0.00438352 0.0033258 0.00629489 0.00435026 0.00553897 0.018266 0.00474148 0.0115743 0.0236518 0.143855	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.109174 0.162919 0.133631 0.0401883 0.0151921 0.00727144 0.0137898 0.0106663 0.00273235 0.00414363 0.00254904 0.00191572 0.00320738 0.00211342 0.00350894 0.00218499 0.00363347 0.00222703 0.00375667 0.00229653 0.00402019 0.00250075 0.00467478 0.00338861 0.00263078 0.00500149 0.00353704 0.00819749 0.00789646 0.032163 0.00570497 0.00670869 0.0057512 0.00497163 0.00406293 0.00666246 0.00549607 0.00820474 0.0116352 0.0284774 0.00489915 0.00471204 0.00356583 0.00487048 0.00352226 0.00378857 0.00757131 0.0140823 0.00524554 0.00417823 0.00303497 0.0050877 0.0030164 0.00297943 0.00560584 0.00885903 0.0445217 0.0283759 0.153296	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.118983 0.182005 0.144464 0.0427759 0.0161088 0.00780492 0.0148069 0.0116628 0.00302783 0.00449626 0.00280565 0.00212133 0.00347592 0.00231886 0.00376259 0.00239135 0.00388244 0.00243227 0.00400442 0.00249769 0.00425862 0.00268417 0.00486909 0.00356196 0.00260631 0.00456414 0.00300001 0.00571585 0.00407653 0.00931721 0.00758564 0.0102784 0.0608536 0.0148746 0.00777275 0.0106859 0.0155411 0.00337913 0.00562402 0.00700384 0.00259701 0.0032023 0.00257271 0.0042731 0.00274446 0.00246622 0.0051073 0.00451487 0.00367481 0.00260796 0.00236092 0.00436902 0.00259771 0.00250143 0.00444363 0.00422661 0.0125123 0.0216435 0.147504	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG2 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.114447 0.175736 0.14176 0.0423542 0.0154843 0.00764858 0.0140443 0.0115316 0.00290475 0.00423734 0.00267252 0.00201244 0.0032402 0.00219598 0.00349198 0.00225989 0.00359402 0.00229642 0.00369894 0.00235893 0.00392858 0.0025405 0.00451639 0.00342766 0.00249324 0.00423735 0.00288829 0.00529165 0.0039682 0.00854034 0.00739847 0.0102339 0.0542415 0.0118416 0.00573474 0.00893047 0.00680563 0.0119243 0.0309541 0.00674367 0.00265623 0.00359348 0.00266474 0.00461202 0.00268859 0.00244559 0.005242 0.00436175 0.00398447 0.00269596 0.00245225 0.00454003 0.00254964 0.00253152 0.00458738 0.00434076 0.0127449 0.0222909 0.154407	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG2 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.109122 0.166239 0.132929 0.0395626 0.0147001 0.00718896 0.0134459 0.0107143 0.00273309 0.00406141 0.00252516 0.00191519 0.00311042 0.00209072 0.00336473 0.00215336 0.00346803 0.00218913 0.00357302 0.00224972 0.00379937 0.00242134 0.00434499 0.00321961 0.00239746 0.00415411 0.00280028 0.00527071 0.0039228 0.00873724 0.00728792 0.00968989 0.0505743 0.0101469 0.00537058 0.00824117 0.00647166 0.0106084 0.0157365 0.0615892 0.00908234 0.0131489 0.00313928 0.00442392 0.00322992 0.00273181 0.00526166 0.0050583 0.00360758 0.00267886 0.00235896 0.00423564 0.00266074 0.00249669 0.00432338 0.00419615 0.01211 0.021314 0.139821	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.110396 0.167187 0.133762 0.0398977 0.0149883 0.00728109 0.0137333 0.0108167 0.00279231 0.00415522 0.00258779 0.00195913 0.00319579 0.00214096 0.00346015 0.00220706 0.0035687 0.0022444 0.00367898 0.00230651 0.00391412 0.00248442 0.00448668 0.0032932 0.00245638 0.00428694 0.00286613 0.00543919 0.00400817 0.00903545 0.00744453 0.00981431 0.051856 0.0100776 0.00545382 0.0083702 0.00680005 0.0114653 0.0149701 0.0401327 0.00648939 0.00628449 0.00726844 0.014298 0.00389091 0.0029279 0.00546712 0.00505179 0.00372675 0.00280536 0.00246225 0.00445076 0.00275909 0.00257715 0.00448676 0.00431876 0.0125898 0.0219638 0.145167	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.108111 0.16468 0.131801 0.0393395 0.0146302 0.00714437 0.0133971 0.0106284 0.00273123 0.00404185 0.00252193 0.00190596 0.00310174 0.00208161 0.00335495 0.00214517 0.00345886 0.00218055 0.0035649 0.00223978 0.00379153 0.00241179 0.00435543 0.00320188 0.00238101 0.00414427 0.00277242 0.00525009 0.00387531 0.0087294 0.00719579 0.00957909 0.050761 0.0103082 0.00549263 0.00853121 0.00687885 0.0115498 0.0146849 0.0402122 0.00678722 0.00544416 0.00416841 0.00627644 0.00537081 0.00671991 0.0137568 0.00527307 0.00396277 0.00304896 0.00254625 0.00462247 0.00270191 0.00258077 0.00458445 0.00431632 0.0129995 0.0222242 0.153448	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.105854 0.159348 0.127599 0.037994 0.0144984 0.00700247 0.0132572 0.0103602 0.00269722 0.00402505 0.0025076 0.00190292 0.00310282 0.00208119 0.00336366 0.00214615 0.00347023 0.00218251 0.00357676 0.00224175 0.00380196 0.00241199 0.00434464 0.00317985 0.00236402 0.00412939 0.00273601 0.00519035 0.00374787 0.0084945 0.00688245 0.00887693 0.0486975 0.00815335 0.00465925 0.00692358 0.00597459 0.00897234 0.0124241 0.0297229 0.00583059 0.00515753 0.00395018 0.00539878 0.00394949 0.00451121 0.0106015 0.0291066 0.0189127 0.00487365 0.00301134 0.0048501 0.00295454 0.00280705 0.00483993 0.00465582 0.0134549 0.0232734 0.156962	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.108511 0.164162 0.131217 0.0391577 0.0147592 0.00715688 0.0135132 0.0105978 0.00276033 0.00409967 0.00255856 0.00193614 0.00315915 0.00211639 0.00342116 0.00218266 0.00352922 0.00221943 0.00363904 0.00227983 0.0038711 0.00245532 0.00444674 0.00324127 0.00242173 0.00423666 0.00281612 0.00536418 0.0039157 0.0089101 0.00730429 0.00960962 0.0515933 0.00921461 0.00506569 0.00760852 0.0063632 0.0101461 0.0134867 0.0347279 0.00632583 0.00523801 0.00408808 0.00532945 0.00394386 0.0045973 0.00891539 0.016808 0.00696247 0.00627845 0.00618576 0.0139381 0.00412288 0.00327327 0.00495362 0.00470022 0.0123376 0.0225183 0.139709	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.109254 0.166373 0.132735 0.0395218 0.0147661 0.00718724 0.0135076 0.0106688 0.00276387 0.00409385 0.00255416 0.00193274 0.00314731 0.00211064 0.00340509 0.00217542 0.003511 0.00221105 0.00361903 0.00227026 0.00384827 0.00244321 0.00442012 0.00323062 0.00240957 0.00420794 0.00280199 0.00533395 0.0039093 0.00888538 0.00730316 0.00970782 0.0517923 0.00949076 0.00515321 0.00777505 0.00640838 0.0105279 0.0135469 0.0355877 0.00638634 0.00518553 0.00406877 0.00517619 0.00382537 0.00441678 0.00811936 0.0155681 0.00563766 0.0044521 0.00338949 0.00623484 0.00428651 0.0054061 0.0175387 0.00455279 0.01099 0.0225251 0.135649	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.104984 0.159597 0.127802 0.0381026 0.0142147 0.00691754 0.0129759 0.0102567 0.00264983 0.00392615 0.00245142 0.00185396 0.00301557 0.00202433 0.00326113 0.00208569 0.00336074 0.00211922 0.00346196 0.00217561 0.00367923 0.00234091 0.00422065 0.00309658 0.00230974 0.00401975 0.00268477 0.00507964 0.00373302 0.00841384 0.00692594 0.00916816 0.0489136 0.00900694 0.00491409 0.00750859 0.00614917 0.0101772 0.0131093 0.0350505 0.00613066 0.00486539 0.00382453 0.00479529 0.00364299 0.00422327 0.00755084 0.0150147 0.00535065 0.00431215 0.00310578 0.00503579 0.0029719 0.00295626 0.00552135 0.00867848 0.0429787 0.0272772 0.144027	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG1 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.0966885 0.144789 0.116668 0.0346769 0.0134802 0.00647886 0.0124043 0.00967637 0.00249803 0.00369471 0.00231253 0.0017802 0.0028511 0.00195148 0.0031035 0.00201439 0.003208 0.00205292 0.00330891 0.00211535 0.00351907 0.00227748 0.00393461 0.00295873 0.00222091 0.00370319 0.00247107 0.00435793 0.00304543 0.00588194 0.00357928 0.00354303 0.00745227 0.00832086 0.00993623 0.0178572 0.0709889 0.0200442 0.0255395 0.0910762 0.0115851 0.0143987 0.00323223 0.00453957 0.00337068 0.00290057 0.00551107 0.00568964 0.00360855 0.00268776 0.00233339 0.00413979 0.00263224 0.0024429 0.00419515 0.00408939 0.011624 0.0207058 0.131853	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.095199 0.141302 0.114537 0.0343084 0.0134617 0.00645522 0.0124162 0.00959958 0.00250994 0.003732 0.0023358 0.00179597 0.00288701 0.00197178 0.00314778 0.00203847 0.00325878 0.00208024 0.00336746 0.0021471 0.00359041 0.00231919 0.00405047 0.00300568 0.00227964 0.00382469 0.00254868 0.00452361 0.00317732 0.00614163 0.00371874 0.0037257 0.0079648 0.00934963 0.0113733 0.020757 0.0808307 0.0236747 0.0252918 0.061754 0.0104653 0.00772159 0.00940149 0.0155893 0.00402871 0.0030044 0.00554375 0.00537982 0.00367133 0.00279389 0.00242531 0.00432288 0.00271406 0.00251658 0.00433731 0.00419658 0.0120311 0.021174 0.136229	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0927269 0.137903 0.112025 0.0336471 0.0131246 0.00630844 0.0121055 0.00939227 0.00245089 0.00363292 0.00227846 0.0017471 0.00280866 0.00191828 0.00306076 0.00198343 0.00316861 0.00202396 0.00327487 0.00208888 0.00349301 0.00225828 0.00395782 0.00293187 0.00222006 0.00372686 0.00248236 0.00440771 0.0030984 0.00599643 0.00363075 0.00364409 0.00782651 0.0092391 0.0112436 0.0208486 0.0810746 0.0237346 0.0244085 0.0621999 0.0110798 0.00670851 0.0058929 0.00725198 0.00684288 0.00838748 0.0137513 0.00558397 0.00381713 0.00300766 0.00248585 0.00445005 0.00264414 0.00250766 0.00439492 0.00416556 0.012395 0.0212708 0.14327	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0927558 0.137803 0.11145 0.0334544 0.0131794 0.00627123 0.0121956 0.00933082 0.00245282 0.00363485 0.00228322 0.0017422 0.00282088 0.00191171 0.00307117 0.00197562 0.00317661 0.00201293 0.00327933 0.00207153 0.00349013 0.00223332 0.00395048 0.00290307 0.00215551 0.00367132 0.0023926 0.00432331 0.00295662 0.00587497 0.00349809 0.00337884 0.00734406 0.00754739 0.00947182 0.0182606 0.0729186 0.0199996 0.0205525 0.049089 0.009052 0.00613308 0.00543319 0.00588972 0.00449868 0.0055053 0.0116207 0.0338058 0.0177898 0.00471512 0.00287304 0.00459203 0.00282673 0.00267593 0.00460265 0.00442739 0.012815 0.022106 0.145752	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0930989 0.138352 0.111966 0.0336722 0.0131998 0.00630482 0.0122152 0.00937023 0.00246939 0.00366069 0.00229736 0.00175508 0.00283871 0.00192633 0.00309235 0.00199193 0.0032011 0.00203124 0.0033083 0.00209313 0.00352647 0.00226071 0.00400532 0.00293333 0.00220106 0.0037444 0.00245162 0.00442608 0.00305263 0.00603113 0.00358687 0.00353669 0.00770132 0.00838397 0.0105417 0.0200674 0.0790097 0.0222166 0.0226942 0.0552278 0.00967094 0.00624514 0.00554291 0.00580183 0.0048106 0.00605171 0.0100813 0.0212764 0.00773533 0.00729104 0.00703301 0.0138084 0.00405591 0.00316855 0.00476139 0.00453737 0.0116217 0.0214703 0.128593	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0930017 0.138454 0.112143 0.0336952 0.0131737 0.00630138 0.012183 0.0093793 0.00246446 0.00365372 0.00229254 0.00175211 0.0028303 0.00192317 0.00308323 0.00198868 0.00319178 0.00202818 0.00329902 0.00209059 0.00351764 0.00225878 0.00399851 0.00293248 0.00220411 0.00374218 0.00245825 0.00442749 0.00306549 0.00603788 0.00359889 0.00357267 0.00778162 0.00870768 0.0108809 0.0205439 0.0804726 0.0226722 0.0227679 0.0565716 0.00986218 0.00626705 0.00557239 0.00568908 0.00472423 0.00584816 0.00925835 0.0197112 0.00631082 0.00533611 0.00409963 0.00673065 0.00470122 0.00574135 0.0171715 0.00443198 0.010454 0.021613 0.125336	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.089954 0.133893 0.108726 0.0326862 0.0127466 0.00610415 0.0117545 0.00907787 0.00237985 0.00352009 0.00221274 0.00169099 0.00272531 0.00185554 0.00296697 0.00191806 0.00306991 0.00195563 0.00317145 0.00201551 0.00337986 0.00217697 0.00383745 0.00282621 0.00212587 0.00359255 0.00236903 0.0042407 0.00294724 0.0057706 0.00345649 0.00342289 0.0073795 0.00826317 0.0102483 0.0193957 0.0760475 0.0216247 0.0219473 0.0549389 0.00951164 0.0059483 0.00528278 0.00533444 0.00460977 0.00569241 0.00878486 0.0192905 0.00611916 0.00539951 0.00384387 0.0054261 0.00323119 0.0032367 0.00572523 0.00907189 0.0419128 0.0261549 0.131009	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG1 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.0913405 0.132065 0.111559 0.0341782 0.0138978 0.0064518 0.0132039 0.00982262 0.00255124 0.00401888 0.00246495 0.00186398 0.00314748 0.00207767 0.00347531 0.00216434 0.00361813 0.00221777 0.00374672 0.00229224 0.0040061 0.00247983 0.00454891 0.00322172 0.00232235 0.0040641 0.00254896 0.00468921 0.00305846 0.00660901 0.00365241 0.00331577 0.00708637 0.00532286 0.0048125 0.00778828 0.0149998 0.0241375 0.139091 0.0756148 0.0115097 0.016068 0.0033278 0.00453041 0.00326176 0.00276531 0.00514587 0.00499185 0.00341345 0.00249262 0.00218548 0.00393337 0.00242423 0.00225401 0.00389181 0.00374338 0.0109069 0.0189127 0.124714	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG2 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0910121 0.131902 0.111696 0.0344645 0.013872 0.00653975 0.0130959 0.00988217 0.00258285 0.0040167 0.00249044 0.00187668 0.00313879 0.00208776 0.00345698 0.0021744 0.00359809 0.00222813 0.00372941 0.00230458 0.00399089 0.00249946 0.004585 0.00323865 0.00237335 0.00411418 0.00260399 0.00475147 0.00316054 0.00674488 0.00375751 0.00345833 0.00726225 0.00555312 0.0052874 0.00871659 0.0167017 0.0271744 0.137417 0.0545603 0.0092619 0.00757748 0.00853951 0.0154003 0.00405237 0.00299958 0.00541658 0.00507152 0.00360883 0.0026972 0.00235634 0.00422314 0.00259657 0.00240162 0.00414897 0.0039713 0.0115301 0.0198995 0.130147	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG2 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0890816 0.129365 0.10961 0.0338602 0.0135823 0.0064095 0.0128364 0.00970197 0.00252855 0.00392934 0.00243606 0.00183365 0.00306867 0.00204013 0.00337928 0.00212496 0.00351731 0.00217737 0.0036459 0.00225184 0.00390248 0.00244308 0.00449188 0.00317087 0.00231736 0.00402214 0.00254255 0.00464279 0.00308425 0.00659002 0.00366612 0.00337578 0.00711393 0.00540172 0.00510736 0.00849153 0.0164611 0.0267098 0.133869 0.0556476 0.00984106 0.00667667 0.00515254 0.00702086 0.0059215 0.00733409 0.0134436 0.00532334 0.00382129 0.00296025 0.00247133 0.00443976 0.00259158 0.00245105 0.00431325 0.00404639 0.0120914 0.0204752 0.139194	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0893366 0.129605 0.109122 0.0336819 0.0135509 0.00632442 0.0128289 0.009568 0.00251899 0.00390885 0.00242485 0.00181705 0.00306456 0.0020193 0.0033708 0.00210208 0.00350596 0.0021509 0.00363087 0.00221853 0.00387922 0.00240028 0.0044565 0.00311936 0.00223192 0.00392547 0.00243088 0.00450333 0.00289856 0.0063107 0.00346124 0.00308167 0.00671045 0.00483812 0.00430696 0.00725642 0.014946 0.024663 0.124086 0.0428152 0.00810908 0.00603815 0.00475313 0.00578238 0.00405509 0.00484396 0.0106674 0.028991 0.0174771 0.00462053 0.00281045 0.00449321 0.00275161 0.00259876 0.004465 0.00428218 0.0123519 0.0211937 0.140644	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0897309 0.130012 0.109783 0.0339663 0.0136562 0.00639534 0.0129289 0.00966296 0.0025486 0.00396276 0.00245696 0.00184303 0.00310674 0.00204993 0.00342095 0.00213554 0.00356114 0.00218703 0.00369173 0.00225877 0.0039499 0.00244912 0.00455322 0.00317411 0.0022993 0.00404267 0.00251341 0.00465954 0.00303254 0.0065845 0.00360744 0.00327646 0.00707043 0.00513873 0.00475107 0.00804479 0.0163345 0.0269265 0.133036 0.0495863 0.00884566 0.0062362 0.00499226 0.00576099 0.00416084 0.00521519 0.00903122 0.0171027 0.00691299 0.00618606 0.00605335 0.0129151 0.00383115 0.00302123 0.00455222 0.0043306 0.0112889 0.0204259 0.124748	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.0894822 0.129718 0.109762 0.0339406 0.0136466 0.00640538 0.0129084 0.00968536 0.0025451 0.00396061 0.00245433 0.00184414 0.00310098 0.00205166 0.00341583 0.00213743 0.00355621 0.00218947 0.00368695 0.00226241 0.003946 0.00245417 0.00454903 0.00317849 0.0023131 0.00405329 0.00253282 0.00467865 0.00307012 0.00663551 0.00364313 0.00333644 0.0071439 0.00525775 0.00493147 0.00832209 0.0166696 0.0274252 0.13542 0.0517521 0.00904782 0.00627092 0.00506046 0.0056662 0.0040929 0.0050542 0.0082427 0.0157091 0.00559676 0.00440556 0.00335708 0.00601286 0.0040698 0.00508584 0.0159448 0.00417897 0.010025 0.0204201 0.121693	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.0867042 0.125617 0.106526 0.0329247 0.0132126 0.00620909 0.0124649 0.00937007 0.00245746 0.00382117 0.00237036 0.00178207 0.00298727 0.00198176 0.00328859 0.00206362 0.00342165 0.00211315 0.00354509 0.00218312 0.00379142 0.00236661 0.00436463 0.00306503 0.002234 0.00389322 0.00244511 0.00448716 0.00295867 0.00635887 0.00351115 0.00321305 0.00681473 0.00506522 0.00474293 0.00793727 0.0156996 0.0257146 0.128002 0.0499054 0.00879463 0.00597757 0.00482715 0.00533327 0.00396427 0.00490249 0.00778721 0.0154022 0.00538831 0.00434734 0.00311607 0.00489849 0.00283472 0.00281657 0.00516615 0.00817268 0.0392432 0.0249353 0.130477	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG1 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.107009 0.165593 0.129352 0.0379208 0.0144577 0.00698315 0.0133278 0.010641 0.00277645 0.00399941 0.00252692 0.00192835 0.00308323 0.00210136 0.00333637 0.0021649 0.00344071 0.00219755 0.00354198 0.00224631 0.00373795 0.00239427 0.00417288 0.00308549 0.00221704 0.00365316 0.00230747 0.00402712 0.00256809 0.00516388 0.00297706 0.00242 0.00476072 0.00358521 0.00272044 0.00308116 0.00637355 0.0057975 0.0199778 0.0460567 0.0144636 0.0591449 0.0106726 0.00987765 0.00902156 0.010039 0.0173024 0.00653659 0.00421236 0.00333793 0.00277391 0.00488154 0.00288413 0.00272173 0.00470957 0.00446108 0.0129639 0.0222409 0.14805	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG1 , DRUG0 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.101854 0.155861 0.122232 0.03595 0.0139186 0.00668996 0.0128278 0.0101303 0.00265711 0.0038488 0.00242849 0.00185609 0.00296896 0.00202357 0.00321624 0.00208464 0.00331673 0.00211551 0.0034129 0.00216157 0.00360048 0.00230222 0.00401802 0.00295571 0.00212721 0.00351341 0.00221383 0.00387193 0.00246798 0.00498564 0.00285698 0.00231332 0.00456856 0.00341085 0.00256348 0.00290329 0.00610873 0.00549783 0.0193294 0.0433806 0.0133615 0.0541753 0.00959826 0.00790831 0.00557724 0.00646335 0.0132475 0.0357172 0.0188932 0.00521776 0.00317392 0.00501876 0.00309374 0.00289979 0.00494227 0.00477633 0.0135488 0.0236613 0.152181	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG1 , DRUG0 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102831 0.157907 0.12345 0.0363273 0.0139769 0.00672797 0.0129057 0.0102036 0.00268878 0.00388883 0.00245331 0.00187434 0.00300271 0.00204399 0.00325328 0.00210707 0.00335709 0.00213925 0.00345773 0.00218655 0.00365144 0.00233026 0.00409148 0.00298837 0.0021574 0.00357628 0.0022453 0.00395222 0.00250927 0.00511228 0.00291126 0.00236651 0.00472983 0.00349161 0.00264168 0.0030709 0.0065873 0.00598758 0.0210571 0.0485686 0.0150466 0.0591032 0.0101249 0.00795161 0.00603502 0.00721588 0.0114016 0.0240747 0.00808291 0.00801818 0.00775683 0.0150566 0.00449365 0.0034492 0.00515784 0.00490284 0.0124398 0.0228624 0.136017	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG1 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.102823 0.15831 0.123819 0.0364342 0.0139695 0.00672557 0.0129174 0.0102372 0.00268944 0.0038916 0.00245271 0.00187244 0.0030026 0.00204229 0.00325346 0.00210572 0.00335797 0.0021382 0.00345951 0.00218576 0.00365486 0.00232988 0.00410137 0.00299199 0.00215653 0.00358055 0.00224515 0.00395925 0.00250935 0.00513232 0.00291612 0.00237278 0.00476582 0.00351349 0.00266099 0.00312258 0.00671559 0.00617492 0.0217668 0.0508814 0.0156143 0.0604534 0.0101093 0.0077599 0.00589257 0.00692751 0.0103837 0.0222498 0.00668636 0.00584301 0.00467405 0.00722683 0.00516419 0.00628061 0.018362 0.00482366 0.0111607 0.0229029 0.132247	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG1 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.0997376 0.153515 0.120483 0.035505 0.0135463 0.0065312 0.0124971 0.00993263 0.00259866 0.00375422 0.00236824 0.00180704 0.00289178 0.00196993 0.00313085 0.00203004 0.00322915 0.00206043 0.0033243 0.00210567 0.00350952 0.00224376 0.00393176 0.0028824 0.00207659 0.00343353 0.00216144 0.00379061 0.00241264 0.00490793 0.00280289 0.00227974 0.00454496 0.003373 0.00255842 0.00298395 0.00628629 0.00584116 0.0204367 0.0476895 0.0145448 0.0570071 0.00957056 0.007299 0.00577624 0.0067239 0.00988637 0.021818 0.00647508 0.00598596 0.00441874 0.00579494 0.0035459 0.00358697 0.00622254 0.00967876 0.0442262 0.0274619 0.136812	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG1 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.121195 0.188 0.146962 0.0426279 0.0163235 0.00791477 0.0149124 0.0119323 0.00310741 0.00443373 0.00283495 0.00215373 0.00341064 0.00233575 0.00367176 0.00239687 0.00376985 0.00242306 0.00386213 0.00246574 0.00404859 0.0026149 0.0044673 0.00336404 0.00239965 0.0038928 0.00246916 0.00420699 0.00268814 0.00516647 0.00309398 0.00241591 0.00439953 0.00344961 0.00249439 0.00240558 0.00460188 0.00340971 0.0111267 0.0149611 0.00419727 0.007951 0.00770339 0.0333417 0.00944026 0.00990893 0.0181417 0.00652004 0.00449404 0.00355977 0.00299178 0.00541262 0.00311584 0.0029086 0.00509625 0.00475986 0.0140308 0.0236311 0.158385	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG1 (e.g. , DRUG2 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.115159 0.177857 0.138582 0.0402164 0.0154656 0.00752143 0.0140983 0.0112929 0.00295432 0.00421665 0.00268644 0.00205252 0.00322661 0.00222184 0.00347021 0.00227888 0.00356075 0.00230306 0.00364609 0.00234312 0.00381905 0.00248328 0.00422171 0.00317478 0.00228643 0.00367918 0.00234584 0.00397226 0.00255774 0.00490333 0.0029312 0.00229624 0.00417557 0.00326009 0.00237712 0.0023012 0.00435681 0.00324953 0.0106861 0.0145775 0.00411402 0.00774516 0.0072335 0.0305356 0.00631257 0.00651174 0.0134504 0.0325444 0.0195663 0.00520682 0.00329113 0.00542344 0.00332407 0.00308195 0.00528497 0.00508695 0.0145332 0.0254056 0.16254	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG1 (e.g. , DRUG0 - DRUG2 ) , DRUG0 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.117478 0.181887 0.142124 0.041473 0.0157651 0.00773175 0.014363 0.011598 0.00303314 0.00429013 0.00274282 0.00209198 0.00327862 0.00226327 0.0035219 0.00232119 0.0036127 0.00234529 0.00369964 0.00238594 0.00387616 0.00253004 0.00430037 0.00322839 0.00233154 0.00373994 0.00238928 0.00403902 0.00260782 0.0049915 0.00299655 0.00234395 0.0042763 0.00332527 0.00243429 0.00236751 0.00449268 0.00335902 0.0111053 0.0151988 0.00435179 0.00825935 0.00794528 0.0328704 0.00666839 0.0071498 0.0115617 0.0232276 0.00771919 0.00742906 0.00753265 0.0155583 0.00469507 0.0036643 0.00553185 0.00525306 0.0135194 0.0246408 0.148481	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG1 (e.g. , DRUG0 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.118431 0.184316 0.143921 0.0419265 0.0157928 0.00777534 0.014367 0.0116924 0.00303923 0.00428246 0.00273726 0.00208797 0.00326166 0.00225603 0.00349949 0.00231178 0.00358683 0.00233408 0.00367049 0.00237305 0.00384269 0.00251479 0.0042604 0.00321276 0.00231746 0.0037035 0.00237179 0.00399434 0.00258426 0.00492778 0.00296626 0.00232174 0.0042151 0.00329668 0.00241105 0.00233582 0.00441218 0.00330271 0.0108938 0.0150739 0.00430393 0.00824658 0.00803543 0.0334026 0.00651851 0.00684467 0.0105027 0.0215342 0.00637693 0.00524612 0.00434044 0.00724305 0.00533042 0.00646924 0.0195582 0.00515646 0.0121883 0.0249579 0.145122	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG1 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.114625 0.178217 0.139601 0.0407119 0.0152634 0.00751737 0.0138567 0.0112938 0.00291982 0.00411264 0.00262876 0.00200471 0.00312681 0.00216425 0.00335178 0.00221583 0.0034323 0.00223555 0.00350863 0.00227159 0.00366943 0.00240535 0.00405483 0.00307465 0.00221436 0.00352721 0.00226494 0.00379575 0.00246195 0.00466521 0.00282244 0.00221174 0.00397871 0.00314032 0.00229874 0.00222049 0.00414115 0.00312657 0.0101658 0.0143306 0.00404005 0.00760243 0.00743332 0.0310872 0.0062873 0.00660781 0.00990813 0.0210826 0.00604769 0.00518516 0.00401791 0.00578044 0.00369957 0.00362707 0.00651835 0.00992524 0.0468567 0.0291964 0.149468	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG1 (e.g. , DRUG0 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.111146 0.169053 0.132831 0.0391821 0.0153418 0.00736633 0.0141771 0.011107 0.00296363 0.00424091 0.00270231 0.0020603 0.00327788 0.002237 0.00352922 0.00229901 0.00362673 0.00232512 0.00372031 0.00236606 0.00391197 0.0025091 0.00437931 0.0031928 0.00230013 0.00377905 0.00237385 0.00410118 0.002597 0.00513725 0.00300195 0.00235115 0.00441137 0.00333226 0.00240021 0.00243128 0.00474417 0.00358702 0.0120207 0.0152881 0.0039 0.00629524 0.0044485 0.0100108 0.0075713 0.0101556 0.0524625 0.0303941 0.00967181 0.00876835 0.0085966 0.0174734 0.00497441 0.00386159 0.00575413 0.00551662 0.0139145 0.0250179 0.14781	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG1 - DRUG0 ) , DRUG2 (e.g. , DRUG0 , DRUG0 ) .
4	4	0.110787 0.168847 0.132807 0.0391734 0.015291 0.0073392 0.0141323 0.0111077 0.0029505 0.00421817 0.00268756 0.00204643 0.00325713 0.0022215 0.00350555 0.00228247 0.00360144 0.0023077 0.00369341 0.00234773 0.00388345 0.00248936 0.00434937 0.00317323 0.00228 0.00374974 0.00235386 0.00406748 0.00257328 0.00509661 0.00297745 0.0023303 0.00438007 0.00331251 0.00237937 0.0024165 0.00470805 0.0035714 0.0120537 0.0155027 0.00392913 0.00638168 0.00454457 0.0102455 0.00798695 0.0108795 0.0566066 0.0284075 0.00824045 0.00627568 0.00505585 0.00823854 0.00597349 0.00708807 0.0208853 0.00533743 0.0123614 0.0251118 0.144199	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG1 - DRUG0 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.107247 0.163443 0.128846 0.0379877 0.0147479 0.007091 0.0135835 0.0107191 0.00282963 0.0040401 0.00257529 0.00196119 0.00311005 0.00212652 0.00334323 0.0021826 0.00343091 0.00220485 0.00351424 0.00224153 0.00368989 0.00237433 0.00411791 0.00302758 0.00217297 0.00355168 0.00224011 0.00384171 0.00244184 0.0047977 0.00282084 0.00221081 0.00410383 0.00313985 0.00226218 0.00228275 0.00437527 0.0033572 0.0111602 0.0146775 0.00368564 0.00588233 0.00423553 0.00932909 0.00739502 0.0101584 0.052647 0.0272257 0.00782819 0.00624131 0.00467954 0.00658723 0.00411094 0.00400535 0.0069477 0.0106903 0.048829 0.0298594 0.149791	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG1 - DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.0958998 0.145276 0.113428 0.0327804 0.0128485 0.00642752 0.0114792 0.00945616 0.00251378 0.00356863 0.00226391 0.0017977 0.00270364 0.00193154 0.00288899 0.00197226 0.00295349 0.00198976 0.00301295 0.00202332 0.00313991 0.00213001 0.00342431 0.00266631 0.00198888 0.00301582 0.00202484 0.0032349 0.00219465 0.0039753 0.00242432 0.00201274 0.00336363 0.00277216 0.00211406 0.00208524 0.00358817 0.00299037 0.00855412 0.0124209 0.00338697 0.00497879 0.00376007 0.00687712 0.00553989 0.00685222 0.0193048 0.0349339 0.0970235 0.0238869 0.0146615 0.0110174 0.00884451 0.0112317 0.0259708 0.00665487 0.0135425 0.0282193 0.145977	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG1 ) , DRUG0 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.0924002 0.139586 0.109538 0.0317217 0.0124205 0.00621296 0.0110739 0.00915094 0.00242462 0.00343803 0.00218481 0.00173458 0.00260513 0.00186442 0.00278389 0.00190374 0.0028458 0.00192065 0.00290244 0.00195332 0.00302442 0.00205629 0.00329333 0.00257176 0.00191953 0.00290269 0.00195553 0.00311277 0.00211982 0.00382274 0.00234222 0.00194692 0.00324218 0.00267866 0.00205277 0.00202919 0.00345727 0.00291903 0.00829113 0.012302 0.00333331 0.00480436 0.00364976 0.00655565 0.00547998 0.00668677 0.0184471 0.0334492 0.092339 0.0235357 0.0145273 0.00862265 0.00606981 0.00729233 0.00912326 0.0164463 0.0593954 0.0334901 0.138046	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG1 ) , DRUG0 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.121189 0.190437 0.146054 0.0419527 0.0158784 0.00779864 0.0144474 0.0117437 0.00309085 0.00434137 0.00276467 0.002135 0.00329776 0.00229671 0.0035226 0.00234774 0.00360034 0.0023654 0.00367407 0.00239912 0.00383066 0.00253344 0.00421867 0.00321384 0.00233845 0.00367378 0.00237984 0.00394218 0.0025802 0.00479431 0.00294084 0.00231982 0.00406122 0.00325082 0.00237927 0.0022232 0.00415346 0.00309191 0.00919305 0.0121442 0.00292657 0.00439826 0.002847 0.00576084 0.00328694 0.00295095 0.00943152 0.00864246 0.00760483 0.00684691 0.00694265 0.0327478 0.0110814 0.0117866 0.024095 0.00605813 0.0130932 0.0279307 0.146969	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG1 (e.g. , DRUG2 , DRUG0 ) .
4	4	0.11903 0.187545 0.144514 0.0417776 0.0154801 0.00770758 0.0139884 0.0116136 0.00302201 0.00418293 0.00267187 0.00206603 0.00315391 0.00221491 0.00335569 0.00226034 0.00342242 0.00227399 0.00348614 0.00230429 0.00362788 0.00243291 0.00399957 0.00308006 0.00224913 0.0034735 0.0022788 0.00370951 0.00246551 0.00449422 0.00281017 0.00221923 0.00381921 0.00310836 0.00229863 0.0021259 0.00385793 0.00292597 0.0084547 0.0119911 0.00281136 0.0041117 0.00270632 0.0052961 0.00311026 0.00283274 0.00892309 0.00866863 0.00704243 0.00649043 0.00675048 0.0321652 0.00804243 0.00859626 0.00930208 0.0164137 0.0532842 0.0290767 0.132883	DRUG0 may interact with DRUG0 ( DRUG0 type) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , other DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 (e.g. , DRUG0 - DRUG0 ) , DRUG1 (e.g. , DRUG0 , DRUG2 ) .
4	4	0.0191956 0.0470268 0.0460116 0.02928 0.0211121 0.0230405 0.0246286 0.0222088 0.0212007 0.0215755 0.0317669 0.0317698 0.0412653 0.0588879 0.0397506 0.0156764 0.0533554 0.0564722 0.0451162 0.0161808 0.0142934 0.0319696 0.0242506 0.0499536 0.0351185 0.0507815 0.0532235 0.0748875	Although DRUG1 (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation , the interaction between DRUG0 and DRUG2 has not been systematically studied .
4	4	0.00763707 0.0220332 0.0434332 0.0391638 0.0149542 0.0138416 0.0162714 0.01268 0.0151761 0.0222134 0.0323311 0.0340049 0.042471 0.0567764 0.0393913 0.0161431 0.0381087 0.0576781 0.0474755 0.0822272 0.021418 0.0380704 0.0256413 0.0447413 0.0414293 0.0525931 0.0524354 0.0696597	Although DRUG0 (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation , the interaction between DRUG1 and DRUG2 has not been systematically studied .
2	2	0.0795405 0.0655016 0.0598568 0.0587632 0.134198 0.0647153 0.0745067 0.044975 0.093628 0.0630716 0.102347 0.097116 0.0617804	Prior administration of DRUG1 can potentiate the neuromuscular blocking effects of DRUG2 .
1	1	0.0509058 0.0657651 0.141502 0.108572 0.0619969 0.112961 0.024995 0.0255605 0.0480143 0.0340926 0.0577831 0.0503127 0.08305 0.0752512 0.0592381	Evidence of spontaneous recovery from DRUG1 should be observed before the administration of DRUG2 .
4	4	0.0636354 0.0453252 0.0540284 0.0606862 0.108909 0.0806221 0.0513076 0.100098 0.0251868 0.0230664 0.0214171 0.0178046 0.0210029 0.022204 0.0287068 0.0367899 0.0661355 0.0418945 0.0488365 0.0823432	The use of DRUG1 before DRUG2 to attenuate some of the side effects of DRUG0 has not been studied .
4	4	0.0377751 0.0477428 0.0524321 0.0495494 0.0413914 0.0348593 0.05507 0.125222 0.0422841 0.0505375 0.0456125 0.0397373 0.0511303 0.0654581 0.0561421 0.0369139 0.0437065 0.0314453 0.0366166 0.0563743	The use of DRUG1 before DRUG0 to attenuate some of the side effects of DRUG2 has not been studied .
4	4	0.0387713 0.0475106 0.0661586 0.0545362 0.0728156 0.0552977 0.0723703 0.0758922 0.0804344 0.0966323 0.082558 0.0434611 0.0936237 0.119938	There are no clinical data on the use of DRUG1 with other DRUG2 .
4	4	0.187689 0.0428024 0.056271 0.0339463 0.0289152 0.0286094 0.0198494 0.0451897 0.0657909 0.112914 0.164831 0.0954732 0.117718	DRUG1 and DRUG2 (administered with DRUG0 / DRUG0 to achieve 1.25 M.C .
2	4	0.103004 0.0308655 0.0458727 0.174537 0.110784 0.0500613 0.0187262 0.0266653 0.0440542 0.0890476 0.133863 0.0775414 0.094977	DRUG1 and DRUG0 (administered with DRUG2 / DRUG0 to achieve 1.25 M.C .
4	4	0.0903212 0.0191561 0.0358632 0.124895 0.0650398 0.0429332 0.0796295 0.0973637 0.0508133 0.0786587 0.137039 0.0823034 0.095984	DRUG1 and DRUG0 (administered with DRUG0 / DRUG2 to achieve 1.25 M.C .
4	4	0.0295528 0.0225243 0.113451 0.220713 0.113261 0.0447531 0.0158211 0.0232022 0.0388215 0.0852864 0.128111 0.0732765 0.0912264	DRUG0 and DRUG1 (administered with DRUG2 / DRUG0 to achieve 1.25 M.C .
4	4	0.0272666 0.0207312 0.0998959 0.138185 0.0609888 0.0442511 0.0693352 0.0917829 0.0489583 0.0835734 0.138248 0.0814926 0.0952916	DRUG0 and DRUG1 (administered with DRUG0 / DRUG2 to achieve 1.25 M.C .
4	4	0.013787 0.00700496 0.0364802 0.118693 0.107542 0.122096 0.120621 0.105344 0.0511405 0.0698066 0.112377 0.0614788 0.0736288	DRUG0 and DRUG0 (administered with DRUG1 / DRUG2 to achieve 1.25 M.C .
2	4	0.0426011 0.0689407 0.0554346 0.032709 0.030079 0.0265088 0.0849227 0.0553296 0.0456556 0.0877137 0.0700785 0.0337295 0.052166 0.0376209 0.0429284 0.0487267 0.0511813 0.0338384 0.01638 0.01902 0.0644355	A greater potentiation of the neuromuscular blocking effects of DRUG1 may be expected with higher concentrations of DRUG2 or DRUG0 .
3	4	0.0476292 0.0768309 0.0614093 0.0353043 0.0319944 0.0280333 0.0870731 0.0563625 0.0467824 0.0882043 0.0681819 0.0324629 0.0491305 0.0359024 0.0363259 0.0406018 0.029667 0.0170423 0.0216123 0.0463257 0.0631237	A greater potentiation of the neuromuscular blocking effects of DRUG1 may be expected with higher concentrations of DRUG0 or DRUG2 .
2	0	0.0137023 0.015109 0.0186157 0.0649785 0.0496164 0.0313909 0.0308219 0.0973444 0.0611042 0.0518544 0.0753815 0.028312 0.0410708 0.0747619 0.122354 0.0226884 0.0153153 0.00426545 0.00238353 0.00240919 0.00186339 0.00240644 0.00184924 0.00239964 0.00179087 0.0023597 0.00174744 0.0023389 0.00172619 0.00234658 0.00175804 0.00259776 0.00176595 0.00180813 0.00268543 0.00183797 0.00182031 0.00371508 0.00375351 0.00190186 0.00299584 0.0021684 0.00337639 0.00292451 0.00230707 0.00390024 0.00298085 0.00526895 0.021247 0.0848784	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0134499 0.0147525 0.0183967 0.062291 0.0479898 0.0307146 0.0298912 0.0895067 0.0568392 0.0506033 0.0779009 0.0314753 0.0465669 0.0807578 0.123333 0.0217654 0.00727861 0.0053633 0.00593976 0.0108646 0.00235885 0.0024369 0.00184656 0.00236267 0.00181162 0.00235227 0.00177756 0.00234332 0.00175511 0.00235255 0.00178819 0.00262166 0.00178113 0.00179104 0.00268084 0.00186752 0.00179838 0.00366509 0.00390506 0.00189131 0.00296396 0.00216586 0.00352039 0.00288626 0.00226155 0.0037973 0.00294857 0.00520609 0.0208863 0.082496	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0136334 0.0149383 0.0185911 0.0629655 0.0484111 0.0309462 0.0300935 0.0897282 0.0565943 0.0504155 0.0776651 0.0319366 0.0472683 0.080209 0.119544 0.0201195 0.00585955 0.00357639 0.00371164 0.00490559 0.00531486 0.0105264 0.00219499 0.00242549 0.00186229 0.00237808 0.0018342 0.00237921 0.0018116 0.00239337 0.00184259 0.00266314 0.00183146 0.00182874 0.00272372 0.00193415 0.00184363 0.00373489 0.00408975 0.00195979 0.00301181 0.00223429 0.0036889 0.00295028 0.00231746 0.00385702 0.00302421 0.00532262 0.0213357 0.0835728	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0136957 0.015001 0.0186544 0.0632471 0.0485886 0.0310384 0.0301817 0.0899851 0.0566092 0.050379 0.0775207 0.0320254 0.0473225 0.079869 0.117208 0.0192445 0.00544062 0.00325421 0.00319132 0.00369218 0.00313593 0.00472598 0.00537 0.0103726 0.00216968 0.00247085 0.0018836 0.00242679 0.00185756 0.00243825 0.0018827 0.0027089 0.00186541 0.00185077 0.00275437 0.00197408 0.00186959 0.00378399 0.00419726 0.00198995 0.00304477 0.00226629 0.00376562 0.00298102 0.00233803 0.00388249 0.00305128 0.00536349 0.0214709 0.0839597	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0137132 0.0150178 0.0186657 0.0633211 0.0486243 0.0310467 0.0301886 0.0900214 0.0565595 0.0503035 0.0773384 0.0320243 0.04729 0.0796453 0.116017 0.0188231 0.00527577 0.00315659 0.00311804 0.00352476 0.00276989 0.00363292 0.00320838 0.00473026 0.00537096 0.01043 0.00215148 0.0024989 0.00189885 0.00246893 0.0019128 0.00272702 0.00189072 0.0018573 0.00275784 0.00200045 0.00187991 0.00380069 0.0042621 0.00200481 0.00304566 0.00228205 0.00380735 0.00298712 0.00234703 0.0038849 0.00306349 0.00537503 0.0214782 0.0838004	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.013718 0.0150222 0.0186636 0.0633324 0.0486187 0.0310349 0.030177 0.0899898 0.0564937 0.0502247 0.077173 0.0320058 0.0472554 0.0794704 0.115204 0.0185519 0.00517429 0.00309358 0.00306396 0.00343836 0.00272378 0.00349841 0.00284753 0.00365157 0.00318646 0.00473043 0.00535907 0.0105579 0.00214571 0.00253874 0.00195482 0.00274846 0.00192745 0.00186405 0.00275062 0.00203216 0.00189063 0.00380955 0.00432237 0.00201873 0.00303587 0.00229577 0.00384197 0.00298614 0.00235448 0.00388109 0.0030736 0.00537946 0.021448 0.0834394	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0137186 0.0150232 0.0186599 0.0633243 0.0486042 0.0310265 0.0301702 0.0899409 0.0564281 0.0501567 0.0770628 0.0319897 0.0472166 0.0792769 0.114545 0.0183668 0.00509872 0.00304799 0.00302282 0.00338148 0.00268774 0.00342715 0.00280876 0.00352661 0.00283433 0.00364945 0.00313418 0.0047139 0.00536076 0.0107333 0.0021775 0.00277912 0.00198617 0.00188104 0.0027411 0.00208325 0.00191043 0.00381891 0.00439471 0.00203785 0.00302017 0.00231293 0.0038804 0.00298297 0.00236415 0.00387526 0.00308632 0.00538327 0.0214027 0.0829441	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0137035 0.0150014 0.018631 0.0632356 0.0485343 0.0309642 0.0301031 0.0897514 0.0563355 0.0500903 0.0769001 0.0318755 0.0471358 0.0793633 0.114263 0.0182376 0.00504667 0.00302087 0.00299827 0.00334484 0.00266286 0.00338606 0.00278294 0.00347263 0.00281059 0.0035508 0.00281032 0.00366711 0.00309904 0.00471476 0.00531588 0.0118754 0.00232692 0.00191548 0.00269245 0.0021838 0.00195557 0.00381191 0.00448666 0.00207108 0.00296139 0.00233856 0.00393208 0.00296564 0.00238763 0.00386267 0.00312108 0.00540093 0.0212542 0.081647	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0136276 0.014882 0.0183958 0.0626966 0.0479925 0.0303842 0.0295173 0.0887738 0.0555723 0.0490536 0.073998 0.0311928 0.046713 0.07985 0.110362 0.0167215 0.00479248 0.00284433 0.00279122 0.00321683 0.00254633 0.00330517 0.002678 0.00340994 0.00272715 0.00350114 0.00277636 0.00362546 0.00290016 0.00390292 0.00341518 0.00486066 0.00489489 0.00849021 0.0125363 0.00331724 0.00220725 0.00412365 0.00436028 0.00210545 0.00328454 0.00233877 0.00376905 0.00312487 0.00236109 0.00401564 0.00303635 0.0054281 0.0217881 0.0857924	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0134978 0.0147734 0.0183295 0.0621498 0.0476692 0.030421 0.0295782 0.0878627 0.0550269 0.048933 0.0751076 0.031165 0.0462675 0.078398 0.111024 0.0178854 0.00484215 0.00295392 0.00292451 0.00319848 0.00258215 0.00322015 0.00268994 0.00328887 0.00271305 0.00334383 0.00271837 0.00340776 0.00276352 0.0035575 0.00304517 0.00404776 0.00329166 0.00500999 0.00501675 0.0060337 0.006227 0.0130203 0.00627638 0.00312699 0.00391944 0.00306419 0.00492385 0.00327945 0.00277566 0.00419937 0.00356192 0.00579431 0.0214322 0.0796606	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG2 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0136827 0.0149704 0.0184604 0.0629172 0.0481277 0.0305334 0.0297293 0.0894158 0.0557375 0.0489401 0.0736173 0.0314515 0.0467181 0.0789532 0.10735 0.0156457 0.00455404 0.00264987 0.00253494 0.00305675 0.00236737 0.00314306 0.00247091 0.00322832 0.00249691 0.00329122 0.00251336 0.00336924 0.00256636 0.00353947 0.0028387 0.00409107 0.00314018 0.00424001 0.00440888 0.00377015 0.00334442 0.00638698 0.0104568 0.00568715 0.0128142 0.00303377 0.00461905 0.00335995 0.00286322 0.00429645 0.00356521 0.00571599 0.0217037 0.0816317	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.0136997 0.0149801 0.0184755 0.0629596 0.0482019 0.0305911 0.0298038 0.0897007 0.0560103 0.0492411 0.0739561 0.0313876 0.0468634 0.0787905 0.105984 0.015351 0.0044319 0.00254286 0.00244645 0.00297538 0.0022855 0.00305069 0.00238123 0.00312918 0.00240447 0.00318766 0.00241935 0.0032618 0.00247122 0.00342663 0.00273409 0.00395245 0.00304442 0.00411348 0.00420533 0.00358076 0.00305771 0.00521481 0.0073301 0.00304692 0.00451535 0.00534119 0.0141407 0.0155741 0.00304745 0.00414126 0.0032443 0.00482754 0.0195489 0.0789284	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
2	0	0.0137912 0.0150817 0.0186137 0.0634031 0.0485488 0.0308179 0.0300093 0.0901717 0.0563265 0.0496074 0.0746943 0.0316315 0.0472694 0.079577 0.107663 0.0157143 0.00446147 0.00257497 0.00247664 0.00298662 0.00229912 0.00305448 0.0023938 0.00313026 0.00241599 0.00318756 0.00242979 0.00326104 0.00248251 0.00342871 0.00275621 0.0039628 0.00310218 0.0042515 0.00423181 0.00370981 0.00310985 0.00513317 0.00750387 0.00299 0.0042564 0.00385421 0.00831427 0.00504563 0.0051074 0.015297 0.0035243 0.00462857 0.0181606 0.077557	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
2	0	0.0133227 0.0145565 0.0179824 0.0611664 0.0467384 0.0296442 0.0288177 0.0859769 0.0533839 0.0469708 0.0708505 0.0299065 0.044806 0.0768969 0.102994 0.0155649 0.00415256 0.00252798 0.00243625 0.00273369 0.00219019 0.00275849 0.00226684 0.00280537 0.00227576 0.00283807 0.00227559 0.00288444 0.00232433 0.0030284 0.00262498 0.0034811 0.0031019 0.00447212 0.00381681 0.00386767 0.00292156 0.00434294 0.00676816 0.00263299 0.00339173 0.00315119 0.00670826 0.00342676 0.00248123 0.0042555 0.00618581 0.0151908 0.0526767 0.0874252	Other drugs which may enhance the neuromuscular blocking action of DRUG1 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
2	0	0.00820042 0.00818134 0.0113278 0.0435246 0.0337095 0.0194861 0.0178504 0.0519915 0.0404707 0.0415378 0.0264121 0.0427205 0.067819 0.23165 0.129767 0.0260043 0.0160325 0.00459668 0.00261663 0.00268837 0.00207082 0.00265596 0.00202446 0.00261653 0.00193751 0.00253578 0.00186009 0.00247225 0.00180568 0.00244136 0.00180947 0.00266522 0.00179642 0.00183514 0.00271629 0.00183602 0.00181809 0.00371408 0.00372335 0.00186383 0.00295784 0.00211975 0.00327024 0.00284513 0.00224978 0.00382169 0.00291039 0.00515725 0.0204847 0.0813978	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00813145 0.00820674 0.0114704 0.0434031 0.0337854 0.0189218 0.0168165 0.0480053 0.0381024 0.0403883 0.0269805 0.0459667 0.0716864 0.237253 0.119102 0.0262669 0.00888856 0.0062706 0.00699216 0.0122137 0.00275724 0.00281125 0.00210907 0.00263193 0.00201147 0.00257027 0.00194242 0.0025221 0.00188897 0.00249395 0.00189484 0.00273667 0.00185946 0.00186675 0.00274618 0.00190542 0.00183173 0.00369098 0.0039393 0.00189243 0.00294721 0.00214252 0.00342721 0.00283093 0.00221671 0.00372052 0.00288682 0.00510029 0.0199274 0.0778463	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00818191 0.00817387 0.0113969 0.0433428 0.0335524 0.0185639 0.0164638 0.0470113 0.0374069 0.0394722 0.0265223 0.0455336 0.071584 0.238895 0.118009 0.0250058 0.00751574 0.00440576 0.00482615 0.00572139 0.00599919 0.0113537 0.00251952 0.00276026 0.00209398 0.00262782 0.0020177 0.00258842 0.0019649 0.00256899 0.00197077 0.00281701 0.00193244 0.00192891 0.00282551 0.00199365 0.00190127 0.00381078 0.00416243 0.00198409 0.00304135 0.00223688 0.00361344 0.0029295 0.00229793 0.00382769 0.00299328 0.00527167 0.0205671 0.0798146	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00819397 0.00815621 0.0113665 0.0433084 0.0334771 0.0184594 0.0163651 0.0467613 0.0372557 0.0392756 0.0264014 0.0454751 0.0717722 0.239878 0.116566 0.0242356 0.00707976 0.00407096 0.00433389 0.00446264 0.00371949 0.00519065 0.00577052 0.0107315 0.00241493 0.00272465 0.00206058 0.00262154 0.00200273 0.00260533 0.00200587 0.00285845 0.001966 0.00195005 0.00285534 0.00203411 0.00192855 0.00386159 0.00426935 0.0020182 0.00307941 0.00227399 0.00368756 0.00296443 0.0023237 0.00386067 0.00302657 0.00532124 0.0207169 0.0802607	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00819189 0.00814176 0.0113432 0.0432524 0.0334124 0.0183897 0.0162971 0.0465818 0.0371343 0.0391449 0.026325 0.0454344 0.0718229 0.240273 0.115713 0.0238301 0.00690386 0.003973 0.00429374 0.00429875 0.00337974 0.00411992 0.0036005 0.00501553 0.00562059 0.0105238 0.00233721 0.00268637 0.00203059 0.00261969 0.00202614 0.00286709 0.00198657 0.00195083 0.00285453 0.00205847 0.00193722 0.00387499 0.00433073 0.00203449 0.00308229 0.00229194 0.00372663 0.00297129 0.00233352 0.00386352 0.00303937 0.0053324 0.0207036 0.080043	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00818811 0.00813145 0.0113262 0.0432042 0.0333617 0.0183368 0.0162448 0.0464445 0.0370357 0.0390472 0.0262738 0.0454107 0.0718575 0.240455 0.115066 0.0235594 0.00679298 0.00390516 0.00423979 0.00421184 0.0033608 0.00399695 0.00327589 0.00398447 0.00344481 0.00488189 0.0054941 0.0104598 0.00228145 0.00267554 0.00205208 0.00287217 0.00201489 0.00194751 0.0028405 0.0020861 0.00194435 0.00387856 0.00438716 0.00204957 0.00307443 0.00230775 0.00376023 0.00297129 0.0023414 0.00385965 0.00304973 0.00533645 0.0206496 0.0796281	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00818316 0.00812179 0.0113118 0.0431573 0.0333183 0.0182955 0.0162035 0.0463301 0.0369603 0.0389835 0.026242 0.045423 0.0718794 0.240481 0.114487 0.0233926 0.00671345 0.00385591 0.00419255 0.00415275 0.00333234 0.00393119 0.00326368 0.00387298 0.00313035 0.00386887 0.00329358 0.00476659 0.00540571 0.0104887 0.00227483 0.00288435 0.00205872 0.00194865 0.00281946 0.00213041 0.00195814 0.00388086 0.00445533 0.00207001 0.00306116 0.00232798 0.00380007 0.00297039 0.00235265 0.00385547 0.0030645 0.00534326 0.0205873 0.0791168	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00818081 0.0081184 0.0113061 0.0431389 0.033297 0.0182707 0.0161772 0.0462761 0.0369114 0.038941 0.0262273 0.0454244 0.0718853 0.240355 0.114061 0.0232503 0.00665196 0.00382697 0.00415941 0.00410916 0.00330285 0.00388528 0.00324123 0.00381914 0.00312405 0.00377788 0.00300499 0.00379458 0.00318137 0.00468661 0.0052813 0.0114468 0.00239568 0.00195932 0.00275056 0.00222008 0.00199142 0.00386 0.00453514 0.00210152 0.0030014 0.00235615 0.00385547 0.00295448 0.00237766 0.00384438 0.00310186 0.00536492 0.0204088 0.0778069	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00818325 0.0081234 0.011247 0.0430639 0.0330902 0.0179937 0.0159139 0.0459298 0.0362196 0.0377699 0.0255335 0.043579 0.0716124 0.240043 0.111619 0.0211848 0.00625847 0.00358472 0.00379759 0.00388471 0.00308839 0.00372481 0.00305485 0.00368054 0.00297902 0.00366138 0.00293544 0.00370012 0.00299134 0.00390786 0.00343766 0.00472885 0.00472693 0.0080429 0.0117652 0.00330881 0.00222422 0.00412737 0.0044282 0.00213485 0.00330768 0.00236169 0.00371881 0.00310613 0.002345 0.00396672 0.00300565 0.00535114 0.0208183 0.0807388	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00803689 0.00796234 0.0110842 0.0422924 0.0326151 0.0178361 0.0157747 0.0451183 0.0360743 0.0380764 0.0257775 0.0449479 0.0712874 0.235997 0.110386 0.0228722 0.00641575 0.00374932 0.00407061 0.00393975 0.00321286 0.00370249 0.00314119 0.00362337 0.0030269 0.00356878 0.00293163 0.00355115 0.00291255 0.00364485 0.00316465 0.00405318 0.00334072 0.00507248 0.00482481 0.0057655 0.00598475 0.0125869 0.0063714 0.00319113 0.0039878 0.00312199 0.00487509 0.00328838 0.00278479 0.00421401 0.00358225 0.00578845 0.0205499 0.0758216	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG2 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.00820401 0.00814897 0.0112629 0.0432036 0.0331929 0.0180127 0.0159407 0.0461428 0.036277 0.0377338 0.0254487 0.0430716 0.0714551 0.240419 0.109721 0.0199832 0.00597445 0.00333056 0.00337566 0.00367774 0.00282528 0.00353594 0.0027798 0.00347832 0.00269572 0.00343886 0.00263464 0.00344237 0.00263726 0.00356254 0.0028827 0.00403967 0.00316298 0.00433446 0.00425029 0.00358563 0.00324717 0.00611334 0.00959583 0.00548502 0.0123431 0.00304371 0.00455271 0.00331868 0.00284077 0.00427649 0.0035697 0.00570462 0.0207222 0.0773233	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
2	0	0.008221 0.00817339 0.0113146 0.0433034 0.0333006 0.0181033 0.0160067 0.046214 0.0363956 0.0379919 0.0256001 0.0434979 0.0715347 0.240534 0.108442 0.0196522 0.0058734 0.00321417 0.00326849 0.00359993 0.00273497 0.0034501 0.00268563 0.00338778 0.00260221 0.00334601 0.00254287 0.00334795 0.00254685 0.00346496 0.0027876 0.00392236 0.00308267 0.00423805 0.00407974 0.00342641 0.0029917 0.00502661 0.0069304 0.00297677 0.00440443 0.00514068 0.0130007 0.0151583 0.00307583 0.00413395 0.00326236 0.00483338 0.018659 0.0745183	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
2	0	0.0082776 0.00822354 0.0113932 0.0435752 0.033515 0.0182279 0.0161145 0.0464491 0.0366563 0.0383318 0.0258679 0.0441568 0.0722657 0.242185 0.109962 0.0202012 0.00592736 0.00326372 0.00332876 0.00362534 0.00276325 0.00346461 0.00271011 0.00339854 0.00262301 0.00335411 0.00256038 0.00335416 0.00256405 0.00347347 0.00281626 0.00393788 0.00314546 0.00438292 0.00411064 0.0035535 0.00304328 0.00495264 0.00709995 0.00293774 0.00417919 0.0037435 0.00767567 0.00486952 0.00496423 0.0148646 0.00352687 0.00456837 0.0171853 0.0726292	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
2	0	0.00798967 0.00791992 0.0109839 0.0418481 0.0321499 0.0174595 0.0153983 0.0441945 0.0350446 0.0367015 0.0250727 0.0434956 0.0708583 0.23136 0.103848 0.020007 0.00553579 0.00321014 0.00333333 0.00335063 0.00267834 0.00316238 0.00260737 0.00307911 0.00250351 0.00301712 0.00242374 0.00299609 0.00242539 0.00309955 0.00271538 0.00349389 0.00316706 0.00458898 0.00373291 0.00374825 0.00286695 0.00421444 0.00640586 0.00258528 0.00333909 0.00305937 0.00623265 0.00332738 0.00241978 0.00414268 0.00587343 0.0142594 0.0503244 0.0817489	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG1 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0139609 0.0140946 0.0173066 0.0659572 0.0471882 0.0221053 0.0188671 0.0694054 0.0491258 0.0329144 0.0216494 0.0112625 0.0203488 0.0829775 0.158189 0.0326492 0.0478583 0.011947 0.00936379 0.0134251 0.00310885 0.00342283 0.00266767 0.0032576 0.00254796 0.00321733 0.00247897 0.003212 0.00245337 0.00324003 0.00252106 0.00361984 0.00251309 0.00250952 0.00372842 0.00262807 0.00258532 0.00507047 0.00532535 0.00269004 0.00416174 0.00305455 0.00504242 0.00397754 0.00320227 0.00531372 0.00415286 0.00735554 0.0272836 0.113062	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0138646 0.0141361 0.0173646 0.0656073 0.0469469 0.0223559 0.0190712 0.0707708 0.0493175 0.0331218 0.0211686 0.0111031 0.0206497 0.0838034 0.157625 0.0328379 0.0464504 0.0085768 0.00893094 0.00720631 0.00755644 0.0136974 0.00291375 0.00328878 0.00256155 0.00313786 0.00247625 0.00312411 0.00243141 0.00314915 0.00248611 0.00350142 0.00246733 0.00244934 0.00362011 0.00259815 0.00253665 0.00494055 0.00534166 0.00267022 0.00404024 0.00299601 0.00502452 0.00387025 0.00311886 0.00515848 0.00405845 0.00720559 0.0266475 0.110023	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0137464 0.0140096 0.0172102 0.0650684 0.0465881 0.022149 0.0188845 0.0701405 0.0488971 0.0329668 0.0211146 0.0110817 0.0207815 0.0841559 0.157205 0.0324582 0.0455932 0.00822526 0.00868619 0.00622456 0.0065057 0.00630676 0.00712263 0.0127811 0.00281669 0.00325462 0.00253043 0.00313855 0.00246917 0.00315236 0.00250142 0.00348672 0.00247605 0.00243761 0.00360076 0.002617 0.00253365 0.00493601 0.00542219 0.00268331 0.00402283 0.00300919 0.00507362 0.00386641 0.00311885 0.00514959 0.00406631 0.0072072 0.0266788 0.109848	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0136713 0.0139241 0.017105 0.0646966 0.0463252 0.0219858 0.0187391 0.0695872 0.0485201 0.0327565 0.0210394 0.0110411 0.0207571 0.0839085 0.156393 0.032076 0.0450197 0.00810053 0.00863026 0.0060463 0.00643616 0.00543443 0.00598637 0.00600665 0.00682815 0.0124621 0.00275354 0.00325731 0.00252269 0.00317701 0.00253425 0.0034865 0.00249542 0.00242535 0.00358881 0.00264065 0.0025303 0.00494161 0.00549454 0.00269329 0.00400171 0.00301994 0.00511553 0.00386086 0.00312269 0.0051429 0.0040764 0.00720919 0.0267138 0.109719	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0136256 0.0138723 0.0170386 0.0644518 0.0461493 0.0218763 0.0186437 0.0692109 0.0482455 0.0325775 0.0209697 0.0110002 0.0206977 0.0834873 0.155471 0.0317038 0.0442956 0.00792308 0.00847418 0.00591255 0.0064326 0.00530032 0.00593975 0.00514865 0.0055315 0.00584113 0.00665196 0.0124188 0.00272617 0.00330481 0.00258621 0.00350868 0.00254184 0.00242471 0.00358754 0.00268051 0.00253447 0.00495965 0.0055741 0.00270583 0.00398219 0.00303376 0.00515873 0.00385759 0.00313125 0.00514093 0.0040913 0.00721542 0.0267536 0.109609	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0135857 0.0138299 0.0169825 0.0642406 0.0459978 0.0217873 0.0185664 0.0689107 0.0480121 0.0324156 0.0208981 0.0109604 0.020638 0.0830804 0.154581 0.0313741 0.0436762 0.00777842 0.00833456 0.00580428 0.00633182 0.00519564 0.00597728 0.0050396 0.00548716 0.00496986 0.00516062 0.00572565 0.00657014 0.0125677 0.00276442 0.003609 0.00261584 0.00244579 0.00359911 0.00275289 0.0025541 0.00499207 0.00567351 0.00272442 0.0039575 0.0030513 0.00520647 0.00385201 0.00314305 0.0051381 0.00411011 0.0072224 0.0267699 0.109338	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0135304 0.0137648 0.0169032 0.063994 0.0458301 0.0216926 0.0184893 0.0686184 0.0478682 0.0323619 0.0208566 0.0109301 0.0205778 0.082733 0.153674 0.0311535 0.0433467 0.00770435 0.00825874 0.0057282 0.00625031 0.00511374 0.00592068 0.00496151 0.00557601 0.00489446 0.0051476 0.00486696 0.00488736 0.00566889 0.00657362 0.0137995 0.0029273 0.00247882 0.00355545 0.00289427 0.00260558 0.00502814 0.00580511 0.00275344 0.00387376 0.00307036 0.00525225 0.00381853 0.00316479 0.00511817 0.00414716 0.00723306 0.0266225 0.107975	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0133897 0.0135754 0.0166666 0.063071 0.0451811 0.0213052 0.0181899 0.0672622 0.0470324 0.0318443 0.0206879 0.0107919 0.0202403 0.0805483 0.149862 0.0301588 0.040615 0.00707108 0.00761738 0.00545074 0.00582617 0.00489263 0.00552003 0.00475667 0.00526725 0.00473505 0.00513056 0.00480543 0.00517641 0.00507251 0.00568356 0.00596164 0.00688611 0.00973685 0.0141361 0.00383225 0.00282384 0.0053364 0.0054869 0.00275043 0.00422138 0.00306444 0.00504522 0.00403045 0.00313922 0.0052894 0.00403944 0.00722302 0.0271487 0.112421	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0131513 0.0133896 0.016438 0.062176 0.0445483 0.0210917 0.0179727 0.0666408 0.0463384 0.0313127 0.0201907 0.0105904 0.0199665 0.079888 0.146846 0.029448 0.0411838 0.00745931 0.00791467 0.00539198 0.00594576 0.00477938 0.00560455 0.0046056 0.00528771 0.00452554 0.00504472 0.00450784 0.00497095 0.0046295 0.00525404 0.0050308 0.00571034 0.00800073 0.00589121 0.00835238 0.00745528 0.0146551 0.00755274 0.00389361 0.00498424 0.00396047 0.00640576 0.0042163 0.0036566 0.00559683 0.00471939 0.00769098 0.0272618 0.107871	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG2 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.013421 0.0136272 0.0166963 0.0629927 0.0451336 0.0212481 0.0181355 0.0670496 0.0467189 0.0315005 0.020571 0.0106949 0.0200219 0.0791676 0.146523 0.0289625 0.0381182 0.00632564 0.00677173 0.00510157 0.0051533 0.00456872 0.00479873 0.00440899 0.00449607 0.00434646 0.0042929 0.00435936 0.00428662 0.00455446 0.00474512 0.00506071 0.00523723 0.00714099 0.00545492 0.00539032 0.00479376 0.00775817 0.0140029 0.00715661 0.0152427 0.0037807 0.00605183 0.00436866 0.00382803 0.00578126 0.00475947 0.00763182 0.0277852 0.109983	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0134029 0.0135905 0.0166457 0.0628452 0.0450326 0.0211268 0.0180145 0.0665845 0.0464317 0.0313095 0.0205509 0.0106703 0.0199002 0.0785414 0.146066 0.0288541 0.0377071 0.0060845 0.00662926 0.0050485 0.00505267 0.00451381 0.00470586 0.00435187 0.00440993 0.004288 0.00421462 0.00430084 0.00421758 0.00449421 0.00469508 0.00498236 0.00516554 0.00697366 0.00524756 0.00519758 0.00445747 0.00630971 0.0100536 0.00449157 0.005972 0.00680416 0.0180288 0.0188371 0.00389945 0.00568014 0.00436369 0.00653448 0.0257131 0.107007	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0134563 0.0136494 0.0167219 0.0631748 0.0452793 0.0212642 0.0181348 0.0670588 0.0467963 0.0315915 0.0206717 0.0107415 0.0200628 0.0791839 0.146796 0.0291199 0.0381276 0.00619087 0.0067314 0.00507077 0.00510758 0.00452663 0.00475568 0.00436176 0.00445471 0.00429531 0.00425382 0.0043056 0.00425305 0.00449653 0.00473093 0.00498831 0.00528167 0.00712809 0.0052749 0.00538168 0.00452652 0.00621562 0.0103926 0.00461489 0.00561749 0.00520225 0.0124601 0.00648893 0.00682143 0.0198998 0.00466332 0.0062571 0.0241268 0.105293	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0128791 0.0131561 0.0161392 0.0607521 0.0435223 0.0206843 0.0176157 0.065074 0.0447439 0.0300768 0.0191902 0.0100163 0.0186765 0.0734918 0.133271 0.026043 0.0349166 0.00613234 0.00654921 0.00462199 0.00489848 0.00409746 0.0045746 0.00392958 0.00428411 0.0038443 0.00407427 0.00382402 0.0040568 0.00396135 0.00446469 0.00437889 0.00536265 0.00691114 0.0046675 0.00541807 0.00413682 0.00527691 0.0094213 0.00391759 0.00436084 0.00419733 0.0100035 0.00432401 0.0034045 0.00576797 0.00842698 0.0176678 0.065434 0.12336	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0145353 0.0146464 0.0179681 0.0682351 0.0483316 0.0227823 0.0195922 0.0713629 0.048148 0.0322941 0.0218115 0.0107994 0.0186586 0.0587683 0.0980127 0.0134989 0.0118162 0.00829095 0.0096484 0.0439422 0.00893147 0.00619834 0.00655632 0.0054843 0.00621174 0.00531912 0.00593121 0.00529845 0.00587599 0.00545423 0.00626781 0.00601607 0.00703702 0.00890388 0.00642289 0.00689603 0.00594505 0.00875049 0.0163282 0.00808375 0.0161223 0.00411232 0.00653569 0.00473207 0.00415073 0.00625605 0.00516127 0.0082926 0.0302275 0.119354	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0145042 0.0146008 0.0179057 0.0680235 0.0481926 0.0226636 0.0194726 0.0709618 0.0478534 0.032087 0.02174 0.0107558 0.0185392 0.0582062 0.0972068 0.0134053 0.0116575 0.00819529 0.00947262 0.0432987 0.00875372 0.00611362 0.00642385 0.00540783 0.00608538 0.00524098 0.00581753 0.00522025 0.00577886 0.00537569 0.00619842 0.00592437 0.0069482 0.00864993 0.00616373 0.00659859 0.00551739 0.00712732 0.0122649 0.0055261 0.00671746 0.00767036 0.0195926 0.0200235 0.00421929 0.00614149 0.00471162 0.00706685 0.0280057 0.115972	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.014526 0.0146322 0.0179465 0.0682098 0.0483349 0.0227546 0.0195533 0.071281 0.0480899 0.0322567 0.0218005 0.0107887 0.0186143 0.0584802 0.0975012 0.0134643 0.0117402 0.00827214 0.00960704 0.0438689 0.00886574 0.00613205 0.0064764 0.00540983 0.00613631 0.00523979 0.00586523 0.00521686 0.00582256 0.00536983 0.00623744 0.00592534 0.00710551 0.00881678 0.0061932 0.00680605 0.00561229 0.00705604 0.0128559 0.00580748 0.00631375 0.00587796 0.0148811 0.00717824 0.00756732 0.0215907 0.0050607 0.00677648 0.026151 0.113929	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0137619 0.0139556 0.0171403 0.0650403 0.0460922 0.021897 0.018755 0.0684187 0.0456457 0.0305928 0.0201958 0.0100389 0.0173462 0.0542759 0.0894702 0.0123058 0.0102718 0.00745018 0.00872948 0.0399442 0.00842345 0.00554503 0.00608042 0.00482077 0.00578107 0.00463807 0.00552066 0.00458547 0.00546007 0.00468849 0.00577054 0.00516562 0.00702768 0.00829615 0.00541989 0.00660829 0.00504366 0.00597299 0.0118203 0.00493866 0.00487868 0.00470575 0.011975 0.00477206 0.00382417 0.00636208 0.00953491 0.0192154 0.0705344 0.131262	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0151706 0.0150379 0.0183255 0.0690544 0.0484091 0.0224553 0.0195105 0.0696924 0.0459096 0.0297706 0.021347 0.0105524 0.0176118 0.0536384 0.0908875 0.0119833 0.00885083 0.00448066 0.00394402 0.010463 0.0106123 0.0456532 0.00903583 0.00703738 0.00693932 0.00618628 0.00649086 0.0059409 0.00626621 0.00600364 0.0065996 0.0064932 0.00707241 0.00911801 0.006774 0.00689637 0.00602766 0.00923371 0.0158972 0.00832601 0.0170312 0.00436609 0.00694952 0.00508674 0.00444394 0.00672223 0.0055064 0.0088759 0.032553 0.128766	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0151417 0.014994 0.0182635 0.0688273 0.0482603 0.0223294 0.0193793 0.0692737 0.0455979 0.0295619 0.0212959 0.0105167 0.0175151 0.0532642 0.0902867 0.0119457 0.00874271 0.00444559 0.00387508 0.0103419 0.0104437 0.0450451 0.0088457 0.0069374 0.00679275 0.00610199 0.00636253 0.00586001 0.00615573 0.00592091 0.00652518 0.00640332 0.0070007 0.00891063 0.00652118 0.0066494 0.00559954 0.00748233 0.0115478 0.00526838 0.00694874 0.00791622 0.0201546 0.0212515 0.00452051 0.00660831 0.00505957 0.00759339 0.0301861 0.125528	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0152239 0.0150894 0.0183825 0.0693158 0.0486216 0.0225284 0.019555 0.0699358 0.0460521 0.0298661 0.0214488 0.0105901 0.0176462 0.0536958 0.0908726 0.012052 0.00880472 0.00447859 0.00391301 0.010458 0.010624 0.0458559 0.00898801 0.00698404 0.00688442 0.00613013 0.00644927 0.00588303 0.00623838 0.00594035 0.00660883 0.00643458 0.00720875 0.00914859 0.00658094 0.00692041 0.00572421 0.00740821 0.0120423 0.005494 0.00660314 0.00606113 0.014347 0.00753062 0.00787504 0.0225736 0.00536515 0.00719733 0.0279856 0.122382	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0143139 0.0143042 0.0174574 0.0658101 0.0461967 0.021627 0.0187059 0.0671456 0.0437448 0.02841 0.0197755 0.00981538 0.0164254 0.0496336 0.0826217 0.0108449 0.00766129 0.00401377 0.00346577 0.00885059 0.00948081 0.0412588 0.0083887 0.0062145 0.00641551 0.00538392 0.0060137 0.00512566 0.00581836 0.0051399 0.00611092 0.00556934 0.00715972 0.00860876 0.00569845 0.00666095 0.00510209 0.0061538 0.010822 0.00465212 0.00506887 0.00479476 0.0113488 0.00493087 0.00383836 0.00653265 0.00960359 0.0203009 0.07506 0.14192	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.015397 0.0151296 0.0183719 0.0687316 0.0478857 0.0219888 0.0191449 0.0675039 0.0439236 0.0278859 0.020679 0.010321 0.0169599 0.0507262 0.0853859 0.0107708 0.00806176 0.00405729 0.00306891 0.00608048 0.00457908 0.0121418 0.0114593 0.0498926 0.00978774 0.00758408 0.00743715 0.00667137 0.0070745 0.00653379 0.00729014 0.00696017 0.00760117 0.0097046 0.00716536 0.00729068 0.00636529 0.00969783 0.0166337 0.00861568 0.0174656 0.00450285 0.00717763 0.00525261 0.00459106 0.00694217 0.00568641 0.00917169 0.0336415 0.133008	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0153644 0.0150816 0.0183051 0.068482 0.0477209 0.0218569 0.0190087 0.0670601 0.0436062 0.0276808 0.0206275 0.0102832 0.016863 0.0503782 0.0848293 0.0107487 0.00796781 0.00403059 0.00302409 0.00603551 0.00450243 0.0120079 0.0112884 0.0492281 0.00957468 0.00747033 0.00728442 0.0065799 0.0069474 0.00644521 0.00720409 0.00686323 0.00751949 0.00947037 0.00689308 0.00702681 0.00591447 0.00785414 0.0121067 0.00551703 0.00720088 0.00818837 0.0207478 0.0218232 0.00465885 0.00681716 0.0052213 0.0078402 0.0312042 0.129645	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0154423 0.0151719 0.0184174 0.0689416 0.0480589 0.0220417 0.0191726 0.0676761 0.0440196 0.0279503 0.0207686 0.0103505 0.0169811 0.0507621 0.085351 0.0108431 0.00802201 0.0040607 0.00304311 0.00608628 0.00454734 0.012137 0.0114867 0.0501119 0.00973128 0.00752024 0.00738322 0.00660913 0.00704097 0.00646841 0.00729894 0.00689816 0.00774437 0.00972191 0.00695506 0.00731008 0.00604512 0.00777633 0.0126338 0.0057645 0.00683568 0.00626721 0.0149616 0.00777886 0.00814454 0.0232961 0.0055417 0.00743672 0.0289371 0.126455	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0144923 0.0143491 0.0174525 0.0653182 0.0455467 0.021102 0.0183013 0.0648916 0.0417701 0.0265735 0.019113 0.00958418 0.0157977 0.0468413 0.0773228 0.00974194 0.00698952 0.00363824 0.00269314 0.00518944 0.00395724 0.0101588 0.0101999 0.0449469 0.00910166 0.0066834 0.00688191 0.00578619 0.00656451 0.00561761 0.00675803 0.00598592 0.00770388 0.00915253 0.00602737 0.007032 0.00538406 0.00645901 0.0113778 0.00488652 0.00525229 0.00496008 0.0118525 0.00509427 0.00397218 0.00674876 0.00996062 0.0209686 0.0773898 0.146427	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0156085 0.0152648 0.0185019 0.0688803 0.047796 0.0218115 0.0189787 0.0663012 0.042791 0.0268229 0.0203088 0.0102255 0.0166863 0.0493914 0.0823092 0.0100288 0.00752598 0.00379392 0.00278296 0.00503366 0.00334752 0.00692144 0.00491452 0.0125922 0.0118345 0.0521787 0.0102266 0.00797584 0.00793599 0.00720147 0.00807203 0.00745642 0.00813416 0.0102995 0.00753534 0.00761903 0.00663675 0.0100652 0.0172435 0.00882046 0.0177003 0.00459594 0.0073354 0.00536353 0.00469266 0.00709154 0.00580983 0.00937646 0.0343547 0.135825	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.01557 0.0152107 0.0184281 0.068607 0.0476153 0.0216733 0.0188383 0.0658384 0.0424723 0.026623 0.0202567 0.0101857 0.0165886 0.049049 0.0817878 0.0100131 0.00744385 0.00376998 0.0027439 0.00499987 0.00330048 0.00686893 0.00483287 0.0124645 0.0116716 0.0515306 0.0100089 0.00785399 0.00778474 0.00710112 0.00796465 0.00734841 0.00803706 0.0100315 0.00724117 0.00734009 0.00617292 0.00815217 0.0125957 0.00573787 0.00737988 0.00836783 0.0210758 0.0221344 0.00474848 0.006955 0.0053306 0.0080083 0.0318776 0.132368	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.015644 0.015296 0.018534 0.0690358 0.0479284 0.0218438 0.0189896 0.066402 0.0428412 0.0268555 0.0203811 0.0102458 0.0166934 0.0493873 0.0822315 0.0100916 0.00748612 0.00379487 0.00275711 0.00503405 0.00331932 0.00692352 0.00487974 0.0125914 0.0118748 0.0524422 0.0101709 0.00790323 0.00788597 0.0071286 0.00806587 0.00738689 0.00827418 0.010293 0.00730396 0.00763116 0.00630605 0.00807203 0.0131563 0.00601011 0.00699638 0.00640522 0.0154242 0.00793364 0.00833063 0.0237862 0.0056648 0.00760233 0.0295744 0.12919	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0146903 0.0144652 0.0175582 0.0653593 0.0453602 0.0208694 0.0180938 0.0635457 0.0405478 0.0254465 0.0186981 0.00947439 0.0155087 0.0454327 0.0741471 0.00904482 0.00651215 0.0033964 0.00243558 0.00430782 0.00290003 0.00582922 0.00422525 0.0104709 0.0105027 0.0468593 0.00951547 0.00700926 0.00735277 0.00622688 0.00747322 0.00644136 0.00826413 0.00971749 0.00634842 0.00736514 0.00562255 0.00671903 0.011898 0.00510933 0.00539087 0.00508392 0.0122669 0.00520801 0.00407744 0.00691046 0.0102457 0.021425 0.0790026 0.149645	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0157179 0.0153384 0.0185804 0.0689887 0.0477651 0.0217343 0.0188977 0.0656727 0.042244 0.0263467 0.020169 0.0102053 0.016615 0.0489187 0.0810227 0.00968367 0.00724165 0.00366266 0.00265504 0.00456042 0.00299224 0.00564433 0.00350708 0.00719096 0.00507393 0.0127966 0.0121618 0.0544597 0.0107901 0.00851929 0.00898083 0.00814094 0.00872133 0.0109645 0.00792801 0.0079049 0.00686752 0.0103756 0.0177755 0.00895303 0.0177624 0.00464674 0.00742166 0.00541756 0.00474697 0.00716688 0.00587398 0.00948553 0.0346747 0.137035	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0156722 0.0152777 0.0184987 0.0686939 0.0475718 0.0215917 0.0187548 0.0652043 0.0419278 0.0261518 0.0201152 0.0101633 0.0165152 0.0485764 0.0805273 0.00967344 0.00717003 0.00364155 0.00261998 0.00453814 0.00295234 0.00560544 0.00345826 0.00714244 0.00499463 0.0126966 0.0120293 0.0539033 0.0105692 0.00838158 0.00883619 0.00801072 0.00859952 0.0106536 0.00760857 0.00761571 0.00640049 0.00841013 0.0130514 0.00593883 0.00749421 0.00846329 0.0211474 0.0221819 0.00478539 0.00701553 0.00538313 0.00809099 0.0321834 0.133511	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0157386 0.0153548 0.0185946 0.06908 0.047853 0.0217466 0.0188926 0.0657139 0.0422564 0.0263542 0.0202216 0.0102156 0.0166065 0.0488706 0.0808977 0.00973943 0.00720125 0.00366168 0.002629 0.00456322 0.00296343 0.00563835 0.00347637 0.00719445 0.00503995 0.0128153 0.0122316 0.0548032 0.010732 0.00842668 0.00893741 0.00805292 0.00883769 0.0109175 0.00766863 0.00790976 0.00653078 0.00832582 0.0136418 0.00623446 0.00708868 0.00647548 0.0157428 0.00799496 0.00842931 0.0240216 0.00572761 0.0076861 0.0298715 0.130393	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0148131 0.014548 0.0176469 0.0654811 0.0453221 0.0207831 0.0180079 0.062887 0.0399612 0.0249259 0.0185171 0.00944382 0.0154228 0.0448591 0.0726812 0.00870284 0.00624414 0.00326871 0.00231757 0.00390875 0.00258779 0.0047671 0.0030239 0.00601703 0.00434911 0.0105883 0.010773 0.0487066 0.0100525 0.00747075 0.00827634 0.00707494 0.00887236 0.010355 0.00669076 0.00768067 0.0058285 0.00694949 0.0123898 0.0053159 0.00547966 0.00515884 0.0125831 0.00526519 0.00414736 0.0070044 0.0104398 0.0216279 0.0796798 0.151102	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0157132 0.0153206 0.0185552 0.0688153 0.0475938 0.0216296 0.0187978 0.0651515 0.041873 0.0260877 0.0201101 0.0101993 0.0166015 0.0487676 0.0806161 0.009556 0.0071219 0.00361102 0.00260402 0.00437751 0.0028501 0.00511599 0.00311471 0.00586817 0.00360804 0.007407 0.00529253 0.0132563 0.0130252 0.0587131 0.0119925 0.00968918 0.00922307 0.0116148 0.00839923 0.00813053 0.00708371 0.0106832 0.0183746 0.00906124 0.0177482 0.00467712 0.00746776 0.00543369 0.00477289 0.00719384 0.00590229 0.00953582 0.0347035 0.136959	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0156574 0.0152518 0.018463 0.0684952 0.0473861 0.0214836 0.0186531 0.0646873 0.041558 0.0258939 0.0200496 0.010153 0.0164965 0.0484182 0.0801353 0.00955116 0.00705952 0.0035933 0.00257188 0.00436204 0.00281507 0.00509139 0.00307385 0.00583251 0.00356001 0.00737372 0.0052243 0.0132066 0.0129609 0.0583506 0.0117596 0.00948617 0.00906404 0.0112565 0.00804861 0.00784657 0.00663367 0.00868241 0.0136017 0.00616611 0.00757784 0.00851151 0.0210263 0.0220351 0.00478483 0.00702033 0.00539895 0.00811734 0.0322127 0.133361	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0157073 0.0153124 0.0185392 0.0688057 0.0476139 0.0216139 0.0187694 0.0651211 0.0418341 0.0260611 0.0201299 0.010193 0.016568 0.0486534 0.0804189 0.00960722 0.00708162 0.00360951 0.0025775 0.00438087 0.00282143 0.00511445 0.00308373 0.00586363 0.0035777 0.00742651 0.00527459 0.0133303 0.0131932 0.0592867 0.011939 0.00955127 0.00927242 0.0114898 0.00809914 0.00813413 0.00675157 0.00858924 0.014221 0.00648466 0.0071381 0.00650065 0.0159731 0.00798269 0.00847159 0.0240886 0.00574978 0.00771454 0.0299141 0.130364	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0148256 0.0145501 0.0176423 0.0653843 0.0451972 0.0206996 0.0179266 0.0624472 0.0396076 0.02466 0.0184263 0.00943007 0.0154048 0.0446519 0.0721542 0.00856942 0.00612943 0.00321663 0.00226969 0.00374841 0.0024632 0.00433355 0.00268729 0.00493646 0.00310993 0.00619483 0.00457865 0.0110482 0.0116957 0.0525087 0.0112065 0.00857981 0.00928092 0.0109288 0.00709523 0.00798239 0.0060165 0.00718929 0.0129534 0.00553762 0.00553178 0.0051982 0.0128401 0.0052747 0.00419739 0.00705006 0.0105799 0.0215981 0.0795045 0.150957	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0154462 0.0151425 0.0181654 0.0681034 0.0474327 0.0213391 0.0184672 0.0643032 0.0419748 0.0263215 0.0208601 0.0104314 0.0169438 0.0503596 0.0843453 0.00996129 0.00757134 0.0038044 0.00272202 0.00462416 0.00294273 0.00527944 0.00311845 0.00572398 0.00336715 0.00652751 0.00394814 0.0083998 0.00599052 0.0156953 0.0154045 0.0769618 0.0155081 0.0175245 0.0231286 0.0056929 0.004056 0.00745512 0.00733489 0.00361815 0.00551253 0.00388047 0.00631171 0.0050545 0.00394032 0.00660053 0.00502321 0.00899585 0.0332623 0.135421	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0156295 0.0153187 0.0184738 0.0686145 0.0475443 0.0215082 0.0185874 0.0645849 0.0415816 0.0259237 0.0202208 0.0102132 0.016667 0.0493794 0.0812008 0.00957785 0.00712431 0.00361226 0.00259124 0.00435142 0.0027933 0.00494644 0.00295366 0.00534424 0.00317846 0.00606544 0.0037161 0.00777865 0.00559945 0.0141639 0.0140773 0.0678739 0.0112825 0.012431 0.00897624 0.00826451 0.00725157 0.010906 0.0190355 0.00904875 0.0174976 0.00466892 0.00747204 0.00539303 0.00476706 0.00715043 0.00589026 0.00951843 0.0343055 0.134945	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0155418 0.0152221 0.0183417 0.0682049 0.0472869 0.0213384 0.018425 0.0640951 0.0412596 0.0257279 0.0201583 0.0101612 0.0165533 0.0490221 0.080803 0.00958856 0.00708734 0.00360481 0.00256554 0.00434992 0.00276687 0.00494213 0.00292491 0.00533886 0.00314776 0.0060621 0.00368666 0.00780932 0.0055888 0.0142731 0.0142435 0.0679115 0.0110872 0.0120101 0.00858063 0.00801367 0.00686748 0.0089603 0.0142711 0.00643537 0.0075632 0.0084185 0.0203593 0.0213465 0.00471028 0.00692831 0.00536207 0.00806323 0.0318283 0.131161	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0155549 0.015249 0.0183732 0.068359 0.0474126 0.0214182 0.0184961 0.0643881 0.0414453 0.025836 0.0201961 0.0101794 0.0165922 0.0491715 0.0809594 0.00963179 0.00710036 0.00361701 0.00256735 0.00436395 0.00276919 0.00495917 0.00292966 0.00536185 0.00315703 0.00609631 0.00370628 0.00787152 0.0056498 0.0144219 0.0144922 0.0687543 0.0113202 0.0121944 0.00860994 0.00825791 0.00695121 0.00884791 0.0148979 0.00677103 0.00706354 0.00639727 0.0158855 0.00775895 0.00841092 0.0238972 0.00572117 0.00768085 0.0296355 0.128618	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0148201 0.0146173 0.0176397 0.0655434 0.0454082 0.0206897 0.0178198 0.0622933 0.0395976 0.0246709 0.0186391 0.00950162 0.0155688 0.0454333 0.0730874 0.00863992 0.00617469 0.00323892 0.00227206 0.00374798 0.00242883 0.00421787 0.00256312 0.00453618 0.00275257 0.00511767 0.0032132 0.00651515 0.00487272 0.0118763 0.0124772 0.0584317 0.0110779 0.0116569 0.0076421 0.00827175 0.00621198 0.00749043 0.013634 0.00581021 0.00552834 0.00519411 0.0130314 0.00520188 0.00427334 0.00707817 0.0107669 0.021215 0.0782235 0.149286	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0163464 0.0160743 0.0195419 0.0717184 0.0494807 0.0225375 0.0193121 0.0667941 0.0427588 0.0267537 0.0205691 0.0105708 0.0173369 0.0513071 0.0819998 0.00973997 0.00683645 0.00358524 0.00255151 0.00415792 0.00268886 0.00459532 0.00278027 0.00476558 0.00285498 0.00495846 0.00300004 0.00537569 0.00334377 0.00636897 0.00451929 0.00986924 0.00776089 0.0147056 0.0624709 0.0123573 0.00838228 0.0122811 0.0192516 0.00913202 0.0187698 0.00480197 0.00763236 0.00554237 0.00485671 0.00727407 0.00595127 0.00966398 0.0352232 0.138849	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) , DRUG0 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0162924 0.0160039 0.0194512 0.0714743 0.0493219 0.02239 0.0191547 0.0663303 0.0424609 0.0265847 0.0205408 0.0105453 0.0172783 0.0510837 0.0817445 0.00976472 0.00681016 0.00358178 0.00253022 0.00415327 0.00266549 0.00458351 0.0027537 0.00474859 0.00282433 0.00493597 0.00296388 0.00534507 0.00329983 0.00633391 0.00447677 0.00989787 0.00778698 0.01483 0.0616385 0.0119657 0.0078797 0.00995698 0.0138194 0.00604363 0.00778768 0.00846241 0.0210736 0.0225923 0.0048651 0.00709141 0.00547561 0.00822874 0.0326179 0.135558	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) , DRUG0 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0163305 0.0160561 0.019511 0.0717757 0.0495541 0.0225185 0.0192666 0.0668074 0.0427689 0.0267726 0.0206239 0.0105875 0.0173556 0.0513509 0.0821249 0.00983561 0.00683559 0.00360447 0.00253565 0.00417341 0.00267133 0.00460518 0.00276142 0.00477331 0.00283455 0.00496726 0.00297996 0.00539289 0.00333217 0.00642042 0.00456831 0.0101145 0.00805705 0.0153722 0.0630231 0.0124889 0.00802065 0.00984845 0.0143477 0.00627486 0.00729137 0.00646239 0.0156333 0.00813479 0.00849711 0.0244163 0.00583368 0.00781608 0.0302944 0.132377	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0155167 0.0153147 0.0186677 0.0684759 0.0472088 0.0216246 0.0184688 0.0642099 0.0406729 0.0254938 0.0189226 0.00984147 0.0161786 0.0469099 0.0733551 0.00881186 0.00591061 0.003204 0.00223352 0.00355681 0.0023331 0.00389274 0.00240604 0.00401636 0.00246236 0.00415767 0.00258099 0.00448807 0.0028827 0.00529026 0.00391143 0.00809824 0.00687067 0.0128838 0.0522058 0.0124343 0.00722975 0.0083452 0.012824 0.0053562 0.00571532 0.0052425 0.0126623 0.00540499 0.0042273 0.0071735 0.0105534 0.0221142 0.0814014 0.156257	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG1 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0161168 0.0159433 0.0191888 0.0710336 0.0495162 0.0225158 0.0194256 0.0675474 0.0440686 0.0277443 0.0217648 0.0109681 0.0181679 0.054008 0.0865784 0.0102615 0.00730331 0.00383806 0.00266704 0.00451654 0.00283717 0.00501959 0.00294215 0.00520412 0.00300777 0.00535361 0.00310092 0.00557979 0.00325706 0.00598316 0.00365407 0.00750952 0.0043378 0.00550207 0.0110991 0.0102 0.0108277 0.0441323 0.027337 0.0125128 0.0212582 0.00535726 0.00857285 0.00588904 0.00534328 0.00782611 0.00660107 0.0103606 0.0359054 0.140315	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG1 salts , DRUG2 , local DRUG0 , DRUG0 , and DRUG0 .
4	4	0.016023 0.0158464 0.0191587 0.0705773 0.0490674 0.0224957 0.0194406 0.0674654 0.0437247 0.0275108 0.0213226 0.0108081 0.0179614 0.0533571 0.0847548 0.0102227 0.00705901 0.00377658 0.00258754 0.00439647 0.00274975 0.00487252 0.00285245 0.00505032 0.00291474 0.00519683 0.00300415 0.00542052 0.00315897 0.00582724 0.00355378 0.00729532 0.00425864 0.00542629 0.0108951 0.0101528 0.0110425 0.0439185 0.0222402 0.0110561 0.0104819 0.0115176 0.0240644 0.0233328 0.00503184 0.00731645 0.00578531 0.00859723 0.0327397 0.13269	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG1 salts , DRUG0 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0158891 0.0157275 0.0190223 0.0701306 0.0487708 0.0224173 0.0193914 0.0673734 0.0436123 0.02742 0.0210982 0.0107102 0.0178284 0.0529726 0.0839232 0.0101623 0.00697171 0.00374024 0.00255244 0.00434123 0.00271161 0.00480961 0.00281417 0.00498618 0.00287635 0.00513275 0.00296564 0.00535734 0.0031211 0.00576827 0.00352059 0.00724487 0.00423173 0.00545639 0.0109526 0.0102417 0.0112579 0.0449365 0.0236017 0.0113882 0.00932779 0.00828885 0.0201463 0.00869003 0.00991849 0.026615 0.00626194 0.00839257 0.0312944 0.133634	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG1 salts , DRUG0 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.015157 0.015112 0.0182847 0.0673084 0.0467915 0.02167 0.0186821 0.0651913 0.0417141 0.0261847 0.0195008 0.00998715 0.016678 0.048861 0.0757984 0.00920315 0.00609432 0.00335143 0.00226693 0.00375013 0.00238487 0.00411605 0.00246751 0.00424541 0.00251174 0.00434284 0.00257642 0.00450177 0.0026995 0.00481998 0.00301298 0.0059708 0.00367621 0.00461737 0.00895371 0.00886957 0.00974732 0.0394142 0.0221095 0.00993091 0.00738646 0.00677636 0.0168532 0.00586514 0.00534862 0.00804712 0.0129151 0.0226832 0.079738 0.151831	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG1 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0153397 0.0150193 0.017905 0.0665142 0.0460081 0.0202114 0.0173488 0.0598644 0.038779 0.0241913 0.0201786 0.0102004 0.0170354 0.0508155 0.0812792 0.00942859 0.00670698 0.00353628 0.00252455 0.00425931 0.00269158 0.00473194 0.00278521 0.0049069 0.00284309 0.00505055 0.00292204 0.00524576 0.00304254 0.00555701 0.00330803 0.00663395 0.00373655 0.00460252 0.00810661 0.00534615 0.0060943 0.0177741 0.0234744 0.0143995 0.0749976 0.0150327 0.0249205 0.0255802 0.00556727 0.00782593 0.00635968 0.00934761 0.0337166 0.136253	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG1 , local DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0155387 0.0152041 0.0182466 0.0674588 0.046486 0.0206741 0.0178001 0.0614241 0.0393673 0.0244796 0.0197596 0.0101188 0.0170067 0.0504872 0.0798766 0.00942172 0.00650538 0.00349301 0.00246972 0.00411881 0.0026274 0.00456507 0.00272143 0.00473265 0.0027774 0.0048712 0.00285445 0.00506463 0.00297735 0.00538658 0.00324919 0.00646551 0.00373423 0.00460049 0.00796936 0.00532702 0.00605072 0.0167376 0.0230031 0.0133414 0.0667124 0.0109488 0.0247287 0.0102907 0.0124867 0.0300577 0.00690154 0.00919498 0.0322192 0.137466	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG1 , local DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0149867 0.0147345 0.0177788 0.0653534 0.0448855 0.0202543 0.0174043 0.060244 0.0379593 0.0235808 0.0181578 0.0094503 0.0158925 0.0461022 0.0717793 0.00852199 0.00566266 0.00312612 0.0021877 0.00352982 0.00230615 0.00388079 0.00238296 0.00400431 0.00242292 0.00409682 0.00247892 0.00423341 0.00257711 0.00448377 0.00279483 0.00533615 0.00327289 0.00391355 0.006549 0.00467125 0.00501661 0.0128812 0.0172944 0.0107076 0.0544459 0.00915008 0.0224293 0.00751592 0.00870036 0.00970752 0.0180823 0.0253435 0.0867133 0.151015	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG1 , local DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0147303 0.014452 0.0173657 0.0638846 0.0438555 0.019581 0.0167764 0.0577558 0.0367034 0.0228429 0.0179884 0.00932777 0.0156389 0.0448862 0.070778 0.00804013 0.00539253 0.00295838 0.00212138 0.00336799 0.00223293 0.00370041 0.00229411 0.00379978 0.00231905 0.00385787 0.00235234 0.00393311 0.00240708 0.00406061 0.00252015 0.00458965 0.00282713 0.00305668 0.00483351 0.00352069 0.003105 0.00712713 0.0066644 0.00321212 0.00651024 0.00468583 0.00988802 0.012044 0.0143752 0.0878594 0.0221926 0.0292486 0.0951755 0.157159	Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG1 , and DRUG2 .
2	2	0.027564 0.022323 0.0608153 0.0453159 0.0370828 0.0734069 0.0474116 0.0276176 0.0453235 0.0270426 0.0150889 0.0128741 0.0187017 0.0197808 0.018543 0.00979511 0.00882084 0.0157757 0.0331839 0.032744 0.02345 0.0113342 0.00205946 0.00226936 0.0015508 0.00192016 0.00207418 0.00254284 0.00259255 0.00322342 0.0102633 0.00908648 0.0103126 0.0280428 0.021186 0.0180153 0.014942 0.0143827 0.00984521 0.00470192 0.00535172 0.00472153 0.0131663 0.00990103 0.00860168 0.00891351 0.0124609 0.00892239 0.00737528 0.00695498 0.00595426 0.00706596 0.0126928 0.0113997 0.00763413 0.00507044 0.0173071 0.0535002	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG2 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
2	2	0.0285379 0.0231407 0.0630869 0.0469525 0.0384095 0.0757733 0.0490988 0.0286536 0.047365 0.0281788 0.0158125 0.0134273 0.0194379 0.0202136 0.0189418 0.00996405 0.00864888 0.014493 0.0299153 0.0230687 0.0122683 0.00478889 0.00324113 0.00727624 0.00170206 0.00206787 0.00184239 0.00237504 0.00255417 0.00321016 0.00917348 0.00834192 0.00937876 0.0267651 0.0210726 0.0186822 0.0157972 0.0154783 0.0104661 0.00496604 0.00559099 0.00493264 0.0136967 0.0103013 0.00892116 0.00925369 0.0129487 0.00926127 0.00765123 0.00723125 0.00619738 0.00736227 0.0132348 0.0118709 0.0079426 0.00527909 0.0180207 0.0557351	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG2 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
2	2	0.0276824 0.0226002 0.0614051 0.0453276 0.037 0.0731344 0.0471277 0.0277156 0.0455093 0.0270873 0.0141346 0.0117681 0.0167221 0.0178624 0.0160171 0.00681049 0.00523035 0.0114983 0.0279231 0.0178455 0.00926658 0.00353174 0.00155958 0.00291543 0.00270212 0.00310093 0.0131857 0.0170314 0.00638722 0.00616041 0.0132799 0.011555 0.0124863 0.0320138 0.0246163 0.0206503 0.0164777 0.0154593 0.010372 0.00492416 0.00560002 0.00491113 0.0136699 0.0102473 0.00887506 0.00917177 0.0127175 0.00911467 0.00753184 0.00710187 0.00607785 0.00721373 0.0129592 0.011619 0.00777154 0.00516619 0.0176348 0.0545386	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG2 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
2	4	0.0231215 0.0191417 0.051013 0.0364891 0.0299595 0.0579185 0.0394945 0.0230453 0.0373191 0.0223506 0.00895609 0.00642904 0.00915048 0.00959225 0.00752972 0.00316526 0.00211498 0.00345364 0.0102059 0.00760761 0.00366254 0.00233071 0.00105838 0.00222608 0.00117851 0.00123262 0.00200738 0.00327732 0.00243792 0.00264155 0.0124672 0.0150606 0.0156165 0.0407338 0.0372969 0.0261445 0.0230892 0.0305737 0.0251126 0.0127476 0.0136294 0.0126583 0.0325172 0.0207804 0.0218476 0.0323592 0.0208781 0.0103976 0.00934679 0.00888681 0.00976596 0.0122272 0.0212108 0.0144736 0.00777693 0.0053304 0.0176113 0.0593489	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG2 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.0230486 0.0190765 0.0508565 0.0363882 0.0298432 0.057761 0.0392634 0.0229078 0.0370733 0.0221577 0.00892939 0.00643432 0.00911155 0.00951344 0.00741436 0.00310509 0.00208621 0.00344368 0.0101481 0.00750227 0.00360869 0.00226454 0.00103159 0.00214342 0.00115348 0.00120952 0.0019406 0.00311378 0.0023501 0.00250824 0.0116272 0.0130468 0.0119133 0.028645 0.023426 0.017239 0.0141549 0.0144895 0.00998693 0.0044851 0.00537816 0.00489218 0.0163626 0.0119001 0.0110227 0.0144523 0.0217442 0.028895 0.0346812 0.0320532 0.0232986 0.0252819 0.0387492 0.0520499 0.0259794 0.012929 0.0132389 0.0506896	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG2 or DRUG0 .
2	4	0.0251808 0.020842 0.0555601 0.0397484 0.0325993 0.0630893 0.0429004 0.025026 0.0405033 0.0242066 0.00974639 0.00701968 0.00994098 0.0103793 0.00808334 0.003385 0.00227514 0.00374955 0.0110359 0.00815812 0.00392447 0.00246911 0.00112552 0.00233661 0.00125785 0.00131939 0.00211341 0.00338653 0.00255685 0.0027239 0.0125773 0.0141253 0.0128785 0.030934 0.0251768 0.0185506 0.0151196 0.0153463 0.0105302 0.00472013 0.00564276 0.00510171 0.0168597 0.0121602 0.0111851 0.014517 0.0220994 0.0289947 0.0331873 0.026158 0.0175873 0.0187842 0.0321421 0.0225189 0.0110985 0.0127173 0.0316289 0.0510151	The neuromuscular blocking effect of DRUG1 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG2 .
4	4	0.0145968 0.00771369 0.0184662 0.00989104 0.0111705 0.0185249 0.0299548 0.0352363 0.0616922 0.0288174 0.0216409 0.0163742 0.0207883 0.020262 0.0150239 0.00853927 0.00775278 0.0172348 0.0495919 0.0411394 0.0327631 0.0421901 0.0122925 0.0065584 0.00556932 0.00926324 0.0233639 0.0200403 0.00796643 0.0083201 0.0160076 0.0130058 0.0146649 0.0348767 0.0230932 0.0196766 0.0156698 0.0151347 0.0101523 0.0048268 0.00552678 0.00487826 0.013563 0.0102003 0.00882785 0.00911811 0.0125991 0.00902695 0.00746013 0.00704393 0.00602904 0.00716011 0.0128607 0.0115158 0.00769755 0.00511802 0.0174739 0.0540531	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG1 , DRUG0 , or certain DRUG2 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.0122661 0.00642181 0.0150349 0.0081306 0.00915079 0.0149278 0.0236457 0.0272596 0.0476223 0.0207223 0.0153974 0.0109442 0.0134532 0.0138653 0.0101036 0.00529739 0.00450353 0.0104274 0.03865 0.0309781 0.0282725 0.0287911 0.00636291 0.0037939 0.00230089 0.00330485 0.00487751 0.00332028 0.00463642 0.0066724 0.0137465 0.00907344 0.0114046 0.0269076 0.0271976 0.0239299 0.0235241 0.0340263 0.0273151 0.0149615 0.0160461 0.01398 0.0352008 0.0227463 0.0241797 0.0355377 0.0226791 0.0115969 0.010628 0.00980621 0.0105202 0.0129748 0.0222735 0.0151507 0.00809802 0.00552706 0.0182856 0.0615483	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG1 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG2 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.0119715 0.00626951 0.0146884 0.00794333 0.00894269 0.0145953 0.0231511 0.0267296 0.0466838 0.0203745 0.0151233 0.010756 0.0131651 0.0135356 0.00984614 0.00514538 0.00437925 0.0101122 0.0365327 0.0290006 0.0260215 0.0265323 0.00566677 0.00337252 0.00211346 0.00304927 0.00459338 0.00304079 0.00440008 0.00623569 0.013075 0.00781182 0.00925233 0.0207904 0.01744 0.0155278 0.0143713 0.0165626 0.0117111 0.00542176 0.00649222 0.00577077 0.0185785 0.0137684 0.0130001 0.0165899 0.023797 0.0319954 0.0378111 0.0345664 0.0250882 0.0269987 0.0404733 0.0537889 0.0267218 0.0132657 0.0135646 0.0517938	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG1 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG2 or DRUG0 .
4	4	0.0131374 0.00688002 0.0161179 0.0087166 0.00981326 0.0160156 0.0254032 0.0293289 0.0512227 0.0223518 0.0165898 0.0117963 0.0144349 0.0148458 0.0107971 0.00564163 0.00480165 0.0110827 0.0400298 0.0317733 0.0285062 0.029053 0.00618488 0.0036863 0.00231321 0.00333265 0.00500974 0.00331756 0.00479519 0.00680128 0.0142349 0.00851305 0.0100864 0.0226758 0.0189248 0.0168354 0.0154828 0.0177189 0.012459 0.00573586 0.00685361 0.00605 0.0192946 0.0141656 0.0132677 0.0167857 0.0242772 0.0322573 0.0363436 0.0283742 0.0190249 0.020187 0.0337887 0.0236208 0.0115662 0.0131598 0.0325135 0.0520225	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG1 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG2 .
4	4	0.0159598 0.00835411 0.0196713 0.0106276 0.0119817 0.0195496 0.0311839 0.036409 0.0629585 0.0284845 0.0212676 0.0155898 0.0192091 0.0189923 0.0129476 0.00608384 0.00463484 0.0115636 0.0458626 0.0345426 0.0218414 0.0101832 0.00588906 0.0258014 0.00532573 0.00960512 0.0233559 0.0204885 0.00776456 0.00819615 0.0172112 0.0136161 0.015321 0.0389364 0.0261844 0.0231697 0.0180272 0.0173857 0.0115515 0.0055001 0.00625835 0.00552699 0.0153251 0.0115227 0.00995892 0.0102819 0.0142916 0.0102494 0.00847497 0.00800634 0.00685812 0.0081506 0.0146447 0.0131183 0.00877014 0.00583334 0.0199124 0.0615881	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG1 , or certain DRUG2 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.0131894 0.00687954 0.0160476 0.00867783 0.00978685 0.0158906 0.0251726 0.0289944 0.0501779 0.0215882 0.0159477 0.0113202 0.0137732 0.014374 0.00947595 0.00443922 0.00342099 0.00816134 0.0330916 0.0231827 0.0149666 0.00713857 0.00337888 0.01317 0.00226315 0.00366424 0.00425186 0.00321847 0.00472382 0.00681901 0.0149806 0.00990471 0.01228 0.0285304 0.0270538 0.0237387 0.0243487 0.0352479 0.0285922 0.0155849 0.0166923 0.0147182 0.0376902 0.0242583 0.0257584 0.0379587 0.0242242 0.0123893 0.0113275 0.0104988 0.0113117 0.0139901 0.0240746 0.0163889 0.00876832 0.00598958 0.0198067 0.066706	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG1 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG2 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.0128208 0.00668622 0.0155913 0.00843136 0.0095114 0.0154363 0.0244699 0.0281736 0.0487223 0.0209089 0.0153543 0.0108292 0.0130549 0.0136333 0.00892413 0.00416267 0.00322805 0.00769005 0.0307953 0.0213509 0.0139244 0.00661272 0.0031198 0.0122774 0.00206035 0.00333346 0.00392997 0.0028964 0.00436364 0.00626271 0.0140549 0.00846412 0.00984785 0.021583 0.0173464 0.015509 0.0148987 0.0172237 0.0122127 0.00564901 0.00676855 0.00604748 0.0198469 0.014628 0.0136982 0.0175285 0.0252536 0.0338034 0.0400295 0.0367487 0.026745 0.0288025 0.0434242 0.0578146 0.0287715 0.0142922 0.0146181 0.0558339	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG1 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG2 or DRUG0 .
4	4	0.0141656 0.00738754 0.0172262 0.00931566 0.0105091 0.0170548 0.0270357 0.0311278 0.0538278 0.023096 0.0169568 0.0119558 0.014407 0.015049 0.00984699 0.00459074 0.00356076 0.00847922 0.0339427 0.0235332 0.0153476 0.00729256 0.00343938 0.0135377 0.00227047 0.00366948 0.00431652 0.00318253 0.00478693 0.00687396 0.0154002 0.00928098 0.0108029 0.0236875 0.0189482 0.0169258 0.0161561 0.0185469 0.0130789 0.00601858 0.00719524 0.00638399 0.0207424 0.015149 0.0140723 0.0178482 0.0259411 0.0343134 0.0387502 0.0303711 0.0204236 0.0216766 0.0364796 0.0255055 0.0125023 0.0142537 0.0352674 0.0564926	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG1 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG2 .
4	4	0.0131979 0.00685398 0.0157593 0.00858728 0.00966986 0.0155507 0.0242678 0.0275619 0.0472663 0.0192683 0.0143865 0.00982831 0.0119167 0.0130192 0.00813048 0.00360573 0.00257458 0.00564157 0.0220163 0.0149583 0.00814122 0.00388844 0.00180764 0.00424259 0.00256618 0.00410199 0.0153415 0.0326329 0.00897898 0.00982356 0.0175803 0.0100098 0.0117585 0.0276733 0.0267306 0.0242224 0.0240611 0.0369893 0.0290938 0.0162631 0.0174331 0.01503 0.0378799 0.0246021 0.0262476 0.038773 0.0248899 0.012828 0.0118116 0.010857 0.0116175 0.0142982 0.0245079 0.0166589 0.00889513 0.00606779 0.0200722 0.0675621	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG1 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG2 has been demonstrated in patients chronically administered DRUG0 or DRUG0 .
4	4	0.01272 0.00660501 0.0151815 0.0082742 0.00932064 0.0149785 0.0233985 0.026579 0.04553 0.0185174 0.0137325 0.00932646 0.0112074 0.0122304 0.00758002 0.00333505 0.00240107 0.00526547 0.0202436 0.0136184 0.00744523 0.00354734 0.00165271 0.00384286 0.00236659 0.00381877 0.0143031 0.0305046 0.00828695 0.00894236 0.0162744 0.00847744 0.00944454 0.0211321 0.016788 0.0155831 0.0146345 0.0181671 0.0128139 0.00603495 0.00715036 0.00630317 0.0201433 0.0150593 0.0142822 0.0181896 0.0260809 0.0351853 0.0415303 0.0378523 0.0274669 0.0295211 0.0441491 0.0585443 0.0290623 0.0144226 0.014742 0.0562092	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG1 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG2 or DRUG0 .
4	4	0.0140828 0.00731267 0.0168076 0.00916051 0.0103193 0.0165828 0.0259047 0.0294256 0.0504024 0.0204943 0.0151948 0.0103161 0.0123919 0.0135265 0.00838004 0.00368517 0.0026543 0.0058176 0.0223508 0.0150329 0.00821681 0.00391923 0.00182635 0.00424599 0.00261499 0.00421827 0.0157925 0.033626 0.00910978 0.00983671 0.0178686 0.0093166 0.010382 0.0232391 0.0183774 0.0170455 0.0159142 0.0196268 0.0137657 0.00644182 0.00761465 0.0066678 0.0211152 0.0156371 0.0147098 0.0185771 0.0268441 0.0357906 0.0402756 0.0313546 0.0210113 0.0222797 0.037189 0.0259737 0.0127048 0.01444 0.0356441 0.0569434	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG1 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG0 has been demonstrated in patients chronically administered DRUG0 or DRUG2 .
2	2	0.0119153 0.0061702 0.0138209 0.00765151 0.00858211 0.0137216 0.0204303 0.0223294 0.0380734 0.0137736 0.0109945 0.00678168 0.00837911 0.00978333 0.00576146 0.00241901 0.00168512 0.00282927 0.00861144 0.00641365 0.00310735 0.00209291 0.000963019 0.00205339 0.00108929 0.00113574 0.00188319 0.0031278 0.00233278 0.00247586 0.0116356 0.0143964 0.0147856 0.0396917 0.0357204 0.0247673 0.0224086 0.0269035 0.0231745 0.0125695 0.0137178 0.0129132 0.0400076 0.0289662 0.032848 0.033742 0.0542842 0.0247942 0.0270684 0.0249039 0.0319005 0.0257627 0.0349094 0.0472305 0.0230088 0.0111921 0.0146474 0.0516621	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG1 has been demonstrated in patients chronically administered DRUG2 or DRUG0 .
2	2	0.0124683 0.00645684 0.0144633 0.00800653 0.00898143 0.0143623 0.0213824 0.0233687 0.0398494 0.0144116 0.0115018 0.00709451 0.00876183 0.0102359 0.00602673 0.00252966 0.00176217 0.00295501 0.00899032 0.00669039 0.0032393 0.00218765 0.00100698 0.0021461 0.00113748 0.00118667 0.00196863 0.00326661 0.00243516 0.00259516 0.0121781 0.0150444 0.0155056 0.0416406 0.0376196 0.0260304 0.0237635 0.0292044 0.0258082 0.0143075 0.0155536 0.0145482 0.0446129 0.0314149 0.0353784 0.0335608 0.0592757 0.0235405 0.0273347 0.0202226 0.025115 0.0183425 0.0299537 0.027631 0.0133316 0.0131037 0.0303629 0.0441458	The neuromuscular blocking effect of DRUG0 may be enhanced by drugs that reduce plasma cholinesterase activity (e.g. , chronically administered oral DRUG0 , DRUG0 , or certain DRUG0 ) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing DRUG1 has been demonstrated in patients chronically administered DRUG0 or DRUG2 .
2	2	0.0295083 0.0490494 0.0314916 0.0207863 0.0251978 0.0280211 0.0150395 0.0120588 0.0300399 0.0296098 0.0561027 0.040936 0.0774908 0.0422068 0.0214171 0.018679 0.0182106 0.0784712 0.0675479 0.0303962 0.010781 0.0103721 0.0169165 0.0190893 0.0171538 0.0279538 0.00941017 0.0188825 0.0234068 0.0100055 0.0142768 0.0130671 0.0361555 0.0502681	While the effects of chronic DRUG1 or DRUG0 therapy on the action of DRUG2 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
2	2	0.0287436 0.0442947 0.0274273 0.027552 0.0282275 0.0182383 0.0216134 0.0661897 0.0290214 0.0285854 0.0554181 0.0380251 0.0730527 0.0404809 0.0207819 0.0186223 0.0177374 0.0733073 0.0619342 0.0277841 0.00988589 0.00950751 0.0154715 0.0174449 0.0156709 0.0254501 0.0085653 0.0171768 0.0212807 0.0090997 0.0129842 0.0118839 0.0328616 0.0456797	While the effects of chronic DRUG0 or DRUG1 therapy on the action of DRUG2 are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
4	4	0.0704067 0.072026 0.0772468 0.0317042 0.0211118 0.0335991 0.0183422 0.0380348 0.0350531 0.0223151 0.0199204 0.0374257 0.0157188 0.0159232 0.0210978 0.0161815 0.00970403 0.0235565 0.0158062 0.0154502 0.0116704 0.0233053 0.0379225 0.0461529 0.0154392 0.0180185 0.0194145 0.0321103 0.0207489 0.00670065 0.00817033 0.0103944 0.0032343 0.00332786 0.00303862 0.00312196 0.00593673 0.00794333 0.00654424 0.0169972 0.00453588 0.00468983 0.00242171 0.00370583 0.00246605 0.00368538 0.00230788 0.00267333 0.00135619 0.00297056 0.00231873 0.00195522 0.00295466 0.00200165 0.00155501 0.00345028 0.0028736 0.00471611 0.00463608 0.00350283 0.00501475 0.0023989 0.00376312 0.0172298	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG2 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0718306 0.07348 0.0788052 0.0323439 0.0215391 0.0342768 0.0187046 0.0387836 0.0357472 0.0227738 0.0203337 0.0382394 0.0160912 0.0163038 0.0216403 0.0165995 0.00994315 0.024136 0.016111 0.015883 0.0123536 0.0243421 0.0399913 0.048431 0.0157308 0.0178407 0.0180779 0.0270184 0.0141577 0.00434157 0.00252977 0.00471661 0.00445681 0.00938451 0.0033283 0.00285406 0.00583402 0.00778046 0.0064274 0.016713 0.00454538 0.00474906 0.00244091 0.00375709 0.0024958 0.00374481 0.00233659 0.0027126 0.00136658 0.00300953 0.00233971 0.00197299 0.00298436 0.00201126 0.00156807 0.0034835 0.0028935 0.00476132 0.0046929 0.00353537 0.00507502 0.00241251 0.00378938 0.0174456	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG2 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0659077 0.0673821 0.0721973 0.0295861 0.0196991 0.0313365 0.0171008 0.0355154 0.0327196 0.0208059 0.0185219 0.0346474 0.0144436 0.0144669 0.0189568 0.0145798 0.00866546 0.0211096 0.014319 0.0140611 0.010501 0.0213662 0.0351943 0.0430905 0.0125704 0.0136031 0.0133418 0.0205225 0.012128 0.00370715 0.0022929 0.00360753 0.00285196 0.00761412 0.0120647 0.0247078 0.0277074 0.0154061 0.01343 0.0305543 0.00961692 0.00718275 0.00336494 0.00486371 0.00327837 0.00461237 0.00297838 0.00326465 0.00155833 0.00352935 0.0027264 0.00220616 0.00330842 0.00215681 0.00172189 0.00382188 0.00315152 0.00512285 0.00510795 0.00383709 0.00552663 0.00254506 0.0039987 0.0182352	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG2 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0659571 0.0673358 0.0721062 0.0295231 0.0196119 0.0311437 0.0169791 0.035313 0.0324055 0.0205167 0.0181486 0.0334459 0.0134675 0.0131641 0.0168611 0.013039 0.00779872 0.0192303 0.0135674 0.0129739 0.00796539 0.0166385 0.0272292 0.0342087 0.00936812 0.00873666 0.00767978 0.0144668 0.0100295 0.00289714 0.00189815 0.00307241 0.00192388 0.00459772 0.00357773 0.0054816 0.0230256 0.0414802 0.0437486 0.0525706 0.0265526 0.0194854 0.00539782 0.0037862 0.0026742 0.00339859 0.0024854 0.00257934 0.00139115 0.00287977 0.00232964 0.00196761 0.00284171 0.00198942 0.0015075 0.00329905 0.00285973 0.00459982 0.00438706 0.00344435 0.00480307 0.00235612 0.00365258 0.0161473	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG2 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0702289 0.0717109 0.0767716 0.0314281 0.0208868 0.0331777 0.0180667 0.0375496 0.0344839 0.0218457 0.0193423 0.035833 0.0144841 0.0141548 0.0182115 0.0139536 0.00834943 0.0204668 0.0142699 0.0137755 0.00893088 0.0185475 0.0302676 0.0373442 0.0101961 0.00976544 0.00891988 0.0155328 0.010223 0.00291527 0.00190997 0.00295461 0.00189809 0.0043589 0.00349395 0.00513985 0.019645 0.0314954 0.0263741 0.0316252 0.0122358 0.011146 0.0149097 0.0146273 0.00379909 0.00332732 0.0025351 0.00264733 0.00155776 0.00299038 0.00250931 0.00212107 0.00302742 0.00217176 0.00160823 0.00348964 0.0030731 0.00488202 0.00459616 0.00364015 0.00500793 0.00253298 0.00389007 0.0171456	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG2 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0722335 0.0737358 0.0789184 0.0322949 0.0214562 0.0340774 0.0185493 0.0385801 0.0354199 0.0224259 0.0198337 0.0366795 0.0147505 0.0143556 0.0184128 0.014105 0.00844169 0.0206793 0.0144907 0.0139713 0.00884352 0.018361 0.0298976 0.0371568 0.0100625 0.00949352 0.00866192 0.0153712 0.0103031 0.00291411 0.00192604 0.00297858 0.00190754 0.00432586 0.00340792 0.00494464 0.0180284 0.0272212 0.0223603 0.027287 0.00964647 0.00638508 0.00520692 0.00853314 0.0143462 0.0137864 0.00338233 0.00288608 0.00183081 0.00316542 0.00268312 0.00224752 0.00317357 0.00231466 0.00168597 0.0036073 0.00322399 0.00508101 0.00474449 0.00378214 0.00515812 0.00262467 0.00401385 0.0176263	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG2 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0752127 0.0767282 0.082075 0.0335596 0.0222824 0.0353804 0.0192449 0.0400937 0.036793 0.0232765 0.0205372 0.037847 0.0150652 0.0145505 0.0185488 0.0142113 0.0085015 0.0207844 0.0147042 0.0141668 0.00858596 0.0177723 0.0288047 0.0363787 0.00972069 0.00893476 0.00814382 0.0149393 0.0102995 0.00290974 0.00195299 0.003025 0.00192975 0.0042935 0.00330765 0.00467553 0.0159289 0.0224505 0.0181003 0.0242863 0.00828021 0.00585732 0.00415661 0.00484394 0.00485836 0.00822997 0.0120278 0.0117268 0.00289979 0.00338032 0.00280741 0.00262961 0.00320992 0.00266418 0.00181919 0.00368304 0.00355677 0.00518313 0.00463493 0.00389969 0.00502601 0.00282564 0.0041974 0.0175988	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.075648 0.0771641 0.0825357 0.0337442 0.0224028 0.035571 0.0193474 0.0403197 0.0369985 0.0233999 0.0206428 0.0380156 0.0151197 0.0145966 0.0185902 0.0142465 0.00852214 0.0208222 0.01474 0.0142059 0.0085828 0.0177704 0.028814 0.0365127 0.00974415 0.00894391 0.00815047 0.0151339 0.0105197 0.00296029 0.00198812 0.00308669 0.00198613 0.00443556 0.00342058 0.00501775 0.0178226 0.0257361 0.0206543 0.0255057 0.00844911 0.00561781 0.00403972 0.00438849 0.00435469 0.00449612 0.00466899 0.00424224 0.00368635 0.00995992 0.00282626 0.00259877 0.00324867 0.00252608 0.00173128 0.00351692 0.0034196 0.00498471 0.00457672 0.00380732 0.00496691 0.00274664 0.0041227 0.017605	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0758053 0.0773294 0.0827166 0.0338214 0.0224546 0.0356533 0.0193925 0.0404049 0.0370761 0.0234524 0.0206899 0.0381207 0.0151602 0.0146361 0.0186546 0.0142931 0.00855323 0.0209219 0.014805 0.0142506 0.00859892 0.0177846 0.0288109 0.0364086 0.00972832 0.0089079 0.00810027 0.0149281 0.0103549 0.00292169 0.00196561 0.00304691 0.00194822 0.00432042 0.00332222 0.00480269 0.0163934 0.0230502 0.01832 0.0236613 0.00785573 0.00539283 0.003698 0.0042508 0.00387353 0.00441543 0.00406328 0.00297324 0.00173234 0.00444898 0.00691565 0.00816964 0.00978005 0.003191 0.00217044 0.00379484 0.00390754 0.00505835 0.00452972 0.00415427 0.00494081 0.00319765 0.00450803 0.0174109	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0762069 0.077718 0.0831136 0.0339721 0.022549 0.0357999 0.0194681 0.0405936 0.0372458 0.0235537 0.0207613 0.0381937 0.0151387 0.0145796 0.0185378 0.0142117 0.00849976 0.020765 0.0147419 0.0142045 0.00846977 0.0174988 0.0283192 0.036041 0.00959229 0.00872525 0.00793225 0.0148351 0.0103999 0.00293895 0.00198898 0.00309551 0.00197938 0.00440217 0.00335837 0.00492174 0.0170063 0.0237682 0.0188335 0.0244948 0.00810303 0.00556879 0.00379268 0.00434512 0.0039408 0.0044609 0.00410559 0.00274143 0.00157699 0.00376635 0.00458215 0.00318678 0.00346325 0.00333706 0.00541979 0.0106398 0.00387357 0.0048182 0.00464858 0.00424481 0.0052235 0.00305973 0.00437898 0.0182659	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0750342 0.0765005 0.081793 0.0334214 0.0221769 0.0352041 0.0191381 0.0399348 0.0366356 0.0231663 0.0203957 0.037465 0.0147705 0.014172 0.0179705 0.0137824 0.00823829 0.0201021 0.0143328 0.0138188 0.00807944 0.016612 0.026803 0.0344088 0.00911722 0.00818622 0.00743595 0.0140092 0.00993019 0.0028241 0.00192796 0.00299353 0.00190889 0.00418442 0.0031649 0.00447358 0.0145827 0.0195417 0.0155313 0.0220905 0.00724561 0.00532935 0.00342946 0.00432176 0.0036241 0.00449197 0.00380213 0.00276957 0.00156002 0.0036639 0.00402031 0.00294776 0.00321382 0.00245166 0.00187086 0.00567799 0.00878119 0.0247909 0.0183868 0.00649824 0.00633532 0.00386055 0.00505299 0.020015	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0769259 0.0783929 0.0837854 0.0342166 0.0226942 0.0360186 0.0195734 0.0408948 0.0375121 0.023717 0.020848 0.0381982 0.0149671 0.0143005 0.0180617 0.0138668 0.00828077 0.0201513 0.014445 0.0139618 0.0080122 0.0163984 0.0263831 0.0342563 0.00901276 0.00800521 0.00729244 0.0139682 0.01001 0.00285349 0.0019649 0.00305384 0.00194835 0.00425653 0.00318535 0.00448794 0.0144238 0.0189672 0.0150981 0.0221219 0.00717582 0.00539642 0.00342021 0.00440815 0.00363364 0.00462514 0.00384277 0.00278129 0.00157216 0.0037006 0.00403318 0.00293684 0.00305784 0.00248839 0.0018785 0.00478367 0.00557924 0.00804827 0.0110037 0.0154564 0.0167143 0.00624417 0.00495252 0.0157548	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0753019 0.0767195 0.0819771 0.0334637 0.0221918 0.0352227 0.0191426 0.0400367 0.0367365 0.0232238 0.0204048 0.0373362 0.0146385 0.0139905 0.0176558 0.0135865 0.00810045 0.0196777 0.0141261 0.0136799 0.00786852 0.0161557 0.0260055 0.0339216 0.00889461 0.007908 0.00721494 0.0140269 0.0100911 0.0028811 0.00197402 0.00306896 0.00196533 0.00432123 0.00323754 0.00467744 0.0154619 0.0208824 0.0168635 0.023772 0.0078481 0.0055713 0.00368238 0.0044612 0.00394229 0.004669 0.00419246 0.00272861 0.00162515 0.00373774 0.0044764 0.00315112 0.00297185 0.00256855 0.00196249 0.00472658 0.00611863 0.00914908 0.0077132 0.00788479 0.00594389 0.00468267 0.0114696 0.0363176	Some drug interactions are :  - birth control pills - DRUG1 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.067821 0.0645425 0.0640138 0.0224775 0.0155798 0.0271725 0.0111737 0.0188538 0.0161921 0.0115434 0.00585486 0.00746436 0.00524918 0.0145568 0.0123931 0.0115816 0.00466911 0.0169061 0.0133395 0.0173651 0.00888063 0.0211515 0.0330682 0.0478021 0.0165758 0.0205484 0.0222316 0.0343055 0.0189437 0.00695195 0.00681693 0.0203559 0.00950222 0.00862959 0.0251603 0.0359536 0.0283478 0.0197038 0.0186191 0.0429706 0.0126446 0.00911192 0.00405515 0.00578514 0.00381875 0.00534842 0.00339028 0.00370614 0.0017721 0.00400234 0.00309167 0.00249079 0.0037307 0.00244558 0.00193144 0.00430339 0.0035613 0.00575334 0.00569538 0.00429992 0.00616708 0.00285639 0.00449102 0.0202784	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG2 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0654155 0.0623286 0.0620795 0.0218171 0.0149155 0.0260143 0.0106256 0.0177253 0.0152317 0.0107707 0.00541703 0.00713593 0.00489378 0.0134167 0.0113342 0.0106961 0.00429272 0.0155187 0.0122652 0.0158772 0.00779699 0.0183739 0.0280679 0.0409808 0.0136844 0.0162576 0.0175731 0.0300182 0.0181228 0.00639688 0.0068643 0.0182407 0.00711618 0.00564474 0.00906602 0.0108063 0.022799 0.0547767 0.0523399 0.0659009 0.0353121 0.0181155 0.00617047 0.00470095 0.0032542 0.00410614 0.00296988 0.00295516 0.00158062 0.00323614 0.00259837 0.0021438 0.0030617 0.00215308 0.00159632 0.00349892 0.00304202 0.00481685 0.00456437 0.00360443 0.00499925 0.00245267 0.00379921 0.016669	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG2 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0668377 0.063664 0.0633293 0.0222561 0.0152409 0.026561 0.0108598 0.0181177 0.0155658 0.0110257 0.00556115 0.00730082 0.00502083 0.0137793 0.0116657 0.0109995 0.00442373 0.0159666 0.0126232 0.0163992 0.00814449 0.0193138 0.0297311 0.0431341 0.0145295 0.0175354 0.0192584 0.0317652 0.0187573 0.00658717 0.00696323 0.0183704 0.00654249 0.00521965 0.00935044 0.0105903 0.0217538 0.0489063 0.0372265 0.0529556 0.0224289 0.0162364 0.0184379 0.016743 0.00442791 0.00400689 0.00302824 0.00308364 0.00179376 0.00340477 0.00282477 0.00231608 0.00328418 0.00236462 0.00171905 0.00373741 0.00327116 0.00508242 0.00478921 0.00381426 0.00522088 0.00264122 0.00404979 0.0174605	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG2 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.067793 0.0645574 0.0641875 0.0225612 0.0154477 0.026904 0.0110013 0.0183323 0.0157448 0.0111498 0.00562372 0.0073902 0.00507546 0.0139118 0.0117686 0.011102 0.00446313 0.0160913 0.0127156 0.0165095 0.00815898 0.0192788 0.0295387 0.0429691 0.0143786 0.0172514 0.018954 0.0316262 0.0187724 0.00651787 0.00686001 0.0181593 0.00639095 0.00509178 0.00868526 0.0100561 0.0209013 0.0464504 0.0355772 0.0494815 0.0188327 0.0101915 0.00760257 0.0114746 0.0199653 0.0169975 0.00405791 0.00335829 0.0020865 0.00360314 0.00301928 0.00245098 0.00344 0.00251045 0.00179921 0.00385358 0.00340504 0.00524023 0.00490482 0.00391639 0.00532071 0.00269394 0.00411536 0.0177299	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG2 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0692795 0.0659422 0.0655147 0.0230313 0.0157646 0.027428 0.0112167 0.0186571 0.0160224 0.0113421 0.00572012 0.00752819 0.00515755 0.0141087 0.0119207 0.0112574 0.00452122 0.0162704 0.0128466 0.0166727 0.00817346 0.0192068 0.029201 0.0427036 0.0141497 0.0168241 0.0185087 0.0314967 0.0188573 0.00644055 0.00675074 0.0180051 0.00631339 0.00498606 0.00775287 0.00900135 0.0190859 0.0438654 0.0348025 0.0498301 0.0180251 0.00947352 0.00620584 0.0066452 0.00724823 0.0109787 0.0160864 0.0142975 0.00346689 0.00399124 0.00324333 0.00292171 0.00355484 0.00296691 0.00199684 0.00405817 0.00386571 0.00542483 0.00487115 0.00412028 0.00526226 0.00295309 0.00436792 0.0178169	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0704248 0.0670325 0.0666067 0.0234163 0.0160222 0.0278752 0.0113984 0.0189542 0.0162773 0.0115187 0.00580665 0.00764809 0.00523487 0.0143138 0.0120878 0.0114182 0.00458335 0.0164917 0.013018 0.0168819 0.00825124 0.0193487 0.0293363 0.0429668 0.0141923 0.0167797 0.0183678 0.0315908 0.0190525 0.00648775 0.00680366 0.0183382 0.00643351 0.00517154 0.00841615 0.0101045 0.0217489 0.0478529 0.036778 0.0497138 0.0179038 0.0091164 0.0059722 0.00613645 0.00646114 0.00613369 0.00642937 0.00524014 0.00433349 0.0117089 0.00324545 0.00286872 0.00352876 0.00278525 0.00187846 0.00381722 0.00368134 0.00515374 0.00476628 0.00399767 0.00515714 0.00287424 0.0042831 0.0177814	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0701214 0.0667448 0.0663141 0.0233152 0.0159551 0.0277569 0.0113499 0.0188702 0.0161982 0.0114634 0.00577955 0.00761331 0.00521258 0.0142504 0.012035 0.0113666 0.00456451 0.0164249 0.0129647 0.0168099 0.008222 0.0192792 0.0292382 0.0427894 0.0141456 0.0167321 0.0183425 0.0314114 0.0188909 0.00642916 0.0067357 0.018075 0.00632043 0.00503024 0.0078168 0.00935543 0.0201039 0.0455996 0.0354671 0.0490571 0.0173551 0.00874314 0.00546935 0.00590549 0.00579561 0.00595414 0.0056882 0.00362522 0.00214382 0.00544417 0.00855058 0.00991249 0.0112812 0.0036581 0.00240043 0.00418862 0.004274 0.00534876 0.00474359 0.00441197 0.0051888 0.00338397 0.00472899 0.0176518	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0703458 0.0669484 0.0665066 0.023383 0.0159965 0.0278213 0.0113761 0.0189034 0.0162319 0.0114845 0.00578882 0.0076301 0.00521781 0.0142551 0.0120327 0.0113708 0.00456311 0.0164089 0.0129482 0.0167894 0.00818366 0.0191515 0.0289595 0.0425055 0.0140029 0.0164999 0.0180793 0.0312947 0.0189375 0.00642346 0.00673625 0.0181081 0.00634939 0.00507884 0.0079135 0.00960418 0.0208376 0.0466269 0.0363916 0.0501292 0.017892 0.00897538 0.00560717 0.00605972 0.00590528 0.00605862 0.00577538 0.00333586 0.001928 0.00460544 0.00578105 0.00393512 0.0040434 0.00384265 0.00608608 0.011706 0.00425636 0.00511992 0.00488613 0.00450826 0.00549401 0.00323086 0.00458307 0.0185688	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0685233 0.0651977 0.0647345 0.0227609 0.015574 0.027072 0.0110704 0.0183791 0.0157774 0.0111635 0.00562856 0.00742124 0.00507237 0.0138461 0.0116851 0.0110468 0.00443255 0.0159231 0.01256 0.0162924 0.00792769 0.0185203 0.0279485 0.041108 0.0135125 0.0158894 0.0174434 0.0302597 0.0183038 0.00617488 0.00645974 0.0173727 0.00609017 0.00480458 0.00703195 0.0082547 0.0175918 0.0413287 0.0334081 0.0485443 0.016951 0.00862375 0.00504173 0.00599039 0.00539762 0.005991 0.00536017 0.00333637 0.00187842 0.0043889 0.00501943 0.00357667 0.00366788 0.00285946 0.0020922 0.00634603 0.00992438 0.0275873 0.0200834 0.00712704 0.00679611 0.00410932 0.00530311 0.0204122	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.069959 0.0665459 0.0660481 0.0232234 0.0158846 0.0275972 0.011285 0.0187165 0.0160727 0.0113694 0.00573128 0.00756336 0.00516061 0.0140711 0.0118673 0.0112286 0.00450173 0.0161515 0.0127332 0.0165228 0.00800376 0.0186452 0.0280183 0.0413817 0.0135406 0.0158475 0.0174137 0.0305883 0.0186286 0.00623919 0.00652699 0.0176075 0.00618005 0.0048861 0.00703809 0.00822715 0.0175925 0.0412424 0.0337992 0.0494865 0.0171219 0.00875514 0.00501932 0.00611901 0.00539734 0.00617126 0.00542339 0.00335125 0.00188992 0.00444742 0.00505359 0.00355892 0.00347934 0.00289847 0.00209083 0.00535787 0.00634024 0.00910084 0.01208 0.0169883 0.0181351 0.00679275 0.00520476 0.0160961	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0682813 0.0649393 0.064457 0.0226576 0.0154905 0.0269137 0.0110078 0.0182672 0.01572 0.0111193 0.00560437 0.00738953 0.0050361 0.0137382 0.0115855 0.0109704 0.00439329 0.0157579 0.0124251 0.0161422 0.00780741 0.0182129 0.0273541 0.0404887 0.0132303 0.0155146 0.0170755 0.0302754 0.0184893 0.00620927 0.0064826 0.0174149 0.00622439 0.00491754 0.00744719 0.00891478 0.0189967 0.0430572 0.0352419 0.0499709 0.0182275 0.00901846 0.00543579 0.00624942 0.0058756 0.00628384 0.00586246 0.00326967 0.0019492 0.00448762 0.00560009 0.00379791 0.00336347 0.0029701 0.0021725 0.00526221 0.0069001 0.0102769 0.00836809 0.00867626 0.00636878 0.00496852 0.0119451 0.0374487	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG1 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0700393 0.0666 0.0660994 0.0231594 0.0159164 0.0277376 0.0113735 0.0190955 0.0165626 0.0117413 0.00586926 0.0075854 0.00523272 0.0144376 0.0121708 0.0114939 0.00455528 0.0163253 0.0128243 0.0169994 0.00829012 0.0197529 0.0302486 0.0452756 0.01448 0.0176657 0.020165 0.0314104 0.017491 0.00605861 0.00461333 0.0095217 0.0094749 0.0321823 0.0217903 0.0351664 0.0287936 0.0204151 0.0191241 0.0449273 0.0129146 0.00926375 0.0041059 0.00589816 0.00387514 0.00545264 0.00343286 0.00377982 0.00181508 0.00408517 0.00314426 0.0025407 0.00381006 0.00250574 0.00197658 0.00439625 0.0036431 0.00588202 0.00581965 0.0044172 0.00632903 0.0029453 0.00463435 0.0206666	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG2 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0667455 0.0636128 0.0634457 0.0222763 0.015164 0.0264678 0.0107953 0.017995 0.0155284 0.010955 0.00545985 0.0072407 0.00493454 0.0134969 0.0113356 0.0107404 0.00427469 0.0153937 0.0120928 0.0157632 0.00762202 0.017926 0.027185 0.0401402 0.012837 0.0143961 0.0149719 0.0253175 0.014588 0.00472445 0.00346326 0.00842538 0.00722533 0.0254935 0.00868399 0.00962074 0.0217952 0.056279 0.0539497 0.0678767 0.0353541 0.0182253 0.00629313 0.00484108 0.00336567 0.00422941 0.00305767 0.00305071 0.00163266 0.00333016 0.0026617 0.00219646 0.00314266 0.00221371 0.00163885 0.00358642 0.00311588 0.00491942 0.00466754 0.00369573 0.00512089 0.00252003 0.00390304 0.0169987	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG2 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0680069 0.0647749 0.0644786 0.0226415 0.0154393 0.0269105 0.0109902 0.0183073 0.0157908 0.0111554 0.00557043 0.00736148 0.00502421 0.0137462 0.0115593 0.0109491 0.0043625 0.0156636 0.0123065 0.016114 0.00783247 0.0184959 0.0281046 0.0414934 0.0132645 0.0151605 0.0163775 0.0267746 0.0151893 0.00490661 0.00371808 0.00882242 0.00811057 0.0281629 0.0088642 0.00967816 0.0213826 0.0508008 0.0385315 0.0546394 0.0226952 0.016493 0.0183966 0.0169573 0.00454434 0.00412467 0.00311965 0.00317585 0.00184708 0.00349528 0.00289275 0.00236754 0.00335668 0.00241819 0.0017561 0.00380976 0.00333375 0.00516282 0.0048707 0.00388838 0.00531896 0.00269316 0.00413022 0.0176893	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG2 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0690008 0.065705 0.0653673 0.022956 0.0156535 0.0272659 0.0111379 0.0185356 0.0159862 0.0112924 0.0056404 0.00745665 0.00508342 0.013893 0.0116753 0.011062 0.00440569 0.0157998 0.0124053 0.0162383 0.0078626 0.0185103 0.0280206 0.0414745 0.0131917 0.0149623 0.0161126 0.0266466 0.0152457 0.00488371 0.00369146 0.0087599 0.00789537 0.0272653 0.00833502 0.00915873 0.0203749 0.0483449 0.0367507 0.0509599 0.0190581 0.0103184 0.00765115 0.0117824 0.0199839 0.0172251 0.0041504 0.00344945 0.0021408 0.0036887 0.00308682 0.00250421 0.00351498 0.00256797 0.00183825 0.00392805 0.00347188 0.00532398 0.00498857 0.0039941 0.0054209 0.00274816 0.00419834 0.0179584	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG2 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0704759 0.067079 0.0666757 0.0234164 0.015967 0.0277845 0.0113526 0.0188657 0.0162758 0.0114969 0.00574513 0.00759904 0.00517136 0.014111 0.0118495 0.0112355 0.0044717 0.016008 0.0125566 0.0164367 0.00791305 0.0185495 0.0279208 0.0415088 0.0131098 0.0147109 0.0157675 0.0265595 0.0153767 0.00488074 0.00367595 0.0087153 0.00764116 0.0260617 0.0076459 0.00823462 0.018438 0.0458051 0.0358831 0.0510056 0.0181656 0.00960649 0.0062455 0.00680764 0.00728838 0.0112545 0.0160969 0.0144834 0.00352938 0.00406263 0.00329786 0.00297411 0.00361798 0.0030253 0.00203555 0.00412544 0.0039358 0.0055002 0.0049419 0.00419942 0.00535535 0.00301333 0.00445477 0.0180052	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0717063 0.0682522 0.0678549 0.0238311 0.0162443 0.0282694 0.011549 0.0191893 0.0165545 0.0116892 0.00583856 0.00772773 0.00525515 0.0143346 0.0120316 0.0114088 0.0045381 0.016244 0.012737 0.0166543 0.0079974 0.0187123 0.0281235 0.0418458 0.0131854 0.0146944 0.0156023 0.0265701 0.0154934 0.0049085 0.00369055 0.00876441 0.00773658 0.0266428 0.00817334 0.00914598 0.0210363 0.0499456 0.0378251 0.0509729 0.0179931 0.00917258 0.00598529 0.00624074 0.00646415 0.00620646 0.00640973 0.00530889 0.00438802 0.0118595 0.00331164 0.00292455 0.00359783 0.00284586 0.00191861 0.00389029 0.00375702 0.00523298 0.00484712 0.00408302 0.00526094 0.00293742 0.00437491 0.0180123	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0714013 0.0679643 0.0675646 0.0237306 0.0161763 0.0281497 0.0114999 0.0191049 0.0164764 0.0116348 0.00581177 0.00769394 0.00523305 0.0142715 0.0119782 0.011357 0.00451893 0.0161772 0.0126835 0.0165838 0.00796674 0.0186389 0.0280047 0.0416445 0.0131291 0.0146418 0.0155923 0.0264382 0.0153771 0.0048669 0.00365805 0.00870313 0.00762903 0.0261728 0.00773119 0.00852352 0.0194203 0.0476671 0.0365178 0.0502022 0.0174391 0.00884455 0.00549852 0.00603503 0.00581219 0.00605838 0.00568669 0.00370515 0.00216222 0.00552763 0.00855588 0.00986016 0.0113909 0.00372197 0.00244118 0.00425811 0.00434818 0.00543281 0.00480609 0.0044924 0.00527849 0.0034512 0.00481873 0.0178375	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.071604 0.0681484 0.0677377 0.0237908 0.0162144 0.02821 0.0115247 0.019139 0.0165117 0.0116582 0.00582319 0.00771107 0.00524032 0.0142846 0.0119855 0.0113683 0.00452118 0.0161766 0.0126793 0.0165775 0.00794466 0.0185594 0.0278339 0.0414817 0.0130469 0.0144856 0.0153655 0.026312 0.0153953 0.00486406 0.00365421 0.00871006 0.00758982 0.0260709 0.00779377 0.00872584 0.0201193 0.0487668 0.0374241 0.0512862 0.0179374 0.00905411 0.00561949 0.00617323 0.00590125 0.00614365 0.00574608 0.00339542 0.0019448 0.00466043 0.0057639 0.00391353 0.00409176 0.00388378 0.00614561 0.0118699 0.00433066 0.00520148 0.00495484 0.00459694 0.00559416 0.00329666 0.0046728 0.0187718	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0696931 0.0663118 0.0658729 0.0231356 0.0157735 0.0274269 0.0112064 0.0185963 0.0160414 0.0113296 0.00566202 0.00749702 0.00509391 0.0138765 0.0116432 0.0110474 0.00439397 0.0157069 0.0123067 0.0161017 0.00770964 0.0179889 0.0269363 0.0402133 0.012629 0.0140061 0.0149 0.0255227 0.0149391 0.00470747 0.00353034 0.00840053 0.00725132 0.0247445 0.00708957 0.00759106 0.0169162 0.0430372 0.0342111 0.0495314 0.0169842 0.00874233 0.00507241 0.00611408 0.005404 0.00608421 0.00533355 0.00339944 0.00189897 0.00445081 0.00501329 0.00356406 0.00371712 0.00289467 0.00211652 0.00641965 0.00997338 0.0276672 0.0202733 0.00722562 0.00690472 0.00418419 0.0053954 0.0205942	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0711067 0.0676399 0.0671646 0.0235887 0.0160795 0.0279458 0.0114189 0.0189345 0.0163407 0.0115399 0.0057673 0.00763932 0.00518412 0.0141103 0.0118347 0.0112363 0.00446627 0.015948 0.012489 0.0163466 0.00780043 0.0181619 0.0271162 0.0406259 0.0127149 0.0140317 0.0148978 0.0258062 0.0152166 0.00477734 0.0035821 0.00853117 0.00731089 0.024892 0.00711721 0.00758244 0.016882 0.0428398 0.0344972 0.0505042 0.0171441 0.00887942 0.00505431 0.0062419 0.00540274 0.00626214 0.00539037 0.0034106 0.0019094 0.00450308 0.00503871 0.0035421 0.00352056 0.0029302 0.00211283 0.00540505 0.00635662 0.0090895 0.0121931 0.0171407 0.018392 0.00690183 0.00527445 0.0162353	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0693894 0.0659987 0.0655363 0.023011 0.0156819 0.0272576 0.0111402 0.0184839 0.015979 0.0112847 0.00564007 0.00746273 0.00506086 0.0137834 0.0115625 0.0109834 0.00436249 0.0155746 0.0122009 0.0159822 0.00762261 0.0177728 0.0265468 0.0398129 0.0124457 0.0137465 0.0145693 0.025441 0.0150289 0.00473346 0.00353987 0.00841159 0.00717836 0.0244068 0.00729298 0.00813657 0.0182884 0.0452486 0.0362734 0.0513393 0.018251 0.00909708 0.00543425 0.00634636 0.00585661 0.00635614 0.00581314 0.00331775 0.00196224 0.00453081 0.00556162 0.00376757 0.00339676 0.00299653 0.00219064 0.00529799 0.00690616 0.0102403 0.00841961 0.00871357 0.00643522 0.00502793 0.0120311 0.037838	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG1 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0661031 0.0623272 0.0611661 0.0212912 0.0143088 0.0245445 0.0099513 0.0159216 0.0141228 0.00991712 0.00495792 0.00672244 0.00432407 0.0113793 0.00956353 0.00945918 0.00365961 0.0122418 0.00946329 0.0128296 0.00560233 0.0122425 0.0178452 0.0304238 0.00872367 0.00874445 0.00850654 0.0176346 0.0121139 0.0036849 0.00287648 0.00487654 0.00414774 0.00982586 0.0154504 0.0361656 0.0774027 0.0706343 0.0499652 0.0614845 0.0421458 0.0191396 0.00746611 0.00566833 0.0038264 0.00467745 0.00338441 0.00327817 0.00174552 0.00357994 0.00289318 0.00234143 0.00331403 0.00231894 0.00169969 0.00373119 0.00325456 0.0050919 0.00481455 0.00377859 0.00522199 0.00255924 0.00395413 0.0175091	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG2 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0640101 0.060289 0.0590347 0.0205465 0.0138186 0.0236556 0.00959741 0.0153171 0.0136032 0.00956148 0.00479906 0.00649758 0.00416968 0.0109548 0.00923134 0.00916247 0.00354502 0.0118012 0.00914244 0.0124429 0.00542866 0.0118428 0.0172905 0.029774 0.00848976 0.00855978 0.00835514 0.017431 0.012138 0.0036917 0.00294299 0.00483646 0.00424674 0.0100388 0.0186879 0.0414712 0.08248 0.068144 0.0405617 0.053779 0.0302685 0.0204586 0.023826 0.019585 0.00548611 0.0045854 0.00332139 0.00329018 0.00189101 0.0035834 0.00297001 0.00237556 0.00334908 0.00238671 0.00172799 0.0037575 0.00326586 0.00503655 0.0047618 0.00375834 0.00515713 0.00258306 0.00396082 0.0172439	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG2 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0649422 0.0611414 0.0597915 0.0208073 0.0139943 0.023927 0.00971159 0.0154739 0.0137446 0.00965935 0.00485114 0.00656547 0.00420619 0.0110299 0.00929155 0.00922599 0.00356786 0.0118423 0.0091593 0.0124646 0.00541939 0.0117774 0.0171527 0.0296573 0.00841594 0.00843007 0.00820832 0.0172474 0.0121344 0.00366158 0.00290113 0.00479161 0.00415496 0.00987712 0.0178195 0.0403089 0.0802787 0.062381 0.0386598 0.0489215 0.0260486 0.0143094 0.0119784 0.014447 0.0261666 0.019923 0.00487077 0.00375491 0.00226861 0.0038444 0.00324763 0.0025556 0.00355341 0.00256956 0.00183246 0.00391561 0.00343803 0.00522861 0.00491529 0.00389085 0.00529421 0.00265897 0.00405964 0.0176321	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG2 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0664432 0.0626064 0.0613094 0.0213283 0.0143093 0.0245 0.00992898 0.0158183 0.0140599 0.00986647 0.00493796 0.0067074 0.00428741 0.0112302 0.0094391 0.00937488 0.00361952 0.0120218 0.00927719 0.0126031 0.00545334 0.0118105 0.0171284 0.0297585 0.00841051 0.00836295 0.00807666 0.0170993 0.0121423 0.00360048 0.0027904 0.00467952 0.00394848 0.00957285 0.0159668 0.0381246 0.0786577 0.0585858 0.0386044 0.0482659 0.0250612 0.0132597 0.00959774 0.0086676 0.010207 0.0136089 0.0204993 0.0164993 0.00401186 0.00446147 0.00360197 0.00312632 0.00374442 0.0031164 0.00208994 0.00422649 0.00401446 0.005532 0.00498016 0.00419194 0.00534522 0.00298816 0.00441065 0.0180496	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0683583 0.064311 0.0627784 0.0218344 0.0146748 0.0250437 0.0101649 0.0161418 0.0143523 0.0100811 0.00506571 0.00686192 0.00437871 0.0114387 0.00963295 0.00958354 0.00370072 0.012212 0.00941862 0.0128231 0.00553426 0.0119319 0.0173008 0.0301754 0.00848156 0.00837459 0.00811373 0.0172624 0.0124203 0.0037197 0.00294118 0.00488632 0.00418053 0.00997112 0.017241 0.0404303 0.0815345 0.060127 0.039344 0.0482017 0.0246125 0.0129473 0.00934991 0.00840951 0.00936825 0.00825745 0.008681 0.00652837 0.00509883 0.0132958 0.00366545 0.00311262 0.00374762 0.00296171 0.00198989 0.00401041 0.00385855 0.00529851 0.00490968 0.00410843 0.00527847 0.00294745 0.00437671 0.0181566	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0679613 0.0639952 0.0625825 0.0217625 0.0145972 0.0249552 0.0101148 0.0160751 0.0142998 0.010035 0.00502769 0.00683156 0.00435552 0.01138 0.00956913 0.00952014 0.00367321 0.0121481 0.00936158 0.0127292 0.00548557 0.0118232 0.0171165 0.0299108 0.00840841 0.00829802 0.00800084 0.0170796 0.0122854 0.00364333 0.0028405 0.00477056 0.00403217 0.00976223 0.0161427 0.0387907 0.0794403 0.0581859 0.0387824 0.0471583 0.0239971 0.0121538 0.00831694 0.00790681 0.0082893 0.00790286 0.00765962 0.00441892 0.00265994 0.00657782 0.0102753 0.0116907 0.0126615 0.00403938 0.00257431 0.00443848 0.00454191 0.00558308 0.00491812 0.00457846 0.00535793 0.003505 0.00487646 0.0181441	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0683961 0.06437 0.0628772 0.0218639 0.0146772 0.0250637 0.0101653 0.0161401 0.0143566 0.010078 0.00505617 0.00686126 0.00437327 0.0114178 0.00960609 0.00955962 0.00368869 0.0121751 0.00937975 0.0127606 0.00549551 0.0118283 0.0171184 0.0299419 0.00840278 0.0082748 0.00798761 0.0170662 0.0123191 0.00366079 0.00286461 0.00479415 0.00405501 0.00977272 0.0162599 0.0390875 0.0799808 0.0581546 0.0391941 0.0477286 0.0245397 0.0124266 0.00858657 0.00819389 0.00852789 0.00812965 0.00785602 0.0041018 0.00237294 0.00562198 0.00707439 0.00474701 0.00456984 0.0042868 0.00670236 0.0125407 0.00456505 0.00538219 0.00511346 0.00470413 0.00571769 0.00336493 0.00475494 0.0192657	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.066307 0.0624906 0.0612186 0.0212906 0.0142673 0.0244354 0.00989466 0.0157526 0.0140068 0.00982377 0.00490883 0.00668171 0.00426481 0.0111573 0.00936777 0.00930867 0.00359093 0.0119215 0.00918251 0.0124641 0.00537531 0.0116032 0.0167759 0.0292635 0.0082429 0.00815187 0.00783562 0.0166751 0.0119259 0.00350153 0.00266985 0.00451474 0.00376866 0.00928998 0.0143093 0.0354687 0.0743654 0.0536413 0.036531 0.0451793 0.0233832 0.011463 0.00735751 0.00775367 0.00753946 0.00780842 0.00716537 0.00399989 0.0022413 0.00523611 0.00601866 0.00421794 0.00404553 0.0031747 0.00228144 0.00686502 0.0109634 0.030129 0.0213975 0.00754293 0.00712456 0.00427501 0.00547861 0.0211134	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0676662 0.0637667 0.0624604 0.0217233 0.0145607 0.0249342 0.0100979 0.0160764 0.0142932 0.0100252 0.00501025 0.00681766 0.00435243 0.011387 0.00956051 0.00949856 0.0036645 0.0121669 0.00937117 0.0127188 0.00548552 0.0118412 0.0171114 0.0298325 0.00839922 0.00830453 0.0079888 0.0169776 0.0121345 0.00355518 0.00270201 0.00456442 0.00379871 0.00937161 0.0142143 0.0354661 0.0749218 0.0536115 0.036772 0.0457269 0.0236726 0.0115653 0.00729038 0.00789539 0.00752643 0.00804009 0.00725601 0.00402253 0.00225232 0.00533287 0.00610159 0.00420132 0.00383878 0.00321818 0.00227293 0.0058217 0.00701935 0.010039 0.012941 0.0182384 0.0191505 0.00716416 0.00542662 0.0167809	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0663231 0.0624393 0.061019 0.0212202 0.0142515 0.0243538 0.00987819 0.015706 0.0139605 0.00979866 0.00491154 0.00666019 0.0042523 0.0111161 0.00934437 0.00928485 0.00358291 0.0118534 0.00912873 0.0124036 0.00534832 0.011529 0.0166643 0.0290511 0.00815511 0.00804378 0.00776542 0.0164914 0.01181 0.0034786 0.0026671 0.00444816 0.00370926 0.00900304 0.0142067 0.0351636 0.0740814 0.0540363 0.0377621 0.0464229 0.0246907 0.012087 0.00814717 0.00834761 0.00843677 0.00841221 0.00798218 0.00402111 0.00238442 0.0055049 0.00692921 0.00457607 0.00377499 0.00334034 0.00240577 0.00581857 0.00776453 0.0114846 0.00911815 0.00954148 0.00683212 0.00528263 0.0126685 0.039123	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG1 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0650203 0.061281 0.0602467 0.0210761 0.0142185 0.024345 0.00989237 0.015856 0.0138989 0.00975616 0.00487715 0.00662771 0.00430705 0.0113504 0.009482 0.00923784 0.00361739 0.012331 0.00947515 0.0125101 0.00553732 0.0121064 0.0173189 0.0277893 0.00823939 0.00817077 0.00762764 0.0150753 0.0105512 0.00332561 0.00227114 0.00358779 0.00240533 0.00579251 0.00456168 0.00824287 0.0263062 0.0483245 0.0483795 0.0565391 0.0326519 0.0641387 0.033918 0.0228216 0.0375391 0.0215654 0.00648562 0.00432008 0.00272924 0.00404428 0.00354004 0.00285526 0.00385959 0.00285058 0.00195511 0.00413019 0.00373023 0.00551127 0.00504141 0.00411376 0.00541141 0.00286952 0.00433056 0.0180279	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG2 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0636193 0.0598849 0.0588385 0.0205705 0.0138332 0.0236359 0.00959756 0.0153213 0.0135018 0.00946959 0.00473509 0.00645611 0.00415867 0.0109056 0.00911209 0.00892196 0.00348548 0.011813 0.00905202 0.011963 0.005242 0.0113542 0.0160429 0.0261581 0.00771357 0.0075391 0.00700238 0.0142707 0.0102695 0.00324612 0.00222103 0.00354653 0.00234524 0.00575967 0.00441262 0.00795831 0.0257612 0.04775 0.0488659 0.060104 0.0347511 0.065548 0.0305699 0.0166199 0.0205314 0.0162765 0.030097 0.0191714 0.00539396 0.00485862 0.00383471 0.00333538 0.00387433 0.00320603 0.00210525 0.00424089 0.00407479 0.00557282 0.00494209 0.00419257 0.00528278 0.00297384 0.00438772 0.0177202	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0643801 0.060557 0.0594101 0.0207677 0.0139551 0.0238054 0.00966789 0.0153936 0.0135887 0.0095335 0.00477439 0.00651679 0.00418216 0.0109373 0.00914926 0.0089831 0.00350956 0.0118521 0.00907711 0.012009 0.00524852 0.0113192 0.0159226 0.0261614 0.00772339 0.00750886 0.00697746 0.0144224 0.0105224 0.00332785 0.00230688 0.00370803 0.00249203 0.00608897 0.00472784 0.00851936 0.0274284 0.0504663 0.0514037 0.0627078 0.0362119 0.0676813 0.0304122 0.0175451 0.0204943 0.0123253 0.0159804 0.00829121 0.00656531 0.0140338 0.00423596 0.00358231 0.00402315 0.00313711 0.00206189 0.00408911 0.003953 0.00534712 0.00484963 0.00408898 0.00517033 0.00292365 0.00432924 0.0176345	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0649577 0.0611077 0.0600291 0.0209854 0.0140855 0.0240391 0.00975485 0.0155291 0.0137101 0.00961105 0.00480631 0.00657339 0.00421403 0.0110143 0.0092053 0.0090373 0.00352777 0.0119178 0.00911792 0.0120392 0.00524766 0.011284 0.0158269 0.0260119 0.00765575 0.00740113 0.0068286 0.0141343 0.0103626 0.0032742 0.00224504 0.0036086 0.00237209 0.00584706 0.00440579 0.00790112 0.0262081 0.0472086 0.0487715 0.0605783 0.0347507 0.0646607 0.0295717 0.0160112 0.0180378 0.0114509 0.0134934 0.00526903 0.00387733 0.00807089 0.013505 0.0136665 0.0131697 0.00430713 0.00263011 0.0044052 0.00455214 0.00553488 0.00485734 0.00454628 0.00527338 0.00345576 0.00480612 0.0176605	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0649122 0.0610416 0.0599326 0.0209471 0.0140496 0.0239602 0.00972168 0.015455 0.0136631 0.00957757 0.00479151 0.00655863 0.00419471 0.0109471 0.00915249 0.00899973 0.00351157 0.0118394 0.00905254 0.0119586 0.00520055 0.0111532 0.015603 0.0257601 0.00757237 0.0072926 0.00672464 0.0140221 0.010358 0.00327289 0.00225367 0.00363309 0.00239491 0.00591169 0.00445302 0.00798798 0.02659 0.048087 0.0498114 0.0622435 0.0357738 0.0668574 0.0304569 0.0164884 0.0187823 0.0118746 0.0139694 0.00495412 0.00343053 0.00695005 0.00948614 0.0059894 0.00483941 0.00453565 0.00686017 0.0126629 0.00467119 0.00533751 0.00496746 0.00460445 0.00553596 0.00328387 0.00463134 0.0184645	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0644553 0.0606282 0.0596216 0.0208409 0.0139674 0.0238398 0.00966565 0.0153747 0.0135894 0.009519 0.00475457 0.00651711 0.00416835 0.0108814 0.00908879 0.00893121 0.00348217 0.0117555 0.00898224 0.0118446 0.00514301 0.0110158 0.0153892 0.0253715 0.00743294 0.00712947 0.00652799 0.0135777 0.0100389 0.00316161 0.00215085 0.00345593 0.00222776 0.00552985 0.00406976 0.00720614 0.0247729 0.0432844 0.045315 0.0576767 0.0327903 0.0614547 0.0290941 0.0148247 0.0160156 0.0109736 0.0122008 0.00470207 0.00308909 0.00635814 0.00775999 0.00519233 0.00420601 0.0032358 0.00233055 0.00674145 0.0117167 0.0299481 0.0205003 0.00744428 0.00699436 0.00423364 0.00538269 0.0204253	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0658463 0.0619159 0.0608748 0.0212752 0.0142463 0.0243017 0.00985103 0.0156512 0.0138524 0.00970128 0.00484652 0.00664923 0.00424317 0.0110617 0.00924119 0.00909301 0.00354331 0.0119417 0.00911904 0.0120265 0.00520947 0.0111303 0.0155064 0.0256536 0.00749989 0.00716371 0.00655564 0.0136981 0.0101894 0.00320639 0.00218651 0.00351246 0.00226288 0.00562313 0.00412435 0.00728392 0.0250441 0.0436904 0.0458649 0.0590551 0.0335923 0.0628393 0.0295844 0.0149922 0.0157387 0.0111329 0.0119847 0.00463855 0.00302216 0.00637119 0.00771561 0.00505302 0.0039169 0.00323664 0.00226898 0.00572977 0.00745675 0.0104103 0.0121465 0.0177249 0.0183478 0.00696947 0.00527716 0.0161076	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0637849 0.0599597 0.0588912 0.0205746 0.0137918 0.0235158 0.00953903 0.0151599 0.0134258 0.00940696 0.00470305 0.00643782 0.00411107 0.0107237 0.00896345 0.00882141 0.00343711 0.0115756 0.00884154 0.0116846 0.00506564 0.0108488 0.0151518 0.0250905 0.00733438 0.00702756 0.00646013 0.0135271 0.0100277 0.00315977 0.00215747 0.00346419 0.00224994 0.0055819 0.00412399 0.00731596 0.0247274 0.044264 0.0463147 0.0589528 0.0336179 0.0635692 0.0302341 0.0155983 0.0179457 0.0115428 0.0135447 0.00472286 0.0032635 0.00661085 0.00908938 0.00563248 0.00384639 0.00334465 0.00238454 0.00573818 0.00832594 0.011826 0.00864965 0.00947472 0.00644208 0.00511545 0.0123059 0.0369799	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG1 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0701729 0.0660393 0.0649274 0.0227214 0.0153278 0.0261811 0.010642 0.0170101 0.0149257 0.0104706 0.00523271 0.00711724 0.00461388 0.0121256 0.0101178 0.00986322 0.00385424 0.0130812 0.0100097 0.0132383 0.00582311 0.0126441 0.0179431 0.0289646 0.00851831 0.00834466 0.00775632 0.0151993 0.0108264 0.00340517 0.00227353 0.00353846 0.00224067 0.00542234 0.00403832 0.00627262 0.0207647 0.0319302 0.0307975 0.0487887 0.0232501 0.0238001 0.0253843 0.0531889 0.0316896 0.0178074 0.0326675 0.0195019 0.00592484 0.00511902 0.00425007 0.00375319 0.00437105 0.00366389 0.00238107 0.00482856 0.00462994 0.00625965 0.00553155 0.00474009 0.00593905 0.00339959 0.00499976 0.0197544	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG2 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0687712 0.0646288 0.0634121 0.0221922 0.0149731 0.0255094 0.0103827 0.01656 0.0145721 0.0102289 0.00512507 0.00695909 0.00449587 0.0117915 0.00985368 0.00962768 0.00376168 0.0127133 0.00972253 0.0128969 0.00566082 0.012273 0.0173527 0.028227 0.00831339 0.00811696 0.00760551 0.0151443 0.0109547 0.00346946 0.00234396 0.00365265 0.00235846 0.00565628 0.00421591 0.00649889 0.0205849 0.0322811 0.0311899 0.0501674 0.0250544 0.028417 0.0316501 0.0614381 0.0326924 0.0153672 0.0208204 0.00944831 0.00755241 0.015 0.00475414 0.00406826 0.00457599 0.00367178 0.00238212 0.00475535 0.00458458 0.00607605 0.00541311 0.0046147 0.00576157 0.00331043 0.00487245 0.0194741	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0688557 0.0647303 0.0635772 0.0222501 0.0150012 0.0255743 0.0104002 0.0165861 0.0145852 0.0102328 0.0051215 0.00696739 0.00450044 0.0118001 0.00985459 0.00962663 0.00376026 0.0127172 0.009723 0.0128733 0.00564312 0.0122062 0.0172324 0.0279918 0.00822241 0.00800001 0.00745822 0.0148078 0.0106979 0.00337597 0.0022715 0.00354263 0.00225868 0.00543188 0.00402839 0.00615726 0.0198263 0.0303675 0.0293796 0.0482778 0.0236563 0.0270493 0.0297392 0.0573633 0.0302568 0.0139194 0.0173876 0.00618719 0.00511967 0.0097259 0.0165378 0.0149351 0.0138157 0.00466264 0.00288003 0.00494655 0.00510456 0.00619214 0.00535787 0.00502871 0.00582185 0.00380737 0.00529865 0.0192915	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0685306 0.0643997 0.0632269 0.022126 0.0149122 0.0254047 0.0103323 0.0164625 0.0144915 0.0101672 0.00509105 0.00692784 0.00446779 0.0117029 0.00977604 0.00955938 0.00373294 0.0126066 0.00963428 0.0127635 0.005586 0.0120642 0.0169986 0.0276948 0.00812794 0.00788661 0.00735598 0.0146801 0.0106648 0.00336639 0.00227242 0.00354737 0.00226702 0.00545305 0.00403915 0.00614356 0.0196857 0.0302413 0.0293181 0.0490713 0.0243274 0.0286148 0.0318566 0.060735 0.031698 0.0146269 0.0181826 0.00591877 0.00468137 0.00861583 0.0123559 0.0075618 0.00535574 0.00504996 0.00753118 0.0136806 0.00509656 0.00589283 0.00543421 0.00507041 0.00607968 0.00362262 0.00510508 0.0201259	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0673772 0.0633322 0.0622138 0.0217701 0.0146666 0.0249979 0.0101613 0.0161889 0.0142433 0.00999014 0.00499889 0.00680975 0.00439164 0.0115014 0.00960339 0.00938982 0.00366568 0.012384 0.00946201 0.0125213 0.00547502 0.0118055 0.0166193 0.0270618 0.00792124 0.00766549 0.00711972 0.0141715 0.0102804 0.00322907 0.00217139 0.00338584 0.00214444 0.00516308 0.00381291 0.00577713 0.0187716 0.0283019 0.0273659 0.0465232 0.0226529 0.0262827 0.0283866 0.0545087 0.0292873 0.0129236 0.0158036 0.00544243 0.00406778 0.00773004 0.00977747 0.00644936 0.00461454 0.00349301 0.00252723 0.00735937 0.0132202 0.0322252 0.0214115 0.00780091 0.00740774 0.00452548 0.00578136 0.0218851	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0686695 0.0645334 0.0633936 0.0221794 0.0149257 0.0254299 0.0103331 0.0164458 0.014491 0.0101614 0.00508422 0.00693558 0.00446192 0.0116704 0.00974583 0.00954287 0.00372346 0.012563 0.00959448 0.0127002 0.00553985 0.0119197 0.0167318 0.0273452 0.00799003 0.00770276 0.00715028 0.0143175 0.0104424 0.00327562 0.00220919 0.0034483 0.00218204 0.00525856 0.00386829 0.0058309 0.0188726 0.0283029 0.0273285 0.0473436 0.0231527 0.0273825 0.0295651 0.056263 0.0298824 0.0132534 0.01557 0.00535982 0.0039684 0.00772537 0.00965105 0.00620729 0.00428054 0.00346811 0.00244305 0.00628387 0.00845887 0.0116496 0.0128763 0.0189811 0.0194302 0.00740893 0.00566137 0.0174323	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0668246 0.0627754 0.0616056 0.0215468 0.0145185 0.0247249 0.0100549 0.0160109 0.0141158 0.00990209 0.00495812 0.00674443 0.00434325 0.0113694 0.00949866 0.00929954 0.00362748 0.0122312 0.00934177 0.0123893 0.00540876 0.0116675 0.0164197 0.026848 0.00784103 0.00758228 0.00706971 0.014182 0.0103082 0.00324435 0.00218334 0.00340584 0.00216375 0.00521504 0.00384488 0.00581865 0.0187532 0.0285023 0.027512 0.0465328 0.0228475 0.0265808 0.0293846 0.0568515 0.0310861 0.0137258 0.0176903 0.00555034 0.00432412 0.00809279 0.0116922 0.00704254 0.00419737 0.00361623 0.00257651 0.00634364 0.00960043 0.0133092 0.00927492 0.0103977 0.00689815 0.0055531 0.013353 0.0396251	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG1 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0708482 0.066329 0.0645367 0.0225967 0.0153364 0.0259356 0.0106037 0.0168006 0.0147505 0.0103738 0.00524158 0.00705461 0.00455415 0.0118822 0.00995765 0.0097389 0.00380837 0.0127119 0.00969052 0.0128813 0.00562873 0.0120573 0.0169181 0.0277384 0.00811345 0.00777718 0.00731128 0.0146299 0.0107838 0.0034194 0.00233539 0.00356349 0.00237444 0.00551522 0.0041763 0.00639737 0.0201404 0.0309729 0.0300183 0.0502202 0.0219818 0.0161849 0.0135786 0.0258869 0.0310695 0.062031 0.0335728 0.0119109 0.0087088 0.0160381 0.0054382 0.00457886 0.00493076 0.00407425 0.0026151 0.00513062 0.00501702 0.00643869 0.00560394 0.00488629 0.00595375 0.00354098 0.00513867 0.0199655	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG2 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.067559 0.0632447 0.0615957 0.021557 0.0146021 0.0246966 0.0100875 0.0159712 0.0140608 0.00988352 0.00498906 0.00673151 0.00433112 0.0112874 0.00945947 0.00927129 0.00362176 0.0120821 0.00920882 0.0122475 0.00533689 0.0114177 0.0159818 0.0263237 0.00769492 0.0073578 0.00691768 0.0139948 0.0103723 0.00330236 0.00226112 0.0034867 0.00229765 0.00540787 0.00403632 0.00612994 0.0192583 0.0293265 0.0283885 0.0491694 0.0216317 0.016536 0.0140755 0.0287868 0.0343094 0.0641009 0.0299033 0.00807784 0.00709448 0.0110254 0.0191169 0.014686 0.0149323 0.00510029 0.00305486 0.00519618 0.00544402 0.00647611 0.00548342 0.00519881 0.00590352 0.0039479 0.00543956 0.0195286	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0662012 0.0619101 0.0601981 0.0210688 0.0142774 0.0241042 0.00985419 0.0155762 0.0137305 0.00965431 0.00488217 0.00657882 0.00422549 0.010995 0.00922317 0.00905137 0.00353555 0.0117587 0.00895831 0.0119326 0.00519192 0.0110886 0.0154958 0.0256241 0.00749087 0.00714271 0.00673991 0.0137249 0.0102513 0.00327369 0.00225662 0.00348154 0.00231132 0.00543479 0.00405143 0.00611764 0.0189724 0.0290989 0.0281725 0.0496732 0.0220801 0.0171357 0.0149242 0.0320596 0.0385311 0.0702263 0.0314605 0.00806668 0.00701824 0.0100602 0.015282 0.00911856 0.00567396 0.00559131 0.00789442 0.0140805 0.00537456 0.00607615 0.00553805 0.0051845 0.00613458 0.00371257 0.00519355 0.0202724	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0656297 0.0614091 0.0597956 0.0209232 0.0141609 0.0239305 0.00977211 0.0154492 0.0136188 0.00957012 0.00483211 0.00652627 0.0041884 0.0108979 0.00913429 0.00896415 0.0034992 0.0116487 0.0088716 0.0117947 0.00512149 0.0109178 0.0152316 0.0251742 0.00732629 0.00696097 0.00653515 0.0132839 0.00990375 0.00314722 0.00215819 0.00332531 0.00218261 0.00513055 0.0038085 0.00570403 0.0178083 0.0267368 0.0258914 0.0467332 0.0203976 0.0160419 0.0136405 0.0295551 0.0350445 0.0640658 0.0289514 0.00718443 0.00587604 0.00889279 0.0118981 0.00767429 0.00486775 0.00369895 0.00264853 0.00737421 0.0140419 0.0320261 0.0208635 0.00771406 0.00737602 0.00460451 0.00584049 0.0220236	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0664667 0.0621694 0.060522 0.0211725 0.0143143 0.0241735 0.00986876 0.0155823 0.013761 0.00966808 0.00488241 0.00660222 0.00422553 0.0109779 0.00920447 0.00904793 0.00352993 0.0117302 0.00892958 0.0118763 0.00514362 0.0109404 0.0152239 0.0252602 0.00733882 0.00694533 0.00652216 0.0133384 0.0100072 0.00318039 0.00218877 0.00337598 0.00221572 0.00520984 0.00385155 0.00572883 0.0177486 0.0265073 0.0256203 0.0471912 0.0205993 0.016558 0.0141896 0.0314625 0.0374296 0.0674043 0.0294752 0.00720206 0.00580203 0.00889837 0.0117018 0.00728044 0.00448884 0.00361478 0.00252161 0.00633082 0.00908822 0.012237 0.0124394 0.0186621 0.0193285 0.00752535 0.00573692 0.01778	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0647653 0.0605532 0.0588753 0.0205923 0.0139454 0.0235405 0.00961955 0.0151965 0.0134187 0.00943154 0.0047672 0.00642646 0.00412014 0.0107132 0.00898696 0.00883181 0.00344527 0.0114426 0.00871266 0.011613 0.00503777 0.0107446 0.0149967 0.0248873 0.00723542 0.00687554 0.00648303 0.0132632 0.00990506 0.00315303 0.0021666 0.00334342 0.00220275 0.00519126 0.0038455 0.0057678 0.0179485 0.0272417 0.0263181 0.0467011 0.0205754 0.0160101 0.0138563 0.0300393 0.036198 0.0676043 0.0303695 0.00734018 0.0063788 0.00943397 0.0144395 0.00843673 0.00441581 0.00381352 0.00267437 0.00651291 0.0106523 0.0141739 0.00912136 0.0106398 0.00675936 0.00562469 0.0134212 0.0392027	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG1 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0802617 0.0756666 0.0745435 0.0261057 0.0175751 0.0300838 0.0121861 0.0194198 0.0169195 0.0118539 0.00590432 0.00811601 0.00526548 0.0137905 0.0114934 0.0112073 0.00438292 0.0148818 0.0113902 0.0149739 0.00658115 0.0141164 0.0199639 0.0320675 0.00942798 0.00913522 0.00833102 0.015858 0.0112694 0.0033984 0.00225273 0.00348436 0.00215432 0.00498486 0.00370373 0.00540531 0.018091 0.0251298 0.0227331 0.0377835 0.0141201 0.010879 0.00746597 0.0104459 0.00957061 0.0160659 0.0175255 0.0335463 0.0146071 0.0136256 0.0223258 0.0140419 0.0155335 0.00546472 0.00332177 0.00573065 0.0060708 0.00718807 0.00599156 0.00582198 0.0065228 0.00447303 0.00611948 0.0216487	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG1 or DRUG0 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.078135 0.073638 0.0725707 0.0254164 0.0170883 0.0292364 0.0118422 0.0188609 0.0164679 0.011536 0.00574673 0.00790696 0.0051163 0.0133872 0.0111583 0.0108939 0.00425884 0.0144477 0.0110515 0.0145324 0.00637376 0.0136553 0.0192524 0.0310475 0.00912887 0.00882296 0.00804469 0.0154772 0.0110804 0.00335576 0.00223154 0.00346492 0.00213987 0.00498367 0.00368069 0.00539866 0.0182069 0.0253017 0.0231055 0.0393658 0.0148893 0.0114938 0.00784906 0.0111735 0.0103455 0.0189259 0.0203693 0.0365016 0.0142988 0.0120644 0.0197349 0.0123706 0.00612294 0.00732967 0.00914924 0.0156963 0.00609798 0.00686299 0.00611774 0.00589507 0.00686211 0.00426125 0.00590101 0.0222775	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG1 or DRUG0 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0764312 0.0720107 0.0709051 0.0248339 0.0167047 0.0285571 0.0115709 0.0184103 0.0160675 0.0112576 0.00561307 0.00771973 0.00499365 0.0130545 0.0108837 0.0106267 0.00415561 0.0140772 0.0107644 0.0141525 0.00620293 0.0132583 0.0186601 0.0301011 0.00884365 0.00852324 0.00777653 0.0149568 0.0107079 0.00324677 0.00216348 0.00335794 0.00207472 0.00480927 0.00354466 0.00516608 0.0172117 0.0236734 0.0215345 0.0371625 0.0140155 0.010879 0.00738959 0.0105866 0.00968363 0.0178765 0.0192262 0.033729 0.0131278 0.0104108 0.0150112 0.0106097 0.00524598 0.00451876 0.00304304 0.00762993 0.0159931 0.0323852 0.0213096 0.00809191 0.0079007 0.00514857 0.00644771 0.0239747	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG1 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0772782 0.0727959 0.0716861 0.025106 0.0168626 0.0288162 0.0116718 0.0185529 0.0162221 0.0113631 0.00566484 0.00780334 0.00503349 0.0131402 0.0109563 0.0107126 0.00418784 0.0141697 0.0108282 0.0142369 0.00622381 0.0132721 0.0186097 0.0301377 0.0088441 0.00849012 0.00774574 0.0150233 0.0108072 0.00328143 0.0021942 0.00341272 0.00210442 0.00488882 0.00357942 0.00519529 0.0171386 0.0233962 0.0212927 0.0377708 0.0142356 0.0112327 0.00753275 0.0110567 0.010056 0.0195574 0.0208365 0.0353081 0.0134273 0.0106411 0.0147947 0.00998455 0.00481631 0.00434957 0.00287162 0.00668327 0.0112321 0.014475 0.0124032 0.0189033 0.020757 0.00831443 0.00630229 0.0197318	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG1 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0748286 0.0704762 0.0693691 0.0242827 0.0163202 0.0278904 0.0113037 0.0179863 0.0157493 0.0110344 0.00550218 0.00755929 0.0048783 0.0127508 0.0106332 0.0103977 0.00406126 0.0137388 0.0104993 0.0138307 0.00604775 0.0129423 0.0182023 0.0295211 0.00864931 0.00832844 0.0076165 0.0148483 0.0106523 0.00324463 0.0021561 0.00335473 0.00206976 0.00484351 0.00355676 0.00525074 0.0177224 0.0245671 0.0225444 0.0384252 0.0147185 0.0111069 0.00765538 0.0106287 0.00993608 0.0182657 0.020024 0.0346735 0.0136907 0.0110883 0.0184916 0.0114955 0.00476992 0.0046958 0.00308914 0.00708135 0.013554 0.0169251 0.00939481 0.0117164 0.00699662 0.00616211 0.0143609 0.041843	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG1 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0799759 0.0754678 0.0751738 0.0263084 0.0174348 0.0300223 0.012073 0.019269 0.0170757 0.0119101 0.00586888 0.00820865 0.00523581 0.013679 0.0113814 0.0112214 0.00435652 0.0148643 0.0113634 0.0149687 0.00648605 0.0139113 0.0194216 0.032122 0.00942759 0.0090465 0.00816896 0.0165254 0.0121819 0.00368211 0.00245453 0.0038703 0.00234154 0.00559419 0.00401059 0.00575668 0.0183039 0.0248885 0.0223489 0.0425373 0.0148061 0.0126951 0.00777915 0.0118972 0.00963508 0.0135675 0.0108358 0.0140914 0.0109126 0.0389724 0.0220467 0.0134465 0.013479 0.00520436 0.00323067 0.00562305 0.00595283 0.00703617 0.0058311 0.00574158 0.00638746 0.00448361 0.00609208 0.0213138	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG1 - local DRUG2 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.0770885 0.0727077 0.0722731 0.0252944 0.0167729 0.0288298 0.0116132 0.0185217 0.0164343 0.0114728 0.00566767 0.00790581 0.00503563 0.0131463 0.0109456 0.0107928 0.00419359 0.0142724 0.0109049 0.0143788 0.0062303 0.0133679 0.0186526 0.0309084 0.00907298 0.00870024 0.007873 0.0160662 0.0118807 0.00361219 0.00240912 0.00381111 0.00231217 0.00557414 0.00399003 0.00584269 0.0192244 0.0264662 0.0240795 0.045478 0.0166522 0.0138499 0.00874445 0.0131 0.0108989 0.0150012 0.0122255 0.0158153 0.0123093 0.0386746 0.0188476 0.0118985 0.0053789 0.00729305 0.00864246 0.0145262 0.00582359 0.00663298 0.00587974 0.0057349 0.00662285 0.00421501 0.00579887 0.0216303	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG1 - local DRUG0 such as DRUG2 - general DRUG0 - DRUG0 or other DRUG0
4	4	0.075516 0.0712072 0.0706482 0.0247238 0.0164201 0.028188 0.0113651 0.0181076 0.0160447 0.0112085 0.00554634 0.00772241 0.00492261 0.0128422 0.0106958 0.0105392 0.0040987 0.0139239 0.0106339 0.0140184 0.00607624 0.0130098 0.0181382 0.0300121 0.00880328 0.00842154 0.00763501 0.0155298 0.0114526 0.00348848 0.00232732 0.00367933 0.00223121 0.00535463 0.00382739 0.00557227 0.0181783 0.024812 0.0224621 0.0426422 0.0155553 0.0129362 0.00814261 0.012224 0.0100866 0.0140323 0.0115682 0.0151571 0.0119018 0.036909 0.014925 0.010527 0.00479079 0.00455124 0.0029935 0.00721497 0.0147626 0.0295034 0.0202397 0.00764068 0.00751936 0.00509847 0.00637703 0.0233166	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG1 - local DRUG0 such as DRUG0 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0757047 0.0713806 0.0708538 0.0247949 0.0164253 0.0281958 0.011361 0.0180841 0.0160695 0.011221 0.00554893 0.0077461 0.00491921 0.0128111 0.0106719 0.0105376 0.00409629 0.0139013 0.0106089 0.0139888 0.0060466 0.0129217 0.0179541 0.0298586 0.008749 0.00833257 0.00755071 0.0155155 0.0115031 0.00350524 0.0023471 0.00372129 0.00225201 0.00542565 0.00385036 0.00558114 0.0180693 0.0245829 0.0222077 0.0433865 0.0157835 0.0133896 0.00835464 0.0128038 0.010469 0.0148133 0.0122053 0.0165364 0.0129067 0.0397506 0.0146785 0.00996492 0.00440929 0.00434695 0.00281254 0.00631822 0.0107801 0.0139296 0.0116383 0.0174429 0.0201752 0.00820132 0.00624278 0.0197645	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG1 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0740144 0.0697767 0.0692556 0.0242235 0.0160578 0.027571 0.011112 0.0177019 0.0157425 0.0109926 0.00543543 0.0075733 0.00481209 0.0125467 0.0104523 0.0103215 0.00400817 0.0136015 0.0103825 0.0137084 0.00592504 0.0126937 0.0176788 0.0294228 0.00860482 0.00821657 0.0074555 0.0153534 0.0113511 0.00346237 0.00230817 0.0036561 0.00221689 0.00535683 0.00381643 0.00559761 0.0184133 0.0253146 0.0230482 0.0433469 0.0160645 0.0131123 0.00838382 0.0122914 0.0103359 0.0139318 0.0116772 0.0152558 0.0124012 0.038021 0.0174336 0.0113789 0.00438147 0.00473072 0.00303718 0.006815 0.013275 0.016678 0.00895707 0.0113626 0.0067056 0.00614307 0.0140124 0.0410853	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG1 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0806193 0.075941 0.0746581 0.0261245 0.0174722 0.0298296 0.0120838 0.0191698 0.0168795 0.0118218 0.00590103 0.00813953 0.00520789 0.0135507 0.0113014 0.0110904 0.00433095 0.0145816 0.0111259 0.0146483 0.00636273 0.0135284 0.0188631 0.0308114 0.00900755 0.00859709 0.00790238 0.015646 0.011402 0.00346269 0.00232274 0.0036088 0.00223841 0.00515562 0.00375061 0.00552104 0.0180219 0.0242823 0.0215848 0.0365667 0.0126223 0.00967804 0.00620372 0.00851723 0.00721894 0.00980581 0.00772329 0.00548159 0.00340586 0.00883038 0.0102876 0.0108134 0.0298772 0.0123689 0.00653845 0.00846969 0.0168103 0.0203636 0.0119242 0.0193936 0.0221639 0.00921833 0.00697385 0.0221965	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG1 such as DRUG0 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.07776 0.0732892 0.0721326 0.0252381 0.0168716 0.0288449 0.0116841 0.0185779 0.0163745 0.0114654 0.00571671 0.00787871 0.00504574 0.013156 0.0109678 0.010756 0.00419797 0.014167 0.0108182 0.0142512 0.00619873 0.0132461 0.0185427 0.0302479 0.00884837 0.00848892 0.0078016 0.0154845 0.0112143 0.0034092 0.00227032 0.00353483 0.00218327 0.00507804 0.00369824 0.00551357 0.0183325 0.0249672 0.0222791 0.0365241 0.0128074 0.00953393 0.00627869 0.00825182 0.0072491 0.00936397 0.00766323 0.00518249 0.0033474 0.0082789 0.00985679 0.0103124 0.0285967 0.0137745 0.00709885 0.00886142 0.0208474 0.0247128 0.0101226 0.0162711 0.00747844 0.00744157 0.0160698 0.0435416	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG1 such as DRUG0 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0884433 0.0833131 0.0820044 0.0286564 0.0191958 0.032828 0.0132574 0.0210051 0.0184306 0.0129041 0.00641193 0.00888438 0.00570425 0.0148375 0.0123684 0.0121712 0.00474173 0.0159824 0.0121821 0.0160875 0.00698429 0.0147942 0.0206434 0.0339766 0.00989526 0.00941372 0.00857409 0.0167568 0.0122341 0.00365556 0.00244638 0.00380642 0.00233427 0.00534071 0.0039033 0.0054614 0.0168598 0.0222156 0.0189021 0.0336121 0.0106623 0.00853727 0.00514232 0.00727645 0.00566201 0.00780462 0.00576398 0.00453401 0.00244822 0.00629624 0.00600419 0.00494663 0.00642644 0.00541146 0.00763816 0.0277743 0.01769 0.0255383 0.0194576 0.00766628 0.00760802 0.00564658 0.00712547 0.0257196	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG1 - general DRUG2 - DRUG0 or other DRUG0
4	4	0.0877171 0.0826071 0.0810737 0.0283245 0.018992 0.03243 0.0131114 0.020743 0.0181979 0.0127499 0.00634764 0.0087774 0.00563183 0.0146274 0.0122017 0.012011 0.00468247 0.0157319 0.0119817 0.0158402 0.00687132 0.0145213 0.020233 0.0333816 0.00969846 0.00919465 0.00839259 0.0164422 0.0120114 0.00358929 0.0024046 0.00373591 0.0022994 0.00525381 0.00384526 0.00538313 0.0167 0.0221314 0.0188493 0.0336348 0.0107656 0.00858383 0.00522763 0.00737737 0.00581856 0.0080496 0.00603209 0.00460139 0.00251202 0.00652548 0.00624996 0.00522176 0.00677476 0.00609708 0.00870852 0.0282242 0.0136916 0.0158472 0.0111284 0.0187823 0.0224534 0.00923367 0.00701407 0.0227262	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG1 - general DRUG0 - DRUG2 or other DRUG0
4	4	0.0849596 0.0800248 0.0785756 0.0274371 0.0183887 0.0314262 0.0127057 0.020131 0.0176971 0.012396 0.00616695 0.00851572 0.00546208 0.0142062 0.0118487 0.011668 0.00454275 0.0152716 0.0116348 0.0154017 0.00667771 0.0141645 0.0197859 0.0327067 0.00948175 0.00901554 0.00823845 0.0162472 0.0118331 0.00354083 0.00235573 0.00366101 0.00224905 0.00517115 0.00379004 0.00537656 0.016993 0.0228664 0.0196963 0.0340279 0.0110414 0.00845471 0.0052944 0.00716414 0.0059071 0.00776635 0.00607544 0.00431722 0.0024537 0.00616647 0.00627366 0.00518568 0.00619068 0.00591457 0.00862528 0.0291403 0.0158709 0.0198185 0.00958787 0.0159672 0.00745961 0.00766699 0.0162507 0.0450681	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG1 - general DRUG0 - DRUG0 or other DRUG2
4	4	0.0789701 0.07376 0.0712658 0.0248492 0.0167977 0.0282643 0.0115055 0.0179322 0.0157969 0.0110885 0.00560569 0.00762818 0.00484757 0.0124336 0.0104367 0.0103439 0.00402416 0.0131288 0.00993759 0.0132073 0.00563207 0.0115818 0.015846 0.026784 0.00761659 0.00700941 0.00654537 0.0130815 0.00995062 0.00304001 0.00208431 0.00313951 0.00204268 0.00439796 0.00326321 0.0045555 0.0133149 0.0173302 0.0152989 0.027361 0.00888149 0.00696443 0.0042675 0.00600604 0.00485711 0.00662915 0.00507172 0.00372668 0.00213791 0.00523034 0.00516223 0.00414941 0.00454228 0.00365495 0.00359307 0.00990543 0.0164694 0.0378074 0.0756443 0.039475 0.0119469 0.0120803 0.0229889 0.0571088	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG1 - DRUG0 or other DRUG2
4	4	0.0829108 0.0779652 0.0762388 0.0266226 0.0178624 0.0304034 0.0122984 0.0193478 0.0169749 0.0118922 0.00594019 0.00821054 0.00524612 0.0135574 0.0113271 0.0111809 0.00435542 0.0144968 0.0110292 0.0145839 0.00628624 0.013121 0.0181546 0.0301459 0.00869339 0.00814902 0.00747763 0.014666 0.0108614 0.00322828 0.00218766 0.00335665 0.00212121 0.00468386 0.00346255 0.00489616 0.0152838 0.020098 0.0170716 0.0274514 0.00882483 0.00666144 0.0042082 0.00558643 0.00464847 0.00604791 0.00491435 0.00342502 0.0019923 0.00477507 0.0051994 0.00393099 0.00390012 0.00310144 0.00242719 0.00637315 0.00781617 0.0119031 0.0137036 0.0179148 0.0442885 0.0306649 0.0410917 0.0627609	Some drug interactions are :  - birth control pills - DRUG0 - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as DRUG0 or DRUG0 - certain DRUG0 given by injection - DRUG0 - DRUG0 - DRUG0 - DRUG0 or DRUG0 - local DRUG0 such as DRUG0 - general DRUG0 - DRUG1 or other DRUG2
4	4	0.0414582 0.0135563 0.0302047 0.0278557 0.0173451 0.0165552 0.0254575 0.0431013 0.0529343 0.0928525 0.168282 0.11731 0.0631977 0.0387609 0.0588133 0.10153 0.090786	DRUG1 : The effects of chronic DRUG0 use on the metabolism of DRUG2 are not known .
4	4	0.0156813 0.0163565 0.0302609 0.0333963 0.0355015 0.0470955 0.0731143 0.0305872 0.0517386 0.0611313 0.124013 0.0961576 0.0619498 0.0425183 0.0615549 0.116283 0.102659	DRUG0 : The effects of chronic DRUG1 use on the metabolism of DRUG2 are not known .
3	3	0.0296484 0.028838 0.0454085 0.0321468 0.0184086 0.0111145 0.0189785 0.0186035 0.0161732 0.0141335 0.0140399 0.0185516 0.0167983 0.0243925 0.0174641 0.0393958 0.0266645 0.0160991 0.013788 0.0226934 0.0214871 0.0134979 0.0116564 0.00470853 0.0128533 0.0186016 0.0114466 0.013072 0.0184699 0.00948224 0.0114053 0.0203713 0.00708406 0.00729294 0.0149174 0.00989315 0.0130774 0.0161264 0.0406966 0.014104 0.0196421 0.0223744 0.00639979 0.00914457 0.0138996 0.0126041 0.0165464 0.0221013 0.00796383 0.0101153 0.011016 0.00675514 0.00650772 0.0079112 0.0153433 0.011347 0.00792136 0.00906445 0.049758	When a single 100 mg dose of DRUG1 was administered one hour after the initiation of DRUG2 (300 mg four times a day) , the apparent total DRUG0 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG0 clearance in the same subjects in the absence of DRUG0 ) .
4	4	0.0202041 0.0182541 0.0329629 0.023435 0.0127309 0.00914347 0.0145079 0.0141048 0.0103172 0.00674521 0.00751259 0.0109564 0.0166427 0.0143052 0.0147168 0.018423 0.018813 0.0241268 0.0132055 0.0257945 0.017549 0.00813075 0.00714849 0.00885234 0.0370461 0.0559374 0.0604875 0.0428372 0.026538 0.0159944 0.0148688 0.0292793 0.00991727 0.0109627 0.0150282 0.0110614 0.0143601 0.0168027 0.0330348 0.0122468 0.0169114 0.0183187 0.00541094 0.00800394 0.0118305 0.0108174 0.0142375 0.0186891 0.0067547 0.00852615 0.00926383 0.00571357 0.0054988 0.00666292 0.0128721 0.00953783 0.00664111 0.00762497 0.0416996	When a single 100 mg dose of DRUG1 was administered one hour after the initiation of DRUG0 (300 mg four times a day) , the apparent total DRUG2 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG0 clearance in the same subjects in the absence of DRUG0 ) .
4	4	0.0212745 0.0192873 0.0346447 0.0246807 0.0134908 0.0096312 0.0152757 0.0148131 0.0108579 0.00707992 0.00785596 0.0114844 0.0175531 0.0152478 0.0160653 0.0208901 0.0208868 0.0256085 0.0148244 0.0267692 0.0184861 0.00834726 0.00568952 0.00283512 0.00708837 0.0134726 0.00800188 0.00936758 0.0144319 0.00758838 0.00964122 0.0171415 0.00586727 0.00606127 0.0125025 0.00849941 0.0124595 0.0166872 0.0399464 0.0125782 0.0146347 0.0199125 0.0131355 0.0262495 0.0347717 0.0512723 0.0389231 0.0337472 0.0194284 0.0160835 0.0157258 0.0102023 0.0111432 0.0113072 0.0187263 0.0136798 0.00801589 0.00947829 0.048648	When a single 100 mg dose of DRUG1 was administered one hour after the initiation of DRUG0 (300 mg four times a day) , the apparent total DRUG0 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG2 clearance in the same subjects in the absence of DRUG0 ) .
4	4	0.0227068 0.020586 0.036976 0.0263406 0.0143983 0.0102782 0.016302 0.0158079 0.0115851 0.00755359 0.00837803 0.0122376 0.0186938 0.0162451 0.017118 0.0222765 0.0222691 0.0272772 0.0157826 0.0284734 0.0197683 0.00894137 0.00608291 0.00304218 0.00754938 0.0143823 0.00848809 0.0099789 0.0152203 0.00796391 0.0100604 0.0178212 0.00614253 0.00634357 0.0132592 0.00879315 0.011989 0.015064 0.0382218 0.0137652 0.0199738 0.023913 0.00669915 0.00956182 0.0150132 0.0133462 0.018018 0.0265361 0.0109721 0.0164118 0.0200107 0.0131783 0.0133472 0.02453 0.0274422 0.0342751 0.0301616 0.01832 0.0441263	When a single 100 mg dose of DRUG1 was administered one hour after the initiation of DRUG0 (300 mg four times a day) , the apparent total DRUG0 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG0 clearance in the same subjects in the absence of DRUG2 ) .
4	4	0.0129148 0.00846429 0.0187561 0.0121661 0.00521422 0.00458481 0.00954312 0.0157009 0.0193536 0.0187472 0.0172772 0.0280802 0.0247855 0.0309107 0.0271306 0.0372939 0.0346695 0.0137796 0.0076087 0.0109834 0.0112809 0.00949074 0.0117214 0.0101338 0.0282036 0.0359944 0.0510031 0.034755 0.0225494 0.0141578 0.0158992 0.031514 0.010896 0.0118745 0.0159503 0.0118141 0.015075 0.0177022 0.0344049 0.0127637 0.0176382 0.0191451 0.00566172 0.0083688 0.0123351 0.0112753 0.0148539 0.0194999 0.00704746 0.00889286 0.00965487 0.00595869 0.00573279 0.00694571 0.0134218 0.00995843 0.00694012 0.00797183 0.0435486	When a single 100 mg dose of DRUG0 was administered one hour after the initiation of DRUG1 (300 mg four times a day) , the apparent total DRUG2 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG0 clearance in the same subjects in the absence of DRUG0 ) .
4	4	0.0125849 0.0082456 0.0182799 0.0118569 0.00508746 0.00447977 0.00933011 0.0153551 0.018964 0.0184109 0.0169735 0.0275925 0.0242114 0.0300938 0.02576 0.0353471 0.0329235 0.0122171 0.00632167 0.00865644 0.00908698 0.00740766 0.00720339 0.00324515 0.0099883 0.0151599 0.0101898 0.0115472 0.0168678 0.0088555 0.0105635 0.018706 0.00644964 0.0065742 0.0130223 0.00908278 0.0133109 0.0175557 0.0405611 0.0129187 0.0147967 0.0198844 0.0130896 0.0260351 0.0341531 0.0502212 0.0380408 0.0331205 0.0191036 0.0158799 0.0154989 0.0100567 0.0109611 0.0111366 0.0184402 0.0134928 0.0079137 0.0093447 0.0478418	When a single 100 mg dose of DRUG0 was administered one hour after the initiation of DRUG1 (300 mg four times a day) , the apparent total DRUG0 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG2 clearance in the same subjects in the absence of DRUG0 ) .
4	4	0.0114438 0.00717214 0.0152037 0.00916571 0.00379936 0.00322935 0.00572068 0.00834717 0.0074842 0.00666282 0.00647394 0.010803 0.0082211 0.00570046 0.00707281 0.00579095 0.00917544 0.0120446 0.00691115 0.0169425 0.0115712 0.00583087 0.00428852 0.00467274 0.0213779 0.0530741 0.056292 0.0563898 0.0207471 0.0152589 0.0212221 0.0317573 0.0107178 0.0121077 0.0171738 0.0128292 0.0156691 0.0195513 0.0377126 0.0149693 0.0209304 0.0233884 0.00678551 0.0101796 0.0153898 0.013766 0.0186704 0.026901 0.0111794 0.0166121 0.0201038 0.0134103 0.0135441 0.024726 0.027371 0.0342403 0.0299649 0.0182057 0.044053	When a single 100 mg dose of DRUG0 was administered one hour after the initiation of DRUG0 (300 mg four times a day) , the apparent total DRUG1 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG0 clearance in the same subjects in the absence of DRUG2 ) .
4	4	0.0120754 0.0075575 0.0158981 0.00963884 0.00399115 0.00337833 0.00597513 0.00885648 0.00792129 0.00704422 0.00682019 0.0114177 0.00867196 0.00606915 0.0075678 0.00626212 0.0100356 0.0132968 0.00762322 0.0179275 0.0132768 0.00654437 0.00484252 0.00266212 0.00615904 0.0127343 0.00804214 0.00984473 0.01541 0.00828542 0.0106663 0.0194003 0.0067479 0.00699359 0.0148238 0.00991958 0.0147349 0.0207206 0.0499372 0.0153236 0.0178287 0.0192266 0.0114138 0.0257337 0.0442995 0.0471989 0.0475597 0.039188 0.0318005 0.0330716 0.03141 0.0242485 0.0213915 0.027473 0.0232527 0.0340329 0.0276114 0.0169668 0.0411946	When a single 100 mg dose of DRUG0 was administered one hour after the initiation of DRUG0 (300 mg four times a day) , the apparent total DRUG0 clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total DRUG1 clearance in the same subjects in the absence of DRUG2 ) .
4	4	0.144317 0.0469136 0.0725127 0.018907 0.0758314 0.0247317 0.0173716 0.0297081 0.0305101 0.0431202 0.0786873 0.0561451 0.0483911 0.0323159 0.0221702 0.0281347 0.0451318 0.0438075 0.141293	DRUG1 : DRUG2 , 100 mg , was given twice daily for 13 days to 12 healthy volunteers .
3	3	0.0605734 0.0528105 0.0582329 0.0710377 0.0501763 0.0444077 0.0476895 0.026128 0.0711156 0.0603699 0.12555 0.0749786 0.0419454 0.0410278 0.0720397 0.101917	Coadministration with DRUG1 reduced the peak concentration and AUC values for DRUG2 by approximately 11% .
4	4	0.143921 0.0473446 0.0732379 0.0196577 0.0799132 0.0262075 0.0186724 0.0305172 0.0301656 0.03889 0.049195 0.0670439 0.0603371 0.0360234 0.023858 0.0270494 0.0436076 0.0432118 0.141146	DRUG1 : DRUG2 , 100 mg , was given twice daily fro 13 days to 12 healthy volunteers .
3	3	0.0452128 0.0466964 0.0438613 0.0313227 0.061221 0.0465459 0.0752822 0.049388 0.097985 0.0546677 0.0662024 0.0547243 0.0654208 0.0450511 0.077554 0.0713821 0.0674825	Peak plasma concentrations and AUC of DRUG1 were reduced approximately 10% in the presence of DRUG2 .
4	2	0.013314 0.0148414 0.0654085 0.070495 0.0791632 0.0562885 0.0408093 0.0547833 0.0459739 0.0272348 0.0214425 0.0103769 0.0485693 0.0205971 0.0552794 0.0754735 0.0512774 0.0653276 0.062941 0.0212695 0.00458155 0.00325254 0.0020312 0.00274816 0.00211192 0.0032533 0.00228987 0.00376631 0.0148745 0.0602247	Agents that might be coadministered with DRUG1 in AIDS patients for other indications that could elicit this activity include DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.0143391 0.0159639 0.0702322 0.0755462 0.0847949 0.0602685 0.0436981 0.058108 0.0479538 0.0282423 0.0218995 0.0102442 0.0469114 0.0214932 0.0587517 0.0778021 0.0494425 0.0559195 0.0387071 0.00659687 0.00512941 0.0111882 0.00220074 0.00253621 0.00200488 0.00312716 0.00229065 0.00378509 0.0154701 0.0653525	Agents that might be coadministered with DRUG1 in AIDS patients for other indications that could elicit this activity include DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
2	2	0.0147426 0.0164171 0.0722331 0.0777508 0.0872793 0.0620112 0.0448786 0.0594627 0.0489594 0.0288254 0.0223942 0.0106138 0.048425 0.0214447 0.0563116 0.0747388 0.0476498 0.054116 0.0329911 0.00531554 0.00247478 0.00368149 0.00397772 0.00942351 0.00214248 0.00310729 0.00237542 0.00374447 0.0153917 0.0671206	Agents that might be coadministered with DRUG1 in AIDS patients for other indications that could elicit this activity include DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	2	0.0150108 0.0167151 0.0735342 0.0791862 0.0888788 0.0630934 0.0455614 0.0599887 0.0491869 0.0288583 0.0222552 0.0104513 0.0475574 0.0210987 0.0556193 0.0734476 0.046397 0.0523273 0.0313912 0.00506682 0.00229766 0.00291908 0.00187637 0.0035828 0.00413358 0.0112025 0.0027326 0.00367385 0.0149397 0.0670164	Agents that might be coadministered with DRUG1 in AIDS patients for other indications that could elicit this activity include DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
2	2	0.01443 0.0160845 0.0708413 0.0764007 0.0858696 0.0610101 0.0440474 0.0578246 0.0473856 0.0278473 0.0214966 0.0102098 0.0462431 0.0198337 0.0513506 0.0706083 0.0474782 0.0523508 0.0295775 0.00450322 0.00210974 0.00245473 0.00162219 0.00250782 0.00187009 0.00336026 0.004026 0.0122194 0.0392492 0.0751875	Agents that might be coadministered with DRUG1 in AIDS patients for other indications that could elicit this activity include DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0126473 0.0123653 0.0510031 0.0339266 0.0545423 0.0243452 0.0296662 0.0230381 0.0404853 0.0211233 0.0135379 0.00938058 0.0515912 0.0194412 0.0525783 0.0659975 0.0364114 0.0523636 0.045893 0.00793446 0.00374145 0.00617477 0.00438193 0.0108415 0.0117095 0.0625639 0.0176097 0.0237215 0.0773336 0.12365	Agents that might be coadministered with DRUG0 in AIDS patients for other indications that could elicit this activity include DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	3	0.0249022 0.0165268 0.0218617 0.0200256 0.0389394 0.0634811 0.041303 0.0272483 0.0319413 0.029765 0.0736571 0.0612849 0.0393761 0.0417679 0.0321907 0.0456851 0.0387429 0.0331524 0.00971842 0.0107952 0.0217293 0.0336943 0.0174122 0.014546 0.0142484 0.00756448 0.0116057 0.0187135 0.0111717 0.0121712 0.0251252 0.0159679 0.0238506 0.0287984 0.0410358	In vitro perfusion of isolated rat liver has shown that DRUG1 caused a significant reduction in DRUG2 metabolism and that DRUG0 altered the relative concentration of DRUG0 metabolites possibly by competing for sulfate metabolites .
4	4	0.0238383 0.0159658 0.0210648 0.01974 0.0385879 0.0627088 0.0399284 0.0238386 0.0280097 0.0274723 0.0730275 0.0527708 0.0280263 0.0197458 0.0187989 0.027304 0.0327724 0.0573687 0.0316459 0.05307 0.0479792 0.0312925 0.018783 0.0161986 0.0151971 0.00878258 0.0112783 0.0162931 0.00967527 0.0108035 0.0217058 0.0142789 0.0207188 0.0253508 0.0359774	In vitro perfusion of isolated rat liver has shown that DRUG1 caused a significant reduction in DRUG0 metabolism and that DRUG2 altered the relative concentration of DRUG0 metabolites possibly by competing for sulfate metabolites .
3	4	0.019944 0.0114424 0.0154216 0.013463 0.0237433 0.03349 0.0204718 0.00905409 0.0111175 0.0107213 0.0269703 0.0570753 0.029294 0.0364471 0.0367999 0.0446069 0.0660234 0.0594119 0.0253654 0.0524832 0.0510393 0.0489884 0.029672 0.0230804 0.0207627 0.0131308 0.0154921 0.0218864 0.0124767 0.0137859 0.0272312 0.017791 0.025549 0.0309882 0.0447796	In vitro perfusion of isolated rat liver has shown that DRUG0 caused a significant reduction in DRUG1 metabolism and that DRUG2 altered the relative concentration of DRUG0 metabolites possibly by competing for sulfate metabolites .
4	3	0.0339887 0.0268296 0.0389508 0.0210114 0.0214414 0.0611165 0.0529055 0.0411587 0.0124518 0.0390283 0.0560484 0.0321389 0.0101724 0.00376214 0.00283235 0.004203 0.0045027 0.00734083 0.011446 0.0220048 0.0400765 0.0178836 0.0668317 0.0260006 0.068825 0.0740155 0.123338 0.0796943	Based on an in vitro rat liver model , nitrogen substituted DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) were potent , non-competitive inhibitors of DRUG2 metabolism .
4	3	0.035702 0.0284878 0.0417117 0.0218588 0.0221493 0.0647592 0.0532193 0.0429166 0.0129805 0.0479663 0.0409703 0.015134 0.011492 0.0271469 0.00525561 0.00539879 0.00605121 0.00795519 0.0126238 0.0204048 0.0305692 0.0154877 0.0605319 0.0244827 0.066061 0.0708481 0.126377 0.0814579	Based on an in vitro rat liver model , nitrogen substituted DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) were potent , non-competitive inhibitors of DRUG2 metabolism .
4	3	0.0379874 0.0304126 0.0443528 0.0229872 0.0231039 0.0646814 0.0504013 0.038441 0.0110115 0.0352037 0.0285054 0.00722685 0.00480787 0.00787514 0.00625702 0.0269962 0.00595082 0.00868378 0.0137913 0.0229909 0.0322187 0.016732 0.0657688 0.0265805 0.0704286 0.0756076 0.134003 0.0869925	Based on an in vitro rat liver model , nitrogen substituted DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) were potent , non-competitive inhibitors of DRUG2 metabolism .
4	3	0.0364542 0.0292095 0.04225 0.0212599 0.0209149 0.0579976 0.0443761 0.032162 0.00898902 0.0269413 0.0219762 0.0059547 0.00351858 0.00476235 0.00329272 0.00947084 0.00874742 0.0491878 0.0163912 0.0287672 0.0384529 0.0192881 0.0721094 0.0279885 0.0717965 0.0773409 0.133911 0.086489	Based on an in vitro rat liver model , nitrogen substituted DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) were potent , non-competitive inhibitors of DRUG2 metabolism .
4	4	0.0348411 0.0100003 0.0115194 0.00861578 0.0119844 0.0131957 0.011459 0.0217952 0.0235008 0.01994 0.0149994 0.0174522 0.015744 0.0138784 0.0126021 0.0084365 0.0171909 0.0212174 0.0222322 0.0232034 0.0337266 0.0395479 0.0219936 0.0274877 0.0768376 0.0398861 0.0361746 0.0478908 0.0283024 0.017142 0.0340011 0.0363225 0.0283056 0.0291778 0.0393544 0.0286825 0.0378229 0.0288988 0.0346366	DRUG1 at a Dose of 10 mg Once Daily Dosed to Pharmacokinetic Steady State  - did not cause clinically significant changes in the kinetics of a single intravenous dose of DRUG2 (predominantly a cytochrome P450 1A2 substrate) .
4	4	0.0127626 0.0243413 0.0331772 0.028129 0.0237725 0.0557602 0.0467482 0.0433737 0.0369431 0.0584157 0.0718072 0.0606765 0.0390424 0.0444145 0.0374109 0.024146 0.0146463 0.0180638 0.0053059 0.0184732 0.0156576 0.00676256 0.00243057 0.00332518 0.0131253 0.0190262 0.0345164 0.0138876 0.00615533 0.00581322 0.0105831 0.0181605 0.0136873 0.0193211 0.0264495 0.0107528 0.0125128 0.0202404 0.0501823	- did not change the plasma concentration profile of DRUG1 (a substrate of cytochrome P450 3A4) or DRUG2 , its carboxylated metabolite , and did not prolong the QTc interval following co-administration with DRUG0 60 mg twice daily .
4	4	0.0118174 0.0186368 0.0249387 0.0202266 0.0122231 0.0253973 0.0186358 0.0172561 0.016767 0.0305144 0.0532489 0.0488826 0.0262184 0.0323033 0.0299601 0.0255437 0.0211114 0.0514224 0.0102184 0.0156422 0.0109638 0.00800041 0.00377807 0.00457687 0.016718 0.032673 0.0810833 0.0425274 0.0225498 0.0195193 0.0344909 0.0321489 0.0364883 0.0286127 0.0206688 0.0145956 0.016926 0.0196766 0.0430376	- did not change the plasma concentration profile of DRUG0 (a substrate of cytochrome P450 3A4) or DRUG1 , its carboxylated metabolite , and did not prolong the QTc interval following co-administration with DRUG2 60 mg twice daily .
4	4	0.0401601 0.0125966 0.0124066 0.0164658 0.0193892 0.0218596 0.0259191 0.0259056 0.0174072 0.0355678 0.0261243 0.0197479 0.0204119 0.0118575 0.00562858 0.00394235 0.00950691 0.00606148 0.0146074 0.0232004 0.0336326 0.0267242 0.0166078 0.0274818 0.0221294 0.0206391 0.0280358 0.0573528 0.0426435 0.0618609 0.0460056 0.0285065 0.0174726 0.0145117 0.0195178 0.0197619 0.0309235 0.0403408 0.0268354 0.05025	DRUG1 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG2 containing DRUG0 1 mg/ethinyl DRUG0 35 mcg .
4	4	0.0407974 0.0127944 0.0126019 0.0167211 0.0196869 0.0221928 0.0263128 0.0262985 0.0176848 0.036141 0.0265642 0.0200743 0.0207634 0.0120331 0.00572159 0.00402351 0.00969187 0.00617463 0.0149087 0.0236838 0.0341922 0.0268991 0.0167927 0.0278504 0.0221436 0.0207061 0.0267317 0.0521056 0.0355536 0.0457348 0.0289957 0.0230283 0.0299604 0.0239026 0.0218068 0.0270991 0.0345424 0.04567 0.0296794 0.0517348	DRUG1 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG0 containing DRUG2 1 mg/ethinyl DRUG0 35 mcg .
4	4	0.0425705 0.0133423 0.013144 0.0174312 0.0205131 0.0231045 0.0273657 0.0273556 0.018429 0.0377008 0.0276615 0.0207361 0.0213457 0.0124227 0.00583667 0.00402734 0.00970201 0.00613074 0.0144342 0.0227302 0.031627 0.0246547 0.0145886 0.0247104 0.017005 0.012324 0.0158149 0.0348624 0.0197368 0.0307335 0.0202368 0.0207555 0.0223671 0.0341384 0.0537549 0.0721623 0.0432048 0.0283345 0.0313236 0.0616811	DRUG1 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG0 containing DRUG0 1 mg/ethinyl DRUG2 35 mcg .
4	4	0.0186359 0.0186361 0.024448 0.0252149 0.0202438 0.0161749 0.0181018 0.0238061 0.0157602 0.037399 0.0310078 0.0193086 0.0187888 0.0107287 0.00539326 0.00387797 0.00916376 0.00595918 0.0140833 0.0220413 0.0323647 0.0251874 0.0158695 0.0260183 0.0198968 0.0162144 0.0183045 0.0372236 0.0293273 0.0378018 0.0315785 0.0401055 0.0527525 0.0243313 0.0300046 0.0354276 0.0409046 0.0496236 0.0310922 0.0471978	DRUG0 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG1 containing DRUG2 1 mg/ethinyl DRUG0 35 mcg .
4	4	0.016838 0.0168299 0.0220635 0.0227197 0.0182358 0.0145705 0.0163 0.0214353 0.0141827 0.0336169 0.0278316 0.0172924 0.0167939 0.00960796 0.0047936 0.00336146 0.00798741 0.00518877 0.0123853 0.0193696 0.0280262 0.0218772 0.0138338 0.0234941 0.0177969 0.0149022 0.0216869 0.0478306 0.0337121 0.0400634 0.029942 0.0297434 0.0369675 0.0373644 0.0597935 0.0684873 0.0414472 0.027954 0.0305466 0.0531263	DRUG0 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG1 containing DRUG0 1 mg/ethinyl DRUG2 35 mcg .
4	4	0.0194577 0.0194443 0.0254842 0.0262387 0.0210485 0.0168047 0.0187967 0.024723 0.0163763 0.0388315 0.0321653 0.0199734 0.0194885 0.011043 0.00553344 0.00397513 0.00941064 0.00607237 0.0143091 0.0222451 0.0316906 0.0245888 0.015449 0.0250175 0.0189781 0.0154515 0.0213549 0.0433108 0.0289457 0.0348657 0.0296612 0.0207101 0.0252313 0.0337636 0.0440552 0.0514845 0.0382976 0.033248 0.0340333 0.0584409	DRUG0 at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State :  - did not significantly alter the plasma concentrations of either component of an oral DRUG0 containing DRUG1 1 mg/ethinyl DRUG2 35 mcg .
4	4	0.017283 0.0302488 0.0348498 0.034568 0.0438234 0.0410642 0.0559088 0.0355168 0.0263487 0.0611076 0.0580193 0.0322867 0.0351769 0.0207481 0.0194207 0.0269295 0.0277571 0.0352649 0.043229 0.0474497 0.0216613 0.0219515 0.0768392 0.0717713 0.0807757	- did not cause any clinically significant change in plasma profiles of DRUG1 or DRUG0 following administration of either oral DRUG0 or intravenous DRUG2 .
4	4	0.0160455 0.0282918 0.0320452 0.0316613 0.0420613 0.0417147 0.0583028 0.0367452 0.0290235 0.0593643 0.0591045 0.0363736 0.02305 0.0224652 0.085146 0.0206932 0.024977 0.0372814 0.0416203 0.0480412 0.035415 0.0189192 0.0337674 0.0387766 0.0991138	- did not cause any clinically significant change in plasma profiles of DRUG0 or DRUG1 following administration of either oral DRUG2 or intravenous DRUG0 .
4	4	0.0178148 0.0304147 0.0338832 0.0329923 0.0443895 0.041169 0.0498102 0.0274867 0.019974 0.0453572 0.0408705 0.0179148 0.0121356 0.0110092 0.0363093 0.0648994 0.0423967 0.0510739 0.0509551 0.0455223 0.050345 0.0341026 0.0622567 0.066032 0.0708852	- did not cause any clinically significant change in plasma profiles of DRUG0 or DRUG0 following administration of either oral DRUG1 or intravenous DRUG2 .
3	4	0.0925059 0.021821 0.0281342 0.0693622 0.0287891 0.0403858 0.0270754 0.0737392 0.0726295 0.0893073 0.0868196 0.0528207 0.0249951 0.0281239 0.0191536 0.0180355 0.0389367 0.0331163 0.0181972 0.033133 0.0341654 0.0687533	DRUG1 , which induces hepatic metabolism , decreased the AUC of DRUG2 approximately 40% following a single 10-mg dose of DRUG0 .
3	4	0.099257 0.0227575 0.027671 0.0683687 0.0283659 0.041135 0.0200804 0.0427149 0.0256601 0.028328 0.0213967 0.0251189 0.0409546 0.06912 0.0530605 0.0387658 0.0587769 0.0544186 0.0304627 0.0685904 0.0689879 0.0660089	DRUG1 , which induces hepatic metabolism , decreased the AUC of DRUG0 approximately 40% following a single 10-mg dose of DRUG2 .
4	1	0.0288291 0.0226766 0.0329623 0.0313303 0.0604281 0.0609767 0.0345379 0.083563 0.0493871 0.0373248 0.0320396 0.0183163 0.00775607 0.0106988 0.00354812 0.00463172 0.00483914 0.0192198 0.0131686 0.016326 0.0264369 0.0822948 0.0847677 0.0941812 0.0714628 0.0682966	It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers , such as DRUG1 or DRUG0 , are co-administered with DRUG2 .
4	1	0.0259472 0.0201281 0.0295296 0.0282939 0.0597194 0.0588106 0.0316438 0.0792921 0.0479542 0.0430344 0.0375027 0.0246859 0.0136553 0.0178204 0.00552936 0.00889693 0.00708309 0.0126919 0.0192558 0.0858928 0.0227299 0.0464312 0.0640002 0.0807445 0.0646925 0.0640341	It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers , such as DRUG0 or DRUG1 , are co-administered with DRUG2 .
4	4	0.0418493 0.0572649 0.0224896 0.0112415 0.0327968 0.0247491 0.0257284 0.0195357 0.036931 0.0446786 0.0353791 0.0314094 0.0143175 0.0196867 0.0432211 0.0299585 0.0404781 0.0474772 0.0585213 0.0485584 0.0562336 0.0513541 0.0305417 0.0106557 0.0128019 0.00179505 0.00158215 0.0011509 0.00171539 0.0012879 0.00258465 0.00289987 0.00179879 0.00564116 0.0114174 0.0100651 0.0120043 0.008285 0.00360323 0.00139849 0.00205191 0.00151658 0.00274799 0.00181918 0.00336132 0.0140002 0.0594141	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG2 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0415137 0.056795 0.0222872 0.011119 0.0323031 0.0243385 0.0252499 0.0192492 0.0364596 0.0442265 0.0352221 0.0312095 0.0144264 0.019679 0.0433321 0.0301222 0.0400686 0.0474591 0.0584992 0.049414 0.0566599 0.0516929 0.0255239 0.0113713 0.00552865 0.0034037 0.00705544 0.001297 0.00163508 0.00131547 0.00260455 0.00291374 0.00188591 0.00598074 0.0128511 0.0116701 0.0132233 0.00934264 0.00383964 0.00144004 0.00205758 0.00153584 0.00275378 0.00184327 0.00339852 0.0141458 0.0600563	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG2 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0416193 0.0569418 0.0223468 0.0111468 0.0323697 0.0243829 0.0252681 0.0192582 0.0364626 0.0442229 0.0352131 0.0311654 0.0143821 0.0195597 0.0430574 0.030001 0.0397682 0.0471581 0.0580398 0.048641 0.0561897 0.050775 0.0245645 0.00981871 0.00420299 0.00162561 0.0023387 0.00254208 0.0071847 0.00159936 0.00290029 0.00314848 0.00204847 0.0064537 0.0141237 0.0126899 0.0139832 0.00990932 0.00403269 0.00148911 0.00210606 0.00157395 0.00281766 0.00188657 0.00347308 0.014425 0.0610928	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG2 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0406105 0.0555767 0.0218447 0.0109114 0.0317901 0.0239535 0.0248357 0.0188743 0.0357135 0.0432439 0.0341514 0.0300277 0.0134907 0.0184786 0.0406158 0.0281261 0.0377312 0.0444655 0.0556478 0.0454647 0.0532092 0.046424 0.0209088 0.00887373 0.00381539 0.00149186 0.00209093 0.00141928 0.00333232 0.00441379 0.0223941 0.0122769 0.00302513 0.00640539 0.0147088 0.0150678 0.0158704 0.0114996 0.00470321 0.00158626 0.00224884 0.00164416 0.00297045 0.00195024 0.00358359 0.0150574 0.0634747	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG2 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0374112 0.0511874 0.0200951 0.0100227 0.0291255 0.0219446 0.0226798 0.0172646 0.0327067 0.0395938 0.0317547 0.028277 0.0128793 0.0174413 0.0382609 0.0269283 0.0357779 0.0422078 0.0519803 0.0436205 0.0517403 0.0462818 0.0236248 0.0095076 0.00388699 0.00147166 0.00189789 0.00128017 0.00253896 0.00262535 0.01102 0.0107396 0.0150235 0.0187968 0.0216816 0.0208841 0.0217948 0.0151516 0.00598721 0.00194316 0.00262469 0.00187162 0.00339287 0.00219313 0.0040497 0.0163954 0.0704355	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG2 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0369394 0.0505901 0.02 0.0100176 0.0294133 0.0220804 0.0228156 0.0171146 0.0321594 0.0387766 0.0300831 0.0265465 0.0115377 0.015858 0.0350363 0.0245138 0.0309143 0.0367669 0.0470772 0.03496 0.0392254 0.0325515 0.0130724 0.00628848 0.0034695 0.0013863 0.00233198 0.00148263 0.00387803 0.00239664 0.00861293 0.00870693 0.00645347 0.0254248 0.0562778 0.0714322 0.0342117 0.0129476 0.00611888 0.00210856 0.00261619 0.00182011 0.00302425 0.0020486 0.00368242 0.0144288 0.0608013	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0423476 0.0579911 0.0228735 0.0114457 0.0334802 0.0251743 0.0261082 0.0197234 0.0371587 0.0449149 0.0348815 0.0303928 0.0131369 0.0181441 0.0397471 0.0273323 0.0358924 0.0420924 0.0532587 0.0406847 0.0467582 0.0381188 0.0146709 0.00639382 0.00341501 0.0013699 0.00212745 0.00135804 0.00339563 0.00215449 0.00612649 0.00643987 0.003975 0.013739 0.0256424 0.0232796 0.018838 0.0276141 0.0141073 0.00502454 0.0100385 0.0018516 0.00237323 0.00184871 0.00280545 0.0113315 0.0484218	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0428255 0.0586391 0.0231142 0.0115635 0.0338002 0.0254216 0.0263654 0.0199417 0.0375953 0.0454484 0.0353427 0.0307799 0.013308 0.0183761 0.0402149 0.0277489 0.0366243 0.0429346 0.0542151 0.0415042 0.0476987 0.0389039 0.0150263 0.00657445 0.00345558 0.00138204 0.0021419 0.00136822 0.0034332 0.00218864 0.0063981 0.00662567 0.00415869 0.0142085 0.0269906 0.024446 0.0173995 0.0218996 0.0086593 0.00218382 0.00297211 0.00317538 0.00916952 0.00206568 0.00273476 0.0107385 0.0482377	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0410387 0.0561906 0.0221428 0.0110781 0.0323816 0.0243615 0.0252446 0.0190933 0.0360056 0.0435194 0.0338993 0.0296106 0.0128407 0.0177027 0.0387629 0.0269263 0.0356659 0.0420168 0.0528307 0.0405353 0.0466951 0.03825 0.0148381 0.00663444 0.00336013 0.00133799 0.00205333 0.00133015 0.00331994 0.00215714 0.00651702 0.00662466 0.00433321 0.0147019 0.0279181 0.0228892 0.0158716 0.0202897 0.00799534 0.00187175 0.0021266 0.00156801 0.00265093 0.00328848 0.00953399 0.030277 0.0597188	In drug-interaction studies , the recommended clinical dose of DRUG1 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0286906 0.0357311 0.0125954 0.00650781 0.0145224 0.0107244 0.0078955 0.00640871 0.00905795 0.00959009 0.0140864 0.0231779 0.0078494 0.0125645 0.0381012 0.0251691 0.0288165 0.0413884 0.0628888 0.0509071 0.0560664 0.0491882 0.0249344 0.0244336 0.0390722 0.00864605 0.00521964 0.00596863 0.00700712 0.0137777 0.0471382 0.0167724 0.00553539 0.0099406 0.0271432 0.0266968 0.0265958 0.0202317 0.00723025 0.0024386 0.00330876 0.00245843 0.00427854 0.00292814 0.00533293 0.0212138 0.0897693	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG2 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0261547 0.0325709 0.0114685 0.00592414 0.013233 0.00977719 0.00717661 0.00581194 0.00820274 0.00865596 0.0127236 0.020933 0.00708501 0.0113344 0.0341502 0.0222794 0.0253988 0.0363451 0.0541694 0.0442523 0.048816 0.0421192 0.0209869 0.0215584 0.034798 0.00849279 0.00488264 0.00559789 0.00540518 0.00875158 0.0288097 0.0127744 0.0350701 0.0348023 0.0453771 0.037089 0.0317363 0.0242739 0.00894465 0.00293043 0.00387074 0.00271553 0.00485921 0.00320417 0.0058994 0.0223887 0.0961988	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG2 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.023654 0.0294565 0.010389 0.00536486 0.0119475 0.00879661 0.00645552 0.00523653 0.00740777 0.00784883 0.0115386 0.0189888 0.0064111 0.0102188 0.031337 0.0207782 0.0233192 0.0336563 0.0523043 0.0408659 0.0438162 0.0382365 0.0190019 0.0160244 0.0242013 0.00480893 0.00401562 0.0041997 0.00539552 0.00678255 0.0248662 0.00945468 0.0113704 0.0380269 0.0869616 0.101085 0.0431442 0.0190991 0.00943282 0.00359769 0.00415633 0.00274211 0.00438961 0.003116 0.00559753 0.0197225 0.080779	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0255077 0.0317694 0.0112114 0.00579178 0.0129086 0.00951289 0.00697278 0.0056624 0.00801655 0.00850197 0.0124839 0.0205414 0.00694241 0.0110547 0.0336454 0.0222863 0.0252741 0.036452 0.0567898 0.0455117 0.0498492 0.0434178 0.0212927 0.0177292 0.0279231 0.00487663 0.0038937 0.00388809 0.00492988 0.00624951 0.0195897 0.00702997 0.00857867 0.0285377 0.0808766 0.0515882 0.0313022 0.0552254 0.0255874 0.00744973 0.0141051 0.00266513 0.00327596 0.00253423 0.00379965 0.0150856 0.0618818	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.025731 0.0320475 0.0113088 0.00584263 0.0130236 0.00959895 0.00703737 0.00571489 0.00809066 0.00857938 0.012598 0.020729 0.00700577 0.0111573 0.0339421 0.022491 0.0255318 0.0368225 0.0573242 0.0458745 0.0501422 0.0437053 0.0214852 0.0179909 0.0283431 0.00498756 0.00395728 0.00397495 0.00503864 0.00652716 0.0206289 0.00732748 0.00905513 0.0299559 0.0854985 0.0544132 0.0311736 0.0478834 0.0171447 0.00409294 0.00454587 0.00450807 0.0130545 0.00290679 0.00374288 0.0145037 0.0629612	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0256123 0.0318968 0.0112545 0.00581463 0.0129591 0.00955163 0.00700784 0.00568985 0.00805413 0.00853908 0.0125417 0.0206424 0.00697711 0.0111227 0.0338589 0.022447 0.0254985 0.0368205 0.057131 0.0454712 0.049366 0.042974 0.0211838 0.0178603 0.0279777 0.00507147 0.00394343 0.004033 0.00507182 0.00672097 0.0216567 0.00752606 0.00911219 0.029623 0.0781749 0.0454459 0.0262965 0.0410139 0.01536 0.00341241 0.00315457 0.00229879 0.00376289 0.00507744 0.0124845 0.0395155 0.0729914	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG1 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0306045 0.0380885 0.0133871 0.0069026 0.0154382 0.0113624 0.00799697 0.00638378 0.00902868 0.00950201 0.0140439 0.0230089 0.00775687 0.0122435 0.0371471 0.0239802 0.0264161 0.0386586 0.0625997 0.0490445 0.0575336 0.0530098 0.0248526 0.0204103 0.0116027 0.00753606 0.0300585 0.00656748 0.00699271 0.0125957 0.04606 0.0174261 0.00550411 0.0098491 0.0267284 0.0268998 0.0270694 0.0202628 0.0074747 0.0025284 0.00346183 0.00256909 0.00449804 0.00304785 0.00554434 0.0219999 0.0943227	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG2 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0275474 0.0342998 0.0120425 0.00621002 0.0139225 0.0102811 0.00718501 0.0057142 0.0080671 0.00846434 0.0124955 0.0204631 0.0068958 0.010886 0.0327915 0.0209007 0.0232271 0.0340385 0.0545954 0.0438727 0.0527452 0.0481279 0.0232514 0.0180911 0.00960823 0.00670276 0.0266578 0.00624638 0.00565571 0.00770887 0.0255818 0.0125464 0.0322229 0.0328272 0.0438059 0.0376101 0.0344808 0.0251786 0.009383 0.00300475 0.00397987 0.00280055 0.00502395 0.00328377 0.00603082 0.0231766 0.100368	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG0 ( DRUG2 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0247658 0.0308213 0.0108431 0.0055907 0.0124928 0.00917938 0.00642022 0.00511531 0.0072385 0.00762282 0.0112629 0.018471 0.00622648 0.00978864 0.0297275 0.0192941 0.0205397 0.0295543 0.0477684 0.0360461 0.0408602 0.0374697 0.0173899 0.014492 0.00870199 0.00496492 0.0196433 0.00438818 0.00531286 0.00640763 0.0236851 0.0105573 0.0121909 0.0392557 0.0949864 0.109082 0.0455725 0.0200241 0.00969833 0.00360868 0.00420319 0.00275355 0.00442189 0.00310314 0.00557101 0.0199354 0.0829511	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0271069 0.0337435 0.0118792 0.00612614 0.0136904 0.0100589 0.00705141 0.00562967 0.00796671 0.00839364 0.0123929 0.0203125 0.00684059 0.0107349 0.0325425 0.0211003 0.0225714 0.0325309 0.0529481 0.0404776 0.0465501 0.0427543 0.0196271 0.0160013 0.00990586 0.00577185 0.0229349 0.00432309 0.00484062 0.00561905 0.017797 0.00749158 0.00881765 0.0283415 0.0841825 0.0577984 0.0343399 0.0576714 0.0262449 0.0078542 0.0147522 0.00276327 0.00338134 0.00261478 0.00391371 0.0154513 0.0641582	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0273919 0.0340976 0.0120028 0.00619016 0.0138353 0.010167 0.0071286 0.00569149 0.00805399 0.00848448 0.012528 0.0205306 0.00691388 0.0108496 0.0328783 0.0213224 0.022829 0.0329004 0.0535507 0.04087 0.0469604 0.0431425 0.0197861 0.0161741 0.0100228 0.00583785 0.0232806 0.00442587 0.00494035 0.00585968 0.018747 0.00780002 0.00932365 0.0297454 0.089305 0.06152 0.0343269 0.049718 0.0174251 0.00403251 0.00460859 0.00464982 0.0133629 0.00298122 0.00383231 0.014821 0.065154	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0270649 0.033684 0.0118559 0.0061146 0.0136625 0.0100424 0.00704346 0.00562139 0.00795555 0.00837992 0.012378 0.0202909 0.00683416 0.0107352 0.0325408 0.0210993 0.0226555 0.0327355 0.0531496 0.0404567 0.0463764 0.0425186 0.0194769 0.0159583 0.00967884 0.00567978 0.0226676 0.00445357 0.00493454 0.00603123 0.0196927 0.00803401 0.00947046 0.0295668 0.0822844 0.0513907 0.0293841 0.0431617 0.0155603 0.00339563 0.00322627 0.00234338 0.00384596 0.00509338 0.0130112 0.0415956 0.0768671	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG1 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0301004 0.0374105 0.0131708 0.00679576 0.0151868 0.0111335 0.00791974 0.00635218 0.00900578 0.00950084 0.0141148 0.0230346 0.00774011 0.0120661 0.0367241 0.0239336 0.0251786 0.0353544 0.0574427 0.0411826 0.0448032 0.0423884 0.0212953 0.0158253 0.00904315 0.0041383 0.0112017 0.0130503 0.0684979 0.0142072 0.0533103 0.0208903 0.00626423 0.0103373 0.0264702 0.0263602 0.0266605 0.0195774 0.00727084 0.00249701 0.00342165 0.00254704 0.00444727 0.00301375 0.00546982 0.0215299 0.0921337	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG2 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0274691 0.0341809 0.012018 0.00619652 0.0138707 0.0102299 0.00715213 0.00570507 0.00807695 0.00851569 0.0125987 0.0205995 0.00696135 0.0109386 0.0328978 0.021096 0.023108 0.0333208 0.0529389 0.0406109 0.0475376 0.04377 0.0211614 0.0140566 0.00695942 0.00311059 0.00722733 0.00803792 0.0404843 0.00885517 0.0284487 0.0144383 0.0355355 0.0340326 0.0437716 0.0380311 0.0348659 0.0251621 0.00937524 0.00299027 0.00395302 0.00277924 0.00498363 0.00325189 0.00596853 0.0230111 0.0997153	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG0 ( DRUG2 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0242359 0.0301514 0.0106133 0.0054738 0.012247 0.00900224 0.00626821 0.00499023 0.00706814 0.00745076 0.0110246 0.018055 0.00609144 0.00953955 0.0288077 0.0187046 0.0197861 0.0281486 0.0452411 0.0325882 0.0362304 0.033629 0.0160033 0.0115164 0.00633826 0.00272832 0.00696856 0.00661342 0.0334075 0.00726773 0.0259024 0.0113828 0.0128504 0.043452 0.0977257 0.110824 0.0461004 0.0202696 0.00973835 0.00360975 0.00419992 0.00274164 0.00440302 0.00308389 0.00553537 0.0198107 0.0821793	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG0 ( DRUG0 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0260467 0.0324077 0.0114203 0.00589235 0.0131829 0.0096771 0.00677245 0.00540756 0.0076633 0.00808662 0.0119683 0.0195841 0.00659299 0.0102816 0.0311087 0.0202473 0.0212421 0.0299986 0.0487299 0.0350757 0.0388221 0.036422 0.01754 0.0126558 0.00735773 0.00314917 0.00830544 0.00808367 0.0405128 0.0066828 0.0202961 0.00830924 0.00967041 0.0325822 0.0905955 0.0613303 0.0362157 0.059201 0.0269754 0.00798803 0.014903 0.00276787 0.0033694 0.00260819 0.00389592 0.0152421 0.0631317	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0263255 0.0327537 0.0115413 0.00595516 0.0133255 0.0097824 0.00684905 0.00546939 0.00775088 0.00817789 0.0121051 0.0198048 0.00666678 0.0103952 0.0314467 0.0204753 0.02149 0.0303363 0.0492854 0.0354023 0.0391181 0.0367249 0.0176898 0.0128241 0.00746839 0.00319815 0.00845803 0.00826299 0.0416905 0.00697433 0.0214076 0.00866147 0.0101816 0.0342013 0.0956681 0.0650432 0.0360998 0.0509463 0.0179681 0.00407686 0.00466247 0.00468142 0.0132962 0.00297018 0.0037972 0.0145941 0.0639962	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0260449 0.0323991 0.0114141 0.00588942 0.0131749 0.0096745 0.00677659 0.00540972 0.00766683 0.00808729 0.0119772 0.0195996 0.00659809 0.0102981 0.0311607 0.0202807 0.0213666 0.0302579 0.049055 0.0352007 0.0388533 0.0364015 0.0174985 0.0127567 0.00724531 0.00312072 0.00814764 0.00809979 0.0411175 0.00715934 0.022396 0.00892612 0.0103173 0.0339027 0.0879207 0.0543008 0.0309536 0.0442015 0.0159749 0.00343437 0.00325515 0.00235828 0.00387459 0.00509738 0.0130542 0.0414069 0.0758936	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG1 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0247941 0.0308173 0.0108518 0.00560454 0.012522 0.00923845 0.00650593 0.00521129 0.00736307 0.00775843 0.0114421 0.0187194 0.00631957 0.00992273 0.0295191 0.0192209 0.021047 0.0302861 0.0466612 0.0326895 0.035837 0.0318445 0.0143614 0.010294 0.00505535 0.00204501 0.00398736 0.00278322 0.00827242 0.00948342 0.03439 0.0340554 0.0181049 0.0407406 0.100549 0.102671 0.045253 0.0189932 0.00934224 0.00358129 0.00413387 0.00276546 0.00444695 0.00314535 0.00565269 0.01997 0.0817478	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG1 ( DRUG0 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0257594 0.031996 0.0112725 0.0058239 0.0129989 0.00956621 0.00680634 0.00547696 0.0077426 0.00815894 0.0120459 0.0196596 0.00661417 0.0103228 0.0307966 0.0201696 0.0216955 0.0308229 0.0480841 0.0332608 0.0355746 0.032014 0.0148172 0.0110186 0.00586035 0.0023213 0.00510658 0.00354095 0.0118581 0.0148012 0.0477666 0.0528839 0.0167635 0.0360248 0.0845938 0.0492433 0.0286287 0.0536763 0.0246167 0.00733179 0.0140561 0.00266515 0.00325141 0.00252114 0.00378235 0.0148443 0.0613635	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG1 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0257429 0.0319736 0.0112647 0.00582079 0.0129923 0.00956075 0.00681968 0.00549238 0.00776423 0.00818044 0.0120813 0.0197138 0.00662857 0.0103402 0.0308658 0.0202424 0.0217645 0.0308749 0.0482095 0.0332684 0.0355058 0.032031 0.0148741 0.0112246 0.00594544 0.00236448 0.00518629 0.00362512 0.0120335 0.0153788 0.0498656 0.05691 0.0177369 0.0376499 0.0889244 0.0518047 0.0284318 0.0462183 0.016478 0.00396007 0.00450495 0.00448271 0.0128339 0.00288719 0.00369628 0.0141126 0.0617322	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG1 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0255795 0.0317694 0.011191 0.00578325 0.0129096 0.00950156 0.00678871 0.00546858 0.00773063 0.00814362 0.012032 0.0196383 0.00660264 0.0103053 0.0307771 0.0201852 0.021783 0.0309622 0.0482479 0.0333093 0.0355638 0.0320508 0.0148529 0.0112921 0.00581561 0.00233157 0.00498426 0.00354348 0.0114943 0.0149612 0.0479551 0.054788 0.0176189 0.0367886 0.0829876 0.0441429 0.0243772 0.0397996 0.0148837 0.00334534 0.00316739 0.00232262 0.00376896 0.0050517 0.0124789 0.0387638 0.0721609	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG1 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0268866 0.0334023 0.0117683 0.00609197 0.013664 0.0100167 0.00720297 0.00578196 0.00813524 0.00848426 0.0125909 0.0205464 0.00680481 0.0104371 0.031211 0.0199911 0.0205819 0.0271515 0.0427281 0.0268295 0.0275207 0.0248516 0.0131489 0.00986996 0.00541049 0.00233665 0.00439591 0.00313354 0.00778926 0.00692107 0.0268348 0.027654 0.0260801 0.0618169 0.108138 0.0890413 0.0345274 0.0194939 0.0101741 0.00412551 0.00481936 0.00314707 0.00508799 0.00357071 0.00635019 0.0225496 0.0909043	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG1 1 mg/ DRUG2 35 mcg) , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0272692 0.0338861 0.0119503 0.00618753 0.0138582 0.0101621 0.00722338 0.00576458 0.00811064 0.00846272 0.0125422 0.0205568 0.0068034 0.0104623 0.0312233 0.0198149 0.0204736 0.0273288 0.0435594 0.0274799 0.0290481 0.0266215 0.0139634 0.00961082 0.00541171 0.0022037 0.00428429 0.00290442 0.00782294 0.00661584 0.0274717 0.030117 0.0340378 0.0717417 0.100045 0.0513005 0.0266639 0.0484465 0.0243176 0.00747967 0.0149677 0.00324471 0.00397178 0.00303184 0.004556 0.0170267 0.0699738	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG1 1 mg/ DRUG0 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0274137 0.0340595 0.012016 0.00622363 0.0139411 0.0102226 0.00728507 0.00581802 0.00818461 0.00853765 0.012653 0.0207252 0.00685396 0.010519 0.0314016 0.0199641 0.0205623 0.0272459 0.0433541 0.0269934 0.0281888 0.0257408 0.0136603 0.00965542 0.00547716 0.0022462 0.00435957 0.00297533 0.00785625 0.00669082 0.0280291 0.0309107 0.0366073 0.0753731 0.101993 0.0536052 0.0274114 0.0441272 0.0172242 0.00433699 0.00530474 0.00521833 0.0150614 0.00349699 0.00439279 0.0160503 0.0700323	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG1 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.027208 0.0337897 0.0119171 0.00617104 0.0138242 0.0101364 0.00725121 0.00580165 0.00816476 0.00851935 0.012638 0.020656 0.00683446 0.0104792 0.0313105 0.019974 0.0205819 0.0272542 0.0432347 0.0269878 0.0279659 0.025532 0.0135431 0.00991106 0.005516 0.00227531 0.00439709 0.00303378 0.00781047 0.00676896 0.027565 0.0300309 0.0349552 0.0713135 0.0901457 0.0446773 0.0234485 0.0386624 0.0158051 0.00361257 0.00368432 0.00270901 0.0044441 0.00590066 0.0142956 0.0457692 0.083493	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG1 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0258911 0.0321382 0.0113804 0.00591364 0.0131878 0.0098425 0.00678672 0.00538352 0.00754094 0.00789538 0.011404 0.0186663 0.00618981 0.00942858 0.0272882 0.0179351 0.0174396 0.0223292 0.0353472 0.0197014 0.0201876 0.0172594 0.00931278 0.00620852 0.00504115 0.00205417 0.004271 0.00261849 0.00740982 0.00404112 0.01434 0.0171456 0.012408 0.0417155 0.063479 0.0884757 0.115042 0.0790848 0.0338395 0.0115433 0.019678 0.00438619 0.00477715 0.00363412 0.00529524 0.0193255 0.0757364	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG1 35 mcg) , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0250578 0.0310949 0.0110104 0.00572523 0.0127648 0.00953845 0.0065933 0.00523559 0.00733183 0.00767431 0.0110795 0.0181171 0.00600151 0.00912292 0.0263491 0.0173934 0.0168421 0.021422 0.0339616 0.0187045 0.0190519 0.0163141 0.00894366 0.00604862 0.00495859 0.00202384 0.00419505 0.0025975 0.00724221 0.00400549 0.014168 0.0168928 0.0122679 0.0406237 0.0638037 0.0900992 0.126156 0.081378 0.0304922 0.00973392 0.0080503 0.00726253 0.01939 0.00462201 0.00529881 0.0178343 0.0755255	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG1 35 mcg) , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0260729 0.0323478 0.0114483 0.00595274 0.0132723 0.00991033 0.00684248 0.00542679 0.00759624 0.00793994 0.0114715 0.0187571 0.00621151 0.00943694 0.0272282 0.0179088 0.0173598 0.0220848 0.0349522 0.0191678 0.0194663 0.01661 0.00905735 0.00609429 0.00496408 0.00202787 0.00415804 0.00258506 0.00715228 0.00391952 0.0137448 0.0165403 0.0116581 0.0384889 0.056635 0.0765253 0.100469 0.070567 0.0311577 0.00863976 0.00560166 0.0040402 0.00595307 0.00864258 0.0168334 0.0545602 0.0925197	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG1 35 mcg) , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0335942 0.0417458 0.0147263 0.00763449 0.0170507 0.0126902 0.00858373 0.00675928 0.00951458 0.00997971 0.0145418 0.0239084 0.00808648 0.0127062 0.0361575 0.0230366 0.0256661 0.0366578 0.0542402 0.0381339 0.0437477 0.0367195 0.0155638 0.00827576 0.00472071 0.00197134 0.00325979 0.00202134 0.00544167 0.00310895 0.00898852 0.00991528 0.00555159 0.0178372 0.0319088 0.0308525 0.025333 0.0227204 0.0103613 0.00394046 0.00744404 0.0092252 0.0539847 0.0142579 0.0192774 0.062858 0.105299	In drug-interaction studies , the recommended clinical dose of DRUG0 did not have clinically important effects on the pharmacokinetics of the following drugs : DRUG0 , DRUG0 , DRUG0 , oral DRUG0 ( DRUG0 1 mg/ DRUG0 35 mcg) , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.102032 0.0694377 0.0519185 0.0145098 0.00654539 0.0128788 0.0104942 0.0247348 0.0269994 0.147478 0.0394745 0.0534739 0.172104 0.267919	These medications included DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
3	4	0.0925059 0.021821 0.0281342 0.0693622 0.0287891 0.0403858 0.0270754 0.0737392 0.0726295 0.0893073 0.0868196 0.0528207 0.0249951 0.0281239 0.0191536 0.0180355 0.0389367 0.0331163 0.0181972 0.033133 0.0341654 0.0687533	DRUG1 , which induces hepatic metabolism , decreased the AUC of DRUG2 approximately 40% following a single 10-mg dose of DRUG0 .
3	4	0.099257 0.0227575 0.027671 0.0683687 0.0283659 0.041135 0.0200804 0.0427149 0.0256601 0.028328 0.0213967 0.0251189 0.0409546 0.06912 0.0530605 0.0387658 0.0587769 0.0544186 0.0304627 0.0685904 0.0689879 0.0660089	DRUG1 , which induces hepatic metabolism , decreased the AUC of DRUG0 approximately 40% following a single 10-mg dose of DRUG2 .
4	1	0.0288291 0.0226766 0.0329623 0.0313303 0.0604281 0.0609767 0.0345379 0.083563 0.0493871 0.0373248 0.0320396 0.0183163 0.00775607 0.0106988 0.00354812 0.00463172 0.00483914 0.0192198 0.0131686 0.016326 0.0264369 0.0822948 0.0847677 0.0941812 0.0714628 0.0682966	It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers , such as DRUG1 or DRUG0 , are co-administered with DRUG2 .
4	1	0.0259472 0.0201281 0.0295296 0.0282939 0.0597194 0.0588106 0.0316438 0.0792921 0.0479542 0.0430344 0.0375027 0.0246859 0.0136553 0.0178204 0.00552936 0.00889693 0.00708309 0.0126919 0.0192558 0.0858928 0.0227299 0.0464312 0.0640002 0.0807445 0.0646925 0.0640341	It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers , such as DRUG0 or DRUG1 , are co-administered with DRUG2 .
2	2	0.102483 0.0414142 0.0485921 0.0721356 0.0540109 0.0671722 0.0796223 0.0695221 0.0535458 0.0959689 0.0408528 0.0393011 0.095998 0.0624107 0.0769707	DRUG1 failure in an HIV-positive woman on DRUG2 therapy resulting in two ectopic pregnancies .
2	2	0.0398669 0.0271258 0.0447989 0.0764947 0.0342746 0.0281553 0.0398942 0.039089 0.040287 0.0494456 0.0589566 0.0236848 0.0275819 0.0350231 0.0274886 0.0213287 0.0336639 0.0452705 0.038602 0.0532293 0.0377886 0.0386909 0.0596654 0.079594	We present an interesting case of an HIV-positive woman on DRUG1 therapy having tubal pregnancies on two separate occasions with DRUG2 in place .
4	4	0.0667628 0.0344063 0.058504 0.0438274 0.0343936 0.0137072 0.00950084 0.0120981 0.0336613 0.0544424 0.0527091 0.0456317 0.0280347 0.0352454 0.0270388 0.042944 0.0367768 0.0691209 0.0333576 0.0715578 0.0682714 0.0375709 0.0346741 0.0557628	Drug-Drug Interactions Effect of DRUG1 ( DRUG0 ) on the Metabolism of Other Drugs : DRUG2 is primarily metabolized through hydrolysis by esterases .
4	4	0.0617999 0.0315921 0.0465295 0.0374375 0.024737 0.0219741 0.041454 0.0138093 0.0336875 0.0539372 0.0513395 0.0431705 0.0270749 0.0338145 0.0259292 0.0412885 0.0367216 0.0709633 0.033852 0.0723747 0.0684252 0.0376217 0.0346514 0.0558152	Drug-Drug Interactions Effect of DRUG0 ( DRUG1 ) on the Metabolism of Other Drugs : DRUG2 is primarily metabolized through hydrolysis by esterases .
4	4	0.126902 0.0812044 0.065192 0.0697805 0.0996287 0.0954572 0.122627 0.0183984 0.0191133 0.00416451 0.00414878 0.00333023 0.00458149 0.00409753 0.0066614 0.0204407 0.0316744 0.0392479 0.0257984 0.0289919 0.028037 0.100523	No pharmacokinetic interaction was observed between DRUG1 and DRUG2 , DRUG0 , DRUG0 , or DRUG0 in studies in healthy volunteers .
4	4	0.128618 0.0846322 0.0701737 0.0768172 0.106434 0.089222 0.0939986 0.0192836 0.0101359 0.0108271 0.0187127 0.00399804 0.00484891 0.00423166 0.00701735 0.0198436 0.0311493 0.0368554 0.0258925 0.0295649 0.0287216 0.0990215	No pharmacokinetic interaction was observed between DRUG1 and DRUG0 , DRUG2 , DRUG0 , or DRUG0 in studies in healthy volunteers .
4	4	0.0580162 0.0720964 0.045006 0.0368671 0.0366756 0.0859745 0.0812266 0.0878955 0.0277929 0.0436885 0.0717861 0.0730352 0.0569299 0.089855 0.075657 0.0574977	The elevation of prothrombin time induced by DRUG1 is not affected by administration of DRUG2 .
4	4	0.0249771 0.0130783 0.00845894 0.0115735 0.0205037 0.0333518 0.0375976 0.0326111 0.0255441 0.00556673 0.0068308 0.00712217 0.019243 0.011276 0.0548568 0.0387956 0.0641404 0.025142 0.0274441 0.0285549 0.0270928 0.05768 0.0686236 0.119849 0.086533 0.0743133 0.0692396	Effect of Other Drugs on the Metabolism of DRUG1 : Drugs that induce or inhibit CYP450 metabolism are not expected to alter the metabolism of DRUG2 .
4	4	0.0377647 0.0184629 0.0262441 0.0246235 0.0187991 0.0241796 0.0450112 0.0985987 0.0581581 0.0756981 0.0207935 0.0329464 0.0653688 0.0703034 0.0523215 0.0768611 0.0535113 0.0650454 0.0266367 0.00465094 0.0038404 0.00240107 0.00365437 0.00260428 0.0046804 0.0190417 0.0677988	Single dose pharmacokinetic studies demonstrated that the metabolism of DRUG1 is not significantly affected by concurrent administration of DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0430713 0.0210483 0.0298755 0.0280159 0.0210917 0.0270756 0.0504761 0.110265 0.0647238 0.0815994 0.0221345 0.033785 0.0678778 0.067561 0.0490034 0.0620475 0.0484531 0.0418591 0.0160776 0.00794581 0.0135715 0.00268713 0.00332903 0.0026946 0.0049563 0.0161953 0.0625787	Single dose pharmacokinetic studies demonstrated that the metabolism of DRUG1 is not significantly affected by concurrent administration of DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0441225 0.0215422 0.0305631 0.0286296 0.021411 0.0273331 0.0509984 0.11121 0.0654024 0.0824316 0.0222002 0.0336304 0.0682707 0.0670599 0.0483207 0.0613217 0.0455627 0.0384427 0.0129864 0.00397435 0.00570686 0.00568207 0.0143159 0.00381304 0.00633882 0.0153461 0.0633835	Single dose pharmacokinetic studies demonstrated that the metabolism of DRUG1 is not significantly affected by concurrent administration of DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0443638 0.0216137 0.0306552 0.0286442 0.021397 0.0271519 0.0507024 0.110403 0.0647067 0.0823576 0.0218702 0.032799 0.0645663 0.0641863 0.0466546 0.055076 0.04101 0.0360161 0.0122898 0.00360302 0.00409925 0.00278568 0.00489976 0.00618101 0.0138322 0.0413773 0.0667583	Single dose pharmacokinetic studies demonstrated that the metabolism of DRUG1 is not significantly affected by concurrent administration of DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0252034 0.0354191 0.0452268 0.0210334 0.00823502 0.0108439 0.00867474 0.0129516 0.0102436 0.0126207 0.0152594 0.0286173 0.0412825 0.0300154 0.033252 0.0257606 0.0421375 0.0850606 0.071624 0.0796636 0.0839104 0.0242574 0.00770351 0.00831934 0.0134631 0.00474658 0.00213809 0.00427642 0.00673075 0.0019536 0.00390975 0.00551112 0.00191458 0.00390194 0.00544631 0.00184944 0.00412233 0.0072843 0.00187694 0.00402575 0.00607311 0.00178137 0.00360342 0.00582001 0.0019359 0.00518596 0.0075611 0.00174972 0.00265383 0.0109293 0.0554503 0.0567887	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG2 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0257042 0.0361277 0.0461542 0.0215153 0.00844043 0.0111532 0.00892441 0.0133819 0.0105733 0.013029 0.0157948 0.0296326 0.0430118 0.0316576 0.0353071 0.0284222 0.0432552 0.0909666 0.0688475 0.0805871 0.0572701 0.0104552 0.00308182 0.00218854 0.00501107 0.0140937 0.00566281 0.01451 0.00775 0.00265666 0.00493787 0.00690567 0.00228248 0.00469564 0.0064998 0.0021158 0.00473036 0.0084879 0.00210685 0.00449613 0.0068277 0.00195383 0.00393777 0.00642383 0.00209302 0.0055796 0.0081341 0.00185235 0.00281525 0.0115311 0.0577177 0.0587096	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG2 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.025955 0.0364656 0.0465905 0.0217402 0.00853468 0.0112836 0.00903005 0.0135607 0.0107092 0.0132557 0.0160708 0.0299536 0.0433737 0.0320061 0.0355216 0.0296262 0.0432528 0.0898393 0.0659314 0.0786126 0.050079 0.00800191 0.00258543 0.00177412 0.00345277 0.00508897 0.00216048 0.00668493 0.0248667 0.00719095 0.0161565 0.0077701 0.00274995 0.00499561 0.00683342 0.00223122 0.00494393 0.00880349 0.00213434 0.00450949 0.00688408 0.00194283 0.00390079 0.00639726 0.00207309 0.00551685 0.00807171 0.00182742 0.00277537 0.0113645 0.0568144 0.0581055	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG2 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0262906 0.0369271 0.047179 0.022027 0.00865156 0.0114398 0.00915647 0.0137643 0.0108745 0.0135124 0.0164169 0.0304538 0.0438518 0.03234 0.0358135 0.030417 0.0436102 0.0899446 0.0637028 0.0763796 0.0452179 0.00688914 0.00229939 0.00161929 0.00302682 0.00443418 0.0016997 0.00445478 0.00844834 0.00250915 0.00667773 0.0267996 0.00755486 0.0164764 0.00745715 0.00256926 0.00552723 0.00938274 0.00231434 0.00476029 0.00700476 0.00199626 0.00395504 0.00642186 0.00210792 0.00556502 0.00814681 0.00184566 0.00279871 0.0114474 0.0570474 0.058792	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG2 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0263627 0.0370195 0.0472921 0.0220875 0.00867933 0.0114754 0.00918548 0.0138159 0.0109222 0.0136148 0.0165915 0.0306709 0.0439022 0.0323347 0.0357895 0.0305632 0.0432757 0.0891493 0.0608238 0.073375 0.041313 0.00616315 0.00210794 0.00152153 0.00280933 0.00395683 0.00154187 0.0039376 0.00723245 0.00187062 0.00430402 0.00794419 0.00256034 0.00731518 0.029342 0.00754465 0.0164585 0.0106214 0.00297974 0.00586935 0.00842086 0.00227028 0.00442628 0.00728485 0.0023268 0.0059554 0.00885278 0.00197625 0.00299003 0.0120074 0.0593555 0.0598088	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG2 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0269886 0.037894 0.048393 0.0226062 0.00888687 0.0117484 0.00939892 0.0141529 0.0112237 0.0140824 0.0172704 0.0317903 0.0450003 0.0330536 0.0366559 0.0313478 0.0439414 0.0911791 0.0582115 0.0703332 0.0378275 0.00568945 0.00202223 0.00150352 0.00273317 0.00367176 0.00149166 0.00367397 0.00643011 0.00174592 0.00386184 0.00664622 0.00206273 0.00510934 0.00929618 0.00242968 0.00710795 0.0304233 0.00778218 0.0165939 0.00814859 0.00255997 0.00490415 0.00774768 0.00244006 0.00610137 0.00897397 0.00201342 0.00302866 0.0120778 0.0593475 0.0603955	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0272944 0.0383189 0.0489277 0.0228583 0.00898796 0.0118801 0.00950364 0.014316 0.0113682 0.0143072 0.0175952 0.0323226 0.0455196 0.0333841 0.0370303 0.0316366 0.0441655 0.0918635 0.0566219 0.068546 0.0360112 0.00541782 0.00195871 0.00147856 0.00266834 0.00352241 0.00145585 0.00351811 0.00602442 0.00167214 0.00357909 0.00592075 0.00188246 0.00441834 0.00746597 0.00192614 0.00477452 0.0106293 0.00250252 0.00653237 0.0272102 0.00740028 0.0158482 0.00835678 0.00307783 0.00711448 0.010031 0.00227059 0.00331534 0.0127871 0.0609554 0.0618259	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0275338 0.0386563 0.0493534 0.0230581 0.00906716 0.0119856 0.00958658 0.0144472 0.0114859 0.0144832 0.0178391 0.0327455 0.0459891 0.0337035 0.0374297 0.0320091 0.0446498 0.0932266 0.0561528 0.068024 0.0350628 0.00527693 0.0019249 0.00145804 0.00261329 0.00338114 0.00142387 0.00338943 0.00568232 0.00161262 0.00338757 0.00544397 0.00176216 0.00399728 0.0064878 0.00176921 0.0043037 0.00923041 0.00203965 0.00472289 0.009623 0.00228141 0.005899 0.0226512 0.00755451 0.0207594 0.0122972 0.00313403 0.00445862 0.0133758 0.0607615 0.0608079	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0275955 0.0387411 0.0494431 0.0231012 0.00908603 0.0120084 0.00960158 0.0144852 0.0115659 0.0146925 0.0182064 0.0333091 0.0462713 0.0337998 0.0375887 0.0320284 0.0447017 0.0944816 0.0529535 0.064076 0.0324246 0.00497015 0.00186454 0.0014362 0.0025475 0.00320181 0.00138527 0.0032339 0.00524078 0.00154518 0.00317793 0.0048891 0.0016486 0.00362023 0.00557142 0.00162767 0.00382547 0.00759879 0.00174281 0.00394708 0.00702305 0.00166227 0.00357494 0.0070313 0.00271615 0.00972902 0.0313811 0.00694091 0.0135053 0.033912 0.0524286 0.0668594	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG1 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0257686 0.0358537 0.0448451 0.0205373 0.00798596 0.0100996 0.00744733 0.0105286 0.00855804 0.00940291 0.00963075 0.0180379 0.03133 0.0169725 0.0158604 0.0191129 0.0401047 0.0739085 0.0476456 0.0551926 0.0590524 0.0204293 0.0110021 0.0122079 0.0359948 0.042431 0.0112988 0.0181562 0.00902217 0.00354198 0.00627611 0.00873975 0.00300964 0.00603338 0.00845081 0.00276119 0.00601202 0.010737 0.00270384 0.00565397 0.00860611 0.00248742 0.00493524 0.00809005 0.00267216 0.00688215 0.0100976 0.00236921 0.00355107 0.0142339 0.0710923 0.0726456	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG2 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0246343 0.0342775 0.0428735 0.019637 0.00763724 0.00966735 0.00713405 0.0100997 0.00824074 0.00909843 0.00937722 0.0175952 0.0305096 0.0166188 0.0157465 0.0189797 0.0399019 0.0737754 0.0478349 0.0543814 0.0569656 0.0195372 0.0104241 0.0110694 0.0305071 0.0180836 0.00685105 0.0133847 0.0559054 0.0103199 0.01791 0.00811771 0.00331323 0.00602043 0.00865389 0.00284132 0.00625293 0.0110943 0.00267191 0.00557192 0.00853968 0.00238926 0.0047373 0.00784023 0.00253803 0.00656619 0.00965721 0.00222399 0.00333447 0.0134462 0.0671466 0.0680648	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG2 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0243992 0.0339381 0.0424407 0.0194434 0.0075626 0.00956994 0.00705861 0.00998304 0.00814259 0.00898852 0.0092708 0.0173823 0.0302144 0.0163829 0.015501 0.0187342 0.0394067 0.0725766 0.046594 0.054055 0.0569696 0.0192217 0.00993375 0.0100958 0.0275796 0.0144271 0.00554136 0.00815632 0.0175329 0.00516504 0.0121886 0.0519375 0.0107125 0.0191123 0.00840213 0.0032479 0.00696349 0.012188 0.00299834 0.00613685 0.00906038 0.00253634 0.00494568 0.00811165 0.00263135 0.00674647 0.00991008 0.00226092 0.00338303 0.0136086 0.0678571 0.0687929	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG2 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0238761 0.0332025 0.0415204 0.0190248 0.00739999 0.00936168 0.00690318 0.00975865 0.00795407 0.00877746 0.00905302 0.0169591 0.029509 0.0159722 0.0150964 0.0182703 0.0383842 0.0704445 0.0447579 0.0525329 0.0553578 0.0185012 0.00943922 0.00937944 0.0251925 0.0117087 0.00457012 0.00695664 0.013995 0.00370634 0.00771327 0.0171946 0.00554214 0.0136031 0.0559788 0.0107089 0.0202466 0.0123404 0.00384285 0.00749736 0.0108523 0.00292295 0.00562951 0.00924098 0.00293222 0.00725734 0.0107152 0.00241144 0.00359897 0.0141984 0.0693855 0.0686218	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG2 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0243107 0.0338027 0.0422792 0.0193754 0.00753529 0.00953093 0.00702608 0.00993153 0.00808375 0.00891327 0.00918326 0.0171832 0.0299515 0.0161697 0.0152687 0.01847 0.038766 0.0711919 0.0446184 0.0527059 0.0553052 0.0183386 0.00934784 0.00910563 0.0243896 0.0105362 0.00418395 0.00624686 0.0115188 0.00315996 0.00666295 0.0135292 0.00404094 0.0091172 0.0185017 0.00463542 0.0129064 0.0530665 0.01076 0.0199454 0.00962021 0.00331536 0.00627211 0.00991516 0.00313636 0.00759558 0.0110312 0.00249226 0.00368849 0.0144069 0.0696786 0.0692519	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0245551 0.0341389 0.0427012 0.0195686 0.00760964 0.00962334 0.00709321 0.0100246 0.00815292 0.00898518 0.00925085 0.0172984 0.0301707 0.0162663 0.0153504 0.0185692 0.0389524 0.0714216 0.0443954 0.0526138 0.0550469 0.0181759 0.00927319 0.0089824 0.0241852 0.0100695 0.00403315 0.00599208 0.0107593 0.00297827 0.00606703 0.0115301 0.00336138 0.00760861 0.0143641 0.00338904 0.00812271 0.0198325 0.00446193 0.0109494 0.0450155 0.0100308 0.0195294 0.00992662 0.00397502 0.00875538 0.0124117 0.00286575 0.00411545 0.0154867 0.0715064 0.0704567	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.025027 0.0347954 0.0435247 0.0199455 0.0077559 0.00980786 0.00722929 0.0102167 0.00830842 0.00915552 0.00942697 0.0176243 0.030731 0.016578 0.0156387 0.018917 0.0396747 0.0729194 0.04521 0.0534286 0.0556082 0.0183044 0.00929299 0.00899554 0.0242469 0.00981024 0.00394643 0.00581052 0.0102344 0.0028766 0.00572762 0.0105388 0.00304902 0.00668113 0.012069 0.00297482 0.00699372 0.0168394 0.00348155 0.00756227 0.0160165 0.00369219 0.00945027 0.0355016 0.0104866 0.0252022 0.014484 0.00409801 0.00573439 0.0164169 0.0700886 0.0678704	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0248981 0.0346157 0.0433114 0.0198523 0.00771894 0.00976086 0.00719321 0.0101684 0.00825956 0.00909335 0.00935171 0.0174702 0.0304877 0.0164378 0.0154928 0.018726 0.0392531 0.0724097 0.0444059 0.0523608 0.0541908 0.0177298 0.00897838 0.00863275 0.0234738 0.00915306 0.00373438 0.00546161 0.00937684 0.00274042 0.00536279 0.00949773 0.00282 0.00602188 0.0103452 0.00269065 0.00608588 0.0135519 0.00279045 0.00604125 0.0116321 0.00254771 0.00538551 0.0113621 0.00420451 0.0138293 0.0448681 0.00962147 0.017185 0.0430267 0.0623374 0.074053	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG1 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0267107 0.037088 0.0465069 0.0213007 0.00823067 0.0103573 0.00759861 0.0106649 0.00847846 0.00917041 0.00920934 0.0170074 0.0298944 0.0157456 0.0144142 0.0173704 0.0346914 0.0628151 0.0294628 0.0344491 0.0333343 0.00934545 0.00453746 0.00482037 0.0130979 0.0260456 0.0126526 0.0621761 0.0777165 0.0145324 0.0217916 0.00936909 0.00383222 0.0067619 0.00915255 0.00305773 0.00664319 0.0115346 0.00283121 0.0058658 0.00891455 0.00253391 0.00501423 0.00825066 0.00270449 0.00695705 0.0102254 0.00238895 0.00356789 0.014358 0.0715948 0.0732249	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG2 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.026154 0.0363257 0.0455153 0.0208348 0.00805693 0.0101521 0.00745411 0.0104775 0.00836825 0.00908133 0.00916992 0.0170187 0.029825 0.0158814 0.014601 0.0176558 0.0355044 0.0647397 0.0319996 0.0370652 0.0339833 0.00916859 0.00423342 0.00431984 0.0119452 0.0251878 0.010825 0.0506496 0.0285907 0.00824964 0.0156362 0.0588392 0.0111993 0.0200634 0.00862349 0.00338152 0.00723946 0.0125111 0.00310209 0.00636922 0.00936962 0.00263493 0.00514922 0.00843892 0.00275205 0.00705827 0.0103702 0.00238315 0.00356002 0.0143259 0.071328 0.0726307	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG2 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0255969 0.0355442 0.0445398 0.020398 0.00788955 0.00994102 0.00729627 0.0102539 0.0081929 0.00889275 0.00898887 0.0166786 0.0292444 0.0155599 0.0143431 0.0173521 0.034866 0.0632717 0.0308394 0.0357698 0.0327095 0.0087514 0.00400772 0.00412633 0.0116914 0.0243651 0.0101132 0.0465077 0.0231454 0.00651335 0.00984995 0.0198482 0.00630591 0.0150753 0.0591947 0.0106953 0.020131 0.0124381 0.00387721 0.00765771 0.0111243 0.00299445 0.00579722 0.0095359 0.00302847 0.00753128 0.0111312 0.00251769 0.00375573 0.0148626 0.0728095 0.0724481	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG2 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0260584 0.0361871 0.0453497 0.0207768 0.00803947 0.0101343 0.00743765 0.0104603 0.00836505 0.00908355 0.00918868 0.0170618 0.0299533 0.0159429 0.0147488 0.0178416 0.0359024 0.0650969 0.0317645 0.0369211 0.0332733 0.00875187 0.00395255 0.00401564 0.0114518 0.0231174 0.00924154 0.0419963 0.0186248 0.00539594 0.00856822 0.0155069 0.00462784 0.00980653 0.0196679 0.00489386 0.0135402 0.0557965 0.0109179 0.0199948 0.00974146 0.00336828 0.00643612 0.0102655 0.00323364 0.00788976 0.0114932 0.00259933 0.00385234 0.0151125 0.0733044 0.0732474	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0262811 0.0364949 0.0457345 0.0209544 0.00810903 0.0102225 0.0075019 0.0105513 0.00843983 0.00916602 0.00927421 0.0172222 0.0302425 0.0160925 0.0149047 0.0180332 0.0363057 0.0656897 0.031963 0.0371964 0.0333635 0.00871796 0.00392026 0.00397838 0.0114049 0.022796 0.00899512 0.0408219 0.0170968 0.00499993 0.00776997 0.0130788 0.00383058 0.00819849 0.0152662 0.00357473 0.00850004 0.0207334 0.00466452 0.0113898 0.0470845 0.010253 0.0198185 0.0101466 0.00408018 0.00911032 0.0129523 0.00297371 0.00428587 0.0162407 0.0752117 0.0743613	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0268302 0.0372602 0.0466921 0.0213922 0.00827935 0.0104389 0.00766198 0.0107788 0.00862694 0.00937263 0.00949041 0.0176316 0.0309445 0.016497 0.0152881 0.0185033 0.0372731 0.0675405 0.0329795 0.0382315 0.0339999 0.00882835 0.00393441 0.00394916 0.0113624 0.0224169 0.00877743 0.0398344 0.0161711 0.004794 0.00732758 0.0118986 0.00348188 0.00723227 0.0128242 0.00315003 0.00736253 0.0175539 0.0036545 0.00789152 0.0167091 0.00382734 0.00978504 0.0372823 0.0108675 0.0260881 0.0149254 0.00421793 0.00592185 0.0170572 0.0737743 0.0713862	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0266096 0.0369584 0.0463193 0.0212287 0.00821964 0.0103682 0.00761036 0.0107152 0.00858095 0.00932242 0.00943962 0.0175505 0.0308264 0.016442 0.0152691 0.0184814 0.0372842 0.0676013 0.0330403 0.0380086 0.0335061 0.00860739 0.00378734 0.00374103 0.010739 0.0209164 0.00808196 0.0370542 0.0144183 0.00444867 0.00674002 0.01057 0.00319579 0.00650333 0.0109653 0.0028489 0.00640274 0.0140221 0.00292339 0.0063082 0.0121063 0.00264993 0.00559408 0.0118652 0.00440501 0.0144222 0.0470962 0.00999362 0.0179487 0.0449702 0.0652909 0.0780011	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG1 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0267673 0.037117 0.0465044 0.0213388 0.00826166 0.0103802 0.00759099 0.0106242 0.0084735 0.00917531 0.00925793 0.0171587 0.0301408 0.015943 0.0147893 0.0178014 0.0351994 0.0608669 0.0271268 0.0304258 0.0248135 0.00623525 0.0029483 0.00239436 0.00527246 0.0065551 0.0045579 0.015843 0.0424041 0.0145671 0.0635528 0.0694231 0.0146312 0.0231309 0.00951081 0.00369103 0.00753898 0.0125221 0.0031781 0.00648803 0.00948366 0.00269807 0.00525399 0.00858049 0.00282825 0.00720929 0.0105991 0.00246871 0.00367436 0.0146975 0.073255 0.0750501	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG2 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0252761 0.03506 0.0439115 0.0201444 0.00780349 0.00981409 0.00718373 0.0100681 0.00805602 0.00875007 0.00887458 0.0165035 0.0289144 0.0154549 0.0143742 0.0173609 0.0343835 0.0598188 0.0276281 0.0308211 0.0243516 0.00596171 0.0027263 0.00215694 0.00485201 0.00590619 0.00407395 0.0147983 0.0440363 0.0134447 0.0554216 0.0294028 0.00917804 0.0177418 0.0660043 0.0109347 0.0205606 0.0122554 0.00383561 0.0074968 0.0107978 0.00292472 0.0056898 0.00932021 0.0029769 0.00742025 0.0109555 0.00249878 0.00371865 0.0147115 0.071873 0.0717719	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG0 (n=21) , DRUG2 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0254771 0.0353372 0.0442682 0.0203193 0.00787404 0.0099057 0.0072502 0.0101667 0.00814012 0.00884601 0.008981 0.0167022 0.0292769 0.0156659 0.0146161 0.017662 0.034962 0.0607576 0.0279135 0.0311573 0.0243678 0.00591268 0.00269148 0.00212284 0.00480188 0.00574201 0.00393587 0.0146325 0.0441977 0.0128212 0.0527856 0.0243528 0.00743618 0.0114406 0.0225095 0.00539673 0.0144115 0.0575939 0.0107093 0.0192099 0.00942241 0.00326128 0.00627234 0.010024 0.0031618 0.0077751 0.0113347 0.00257275 0.00380418 0.0149442 0.0725033 0.0725727	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0257386 0.035698 0.0447223 0.020531 0.00795688 0.0100106 0.00732648 0.0102749 0.00822857 0.00894409 0.0090837 0.0168923 0.0296142 0.0158481 0.014807 0.0178981 0.0354382 0.0614989 0.0281428 0.0314363 0.0244713 0.00591519 0.00269127 0.00212398 0.00484194 0.00573286 0.00391954 0.0146478 0.0440674 0.0124381 0.0503659 0.0208022 0.00617132 0.00969822 0.0174363 0.00400966 0.00905637 0.0215473 0.00486467 0.0116482 0.0477315 0.00989327 0.0188368 0.00980847 0.00396802 0.00896804 0.0128146 0.00293826 0.00423377 0.016097 0.0744813 0.0736887	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0263747 0.0365835 0.0458304 0.0210387 0.00815451 0.0102618 0.00751205 0.0105387 0.00844523 0.00918416 0.00933595 0.0173703 0.0304446 0.0163206 0.0152591 0.0184537 0.0365638 0.0635831 0.0292271 0.0326076 0.0251676 0.00603679 0.00273524 0.00214613 0.00488579 0.00574596 0.003902 0.0145578 0.043586 0.0119911 0.0481555 0.0186997 0.00557252 0.008595 0.0144983 0.00353262 0.00788136 0.0181139 0.00383267 0.00808396 0.0170846 0.00384957 0.00985887 0.037777 0.0106878 0.0252385 0.0146085 0.0041463 0.00582438 0.0168419 0.0728757 0.0703973	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0262312 0.0363876 0.0455863 0.0209285 0.00811386 0.0102141 0.00747861 0.0104976 0.00841689 0.00915479 0.00931012 0.0173333 0.0303852 0.0163024 0.015262 0.0184628 0.0366296 0.0637703 0.0293501 0.0324757 0.0249032 0.00592556 0.00267187 0.00208413 0.00472452 0.00551295 0.00367333 0.0136525 0.0406911 0.010902 0.0441672 0.0161962 0.00500886 0.00764049 0.0121931 0.00317503 0.00679702 0.0142103 0.00302639 0.00643645 0.0123381 0.00266998 0.0056424 0.01207 0.0045001 0.0145985 0.048034 0.00999739 0.0178155 0.0445519 0.0648701 0.0770288	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG1 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.025964 0.0359851 0.0450435 0.0206856 0.00802348 0.0100771 0.00736533 0.0102989 0.00823996 0.00894233 0.00906878 0.0168781 0.0296126 0.0157712 0.0147314 0.0177772 0.035056 0.0595907 0.0264228 0.0287601 0.0208235 0.00480624 0.00221195 0.00175071 0.00356905 0.00435118 0.0019993 0.00581529 0.0105368 0.00493175 0.0155382 0.0427979 0.0160207 0.0759298 0.07212 0.0128873 0.0226241 0.0134307 0.0041716 0.00800133 0.0110773 0.00305641 0.00591321 0.0095296 0.00307643 0.00761849 0.0112001 0.00259144 0.00383238 0.0151421 0.0739523 0.074399	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG1 (n=21) , DRUG2 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0252408 0.0349941 0.0437988 0.0201135 0.00780467 0.00981137 0.00717576 0.0100483 0.0080565 0.00876045 0.00891046 0.0166203 0.0291394 0.0156193 0.0146242 0.0176757 0.0349002 0.0596739 0.027201 0.02971 0.0210769 0.00476814 0.00214769 0.00167294 0.00345541 0.00420882 0.00189342 0.00560339 0.0101319 0.00473331 0.0154609 0.0462645 0.0157521 0.0662978 0.0315525 0.0071991 0.0164084 0.0637675 0.010974 0.019452 0.00957223 0.00329941 0.00632653 0.0099525 0.00316324 0.00779859 0.0113121 0.00258084 0.00379576 0.0149376 0.0722411 0.0723206	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG1 (n=21) , DRUG0 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0252712 0.0350328 0.0438531 0.0201461 0.0078185 0.00982853 0.00718718 0.010065 0.008071 0.008778 0.0089313 0.0166524 0.0291876 0.015658 0.0146805 0.0177537 0.0350245 0.0597934 0.0270436 0.029519 0.0209168 0.00474647 0.00213713 0.00167032 0.00347491 0.00418171 0.00186947 0.00553336 0.00988184 0.00463507 0.0155016 0.0463892 0.0155882 0.0643387 0.0267166 0.00576175 0.0106198 0.0242073 0.00549474 0.0125315 0.0493941 0.00969885 0.0182563 0.00969863 0.00393472 0.00895233 0.0128141 0.00292991 0.00420735 0.0160482 0.0742239 0.0733499	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG1 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0260209 0.036076 0.0451601 0.020748 0.00805337 0.0101271 0.00740746 0.0103789 0.00832972 0.0090664 0.00923582 0.0172303 0.0301889 0.0162392 0.0152434 0.018447 0.0364035 0.0623057 0.0283662 0.0309987 0.0217597 0.00489427 0.00218903 0.00170178 0.00354205 0.00424309 0.00189044 0.00559603 0.0098961 0.00459106 0.0154038 0.0455016 0.0146036 0.0593454 0.0221801 0.00501468 0.00933355 0.0200001 0.00435802 0.0086902 0.0177449 0.00397851 0.0100657 0.0386117 0.010575 0.0245995 0.0145274 0.00411993 0.00579067 0.0167994 0.0725679 0.0698579	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG1 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0259514 0.035982 0.0450439 0.0206952 0.00803449 0.0101061 0.00739407 0.0103647 0.00832429 0.00906449 0.00924311 0.0172547 0.0302118 0.0162903 0.0153056 0.0185335 0.0365912 0.0627203 0.0286404 0.0310219 0.0216734 0.0048459 0.00215566 0.00166869 0.00346365 0.00413025 0.00184029 0.00541402 0.0094347 0.00427392 0.0143603 0.0420881 0.0129764 0.0531891 0.018245 0.00446055 0.00794144 0.0150923 0.00337638 0.00686913 0.0125808 0.00273623 0.00575522 0.0123045 0.00469125 0.0149005 0.0494989 0.0100963 0.0178134 0.0442632 0.0647224 0.0763647	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG1 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0267914 0.0371174 0.0464572 0.0213614 0.00829558 0.0104163 0.00761265 0.0106439 0.00853726 0.00928947 0.00946729 0.0176358 0.0308167 0.0166003 0.0155713 0.0188535 0.0369741 0.0623443 0.0276765 0.0296239 0.0204365 0.00468639 0.00210645 0.00166061 0.00326577 0.00379613 0.00177216 0.0048669 0.00768785 0.00237363 0.00587972 0.00980921 0.00496883 0.0175692 0.0437907 0.0137186 0.0553389 0.0807693 0.0131676 0.0214666 0.0105112 0.00362386 0.00680495 0.010312 0.00337902 0.00821071 0.0117964 0.00276743 0.00402731 0.0156951 0.075153 0.0765016	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG1 (n=79) , DRUG2 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0262613 0.0363875 0.0455315 0.0209242 0.00812646 0.0102089 0.00746528 0.0104433 0.00839001 0.00914509 0.00934644 0.0174447 0.0304457 0.0164878 0.0154827 0.0187577 0.0368412 0.0623895 0.0283261 0.0303824 0.020548 0.00462297 0.00204582 0.0015928 0.00315365 0.00370669 0.00170676 0.00473392 0.00753751 0.00228308 0.00569816 0.00956429 0.00477383 0.017021 0.0453743 0.012808 0.0482581 0.0348765 0.0080141 0.0149157 0.0550964 0.00997092 0.0188602 0.00994771 0.00410097 0.00926766 0.0133115 0.00308885 0.00441037 0.0167653 0.0768242 0.0763329	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG1 (n=79) , DRUG0 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0269038 0.0372792 0.0466471 0.0214373 0.00832654 0.0104623 0.0076511 0.0107063 0.00860461 0.00938171 0.00959269 0.0179092 0.0312622 0.0169416 0.015923 0.0192957 0.0379318 0.0643554 0.0291894 0.0313126 0.0210148 0.00469344 0.00207749 0.00161494 0.00319391 0.00374645 0.00172712 0.00476252 0.00755961 0.00229352 0.00567719 0.00943678 0.00470177 0.0168211 0.0447917 0.0118388 0.0430481 0.0293046 0.00685265 0.0104381 0.0196848 0.00443289 0.011208 0.0413762 0.0107786 0.0247545 0.0148259 0.00428429 0.00602352 0.0175674 0.0755823 0.0727733	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG1 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0267446 0.0370595 0.0463703 0.0213071 0.00827663 0.0104013 0.00760746 0.0106471 0.00856028 0.00933429 0.00954883 0.0178372 0.0311303 0.0168831 0.015877 0.01924 0.0378672 0.0643305 0.0291602 0.031007 0.020711 0.00460023 0.0020383 0.00158146 0.00311716 0.00365658 0.00169295 0.00463291 0.00735162 0.00223823 0.00547824 0.00897107 0.0043624 0.0155848 0.0414973 0.0103134 0.0365552 0.0215207 0.00523662 0.00841557 0.0137516 0.00309282 0.00637651 0.0131019 0.00521292 0.0161455 0.0528091 0.0106139 0.0185155 0.0457893 0.0672914 0.0785538	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG1 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0262012 0.0362729 0.0453784 0.0208632 0.00810421 0.0101638 0.00742276 0.0103571 0.00830366 0.00903546 0.00921261 0.0171478 0.02994 0.0161024 0.0151233 0.0183024 0.0358605 0.0596647 0.0258822 0.0275011 0.01833 0.00421489 0.00191457 0.00153712 0.00294539 0.00337715 0.00161842 0.00423197 0.00637105 0.00217784 0.00498109 0.00716201 0.00250297 0.00669338 0.0111956 0.00524048 0.0190652 0.0518586 0.016818 0.0714451 0.0699998 0.0128045 0.0218352 0.0109451 0.00450315 0.00963865 0.0134662 0.00322056 0.00450085 0.0168882 0.0756985 0.0759792	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG1 (n=70) , DRUG2 (n=177) , DRUG0 (n=35) , and DRUG0 (n=15) .
4	4	0.0260747 0.0361074 0.0451622 0.0207554 0.00806348 0.0101193 0.00739449 0.0103273 0.00829156 0.00903567 0.00923294 0.0172201 0.030051 0.0162469 0.0152707 0.018493 0.0362868 0.0608178 0.0269019 0.0286844 0.0187474 0.00421091 0.00188247 0.00149086 0.00287026 0.00333107 0.00156891 0.00413672 0.00630609 0.00210187 0.00486548 0.00702993 0.00242312 0.0065725 0.0109917 0.00506542 0.0186249 0.0544594 0.0163542 0.0614459 0.0297291 0.00695672 0.014502 0.0508569 0.0114405 0.0253681 0.0146221 0.00430035 0.00598706 0.0174077 0.0731918 0.0706216	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG1 (n=70) , DRUG0 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0260354 0.0360548 0.0450947 0.0207213 0.00805107 0.0101061 0.00738684 0.0103196 0.00829171 0.0090407 0.00925018 0.0172667 0.0301054 0.0163196 0.0153471 0.0185956 0.0365159 0.0613546 0.0272086 0.0287245 0.0186489 0.00415607 0.00185088 0.00145964 0.00280724 0.00326209 0.00153755 0.00404341 0.0061652 0.00205028 0.00472925 0.0067778 0.00233571 0.00625984 0.0101502 0.00446297 0.0167309 0.0500159 0.0138684 0.0510565 0.0203539 0.0051624 0.00823919 0.0151552 0.00640553 0.0176674 0.0575709 0.0115686 0.0187569 0.0453004 0.0646535 0.0750071	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG1 (n=70) , DRUG0 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0274445 0.0379968 0.0475121 0.0218473 0.00849374 0.0106567 0.007788 0.0108744 0.00874513 0.00955051 0.00979276 0.0182936 0.031825 0.0173585 0.0163267 0.0198036 0.0387801 0.0648284 0.0288332 0.0301851 0.0190219 0.00423386 0.00187221 0.00148816 0.0027769 0.00322684 0.00153635 0.00391014 0.00580693 0.00195969 0.00431187 0.00590269 0.00220513 0.00534733 0.00741761 0.00233094 0.00642222 0.0125529 0.00469122 0.0156752 0.0436734 0.0139145 0.0542155 0.0674388 0.0145385 0.029383 0.0162445 0.00478587 0.00653734 0.0190495 0.0764464 0.0741466	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG1 (n=177) , DRUG2 (n=35) , and DRUG0 (n=15) .
4	4	0.0271963 0.0376614 0.047078 0.0216306 0.00840962 0.0105566 0.0077195 0.0107849 0.0086837 0.00949271 0.0097501 0.0182534 0.0317415 0.0173607 0.0163386 0.0198076 0.0388887 0.0653641 0.0295778 0.0308262 0.0191363 0.00414902 0.00181697 0.00142419 0.00264808 0.00313839 0.00147258 0.00375266 0.00570639 0.00187432 0.00414158 0.00580407 0.00212392 0.00518636 0.00728889 0.00225298 0.00622012 0.012013 0.00414222 0.0134895 0.0394832 0.0103339 0.0392951 0.0231614 0.00922308 0.0205767 0.0645292 0.0131032 0.0196259 0.0472059 0.0643328 0.0742262	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG1 (n=177) , DRUG0 (n=35) , and DRUG2 (n=15) .
4	4	0.0256111 0.0354444 0.0442975 0.0203588 0.00791557 0.00992184 0.00724391 0.0100995 0.00809899 0.00881691 0.00899482 0.0167878 0.0292986 0.0158147 0.0148787 0.018 0.0353528 0.0585753 0.0246166 0.0251373 0.0156037 0.00350899 0.00160636 0.00129963 0.00236032 0.00270871 0.00133592 0.00324851 0.0047268 0.00167758 0.00353927 0.00467209 0.00183128 0.00412519 0.00544148 0.0019492 0.00488292 0.00860243 0.0022827 0.00578222 0.0101807 0.00448153 0.0154197 0.0459549 0.0175531 0.0773267 0.0766703 0.0227179 0.0272939 0.0572078 0.0646416 0.0741015	Population PK analysis with a database of 625 patients showed that the pharmacokinetics of DRUG0 were not influenced by commonly prescribed medications such as DRUG0 (n=77) , DRUG0 (n=72) , DRUG0 (n=75) , DRUG0 (n=21) , DRUG0 (n=79) , DRUG0 (n=70) , DRUG0 (n=177) , DRUG1 (n=35) , and DRUG2 (n=15) .
4	4	0.068639 0.0604163 0.0510476 0.0326789 0.102199 0.0464574 0.0395889 0.10753 0.0601387 0.0515833 0.0209805 0.0415589 0.0232776 0.0329549 0.0352615 0.0134677 0.0272318 0.0214423 0.0113341 0.0103901 0.0188584 0.0297151 0.0932489	Use with DRUG1 : Because of their mechanism of action , DRUG2 have the potential to interfere with the activity of DRUG0 .
4	4	0.0621006 0.0532662 0.046683 0.0249397 0.0753128 0.021087 0.0194659 0.0544162 0.0133167 0.0101346 0.00592736 0.0181727 0.0255773 0.0652419 0.0544373 0.0250591 0.0459298 0.0480723 0.0389307 0.0276063 0.0829467 0.0808582 0.100517	Use with DRUG1 : Because of their mechanism of action , DRUG0 have the potential to interfere with the activity of DRUG2 .
2	0	0.0246647 0.0195453 0.0126474 0.0187901 0.0498717 0.0234478 0.0251083 0.0867177 0.0475764 0.0410945 0.0195329 0.0767764 0.0286706 0.0496237 0.0374999 0.0293457 0.0592879 0.0394082 0.0468472 0.0287427 0.0872568 0.0761789 0.0713653	Use with DRUG0 : Because of their mechanism of action , DRUG1 have the potential to interfere with the activity of DRUG2 .
4	4	0.0946511 0.087722 0.10037 0.0200961 0.0596338 0.0564841 0.0307809 0.0419044 0.0978439 0.0429996 0.0321135 0.016939 0.022572 0.0187364 0.0230373 0.0124028 0.0143697 0.023978 0.015716 0.0107302 0.00503695 0.0108966 0.0103051 0.00465467 0.00864539 0.00501826 0.00649569 0.0257198 0.100146	Use with DRUG1 and Other DRUG2 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG0 or DRUG0 such as DRUG0 .
4	4	0.0699829 0.0611752 0.047312 0.00578837 0.00982538 0.00797325 0.0143604 0.0457052 0.103979 0.0592154 0.0514926 0.0373804 0.052618 0.0608136 0.039985 0.0314923 0.04313 0.0671492 0.0302665 0.012476 0.00493091 0.0105871 0.00884849 0.00378922 0.00685822 0.00396843 0.00510917 0.0210625 0.0827252	Use with DRUG1 and Other DRUG0 : A synergistic effect may be expected when DRUG2 are given concurrently with DRUG0 , similar DRUG0 or DRUG0 such as DRUG0 .
4	4	0.0781067 0.0676727 0.050781 0.00607696 0.00859508 0.00742904 0.0113381 0.0322092 0.0852882 0.0479632 0.0434502 0.0251441 0.029272 0.0342215 0.0388651 0.0382516 0.0573918 0.0922509 0.0798333 0.0294833 0.00652473 0.0102316 0.00589739 0.00347712 0.00545913 0.00473229 0.00490237 0.0190654 0.0760858	Use with DRUG1 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG2 , similar DRUG0 or DRUG0 such as DRUG0 .
4	4	0.0952677 0.0822922 0.0628056 0.00741905 0.0107681 0.00886053 0.0134194 0.0364973 0.0903849 0.0482878 0.0381066 0.0205625 0.0256751 0.0253475 0.0361936 0.0260761 0.0325536 0.0535543 0.0386595 0.0165259 0.0248745 0.033186 0.0280009 0.00948294 0.00786767 0.0065975 0.00626183 0.0234987 0.0909728	Use with DRUG1 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG2 or DRUG0 such as DRUG0 .
4	4	0.0928483 0.0803119 0.0604879 0.00717723 0.0104307 0.0086468 0.013277 0.0363441 0.0909204 0.0495583 0.0410975 0.0222672 0.0268198 0.0292595 0.0401931 0.0340054 0.0421009 0.0679317 0.0429482 0.0136457 0.0119447 0.0176099 0.0142044 0.00895671 0.019312 0.00721352 0.00687597 0.0223397 0.0812714	Use with DRUG1 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG0 or DRUG2 such as DRUG0 .
4	4	0.0919388 0.0794722 0.0597758 0.00711265 0.0104113 0.0086061 0.0133012 0.036519 0.0907325 0.0496757 0.0413239 0.0223507 0.0268642 0.0292694 0.0388225 0.0333196 0.0405297 0.0634374 0.0385704 0.0119601 0.0106876 0.0149804 0.00822363 0.00417723 0.0057673 0.00793024 0.0129588 0.0483 0.0929812	Use with DRUG1 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG0 or DRUG0 such as DRUG2 .
4	4	0.046188 0.0298056 0.0113598 0.00760474 0.0143313 0.0325923 0.0160562 0.0379808 0.101457 0.0544314 0.0484334 0.0275957 0.0317146 0.0368027 0.0420353 0.0411471 0.0614404 0.097981 0.0847771 0.0313964 0.00694595 0.0108824 0.00627111 0.0036982 0.00581258 0.00503565 0.00521464 0.0202489 0.0807601	Use with DRUG0 and Other DRUG1 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG2 , similar DRUG0 or DRUG0 such as DRUG0 .
4	4	0.0579826 0.0368783 0.0141461 0.00932975 0.0181014 0.0401746 0.019323 0.0437596 0.108817 0.055522 0.0432048 0.0230783 0.028466 0.0278304 0.0398984 0.0286807 0.0358166 0.0585487 0.0423296 0.0181017 0.0271457 0.0360478 0.0303627 0.0102904 0.00854943 0.0071519 0.00678567 0.0253861 0.0982909	Use with DRUG0 and Other DRUG1 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG2 or DRUG0 such as DRUG0 .
4	4	0.0561115 0.0356545 0.0136467 0.00896907 0.0173892 0.0389425 0.0190762 0.0434988 0.109299 0.0568313 0.0464436 0.0248923 0.0295938 0.0320514 0.0442377 0.0372988 0.0460707 0.0737244 0.0467744 0.0148729 0.012993 0.0190835 0.0153882 0.00968412 0.0208339 0.00778161 0.00741895 0.0240485 0.0873898	Use with DRUG0 and Other DRUG1 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG0 or DRUG2 such as DRUG0 .
4	4	0.0555611 0.0352513 0.0134921 0.00884725 0.0172336 0.0387356 0.019068 0.0436165 0.108863 0.0568614 0.0466193 0.0249473 0.0295894 0.0320276 0.042654 0.0364885 0.0442728 0.0687338 0.0419495 0.0130209 0.0115989 0.0162019 0.00888739 0.0045161 0.00623258 0.00854062 0.0139488 0.0519896 0.100251	Use with DRUG0 and Other DRUG1 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG0 or DRUG0 such as DRUG2 .
2	2	0.018906 0.0126293 0.00668202 0.00342201 0.00447537 0.00909084 0.013795 0.0390671 0.109116 0.0643688 0.0689993 0.0529772 0.0759749 0.055951 0.078474 0.0467609 0.0434036 0.064594 0.0587476 0.0235671 0.00808855 0.0155417 0.00830166 0.00440586 0.00603826 0.00550088 0.00536815 0.0202707 0.0754816	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG1 are given concurrently with DRUG2 , similar DRUG0 or DRUG0 such as DRUG0 .
2	2	0.018745 0.0122546 0.00614457 0.00325227 0.00374011 0.00775825 0.0109476 0.031319 0.0920114 0.0461176 0.0475183 0.0459882 0.061974 0.0531111 0.0662359 0.0499511 0.0492875 0.0669502 0.0637263 0.0304128 0.0243225 0.041692 0.0309265 0.0112418 0.00923689 0.00742246 0.00675307 0.0222117 0.0787474	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG1 are given concurrently with DRUG0 , similar DRUG2 or DRUG0 such as DRUG0 .
2	2	0.0188251 0.0125839 0.00658964 0.00338172 0.0042645 0.0087477 0.0128829 0.0356876 0.101206 0.0578673 0.0650459 0.052554 0.0713011 0.0546992 0.0730907 0.0461814 0.0446582 0.0631892 0.0615894 0.0214206 0.0110175 0.0228725 0.0174545 0.00938556 0.0187978 0.00709743 0.00654144 0.0203742 0.070693	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG1 are given concurrently with DRUG0 , similar DRUG0 or DRUG2 such as DRUG0 .
2	2	0.0197 0.0131248 0.0068585 0.00352759 0.00441681 0.00905225 0.0133204 0.0367703 0.10417 0.0585693 0.0642172 0.0517088 0.0693384 0.0535812 0.0722966 0.0448971 0.0432435 0.0609166 0.0568235 0.0200689 0.010128 0.0199065 0.0104676 0.00503779 0.00629911 0.00795204 0.0133152 0.0455124 0.07478	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG1 are given concurrently with DRUG0 , similar DRUG0 or DRUG0 such as DRUG2 .
4	4	0.0175269 0.0113586 0.00584307 0.0032069 0.00318076 0.00688691 0.0086142 0.0232454 0.0789433 0.0453092 0.0396124 0.0252783 0.0306221 0.0396162 0.050264 0.0490164 0.0573493 0.0906301 0.102448 0.078211 0.0214097 0.0566605 0.0306123 0.0105459 0.00766045 0.00671363 0.00595471 0.020874 0.0724052	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG1 , similar DRUG2 or DRUG0 such as DRUG0 .
4	4	0.0176499 0.0114646 0.00588638 0.00324159 0.00323623 0.00704898 0.00893414 0.0244217 0.0826039 0.047771 0.041526 0.0261173 0.0319006 0.0412785 0.0526205 0.0520427 0.0611173 0.0922821 0.0967523 0.0772614 0.0173409 0.0456899 0.0165297 0.00958472 0.019653 0.00748944 0.0066303 0.0211773 0.0707476	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG1 , similar DRUG0 or DRUG2 such as DRUG0 .
4	4	0.0178751 0.0116012 0.00596575 0.00328262 0.00326883 0.00710288 0.00897838 0.0244382 0.0829479 0.0476688 0.0419764 0.0259217 0.0315427 0.0409682 0.0517974 0.0501764 0.0600241 0.0878338 0.0885152 0.0824189 0.0183963 0.0398328 0.00907383 0.00457725 0.00576387 0.00928681 0.0134554 0.0450246 0.0802848	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG1 , similar DRUG0 or DRUG0 such as DRUG2 .
4	4	0.0262339 0.0167013 0.00847281 0.00457997 0.00446866 0.00923232 0.0115465 0.0288485 0.0939583 0.0507414 0.0420482 0.0222806 0.0288021 0.0301302 0.0451243 0.0347159 0.0446961 0.0712977 0.0479845 0.018277 0.0191297 0.0357047 0.032476 0.0153983 0.0119167 0.0277762 0.0275763 0.0724188 0.117463	Use with DRUG0 and Other DRUG0 : A synergistic effect may be expected when DRUG0 are given concurrently with DRUG0 , similar DRUG1 or DRUG0 such as DRUG2 .
2	4	0.0366838 0.0438818 0.0367383 0.0420886 0.0313426 0.0223224 0.0219123 0.0310127 0.0717769 0.0516146 0.0484293 0.0602268 0.0325888 0.0131366 0.0203258 0.00907181 0.0110627 0.019328 0.0215305 0.0270521 0.013686 0.0125151 0.0209749 0.00696016 0.0174695 0.0152908 0.0216912 0.0197493 0.0281774 0.0241277 0.0272208 0.0496116 0.0300752 0.0603239	Co-administration of oral DRUG1 200 mg twice daily increased DRUG2 geometric mean AUC(0-24) and Cmax by 81% after topical application of DRUG0 ointment , 1% on the abraded skin of healthy adult males .
4	3	0.0321493 0.0367211 0.0339916 0.0332251 0.0166455 0.00923866 0.00996942 0.0150455 0.0412363 0.0358385 0.0418079 0.0415238 0.0259916 0.0168077 0.0346941 0.0242662 0.0301167 0.0362274 0.0291498 0.0325258 0.0445036 0.0398831 0.0420565 0.0103349 0.0270484 0.026546 0.0287929 0.0215082 0.0255642 0.0229436 0.0248606 0.0386943 0.0239727 0.0461191	Co-administration of oral DRUG1 200 mg twice daily increased DRUG0 geometric mean AUC(0-24) and Cmax by 81% after topical application of DRUG2 ointment , 1% on the abraded skin of healthy adult males .
1	4	0.0428654 0.0293126 0.0526338 0.0272213 0.0602778 0.050324 0.0876039 0.0224569 0.0313292 0.0467661 0.0394671 0.0229164 0.00644732 0.0174825 0.0418639 0.0276321 0.0313467 0.0311705 0.0678917 0.0533268 0.0586379 0.0323027 0.0151226 0.00473982 0.00403299 0.00658133 0.00954023 0.0299966 0.0487099	Due to low systemic exposure to DRUG1 following topical application in patients , dosage adjustments for DRUG0 are unnecessary when co-administered with CYP3A4 inhibitors , such as DRUG2 .
4	4	0.0339222 0.0188182 0.0358827 0.0124412 0.0244572 0.0153989 0.0234835 0.0416371 0.0352755 0.05757 0.0222783 0.0171134 0.00751083 0.0287118 0.0829429 0.0773609 0.0880065 0.0417164 0.055176 0.0466657 0.0503603 0.0297025 0.0200917 0.00669459 0.00499904 0.00840111 0.0121428 0.0381835 0.0630552	Due to low systemic exposure to DRUG0 following topical application in patients , dosage adjustments for DRUG1 are unnecessary when co-administered with CYP3A4 inhibitors , such as DRUG2 .
4	4	0.0759488 0.0658825 0.0824887 0.0499985 0.0366452 0.0355908 0.035246 0.0271328 0.0209486 0.0184021 0.0269563 0.0297972 0.0310695 0.0349013 0.0356785 0.0468166 0.0843079 0.107238 0.0777374 0.0772136	DRUG1 AND OTHER DRUG2 WILL BE ADDITIVE TO DRUG0 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG0 TO TOXIC LEVELS .
4	2	0.0436509 0.0238963 0.0365598 0.0286615 0.0592042 0.060664 0.0684619 0.0979699 0.0465617 0.0247993 0.0304228 0.0358089 0.0379504 0.0404327 0.04159 0.0423949 0.0706103 0.0873249 0.0624575 0.0605783	DRUG1 AND OTHER DRUG0 WILL BE ADDITIVE TO DRUG2 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG0 TO TOXIC LEVELS .
2	4	0.0423219 0.0195706 0.0263568 0.019911 0.0369622 0.0351201 0.0356491 0.029345 0.0223254 0.0318998 0.0490696 0.0597222 0.0607847 0.0683066 0.0872933 0.0776237 0.0589592 0.0836761 0.0753825 0.07972	DRUG1 AND OTHER DRUG0 WILL BE ADDITIVE TO DRUG0 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG2 TO TOXIC LEVELS .
4	2	0.0262648 0.0495666 0.0737033 0.0922243 0.0477926 0.0420977 0.0564097 0.0715298 0.0393429 0.0221388 0.0288818 0.0344126 0.036579 0.0390182 0.040275 0.0403755 0.0663172 0.0803845 0.0572162 0.0554696	DRUG0 AND OTHER DRUG1 WILL BE ADDITIVE TO DRUG2 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG0 TO TOXIC LEVELS .
4	4	0.0276292 0.0490868 0.0869377 0.084135 0.0365385 0.0281641 0.0330992 0.0311177 0.0181669 0.0268324 0.040081 0.0475063 0.0505463 0.0576115 0.0753691 0.0648089 0.0487475 0.0686881 0.0609003 0.0640335	DRUG0 AND OTHER DRUG1 WILL BE ADDITIVE TO DRUG0 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG2 TO TOXIC LEVELS .
4	4	0.0122634 0.0105806 0.0213685 0.0311125 0.0540114 0.0671861 0.0832676 0.0862012 0.0978534 0.0383836 0.0344448 0.0354446 0.0392501 0.0464296 0.0637034 0.0561844 0.0441136 0.0635151 0.0554774 0.0592086	DRUG0 AND OTHER DRUG0 WILL BE ADDITIVE TO DRUG1 AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUG2 TO TOXIC LEVELS .
2	2	0.103859 0.0828765 0.0661015 0.102003 0.102642 0.155736 0.113743 0.0356822 0.0341728 0.0726346 0.130549	DRUG1 given concomitantly with DRUG2 may predispose to systemic bleeding .
2	2	0.106767 0.110748 0.0581014 0.0565212 0.0598121 0.0609493 0.0749408 0.0884005 0.0763836 0.0623058 0.0558474 0.0538666 0.0415732 0.0937829	DRUG1 may enhance the hypoglycemic effect of oral DRUG2 of the sulfonylurea class .
3	3	0.11357 0.113637 0.0506489 0.0365772 0.0511523 0.068408 0.0427499 0.0448396 0.0531461 0.0916555 0.0716948 0.0245077 0.0558226 0.0178698 0.00349972 0.00283606 0.00195719 0.00248178 0.00185393 0.00243103 0.00178581 0.00239377 0.0017507 0.00239182 0.00175208 0.00244247 0.00179597 0.00258482 0.0019754 0.00317985 0.00222005 0.00299207 0.013166 0.0254126 0.0828182	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.126312 0.127934 0.0581914 0.040874 0.0550511 0.0743268 0.0459792 0.0469723 0.0543804 0.0863083 0.0612462 0.0152868 0.0236196 0.00596473 0.00519931 0.010042 0.00207416 0.00231125 0.00177669 0.00231 0.00172989 0.00231283 0.00172281 0.00235218 0.00174895 0.00243817 0.00181525 0.00261594 0.00201189 0.00322437 0.00230799 0.00317301 0.013572 0.0258563 0.0869582	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.128054 0.129343 0.0587431 0.0413818 0.0556857 0.0749679 0.045722 0.0462775 0.053636 0.0847004 0.0589618 0.0138568 0.0194525 0.00449582 0.00241378 0.00403471 0.00467894 0.00982436 0.00201843 0.00235161 0.00180856 0.00238457 0.00177924 0.00241413 0.00179584 0.00249732 0.00185726 0.00267563 0.00205499 0.00330358 0.00235667 0.00325374 0.0141852 0.0269422 0.0900905	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.128298 0.129415 0.0587252 0.0414347 0.0557412 0.0749189 0.0454909 0.0459972 0.053456 0.0845042 0.0581908 0.0132824 0.0183754 0.0042214 0.00219776 0.00313938 0.00223176 0.00400788 0.00475338 0.00991542 0.00201933 0.00241219 0.00184079 0.00245801 0.00182978 0.00252486 0.00187806 0.00269608 0.00206553 0.00332178 0.00236237 0.00326477 0.0143781 0.0272805 0.0913701	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.128258 0.129314 0.0586523 0.0414172 0.0557025 0.0748038 0.0453525 0.045815 0.053319 0.0843017 0.0577582 0.0130243 0.0179378 0.00411839 0.00214994 0.00299231 0.00203689 0.00313874 0.0022495 0.00408891 0.00480114 0.0101364 0.00204608 0.00248834 0.00189287 0.00256371 0.00191117 0.00271604 0.00208067 0.00332777 0.00237069 0.0032781 0.0145017 0.0273591 0.0920949	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.128123 0.129171 0.0585779 0.041389 0.055646 0.0746854 0.0452456 0.0456565 0.0531948 0.0840999 0.0574576 0.0129031 0.0177161 0.00406274 0.0021281 0.00294081 0.00199947 0.00300098 0.00205521 0.00320371 0.00226303 0.00414559 0.00480992 0.0103926 0.00209428 0.00259752 0.0019776 0.00275713 0.00211207 0.00333701 0.00239238 0.00330564 0.0146152 0.0273116 0.0926314	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.127919 0.129001 0.0585062 0.0413594 0.0555834 0.0745712 0.0451509 0.0455067 0.0530856 0.0839339 0.0572477 0.0128606 0.0176046 0.004026 0.00211655 0.0029157 0.00198264 0.00295271 0.00201938 0.00306609 0.00206547 0.00324529 0.00227176 0.0041937 0.00480399 0.0107184 0.00217937 0.00279886 0.00218191 0.00336291 0.00243744 0.00335562 0.0147452 0.027161 0.0930703	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and possibly DRUG0 .
3	3	0.127615 0.128789 0.0584432 0.0413351 0.055517 0.0744746 0.0450583 0.0453637 0.0529928 0.0838214 0.0571049 0.0128844 0.017572 0.00399861 0.0021115 0.00289779 0.00197299 0.00292714 0.00200333 0.00301472 0.00202959 0.00310543 0.00206993 0.00327872 0.00228919 0.00425753 0.00480263 0.0112754 0.00237497 0.00334033 0.00252833 0.00345815 0.0149215 0.0268891 0.0934817	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and possibly DRUG0 .
3	3	0.127296 0.128606 0.0584092 0.0413381 0.0554869 0.0743762 0.0448963 0.045149 0.0529105 0.0838754 0.0571274 0.0130473 0.0178331 0.00399264 0.00211445 0.00287367 0.00196485 0.00289231 0.00198979 0.00296897 0.0020087 0.00303468 0.00202959 0.00312452 0.00208113 0.00332282 0.00234268 0.00434251 0.00471329 0.0132457 0.00292221 0.00361149 0.015279 0.0258748 0.0929189	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and possibly DRUG0 .
3	3	0.115444 0.113834 0.0498362 0.035391 0.0479916 0.0632708 0.038851 0.0384615 0.0442777 0.0666334 0.04337 0.00881504 0.0115897 0.00331689 0.00175055 0.00259725 0.00169076 0.00265574 0.00171513 0.00273344 0.00173459 0.00280282 0.0017656 0.00289107 0.00182615 0.00304212 0.00196385 0.00340012 0.00245709 0.00495032 0.00455729 0.0129778 0.0750913 0.0883449 0.0979694	DRUG1 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0498903 0.134167 0.0634591 0.0274774 0.0359727 0.0335185 0.0335057 0.0280364 0.0455816 0.0905551 0.0654163 0.0247294 0.051635 0.0437222 0.00921078 0.00403451 0.00392879 0.00310093 0.00362584 0.00286509 0.00336131 0.00275195 0.00313854 0.00268706 0.00296169 0.00269249 0.00295348 0.00300456 0.00385633 0.00484328 0.00720348 0.0128854 0.0635863 0.0625444 0.0670967	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0622441 0.172922 0.0784311 0.0336982 0.0427808 0.0404679 0.03759 0.0301421 0.0406577 0.0685244 0.0423413 0.0107741 0.0184056 0.00647471 0.00477056 0.0217606 0.0046518 0.00345314 0.00347864 0.0029804 0.00321409 0.00284543 0.00299952 0.00279867 0.0028558 0.00282733 0.00286148 0.00314687 0.00377337 0.00515851 0.00771336 0.0137142 0.0690672 0.0701317 0.0803431	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0649064 0.18039 0.0809026 0.0345381 0.0433484 0.0403701 0.0364831 0.0281246 0.0360867 0.0598112 0.0365971 0.00851648 0.0132555 0.0042961 0.00233483 0.00510183 0.0049705 0.0227225 0.00479128 0.00366812 0.00369963 0.00322043 0.00345829 0.00309307 0.0032487 0.00308588 0.00318748 0.00338601 0.00410482 0.00549368 0.00831558 0.0146716 0.0731703 0.0727896 0.0838598	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0657614 0.182624 0.0815939 0.034749 0.043458 0.0401926 0.0359407 0.0273781 0.0346228 0.0569278 0.0346553 0.00782516 0.011607 0.00374835 0.00184417 0.00324014 0.00243197 0.00549749 0.00517588 0.0233518 0.00499186 0.00385978 0.00386948 0.00340694 0.00362719 0.00331091 0.00348686 0.0035738 0.00436153 0.00573014 0.00879376 0.015318 0.0753195 0.0731959 0.0845286	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0661605 0.183682 0.0819411 0.0348683 0.0435421 0.0401189 0.0356962 0.0270741 0.0340796 0.0558268 0.0338707 0.00753198 0.0108871 0.00351869 0.00167578 0.00274542 0.001838 0.00340702 0.00257522 0.00570983 0.00521059 0.023633 0.00514919 0.00401904 0.00401084 0.00360121 0.0038341 0.00377298 0.0046398 0.00595401 0.00931101 0.0159057 0.0770222 0.0729325 0.0842545	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0663435 0.184198 0.0821294 0.0349452 0.0436098 0.0400935 0.0355788 0.0269409 0.0338627 0.0553921 0.0335686 0.0073984 0.0105413 0.00341504 0.00160923 0.00254617 0.00165725 0.00286561 0.00189631 0.00353132 0.00265764 0.00578175 0.00519787 0.0237441 0.00530474 0.00421956 0.00422262 0.00406624 0.00498276 0.00621407 0.00995353 0.0165584 0.078866 0.0725669 0.0835401	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0662439 0.183972 0.0820386 0.0349155 0.0435644 0.040009 0.0354396 0.0268175 0.0337111 0.055159 0.0334757 0.00732672 0.0103366 0.00335939 0.00157941 0.0024743 0.00158509 0.00265389 0.00169944 0.0029721 0.00193158 0.00359362 0.00270718 0.00583476 0.00521547 0.0239723 0.00555808 0.00472226 0.00535796 0.00657963 0.010824 0.0174157 0.081613 0.0726441 0.0826972	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , and possibly DRUG2 .
4	4	0.0654686 0.181911 0.0812064 0.0345789 0.0431574 0.039655 0.0350841 0.0265424 0.0334328 0.0548734 0.0335427 0.00729485 0.0102216 0.00332975 0.00156242 0.00246049 0.00154958 0.0025957 0.0016202 0.00277417 0.00172506 0.00305041 0.00195146 0.00366057 0.00274727 0.00599751 0.00544435 0.0253694 0.00658905 0.0072901 0.0116545 0.0184874 0.0867893 0.0740964 0.0822859	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , and possibly DRUG2 .
4	4	0.0617938 0.171643 0.0767953 0.0326172 0.0407362 0.0375637 0.0334474 0.0252377 0.0317929 0.0527384 0.0328709 0.00718898 0.0103716 0.00338335 0.00158009 0.00253011 0.00156567 0.00267348 0.00163193 0.00283407 0.00171212 0.00302268 0.00185412 0.00340759 0.00220866 0.00437713 0.00346328 0.00782756 0.00889937 0.0495308 0.012276 0.0197576 0.0940518 0.0756383 0.0809774	DRUG0 competes with a number of drugs for protein binding sites , notably DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and possibly DRUG2 .
2	0	0.156992 0.166998 0.08774 0.113786 0.0603777 0.0910089 0.0796481 0.0371893 0.00705739 0.00475299 0.00378406 0.00314891 0.0040994 0.00340931 0.00451105 0.00351402 0.00492614 0.00396762 0.00619883 0.00445106 0.0077315 0.0281352 0.116573	DRUG1 may decrease the effectiveness of oral DRUG2 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	0	0.166904 0.17268 0.0962454 0.116049 0.0520278 0.0565328 0.0499277 0.0182973 0.0125612 0.0265299 0.0264847 0.00473041 0.00475699 0.00359612 0.00481259 0.00362495 0.00513622 0.00397563 0.0063802 0.00451811 0.00782044 0.0312241 0.125184	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	0	0.177603 0.179522 0.0988831 0.116794 0.0513616 0.0568353 0.0475206 0.0159943 0.00765417 0.00795649 0.00721741 0.00769856 0.0188694 0.00374573 0.00463797 0.00359533 0.00508921 0.00395423 0.00642365 0.00458363 0.00797821 0.0323046 0.133778	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
2	0	0.176956 0.17779 0.0984478 0.115605 0.0506435 0.0544543 0.0459186 0.0156158 0.00739912 0.00724298 0.00561446 0.00369674 0.00714224 0.00810224 0.0208584 0.00409201 0.00532054 0.00419381 0.00661613 0.00477536 0.00808707 0.0330077 0.138419	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
2	0	0.177128 0.177505 0.098444 0.115321 0.0504997 0.0537486 0.0453277 0.0154203 0.0072565 0.00700602 0.00535948 0.0033754 0.00553504 0.00396982 0.0077584 0.00831955 0.0223353 0.00462751 0.00671922 0.00500466 0.00800086 0.0325898 0.138748	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
2	0	0.17794 0.178078 0.0989599 0.115607 0.0507568 0.0539619 0.0455945 0.0154363 0.00726303 0.00701924 0.00529677 0.00332645 0.00533863 0.0036142 0.0060625 0.00413275 0.00813607 0.00863638 0.0261545 0.00594201 0.00774387 0.0307731 0.134226	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
2	0	0.168045 0.167435 0.0926388 0.106684 0.0459101 0.0503247 0.042572 0.0136678 0.00661545 0.00620374 0.00453137 0.00296126 0.00446255 0.00321205 0.00491586 0.00348461 0.00545794 0.00418055 0.00750445 0.00935661 0.027975 0.085136 0.136725	DRUG1 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0750915 0.109101 0.121024 0.139997 0.0942907 0.0826068 0.0722475 0.0871356 0.0191948 0.0334758 0.018938 0.00402474 0.00367986 0.00273111 0.00341563 0.00272549 0.00361202 0.0029723 0.00443251 0.00342732 0.0059404 0.0214982 0.0884387	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.080897 0.116629 0.125526 0.141262 0.0897083 0.0783835 0.0684294 0.0807162 0.0152983 0.0288765 0.00810714 0.00842047 0.015643 0.00318924 0.00360576 0.0027849 0.00356252 0.00299301 0.00433521 0.00354378 0.00624376 0.0211902 0.0906555	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0799673 0.115227 0.12441 0.140295 0.087952 0.0781718 0.0677592 0.0813308 0.0155287 0.029006 0.00676918 0.00671886 0.00649038 0.00803224 0.0149538 0.00327504 0.00393756 0.00311156 0.00443765 0.00368612 0.00626198 0.021564 0.0911131	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0794805 0.114482 0.123856 0.139622 0.0871542 0.0778049 0.0672201 0.0810145 0.0153056 0.0285499 0.00666306 0.00672961 0.00533478 0.00642619 0.00607658 0.00773815 0.0156743 0.00357849 0.00475235 0.00380837 0.00610338 0.0214697 0.0911558	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0793178 0.114212 0.123616 0.13919 0.0868143 0.077332 0.0667126 0.0802088 0.0151901 0.0284123 0.00663713 0.00692077 0.0052895 0.0066221 0.0050299 0.00594167 0.00594768 0.0078406 0.0183313 0.00457167 0.00600498 0.0202699 0.0895869	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0795109 0.112896 0.122319 0.134903 0.0790712 0.0674568 0.057092 0.0693131 0.0142994 0.0242425 0.00613159 0.00680306 0.00468148 0.00656998 0.00451715 0.00608455 0.00464851 0.00647171 0.00658988 0.0120899 0.0187406 0.0625452 0.0930221	DRUG0 may decrease the effectiveness of oral DRUG1 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0754625 0.100602 0.103854 0.102227 0.0548686 0.0256105 0.0179538 0.0101316 0.00445999 0.00492599 0.00484905 0.00285895 0.00544372 0.00376211 0.0077831 0.00618157 0.0146268 0.0185067 0.100651 0.0277197 0.0346971 0.108588 0.164236	DRUG0 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0367515 0.0108387 0.0220557 0.0229538 0.0159265 0.0296573 0.0355478 0.020512 0.0180543 0.0204868 0.0190719 0.0197377 0.0256582 0.0124263 0.00371963 0.00801895 0.00605617 0.0258661 0.0157104 0.0112042 0.0172614 0.0109509 0.00490593 0.0176932 0.0204185 0.0287458 0.04379 0.0354601 0.0320475 0.0500701 0.059226 0.059556 0.0512495 0.0350978 0.0473119 0.0351221 0.0708392	DRUG1 : There was a slight increase in the area under the curve (AUC , 11%) and mean peak drug concentration (Cmax , 18%) of DRUG0 with the co-administration of 100 mg DRUG2 for 10 days .
3	3	0.00937729 0.00844172 0.0128533 0.0137231 0.0104933 0.0228621 0.0297384 0.0172499 0.0160561 0.017904 0.016446 0.0168811 0.0219824 0.0104903 0.0032191 0.0075075 0.00683127 0.0382352 0.0300204 0.024451 0.0349658 0.0348966 0.0133431 0.0322167 0.0317253 0.0592711 0.0178548 0.0270296 0.0232821 0.0378928 0.0313958 0.0506632 0.0501075 0.0485887 0.0615042 0.0445165 0.0659826	DRUG0 : There was a slight increase in the area under the curve (AUC , 11%) and mean peak drug concentration (Cmax , 18%) of DRUG1 with the co-administration of 100 mg DRUG2 for 10 days .
2	2	0.0374519 0.0360741 0.0319116 0.0193452 0.018083 0.054113 0.0326776 0.0206762 0.00523153 0.00444471 0.0186811 0.00303892 0.00278148 0.00251331 0.00283051 0.00292318 0.00394827 0.00484527 0.00895142 0.0193709 0.0830883 0.0361 0.0263453 0.0345064 0.0235737 0.0284123 0.0287653 0.0459477 0.0301211 0.014875 0.0112617 0.00545545 0.0113387 0.0113737 0.0115874 0.00985809 0.0102969 0.0163877 0.0234632 0.0299296 0.0240937 0.0283636 0.00778021 0.00799053 0.021064 0.0282363 0.059891	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG2 . Therefore , caution should be used when DRUG0 is administered concomitantly with agents that cause vasoconstriction .
4	4	0.0322587 0.0312347 0.0269036 0.0163728 0.0151334 0.0451311 0.0258942 0.0165963 0.00428909 0.00370592 0.0156973 0.00235935 0.00219625 0.00193629 0.0021034 0.00199257 0.00238252 0.00249406 0.00392968 0.00648272 0.036143 0.0176786 0.0113711 0.0172514 0.0116084 0.013971 0.0167317 0.0152649 0.0111852 0.0229432 0.0211484 0.00961951 0.0195999 0.0241627 0.0248212 0.0340578 0.0478316 0.0585625 0.0532719 0.0525406 0.0593244 0.0375514 0.012133 0.0095158 0.0214501 0.0271891 0.0539774	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG0 . Therefore , caution should be used when DRUG2 is administered concomitantly with agents that cause vasoconstriction .
2	2	0.0366172 0.0343737 0.0293613 0.0175543 0.0156612 0.0454598 0.0276867 0.0155654 0.00382744 0.0030413 0.00468717 0.00377705 0.0161574 0.00268306 0.00305927 0.00290884 0.00418181 0.00483528 0.00945567 0.0202996 0.0895348 0.0388426 0.0273273 0.0370828 0.0248471 0.0294999 0.0298441 0.0475973 0.0310223 0.0152977 0.0115271 0.00558712 0.0115836 0.0116175 0.0118426 0.0101003 0.0105617 0.0168177 0.0241684 0.0308889 0.0248918 0.0292909 0.00803557 0.00825263 0.0217563 0.0291578 0.0618305	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG2 . Therefore , caution should be used when DRUG0 is administered concomitantly with agents that cause vasoconstriction .
1	4	0.0318406 0.0298636 0.0249456 0.0148979 0.0131581 0.0374779 0.021907 0.0125915 0.00317094 0.00248334 0.00386522 0.0031463 0.0135218 0.00209895 0.00228983 0.00202037 0.00254876 0.00253789 0.00417065 0.0066599 0.0379221 0.0186542 0.0116634 0.0180704 0.0119354 0.0141291 0.0167347 0.0151358 0.0112319 0.0229417 0.0213127 0.00973243 0.0200198 0.0249992 0.0255916 0.0352027 0.0494782 0.0607071 0.0552527 0.054498 0.0614549 0.0389803 0.01257 0.00986111 0.0222804 0.0282874 0.0561566	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG0 . Therefore , caution should be used when DRUG2 is administered concomitantly with agents that cause vasoconstriction .
2	2	0.0351756 0.0326122 0.0272499 0.0162026 0.0143197 0.0406562 0.0239598 0.0134028 0.00324323 0.0023519 0.00338589 0.0025655 0.00540237 0.00435962 0.0182318 0.00321805 0.00465724 0.00548302 0.0105587 0.0223907 0.0932271 0.0396965 0.0283969 0.0381485 0.0257044 0.0302202 0.0303846 0.048319 0.0313531 0.0153723 0.011609 0.0056306 0.011675 0.0116932 0.0119242 0.0101685 0.0106305 0.0169222 0.0242977 0.0310483 0.0250164 0.0294411 0.00807638 0.00829505 0.0218667 0.0293051 0.0621506	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG2 . Therefore , caution should be used when DRUG0 is administered concomitantly with agents that cause vasoconstriction .
1	4	0.0307936 0.0284945 0.0233401 0.0138496 0.0121261 0.0336233 0.0188969 0.0108 0.00269844 0.00193446 0.00271436 0.00208214 0.00432867 0.00351835 0.0146537 0.00225699 0.002844 0.00285436 0.00460968 0.00737211 0.0406941 0.0191081 0.0121855 0.0187886 0.0123491 0.0145434 0.0170889 0.0154237 0.0114165 0.023142 0.0214591 0.00980768 0.0201811 0.0252501 0.0258482 0.0355371 0.0498995 0.0612249 0.0557328 0.0549719 0.061964 0.0393185 0.0126721 0.00994126 0.0224719 0.0285411 0.0566476	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG0 . Therefore , caution should be used when DRUG2 is administered concomitantly with agents that cause vasoconstriction .
2	2	0.0346297 0.0314555 0.0263647 0.0157201 0.0139375 0.0381328 0.0210703 0.0104102 0.00252551 0.00181196 0.00262733 0.0017257 0.00307177 0.00237948 0.00473121 0.00373148 0.0157915 0.00723229 0.0116738 0.0236726 0.09788 0.0438243 0.0307411 0.0408742 0.0278328 0.0320247 0.0312108 0.0496676 0.0318191 0.0154195 0.0115421 0.00561465 0.0115646 0.0114816 0.0117331 0.0100335 0.0105042 0.0166565 0.0239729 0.03071 0.0247636 0.0291321 0.00799224 0.0082084 0.0216366 0.0289871 0.061477	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG2 . Therefore , caution should be used when DRUG0 is administered concomitantly with agents that cause vasoconstriction .
1	4	0.0314542 0.0285106 0.0235456 0.0140203 0.012125 0.0322022 0.016792 0.00831268 0.00206956 0.00148172 0.00206668 0.00140567 0.00238793 0.00185288 0.00365924 0.00270991 0.00995399 0.00369925 0.00490258 0.00780776 0.0425663 0.0205903 0.0132793 0.020521 0.0135061 0.0156901 0.0178421 0.0161224 0.0117908 0.0238156 0.02198 0.00997218 0.0203729 0.0254088 0.0260487 0.0357158 0.0499733 0.0612399 0.0557764 0.0550624 0.0621055 0.039369 0.0126893 0.00995433 0.0224728 0.0285434 0.0566316	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 or DRUG0 ) may enhance or potentiate the pressor effects of DRUG0 . Therefore , caution should be used when DRUG2 is administered concomitantly with agents that cause vasoconstriction .
2	2	0.0293814 0.0276272 0.0230928 0.0140547 0.0126884 0.0354793 0.021641 0.0126603 0.0029627 0.00206366 0.00282359 0.00199881 0.00351901 0.0027033 0.00495453 0.00436471 0.0108508 0.0154045 0.0726893 0.0212779 0.0928824 0.0418979 0.0302023 0.0416153 0.0291653 0.0321304 0.0304423 0.047152 0.0293559 0.0140858 0.0103828 0.00506694 0.0104918 0.0103444 0.0105918 0.009022 0.00941179 0.0148636 0.021196 0.027016 0.0217808 0.0256572 0.00704321 0.00723222 0.0190605 0.0255418 0.0541298	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG1 ) may enhance or potentiate the pressor effects of DRUG2 . Therefore , caution should be used when DRUG0 is administered concomitantly with agents that cause vasoconstriction .
4	4	0.0285285 0.0266213 0.0219131 0.0132322 0.0117071 0.0315849 0.0178581 0.0102525 0.00248211 0.00170512 0.00231913 0.00163252 0.0028301 0.00213062 0.00391329 0.00325414 0.00858363 0.00988915 0.0417136 0.00904955 0.0450829 0.0184801 0.0125386 0.0188003 0.0125975 0.0153106 0.0171438 0.0155168 0.0114073 0.0222092 0.0205373 0.00936218 0.0191645 0.0242548 0.0251471 0.0340651 0.0469997 0.0573865 0.0525254 0.0518922 0.0585968 0.0370836 0.0119387 0.00937483 0.0211381 0.0269248 0.0533204	The use of drugs that stimulate alpha-adrenergic receptors (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG1 ) may enhance or potentiate the pressor effects of DRUG0 . Therefore , caution should be used when DRUG2 is administered concomitantly with agents that cause vasoconstriction .
4	4	0.107572 0.0392944 0.0354132 0.0258417 0.0338273 0.0235987 0.0325942 0.0392986 0.0334677 0.0419707 0.064298 0.0412248 0.0321255 0.0123261 0.0208736 0.00829968 0.00686231 0.0245465 0.0123528 0.0388116 0.106906 0.10614 0.112355	DRUG1 has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e. , DRUG2 ) , with or without salt supplementation .
4	4	0.0436543 0.0245538 0.0103757 0.00252501 0.00244092 0.00169966 0.00200169 0.00177704 0.00247953 0.00179153 0.00261386 0.00602425 0.0106902 0.0477164 0.0309716 0.0195736 0.0157583 0.0191161 0.0220216 0.0630221 0.0643094 0.0519068 0.0367829 0.0154011 0.0131553 0.0132104 0.0213884 0.00951581 0.00723162 0.0207871 0.00861349 0.00860074 0.0113407 0.0179877 0.0168835 0.00860736 0.0020405 0.0029828 0.00734919 0.00642663 0.00384505 0.0135537 0.00881846 0.0136087 0.018292 0.0135661 0.0146584 0.0228759 0.0120867 0.0196289 0.0185959 0.0150716 0.0117045 0.0147605 0.0246133 0.0101397 0.00952171 0.0137916 0.00548769 0.00340444 0.00342884 0.00196471 0.00127556 0.000885481 0.000671754 0.000902879 0.000635434 0.000970646 0.000657659 0.00104534 0.00068973 0.00112718 0.000741111 0.00125516 0.00088708 0.00166049 0.0010132 0.00183386 0.00740355 0.027597	DRUG1 . DRUG2 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0466577 0.0272529 0.00440056 0.00274458 0.00453248 0.00444137 0.00739364 0.00170307 0.00219259 0.00163569 0.00237409 0.00522711 0.00889477 0.0521907 0.0328178 0.0206344 0.0162605 0.0196623 0.0216331 0.061781 0.0617462 0.0501295 0.0355404 0.0149214 0.0127478 0.0128021 0.0207068 0.00926004 0.00705689 0.0202914 0.00842664 0.00843429 0.0111257 0.0176971 0.0166569 0.00848202 0.00201338 0.00294455 0.00724673 0.00634292 0.00379426 0.0133711 0.0087042 0.0134246 0.0180597 0.013405 0.0144825 0.0226075 0.0119403 0.0193994 0.0183873 0.0148985 0.0115649 0.0145819 0.0243621 0.0100351 0.00942244 0.0136485 0.00543404 0.00337113 0.00339721 0.00194639 0.00126408 0.00087744 0.000665571 0.000894399 0.000629485 0.000961502 0.00065146 0.00103545 0.000683193 0.00111648 0.000734057 0.00124322 0.000878605 0.00164469 0.00100353 0.00181641 0.00733407 0.027325	DRUG1 . DRUG0 , such as DRUG2 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0482702 0.0274304 0.00399278 0.00224776 0.00320094 0.00208543 0.00258911 0.0033035 0.00791128 0.00196654 0.00220881 0.00498974 0.0083525 0.055335 0.0342267 0.0215096 0.0167422 0.0201387 0.0216852 0.0614922 0.0603496 0.0490636 0.034786 0.0146788 0.0126087 0.0126915 0.0204529 0.00917636 0.00699043 0.0200945 0.00836143 0.00838569 0.0110704 0.0176243 0.0166062 0.00845307 0.00200767 0.00293685 0.00722523 0.00632632 0.00378444 0.013337 0.00868373 0.0133907 0.0180192 0.0133789 0.0144536 0.022565 0.0119162 0.0193634 0.0183561 0.0148719 0.0115424 0.0145526 0.0243292 0.0100208 0.00940864 0.0136288 0.00542727 0.00336692 0.00339359 0.00194424 0.00126281 0.000876537 0.000664856 0.000893386 0.000628773 0.000960408 0.000650711 0.00103426 0.000682396 0.00111519 0.000733192 0.00124177 0.00087756 0.00164278 0.00100234 0.00181428 0.00732581 0.0272899	DRUG1 . DRUG0 , such as DRUG0 , DRUG2 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0442675 0.0255488 0.00350877 0.00199303 0.00311633 0.00192078 0.00185287 0.00168993 0.00232797 0.00332509 0.0059091 0.0180139 0.00801534 0.053364 0.0366948 0.0236565 0.0177135 0.0210572 0.0221292 0.0625979 0.0590713 0.0477409 0.0338346 0.0143213 0.0123759 0.0125151 0.0202033 0.00907454 0.00690031 0.0198149 0.00825764 0.00829365 0.010959 0.0174456 0.0164354 0.00836681 0.00198762 0.00290765 0.0071539 0.00626407 0.00374772 0.0132107 0.00860105 0.0132638 0.0178475 0.0132511 0.0143157 0.0223498 0.011803 0.019179 0.0181812 0.0147307 0.0114332 0.014415 0.0240965 0.00992479 0.00931864 0.0134987 0.00537522 0.00333462 0.00336085 0.00192549 0.00125059 0.000868064 0.000658435 0.000884773 0.000622708 0.000951154 0.000644437 0.0010243 0.00067582 0.00110445 0.000726129 0.00122982 0.000869109 0.00162697 0.000992689 0.00179682 0.00725521 0.0270279	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG2 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0195373 0.00693476 0.00194533 0.00132643 0.00179713 0.00138225 0.00160639 0.00146483 0.00192204 0.00162031 0.00247889 0.00474509 0.00851054 0.0522441 0.0304978 0.0224811 0.0191466 0.0247874 0.0208764 0.0542063 0.0537161 0.0464635 0.0333328 0.0139116 0.0112816 0.0114174 0.0177691 0.00792402 0.00609559 0.0179359 0.00742062 0.00776343 0.0100955 0.0170595 0.0162633 0.00950199 0.00262825 0.0058645 0.0163794 0.0149307 0.0138447 0.0458677 0.0386451 0.0309034 0.0219549 0.0196369 0.016095 0.0170314 0.0105282 0.0148359 0.0161261 0.015377 0.0129929 0.0141827 0.0216336 0.00831002 0.0083803 0.0115781 0.00495206 0.00298447 0.00285901 0.00164962 0.00106623 0.000744879 0.000573042 0.000762519 0.000537953 0.000814794 0.000553306 0.000873506 0.000577517 0.000938282 0.000618197 0.0010417 0.000737448 0.00137421 0.000840494 0.00151874 0.00612519 0.022667	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0200593 0.00711958 0.0019972 0.00136171 0.00184452 0.00141839 0.00164849 0.00150267 0.00197117 0.00166009 0.00253943 0.00486274 0.00872106 0.0535246 0.0312356 0.0230192 0.0196089 0.0253549 0.0214051 0.0554808 0.0549925 0.0474659 0.0341023 0.0143829 0.0117933 0.0119174 0.0184853 0.008287 0.00639009 0.0183852 0.00758988 0.00754987 0.0099058 0.0157575 0.014853 0.00754296 0.00179057 0.00262144 0.00645305 0.00565752 0.00337257 0.0118734 0.00775924 0.0120384 0.0164315 0.0123633 0.0136447 0.0219079 0.0122246 0.0201924 0.0208226 0.0177708 0.0142664 0.0181066 0.0310524 0.0153719 0.0175094 0.032695 0.0193465 0.0147127 0.0115222 0.00639336 0.00320783 0.00317856 0.0020728 0.00390561 0.000738743 0.000849765 0.00065703 0.000876662 0.000662665 0.000919964 0.000693698 0.00101585 0.000793176 0.00130417 0.000931717 0.00166377 0.00648299 0.0264081	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0202708 0.00719462 0.00201825 0.00137607 0.00186397 0.00143333 0.00166587 0.0015185 0.00199194 0.00167759 0.00256618 0.00491398 0.00881294 0.0540883 0.0315646 0.0232615 0.0198153 0.0256219 0.0216305 0.0560649 0.0555714 0.0479653 0.0344608 0.0145339 0.0119171 0.0120424 0.018679 0.00837363 0.00645671 0.0185769 0.00766772 0.00762751 0.0100071 0.0159171 0.0150027 0.00761747 0.00180831 0.00264634 0.0065121 0.00570867 0.00340384 0.0119816 0.00783109 0.0121368 0.0165496 0.0124244 0.0136819 0.0219767 0.0122481 0.0202224 0.0207812 0.0177115 0.0141923 0.0180519 0.0311735 0.0154499 0.0176913 0.0325501 0.0187618 0.014035 0.0103205 0.00510547 0.00225451 0.00179316 0.000724784 0.00120705 0.00125764 0.00334645 0.000684949 0.000860134 0.000667113 0.000911548 0.00068803 0.00100601 0.000783114 0.00129092 0.00091731 0.00162199 0.00644985 0.0268117	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0203368 0.00721805 0.00202482 0.00138055 0.00187004 0.001438 0.00167129 0.00152345 0.00199843 0.00168304 0.00257453 0.00492996 0.0088416 0.0542641 0.0316671 0.023337 0.0198796 0.025705 0.0217007 0.0562468 0.0557517 0.0481207 0.0345724 0.014581 0.0119557 0.0120814 0.0187393 0.00840072 0.00647754 0.0186366 0.00769219 0.00765158 0.0100384 0.0159663 0.0150494 0.00764167 0.00181405 0.0026545 0.00653179 0.00572578 0.00341429 0.0120173 0.00785724 0.0121726 0.0165932 0.0124494 0.0137008 0.0220009 0.0122568 0.0202258 0.0207394 0.017649 0.0141235 0.0179717 0.0310895 0.0153819 0.0176162 0.032092 0.0182891 0.0136536 0.00997121 0.00478825 0.0020652 0.00152705 0.000647531 0.000925538 0.000646372 0.00121904 0.00131475 0.00343712 0.00071282 0.000930529 0.000717808 0.0010258 0.000795881 0.00130348 0.000926652 0.00161082 0.00647603 0.02729	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0203696 0.00722969 0.00202809 0.00138278 0.00187305 0.00144032 0.00167399 0.0015259 0.00200164 0.00168575 0.00257867 0.00493789 0.00885582 0.0543512 0.0317178 0.0233743 0.0199114 0.0257462 0.0217355 0.0563369 0.055841 0.0481976 0.0346276 0.0146043 0.0119749 0.0121008 0.0187692 0.00841416 0.00648788 0.0186662 0.00770425 0.00766332 0.0100535 0.01599 0.0150723 0.00765361 0.00181689 0.00265842 0.00654114 0.00573426 0.00341925 0.0120345 0.0078704 0.012191 0.0166139 0.0124593 0.013706 0.0220087 0.0122588 0.0202247 0.0207012 0.017598 0.0140677 0.0178994 0.0309851 0.0153282 0.017584 0.0319041 0.0181229 0.0134865 0.00980317 0.00465164 0.00198744 0.00144018 0.000620598 0.000883217 0.000595121 0.000952042 0.00067353 0.00127222 0.00135446 0.00360233 0.000759291 0.00104416 0.000824203 0.00131484 0.000943928 0.00159223 0.00645039 0.0274437	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.020372 0.00723054 0.00202833 0.00138294 0.00187327 0.00144049 0.00167418 0.00152608 0.00200187 0.00168594 0.00257895 0.00493845 0.00885681 0.0543572 0.0317212 0.0233768 0.0199135 0.0257489 0.0217378 0.0563428 0.0558469 0.0482025 0.034631 0.0146058 0.0119763 0.0121021 0.0187711 0.0084151 0.00648858 0.018668 0.00770496 0.00766372 0.0100537 0.0159902 0.0150735 0.00765459 0.00181712 0.00265859 0.00654151 0.00573504 0.00341941 0.0120353 0.00787332 0.0121949 0.0166163 0.0124578 0.0137023 0.022006 0.0122588 0.0202233 0.0206747 0.0175652 0.0140344 0.0178574 0.0309347 0.0153253 0.0176151 0.0319065 0.0181631 0.0135012 0.00977139 0.00460384 0.00196148 0.00141306 0.000610479 0.000866462 0.000582615 0.000917574 0.000618678 0.000995241 0.000692982 0.00131149 0.0013964 0.00389803 0.000859478 0.00132651 0.000989961 0.00158004 0.00639458 0.027456	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0203769 0.00723225 0.00202881 0.00138327 0.00187371 0.00144083 0.00167457 0.00152643 0.00200233 0.00168632 0.00257953 0.00493957 0.0088588 0.0543692 0.0317281 0.0233817 0.0199177 0.0257543 0.0217425 0.0563549 0.055859 0.0482126 0.0346383 0.0146091 0.0119791 0.0121049 0.0187752 0.00841717 0.00649018 0.0186722 0.00770683 0.00766491 0.0100549 0.0159922 0.0150772 0.00765748 0.00181774 0.00265943 0.00654402 0.00573782 0.00342055 0.0120397 0.00788016 0.0122057 0.0166274 0.0124635 0.0137079 0.02202 0.0122712 0.020244 0.0206497 0.0175282 0.0139942 0.0178003 0.0308716 0.0153298 0.0176802 0.0320215 0.0183446 0.0136065 0.00980013 0.00458703 0.00196701 0.00141549 0.000607733 0.000864341 0.000577104 0.000906632 0.000606682 0.000963707 0.000635745 0.00103065 0.000715745 0.00135494 0.00149337 0.00465808 0.00110966 0.00152443 0.00616075 0.0267918	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0200448 0.00711439 0.00199574 0.00136072 0.00184317 0.00141734 0.00164728 0.00150154 0.00196968 0.0016588 0.00253744 0.00485898 0.00871425 0.0534818 0.03121 0.0229997 0.0195923 0.0253335 0.0213873 0.0554342 0.0549468 0.0474249 0.0340724 0.0143708 0.0117842 0.0119079 0.0184691 0.00828051 0.00638492 0.0183682 0.00758237 0.00753966 0.0098902 0.015731 0.0148343 0.00753705 0.00178889 0.00261763 0.00644239 0.00564886 0.00336768 0.0118528 0.00776525 0.0120253 0.016377 0.0122832 0.0135115 0.021696 0.0121083 0.0199963 0.0202554 0.0171279 0.0135744 0.0171699 0.0297556 0.0147415 0.0171928 0.0314377 0.0189651 0.0140109 0.00984784 0.00475237 0.00206524 0.00141831 0.000586344 0.000774329 0.000536855 0.000800186 0.000561368 0.000837762 0.000585062 0.000876135 0.000626204 0.000950881 0.000735936 0.00127628 0.0016423 0.00487495 0.0176334 0.0316793	DRUG1 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0160269 0.0272322 0.0312612 0.00437603 0.00569167 0.00542015 0.00819921 0.00190632 0.00221006 0.00167515 0.00234222 0.00510194 0.00859573 0.0531463 0.0347829 0.0217298 0.0169145 0.0204897 0.0219684 0.0615352 0.0611309 0.0497011 0.0352713 0.0148384 0.0126867 0.0127616 0.0205523 0.00916793 0.0069861 0.0201115 0.00835028 0.00835392 0.0110189 0.0175224 0.016486 0.00839759 0.00199287 0.00291456 0.00717484 0.00627843 0.00375588 0.0132384 0.00861691 0.013291 0.0178773 0.0132676 0.0143349 0.0223741 0.0118186 0.0191999 0.0181967 0.0147455 0.0114475 0.0144342 0.0241065 0.00993068 0.00932507 0.0135073 0.00537744 0.00333599 0.00336139 0.0019259 0.0012507 0.000868164 0.000658563 0.000885004 0.000622881 0.000951398 0.000644632 0.00102457 0.000676038 0.00110476 0.000726374 0.00123017 0.000869415 0.00162743 0.000993029 0.00179735 0.00725705 0.0270407	DRUG0 . DRUG1 , such as DRUG2 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0173562 0.0310808 0.0338872 0.00377346 0.00438811 0.00327481 0.00305491 0.00398627 0.00841817 0.00212553 0.00224802 0.0048309 0.00790139 0.0549548 0.0354237 0.0221676 0.0171756 0.0207649 0.0217827 0.0605035 0.0591691 0.0481995 0.0342527 0.0144965 0.0124719 0.0125858 0.0201916 0.00904295 0.006891 0.0198347 0.00825254 0.00827354 0.0109219 0.0173829 0.0163742 0.00833735 0.00197985 0.00289615 0.00712667 0.00623881 0.00373228 0.0131554 0.00856485 0.0132083 0.0177715 0.0131934 0.0142538 0.0222509 0.0117516 0.0190943 0.0181 0.0146655 0.0113833 0.0143523 0.0239873 0.00988066 0.00927757 0.0134389 0.00535133 0.00331978 0.00334575 0.00191686 0.00124497 0.000864162 0.000655492 0.000880821 0.000619937 0.000946898 0.000641571 0.00101972 0.000672816 0.00109951 0.000722902 0.00122432 0.000865248 0.00161968 0.000988276 0.00178879 0.0072228 0.0269082	DRUG0 . DRUG1 , such as DRUG0 , DRUG2 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0147077 0.0238489 0.0275487 0.00333268 0.00443138 0.00338685 0.00223983 0.00258379 0.00267545 0.00480385 0.00727236 0.0196827 0.00799655 0.0531568 0.0377375 0.0241159 0.0180641 0.0215669 0.0221779 0.0617418 0.0583857 0.0473512 0.0336662 0.0142608 0.0123272 0.0124962 0.0200944 0.00900612 0.00685104 0.0196964 0.00820885 0.00824112 0.0108876 0.0173311 0.0163264 0.00831254 0.00197454 0.00288856 0.00710768 0.0062229 0.00372311 0.0131253 0.00854514 0.0131777 0.0177309 0.0131639 0.014222 0.0222017 0.0117256 0.0190525 0.0180609 0.0146339 0.0113587 0.0143212 0.0239368 0.00985957 0.0092578 0.0134104 0.00534007 0.00331279 0.00333871 0.00191282 0.00124234 0.000862338 0.000654106 0.00087896 0.000618624 0.000944898 0.000640211 0.00101756 0.00067139 0.00109719 0.000721371 0.00122173 0.000863414 0.00161627 0.000986182 0.00178501 0.00720754 0.0268513	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG2 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	2	0.0147306 0.0215289 0.0188869 0.00207778 0.00244871 0.00181137 0.00194521 0.00179413 0.00219155 0.00206318 0.00334826 0.00660914 0.0131383 0.0704396 0.0303146 0.0417566 0.0274239 0.0481694 0.0446583 0.0431018 0.043648 0.0401393 0.0262695 0.012292 0.00972478 0.0114629 0.0199313 0.00915837 0.00679182 0.0193699 0.00805776 0.00818296 0.0108612 0.0173176 0.0163581 0.00828865 0.00197147 0.0028863 0.00709079 0.0062166 0.0037196 0.0130934 0.00853734 0.0131617 0.0177269 0.0131759 0.0142268 0.0222365 0.0117297 0.0190755 0.0180915 0.0146457 0.0113554 0.0143133 0.0239947 0.00987502 0.00926604 0.0134233 0.00534777 0.00331786 0.00334694 0.00191722 0.00124573 0.000864613 0.000655581 0.000880787 0.000619821 0.00094693 0.000641411 0.00101973 0.000672607 0.00109949 0.000722642 0.00122428 0.000864901 0.00161965 0.000987928 0.00178861 0.00722282 0.0268869	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG2 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0126707 0.0183093 0.0162723 0.00173594 0.00209317 0.00156622 0.00166558 0.0015469 0.00184532 0.00172796 0.00260848 0.00460205 0.00801175 0.0483724 0.0267478 0.0209694 0.0188871 0.0250535 0.0205 0.0533814 0.0520668 0.0459925 0.0329657 0.0139185 0.011218 0.0114173 0.0174441 0.00782365 0.00602299 0.0177205 0.00733516 0.00767572 0.00997814 0.0168552 0.0160807 0.0093906 0.00259791 0.00579782 0.0161886 0.0147547 0.0136796 0.045329 0.0381985 0.0305465 0.0216893 0.0193979 0.0159032 0.0168326 0.010404 0.0146638 0.0159404 0.0152002 0.0128435 0.0140198 0.0213899 0.00821668 0.00828633 0.0114481 0.00489677 0.00295117 0.00282717 0.00163125 0.00105437 0.000736592 0.000566663 0.000754026 0.00053196 0.000805716 0.000547141 0.000863771 0.00057108 0.000927823 0.000611305 0.00103008 0.000729224 0.00135889 0.000831121 0.0015018 0.00605692 0.0224139	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0130085 0.0187972 0.0167053 0.00178193 0.00214822 0.00160714 0.00170919 0.00158679 0.0018926 0.00177047 0.0026721 0.00471549 0.00820728 0.0495299 0.0273666 0.0214432 0.0193264 0.0256004 0.0210009 0.0546106 0.0532899 0.0469649 0.0337189 0.0143907 0.0117252 0.0119146 0.0181444 0.0081814 0.00631293 0.0181629 0.00750194 0.00746334 0.00978891 0.0155641 0.0146827 0.0074524 0.00176931 0.00259064 0.00637535 0.00559076 0.0033324 0.0117269 0.00766541 0.0118919 0.0162355 0.0122181 0.0134827 0.0216531 0.0120794 0.0199559 0.0205808 0.0175607 0.0140949 0.017888 0.0306925 0.0151915 0.0173016 0.0323107 0.0191202 0.0145415 0.0113878 0.0063185 0.00317039 0.00314189 0.00204888 0.00386023 0.000730151 0.000839883 0.0006494 0.000866456 0.000654966 0.000909242 0.000685631 0.001004 0.00078394 0.00128895 0.000920861 0.00164438 0.00640768 0.0260974	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.013144 0.018993 0.0168793 0.00180049 0.0021706 0.00162388 0.00172699 0.00160332 0.00191231 0.0017889 0.00269993 0.0047646 0.00829274 0.0500455 0.0276515 0.0216664 0.0195275 0.0258668 0.0212195 0.0551788 0.0538444 0.0474532 0.0340693 0.0145401 0.0118468 0.012038 0.0183322 0.00826591 0.00637796 0.01835 0.00757795 0.00753917 0.00988779 0.0157198 0.0148288 0.00752511 0.00178662 0.00261493 0.00643291 0.00564062 0.00336288 0.0118324 0.00773545 0.0119877 0.0163502 0.0122769 0.0135178 0.0217185 0.0121011 0.0199831 0.0205373 0.0175 0.0140199 0.0178318 0.0308087 0.0152668 0.0174792 0.0321637 0.0185398 0.0138698 0.0101989 0.00504503 0.00222795 0.00177232 0.000716324 0.0011929 0.00124284 0.00330688 0.000676852 0.000849969 0.000659253 0.000900781 0.000679922 0.000994128 0.000773878 0.00127567 0.000906486 0.00160285 0.00637403 0.0264925	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0131863 0.0190542 0.0169336 0.00180629 0.00217759 0.00162911 0.00173255 0.00160847 0.00191846 0.00179465 0.0027086 0.00477992 0.00831939 0.0502062 0.0277402 0.0217358 0.0195901 0.0259498 0.0212875 0.0553557 0.0540171 0.0476051 0.0341783 0.0145866 0.0118847 0.0120766 0.0183907 0.00829232 0.00639829 0.0184083 0.00760184 0.00756267 0.00991831 0.0157678 0.0148744 0.00754872 0.00179223 0.00262289 0.00645211 0.00565731 0.00337308 0.0118671 0.00776098 0.0120225 0.0163927 0.0123012 0.0135359 0.0217416 0.0121093 0.0199857 0.0204951 0.0174376 0.0139514 0.0177518 0.0307245 0.015199 0.0174043 0.0317099 0.018072 0.0134924 0.00985331 0.00473138 0.00204079 0.00150924 0.000639944 0.000914641 0.000638758 0.00120465 0.00129918 0.00339627 0.000704353 0.000919481 0.000709313 0.00101363 0.00078646 0.00128802 0.00091568 0.00159175 0.00639966 0.0269641	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0132073 0.0190846 0.0169606 0.00180917 0.00218106 0.0016317 0.00173531 0.00161103 0.00192152 0.00179751 0.0027129 0.00478751 0.0083326 0.0502858 0.0277841 0.0217702 0.0196211 0.0259908 0.0213212 0.0554433 0.0541025 0.0476803 0.0342322 0.0146096 0.0119036 0.0120957 0.0184197 0.00830543 0.00640837 0.0184371 0.00761361 0.00757413 0.00993305 0.0157909 0.0148968 0.00756036 0.001795 0.00262671 0.00646121 0.00566558 0.00337792 0.011884 0.00777384 0.0120405 0.0164127 0.0123108 0.0135409 0.0217488 0.012111 0.0199842 0.020457 0.0173869 0.013896 0.01768 0.0306208 0.0151457 0.0173721 0.0315236 0.0179075 0.013327 0.00968709 0.00459631 0.00196393 0.00142336 0.000613314 0.0008728 0.000588099 0.000940776 0.000665567 0.00125716 0.00133838 0.00355943 0.000750253 0.00103174 0.000814427 0.00129921 0.000932733 0.00157335 0.0063742 0.0271157	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0132088 0.0190868 0.0169626 0.00180938 0.00218131 0.00163189 0.00173551 0.00161122 0.00192173 0.00179771 0.00271321 0.00478804 0.00833352 0.0502912 0.027787 0.0217724 0.0196231 0.0259935 0.0213235 0.0554491 0.0541082 0.047685 0.0342356 0.0146111 0.0119049 0.012097 0.0184215 0.00830634 0.00640906 0.0184389 0.0076143 0.0075745 0.00993326 0.0157911 0.0148979 0.00756132 0.00179522 0.00262687 0.00646157 0.00566634 0.00337807 0.0118847 0.00777671 0.0120444 0.0164152 0.0123092 0.0135371 0.0217461 0.012111 0.0199828 0.0204308 0.0173545 0.0138632 0.0176385 0.0305709 0.0151428 0.0174029 0.0315259 0.0179471 0.0133415 0.00965568 0.00454908 0.00193827 0.00139654 0.000603313 0.000856239 0.000575738 0.000906714 0.000611365 0.00098345 0.00068478 0.00129595 0.00137981 0.00385159 0.000849241 0.00131072 0.00097822 0.00156129 0.00631903 0.0271281	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0132119 0.0190912 0.0169665 0.0018098 0.00218181 0.00163227 0.00173591 0.00161159 0.00192217 0.00179811 0.00271381 0.00478911 0.00833537 0.0503021 0.0277929 0.0217768 0.0196272 0.0259989 0.021328 0.0554608 0.0541198 0.0476949 0.0342426 0.0146143 0.0119077 0.0120998 0.0184254 0.00830836 0.00641061 0.018443 0.00761611 0.00757566 0.00993439 0.015793 0.0149016 0.00756414 0.00179583 0.00262769 0.00646402 0.00566906 0.00337917 0.011889 0.00778343 0.012055 0.016426 0.0123148 0.0135427 0.0217599 0.0121232 0.0200032 0.020406 0.0173179 0.0138234 0.0175821 0.0305085 0.0151472 0.0174671 0.0316395 0.0181264 0.0134455 0.00968408 0.00453247 0.00194373 0.00139894 0.000600597 0.000854143 0.000570293 0.0008959 0.000599511 0.000952289 0.000628222 0.00101844 0.000707266 0.00133888 0.00147562 0.00460256 0.00109644 0.00150633 0.00608793 0.0264724	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0129992 0.0187838 0.0166933 0.00178065 0.00214667 0.00160597 0.00170795 0.00158562 0.00189119 0.00176911 0.00267004 0.00471189 0.00820094 0.0494905 0.0273442 0.0214251 0.0193103 0.025579 0.0209837 0.0545653 0.0532463 0.0469247 0.0336897 0.0143788 0.0117162 0.0119052 0.0181286 0.00817506 0.00630786 0.0181462 0.00749458 0.00745331 0.00977356 0.015538 0.0146643 0.00744662 0.00176767 0.00258689 0.00636486 0.00558225 0.00332759 0.0117067 0.00767142 0.0118791 0.0161818 0.012139 0.0133511 0.0214438 0.0119646 0.0197622 0.0200202 0.0169256 0.0134113 0.0169626 0.0294114 0.0145687 0.0169889 0.0310686 0.0187432 0.0138479 0.00973309 0.00469673 0.00204116 0.00140198 0.000579567 0.000765344 0.00053062 0.000790863 0.000554837 0.000827988 0.000578247 0.00086591 0.000618903 0.000939782 0.000727345 0.00126139 0.00162308 0.00481816 0.0174272 0.031307	DRUG0 . DRUG1 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
3	2	0.0092957 0.0106012 0.00404096 0.00203889 0.00342213 0.00351167 0.0114804 0.00200795 0.00231434 0.00206564 0.00349168 0.00761361 0.013192 0.0626286 0.0270995 0.0386162 0.0247403 0.0472007 0.0446998 0.0424493 0.0444841 0.0411191 0.0270861 0.0126496 0.0100071 0.0120442 0.0212982 0.00983309 0.00726614 0.0206641 0.00860822 0.00875049 0.0116181 0.0185278 0.0175065 0.00886948 0.00210974 0.00308886 0.00758766 0.00665273 0.0039804 0.0140105 0.00913599 0.0140843 0.0189707 0.0141014 0.0152258 0.0237985 0.0125533 0.0204155 0.0193631 0.0156746 0.0121527 0.015318 0.0256833 0.0105699 0.00991795 0.0143677 0.00572437 0.0035515 0.00358281 0.00205231 0.00133355 0.000925556 0.000701783 0.000942843 0.000663493 0.00101364 0.0006866 0.00109157 0.00071999 0.00117695 0.000773547 0.00131052 0.000925825 0.00173374 0.00105752 0.0019146 0.00773174 0.02878	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG2 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
3	4	0.00758005 0.00841436 0.00342235 0.00167165 0.00307648 0.0031885 0.0104888 0.00168582 0.00191732 0.00168302 0.00261359 0.00504697 0.00798581 0.0451711 0.0246033 0.0195711 0.0178424 0.0243587 0.020164 0.0542473 0.0529485 0.0473615 0.0339139 0.0143889 0.0115454 0.011804 0.0180202 0.00809472 0.00623398 0.0183395 0.00759386 0.00794946 0.0103351 0.0174583 0.0166573 0.00972683 0.00269116 0.00600629 0.0167699 0.0152843 0.014171 0.0469588 0.039573 0.0316451 0.0224691 0.0200951 0.0164748 0.0174378 0.010778 0.0151911 0.0165133 0.0157465 0.0133051 0.0145238 0.0221589 0.00851204 0.00858417 0.0118595 0.00507278 0.00305726 0.0029288 0.00168989 0.00109227 0.000763071 0.000587033 0.000781132 0.000551083 0.00083468 0.000566809 0.000894822 0.000591608 0.000961176 0.00063328 0.00106711 0.000755438 0.00140774 0.000860998 0.00155579 0.00627465 0.0232196	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00778768 0.00864197 0.00351653 0.00171755 0.0031602 0.00327585 0.0107745 0.00173137 0.00196901 0.00172722 0.0026802 0.00517686 0.00818867 0.046285 0.025184 0.0200154 0.0182649 0.0248977 0.0206654 0.0555384 0.0542435 0.0484054 0.034723 0.0148935 0.0120794 0.0123302 0.0187618 0.00847325 0.00654051 0.0188163 0.00777451 0.00773743 0.0101495 0.016137 0.0152236 0.00772619 0.00183452 0.00268623 0.00661032 0.00579732 0.00345564 0.0121607 0.00794906 0.012332 0.0168368 0.0126709 0.0139821 0.0224569 0.0125271 0.0206962 0.0213446 0.0182119 0.014617 0.0185506 0.0318309 0.0157541 0.0179419 0.0335066 0.0198277 0.0150797 0.0118092 0.00655231 0.00328766 0.00325813 0.00212468 0.00400302 0.000757157 0.000870952 0.000673421 0.000898507 0.00067919 0.000942873 0.000710987 0.00104113 0.000812931 0.00133663 0.000954914 0.00170519 0.00664466 0.0270621	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00787184 0.00873536 0.00355454 0.00173611 0.00319436 0.00331126 0.010891 0.00175008 0.00199028 0.00174589 0.00270916 0.00523279 0.00827713 0.0467849 0.025456 0.0202315 0.0184621 0.0251665 0.0208886 0.056138 0.054829 0.0489276 0.0350974 0.0150538 0.0122094 0.0124628 0.0189633 0.00856408 0.00661044 0.0190175 0.00785631 0.00781906 0.010256 0.0163047 0.015381 0.00780458 0.00185319 0.00271246 0.00667257 0.00585128 0.00348861 0.0122748 0.00802479 0.0124361 0.0169623 0.0127369 0.0140239 0.0225333 0.0125545 0.0207324 0.0213077 0.0181559 0.0145449 0.0184994 0.0319637 0.0158382 0.018133 0.033367 0.0192332 0.0143886 0.0105804 0.00523372 0.00231125 0.0018386 0.000743109 0.0012375 0.00128929 0.00343048 0.00070215 0.000881741 0.000683895 0.000934455 0.000705336 0.00103129 0.000802802 0.00132335 0.000940366 0.00166276 0.00661229 0.0274823	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00789813 0.00876453 0.00356641 0.00174191 0.00320502 0.00332232 0.0109273 0.00175592 0.00199693 0.00175171 0.0027182 0.00525025 0.00830474 0.0469408 0.0255407 0.0202988 0.0185236 0.0252502 0.0209581 0.0563248 0.0550114 0.0490901 0.0352139 0.0151039 0.01225 0.0125042 0.0190261 0.00859248 0.00663231 0.0190802 0.00788203 0.00784438 0.0102889 0.0163565 0.0154301 0.00783001 0.00185923 0.00272105 0.00669329 0.00586929 0.0034996 0.0123123 0.00805224 0.0124737 0.0170084 0.0127637 0.0140444 0.02256 0.0125645 0.0207376 0.0212665 0.0180933 0.0144756 0.0184187 0.0318802 0.0157698 0.0180575 0.0329002 0.0187502 0.0139988 0.0102231 0.00490892 0.00211735 0.00156587 0.000663952 0.000948955 0.000662716 0.00124983 0.0013479 0.00352362 0.000730765 0.000953965 0.000735914 0.00105165 0.000815953 0.00133633 0.000950018 0.00165144 0.00663968 0.0279749	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00791118 0.00877901 0.00357231 0.00174479 0.00321032 0.00332781 0.0109454 0.00175882 0.00200023 0.0017546 0.00272268 0.0052589 0.00831842 0.0470181 0.0255826 0.020332 0.0185539 0.0252917 0.0209925 0.0564172 0.0551018 0.0491705 0.0352715 0.0151286 0.0122702 0.0125247 0.0190572 0.00860657 0.00664316 0.0191112 0.0078947 0.00785673 0.0103048 0.0163814 0.0154543 0.00784256 0.00186222 0.00272517 0.00670313 0.00587822 0.00350483 0.0123305 0.00806606 0.0124932 0.0170302 0.0127743 0.0140504 0.0225689 0.0125669 0.0207373 0.0212282 0.0180418 0.0144189 0.0183453 0.0317745 0.0157154 0.0180252 0.0327089 0.0185805 0.013828 0.0100512 0.00476907 0.00203772 0.00147685 0.00063636 0.000905598 0.000610193 0.000976121 0.000690569 0.00130438 0.00138866 0.00369311 0.000778431 0.00107049 0.000845019 0.00134802 0.000967769 0.00163245 0.00661366 0.0281338	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00791213 0.00878006 0.00357274 0.001745 0.0032107 0.00332821 0.0109467 0.00175903 0.00200047 0.00175481 0.00272299 0.00525951 0.00831938 0.0470233 0.0255854 0.0203342 0.0185559 0.0252944 0.0209948 0.0564233 0.0551078 0.0491757 0.0352751 0.0151302 0.0122716 0.0125261 0.0190591 0.00860755 0.0066439 0.0191131 0.00789545 0.00785715 0.0103051 0.0163817 0.0154555 0.00784358 0.00186245 0.00272535 0.00670353 0.00587904 0.003505 0.0123314 0.00806907 0.0124972 0.0170328 0.0127728 0.0140465 0.0225661 0.012567 0.0207359 0.0212011 0.0180082 0.0143849 0.0183023 0.0317229 0.0157125 0.0180572 0.0327114 0.0186217 0.0138431 0.0100187 0.00472008 0.0020111 0.00144904 0.000625985 0.000888418 0.00059737 0.000940783 0.000634332 0.0010204 0.000710504 0.00134464 0.00143165 0.00399626 0.000881141 0.00135996 0.00101497 0.00161995 0.00655646 0.0281468	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.00791404 0.00878216 0.0035736 0.00174542 0.00321148 0.00332901 0.0109493 0.00175946 0.00200094 0.00175522 0.00272362 0.00526074 0.0083213 0.0470339 0.025591 0.0203385 0.01856 0.0252999 0.0209994 0.0564357 0.05512 0.0491862 0.0352827 0.0151336 0.0122746 0.0125291 0.0190634 0.00860972 0.00664557 0.0191175 0.0078974 0.00785842 0.0103063 0.0163838 0.0154594 0.00784658 0.0018631 0.00272623 0.00670613 0.00588191 0.00350618 0.0123359 0.00807612 0.0125083 0.0170442 0.0127787 0.0140524 0.0225806 0.0125798 0.0207573 0.0211755 0.0179704 0.0143437 0.0182439 0.0316585 0.0157172 0.0181239 0.0328296 0.0188079 0.0139512 0.0100482 0.00470288 0.00201678 0.00145154 0.000623172 0.00088625 0.000591724 0.000929571 0.000622038 0.000988075 0.000651827 0.00105671 0.00073384 0.00138919 0.00153106 0.00477548 0.00113764 0.00156293 0.00631673 0.0274668	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.00778185 0.00863545 0.00351392 0.00171627 0.00315783 0.00327341 0.0107664 0.00173006 0.00196751 0.00172589 0.00267808 0.00517279 0.00818216 0.046247 0.0251626 0.0199978 0.0182492 0.0248762 0.0206479 0.0554909 0.0541976 0.0483626 0.034692 0.0148807 0.0120699 0.0123202 0.018745 0.00846646 0.00653509 0.0187985 0.00776668 0.00772682 0.0101333 0.0161095 0.0152041 0.00772 0.00183278 0.00268227 0.00659927 0.00578833 0.00345056 0.0121395 0.00795507 0.0123183 0.0167806 0.0125886 0.0138453 0.0222392 0.0124077 0.0204948 0.0207627 0.0175527 0.0139077 0.0175904 0.0305016 0.0151079 0.0176171 0.0322177 0.0194362 0.01436 0.010093 0.00487039 0.0021166 0.00145381 0.000600989 0.000793635 0.000550229 0.00082009 0.000575338 0.000858585 0.000599611 0.000897905 0.000641769 0.000974506 0.000754217 0.00130799 0.00168305 0.00499619 0.018071 0.0324632	DRUG0 . DRUG0 , such as DRUG1 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.00785589 0.00914205 0.00292249 0.00160786 0.00211735 0.00161282 0.00332998 0.00423873 0.0230345 0.0050373 0.00703565 0.0192344 0.00729329 0.0575594 0.038584 0.0247109 0.0184641 0.0219413 0.0225468 0.0628783 0.0598169 0.04859 0.0345947 0.0146109 0.0126463 0.0128573 0.0207995 0.00932262 0.00710375 0.0204378 0.00851772 0.00855102 0.0112975 0.0179886 0.0169407 0.00862641 0.00204945 0.0029981 0.00737738 0.00645941 0.00386473 0.0136258 0.00887009 0.0136791 0.0184046 0.0136634 0.0147622 0.0230436 0.012171 0.0197754 0.0187458 0.0151897 0.0117907 0.0148662 0.0248442 0.0102338 0.0096096 0.0139201 0.00554289 0.0034386 0.00346534 0.00198539 0.00128945 0.000895041 0.000678926 0.000912319 0.000642108 0.000980755 0.000664517 0.00105618 0.000696881 0.00113883 0.000748761 0.0012681 0.0008962 0.0016776 0.00102363 0.00185276 0.00748106 0.0278713	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG2 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	2	0.00800566 0.00861158 0.00340755 0.00164739 0.0022592 0.0016245 0.0033974 0.00265979 0.0113226 0.00223274 0.00343578 0.00778429 0.0133961 0.067284 0.0286866 0.0397407 0.0251951 0.0476648 0.0449895 0.0427972 0.0442843 0.0407292 0.0268 0.0125208 0.00991663 0.0119231 0.0211553 0.00977206 0.00721989 0.0205405 0.00855864 0.00870359 0.0115605 0.0184396 0.017422 0.00882775 0.00209975 0.00307419 0.00755214 0.00662116 0.00396171 0.0139463 0.00909374 0.0140193 0.0188825 0.0140352 0.0151547 0.0236864 0.0124947 0.0203197 0.0192719 0.0156013 0.0120963 0.0152471 0.0255616 0.0105201 0.00987152 0.0143004 0.00569746 0.00353479 0.0035658 0.00204258 0.00132719 0.000921151 0.000698454 0.000938378 0.000660354 0.00100884 0.000683353 0.0010864 0.000716588 0.00117138 0.000769894 0.00130432 0.000921454 0.00172554 0.00105252 0.00190555 0.00769514 0.0286447	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG2 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0066588 0.00697452 0.00293637 0.00135757 0.00193051 0.00134347 0.00284939 0.00243363 0.0106621 0.00184886 0.00260727 0.00520813 0.0081366 0.0465651 0.0248523 0.0192822 0.0173747 0.0239849 0.0202128 0.0544205 0.0540492 0.0470858 0.0336999 0.0141627 0.0114514 0.0116883 0.0181277 0.00812167 0.00626629 0.0184457 0.0076311 0.00798916 0.0103939 0.0175537 0.0167329 0.00977793 0.00270548 0.00603671 0.0168603 0.0153693 0.014253 0.0472233 0.0397871 0.0318148 0.0226016 0.0202132 0.0165656 0.0175286 0.0108355 0.015268 0.0165946 0.0158233 0.0133698 0.0145944 0.0222598 0.00855034 0.00862248 0.0119127 0.00509505 0.00307066 0.00294155 0.00169725 0.00109701 0.000766384 0.000589585 0.000784535 0.000553484 0.000838322 0.000569282 0.000898729 0.000594193 0.000965378 0.000636048 0.00107178 0.000758743 0.0014139 0.000864765 0.0015626 0.00630206 0.0233217	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0068411 0.00716262 0.00301663 0.0013948 0.00198268 0.00137963 0.00292812 0.00249992 0.0109523 0.0018979 0.00267382 0.00534273 0.00834505 0.0477264 0.0254454 0.0197272 0.0177907 0.0245215 0.02072 0.0557287 0.0553762 0.0481309 0.0345069 0.0146573 0.0119813 0.0122103 0.0188731 0.00850085 0.00657468 0.0189234 0.00781205 0.00777677 0.0102082 0.0162291 0.015294 0.00776717 0.00184459 0.00270032 0.00664672 0.00582936 0.00347546 0.0122351 0.00799518 0.0124056 0.0169325 0.01274 0.0140596 0.0225779 0.0125971 0.0208084 0.0214572 0.0183112 0.0146996 0.0186568 0.0319934 0.0158357 0.0180365 0.0336785 0.0199268 0.015154 0.0118678 0.00658518 0.00330393 0.00327376 0.00213488 0.0040226 0.000760863 0.000875217 0.000676699 0.000902924 0.0006825 0.000947522 0.000714459 0.00104627 0.000816913 0.00134323 0.000959602 0.00171358 0.00667701 0.0271983	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0069154 0.0072404 0.0030494 0.00140994 0.00200421 0.00139461 0.00295991 0.00252707 0.0110712 0.00191851 0.00270284 0.00540074 0.00843564 0.0482445 0.0257215 0.0199412 0.0179837 0.0247875 0.0209448 0.0563333 0.0559769 0.0486527 0.0348807 0.0148159 0.0121109 0.0123422 0.0190768 0.00859244 0.00664532 0.0191268 0.00789466 0.00785922 0.0103159 0.0163986 0.0154529 0.00784639 0.00186346 0.00272683 0.00670967 0.00588393 0.0035088 0.0123506 0.00807177 0.012511 0.0170596 0.012807 0.0141024 0.0226559 0.0126252 0.0208458 0.0214213 0.0182559 0.0146278 0.0186063 0.0321285 0.015921 0.0182296 0.0335399 0.0193305 0.0144605 0.0106335 0.00526029 0.00232276 0.00184744 0.000746716 0.0012436 0.00129568 0.00344768 0.000705668 0.000886171 0.000687294 0.000939144 0.000708841 0.00103647 0.000806799 0.00132999 0.000945055 0.00167106 0.00664494 0.0276225	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00693862 0.00726472 0.00305964 0.00141468 0.00201094 0.00139929 0.00296986 0.00253556 0.0111084 0.00192495 0.00271191 0.00541885 0.00846393 0.0484061 0.0258076 0.0200079 0.0180438 0.0248704 0.0210149 0.0565217 0.0561641 0.0488153 0.0349971 0.0148654 0.0121514 0.0123835 0.0191404 0.00862109 0.00666744 0.0191901 0.00792065 0.00788482 0.0103491 0.016451 0.0155025 0.0078721 0.00186957 0.00273551 0.00673063 0.00590216 0.00351992 0.0123885 0.00809954 0.0125491 0.0171062 0.0128341 0.0141233 0.0226832 0.0126355 0.0208515 0.0213803 0.0181933 0.0145584 0.0185254 0.0320451 0.0158525 0.0181541 0.0330712 0.0188454 0.014069 0.0102746 0.00493392 0.00212792 0.00157342 0.000667189 0.000953656 0.000665988 0.00125606 0.00135465 0.00354143 0.000734454 0.000958794 0.000739596 0.00105696 0.000820036 0.00134307 0.000954774 0.00165972 0.00667257 0.028118	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00695015 0.00727678 0.00306472 0.00141703 0.00201428 0.00140161 0.00297479 0.00253977 0.0111268 0.00192815 0.0027164 0.00542784 0.00847795 0.0484862 0.0258502 0.0200408 0.0180736 0.0249115 0.0210496 0.056615 0.0562568 0.0488956 0.0350547 0.0148899 0.0121715 0.0124039 0.0191718 0.0086353 0.00667839 0.0192215 0.00793346 0.0078973 0.0103652 0.0164763 0.015527 0.00788479 0.00187259 0.00273969 0.00674059 0.00591119 0.00352521 0.012407 0.00811351 0.0125687 0.0171284 0.0128449 0.0141294 0.0226923 0.0126381 0.0208513 0.0213421 0.0181416 0.0145015 0.0184518 0.0319391 0.015798 0.0181217 0.0328791 0.0186751 0.0138974 0.0101019 0.00479338 0.0020479 0.00148399 0.000639469 0.000910092 0.000613211 0.000980999 0.000693998 0.0013109 0.00139564 0.00371183 0.000782373 0.00107593 0.000849261 0.00135484 0.000972623 0.00164064 0.00664649 0.0282777	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00695099 0.00727766 0.00306509 0.0014172 0.00201453 0.00140178 0.00297515 0.00254008 0.0111282 0.00192838 0.00271672 0.00542847 0.00847894 0.0484917 0.025853 0.020043 0.0180755 0.0249141 0.0210519 0.0566212 0.056263 0.0489008 0.0350584 0.0148915 0.0121729 0.0124053 0.0191738 0.0086363 0.00667915 0.0192235 0.00793422 0.00789774 0.0103655 0.0164765 0.0155282 0.00788583 0.00187283 0.00273987 0.006741 0.00591202 0.00352539 0.0124078 0.00811655 0.0125728 0.017131 0.0128434 0.0141255 0.0226896 0.0126382 0.0208499 0.0213148 0.0181079 0.0144673 0.0184085 0.0318872 0.015795 0.0181539 0.0328817 0.0187165 0.0139126 0.0100692 0.00474415 0.00202115 0.00145604 0.000629045 0.000892828 0.000600325 0.000945487 0.000637481 0.00102551 0.000714042 0.00135137 0.00143886 0.00401652 0.000885608 0.00136688 0.00102006 0.00162809 0.00658903 0.0282904	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.00695269 0.00727942 0.00306584 0.00141755 0.00201501 0.00140212 0.00297588 0.0025407 0.0111309 0.00192884 0.00271735 0.00542975 0.00848092 0.0485028 0.0258587 0.0200473 0.0180795 0.0249196 0.0210565 0.0566337 0.0562756 0.0489114 0.0350659 0.0148949 0.0121759 0.0124083 0.0191781 0.00863849 0.00668084 0.0192279 0.0079362 0.00789903 0.0103668 0.0164787 0.0155322 0.00788887 0.00187348 0.00274076 0.00674364 0.00591493 0.00352658 0.0124124 0.00812366 0.012584 0.0171425 0.0128494 0.0141315 0.0227043 0.0126511 0.0208715 0.0212892 0.0180699 0.014426 0.0183498 0.0318225 0.0157998 0.0182211 0.0330005 0.0189036 0.0140212 0.0100989 0.00472685 0.00202686 0.00145855 0.000626217 0.000890648 0.000594651 0.000934217 0.000625124 0.00099302 0.000655069 0.001062 0.0007375 0.00139614 0.00153877 0.00479971 0.0011434 0.00157078 0.00634817 0.0276062	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.00683597 0.00715719 0.00301438 0.00139376 0.00198118 0.00137858 0.00292593 0.00249804 0.010944 0.00189644 0.00267169 0.00533853 0.00833842 0.0476874 0.0254236 0.0197097 0.0177752 0.0245002 0.0207022 0.0556808 0.0553291 0.0480883 0.034476 0.0146447 0.0119719 0.0122003 0.0188562 0.00849403 0.00656923 0.0189055 0.00780418 0.00776611 0.0101919 0.0162015 0.0152744 0.00776095 0.00184284 0.00269634 0.00663562 0.00582033 0.00347036 0.0122137 0.00800123 0.0123919 0.0168759 0.0126572 0.013922 0.022359 0.012477 0.0206058 0.0208723 0.0176484 0.0139863 0.0176912 0.030657 0.015186 0.0177101 0.0323828 0.0195335 0.0144308 0.010143 0.00489483 0.00212704 0.00146075 0.000603882 0.000797505 0.000552907 0.000824127 0.000578148 0.000862819 0.000602548 0.000902335 0.00064492 0.000979313 0.000757932 0.00131444 0.00169141 0.0050207 0.0181605 0.0326258	DRUG0 . DRUG0 , such as DRUG0 , DRUG1 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
2	2	0.00726065 0.00813091 0.00310853 0.00147601 0.00220572 0.00148788 0.00236145 0.00204741 0.00408759 0.00446564 0.00847228 0.0579384 0.0146758 0.0704038 0.0352158 0.0475701 0.0278049 0.0496654 0.045515 0.0419774 0.0414 0.0376413 0.024434 0.0113272 0.00892567 0.0106395 0.0187785 0.00864424 0.00639304 0.0181615 0.00756603 0.00768226 0.0101973 0.0162548 0.0153485 0.00777812 0.00184942 0.0027073 0.00665169 0.00583036 0.00348849 0.0122817 0.00800717 0.0123443 0.0166248 0.0123556 0.013342 0.0208507 0.0110002 0.0178878 0.0169644 0.0137346 0.0106501 0.0134246 0.0224996 0.00926073 0.00869039 0.0125893 0.00501546 0.00311164 0.00313863 0.00179791 0.00116817 0.000810785 0.000614794 0.000825997 0.000581277 0.000888015 0.000601526 0.000956286 0.000630785 0.00103109 0.000677712 0.00114811 0.00081113 0.00151889 0.000926503 0.00167735 0.00677353 0.0252162	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG2 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00622867 0.00670159 0.00272328 0.00128049 0.00189719 0.00126626 0.00198546 0.00167976 0.00336636 0.00357009 0.00677943 0.0451213 0.00924406 0.0501747 0.0295978 0.0227983 0.0190095 0.0259323 0.0208539 0.0534381 0.0514668 0.0441464 0.0314237 0.0131287 0.010643 0.0108281 0.0168866 0.00755025 0.00581413 0.0171029 0.00707618 0.00740589 0.00963681 0.0162683 0.0155004 0.00906046 0.00250653 0.00559207 0.0156213 0.0142405 0.0132073 0.0437533 0.0368591 0.0294732 0.0209449 0.0187322 0.0153493 0.0162391 0.0100391 0.014144 0.015372 0.0146573 0.0123845 0.0135187 0.0206162 0.00791883 0.00798553 0.0110328 0.00471852 0.00284372 0.00272411 0.0015718 0.00101591 0.000709728 0.000546001 0.000726543 0.000512572 0.000776355 0.000527202 0.0008323 0.000550273 0.000894023 0.000589036 0.000992562 0.000702663 0.00130939 0.000800849 0.0014471 0.00583625 0.0215982	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00638573 0.00686732 0.00279113 0.00131258 0.00194395 0.00129725 0.00203476 0.00172109 0.00345076 0.00365808 0.00694903 0.0462354 0.00946548 0.0513564 0.0302626 0.0232965 0.0194368 0.0264745 0.0213428 0.0546221 0.0526278 0.0450407 0.0321125 0.0135589 0.0111132 0.0112893 0.017545 0.00788628 0.00608796 0.0175099 0.00722932 0.00719475 0.00944593 0.0150118 0.01414 0.00718343 0.00170567 0.00249669 0.00614682 0.00538985 0.00321362 0.011316 0.00739357 0.0114729 0.0156569 0.0117787 0.0129997 0.0208727 0.0116474 0.0192376 0.0198361 0.0169298 0.0135924 0.0172521 0.029575 0.01464 0.016676 0.0311356 0.0184214 0.0140086 0.0109711 0.00608776 0.0030543 0.00302614 0.0019734 0.00371853 0.000703354 0.000809063 0.000625543 0.000834683 0.000630909 0.000875918 0.000660457 0.000967213 0.000755175 0.00124174 0.000887084 0.00158409 0.00617229 0.0251447	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00644979 0.00693621 0.00281912 0.00132574 0.00196345 0.00131026 0.00205517 0.00173836 0.00348538 0.00369478 0.00701874 0.0466991 0.00956039 0.0518712 0.0305659 0.02353 0.0196315 0.0267399 0.0215567 0.0551694 0.0531551 0.0454917 0.0324338 0.0136944 0.0112242 0.0114019 0.0177199 0.00796472 0.00614833 0.0176836 0.00729979 0.00726508 0.0095377 0.0151562 0.0142752 0.00725075 0.0017217 0.00251914 0.00619995 0.00543585 0.00324179 0.0114134 0.00745828 0.0115609 0.0157615 0.011831 0.0130286 0.0209276 0.0116639 0.0192564 0.0197866 0.0168648 0.013515 0.0171913 0.0296753 0.0147068 0.0168407 0.030982 0.0178557 0.0133568 0.00982196 0.00485899 0.00214549 0.00170626 0.000689676 0.00114864 0.00119678 0.00318462 0.000651826 0.000818555 0.000634837 0.000867482 0.000654741 0.000957381 0.000745227 0.00122851 0.000872935 0.00154354 0.00613768 0.0255164	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00646979 0.00695771 0.00282786 0.00132985 0.00196953 0.00131432 0.00206154 0.00174375 0.00349618 0.00370623 0.0070405 0.0468438 0.00958999 0.0520317 0.0306604 0.0236026 0.0196922 0.0268224 0.0216233 0.0553398 0.0533193 0.045632 0.0325337 0.0137366 0.0112588 0.0114371 0.0177744 0.00798924 0.00616721 0.0177377 0.00732194 0.00728687 0.00956602 0.0152007 0.0143174 0.00727264 0.00172691 0.00252651 0.00621773 0.00545129 0.00325123 0.0114456 0.00748202 0.0115931 0.0158006 0.011853 0.0130445 0.0209474 0.0116705 0.0192567 0.0197438 0.0168027 0.0134474 0.0171122 0.0295907 0.0146397 0.0167666 0.0305412 0.0174032 0.0129918 0.00948798 0.00455635 0.001965 0.00145282 0.000616068 0.000880619 0.000614985 0.00115989 0.00125095 0.00327043 0.000678248 0.000885421 0.000682979 0.000976062 0.000757262 0.00124027 0.000881688 0.00153267 0.00616163 0.0259673	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00647972 0.00696838 0.0028322 0.00133189 0.00197255 0.00131634 0.00206471 0.00174642 0.00350155 0.00371191 0.0070513 0.0469156 0.00960467 0.0521113 0.0307071 0.0236385 0.0197221 0.0268633 0.0216562 0.0554241 0.0534005 0.0457013 0.0325831 0.0137575 0.011276 0.0114545 0.0178013 0.0080014 0.00617657 0.0177644 0.00733286 0.00729749 0.00957968 0.0152221 0.0143382 0.00728344 0.00172947 0.00253004 0.00622615 0.00545894 0.0032557 0.0114611 0.00749398 0.0116098 0.015819 0.0118615 0.0130485 0.0209532 0.0116714 0.0192541 0.0197059 0.0167529 0.0133932 0.017042 0.029489 0.0145875 0.0167346 0.03036 0.0172437 0.0128318 0.00932735 0.00442601 0.00189087 0.00137007 0.000590398 0.000840285 0.000566178 0.000905776 0.000640777 0.00121039 0.00128865 0.00342737 0.000722413 0.000993472 0.000784154 0.001251 0.000898058 0.00151486 0.00613676 0.0261114	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00648045 0.00696915 0.00283252 0.00133204 0.00197277 0.00131648 0.00206494 0.00174661 0.00350194 0.00371232 0.00705208 0.0469208 0.0096057 0.0521168 0.0307102 0.0236408 0.0197241 0.0268659 0.0216584 0.0554296 0.0534059 0.0457057 0.0325862 0.0137589 0.0112772 0.0114557 0.017803 0.00800225 0.00617721 0.0177661 0.0073335 0.00729783 0.00957986 0.0152222 0.0143392 0.00728434 0.00172968 0.00253019 0.00622647 0.00545966 0.00325584 0.0114618 0.00749672 0.0116135 0.0158213 0.0118599 0.0130449 0.0209506 0.0116714 0.0192527 0.0196806 0.0167216 0.0133615 0.017002 0.0294409 0.0145847 0.0167642 0.0303621 0.0172818 0.0128457 0.00929705 0.0043805 0.00186615 0.00134426 0.000580769 0.00082434 0.000554275 0.000872979 0.000588588 0.000946869 0.000659283 0.00124775 0.00132855 0.00370869 0.00081773 0.00126211 0.000941852 0.00150326 0.00608366 0.0261227	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.00648191 0.0069707 0.00283315 0.00133234 0.00197321 0.00131677 0.0020654 0.001747 0.00350273 0.00371315 0.00705367 0.0469312 0.00960779 0.0521279 0.0307165 0.0236455 0.0197281 0.0268714 0.0216628 0.0554409 0.0534169 0.0457149 0.0325927 0.0137618 0.0112798 0.0114583 0.0178067 0.00800415 0.00617867 0.0177699 0.0073352 0.0072989 0.00958089 0.0152239 0.0143426 0.00728702 0.00173025 0.00253097 0.0062288 0.00546225 0.00325689 0.0114658 0.00750316 0.0116236 0.0158316 0.0118653 0.0130502 0.0209637 0.011683 0.0192723 0.0196566 0.0166862 0.0133231 0.0169475 0.0293806 0.0145888 0.016826 0.0304712 0.0174542 0.0129457 0.00932427 0.00436444 0.00187138 0.00134655 0.000578148 0.000822311 0.000549026 0.000862557 0.000577168 0.000916856 0.00060482 0.000980546 0.000680934 0.00128906 0.00142079 0.00443177 0.00105575 0.00145033 0.00586118 0.02549	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0063813 0.00686249 0.00278918 0.00131166 0.00194258 0.00129633 0.00203334 0.00171988 0.00344837 0.0036555 0.00694418 0.0462026 0.00945854 0.0513179 0.0302387 0.0232775 0.0194211 0.0264532 0.0213258 0.0545784 0.0525863 0.0450036 0.0320856 0.013548 0.0111051 0.0112807 0.0175304 0.00788044 0.00608328 0.0174944 0.00722248 0.00718533 0.00943145 0.0149872 0.0141228 0.00717811 0.00170415 0.00249316 0.00613693 0.00538183 0.00320909 0.0112969 0.00739961 0.0114609 0.0156056 0.0117029 0.0128733 0.0206716 0.0115371 0.0190515 0.0192965 0.016318 0.0129336 0.0163602 0.028341 0.0140401 0.0163751 0.0299395 0.018059 0.013341 0.00937713 0.00452538 0.00196644 0.00135033 0.00055825 0.000737263 0.000511144 0.000761897 0.000534485 0.000797673 0.000557048 0.000834209 0.000596224 0.000905376 0.000700709 0.00121521 0.00156374 0.00464158 0.0167897 0.0301641	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG1 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.00399833 0.0030362 0.00206293 0.00102494 0.00119465 0.000878381 0.00132037 0.00103358 0.00193099 0.00107982 0.00180256 0.00643011 0.014054 0.0715628 0.0392129 0.0474037 0.0365188 0.0334428 0.046832 0.0423663 0.0257387 0.0273524 0.017254 0.00842291 0.00711864 0.00941593 0.0169294 0.00761179 0.00578744 0.0172026 0.00711603 0.00758599 0.00996039 0.0169723 0.0161773 0.00943201 0.00261403 0.00584623 0.0163383 0.0149044 0.0138323 0.0458031 0.038584 0.0308519 0.0219796 0.0196806 0.0161312 0.0170612 0.0105512 0.0148638 0.016155 0.0154079 0.0130203 0.0142124 0.0216722 0.00832472 0.00839518 0.0115994 0.00496074 0.00298969 0.00286388 0.00165247 0.00106804 0.000746158 0.000574034 0.000763847 0.000538891 0.000816217 0.000554275 0.000875037 0.000578532 0.000939931 0.000619287 0.00104353 0.000738751 0.00137664 0.000841979 0.00152141 0.00613596 0.0227078	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG2 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00409901 0.00311267 0.00211487 0.00105077 0.00122472 0.000900472 0.00135365 0.0010596 0.00197976 0.0011069 0.00184762 0.00659141 0.0144045 0.0733772 0.0402175 0.048633 0.0374763 0.0343139 0.048076 0.0434649 0.0264244 0.0280845 0.0177502 0.00871276 0.00741894 0.00980298 0.0175536 0.00792794 0.00604649 0.0175815 0.00725906 0.00736605 0.00975852 0.0156537 0.0147555 0.00747367 0.00177735 0.00260879 0.0064295 0.00563079 0.0033612 0.0118657 0.00775155 0.012024 0.0164036 0.0123427 0.0136295 0.0218681 0.0122125 0.0201672 0.0207971 0.017762 0.0142665 0.0181082 0.0310364 0.0153717 0.0175182 0.0327063 0.0193564 0.0147182 0.011527 0.00639685 0.00320931 0.00317875 0.00207292 0.00390655 0.000738975 0.000850026 0.000657221 0.00087695 0.000662866 0.000920289 0.000693924 0.00101623 0.000793458 0.00130467 0.000932062 0.00166439 0.00648486 0.0264247	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00414218 0.00314545 0.00213715 0.00106184 0.00123762 0.000909955 0.0013679 0.00107076 0.00200061 0.00111856 0.00186707 0.00666083 0.0145562 0.07415 0.0406411 0.0491453 0.0378711 0.0346752 0.048582 0.0439224 0.0267025 0.0283797 0.0179365 0.00880418 0.00749674 0.00990571 0.0177375 0.00801081 0.00610949 0.0177647 0.00733346 0.00744175 0.00985823 0.0158121 0.014904 0.00754747 0.00179495 0.00263355 0.0064883 0.00568166 0.00339233 0.0119738 0.00782326 0.0121223 0.0165213 0.0124036 0.0136665 0.0219366 0.0122358 0.020197 0.0207555 0.0177026 0.0141923 0.0180534 0.0311569 0.0154494 0.0177002 0.032561 0.018772 0.0140407 0.0103248 0.00510828 0.00225543 0.00179305 0.000724858 0.00120728 0.0012581 0.00334819 0.000685306 0.000860531 0.000667379 0.000911948 0.000688304 0.00100646 0.00078344 0.00129149 0.000917703 0.00162269 0.006452 0.0268296	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00415566 0.00315568 0.0021441 0.00106529 0.00124165 0.000912916 0.00137236 0.00107425 0.00200712 0.0011222 0.00187315 0.0066825 0.0146036 0.0743913 0.0407733 0.0493053 0.0379944 0.034788 0.04874 0.0440651 0.0267892 0.0284718 0.0179946 0.00883268 0.00752104 0.00993777 0.0177947 0.00803669 0.00612918 0.0178217 0.00735684 0.00746522 0.00988901 0.0158609 0.0149503 0.00757141 0.00180065 0.00264167 0.00650789 0.00569866 0.00340273 0.0120093 0.00784935 0.0121579 0.0165648 0.0124286 0.0136853 0.0219607 0.0122445 0.0202004 0.0207137 0.01764 0.0141234 0.0179731 0.0310727 0.0153813 0.017625 0.0321026 0.0182991 0.0136592 0.00997521 0.00479084 0.002066 0.00152697 0.000647608 0.00092576 0.000646577 0.00121949 0.00131535 0.00343917 0.000713218 0.000930992 0.000718112 0.00102627 0.00079622 0.00130406 0.000927051 0.00161152 0.00647819 0.0273078	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00416235 0.00316076 0.00214755 0.001067 0.00124365 0.000914384 0.00137456 0.00107597 0.00201035 0.001124 0.00187616 0.00669325 0.014627 0.074511 0.040839 0.0493847 0.0380556 0.034844 0.0488184 0.0441359 0.0268323 0.0285174 0.0180233 0.00884677 0.00753307 0.00995364 0.017823 0.00804952 0.00613893 0.0178499 0.00736835 0.00747665 0.00990387 0.0158844 0.014973 0.0075832 0.00180346 0.00264555 0.00651719 0.00570708 0.00340766 0.0120266 0.00786247 0.0121763 0.0165853 0.0124384 0.0136905 0.0219683 0.0122464 0.0201992 0.0206755 0.017589 0.0140675 0.0179007 0.0309682 0.0153276 0.0175927 0.0319145 0.0181328 0.013492 0.00980705 0.00465413 0.0019882 0.00144011 0.000620676 0.000883435 0.000595309 0.00095239 0.000673781 0.00127273 0.00135512 0.0036045 0.000759719 0.00104469 0.000824561 0.00131545 0.000944333 0.00159291 0.00645248 0.0274609	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.00416282 0.00316112 0.00214779 0.00106713 0.00124379 0.000914488 0.00137472 0.0010761 0.00201058 0.00112413 0.00187637 0.00669401 0.0146287 0.0745195 0.0408436 0.0493904 0.03806 0.034848 0.048824 0.0441409 0.0268353 0.0285204 0.0180251 0.00884768 0.00753389 0.00995469 0.0178247 0.00805038 0.00613958 0.0178516 0.007369 0.00747702 0.00990406 0.0158845 0.0149741 0.00758414 0.00180367 0.00264571 0.00651753 0.00570783 0.0034078 0.0120273 0.00786535 0.0121801 0.0165877 0.0124368 0.0136867 0.0219655 0.0122463 0.0201977 0.0206489 0.0175561 0.0140342 0.0178587 0.0309176 0.0153246 0.0176239 0.0319168 0.0181729 0.0135066 0.0097752 0.00460629 0.00196222 0.00141298 0.000610558 0.000866676 0.000582798 0.000917908 0.000618903 0.000995636 0.000693257 0.00131203 0.00139709 0.00390037 0.000859964 0.00132719 0.000990384 0.00158072 0.00639659 0.0274724	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.00416378 0.00316185 0.00214829 0.00106737 0.00124408 0.000914698 0.00137504 0.00107634 0.00201104 0.00112439 0.0018768 0.00669555 0.014632 0.0745367 0.0408531 0.0494019 0.0380689 0.0348561 0.0488354 0.0441511 0.0268415 0.0285267 0.018029 0.00884961 0.00753563 0.00995695 0.0178285 0.00805231 0.00614105 0.0178555 0.00737074 0.00747815 0.00990517 0.0158863 0.0149778 0.00758696 0.00180427 0.00264653 0.00651999 0.00571056 0.00340891 0.0120315 0.00787212 0.0121908 0.0165986 0.0124424 0.0136922 0.0219794 0.0122586 0.0202183 0.0206238 0.0175191 0.0139939 0.0178015 0.0308543 0.0153289 0.0176888 0.0320316 0.0183543 0.0136118 0.00980383 0.00458942 0.00196772 0.00141541 0.000607807 0.000864548 0.000577281 0.000906955 0.000606897 0.00096408 0.000635986 0.00103107 0.000716035 0.0013555 0.00149409 0.00466085 0.00111028 0.00152511 0.00616259 0.0268061	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.00409582 0.00311024 0.00211323 0.00104995 0.00122377 0.000899768 0.00135259 0.00105877 0.00197822 0.00110603 0.00184616 0.00658625 0.0143932 0.0733201 0.0401863 0.0485956 0.0374477 0.0342873 0.0480386 0.0434306 0.0264034 0.0280609 0.0177344 0.00870514 0.00741281 0.00979465 0.0175373 0.00792132 0.00604128 0.0175643 0.00725153 0.00735578 0.00974268 0.0156265 0.014736 0.00746742 0.00177559 0.00260486 0.00641854 0.00562186 0.00335613 0.0118445 0.00775711 0.0120103 0.0163482 0.0122621 0.0134956 0.0216553 0.0120956 0.0199702 0.0202294 0.0171184 0.0135737 0.0171707 0.0297379 0.0147401 0.0172003 0.0314463 0.0189741 0.0140156 0.00985137 0.00475481 0.00206604 0.00141827 0.000586414 0.000774484 0.000537005 0.000800462 0.00056156 0.000838086 0.000585279 0.000876485 0.00062645 0.00095127 0.000736244 0.00127681 0.00164306 0.0048768 0.0176419 0.0316993	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG1 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
3	3	0.00362415 0.0028368 0.00204056 0.000968513 0.00124703 0.000960737 0.0013327 0.00110326 0.00177961 0.00118253 0.00180953 0.00518735 0.00938687 0.0366976 0.0211196 0.0147212 0.0124952 0.0148819 0.0165152 0.046933 0.0507301 0.0420862 0.030244 0.0123587 0.0101129 0.0102112 0.0173059 0.00756415 0.00579671 0.0170567 0.00688203 0.00722899 0.00940357 0.0156054 0.0147959 0.00808419 0.00208808 0.00389845 0.0112989 0.00963057 0.0107662 0.0338704 0.0261881 0.0376133 0.0214245 0.0142963 0.012503 0.0183645 0.0151429 0.0222762 0.0225747 0.0242923 0.0207769 0.0226322 0.033325 0.0154381 0.0186622 0.0311918 0.0206779 0.0156738 0.0115991 0.00650527 0.00313363 0.00302449 0.00201231 0.00378485 0.000744115 0.000857945 0.000668256 0.000888052 0.000672157 0.000926842 0.000699005 0.00101785 0.000794696 0.00130156 0.000930178 0.00165564 0.00640892 0.025479	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.00366165 0.00286616 0.00206167 0.000978536 0.00125994 0.000970679 0.00134649 0.00111467 0.00179803 0.00119477 0.00182826 0.00524103 0.00948401 0.0370774 0.0213382 0.0148735 0.0126245 0.0150359 0.0166861 0.0474186 0.051255 0.0425215 0.0305568 0.0124866 0.0102176 0.0103169 0.0174851 0.00764251 0.00585671 0.0172325 0.00695285 0.00730259 0.00949902 0.0157622 0.0149454 0.00816614 0.00210908 0.0039344 0.0113964 0.00970838 0.010834 0.0340769 0.026353 0.0378176 0.0214576 0.014321 0.0125156 0.0184061 0.0151569 0.0223183 0.0226311 0.0243771 0.0208777 0.0228022 0.0337456 0.0155618 0.0188211 0.0310469 0.0201707 0.0151556 0.0104342 0.00522067 0.00220141 0.00171874 0.000725603 0.0012011 0.00124518 0.00327317 0.000685223 0.000852996 0.000665429 0.000904755 0.000684506 0.000995351 0.000775711 0.00127354 0.000906226 0.00159787 0.00633728 0.0256465	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.003675 0.0028766 0.00206919 0.000982102 0.00126453 0.000974217 0.0013514 0.00111873 0.00180458 0.00119912 0.00183492 0.00526013 0.00951858 0.0372125 0.0214159 0.0149278 0.0126705 0.0150907 0.0167469 0.0475914 0.0514417 0.0426764 0.0306681 0.012532 0.0102548 0.0103545 0.0175488 0.00767034 0.005878 0.0172949 0.00697786 0.00732862 0.00953279 0.0158174 0.014997 0.00819422 0.00211624 0.00394624 0.0114283 0.00973329 0.0108529 0.0341351 0.0263974 0.0378716 0.0214576 0.0143201 0.0125097 0.0184024 0.0151408 0.0222964 0.0226013 0.0243319 0.0208428 0.022779 0.0337622 0.0155062 0.0187488 0.0306194 0.0196941 0.0147794 0.0100837 0.00489397 0.00201286 0.00146892 0.000648378 0.000924489 0.000650978 0.00122326 0.00130876 0.00338712 0.000711538 0.000918739 0.000712212 0.00101305 0.000787744 0.00128449 0.00091525 0.00158658 0.00635682 0.0260859	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.00368191 0.00288202 0.00207308 0.000983951 0.00126691 0.000976051 0.00135394 0.00112084 0.00180798 0.00120138 0.00183838 0.00527003 0.0095365 0.0372825 0.0214562 0.0149559 0.0126944 0.0151191 0.0167785 0.047681 0.0515386 0.0427568 0.0307259 0.0125556 0.0102742 0.010374 0.0175819 0.0076848 0.00588906 0.0173273 0.00699084 0.00734206 0.00955023 0.0158458 0.0150237 0.00820876 0.00211993 0.00395211 0.0114437 0.00974479 0.0108596 0.0341553 0.0264126 0.0378856 0.0214426 0.014309 0.0124961 0.0183866 0.0151189 0.0222698 0.0225687 0.024294 0.0208189 0.0227559 0.0337226 0.0154581 0.0187165 0.0304382 0.0195172 0.0146074 0.00991688 0.00475514 0.00193641 0.00138734 0.000622022 0.000883873 0.000598849 0.000954643 0.000679344 0.00127484 0.00134605 0.00355176 0.000755734 0.00102808 0.000815311 0.00129569 0.000933179 0.00157009 0.00632783 0.0262429	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.00368279 0.0028827 0.00207357 0.000984184 0.00126721 0.000976283 0.00135426 0.00112111 0.0018084 0.00120166 0.00183881 0.00527128 0.00953876 0.0372914 0.0214613 0.0149594 0.0126974 0.0151227 0.0167824 0.0476923 0.0515508 0.0427669 0.0307331 0.0125586 0.0102766 0.0103765 0.017586 0.00768661 0.00589044 0.0173313 0.00699242 0.00734367 0.00955229 0.015849 0.0150268 0.00821036 0.0021203 0.00395248 0.0114443 0.00974489 0.0108589 0.0341532 0.0264105 0.037879 0.0214267 0.0142972 0.0124836 0.0183704 0.0151013 0.0222498 0.0225462 0.0242728 0.0208111 0.0227502 0.0337156 0.0154575 0.0187377 0.030411 0.0195344 0.0146134 0.00988205 0.00470516 0.00191073 0.00136188 0.000612028 0.000867725 0.000586617 0.000920858 0.00062307 0.000996148 0.000695952 0.00130901 0.00138419 0.00384008 0.000853444 0.00130306 0.000978725 0.00155824 0.00626217 0.026267	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
3	3	0.00368409 0.00288372 0.00207431 0.000984532 0.00126766 0.000976628 0.00135474 0.0011215 0.00180905 0.00120209 0.00183946 0.00527315 0.00954214 0.0373046 0.0214689 0.0149647 0.0127019 0.0151281 0.0167884 0.0477092 0.0515691 0.0427821 0.030744 0.0125631 0.0102803 0.0103802 0.0175923 0.00768936 0.00589254 0.0173373 0.00699488 0.00734617 0.00955554 0.0158542 0.0150321 0.00821296 0.00212089 0.00395312 0.0114457 0.00974602 0.0108612 0.0341601 0.0264148 0.0378794 0.0214102 0.0142846 0.01247 0.0183541 0.0150844 0.0222377 0.0225237 0.0242572 0.0208181 0.0227661 0.0337179 0.0154667 0.0187815 0.0304548 0.0196711 0.014702 0.00991222 0.00469 0.00191757 0.00136502 0.000609479 0.000865962 0.000581226 0.000910354 0.000611333 0.000965547 0.000637633 0.00102783 0.000715616 0.0013472 0.00147717 0.0045853 0.00110114 0.00150007 0.00600524 0.025688	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
3	3	0.00363019 0.00284153 0.00204396 0.000970128 0.00124911 0.000962339 0.00133492 0.00110509 0.00178258 0.0011845 0.00181255 0.005196 0.00940253 0.0367588 0.0211548 0.0147458 0.012516 0.0149067 0.0165428 0.0470112 0.0508147 0.0421563 0.0302944 0.0123794 0.0101301 0.0102286 0.0173353 0.00757706 0.00580647 0.0170835 0.00689266 0.0072386 0.00941583 0.0156221 0.0148134 0.0080917 0.0020891 0.00389286 0.0112704 0.00959762 0.0107065 0.0336679 0.0260217 0.0373017 0.0210492 0.0140426 0.0122461 0.018022 0.0148151 0.0218901 0.0221552 0.0238718 0.0204685 0.0223663 0.0327766 0.0149673 0.0182818 0.0297191 0.0198963 0.014843 0.00988711 0.00483856 0.00202409 0.00136889 0.000588038 0.000771018 0.000537087 0.000798037 0.000563153 0.000835544 0.0005852 0.000871461 0.000623862 0.000943598 0.000731306 0.00126786 0.00162549 0.00482374 0.0171774 0.0301481	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG1 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.00396522 0.0031037 0.00223235 0.00105947 0.0013641 0.0010508 0.00145758 0.00120653 0.00194596 0.00129267 0.00197795 0.00567114 0.0102605 0.0401367 0.023106 0.0161099 0.013677 0.0162829 0.0180922 0.0514102 0.0556271 0.0462189 0.0332976 0.0137254 0.0113558 0.0114852 0.0194315 0.00859263 0.00662639 0.0190905 0.0078888 0.00786526 0.0103289 0.0165561 0.0156557 0.00796089 0.00189216 0.00277281 0.00682391 0.00598332 0.00357202 0.0125618 0.00820816 0.0127171 0.017334 0.0130426 0.0144189 0.023209 0.0129548 0.0214769 0.021914 0.0187221 0.015228 0.0196505 0.0350641 0.0175034 0.0184601 0.029487 0.0140602 0.00791115 0.00587552 0.00307937 0.00174163 0.00111899 0.000680346 0.000967571 0.000642208 0.00109365 0.000724741 0.00131689 0.000886756 0.00175685 0.00138671 0.00327015 0.0041649 0.0250002 0.00667188 0.00870669 0.027586 0.0412513	DRUG0 . DRUG0 , such as DRUG0 , DRUG0 , and DRUG0 , can antagonize the effects of DRUG0 . Potential for Drug Interactions : It appears possible , although there is no supporting experimental evidence , that the high renal clearance of DRUG0 (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0748061 0.0609375 0.073928 0.0538228 0.020209 0.045088 0.0229258 0.0176688 0.00407771 0.00486857 0.00389019 0.00588413 0.00429027 0.00701967 0.00538277 0.00361438 0.00572528 0.00357634 0.00389918 0.00493076 0.00397843 0.00598678 0.00495024 0.00849923 0.0053394 0.0085083 0.0328521 0.087952 0.0683735 0.087826 0.0595082 0.0582182 0.054166 0.0872963	The concomitant use of other DRUG1 including DRUG2 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0768076 0.0569126 0.0586225 0.0459817 0.0199358 0.0498929 0.0320146 0.0114785 0.0120069 0.020489 0.0039097 0.00548267 0.00419533 0.00672737 0.00500559 0.00343308 0.00541036 0.00341137 0.00365809 0.00447668 0.00367123 0.00546947 0.0045907 0.00792602 0.00502606 0.00804099 0.0302719 0.0909996 0.0730181 0.0915099 0.0597855 0.0565392 0.0521864 0.0811129	The concomitant use of other DRUG1 including DRUG0 , DRUG2 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0760912 0.0558526 0.0568573 0.0454096 0.0202841 0.0493649 0.0293484 0.0094694 0.00819356 0.00944513 0.011316 0.0213069 0.0051458 0.00647654 0.004825 0.00358588 0.00531654 0.00362487 0.00377934 0.00442613 0.0037778 0.00544101 0.00463715 0.00777707 0.00507891 0.00809935 0.0295539 0.0913646 0.0734254 0.0919351 0.059876 0.0564243 0.0521405 0.0803497	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG2 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0681187 0.0510287 0.0556387 0.0405676 0.0159868 0.0381184 0.0236102 0.00800761 0.00693437 0.00770272 0.0081569 0.011392 0.0190938 0.0611009 0.028558 0.0050185 0.00537321 0.00374262 0.00397394 0.00463376 0.0039557 0.00559039 0.00467407 0.00766767 0.00502247 0.00798254 0.0295462 0.0820713 0.0647791 0.0839787 0.0563231 0.0537506 0.0491129 0.0787879	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG2 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0715721 0.0530941 0.0567833 0.0428158 0.0179156 0.0431595 0.0257554 0.00839114 0.00754396 0.00772795 0.00848061 0.00958798 0.0113381 0.0331939 0.00912317 0.00932717 0.0201148 0.00428535 0.00395749 0.00428573 0.00375086 0.00515081 0.00436312 0.00712739 0.0047788 0.00757564 0.0270564 0.085761 0.0688221 0.0901529 0.0591503 0.0555931 0.0512007 0.0810637	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG2 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0701974 0.0523893 0.0565247 0.0423337 0.0173123 0.0415283 0.0246698 0.00806824 0.00718165 0.00759189 0.00830756 0.0096851 0.0107508 0.028668 0.00684942 0.00514428 0.00793998 0.00716428 0.0138219 0.0197508 0.00408565 0.00544847 0.00420056 0.00690089 0.00471367 0.00745213 0.0280334 0.0873452 0.0689023 0.0911225 0.0602269 0.0557617 0.0504847 0.0794426	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0681884 0.0506215 0.0540988 0.0407662 0.0170234 0.0410278 0.0244583 0.00797145 0.00715025 0.00739707 0.00820632 0.00942651 0.0108346 0.0296344 0.00656248 0.00495245 0.0068032 0.00526492 0.00863084 0.0078929 0.00938782 0.022179 0.00441279 0.00644018 0.00459606 0.00706035 0.026089 0.0886097 0.0715587 0.0959707 0.0619532 0.0561875 0.0506742 0.0779693	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0676896 0.0501173 0.0534789 0.0402663 0.016951 0.0406812 0.0242913 0.00790556 0.00709618 0.00728719 0.00810773 0.00928118 0.0106989 0.0291867 0.00638356 0.00480466 0.00645568 0.00485394 0.00747491 0.00593717 0.00491698 0.0080198 0.00952556 0.0247098 0.00533759 0.0065704 0.0250424 0.0874257 0.071885 0.0979649 0.0626884 0.0566258 0.0513352 0.0790034	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0570174 0.0417938 0.0430556 0.0323269 0.013886 0.0332693 0.0210264 0.00656942 0.00612171 0.00584863 0.00676118 0.00721012 0.00923979 0.0247496 0.00506092 0.00387243 0.00479306 0.0036763 0.00609141 0.00426645 0.00355034 0.00464633 0.0043767 0.00681066 0.0106604 0.024052 0.0795657 0.123568 0.0795426 0.0965769 0.0627271 0.0554537 0.0476174 0.0642155	The concomitant use of other DRUG1 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0650904 0.0468944 0.0536069 0.0369731 0.0154077 0.0194265 0.0222615 0.0639178 0.0141068 0.00887903 0.00989404 0.0111036 0.0197533 0.0524436 0.0231314 0.00438705 0.00501328 0.00353327 0.00378371 0.00444076 0.00380846 0.00539281 0.00456132 0.00743986 0.00495417 0.0078883 0.0287411 0.0826056 0.0640499 0.0818889 0.0538709 0.0508332 0.0462788 0.0736386	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG2 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0659303 0.0480184 0.0541374 0.0378364 0.0162571 0.0203396 0.0237865 0.0689073 0.0151981 0.00891309 0.00981106 0.00938055 0.0118026 0.0344402 0.00874768 0.00950311 0.0181725 0.00402225 0.0037526 0.00409291 0.00361409 0.00488282 0.00423112 0.00678424 0.00469316 0.00746507 0.0258628 0.089124 0.069373 0.0868903 0.0548454 0.0506302 0.0465432 0.0720112	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG0 , DRUG2 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0649132 0.0471321 0.0532573 0.0368994 0.0158346 0.0202292 0.0234515 0.0677729 0.0145835 0.00890266 0.00981439 0.00973033 0.0111578 0.0310133 0.0069976 0.006133 0.0075894 0.00690626 0.0134668 0.0173683 0.00376408 0.00507576 0.0039988 0.00647991 0.00455954 0.00727545 0.0268986 0.0887168 0.0681248 0.0870417 0.0559873 0.0511856 0.0462003 0.071538	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0633709 0.04614 0.0519385 0.03618 0.0155727 0.0196578 0.0229534 0.0665799 0.014595 0.00870866 0.00955319 0.00951118 0.0114586 0.0323308 0.00682881 0.00616611 0.00655119 0.0052028 0.00931464 0.00743105 0.00939104 0.0204678 0.00416354 0.00611415 0.00443251 0.00687611 0.025023 0.0899876 0.0696293 0.0891847 0.056389 0.0512155 0.0464252 0.0706552	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.063349 0.0461024 0.0518398 0.0361435 0.0155667 0.0196176 0.0229367 0.0664694 0.0146409 0.00866187 0.00947909 0.00945619 0.0114288 0.0320843 0.00672176 0.00609338 0.00630654 0.0048688 0.00850419 0.00591716 0.00550033 0.00750597 0.00962001 0.0228613 0.00503136 0.00633721 0.0238231 0.0873344 0.0686515 0.0894891 0.0565588 0.0516253 0.0472511 0.0722226	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0549785 0.0406482 0.0437312 0.0307325 0.013049 0.0152309 0.0181953 0.0524459 0.0121744 0.00683958 0.00770115 0.0072589 0.00990541 0.0268039 0.00529706 0.00488549 0.00467447 0.00367796 0.006877 0.00432315 0.00412711 0.00451917 0.0049178 0.00654698 0.0114351 0.0230212 0.0761542 0.120143 0.0723819 0.0885479 0.0588038 0.0530982 0.0460741 0.0607995	The concomitant use of other DRUG0 including DRUG1 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0523457 0.0354804 0.0420409 0.0274634 0.0100672 0.012546 0.00741573 0.0136863 0.0138099 0.0564315 0.0121576 0.0132775 0.0201262 0.0580513 0.027696 0.00506876 0.00588175 0.0041562 0.00444522 0.00520607 0.00441716 0.00626405 0.00524431 0.00863639 0.00565908 0.00902247 0.0324436 0.0901125 0.0696459 0.089891 0.0590126 0.0563226 0.0518617 0.0841131	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG2 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0545119 0.0375941 0.0447323 0.0292484 0.0108945 0.0133701 0.008143 0.0153468 0.0162017 0.0667353 0.0133773 0.0118113 0.0116753 0.0309096 0.00979477 0.0102995 0.0201183 0.00458551 0.00436635 0.00484242 0.0042117 0.00580898 0.00491498 0.00806355 0.00538683 0.0085834 0.0298562 0.0938716 0.0725186 0.0932678 0.0601264 0.0569796 0.0530337 0.0848181	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG0 , DRUG2 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0534328 0.036835 0.0439829 0.0286972 0.0107188 0.0131204 0.0079275 0.0148605 0.0157972 0.0645943 0.013035 0.0117946 0.0113257 0.0279386 0.00774915 0.00606398 0.00858704 0.00758492 0.0134907 0.0188868 0.00432596 0.00595995 0.00465522 0.00769075 0.00525054 0.00837584 0.0308798 0.0947198 0.0723102 0.094017 0.061337 0.0575383 0.0526147 0.0839018	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG0 , DRUG0 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0520635 0.0360087 0.042993 0.0281527 0.0105035 0.0128979 0.00786405 0.0148707 0.0159209 0.0649555 0.0130289 0.0116643 0.0114679 0.0288624 0.00751575 0.00609101 0.00748198 0.00577602 0.00897966 0.00821409 0.00987493 0.0218462 0.00473485 0.00715676 0.00508414 0.00791752 0.0288111 0.0952276 0.0730613 0.0961904 0.0620714 0.0574923 0.0525405 0.0826786	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.051773 0.0357609 0.0426968 0.0279953 0.0104329 0.0128464 0.00786183 0.0149441 0.0159785 0.0649437 0.0130094 0.0115684 0.0113952 0.0286433 0.00737713 0.00600021 0.0071915 0.00540178 0.00805043 0.00645423 0.00529649 0.00835576 0.0101129 0.0244908 0.00568164 0.00726602 0.0275276 0.0927117 0.0725773 0.0978404 0.0628869 0.0579524 0.0531965 0.0837786	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0450286 0.031769 0.0360542 0.0233756 0.0084876 0.00977315 0.0064263 0.0116341 0.012629 0.0521661 0.0104915 0.00878493 0.00948938 0.0236659 0.00564597 0.00468962 0.00519746 0.0039474 0.00644657 0.00452442 0.0037921 0.00486823 0.00459977 0.00699424 0.0111063 0.0247046 0.0821017 0.125025 0.0791549 0.0981445 0.0644078 0.057352 0.0493674 0.0681544	The concomitant use of other DRUG0 including DRUG0 , DRUG1 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0394273 0.0276066 0.0375322 0.0260088 0.00945041 0.0132645 0.00705604 0.0104363 0.0069098 0.0198175 0.0219609 0.101183 0.0227852 0.0595666 0.0309658 0.005554 0.00626435 0.00443877 0.00471276 0.0054027 0.00458877 0.00640462 0.00537837 0.00877856 0.0057352 0.00909603 0.0320713 0.0869296 0.0654867 0.0845502 0.0540997 0.0513899 0.0476694 0.0774781	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG2 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0467275 0.0324413 0.0408825 0.0272396 0.00987265 0.0128337 0.00696714 0.00997085 0.00662769 0.0181959 0.0195691 0.0869264 0.0141818 0.0310964 0.0111219 0.0113024 0.0217079 0.00492725 0.00468137 0.00512613 0.00446837 0.00609655 0.0051732 0.00839106 0.00563291 0.00893295 0.0304444 0.0947168 0.0720258 0.0921619 0.0587067 0.05566 0.0520963 0.0830935	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG0 , DRUG2 , other DRUG0 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0448795 0.0314712 0.0405277 0.0271993 0.00998843 0.0130145 0.00707331 0.0101387 0.00678464 0.0188856 0.021024 0.0911247 0.013725 0.0280471 0.00872439 0.00692944 0.00924042 0.00803725 0.0136816 0.019204 0.0044679 0.00612668 0.00482967 0.00788123 0.00541955 0.00859464 0.0310853 0.0938157 0.0706487 0.0914521 0.0588878 0.0553028 0.0508849 0.0809023	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG0 , DRUG0 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0434455 0.0306577 0.0396677 0.0267767 0.00981718 0.0128481 0.00698059 0.0101037 0.00678348 0.0192114 0.0216099 0.0929907 0.0139356 0.0289273 0.0084581 0.00700782 0.00800858 0.00610443 0.00938438 0.00840239 0.0100325 0.0219898 0.00484162 0.00731084 0.00522268 0.00809557 0.0291055 0.094072 0.0709488 0.0928021 0.0591347 0.0549931 0.0506564 0.0796732	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG0 , DRUG0 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0431158 0.0304196 0.0394622 0.0267292 0.00979297 0.0128501 0.00696589 0.0101567 0.00682236 0.019417 0.0217642 0.0931707 0.0139187 0.0287347 0.00830805 0.00690501 0.00768921 0.00571302 0.00841589 0.00659882 0.00547573 0.00843399 0.0102349 0.0243941 0.00574998 0.00739032 0.0279373 0.0914585 0.0703692 0.0942494 0.0598616 0.0554169 0.0512777 0.0807999	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0377632 0.0268735 0.0327475 0.0218419 0.00775293 0.00963397 0.0054026 0.00765514 0.00520609 0.0143746 0.0159907 0.0707613 0.0113484 0.0244849 0.00645641 0.00553783 0.00568834 0.00431726 0.00692839 0.00470785 0.00400776 0.00502393 0.0047769 0.00717971 0.0114365 0.0250124 0.082721 0.124799 0.0776801 0.0965523 0.0631269 0.0562614 0.0486054 0.0673439	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG1 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0303851 0.019048 0.0230434 0.01552 0.00595407 0.0084169 0.00447694 0.00660644 0.00404011 0.0102036 0.00703126 0.0220452 0.0263933 0.0791499 0.101022 0.0212338 0.0136842 0.0114432 0.0208857 0.0240861 0.00507455 0.00622225 0.00493648 0.00753824 0.00549457 0.00857606 0.0294464 0.0978402 0.0718628 0.0881084 0.0547483 0.0501206 0.0462545 0.0691071	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG1 , DRUG0 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0285432 0.0181051 0.0222624 0.0151565 0.00583788 0.0082718 0.00439447 0.00650058 0.0040106 0.0103576 0.00728745 0.0231526 0.0284793 0.0855705 0.108923 0.0214035 0.0117318 0.00811369 0.0150879 0.0102414 0.0134635 0.0256982 0.00525143 0.00711037 0.00521336 0.00798561 0.0271964 0.0969483 0.0706075 0.0852244 0.0523276 0.0482198 0.0450671 0.0662546	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG1 , DRUG0 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0280559 0.0178059 0.0220283 0.0150724 0.00582457 0.0082728 0.00439558 0.00652916 0.00403929 0.0104962 0.00741338 0.0236921 0.029117 0.0873484 0.110027 0.0214475 0.0113906 0.00763942 0.0139929 0.00824862 0.00903202 0.00940813 0.0129469 0.026937 0.005988 0.00736248 0.0260376 0.0940678 0.0687955 0.0840708 0.0516213 0.0479941 0.0454194 0.0674815	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG1 , DRUG0 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.025724 0.0166278 0.0191751 0.012903 0.00481423 0.00638829 0.00360078 0.00516182 0.00326151 0.00798718 0.00591784 0.0174787 0.0218371 0.0600668 0.0817094 0.0173578 0.00860281 0.00596942 0.0115327 0.0062527 0.0071641 0.00589419 0.00753388 0.00829118 0.0168429 0.0281867 0.0904003 0.123449 0.0703309 0.0856759 0.0565873 0.051875 0.0460313 0.0593688	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG1 , DRUG0 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0451157 0.0279058 0.0305517 0.0190806 0.00645179 0.00874694 0.00472634 0.00650445 0.00382443 0.00804429 0.00497844 0.0134879 0.00744523 0.0168328 0.0141987 0.0122378 0.0668071 0.0117819 0.0173918 0.024805 0.00522284 0.00688993 0.00555312 0.00866731 0.00611234 0.0094413 0.0318215 0.109012 0.0829223 0.107455 0.0669884 0.0616939 0.057396 0.0899057	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG1 , other DRUG2 , DRUG0 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0465787 0.0295398 0.0313662 0.0191693 0.0064195 0.00833433 0.00457608 0.00616816 0.00369389 0.00760388 0.00478053 0.012638 0.00739866 0.0165779 0.0133582 0.0118796 0.0626342 0.00862128 0.0128395 0.0104161 0.0125811 0.0265591 0.00542541 0.00789265 0.00579559 0.00884924 0.0299533 0.109576 0.0837853 0.107619 0.0672508 0.0623239 0.0584239 0.0893712	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG1 , other DRUG0 , DRUG2 , DRUG0 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0462652 0.0294484 0.0313186 0.0192119 0.00641393 0.00830692 0.00455348 0.00615349 0.00367189 0.00758705 0.00476582 0.012644 0.00729178 0.0166623 0.0137756 0.0121115 0.0632525 0.00811379 0.011872 0.00852199 0.00802411 0.00937832 0.0123295 0.0277091 0.00629708 0.00805369 0.0293128 0.106467 0.0823731 0.107782 0.0671897 0.0626172 0.0593307 0.0911929	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG1 , other DRUG0 , DRUG0 , DRUG2 , and DRUG0 may produce additive CNS depressant effects .
4	4	0.0396409 0.0258538 0.0258769 0.0157023 0.00498358 0.00599202 0.00345932 0.00457743 0.00279521 0.00543129 0.00352084 0.00877578 0.00547913 0.011627 0.00908911 0.00838084 0.0434676 0.00623834 0.0100851 0.00613233 0.00621007 0.00577564 0.00654926 0.00811888 0.0150901 0.0270722 0.087454 0.140257 0.0863471 0.10516 0.0691122 0.0631637 0.056084 0.0764964	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG1 , other DRUG0 , DRUG0 , DRUG0 , and DRUG2 may produce additive CNS depressant effects .
4	4	0.0318262 0.0201255 0.0213253 0.0133139 0.00430692 0.00554766 0.00315981 0.00428413 0.00253755 0.00491263 0.00296951 0.00750616 0.00396438 0.00762927 0.00498342 0.00275939 0.00576842 0.0030524 0.003496 0.00624424 0.00474236 0.0122685 0.0149015 0.0934141 0.0236175 0.0352682 0.103038 0.13877 0.0842715 0.0990719 0.0617684 0.0547932 0.048346 0.066016	The concomitant use of other DRUG0 including DRUG0 , DRUG0 , DRUG0 , general DRUG0 , DRUG0 , other DRUG0 , DRUG0 , DRUG1 , and DRUG2 may produce additive CNS depressant effects .
2	2	0.0355082 0.0149569 0.0149114 0.0246129 0.0256946 0.0305174 0.0251039 0.0294311 0.0303203 0.0419478 0.0634204 0.0564228 0.0756669 0.0462402 0.0487087 0.0728533 0.0392012 0.0244244 0.0429202 0.0327847 0.015655 0.0347027 0.0116496 0.00482514 0.00789074 0.0257409 0.0167846 0.00903826 0.0219188 0.028895 0.0472516	DRUG1 or other medications with anticholinergic activity when used concurrently with DRUG2 may result in increased risk of urinary retention and/or severe constipation , which may lead to paralytic ileus .
2	2	0.0243396 0.0168932 0.0174411 0.0301889 0.0170496 0.0304841 0.0333499 0.0284139 0.0287217 0.0431032 0.0920612 0.0520861 0.061534 0.0489943 0.0422526 0.0653371 0.0526164 0.0521802 0.0828413 0.0613231 0.0463119 0.0724768	It has been reported that the incidence of bradycardia was increased when DRUG1 was combined with DRUG2 for induction of anesthesia .
2	2	0.03037 0.0230657 0.0110697 0.0353526 0.0401776 0.0252147 0.0297056 0.0362046 0.020255 0.00771767 0.0198838 0.00755308 0.0184417 0.0220623 0.0225574 0.0963564 0.0367796 0.0906446 0.059641 0.0542257 0.0551481 0.0768768 0.089984 0.0638141 0.0268982	In addition , CNS toxicity has been reported (confusion , disorientation , respiratory depression , apnea , seizures) following coadministration of DRUG1 with DRUG2 ;
4	4	0.123137 0.105778 0.095228 0.149202 0.048598 0.100136 0.107585 0.103549 0.0586694 0.108119	Interaction study of DRUG1 and DRUG2 with co-administered drugs .
4	4	0.130575 0.0311359 0.0549359 0.044454 0.0484877 0.0782285 0.0851881 0.130614 0.118855 0.0324854 0.0319064 0.0645515 0.0676813 0.0809007	DRUG1 and DRUG2 are DRUG0 used in treating urinary and respiratory tract infections .
4	4	0.085123 0.022823 0.0632443 0.114834 0.0924389 0.0621214 0.073508 0.126392 0.128049 0.0299176 0.0279063 0.0521621 0.0549498 0.0665308	DRUG1 and DRUG0 are DRUG2 used in treating urinary and respiratory tract infections .
4	4	0.0220008 0.0216162 0.0930186 0.137946 0.0963807 0.0659089 0.0810523 0.134177 0.122396 0.0282175 0.026925 0.050933 0.0541572 0.065271	DRUG0 and DRUG1 are DRUG2 used in treating urinary and respiratory tract infections .
4	4	0.0804163 0.142282 0.039905 0.158428 0.0633972 0.0420545 0.0380169 0.0460186 0.042498 0.038273 0.0512308 0.0397663 0.0214726 0.0100057 0.00357376 0.00591929 0.00426045 0.0104778 0.00770579 0.0364819 0.117816	Being DRUG1 and lomefloxacin DRUG2 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.0925428 0.0743747 0.0129438 0.0465166 0.0418148 0.0616313 0.0589498 0.055244 0.0590141 0.0567706 0.105072 0.117885 0.0917969 0.0306296 0.0051685 0.00388496 0.00289083 0.00484711 0.00448593 0.0150672 0.0584698	Being DRUG1 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG2 , DRUG0 , DRUG0 and DRUG0 .
4	4	0.113977 0.0910356 0.01558 0.0544756 0.0500483 0.0682356 0.0628401 0.0560441 0.0586188 0.05731 0.0919075 0.0980543 0.0489008 0.0105504 0.00647218 0.0141767 0.00307501 0.00486038 0.0045688 0.0169451 0.0723238	Being DRUG1 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG0 , DRUG2 , DRUG0 and DRUG0 .
4	4	0.117841 0.0938331 0.0160143 0.0556801 0.0512879 0.0694318 0.0633801 0.0560501 0.0587471 0.0573373 0.0920678 0.0928768 0.0446313 0.00800002 0.00283734 0.00487447 0.00529709 0.0174959 0.00498653 0.0165916 0.0707384	Being DRUG1 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG2 and DRUG0 .
4	4	0.117085 0.0937113 0.0159127 0.0557205 0.0501437 0.0671275 0.0598601 0.0522524 0.0537441 0.0539462 0.084659 0.0833447 0.0384396 0.00697803 0.00250861 0.00373535 0.00289173 0.00847093 0.0166504 0.0498499 0.0829687	Being DRUG1 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG0 and DRUG2 .
4	4	0.0392868 0.0222617 0.0202703 0.101048 0.126136 0.0626898 0.0450074 0.0529299 0.0544007 0.0566802 0.0877356 0.113796 0.092426 0.0300313 0.00537902 0.00416265 0.00296872 0.00496518 0.00455469 0.015253 0.0580173	Being DRUG0 and lomefloxacin DRUG1 the interaction study of was carried out with DRUG2 , DRUG0 , DRUG0 and DRUG0 .
1	4	0.0494418 0.0277164 0.0247064 0.115208 0.141535 0.0668663 0.045065 0.0512768 0.0510485 0.0562131 0.0796036 0.102879 0.0540116 0.0110145 0.00665669 0.0142742 0.0031929 0.00496471 0.00465448 0.0170817 0.0725896	Being DRUG0 and lomefloxacin DRUG1 the interaction study of was carried out with DRUG0 , DRUG2 , DRUG0 and DRUG0 .
1	4	0.0503381 0.0284112 0.0251301 0.118263 0.143933 0.0667667 0.0449003 0.0506602 0.0510751 0.0567743 0.0809993 0.0999314 0.0497846 0.00824881 0.00295096 0.00510363 0.00558177 0.0180798 0.00515909 0.0166746 0.0712339	Being DRUG0 and lomefloxacin DRUG1 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG2 and DRUG0 .
1	4	0.0503705 0.0284193 0.0248458 0.116268 0.142616 0.0658589 0.043528 0.0484586 0.0471062 0.0533704 0.0740879 0.0860939 0.0422536 0.00739125 0.00266911 0.00398996 0.00317608 0.00918719 0.0173543 0.0507434 0.0822123	Being DRUG0 and lomefloxacin DRUG1 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG0 and DRUG2 .
4	4	0.0295527 0.0184531 0.00918884 0.0541572 0.0783554 0.0782054 0.0629851 0.0431694 0.0368112 0.0401937 0.0917747 0.0908475 0.0513186 0.0159161 0.0104509 0.039349 0.0116827 0.0167104 0.0228752 0.0814759 0.116527	Being DRUG0 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG0 , DRUG1 , DRUG0 and DRUG2 .
4	4	0.0316732 0.0194791 0.00972899 0.053451 0.0714737 0.0635197 0.0501581 0.0339413 0.0262859 0.0287298 0.0662126 0.0592576 0.0375525 0.0128689 0.0067869 0.0158915 0.0221439 0.128327 0.030634 0.0950462 0.136838	Being DRUG0 and lomefloxacin DRUG0 the interaction study of was carried out with DRUG0 , DRUG0 , DRUG1 and DRUG2 .
4	4	0.0599259 0.0439668 0.0472872 0.0952013 0.0246802 0.0591881 0.0966589 0.0829602 0.0578439 0.0404386 0.0232534 0.0256622 0.0676653 0.0249058 0.00707169 0.0142386 0.0150018 0.0228778 0.0180348 0.0140603 0.0182874 0.0241338 0.018349 0.0205789 0.0180885 0.017467 0.0421728	The response of DRUG1 and DRUG2 after interaction with co-administered drugs at different conditions and temperature were noted using a Shimadzu HPLC system with PDA detector .
4	4	0.148761 0.0483562 0.0636117 0.0462622 0.075398 0.0336338 0.0211522 0.0100338 0.028353 0.0260012 0.0522422 0.0448741 0.0275378 0.0154954 0.0157308 0.00951825 0.0163449 0.0207899 0.00843728 0.0236416 0.025927 0.0693132 0.0910412 0.0775433	DRUG1 and DRUG2 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
3	3	0.0869943 0.0245441 0.0374551 0.0993522 0.142036 0.123803 0.046743 0.0104045 0.0179783 0.0226645 0.0587616 0.0426373 0.0286264 0.0132909 0.0116726 0.00621372 0.0106475 0.014178 0.00558397 0.0158105 0.0173052 0.0473423 0.0630203 0.052934	DRUG1 and DRUG0 reacts faster with DRUG2 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
4	3	0.0812493 0.0209233 0.0386047 0.0934369 0.114408 0.061037 0.0255804 0.0277242 0.0516813 0.0401568 0.071988 0.0559682 0.0399561 0.0178233 0.0143245 0.00718285 0.0115915 0.0149423 0.00603968 0.016951 0.0184739 0.0492941 0.0655104 0.0551518	DRUG1 and DRUG0 reacts faster with DRUG0 and DRUG2 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
4	3	0.0531852 0.00770464 0.0118594 0.0248883 0.0289499 0.0149842 0.00953057 0.00529479 0.0199298 0.0301018 0.0945508 0.119352 0.116199 0.102601 0.0532555 0.0302209 0.0270244 0.0282939 0.00901373 0.0222934 0.0224615 0.0521253 0.0663665 0.0498134	DRUG1 and DRUG0 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG2 in basic media and DRUG0 in neutral media .
4	3	0.067379 0.010011 0.0153125 0.032448 0.0369015 0.0197985 0.0137068 0.00689322 0.0210626 0.0256238 0.0562271 0.0479718 0.0296503 0.0190512 0.0246095 0.0253625 0.0670348 0.0952142 0.0344061 0.0513954 0.0418743 0.0711428 0.101924 0.0849994	DRUG1 and DRUG0 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG2 in neutral media .
4	3	0.027003 0.0212816 0.094132 0.110374 0.178248 0.112459 0.0385901 0.00878023 0.0163493 0.019293 0.0518404 0.0390627 0.026326 0.0126499 0.0112691 0.00600104 0.0103978 0.0140476 0.00551042 0.0156415 0.0171057 0.0472827 0.0632515 0.0531038	DRUG0 and DRUG1 reacts faster with DRUG2 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
4	3	0.0229632 0.0187608 0.0712829 0.11432 0.157574 0.0578509 0.0248051 0.024874 0.0478169 0.0374104 0.0664231 0.0514829 0.03723 0.0168712 0.0136598 0.00682818 0.0110628 0.0143595 0.00582092 0.0163613 0.017833 0.0476179 0.0633795 0.0534113	DRUG0 and DRUG1 reacts faster with DRUG0 and DRUG2 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
4	3	0.0168778 0.00968377 0.0330977 0.0270603 0.039841 0.0168129 0.010223 0.00567264 0.021497 0.0302996 0.0936046 0.121402 0.116554 0.0990262 0.0513701 0.0293633 0.0265952 0.0281082 0.00901618 0.0223332 0.0224509 0.0522288 0.066716 0.0501654	DRUG0 and DRUG1 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG2 in basic media and DRUG0 in neutral media .
4	3	0.0216289 0.0122792 0.0417479 0.0365478 0.0509696 0.0218353 0.0141442 0.00711382 0.0213179 0.0226724 0.0506361 0.0442038 0.0278051 0.0181584 0.0245555 0.0252065 0.0684138 0.0975276 0.0347681 0.0527534 0.0431497 0.0733531 0.103879 0.0853327	DRUG0 and DRUG1 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG2 in neutral media .
4	4	0.0127414 0.00623704 0.0260486 0.0886234 0.135972 0.0811428 0.120733 0.0407002 0.0668101 0.0505741 0.0589113 0.0449779 0.0337869 0.015236 0.0121205 0.00589915 0.00945133 0.0121244 0.00495792 0.0139988 0.0152686 0.0412876 0.0554177 0.0469788	DRUG0 and DRUG0 reacts faster with DRUG1 and DRUG2 in acidic media whereas with DRUG0 in basic media and DRUG0 in neutral media .
4	4	0.00881288 0.00426658 0.0186321 0.0768274 0.126172 0.0820618 0.052071 0.00968316 0.0160439 0.0380261 0.0722922 0.0733832 0.0666501 0.0717765 0.0379298 0.0231485 0.0237132 0.0245153 0.00781547 0.0187114 0.0174572 0.0400855 0.0519373 0.0379876	DRUG0 and DRUG0 reacts faster with DRUG1 and DRUG0 in acidic media whereas with DRUG2 in basic media and DRUG0 in neutral media .
4	4	0.00964978 0.00474693 0.0210413 0.0879284 0.149085 0.101827 0.0570948 0.00797725 0.0143763 0.0250703 0.033249 0.033478 0.0306593 0.017922 0.0209292 0.0203827 0.0472976 0.0635871 0.0219768 0.0336837 0.0279602 0.0485852 0.0673303 0.0541616	DRUG0 and DRUG0 reacts faster with DRUG1 and DRUG0 in acidic media whereas with DRUG0 in basic media and DRUG2 in neutral media .
4	4	0.00704621 0.00359136 0.0126565 0.0474355 0.0637587 0.0381452 0.0172719 0.0129561 0.0332585 0.051057 0.108621 0.0938622 0.0806581 0.0878192 0.0463789 0.0280275 0.0286237 0.0292725 0.00935042 0.0223456 0.020762 0.0482243 0.0628728 0.0460049	DRUG0 and DRUG0 reacts faster with DRUG0 and DRUG1 in acidic media whereas with DRUG2 in basic media and DRUG0 in neutral media .
4	4	0.00822705 0.004068 0.0141263 0.0493975 0.0692437 0.044739 0.0220907 0.0166211 0.0343732 0.0384446 0.0630129 0.0567796 0.0489234 0.0265974 0.0279512 0.025902 0.0578091 0.0783838 0.0273884 0.0417271 0.0346626 0.0600325 0.0830949 0.066404	DRUG0 and DRUG0 reacts faster with DRUG0 and DRUG1 in acidic media whereas with DRUG0 in basic media and DRUG2 in neutral media .
4	4	0.0078109 0.00352134 0.00996678 0.0236094 0.0336012 0.0146768 0.00882144 0.0051408 0.0150942 0.01731 0.0531148 0.0912271 0.0698703 0.0557463 0.0522947 0.072593 0.046594 0.0787838 0.0313233 0.0439616 0.0432859 0.0652349 0.0870846 0.0693328	DRUG0 and DRUG0 reacts faster with DRUG0 and DRUG0 in acidic media whereas with DRUG1 in basic media and DRUG2 in neutral media .
1	1	0.0634632 0.0502309 0.058106 0.067833 0.0696951 0.047123 0.0566662 0.0316579 0.0394706 0.0711607 0.0364581 0.0357214 0.0334173 0.042592 0.0347715 0.0578143 0.0341907 0.0152907 0.01044 0.0297262 0.0355725 0.0148175 0.0637813	Do not exceed a 5 mg daily dose of DRUG1 when administered with therapeutic doses of DRUG2 or other potent CYP3A4 inhibitors .
2	4	0.0377528 0.0250299 0.0167031 0.0138573 0.0655708 0.0457261 0.0647738 0.024047 0.0152464 0.0180107 0.0204093 0.0235932 0.0214355 0.0227261 0.0225133 0.0114127 0.0177322 0.00905732 0.00520363 0.00770424 0.0109748 0.00951778 0.0114738 0.00366795 0.00853111 0.00852725 0.0203889 0.00934275 0.00812513 0.00697519 0.00393033 0.00776769 0.00824483 0.00372193 0.0046319 0.00714875 0.00464647 0.00372396 0.00983563 0.00658672 0.00625387 0.006862 0.00377728 0.0034117 0.00133708 0.00187166 0.00390327 0.00434426 0.00390522 0.00670611 0.00849753 0.00633367 0.0075821 0.0113847 0.013252 0.00447419 0.00857216 0.00278987 0.00466339 0.0115624 0.0215178 0.0346027 0.0392275 0.0204424 0.0113298 0.0228711 0.0295592 0.0137332 0.0389635	Patients with Congenital or Acquired QT Prolongation In a study of the effect of DRUG1 on the QT interval in 76 healthy women , the QT prolonging effect appeared less with DRUG0 10 mg than with 30 mg (three times the maximum recommended dose) , and the effect of DRUG0 30 mg did not appear as large as that of the positive control DRUG2 at its therapeutic dose .
4	4	0.032126 0.0174214 0.00968782 0.00767724 0.0376448 0.0298736 0.031065 0.00881543 0.00497236 0.00476584 0.00461721 0.00435169 0.00451268 0.00355802 0.00502627 0.00534468 0.00799711 0.00732166 0.00519399 0.00591678 0.0118859 0.0105511 0.0157055 0.00531948 0.0140913 0.0163371 0.0502047 0.0288197 0.0385505 0.0558187 0.0476775 0.0474741 0.0134712 0.00616529 0.00631716 0.00449054 0.00380112 0.00310587 0.00669568 0.00626427 0.0081388 0.00799183 0.00417538 0.0043151 0.00159666 0.00218323 0.00478047 0.00517906 0.00474263 0.00791034 0.0100459 0.00716131 0.00850352 0.0124984 0.0143887 0.00475364 0.00902367 0.00284761 0.00477638 0.0118205 0.0218933 0.0344683 0.0390326 0.020362 0.011355 0.0231776 0.0298476 0.0138109 0.038583	Patients with Congenital or Acquired QT Prolongation In a study of the effect of DRUG0 on the QT interval in 76 healthy women , the QT prolonging effect appeared less with DRUG1 10 mg than with 30 mg (three times the maximum recommended dose) , and the effect of DRUG0 30 mg did not appear as large as that of the positive control DRUG2 at its therapeutic dose .
4	4	0.0342525 0.0184358 0.0101644 0.00797083 0.0393172 0.0310718 0.0319356 0.00915864 0.00516091 0.00498568 0.00479264 0.00446522 0.00460401 0.00359975 0.0050145 0.00508106 0.00720367 0.0065086 0.00426012 0.00459192 0.00867024 0.00701264 0.0100019 0.00352142 0.00748643 0.00808731 0.0210397 0.00985791 0.00894361 0.00783842 0.00435244 0.00876075 0.0100469 0.00459533 0.00617193 0.0107444 0.00708895 0.00590306 0.0168548 0.0123238 0.0122871 0.014713 0.00914221 0.00892501 0.00374345 0.00595169 0.0226655 0.0260011 0.034501 0.0410816 0.0181898 0.0132972 0.0173391 0.0199255 0.0296475 0.0079766 0.018941 0.00418513 0.00678829 0.0153462 0.0245461 0.0336335 0.0412206 0.0217364 0.0120805 0.0252194 0.0323767 0.0151775 0.0414844	Patients with Congenital or Acquired QT Prolongation In a study of the effect of DRUG0 on the QT interval in 76 healthy women , the QT prolonging effect appeared less with DRUG0 10 mg than with 30 mg (three times the maximum recommended dose) , and the effect of DRUG1 30 mg did not appear as large as that of the positive control DRUG2 at its therapeutic dose .
4	4	0.0378794 0.0136821 0.028995 0.0393255 0.0506286 0.103784 0.100535 0.0803709 0.0997192 0.0810244 0.108115 0.0648591 0.0447913 0.0643497 0.0819416	DRUG1 : Concomitant DRUG0 administration decreased the mean AUC of total DRUG2 approximately 55% .
3	3	0.024535 0.0305812 0.0523819 0.0558149 0.0343531 0.0805998 0.0640627 0.0591804 0.0699329 0.0637072 0.126748 0.0865417 0.0589409 0.0824002 0.11022	DRUG0 : Concomitant DRUG1 administration decreased the mean AUC of total DRUG2 approximately 55% .
2	2	0.0706429 0.0718817 0.032727 0.0297015 0.0490393 0.0361958 0.048899 0.072771 0.077562 0.069265 0.0609757 0.0591499 0.0962257 0.0458111 0.0426463 0.0466158 0.0898905	The incremental LDL-C reduction due to adding DRUG1 to DRUG2 may be reduced by this interaction .
4	4	0.0771114 0.0294937 0.0758264 0.113292 0.0467579 0.0887577 0.072677 0.0530055 0.0431045 0.0336728 0.0284817 0.0240413 0.0656819 0.047626 0.096302 0.104168	DRUG1 : The safety and effectiveness of DRUG2 administered with DRUG0 have not been established .
4	4	0.0197791 0.024198 0.0461198 0.062753 0.0343965 0.0628925 0.0634474 0.0595117 0.0548591 0.0616013 0.0521382 0.0305719 0.0748314 0.0793442 0.134608 0.138948	DRUG0 : The safety and effectiveness of DRUG1 administered with DRUG2 have not been established .
1	1	0.0630724 0.0642927 0.0743569 0.109084 0.0718768 0.0597476 0.0656571 0.0347732 0.0897888 0.0688727 0.0645784 0.0459519 0.0501635 0.0648124 0.0729715	Co-administration of DRUG1 with DRUG2 is not recommended until use in patients is studied .
4	4	0.0738137 0.0186493 0.0377301 0.021831 0.0207823 0.014501 0.00580895 0.016664 0.0398074 0.072771 0.148724 0.135747 0.0816791 0.0637212 0.0442272 0.0860838 0.117459	DRUG1 : In a pharmacokinetic study , concomitant DRUG0 administration increased total DRUG2 concentrations approximately 1.5-fold .
3	3	0.0224158 0.0219895 0.0355744 0.0304498 0.0346624 0.0259575 0.0162973 0.0463039 0.0818533 0.0519556 0.0931985 0.0911287 0.0811559 0.0703153 0.0553632 0.107553 0.133826	DRUG0 : In a pharmacokinetic study , concomitant DRUG1 administration increased total DRUG2 concentrations approximately 1.5-fold .
4	4	0.073455 0.0185489 0.037539 0.0216971 0.0206689 0.0144105 0.00575767 0.0164007 0.039371 0.0719327 0.146996 0.133826 0.0812119 0.0640534 0.0445452 0.0910069 0.118579	DRUG1 : In a pharmacokinetic study , concomitant DRUG0 administration increased total DRUG2 concentrations approximately 1.7-fold .
3	4	0.0223454 0.0219133 0.0354575 0.0302951 0.0345054 0.025773 0.0161 0.0458272 0.0809402 0.0513112 0.0921862 0.0896434 0.080348 0.0706222 0.0549955 0.113102 0.134635	DRUG0 : In a pharmacokinetic study , concomitant DRUG1 administration increased total DRUG2 concentrations approximately 1.7-fold .
4	4	0.05995 0.0300084 0.107744 0.0644613 0.0833691 0.0640474 0.095345 0.0538155 0.078957 0.0756468 0.0379965 0.0297428 0.0361525 0.0187046 0.00717774 0.00249111 0.0038963 0.00228289 0.00415859 0.00272714 0.00606774 0.00322159 0.00681819 0.029042 0.0961762	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG2 was co-administered with DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0642973 0.0316482 0.108227 0.060112 0.0711043 0.0467547 0.0681442 0.033376 0.0337131 0.038406 0.0572352 0.0764525 0.0841072 0.0856416 0.0292341 0.00429068 0.0030015 0.00217779 0.0028041 0.00225268 0.00356803 0.00292048 0.00562587 0.0173736 0.0675318	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG0 was co-administered with DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0762943 0.0371726 0.124594 0.0683861 0.0790442 0.0505346 0.0705044 0.0340519 0.0318938 0.0345074 0.0530016 0.0603804 0.0684842 0.0430914 0.0120732 0.00892715 0.0157149 0.00268115 0.00311064 0.00248995 0.00398966 0.00330422 0.00641689 0.0216919 0.0876592	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG0 was co-administered with DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0778239 0.0380595 0.127325 0.07 0.0804922 0.0517116 0.0716388 0.03438 0.0318271 0.0343808 0.0521721 0.0581083 0.0638557 0.0384961 0.00925872 0.00402871 0.00558026 0.00613563 0.0133507 0.00284566 0.00416663 0.00358066 0.0069912 0.0223104 0.0914803	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG0 was co-administered with DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0778191 0.0382169 0.127722 0.0703128 0.0807066 0.0519802 0.0718924 0.0345124 0.0319691 0.0345619 0.0522599 0.0574404 0.0623623 0.0371328 0.00888526 0.00377131 0.00440459 0.00273505 0.00529582 0.00621618 0.0160625 0.00428983 0.00800676 0.0218015 0.0896425	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG0 was co-administered with DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0720295 0.0353634 0.118979 0.0652465 0.0754043 0.0484492 0.0681595 0.033117 0.0301671 0.0355705 0.0542957 0.0650881 0.0649823 0.0360459 0.00783565 0.0034246 0.00359439 0.00233228 0.0036439 0.00263698 0.00497535 0.00637105 0.0153057 0.0482079 0.0987739	DRUG1 : No clinically significant pharmacokinetic interactions were seen when DRUG0 was co-administered with DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0172083 0.0309253 0.0885915 0.0532772 0.0718695 0.0550412 0.074423 0.0513839 0.0616746 0.0630275 0.0651457 0.0618026 0.0694499 0.069195 0.0236175 0.00465725 0.00444095 0.00318275 0.00408242 0.00337344 0.0051567 0.00437015 0.00800335 0.0251855 0.0809149	DRUG0 : No clinically significant pharmacokinetic interactions were seen when DRUG1 was co-administered with DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0177834 0.0317978 0.0905527 0.0546843 0.0746878 0.0567438 0.0724712 0.0524979 0.0614242 0.0610263 0.0649683 0.061319 0.0666691 0.0587939 0.012873 0.0076378 0.0151239 0.00318598 0.00359687 0.002897 0.00456919 0.00392444 0.00757879 0.0253477 0.0878454	DRUG0 : No clinically significant pharmacokinetic interactions were seen when DRUG1 was co-administered with DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0179244 0.0320767 0.0912619 0.0551376 0.0753223 0.0571104 0.0726938 0.0523156 0.0605491 0.0602657 0.0641825 0.0612747 0.0649984 0.055287 0.01046 0.00407647 0.00640671 0.00691681 0.0157538 0.00352598 0.00476748 0.00417915 0.00818178 0.0250892 0.0902425	DRUG0 : No clinically significant pharmacokinetic interactions were seen when DRUG1 was co-administered with DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0180174 0.0322587 0.0918226 0.0553862 0.075664 0.0572062 0.0724552 0.0520783 0.0602738 0.0600448 0.0637474 0.061571 0.0650685 0.0541155 0.0101273 0.00370524 0.00506593 0.00361105 0.0066145 0.00691937 0.0187757 0.00533018 0.00944953 0.0228405 0.087851	DRUG0 : No clinically significant pharmacokinetic interactions were seen when DRUG1 was co-administered with DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0179879 0.0322688 0.0905143 0.0551537 0.0746057 0.0568198 0.0738706 0.0522501 0.0570892 0.0560992 0.062288 0.0581124 0.0584673 0.0499305 0.00923867 0.00346479 0.00432018 0.00316129 0.00463803 0.0036078 0.00609499 0.00784632 0.0183265 0.0545453 0.0892986	DRUG0 : No clinically significant pharmacokinetic interactions were seen when DRUG1 was co-administered with DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0512748 0.0323804 0.0956815 0.160648 0.0842654 0.0849055 0.120038 0.071719 0.0520166 0.0357227 0.0156493 0.0186492 0.0180791 0.0197507 0.0379925 0.0107 0.003542 0.00575719 0.0169081 0.0643206	DRUG1 : The total DRUG2 level increased 12-fold in one renal transplant patient receiving multiple medications , including DRUG0 .
3	3	0.0206373 0.0230824 0.0494319 0.0838213 0.0627003 0.0690821 0.109691 0.0654288 0.0533312 0.0547389 0.0342326 0.0387791 0.0444784 0.032575 0.0676991 0.0391493 0.00925941 0.018425 0.048953 0.0745041	DRUG0 : The total DRUG1 level increased 12-fold in one renal transplant patient receiving multiple medications , including DRUG2 .
1	1	0.0854747 0.0584467 0.113244 0.0848366 0.177849 0.0671378 0.0826381 0.0450006 0.0533888 0.0742631 0.0565193 0.101201	Patients who take both DRUG1 and DRUG2 should be carefully monitored .
4	4	0.0647621 0.0365649 0.0598371 0.0752542 0.0708472 0.0677598 0.0796553 0.0640591 0.0614095 0.0231873 0.00729648 0.00729413 0.00879866 0.0225105 0.033619 0.0118268 0.0267172 0.0277443 0.020655 0.0151712 0.0107193 0.0154635 0.0161754 0.0109476 0.0429207 0.0380585 0.0807452	Multiple dose studies of DRUG1 given in combination with DRUG2 ( DRUG0 ) in rats and rabbits during organogenesis result in higher DRUG0 and statin exposures .
4	4	0.0562029 0.031101 0.0494858 0.0618338 0.0564646 0.0567979 0.0698027 0.0648708 0.0483521 0.0271273 0.0336381 0.0361594 0.015212 0.0230495 0.0291216 0.0107112 0.0279539 0.0296012 0.0220444 0.016678 0.0118561 0.0170248 0.0178215 0.0120392 0.0462894 0.0411263 0.0876346	Multiple dose studies of DRUG1 given in combination with DRUG0 ( DRUG2 ) in rats and rabbits during organogenesis result in higher DRUG0 and statin exposures .
4	4	0.0301181 0.0143848 0.0202202 0.0197894 0.0304805 0.0380338 0.0333593 0.0540463 0.0766427 0.039777 0.0136921 0.010173 0.013499 0.0293456 0.0312013 0.0119789 0.0403354 0.0465948 0.0526956 0.0480331 0.0512692 0.104328 0.0361885 0.0089719 0.0259389 0.0377547 0.0811482	Multiple dose studies of DRUG0 given in combination with DRUG1 ( DRUG0 ) in rats and rabbits during organogenesis result in higher DRUG2 and statin exposures .
4	4	0.0246671 0.011392 0.0152534 0.0154628 0.0240075 0.0288946 0.0259681 0.0423985 0.0416682 0.0287806 0.0301852 0.065428 0.017175 0.0354476 0.0309302 0.0115139 0.0453575 0.046988 0.0524136 0.0509109 0.0540803 0.103213 0.0356355 0.00899128 0.0271472 0.039865 0.0862248	Multiple dose studies of DRUG0 given in combination with DRUG0 ( DRUG1 ) in rats and rabbits during organogenesis result in higher DRUG2 and statin exposures .
3	4	0.0741531 0.0781918 0.0456282 0.0503323 0.0464938 0.0776549 0.0685567 0.0587089 0.0413074 0.0553392 0.0484351 0.0616146 0.0328271 0.00710004 0.0128383 0.00851385 0.0124359 0.0186274 0.0131372 0.00643053 0.0301418 0.0297394 0.0200432 0.0189403 0.0230986 0.0597102	When DRUG1 is administered with an DRUG2 in a woman of childbearing potential , refer to the pregnancy category and package labeling for the DRUG0 .
4	4	0.074801 0.0602528 0.0384901 0.0373917 0.0341685 0.0466343 0.0345116 0.0264788 0.0348097 0.0414621 0.036452 0.0458171 0.0273198 0.00633879 0.0141228 0.00884203 0.0125083 0.0207074 0.0183478 0.0114285 0.0539945 0.0714178 0.0607106 0.0659917 0.0582136 0.0587865	When DRUG1 is administered with an DRUG0 in a woman of childbearing potential , refer to the pregnancy category and package labeling for the DRUG2 .
3	4	0.103317 0.0802622 0.123408 0.0357658 0.0441813 0.0156242 0.038854 0.0158072 0.00838176 0.015992 0.0247986 0.0104178 0.0262898 0.0632458 0.0818186 0.0827837 0.121398 0.107656	Interaction of DRUG1 and DRUG2 , in vitro and in vivo , in human A375 melanoma cells .
4	4	0.0339746 0.0356737 0.0768239 0.0349033 0.0322189 0.039662 0.0507947 0.0706876 0.083188 0.0407348 0.0153909 0.0109591 0.014101 0.0106306 0.0326348 0.0436888 0.010531 0.0178069 0.00678712 0.0232908 0.032574 0.0494308 0.0591768 0.0405349 0.0457755 0.0372822 0.0507434	We evaluated mechanisms of interaction between the alkyating agent DRUG1 ( DRUG0 ) and the pro-oxidant , DRUG2 , in the human A375 melanoma cell line .
4	4	0.0359312 0.0367273 0.0751628 0.0366183 0.0347004 0.038147 0.046901 0.0640526 0.0486596 0.0206876 0.0154984 0.0348517 0.0143817 0.0106735 0.0381755 0.0404852 0.0102791 0.0174562 0.00657734 0.0241065 0.0363862 0.0545017 0.0648856 0.0448185 0.0510233 0.0415672 0.0567447	We evaluated mechanisms of interaction between the alkyating agent DRUG0 ( DRUG1 ) and the pro-oxidant , DRUG2 , in the human A375 melanoma cell line .
2	4	0.0629865 0.0597365 0.0488465 0.0694741 0.0167573 0.0198314 0.00621538 0.0187486 0.00777624 0.0167164 0.0138005 0.00605759 0.0170849 0.0328552 0.0245168 0.0622706 0.0542045 0.0250481 0.0140813 0.0430364 0.0191562 0.0543422 0.0235691 0.0369631 0.0161021 0.0201733 0.00818441 0.00342214 0.00594766 0.0279379 0.0274494 0.0314587 0.026485 0.0360551 0.0427089	The effect of DRUG1 and DRUG2 , alone and in combination , was evaluated for growth inhibition (MTT) , radiolabeled drug uptake , cellular thiol content (HPLC) , and DNA strand breaks (Comet assay) .
4	4	0.0342961 0.0347705 0.0288288 0.0403395 0.0396259 0.0498304 0.114759 0.0708379 0.0256209 0.0858075 0.0820556 0.0976485 0.0435575 0.0903516 0.0801688 0.0815018	There was a >75% reduction in cellular glutathione and cysteine with DRUG1 but not DRUG2 .
4	2	0.138245 0.039794 0.0698097 0.0765338 0.0994305 0.0517258 0.0206948 0.0154791 0.0152384 0.0342249 0.0237293 0.0339884 0.0245484 0.0434556 0.0623362 0.066432 0.0980179 0.0863161	DRUG1 and DRUG2 show additive effects in vitro but not in vivo in human A375 melanoma cells .
3	3	0.0448851 0.038693 0.0421965 0.078115 0.0677029 0.0808535 0.0467149 0.0456385 0.038616 0.0430415 0.0367575 0.0363097 0.0198566 0.0580747 0.0440439 0.0473177 0.0336457 0.0211244 0.0166373 0.00494606 0.00679932 0.0228137 0.0165844 0.0268497 0.0214861 0.0205931 0.0397034	Coadministration of DRUG1 with DRUG2 resulted in increased plasma DRUG0 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG0 plasma concentrations (31%) .
4	4	0.0737258 0.0784324 0.0754863 0.0389692 0.0604685 0.0816098 0.0513815 0.0667955 0.0521883 0.03449 0.0336114 0.0316709 0.0163006 0.047072 0.0429041 0.0413963 0.0275647 0.0180233 0.0134965 0.00385242 0.00507288 0.0164386 0.0119782 0.0191494 0.0152956 0.0145783 0.0280475	Coadministration of DRUG1 with DRUG0 resulted in increased plasma DRUG2 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG0 plasma concentrations (31%) .
4	4	0.0815977 0.0849767 0.0870984 0.0453143 0.0586269 0.0614621 0.0270488 0.0290499 0.0197602 0.0201118 0.0183928 0.0213232 0.0135841 0.039977 0.0340222 0.039391 0.0359739 0.0268997 0.0246233 0.0126924 0.0183097 0.0506203 0.0342189 0.0303882 0.0245057 0.0213324 0.0386985	Coadministration of DRUG1 with DRUG0 resulted in increased plasma DRUG0 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG2 plasma concentrations (31%) .
4	4	0.0645853 0.0698709 0.0524111 0.0617015 0.0572789 0.0764022 0.045538 0.0579716 0.0575284 0.0383155 0.037411 0.0329326 0.0165689 0.0491245 0.0470134 0.0445312 0.0293658 0.0193627 0.0146987 0.0042022 0.00554678 0.0180697 0.0132858 0.0213496 0.0170919 0.0163272 0.0315146	Coadministration of DRUG0 with DRUG1 resulted in increased plasma DRUG2 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG0 plasma concentrations (31%) .
4	4	0.0713421 0.0795648 0.0668067 0.072278 0.066729 0.0509 0.0205978 0.0210217 0.0186798 0.0185159 0.0170232 0.0198408 0.0134012 0.0423271 0.0382831 0.0423694 0.0380106 0.0278187 0.0252905 0.0129299 0.0192749 0.0556909 0.0367684 0.0324823 0.0263739 0.0232317 0.042448	Coadministration of DRUG0 with DRUG1 resulted in increased plasma DRUG0 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG2 plasma concentrations (31%) .
4	4	0.0435228 0.034121 0.026695 0.0206759 0.0443019 0.0524392 0.0285648 0.0530423 0.0487715 0.0476872 0.038512 0.0260595 0.0171692 0.0510809 0.0478958 0.0517186 0.0414952 0.0320541 0.0312066 0.0158782 0.0212307 0.0585919 0.0393808 0.0332592 0.0272163 0.0241426 0.043287	Coadministration of DRUG0 with DRUG0 resulted in increased plasma DRUG1 concentrations (57%) , increased plasma bismuth trough concentrations (48%) , and increased DRUG2 plasma concentrations (31%) .
3	4	0.0606681 0.0531238 0.0786135 0.074531 0.0592491 0.0400964 0.0500416 0.0626993 0.0534522 0.055016 0.0558648 0.069186 0.0645046 0.0576763 0.0223295 0.0221345 0.0227193 0.0360399 0.0620541	Coadministration with DRUG1 results in a slight decrease in the rate of DRUG2 absorption that is clinically unimportant .
3	3	0.0841361 0.0605257 0.0298076 0.0226837 0.0185614 0.034623 0.0388346 0.035574 0.0416118 0.0509737 0.0341666 0.0274249 0.036469 0.0588407 0.036211 0.0410397 0.0383824 0.0427056 0.031488 0.0086845 0.0236406 0.0182469 0.0224909 0.0192876 0.0157735 0.0311099 0.0249821 0.0253827 0.0463416	Coadministration with a high dose of DRUG1 (170 mEq) results in a 28% decrease in plasma concentrations of DRUG2 and may decrease plasma concentrations of bismuth from DRUG0 .
4	3	0.0704395 0.0508136 0.0254242 0.0194873 0.0161992 0.0302917 0.0338463 0.0293652 0.033981 0.0431127 0.0289623 0.0228951 0.0227121 0.0290699 0.0150603 0.0213075 0.0200284 0.0185207 0.0167471 0.0141391 0.0494578 0.0306186 0.0365749 0.0312554 0.0327452 0.0654032 0.0652589 0.0631281 0.0631546	Coadministration with a high dose of DRUG1 (170 mEq) results in a 28% decrease in plasma concentrations of DRUG0 and may decrease plasma concentrations of bismuth from DRUG2 .
4	4	0.0253492 0.0126472 0.00557245 0.00520057 0.0049232 0.0112558 0.0157084 0.0326758 0.052976 0.0581137 0.0199532 0.0213698 0.0422046 0.069068 0.03759 0.0492342 0.0477016 0.046042 0.10047 0.0118362 0.0474115 0.0313277 0.0277788 0.022598 0.0230466 0.0412621 0.0529652 0.0452267 0.0384919	Coadministration with a high dose of DRUG0 (170 mEq) results in a 28% decrease in plasma concentrations of DRUG1 and may decrease plasma concentrations of bismuth from DRUG2 .
4	4	0.0553588 0.0588434 0.0383783 0.0507217 0.0759629 0.0860556 0.0961736 0.0869389 0.0178717 0.0538793 0.0448255 0.0811236 0.0600975 0.0552001 0.0601957 0.0783736	For information on drug interactions associated with DRUG1 , refer to the DRUG2 package insert .
1	1	0.0686782 0.114073 0.0902229 0.0909269 0.0594301 0.0482174 0.0397212 0.0747819 0.053881 0.0198041 0.00507373 0.00433733 0.00280922 0.00263361 0.00185077 0.00256405 0.00212595 0.0025432 0.00175954 0.00151239 0.00254385 0.00192506 0.00253153 0.00172611 0.00154531 0.00175164 0.00304549 0.00293411 0.0069715 0.00658645 0.0211132 0.0389971 0.0507912 0.0591188 0.0381492 0.0733234	You cannot take DRUG1 if you have taken a DRUG2 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
1	1	0.0622919 0.106232 0.0850974 0.0838832 0.0545804 0.0371194 0.0366402 0.0646061 0.0359175 0.0147105 0.013517 0.0184156 0.00498869 0.00380518 0.00237881 0.00308751 0.0025912 0.0031409 0.00217009 0.00184242 0.00314202 0.00236805 0.00312415 0.00212639 0.00188984 0.00213956 0.00382802 0.00363917 0.00865188 0.00796273 0.0246404 0.0444315 0.0569076 0.067924 0.0439127 0.0862959	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG2 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
1	1	0.0657854 0.110712 0.0883366 0.0872624 0.0569373 0.0363352 0.0348579 0.0584444 0.0292398 0.00965888 0.00678212 0.00656758 0.00529293 0.00440721 0.00597377 0.0111081 0.00263588 0.00283195 0.00212591 0.00181275 0.00309739 0.00227938 0.00318923 0.00211449 0.00189321 0.00207221 0.00378642 0.00355786 0.00875141 0.00784934 0.0241815 0.0444197 0.0590919 0.0710609 0.0453385 0.0902082	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	1	0.0609953 0.103505 0.0835794 0.0814988 0.053275 0.0315974 0.0324565 0.0543638 0.0266672 0.00886393 0.0055554 0.00552402 0.00417261 0.00317238 0.00244845 0.0067701 0.00932059 0.0139295 0.00351011 0.00225152 0.00341698 0.00267289 0.00366985 0.00250175 0.00212142 0.0023647 0.00421948 0.00405117 0.0097203 0.00920562 0.0283427 0.0495507 0.0653623 0.0764886 0.0486451 0.0942093	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
1	1	0.064119 0.107727 0.0858048 0.0849415 0.0550702 0.0342669 0.0328577 0.0536842 0.0259279 0.00836398 0.00542703 0.00505388 0.0037748 0.00287684 0.0019991 0.00396511 0.00368805 0.00463571 0.00403765 0.00418476 0.0103635 0.0024261 0.00286291 0.00219554 0.00199778 0.00227565 0.00375202 0.00364385 0.00876746 0.00858255 0.0278366 0.0493686 0.0656111 0.0750232 0.0491622 0.093725	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	1	0.0598296 0.101344 0.0817012 0.0798052 0.0520879 0.0301783 0.0309056 0.0512026 0.024876 0.00823812 0.00498239 0.00498767 0.0036783 0.00277062 0.00197582 0.00383877 0.00341163 0.00421875 0.00322199 0.00258738 0.00704005 0.01006 0.0165173 0.00393473 0.0027768 0.00318986 0.00433583 0.00437266 0.00998639 0.00974038 0.0304568 0.0508185 0.0661589 0.0769283 0.0508115 0.0970302	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
1	1	0.0639002 0.107457 0.0853271 0.0847288 0.0543625 0.0340276 0.0328292 0.0530854 0.0258048 0.00831924 0.00539762 0.00489838 0.0036461 0.00278209 0.00190885 0.00365221 0.00322181 0.00383634 0.00294328 0.00208166 0.00426874 0.0040313 0.00504907 0.0042757 0.00380588 0.00520854 0.0136333 0.00382509 0.00740706 0.00909759 0.0270524 0.0466324 0.0603806 0.0725372 0.0516278 0.0969567	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG2 ( DRUG0 ) in the last 14 days .
1	1	0.0592851 0.10009 0.0796665 0.0787374 0.0503937 0.0311219 0.03066 0.0493518 0.0243589 0.00779566 0.00499157 0.0045515 0.00339705 0.00254633 0.00175548 0.00327118 0.00294679 0.00350312 0.00269541 0.00188562 0.00372907 0.00342225 0.00415573 0.00319452 0.00242668 0.00342327 0.00869529 0.0184226 0.0304024 0.0150681 0.0327668 0.0477713 0.0650585 0.0727557 0.0546068 0.0910955	You cannot take DRUG1 if you have taken a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG2 ) in the last 14 days .
4	4	0.0426684 0.0651499 0.071042 0.0501137 0.0504918 0.0643955 0.0441691 0.0789128 0.0622541 0.0693594 0.0219661 0.00900663 0.0062237 0.00656415 0.0069692 0.011273 0.00255577 0.00248787 0.00192401 0.00158289 0.00259944 0.00191747 0.00253296 0.00172502 0.00153561 0.00169884 0.00298291 0.00285613 0.00672885 0.00650963 0.0205801 0.0384322 0.0529385 0.0638334 0.0411133 0.0829056	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0416897 0.0634835 0.0692512 0.048813 0.0487964 0.0621047 0.0425003 0.0755233 0.0587312 0.0618786 0.0187725 0.00702245 0.00459357 0.00475648 0.00355491 0.00614906 0.00915462 0.0109234 0.00293917 0.00184678 0.00262902 0.00208513 0.00269132 0.00191823 0.00163345 0.00185699 0.00318606 0.0031344 0.00716708 0.00766308 0.0247323 0.0441766 0.0595913 0.0681476 0.0436032 0.0832996	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0407854 0.0622178 0.0680983 0.0481414 0.0484573 0.0621061 0.0424508 0.0758626 0.0599324 0.0641015 0.0183709 0.00692115 0.00441003 0.0045141 0.00358367 0.00499159 0.00680329 0.00457925 0.00406092 0.00393842 0.00895688 0.00215119 0.00232922 0.00183741 0.00162406 0.00188805 0.00298705 0.00294128 0.0067503 0.00734628 0.0245518 0.0443952 0.060084 0.0680614 0.0449932 0.084776	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0406918 0.0617351 0.0677066 0.0476743 0.0474992 0.0606268 0.0411798 0.0737849 0.0575047 0.0590491 0.0171606 0.00635187 0.00409514 0.00413436 0.00319156 0.00463903 0.00632287 0.00395273 0.0031693 0.00266366 0.00564617 0.00857464 0.0123566 0.00296688 0.00212363 0.00247411 0.00326466 0.00329762 0.00732335 0.00796818 0.0259723 0.0450528 0.0600349 0.0686047 0.0454983 0.0857075	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0407234 0.0620223 0.068139 0.048265 0.0485218 0.0625241 0.0426616 0.0770322 0.0610836 0.0645634 0.0181468 0.00672718 0.00426592 0.00426805 0.00330746 0.0046605 0.00621044 0.00381243 0.00303333 0.00253156 0.00451904 0.0059209 0.00450788 0.00385863 0.00323555 0.00425527 0.0111285 0.00304922 0.00570233 0.00744962 0.0223623 0.0403299 0.0536432 0.0649023 0.0460577 0.0865778	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG2 ( DRUG0 ) in the last 14 days .
4	4	0.0402871 0.061401 0.0672631 0.0470152 0.0467414 0.0593849 0.0403171 0.0714099 0.056642 0.0597117 0.0171141 0.00625471 0.00392474 0.0039766 0.00292698 0.00411235 0.00558654 0.00342103 0.00272347 0.00219476 0.00384369 0.004901 0.00365277 0.00278723 0.00207375 0.00330567 0.00655519 0.0171595 0.0242427 0.0117334 0.0261695 0.0436258 0.0606818 0.0638449 0.0473706 0.0756437	You cannot take DRUG0 if you have taken a DRUG1 ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG2 ) in the last 14 days .
4	4	0.0473294 0.0665258 0.0705692 0.0473393 0.0406507 0.0458575 0.0255042 0.0451514 0.024735 0.0188035 0.0208748 0.054804 0.0113115 0.00951628 0.00905425 0.0133408 0.00302811 0.00308021 0.00246246 0.00203558 0.00335557 0.00249866 0.00325153 0.00225555 0.0020111 0.00223979 0.00386239 0.00371792 0.00863608 0.00854709 0.02709 0.0508193 0.0700497 0.0843051 0.0546893 0.110697	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0450567 0.0634305 0.0674555 0.0448936 0.0382325 0.0428299 0.023444 0.0423151 0.0231839 0.0181335 0.0194917 0.0470619 0.00863738 0.00727904 0.0057555 0.00786805 0.011801 0.0124818 0.0034461 0.00223353 0.00332084 0.00263556 0.00337187 0.00243707 0.00209105 0.0023962 0.00406991 0.00401053 0.00906171 0.00997916 0.0323843 0.0578269 0.0776862 0.0883972 0.0568089 0.108491	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0440112 0.0620569 0.0664812 0.0446065 0.0387817 0.0433819 0.0239467 0.0414429 0.0231066 0.0177365 0.0196728 0.0459763 0.00824292 0.00710175 0.00622064 0.00652439 0.00924322 0.00566925 0.00513597 0.00496978 0.0109282 0.00264204 0.00291547 0.00232381 0.00205677 0.00242003 0.0037945 0.00374496 0.00851753 0.00958074 0.032205 0.0582785 0.0786659 0.0884925 0.0588667 0.110258	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.0432771 0.0607867 0.0649565 0.0432223 0.0366723 0.0409405 0.0222831 0.0403223 0.022259 0.0177349 0.018844 0.0439553 0.00759465 0.0065207 0.0056141 0.00616659 0.00880381 0.00499548 0.00417782 0.00367491 0.00714517 0.0110702 0.0151151 0.00364667 0.00265333 0.00313621 0.00414553 0.00416783 0.00922769 0.0102568 0.0335775 0.0582422 0.0773652 0.0881574 0.0587263 0.110565	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , or DRUG0 ( DRUG0 ) in the last 14 days .
4	4	0.044018 0.062017 0.0666659 0.0447491 0.0388511 0.0435788 0.0238638 0.0416181 0.0233435 0.0183011 0.0203645 0.0464193 0.00797756 0.00678067 0.00578522 0.00612224 0.00855089 0.00488302 0.00422614 0.00394388 0.00597664 0.00825367 0.00578426 0.00499129 0.00414009 0.00538942 0.0141162 0.00387216 0.00727102 0.00967955 0.0290284 0.052402 0.069941 0.0843309 0.0600855 0.112678	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG2 ( DRUG0 ) in the last 14 days .
4	4	0.0429562 0.0605474 0.0650666 0.0431963 0.0371781 0.0411164 0.0229884 0.0395503 0.0220557 0.0168671 0.0181906 0.0416899 0.00716631 0.0061476 0.00506591 0.0053059 0.00755247 0.00426731 0.00366601 0.00326543 0.0049738 0.0066732 0.00455164 0.00350783 0.00262139 0.00437628 0.00815654 0.0222742 0.0303744 0.014774 0.0337068 0.0559012 0.078224 0.0808359 0.0600436 0.0951652	You cannot take DRUG0 if you have taken a DRUG0 ( DRUG1 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG2 ) in the last 14 days .
4	1	0.212221 0.144741 0.11431 0.011216 0.0151844 0.0335651 0.024341 0.0301089 0.0513879 0.0322562 0.0236432 0.0509571 0.0445265 0.0747256 0.0651033 0.0717127	Changes in DRUG1 and other diabetes drug therapies may be necessary during treatment with DRUG2 .
2	2	0.158044 0.185719 0.0781591 0.102207 0.080553 0.102826 0.0564958 0.0204604 0.021692 0.0325813 0.161262	DRUG1 may reduce the effects of DRUG2 ( DRUG0 ) .
2	2	0.133579 0.151073 0.0731736 0.0893438 0.0810041 0.0866328 0.0456039 0.05296 0.0835814 0.054668 0.148381	DRUG1 may reduce the effects of DRUG0 ( DRUG2 ) .
4	4	0.0457599 0.033919 0.0431208 0.0285499 0.0286097 0.0807906 0.053199 0.0413155 0.0375341 0.0608351 0.0535261 0.0509747 0.0448217 0.04646 0.0138772 0.010826 0.0106881 0.0184949 0.015534 0.00456122 0.00280131 0.00365798 0.0029988 0.003657 0.00268021 0.00215779 0.00338145 0.00268942 0.00349171 0.00247299 0.00202108 0.00329223 0.00255611 0.00345389 0.00239939 0.00197693 0.00332395 0.00253122 0.00351709 0.00239411 0.00199329 0.00345588 0.00259034 0.00369097 0.00245423 0.00209109 0.00377348 0.00278946 0.00402458 0.00271352 0.00235597 0.00265445 0.00490361 0.00498565 0.0127343 0.0193333 0.142604	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0447595 0.0332455 0.0422488 0.0279934 0.028036 0.0792243 0.0524357 0.0407038 0.0369138 0.0598762 0.0518858 0.049222 0.0444842 0.0487899 0.0152522 0.0130855 0.00946341 0.0156082 0.00857874 0.00870951 0.00748233 0.0143627 0.00345689 0.00343727 0.00274772 0.00218847 0.00332159 0.00266087 0.00337289 0.0023984 0.00199664 0.00318051 0.0024968 0.00331583 0.00230978 0.00193869 0.00318941 0.00246139 0.00337406 0.00230497 0.00195061 0.00331514 0.00251646 0.00354704 0.00236838 0.00204496 0.00362906 0.00270951 0.00388157 0.00262225 0.00231363 0.00263441 0.00478265 0.00488867 0.0125565 0.0191182 0.142607	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0439496 0.0325926 0.0413089 0.0273105 0.0274754 0.077864 0.0511099 0.0396035 0.035664 0.0578802 0.0501914 0.0479251 0.0428789 0.0454374 0.0137314 0.0117223 0.00876043 0.0147172 0.00758907 0.00747273 0.00668726 0.00891103 0.013998 0.0175375 0.00436139 0.00266147 0.00352059 0.00288562 0.0036411 0.00262911 0.00209589 0.00335261 0.00265838 0.00353103 0.00246164 0.00199576 0.00332187 0.00256837 0.00353383 0.00241439 0.0019846 0.00342058 0.00259579 0.00367261 0.00245381 0.00206704 0.00371881 0.00277632 0.00398399 0.00270234 0.00232908 0.00265474 0.00487304 0.00499498 0.012811 0.0195321 0.143478	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0437716 0.0325117 0.0412204 0.0273014 0.0274242 0.0774392 0.0511815 0.0395304 0.0355142 0.0575492 0.0494513 0.0473684 0.0431878 0.0460673 0.014315 0.0119094 0.00853197 0.0145657 0.00776167 0.00830828 0.00793958 0.00759858 0.0117132 0.00765937 0.00734132 0.00640218 0.0132932 0.0031278 0.00324545 0.00258842 0.00206974 0.00322027 0.00259401 0.00334101 0.00235421 0.00196469 0.00318442 0.00250499 0.00335987 0.00231278 0.00195329 0.00327794 0.00252945 0.00350671 0.00235975 0.00203401 0.00357254 0.00270511 0.00382604 0.00260002 0.00229809 0.00264624 0.00474322 0.00489188 0.0125467 0.0191872 0.142596	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0430997 0.0319585 0.0404312 0.026709 0.0269508 0.0763767 0.0500337 0.0386742 0.0346299 0.0563221 0.0485914 0.0467954 0.0419867 0.0430267 0.0127001 0.0105798 0.00804663 0.0135375 0.0069314 0.00745614 0.00726392 0.00718435 0.0110859 0.00671029 0.00628075 0.00523455 0.00804529 0.0119984 0.0174273 0.00417301 0.00255383 0.00347582 0.00285424 0.00365454 0.00260464 0.00207574 0.00338 0.00267872 0.00359415 0.0024727 0.00201598 0.00342386 0.00264501 0.00368211 0.00247527 0.0020747 0.0036932 0.00279663 0.00396508 0.0027033 0.00232955 0.00267919 0.00485655 0.00502057 0.0128346 0.0196162 0.143603	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0429851 0.0319242 0.0404231 0.0267598 0.0269359 0.0760855 0.0502223 0.0387205 0.0346609 0.0562272 0.0481509 0.0464108 0.0424653 0.0443573 0.0136302 0.0112326 0.00812438 0.0138139 0.00719997 0.00779532 0.00744493 0.00706237 0.0111038 0.00678413 0.00690308 0.00610345 0.00665185 0.00975687 0.006981 0.00641643 0.00572588 0.0125048 0.00294495 0.00316279 0.00251023 0.00201718 0.00320199 0.00257771 0.00335471 0.00233833 0.00197101 0.00325884 0.0025571 0.00346986 0.00235416 0.00203165 0.00352583 0.00270664 0.00376866 0.0025741 0.00228871 0.00266246 0.00470581 0.00489275 0.012494 0.0191869 0.14188	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0424002 0.0314391 0.0397364 0.0262387 0.0265229 0.0751971 0.0492278 0.0380221 0.0339746 0.0553519 0.0476331 0.0460947 0.0414839 0.041822 0.0122126 0.0100781 0.00773862 0.0128944 0.00648115 0.00683706 0.00665811 0.0066362 0.01019 0.00610794 0.00616379 0.00552332 0.00632953 0.00927232 0.00610642 0.00533527 0.00438853 0.00756135 0.0110482 0.0172357 0.00408219 0.00250019 0.00348535 0.00286036 0.00369759 0.00260222 0.00209026 0.00347152 0.00274575 0.00372309 0.00252385 0.00210286 0.00368858 0.00284044 0.00395885 0.00271495 0.00234151 0.00271805 0.00485429 0.00506562 0.012868 0.0197288 0.143393	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0423167 0.0314256 0.0397631 0.0263144 0.0265212 0.0749432 0.0494335 0.0380911 0.0340498 0.0552875 0.0472671 0.0457177 0.0419155 0.0432471 0.0131675 0.0108082 0.0078794 0.013353 0.00686571 0.00741562 0.00709959 0.00675099 0.0105568 0.00635565 0.00653149 0.0058056 0.00625975 0.00928029 0.00607893 0.0056738 0.00485007 0.00614259 0.00868652 0.00658847 0.00591433 0.00534857 0.0121417 0.00287077 0.00316142 0.00249268 0.00201612 0.0032694 0.00262256 0.00345197 0.00237951 0.00204847 0.0035013 0.00273216 0.00372433 0.00256197 0.00229399 0.00269942 0.00468748 0.00491865 0.0124671 0.0192455 0.141007	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0417953 0.0309906 0.0391506 0.0258471 0.0261521 0.0741673 0.0485464 0.0374841 0.0334656 0.05457 0.0468843 0.0454886 0.0410337 0.0410208 0.0119085 0.00977609 0.00755291 0.0125397 0.00625003 0.00654019 0.00637723 0.00638799 0.00972577 0.00575221 0.00566487 0.00503058 0.00589511 0.00853262 0.00557346 0.00511596 0.00438561 0.00589719 0.00831454 0.00580554 0.00482344 0.00391281 0.00730508 0.0104846 0.0171579 0.00408818 0.00250612 0.00358027 0.00293009 0.00382412 0.00265805 0.00217938 0.0037391 0.00294684 0.00399659 0.0027638 0.00238421 0.0027975 0.00489473 0.0051645 0.012978 0.0199639 0.143298	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0417367 0.0309929 0.0391997 0.0259368 0.0261612 0.0739468 0.0487576 0.0375677 0.033568 0.0545385 0.0465854 0.0451434 0.0414347 0.0424055 0.0128151 0.0104919 0.00769743 0.0130095 0.00663545 0.00715057 0.00686596 0.00655141 0.0102034 0.00608796 0.00622682 0.00553872 0.00602242 0.00887728 0.00575329 0.0054117 0.00465561 0.00584304 0.00830865 0.00570921 0.00492507 0.00404777 0.00584416 0.00792174 0.00634168 0.00560066 0.00513223 0.0121083 0.00289488 0.00325926 0.00255201 0.00208962 0.00351118 0.00280066 0.00370199 0.00258467 0.00232952 0.00278535 0.00471235 0.00499538 0.0125076 0.0194262 0.140097	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0412213 0.0305654 0.0386052 0.0254863 0.0257985 0.073172 0.0479009 0.0369785 0.0330059 0.0538308 0.046193 0.0448756 0.0405591 0.0403515 0.011672 0.00954538 0.00740285 0.0122631 0.0060852 0.00634512 0.00619389 0.00622323 0.00944607 0.00555614 0.00541816 0.00480194 0.00568543 0.00815695 0.00528938 0.00473577 0.00399546 0.00552557 0.007654 0.00531963 0.00451677 0.00368753 0.00565593 0.00764598 0.00564658 0.00453816 0.00363021 0.00718111 0.0101403 0.0173345 0.00422661 0.00260365 0.00386801 0.00314674 0.00410758 0.0029082 0.00250566 0.00299606 0.00505442 0.00538871 0.013274 0.020433 0.143651	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0411977 0.0305917 0.0386845 0.0255944 0.0258267 0.0730127 0.0481371 0.0370927 0.0331476 0.0538685 0.0459838 0.0445952 0.0409697 0.0417047 0.0125283 0.0102387 0.00754195 0.0127146 0.0064546 0.00694021 0.00668082 0.00639155 0.00992158 0.00589378 0.00600314 0.00534886 0.00585525 0.00859113 0.005539 0.00517787 0.00444984 0.00564655 0.00797694 0.00544239 0.00472703 0.00390282 0.00561294 0.00764214 0.0055154 0.00449754 0.00356565 0.00566016 0.0073438 0.00625481 0.00544196 0.0050677 0.0125653 0.00308012 0.0035372 0.00277155 0.00244909 0.00304757 0.0048214 0.00512148 0.0125945 0.0197141 0.139321	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG2 ( DRUG0 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0405617 0.0300796 0.0379947 0.0250878 0.0253904 0.0719978 0.0471605 0.0363878 0.0324775 0.0529172 0.0453292 0.0440175 0.0398988 0.0396394 0.0114572 0.00934403 0.007236 0.0119823 0.00593577 0.00619045 0.00604064 0.0060624 0.00919357 0.00539762 0.00525348 0.00465509 0.0055168 0.00789266 0.00510754 0.00454067 0.00381525 0.00531222 0.00729387 0.00506523 0.00422548 0.00338712 0.00529905 0.00701121 0.00519179 0.00419441 0.00328866 0.00551096 0.00716718 0.00564873 0.00445273 0.00352425 0.00725695 0.0105128 0.0191735 0.00474978 0.00326355 0.00397606 0.00540395 0.00576042 0.0135655 0.0208281 0.144375	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG2 ) , or DRUG0 ( DRUG0 ) .
4	4	0.0406247 0.0301686 0.0381465 0.0252404 0.0254807 0.0720528 0.0475353 0.0366719 0.0328204 0.0533949 0.0455693 0.0442437 0.0407044 0.0412451 0.0124182 0.0101569 0.00747566 0.0125247 0.00637628 0.00682648 0.00659204 0.00632122 0.00973266 0.00580579 0.00588709 0.00526762 0.00578477 0.00840705 0.00543901 0.0050592 0.00436306 0.00557182 0.00778165 0.00531603 0.00458859 0.00378302 0.00551251 0.00738851 0.00532245 0.00434014 0.00343253 0.00553285 0.00710863 0.0054831 0.00426263 0.0032658 0.00568003 0.00691907 0.0064351 0.00521441 0.00448406 0.00631429 0.0186208 0.0059336 0.0110521 0.0198132 0.132507	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG2 ( DRUG0 ) .
4	4	0.038945 0.0289172 0.0365582 0.0241804 0.024421 0.0691207 0.0455405 0.0350872 0.0313522 0.0509529 0.0433846 0.042017 0.0386067 0.0388283 0.0115123 0.00940637 0.00694285 0.0115547 0.00587188 0.0062056 0.00601773 0.00581623 0.00886981 0.00531038 0.00530737 0.00474813 0.00527996 0.00758365 0.00495101 0.00454276 0.00389506 0.00504503 0.00695389 0.00482256 0.00411857 0.00336121 0.00495334 0.00654917 0.0048253 0.00391782 0.0030645 0.00495849 0.00631134 0.00499783 0.00390789 0.00296762 0.00509995 0.00610347 0.00532251 0.00404678 0.00296494 0.00449405 0.00896165 0.0212772 0.0488351 0.0292455 0.131167	Before taking this medication , tell your doctor if you are taking a DRUG1 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG2 ) .
4	4	0.0282713 0.0317622 0.0215604 0.0330421 0.0530672 0.025927 0.0236907 0.0170123 0.0198284 0.00868592 0.0224852 0.0365548 0.0276857 0.0145977 0.0130404 0.0310566 0.0209598 0.0133711 0.0156346 0.0250676 0.013073 0.0337561 0.0548841 0.0344001 0.0369335 0.0318826 0.0250536 0.0335991 0.0350981 0.031856 0.0637336 0.0345763 0.0157629 0.00488852 0.00811653 0.00157097 0.00155588 0.00121956 0.00192632 0.00167019 0.00315029 0.0101583 0.0378334	DRUG1 containing cDNA encoding enhanced green fluorescent protein (GFP) , under the control of a chicken   -actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0293301 0.0329517 0.0223672 0.034277 0.0550435 0.0268888 0.024565 0.0176349 0.0205482 0.00900129 0.0233026 0.0378534 0.0286376 0.0150759 0.0134479 0.0320129 0.0216167 0.0138216 0.016162 0.02583 0.0133823 0.0343927 0.056264 0.035253 0.0374942 0.0325578 0.0256343 0.0335519 0.0328606 0.0304576 0.0604022 0.0253265 0.012987 0.00339382 0.00234586 0.00192142 0.00558316 0.00129483 0.00185031 0.00167845 0.00322647 0.00986216 0.037911	DRUG1 containing cDNA encoding enhanced green fluorescent protein (GFP) , under the control of a chicken   -actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0293509 0.0329746 0.0223823 0.0342998 0.0550773 0.0269035 0.0245764 0.0176412 0.0205533 0.00900395 0.0233116 0.0378551 0.0286275 0.0150613 0.0134301 0.031963 0.0215739 0.0137917 0.0161231 0.0257491 0.0133481 0.0344494 0.0564394 0.0353605 0.0376766 0.0328106 0.0258617 0.0337532 0.0325547 0.0307698 0.0610047 0.0238778 0.0119849 0.00297259 0.00182108 0.00102262 0.0018107 0.00213725 0.00703919 0.00195994 0.00371372 0.00962707 0.0377547	DRUG1 containing cDNA encoding enhanced green fluorescent protein (GFP) , under the control of a chicken   -actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0299601 0.033662 0.0228501 0.0350177 0.0562417 0.0274834 0.0251157 0.0180356 0.0210212 0.00920512 0.0238118 0.0386937 0.0292931 0.0154359 0.0137772 0.0327548 0.0220424 0.0139728 0.0161679 0.0253908 0.0130074 0.0336053 0.0551295 0.0336756 0.0360283 0.0310368 0.0243184 0.0317551 0.0302835 0.0276307 0.0524808 0.0225367 0.0123292 0.00298397 0.00168615 0.000953887 0.00135994 0.00109543 0.00186904 0.0028001 0.00720284 0.0222905 0.0440078	DRUG1 containing cDNA encoding enhanced green fluorescent protein (GFP) , under the control of a chicken   -actin promoter , was delivered by intravitreal injection to adult mice in conjunction with enzymes including DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.117486 0.091883 0.0752452 0.0672962 0.111273 0.0365797 0.0853017 0.0966328 0.150882 0.16742	DRUG1 had a limited effect and DRUG2 was ineffective .
4	4	0.0928923 0.115855 0.0784754 0.0705456 0.0661216 0.0565872 0.111009 0.0251139 0.0284723 0.0194537 0.0181074 0.0147406 0.0248226 0.0842576 0.0610827 0.0601833 0.0722799	Electroretinograms survived with higher concentrations of DRUG1 and DRUG2 than were required for optimal retinal transduction .
2	2	0.0847197 0.0901549 0.0687614 0.0612494 0.0688959 0.15982 0.0932176 0.0862951 0.090365 0.0522169 0.0249823 0.0293318 0.0899896	DRUG1 -mediated retinal transduction is improved by co-injection of DRUG2 or DRUG0 .
2	2	0.0929455 0.0944339 0.0715025 0.0633856 0.0729119 0.144768 0.0822289 0.0783958 0.0594181 0.0315876 0.0347318 0.0761994 0.0974907	DRUG1 -mediated retinal transduction is improved by co-injection of DRUG0 or DRUG2 .
0	0	0.0813494 0.2341 0.159292 0.135828 0.165909 0.132513 0.0910086	Some DRUG1 may interact with DRUG2 .
4	4	0.115985 0.405775 0.196122 0.0500362 0.011983 0.0130354 0.00812135 0.011349 0.0433727 0.144221	Those DRUG1 include DRUG2 , DRUG0 , and DRUG0 .
4	4	0.110546 0.330611 0.24811 0.0286093 0.0210598 0.0437368 0.0120567 0.0133373 0.0407829 0.151151	Those DRUG1 include DRUG0 , DRUG2 , and DRUG0 .
2	4	0.099081 0.301449 0.210008 0.0261199 0.0171463 0.0184244 0.0274574 0.041341 0.114944 0.144029	Those DRUG1 include DRUG0 , DRUG0 , and DRUG2 .
4	4	0.182263 0.184863 0.14831 0.0371911 0.026682 0.106564 0.028036 0.0323027 0.102572 0.151216	Those DRUG0 include DRUG0 , DRUG1 , and DRUG2 .
2	2	0.0982357 0.0865648 0.0421245 0.0383301 0.0625269 0.0457653 0.0255583 0.00766049 0.0135346 0.0180898 0.0527523 0.0612319 0.0221113 0.0145955 0.0029696 0.00376154 0.00298782 0.00660078 0.0115247 0.00346775 0.00279483 0.00729427 0.00780602 0.00357496 0.00183003 0.00265356 0.00180397 0.00392633 0.00292461 0.00824625 0.0181497 0.0196089 0.00927589 0.0335256 0.0450623 0.0317236 0.0127055 0.00334846 0.00823541 0.00562933 0.00648493 0.0152968 0.0182865 0.0490042 0.0604145	DRUG1 may also affect the effects of other drugs , which include some DRUG2 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
2	2	0.104191 0.0913508 0.0445037 0.0399624 0.0668374 0.0500235 0.0278464 0.00881978 0.0157775 0.0200027 0.0534637 0.04814 0.0088729 0.0047485 0.00478466 0.0122508 0.00267948 0.00486353 0.00951783 0.00318714 0.00278086 0.00739166 0.00799255 0.00368691 0.00184537 0.00264969 0.0018103 0.00387441 0.00291967 0.00810898 0.018058 0.0195078 0.00916119 0.0333449 0.0441222 0.0311245 0.012642 0.0033348 0.00814619 0.00557677 0.00647936 0.015336 0.018343 0.0491714 0.0607675	DRUG1 may also affect the effects of other drugs , which include some DRUG0 , DRUG2 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	2	0.0925151 0.0778807 0.0352879 0.0333021 0.0516132 0.0341522 0.015751 0.00466807 0.00616941 0.00769189 0.0226386 0.0294608 0.00512154 0.00410565 0.00262155 0.00744568 0.00904503 0.0222149 0.0369901 0.0148338 0.0139338 0.0466882 0.035443 0.0125595 0.00627959 0.0120351 0.00247596 0.00306595 0.00242375 0.00653344 0.017373 0.0203057 0.0101324 0.0346573 0.0434178 0.0292467 0.0122508 0.00339934 0.00823889 0.00567799 0.00678155 0.0163304 0.0196589 0.0525297 0.065052	DRUG1 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG2 , DRUG0 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	2	0.0965204 0.0809649 0.0365183 0.0347045 0.0532821 0.0352144 0.0161378 0.00480636 0.00621943 0.00775572 0.0227522 0.0305954 0.00536063 0.0043665 0.00280432 0.00804508 0.00977231 0.0242664 0.0410367 0.0159758 0.013489 0.0394837 0.0227073 0.00730711 0.00278438 0.00417237 0.00411101 0.0120754 0.00250121 0.00573819 0.0139406 0.0180224 0.00991517 0.0351634 0.0433554 0.0296337 0.0126375 0.00350943 0.00862605 0.00592221 0.0070419 0.0169785 0.0204677 0.0549414 0.0683757	DRUG1 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG2 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	2	0.0873209 0.0732084 0.0330421 0.0314222 0.0482156 0.0319955 0.0146864 0.00437225 0.00565705 0.00710875 0.0209647 0.0280557 0.00490199 0.00394324 0.00253716 0.00722759 0.00863994 0.0215548 0.0363352 0.0143637 0.0130421 0.0360119 0.0209498 0.00723138 0.00246246 0.00318125 0.00197634 0.0056404 0.0105247 0.0259413 0.0292 0.0296688 0.016358 0.0424598 0.0470507 0.031625 0.0133731 0.00360179 0.00894742 0.00619261 0.00706793 0.0164372 0.0198479 0.0518561 0.0637989	DRUG1 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG2 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0353524 0.0585183 0.0316071 0.0265549 0.0387056 0.0286853 0.0124437 0.00442 0.00938804 0.0131329 0.0557693 0.0599717 0.0259403 0.0386244 0.00759947 0.00803021 0.0115217 0.025713 0.0256986 0.0179924 0.0182851 0.0411164 0.0336994 0.0156886 0.00564523 0.00992241 0.00238661 0.00305481 0.0024062 0.00638255 0.0175081 0.0205448 0.0100985 0.0338811 0.041792 0.0282659 0.0119297 0.00321345 0.00745883 0.00523632 0.0063547 0.0151137 0.0181402 0.0479447 0.0582615	DRUG0 may also affect the effects of other drugs , which include some DRUG1 , DRUG0 , certain heart medicines , birth control pills , DRUG2 , DRUG0 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0373815 0.0618361 0.033363 0.0280134 0.0408307 0.0302347 0.0130898 0.00464969 0.00979114 0.013629 0.0580081 0.0627357 0.0268948 0.0396671 0.00777925 0.00832365 0.0118682 0.0264718 0.0259884 0.0179351 0.0174357 0.03713 0.0237367 0.0111369 0.00403174 0.00455871 0.00411603 0.0118849 0.00247947 0.00548215 0.0139698 0.0175807 0.00942557 0.0333933 0.0397683 0.027012 0.011777 0.00322945 0.00758428 0.00534368 0.00647993 0.0154784 0.0186775 0.049382 0.0604147	DRUG0 may also affect the effects of other drugs , which include some DRUG1 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG2 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0337146 0.0557703 0.0300837 0.025253 0.0368135 0.0272578 0.0117887 0.00418815 0.00880895 0.0122147 0.0518827 0.0562231 0.0239294 0.0348937 0.00686021 0.00727247 0.0102887 0.0229798 0.0218316 0.0150381 0.0158576 0.0313517 0.0219751 0.0116561 0.00379699 0.00333696 0.00209834 0.00550414 0.0101255 0.0261589 0.0310059 0.0312653 0.0188239 0.0418794 0.0446559 0.0292159 0.0125616 0.00336385 0.00815982 0.00574307 0.00656919 0.0151542 0.0181595 0.0473314 0.0571568	DRUG0 may also affect the effects of other drugs , which include some DRUG1 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG2 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0294419 0.0486876 0.026143 0.0216668 0.0314137 0.0236375 0.0101275 0.00363513 0.00760116 0.0106109 0.0446428 0.0495828 0.0220694 0.0331822 0.00566969 0.00566562 0.00586614 0.0137008 0.0120334 0.00515986 0.00445838 0.0133058 0.0105127 0.00474564 0.00212968 0.00300279 0.00262769 0.00597222 0.00591104 0.0189281 0.0690603 0.0733678 0.0608699 0.0690007 0.0568075 0.0316676 0.0125184 0.00309404 0.00578815 0.0045275 0.00584866 0.0136983 0.0170029 0.0436864 0.0509299	DRUG0 may also affect the effects of other drugs , which include some DRUG1 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG0 Please note that DRUG2 may interact with other drugs that are not listed here .
4	4	0.0372277 0.0610258 0.0320477 0.0257612 0.0373108 0.0275903 0.0110488 0.00403548 0.00719691 0.00824914 0.0307261 0.0403732 0.0128661 0.0106558 0.0113698 0.0540912 0.0115597 0.0298792 0.0340265 0.0202714 0.0226272 0.0517505 0.0380349 0.0148996 0.00553333 0.00997203 0.00243097 0.00317229 0.00253009 0.00675432 0.0177534 0.021036 0.0103277 0.0348038 0.0423537 0.0284755 0.0121194 0.00329811 0.00774417 0.00541959 0.00657107 0.0156667 0.0187972 0.0498371 0.0607786	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG1 , certain heart medicines , birth control pills , DRUG2 , DRUG0 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0394901 0.0647484 0.0340225 0.0273507 0.0395664 0.0292818 0.0117191 0.00428774 0.00762435 0.00873215 0.0326554 0.042835 0.013745 0.0113315 0.0119739 0.0568588 0.0120269 0.0309646 0.0346012 0.0202377 0.0216065 0.0458179 0.0258962 0.0102365 0.00354408 0.00446767 0.00407797 0.0118622 0.00251963 0.0057873 0.014227 0.0181912 0.00975015 0.034493 0.04096 0.0277641 0.0120862 0.00332422 0.007891 0.00552977 0.00668057 0.0159817 0.0192693 0.051163 0.0628197	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG1 , certain heart medicines , birth control pills , DRUG0 , DRUG2 and DRUG0 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0359165 0.0588771 0.0309285 0.0248577 0.0359447 0.026603 0.0106448 0.00389525 0.00691211 0.00790127 0.029531 0.0388253 0.0124318 0.0102504 0.0106647 0.0502418 0.0104391 0.0267874 0.0289656 0.0171151 0.0198319 0.0390318 0.0240723 0.0110701 0.00335095 0.00329562 0.00204094 0.00548985 0.009931 0.0259582 0.0311193 0.0308498 0.0183919 0.0421861 0.0448161 0.0295013 0.0127804 0.0034445 0.00845887 0.0059485 0.00680729 0.0157514 0.0188652 0.0493731 0.0599003	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG1 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG2 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0320054 0.0525637 0.0276842 0.022169 0.0318756 0.0239431 0.00963425 0.00353405 0.00635691 0.0076028 0.0279778 0.0349419 0.0109158 0.00900799 0.00851356 0.0379982 0.00621596 0.0151405 0.0157371 0.00554775 0.00510871 0.0146305 0.0107377 0.00451569 0.00208393 0.00299991 0.0026699 0.00616053 0.00611641 0.0201716 0.0713811 0.0760341 0.0607434 0.070062 0.0572462 0.0323459 0.0128854 0.00320358 0.00607661 0.0047666 0.0061719 0.0145783 0.018122 0.0469477 0.0548748	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG1 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG0 Please note that DRUG2 may interact with other drugs that are not listed here .
4	4	0.0340156 0.0529508 0.0261132 0.0190151 0.0256074 0.0200316 0.00787095 0.00295269 0.00437962 0.00532458 0.0159962 0.0231484 0.00436721 0.00368333 0.00229538 0.00615022 0.0069559 0.0170763 0.0299134 0.0125246 0.0139595 0.0464707 0.0372916 0.0199108 0.00987903 0.0385906 0.0110717 0.0141416 0.0204908 0.0434606 0.0334676 0.0307893 0.0215251 0.0490371 0.0523955 0.0326801 0.0142522 0.00398209 0.00915955 0.00659682 0.00764439 0.0177426 0.0215858 0.0558481 0.0676541	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG1 , DRUG0 and DRUG2 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0335264 0.0518623 0.0254602 0.0182181 0.023881 0.0191069 0.00749186 0.00284992 0.00396285 0.00484262 0.014449 0.0218811 0.00416463 0.0035797 0.00221414 0.00579984 0.00596665 0.0140649 0.0232437 0.00899047 0.00868811 0.0285657 0.0267672 0.0145439 0.00723475 0.0288658 0.0063046 0.00868513 0.00915645 0.0206662 0.0595638 0.0525232 0.0515569 0.0595471 0.0610877 0.0370731 0.016012 0.00412362 0.00811723 0.00645184 0.00829917 0.019786 0.02438 0.0633438 0.0731006	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG1 , DRUG0 and DRUG0 Please note that DRUG2 may interact with other drugs that are not listed here .
4	4	0.0372296 0.0578232 0.0282517 0.0199961 0.0265891 0.0213295 0.00822854 0.00309876 0.0045592 0.00557657 0.016167 0.0245504 0.00449546 0.0038733 0.00233385 0.00632254 0.00655675 0.0146142 0.0247302 0.00961783 0.00900184 0.0274811 0.0228966 0.0111571 0.00607993 0.0104198 0.0133446 0.0871141 0.0216016 0.0402362 0.0325396 0.0313973 0.0200877 0.0483844 0.0481712 0.0303813 0.0138359 0.00390082 0.00964239 0.00682589 0.0079011 0.0185023 0.0222129 0.0586701 0.0722704	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG1 and DRUG2 Please note that DRUG0 may interact with other drugs that are not listed here .
4	4	0.0364556 0.0563547 0.0274718 0.0194707 0.0254984 0.0203901 0.00792968 0.00300361 0.00422647 0.00516877 0.0151424 0.0229189 0.00424507 0.0036537 0.00222986 0.00585298 0.00586479 0.0132677 0.0217462 0.00799559 0.00693043 0.0192691 0.0156704 0.00718659 0.00369178 0.00627368 0.00520045 0.0289581 0.00821873 0.0225868 0.0659906 0.0594335 0.0514838 0.0602164 0.0595409 0.0369393 0.016126 0.0041702 0.00826322 0.00658554 0.00849823 0.0205483 0.0254307 0.0666734 0.077227	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG1 and DRUG0 Please note that DRUG2 may interact with other drugs that are not listed here .
4	4	0.033546 0.0518124 0.025075 0.0172569 0.0221795 0.0182391 0.0069714 0.00269042 0.00365589 0.00463107 0.0133022 0.0210399 0.00381357 0.00330716 0.00200721 0.00506564 0.0042379 0.00882341 0.015812 0.00576239 0.00530633 0.0161794 0.0159958 0.00782024 0.00359221 0.00523122 0.00434264 0.0131509 0.0149129 0.0609491 0.0820486 0.067564 0.0576128 0.0622022 0.0585032 0.0365622 0.0157578 0.00404638 0.00798223 0.00629894 0.00804439 0.0192646 0.0236593 0.0618944 0.0718491	DRUG0 may also affect the effects of other drugs , which include some DRUG0 , DRUG0 , certain heart medicines , birth control pills , DRUG0 , DRUG0 and DRUG1 Please note that DRUG2 may interact with other drugs that are not listed here .
4	4	0.0546058 0.0300211 0.140642 0.0623564 0.0352342 0.0221343 0.017572 0.00569752 0.0163613 0.033841 0.0437253 0.0500725 0.0432724 0.0412498 0.0381383 0.0387728 0.0619354 0.0345176 0.053901 0.0454315 0.0420822 0.0884354	DRUG1 : Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving DRUG2 concomitantly with DRUG0 .
2	2	0.0202978 0.0308219 0.0997499 0.0488494 0.0296546 0.0230637 0.0224809 0.00795071 0.0269987 0.0558016 0.0667599 0.0744315 0.0603425 0.0476997 0.038412 0.037638 0.0392427 0.0455348 0.049466 0.0619759 0.056732 0.0560959	DRUG0 : Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving DRUG1 concomitantly with DRUG2 .
1	1	0.0503037 0.0361506 0.0451088 0.0900184 0.0948452 0.0377604 0.0739695 0.0558229 0.0450877 0.0613613 0.0692953 0.114747 0.040803 0.0913307 0.0933952	Physicians should carefully monitor PT and INR in patients concurrently administered DRUG1 and DRUG2 .
2	4	0.058177 0.126357 0.167223 0.128647 0.0226167 0.0394875 0.028607 0.0267265 0.0467305 0.0768364 0.0318142 0.0295874 0.0344198 0.040138 0.0197834 0.00373373 0.00265676 0.00344897 0.00257798 0.00274995 0.00768505 0.01372 0.086276	Other DRUG1 Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUG2 and other DRUG0 (e.g. , DRUG0 ) .
2	4	0.0613827 0.132738 0.175846 0.134349 0.0231371 0.0379863 0.0259785 0.0224385 0.0370113 0.0681875 0.0275337 0.0239811 0.0311447 0.0208775 0.00739924 0.00324797 0.0025441 0.00458822 0.00389822 0.00600999 0.029359 0.0208838 0.0994776	Other DRUG1 Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUG0 and other DRUG0 (e.g. , DRUG2 ) .
2	2	0.0297627 0.060946 0.216774 0.148666 0.0254447 0.0368435 0.0265764 0.0216388 0.0381208 0.0669506 0.0308206 0.026425 0.0303272 0.030405 0.0468347 0.0113053 0.0137935 0.0173488 0.00589385 0.00480298 0.00931442 0.018798 0.0822072	Other DRUG0 Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUG1 and other DRUG2 (e.g. , DRUG0 ) .
2	2	0.0292382 0.0593148 0.212227 0.149516 0.0265153 0.0376993 0.0272679 0.0221939 0.0396028 0.0686118 0.0312979 0.0253242 0.0264319 0.0286748 0.0448399 0.00909659 0.00944996 0.00715736 0.010317 0.0109787 0.0325022 0.0222269 0.0695155	Other DRUG0 Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUG1 and other DRUG0 (e.g. , DRUG2 ) .
4	4	0.0321991 0.0657494 0.232746 0.156055 0.0252269 0.0350038 0.0225229 0.015621 0.0260964 0.0606822 0.0237876 0.0232473 0.042951 0.028695 0.0122424 0.00594128 0.00819353 0.0267174 0.0126338 0.0124081 0.0323373 0.0200708 0.0788715	Other DRUG0 Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUG0 and other DRUG1 (e.g. , DRUG2 ) .
3	3	0.100479 0.0441386 0.0466111 0.0676283 0.0342534 0.09372 0.0652019 0.0585513 0.0724941 0.0945896 0.0540722 0.0145231 0.0351004 0.0325466 0.0243527 0.0559389 0.0382474 0.0293017 0.03825	DRUG1 has been reported to prolong the elimination half-life of DRUG2 and may lead to severe bone marrow suppression;
1	1	0.0354117 0.0513465 0.0701061 0.0849186 0.0824099 0.0505594 0.0361411 0.0452013 0.0848153 0.0661332 0.063409 0.0795949 0.0713729 0.0673333 0.111247	a reduction of the DRUG1 dosage should be considered in patients receiving DRUG2 concurrently .
2	2	0.0698318 0.07793 0.0617207 0.0486408 0.0778895 0.0263516 0.0515302 0.0374253 0.0488133 0.0743711 0.0425954 0.0469887 0.049749 0.0174333 0.0215002 0.0220515 0.0365054 0.047032 0.0683496 0.0732906	The concurrent use of DRUG1 and DRUG2 has been reported in one case to result in reduced DRUG0 cytotoxicity .
4	4	0.0324 0.0673201 0.0644391 0.0606665 0.0347343 0.0197673 0.042604 0.0363083 0.051487 0.0634522 0.0261979 0.0307421 0.0408453 0.0308373 0.0515852 0.0590508 0.0855411 0.0591034 0.0650611 0.0778571	The concurrent use of DRUG0 and DRUG1 has been reported in one case to result in reduced DRUG2 cytotoxicity .
4	4	0.00741198 0.014873 0.0101405 0.00897918 0.0288786 0.0363602 0.0339276 0.036636 0.0110112 0.0156625 0.0146581 0.0141829 0.00370795 0.0115122 0.0251573 0.0237058 0.0213692 0.022893 0.0193333 0.0261133 0.0241023 0.0191924 0.0804321 0.0389766 0.0267084 0.0333688 0.0126299 0.0284669 0.0237379 0.0309721 0.0181028 0.0100379 0.001872 0.00171118 0.00119746 0.00195872 0.00158932 0.0026789 0.0135304 0.0247572 0.0259719 0.0181053 0.0176694 0.0336316 0.0202349 0.0145568 0.0178136 0.0135198 0.00811767 0.00838484 0.0394572	Although specific drug or food interactions with DRUG1 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG2 , DRUG0 , DRUG0 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG0 ) .
4	4	0.00756952 0.0151856 0.0103523 0.00916515 0.0294741 0.0371056 0.0346147 0.0373667 0.0112311 0.0159727 0.0149382 0.0144488 0.00377286 0.0117087 0.0255929 0.0241713 0.0217983 0.0235554 0.0199126 0.0268832 0.0247535 0.0199375 0.0852551 0.0413985 0.0293061 0.0359604 0.012966 0.0267318 0.0205481 0.0224336 0.00677616 0.00304737 0.00230189 0.00512697 0.00110622 0.00157286 0.00138165 0.00232896 0.0120931 0.0242485 0.0272646 0.0192704 0.0187032 0.0347188 0.0210125 0.0151933 0.018568 0.0140389 0.00834951 0.00859035 0.0401963	Although specific drug or food interactions with DRUG1 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG0 , DRUG2 , DRUG0 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG0 ) .
4	4	0.00762193 0.0152891 0.0104225 0.00922683 0.0296726 0.0373505 0.0348374 0.0376092 0.0113005 0.0160661 0.015018 0.0145216 0.00378291 0.0117283 0.0256254 0.024193 0.0217506 0.0234799 0.0197937 0.026702 0.0245051 0.0197791 0.0849551 0.0410383 0.0290373 0.0354497 0.0125211 0.0244389 0.0189957 0.0192375 0.00525893 0.00228124 0.00102387 0.00175074 0.00200718 0.00616092 0.00140354 0.00235994 0.013255 0.0253922 0.0298211 0.0212025 0.0199703 0.0349193 0.0212339 0.0155546 0.0188903 0.0142919 0.00842723 0.00865753 0.0401882	Although specific drug or food interactions with DRUG1 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG0 , DRUG0 , DRUG2 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG0 ) .
4	3	0.0065448 0.010885 0.00672312 0.00665511 0.0263476 0.0186359 0.00820399 0.00643453 0.0029499 0.00906019 0.00475819 0.00628322 0.00194628 0.0069002 0.0145605 0.0188645 0.0157372 0.0203975 0.0187487 0.0248518 0.0214541 0.0173679 0.0737982 0.0362566 0.0185386 0.0240282 0.00761135 0.0197056 0.0225111 0.0285691 0.0193705 0.0262954 0.00523178 0.00431013 0.00438438 0.00571804 0.00680133 0.00622313 0.0177862 0.0176363 0.0375061 0.0260725 0.0210961 0.0469717 0.0364721 0.0366569 0.0391874 0.0401318 0.0353808 0.02237 0.0390685	Although specific drug or food interactions with DRUG0 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG1 , DRUG0 , DRUG0 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG2 ) .
4	3	0.00696868 0.0115931 0.00716186 0.00709022 0.0280927 0.0198817 0.00874866 0.006865 0.00314695 0.00967056 0.0050825 0.00672268 0.00208989 0.00745718 0.0157967 0.0204798 0.0172337 0.0223669 0.0206771 0.0274005 0.0239878 0.0193362 0.0830084 0.0409415 0.0211754 0.0271321 0.0080626 0.0161341 0.0149227 0.0172284 0.00769832 0.00530148 0.00301873 0.0116445 0.00271965 0.00405442 0.00470709 0.00535109 0.0197544 0.0216335 0.0400026 0.0271746 0.021108 0.0472364 0.0367938 0.0363261 0.0394955 0.0405699 0.0357477 0.0228298 0.0403771	Although specific drug or food interactions with DRUG0 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG0 , DRUG1 , DRUG0 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG2 ) .
4	3	0.00680694 0.0113275 0.00699958 0.00693069 0.0274573 0.0194338 0.00855445 0.00671039 0.00307653 0.00945043 0.00496788 0.00656961 0.00204219 0.00728648 0.0154308 0.0199511 0.0167549 0.0216095 0.0199256 0.0263716 0.0230632 0.0185419 0.0777388 0.0381452 0.0194196 0.0247428 0.0071458 0.0131315 0.0119844 0.0136694 0.0059156 0.00394341 0.00205223 0.00522271 0.00554372 0.0280366 0.00545258 0.00615672 0.0244651 0.0247102 0.0422874 0.0289132 0.0218967 0.0476957 0.0370557 0.0362631 0.0396417 0.0406037 0.0359385 0.0228511 0.0401144	Although specific drug or food interactions with DRUG0 have not been studied , on the basis of this drug   s metabolism by CYP 3A4 , it is possible that DRUG0 , DRUG0 , DRUG1 , and grapefruit juice may inhibit its metabolism (increasing serum levels of DRUG2 ) .
3	3	0.0759236 0.0547288 0.0273891 0.0159727 0.0213255 0.00462206 0.0044604 0.00899914 0.0196608 0.00739135 0.00415773 0.00413721 0.00599249 0.00725688 0.0147092 0.0278698 0.0924595 0.0641213 0.0796298 0.117573 0.063358 0.0479547 0.0499671 0.0395368 0.0233716 0.0234572 0.0939738	John   s Wort , and certain DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) may induce DRUG2 metabolism (lowering serum levels of DRUG0 ) .
4	4	0.0614187 0.0450476 0.0221289 0.0125468 0.0181781 0.0041196 0.00433191 0.00934125 0.0181234 0.00604624 0.00341817 0.0028736 0.00378887 0.0038912 0.00686794 0.0111696 0.0568655 0.050945 0.0734816 0.134155 0.098505 0.0718577 0.0615611 0.0626038 0.0556863 0.0375833 0.0634642	John   s Wort , and certain DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) may induce DRUG0 metabolism (lowering serum levels of DRUG2 ) .
3	3	0.0745643 0.0513931 0.0249353 0.0141928 0.0178379 0.0040017 0.00370301 0.00578288 0.00691571 0.0102624 0.0318606 0.00648012 0.00728087 0.00903952 0.0178423 0.0298513 0.0828288 0.0635216 0.0854592 0.119209 0.060762 0.0459985 0.0483777 0.0378546 0.0226985 0.0229325 0.094414	John   s Wort , and certain DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) may induce DRUG2 metabolism (lowering serum levels of DRUG0 ) .
4	4	0.0604027 0.0423546 0.0200724 0.0111165 0.0149671 0.00336612 0.00332515 0.00550967 0.0071054 0.00964428 0.0290203 0.00471626 0.00483838 0.00508629 0.00762612 0.0122447 0.057024 0.0456365 0.0694605 0.129378 0.0956261 0.0726761 0.0640346 0.0652169 0.0573996 0.0387357 0.0634159	John   s Wort , and certain DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) may induce DRUG0 metabolism (lowering serum levels of DRUG2 ) .
3	3	0.076748 0.052853 0.025304 0.0138829 0.0166679 0.00359451 0.00324487 0.00460647 0.00409051 0.00423637 0.00576379 0.00646643 0.0329666 0.00811174 0.0169902 0.0296265 0.0902333 0.0677658 0.084448 0.119038 0.0608801 0.0457541 0.0483696 0.0379011 0.0228396 0.0229552 0.0946619	John   s Wort , and certain DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) may induce DRUG2 metabolism (lowering serum levels of DRUG0 ) .
4	4	0.0624879 0.043421 0.0200594 0.0105456 0.013737 0.00296648 0.00279267 0.00378504 0.00379765 0.00391034 0.00590804 0.00499948 0.0258147 0.00459512 0.00712041 0.0115187 0.0568672 0.0482411 0.0733622 0.134098 0.0978002 0.0728003 0.0638316 0.0649491 0.0574488 0.0388115 0.0643308	John   s Wort , and certain DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) may induce DRUG0 metabolism (lowering serum levels of DRUG2 ) .
3	3	0.0708128 0.0479493 0.0231889 0.0129035 0.0156291 0.0033237 0.00306034 0.00424978 0.00369317 0.00367002 0.00417125 0.00406322 0.00808484 0.0110445 0.0644369 0.0285788 0.0981146 0.0782539 0.0908692 0.114746 0.0583396 0.0425493 0.0446546 0.0349807 0.0209063 0.0209052 0.0868206	John   s Wort , and certain DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) may induce DRUG2 metabolism (lowering serum levels of DRUG0 ) .
4	4	0.0571149 0.038837 0.0175198 0.00892494 0.0114831 0.00240327 0.00223653 0.00275624 0.00279542 0.00236735 0.00295574 0.00213573 0.0052138 0.00529272 0.0312362 0.0113799 0.0588308 0.0565288 0.0821923 0.145204 0.100468 0.0729801 0.0621597 0.0624915 0.0556052 0.0372531 0.061634	John   s Wort , and certain DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) may induce DRUG0 metabolism (lowering serum levels of DRUG2 ) .
4	4	0.0500019 0.0277761 0.0437546 0.0958566 0.0538563 0.0632027 0.0441933 0.04401 0.0569368 0.0550313 0.082825 0.0471036 0.0464924 0.0230589 0.0210999 0.0416269 0.0199499 0.0330463 0.0257017 0.02109 0.0280109 0.0322419 0.0431331	DRUG1 does not inhibit the absorption of 5 milligrams of nonheme or DRUG2 at doses less than 800 milligrams in nonpregnant women .
3	3	0.0852694 0.0339059 0.0527367 0.0458011 0.126771 0.0714603 0.0468157 0.0371027 0.027144 0.0226807 0.0568383 0.0371343 0.0620164 0.0468763 0.0357469 0.0540342 0.0264358 0.0549559 0.0762747	DRUG1 is the only known component in the diet that may affect absorption of both nonheme and DRUG2 .
4	3	0.0295175 0.0188028 0.0536143 0.0571055 0.051264 0.044008 0.109751 0.039833 0.0574881 0.0564645 0.0533073 0.0438675 0.0415404 0.013316 0.00756085 0.00482246 0.0117835 0.0134335 0.0165723 0.0194213 0.0148352 0.00984481 0.0127605 0.0135987 0.00796049 0.00644638 0.00300626 0.0165074 0.0299391 0.00763956 0.0120007 0.0127989 0.0113233 0.0208937 0.0137198 0.0184682 0.0142405 0.0305423	However , the evidence for a DRUG1 effect on DRUG2 absorption mainly comes from studies that did not isolate the effect of DRUG0 from that of other dietary components , because it was detected in single-meal studies .
4	4	0.0150513 0.00706605 0.0212313 0.0275481 0.0157033 0.0133236 0.0358059 0.0419756 0.0319505 0.0470411 0.0681714 0.0374013 0.0449065 0.0203263 0.0108775 0.00836595 0.0208598 0.0273349 0.0371528 0.0626613 0.0515484 0.050831 0.0375333 0.0236943 0.00983633 0.00858555 0.00381264 0.0189461 0.0436205 0.0107596 0.0150129 0.0138251 0.0133894 0.0230345 0.0156337 0.0195718 0.0147333 0.0308771	However , the evidence for a DRUG0 effect on DRUG1 absorption mainly comes from studies that did not isolate the effect of DRUG2 from that of other dietary components , because it was detected in single-meal studies .
4	4	0.111591 0.0685725 0.0356556 0.0213389 0.0356359 0.045828 0.0437921 0.0448223 0.0398694 0.0324147 0.0654537 0.0465202 0.0560455 0.0184103 0.0202543 0.0045478 0.00602741 0.00555812 0.0177391 0.0108765 0.0142665 0.0173077 0.013788 0.020743 0.0316865 0.0217093 0.0246828 0.0535829 0.0712798	Our objective was to establish potential effects of DRUG1 on absorption of nonheme and DRUG2 and the dose response for this effect in the absence of a meal .
4	4	0.0620292 0.0584118 0.0752399 0.0490025 0.0438049 0.0357331 0.0227603 0.0226164 0.0162966 0.00761629 0.0212023 0.0195941 0.027989 0.0821256 0.0559811 0.0569071 0.0640334 0.0608758 0.0488449 0.0245114 0.0289292 0.115495	We evaluated the effects of DRUG1 doses between 200 and 1500 mg on absorption of 5 mg DRUG2 (as DRUG0 ) .
4	4	0.0674416 0.0630495 0.0818008 0.0534509 0.0479105 0.0397177 0.0245846 0.0250751 0.0208007 0.00939316 0.0236231 0.0184948 0.0220729 0.0591937 0.0309118 0.0295656 0.0351896 0.0594364 0.0873395 0.0603212 0.0376292 0.102998	We evaluated the effects of DRUG1 doses between 200 and 1500 mg on absorption of 5 mg DRUG0 (as DRUG2 ) .
4	4	0.0310933 0.0263987 0.0226166 0.0162986 0.0117703 0.0126874 0.0160883 0.0281746 0.010514 0.00766249 0.0204681 0.0170872 0.0230825 0.0971044 0.0650511 0.0672126 0.0691187 0.124303 0.118423 0.0759103 0.0467155 0.0922201	We evaluated the effects of DRUG0 doses between 200 and 1500 mg on absorption of 5 mg DRUG1 (as DRUG2 ) .
3	4	0.0655783 0.0368512 0.0422956 0.0529649 0.0348419 0.0309083 0.0257249 0.015973 0.0152519 0.00922165 0.00511836 0.0141814 0.0140982 0.0208003 0.0665827 0.0498485 0.0532738 0.0613935 0.068901 0.0691006 0.0811887 0.0579798 0.042972 0.0649496	We also evaluated the effects of DRUG1 doses between 200 and 800 mg on absorption of 5 mg DRUG2 [as concentrated RBC (CRBC)] .
4	4	0.118825 0.103965 0.074688 0.0397473 0.0495805 0.031959 0.0176247 0.0117109 0.0078197 0.0211854 0.0297165 0.0958353 0.0510994 0.0773291 0.0609611 0.0806732 0.12728	DRUG1 was administered as DRUG2 in all studies and DRUG0 were ingested on an empty stomach .
4	4	0.100207 0.0560033 0.0316082 0.0162993 0.0328962 0.0599914 0.0781242 0.0674575 0.0251341 0.0522173 0.0525148 0.0956895 0.055894 0.0714049 0.0529992 0.0639383 0.0876209	DRUG1 was administered as DRUG0 in all studies and DRUG2 were ingested on an empty stomach .
4	4	0.06053 0.0759527 0.0599275 0.0272507 0.0544459 0.0775856 0.0570998 0.0521803 0.0186943 0.0436302 0.04935 0.099333 0.0568534 0.071755 0.051409 0.0611743 0.0828284	DRUG0 was administered as DRUG1 in all studies and DRUG2 were ingested on an empty stomach .
3	3	0.0629445 0.0430667 0.0583958 0.0603325 0.0476226 0.0502532 0.137115 0.0897392 0.0875156 0.049396 0.0603896 0.0864835 0.0485955 0.0431499 0.0750008	DRUG1 doses   1000 mg diminished DRUG2 absorption by an average of 49.6% .
3	3	0.105228 0.114146 0.0204644 0.0383661 0.0315057 0.0325022 0.0890608 0.0556046 0.0529744 0.0496279 0.0862578 0.0922045 0.0675564 0.0696525 0.0948482	A DRUG1 dose of 800 mg diminished absorption of 5 mg DRUG2 by 37.7% .
4	4	0.147877 0.0484087 0.0166695 0.0295321 0.0135244 0.0149289 0.0220123 0.0344492 0.0490629 0.0542269 0.0766939 0.0371666 0.0374075 0.0292631 0.0973968 0.0918768 0.0987613 0.100742	DRUG1 (oral) : The activity of oral DRUG0 may be potentiated by anti-vitamin-K activity attributed to DRUG2 .
2	2	0.0356997 0.0516832 0.0293194 0.0442542 0.0294117 0.0520848 0.0556949 0.0852879 0.0712782 0.0387039 0.0553192 0.0357833 0.0493077 0.0342735 0.0809439 0.0869646 0.0909273 0.0730627	DRUG0 (oral) : The activity of oral DRUG1 may be potentiated by anti-vitamin-K activity attributed to DRUG2 .
4	4	0.0519789 0.0169529 0.0483536 0.0259585 0.0281966 0.0391636 0.0320618 0.0559712 0.0399143 0.0565503 0.0500505 0.0543301 0.0800947 0.105535 0.0757262 0.0627769 0.101463 0.0749222	DRUG1 : Serum digitalis levels may be increased when hyperthyroid patients on a stable DRUG2 regimen become euthyroid;
4	3	0.0597067 0.0294836 0.0302433 0.0539094 0.0639402 0.0644919 0.0579283 0.0375828 0.0878197 0.0449273 0.0621914 0.0676831 0.0605184 0.077668 0.0523422 0.0684528 0.0811108	Drug Interactions : Women on oral DRUG1 have shown a significant increase in plasma DRUG2 levels .
2	4	0.053708 0.0559672 0.0838058 0.0621813 0.104256 0.134326 0.0955684 0.107938 0.116146 0.071801 0.0427682 0.0249323 0.0466019	[Efficacy of fixed combination DRUG1 / DRUG2 in hospitalized patients with hypertensive disease]
4	4	0.0390038 0.0131661 0.0399906 0.0469495 0.0473053 0.0718108 0.0920986 0.0525766 0.0455475 0.0610854 0.0606687 0.0449473 0.0694383 0.0504667 0.0373623 0.0231112 0.0440337 0.0305363 0.0199392 0.0140371 0.00852336 0.00744073 0.01429 0.00662582 0.00628282 0.0145529 0.0382094	Efficacy and tolerability of fixed DRUG1 / DRUG2 combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology .
4	4	0.0465119 0.0230319 0.0176055 0.0344608 0.0488417 0.0728501 0.0310831 0.00909845 0.0164768 0.027765 0.0257533 0.0371245 0.0753746 0.0463769 0.0764556 0.0889882 0.036492 0.0155361 0.00868806 0.0120722 0.0168236 0.0160284 0.0371973 0.0213844 0.025263 0.0231418 0.0284899 0.0275455 0.0535391	All patients had indications for antihypertensive therapy and were randomized either to fixed combination DRUG1 / DRUG2 (n=43) or to therapy which corresponded to the hospital formulary (n=43) .
4	4	0.0583903 0.0471856 0.0567903 0.0472601 0.0704141 0.0455166 0.0479669 0.06412 0.0433387 0.0781307 0.0972438 0.050305 0.0261936 0.0314856 0.0433868 0.0230439 0.0106286 0.0197838 0.0379963 0.0199375 0.0278307 0.0530512	Rate of achievement of target BP with fixed combination DRUG1 / DRUG2 (93%) was comparable with that on traditional therapy (90%) .
4	2	0.0327888 0.0225172 0.0183405 0.0231806 0.0392804 0.0312637 0.0517123 0.0716719 0.0301815 0.0228156 0.0287924 0.0245605 0.0174494 0.0157169 0.0185857 0.014457 0.00852827 0.00571871 0.00363168 0.0122214 0.0130804 0.00924734 0.00631843 0.0318371 0.0205684 0.0163523 0.0253412 0.0156489 0.00907219 0.00331045 0.0100289 0.00605197 0.00427238 0.00978399 0.00250755 0.00440206 0.00223787 0.00886676 0.00739052 0.0050222 0.00680076 0.00818858 0.0029791 0.00763543 0.00409961 0.00175491 0.00308396 0.00307315 0.011629 0.0262591 0.0119615 0.0155835 0.0232998 0.0168381 0.0130718 0.0159503 0.00519439 0.0131756 0.00919826 0.0244031 0.00723629 0.0244502 0.0393778	But the use of fixed combination DRUG1 / DRUG2 compared with traditional therapy was associated with lower clinical and self measured BP , quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days , respectively , 0.05) , lesser number of DRUG0 (2.5+/-0.6 and 3.0+/-0.9 days , respectively) , lower rate of concealed inefficacy of treatment (12 and 31% , respectively , 0.05) .
4	4	0.0229469 0.0196898 0.0195627 0.0306271 0.0745256 0.0478391 0.0235893 0.01538 0.0157019 0.0258732 0.0187977 0.0185426 0.0121999 0.0121992 0.0142656 0.0110093 0.00679515 0.00446762 0.0028482 0.00910016 0.00963577 0.00699481 0.00494064 0.0248184 0.0164884 0.0134939 0.0216401 0.0146544 0.00919795 0.00356205 0.0118907 0.00841311 0.00609038 0.0150015 0.00476754 0.014393 0.010441 0.0381685 0.0268583 0.0396036 0.026267 0.0157501 0.00430796 0.0105754 0.00572553 0.00197087 0.00313157 0.00290692 0.00973049 0.0229824 0.0116989 0.0139659 0.0203962 0.0150259 0.011552 0.013639 0.00442037 0.011115 0.00777833 0.0204746 0.00610696 0.0205433 0.0329204	But the use of fixed combination DRUG1 / DRUG0 compared with traditional therapy was associated with lower clinical and self measured BP , quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days , respectively , 0.05) , lesser number of DRUG2 (2.5+/-0.6 and 3.0+/-0.9 days , respectively) , lower rate of concealed inefficacy of treatment (12 and 31% , respectively , 0.05) .
4	4	0.020839 0.018941 0.0206895 0.0342265 0.0684112 0.0424666 0.0269789 0.0265046 0.0397656 0.0260748 0.0169803 0.0193432 0.0122348 0.012317 0.0143954 0.0109865 0.006596 0.00430522 0.00272021 0.00873794 0.00921751 0.00665678 0.00469018 0.0237354 0.0158086 0.0129354 0.0207393 0.0140105 0.00878887 0.00340018 0.0113471 0.00803048 0.00580951 0.0143123 0.00454783 0.0137307 0.00995731 0.0364038 0.0255969 0.0377453 0.0250338 0.0150107 0.00410531 0.0100766 0.00545414 0.00187713 0.00298235 0.00276812 0.00926688 0.0218906 0.0111433 0.0133012 0.0194217 0.0143077 0.0109992 0.0129854 0.00420847 0.010582 0.00740517 0.0194924 0.00581381 0.0195571 0.0313385	But the use of fixed combination DRUG0 / DRUG1 compared with traditional therapy was associated with lower clinical and self measured BP , quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days , respectively , 0.05) , lesser number of DRUG2 (2.5+/-0.6 and 3.0+/-0.9 days , respectively) , lower rate of concealed inefficacy of treatment (12 and 31% , respectively , 0.05) .
4	2	0.0511859 0.0187471 0.0267599 0.0351878 0.0222717 0.0215298 0.0215476 0.0288477 0.0353651 0.0533554 0.0769901 0.0335183 0.0240385 0.0107713 0.0357657 0.0505629 0.0380351 0.0202192 0.035413 0.0417727 0.00982298 0.00641515 0.0100604 0.00405435 0.00282625 0.00758361 0.00688886 0.00858539 0.00843221 0.00772871 0.00659658 0.00426074 0.00885148 0.0628239 0.0422384 0.0435707 0.0233508 0.0138778 0.0401467	We have demonstrated appropriateness of inhospital administration of fixed DRUG1 / DRUG2 combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUG0 , and diminishing concealed inefficacy of treatment .
4	4	0.0332229 0.0112874 0.0158624 0.0225219 0.0147614 0.0181858 0.0233571 0.0357501 0.0507797 0.0279613 0.0180839 0.0183046 0.0237064 0.0101946 0.0391222 0.0376782 0.032268 0.021157 0.0353428 0.0592098 0.0257286 0.0210036 0.0295215 0.0124357 0.0103271 0.0193966 0.0266318 0.0235101 0.0316378 0.0333954 0.0122494 0.00294663 0.00397545 0.0474925 0.0396711 0.0408223 0.0237704 0.0136085 0.0331181	We have demonstrated appropriateness of inhospital administration of fixed DRUG1 / DRUG0 combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUG2 , and diminishing concealed inefficacy of treatment .
4	4	0.0272385 0.00867133 0.012403 0.0207818 0.0167072 0.0210407 0.0301752 0.0401004 0.0444574 0.0314031 0.0430935 0.0786349 0.0292365 0.00939537 0.035378 0.0316058 0.0272124 0.017426 0.0308919 0.0514358 0.0215339 0.017484 0.0250742 0.0105506 0.00876645 0.0167521 0.0230524 0.0205039 0.0276562 0.0294055 0.0107738 0.00259744 0.00350283 0.0418337 0.0349742 0.0360213 0.020976 0.0120138 0.0292385	We have demonstrated appropriateness of inhospital administration of fixed DRUG0 / DRUG1 combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUG2 , and diminishing concealed inefficacy of treatment .
4	2	0.0989784 0.059905 0.0340416 0.0769225 0.042719 0.0201726 0.0387326 0.0270236 0.0776192 0.0550893 0.0610423 0.0567332 0.0134679 0.0184937 0.0029796 0.00384968 0.00248891 0.00208811 0.00288325 0.00216513 0.00188706 0.0026258 0.00196167 0.00351059 0.00200104 0.00175414 0.00270397 0.00195353 0.0017237 0.00256391 0.00180465 0.00273742 0.00194521 0.00360301 0.00195241 0.00178535 0.00292251 0.00202434 0.00185935 0.00310659 0.00218991 0.00322674 0.00219822 0.00350309 0.002612 0.0048046 0.00313873 0.00363526 0.0050969 0.0202953 0.0360963 0.049389 0.0256144 0.0943778	The following agents may increase certain actions or side effects of DRUG1 : DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0950616 0.0572123 0.0327247 0.0741647 0.0415541 0.0193882 0.0374202 0.0266841 0.0755695 0.0552954 0.0599306 0.0540611 0.0156765 0.00913607 0.00785452 0.0149176 0.00299475 0.00222358 0.00296167 0.00220108 0.00189898 0.00265988 0.00198358 0.00353956 0.00196641 0.00172528 0.00267987 0.00190511 0.00169696 0.00255539 0.00178559 0.00272742 0.0019407 0.00355062 0.00191054 0.00175976 0.00289038 0.00197169 0.00184059 0.0031122 0.00218785 0.00321823 0.00218886 0.00349548 0.00263115 0.00483579 0.00313913 0.00363802 0.00511967 0.0208869 0.0383078 0.0529348 0.0268121 0.0974713	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.093131 0.0559064 0.0320271 0.0724531 0.0405176 0.0187991 0.0360685 0.0258143 0.0732057 0.0544124 0.0601544 0.0541234 0.0151294 0.00755979 0.00379857 0.00671404 0.00574571 0.00639288 0.0162926 0.00319553 0.00208797 0.00290969 0.0020698 0.00366511 0.00196304 0.00174918 0.00282749 0.00202633 0.00174487 0.00278667 0.00181354 0.00295582 0.00201293 0.00369175 0.00187668 0.00177155 0.0030289 0.00201478 0.0018687 0.00334407 0.00227964 0.00339687 0.00220174 0.00365893 0.00269224 0.00511729 0.00326598 0.0038477 0.00526928 0.0245003 0.0408591 0.0553864 0.025089 0.092785	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0942886 0.056728 0.0324804 0.0734823 0.0409593 0.018987 0.0362155 0.0257655 0.0729034 0.0541468 0.0604892 0.0546516 0.0147338 0.00710156 0.00350554 0.00545021 0.00382686 0.00301029 0.00561063 0.00674385 0.00649505 0.0131581 0.0022356 0.00340138 0.00208003 0.00181341 0.00268201 0.00193944 0.00171437 0.00251784 0.00178549 0.00268684 0.0019267 0.00351706 0.00191445 0.00175034 0.00285588 0.00196494 0.00181718 0.00304558 0.00214652 0.00316519 0.00215773 0.00343219 0.00258512 0.00475866 0.00308213 0.00357206 0.00503593 0.0206623 0.0392131 0.0529622 0.0272002 0.0976451	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.093511 0.0561813 0.0322486 0.0731583 0.0409151 0.0189108 0.0362067 0.0259539 0.0734126 0.0545652 0.0603928 0.0540059 0.0139248 0.00691393 0.00342182 0.00524616 0.00361809 0.00275379 0.0046301 0.00406387 0.00291124 0.00467894 0.00590982 0.0127714 0.00260585 0.00202063 0.00281205 0.00205422 0.00179363 0.00256083 0.00185073 0.00272279 0.00198061 0.00356876 0.00195301 0.00177589 0.00286202 0.00197723 0.00184068 0.00305958 0.00217243 0.00317655 0.00218868 0.00345451 0.00262637 0.00478125 0.00312746 0.00361406 0.00512822 0.0208531 0.0399578 0.054248 0.0278747 0.0990522	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0919152 0.05513 0.0316286 0.0716546 0.0400887 0.0184729 0.0354282 0.0255021 0.0722115 0.054066 0.0595392 0.0528792 0.0136899 0.00677154 0.00334979 0.00516349 0.00352936 0.00268428 0.00437848 0.00381303 0.00269399 0.00389386 0.00288272 0.00555578 0.00447927 0.0054918 0.0144517 0.00285808 0.00194184 0.00278639 0.00192241 0.00298842 0.00208219 0.00373554 0.00192885 0.00180328 0.00302509 0.00203623 0.00188796 0.0033308 0.00229892 0.0033846 0.00221659 0.00364238 0.00270761 0.00510354 0.00328851 0.00387633 0.00532196 0.0247984 0.0427815 0.0568538 0.0258827 0.094171	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0929098 0.0558882 0.0320395 0.072591 0.0404747 0.0186732 0.0356791 0.025502 0.0721961 0.053764 0.0597624 0.0536221 0.0140973 0.00686317 0.00343486 0.00512203 0.00360759 0.00272875 0.00425847 0.00381846 0.00264204 0.00366119 0.00265817 0.00458767 0.00305246 0.0025788 0.00495041 0.00552856 0.00564735 0.0117981 0.0020735 0.00253864 0.00194558 0.00352243 0.00200522 0.00180584 0.00283089 0.00200056 0.00183864 0.0029724 0.00212839 0.00309567 0.00215309 0.00335839 0.00256515 0.00464571 0.00305598 0.00354768 0.00501269 0.020418 0.0408603 0.0542116 0.0282791 0.098997	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0924465 0.0556042 0.0318801 0.072241 0.0402874 0.0185782 0.0355017 0.0253779 0.07186 0.0535058 0.059519 0.0534163 0.0140088 0.00683397 0.00342942 0.00509702 0.00360009 0.00272452 0.00423748 0.00380464 0.00263368 0.00363988 0.00264915 0.00445864 0.00295234 0.00241783 0.00418112 0.00361223 0.0026893 0.00450235 0.00550393 0.012465 0.00210904 0.00340792 0.00210926 0.00188187 0.00283417 0.00202347 0.00185632 0.00293372 0.00211516 0.00304319 0.00214115 0.00330453 0.00254135 0.0045619 0.00302624 0.00352205 0.00497412 0.0200756 0.0414632 0.0551896 0.0290659 0.100161	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0921972 0.0554006 0.0318547 0.0723647 0.0404329 0.0186201 0.0356653 0.025634 0.072475 0.0539529 0.0593701 0.0529591 0.0135003 0.00675199 0.00339293 0.00507657 0.00353177 0.00269163 0.00421117 0.00367573 0.00260398 0.00361774 0.00262296 0.00440571 0.00288662 0.00234616 0.00391432 0.00324275 0.00234767 0.00338894 0.00243311 0.004263 0.00531968 0.0122077 0.00260051 0.00207987 0.00302651 0.00220439 0.00195792 0.00304095 0.00219497 0.00313262 0.00221952 0.00340841 0.00261327 0.00465939 0.00310607 0.00358534 0.00508481 0.0203741 0.040958 0.0548357 0.0290715 0.100487	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0906041 0.0543742 0.0312666 0.0709393 0.0396472 0.0182334 0.0349693 0.0252322 0.0713904 0.0534035 0.0583925 0.0517281 0.0132264 0.00658833 0.00328831 0.00499681 0.00343116 0.00261475 0.0041405 0.00359603 0.00254082 0.0035538 0.00256079 0.00433161 0.00281378 0.0022807 0.00380982 0.0031541 0.00227286 0.00324494 0.00227214 0.00354883 0.00257409 0.00510002 0.00395729 0.00506106 0.0136412 0.00295036 0.00204873 0.00323989 0.00229804 0.00334629 0.00227049 0.00363186 0.00274448 0.00506211 0.00331421 0.00391033 0.00537036 0.0248955 0.0450723 0.0585278 0.0269419 0.0955942	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0924657 0.0556232 0.031979 0.0725912 0.0404025 0.0185987 0.0355227 0.0254348 0.0717927 0.0535476 0.0588281 0.052735 0.0135877 0.00672671 0.00335334 0.00505961 0.00351896 0.00266305 0.00417398 0.00368892 0.00257347 0.00358597 0.00258706 0.00433906 0.00284378 0.0022984 0.00377083 0.00318201 0.00225082 0.00317639 0.00220355 0.00334378 0.00234124 0.00427539 0.00275695 0.00234957 0.00493675 0.00528316 0.00550872 0.0144653 0.00236023 0.00296174 0.00217599 0.00322423 0.0024641 0.00430909 0.00292194 0.00345064 0.00461413 0.0185967 0.0392872 0.0529606 0.0292399 0.101068	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0910464 0.0548208 0.0315248 0.0716112 0.0398434 0.0183552 0.0350231 0.0250673 0.0707269 0.0526307 0.0579957 0.0520076 0.0134502 0.00664102 0.00334153 0.00496838 0.00349296 0.00265114 0.00410495 0.00364852 0.00255997 0.00354457 0.00258792 0.00429543 0.0028403 0.00230541 0.00372384 0.00314369 0.00225464 0.00315146 0.00220289 0.00332252 0.00233652 0.00419738 0.00266557 0.0022093 0.00428011 0.00353719 0.00268259 0.00615003 0.0092931 0.0128215 0.00243853 0.00319906 0.00250183 0.00427258 0.00293274 0.00349299 0.00460186 0.0184997 0.040523 0.0548043 0.0304144 0.103261	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0915968 0.0551816 0.0317522 0.0721707 0.0401207 0.0185053 0.0352495 0.0252088 0.0710186 0.0528542 0.0582584 0.0524385 0.013508 0.00668295 0.00336519 0.00498325 0.00351524 0.00266663 0.00410976 0.00366441 0.00256903 0.00355127 0.00259555 0.00428268 0.00284438 0.0023074 0.00369606 0.00313513 0.00224298 0.00312437 0.0021836 0.0032764 0.00230054 0.00406345 0.00258774 0.00211987 0.00390119 0.00320029 0.00224547 0.00396045 0.00308814 0.00480269 0.00578347 0.0134542 0.00258468 0.00390591 0.00294224 0.00354256 0.00454852 0.0173129 0.0402023 0.0545957 0.0314351 0.104763	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	2	0.0913182 0.0550457 0.0317015 0.0721 0.0400445 0.018518 0.0351711 0.0251032 0.0705195 0.0524442 0.0578602 0.0523884 0.0135667 0.0066649 0.00335538 0.00493754 0.00349931 0.0026555 0.00407591 0.00367036 0.00255392 0.00352395 0.0025801 0.00422794 0.00281982 0.00229652 0.00365071 0.00313409 0.00222413 0.0030889 0.00216355 0.00323063 0.00227426 0.00396361 0.00253089 0.00208819 0.00375338 0.00313323 0.0021597 0.00367482 0.00270156 0.00361008 0.00258397 0.00482526 0.00577316 0.0171815 0.00310064 0.00365571 0.00451988 0.0161576 0.0392266 0.054344 0.0323575 0.10625	The following agents may increase certain actions or side effects of DRUG1 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0859788 0.0508741 0.0281422 0.0632815 0.03483 0.0147707 0.0274617 0.0203495 0.0547953 0.0481342 0.040575 0.0264817 0.0359268 0.0585133 0.0133135 0.00956886 0.00879268 0.00955949 0.0148046 0.0036887 0.00247588 0.00329726 0.00245516 0.00410544 0.0023424 0.00205497 0.003141 0.00232785 0.00200283 0.00302155 0.00209931 0.0031821 0.00229999 0.00401532 0.00218904 0.00202752 0.00330787 0.0023191 0.0020985 0.00358991 0.00253685 0.00370064 0.00249738 0.00396933 0.00302686 0.00555661 0.00365647 0.00420865 0.00617069 0.0259872 0.0462406 0.0585659 0.0279681 0.101719	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.083791 0.0496852 0.0274809 0.0619216 0.0338359 0.0144042 0.0268342 0.0199921 0.0534087 0.04623 0.0402424 0.026364 0.0362956 0.0585179 0.0126774 0.00754333 0.00609612 0.00880765 0.00866054 0.014003 0.00941787 0.0116984 0.00273274 0.00385338 0.00269545 0.00232581 0.00308707 0.00243519 0.00212434 0.00285214 0.00221183 0.00296305 0.00235057 0.00380897 0.00235187 0.00211937 0.00316334 0.00237147 0.00213382 0.0033534 0.002479 0.00349859 0.00253644 0.00378212 0.00300594 0.00519378 0.00363609 0.00409829 0.00620927 0.0235653 0.047825 0.0567317 0.0296935 0.100903	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0830159 0.0491712 0.0271914 0.0613984 0.0336567 0.0142148 0.0265628 0.019805 0.0532364 0.046483 0.0399208 0.0263232 0.0356028 0.0575771 0.0120075 0.00724318 0.0057162 0.00846656 0.00700334 0.0091123 0.00916147 0.00713313 0.00867959 0.0135918 0.00339376 0.00245829 0.0031993 0.0024879 0.00211583 0.00284063 0.00217265 0.00293775 0.00228848 0.00379417 0.00228138 0.00205548 0.00310075 0.00228289 0.00207986 0.00327972 0.00241852 0.00341484 0.00245904 0.00370255 0.00291569 0.00508582 0.00353356 0.00402544 0.00602443 0.0231854 0.046493 0.0577658 0.0302184 0.103714	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0812481 0.0480714 0.0266257 0.0600867 0.0330019 0.0139175 0.0260817 0.0193696 0.0520065 0.0455609 0.0390362 0.0257671 0.0340031 0.0551764 0.0113043 0.00688369 0.00544232 0.00806379 0.00656483 0.00874329 0.00896969 0.00609908 0.00572506 0.00718361 0.00677988 0.00772923 0.0135027 0.00327967 0.00222291 0.00300728 0.00218633 0.0031462 0.0023205 0.00392623 0.00220607 0.00201602 0.00318892 0.00229654 0.00207153 0.00345974 0.00248792 0.00356692 0.00245414 0.00382981 0.00296985 0.00536613 0.00358722 0.00414516 0.00620124 0.0266665 0.0491551 0.0606071 0.0287179 0.101973	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0809163 0.047973 0.0265302 0.0598675 0.0326435 0.0138046 0.0257992 0.0192245 0.051508 0.0445156 0.0386156 0.0253641 0.0341862 0.0553339 0.0114449 0.00680451 0.00563281 0.008061 0.00635692 0.00891765 0.00891259 0.00582477 0.00558436 0.00563925 0.00500164 0.00716185 0.00732707 0.0102065 0.00758026 0.0112166 0.0024726 0.00289359 0.00232107 0.0037156 0.0024749 0.00216998 0.0030847 0.00243704 0.00215776 0.00323327 0.00244108 0.00338125 0.00252849 0.0036561 0.00296188 0.00495557 0.00358652 0.00404553 0.00614235 0.0233698 0.0492465 0.0573204 0.0303366 0.101112	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0806046 0.0477868 0.0264168 0.0596243 0.0324936 0.0137252 0.0256465 0.0191191 0.0512572 0.0442567 0.0383414 0.025194 0.0340144 0.0550497 0.0113801 0.00676438 0.00557548 0.007988 0.0063009 0.00883652 0.00883407 0.00579357 0.0055722 0.00545684 0.00498691 0.00700227 0.006088 0.00772959 0.00712585 0.00673849 0.00745896 0.0135183 0.00257614 0.0038867 0.00266601 0.00229864 0.00317996 0.00252126 0.0022048 0.00322496 0.00242359 0.00334102 0.0025011 0.00359555 0.00290929 0.0048639 0.00351819 0.00398957 0.00603341 0.0225802 0.0484869 0.0563446 0.0302678 0.0999059	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0805311 0.0476911 0.0263719 0.0595818 0.0325282 0.0136591 0.0255728 0.0190739 0.051408 0.0445315 0.0381411 0.025126 0.0335988 0.0544257 0.0109961 0.00666592 0.00520162 0.00758976 0.00613603 0.00829363 0.00848091 0.00567333 0.00540442 0.00538919 0.00467796 0.00662188 0.00569738 0.00667999 0.00625702 0.00520622 0.00397279 0.00585235 0.00701748 0.0129147 0.00330865 0.00246001 0.00334163 0.00263731 0.00223714 0.00327939 0.00246421 0.00337472 0.00251291 0.00363415 0.00290217 0.00486738 0.00350432 0.003994 0.00594461 0.0226142 0.0475553 0.0579891 0.0310121 0.103397	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0790336 0.0467654 0.0258916 0.0584851 0.0320204 0.0134253 0.0251924 0.0187304 0.0505267 0.0438803 0.0373115 0.0246209 0.0323271 0.0523655 0.010515 0.00643976 0.00495727 0.00726651 0.00592731 0.00790825 0.0081085 0.00546078 0.00515395 0.00517502 0.00439024 0.00622365 0.00544304 0.00649321 0.00625602 0.00508904 0.00391825 0.00501114 0.00415482 0.0064248 0.0053804 0.00636911 0.0134842 0.00337932 0.0023037 0.00341634 0.00250052 0.00355801 0.00251304 0.00381842 0.00297135 0.00527329 0.00355442 0.00411797 0.00609393 0.0266129 0.0503336 0.0614068 0.029316 0.102704	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0802006 0.0475487 0.026309 0.0594092 0.0323654 0.0136061 0.0254507 0.0189421 0.0509678 0.0439071 0.0377079 0.0247047 0.032849 0.0531845 0.0106816 0.00645495 0.00504855 0.00727192 0.00587178 0.0080286 0.00815947 0.00543576 0.00506254 0.0050468 0.00437913 0.0060824 0.005236 0.00654551 0.00625971 0.00494299 0.0038785 0.00472405 0.00388884 0.00518393 0.00391252 0.00481731 0.00679172 0.00820554 0.00720994 0.0142128 0.00262276 0.00333071 0.00252267 0.0035527 0.00283964 0.00458037 0.00339849 0.0039036 0.00549239 0.0209265 0.0457842 0.05582 0.0309653 0.103775	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0790841 0.0468999 0.0259117 0.0585035 0.031801 0.0133605 0.0249479 0.0186033 0.050087 0.0430858 0.0370508 0.0243172 0.032666 0.0527967 0.0106465 0.00641603 0.00505663 0.00722078 0.00579956 0.00796117 0.00804743 0.00534914 0.00502352 0.00499494 0.00436961 0.0059884 0.00508765 0.00641271 0.00612963 0.00478509 0.00378258 0.00456213 0.00375737 0.00486205 0.00358058 0.00440729 0.00548165 0.00664404 0.00670219 0.00886594 0.0107067 0.0136291 0.00283874 0.00374348 0.00299354 0.0046739 0.00354206 0.00409207 0.00580874 0.0204941 0.0479959 0.0561632 0.0315723 0.100696	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0792488 0.0470053 0.0259557 0.0586079 0.031849 0.0133922 0.0250053 0.0186359 0.0501358 0.0430635 0.0369577 0.0241827 0.0325041 0.0525569 0.0106073 0.00636776 0.00502896 0.00716693 0.00574909 0.00790634 0.00799369 0.00529949 0.00496365 0.00491729 0.0043081 0.00589526 0.00499614 0.00629539 0.00602011 0.00469628 0.00369483 0.00446795 0.00365545 0.00471096 0.00342512 0.00410901 0.00507487 0.00549554 0.00559173 0.0065272 0.00594002 0.00636009 0.00703097 0.0145015 0.00305389 0.00455758 0.00354805 0.00413016 0.00581253 0.0200468 0.0477773 0.0568118 0.0324005 0.103963	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0794751 0.0471171 0.0260045 0.058653 0.031829 0.013425 0.0250598 0.0186725 0.0500194 0.0428349 0.0369031 0.0240736 0.0324512 0.0523557 0.0106262 0.00633771 0.00509385 0.00719705 0.00572243 0.00794716 0.00800305 0.00526505 0.00493705 0.00483393 0.00434726 0.00588861 0.00491412 0.00630816 0.00600749 0.0046083 0.00366301 0.00435008 0.0035848 0.00454624 0.00335127 0.00400216 0.00485027 0.005429 0.00559477 0.00621103 0.00508441 0.00485002 0.00381885 0.00616844 0.00690509 0.0172504 0.00365594 0.00431346 0.00584988 0.0192485 0.0463083 0.0558308 0.0328265 0.105396	The following agents may increase certain actions or side effects of DRUG0 : DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0882277 0.0498942 0.0266977 0.0571804 0.0314538 0.0120792 0.0230446 0.0169875 0.0494651 0.0550759 0.0336114 0.0227669 0.0244551 0.0158765 0.0110072 0.0424012 0.0100034 0.00978404 0.0167176 0.00398086 0.00276441 0.00383022 0.00281289 0.00495974 0.00268036 0.00236311 0.00372113 0.00266014 0.002321 0.00356761 0.00242489 0.00376322 0.00268604 0.00483317 0.00252528 0.00237281 0.0039622 0.0026739 0.00247437 0.00430325 0.00299866 0.00439854 0.00292284 0.00471516 0.00355192 0.00656552 0.00428554 0.00495726 0.00699875 0.0295176 0.0484472 0.0652495 0.0310737 0.119908	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG2 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0877577 0.0499478 0.0270462 0.0580884 0.0317678 0.0122439 0.0232648 0.0169356 0.0492149 0.0544279 0.0343122 0.0226037 0.025717 0.0157497 0.0106389 0.0380723 0.00759795 0.00941882 0.00896883 0.0113007 0.00813124 0.0125798 0.00290349 0.00422161 0.00288712 0.00250146 0.00341697 0.00263812 0.00232695 0.00317301 0.00240824 0.00332894 0.00258519 0.00437433 0.00259812 0.00235549 0.00359836 0.00263424 0.00240631 0.00381626 0.00279766 0.00398362 0.00284534 0.00431408 0.00337415 0.00591669 0.00407932 0.00464609 0.00685723 0.0260455 0.0499877 0.0628123 0.0331722 0.119207	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0869818 0.0493912 0.0267639 0.0575038 0.0315705 0.0121156 0.0231327 0.016697 0.0487253 0.0545483 0.0341681 0.0226294 0.0256716 0.0159961 0.0106755 0.0373596 0.00716987 0.00883728 0.00763503 0.00723013 0.00702025 0.00691835 0.00745519 0.0135438 0.0035484 0.00265616 0.00355791 0.00270289 0.00232689 0.00319481 0.00238371 0.00333556 0.00253743 0.00438474 0.00252795 0.00229651 0.00356318 0.00255322 0.00235814 0.00378753 0.00275933 0.00394141 0.00278808 0.00428175 0.00331712 0.005888 0.00401599 0.00461127 0.00673599 0.0261962 0.0491381 0.0637826 0.0334188 0.12167	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0849791 0.0480715 0.0260699 0.0558624 0.0306892 0.0118084 0.0225476 0.0162928 0.0474657 0.0528828 0.0334809 0.0221366 0.0253118 0.0157375 0.0103915 0.0364304 0.00696106 0.00859218 0.00727599 0.00706337 0.00713944 0.00612621 0.00497502 0.00738509 0.00612935 0.00692143 0.0139876 0.00345773 0.00243431 0.00342146 0.00243658 0.00359341 0.002613 0.0045463 0.00247262 0.00228709 0.00369253 0.00258566 0.00237598 0.00402972 0.00287013 0.00413882 0.00281095 0.00444771 0.0034152 0.00622439 0.00413103 0.00480232 0.00694328 0.0298452 0.0519134 0.0669098 0.0314778 0.117409	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.085007 0.0482554 0.0261059 0.056026 0.030603 0.011775 0.0224316 0.0161265 0.0469164 0.0521152 0.0333739 0.0220113 0.0255422 0.0157272 0.010509 0.0365425 0.00707886 0.00853295 0.00697374 0.00739918 0.0072759 0.00578688 0.00487885 0.00596638 0.00440746 0.00582003 0.00705424 0.00816841 0.00685649 0.0116342 0.0026731 0.00322452 0.00253959 0.00428544 0.00269336 0.00238269 0.00350883 0.00268539 0.00241046 0.00368913 0.00274766 0.00386986 0.00282653 0.00418901 0.00332485 0.00569649 0.00402097 0.00457916 0.00679351 0.0259856 0.0520537 0.0637129 0.0338829 0.119323	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0846139 0.048032 0.0259729 0.0557525 0.0304533 0.0117023 0.0223125 0.0160052 0.0465882 0.0518935 0.0331572 0.021913 0.0253236 0.0156632 0.0104612 0.0363152 0.00697958 0.0084397 0.00690995 0.00736467 0.00726807 0.00575696 0.00490124 0.00579162 0.00428178 0.00576494 0.00602081 0.00595013 0.00540494 0.00654051 0.00678947 0.013588 0.00277367 0.00436506 0.00287253 0.00249905 0.00357872 0.00274351 0.00243616 0.00365983 0.00271503 0.00381441 0.00278387 0.00411717 0.00325734 0.00559114 0.00394214 0.00451587 0.00666657 0.0253439 0.0518194 0.0634721 0.0341672 0.118953	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0846303 0.0479063 0.025898 0.0555755 0.0304065 0.0116458 0.0222452 0.0159055 0.0464552 0.0518988 0.0328616 0.0217534 0.0250228 0.0156502 0.0103384 0.0357063 0.00663905 0.00816732 0.00682623 0.0068739 0.00694411 0.00571227 0.0048076 0.00576429 0.00413274 0.00547726 0.00572098 0.00503727 0.00449048 0.00507204 0.00357798 0.00573042 0.00643015 0.0129101 0.00352124 0.00270949 0.00380373 0.00291346 0.00250746 0.00377117 0.00279086 0.0038881 0.00283083 0.00420029 0.00329278 0.00566253 0.00397892 0.00457252 0.00666818 0.0257044 0.0511548 0.0647748 0.0347018 0.122339	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0830726 0.0468922 0.0253927 0.0543275 0.0297574 0.0114298 0.021828 0.0156725 0.0457779 0.0509315 0.0323277 0.0213793 0.0245997 0.0153673 0.010063 0.0347611 0.00644818 0.00793056 0.00667335 0.00658906 0.00669564 0.00555819 0.0046412 0.00558426 0.00399653 0.00523638 0.00551481 0.0049346 0.00452862 0.00498362 0.00346835 0.00504082 0.00382315 0.00654822 0.00506343 0.00598331 0.0143096 0.00367359 0.00258373 0.00397 0.00286814 0.00412276 0.00286595 0.00443135 0.00341639 0.00613725 0.00411262 0.004797 0.0068734 0.0300409 0.0539846 0.0682378 0.0323294 0.118423	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0848419 0.0480923 0.0259889 0.0557291 0.030375 0.0116599 0.0221791 0.0159104 0.0463749 0.0512764 0.0326811 0.0214439 0.0247965 0.0153303 0.0101047 0.0350455 0.00651922 0.00790818 0.00655333 0.00665227 0.00670133 0.00547638 0.004569 0.00542022 0.0039465 0.00512719 0.0053197 0.00493441 0.00451502 0.00480011 0.00336629 0.00471885 0.00355315 0.00538799 0.0036962 0.00380723 0.00673926 0.0070954 0.00692328 0.0150942 0.0029212 0.00379357 0.00281785 0.00407548 0.00317826 0.00528387 0.00381493 0.00443178 0.00608814 0.0236076 0.0490141 0.0621843 0.0347991 0.123335	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0836585 0.0474498 0.0256005 0.0548934 0.029872 0.0114571 0.0218114 0.0155612 0.0454033 0.0504331 0.0321391 0.0211659 0.0244672 0.0151682 0.0100513 0.0346235 0.00646228 0.00782824 0.00645503 0.00665066 0.00666578 0.00539962 0.00455242 0.00537442 0.00388434 0.00505498 0.00518605 0.00486093 0.00444564 0.00467589 0.00330115 0.0045985 0.00346497 0.00511667 0.00340914 0.00349004 0.00554703 0.00522272 0.00514114 0.00867547 0.0105757 0.0142677 0.00314154 0.00421468 0.00332171 0.00535928 0.00393116 0.00458991 0.00626293 0.0229198 0.051433 0.0633293 0.0359907 0.121444	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.084086 0.0477195 0.0257263 0.0551651 0.0299978 0.0115063 0.0218739 0.0156191 0.045553 0.0505331 0.0322228 0.0211957 0.02451 0.0151928 0.0100555 0.0346963 0.00641806 0.00775208 0.00638289 0.00656917 0.0065895 0.00534254 0.00449342 0.00528718 0.00383101 0.00497083 0.00509394 0.0047619 0.00435233 0.00459186 0.00323706 0.00451058 0.00338608 0.00497122 0.00330055 0.0032987 0.00516955 0.00434198 0.00391347 0.00607444 0.00491892 0.00649753 0.00696755 0.0151516 0.00337177 0.0051241 0.00394469 0.00464376 0.0062556 0.0223567 0.051107 0.0637065 0.03686 0.124801	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0843109 0.0478732 0.0257855 0.0552818 0.0300131 0.0115267 0.0218586 0.0156442 0.0454882 0.0502517 0.032241 0.0211567 0.0246469 0.0151875 0.0100761 0.0348314 0.00645624 0.00774199 0.00629586 0.00661755 0.00658945 0.00525852 0.00444869 0.00516436 0.00380701 0.00493474 0.00496926 0.00476612 0.00431712 0.00446179 0.00317686 0.00436148 0.00330401 0.00477385 0.00321173 0.00319866 0.00492052 0.0042201 0.00382115 0.00573533 0.00419079 0.0049116 0.00360749 0.00636203 0.00686458 0.0180649 0.00402933 0.00481466 0.0062703 0.0212227 0.0496615 0.0630061 0.0376332 0.126635	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0808807 0.0463307 0.0252741 0.0547284 0.0303143 0.0116226 0.0219163 0.0168344 0.04888 0.0537769 0.0312462 0.0193896 0.0198261 0.0106837 0.00521714 0.0115638 0.00870946 0.0112527 0.0528235 0.0136884 0.00997422 0.00687353 0.00633615 0.00769041 0.00635368 0.00755019 0.0135905 0.00339543 0.00238745 0.00331593 0.00237969 0.00347812 0.00254321 0.00433612 0.00239404 0.00221538 0.00353609 0.00251328 0.00229316 0.0038614 0.00276331 0.00396221 0.00270447 0.0042488 0.00328227 0.00595639 0.00396968 0.0046116 0.00678059 0.0292669 0.0517522 0.0652848 0.0305675 0.112872	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0805214 0.0463297 0.0252326 0.0547333 0.0301547 0.0115838 0.0217599 0.0166559 0.0482786 0.052825 0.0309543 0.0191574 0.019712 0.0104511 0.00515445 0.0113977 0.00868904 0.0115064 0.0525395 0.0141079 0.0102241 0.00657581 0.00625173 0.00607351 0.00467353 0.00704701 0.00737326 0.00974601 0.00759365 0.0110808 0.00258364 0.00308524 0.00244979 0.00402433 0.00258676 0.00229616 0.00333537 0.00258695 0.00231706 0.00353415 0.00264875 0.00369331 0.00272281 0.00398996 0.00320511 0.00543627 0.0038721 0.00439445 0.00663765 0.0255895 0.0522472 0.0623118 0.0326226 0.113445	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0801602 0.04613 0.0251162 0.0545042 0.0300252 0.0115208 0.0216503 0.016545 0.0479844 0.0525553 0.0307504 0.0190473 0.0195532 0.0103812 0.00511581 0.0113573 0.00863334 0.0114564 0.0522798 0.0139802 0.0101571 0.00653128 0.00624285 0.00587035 0.00456758 0.00678863 0.00619577 0.00738694 0.00710819 0.00684337 0.00756071 0.0133828 0.00269466 0.00416086 0.0027608 0.00241824 0.00341923 0.00265218 0.00235132 0.00351725 0.00262216 0.00364963 0.00268594 0.00392547 0.00314318 0.00534084 0.00379586 0.00432681 0.00649719 0.024758 0.0515461 0.0613936 0.032638 0.11232	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0801107 0.0460106 0.0250535 0.0544393 0.030059 0.0114685 0.0216313 0.0164665 0.0479625 0.0526599 0.030528 0.0189244 0.0193361 0.0103906 0.00509035 0.0114458 0.0085591 0.0111833 0.0515432 0.0132056 0.00967955 0.00641869 0.00609428 0.00582442 0.00435139 0.00644152 0.00587194 0.00638904 0.00617227 0.00539463 0.00396486 0.0059768 0.00707224 0.012751 0.00341831 0.00261875 0.00363052 0.00281516 0.00241189 0.00359899 0.00268084 0.00370388 0.00272068 0.00398821 0.00315991 0.00537336 0.00381202 0.00436093 0.00645113 0.0248412 0.0503982 0.0625084 0.0332226 0.115814	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0785073 0.0449687 0.024506 0.0531232 0.0293618 0.0112037 0.0211559 0.0161353 0.047055 0.0515474 0.0298988 0.0185686 0.0189314 0.0102112 0.00498453 0.0111984 0.00830959 0.0106899 0.0499037 0.0126571 0.00925577 0.00622784 0.00587131 0.00564292 0.00415708 0.00609434 0.00564989 0.00619751 0.00615074 0.0052955 0.00392735 0.00522184 0.00417198 0.00659305 0.0052592 0.00640411 0.013879 0.00357504 0.00249512 0.00376916 0.00274149 0.00391339 0.00273944 0.00419547 0.00325276 0.00581044 0.00390464 0.00455109 0.00663774 0.0292823 0.0533883 0.0661326 0.0312045 0.113489	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.079893 0.045907 0.0249753 0.0541714 0.0298088 0.0113955 0.0214182 0.0163207 0.0474646 0.0517563 0.0301845 0.0186662 0.0190977 0.0101926 0.00500484 0.0111337 0.00834353 0.0108926 0.0501605 0.0129142 0.00938414 0.00617714 0.00577603 0.00548265 0.00411684 0.00596688 0.00542763 0.00625024 0.00616333 0.00514759 0.00388517 0.00495087 0.00392093 0.00539653 0.00384821 0.00467764 0.00695585 0.00793056 0.00732089 0.0147368 0.00284397 0.00363084 0.00271471 0.0038811 0.00306454 0.00503868 0.00366842 0.00423192 0.00591438 0.0230536 0.048478 0.0602419 0.0332356 0.116785	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0788454 0.0453913 0.0246585 0.0535577 0.0294271 0.011239 0.0211208 0.0160358 0.0466784 0.0510095 0.0296785 0.0183733 0.0187546 0.0100033 0.00491357 0.0110109 0.00824877 0.0108556 0.0497013 0.0128568 0.00932942 0.00607788 0.00571756 0.00542515 0.00408075 0.00588765 0.00527747 0.00614775 0.00605191 0.00499617 0.00380248 0.00480469 0.00381815 0.00510323 0.00354512 0.00427503 0.00566519 0.00631362 0.00641629 0.00899511 0.0111017 0.0138529 0.00301581 0.00401711 0.00318406 0.00510149 0.00377237 0.00437357 0.00608538 0.0222676 0.0506116 0.0607203 0.0340824 0.113723	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0792044 0.0456284 0.0247713 0.0538111 0.0295487 0.0112908 0.0211954 0.0161035 0.0468559 0.0511404 0.0297872 0.0184319 0.0188141 0.0100253 0.00492745 0.0110213 0.00826772 0.0108872 0.0497521 0.0127984 0.0092615 0.00602995 0.00565792 0.00534221 0.00402498 0.00579572 0.00518601 0.00602989 0.00593463 0.00490671 0.00371819 0.0047095 0.00371934 0.00495316 0.00340652 0.0039992 0.00526537 0.0052265 0.00526722 0.00660634 0.00578218 0.00658577 0.0072666 0.0148266 0.00324367 0.00491148 0.00377544 0.0044148 0.00606224 0.0215705 0.0498818 0.0607836 0.0348099 0.116782	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0795095 0.0458136 0.0248649 0.0539676 0.0295923 0.0113379 0.0212272 0.0161706 0.0468923 0.0509311 0.0298365 0.0184365 0.0189219 0.0100167 0.00494298 0.0109711 0.0082899 0.0109524 0.0496066 0.0128727 0.00932105 0.00597879 0.00561213 0.00524435 0.00402808 0.0057802 0.00507693 0.006036 0.00591987 0.00480189 0.0036712 0.00457678 0.00363744 0.00477205 0.00331431 0.00387413 0.0050173 0.00512263 0.00521694 0.00626206 0.00490152 0.00503221 0.0037989 0.00639335 0.00711886 0.0178542 0.00388456 0.00458804 0.00607835 0.0204134 0.0481537 0.0597408 0.0353762 0.118248	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0793568 0.045183 0.0244069 0.0530756 0.0296244 0.0110356 0.0209763 0.0155801 0.0465668 0.0510876 0.0290247 0.0179385 0.0171016 0.00949723 0.00436161 0.00862032 0.00494775 0.00410925 0.00994911 0.0118673 0.0129323 0.056535 0.0111879 0.010241 0.0081973 0.00950441 0.0156277 0.00375041 0.00262425 0.00364804 0.00258731 0.00377949 0.00276164 0.00468928 0.00255832 0.00236295 0.00377449 0.00266531 0.00242943 0.00409333 0.00292467 0.00419394 0.00285128 0.00448005 0.00345672 0.00627272 0.00417597 0.00483803 0.00710132 0.030345 0.0534323 0.0671771 0.0316713 0.116819	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0780957 0.0446425 0.0240185 0.0525315 0.0291449 0.0108408 0.020575 0.0153167 0.0457538 0.049823 0.0283726 0.0176149 0.0168219 0.00928605 0.00424096 0.00850507 0.00477912 0.0041809 0.0102034 0.0128041 0.0139928 0.0585071 0.010934 0.00812416 0.00577532 0.00856438 0.00870256 0.0121918 0.00920766 0.0116431 0.00277431 0.00329711 0.00262575 0.00424104 0.00276121 0.00246419 0.00354189 0.00274753 0.0024662 0.00374264 0.00280229 0.00389423 0.00287542 0.00419515 0.00338333 0.00570798 0.0040869 0.00462702 0.00701701 0.0266764 0.0546163 0.0641961 0.0337869 0.116279	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.077631 0.0444088 0.0238657 0.0522786 0.0290077 0.0107743 0.0204685 0.0152124 0.0454582 0.0495703 0.0281931 0.0175482 0.0167095 0.00924333 0.0042128 0.00848815 0.00475185 0.00418041 0.0103145 0.0129769 0.014182 0.0590515 0.0109098 0.00784496 0.00565487 0.00826565 0.00720785 0.00891754 0.00882199 0.00770152 0.00898749 0.0141113 0.00286992 0.00437304 0.00290607 0.002566 0.00360461 0.00279262 0.00249206 0.00371424 0.00276515 0.00384053 0.00282937 0.00412027 0.00330984 0.00559882 0.00399722 0.00454333 0.006833 0.0257203 0.0532369 0.0625914 0.033464 0.114881	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0775481 0.0442982 0.02382 0.0521657 0.0289732 0.010732 0.0204318 0.0151227 0.045335 0.0495542 0.0280449 0.0174033 0.0165671 0.00921291 0.00419846 0.00846844 0.00473264 0.00412598 0.0102841 0.0127016 0.0139759 0.0579805 0.0104906 0.00767427 0.00531012 0.00782397 0.00680294 0.00783118 0.00783545 0.00612626 0.00474275 0.00668544 0.00830572 0.0132575 0.00357368 0.00273924 0.00378068 0.00293169 0.00251969 0.0037547 0.00279705 0.00386202 0.00283924 0.00415214 0.0032965 0.00558667 0.00397669 0.00453905 0.00673047 0.0257462 0.0519114 0.063906 0.0340612 0.118733	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0757727 0.0431617 0.02327 0.0507938 0.0282466 0.0104964 0.0200047 0.0148419 0.0444529 0.0484169 0.027532 0.0170577 0.0162548 0.0090057 0.0041107 0.00826411 0.00463594 0.00400751 0.00995944 0.0121235 0.0132186 0.0551132 0.00992412 0.00735975 0.0050161 0.00734031 0.00649297 0.00754179 0.00767204 0.00597389 0.00486232 0.00581068 0.00487271 0.00720468 0.00581263 0.00731118 0.014016 0.00369414 0.00259832 0.0038991 0.00284358 0.00405248 0.00284747 0.00434402 0.0033794 0.00600834 0.00404864 0.00470527 0.00691443 0.0303872 0.0552702 0.0680341 0.0321776 0.116843	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0767651 0.0438328 0.0235655 0.0515364 0.0285443 0.0106078 0.0201449 0.0149614 0.0447068 0.0484224 0.02759 0.0171003 0.0162911 0.008994 0.00410528 0.00825516 0.00461331 0.00405238 0.00995779 0.0123813 0.0134649 0.055959 0.00996489 0.00723354 0.00504153 0.00726278 0.00626977 0.00762254 0.0077378 0.00586602 0.00492502 0.00556228 0.00468385 0.0058795 0.00430753 0.00589226 0.00761155 0.00910786 0.0082572 0.0149375 0.00295078 0.00375029 0.00281802 0.00401129 0.0031842 0.00520046 0.00381336 0.00438745 0.00615555 0.0239763 0.0498471 0.0617055 0.0341063 0.120078	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0757017 0.0432801 0.0232095 0.0508313 0.0280908 0.0104138 0.0197796 0.014633 0.0438048 0.047523 0.0269779 0.0167679 0.0159334 0.00881297 0.00401444 0.00811108 0.00449815 0.0039724 0.0098588 0.0123056 0.0135254 0.0557338 0.00994869 0.00717642 0.00500025 0.00716493 0.00611728 0.00748621 0.00759484 0.00570411 0.00481751 0.0054012 0.0045625 0.00556588 0.00397925 0.00532542 0.00615339 0.00751446 0.00770277 0.00991896 0.0123352 0.0142192 0.00314164 0.00417744 0.00331333 0.00528412 0.00393776 0.00455526 0.00634211 0.0231338 0.0519817 0.0616758 0.0347787 0.11621	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0759876 0.0434718 0.0232918 0.0510252 0.0281845 0.0104482 0.0198224 0.0146747 0.0439208 0.0475994 0.0270249 0.0167968 0.0159447 0.00882208 0.00401814 0.00811365 0.00450031 0.00397955 0.00986313 0.0123526 0.0135505 0.0558125 0.0098843 0.00708644 0.00495025 0.00707505 0.0060245 0.00736124 0.00747398 0.00561274 0.00472045 0.00529827 0.00444635 0.00540145 0.00381037 0.00498463 0.00571996 0.0064433 0.00673288 0.00754216 0.00678299 0.00709177 0.00816352 0.0151977 0.00336426 0.00507023 0.0039107 0.00456681 0.00626512 0.0222937 0.050951 0.061622 0.0354792 0.119468	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0761912 0.0436087 0.0233465 0.0511524 0.0282202 0.0104747 0.0198283 0.0147229 0.0439548 0.0474421 0.0270173 0.0167961 0.0159634 0.00880772 0.00401105 0.00808473 0.00448273 0.00399698 0.00982885 0.0124366 0.0135627 0.0557757 0.00988297 0.00699748 0.00498599 0.00707665 0.0059211 0.00736453 0.00748178 0.00552885 0.00469317 0.00517466 0.00436457 0.00522424 0.00372073 0.00485302 0.00547136 0.00631485 0.00669101 0.00716108 0.0058604 0.00550075 0.00420584 0.00685744 0.00797656 0.0184566 0.00401684 0.00473781 0.0062594 0.02102 0.0490792 0.0604815 0.0360484 0.120885	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0857416 0.0482916 0.0258933 0.0549829 0.0306444 0.0112879 0.0209606 0.0147951 0.0442976 0.0498428 0.027327 0.01696 0.015389 0.00868995 0.00399878 0.00744011 0.00425297 0.00310443 0.00647502 0.00529059 0.00393491 0.00921562 0.00917623 0.0405364 0.00977433 0.0102704 0.0185057 0.00427398 0.00301403 0.00423495 0.00296399 0.00433241 0.00314234 0.00547875 0.00288636 0.0026564 0.0043086 0.00294684 0.00270945 0.004606 0.00325617 0.00469132 0.00315448 0.00499703 0.00381497 0.00695064 0.0045989 0.00531807 0.00756995 0.0319961 0.0539842 0.0710057 0.0340842 0.129945	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG2 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.085069 0.0481086 0.0259318 0.0550649 0.0305061 0.0113003 0.0209108 0.0147538 0.0441073 0.0495389 0.0273853 0.0165901 0.0152213 0.00837134 0.00386576 0.00711379 0.00408847 0.00300975 0.00618729 0.00509647 0.00391899 0.00900753 0.00913381 0.037367 0.0073136 0.00927655 0.00957126 0.0110511 0.00898182 0.0135831 0.0030923 0.00367038 0.00295133 0.00480701 0.00311209 0.00277079 0.00396651 0.00305007 0.00275022 0.00412339 0.00308034 0.00428268 0.00315154 0.00460804 0.00368497 0.00623084 0.00445437 0.00506476 0.0075387 0.0282513 0.0567713 0.0688688 0.0371857 0.131107	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG2 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0844491 0.0477931 0.0257616 0.0547223 0.0303578 0.0112336 0.0208252 0.0146367 0.0437669 0.0492897 0.0272881 0.0165199 0.0151106 0.00830784 0.00382903 0.00706586 0.00405982 0.00298285 0.00618578 0.00507884 0.00393814 0.00922534 0.00937398 0.0378398 0.00720673 0.00898782 0.00815446 0.00810869 0.00784133 0.00801644 0.00868276 0.0155329 0.00317543 0.00489615 0.00324276 0.00284951 0.00401498 0.00307834 0.0027559 0.00408895 0.00303349 0.00423025 0.00309539 0.00453719 0.00360609 0.00613879 0.00435886 0.00497798 0.00736573 0.0276805 0.0559254 0.0678142 0.0369125 0.130049	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG2 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0839917 0.0474231 0.0255684 0.0543321 0.0301884 0.0111428 0.0207208 0.0145104 0.0434887 0.0490271 0.0270432 0.016398 0.0150212 0.00831898 0.00383312 0.00711632 0.00406844 0.00298326 0.00624974 0.00505507 0.00395067 0.00938768 0.00934517 0.037118 0.00679775 0.00858359 0.0077189 0.00690747 0.00681274 0.0063398 0.00470377 0.00689453 0.00802433 0.0142623 0.0039235 0.00302428 0.00420305 0.0032219 0.0027832 0.00415757 0.00308016 0.00427141 0.00311363 0.00459297 0.00361085 0.00617436 0.00435875 0.00499803 0.00731255 0.0280165 0.0550123 0.0694582 0.0374643 0.133895	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG2 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0818501 0.0460507 0.0248872 0.0527151 0.0293106 0.0108595 0.0202062 0.0142073 0.0425928 0.0476941 0.0264577 0.0160547 0.014761 0.00815073 0.00375971 0.00697846 0.00398257 0.00292608 0.00611791 0.00495005 0.00386669 0.00912442 0.00896983 0.0354574 0.0064842 0.00816878 0.00738698 0.00674671 0.00684454 0.00622698 0.00469023 0.00609008 0.00484068 0.00769417 0.00594157 0.00726075 0.0151813 0.00401939 0.00285747 0.00434644 0.00315045 0.00450131 0.0031425 0.00481523 0.00372813 0.0066446 0.00447012 0.00519975 0.0075182 0.0326516 0.0584736 0.0737648 0.0351902 0.130038	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0835337 0.0471565 0.0254078 0.0539014 0.0298298 0.0110406 0.0204429 0.0143747 0.0430146 0.0479213 0.0265614 0.0160407 0.0146574 0.00807014 0.00372454 0.00687058 0.00392378 0.00290154 0.00597583 0.00490747 0.00383343 0.00897606 0.00894896 0.0357011 0.00654509 0.0080976 0.00716189 0.00687743 0.0068996 0.00605951 0.0046856 0.00577287 0.00462753 0.00633789 0.0044102 0.00545782 0.00786895 0.00862604 0.00823488 0.0160582 0.00319386 0.00412053 0.00308671 0.00442008 0.00347547 0.0057017 0.00416746 0.0048231 0.006661 0.0258131 0.0527893 0.0669538 0.0376942 0.135663	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.082232 0.0464665 0.0249939 0.0530482 0.0293115 0.0108305 0.0200781 0.0140569 0.04214 0.0470343 0.0260432 0.0157572 0.0143603 0.00790638 0.00364552 0.00676652 0.00384437 0.00283965 0.00589065 0.00479324 0.00377422 0.00898866 0.00897369 0.0353838 0.00643274 0.00792783 0.00697704 0.00676787 0.00677012 0.00590472 0.00459041 0.00561823 0.00450907 0.00599541 0.00405193 0.0050372 0.00644421 0.0068937 0.00721015 0.0100325 0.0124383 0.0153877 0.00344405 0.00459964 0.00362778 0.00580506 0.00430084 0.00500461 0.00685371 0.0249936 0.0552205 0.0672728 0.0385888 0.13214	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0826738 0.0467461 0.0251219 0.0533237 0.0294531 0.0108814 0.0201419 0.0141084 0.0422766 0.0471263 0.0260642 0.0157685 0.0143339 0.00790965 0.00364375 0.00674691 0.00383269 0.00283731 0.00585997 0.00478871 0.00376937 0.00899819 0.00897918 0.0355159 0.00638063 0.00783302 0.00687427 0.00664373 0.00665413 0.00581175 0.00450185 0.00551778 0.00440332 0.00582613 0.00390955 0.00473772 0.00600778 0.00568288 0.00581338 0.00733375 0.00625211 0.00735106 0.00819338 0.0162887 0.00368152 0.00555686 0.00428662 0.00503333 0.00679096 0.0242835 0.0545258 0.0674983 0.0394566 0.135968	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0829057 0.0469039 0.0251807 0.0534398 0.0294806 0.0109015 0.0201251 0.0141402 0.0422698 0.0469256 0.0260044 0.0157392 0.01428 0.00787924 0.00362558 0.00668866 0.00379937 0.00282672 0.00578878 0.00477724 0.00376247 0.00896041 0.00899433 0.0356363 0.00642029 0.00781057 0.00674774 0.00669248 0.00663654 0.00568366 0.00444293 0.00536107 0.00430919 0.00561656 0.00381292 0.00459047 0.00573034 0.00556266 0.00574437 0.00694326 0.00531999 0.00563478 0.0041833 0.00713429 0.00803715 0.0194203 0.00438135 0.00522165 0.00679666 0.0229863 0.0528765 0.0666715 0.0402876 0.137908	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0766566 0.0433474 0.0233494 0.0496393 0.0276376 0.0101911 0.0187761 0.0133463 0.0395058 0.0451381 0.0246706 0.0148524 0.0137703 0.00742461 0.00353688 0.00638711 0.00371695 0.00274753 0.00538618 0.00433617 0.00319797 0.00610685 0.00439084 0.0106143 0.00846435 0.0115502 0.0555787 0.0136426 0.0102897 0.00727259 0.00685787 0.006655 0.00612031 0.00804294 0.00631997 0.00801904 0.014916 0.0040002 0.00282995 0.00421258 0.00308812 0.00436399 0.00307994 0.00465035 0.00363398 0.00640145 0.00433331 0.00503116 0.00741803 0.0322277 0.0596006 0.0730328 0.0347321 0.124908	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0777867 0.0441114 0.0237141 0.0504163 0.0279388 0.0103092 0.0188949 0.0134286 0.0396697 0.0450934 0.0247182 0.0148278 0.0137211 0.00735359 0.00350931 0.00631679 0.00367374 0.00273321 0.00528876 0.00430905 0.00318811 0.00600719 0.00437502 0.0104228 0.00842473 0.0116649 0.055357 0.013897 0.0104523 0.0071407 0.00694383 0.00637211 0.0060218 0.00645882 0.004782 0.00726923 0.0083218 0.0102898 0.00899924 0.0158076 0.0031692 0.00399992 0.0030368 0.0042738 0.00341922 0.00551928 0.00408133 0.00468343 0.00659441 0.0255923 0.0539648 0.0664882 0.0367514 0.128415	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0765874 0.0435272 0.0233452 0.0497327 0.0275117 0.0101304 0.0185783 0.0131504 0.0388931 0.0443228 0.0242457 0.0145474 0.0134221 0.00718459 0.00342977 0.00620018 0.00359583 0.0026705 0.00519717 0.00420155 0.0031165 0.00589952 0.00429048 0.0103502 0.00833336 0.0116389 0.0547095 0.0136487 0.0102505 0.00693223 0.00672663 0.00616098 0.00578752 0.00605618 0.00437638 0.00645768 0.00671795 0.00866527 0.00923623 0.0109127 0.0134333 0.0153424 0.00338792 0.00448014 0.00356977 0.00564318 0.00423379 0.00488348 0.00684447 0.0248459 0.0564193 0.0660432 0.0371881 0.122944	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0767289 0.0436433 0.02339 0.0498488 0.027569 0.0101506 0.0185991 0.0131735 0.0389528 0.0443444 0.0242463 0.0145521 0.0134096 0.00718489 0.00342827 0.00619113 0.00359068 0.00267123 0.00518421 0.00420424 0.00311812 0.0059005 0.00429688 0.0103476 0.00835084 0.0116629 0.054672 0.0134995 0.0100991 0.0068271 0.00659973 0.00604034 0.00563693 0.0058549 0.00416846 0.00604427 0.00621333 0.00759996 0.00839219 0.00888738 0.00823572 0.00760677 0.0088365 0.016303 0.00361733 0.00542938 0.00419005 0.00487874 0.0067404 0.0238802 0.0550807 0.0658249 0.037843 0.126258	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0770543 0.0438237 0.0234823 0.0499848 0.0276094 0.0101833 0.0186088 0.0132229 0.0389983 0.0441769 0.0242311 0.0145519 0.0134143 0.00717783 0.00342327 0.00616241 0.00357117 0.00267166 0.00513848 0.00420571 0.00312549 0.00587653 0.00431615 0.0102743 0.00838624 0.0117246 0.054489 0.0136157 0.0101872 0.00675596 0.00657199 0.00592067 0.00553378 0.0056742 0.00408471 0.00589264 0.00595709 0.00747424 0.00835645 0.00847352 0.00726722 0.00595917 0.00472635 0.00733323 0.00865099 0.0196231 0.0043127 0.00507103 0.00674601 0.0225521 0.0528393 0.0643761 0.0383629 0.127797	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG1 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0774756 0.0437646 0.0235421 0.0502085 0.0279824 0.0103366 0.0190793 0.0136448 0.0409661 0.0454083 0.0246058 0.0146568 0.0134302 0.00734234 0.00345442 0.00607287 0.00356675 0.00261312 0.00489385 0.00401373 0.00276775 0.00514447 0.00336241 0.00735412 0.00419636 0.00388639 0.00962986 0.0110113 0.0127179 0.0542837 0.0117937 0.00828626 0.00805182 0.00938855 0.00745332 0.00953266 0.0155036 0.00415007 0.00295405 0.00434962 0.00318802 0.00448862 0.00317828 0.00474978 0.00373768 0.00650542 0.00442916 0.00510742 0.00758314 0.0321583 0.0605745 0.0727538 0.0350029 0.123667	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0778472 0.0440591 0.0236185 0.0504559 0.0279892 0.0103298 0.0189985 0.0135962 0.0407221 0.0448228 0.0243336 0.0145046 0.0132395 0.00722273 0.00340121 0.00597265 0.00349192 0.00258284 0.00477624 0.00395895 0.00274527 0.00506599 0.00333522 0.00728673 0.00413177 0.00394424 0.00965272 0.0115303 0.0132511 0.0559497 0.0120996 0.00803018 0.007976 0.00739323 0.0055818 0.00901941 0.00928661 0.0124729 0.0102755 0.0157802 0.00322892 0.00407762 0.00312153 0.00434892 0.0035181 0.00561568 0.0041992 0.00479339 0.00679046 0.0259076 0.0547528 0.0660054 0.0367086 0.1262	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0768054 0.0435211 0.023254 0.0497498 0.0275302 0.0101275 0.0186199 0.0132667 0.0398069 0.043873 0.0237275 0.0141682 0.0128873 0.00703699 0.00331728 0.00584766 0.00339967 0.00251766 0.00466325 0.00384008 0.00267746 0.00495939 0.00325205 0.00716057 0.00401353 0.00384632 0.00952667 0.0113549 0.0132643 0.0550845 0.0118122 0.00775556 0.00757299 0.0069183 0.00515584 0.00804907 0.00748215 0.0103647 0.0111591 0.0124122 0.0148987 0.0157628 0.00351224 0.00463037 0.00369176 0.0057742 0.00439693 0.00505034 0.00711087 0.0254317 0.0568644 0.0646022 0.0366462 0.119845	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0766939 0.043491 0.0232136 0.0496893 0.0274887 0.0101061 0.0185595 0.0132288 0.0396843 0.0436884 0.0236 0.0141022 0.0128047 0.00700371 0.00330094 0.00580704 0.00337491 0.00250581 0.0046195 0.00381827 0.00266272 0.00492778 0.00323201 0.00711177 0.00398672 0.00382605 0.00945477 0.0113166 0.013192 0.0546729 0.0116144 0.00760505 0.0073798 0.00666182 0.0048831 0.00753874 0.00689018 0.00937886 0.0104427 0.0110456 0.0101578 0.00813672 0.0100161 0.0165429 0.00371287 0.00553396 0.00428969 0.00498175 0.00691259 0.024292 0.055325 0.0646007 0.0373462 0.123548	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0770259 0.0436854 0.0233009 0.0498551 0.0275438 0.0101367 0.0185656 0.0132735 0.0397272 0.0435215 0.0235589 0.0140921 0.0127873 0.00699219 0.00329526 0.0057702 0.00335181 0.00250409 0.00456791 0.00381012 0.00266046 0.00489577 0.00322478 0.00706309 0.00396402 0.00384224 0.00938049 0.0114135 0.0132068 0.0545479 0.0116756 0.00749416 0.0072618 0.0064728 0.00481642 0.00739728 0.00664567 0.00925218 0.0103977 0.0106078 0.00933651 0.00652452 0.00560153 0.00783263 0.00985456 0.0199556 0.00439318 0.00515854 0.00687274 0.0228837 0.052673 0.0627748 0.0377054 0.124848	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0801334 0.0452748 0.0242917 0.0516652 0.0289356 0.0106287 0.0196306 0.0138507 0.0418995 0.0470035 0.025167 0.0150517 0.013657 0.00755259 0.00354657 0.00621234 0.00365197 0.00264586 0.00488962 0.00395905 0.00265028 0.00481458 0.00299641 0.00652124 0.0035683 0.00290336 0.00657387 0.00501739 0.00435893 0.0107896 0.0112745 0.0520352 0.0100366 0.0109878 0.00811018 0.00968543 0.0170996 0.00441359 0.00312979 0.00464428 0.00337088 0.00473191 0.00330931 0.00495846 0.00386345 0.00674053 0.00454978 0.00524909 0.00762088 0.0321171 0.0589536 0.072605 0.0349781 0.125694	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0800577 0.0453642 0.0242384 0.0517699 0.0288784 0.0105852 0.0195221 0.0137829 0.0416245 0.0464404 0.024899 0.0149068 0.0134418 0.00741811 0.00347956 0.00610931 0.00357176 0.00260653 0.00477949 0.00389848 0.00261563 0.00473809 0.00296192 0.00648336 0.00351796 0.00290515 0.00660481 0.00506708 0.00462697 0.0114815 0.0127098 0.0554448 0.0101125 0.00892547 0.00595868 0.00883427 0.00967923 0.0121806 0.010127 0.016029 0.00330933 0.00419808 0.00320787 0.004471 0.00359093 0.00573401 0.00425355 0.00485684 0.00679656 0.0257975 0.0534615 0.0658972 0.0369265 0.129121	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0787859 0.0446901 0.0237996 0.050907 0.028349 0.0103531 0.0191013 0.0134113 0.0405926 0.0453815 0.0242432 0.0145551 0.0130644 0.00722005 0.00338819 0.0059774 0.00347244 0.00253702 0.00466448 0.00377584 0.00254711 0.00463379 0.00288563 0.00638083 0.00342111 0.00283084 0.00648806 0.00490278 0.00457374 0.0116891 0.0129709 0.0552983 0.00980862 0.00836348 0.00548047 0.00799457 0.00788997 0.0103309 0.0111147 0.0121818 0.0147162 0.0157524 0.00356909 0.00471144 0.00373528 0.00586561 0.00442079 0.00507801 0.00703747 0.0251807 0.0555045 0.0645554 0.0369422 0.122875	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0787838 0.0447232 0.0237898 0.0509138 0.028344 0.0103447 0.0190638 0.0133899 0.040521 0.0452406 0.0241392 0.01451 0.0129937 0.00719697 0.00337523 0.00594543 0.00345004 0.0025286 0.00462565 0.00375865 0.00253675 0.00460947 0.00287199 0.006344 0.0033985 0.00281754 0.00644238 0.00488655 0.0045698 0.0117041 0.0130097 0.0552052 0.0095729 0.00805453 0.00521928 0.00752187 0.00728936 0.00929113 0.0103464 0.0107306 0.00987016 0.00812826 0.00970001 0.0162553 0.00374424 0.00559816 0.00431786 0.00501385 0.0068293 0.0240881 0.0539524 0.0643644 0.0375782 0.1265	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0792483 0.0450026 0.0239157 0.0511689 0.0284491 0.0103909 0.0190923 0.0134539 0.0406265 0.0451287 0.0241177 0.014515 0.0129736 0.00719167 0.00337111 0.00591269 0.00342856 0.00252878 0.00457445 0.00375334 0.0025347 0.00457905 0.00286426 0.00629181 0.00337186 0.00281101 0.00636411 0.00488453 0.00459297 0.0116498 0.013089 0.0551119 0.00948405 0.00785413 0.00514494 0.00735675 0.00701506 0.00915383 0.0102957 0.0102674 0.00893951 0.00651164 0.00539038 0.00777274 0.00947949 0.0193297 0.00439566 0.00517297 0.00676369 0.0226111 0.0514307 0.0626998 0.0380537 0.127888	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG1 , DRUG0 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0850939 0.0480048 0.0258038 0.0544642 0.0303614 0.0111707 0.0204011 0.0143426 0.0433108 0.0491945 0.0261213 0.0154377 0.014181 0.00781553 0.00370384 0.00639726 0.0038082 0.00274863 0.00496161 0.00403318 0.00269834 0.00476955 0.00293025 0.00616095 0.00340803 0.00264639 0.00546508 0.00412865 0.00291132 0.00590832 0.0037708 0.00906258 0.00850825 0.0383641 0.00981796 0.0107692 0.0195487 0.00480793 0.00339113 0.00501683 0.00360181 0.00504823 0.00350454 0.00525722 0.00406115 0.00708344 0.00475446 0.00544681 0.00774429 0.0318896 0.0574831 0.072372 0.0357455 0.130568	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG2 ) , DRUG0 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0860963 0.0487217 0.0262378 0.0553757 0.0306967 0.0113518 0.0205974 0.0144909 0.0435925 0.0492725 0.0263905 0.0152554 0.0140861 0.00759515 0.00362151 0.00616628 0.00371696 0.00268881 0.00476042 0.00393179 0.00263852 0.00455875 0.00284134 0.00582678 0.00328207 0.00256253 0.00517163 0.00399427 0.00285224 0.00566586 0.00369559 0.00866979 0.00831511 0.0360643 0.00760916 0.00992267 0.010414 0.0119124 0.0103081 0.0176121 0.00341482 0.00436554 0.00337282 0.00465215 0.00375035 0.00592049 0.00444676 0.00509298 0.00704121 0.0259287 0.0539533 0.0667048 0.0383932 0.1344	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG2 and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0846845 0.0479359 0.0257918 0.0543725 0.0301137 0.011127 0.0201874 0.0141252 0.0425358 0.0480599 0.0257848 0.0149196 0.0137172 0.00737501 0.00351967 0.00601778 0.00361184 0.00261376 0.00463738 0.00381038 0.00256531 0.0044353 0.00276267 0.00570782 0.00319361 0.00249429 0.00505993 0.00387214 0.00279619 0.00561615 0.00365192 0.00881076 0.00839398 0.0352827 0.00710242 0.00893272 0.00860451 0.0101554 0.0112547 0.0122641 0.0148254 0.0170708 0.00375572 0.00493849 0.00392922 0.00605735 0.0046349 0.00533855 0.00740422 0.0257835 0.0562821 0.0655665 0.0382807 0.128235	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0846562 0.0479474 0.0257814 0.0543591 0.0300993 0.011119 0.0201537 0.014105 0.0424525 0.0478882 0.0256645 0.0148474 0.0136118 0.00733443 0.0034964 0.00596248 0.00357688 0.00259622 0.00457734 0.00378007 0.00254428 0.00439133 0.00273631 0.00563384 0.00314982 0.00246844 0.00497051 0.0038247 0.00275885 0.00554353 0.0036061 0.00874159 0.00827228 0.0348435 0.00680879 0.00847877 0.00796136 0.00887914 0.0102289 0.0104025 0.00953496 0.00828778 0.00961403 0.0174081 0.00393432 0.00582407 0.00453548 0.0052777 0.00721945 0.0249542 0.0554227 0.0661002 0.0391414 0.132492	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0852321 0.0482821 0.0259446 0.0546521 0.0302225 0.0111776 0.0201983 0.0141741 0.042555 0.0477412 0.0256405 0.0148282 0.0135619 0.00731398 0.00348327 0.00590647 0.0035437 0.00258918 0.00450584 0.00376528 0.00253383 0.00434575 0.00271833 0.0055467 0.00310511 0.00245123 0.00485882 0.0037913 0.0027328 0.00544639 0.00356805 0.00859217 0.00816627 0.0344737 0.00673575 0.00829028 0.00766001 0.00885999 0.0102863 0.00998842 0.00855932 0.00658053 0.00538884 0.00793285 0.0095301 0.0200966 0.00460139 0.00545738 0.00719137 0.023767 0.0531059 0.0644955 0.0396219 0.134202	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG1 (e.g. , DRUG0 ) , DRUG0 and DRUG0 , DRUG0 , DRUG2 , and other drugs having anticholinergic activity .
4	4	0.0688239 0.0392536 0.0207481 0.0446853 0.0248141 0.00905978 0.0166115 0.011777 0.035232 0.0403311 0.0213122 0.0128538 0.011644 0.0065505 0.00307712 0.00542948 0.00317816 0.00232029 0.00422643 0.0034143 0.00228276 0.00406833 0.00249111 0.00531931 0.00290516 0.00229957 0.0046173 0.00348115 0.00243419 0.00461557 0.00280091 0.00564049 0.00369959 0.00870932 0.00498769 0.00557656 0.0156437 0.0227354 0.0247373 0.13898 0.0241911 0.0224626 0.004182 0.00491784 0.00402784 0.00579015 0.00461724 0.0051547 0.0073589 0.0247181 0.0519272 0.0545088 0.0316301 0.101145	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 and DRUG2 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity .
4	4	0.0744734 0.0416402 0.0225148 0.0468631 0.0259306 0.00971933 0.0174598 0.0124834 0.0373866 0.0415439 0.0225631 0.0132705 0.0123772 0.00665144 0.0031928 0.00544636 0.00323863 0.0024085 0.00416519 0.00348175 0.00237554 0.00401787 0.00256355 0.00521939 0.00292384 0.00235432 0.00445819 0.00349174 0.00252395 0.00451482 0.00288966 0.00548013 0.00380576 0.00830465 0.00501486 0.00570075 0.0142973 0.0212425 0.020684 0.0907929 0.0203094 0.0109415 0.0133657 0.0209453 0.00421431 0.00594888 0.00475327 0.00540511 0.00767842 0.025659 0.0551217 0.0592157 0.0350068 0.111969	The following agents may increase certain actions or side effects of DRUG0 : DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , DRUG1 and DRUG0 , DRUG2 , DRUG0 , and other drugs having anticholinergic activity .
2	2	0.252959 0.12539 0.131733 0.0846204 0.160991 0.143773 0.100533	DRUG1 antagonize the effects of DRUG2 .
2	2	0.0620428 0.0577115 0.0473309 0.030301 0.0420216 0.0959853 0.0639585 0.0454348 0.0768536 0.0490834 0.0531685 0.0380851 0.0608163 0.0651043 0.0439588 0.0162834 0.0127698 0.0171442 0.0491113 0.0728348	DRUG1 in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as DRUG2 .
3	3	0.124387 0.0790778 0.0545485 0.0602796 0.0760691 0.0559265 0.0624588 0.0153104 0.005261 0.0086896 0.018408 0.0754858 0.108103 0.0427526 0.0703153 0.0754062 0.0484777 0.0190436	DRUG1 may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of DRUG2 ;
3	2	0.146634 0.135961 0.075839 0.110259 0.0629316 0.0774978 0.040206 0.0358726 0.0630923 0.0562266 0.0254298 0.00762491 0.01224 0.0180919 0.0514111 0.0806833	DRUG1 may antagonize the effects of drugs that alter gastrointestinal motility , such as DRUG2 .
3	3	0.0700005 0.138465 0.126595 0.0877324 0.0712466 0.0624603 0.0806595 0.0721903 0.0440859 0.0106223 0.0490545 0.028401 0.0185314 0.0111396 0.0123356 0.0162592 0.0167453 0.0264346 0.0570408	Because DRUG1 may interfere with the absorption of DRUG2 , simultaneous use of these drugs should be avoided .
4	4	0.0828612 0.0518047 0.0388034 0.0184488 0.0293693 0.0392017 0.0417662 0.0503465 0.0970822 0.0577105 0.0379933 0.0228884 0.00934857 0.026487 0.0191182 0.0134919 0.0139262 0.0146964 0.0259014 0.0603274 0.0778193 0.0245156 0.0145237 0.0273833 0.0321911 0.0280102 0.0439832	Interaction with DRUG1 : Although DRUG2 does not itself cause orthostatic hypotension , its administration to patients already receiving DRUG0 can result in profound orthostatic effects .
2	2	0.0353398 0.0213579 0.00899116 0.00942577 0.00923222 0.0269625 0.017046 0.025459 0.078143 0.0616404 0.0479686 0.0353695 0.0207287 0.0557381 0.0409591 0.0436097 0.0324649 0.053071 0.0563878 0.0602701 0.0874881 0.0258264 0.0227985 0.0287377 0.0338999 0.0257471 0.0353372	Interaction with DRUG0 : Although DRUG1 does not itself cause orthostatic hypotension , its administration to patients already receiving DRUG2 can result in profound orthostatic effects .
1	1	0.0638147 0.0406856 0.0429047 0.0480087 0.114648 0.0308185 0.0435574 0.057349 0.0596908 0.0975847 0.0977121 0.0702534 0.109981 0.122991	If at all possible DRUG1 should be discontinued well before DRUG2 is begun .
1	4	0.0917806 0.0541831 0.0269826 0.0474968 0.0266971 0.044314 0.0448852 0.0606719 0.0510721 0.0407796 0.0350706 0.0282639 0.0252037 0.0326774 0.0349159 0.0374727 0.0208046 0.0118816 0.0114462 0.021 0.0156796 0.013402 0.00676106 0.004206 0.00196632 0.00511205 0.00256965 0.00138395 0.00306538 0.00209372 0.00721061 0.00351279 0.0017733 0.00535249 0.00685222 0.00350235 0.00175014 0.00196779 0.00622072 0.0125794 0.0192648 0.014067 0.0138448 0.012582 0.0133159 0.0723641	Interaction with Other DRUG1 : DRUG2 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0389823 0.0252558 0.00998743 0.0244574 0.0106906 0.0159167 0.0498549 0.0595244 0.0543782 0.0455073 0.0379054 0.0304958 0.0310793 0.0455546 0.0471696 0.0490393 0.0298587 0.0247647 0.0205131 0.0478312 0.0452354 0.0625931 0.0525062 0.0139406 0.00304121 0.00280171 0.00165649 0.000998218 0.0016648 0.00147956 0.00360659 0.00192581 0.0011001 0.00299095 0.00393008 0.00193402 0.0010123 0.00114092 0.00370292 0.00771256 0.0111439 0.00858521 0.00843116 0.00732843 0.00752765 0.0432436	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG2 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0432108 0.0279814 0.0110792 0.0270305 0.0117422 0.017255 0.053974 0.064168 0.0579634 0.0475541 0.0372523 0.0272737 0.0267405 0.0395169 0.0402748 0.0393277 0.0228895 0.0184432 0.0207062 0.0459288 0.0398283 0.0381034 0.0193397 0.0097074 0.0109982 0.050259 0.0142686 0.00239054 0.00207284 0.00160876 0.00376165 0.00215679 0.00132071 0.00346336 0.00446929 0.00219202 0.00118828 0.00132027 0.00437537 0.00891004 0.0126976 0.00960558 0.00949821 0.00831355 0.0086241 0.0492142	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG2 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0435533 0.0282134 0.0111645 0.0272201 0.01187 0.0175166 0.0549362 0.0654114 0.0593459 0.0490767 0.0393365 0.0298789 0.029929 0.0442885 0.0457203 0.0455545 0.0270877 0.0223472 0.022763 0.0498014 0.0452225 0.0470495 0.0211556 0.00633294 0.00504968 0.01426 0.00315671 0.00250395 0.00643319 0.00150904 0.0027026 0.00177206 0.00121242 0.00298504 0.0037343 0.00198577 0.00113665 0.001252 0.00416778 0.00837281 0.0118099 0.00911363 0.00899514 0.00788684 0.00821517 0.0469697	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG2 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0427861 0.0277112 0.0109787 0.0267964 0.0116469 0.0170868 0.0532636 0.0631923 0.0569403 0.046572 0.0364172 0.026573 0.0257712 0.0378605 0.0382237 0.0372554 0.0208336 0.0153215 0.0170336 0.0381477 0.034244 0.0322576 0.0133817 0.00507901 0.00261841 0.00914585 0.00337266 0.00196895 0.00598165 0.0152467 0.0754235 0.0198868 0.00329714 0.00368057 0.0043607 0.0024074 0.00137911 0.00144696 0.00474712 0.00964175 0.0132797 0.00988835 0.00997082 0.00858957 0.00886817 0.0494241	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG2 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0428219 0.027731 0.0109768 0.0267738 0.0116371 0.0171229 0.0535577 0.0636547 0.0575096 0.0471831 0.0370301 0.0272697 0.0269221 0.0399142 0.0410581 0.0402803 0.0234757 0.0190805 0.0213025 0.0478751 0.0428698 0.0411586 0.0173474 0.00556469 0.00368799 0.01004 0.00243074 0.00142231 0.00300835 0.0050081 0.0173782 0.00397896 0.00357792 0.0106137 0.00557413 0.00289132 0.00164283 0.00170746 0.00567891 0.0133314 0.0171826 0.0123904 0.0124328 0.0103972 0.0106257 0.0548815	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG2 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0450062 0.0291502 0.0115453 0.0281956 0.0122492 0.0179888 0.0560407 0.0665133 0.0599664 0.0491007 0.0386476 0.0284871 0.0274806 0.0401071 0.0399161 0.0390368 0.021328 0.0143431 0.0155587 0.0337714 0.0286083 0.0259119 0.0114151 0.00495634 0.00240245 0.00658619 0.00244202 0.0012361 0.00307646 0.00271348 0.0109417 0.00455878 0.00268715 0.0129407 0.0500561 0.0163431 0.00398117 0.00221932 0.0049354 0.00940106 0.016058 0.011745 0.0121688 0.010404 0.0107154 0.057063	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0442583 0.028662 0.01135 0.0276951 0.0120335 0.0176728 0.0551631 0.0654888 0.0590554 0.048326 0.0377732 0.0276074 0.0269767 0.0398441 0.04062 0.0396668 0.0225214 0.0173838 0.0195081 0.0441515 0.0392465 0.035797 0.0149219 0.00511884 0.00293652 0.00749305 0.00224168 0.00123496 0.00285753 0.00322241 0.0118178 0.00317205 0.00183048 0.00665624 0.0148217 0.00546009 0.00421674 0.00385352 0.0115456 0.0104523 0.0168965 0.0123956 0.0137129 0.0116219 0.0123059 0.0584122	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.039001 0.0252604 0.00999986 0.0244177 0.0105938 0.0155812 0.0486284 0.0577704 0.0521251 0.0427009 0.0337026 0.0249415 0.0239162 0.034343 0.0337904 0.0328083 0.0175072 0.0109816 0.0114507 0.0228647 0.0180735 0.0161572 0.00766374 0.0039531 0.00175299 0.00515318 0.00221648 0.00110351 0.0028114 0.00203203 0.00802587 0.00336629 0.00158192 0.00599193 0.00926987 0.00434663 0.00247104 0.00316331 0.0135744 0.0541784 0.10088 0.0456882 0.0264027 0.0162341 0.0150137 0.0565098	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0436062 0.0282427 0.0111822 0.0273075 0.0118526 0.0174267 0.0543221 0.0645043 0.0581741 0.0476333 0.0375904 0.0278387 0.0267472 0.0385484 0.0379833 0.036965 0.0197227 0.0124483 0.0130045 0.0264208 0.0207576 0.0176724 0.00776581 0.00387269 0.00178498 0.00474085 0.00208527 0.00105086 0.00251264 0.00191835 0.0070046 0.00309726 0.00143696 0.00512752 0.0072193 0.00319797 0.00167866 0.00180326 0.00654614 0.0186595 0.0314007 0.0318969 0.0553525 0.0398268 0.0246148 0.0554544	Interaction with Other DRUG1 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
1	1	0.0311826 0.0186759 0.00685623 0.0080293 0.015015 0.0604772 0.0234844 0.0282675 0.031453 0.0274218 0.0278384 0.0262414 0.0299832 0.0379332 0.0437932 0.050532 0.033352 0.0321262 0.0279042 0.060913 0.0570271 0.077698 0.0643926 0.0166678 0.00385629 0.00375901 0.00222973 0.00133297 0.00221726 0.0019692 0.0047253 0.00252767 0.00144371 0.00388663 0.00510053 0.00250571 0.00130934 0.00147415 0.00477258 0.0099139 0.014222 0.0109771 0.0107838 0.00934844 0.00958595 0.0547941	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG2 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
1	1	0.0355965 0.0213479 0.00753567 0.00867326 0.0149624 0.0601013 0.0210943 0.0257968 0.0276515 0.0241785 0.0233366 0.0217473 0.0253807 0.0328441 0.0381738 0.0402775 0.0259433 0.0243641 0.0289234 0.0611307 0.0527289 0.0513624 0.0270347 0.0136908 0.0153114 0.0691721 0.0195983 0.00334954 0.0028935 0.00222952 0.00513077 0.00292918 0.00179451 0.00465509 0.00600527 0.0029361 0.00158902 0.0017625 0.00583171 0.0118688 0.0167838 0.012716 0.012574 0.0109718 0.0113619 0.0646588	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG2 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
1	1	0.035824 0.021411 0.00766079 0.00895611 0.0161734 0.0650027 0.0236206 0.0287762 0.0310962 0.0271032 0.0265347 0.0248534 0.0291041 0.0376066 0.043789 0.0478867 0.0312922 0.0297999 0.0318247 0.0657193 0.0585335 0.0617617 0.0283209 0.00871206 0.00706286 0.0200746 0.00446328 0.00349707 0.00894603 0.00213517 0.00369658 0.00241335 0.00165442 0.00402091 0.00505984 0.00268634 0.00153281 0.00168517 0.00558901 0.0112337 0.0156699 0.0121378 0.0120047 0.0104915 0.0108914 0.0616906	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG2 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	1	0.0354614 0.0212985 0.0074983 0.00855738 0.0145006 0.0582273 0.0202693 0.0247587 0.0264445 0.0230997 0.0222404 0.0206681 0.0239215 0.0307865 0.0355404 0.036965 0.0229083 0.0199934 0.0237777 0.0507612 0.0451024 0.0431972 0.0187784 0.00718216 0.00376044 0.0127166 0.00469566 0.0027426 0.00824152 0.0208371 0.103745 0.0273172 0.00458138 0.00504276 0.00592982 0.0032547 0.00186173 0.00194997 0.00638071 0.0129385 0.0176013 0.0131382 0.0132519 0.0113742 0.0117178 0.0649828	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG2 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
1	1	0.0351966 0.0210843 0.007467 0.00862119 0.0150472 0.0604022 0.0213021 0.0260381 0.0279029 0.0243538 0.0235253 0.0219166 0.0257133 0.0333651 0.0389092 0.0413641 0.0266344 0.0252017 0.029586 0.0630028 0.0555423 0.0540831 0.0235242 0.00770117 0.00520448 0.0140777 0.00340519 0.00198666 0.00417003 0.00691923 0.024071 0.0055103 0.00492796 0.0145219 0.00763811 0.00396144 0.00224114 0.0023183 0.00766479 0.0179768 0.0229009 0.0165331 0.0165818 0.0137875 0.014056 0.0720609	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG2 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	1	0.0381751 0.0229562 0.00809879 0.00920406 0.0155423 0.0625153 0.0217486 0.0265257 0.0283666 0.0248002 0.0240197 0.0223891 0.0256746 0.0327655 0.0374582 0.0388812 0.0234679 0.0188817 0.0222181 0.046269 0.0391699 0.0362429 0.0167772 0.00722234 0.00353552 0.00931905 0.00344995 0.00174789 0.00431143 0.003839 0.0153006 0.00639303 0.00377621 0.0179403 0.0697178 0.0227486 0.00558032 0.0031032 0.00683765 0.0129922 0.0219248 0.0160162 0.0165967 0.0141066 0.0144895 0.0769032	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	1	0.0369941 0.0221933 0.00783117 0.00897729 0.0153891 0.0617766 0.0215709 0.0263671 0.028181 0.024603 0.0237012 0.0220397 0.0257006 0.0332363 0.0385617 0.0404584 0.0254422 0.0231347 0.0275126 0.0591064 0.0517727 0.0479828 0.020799 0.00722828 0.00422326 0.0105945 0.00315457 0.0017348 0.00397628 0.00452621 0.0165221 0.00443842 0.00256146 0.00916833 0.0206379 0.00754555 0.00580099 0.00531574 0.0158571 0.0143523 0.0230914 0.0169724 0.0187467 0.015744 0.0166331 0.0778429	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	1	0.0315595 0.0189802 0.00672029 0.00762563 0.0129294 0.0520207 0.0181049 0.022037 0.0235799 0.0206039 0.0199498 0.0185508 0.0211481 0.0267053 0.0302381 0.0311205 0.018406 0.0138093 0.0157835 0.0305907 0.0245091 0.0223887 0.0109955 0.00550369 0.00244113 0.00690155 0.00295979 0.00147787 0.00372608 0.00272136 0.010583 0.00443531 0.00209049 0.00785058 0.0121645 0.00567207 0.00321646 0.00414542 0.0176821 0.070777 0.131219 0.0592675 0.0341527 0.0209741 0.0193906 0.0722906	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	1	0.0365741 0.0219984 0.00778144 0.00882835 0.0149432 0.0601315 0.0209224 0.0254836 0.0272697 0.0238345 0.0231105 0.0215252 0.024563 0.0310744 0.0352222 0.0363387 0.0214526 0.0162059 0.0185249 0.0364108 0.0289281 0.0251708 0.0115148 0.00559097 0.0025814 0.00660264 0.00289684 0.00146203 0.00346074 0.00266852 0.00960793 0.00425037 0.00197353 0.00698163 0.0098378 0.00433535 0.00226135 0.00244556 0.00887583 0.025359 0.0425357 0.0430682 0.0744947 0.0536184 0.0332785 0.0740042	Interaction with Other DRUG0 : DRUG1 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0105308 0.00788183 0.00289111 0.00481963 0.00676271 0.0130424 0.0296024 0.0420496 0.0391458 0.0333465 0.0278352 0.0225963 0.0223147 0.0324242 0.0359698 0.0398682 0.0252564 0.0193255 0.0189597 0.0441222 0.0476223 0.0582211 0.0667138 0.0884288 0.0327853 0.0694221 0.0132799 0.00306414 0.00298759 0.00220726 0.00458388 0.00263957 0.00159137 0.00414263 0.00526953 0.00255174 0.00131334 0.00144605 0.00484286 0.0100752 0.0133981 0.0102214 0.00993997 0.00842152 0.00855433 0.0475313	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG2 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0118584 0.00887423 0.00325724 0.00542588 0.00761789 0.0146558 0.0331304 0.0469087 0.043493 0.0368106 0.0302953 0.0241725 0.0236529 0.0343046 0.0380115 0.0417587 0.0259603 0.0193353 0.0187374 0.0418217 0.0448261 0.0539637 0.0645553 0.079377 0.0225594 0.0450921 0.00742189 0.00682522 0.0134753 0.00357523 0.00483292 0.00273816 0.00181037 0.00435271 0.00557768 0.00280316 0.00150695 0.00161294 0.00528744 0.0110669 0.0138125 0.0108282 0.010683 0.00928419 0.00957247 0.0524769	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG2 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0113163 0.0084605 0.00310867 0.00517019 0.00726967 0.0139084 0.0313867 0.0443138 0.0409526 0.0344932 0.0281224 0.022146 0.0214712 0.0312733 0.0344203 0.0373416 0.0228151 0.0163752 0.0169425 0.0374424 0.0408268 0.0487935 0.0568208 0.0552697 0.0119004 0.0316129 0.00658681 0.00637331 0.0120954 0.0276226 0.0794097 0.0177924 0.00370965 0.00430171 0.00477218 0.00262101 0.00152394 0.00160434 0.00523174 0.0105436 0.0137821 0.0104155 0.0104794 0.008874 0.00907564 0.0492308	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG2 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0111984 0.00837559 0.00307599 0.00511871 0.00718996 0.0138036 0.0311952 0.0441274 0.0408664 0.0345393 0.028341 0.0225001 0.0219411 0.0318292 0.0351954 0.0384635 0.0235864 0.0172045 0.017098 0.0383106 0.0416031 0.0499139 0.0593159 0.066656 0.016642 0.0367283 0.00597086 0.00521462 0.00671711 0.0123061 0.0286471 0.00545659 0.00563227 0.0146035 0.00763337 0.00389486 0.00221718 0.00218597 0.00711493 0.0167603 0.0200052 0.0144448 0.0143568 0.011641 0.0118001 0.0585779	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG2 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0115857 0.00866123 0.00318694 0.00529741 0.00746031 0.0142691 0.0322119 0.0454573 0.0420095 0.0354605 0.029105 0.0230094 0.0221962 0.0321712 0.0350124 0.0380998 0.0227293 0.0153232 0.0156311 0.0344411 0.0378402 0.0453031 0.0523675 0.0510098 0.0118943 0.0274973 0.00438872 0.00322106 0.00499368 0.00682447 0.021501 0.00658273 0.00492451 0.017736 0.0639895 0.018303 0.00511111 0.00279834 0.00568973 0.0112754 0.0178282 0.0129564 0.0133351 0.0109448 0.0111082 0.0572574	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0114775 0.00858128 0.00315414 0.00524446 0.00737516 0.0141343 0.0319238 0.045103 0.0417147 0.0352078 0.0288313 0.0227918 0.0221137 0.0320681 0.0352908 0.038455 0.0232812 0.0164907 0.0165727 0.0370299 0.0405482 0.0488384 0.0578361 0.0616962 0.0141758 0.0319221 0.00491099 0.004167 0.0058199 0.00892013 0.0240479 0.00524667 0.00381894 0.00894242 0.0248471 0.00695824 0.00581075 0.00521385 0.0134432 0.0124451 0.0191357 0.0135868 0.0150738 0.0125273 0.0132091 0.060017	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0101348 0.00757559 0.00278935 0.00463557 0.00653631 0.0124869 0.0281991 0.0397835 0.0367738 0.0310891 0.025668 0.0204161 0.019622 0.02844 0.0305889 0.0332468 0.0196489 0.0128205 0.0132801 0.0291008 0.0320611 0.0376202 0.0415247 0.0368381 0.00847299 0.0198112 0.00363495 0.002567 0.00428169 0.00504237 0.015631 0.00432497 0.00255385 0.00785437 0.0145138 0.00529712 0.00323939 0.00425541 0.0155176 0.0582231 0.0950633 0.044801 0.0284129 0.0182867 0.0173665 0.0599686	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.011234 0.00839735 0.00309127 0.00513742 0.0072411 0.0138379 0.0312347 0.0440581 0.0407067 0.0343762 0.0282823 0.0223931 0.0215272 0.0311683 0.0336492 0.0365139 0.0215232 0.0141415 0.0145611 0.0318751 0.0350799 0.0415316 0.0465366 0.0421667 0.00898311 0.0200339 0.00366336 0.00253445 0.00410748 0.005011 0.0144117 0.004294 0.00242407 0.00724479 0.0119774 0.00409144 0.00205089 0.00237352 0.00758325 0.0248199 0.0337492 0.0343726 0.060698 0.0429877 0.028009 0.0543147	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG1 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0106873 0.00797385 0.00293751 0.0048663 0.00689225 0.0131731 0.0298193 0.0420803 0.0388594 0.0329148 0.0273899 0.0219603 0.0208375 0.0294208 0.0309352 0.0325302 0.0194148 0.0135017 0.0153291 0.0323713 0.0322953 0.036555 0.0307953 0.0179772 0.0170756 0.0785691 0.052335 0.0119848 0.0168974 0.0322361 0.0854345 0.01717 0.00361371 0.00430098 0.00473424 0.00264151 0.00155663 0.00163894 0.00540277 0.0107172 0.0140084 0.010393 0.0103983 0.00881276 0.00907627 0.0494847	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG2 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0111075 0.00828785 0.00305238 0.0050571 0.00716047 0.0136895 0.0309997 0.0437654 0.0404232 0.0342423 0.0284727 0.0227898 0.0216182 0.0304792 0.0320603 0.0336536 0.0201661 0.0142077 0.0162279 0.0339036 0.0337689 0.0368929 0.0311666 0.0185689 0.0173209 0.0742623 0.0535939 0.0115867 0.0112746 0.0170879 0.0373747 0.00662611 0.00715365 0.0171921 0.00816143 0.00401467 0.00230631 0.00231744 0.00751148 0.0172238 0.0205222 0.0146551 0.0144571 0.0118098 0.0119874 0.0597985	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG0 , DRUG2 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0110601 0.00824929 0.00304034 0.00503208 0.00713279 0.0136361 0.0308825 0.0435769 0.0402339 0.0340949 0.0284198 0.0227891 0.0215506 0.0302751 0.0316658 0.0331659 0.0195161 0.0132433 0.0148633 0.0305174 0.0294417 0.0326891 0.0297032 0.0195076 0.0173058 0.0751289 0.0458798 0.00870354 0.00767749 0.00846846 0.0280263 0.00724047 0.00584423 0.0195059 0.0624539 0.0165325 0.00476498 0.00263198 0.00546995 0.0107567 0.0172703 0.012277 0.0126363 0.0105006 0.0107724 0.0558655	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0111928 0.00834892 0.00307607 0.00509269 0.00721527 0.0137958 0.0312467 0.0441013 0.04072 0.0344914 0.0287053 0.0229881 0.0217631 0.0305972 0.0320824 0.0335996 0.0199243 0.0137369 0.0155038 0.0320973 0.0314263 0.034582 0.0307422 0.019518 0.018157 0.0772489 0.0517484 0.0103998 0.00926998 0.0114782 0.0317531 0.00623114 0.00481753 0.0100889 0.0269504 0.00710106 0.0063142 0.00570778 0.0139303 0.0124658 0.0184827 0.0129475 0.0144054 0.0121332 0.0127982 0.0590233	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.00983616 0.00733546 0.00270443 0.0044747 0.00634549 0.012128 0.0274652 0.0387411 0.0357591 0.0303037 0.0252741 0.0202687 0.0191447 0.0268882 0.0280868 0.0294144 0.0172039 0.0115646 0.0129413 0.0264826 0.0250434 0.0274541 0.0243558 0.0160729 0.0136394 0.0641749 0.0366245 0.00689898 0.00641593 0.00609448 0.0204231 0.00476555 0.00317658 0.00848705 0.0161856 0.00523374 0.00336665 0.00439079 0.0149169 0.0539547 0.0856135 0.0417593 0.0264486 0.017302 0.0164852 0.0583536	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0106812 0.00796584 0.00293658 0.00485899 0.00688949 0.0131692 0.0298248 0.0420744 0.0388386 0.0329116 0.0274436 0.0220055 0.020791 0.0291885 0.0304944 0.0319177 0.0186698 0.0125622 0.0140486 0.0286964 0.0272152 0.0298927 0.026939 0.0181424 0.0156971 0.0696372 0.0398743 0.0067761 0.00633798 0.00631383 0.0193112 0.00482259 0.00305841 0.00803243 0.0138944 0.00419412 0.00218163 0.0025194 0.00739908 0.0247216 0.0318844 0.0312664 0.0569716 0.0401186 0.025839 0.0509907	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG1 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0114866 0.00856748 0.00316054 0.00523016 0.00742536 0.014186 0.0320968 0.0452374 0.0417492 0.0354113 0.0295802 0.0237652 0.0224577 0.0317889 0.0333221 0.0352922 0.0207408 0.013758 0.0153281 0.0319239 0.0316701 0.0368684 0.0275448 0.0130368 0.00684253 0.0339642 0.0159545 0.0154326 0.0843484 0.0285726 0.0788558 0.0166167 0.00323733 0.00446575 0.00524893 0.00298065 0.00177732 0.00186205 0.00618182 0.0118752 0.01493 0.0111734 0.0110843 0.00956529 0.00991957 0.0534829	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG2 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0122167 0.00911429 0.00336322 0.00556806 0.0079039 0.0150867 0.034104 0.0480561 0.0443631 0.037655 0.0315088 0.0253768 0.0240004 0.0342254 0.0359295 0.0380795 0.0226419 0.0155212 0.0177169 0.0369023 0.0351788 0.0397002 0.0283193 0.0128692 0.00719081 0.0307188 0.0123151 0.0107694 0.0572035 0.0137102 0.03605 0.00556129 0.00695508 0.0166849 0.0078326 0.00400572 0.00238136 0.00248954 0.00819798 0.0180465 0.0217801 0.0157825 0.0154661 0.0128226 0.0129705 0.0656642	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG0 , DRUG2 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0125318 0.00934852 0.00345031 0.00571044 0.00810633 0.0154709 0.0349736 0.0492735 0.0454819 0.038604 0.0323154 0.0260254 0.0246002 0.0350728 0.036772 0.0388809 0.0230742 0.0157678 0.0177965 0.0364899 0.0334066 0.0365397 0.0258803 0.0126726 0.00673307 0.0277076 0.0106919 0.00802879 0.03834 0.00661872 0.019825 0.00545509 0.00536699 0.019608 0.0578417 0.0155077 0.00464492 0.00268498 0.00625875 0.0121265 0.0193091 0.0137407 0.0140591 0.0118291 0.0121095 0.063267	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0124356 0.00927696 0.00342348 0.00566718 0.00804483 0.0153569 0.0347159 0.0489152 0.0451559 0.0383296 0.0320881 0.0258597 0.0244534 0.034873 0.0365728 0.0387329 0.0230082 0.0157017 0.0177566 0.0366632 0.0342225 0.0379163 0.0271912 0.0126989 0.00705973 0.0292545 0.0116535 0.00994709 0.0507547 0.009063 0.0274916 0.00523631 0.00491926 0.0111054 0.0248667 0.00633319 0.00575093 0.00546488 0.0144986 0.0133969 0.0201644 0.0143103 0.015876 0.0135279 0.0142735 0.0659914	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0108476 0.00809197 0.00298646 0.00494256 0.00701628 0.0133913 0.0302767 0.0426573 0.0393752 0.033423 0.0279825 0.0225347 0.0212943 0.030341 0.0317942 0.0335917 0.0199542 0.0136553 0.015401 0.0313784 0.0284669 0.0308914 0.0216438 0.0106903 0.00549199 0.0226794 0.0086065 0.00603798 0.0282279 0.00475588 0.0139113 0.00365596 0.00308278 0.00820862 0.0145087 0.00487796 0.00329968 0.00459372 0.0159843 0.0579476 0.0915059 0.04333 0.0277446 0.0186156 0.0176668 0.062639	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0118281 0.00882352 0.00325644 0.00538949 0.00765068 0.0146041 0.0330195 0.0465243 0.0429483 0.0364606 0.0305352 0.0246001 0.0232504 0.0331246 0.0346996 0.0366737 0.021736 0.0148109 0.0166462 0.0338388 0.0307113 0.0332665 0.023492 0.0117251 0.00611225 0.0247 0.00954539 0.00689234 0.0322738 0.00507326 0.0133909 0.00373378 0.00305082 0.00787718 0.0128414 0.00401835 0.00216647 0.00257989 0.00804947 0.0257853 0.0343772 0.0332649 0.0591688 0.0424505 0.0278128 0.05522	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG1 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0109369 0.00815463 0.00301036 0.00497805 0.00706784 0.0134983 0.0305334 0.043016 0.0396731 0.0336247 0.0281201 0.0225838 0.0212485 0.0296245 0.0306663 0.0319339 0.0180409 0.0114054 0.0120707 0.0240582 0.0212779 0.0219989 0.0128754 0.00648271 0.00264798 0.0110613 0.00583864 0.00351781 0.0116339 0.021306 0.114451 0.0669193 0.0146831 0.0270935 0.0660274 0.0189637 0.00586125 0.00334173 0.00584424 0.0113619 0.0182322 0.0127985 0.0131768 0.010754 0.0109804 0.0566254	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG1 , DRUG0 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0114114 0.00850767 0.00314104 0.00519325 0.00737341 0.0140768 0.0318357 0.0448425 0.0413446 0.0350212 0.0292606 0.0234732 0.0220681 0.0307316 0.0318011 0.0330139 0.0186404 0.0118489 0.012583 0.0251197 0.0221276 0.0224554 0.0129377 0.00643824 0.00271683 0.011354 0.00604853 0.00368852 0.0114779 0.0201336 0.0987152 0.0634481 0.014265 0.0179041 0.0388397 0.0127277 0.0109087 0.00907356 0.0195287 0.0159452 0.0210389 0.0144758 0.0156889 0.0127966 0.0132903 0.0606873	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG1 , DRUG0 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.00966355 0.00720467 0.00265983 0.00439802 0.00624419 0.0119253 0.0269719 0.0379915 0.0350285 0.0296707 0.0247866 0.0198839 0.0187095 0.0260778 0.0270126 0.028113 0.0158489 0.0100176 0.010598 0.021032 0.0184293 0.0187851 0.0107887 0.00560661 0.00223694 0.00869434 0.00457622 0.00262627 0.00884226 0.0152503 0.0922741 0.0511119 0.0108111 0.0144817 0.0271338 0.00786666 0.00485463 0.00556331 0.0166104 0.0546989 0.0842698 0.0421698 0.0264788 0.0171126 0.0165162 0.0583722	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG1 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0103753 0.00773513 0.00285559 0.00472126 0.0067028 0.0128026 0.0289606 0.0407938 0.0376086 0.0318483 0.0265914 0.0213113 0.0200488 0.0278943 0.0288896 0.0300242 0.0168442 0.0105819 0.0111501 0.0220588 0.019323 0.0196309 0.0112627 0.00593215 0.00235787 0.00933766 0.00518173 0.00302042 0.0101928 0.0181579 0.102015 0.0575046 0.0104958 0.0147433 0.0247187 0.00647541 0.00319558 0.00332713 0.00814073 0.0275442 0.0323713 0.031329 0.0582461 0.0402189 0.0256975 0.0497813	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG1 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0121566 0.00906464 0.0033456 0.00553254 0.00785301 0.0150083 0.0339691 0.0478725 0.0441677 0.0374415 0.0312879 0.0251094 0.0237035 0.0332284 0.0346082 0.0363142 0.0208039 0.0133772 0.0142797 0.0283997 0.0259346 0.0276602 0.0176839 0.00906474 0.00365811 0.0129562 0.0048013 0.00240871 0.00691782 0.00625879 0.0345815 0.017642 0.0162126 0.0801405 0.0670529 0.0178961 0.00532489 0.00314931 0.0069613 0.0132391 0.0210339 0.0147598 0.0150764 0.0126365 0.0128331 0.0665922	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG1 (INCLUDING DRUG2 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0126073 0.00940096 0.00347048 0.00573989 0.00814885 0.0155626 0.0351982 0.049589 0.0457515 0.0387966 0.0324505 0.0260907 0.024624 0.0346855 0.0361344 0.0379444 0.021978 0.014431 0.0156524 0.0313142 0.028074 0.0291737 0.018275 0.0088753 0.00373364 0.0128507 0.00470734 0.002491 0.00681278 0.00730819 0.0340807 0.0152131 0.0127549 0.0595222 0.03599 0.0100623 0.00889446 0.00809004 0.0197516 0.017179 0.0238611 0.0164475 0.0175867 0.0145461 0.0151032 0.0690449	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG1 (INCLUDING DRUG0 ) , DRUG2 AND OTHER DRUG0 (INCLUDING DRUG0 ) .
4	4	0.0108222 0.0080701 0.00297914 0.00492748 0.00699563 0.0133595 0.0302164 0.0425696 0.039277 0.0333126 0.0278789 0.0224266 0.0211565 0.0297976 0.0310164 0.0325649 0.0188533 0.0123472 0.0133481 0.0265563 0.0235419 0.0244851 0.0151185 0.00750517 0.00308004 0.0107938 0.00406407 0.00204626 0.00588129 0.00589355 0.0270717 0.0108168 0.00767444 0.0343891 0.0210724 0.00605646 0.00491307 0.00614333 0.0194618 0.0661649 0.0947986 0.043756 0.0275514 0.0185001 0.0176408 0.0631038	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG1 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.011601 0.00865121 0.0031935 0.00528222 0.00749874 0.0143247 0.0324042 0.0456573 0.0421307 0.0357372 0.0299108 0.0240588 0.0227074 0.0319673 0.033277 0.0349648 0.0201823 0.0131376 0.0141273 0.02794 0.0248145 0.0257896 0.0160704 0.00810554 0.00329747 0.0113685 0.00437708 0.00220711 0.00629356 0.00639239 0.0290361 0.0120106 0.00896343 0.0391074 0.02043 0.00515504 0.00321124 0.00358066 0.0101888 0.0323424 0.0402951 0.0371114 0.0634255 0.0440442 0.028426 0.055202	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG1 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0111908 0.00834312 0.00308293 0.00509676 0.00723669 0.0138054 0.03119 0.0439147 0.0404967 0.034328 0.028772 0.0231832 0.021817 0.0305053 0.0315504 0.0328113 0.0186178 0.0120229 0.0127841 0.0253359 0.02079 0.0196705 0.0102767 0.00532547 0.00225177 0.00711988 0.00291731 0.00144297 0.00392079 0.0029657 0.0139321 0.00705792 0.00419622 0.019258 0.0506867 0.032024 0.00839792 0.00735793 0.019672 0.0682117 0.0899336 0.0443987 0.0259525 0.0169045 0.0168302 0.0624203	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG1 ) , DRUG0 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0119968 0.00894359 0.00330462 0.00546265 0.00775603 0.0148014 0.0334516 0.0471093 0.0434483 0.0368355 0.0308887 0.0248952 0.0234196 0.0326217 0.0336768 0.0349503 0.0196863 0.0125375 0.0131556 0.0256991 0.0209341 0.0194836 0.0101782 0.00552813 0.00232677 0.0071658 0.00308612 0.00154062 0.00410262 0.00311885 0.0147379 0.00838018 0.00513021 0.0230952 0.0603322 0.038802 0.00644897 0.00484898 0.00991387 0.0293173 0.0325451 0.0322331 0.0640489 0.0438962 0.0280647 0.0560999	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG1 ) , DRUG0 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0124949 0.00931607 0.00343966 0.00568738 0.00807214 0.0154201 0.0348782 0.0491388 0.0453235 0.0384066 0.0321164 0.0257904 0.0243038 0.0338921 0.0351299 0.03664 0.0206409 0.0130648 0.0137007 0.0265847 0.0227689 0.0227507 0.0129223 0.00706838 0.00282796 0.00918144 0.00381382 0.00184616 0.00494613 0.00362604 0.0146728 0.00582721 0.00284311 0.0114599 0.0222374 0.0106666 0.00797163 0.00887937 0.0454727 0.066019 0.0764664 0.0366973 0.0205739 0.0150464 0.0160976 0.0632757	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG1 AND OTHER DRUG2 (INCLUDING DRUG0 ) .
4	4	0.0135157 0.0100782 0.00372248 0.00615556 0.0087378 0.0166792 0.0377027 0.0531085 0.0489981 0.0415563 0.0348281 0.0280451 0.0264282 0.0370269 0.0383555 0.0400543 0.0227404 0.0146596 0.0155466 0.0305017 0.0255961 0.0250988 0.0137753 0.00735337 0.00299045 0.00953313 0.00392587 0.00188496 0.00507797 0.00382839 0.0152418 0.006138 0.00293313 0.011689 0.0217695 0.00887775 0.00635853 0.00602683 0.0301701 0.0291418 0.0306484 0.0246823 0.058931 0.0392391 0.0250643 0.0555829	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG1 AND OTHER DRUG0 (INCLUDING DRUG2 ) .
4	4	0.0121534 0.00904976 0.00334128 0.00551478 0.00782915 0.014977 0.0339355 0.0477657 0.043922 0.036993 0.0306545 0.0243564 0.0228014 0.0309407 0.0320223 0.0324035 0.0175262 0.0100949 0.0097557 0.0174788 0.0140577 0.0130638 0.00748895 0.00461489 0.00200682 0.00606269 0.00286251 0.00154795 0.00356823 0.00228751 0.00926922 0.00412818 0.00208767 0.00612885 0.0101899 0.00556187 0.00308705 0.00423935 0.0159683 0.0501856 0.0786564 0.0836833 0.0833278 0.0580266 0.0352496 0.0491335	Interaction with Other DRUG0 : DRUG0 SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER DRUG0 , GENERAL DRUG0 , DRUG0 , OTHER DRUG0 , DRUG0 (INCLUDING DRUG0 ) , DRUG0 AND OTHER DRUG1 (INCLUDING DRUG2 ) .
1	1	0.0318912 0.0233885 0.0305995 0.057337 0.0477535 0.0433157 0.0740698 0.0515373 0.0484438 0.0692385 0.0285487 0.0140967 0.0244271 0.0323112 0.0337918 0.0520342 0.0342807 0.0154981 0.0108537 0.0199044 0.0307327 0.00818256 0.0120503 0.00972057 0.0184244 0.0281738 0.0158161 0.0250576 0.0145883 0.0204603 0.0281592 0.0453127	Caution should be observed in administering DRUG1 to patients receiving DRUG2 or DRUG0 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
1	1	0.0325724 0.0236195 0.0295362 0.054858 0.0448716 0.0364309 0.0757917 0.0439443 0.0455305 0.0569814 0.0263148 0.0194962 0.0369454 0.035373 0.0387401 0.0571223 0.0356018 0.016867 0.0122582 0.0195481 0.0295277 0.00795319 0.01156 0.00951914 0.0183093 0.0285264 0.0157539 0.0251127 0.0145966 0.0207175 0.0289332 0.047087	Caution should be observed in administering DRUG1 to patients receiving DRUG0 or DRUG2 because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
2	2	0.102356 0.0810929 0.0702549 0.101965 0.0950207 0.0413069 0.0170415 0.0165827 0.0520828 0.104182 0.0409668 0.0404024 0.114098 0.0602446 0.0624024	Concurrent use of DRUG1 with DRUG2 or other DRUG0 can increase their sedative effects .
2	2	0.081054 0.0663076 0.0626251 0.0870769 0.0784482 0.029659 0.0290343 0.0375578 0.0913363 0.10488 0.0477762 0.0510724 0.112959 0.0602333 0.0599807	Concurrent use of DRUG1 with DRUG0 or other DRUG2 can increase their sedative effects .
4	4	0.0751011 0.0935166 0.0851815 0.0697377 0.0737518 0.037314 0.0270418 0.035807 0.0877217 0.10543 0.0432403 0.0478629 0.106245 0.0543509 0.0576977	Concurrent use of DRUG0 with DRUG1 or other DRUG2 can increase their sedative effects .
2	2	0.155285 0.196013 0.0918334 0.113684 0.0930283 0.116369 0.0487536 0.00968035 0.00882612 0.00637187 0.00938667 0.0306531 0.120116	DRUG1 may enhance the effects of DRUG2 , DRUG0 and other DRUG0 .
2	2	0.147709 0.188848 0.0993862 0.120891 0.101928 0.0790313 0.0282312 0.0147483 0.0378446 0.009093 0.0101587 0.0315973 0.130533	DRUG1 may enhance the effects of DRUG0 , DRUG2 and other DRUG0 .
2	2	0.138984 0.166128 0.0867894 0.0997942 0.082871 0.0708141 0.0218452 0.00989503 0.0172237 0.0169162 0.0378151 0.106264 0.144659	DRUG1 may enhance the effects of DRUG0 , DRUG0 and other DRUG2 .
4	4	0.0847344 0.125022 0.130061 0.165551 0.0978412 0.0825996 0.0800845 0.0175947 0.0157398 0.0141132 0.0306234 0.0636892 0.0923454	DRUG0 may enhance the effects of DRUG1 , DRUG0 and other DRUG2 .
4	4	0.084847 0.125028 0.110018 0.09521 0.0691113 0.051487 0.0321172 0.028266 0.116514 0.0202051 0.0378091 0.0881336 0.141253	DRUG0 may enhance the effects of DRUG0 , DRUG1 and other DRUG2 .
4	4	0.0374468 0.0299775 0.0302625 0.0170557 0.0468832 0.110758 0.0487787 0.0590611 0.0669141 0.0699768 0.033049 0.0579013 0.0783156 0.0525717 0.0470875 0.0346853 0.0597962 0.0421993 0.0772796	In vivo CYP3A activity is significantly lower in DRUG1 -treated as compared with DRUG2 -treated renal allograft recipients .
4	4	0.103559 0.0744904 0.0646601 0.0671722 0.121068 0.206097 0.0419434 0.0615924 0.0253363 0.0701675 0.0278774 0.136036	In vitro studies have identified DRUG1 and DRUG2 as CYP3A inhibitors .
4	3	0.0228101 0.011913 0.0367638 0.0209302 0.0269618 0.0211509 0.0172211 0.0156861 0.0183394 0.0206818 0.0165122 0.0132642 0.0142852 0.0199306 0.0215452 0.0156044 0.0144655 0.0115689 0.00871079 0.00776349 0.00533617 0.00296774 0.00218652 0.00927693 0.0104046 0.00981916 0.00449675 0.0156647 0.0201066 0.0166546 0.0110183 0.0075741 0.00892659 0.019604 0.0228601 0.0158175 0.0149435 0.013887 0.0108017 0.00877129 0.00657881 0.00363808 0.00292196 0.013031 0.0142828 0.0145732 0.00845624 0.0246307 0.0109422 0.0237935 0.0317385 0.0271192 0.0276664 0.0159327 0.010816 0.0102991 0.0105259 0.00505603 0.00749747 0.0117738 0.0136814 0.0215391 0.0129919 0.0104411 0.0132452 0.0281957 0.0314052	Systemic and apparent oral DRUG1 clearance were 24% (269    73 vs . 354    102  ml/min , P = 0.022) and 31% (479    190 vs . 688    265  ml/min , P = 0.013) , respectively , lower in DRUG2 -treated patients (n = 20) than in matched DRUG0 -treated patients (n = 20) .
4	4	0.0221672 0.0115772 0.0357276 0.0203403 0.0262019 0.0205547 0.0167357 0.0152439 0.0178224 0.0200988 0.0160467 0.0128902 0.0138824 0.019369 0.0209387 0.0151656 0.014059 0.0112428 0.00846516 0.00754422 0.00518614 0.00288465 0.00212626 0.00902454 0.0101275 0.00957212 0.00438543 0.0152617 0.0195672 0.0162047 0.0106826 0.00728582 0.0084899 0.0184469 0.0216025 0.0151064 0.014097 0.0123593 0.00884933 0.00645187 0.00458281 0.00247815 0.00169399 0.00583818 0.00575271 0.0062028 0.00350522 0.00948031 0.00245023 0.00371027 0.00528688 0.012043 0.0228168 0.0161779 0.0163001 0.0192263 0.0338087 0.0238293 0.0298421 0.0417464 0.0298222 0.0284887 0.0177773 0.0140716 0.019248 0.02845 0.0315846	Systemic and apparent oral DRUG1 clearance were 24% (269    73 vs . 354    102  ml/min , P = 0.022) and 31% (479    190 vs . 688    265  ml/min , P = 0.013) , respectively , lower in DRUG0 -treated patients (n = 20) than in matched DRUG2 -treated patients (n = 20) .
4	4	0.0106258 0.00480232 0.0145248 0.00925596 0.0152525 0.022286 0.0103885 0.0110186 0.0184595 0.0183076 0.0127312 0.00961864 0.0131822 0.0198354 0.0248381 0.0177806 0.0158762 0.0124521 0.0093797 0.00839353 0.00580939 0.00321156 0.00233534 0.00987405 0.0109615 0.0102518 0.00467312 0.0164145 0.0209614 0.017317 0.0114367 0.00783692 0.00918658 0.0200973 0.0234221 0.016289 0.0152971 0.013713 0.0101624 0.0077101 0.00572041 0.00309401 0.00221475 0.00884832 0.00988439 0.0120572 0.00728939 0.0206196 0.00702935 0.0127671 0.0165624 0.0274545 0.0226184 0.0118344 0.0122518 0.0207694 0.0288584 0.0222869 0.0244826 0.0352706 0.0268967 0.0285885 0.0194352 0.0150958 0.0197322 0.0294252 0.032942	Systemic and apparent oral DRUG0 clearance were 24% (269    73 vs . 354    102  ml/min , P = 0.022) and 31% (479    190 vs . 688    265  ml/min , P = 0.013) , respectively , lower in DRUG1 -treated patients (n = 20) than in matched DRUG2 -treated patients (n = 20) .
4	4	0.0380272 0.0480522 0.0648684 0.0462602 0.0370442 0.0236735 0.0104798 0.009112 0.0144187 0.0186925 0.0700857 0.0370677 0.0458351 0.0543334 0.0420867 0.0394206 0.0228136 0.0132283 0.0119809 0.00936196 0.00375642 0.0106908 0.0168268 0.0143944 0.00407338 0.00447266 0.00598633 0.0127452 0.0131907 0.0316675 0.0751881 0.038466 0.0194959 0.0175796 0.0240711 0.0505524	The latter displayed DRUG1 clearances similar to those in two larger cohorts of nonmatched DRUG2 -treated patients (n = 58 and n = 80) and to those receiving a DRUG0 -free regimen (n = 6) .
4	4	0.0374875 0.0473985 0.0638301 0.0440078 0.0302377 0.0182981 0.00703516 0.00570768 0.00694011 0.00816034 0.0329299 0.0145359 0.00935431 0.0113946 0.0212926 0.0333741 0.0177203 0.0135535 0.0121716 0.0129737 0.00595262 0.0233668 0.0371446 0.0318104 0.0083988 0.0141167 0.0196036 0.0287665 0.0443258 0.0449307 0.0891492 0.0532207 0.0322921 0.0319131 0.035113 0.0514916	The latter displayed DRUG1 clearances similar to those in two larger cohorts of nonmatched DRUG0 -treated patients (n = 58 and n = 80) and to those receiving a DRUG2 -free regimen (n = 6) .
2	4	0.021796 0.0160119 0.0205579 0.0260245 0.0282494 0.0136913 0.00825951 0.00752839 0.00804043 0.0118677 0.0473494 0.0237047 0.0231531 0.0238343 0.0431707 0.0311609 0.0136866 0.0118464 0.0185768 0.0178685 0.00648991 0.0297656 0.0402147 0.0331189 0.00867441 0.0153451 0.0211031 0.0303412 0.0481286 0.0476827 0.0926981 0.0549365 0.0332484 0.0330959 0.0360729 0.0527054	The latter displayed DRUG0 clearances similar to those in two larger cohorts of nonmatched DRUG1 -treated patients (n = 58 and n = 80) and to those receiving a DRUG2 -free regimen (n = 6) .
4	4	0.0263087 0.0569059 0.0138656 0.0135197 0.0139285 0.00693564 0.00561948 0.0177987 0.0248827 0.0140789 0.0127452 0.0377077 0.0192374 0.022278 0.0204146 0.0242485 0.0437591 0.0334646 0.0406997 0.0303534 0.0345252 0.0147233 0.00383702 0.0130034 0.00282767 0.00183059 0.00341558 0.00525372 0.00706146 0.0253611 0.00640674 0.00349338 0.00304018 0.00338483 0.0025474 0.00989798 0.0236155 0.0443726 0.0726215 0.022571 0.019217 0.015092 0.0248651 0.0183736 0.0124416 0.0349215 0.0514105 0.0411363	This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving DRUG1 than in those receiving DRUG2 , indicating that , at the doses generally used in clinical practice , DRUG0 is the stronger of the two with respect to CYP3A inhibition .
4	4	0.0221358 0.0471447 0.0112115 0.0108203 0.0110027 0.0051459 0.00403241 0.0128236 0.0182637 0.00997341 0.00883048 0.0280366 0.011825 0.0156146 0.0167338 0.0223832 0.0107656 0.0131855 0.0156656 0.0194337 0.0283896 0.0600323 0.0144651 0.029269 0.0119634 0.00550976 0.00731258 0.0100685 0.00883267 0.0258926 0.0140846 0.0173959 0.0182414 0.0187611 0.0126013 0.0249732 0.0302431 0.0452426 0.0784451 0.0270271 0.0216291 0.0171837 0.018924 0.0159348 0.0109375 0.0301473 0.0442787 0.0371857	This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving DRUG0 than in those receiving DRUG1 , indicating that , at the doses generally used in clinical practice , DRUG2 is the stronger of the two with respect to CYP3A inhibition .
4	4	0.0330539 0.0252739 0.0337445 0.0257431 0.0443861 0.0227231 0.012296 0.0123115 0.0363665 0.0246482 0.0253536 0.00465579 0.00298049 0.00248425 0.00251488 0.00227604 0.00234121 0.00209464 0.00224231 0.00197976 0.00218633 0.00191629 0.00216209 0.00189061 0.00216595 0.00189878 0.00220605 0.00195132 0.00231705 0.0021271 0.00298165 0.00358161 0.00698908 0.0124114 0.0518276 0.0138163 0.00869122 0.0124422 0.0423048 0.043393 0.0279615 0.0428573 0.0354199 0.0701312 0.0417945 0.0418047 0.0394824 0.0534549 0.0379221 0.0222788 0.0169064 0.0166394 0.0146167	These are described in greater detail below :  Oral DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0317207 0.0242555 0.0324502 0.0247291 0.0427606 0.0219015 0.0117486 0.011615 0.0344867 0.0234397 0.0240793 0.00435018 0.00283524 0.00234627 0.00240228 0.00215439 0.00223739 0.00198583 0.00214343 0.00187886 0.00208995 0.00181947 0.00206628 0.00179494 0.00206872 0.00180143 0.00210446 0.00184817 0.00220356 0.00199765 0.00276305 0.00324206 0.00637733 0.0111324 0.0445945 0.0114787 0.00730867 0.0096495 0.0304909 0.033918 0.0210371 0.0338361 0.0309588 0.0546767 0.0282179 0.0286444 0.0390641 0.0462129 0.0598295 0.0796006 0.0466904 0.0333086 0.0116525	These are described in greater detail below :  Oral DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.035152 0.0269132 0.0362928 0.0280683 0.0493678 0.0259167 0.0137144 0.0107565 0.0266945 0.0127068 0.00652684 0.00433858 0.017438 0.00361102 0.0031463 0.00270091 0.00279257 0.00249028 0.00265253 0.00230546 0.00258036 0.00217584 0.00254371 0.00209825 0.00253836 0.00207024 0.00257891 0.00209392 0.00271902 0.00232728 0.00369272 0.00454358 0.00979821 0.0248078 0.13497 0.0698823 0.0439201 0.0259058 0.0396958 0.0370441 0.0205873 0.0283044 0.0263078 0.0385232 0.016671 0.0162311 0.0222461 0.0218978 0.0187202 0.0184785 0.0113703 0.0158562 0.0132339	These are described in greater detail below :  Oral DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0363781 0.0275236 0.036353 0.0276671 0.0474736 0.0239087 0.0122742 0.00916454 0.0229618 0.0105358 0.00590483 0.00358466 0.0123382 0.00223066 0.00250102 0.00194257 0.00229745 0.00186859 0.00222353 0.00180611 0.00219353 0.0017766 0.00218687 0.00177227 0.00220117 0.00179221 0.00224659 0.00184811 0.00235691 0.00198762 0.00287578 0.00309874 0.00650961 0.0106784 0.0459183 0.0117543 0.00864856 0.0124227 0.0449536 0.046855 0.0290639 0.0450813 0.0379076 0.0762018 0.0449989 0.0449223 0.0423137 0.0575063 0.040927 0.024035 0.0182347 0.0179709 0.0158217	These are described in greater detail below :  Oral DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0347872 0.0263341 0.0348419 0.0264673 0.0456226 0.0228858 0.0115574 0.00850229 0.0213646 0.00974679 0.00558155 0.00337205 0.0116344 0.00209363 0.00236459 0.00183144 0.0021758 0.00176204 0.00210686 0.00170348 0.00207858 0.00167541 0.00207173 0.00167042 0.00208399 0.00168741 0.00212433 0.00173636 0.0022226 0.00185656 0.00265819 0.00278589 0.0058693 0.009397 0.0390714 0.00977916 0.00724351 0.00953684 0.0320815 0.0360246 0.0216531 0.0352875 0.0326857 0.0590911 0.0302159 0.0306297 0.0418085 0.0495955 0.0643524 0.085622 0.0502115 0.0358858 0.0125708	These are described in greater detail below :  Oral DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0355423 0.0268907 0.0353635 0.0270816 0.0471621 0.0238357 0.0118716 0.00826701 0.0198508 0.00891658 0.00424601 0.00214567 0.00527478 0.00479705 0.0189888 0.00371997 0.00334685 0.00283441 0.00299137 0.00262388 0.00283389 0.00243201 0.00275188 0.00230318 0.00271862 0.0022424 0.00274191 0.00224947 0.00287282 0.00246543 0.0038456 0.00475131 0.0101919 0.0261629 0.140169 0.0704999 0.0445601 0.02629 0.0400062 0.0373846 0.020914 0.0289269 0.0269291 0.039422 0.017072 0.0166253 0.0228084 0.022448 0.0191891 0.0189436 0.0116617 0.0162626 0.0135735	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0366517 0.0274072 0.0353206 0.0267638 0.045694 0.0224681 0.0110353 0.00739945 0.0175361 0.00761475 0.00406088 0.00204439 0.00485804 0.00389956 0.013107 0.00224379 0.0025916 0.00203078 0.00241407 0.00196864 0.00234038 0.00190923 0.00231041 0.00188353 0.00231005 0.00188988 0.00234529 0.00193785 0.00244911 0.00207369 0.00297296 0.0032221 0.00669776 0.0110412 0.047024 0.0116583 0.00872657 0.0125845 0.0456539 0.0475102 0.029361 0.0458109 0.03864 0.0778532 0.0458838 0.0457636 0.0431116 0.0586084 0.0417251 0.0245101 0.018596 0.0183346 0.0161509	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0350229 0.026207 0.03384 0.0255894 0.0439077 0.0215345 0.0104425 0.00691296 0.0163882 0.00706901 0.00383804 0.00191587 0.00458123 0.00365931 0.0123345 0.00210229 0.00244337 0.00191041 0.00228016 0.00185222 0.00221143 0.00179627 0.00218286 0.00177123 0.00218129 0.00177529 0.00221186 0.00181636 0.00230356 0.00193257 0.00274186 0.00289118 0.00602641 0.00968483 0.0399734 0.0096762 0.00730366 0.00963739 0.0325128 0.0364203 0.021822 0.0357626 0.0331995 0.0602002 0.0307369 0.0311432 0.0425586 0.050503 0.0655321 0.0871696 0.0511294 0.0365516 0.012809	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0359159 0.0270507 0.0352391 0.0269227 0.0467276 0.0233309 0.0113783 0.00758056 0.0177558 0.00764125 0.00366446 0.00171255 0.00331056 0.00230065 0.00568005 0.00479159 0.019106 0.00372604 0.00341973 0.00285113 0.00307283 0.00264785 0.00291335 0.00246894 0.00284046 0.00236769 0.00284263 0.00235239 0.00296556 0.00255067 0.00393112 0.00484323 0.0104193 0.0270235 0.140884 0.0695232 0.0442511 0.0261398 0.0398918 0.03746 0.0211012 0.0292865 0.0272716 0.0399517 0.0173002 0.0168518 0.0231426 0.022777 0.0194743 0.0192232 0.0118366 0.0165088 0.0137795	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0366752 0.0273258 0.0350086 0.0265305 0.0452953 0.0221543 0.0107583 0.00698158 0.016103 0.00676482 0.00360979 0.0016974 0.00315554 0.00214458 0.00512784 0.00384045 0.0131096 0.00226024 0.00263307 0.00207837 0.00246763 0.00202261 0.00239768 0.00196998 0.00237656 0.00195696 0.00239972 0.0019926 0.00249614 0.00212102 0.00301772 0.00327775 0.00677617 0.0112089 0.0471599 0.0115417 0.00864678 0.012556 0.0456669 0.0475431 0.0294415 0.0460305 0.0388503 0.0783743 0.0461479 0.046011 0.0433431 0.0589328 0.0419629 0.0246541 0.0187044 0.018445 0.0162519	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0350171 0.0261117 0.0335388 0.0253665 0.0435433 0.0212596 0.0102109 0.00655892 0.0151433 0.00633182 0.00342532 0.00160106 0.00296863 0.00200509 0.00482708 0.00359682 0.0123228 0.00211751 0.0024802 0.00195364 0.00232822 0.00190108 0.00226261 0.0018509 0.00224169 0.00183677 0.00226079 0.00186606 0.00234509 0.00197487 0.00278011 0.00293856 0.00609051 0.00981306 0.0400933 0.00957053 0.0072367 0.00960739 0.0324965 0.0364151 0.02186 0.0358853 0.0333252 0.0605131 0.030872 0.0312739 0.0427582 0.0507501 0.0658699 0.0876026 0.0513841 0.0367392 0.0128763	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0363025 0.0273015 0.0354932 0.0271232 0.0470941 0.0234524 0.011354 0.00742409 0.01719 0.00723333 0.00346474 0.00158287 0.00281724 0.00176485 0.00352859 0.00233691 0.00572512 0.00469782 0.0189529 0.00367703 0.00345581 0.00284264 0.00312295 0.00265843 0.00297705 0.00251271 0.00294368 0.00246533 0.00305196 0.00263688 0.00399767 0.00490762 0.0105868 0.0276893 0.140002 0.0677519 0.0435686 0.0258153 0.0396674 0.0374578 0.0212463 0.0295568 0.0275263 0.0403576 0.017471 0.0170234 0.023401 0.0230326 0.0196989 0.0194417 0.0119731 0.0167022 0.0139409	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0366654 0.0272836 0.0349281 0.0264967 0.0453095 0.0221518 0.0107203 0.00685981 0.0156424 0.00647135 0.00343462 0.00159357 0.00278244 0.0017285 0.00332062 0.00215846 0.00513729 0.00375257 0.0130656 0.00227317 0.00265999 0.00211593 0.00250567 0.00206905 0.00244736 0.00203132 0.0024516 0.0020496 0.00253801 0.0021674 0.00305426 0.00332655 0.00682676 0.011315 0.0469999 0.0113975 0.00851017 0.0124787 0.045594 0.0475152 0.0294824 0.046108 0.0389252 0.0785991 0.0462403 0.0460936 0.0434144 0.0590382 0.0420439 0.0247076 0.0187429 0.0184855 0.0162888	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0349869 0.0260567 0.0334502 0.0253274 0.0435522 0.0212618 0.0101837 0.00645521 0.0147414 0.00607773 0.00326527 0.00150953 0.00263062 0.0016293 0.00312 0.0020153 0.00482979 0.00351168 0.0122765 0.00212988 0.00250408 0.00198777 0.0023621 0.001943 0.00230673 0.0019058 0.00230815 0.00191871 0.00238275 0.00201728 0.00281198 0.00298134 0.00613292 0.00989401 0.0399962 0.00944951 0.00712653 0.00954593 0.0324321 0.0363845 0.0218814 0.0359239 0.0333618 0.0606383 0.0309098 0.0313117 0.0428218 0.0508369 0.0659935 0.0877476 0.0514665 0.036804 0.0129004	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0367241 0.0276036 0.0359022 0.0274648 0.0477745 0.0238011 0.0114826 0.00742232 0.0170864 0.00709844 0.00339841 0.00155013 0.0026569 0.00162287 0.0029968 0.0017746 0.00357578 0.00233755 0.00570787 0.00461555 0.0187068 0.0036134 0.00349318 0.00284312 0.00318344 0.00269554 0.00308038 0.00261151 0.0031589 0.00274688 0.00407623 0.00497989 0.0107772 0.0283935 0.138434 0.0657005 0.0427593 0.0254311 0.0393742 0.0374003 0.0213684 0.0297871 0.0277436 0.0407204 0.0176213 0.0171761 0.0236377 0.0232676 0.0199071 0.0196431 0.0120992 0.0168821 0.0140913	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0366729 0.0272722 0.034936 0.0265286 0.0454516 0.0222381 0.0107424 0.00681168 0.0154445 0.00632977 0.0033443 0.00155397 0.00264073 0.0016121 0.00293046 0.00172328 0.00334332 0.00215054 0.00511047 0.00369279 0.0130335 0.00229339 0.00269195 0.00215927 0.00255305 0.00212868 0.0025218 0.00212408 0.00259115 0.0022261 0.00309921 0.00338454 0.00688456 0.011426 0.0466691 0.0112451 0.00835687 0.0123926 0.0454975 0.0474782 0.0295205 0.0461434 0.0389588 0.0787455 0.0462839 0.0461301 0.0434419 0.059086 0.042084 0.0247381 0.0187633 0.0185084 0.0163099	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0349748 0.0260316 0.0334412 0.0253477 0.0436725 0.0213405 0.0102058 0.00641192 0.0145624 0.00595082 0.00318016 0.0014735 0.00250303 0.00152587 0.00276754 0.0016227 0.00313746 0.00200632 0.00479904 0.00345388 0.0122431 0.00214865 0.00253243 0.00202692 0.00240416 0.00199645 0.00237264 0.00198787 0.00243104 0.00207144 0.00285192 0.00303294 0.00618243 0.00997896 0.0397679 0.00932438 0.00700448 0.00947997 0.0323533 0.0363526 0.0219041 0.0359385 0.0333711 0.0607136 0.0309192 0.0313231 0.0428493 0.0508831 0.0660658 0.0878216 0.0515056 0.0368386 0.012914	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0371757 0.0279406 0.0363944 0.0278845 0.0486227 0.0242661 0.0116751 0.00746958 0.0171229 0.0070441 0.00337637 0.00154633 0.00261121 0.00158339 0.00282234 0.00163017 0.00305003 0.0017774 0.00358706 0.00234052 0.00569917 0.00455727 0.0184797 0.0035674 0.00355606 0.00288333 0.00329702 0.00280426 0.00331179 0.00290018 0.0041854 0.00508294 0.0110285 0.0292449 0.136496 0.0635549 0.0418999 0.025021 0.0390033 0.0372726 0.0214608 0.0299742 0.0279228 0.0410407 0.0177522 0.0173109 0.0238563 0.0234849 0.0201012 0.0198294 0.0122169 0.0170508 0.014233	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0367014 0.0272855 0.034995 0.0265961 0.0456567 0.0223647 0.0107861 0.00678763 0.0153368 0.00623803 0.00328376 0.00153278 0.0025748 0.0015642 0.00277371 0.00160408 0.0029572 0.00171481 0.00333986 0.00214809 0.00509526 0.00366221 0.0130693 0.00232939 0.00274072 0.00222098 0.00263148 0.00222597 0.00266819 0.00230786 0.00316192 0.00346486 0.00696617 0.0115823 0.0462362 0.0110975 0.00820097 0.0123094 0.0453746 0.0474234 0.0295567 0.0461516 0.0389661 0.0788493 0.0462989 0.0461394 0.0434451 0.059103 0.0421025 0.0247567 0.0187745 0.0185229 0.0163236	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0349829 0.02603 0.0334789 0.0254015 0.0438497 0.0214556 0.0102467 0.00638942 0.0144634 0.00586756 0.003122 0.00145341 0.00244213 0.00148197 0.00262614 0.00151691 0.00278953 0.00161363 0.00313092 0.00200273 0.00477926 0.00342357 0.0122733 0.0021813 0.00257567 0.00208216 0.00247354 0.0020825 0.00250132 0.00214706 0.00290821 0.00310485 0.00625342 0.0101012 0.0394617 0.00920418 0.00688163 0.0094176 0.0322551 0.036309 0.0219261 0.0359366 0.0333611 0.0607564 0.0309099 0.0313166 0.0428555 0.050906 0.0661117 0.0878575 0.0515216 0.0368571 0.0129223	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0376243 0.0282856 0.0369233 0.0283473 0.0495728 0.0248074 0.0119046 0.00753665 0.0172187 0.00702266 0.00337192 0.00155195 0.00260227 0.00157368 0.00276984 0.00158914 0.00287763 0.00163698 0.00308174 0.00178772 0.00359761 0.00234935 0.00571013 0.00452621 0.0183526 0.00357185 0.00368479 0.00300783 0.00355364 0.00310825 0.0043474 0.00523506 0.0113656 0.0303459 0.134485 0.0614884 0.0410328 0.024598 0.0385259 0.0370429 0.0215043 0.0300896 0.0280383 0.0412819 0.0178481 0.0174125 0.0240361 0.0236641 0.0202633 0.0199833 0.0123155 0.0171934 0.0143539	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0367466 0.0273181 0.0350912 0.0266905 0.0459073 0.0225196 0.0108437 0.00677821 0.0152857 0.00617574 0.00323811 0.00151863 0.00253467 0.00153741 0.0026986 0.00155419 0.00279798 0.00159677 0.002963 0.00171518 0.00334105 0.00215371 0.00509742 0.00366094 0.013215 0.002391 0.00282621 0.00232423 0.00278936 0.00242078 0.00325426 0.00358169 0.00708715 0.0118266 0.0457692 0.0109673 0.00805482 0.0122371 0.0452157 0.0473318 0.0295813 0.0461263 0.0389421 0.0789019 0.0462806 0.0461166 0.0434211 0.0590846 0.0420958 0.0247612 0.0187749 0.0185277 0.0163293	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0350077 0.0260473 0.0335519 0.0254817 0.0440705 0.021598 0.0103012 0.00638067 0.0144183 0.00581193 0.00307805 0.00143982 0.00240455 0.0014567 0.00255693 0.00147133 0.00264619 0.00150898 0.00279213 0.00161308 0.00312932 0.00200678 0.00477571 0.00342041 0.0124057 0.00223627 0.00265103 0.00217322 0.00261195 0.00225161 0.00299174 0.00320982 0.00635996 0.0102962 0.0391346 0.00909863 0.00676811 0.00936512 0.0321307 0.0362386 0.0219403 0.0359132 0.033327 0.0607574 0.030878 0.031288 0.0428367 0.0509009 0.0661259 0.0878481 0.0515109 0.0368567 0.0129241	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0379766 0.0285695 0.0373931 0.028782 0.0505073 0.0253682 0.0121387 0.00759603 0.0173262 0.00701279 0.00337084 0.0015586 0.00260466 0.00157125 0.00275252 0.00157465 0.0028217 0.00159363 0.00291352 0.00165044 0.00311451 0.00180147 0.00360882 0.00235909 0.00573861 0.00452998 0.0184416 0.00369151 0.00397859 0.00334056 0.00461007 0.00544379 0.0118326 0.0319129 0.133167 0.0598375 0.0402204 0.0241748 0.0378961 0.0366593 0.0214617 0.0300724 0.028031 0.0413538 0.0178698 0.017442 0.0241209 0.0237496 0.0203451 0.0200578 0.012366 0.017269 0.0144196	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0367824 0.0273504 0.035195 0.0267913 0.0461664 0.022685 0.0109069 0.00677746 0.0152839 0.00614017 0.00320156 0.00150775 0.00250663 0.0015188 0.00265202 0.00152567 0.00272131 0.00154634 0.00280509 0.00159863 0.00297365 0.00172357 0.00335382 0.00216715 0.00511966 0.00370078 0.0135616 0.00250636 0.00300675 0.00253331 0.00340003 0.00374341 0.00728742 0.012256 0.0455465 0.0108884 0.00794346 0.0121929 0.0450169 0.0471718 0.0295703 0.0460452 0.0388655 0.0788476 0.0462003 0.046034 0.0433436 0.0589919 0.042035 0.024734 0.0187516 0.0185097 0.0163151	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0350284 0.0260681 0.0336362 0.0255717 0.0443049 0.0217536 0.0103632 0.00638172 0.0144234 0.00578293 0.0030436 0.00142967 0.00237887 0.00143925 0.00251404 0.00144479 0.00257631 0.0014632 0.00265073 0.00150999 0.00280004 0.00162026 0.00313937 0.00201841 0.00479114 0.00345437 0.0127232 0.00233757 0.00280888 0.0023556 0.00312488 0.003356 0.0065385 0.0106451 0.0390266 0.00903373 0.00668469 0.00933659 0.0319819 0.036121 0.0219319 0.0358561 0.0332548 0.0606803 0.0308075 0.0312214 0.0427701 0.0508381 0.0660685 0.0877403 0.0514429 0.0368145 0.0129113	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.038048 0.0286581 0.0376214 0.0290496 0.051208 0.0258466 0.0123151 0.00759465 0.0173906 0.00699657 0.00335709 0.00155747 0.00260289 0.00156365 0.00273928 0.00156049 0.00279195 0.00156844 0.00284877 0.00159826 0.0029452 0.00166136 0.00314428 0.00180997 0.00361213 0.00235851 0.00576832 0.00457704 0.0187658 0.00407586 0.00504108 0.00562783 0.0125083 0.0345055 0.134541 0.0592769 0.0395705 0.0237575 0.0370016 0.0359894 0.0212398 0.0297858 0.0277659 0.0410598 0.0177319 0.0173143 0.0239881 0.0236197 0.0202412 0.0199511 0.012305 0.0171878 0.0143551	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0367502 0.0273424 0.0352526 0.0268637 0.0463731 0.0228334 0.0109593 0.00677299 0.0153399 0.00614062 0.0031701 0.00149723 0.00248534 0.00150321 0.00261931 0.00150449 0.00267432 0.00151615 0.00273038 0.0015473 0.00281974 0.00160773 0.00299596 0.00173987 0.00338494 0.00218924 0.00516543 0.00380876 0.014161 0.00276132 0.00364758 0.00386852 0.0076581 0.0131111 0.0464849 0.0109122 0.00792819 0.0122159 0.0447979 0.0468758 0.0294484 0.0458517 0.0386873 0.0785384 0.0459864 0.0458214 0.0431416 0.0587151 0.0418373 0.0246227 0.0186657 0.018429 0.0162449	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0349987 0.0260606 0.0336894 0.0256431 0.0445025 0.0219008 0.0104211 0.00638446 0.0144935 0.00579202 0.00301616 0.00142086 0.00236135 0.00142561 0.00248592 0.00142586 0.00253504 0.00143599 0.00258466 0.0014642 0.00266425 0.00151857 0.00282092 0.00163563 0.00316895 0.00203961 0.00483153 0.00355088 0.0132862 0.0025603 0.00335581 0.00347499 0.00687239 0.0113424 0.0399263 0.00904081 0.0066814 0.00936487 0.0318353 0.0359142 0.0218549 0.0357359 0.0331151 0.0604388 0.0306628 0.03108 0.0425955 0.0506362 0.0658247 0.0873791 0.0512277 0.0366627 0.0128592	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0377543 0.0284808 0.0374725 0.028978 0.0513125 0.0260379 0.012357 0.00752676 0.0175487 0.00707003 0.00335207 0.00155758 0.00261392 0.0015599 0.00274478 0.00155265 0.00279047 0.00155439 0.0028341 0.00157412 0.00290057 0.00161364 0.00300931 0.0016863 0.00322269 0.00185049 0.00372883 0.00244451 0.00611355 0.00512122 0.0221904 0.00632335 0.0134558 0.0377682 0.139198 0.0599784 0.0388825 0.0231441 0.0356546 0.0347932 0.0206855 0.0290021 0.0270262 0.0401814 0.0173347 0.0169331 0.0235083 0.023146 0.0198452 0.0195636 0.0120717 0.016863 0.0140871	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0365213 0.0271793 0.0350283 0.0266812 0.0460321 0.0226696 0.0108701 0.00672815 0.0154853 0.00622957 0.00315484 0.00148772 0.00247448 0.0014915 0.00260154 0.00148939 0.00264913 0.0014961 0.00269286 0.00151918 0.00275647 0.00156034 0.00285806 0.0016319 0.00305274 0.00178551 0.00349999 0.00227928 0.00546429 0.00443184 0.0182399 0.00433771 0.00814539 0.0144021 0.0495707 0.0108753 0.00804335 0.0122895 0.0445782 0.0462075 0.0290092 0.0452834 0.0382164 0.0775583 0.0454208 0.045262 0.0426037 0.0579537 0.0412812 0.0242887 0.0184146 0.0181851 0.0160314	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0348185 0.0259324 0.0335153 0.0254954 0.044223 0.0217722 0.0103601 0.00636122 0.0146736 0.00589389 0.0030088 0.00141524 0.00235782 0.00141797 0.00247641 0.00141499 0.00251883 0.00142045 0.0025572 0.00144126 0.0026138 0.0014787 0.00270463 0.00154322 0.00287829 0.00167924 0.0032786 0.00212319 0.00510352 0.00410464 0.0169228 0.00391113 0.00731555 0.0123929 0.0426888 0.00896894 0.00678646 0.00944628 0.0317259 0.0354516 0.0215794 0.035391 0.0327763 0.0597787 0.0303301 0.0307463 0.0421389 0.0500727 0.0650939 0.0863459 0.0506244 0.0362242 0.0127052	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.034767 0.0258807 0.0332674 0.0249253 0.0431601 0.0213018 0.0105314 0.00703702 0.0167942 0.00728883 0.00350202 0.00159607 0.00273357 0.00161505 0.00288786 0.00161411 0.00293872 0.00161734 0.00297788 0.00163691 0.00303572 0.00167612 0.00313531 0.00174937 0.00334154 0.00191623 0.00388411 0.00239869 0.00540865 0.00400386 0.0102507 0.0137878 0.0936659 0.0344028 0.128771 0.057903 0.0371259 0.021965 0.0339784 0.0322601 0.0192926 0.0265169 0.0245388 0.0370056 0.0158991 0.0154951 0.0215634 0.0212269 0.0182309 0.0179746 0.0110836 0.0154881 0.0129502	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ,  Oral DRUG2 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG0 ;
4	4	0.0337524 0.0250494 0.0321699 0.0241846 0.041459 0.0203212 0.0100575 0.00671372 0.015863 0.00683194 0.0033702 0.00154046 0.00265219 0.00156292 0.00280648 0.00156698 0.00286313 0.00157618 0.00290921 0.00160176 0.00297392 0.00164711 0.0030791 0.00172612 0.00328409 0.00189612 0.00379668 0.00238211 0.00515638 0.00384419 0.00877478 0.0116945 0.0692466 0.0153832 0.0483774 0.0114807 0.00816328 0.0122306 0.043923 0.0433463 0.027538 0.0420078 0.0354296 0.0712185 0.0416238 0.0413529 0.0389705 0.052876 0.0375904 0.0221378 0.0167769 0.016593 0.0146263	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0325095 0.0241379 0.0310334 0.0233113 0.0400283 0.0196023 0.00966206 0.00643092 0.0151964 0.00652735 0.0032301 0.00147547 0.00253874 0.00149675 0.00268478 0.00150029 0.00273727 0.00150887 0.00277951 0.00153306 0.00283922 0.00157587 0.00293669 0.00164999 0.00312663 0.00180745 0.00359961 0.00225571 0.00485888 0.00361439 0.0081986 0.0107567 0.0626487 0.0137389 0.0421449 0.00952153 0.00695913 0.00952418 0.0314908 0.033654 0.020729 0.0333389 0.0308141 0.0553222 0.0280517 0.0284102 0.0390014 0.0463096 0.0600876 0.0794654 0.0465988 0.0333314 0.0117134	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
4	4	0.0312232 0.0228805 0.0296398 0.0225234 0.0399597 0.0198559 0.00980767 0.00574959 0.0123364 0.00463483 0.00244899 0.00122636 0.00195657 0.0011899 0.00199958 0.00116227 0.00199852 0.00114492 0.00199803 0.00113918 0.00200739 0.00114267 0.00202989 0.00115589 0.00207308 0.00118388 0.00215979 0.00124547 0.00237569 0.00143038 0.00328904 0.00246805 0.0086816 0.012846 0.0549033 0.0280215 0.0394696 0.0180665 0.0563197 0.0529148 0.0339187 0.0479835 0.0400089 0.07536 0.044552 0.0439918 0.0409076 0.0547518 0.0386327 0.0226273 0.0171338 0.0168307 0.0146415	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG1 : Clinically significant hypoglycemia may be precipitated by the use of DRUG2 with oral DRUG0 ;
4	4	0.0302604 0.0221711 0.0287627 0.0218126 0.0388189 0.0192791 0.00947307 0.00551102 0.0118134 0.00443606 0.0023732 0.00118778 0.0018976 0.00115209 0.00193886 0.00112541 0.00193775 0.00110881 0.00193736 0.00110346 0.00194658 0.00110703 0.00196849 0.00111991 0.00201013 0.00114678 0.00209267 0.00120494 0.00229578 0.00137504 0.00313764 0.00233191 0.0081893 0.0115756 0.0493968 0.024693 0.0343926 0.0141085 0.0402486 0.0411511 0.0257824 0.0389838 0.0354918 0.0598011 0.0303808 0.0305427 0.0409822 0.0483914 0.0618584 0.0811904 0.047412 0.0337664 0.0118234	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG1 : Clinically significant hypoglycemia may be precipitated by the use of DRUG0 with oral DRUG2 ;
2	2	0.0334186 0.023624 0.028851 0.021178 0.0364427 0.0172788 0.00882953 0.00477749 0.0094031 0.00355298 0.00244332 0.00129719 0.00194249 0.0012307 0.00193797 0.00119049 0.00190695 0.00116475 0.00188112 0.00115137 0.00186525 0.0011471 0.00186044 0.00115144 0.00187106 0.00116718 0.00190951 0.00120432 0.00201283 0.00129568 0.00241046 0.00180145 0.00553969 0.00539937 0.0185608 0.00668696 0.00881845 0.0103738 0.0449465 0.0499316 0.0345197 0.0595 0.0524527 0.0979134 0.0514378 0.0429593 0.03428 0.0408456 0.048931 0.0457542 0.0539152 0.0440889 0.0199457	These are described in greater detail below :  Oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ,  Oral DRUG0 : Clinically significant hypoglycemia may be precipitated by the use of DRUG1 with oral DRUG2 ;
2	2	0.0552428 0.0747263 0.045831 0.0514771 0.0701072 0.0574976 0.0668358 0.0426651 0.0641759 0.0821996 0.0565173 0.116442 0.0253797 0.0478453 0.0450856 0.0979717	one fatality has been reported from hypoglycemia in association with combined DRUG1 and DRUG2 use .
3	3	0.124447 0.153645 0.092152 0.106909 0.0910303 0.0367478 0.00679077 0.00674093 0.0037622 0.00481161 0.0126939 0.0137195 0.0924454 0.0479108 0.0570159 0.0431126 0.0190241 0.0129707 0.0148738 0.0591963	DRUG1 reduces the metabolism of DRUG2 , DRUG0 , and DRUG0 and increases the plasma concentration of these agents .
3	3	0.114488 0.149559 0.0794614 0.105638 0.0615883 0.0229171 0.0134255 0.0280369 0.00592684 0.00527997 0.0132977 0.0143588 0.0981294 0.0534509 0.0642568 0.0473921 0.0209094 0.0145986 0.0175655 0.0697203	DRUG1 reduces the metabolism of DRUG0 , DRUG2 , and DRUG0 and increases the plasma concentration of these agents .
3	3	0.114444 0.144731 0.0782488 0.0923422 0.0554882 0.0183823 0.00693174 0.0107427 0.0102863 0.0221715 0.0469632 0.0168709 0.0885996 0.0523547 0.0650566 0.0482381 0.0215592 0.0149545 0.0181975 0.0734377	DRUG1 reduces the metabolism of DRUG0 , DRUG0 , and DRUG2 and increases the plasma concentration of these agents .
4	4	0.0909297 0.168942 0.0774735 0.0773634 0.0398482 0.0238251 0.0163038 0.0643623 0.015267 0.0190573 0.0412353 0.0119842 0.0927754 0.0483853 0.0532614 0.0399983 0.0192196 0.014054 0.0178031 0.0679115	DRUG0 reduces the metabolism of DRUG0 , DRUG1 , and DRUG2 and increases the plasma concentration of these agents .
1	1	0.128128 0.113186 0.0788275 0.0574682 0.0718755 0.0802977 0.0484052 0.0167693 0.0146817 0.0279771 0.00648277 0.0150538 0.0238091 0.0273085 0.0222593 0.0213673 0.0332263 0.0154129 0.00359948 0.00426767 0.00284415 0.00531822 0.00723899 0.0120149 0.0177751 0.0140594 0.0204319 0.00735073 0.0254521 0.0771111	When DRUG1 is used concomitantly with these or other DRUG2 , blood glucose concentrations should be carefully monitored and the dose of the DRUG0 should be adjusted as necessary .
1	4	0.107645 0.0661639 0.0436372 0.0402655 0.0442033 0.0274775 0.0105495 0.00585122 0.0047343 0.00783499 0.00823291 0.0284933 0.0400969 0.0364078 0.0311526 0.0441401 0.0690543 0.0416591 0.0117759 0.0205604 0.0152174 0.0358811 0.0596187 0.0421122 0.0186737 0.020383 0.0246632 0.00912376 0.0219256 0.0624654	When DRUG1 is used concomitantly with these or other DRUG0 , blood glucose concentrations should be carefully monitored and the dose of the DRUG2 should be adjusted as necessary .
4	4	0.0544241 0.0523351 0.0573027 0.0529467 0.066345 0.0683621 0.0277753 0.015863 0.0202617 0.0679648 0.0113448 0.0224571 0.0178383 0.0231711 0.0169792 0.0305602 0.0511523 0.0387687 0.0121177 0.022077 0.0148175 0.0317679 0.0544412 0.0373972 0.0164204 0.0176759 0.0209781 0.00763408 0.0180215 0.0507991	When DRUG0 is used concomitantly with these or other DRUG1 , blood glucose concentrations should be carefully monitored and the dose of the DRUG2 should be adjusted as necessary .
4	4	0.0908836 0.0240372 0.0415525 0.0327932 0.0796313 0.0757378 0.111853 0.0827248 0.0647477 0.0875455 0.0749741 0.0480947 0.0151834 0.0329742 0.137267	DRUG1 : Prothrombin time may be increased in patients receiving concomitant DRUG2 and DRUG0 .
2	2	0.0257509 0.0233043 0.0302754 0.0292826 0.0844964 0.088822 0.124709 0.0860348 0.0542076 0.0708025 0.0456951 0.12489 0.035889 0.0833176 0.0925235	DRUG0 : Prothrombin time may be increased in patients receiving concomitant DRUG1 and DRUG2 .
4	4	0.0315742 0.0335303 0.0228424 0.00645267 0.0153441 0.0307422 0.0145296 0.0633743 0.0189322 0.0614471 0.0391246 0.0183578 0.0112815 0.028518 0.00763505 0.0132103 0.00777731 0.0039064 0.0069179 0.00291315 0.00400406 0.010139 0.00811508 0.0158975 0.0395497 0.0172804 0.0231596 0.0181978 0.0216793 0.0108917 0.0158784 0.0209092 0.0313592 0.032503 0.0512086 0.0340786 0.0544901 0.0450766 0.0364055 0.0707657	In post-marketing experience , as with other DRUG1 , bleeding events (bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena) have been reported in association with increases in prothrombin time in patients receiving DRUG2 concurrently with DRUG0 .
4	4	0.0306082 0.0325376 0.022205 0.00629273 0.0149528 0.0298932 0.0142961 0.0622945 0.0185582 0.0605821 0.0380183 0.0165573 0.00999126 0.0243811 0.00691797 0.011864 0.00711985 0.00353482 0.00588308 0.00259296 0.00346198 0.00807371 0.00607591 0.00987185 0.0281041 0.0115851 0.0151442 0.0129706 0.0160083 0.00853391 0.0124206 0.0144058 0.0196441 0.0245294 0.0379781 0.0573538 0.0872064 0.0883478 0.0587645 0.0604389	In post-marketing experience , as with other DRUG1 , bleeding events (bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena) have been reported in association with increases in prothrombin time in patients receiving DRUG0 concurrently with DRUG2 .
2	2	0.0163849 0.0133447 0.00795327 0.00300783 0.00340193 0.00718261 0.0045616 0.0117187 0.0178386 0.0696336 0.0677162 0.0219677 0.00920988 0.0238214 0.00739734 0.0156479 0.00971835 0.00485285 0.00862093 0.00361062 0.00513559 0.0138073 0.0114436 0.0229477 0.051898 0.0259131 0.0353896 0.0285664 0.032707 0.0187818 0.0246034 0.027862 0.0340339 0.0335264 0.035955 0.0503962 0.0584442 0.0592632 0.0546891 0.0470454	In post-marketing experience , as with other DRUG0 , bleeding events (bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena) have been reported in association with increases in prothrombin time in patients receiving DRUG1 concurrently with DRUG2 .
1	1	0.0802987 0.105826 0.0768771 0.0595597 0.0482605 0.0592642 0.0575204 0.0515599 0.110321 0.043548 0.0671951 0.0701287 0.0419485 0.127692	Careful monitoring of prothrombin time in patients receiving DRUG1 and DRUG2 is recommended .
4	4	0.126474 0.0705446 0.127614 0.215401 0.0747388 0.0744824 0.0675385 0.0512039 0.0545604 0.137442	DRUG1 : DRUG2 increases the plasma concentrations of DRUG0 .
3	3	0.0422814 0.0579402 0.148971 0.137991 0.0861647 0.106325 0.102145 0.124277 0.0963792 0.0975253	DRUG0 : DRUG1 increases the plasma concentrations of DRUG2 .
4	4	0.0683779 0.0949181 0.0890669 0.0796247 0.139201 0.0993413 0.0735333 0.108041 0.0346613 0.00904371 0.0175594 0.0425586 0.031831 0.112242	Careful monitoring of DRUG1 concentrations in patients receiving DRUG2 and DRUG0 is recommended .
1	1	0.0689114 0.0927961 0.0613551 0.0501026 0.0756759 0.0483634 0.052517 0.0629639 0.133657 0.0496499 0.0711425 0.0688731 0.0409027 0.12309	Careful monitoring of DRUG0 concentrations in patients receiving DRUG1 and DRUG2 is recommended .
4	4	0.0878455 0.0463353 0.0779506 0.0826729 0.0617401 0.0372422 0.0454034 0.0610715 0.0339874 0.0384909 0.0859993 0.0560142 0.0385118 0.0148239 0.0422138 0.0255109 0.062472 0.101714	DRUG1 : DRUG2 may significantly increase DRUG0 levels in renal transplant patients with or without renal impairment .
3	3	0.0242007 0.0371963 0.113297 0.0805853 0.073158 0.103895 0.0658418 0.0817536 0.0555509 0.0415363 0.0753852 0.0502644 0.0305033 0.0128862 0.0289765 0.0169929 0.0412033 0.0667725	DRUG0 : DRUG1 may significantly increase DRUG2 levels in renal transplant patients with or without renal impairment .
4	4	0.0591871 0.0788631 0.0656796 0.0606209 0.044238 0.0128325 0.0333488 0.0661392 0.0731131 0.058321 0.0805684 0.0754236 0.107357 0.0378497 0.01415 0.0311237 0.101185	Careful monitoring of DRUG1 concentrations and serum creatinine is recommended in patients receiving DRUG2 and DRUG0 .
1	1	0.0416627 0.055138 0.0248945 0.0225342 0.0253259 0.0160641 0.0349606 0.101782 0.0981956 0.0677522 0.0527124 0.0566329 0.0481927 0.116958 0.0478432 0.0965484 0.092803	Careful monitoring of DRUG0 concentrations and serum creatinine is recommended in patients receiving DRUG1 and DRUG2 .
4	4	0.056335 0.0347973 0.0640379 0.168117 0.102073 0.121893 0.0897902 0.100218 0.0987233 0.0854942 0.0785225	DRUG1 : DRUG0 enhances the metabolism of concurrently administered DRUG2 .
3	3	0.0294458 0.047205 0.123087 0.158503 0.0649573 0.0945029 0.0903362 0.0865407 0.115136 0.108015 0.0822713	DRUG0 : DRUG1 enhances the metabolism of concurrently administered DRUG2 .
1	1	0.0362908 0.0179994 0.0179148 0.0259738 0.00789939 0.0248744 0.0208817 0.0231235 0.0249467 0.0223005 0.0566801 0.0487117 0.0290934 0.0528699 0.0978701 0.0631318 0.041808 0.0562462 0.0684186 0.0996327 0.0898289 0.0735036	Depending on clinical circumstances , consideration should be given to increasing the dose of DRUG1 when it is administered with DRUG2 .
4	4	0.127135 0.0684588 0.121164 0.182912 0.0800441 0.0576223 0.0835153 0.0616463 0.0634576 0.154045	DRUG1 : DRUG2 increases the serum concentrations of DRUG0 .
3	3	0.041301 0.0576098 0.144473 0.132742 0.0994103 0.0976272 0.11055 0.124431 0.097381 0.094476	DRUG0 : DRUG1 increases the serum concentrations of DRUG2 .
4	4	0.0526351 0.0750474 0.0700611 0.0836999 0.0896348 0.132877 0.0948794 0.0683583 0.0992543 0.0317973 0.0082463 0.0161678 0.0392547 0.0301903 0.107897	Careful monitoring of serum DRUG1 concentrations in patients receiving DRUG2 and DRUG0 is recommended .
1	1	0.0710337 0.082248 0.0469298 0.0486772 0.0481362 0.0744399 0.0462969 0.0496782 0.0576915 0.127739 0.0476704 0.0692416 0.0683239 0.0404527 0.121441	Careful monitoring of serum DRUG0 concentrations in patients receiving DRUG1 and DRUG2 is recommended .
4	4	0.0427281 0.0174544 0.0546667 0.0347575 0.0438669 0.0690636 0.0349814 0.0409429 0.0159863 0.0246351 0.0373705 0.0152642 0.0191272 0.0171094 0.0173084 0.0160023 0.0283099 0.042509 0.035474 0.0427566 0.0255346 0.0336235 0.0548556 0.0271177 0.0145546 0.0118691 0.0568061 0.0328126 0.0134949 0.0178222 0.0149913 0.0462037	DRUG1 : Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving DRUG2 in conjunction with DRUG0 , interaction studies have been performed .
2	2	0.0139802 0.017614 0.0411246 0.0320651 0.0414846 0.068771 0.0380421 0.0470698 0.0181553 0.029406 0.044206 0.0205521 0.0255101 0.0264206 0.0238664 0.0215272 0.0313845 0.0394351 0.034146 0.0363957 0.0343488 0.0492132 0.0343565 0.0387331 0.0252427 0.00901262 0.0418288 0.0220557 0.0114515 0.0177567 0.018414 0.0464298	DRUG0 : Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving DRUG1 in conjunction with DRUG2 , interaction studies have been performed .
3	4	0.0598191 0.031318 0.0210283 0.0236086 0.0294839 0.0125569 0.0337464 0.0323828 0.0169773 0.0266325 0.0386426 0.0443897 0.0473353 0.047447 0.0536606 0.0429875 0.0266192 0.0303641 0.0328451 0.0285211 0.046672 0.0240859 0.0126069 0.0399323 0.0340138 0.0145235 0.0136082 0.0120744 0.00979932 0.0129393 0.0137755 0.0277209 0.0169661 0.0409156	Another study at a 400-mg and 800-mg daily dose of DRUG1 demonstrated that DRUG2 taken in doses of 400 mg per day or greater significantly increases plasma levels of DRUG0 when taken concomitantly .
4	4	0.0502097 0.0256216 0.0172269 0.0195061 0.0245385 0.00982353 0.02774 0.0303737 0.0176232 0.0304979 0.0371613 0.0188244 0.0152417 0.0352781 0.0404337 0.0210765 0.0149077 0.0198622 0.0262883 0.02243 0.0432729 0.0183134 0.00891584 0.0342193 0.0473331 0.0380719 0.0456536 0.0458522 0.0506775 0.0401862 0.0227562 0.0351242 0.0244806 0.0404781	Another study at a 400-mg and 800-mg daily dose of DRUG1 demonstrated that DRUG0 taken in doses of 400 mg per day or greater significantly increases plasma levels of DRUG2 when taken concomitantly .
4	3	0.0401901 0.0167926 0.00885904 0.00904021 0.0130992 0.00498628 0.0150945 0.0227768 0.0109651 0.0196898 0.0268266 0.0442981 0.0469721 0.0728005 0.0387023 0.0289136 0.0161079 0.0192947 0.0219077 0.0201434 0.0384111 0.0183957 0.0103966 0.0367273 0.0503209 0.0415421 0.043442 0.0428343 0.0494238 0.0383504 0.0232984 0.0391591 0.0272884 0.0429491	Another study at a 400-mg and 800-mg daily dose of DRUG0 demonstrated that DRUG1 taken in doses of 400 mg per day or greater significantly increases plasma levels of DRUG2 when taken concomitantly .
1	1	0.0468281 0.0511403 0.0493123 0.0476697 0.0569967 0.0306595 0.0251549 0.0424716 0.0426072 0.0452271 0.0341942 0.102029 0.0866855 0.0815312 0.0925991 0.0673216 0.0975725	The combined use of DRUG1 at doses of 400 mg or greater with DRUG2 is contraindicated .
1	1	0.0729296 0.0766876 0.0684827 0.0832987 0.0331648 0.0364244 0.0372116 0.0381331 0.0832423 0.0738166 0.0990547 0.0621441 0.0353074 0.0370323 0.0534143 0.0392249 0.070431	The coadministration of DRUG1 at doses lower than 400 mg/day with DRUG2 should be carefully monitored .
4	4	0.0747161 0.0217464 0.0457897 0.0221318 0.0317437 0.0368308 0.0281054 0.0314966 0.0307791 0.00672648 0.0101571 0.0482526 0.0589591 0.0537277 0.0554431 0.0425696 0.0514262 0.121811 0.0377768 0.00970168 0.016916 0.0210938 0.0455146 0.0965849	DRUG1 : There have been reports of cardiac events , including torsade de pointes in patients to whom DRUG2 and DRUG0 were coadministered .
2	2	0.018269 0.0186545 0.0308029 0.0171626 0.0250464 0.0309331 0.0261997 0.0318456 0.030781 0.00661421 0.0114565 0.0518136 0.0600421 0.0499888 0.047391 0.0341626 0.047672 0.0544414 0.101497 0.0304533 0.0470681 0.0543442 0.0693045 0.104056	DRUG0 : There have been reports of cardiac events , including torsade de pointes in patients to whom DRUG1 and DRUG2 were coadministered .
3	3	0.0431718 0.045891 0.0352642 0.0398107 0.0324579 0.0339276 0.0632291 0.046273 0.0280135 0.0303599 0.0422196 0.024998 0.0396303 0.0365008 0.0287144 0.0479889 0.0425213 0.0293014 0.0292673 0.0376101 0.0210131 0.0234401 0.0135838 0.00937478 0.0111938 0.0255325 0.0189706 0.0146238 0.0209228 0.0114124 0.0102495 0.0139017 0.0486303	A controlled study found that concomitant DRUG1 200 mg once daily and DRUG2 20 mg four times a day yielded a significant increase in DRUG0 plasma levels and prolongation of QTc interval .
4	4	0.0289562 0.0328729 0.0230353 0.0217913 0.0138038 0.0180477 0.0248435 0.0160927 0.0110386 0.015391 0.0163514 0.00814414 0.0186356 0.0341216 0.0229836 0.0531862 0.0523602 0.0349794 0.0428932 0.0584386 0.0479861 0.0740581 0.0597561 0.0487076 0.0529139 0.0443618 0.0340127 0.0135009 0.0164772 0.0085874 0.00761606 0.00997818 0.0340774	A controlled study found that concomitant DRUG1 200 mg once daily and DRUG0 20 mg four times a day yielded a significant increase in DRUG2 plasma levels and prolongation of QTc interval .
1	1	0.0920445 0.086337 0.0770536 0.0740837 0.089156 0.129531 0.0915762 0.129904 0.0912674 0.139046	The combined use of DRUG1 with DRUG2 is contraindicated .
4	4	0.0705896 0.0249617 0.0554676 0.0523976 0.0657724 0.0434271 0.0406244 0.0369997 0.0643039 0.048257 0.0166331 0.00540226 0.00743888 0.0329855 0.0262021 0.0184671 0.0175326 0.0203099 0.0141312 0.0113136 0.0268404 0.0211073 0.0273556 0.0250921 0.0271923 0.0215975 0.029278 0.0371616 0.0274088 0.0208356 0.0190106 0.0439029	DRUG1 : The use of DRUG2 in patients concurrently taking DRUG0 or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs .
3	3	0.0218251 0.0314903 0.0470402 0.0472284 0.062318 0.0444427 0.0755282 0.0330854 0.0464682 0.0698223 0.0307239 0.0117574 0.00800516 0.0236259 0.0244795 0.0222384 0.0219632 0.027054 0.0154646 0.0104581 0.0261795 0.0246578 0.0285486 0.0249833 0.0267476 0.0211984 0.0284171 0.0359156 0.0267844 0.020396 0.0183307 0.0428219	DRUG0 : The use of DRUG1 in patients concurrently taking DRUG2 or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs .
4	4	0.0857058 0.0232324 0.0469277 0.0229217 0.0318857 0.0426657 0.041411 0.0543877 0.0596512 0.0511922 0.070375 0.170488 0.0521237 0.013689 0.022116 0.0274294 0.0590416 0.124756	DRUG1 : There have been reports of uveitis in patients to whom DRUG2 and DRUG0 were coadministered .
2	2	0.0221054 0.0209 0.0317909 0.0189933 0.0279208 0.0401932 0.0406393 0.0557811 0.0498535 0.042597 0.0635256 0.0670765 0.131447 0.0383087 0.0586027 0.0700959 0.0889267 0.131242	DRUG0 : There have been reports of uveitis in patients to whom DRUG1 and DRUG2 were coadministered .
1	1	0.138531 0.087869 0.182334 0.0726813 0.0968985 0.0965589 0.0465773 0.0515914 0.0722491 0.0533441 0.101366	Patients receiving DRUG1 and DRUG2 concomitantly should be carefully monitored .
4	4	0.086852 0.0231236 0.0464097 0.0225763 0.0310261 0.0399805 0.0354158 0.0567946 0.0657068 0.0548923 0.0699577 0.166728 0.0508346 0.0133405 0.0220774 0.027918 0.0597886 0.126578	DRUG1 : There have been reports of nephrotoxicity in patients to whom DRUG2 and DRUG0 were coadministered .
2	2	0.0219805 0.0204892 0.030641 0.0183121 0.0264655 0.0363809 0.0343358 0.0600126 0.0566494 0.0472482 0.0643126 0.0664685 0.129677 0.0379293 0.0582998 0.0703574 0.0892574 0.131183	DRUG0 : There have been reports of nephrotoxicity in patients to whom DRUG1 and DRUG2 were coadministered .
1	1	0.138531 0.087869 0.182334 0.0726813 0.0968985 0.0965589 0.0465773 0.0515914 0.0722491 0.0533441 0.101366	Patients receiving DRUG1 and DRUG2 concomitantly should be carefully monitored .
4	4	0.0699529 0.0433676 0.116363 0.0812076 0.0788461 0.102973 0.0509651 0.0116414 0.0280863 0.0493618 0.0269823 0.0715819 0.0489775 0.0185514 0.0194764 0.0215792 0.0134591 0.0387237 0.0404608 0.0674433	DRUG1 : Following oral administration of DRUG2 , DRUG0 resulted in substantial increases in DRUG0 concentrations and psychomotor effects .
4	4	0.0602104 0.0405191 0.0946193 0.0643058 0.0710222 0.0650344 0.0331455 0.0268537 0.0742207 0.0676466 0.0408631 0.0847913 0.05725 0.022493 0.022173 0.0228542 0.0142334 0.0375754 0.0384704 0.0617184	DRUG1 : Following oral administration of DRUG0 , DRUG2 resulted in substantial increases in DRUG0 concentrations and psychomotor effects .
4	4	0.0553837 0.0191465 0.0595272 0.0317787 0.0379818 0.0300225 0.0206932 0.00954964 0.0387446 0.068811 0.037066 0.118612 0.13449 0.0749141 0.0640457 0.0444601 0.0197019 0.0376464 0.0334934 0.0639309	DRUG1 : Following oral administration of DRUG0 , DRUG0 resulted in substantial increases in DRUG2 concentrations and psychomotor effects .
4	4	0.0132036 0.0177008 0.0552739 0.0462392 0.0681723 0.0648202 0.0338581 0.0215823 0.0488927 0.0778612 0.0573474 0.100181 0.100684 0.0764469 0.0642053 0.0363 0.0151946 0.0289048 0.0261131 0.0470183	DRUG0 : Following oral administration of DRUG0 , DRUG1 resulted in substantial increases in DRUG2 concentrations and psychomotor effects .
2	2	0.0413193 0.0459211 0.0601792 0.095608 0.0533795 0.026363 0.0279267 0.0469637 0.0881383 0.0596488 0.0533142 0.0685126 0.0829823 0.0394737 0.0165105 0.0193104 0.0285131 0.0321718 0.0404974 0.0732665	This effect on DRUG1 appears to be more pronounced following oral administration of DRUG2 than with DRUG0 administered intravenously .
4	4	0.038005 0.0407334 0.0485501 0.0738947 0.0353068 0.0120418 0.012716 0.0210306 0.0569239 0.0358381 0.041201 0.0640792 0.0671475 0.0395444 0.0534083 0.10442 0.0747981 0.0432137 0.0509919 0.0861552	This effect on DRUG1 appears to be more pronounced following oral administration of DRUG0 than with DRUG2 administered intravenously .
1	1	0.0889186 0.10146 0.0285852 0.0321977 0.0363409 0.0300895 0.0322569 0.0338022 0.0473241 0.0351544 0.0203716 0.0158959 0.0396693 0.0460724 0.0601604 0.0507733 0.0218248 0.0052058 0.0155516 0.0108822 0.00548018 0.0046849 0.00384478 0.0214385 0.00934488 0.00886777 0.00719855 0.00261744 0.00325996 0.009545 0.0102859 0.0169425 0.0189788 0.0473553 0.0255537 0.0520651	If DRUG1 , which are metabolized by the cytochrome P450 system , are concomitantly administered with DRUG2 , consideration should be given to decreasing the DRUG0 dosage , and the patients should be appropriately monitored .
1	4	0.0882233 0.0983504 0.0266841 0.0293318 0.0289406 0.0212242 0.0165393 0.0156725 0.0181552 0.0110648 0.00416452 0.00270321 0.00619886 0.0104734 0.0102973 0.0073797 0.00909125 0.00929876 0.0343077 0.0250097 0.0231005 0.0221752 0.0297036 0.100732 0.0940302 0.046892 0.0198141 0.0050167 0.00427298 0.0102037 0.0106141 0.0153963 0.0191607 0.0470273 0.0259031 0.0528468	If DRUG1 , which are metabolized by the cytochrome P450 system , are concomitantly administered with DRUG0 , consideration should be given to decreasing the DRUG2 dosage , and the patients should be appropriately monitored .
4	4	0.0253 0.0177051 0.0173066 0.0442107 0.0168169 0.0117529 0.0102746 0.0115487 0.0166347 0.0137209 0.0107943 0.00981714 0.0322689 0.0559116 0.0663851 0.0607501 0.0621168 0.0101502 0.0399307 0.0202925 0.0209799 0.0213736 0.0242203 0.0921051 0.0832946 0.0387517 0.0160681 0.00422838 0.00369739 0.00869574 0.00887701 0.0124664 0.0154635 0.0367227 0.0196801 0.0396873	If DRUG0 , which are metabolized by the cytochrome P450 system , are concomitantly administered with DRUG1 , consideration should be given to decreasing the DRUG2 dosage , and the patients should be appropriately monitored .
4	3	0.145914 0.134244 0.132435 0.104632 0.04127 0.0127905 0.00729639 0.0113043 0.0115238 0.0167089 0.0405427 0.0554801 0.0524659 0.0509468 0.0252664 0.0207624 0.0116043 0.0121311 0.00714816 0.0286348 0.0768972	DRUG1 tablets coadministered with DRUG2 - and DRUG0 -containing oral DRUG0 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	3	0.141666 0.120035 0.10754 0.0814207 0.0315563 0.0241009 0.0211741 0.0294652 0.0159986 0.0259987 0.0433068 0.0612731 0.0571455 0.0541907 0.0272438 0.0209997 0.0121614 0.0125095 0.00743633 0.029182 0.0755961	DRUG1 tablets coadministered with DRUG0 - and DRUG2 -containing oral DRUG0 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	4	0.0972445 0.0997451 0.0794789 0.0468888 0.020761 0.0119625 0.0102319 0.0261025 0.0752432 0.0909635 0.0799287 0.0523566 0.0724701 0.0619559 0.0302648 0.0204637 0.0146314 0.0119905 0.00691615 0.0259177 0.0644826	DRUG1 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG2 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	4	0.0677473 0.0562809 0.0561701 0.033687 0.0149264 0.00599874 0.00529109 0.0116121 0.0138394 0.0193409 0.0530775 0.0840409 0.118921 0.155716 0.0889631 0.0603216 0.0397624 0.0370594 0.0077769 0.0162681 0.0531994	DRUG1 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG0 produced an overall mean increase in DRUG2 and DRUG0 levels;
4	4	0.070007 0.0601664 0.0605222 0.036279 0.0156622 0.00631243 0.00551161 0.0119641 0.0140467 0.0203477 0.0567984 0.0893074 0.121002 0.125166 0.0582492 0.0362252 0.0231294 0.0169104 0.0260261 0.0627365 0.0836309	DRUG1 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG0 produced an overall mean increase in DRUG0 and DRUG2 levels;
4	4	0.0802482 0.175143 0.136255 0.118562 0.0648296 0.0467271 0.0176581 0.0277168 0.0137236 0.0185621 0.0282395 0.0437304 0.0406247 0.0410653 0.0204379 0.0161413 0.00966904 0.00988715 0.00602609 0.0232158 0.0615376	DRUG0 tablets coadministered with DRUG1 - and DRUG2 -containing oral DRUG0 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	4	0.0639572 0.143061 0.105969 0.0902805 0.0379979 0.0195376 0.00868529 0.0216332 0.0692157 0.0626815 0.0566477 0.0392387 0.0624694 0.0542791 0.028439 0.0202249 0.0146466 0.0116006 0.00652568 0.0242052 0.0587039	DRUG0 tablets coadministered with DRUG1 - and DRUG0 -containing oral DRUG2 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	4	0.0494867 0.112559 0.0902241 0.0867926 0.0337562 0.00893824 0.00493257 0.00900355 0.0118215 0.0177593 0.0415707 0.0827718 0.1069 0.103894 0.0478042 0.0283694 0.0190992 0.0130376 0.0192344 0.0476191 0.0644262	DRUG0 tablets coadministered with DRUG1 - and DRUG0 -containing oral DRUG0 produced an overall mean increase in DRUG0 and DRUG2 levels;
4	4	0.0495563 0.101168 0.0834285 0.0619243 0.0283658 0.0158516 0.0112307 0.0448779 0.0681065 0.0665094 0.0560687 0.0526155 0.0815845 0.0694941 0.0354196 0.0257896 0.0183733 0.0146669 0.00837948 0.0310017 0.0755877	DRUG0 tablets coadministered with DRUG0 - and DRUG1 -containing oral DRUG2 produced an overall mean increase in DRUG0 and DRUG0 levels;
4	4	0.0357125 0.0693878 0.056507 0.0415362 0.0198073 0.0105265 0.00709879 0.0248476 0.0208782 0.0294988 0.0339638 0.0904897 0.124648 0.145646 0.0913847 0.0518369 0.0404478 0.0356511 0.00808728 0.0142952 0.0477491	DRUG0 tablets coadministered with DRUG0 - and DRUG1 -containing oral DRUG0 produced an overall mean increase in DRUG2 and DRUG0 levels;
4	4	0.0360284 0.0660189 0.0538168 0.039556 0.0203186 0.00794371 0.00698704 0.0241964 0.0528574 0.0562532 0.108436 0.0571748 0.0675031 0.0832249 0.0817213 0.0600014 0.0526505 0.037853 0.00943463 0.0187195 0.0593044	DRUG0 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG1 produced an overall mean increase in DRUG2 and DRUG0 levels;
4	4	0.0353691 0.064737 0.0525618 0.0385979 0.0198978 0.00774396 0.00679785 0.0233191 0.0510366 0.0543926 0.107738 0.059959 0.0759016 0.072457 0.0547896 0.0485555 0.0421 0.0228257 0.0270631 0.0598807 0.0742756	DRUG0 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG1 produced an overall mean increase in DRUG0 and DRUG2 levels;
4	4	0.0201393 0.0278229 0.0235558 0.0154417 0.00990844 0.00388075 0.00283723 0.00764627 0.00787408 0.0107259 0.0346577 0.0644713 0.0734182 0.0924986 0.088743 0.0882432 0.0813641 0.153869 0.0418784 0.0783451 0.0726787	DRUG0 tablets coadministered with DRUG0 - and DRUG0 -containing oral DRUG0 produced an overall mean increase in DRUG1 and DRUG2 levels;
3	4	0.0194567 0.00571094 0.0104731 0.0197228 0.0225549 0.0242282 0.0471405 0.148106 0.0828854 0.0445181 0.0643374 0.0255289 0.0716133 0.0619732 0.105694 0.0325309 0.0536717 0.0789716 0.0808814	however , in some patients there were decreases up to 47% and 33% of DRUG1 and DRUG2 levels .
3	4	0.0389507 0.0281093 0.0277097 0.0456897 0.0454429 0.0266099 0.0390377 0.0710043 0.0374887 0.0479446 0.0547175 0.120793 0.0459802 0.0546449 0.0348789 0.0153209 0.011619 0.0164049 0.0141701 0.011501 0.0362713 0.0217925 0.016055 0.0156652 0.0209232 0.0467558 0.0545194	The data presently available indicate that the decreases in some individual DRUG1 and DRUG2 AUC values with DRUG0 treatment are likely the result of random variation .
4	4	0.0253446 0.0182599 0.0193075 0.0333894 0.0330683 0.0154596 0.0252819 0.0572277 0.0227979 0.0321218 0.0749959 0.0682726 0.0192782 0.0391409 0.101099 0.0613538 0.0820673 0.0410537 0.0192835 0.0204131 0.0399266 0.0254982 0.0174296 0.0158268 0.0175102 0.0354941 0.0390983	The data presently available indicate that the decreases in some individual DRUG1 and DRUG0 AUC values with DRUG2 treatment are likely the result of random variation .
4	4	0.0281737 0.0203259 0.0225787 0.0373508 0.0327534 0.0130219 0.0177714 0.041234 0.0161308 0.0191132 0.0396894 0.0226762 0.019223 0.0588333 0.134829 0.0816712 0.0853674 0.0432069 0.0213154 0.0225895 0.0456649 0.029502 0.0198622 0.0181444 0.0202865 0.0422701 0.0464144	The data presently available indicate that the decreases in some individual DRUG0 and DRUG1 AUC values with DRUG2 treatment are likely the result of random variation .
3	3	0.0312637 0.0393511 0.0473322 0.0492206 0.0356105 0.0589145 0.0715123 0.0883961 0.074259 0.087477 0.0701477 0.0260947 0.00453384 0.00503174 0.00360881 0.0127082 0.0249871 0.0221448 0.0192923 0.00795342 0.0110996 0.00869962 0.00672243 0.0169032 0.0126389 0.00764438 0.00766932 0.00653304 0.0229019 0.064462 0.0548863	While there is evidence that DRUG1 can inhibit the metabolism of DRUG2 and DRUG0 , there is no evidence that DRUG0 is a net inducer of DRUG0 or DRUG0 metabolism .
3	3	0.0321737 0.0392314 0.0455027 0.0482384 0.0348434 0.0573584 0.0652321 0.0794687 0.0589985 0.0757596 0.0469401 0.0215376 0.0157187 0.0228443 0.00543108 0.0145569 0.032923 0.0277293 0.0227064 0.00906535 0.0120707 0.00928978 0.00718613 0.0187341 0.0139374 0.00842933 0.00841687 0.00719933 0.025389 0.0719135 0.0611741	While there is evidence that DRUG1 can inhibit the metabolism of DRUG0 and DRUG2 , there is no evidence that DRUG0 is a net inducer of DRUG0 or DRUG0 metabolism .
4	4	0.0233044 0.0309337 0.0401117 0.0439325 0.0330606 0.0665431 0.0556513 0.0339077 0.0243759 0.0270451 0.0125632 0.00676174 0.00299551 0.00568885 0.00448091 0.0206732 0.0299829 0.0281059 0.0290089 0.013568 0.0198697 0.0244676 0.0282154 0.0738786 0.0587599 0.0547574 0.0398158 0.0191605 0.0223506 0.0683749 0.0576544	While there is evidence that DRUG1 can inhibit the metabolism of DRUG0 and DRUG0 , there is no evidence that DRUG0 is a net inducer of DRUG2 or DRUG0 metabolism .
4	4	0.0237327 0.0314556 0.0406963 0.0445673 0.0336552 0.0673747 0.0576816 0.0356433 0.0257413 0.0284336 0.0132734 0.00699599 0.0031002 0.00587167 0.00474149 0.0225485 0.0329463 0.0309575 0.0314412 0.0149475 0.0218897 0.025583 0.0272093 0.0549539 0.0382523 0.0222912 0.0148273 0.0228792 0.0473272 0.101376 0.0676057	While there is evidence that DRUG1 can inhibit the metabolism of DRUG0 and DRUG0 , there is no evidence that DRUG0 is a net inducer of DRUG0 or DRUG2 metabolism .
4	4	0.0109276 0.0099684 0.0135635 0.0179132 0.0190591 0.0613729 0.127288 0.0729126 0.0604727 0.0930774 0.0643052 0.0916574 0.0212414 0.0288622 0.00618975 0.0156933 0.0269119 0.0221316 0.0190495 0.00766774 0.0107514 0.00829711 0.00617637 0.0156904 0.0119643 0.00713406 0.00718774 0.00616605 0.0217495 0.0615821 0.0530351	While there is evidence that DRUG0 can inhibit the metabolism of DRUG1 and DRUG2 , there is no evidence that DRUG0 is a net inducer of DRUG0 or DRUG0 metabolism .
4	4	0.0101175 0.0089868 0.0119246 0.016047 0.0162448 0.0549078 0.106728 0.0675876 0.0452122 0.0622599 0.0377879 0.0304858 0.00484016 0.00656962 0.00765408 0.0333691 0.0238669 0.0366751 0.0541082 0.0499883 0.0344876 0.0168769 0.0115015 0.0308539 0.0213271 0.0134811 0.0111274 0.00943565 0.0288952 0.0769325 0.0597201	While there is evidence that DRUG0 can inhibit the metabolism of DRUG1 and DRUG0 , there is no evidence that DRUG2 is a net inducer of DRUG0 or DRUG0 metabolism .
4	4	0.00871011 0.00776976 0.0102945 0.0138053 0.0139403 0.0467442 0.0961326 0.0638559 0.0432539 0.0625719 0.0412193 0.0291028 0.00367955 0.00517029 0.00473 0.0186722 0.025644 0.0258808 0.0291356 0.0167787 0.0231555 0.028118 0.0278561 0.0540573 0.0361823 0.0212409 0.0143596 0.0221237 0.0454209 0.0964171 0.063977	While there is evidence that DRUG0 can inhibit the metabolism of DRUG1 and DRUG0 , there is no evidence that DRUG0 is a net inducer of DRUG0 or DRUG2 metabolism .
4	4	0.0119101 0.0106111 0.013768 0.0178835 0.0168632 0.0487283 0.0862823 0.0480363 0.03237 0.0489112 0.0283205 0.0187569 0.0119738 0.0462789 0.00824328 0.0307876 0.0251187 0.0378163 0.0588659 0.0532721 0.0365962 0.0181052 0.0120943 0.033864 0.023333 0.0147488 0.0121868 0.0103365 0.0317098 0.0854356 0.0667919	While there is evidence that DRUG0 can inhibit the metabolism of DRUG0 and DRUG1 , there is no evidence that DRUG2 is a net inducer of DRUG0 or DRUG0 metabolism .
4	4	0.0102525 0.00917114 0.0119196 0.0154372 0.0146354 0.0417646 0.0777529 0.0453118 0.0270424 0.0428137 0.0239432 0.0182604 0.0110786 0.0342544 0.00491817 0.0154652 0.0240336 0.0253303 0.0281816 0.0149426 0.0218136 0.0277592 0.0306847 0.0808969 0.061699 0.0570805 0.0424483 0.0205662 0.0242437 0.0734036 0.062895	While there is evidence that DRUG0 can inhibit the metabolism of DRUG0 and DRUG1 , there is no evidence that DRUG0 is a net inducer of DRUG2 or DRUG0 metabolism .
4	4	0.00959593 0.00821049 0.0096212 0.0112662 0.00955703 0.0225088 0.0381079 0.0155038 0.00837895 0.0181998 0.00539595 0.00435071 0.00214929 0.0046479 0.00427356 0.023381 0.04225 0.0489577 0.0635432 0.0531187 0.044595 0.0276434 0.035087 0.110601 0.0618244 0.0561836 0.0464689 0.0233508 0.0343087 0.0887194 0.0681997	While there is evidence that DRUG0 can inhibit the metabolism of DRUG0 and DRUG0 , there is no evidence that DRUG1 is a net inducer of DRUG2 or DRUG0 metabolism .
4	4	0.00987806 0.00844812 0.00987073 0.01153 0.0097515 0.022863 0.0387407 0.0157175 0.00851162 0.0185292 0.00546984 0.00438329 0.00217126 0.00467813 0.00425295 0.023227 0.0421874 0.0486395 0.0623547 0.0505239 0.045092 0.0296197 0.0397987 0.0939923 0.0555791 0.0354164 0.0178957 0.0229769 0.0546796 0.126902 0.0763196	While there is evidence that DRUG0 can inhibit the metabolism of DRUG0 and DRUG0 , there is no evidence that DRUG1 is a net inducer of DRUG0 or DRUG2 metabolism .
2	4	0.094896 0.0674677 0.0650788 0.0947854 0.0279797 0.0442326 0.082249 0.088459 0.0540031 0.049594 0.0422444 0.0566532 0.0432175 0.0269768 0.0148644 0.00703025 0.0125915 0.00791575 0.0269119 0.092849	Concurrent use of DRUG1 and other DRUG2 may increase the CNS depressant effects of DRUG0 or these other medications .
2	2	0.0768352 0.0836883 0.0840991 0.0807139 0.0143285 0.0219201 0.048419 0.108341 0.0492442 0.0608036 0.0478733 0.0567802 0.0528396 0.0678722 0.034138 0.0129615 0.0108304 0.00694584 0.0185208 0.0628458	Concurrent use of DRUG1 and other DRUG0 may increase the CNS depressant effects of DRUG2 or these other medications .
2	2	0.0890739 0.102541 0.0809894 0.0315684 0.0164832 0.0239041 0.0971137 0.137436 0.0509628 0.0577646 0.0400764 0.0484234 0.0446847 0.0557185 0.0276813 0.0103196 0.00883466 0.00574816 0.0157998 0.0548765	Concurrent use of DRUG0 and other DRUG1 may increase the CNS depressant effects of DRUG2 or these other medications .
0	0	0.26622 0.13894 0.16692 0.156941 0.0607516 0.0110488 0.00933333 0.00584643 0.00686684 0.00539898 0.00759748 0.00591701 0.00925721 0.0314744 0.117487	DRUG1 can interact with DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
0	0	0.281697 0.157492 0.17808 0.134849 0.0287843 0.0175971 0.0280797 0.00587076 0.00592216 0.00431093 0.00618121 0.00471258 0.00758427 0.0275777 0.111261	DRUG1 can interact with DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
0	0	0.283815 0.157838 0.178174 0.129272 0.0233775 0.0086942 0.0114254 0.0124789 0.0256722 0.00575787 0.00689766 0.00503884 0.00772365 0.0279013 0.115933	DRUG1 can interact with DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
0	0	0.28559 0.158829 0.179989 0.128834 0.0227004 0.00781698 0.00890011 0.00582962 0.00963387 0.0113306 0.0271741 0.00683388 0.00784969 0.0259378 0.11275	DRUG1 can interact with DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
0	0	0.278921 0.143672 0.164711 0.115577 0.0221659 0.00785132 0.00806634 0.00563553 0.00723775 0.00622426 0.00944022 0.0121463 0.0307492 0.0771953 0.110405	DRUG1 can interact with DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.151369 0.246182 0.15285 0.0531572 0.0136084 0.00531594 0.00737759 0.00526571 0.0122965 0.0144754 0.0739286 0.0210813 0.0271518 0.0882728 0.127668	DRUG0 can interact with DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
2	2	0.109543 0.110055 0.170427 0.142926 0.185889 0.03681 0.0106863 0.00606417 0.00630339 0.00442189 0.0060759 0.00466672 0.00776782 0.00702674 0.0186088 0.0249784 0.14775	DRUG1 are capable of potentiating DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , etc.)
2	2	0.119123 0.107628 0.173156 0.118435 0.145245 0.0280494 0.0119456 0.0134938 0.0266615 0.00592018 0.00651218 0.00474522 0.00773604 0.00714158 0.0187872 0.0272686 0.178151	DRUG1 are capable of potentiating DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , etc.)
2	2	0.124772 0.106817 0.17003 0.113668 0.138662 0.0241675 0.008682 0.00733691 0.0119844 0.0124591 0.0259489 0.00599212 0.008165 0.00699466 0.0183659 0.0274995 0.188455	DRUG1 are capable of potentiating DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , etc.)
2	2	0.125146 0.105422 0.167295 0.111695 0.13587 0.0227196 0.00804427 0.00638309 0.00890868 0.00637878 0.0113458 0.012705 0.0299319 0.00829779 0.0181681 0.0270456 0.194644	DRUG1 are capable of potentiating DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , etc.)
2	2	0.138594 0.105832 0.162887 0.107452 0.130263 0.0227535 0.00850719 0.00683575 0.00858219 0.00629404 0.00845572 0.00691963 0.0112642 0.0183724 0.0643011 0.0252214 0.167464	DRUG1 are capable of potentiating DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , etc.)
4	4	0.0752998 0.0947064 0.230284 0.135626 0.166293 0.0638549 0.0152217 0.0129584 0.0178415 0.00460964 0.00527652 0.00413713 0.00631915 0.00602398 0.0144252 0.0206705 0.126452	DRUG0 are capable of potentiating DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , etc.)
4	4	0.0782307 0.0973801 0.227365 0.132439 0.159511 0.0657444 0.0119456 0.0120482 0.00971861 0.00999727 0.0200416 0.00469696 0.00632998 0.00560769 0.0131717 0.0199499 0.125822	DRUG0 are capable of potentiating DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , etc.)
4	4	0.078435 0.0969857 0.225766 0.130805 0.158521 0.0648437 0.011132 0.0109074 0.0074833 0.00609631 0.00823108 0.0100904 0.0230269 0.00635224 0.0131173 0.0198417 0.128364	DRUG0 are capable of potentiating DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , etc.)
4	4	0.0868716 0.103825 0.230576 0.123031 0.133359 0.0604573 0.0124538 0.0114945 0.0070683 0.00603236 0.00625157 0.00661559 0.00873699 0.0160063 0.0500805 0.0188265 0.118314	DRUG0 are capable of potentiating DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , etc.)
4	4	0.0852604 0.186101 0.0917986 0.259596 0.0476088 0.133884 0.195751	as well as DRUG1 and DRUG2 .
2	2	0.0750898 0.159007 0.117896 0.0983774 0.0992721 0.0703618 0.112446 0.0532215 0.0293388 0.0302839 0.0119482 0.0239316 0.00693382 0.0108228 0.0220964 0.0789728	The CNS-depressant effect of DRUG1 is additive with that of other DRUG2 , including DRUG0 .
2	2	0.0781082 0.16132 0.120709 0.100151 0.102711 0.0690517 0.103795 0.0473126 0.0232712 0.0237724 0.0077272 0.00638424 0.0076921 0.0232595 0.0528834 0.0718521	The CNS-depressant effect of DRUG1 is additive with that of other DRUG0 , including DRUG2 .
4	4	0.0441611 0.061062 0.0405948 0.0425455 0.0687791 0.13048 0.159948 0.0944188 0.0437052 0.0363911 0.0181442 0.0702334 0.0163453 0.0336535 0.056374 0.0831648	The CNS-depressant effect of DRUG0 is additive with that of other DRUG1 , including DRUG2 .
2	4	0.0793402 0.0866479 0.0462344 0.0616953 0.0881593 0.0652506 0.0787056 0.0648424 0.036712 0.0431022 0.0468379 0.0543606 0.0282755 0.00585721 0.00606974 0.00476474 0.00868209 0.0200362 0.0729228 0.0349151 0.0665883	Such occurrences have been reported when DRUG1 was administered to patients on DRUG2 , DRUG0 , or DRUG0 -like drugs .
2	4	0.0876899 0.0959772 0.05058 0.0652817 0.095775 0.0693064 0.088987 0.0662645 0.0387765 0.0436601 0.0437793 0.0382009 0.0159484 0.00972612 0.0170787 0.00488627 0.00799325 0.014213 0.0509193 0.0292123 0.0657441	Such occurrences have been reported when DRUG1 was administered to patients on DRUG0 , DRUG2 , or DRUG0 -like drugs .
2	4	0.0773691 0.0845713 0.0452428 0.0594114 0.0863252 0.0649299 0.0828363 0.0630517 0.0354535 0.041768 0.042864 0.0362394 0.0139289 0.00577567 0.00751376 0.00954005 0.0203392 0.0427125 0.061891 0.0385794 0.079657	Such occurrences have been reported when DRUG1 was administered to patients on DRUG0 , DRUG0 , or DRUG2 -like drugs .
3	4	0.0686783 0.0933815 0.0792537 0.0300832 0.0223161 0.0465368 0.0425776 0.0744072 0.0480825 0.233408 0.105315 0.0530119 0.047313 0.0275855 0.0280499	Interactions for DRUG1 ( DRUG0 ) : DRUG2 - impairs the intestinal absorption of DRUG0
4	4	0.041697 0.0590537 0.0352534 0.012262 0.00600384 0.00807181 0.0125925 0.0168033 0.0251272 0.184541 0.160678 0.113969 0.132769 0.10666 0.0845185	Interactions for DRUG1 ( DRUG0 ) : DRUG0 - impairs the intestinal absorption of DRUG2
3	4	0.0667859 0.0621491 0.0351559 0.0367998 0.09207 0.0580582 0.0438184 0.0694822 0.0445454 0.234448 0.104786 0.0524679 0.0456317 0.0265203 0.0272809	Interactions for DRUG0 ( DRUG1 ) : DRUG2 - impairs the intestinal absorption of DRUG0
3	3	0.0422867 0.0348669 0.0164674 0.00962991 0.016651 0.0211857 0.0293297 0.0566261 0.0351256 0.160261 0.123041 0.115153 0.120167 0.124048 0.0951612	Interactions for DRUG0 ( DRUG0 ) : DRUG1 - impairs the intestinal absorption of DRUG2
3	3	0.124024 0.0472648 0.0899139 0.067621 0.21213 0.114308 0.135669 0.111736 0.0723169 0.0250153	DRUG1 - concurrent use decreases gastrointestinal absorption of DRUG2 ;
2	2	0.0797813 0.108386 0.15046 0.109934 0.0479507 0.118444 0.074751 0.0640343 0.0882712 0.0903104 0.0676781	requirements for DRUG1 may be increased in patients receiving DRUG2 .
1	1	0.149384 0.0374839 0.046446 0.0461488 0.0489936 0.0263391 0.0440272 0.0460315 0.0736906 0.0487699 0.0433566 0.044485 0.0472893 0.0595341 0.0496659 0.0467413 0.0746982 0.066915	DRUG1 should be administered with caution to patients taking DRUG2 because of the possibility of conduction disturbances .
4	4	0.0145397 0.0182181 0.0180589 0.017406 0.0420026 0.0250031 0.032513 0.0257566 0.0264351 0.0237159 0.0622087 0.029622 0.0377947 0.0778986 0.0667305 0.0315036 0.0225837 0.0198819 0.015915 0.0151618 0.0813443 0.0330751 0.0908952 0.0549125 0.0329676 0.0838558	These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g. , DRUG1 , inhaled DRUG2 ) .
4	4	0.0204918 0.0252461 0.0288156 0.0259944 0.0240207 0.0152319 0.005992 0.00647424 0.0058129 0.00285584 0.00759385 0.00722128 0.00708511 0.0126055 0.0126048 0.0102411 0.0066998 0.00716284 0.0170195 0.0243807 0.0313614 0.0206144 0.0111551 0.0126699 0.00987942 0.0340792 0.0430482 0.0580845 0.0546379 0.0509949 0.0413073 0.0251733 0.0269609 0.0826556 0.0190887 0.0475203 0.0235713 0.00638586 0.0083337 0.00195752 0.00201103 0.00158136 0.00193578 0.00153893 0.0019341 0.00150346 0.00193171 0.00148607 0.00194025 0.00148723 0.0019695 0.00150893 0.00202938 0.0015575 0.00213815 0.00164842 0.00235931 0.00190866 0.0030247 0.00223913 0.00405215 0.0146661 0.0605191	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0202669 0.0249738 0.0284943 0.0257072 0.0237533 0.0150593 0.00592643 0.00640361 0.00574844 0.00282308 0.00750806 0.00713687 0.00700086 0.0124429 0.0124444 0.0101047 0.00662098 0.00707231 0.0167862 0.0239759 0.0308175 0.0202316 0.0109903 0.0124509 0.00960462 0.0331556 0.0417194 0.0561358 0.0527721 0.0488557 0.0395346 0.0238744 0.0281525 0.0878677 0.0195428 0.0492826 0.020234 0.00675904 0.00460203 0.00425769 0.00892702 0.00183187 0.00209351 0.00162968 0.00201402 0.00159158 0.00201008 0.00156584 0.00202016 0.00156111 0.00204895 0.00157862 0.00210723 0.00162412 0.00221401 0.00171307 0.00243323 0.00197744 0.00311534 0.00234897 0.00430677 0.0153178 0.0628791	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204436 0.0251918 0.0287412 0.0259297 0.0239582 0.0151885 0.00597756 0.00645878 0.00579782 0.00284706 0.0075715 0.0071964 0.00705837 0.0125417 0.012543 0.0101834 0.00667392 0.0071271 0.0169114 0.0241402 0.0310179 0.0203553 0.0110625 0.0125252 0.00963614 0.0332237 0.0416061 0.0557327 0.0522964 0.0483114 0.0390382 0.0233856 0.0278291 0.0867995 0.0192345 0.0484044 0.0194778 0.00614624 0.00354559 0.00295791 0.00364733 0.00411376 0.00853245 0.00182204 0.00213785 0.00164316 0.00205798 0.00161792 0.00206704 0.00160644 0.00209672 0.00162004 0.00215496 0.00166412 0.00226291 0.00175435 0.0024878 0.00202164 0.00317521 0.00240809 0.00439148 0.0156973 0.063952	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204453 0.025194 0.028743 0.0259315 0.0239596 0.0151892 0.00597788 0.00645909 0.00579802 0.00284706 0.00757128 0.00719593 0.00705744 0.0125389 0.0125401 0.0101808 0.00667266 0.00712496 0.0169042 0.0241241 0.0309934 0.0203357 0.0110541 0.0125129 0.00961765 0.0331471 0.0414463 0.0554415 0.0519997 0.0479961 0.0387736 0.0231689 0.0276884 0.0866502 0.0191367 0.048241 0.0192452 0.0061002 0.00340532 0.00278992 0.00291494 0.00292391 0.00356475 0.00407166 0.0084957 0.00182185 0.0021676 0.00165029 0.0020917 0.00163567 0.00211539 0.00164081 0.00217182 0.0016796 0.00227788 0.00176724 0.00250298 0.00203185 0.00318951 0.00242457 0.00439831 0.0158367 0.0644259	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204434 0.0251916 0.0287401 0.0259289 0.0239571 0.0151875 0.00597723 0.00645837 0.00579735 0.0028467 0.00757021 0.00719483 0.00705616 0.0125362 0.0125374 0.0101785 0.0066713 0.00712321 0.0168992 0.0241148 0.0309794 0.0203242 0.0110486 0.0125052 0.0096079 0.0331047 0.0413506 0.0552572 0.051801 0.0477811 0.0385891 0.0230153 0.027549 0.0864021 0.0190099 0.0478181 0.018914 0.00601714 0.00333748 0.00283408 0.00284555 0.00277689 0.00286071 0.00284996 0.0035787 0.00406429 0.00865377 0.0018373 0.00220886 0.00166804 0.00214134 0.00166622 0.00218759 0.00169522 0.00229008 0.00177685 0.0025129 0.00203475 0.00319493 0.00242906 0.00437393 0.0158957 0.0648012	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204388 0.0251858 0.0287333 0.0259228 0.0239515 0.0151839 0.00597581 0.00645682 0.00579596 0.00284601 0.00756831 0.00719297 0.00705424 0.0125326 0.0125337 0.0101755 0.00666942 0.00712107 0.0168937 0.0241057 0.0309663 0.0203137 0.0110434 0.0124981 0.0096001 0.033071 0.0412748 0.0551098 0.051638 0.0476042 0.0384334 0.0228842 0.0274187 0.0861255 0.018892 0.0473516 0.0185988 0.00593206 0.00328329 0.00281189 0.00280358 0.00283042 0.00280714 0.00269649 0.00286147 0.00275997 0.00359489 0.00406883 0.00887309 0.0018671 0.00226889 0.00170281 0.00221851 0.00172212 0.00230767 0.00179302 0.00252643 0.00204021 0.00320157 0.00243523 0.00434071 0.0159278 0.0651636	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204315 0.0251768 0.0287229 0.0259135 0.0239428 0.0151784 0.00597365 0.00645448 0.00579385 0.00284497 0.0075655 0.00719028 0.00705151 0.0125275 0.0125287 0.0101713 0.00666684 0.00711822 0.0168867 0.0240946 0.0309508 0.0203018 0.0110375 0.0124905 0.00959208 0.0330372 0.0412028 0.0549731 0.0514871 0.0474419 0.038288 0.022763 0.0272946 0.0858421 0.0187898 0.0469222 0.0183302 0.00585725 0.0032381 0.00277628 0.00276521 0.00281413 0.00277252 0.00275181 0.00281296 0.00259511 0.00286274 0.00268285 0.00361375 0.00408453 0.00916042 0.00191522 0.00235743 0.00176358 0.00234427 0.00182282 0.00254824 0.00205369 0.00321338 0.0024491 0.00430148 0.0159444 0.0655201	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204215 0.0251645 0.0287089 0.0259008 0.0239311 0.0151709 0.00597072 0.00645131 0.005791 0.00284356 0.00756173 0.00718668 0.00704789 0.012521 0.0125221 0.010166 0.00666346 0.00711454 0.0168777 0.0240807 0.0309319 0.0202878 0.0110306 0.0124818 0.00958319 0.0330009 0.0411303 0.0548402 0.0513423 0.0472884 0.0381492 0.0226492 0.027177 0.0855643 0.018704 0.046548 0.0181103 0.00579569 0.00320094 0.00274246 0.00273142 0.00278216 0.00273786 0.00274118 0.00278164 0.00264571 0.0028151 0.00250659 0.00286712 0.00262716 0.00364368 0.00411655 0.00955173 0.00199263 0.00249832 0.00187035 0.00259379 0.00208165 0.00323393 0.00247726 0.004255 0.0159383 0.0658561	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0204096 0.0251498 0.028692 0.0258857 0.0239172 0.0151621 0.00596723 0.00644753 0.0057876 0.00284187 0.00755722 0.00718237 0.00704357 0.0125132 0.0125143 0.0101596 0.00665946 0.00711017 0.0168671 0.0240643 0.0309099 0.0202717 0.0110229 0.0124722 0.00957326 0.0329612 0.0410548 0.054707 0.0512001 0.0471405 0.038014 0.02254 0.0270667 0.0853046 0.018643 0.0462537 0.0179495 0.00575037 0.00317136 0.00271504 0.00270322 0.00275187 0.00270652 0.00271501 0.00274908 0.00263885 0.00278527 0.00254918 0.00281833 0.00244038 0.00287916 0.00258949 0.00368602 0.00417076 0.0100991 0.00212655 0.00277796 0.00213293 0.00327987 0.00253021 0.00419316 0.0158936 0.0661296	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.020395 0.0251319 0.0286714 0.0258674 0.0239002 0.0151513 0.00596298 0.00644293 0.00578344 0.0028398 0.00755167 0.00717708 0.00703823 0.0125035 0.0125046 0.0101517 0.00665455 0.00710476 0.0168539 0.0240438 0.0308825 0.0202521 0.0110138 0.0124609 0.00956132 0.032914 0.040971 0.0545672 0.0510558 0.0469946 0.0378792 0.0224332 0.0269676 0.0850955 0.0186311 0.0461108 0.0178728 0.00572673 0.00315066 0.00269721 0.00268077 0.0027306 0.00268084 0.00269264 0.00271957 0.00262018 0.00275431 0.00254543 0.00278867 0.0024747 0.00282691 0.00239158 0.00289706 0.00256191 0.00374381 0.00428633 0.0110642 0.00242657 0.00348056 0.00262666 0.00411688 0.0157329 0.0661883	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0204157 0.0251575 0.0287006 0.025894 0.0239249 0.0151668 0.00596905 0.00644947 0.00578931 0.00284259 0.00755901 0.00718405 0.00704481 0.012515 0.012516 0.0101611 0.0066611 0.00711166 0.0168703 0.0240645 0.0309073 0.0202652 0.0110237 0.0124705 0.00956329 0.0329163 0.0409342 0.0544827 0.0509661 0.0469036 0.0377742 0.022339 0.0268792 0.0848622 0.0186332 0.0460196 0.017971 0.00577468 0.0031466 0.00269495 0.00266564 0.00272298 0.00266226 0.00268329 0.00269763 0.00261006 0.00272914 0.00253824 0.00276273 0.00248042 0.00280367 0.00242986 0.0028523 0.00237355 0.00294205 0.002562 0.00383485 0.00455958 0.0132096 0.0031877 0.00408938 0.0149753 0.0651028	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0198599 0.0244747 0.0279223 0.0251976 0.023284 0.0147598 0.00580876 0.00627651 0.00563388 0.0027658 0.00735632 0.00699249 0.00685597 0.0121826 0.0121831 0.00989318 0.0064894 0.00692805 0.0164366 0.0234268 0.0300856 0.0197125 0.0107573 0.0121666 0.00928998 0.0319056 0.0394024 0.0521585 0.0486778 0.0447323 0.0357416 0.0211465 0.0254873 0.0800946 0.0188132 0.0446457 0.0181773 0.00552616 0.0027633 0.00249885 0.00229111 0.0025229 0.0022712 0.00249386 0.00228313 0.00242218 0.00229078 0.00234077 0.00229649 0.00226489 0.00230565 0.00219521 0.00232265 0.00214082 0.002372 0.00220343 0.00262003 0.00288139 0.00397296 0.00601552 0.012412 0.0434424 0.0731278	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG1 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0233878 0.0288136 0.0328662 0.0296662 0.0274268 0.0173587 0.00681196 0.00734633 0.0065838 0.00320713 0.00844938 0.00798973 0.00772705 0.0135561 0.0134712 0.0109238 0.00713626 0.00745593 0.0173454 0.0240099 0.029857 0.0194865 0.0107358 0.0120495 0.00880345 0.0293039 0.0369876 0.0484939 0.0479748 0.0494826 0.0549302 0.0312598 0.0140651 0.00997387 0.00653303 0.0123942 0.0066816 0.00169216 0.00211884 0.00123519 0.00213285 0.00130413 0.00227743 0.00135036 0.0023709 0.00139215 0.00245093 0.00143927 0.00254668 0.0015085 0.00271436 0.00165391 0.00310872 0.00203643 0.00410121 0.00320299 0.00714905 0.00849967 0.0473299 0.0131825 0.0170238 0.0538661 0.081766	While no formal drug interaction studies have been performed , the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies : DRUG0 , artificial tears , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
2	2	0.106676 0.0825067 0.0835263 0.0370722 0.109417 0.149814 0.0559097 0.0863677 0.0455791 0.0761001 0.0820683 0.0645037 0.0204594	When administered concurrently , DRUG1 may increase the effects of oral DRUG2 ;
4	4	0.158051 0.0778351 0.0685605 0.109152 0.0721155 0.0793792 0.11203 0.106001 0.0596116 0.0142295 0.0308829 0.112152	DRUG1 has been studied on a background of DRUG2 and DRUG0 .
4	4	0.164839 0.078244 0.0702693 0.102421 0.0690388 0.0763233 0.0932351 0.0560195 0.0321391 0.0329502 0.0903082 0.134213	DRUG1 has been studied on a background of DRUG0 and DRUG2 .
4	4	0.0543767 0.0687321 0.0769399 0.0754493 0.0415807 0.0588116 0.101621 0.105132 0.163177 0.0397484 0.0959444 0.118486	DRUG0 has been studied on a background of DRUG1 and DRUG2 .
2	2	0.077492 0.0763736 0.074254 0.0870171 0.0245922 0.0802215 0.0656418 0.0699238 0.0268619 0.00607791 0.0094487 0.00735179 0.0242281 0.0333348 0.053176 0.0344262 0.022886 0.0273173 0.0146522 0.0175796 0.0165959 0.0086843 0.00938025 0.00654292 0.0195157 0.0359257 0.0704985	The use of DRUG1 , in combination with DRUG2 and DRUG0 , has been associated with an increase in bleeding compared to DRUG0 and DRUG0 alone (see
2	2	0.0726472 0.0669341 0.0689011 0.0890216 0.0230588 0.063143 0.0637573 0.053966 0.0262404 0.0221136 0.0323877 0.00876372 0.0235133 0.0316188 0.0569677 0.0348715 0.0238171 0.0298618 0.0159531 0.018549 0.0174646 0.00906727 0.00967139 0.00678874 0.0201933 0.0371316 0.0735962	The use of DRUG1 , in combination with DRUG0 and DRUG2 , has been associated with an increase in bleeding compared to DRUG0 and DRUG0 alone (see
4	4	0.0535268 0.0597201 0.0535438 0.0446076 0.00781706 0.0184226 0.0194343 0.0179919 0.00826745 0.00441857 0.0111417 0.0111155 0.0502931 0.0629811 0.0695568 0.06959 0.0520779 0.0624145 0.0346098 0.0572623 0.0579129 0.0465524 0.0307784 0.00597936 0.0105489 0.0262423 0.0531928	The use of DRUG1 , in combination with DRUG0 and DRUG0 , has been associated with an increase in bleeding compared to DRUG2 and DRUG0 alone (see
4	4	0.0576534 0.0641937 0.0574056 0.0483188 0.00864529 0.0208902 0.022241 0.0203677 0.00901525 0.00483894 0.0120421 0.0121856 0.0552687 0.0688274 0.0741904 0.0677399 0.0477511 0.0516053 0.0282634 0.0416154 0.0438338 0.0178009 0.0107319 0.0131306 0.0345415 0.0407776 0.0661243	The use of DRUG1 , in combination with DRUG0 and DRUG0 , has been associated with an increase in bleeding compared to DRUG0 and DRUG2 alone (see
4	4	0.0412246 0.0629871 0.0445187 0.0287458 0.0218204 0.0515935 0.0741942 0.0905719 0.125167 0.0315901 0.0375996 0.00925284 0.024615 0.0311687 0.054882 0.0297591 0.0198389 0.0266779 0.0141445 0.0167125 0.0159102 0.00829809 0.00896605 0.00637304 0.0188829 0.0350512 0.069454	The use of DRUG0 , in combination with DRUG1 and DRUG2 , has been associated with an increase in bleeding compared to DRUG0 and DRUG0 alone (see
4	4	0.0328982 0.050003 0.0341802 0.0241114 0.0144419 0.0364001 0.060804 0.0977422 0.0483691 0.00858977 0.0137384 0.0142908 0.0487089 0.0450912 0.055821 0.0458343 0.039096 0.0417124 0.026383 0.0365283 0.0424394 0.017377 0.0103733 0.0123415 0.0333083 0.0400115 0.069405	The use of DRUG0 , in combination with DRUG1 and DRUG0 , has been associated with an increase in bleeding compared to DRUG0 and DRUG2 alone (see
4	4	0.0261507 0.0379692 0.0257218 0.0200891 0.0104299 0.0238577 0.0374686 0.0432293 0.0283173 0.0260327 0.05579 0.0110772 0.0406314 0.042496 0.0617419 0.0508024 0.0483281 0.0564414 0.0378183 0.0564233 0.0636601 0.0493244 0.0309744 0.00662936 0.0126758 0.0317381 0.0641819	The use of DRUG0 , in combination with DRUG0 and DRUG1 , has been associated with an increase in bleeding compared to DRUG2 and DRUG0 alone (see
4	4	0.0187041 0.0222585 0.013941 0.0107033 0.00473829 0.00775576 0.011317 0.00976596 0.00771333 0.00403558 0.0105249 0.0119275 0.0352509 0.0451029 0.0576559 0.0546936 0.0448497 0.059676 0.0370982 0.0724813 0.0759946 0.0680434 0.124573 0.0231496 0.0487478 0.056096 0.0632023	The use of DRUG0 , in combination with DRUG0 and DRUG0 , has been associated with an increase in bleeding compared to DRUG1 and DRUG2 alone (see
2	2	0.0681561 0.0587492 0.0614925 0.0538025 0.0385461 0.0829374 0.0581305 0.0603595 0.154117 0.159256 0.0539665 0.0150184 0.0300811 0.105387	The effects of DRUG1 on gastrointestinal motility are antagonized by DRUG2 and DRUG0 .
2	2	0.0785007 0.0671125 0.0695514 0.0589741 0.0420295 0.088547 0.061534 0.0617384 0.135671 0.0726663 0.0290903 0.0321993 0.0850872 0.117298	The effects of DRUG1 on gastrointestinal motility are antagonized by DRUG0 and DRUG2 .
4	4	0.0373655 0.0309544 0.0233692 0.0300515 0.028682 0.0644165 0.0507602 0.0564584 0.136206 0.120682 0.186639 0.0410205 0.0953707 0.098024	The effects of DRUG0 on gastrointestinal motility are antagonized by DRUG1 and DRUG2 .
2	2	0.0968289 0.147677 0.102799 0.113739 0.0635858 0.0709788 0.0933632 0.0546801 0.060533 0.0541604 0.0212676 0.00438311 0.00390487 0.0026279 0.00333288 0.00268139 0.00407422 0.00336275 0.00612676 0.0204746 0.0694184	Additive sedative effects can occur when DRUG1 is given with DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
2	2	0.102457 0.150886 0.104034 0.109862 0.0633526 0.0666642 0.09317 0.0481276 0.059431 0.0497905 0.0113603 0.00696818 0.0136768 0.00292886 0.00317906 0.00251542 0.00388876 0.00327888 0.00626698 0.0213374 0.0768251	Additive sedative effects can occur when DRUG1 is given with DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
2	2	0.10327 0.152289 0.104449 0.109691 0.0626253 0.0662678 0.0919539 0.0472491 0.0585021 0.0466213 0.00947224 0.00355176 0.00556067 0.00610967 0.0140589 0.00315172 0.00414092 0.0035686 0.00686446 0.0210932 0.07951	Additive sedative effects can occur when DRUG1 is given with DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
2	2	0.102989 0.151826 0.10459 0.109907 0.062694 0.0665335 0.0918833 0.0476013 0.0590159 0.0458061 0.00919519 0.00321625 0.00447709 0.0030584 0.00565296 0.00609461 0.016484 0.004656 0.00810014 0.0190701 0.0771489	Additive sedative effects can occur when DRUG1 is given with DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
2	2	0.103663 0.152329 0.0998889 0.108317 0.0611287 0.0623746 0.0887763 0.0450535 0.0535226 0.0420949 0.00848889 0.00307939 0.00387844 0.00274529 0.00406876 0.00308916 0.00527358 0.00703346 0.0162533 0.0491891 0.0797518	Additive sedative effects can occur when DRUG1 is given with DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
2	1	0.0449879 0.0637892 0.049057 0.061358 0.0682144 0.0461272 0.0484549 0.0360923 0.0327661 0.0560603 0.0807799 0.0473074 0.0118333 0.0152961 0.01239 0.0149233 0.0137326 0.0257563 0.0095199 0.0173624 0.0178841 0.0206978 0.00933773 0.0250597 0.0366029 0.0445252 0.0375497 0.0525344	The finding that DRUG1 releases catecholamines in patients with essential hypertension suggests that it should be used cautiously , if at all , in patients receiving DRUG2 .
4	3	0.0371238 0.0280161 0.0184425 0.0173982 0.0229578 0.0350112 0.0441787 0.0328581 0.0473462 0.0157478 0.0143429 0.0567658 0.0311759 0.0619403 0.0277975 0.00807543 0.0431727 0.0637752 0.0801843 0.0301813 0.0346278 0.0237354 0.0343389 0.0134034 0.00770462 0.0063914 0.00755516 0.00902341 0.00952179 0.00971809 0.00625554 0.00892902 0.00222442 0.0014535 0.00176066 0.00126767 0.00189711 0.00135476 0.00216488 0.00154794 0.00279789 0.00235654 0.00708844 0.0112602 0.0751296	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG2 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0301311 0.0199842 0.0122427 0.0101681 0.0112133 0.0175454 0.0220809 0.0167963 0.0326977 0.00730385 0.00677686 0.0342199 0.0100184 0.0141427 0.0131627 0.0139631 0.101166 0.0820077 0.0855097 0.0327591 0.0415624 0.0314222 0.0463732 0.0229307 0.0145725 0.0117288 0.0160437 0.0230746 0.0325785 0.0294871 0.0222252 0.0251905 0.00469842 0.00410912 0.00933094 0.00173262 0.00174844 0.00136187 0.00183874 0.00148314 0.00229243 0.00216195 0.00577888 0.0101809 0.0622031	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG0 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0311608 0.0206665 0.0126602 0.010515 0.0115963 0.0181434 0.0228292 0.0173647 0.0337962 0.00754831 0.00700353 0.0353621 0.0103456 0.0145875 0.0135739 0.014359 0.104046 0.0843569 0.0879589 0.0337144 0.042645 0.0323696 0.0477165 0.0235648 0.0150957 0.0122121 0.0167964 0.0228672 0.0294194 0.0256912 0.017584 0.0175244 0.00303153 0.00206499 0.002558 0.00249808 0.0066218 0.00143129 0.00179181 0.00148804 0.00227164 0.00211974 0.00558632 0.00999559 0.063466	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG0 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0313781 0.02081 0.012748 0.0105877 0.0116765 0.0182688 0.022986 0.0174833 0.0340264 0.00759912 0.00705013 0.0355937 0.0104106 0.0146732 0.0136567 0.0144368 0.104612 0.0847787 0.0883241 0.0338179 0.0427187 0.0324282 0.0477435 0.0233313 0.0149307 0.0120766 0.0166019 0.0225232 0.0286583 0.0246418 0.0164484 0.0162623 0.00282635 0.00185042 0.0020186 0.00135376 0.0023817 0.00261029 0.0070557 0.001613 0.00235558 0.00221738 0.00558178 0.0102792 0.0645738	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG0 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.031456 0.0208613 0.0127792 0.0106137 0.0117049 0.0183132 0.0230416 0.0175253 0.0341083 0.00761713 0.0070665 0.035674 0.0104331 0.0147019 0.0136856 0.0144633 0.1048 0.0849163 0.0884306 0.0338433 0.042728 0.0324214 0.0476844 0.0231459 0.0147942 0.0119676 0.0164329 0.022325 0.028424 0.0243195 0.0161802 0.0158673 0.00275219 0.00179065 0.0019405 0.00125939 0.00192021 0.00142352 0.00250898 0.002852 0.00884725 0.00224715 0.00546022 0.0107982 0.0638736	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG0 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0311024 0.0206277 0.0126366 0.010495 0.0115747 0.0181104 0.0227876 0.0173297 0.0337303 0.00753223 0.00698782 0.0352762 0.0103169 0.0145369 0.0135274 0.0142861 0.103526 0.083842 0.0872348 0.033389 0.0421059 0.0318554 0.0467689 0.0224654 0.0142678 0.011531 0.015738 0.0213801 0.0272271 0.0228094 0.0149764 0.0148964 0.00264328 0.00172091 0.0018251 0.00119943 0.00180679 0.00130923 0.00200027 0.00150011 0.00262183 0.00434086 0.0207923 0.014103 0.0692643	Absorption of drugs from the stomach may be diminished (e.g. , DRUG1 ) by DRUG0 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) .
4	3	0.0272169 0.0186496 0.0113796 0.00998749 0.0111011 0.0179309 0.0231166 0.0199909 0.0413465 0.0113679 0.0101178 0.0248999 0.0483738 0.115982 0.0954952 0.0182368 0.0363132 0.0342778 0.0333884 0.0187824 0.0262022 0.022855 0.0412856 0.0237795 0.0137907 0.0104227 0.0136698 0.019621 0.0286302 0.0269635 0.0203298 0.0230046 0.0042507 0.00367777 0.0084747 0.00164193 0.00166477 0.00129558 0.00175045 0.00140985 0.00217799 0.00204946 0.00546528 0.00958746 0.058045	Absorption of drugs from the stomach may be diminished (e.g. , DRUG0 ) by DRUG1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0280916 0.0192479 0.0117443 0.010307 0.0114565 0.0185055 0.023857 0.0206252 0.0426569 0.0117201 0.0104243 0.025659 0.0497608 0.119316 0.0981524 0.0187095 0.0371591 0.0350876 0.0341418 0.0192212 0.0267021 0.0233377 0.0421518 0.0244051 0.0141972 0.010846 0.0143121 0.0195032 0.0258287 0.0234437 0.0160784 0.0158951 0.00272144 0.00186189 0.00239164 0.00233083 0.00615557 0.00134028 0.00168252 0.00139749 0.00213581 0.00199034 0.00524103 0.00934768 0.0588591	Absorption of drugs from the stomach may be diminished (e.g. , DRUG0 ) by DRUG1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0282787 0.0193755 0.011822 0.0103751 0.011532 0.0186273 0.0240134 0.0207588 0.042932 0.0117929 0.0104864 0.0258092 0.0500252 0.119953 0.0986574 0.0187929 0.037285 0.0352103 0.0342249 0.019239 0.026692 0.0233081 0.042036 0.0241563 0.0140266 0.0107166 0.0141428 0.0192209 0.02517 0.0224801 0.01504 0.0147363 0.00253349 0.00166995 0.00188705 0.00126824 0.00223802 0.00244194 0.00657662 0.00151038 0.00220868 0.00207858 0.00523223 0.00960543 0.059833	Absorption of drugs from the stomach may be diminished (e.g. , DRUG0 ) by DRUG1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0283503 0.0194242 0.0118516 0.0104011 0.0115608 0.0186737 0.0240728 0.0208095 0.0430361 0.01182 0.0105092 0.0258632 0.0501159 0.120173 0.0988315 0.0188204 0.0373181 0.0352452 0.0342396 0.0192295 0.0266675 0.0232647 0.0419033 0.0239506 0.0138905 0.010612 0.013993 0.0190524 0.0249769 0.0221904 0.0147982 0.0143808 0.00246678 0.00161592 0.00181358 0.00117889 0.001803 0.00133593 0.00235722 0.00267134 0.00826705 0.00210688 0.00511144 0.0100853 0.0591612	Absorption of drugs from the stomach may be diminished (e.g. , DRUG0 ) by DRUG1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0280669 0.0192297 0.0117329 0.0102967 0.0114447 0.0184861 0.0238301 0.0205977 0.0425964 0.0116957 0.0103956 0.0255788 0.0495311 0.118771 0.0976648 0.0185981 0.0368287 0.0347879 0.0337717 0.0189645 0.0262903 0.0228753 0.0410956 0.0233044 0.0134497 0.0102686 0.0134518 0.0183033 0.0240265 0.0208671 0.0137179 0.0135305 0.00237624 0.00155718 0.00170785 0.00112438 0.00169816 0.00122957 0.00188019 0.00140859 0.00246211 0.00406521 0.0194269 0.0132309 0.0637826	Absorption of drugs from the stomach may be diminished (e.g. , DRUG0 ) by DRUG1 , whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) .
4	1	0.0376108 0.0327538 0.02605 0.0322489 0.0489137 0.0155675 0.0228895 0.0260764 0.0288815 0.02471 0.0242712 0.0167223 0.02013 0.0180002 0.0103692 0.0437681 0.0574888 0.0542227 0.0384502 0.0426169 0.0156595 0.0331302 0.0242082 0.0227199 0.0734545 0.0482239 0.0271847 0.0419227 0.0355651 0.0228674 0.0333226	Because the action of DRUG1 will influence the delivery of food to the intestines and thus the rate of absorption , DRUG2 dosage or timing of dosage may require adjustment .
4	4	0.0370772 0.0312761 0.0313335 0.0269504 0.0132934 0.0120326 0.0158332 0.00418104 0.00705529 0.00925239 0.0563963 0.0470351 0.0338859 0.0379914 0.028348 0.0268643 0.0338578 0.0363701 0.112734 0.08231 0.0726148 0.038641 0.0538153 0.082174 0.0686771	Concurrent administration of DRUG1 (e.g. , DRUG2 , DRUG0 ) may diminish the bactericidal effects of DRUG0 by slowing the rate of bacterial growth .
4	4	0.0378212 0.0309153 0.0310934 0.0289265 0.0104716 0.0100885 0.00840662 0.0114825 0.0311881 0.0128522 0.0564449 0.046824 0.0337672 0.0387206 0.028531 0.0270471 0.032723 0.0355523 0.107115 0.078813 0.0695823 0.0370077 0.0512672 0.0783296 0.0650291	Concurrent administration of DRUG1 (e.g. , DRUG0 , DRUG2 ) may diminish the bactericidal effects of DRUG0 by slowing the rate of bacterial growth .
2	2	0.0325994 0.0322854 0.0324516 0.0235605 0.00641804 0.00630762 0.00660702 0.00612185 0.00988694 0.0157959 0.0638705 0.030099 0.0321767 0.0403871 0.042527 0.0702436 0.0664777 0.0457686 0.107742 0.07441 0.054416 0.0349857 0.0479625 0.0631694 0.0537293	Concurrent administration of DRUG1 (e.g. , DRUG0 , DRUG0 ) may diminish the bactericidal effects of DRUG2 by slowing the rate of bacterial growth .
2	2	0.0473338 0.0530139 0.0420617 0.0143118 0.00531623 0.0050991 0.0203115 0.00448078 0.00708648 0.0132791 0.0627726 0.0314945 0.0290974 0.0370859 0.0378193 0.0632958 0.0604515 0.0415686 0.102403 0.0723395 0.0532889 0.034041 0.0467673 0.0621456 0.0531342	Concurrent administration of DRUG0 (e.g. , DRUG1 , DRUG0 ) may diminish the bactericidal effects of DRUG2 by slowing the rate of bacterial growth .
2	2	0.0357369 0.0434866 0.0337103 0.011238 0.00338357 0.00284809 0.00654413 0.00724492 0.0359747 0.0150196 0.0713957 0.0419804 0.0374181 0.0478407 0.0429304 0.0681376 0.0624443 0.0416279 0.0956775 0.0679486 0.0493048 0.0308083 0.0425663 0.0562303 0.0485022	Concurrent administration of DRUG0 (e.g. , DRUG0 , DRUG1 ) may diminish the bactericidal effects of DRUG2 by slowing the rate of bacterial growth .
2	3	0.0973531 0.0179726 0.0300583 0.0453427 0.0297568 0.0957486 0.0581962 0.0734167 0.0566796 0.0756195 0.0765985 0.0355844 0.0790646 0.0455087 0.0185285 0.0227115 0.0208061 0.0220681 0.0279549 0.0710307	DRUG1 blood levels may be prolonged by concurrent administration of DRUG2 which blocks the renal tubular secretion of DRUG0 .
4	4	0.0506416 0.00837795 0.0136806 0.0196473 0.016677 0.0465108 0.0305017 0.0433126 0.0450367 0.0506192 0.0293934 0.0434014 0.0913099 0.0704038 0.0388701 0.0739985 0.0863258 0.0876964 0.0810035 0.0725917	DRUG1 blood levels may be prolonged by concurrent administration of DRUG0 which blocks the renal tubular secretion of DRUG2 .
3	4	0.0208239 0.0236193 0.023965 0.0361626 0.0260482 0.0893947 0.0529241 0.0595748 0.0495244 0.0493128 0.0644156 0.0340086 0.0522828 0.0616797 0.0313266 0.0533722 0.0603068 0.0882219 0.0706352 0.0524005	DRUG0 blood levels may be prolonged by concurrent administration of DRUG1 which blocks the renal tubular secretion of DRUG2 .
4	4	0.0513769 0.0512775 0.0700753 0.0259518 0.0267939 0.0117091 0.0127782 0.0367223 0.0106327 0.0154729 0.0246847 0.0576888 0.0834194 0.0432989 0.035281 0.0343485 0.0193745 0.0176431 0.0131558 0.0395079 0.0200472 0.0211363 0.00901972 0.0111032 0.00842162 0.0151954 0.0399508 0.038369 0.0437149 0.0449576 0.0668911	Drugs that induce hepatic enzymes such as DRUG1 , DRUG0 and DRUG2 may increase the clearance of DRUG0 and may require increases in DRUG0 dose to achieve the desired response .
3	3	0.0422982 0.0404838 0.0616593 0.0229958 0.0262081 0.0128072 0.0126361 0.0407088 0.00871068 0.0131764 0.0149995 0.0360585 0.0902841 0.048168 0.0536963 0.0539894 0.0631492 0.0396921 0.0103243 0.0275356 0.0192754 0.0213199 0.00898233 0.00928734 0.00630619 0.0127926 0.0350309 0.0326896 0.0367984 0.0374588 0.0604768	Drugs that induce hepatic enzymes such as DRUG1 , DRUG0 and DRUG0 may increase the clearance of DRUG2 and may require increases in DRUG0 dose to achieve the desired response .
1	3	0.0391114 0.0381621 0.0569649 0.019303 0.0209432 0.00903735 0.00924889 0.0281969 0.00523711 0.00717889 0.00828894 0.0198788 0.0541785 0.0244658 0.0188873 0.0210778 0.0235044 0.018301 0.0159715 0.0530111 0.0392742 0.0720101 0.0583936 0.0511276 0.0194596 0.0214752 0.046114 0.0500374 0.0501982 0.0399297 0.0610314	Drugs that induce hepatic enzymes such as DRUG1 , DRUG0 and DRUG0 may increase the clearance of DRUG0 and may require increases in DRUG2 dose to achieve the desired response .
4	4	0.0490104 0.0473616 0.0562414 0.0198064 0.0195499 0.00802871 0.0063523 0.0113457 0.0166287 0.109156 0.0271529 0.0549059 0.0788259 0.0387365 0.0312943 0.033745 0.0173543 0.0160227 0.0124711 0.0374088 0.0194118 0.0208094 0.00888654 0.010761 0.0081199 0.0147411 0.0385698 0.0370165 0.0422922 0.0432653 0.0647276	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 and DRUG2 may increase the clearance of DRUG0 and may require increases in DRUG0 dose to achieve the desired response .
3	3	0.0443242 0.0420709 0.0570108 0.018583 0.0169546 0.00790714 0.00529485 0.00821819 0.0104128 0.0571387 0.0138405 0.0382882 0.0953031 0.0506466 0.0553178 0.0550893 0.0628987 0.0401474 0.0102171 0.0270322 0.0194603 0.0213562 0.00903897 0.00935477 0.006355 0.012919 0.0354592 0.0331078 0.0372243 0.0379592 0.0610695	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 and DRUG0 may increase the clearance of DRUG2 and may require increases in DRUG0 dose to achieve the desired response .
1	3	0.0399377 0.0386956 0.0504636 0.0152766 0.0140366 0.00545079 0.0037249 0.00615578 0.00719519 0.0407634 0.00801415 0.0220858 0.0606382 0.0261103 0.0199499 0.0222465 0.0237152 0.01911 0.0162387 0.0514673 0.0402582 0.0723085 0.0563964 0.049547 0.0185247 0.0206688 0.0467824 0.0507272 0.0508387 0.0405936 0.0620781	Drugs that induce hepatic enzymes such as DRUG0 , DRUG1 and DRUG0 may increase the clearance of DRUG0 and may require increases in DRUG2 dose to achieve the desired response .
3	3	0.0317777 0.0291965 0.0443567 0.0175634 0.0183463 0.00914601 0.00622743 0.00850073 0.00865997 0.0203725 0.0238768 0.107037 0.1164 0.0589427 0.0558696 0.05529 0.058845 0.0363842 0.00871077 0.0249352 0.0178001 0.0194783 0.00827286 0.00853378 0.00580214 0.0117952 0.0325403 0.0304085 0.0341006 0.0349105 0.0559182	Drugs that induce hepatic enzymes such as DRUG0 , DRUG0 and DRUG1 may increase the clearance of DRUG2 and may require increases in DRUG0 dose to achieve the desired response .
1	3	0.0267445 0.0247637 0.0367263 0.013096 0.0134345 0.00588526 0.00397535 0.00563086 0.00519631 0.0161358 0.0210835 0.0958912 0.0672241 0.03343 0.0245535 0.0257993 0.0251922 0.0192767 0.0155632 0.0498824 0.0386107 0.0695659 0.052114 0.0458604 0.0167218 0.0185551 0.0429173 0.0464484 0.046281 0.0369928 0.0564478	Drugs that induce hepatic enzymes such as DRUG0 , DRUG0 and DRUG1 may increase the clearance of DRUG0 and may require increases in DRUG2 dose to achieve the desired response .
4	4	0.0148459 0.012533 0.02227 0.00584527 0.00640032 0.00271642 0.00188632 0.00279444 0.00224636 0.00653854 0.0059669 0.0381491 0.0746202 0.0491302 0.050724 0.0636753 0.0536987 0.0944778 0.01268 0.0545132 0.027846 0.0714306 0.0617522 0.0433689 0.0156462 0.0177584 0.0394295 0.0385111 0.036219 0.02842 0.0439062	Drugs that induce hepatic enzymes such as DRUG0 , DRUG0 and DRUG0 may increase the clearance of DRUG1 and may require increases in DRUG2 dose to achieve the desired response .
4	4	0.0352956 0.0307991 0.0313258 0.121733 0.0294576 0.0689615 0.105478 0.0683691 0.0376784 0.0519235 0.0281109 0.0283658 0.0202433 0.0546464 0.0825934 0.0450769 0.076561 0.0833805	Drugs such as DRUG1 and DRUG2 may inhibit the metabolism of DRUG0 and thus decrease their clearance .
3	3	0.0269217 0.0228034 0.0226619 0.0814058 0.021096 0.0485263 0.126021 0.0865446 0.0757093 0.0898712 0.0908187 0.0562918 0.0149246 0.0340426 0.0487694 0.0327747 0.0566864 0.0641307	Drugs such as DRUG1 and DRUG0 may inhibit the metabolism of DRUG2 and thus decrease their clearance .
3	3	0.0261206 0.0173184 0.0132448 0.0213084 0.0244033 0.123913 0.139731 0.100095 0.0796426 0.0916336 0.0848015 0.0501929 0.0120859 0.0301044 0.044941 0.0298479 0.0516225 0.0589935	Drugs such as DRUG0 and DRUG1 may inhibit the metabolism of DRUG2 and thus decrease their clearance .
3	3	0.166837 0.138228 0.0793567 0.0786687 0.0732308 0.0531594 0.0565338 0.0564717 0.071579 0.109785 0.11615	DRUG1 may increase the clearance of chronic high dose DRUG2 .
4	4	0.0321526 0.0587758 0.0609016 0.0554195 0.104901 0.0918146 0.0206379 0.0142394 0.00809557 0.0206432 0.0195084 0.0230995 0.0254931 0.0554771 0.0865384 0.0756686 0.0784761 0.0546487 0.0440281 0.0694807	This could lead to decreased DRUG1 serum levels or increase the risk of DRUG0 toxicity when DRUG2 is withdrawn .
2	2	0.0326525 0.0550026 0.0411195 0.0121733 0.020667 0.0204433 0.0185589 0.0155787 0.0097679 0.0372925 0.0676413 0.0412916 0.0417568 0.109553 0.0732496 0.0852288 0.0859108 0.0705113 0.0684541 0.093147	This could lead to decreased DRUG0 serum levels or increase the risk of DRUG1 toxicity when DRUG2 is withdrawn .
1	1	0.163847 0.035412 0.0441656 0.0366122 0.0634811 0.0587406 0.0630512 0.0837179 0.0707947 0.0692208 0.046261 0.0571123 0.0544617 0.0536209 0.0995006	DRUG1 should be used cautiously in conjunction with DRUG2 in patients suffering from hypoprothrombinemia .
2	2	0.0856177 0.0703225 0.0764414 0.0669891 0.080328 0.0958906 0.0860905 0.0741497 0.197154 0.167016	The effect of DRUG1 on oral DRUG2 is variable .
2	2	0.0302469 0.0195244 0.023966 0.0365997 0.0587784 0.0175661 0.0372441 0.026091 0.125438 0.0807646 0.0656425 0.126683 0.0411668 0.045157 0.0604827 0.0730951 0.0693793 0.0621744	There are reports of enhanced as well as diminished effects of DRUG1 when given concurrently with DRUG2 .
3	3	0.0480764 0.0508743 0.0712888 0.0457067 0.0984592 0.15324 0.0874919 0.0727106 0.0384545 0.0617647 0.0305229 0.0232705 0.0279994 0.0217228 0.0177299 0.0264994 0.0258096 0.0228144 0.0229553 0.0526091	Preliminary evidence suggests that DRUG1 inhibits DRUG2 metabolism and may result in an increase in plasma concentrations of DRUG0 .
4	4	0.0384076 0.0471954 0.0792639 0.0556165 0.0759648 0.0736843 0.044974 0.0499402 0.0319453 0.063174 0.0373199 0.0305309 0.0465592 0.04433 0.0346851 0.0472499 0.0467535 0.0540014 0.0511839 0.0472203	Preliminary evidence suggests that DRUG1 inhibits DRUG0 metabolism and may result in an increase in plasma concentrations of DRUG2 .
3	3	0.137369 0.131914 0.0941744 0.100017 0.0569049 0.151284 0.136094 0.109183 0.0830591	DRUG1 may inhibit the hepatic metabolism of DRUG2 .
3	3	0.0949117 0.0170903 0.0270803 0.016133 0.0238933 0.0388177 0.0315595 0.0307744 0.0265059 0.0714931 0.076924 0.0647883 0.046068 0.0200101 0.0122169 0.00551321 0.0175759 0.0140905 0.0285613 0.0448294 0.0787445 0.079723 0.0320464 0.040305 0.0603442	DRUG1 , given at a common clinical dosage , increased the DRUG2 half-life by 51% and decreased the DRUG0 metabolic clearance rate by 30% .
4	3	0.0747755 0.0121366 0.0171911 0.00946981 0.0135999 0.0181809 0.0124523 0.0118456 0.00941559 0.0393713 0.0261552 0.0259072 0.0491924 0.0289874 0.0211445 0.0168747 0.085968 0.087845 0.0780496 0.0551217 0.0957691 0.0732414 0.0355323 0.0422595 0.0595132	DRUG1 , given at a common clinical dosage , increased the DRUG0 half-life by 51% and decreased the DRUG2 metabolic clearance rate by 30% .
2	3	0.0511578 0.0544692 0.0847843 0.0436076 0.110458 0.0815942 0.0493983 0.0711598 0.0641967 0.0195011 0.0470255 0.057205 0.0414087 0.0844453 0.075686 0.0639027	Limited evidence suggests that DRUG1 may influence the intensity and duration of action of DRUG2 .
1	1	0.030931 0.0151713 0.00938164 0.0136519 0.0851312 0.0415912 0.0290085 0.0376892 0.0361481 0.0577017 0.0421498 0.110035 0.0797196 0.0889627 0.12389 0.111897 0.0869395	Prothrombin time or other suitable anticoagulation test should be monitored if DRUG1 is administered with DRUG2 .
2	2	0.0635341 0.0447643 0.0481627 0.0592981 0.0725323 0.0875755 0.0836063 0.0851593 0.0809841 0.0624654 0.0706237 0.070317 0.0639253 0.107052	Concurrent use of DRUG1 with oral DRUG2 may render oral DRUG0 less effective .
4	4	0.0601371 0.0720699 0.083235 0.0835797 0.0401163 0.0548449 0.0674423 0.0810174 0.0968187 0.108109 0.0908404 0.0362077 0.0446577 0.080924	Concurrent use of DRUG1 with oral DRUG0 may render oral DRUG2 less effective .
2	2	0.148507 0.150271 0.100008 0.0823895 0.0771932 0.119283 0.0885299 0.0708062 0.0674688 0.0955431	DRUG1 enhances the antinociceptive effect of DRUG2 in mice .
4	4	0.0216318 0.016354 0.0139503 0.0164878 0.0167303 0.0135545 0.00963214 0.024655 0.0717442 0.0504948 0.0570279 0.0496163 0.0530253 0.0318899 0.0325045 0.0395176 0.048228 0.0509664 0.068526 0.0664461 0.0179274 0.0419505 0.0303987 0.0156714 0.0168097 0.0195897 0.0149971 0.0186104 0.0320373 0.0390253	The purpose of this study was to evaluate whether the psychostimulant drug DRUG1 has any effect on DRUG2 -induced antinociception and locomotor inhibitor activity in mice in acute application .
4	4	0.0250196 0.0311506 0.0293787 0.0116038 0.0420712 0.0262635 0.0306621 0.0346963 0.0363761 0.0340999 0.0350376 0.0201075 0.0368809 0.0594334 0.0385884 0.0345657 0.0292075 0.016197 0.0101987 0.00738848 0.00547879 0.00286822 0.00961666 0.0171772 0.0140647 0.008287 0.0110287 0.0100709 0.0229372 0.0439248 0.0254015 0.0168853 0.0125125 0.00913424 0.00874466 0.00488267 0.0168404 0.00733025 0.0173138 0.0115618 0.0112921 0.0131302 0.0126972 0.00553373 0.0170186 0.0179854 0.0154766 0.0154229 0.0264553	saline + saline , DRUG1 (10   mg/kg) + saline , saline + DRUG2 (15     g/kg) and DRUG0 (10   mg/kg) + DRUG0 (15     g/kg) , intraperitoneally , 30 min before hot plate or holed open field tests .
4	4	0.0219574 0.0266953 0.0241501 0.0100102 0.0352813 0.0194538 0.0168878 0.0128292 0.011305 0.0106655 0.0082229 0.00401375 0.0144266 0.0181977 0.0216471 0.0336062 0.0155188 0.00880116 0.00616508 0.00495833 0.00424061 0.00280777 0.01271 0.0323213 0.0343778 0.0420216 0.0771697 0.0640403 0.0566059 0.0436284 0.0447064 0.0306785 0.0197107 0.0129528 0.0103107 0.00516922 0.0175025 0.0075707 0.0174659 0.011344 0.0110861 0.0128167 0.0122635 0.00543325 0.0161038 0.0167606 0.014416 0.0144014 0.0245906	saline + saline , DRUG1 (10   mg/kg) + saline , saline + DRUG0 (15     g/kg) and DRUG0 (10   mg/kg) + DRUG2 (15     g/kg) , intraperitoneally , 30 min before hot plate or holed open field tests .
4	4	0.00862973 0.00714592 0.00693464 0.00504572 0.0228381 0.0439879 0.0371266 0.0234245 0.0253373 0.0181209 0.0189197 0.0107767 0.030871 0.0352494 0.0494957 0.0236009 0.0212722 0.0233053 0.0269457 0.029803 0.035663 0.0174767 0.0217479 0.0219558 0.020739 0.0138739 0.0176003 0.0195308 0.0300061 0.0553213 0.0307039 0.0194325 0.0137554 0.0097987 0.00917602 0.00504786 0.0175351 0.00765155 0.0178836 0.0118134 0.0114675 0.0132476 0.0127601 0.00555659 0.0169876 0.0178875 0.0153305 0.0152239 0.0259949	saline + saline , DRUG0 (10   mg/kg) + saline , saline + DRUG1 (15     g/kg) and DRUG2 (10   mg/kg) + DRUG0 (15     g/kg) , intraperitoneally , 30 min before hot plate or holed open field tests .
4	4	0.00834683 0.00694404 0.00643647 0.00437628 0.0178205 0.0273695 0.0202101 0.00979716 0.00939034 0.00698063 0.00576768 0.00289063 0.0109063 0.0140507 0.0255404 0.0483219 0.0282856 0.0205592 0.0201248 0.0223609 0.0259974 0.0110723 0.0464683 0.0249093 0.0279095 0.0267533 0.0492693 0.0553738 0.0477677 0.0446851 0.0446867 0.0312667 0.0202317 0.0132339 0.0101804 0.00520754 0.0183335 0.00818155 0.0187736 0.0123468 0.0121693 0.0141046 0.0135011 0.00599357 0.0177166 0.0184552 0.0158904 0.0158898 0.0271514	saline + saline , DRUG0 (10   mg/kg) + saline , saline + DRUG0 (15     g/kg) and DRUG1 (10   mg/kg) + DRUG2 (15     g/kg) , intraperitoneally , 30 min before hot plate or holed open field tests .
2	2	0.0154639 0.0140547 0.0130296 0.0345746 0.010973 0.0112708 0.0110169 0.00391495 0.0128503 0.0150146 0.0217829 0.0272864 0.0226237 0.0236723 0.031065 0.0737734 0.0751123 0.028514 0.0226701 0.034958 0.0492025 0.0669435 0.0459305 0.0282309 0.0250234 0.0356224 0.0382288 0.00629263 0.0064082 0.0110995 0.0282657 0.015176 0.0106178 0.00837581 0.0114922 0.0222691 0.0176744 0.0206977 0.0488278	In the hot plate test in mice , co-administration of 15     g/kg DRUG1 with 10   mg/kg DRUG2 intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by DRUG0 .
2	4	0.0145377 0.0130401 0.0117351 0.0296408 0.00850348 0.0084427 0.00816834 0.00278182 0.00923826 0.00991617 0.0141589 0.0174553 0.0124206 0.0105167 0.0109944 0.0225832 0.0277876 0.0388628 0.0316457 0.0331399 0.0376434 0.0533675 0.0755756 0.0233623 0.0180167 0.0272643 0.0495323 0.00852905 0.0127053 0.0231764 0.049902 0.0327381 0.0226704 0.0237948 0.0291888 0.0388375 0.0593889 0.0417404 0.0369967	In the hot plate test in mice , co-administration of 15     g/kg DRUG0 with 10   mg/kg DRUG1 intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by DRUG2 .
2	2	0.0316384 0.031131 0.027685 0.0113397 0.00842698 0.0296579 0.065845 0.121953 0.0757577 0.0672896 0.0624571 0.0628936 0.0955467 0.132752 0.101283 0.0743434	At the same time , the locomotor inhibitory effect of DRUG1 was counteracted by DRUG2 .
2	2	0.03919 0.0672508 0.0341943 0.0616542 0.041367 0.0343274 0.0347121 0.0331382 0.0554337 0.0434357 0.0459481 0.0392863 0.0837985 0.0505143 0.0293373 0.0221087 0.0120795 0.014489 0.0175107 0.00971768 0.0137645 0.00844956 0.00388533 0.00661794 0.0122686 0.0095931 0.010527 0.00919682 0.0102738 0.00456667 0.0166924 0.0186168 0.0199876 0.0464605 0.0396059	We concluded that the combined administration of DRUG1 with DRUG2 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUG0 as an DRUG0 in humans .
4	4	0.0264614 0.0500886 0.0292258 0.0492622 0.0405428 0.0521424 0.059788 0.06032 0.0328996 0.0266723 0.0327864 0.0224727 0.0599543 0.0348393 0.0194836 0.0164907 0.00842892 0.0114427 0.0138324 0.00843466 0.0128367 0.00765458 0.00392091 0.00911284 0.017051 0.0156822 0.0180793 0.0185378 0.0157038 0.0214293 0.0543411 0.0361588 0.0332307 0.0418147 0.0388775	We concluded that the combined administration of DRUG1 with DRUG0 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUG0 as an DRUG2 in humans .
4	4	0.021781 0.037498 0.0179802 0.0358993 0.0291552 0.0479805 0.0643242 0.0516099 0.0663156 0.0608308 0.0340767 0.0216651 0.0519943 0.0327558 0.018413 0.0165265 0.0107458 0.0153492 0.0202446 0.0119409 0.018852 0.0120795 0.00689319 0.0150341 0.0281754 0.0316722 0.0249161 0.0326834 0.0162418 0.0055259 0.0155613 0.0191163 0.0219144 0.044285 0.0399629	We concluded that the combined administration of DRUG0 with DRUG1 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUG2 as an DRUG0 in humans .
4	4	0.0215752 0.0372156 0.0178325 0.0355445 0.0287974 0.0473475 0.0632931 0.050804 0.0649103 0.0581825 0.0319047 0.0201575 0.0489597 0.029333 0.0154162 0.0133696 0.00878177 0.0113832 0.0150227 0.0086373 0.0137972 0.00810026 0.00412169 0.00970913 0.0185367 0.0168913 0.0192569 0.0197466 0.0168133 0.0230994 0.0586994 0.0392566 0.0362211 0.0454117 0.0418704	We concluded that the combined administration of DRUG0 with DRUG1 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUG0 as an DRUG2 in humans .
2	4	0.0189816 0.0264504 0.010252 0.0192987 0.0148372 0.0175338 0.0175727 0.0119663 0.0092266 0.0193596 0.0323899 0.0130345 0.0449171 0.0295575 0.0158588 0.0172578 0.0132043 0.0201081 0.0265467 0.0146312 0.0226626 0.0146884 0.0088128 0.0230215 0.0468193 0.0455868 0.0336783 0.0337248 0.0554405 0.024332 0.0795913 0.0462976 0.0503514 0.0619151 0.060093	We concluded that the combined administration of DRUG0 with DRUG0 may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUG1 as an DRUG2 in humans .
4	4	0.180762 0.0707684 0.176438 0.0449395 0.0119003 0.0546736 0.0356086 0.0352977 0.0131988 0.0157344 0.0128561 0.0109815 0.0175199 0.00862255 0.0218211 0.021412 0.0146684 0.0115431 0.0333271 0.0302476 0.0230277 0.0125211 0.00856098 0.025445 0.0166539 0.0239968 0.067474	DRUG1 , particularly DRUG2 , may cause serious cardiac arrhythmias during DRUG0 anesthesia and therefore should be used only with great caution or not at all .
2	2	0.0834717 0.0129494 0.0476128 0.0235953 0.028021 0.134928 0.0648968 0.0636033 0.0455627 0.0517946 0.0783456 0.0685129 0.0465925 0.012066 0.0254298 0.0161855 0.0119954 0.00972347 0.0252474 0.0217927 0.0181069 0.00941167 0.00680727 0.0185726 0.0123049 0.0169245 0.0455455	DRUG1 , particularly DRUG0 , may cause serious cardiac arrhythmias during DRUG2 anesthesia and therefore should be used only with great caution or not at all .
4	2	0.0266654 0.0333867 0.168194 0.195468 0.0363853 0.0798864 0.0466466 0.0436239 0.0316093 0.034714 0.0555964 0.0481902 0.0318442 0.00827957 0.0177724 0.0110648 0.00817719 0.00658499 0.0169576 0.0145974 0.0120908 0.00623967 0.00450702 0.0122581 0.00812616 0.01116 0.0299738	DRUG0 , particularly DRUG1 , may cause serious cardiac arrhythmias during DRUG2 anesthesia and therefore should be used only with great caution or not at all .
4	4	0.0584905 0.025945 0.0552579 0.0634672 0.0588476 0.0673965 0.0589394 0.0533568 0.141244 0.0721987 0.0627592 0.0491042 0.0474268 0.0186403 0.00978574 0.0199807 0.0243055 0.112854	DRUG1 : The pressor effect of DRUG2 is markedly potentiated in patients receiving DRUG0 ( DRUG0 ) .
4	4	0.0469736 0.0145449 0.0313559 0.0320595 0.030874 0.0349821 0.0426233 0.0657629 0.174085 0.106557 0.0730716 0.0671446 0.0924974 0.0387035 0.0165009 0.0126356 0.0181408 0.101487	DRUG1 : The pressor effect of DRUG0 is markedly potentiated in patients receiving DRUG2 ( DRUG0 ) .
4	4	0.0501051 0.0165541 0.0353533 0.0344738 0.0323251 0.0376148 0.044176 0.0660286 0.164072 0.0979534 0.0734277 0.0646468 0.0536947 0.0268198 0.0274624 0.0464568 0.0279005 0.100935	DRUG1 : The pressor effect of DRUG0 is markedly potentiated in patients receiving DRUG0 ( DRUG2 ) .
2	2	0.0174277 0.0213635 0.0348834 0.0626348 0.074228 0.0656254 0.0708074 0.0426541 0.139923 0.0752296 0.0531835 0.0519658 0.0789791 0.0393508 0.0190334 0.0186737 0.0264645 0.107572	DRUG0 : The pressor effect of DRUG1 is markedly potentiated in patients receiving DRUG2 ( DRUG0 ) .
2	2	0.0195616 0.0245338 0.0390532 0.0649007 0.0747272 0.0605404 0.0674384 0.0367371 0.116873 0.0648669 0.0461977 0.0536598 0.0658598 0.0334858 0.0373532 0.0566768 0.0369561 0.100579	DRUG0 : The pressor effect of DRUG1 is markedly potentiated in patients receiving DRUG0 ( DRUG2 ) .
2	2	0.0814965 0.111758 0.0745814 0.0708512 0.118714 0.108165 0.0461523 0.0480452 0.0609828 0.095528 0.100273 0.083452	The pressor response of DRUG1 may also be potentiated by DRUG2 .
4	1	0.0751567 0.107086 0.127558 0.0573878 0.0686759 0.0536983 0.0526806 0.0146929 0.00813781 0.0135964 0.00311386 0.00434902 0.00477333 0.00239856 0.00212852 0.00309353 0.00265514 0.00447429 0.00366069 0.00343599 0.00424173 0.0112033 0.00763845 0.0367668 0.018572 0.0201958 0.00616411 0.00879736 0.0135503 0.00347149 0.00298876 0.0026943 0.0070511 0.00504786 0.0141295 0.00678616 0.0216568 0.016297 0.00499062 0.0119673 0.00936703 0.0237602 0.0247422 0.0336921 0.0714747	Because DRUG1 exhibits some monoamine oxidase inhibitory activity , DRUG2 , DRUG0 drugs (e.g. , DRUG0 , DRUG0 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	1	0.0754867 0.107918 0.129893 0.0576645 0.0620517 0.0416539 0.0304282 0.00797931 0.00392088 0.00507948 0.00530612 0.0199184 0.0050511 0.00248909 0.00212547 0.00328053 0.0027372 0.0049283 0.00408944 0.00384183 0.00488784 0.0145818 0.00941788 0.0480978 0.0243879 0.0226998 0.00697989 0.00952957 0.0144048 0.00371622 0.00313724 0.00281785 0.00738171 0.00524279 0.0147539 0.00704121 0.0225618 0.0169387 0.0051625 0.012315 0.00962566 0.0244488 0.0254579 0.0347862 0.0737822	Because DRUG1 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG2 drugs (e.g. , DRUG0 , DRUG0 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	1	0.0786941 0.112726 0.127039 0.0568197 0.0581091 0.0372283 0.0267274 0.00699986 0.00331076 0.00431336 0.00303531 0.009202 0.0140646 0.00461504 0.00568396 0.0147592 0.00303645 0.00463928 0.00405354 0.00389296 0.00434167 0.0109375 0.00782101 0.0371597 0.0186395 0.0221215 0.0067031 0.00970177 0.0152499 0.00387255 0.00339282 0.00304672 0.00791684 0.00569546 0.0157858 0.00762262 0.0240158 0.0181053 0.00556357 0.0133143 0.0104706 0.0262965 0.027189 0.036996 0.0790908	Because DRUG1 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG0 drugs (e.g. , DRUG2 , DRUG0 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	1	0.077821 0.111697 0.126926 0.0550246 0.0532227 0.0328553 0.023902 0.00633656 0.00304239 0.00407767 0.00276874 0.00782376 0.00937209 0.00299527 0.00280991 0.00558445 0.00658722 0.0214399 0.00555054 0.00429164 0.00450527 0.0136103 0.00915002 0.0479857 0.0248263 0.0227706 0.0070643 0.00986249 0.0149976 0.00390576 0.00330573 0.00297178 0.00778699 0.00552203 0.0155706 0.0074435 0.0238091 0.0179122 0.00545661 0.0129106 0.0100763 0.0253724 0.026305 0.0361129 0.0766375	Because DRUG1 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG0 drugs (e.g. , DRUG0 , DRUG2 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	1	0.0555403 0.0777182 0.0806629 0.0266899 0.0193097 0.0111324 0.0110213 0.00359441 0.00201331 0.00313256 0.00209659 0.00583848 0.00513426 0.00191783 0.0017942 0.00328764 0.00240101 0.00504511 0.00404159 0.0036822 0.00588707 0.0188906 0.0153499 0.0973938 0.0739348 0.095228 0.0673577 0.0585412 0.0323732 0.00617825 0.0048996 0.00338955 0.00711113 0.00482777 0.0134686 0.00595671 0.018133 0.0133251 0.00393361 0.00942515 0.00727464 0.0175312 0.0180283 0.0241509 0.0513564	Because DRUG1 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG0 drugs (e.g. , DRUG0 , DRUG0 ) and other drugs and foods with known high DRUG2 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0676958 0.0586908 0.0915311 0.0499557 0.0523843 0.0477867 0.061553 0.0236416 0.0154719 0.0561969 0.0160789 0.0189503 0.0220615 0.00819689 0.00881844 0.0147456 0.00347975 0.00495058 0.00492152 0.00421441 0.00590858 0.013309 0.00918775 0.038303 0.016133 0.0192322 0.00606267 0.00863813 0.0135179 0.00341441 0.00299911 0.00268283 0.00685139 0.00493679 0.0135071 0.0065564 0.0204049 0.0152782 0.00476978 0.0112968 0.00883281 0.0215266 0.0219699 0.0298814 0.0634736	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG1 , DRUG0 drugs (e.g. , DRUG2 , DRUG0 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0673367 0.0581064 0.0907054 0.0493845 0.0515334 0.0468296 0.0603903 0.0231028 0.0147596 0.0540117 0.015649 0.0170242 0.014063 0.00543547 0.00757517 0.00730401 0.0105771 0.0230037 0.00580155 0.0044273 0.0049386 0.0129759 0.00909598 0.0429331 0.0203268 0.0197697 0.00627192 0.00875318 0.0133201 0.003388 0.00293071 0.00261899 0.00672113 0.00481741 0.0133229 0.00642382 0.0201741 0.0151023 0.00467593 0.0110615 0.00862504 0.021083 0.0215764 0.0294995 0.0625729	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG1 , DRUG0 drugs (e.g. , DRUG0 , DRUG2 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0539966 0.0456807 0.068581 0.0346726 0.0339559 0.0295656 0.0376287 0.0137309 0.00776758 0.0302221 0.00714757 0.00666102 0.00561825 0.00364772 0.00436876 0.00500509 0.00698456 0.00761673 0.0167784 0.009934 0.0163527 0.0346697 0.0153474 0.0668713 0.0371283 0.0574736 0.056123 0.0514114 0.0307423 0.0054114 0.00453589 0.00334153 0.00696345 0.00480886 0.0131232 0.00587124 0.0177088 0.0129865 0.00382775 0.00916844 0.00709188 0.0173494 0.017848 0.0238063 0.0504738	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG1 , DRUG0 drugs (e.g. , DRUG0 , DRUG0 ) and other drugs and foods with known high DRUG2 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0643325 0.0491275 0.0728367 0.033701 0.0314605 0.0267662 0.0327055 0.0123049 0.0083284 0.016447 0.0282318 0.14483 0.0310453 0.00947786 0.0099366 0.0175366 0.00396255 0.00545311 0.00522601 0.00460887 0.00609641 0.0135755 0.00916367 0.0384077 0.016633 0.0202696 0.0063584 0.00919022 0.0143773 0.00365103 0.00321715 0.00288497 0.00735334 0.00531981 0.0144911 0.00705946 0.0218845 0.0164187 0.00514465 0.0121999 0.00957089 0.0233016 0.0237646 0.0323259 0.0690222	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG1 drugs (e.g. , DRUG2 , DRUG0 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0663437 0.050839 0.0758718 0.035389 0.0330337 0.0275395 0.0326922 0.0121304 0.00803695 0.0151015 0.0256523 0.125973 0.0193846 0.00617491 0.00810066 0.00817637 0.010865 0.0240942 0.00636295 0.00493374 0.00534069 0.0141125 0.00967398 0.0455132 0.0218938 0.0210558 0.00668291 0.00942435 0.0143028 0.00366473 0.00316609 0.00283762 0.00727046 0.00522429 0.0144093 0.00696828 0.0218216 0.0163768 0.00508476 0.0120174 0.00939547 0.0229463 0.0234686 0.0321382 0.0685147	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG1 drugs (e.g. , DRUG0 , DRUG2 ) and other drugs and foods with known high DRUG0 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0538785 0.0424676 0.060992 0.0270431 0.0242607 0.0195142 0.0218963 0.00766812 0.00467814 0.00789292 0.00942175 0.0536434 0.00618325 0.00345375 0.0039562 0.00470052 0.00627642 0.00752927 0.0159138 0.0098039 0.0160672 0.0347684 0.0162826 0.0747169 0.0421736 0.063677 0.0585191 0.0538939 0.0316208 0.00568866 0.00472465 0.00348863 0.00735322 0.0050962 0.0139156 0.00624207 0.0188132 0.0138157 0.00407227 0.0097664 0.00757435 0.018484 0.0189827 0.0253192 0.0537701	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG1 drugs (e.g. , DRUG0 , DRUG0 ) and other drugs and foods with known high DRUG2 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0535327 0.0440243 0.0619449 0.0281869 0.0242194 0.0176584 0.0182752 0.00578947 0.00295705 0.00423874 0.00342619 0.0105145 0.0113409 0.00516546 0.00643592 0.0350809 0.00878699 0.0085359 0.0179394 0.0102516 0.0173182 0.0390155 0.0170359 0.0739769 0.0394695 0.0637661 0.0604134 0.0538473 0.0315546 0.00566329 0.00473735 0.00350348 0.00759463 0.00527047 0.0143895 0.00644031 0.019492 0.0142505 0.00416866 0.0100946 0.00783229 0.0191094 0.0197166 0.0265569 0.0564776	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG0 drugs (e.g. , DRUG1 , DRUG0 ) and other drugs and foods with known high DRUG2 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.0510489 0.0416572 0.0573539 0.0254013 0.0215465 0.0148975 0.015359 0.0049287 0.00245115 0.00350652 0.00250727 0.00785196 0.00725424 0.00280129 0.00284408 0.0070687 0.00825629 0.0479019 0.0178158 0.00904144 0.0157297 0.038353 0.01819 0.0846511 0.0455508 0.0718591 0.0616644 0.0546589 0.0304862 0.0056774 0.0047254 0.00349248 0.00762153 0.00529965 0.0144806 0.00649819 0.0196159 0.0143891 0.00422627 0.0102291 0.00794896 0.0192914 0.0198756 0.0268096 0.057182	Because DRUG0 exhibits some monoamine oxidase inhibitory activity , DRUG0 , DRUG0 drugs (e.g. , DRUG0 , DRUG1 ) and other drugs and foods with known high DRUG2 content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
4	4	0.124305 0.193107 0.118056 0.034008 0.101353 0.0293997 0.0680387 0.0485994 0.0559837 0.047578 0.047163 0.0457078 0.0867003	No cross-resistance with other DRUG1 , radiotherapy or DRUG2 has been demonstrated .
2	4	0.07022 0.0448076 0.0556694 0.0616732 0.0600332 0.0306134 0.0612932 0.0692349 0.0603963 0.0213913 0.0602327 0.0540314 0.0350865 0.0362104 0.0583718 0.0536244 0.0448514 0.0541092 0.0681498	Enhancement of humoral immune responses to inactivated Newcastle disease and DRUG1 by oral administration of DRUG2 in chickens .
4	4	0.0184316 0.027606 0.0190214 0.00703962 0.0177078 0.0226047 0.0254051 0.028366 0.0135448 0.0133138 0.00678202 0.0131557 0.0174814 0.0197544 0.0190937 0.0194013 0.0168916 0.0173029 0.0181131 0.0272009 0.0515839 0.0772584 0.0437449 0.0364557 0.0515783 0.0493034 0.0440272 0.0580318 0.0445037 0.05061 0.0574844 0.0672002	In experiment 1 , oral administration of DRUG1 at a dose of 5 mg/kg of BW for 7 d on the immune response in chickens intramuscularly injected with DRUG2 was evaluated .
2	2	0.0152192 0.0208076 0.0145409 0.0104877 0.0374169 0.0622898 0.0494004 0.0433145 0.0474368 0.0332141 0.0226471 0.029349 0.0482496 0.0827176 0.0728318 0.0331022 0.00700011 0.00713575 0.0366728 0.0461919 0.0298904 0.0500094 0.0249711 0.0113653 0.0242484 0.0329085 0.0229088 0.0214156 0.0247009 0.0375557	In experiment 2 , the same regimen of DRUG1 was administered to chickens inoculated with DRUG2 , and an enhanced serum antibody response to AI vaccination was also observed .
4	4	0.0329098 0.0445199 0.0395959 0.0328567 0.0507886 0.0762673 0.0206863 0.0302742 0.0202669 0.026831 0.01332 0.0199924 0.0334339 0.0312928 0.027763 0.0350287 0.0161843 0.0201103 0.0173082 0.034048 0.0124261 0.00597576 0.00451981 0.0044937 0.00199388 0.00361486 0.00471264 0.00537536 0.00344121 0.00231495 0.00508209 0.00831405 0.00811634 0.0201916 0.0116865 0.0116343 0.00361943 0.00920338 0.0441168 0.0195057 0.0177817 0.0226584 0.00979231 0.0158284 0.0144577 0.00862441 0.0154782 0.0131338 0.0133464 0.0148412 0.0402411	CYP 3A4 Inhibitors (e.g . DRUG1 and DRUG2 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG0 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
3	4	0.0209349 0.0287535 0.0297663 0.025107 0.0481189 0.0469863 0.00974361 0.00892715 0.0121462 0.0189152 0.0126058 0.016163 0.0284203 0.0318544 0.0346395 0.0497195 0.0300716 0.0377689 0.0255495 0.056871 0.0276603 0.0193149 0.0164895 0.0198987 0.0110417 0.0150093 0.00966578 0.009761 0.00369907 0.00246384 0.00458297 0.00807469 0.00715388 0.0170097 0.010599 0.0122506 0.00378322 0.00871831 0.0415033 0.0202581 0.0167935 0.0192115 0.0082671 0.0131844 0.0119417 0.007168 0.0129272 0.0111075 0.0113306 0.0125014 0.0335667	CYP 3A4 Inhibitors (e.g . DRUG1 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG2 (e.g . DRUG0 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0222527 0.030533 0.031573 0.0265935 0.050949 0.049619 0.0102745 0.00931569 0.0125493 0.019101 0.0124342 0.0159433 0.0273792 0.0302634 0.0323124 0.0461422 0.0275485 0.0345509 0.0265781 0.056396 0.0232484 0.0116525 0.0092641 0.00962272 0.00496415 0.00679372 0.0181544 0.0325662 0.0174459 0.0026234 0.00381063 0.00494524 0.00472025 0.013655 0.0102272 0.0124249 0.00362272 0.00892302 0.0415191 0.0197699 0.017007 0.0209378 0.00889314 0.0141366 0.0127813 0.00765434 0.0137152 0.0117601 0.0119829 0.0132533 0.0356161	CYP 3A4 Inhibitors (e.g . DRUG1 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG2 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0232755 0.031934 0.0330075 0.0277972 0.0532293 0.0517887 0.0107286 0.00968463 0.0130078 0.0196617 0.0126769 0.0162591 0.0278233 0.0308197 0.0327808 0.0467468 0.0275918 0.0343666 0.0263445 0.0546201 0.0220831 0.0108236 0.00828649 0.00828262 0.00352696 0.00501478 0.0113355 0.0119247 0.00578557 0.00777573 0.0135563 0.00728862 0.00516282 0.0151226 0.0111516 0.0139762 0.00402884 0.00970002 0.0446371 0.0211941 0.0178582 0.0217847 0.00928942 0.0147643 0.0133553 0.00799406 0.0143396 0.012287 0.0125095 0.0138308 0.0371854	CYP 3A4 Inhibitors (e.g . DRUG1 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG0 and DRUG2 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0189685 0.0281953 0.0296347 0.0242786 0.0313078 0.0142585 0.0106554 0.0441222 0.0170646 0.0184647 0.0111145 0.0162389 0.0330776 0.0345583 0.0350955 0.0491169 0.0294152 0.0373275 0.0253374 0.0567663 0.027401 0.0190664 0.0163404 0.0197873 0.0110046 0.0150666 0.00983807 0.00998605 0.00379436 0.00252624 0.00469504 0.00827003 0.00732545 0.0174302 0.0108718 0.0125795 0.00388756 0.0089531 0.0426838 0.0208523 0.017292 0.0197749 0.00850973 0.0135694 0.0122908 0.00737786 0.0133063 0.0114343 0.0116643 0.0128692 0.0345534	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG1 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG2 (e.g . DRUG0 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0202001 0.0300227 0.0315329 0.0257877 0.0331882 0.0150572 0.0112498 0.0464668 0.0177538 0.0187209 0.0109528 0.0159522 0.031668 0.0326433 0.0325041 0.0453102 0.0267846 0.0340466 0.0263303 0.0564636 0.0230387 0.0114745 0.00914336 0.00958059 0.00499523 0.00690506 0.0184911 0.033196 0.0178256 0.00268705 0.00389959 0.00506312 0.00483256 0.0140013 0.0105044 0.0127746 0.00372492 0.00916479 0.0427834 0.0204039 0.0175477 0.0215792 0.00916509 0.0145646 0.0131681 0.00788637 0.0141319 0.0121197 0.0123508 0.013659 0.0367017	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG1 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG2 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0211427 0.031425 0.0329944 0.0269744 0.0346774 0.0157104 0.0117321 0.048432 0.0184458 0.0192992 0.0111872 0.016268 0.032157 0.0332179 0.0329451 0.0459003 0.0268417 0.033896 0.0261142 0.0546926 0.0218951 0.0106563 0.0081762 0.00824375 0.00354472 0.00509953 0.0115522 0.0121841 0.00592023 0.00795965 0.0139034 0.00748309 0.00529112 0.0154995 0.0114574 0.0143816 0.00414562 0.0099711 0.0460331 0.021891 0.0184391 0.0224645 0.00957861 0.0152193 0.0137664 0.00824051 0.0147824 0.0126687 0.0128997 0.014261 0.0383372	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG1 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG0 and DRUG2 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0117535 0.0142722 0.0121381 0.00835934 0.0089924 0.00394133 0.00266276 0.00677179 0.0128184 0.0218819 0.011411 0.0186852 0.0384228 0.0411398 0.0401376 0.0543853 0.0273033 0.0375234 0.0301135 0.0713328 0.0317888 0.0185149 0.017562 0.0189831 0.0108086 0.0298606 0.020331 0.0327744 0.014717 0.00283428 0.00424345 0.00585587 0.00574985 0.0171748 0.0122196 0.0146443 0.00426204 0.0100576 0.0486222 0.0241196 0.0199526 0.0227049 0.00962793 0.0151852 0.0135784 0.0081169 0.0145443 0.0125708 0.0129135 0.0141191 0.0375159	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG1 (e.g . DRUG2 and DRUG0 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0118018 0.0143335 0.0122107 0.00843171 0.00908672 0.00396483 0.00269357 0.00683106 0.0129943 0.0221607 0.011644 0.0189843 0.0389583 0.0415572 0.0402451 0.0540724 0.0267283 0.0369881 0.0294082 0.0700311 0.0300715 0.0171985 0.0170286 0.0193006 0.0115929 0.0308445 0.0173002 0.0233554 0.00964214 0.0109004 0.0183756 0.010624 0.00647603 0.0174507 0.0125022 0.0148656 0.00440522 0.0101076 0.0466416 0.0229646 0.0189488 0.0215655 0.00924136 0.0146094 0.0131638 0.00790113 0.0142388 0.0122879 0.0125786 0.0138063 0.0368845	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG1 (e.g . DRUG0 and DRUG2 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0118506 0.0143529 0.0121829 0.00844275 0.00900898 0.00385147 0.00256548 0.0063441 0.0116715 0.019671 0.0099351 0.0160254 0.0320499 0.0315438 0.0262638 0.0341736 0.0162479 0.0221274 0.019289 0.0468088 0.0208375 0.012433 0.0132514 0.0125099 0.00736004 0.0138418 0.0331446 0.0482864 0.0998385 0.0249139 0.0294806 0.0167439 0.00941821 0.0191704 0.0127147 0.0150125 0.00461701 0.0107422 0.0459413 0.0220021 0.0179436 0.0215067 0.009171 0.0146006 0.0131813 0.00790604 0.0141544 0.012134 0.0123679 0.0136728 0.0366956	CYP 3A4 Inhibitors (e.g . DRUG0 and DRUG0 ) There have been rare reports of serious adverse events in connection with the coadministration of certain DRUG0 (e.g . DRUG1 and DRUG2 ) and potent CYP 3A4 inhibitors , resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities .
4	4	0.0566087 0.0280404 0.0225239 0.0484143 0.0617625 0.0682685 0.0738425 0.0704152 0.110044 0.0773928 0.0972188 0.0552246 0.0146891 0.0106182 0.0144651 0.00326991 0.00335846 0.00259976 0.0035272 0.00316977 0.00326592 0.00603515 0.00678209 0.00251369 0.00290834 0.00166663 0.00142206 0.00190865 0.00152487 0.00209186 0.00156011 0.00218068 0.00171071 0.0025846 0.0018456 0.00185199 0.00263927 0.00164347 0.0015085 0.00232324 0.0018771 0.00322945 0.00299027 0.00848142 0.0143674 0.0936337	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0552787 0.0272926 0.0220382 0.0477907 0.0613467 0.0677543 0.0740161 0.0704735 0.110125 0.075129 0.09592 0.0572647 0.0110187 0.0101999 0.00711388 0.00794823 0.0154302 0.0032732 0.00401804 0.00369705 0.00361175 0.00651729 0.00693741 0.00261867 0.00288481 0.0016849 0.00143343 0.00189328 0.0015208 0.00206321 0.0015484 0.00214684 0.00168988 0.00253715 0.00182855 0.0018449 0.00259105 0.00162508 0.00148767 0.00228187 0.00184588 0.00316995 0.00294673 0.00834895 0.014176 0.0916375	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0550054 0.0271416 0.0218726 0.0473404 0.0608828 0.0671597 0.0728595 0.0689658 0.107644 0.0730643 0.093503 0.0554384 0.0106361 0.0101795 0.00597384 0.00593666 0.00621239 0.00853959 0.019353 0.00552816 0.00405401 0.00567192 0.0065356 0.00256636 0.00312258 0.00165999 0.00142423 0.00198221 0.00153519 0.00216234 0.00155985 0.00223833 0.00170656 0.00263962 0.0018276 0.00183336 0.00265028 0.00160374 0.00149416 0.00234604 0.00186826 0.0032622 0.00298305 0.00853455 0.0145197 0.094982	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0515266 0.0251779 0.0202567 0.0440763 0.0565626 0.0624041 0.0672506 0.0629829 0.102017 0.0699139 0.0883555 0.045037 0.00837569 0.00741909 0.00485937 0.00496086 0.004806 0.00625716 0.00671377 0.0136271 0.0135922 0.0326875 0.0311344 0.00896746 0.0101036 0.00294339 0.00187001 0.00218626 0.00178331 0.00223339 0.00174849 0.00224874 0.00182326 0.00255099 0.00193181 0.00193513 0.0026837 0.00177327 0.00158246 0.00233091 0.00193603 0.00319213 0.00302231 0.00837792 0.0141244 0.0886566	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0520638 0.0254547 0.0204972 0.0446349 0.0572853 0.0632316 0.0684325 0.0642902 0.103662 0.0706431 0.0893219 0.04657 0.00828261 0.00743281 0.00483922 0.00494714 0.00474536 0.00651049 0.00662275 0.0134461 0.0129543 0.0265154 0.0257402 0.00945356 0.00507986 0.00311979 0.0035807 0.00897846 0.00179458 0.00207456 0.00164537 0.00210628 0.00172925 0.00241818 0.00192794 0.00195316 0.0025873 0.00172789 0.00151855 0.00221216 0.00184682 0.00306444 0.00292532 0.00820911 0.013966 0.0879567	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0522337 0.0255356 0.0205619 0.0447758 0.0574571 0.063406 0.0686015 0.0644259 0.103886 0.0707348 0.0893085 0.0466049 0.00830101 0.00745383 0.00484035 0.00496005 0.00474561 0.00648857 0.00659848 0.013316 0.0130945 0.0259712 0.0239242 0.00846626 0.00422192 0.00231645 0.00215525 0.00340862 0.00371495 0.00919469 0.00178897 0.00212405 0.00175572 0.00241694 0.00200441 0.00203793 0.002631 0.0017797 0.00155082 0.00223089 0.00187866 0.00309418 0.00297101 0.00827316 0.0142016 0.0885574	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0522302 0.0255312 0.020556 0.044761 0.0574323 0.0633604 0.0685315 0.0643274 0.103732 0.070618 0.0890852 0.0465186 0.00831203 0.00746213 0.00483864 0.00496768 0.00474876 0.00649315 0.00661778 0.01334 0.013257 0.0259634 0.0231474 0.00809191 0.00394315 0.00215017 0.00191851 0.00259394 0.00222332 0.00344889 0.00375154 0.00933958 0.00190632 0.0024782 0.00218329 0.00219349 0.00272517 0.00185662 0.00159608 0.00226469 0.00191689 0.00313378 0.00301504 0.00834867 0.0143663 0.0887225	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0516199 0.0252226 0.0202835 0.0441212 0.0566243 0.0624721 0.0673456 0.0631507 0.102349 0.0702133 0.0890232 0.0450912 0.00809405 0.00713047 0.00473521 0.00477608 0.00467364 0.00619297 0.00639278 0.0126991 0.0124606 0.0242238 0.0217104 0.00761838 0.00368724 0.00206532 0.00185218 0.00249058 0.00200088 0.00271872 0.00223468 0.00356325 0.00383881 0.0106495 0.00287732 0.00260195 0.00300316 0.00183132 0.00160975 0.00243515 0.00197246 0.00341887 0.00317452 0.00918195 0.015744 0.0988243	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0522999 0.0255443 0.0205556 0.0447501 0.0574029 0.063327 0.0683308 0.0640945 0.104042 0.0712476 0.0901842 0.045789 0.00817334 0.00721721 0.00481628 0.00484633 0.00474464 0.00627546 0.006508 0.0129355 0.0130135 0.024844 0.021477 0.00751161 0.00361919 0.00201779 0.00181543 0.00239615 0.0019385 0.00255598 0.00198117 0.00272867 0.0023891 0.00424409 0.00420691 0.00401614 0.00884946 0.00259007 0.00190172 0.00259949 0.00214644 0.00337436 0.00317131 0.00854304 0.0146349 0.0883485	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0524438 0.0256138 0.0206267 0.0449558 0.0576944 0.0636502 0.0688565 0.0646285 0.10452 0.0712746 0.0897677 0.0462476 0.00820946 0.00733629 0.00482622 0.00489903 0.00472958 0.00633549 0.00648269 0.0129613 0.0130039 0.0250452 0.0215193 0.00748567 0.00361272 0.00200079 0.00180462 0.00237087 0.00192827 0.00252534 0.00199883 0.00270622 0.00221198 0.0032633 0.00286324 0.00292156 0.003649 0.00258508 0.00319879 0.00930168 0.00214415 0.00319675 0.00298162 0.00758997 0.0143066 0.0877248	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0523784 0.0255777 0.0205961 0.0448961 0.0576227 0.0635483 0.0687674 0.0645387 0.10426 0.0710193 0.0892519 0.0460461 0.00817575 0.00732058 0.00479272 0.00487929 0.00469517 0.00632314 0.00646373 0.0129697 0.0130311 0.0252011 0.0216441 0.00752105 0.00359873 0.00199294 0.00179719 0.00235553 0.00192166 0.00250799 0.00200243 0.00268322 0.00220897 0.00310784 0.00271228 0.00271302 0.00314115 0.00195263 0.00182452 0.00322311 0.00372565 0.0121785 0.00309348 0.00749527 0.0149844 0.0872593	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0516542 0.0252179 0.020291 0.0441974 0.0567265 0.0625171 0.0675601 0.0633388 0.102293 0.0697865 0.0874254 0.0445556 0.0079854 0.00710894 0.00463359 0.00472671 0.00454851 0.00612788 0.00629205 0.0126664 0.0127292 0.0246162 0.0209799 0.00734134 0.00344171 0.00193312 0.00172899 0.00222831 0.00183738 0.00236424 0.001909 0.0025268 0.00210436 0.00293795 0.00256575 0.00251151 0.00283654 0.00179486 0.00163481 0.00247393 0.00213708 0.0038139 0.00564552 0.0287241 0.0185282 0.0890019	Examples of some of the more potent CYP 3A4 inhibitors include DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.048719 0.0253412 0.0213751 0.0476743 0.0625461 0.0718085 0.0801306 0.0741849 0.115536 0.0733982 0.0791754 0.0103908 0.00489938 0.00500975 0.0240694 0.00579352 0.00452769 0.00542408 0.00573796 0.0119339 0.0123336 0.0262788 0.025318 0.00753368 0.00788025 0.0024524 0.0016474 0.00201121 0.00165178 0.00208017 0.00162387 0.00209962 0.00170066 0.00238673 0.00182357 0.00181138 0.00252764 0.00166932 0.00148709 0.00220362 0.00182969 0.00302173 0.00287714 0.0080028 0.0135189 0.0845527	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0487025 0.0253629 0.0214509 0.0480092 0.0631817 0.0727293 0.081396 0.075526 0.117455 0.0743113 0.0805489 0.0106033 0.00510723 0.005254 0.0250303 0.00582639 0.00447798 0.00561562 0.00557756 0.0114861 0.0116612 0.0215624 0.0206117 0.00794803 0.00417614 0.0028897 0.00328745 0.00787132 0.00160215 0.00191064 0.00152254 0.00195191 0.0016071 0.0022399 0.00180829 0.0018206 0.00240821 0.00161347 0.0014147 0.00206826 0.00172661 0.00285946 0.00274826 0.00768061 0.0131377 0.0822196	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0487665 0.0253954 0.0214816 0.0480942 0.0632996 0.0728683 0.0815479 0.0756622 0.117705 0.0744368 0.0804767 0.010594 0.00511488 0.00526292 0.0250171 0.00581985 0.00446121 0.00559286 0.00553816 0.0113077 0.011786 0.0211184 0.0192207 0.00716202 0.00347299 0.00213651 0.00203578 0.0031136 0.00343386 0.00834057 0.00162835 0.00197094 0.0016267 0.00223505 0.001876 0.00189377 0.00244593 0.00165701 0.00143996 0.00207953 0.00175014 0.00287825 0.00278278 0.0077186 0.0133166 0.0824376	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.048728 0.0253714 0.0214592 0.0480448 0.0632329 0.0727865 0.081441 0.0755469 0.117552 0.0743606 0.0803033 0.0105673 0.00510345 0.00524946 0.0249554 0.00581798 0.00445534 0.00558696 0.00554121 0.0112968 0.0119285 0.0210647 0.018615 0.00686853 0.00325409 0.00198308 0.00183267 0.00240149 0.00207951 0.00313529 0.00350677 0.00859088 0.00175677 0.00230875 0.00204505 0.00203476 0.00253834 0.00172901 0.00148138 0.00211127 0.00178553 0.00291542 0.00282529 0.0077905 0.0134805 0.0825367	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0483882 0.0251649 0.021234 0.0474217 0.0623179 0.0716682 0.0800433 0.0741484 0.115533 0.0735622 0.0795361 0.0104888 0.00498267 0.00506522 0.0240526 0.00562447 0.00440611 0.0054552 0.00545304 0.0108917 0.0113851 0.0197934 0.0177959 0.00657305 0.00308293 0.00193273 0.00180167 0.00233384 0.00191791 0.00252832 0.00213059 0.00328823 0.00367105 0.00993852 0.00266132 0.00241224 0.00280581 0.00170833 0.00149573 0.00226229 0.00183654 0.00316373 0.0029634 0.00855229 0.0146898 0.0918374	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0489055 0.0254272 0.0214724 0.048017 0.0631076 0.0725964 0.0811316 0.0751402 0.11723 0.0745584 0.0804177 0.0106209 0.00504847 0.00514287 0.0244588 0.00570696 0.00446178 0.00551308 0.00553462 0.0110305 0.0118594 0.0202675 0.0175314 0.00647398 0.0030342 0.0018825 0.001763 0.00224075 0.00185868 0.00237576 0.00191436 0.00255299 0.00231204 0.00386022 0.00389663 0.00381883 0.00800811 0.0023865 0.001754 0.00241703 0.00199156 0.00313257 0.00295172 0.00793735 0.0136812 0.0825758	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0488406 0.0254099 0.0214896 0.048136 0.0633515 0.0729278 0.0816134 0.0756631 0.117905 0.0746969 0.0806006 0.0105912 0.00508383 0.00521035 0.0247909 0.00575001 0.00443568 0.00550586 0.00547202 0.0109691 0.0117612 0.0203483 0.0173931 0.00639863 0.00301151 0.00185175 0.00174124 0.00220727 0.00184328 0.00234259 0.00193431 0.0025246 0.00216532 0.00300341 0.00272377 0.00292633 0.00335703 0.00242809 0.00298622 0.00856 0.0019782 0.0029755 0.00277078 0.00704446 0.0133838 0.0818952	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0487275 0.0253539 0.0214459 0.048044 0.0632393 0.072802 0.0814795 0.0755494 0.117687 0.0745006 0.0802988 0.0105167 0.00505763 0.00518771 0.0246786 0.00572192 0.00440015 0.00547636 0.00543937 0.0109533 0.0117525 0.0204129 0.017439 0.00640906 0.00299424 0.00184077 0.00173314 0.0021892 0.0018363 0.00232505 0.00194324 0.00250528 0.00217763 0.0028653 0.00259235 0.00273761 0.00287921 0.00182441 0.00168647 0.00300136 0.00349102 0.0112618 0.00287587 0.0070116 0.014026 0.0816285	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0482018 0.0250729 0.0211893 0.0474135 0.0623779 0.0717466 0.0802014 0.0743097 0.115709 0.0733233 0.0787449 0.0102404 0.0049111 0.00501647 0.0238202 0.00553879 0.00426657 0.00531955 0.0052944 0.0107246 0.0115003 0.0198493 0.0169265 0.00624475 0.00286305 0.0017956 0.00167362 0.00207737 0.00176016 0.0021976 0.00185691 0.00236598 0.00208668 0.00272426 0.00246879 0.00254258 0.00261064 0.00168769 0.00152523 0.00232028 0.0020192 0.0036124 0.00531612 0.0268806 0.0172384 0.0824339	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0516556 0.0267916 0.0219885 0.047105 0.0600157 0.0684298 0.0740597 0.0660132 0.103278 0.0671687 0.0757079 0.0093491 0.00330092 0.00267491 0.00669546 0.00678992 0.0315207 0.00756656 0.00737873 0.0139276 0.0137398 0.0320315 0.0296471 0.00807857 0.00896524 0.00269423 0.00182013 0.0022175 0.00180679 0.00227762 0.00176808 0.0022934 0.00184967 0.00260914 0.00197739 0.00196484 0.00276433 0.00180774 0.00161084 0.00239266 0.00198197 0.00328119 0.00311995 0.00874075 0.0146752 0.0924663	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0518633 0.0269523 0.0221285 0.0473766 0.0603522 0.0689782 0.0747926 0.0668101 0.104443 0.068195 0.0779123 0.00963981 0.00341882 0.00280972 0.00714821 0.00751194 0.0347353 0.00795944 0.00722983 0.013621 0.0131307 0.0260688 0.0234523 0.00824137 0.00462169 0.00305824 0.00350094 0.00846513 0.00172579 0.00207308 0.00164438 0.00212531 0.00173718 0.00244548 0.00194864 0.00196187 0.00264433 0.00174876 0.00153699 0.00226083 0.00187893 0.00312603 0.0029935 0.00846114 0.0143574 0.0909131	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0519631 0.0270086 0.0221666 0.0474228 0.0603667 0.0689898 0.0747818 0.0667771 0.1044 0.0682249 0.0780782 0.00968009 0.00343485 0.0028308 0.00722317 0.00761625 0.0350723 0.00796532 0.00720834 0.0135221 0.0133195 0.0256605 0.0218635 0.00741447 0.0038491 0.00226046 0.00211668 0.00336332 0.00368108 0.00881223 0.00174597 0.00213796 0.00175852 0.00244244 0.00201543 0.00203393 0.00268602 0.00179274 0.00156182 0.00227309 0.00190227 0.00314521 0.003026 0.00849931 0.0145309 0.0913744	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0519178 0.0269848 0.0221426 0.0473557 0.0602635 0.0688653 0.0746297 0.0666271 0.104175 0.0680993 0.0779932 0.00967204 0.00343127 0.0028297 0.00722296 0.00761788 0.035069 0.00797091 0.00722545 0.0135576 0.0135015 0.0256767 0.0211978 0.00710508 0.00360102 0.00209932 0.00189963 0.00258523 0.00219227 0.00340299 0.00377033 0.00905231 0.00188185 0.00251499 0.00219457 0.00218561 0.00278845 0.00186913 0.00160418 0.00230617 0.00193722 0.00318132 0.00306527 0.00856536 0.0146785 0.0914926	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0514389 0.0266988 0.0218908 0.046818 0.0595946 0.0680713 0.0736628 0.0657121 0.102796 0.0672793 0.0768159 0.00958344 0.00338531 0.00276597 0.00704165 0.0072572 0.0335094 0.00764901 0.00701833 0.0128838 0.0127571 0.023994 0.0200818 0.0067607 0.00340045 0.0020286 0.00185187 0.00249838 0.00200171 0.00271639 0.00223652 0.00354136 0.0038991 0.0104745 0.00281875 0.00257295 0.0030599 0.00184875 0.00161991 0.00246588 0.00199083 0.00345273 0.00321441 0.00938925 0.016017 0.101434	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0521505 0.0270697 0.0221883 0.0474269 0.0603053 0.068875 0.0745118 0.0663423 0.103846 0.0680178 0.0778642 0.00973166 0.00342981 0.00281563 0.00724646 0.00749292 0.0344898 0.00782482 0.00717141 0.0131801 0.0133595 0.0247222 0.0199187 0.00669064 0.00335177 0.00198584 0.00182127 0.00241187 0.00194868 0.0025697 0.00200729 0.00275546 0.00242823 0.00420197 0.00421153 0.00407137 0.00877844 0.00258688 0.00191322 0.00264392 0.0021693 0.00341927 0.0032121 0.00871952 0.0149261 0.0911952	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0521421 0.027085 0.0222171 0.0475152 0.0604509 0.0690734 0.0748266 0.0666902 0.104342 0.0682931 0.0783188 0.00971249 0.00343177 0.00282551 0.00727403 0.00761475 0.0349948 0.00788876 0.00714445 0.0131835 0.0133052 0.0248401 0.0198463 0.00662899 0.00333639 0.00196252 0.00180376 0.00238374 0.0019347 0.00254044 0.00202451 0.00273622 0.0022589 0.00327763 0.00289853 0.00298171 0.00368481 0.00258784 0.00321351 0.00921401 0.0021353 0.0032475 0.00301328 0.00774208 0.0145797 0.090798	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0519874 0.0270091 0.0221592 0.0473954 0.0603052 0.0689136 0.0746756 0.0665915 0.104178 0.0681541 0.078113 0.00965245 0.00341398 0.00281077 0.00721579 0.00757357 0.034818 0.00785127 0.00710502 0.0131754 0.0133036 0.0249476 0.0199103 0.0066442 0.00331399 0.00195039 0.00179306 0.00236373 0.00192517 0.00251992 0.00202813 0.00271231 0.002262 0.00312471 0.00274727 0.00277205 0.0031598 0.00194439 0.00180104 0.00324267 0.00377071 0.0120292 0.00309091 0.00768526 0.0152617 0.0905981	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0511918 0.0265882 0.021813 0.0466535 0.0593772 0.0678171 0.0734506 0.065542 0.102534 0.0670297 0.0764632 0.00939822 0.00332717 0.0027261 0.00692087 0.00723816 0.0334058 0.00755973 0.00687551 0.0128417 0.0129649 0.0242809 0.0192799 0.00647718 0.00315455 0.00188775 0.00172065 0.00222791 0.00183549 0.00236665 0.0019289 0.00254514 0.00215394 0.00294633 0.00259977 0.00256609 0.00284916 0.00178771 0.00161628 0.00248433 0.00213185 0.00382762 0.00571332 0.0288046 0.0185612 0.0925344	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0545037 0.0283182 0.0227614 0.0468585 0.0578915 0.0653797 0.0680689 0.0588008 0.0910397 0.0578222 0.0682091 0.00884372 0.00316358 0.00224695 0.004343 0.00356508 0.00970622 0.0103729 0.0541805 0.0192496 0.0143717 0.0353101 0.032143 0.00873067 0.0103502 0.00293091 0.00195763 0.00233901 0.00188986 0.00238592 0.00183723 0.00239706 0.00192137 0.00274095 0.00204802 0.00203595 0.00289169 0.00186312 0.00166036 0.00247846 0.00204114 0.00340538 0.00322193 0.00915089 0.0152434 0.0973291	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0546432 0.028455 0.0228798 0.0470444 0.0580895 0.0657587 0.0685716 0.0594336 0.0919541 0.0585405 0.0703347 0.00919016 0.00330526 0.0023403 0.00459523 0.00385323 0.0104922 0.0120765 0.0603498 0.0193822 0.0135852 0.0279578 0.0239039 0.0078971 0.00489905 0.00317938 0.00365156 0.00908227 0.00182873 0.00218371 0.00172955 0.00223907 0.0018239 0.00258251 0.00203825 0.00205036 0.00279494 0.0018294 0.0016111 0.00237965 0.00196957 0.00329293 0.0031387 0.00897193 0.0151352 0.0969541	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0547318 0.0285096 0.0229119 0.0470622 0.0580548 0.0657212 0.0684835 0.0593418 0.091812 0.058513 0.0705373 0.00924336 0.0033246 0.00235338 0.00462691 0.00389755 0.0105934 0.0122903 0.0608935 0.0193098 0.0137021 0.027553 0.0221979 0.00704745 0.00408004 0.00233987 0.00214358 0.00346159 0.00380366 0.00930739 0.00183489 0.00224618 0.00185018 0.00258159 0.00210859 0.00212851 0.00284228 0.0018768 0.00163719 0.00239286 0.00199384 0.00331385 0.00317227 0.00902634 0.0153328 0.0978134	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.054665 0.02848 0.02288 0.046965 0.0579012 0.0655456 0.068267 0.059139 0.0914967 0.0583497 0.0705036 0.00924797 0.00332599 0.00235487 0.00463389 0.00391084 0.0106188 0.0123558 0.061064 0.0193682 0.0138766 0.0276442 0.0215298 0.00672604 0.00380527 0.00216809 0.00190703 0.00263797 0.00221018 0.00352268 0.00391417 0.00956773 0.00197597 0.00265324 0.00229638 0.00229067 0.00295219 0.00195751 0.00168114 0.0024272 0.00202906 0.00334936 0.0032097 0.00909385 0.0154773 0.0980234	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0542829 0.0282637 0.0226695 0.0464588 0.0572048 0.0647139 0.0671897 0.0580724 0.0898289 0.0574321 0.0695016 0.00920335 0.0032999 0.0023258 0.00458118 0.0038387 0.0104754 0.0118816 0.0586742 0.0182693 0.0131138 0.0258344 0.0204151 0.00641451 0.00360503 0.00209014 0.00185415 0.00254709 0.00199688 0.00278135 0.00226307 0.00368801 0.0040301 0.0110707 0.0029576 0.00270441 0.00324819 0.00195042 0.00170891 0.00261575 0.00209894 0.00367143 0.00339391 0.0100102 0.0170016 0.108767	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0550577 0.0286772 0.0229896 0.0470575 0.0578615 0.0654492 0.0678946 0.0585498 0.0905823 0.0579726 0.0706402 0.00937912 0.00335983 0.00237328 0.00471565 0.00395493 0.0108327 0.0123783 0.0607302 0.0188279 0.0136847 0.0266349 0.0203316 0.00633985 0.00355128 0.00205409 0.00183135 0.00247092 0.00195133 0.00264221 0.00201625 0.00283913 0.00244582 0.00439248 0.00440582 0.00428233 0.00947467 0.00273149 0.00202123 0.00278732 0.00228143 0.00360616 0.00337518 0.00928204 0.0157587 0.0975235	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0550753 0.0286874 0.0230256 0.047213 0.0581459 0.0657994 0.0684272 0.0590952 0.0914068 0.0583839 0.0708773 0.00932567 0.00334613 0.00236394 0.00469542 0.00394006 0.010784 0.0123907 0.0607734 0.0189337 0.013651 0.0266953 0.0202077 0.00626934 0.00352993 0.00203277 0.00181339 0.00244449 0.00193642 0.00261406 0.00202791 0.00282423 0.0022664 0.00343494 0.00297108 0.00288437 0.00389842 0.00264671 0.00332834 0.0098217 0.00225682 0.00344024 0.00319539 0.00826682 0.0154779 0.0973744	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.054869 0.0285833 0.022949 0.0470685 0.057982 0.0656272 0.0682876 0.0590314 0.0913222 0.0583086 0.0707408 0.00927331 0.00332979 0.00235278 0.00466465 0.00392132 0.0106927 0.0123356 0.0605106 0.0189228 0.0136646 0.0268447 0.0202675 0.00628721 0.00350347 0.00202066 0.00180169 0.00242397 0.00192541 0.00259233 0.00202726 0.00279855 0.0022608 0.00327153 0.0027993 0.00264906 0.00333886 0.0019883 0.00184437 0.00335337 0.00393044 0.01279 0.00325913 0.00817658 0.0162154 0.0971922	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0538507 0.0280503 0.0225215 0.046192 0.0569075 0.0643966 0.0669774 0.0579791 0.089744 0.057317 0.0692813 0.00903422 0.00324433 0.00228907 0.00449455 0.00378977 0.0102525 0.0118282 0.0582168 0.0183123 0.0133454 0.0262574 0.019672 0.00615659 0.00332841 0.00194678 0.0017226 0.00227687 0.00182868 0.00242602 0.0019212 0.00261696 0.00214112 0.00306679 0.00263931 0.00245623 0.00300337 0.00181748 0.00164267 0.0025484 0.00215464 0.00388261 0.00595093 0.0305212 0.0197366 0.100261	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0518127 0.0259019 0.0216867 0.0486421 0.0631771 0.0713206 0.0801586 0.0733283 0.113358 0.0649144 0.0549203 0.00692044 0.0024786 0.00158773 0.00249752 0.00165603 0.00313547 0.00219242 0.00513253 0.00499977 0.00766178 0.0240293 0.0336716 0.0141065 0.0343401 0.00981532 0.00844968 0.0115092 0.00253744 0.00265291 0.00212292 0.00250986 0.00216626 0.00279133 0.00238403 0.00240075 0.00294901 0.00209808 0.00181525 0.00253681 0.00216579 0.00344815 0.0033886 0.00892979 0.0156041 0.0940948	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0504072 0.0252364 0.0212131 0.0477621 0.0622335 0.0704555 0.0796142 0.0733026 0.112831 0.0642464 0.0537697 0.00673923 0.0024228 0.00154197 0.00238856 0.0015881 0.00299471 0.00213315 0.0050632 0.00507078 0.00805582 0.0251336 0.0336504 0.0148371 0.0375771 0.00792909 0.00804837 0.00573069 0.00670579 0.0130022 0.0024483 0.00265859 0.00220274 0.0027488 0.00248075 0.00251009 0.00291836 0.00211006 0.00181402 0.00249163 0.0021384 0.00338154 0.00335129 0.00872655 0.0154365 0.090898	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0499719 0.0250281 0.0210349 0.0473305 0.0616473 0.0697853 0.0788571 0.0725873 0.111718 0.063674 0.05341 0.00669801 0.00240377 0.00152886 0.00237041 0.00157324 0.00297645 0.00212109 0.00508786 0.00510192 0.0081883 0.0254781 0.0339601 0.0149598 0.0376939 0.00798799 0.00805743 0.00479267 0.00492845 0.0049651 0.00633547 0.0127324 0.0025319 0.00294666 0.00275063 0.00272134 0.00303405 0.00221522 0.00188368 0.0025481 0.00220507 0.00345515 0.00343831 0.00886719 0.0157347 0.0906824	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0494497 0.0247488 0.0207526 0.046598 0.0606598 0.0686317 0.0773262 0.070969 0.109335 0.0624953 0.0526201 0.00658639 0.00236741 0.00150413 0.00232858 0.00154784 0.00292522 0.00207934 0.00495231 0.00492907 0.00778596 0.0244123 0.0329269 0.0142354 0.0356505 0.00779593 0.00799201 0.00464909 0.00502968 0.00415523 0.00448894 0.00486048 0.00620138 0.0135561 0.00362295 0.00326708 0.00340827 0.00215062 0.00185033 0.00268024 0.00221811 0.00366366 0.00352668 0.00967718 0.0167375 0.10065	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0498233 0.0249258 0.0209027 0.0469354 0.0610173 0.0689798 0.0777469 0.071339 0.110083 0.0628638 0.0528418 0.00662792 0.00237171 0.00151054 0.00235651 0.00156152 0.00296651 0.00210299 0.00505036 0.00502657 0.00809448 0.0252076 0.0337846 0.0144337 0.0358916 0.00771699 0.00789739 0.00459699 0.00512692 0.00406873 0.00473056 0.00407755 0.00490894 0.00574793 0.00589747 0.00577036 0.00929837 0.00292844 0.00213537 0.00288329 0.00244181 0.00372751 0.00357999 0.00920057 0.0160628 0.0927561	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG2 (e.g. , DRUG0 , DRUG0 , DRUG0 ) .
4	4	0.0495979 0.0248209 0.0208474 0.0468983 0.061049 0.0690624 0.0779777 0.0716819 0.110474 0.062932 0.0525696 0.00657845 0.00235625 0.00150051 0.0023356 0.00154838 0.0029337 0.00208347 0.00499468 0.00499439 0.00802974 0.0249783 0.0333547 0.0143704 0.0361389 0.00762743 0.0078244 0.00456084 0.0051312 0.00402224 0.00489785 0.00401585 0.00471829 0.00426052 0.00409186 0.00531741 0.00445198 0.00350671 0.00426888 0.0111354 0.002515 0.0036377 0.00343284 0.00815536 0.0159517 0.0923679	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0493286 0.0246915 0.0207459 0.0466799 0.0607793 0.0687746 0.0776838 0.0714467 0.110065 0.0626767 0.0523616 0.00653286 0.00234155 0.00148962 0.0023174 0.00153571 0.00290912 0.00206796 0.00496393 0.0049734 0.00801031 0.0249053 0.0331204 0.0143489 0.0361479 0.00766621 0.00782897 0.00454943 0.00518225 0.00400433 0.00500168 0.00399609 0.00477664 0.00404859 0.00390581 0.00502949 0.00379287 0.00256832 0.0024694 0.00398515 0.00486431 0.01483 0.00365394 0.0082482 0.016781 0.0919193	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0488199 0.0244354 0.0205216 0.0461511 0.0601094 0.0680213 0.0767786 0.0705758 0.108678 0.0619022 0.0517979 0.00640709 0.00230225 0.00146091 0.00226012 0.00150113 0.00283176 0.00201827 0.00481538 0.00482286 0.00768243 0.0237962 0.0313111 0.0136074 0.0341986 0.00746536 0.00750516 0.00433458 0.00499399 0.00380977 0.00480593 0.0038114 0.00462006 0.00388384 0.00373004 0.00467907 0.00343644 0.00238689 0.00228823 0.00312028 0.00290262 0.0048059 0.00721237 0.0335552 0.0202593 0.0895866	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0534668 0.0266357 0.0222074 0.0497486 0.0648287 0.0731331 0.0813728 0.0739651 0.114663 0.065594 0.0531237 0.00661648 0.00238766 0.00152933 0.0023665 0.00158207 0.00294336 0.00204056 0.00467582 0.00450417 0.00608752 0.0152047 0.018513 0.00604932 0.00655949 0.00457201 0.00596153 0.0342338 0.00704486 0.0047062 0.00530452 0.00421569 0.00519096 0.00435275 0.00416479 0.00555041 0.00449789 0.00366407 0.00441198 0.0107853 0.00253865 0.00376239 0.00357173 0.00848357 0.0167268 0.0964616	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0531196 0.026469 0.022074 0.0494527 0.0644512 0.0727162 0.0809345 0.0735968 0.11406 0.0652667 0.0529599 0.00658156 0.00237666 0.0015194 0.00235288 0.00157067 0.00292602 0.00202819 0.00466111 0.00449847 0.00609203 0.0152788 0.0185026 0.00605852 0.00654614 0.0045873 0.00600386 0.0343723 0.00707519 0.00468006 0.00534133 0.00417555 0.00521875 0.00414406 0.00395108 0.00527201 0.00379919 0.00265764 0.00266669 0.00409344 0.00504653 0.0147447 0.00375053 0.00862805 0.0175731 0.0961244	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.052555 0.0261873 0.0218285 0.0488659 0.0636825 0.0718405 0.0798923 0.0726033 0.112427 0.064307 0.0523452 0.00644533 0.0023313 0.00148802 0.00228797 0.00153373 0.0028444 0.00198103 0.00453542 0.0043935 0.0059554 0.0150539 0.0179451 0.00591194 0.00623634 0.00437398 0.00567046 0.0323318 0.00678621 0.00443913 0.00511349 0.00396199 0.00502781 0.00395244 0.00376759 0.0049389 0.00344325 0.00249242 0.00255673 0.00325477 0.00315302 0.00500496 0.00766366 0.034302 0.020277 0.092011	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.054552 0.0271185 0.0225993 0.0507151 0.0661668 0.0745272 0.0828362 0.0753374 0.117483 0.0671255 0.0532007 0.00655959 0.00236577 0.00152275 0.00233983 0.00157144 0.00286211 0.00195945 0.00420777 0.00395688 0.00481861 0.0107578 0.0141765 0.00435262 0.00482825 0.00240955 0.00245015 0.00639692 0.00692969 0.0340974 0.00685729 0.00505906 0.00558085 0.00472187 0.00439052 0.00573157 0.00474424 0.00377597 0.00453096 0.0110252 0.00260437 0.00383356 0.00363052 0.0086596 0.0168607 0.0977692	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0542048 0.026952 0.022467 0.0504228 0.0657935 0.0741119 0.0824056 0.0749843 0.116916 0.0668517 0.0531082 0.0065331 0.00235773 0.00151383 0.00232876 0.00156079 0.00284771 0.00194809 0.00419639 0.00394949 0.00481282 0.0107934 0.0141856 0.00436302 0.00482431 0.00240747 0.00245647 0.00643704 0.00706942 0.0346642 0.00692617 0.00502813 0.00561025 0.00450142 0.00418221 0.00546397 0.00400779 0.00274167 0.00269708 0.00416327 0.00508736 0.0147231 0.0037683 0.00871844 0.0176145 0.0972987	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0536505 0.0266734 0.0222217 0.049829 0.0650021 0.0731952 0.0813106 0.0739331 0.115173 0.0658024 0.0523554 0.00637939 0.00230617 0.00147877 0.00225447 0.00151961 0.00275709 0.00189728 0.00407398 0.00385936 0.00472182 0.0107031 0.013817 0.00429078 0.00464383 0.00233255 0.00235828 0.00598659 0.00659964 0.0323647 0.0066241 0.00476846 0.00539269 0.00428519 0.00397769 0.00511733 0.00362221 0.0025627 0.00255655 0.00330036 0.00315527 0.0050469 0.00768691 0.0342075 0.0203234 0.0938819	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0544259 0.0270343 0.0224968 0.0504261 0.0656946 0.0738901 0.0819904 0.0744016 0.116348 0.066538 0.0531956 0.00660015 0.00236821 0.00152894 0.00236409 0.00158144 0.00287834 0.00194825 0.00411465 0.00379141 0.00444644 0.00947598 0.0127185 0.00374173 0.00438329 0.00214141 0.0018359 0.0038178 0.00315013 0.00776642 0.00789186 0.0386559 0.00758582 0.00577534 0.00505504 0.00641346 0.00534227 0.00427124 0.00496532 0.0118566 0.00275578 0.00398109 0.00378105 0.00888243 0.0172343 0.0984576	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0539732 0.0268169 0.0223212 0.0500302 0.0651752 0.0733025 0.081372 0.0738732 0.11551 0.0661586 0.0531873 0.00659056 0.00236499 0.00152151 0.00235831 0.00157216 0.00287134 0.00193972 0.00411822 0.00379285 0.00444976 0.00954993 0.0128408 0.00378481 0.00441427 0.002153 0.00184456 0.00387523 0.0032205 0.00796361 0.00827658 0.0399469 0.00761318 0.00554445 0.00484292 0.00612005 0.00449723 0.00309734 0.00301086 0.00446836 0.0054346 0.0155307 0.00392724 0.00892995 0.0179865 0.0978268	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0534847 0.0265698 0.0221021 0.0494956 0.0644553 0.0724597 0.0803574 0.0728985 0.113902 0.0651827 0.0524281 0.00643237 0.00231166 0.00148552 0.00228015 0.00152978 0.00277662 0.00188733 0.00399156 0.0037025 0.00435864 0.00944079 0.0124917 0.00371631 0.00425835 0.00208678 0.00178365 0.00364977 0.00306723 0.00740195 0.00771106 0.037386 0.00727868 0.00527641 0.00459319 0.00572137 0.00405612 0.0029005 0.00286785 0.00354072 0.00342997 0.0053411 0.00814278 0.0353587 0.0206512 0.0937554	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0546671 0.0271704 0.022771 0.0513944 0.0672202 0.0757081 0.084659 0.0777257 0.120949 0.0673443 0.0518536 0.00643314 0.0023173 0.00150472 0.00231867 0.00155209 0.00277249 0.00189132 0.00390921 0.00362329 0.0042467 0.00877853 0.0104681 0.00292618 0.00360326 0.00180082 0.00146222 0.00267261 0.00185773 0.0036301 0.00278567 0.00694145 0.00693015 0.0383272 0.00683743 0.00747257 0.005677 0.00431613 0.00486516 0.0122035 0.00275693 0.00391932 0.00373382 0.00883513 0.0169344 0.0982332	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) or DRUG0 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0542643 0.0269777 0.022628 0.0511095 0.0668895 0.075369 0.0843597 0.0775587 0.120602 0.0671478 0.0517147 0.00639454 0.00230727 0.00149341 0.00229959 0.00153791 0.00274874 0.00187741 0.00389149 0.00362007 0.00425549 0.00886364 0.0105075 0.00293519 0.00358271 0.00179452 0.00145277 0.00265954 0.00185347 0.00362975 0.00283123 0.00702239 0.00733873 0.0386407 0.00655441 0.00696509 0.00477219 0.00314959 0.00292309 0.00447628 0.00531186 0.0156753 0.00390859 0.00883797 0.0177508 0.0975155	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) or DRUG0 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.053751 0.0267136 0.0223778 0.0504704 0.0660111 0.074335 0.0830492 0.0762191 0.118534 0.0660272 0.0508975 0.00622548 0.00224614 0.0014544 0.00221959 0.00149401 0.00265526 0.00182161 0.0037613 0.00351267 0.00412938 0.00867418 0.0102379 0.00287527 0.00346212 0.00173437 0.00140407 0.00252342 0.00178692 0.00342153 0.00270898 0.00653935 0.00681116 0.0355619 0.00624731 0.00653991 0.00430069 0.00293907 0.00271557 0.00350169 0.00336092 0.00532647 0.00795708 0.035568 0.0209636 0.0949334	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.0545272 0.027087 0.022646 0.0510478 0.0666821 0.0750821 0.0839707 0.0767868 0.119869 0.0674086 0.0526309 0.00656696 0.00234716 0.00153074 0.00235506 0.00158396 0.00285062 0.00195058 0.00407776 0.00382271 0.00465755 0.00938743 0.0108731 0.00296401 0.00353893 0.00180428 0.00145573 0.0025253 0.00174762 0.00304773 0.00205228 0.00387134 0.00294701 0.00661937 0.00688438 0.00790712 0.0281539 0.00957056 0.00919771 0.0143161 0.00333106 0.00447698 0.00444217 0.00927508 0.0190896 0.101039	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG1 (e.g. , DRUG2 , DRUG0 , DRUG0 ) .
4	4	0.0532609 0.0264817 0.0222122 0.0502312 0.0657836 0.0742504 0.0833402 0.0766068 0.119253 0.0667874 0.051446 0.00633748 0.00228375 0.00147996 0.00224795 0.00151828 0.00271366 0.00188056 0.00395173 0.00378288 0.00470149 0.00972922 0.0107116 0.00287112 0.00336472 0.00173242 0.00138783 0.00239304 0.00166228 0.00287954 0.00197888 0.00368656 0.00292315 0.00634951 0.00712173 0.00841387 0.0310682 0.0072063 0.00729116 0.00602493 0.0088452 0.0197836 0.00469526 0.00938474 0.0197968 0.0981474	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG1 (e.g. , DRUG0 , DRUG2 , DRUG0 ) .
4	4	0.0525931 0.0261431 0.0219132 0.0495157 0.0648492 0.0731853 0.0820437 0.0753349 0.117167 0.0655638 0.0505036 0.00614431 0.00222057 0.00143658 0.00216007 0.00146864 0.0026082 0.00181941 0.00380779 0.00366902 0.00456907 0.00957018 0.0104427 0.00281479 0.00323678 0.00167631 0.00133957 0.00227243 0.00159979 0.00272311 0.00190046 0.00346365 0.00279084 0.00596707 0.00681794 0.00808405 0.0295433 0.0072514 0.00757129 0.0048784 0.00613384 0.00674976 0.0133442 0.0411407 0.0220897 0.0878812	Examples of some of the more potent CYP 3A4 inhibitors include DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , HIV protease or DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) or DRUG1 (e.g. , DRUG0 , DRUG0 , DRUG2 ) .
4	4	0.101161 0.139835 0.126456 0.15639 0.102005 0.0220226 0.0121421 0.0123512 0.0147215 0.0279093 0.0735033 0.0296002 0.00929221 0.0160792 0.00412549 0.00476148 0.00372952 0.005673 0.00426976 0.00683841 0.0252718 0.101862	Less potent inhibitors include DRUG1 , DRUG0 , DRUG0 , grapefruit juice , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.102878 0.142213 0.128261 0.158285 0.102074 0.0213731 0.0120753 0.0125829 0.0149661 0.0287084 0.0690246 0.0233367 0.00708252 0.00725082 0.00656941 0.01767 0.00400441 0.00548712 0.00425628 0.00661934 0.0241457 0.101135	Less potent inhibitors include DRUG1 , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.103399 0.143138 0.129496 0.159926 0.101823 0.0212938 0.0121377 0.012555 0.0151544 0.0284607 0.0664212 0.0215508 0.00599181 0.00563299 0.00359502 0.00634941 0.00690258 0.020516 0.00507457 0.00647052 0.0231965 0.100916	Less potent inhibitors include DRUG1 , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0976531 0.134036 0.120792 0.144572 0.0914951 0.0196669 0.0109999 0.0114942 0.0139906 0.0296819 0.0699528 0.0235291 0.00586176 0.00474928 0.00300056 0.00432857 0.00367335 0.00607856 0.00791142 0.0182404 0.064063 0.11423	Less potent inhibitors include DRUG1 , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.110013 0.148424 0.13172 0.143114 0.0235609 0.013788 0.0465336 0.011607 0.0138483 0.0249547 0.0773536 0.0334404 0.0101519 0.0173779 0.00453903 0.00557923 0.00449269 0.00692653 0.00520318 0.00835914 0.031494 0.12752	Less potent inhibitors include DRUG0 , DRUG1 , DRUG0 , grapefruit juice , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.111464 0.150321 0.133606 0.145574 0.0245577 0.0145599 0.0490059 0.0116902 0.0138055 0.0252409 0.0707596 0.0248955 0.00709761 0.0080488 0.00757921 0.0201405 0.00456014 0.00666079 0.00516945 0.00805405 0.0303218 0.126887	Less potent inhibitors include DRUG0 , DRUG1 , DRUG0 , grapefruit juice , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.111352 0.150382 0.133911 0.146517 0.0248707 0.0146892 0.0493624 0.0116539 0.0140051 0.0254195 0.0694615 0.0233425 0.00615525 0.00630159 0.00404873 0.00737269 0.00810341 0.0237185 0.00590356 0.0078122 0.0293196 0.126297	Less potent inhibitors include DRUG0 , DRUG1 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.10603 0.142506 0.126668 0.13199 0.0212149 0.0127965 0.043452 0.0103485 0.0126479 0.0260115 0.0702165 0.023305 0.00546081 0.00496479 0.00320123 0.00480413 0.00392551 0.00670667 0.00879537 0.0206738 0.0746678 0.139614	Less potent inhibitors include DRUG0 , DRUG1 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.08226 0.113519 0.103867 0.13137 0.0206163 0.00985362 0.0243663 0.0257105 0.115775 0.0265883 0.0768854 0.0390418 0.0118074 0.0190802 0.00484545 0.00581216 0.00469013 0.00718454 0.00541498 0.00868987 0.0325894 0.130032	Less potent inhibitors include DRUG0 , DRUG0 , DRUG1 , grapefruit juice , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0803742 0.110878 0.1023 0.132766 0.0217466 0.0107142 0.0265772 0.0297964 0.131227 0.0268415 0.0708283 0.0285645 0.00820556 0.00866911 0.00796044 0.0205932 0.00463257 0.00672605 0.00523851 0.00814172 0.0306464 0.126573	Less potent inhibitors include DRUG0 , DRUG0 , DRUG1 , grapefruit juice , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
4	4	0.0799038 0.110186 0.102018 0.133617 0.02217 0.0109953 0.0272496 0.0306072 0.13342 0.0269335 0.0696953 0.0267668 0.00710966 0.00678109 0.00420876 0.00743118 0.00810326 0.0234257 0.00585973 0.00781196 0.0296043 0.126102	Less potent inhibitors include DRUG0 , DRUG0 , DRUG1 , grapefruit juice , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
4	4	0.0772435 0.107218 0.0986118 0.123063 0.0192438 0.00953733 0.0229377 0.0261498 0.117761 0.0264981 0.0693794 0.0263365 0.00623061 0.00532181 0.00333896 0.00489101 0.00389445 0.00661467 0.00871152 0.0203548 0.0740915 0.142571	Less potent inhibitors include DRUG0 , DRUG0 , DRUG1 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0865081 0.118532 0.0975563 0.0770122 0.0103022 0.00415332 0.00583044 0.00407515 0.00982374 0.0110273 0.0304259 0.0202945 0.00558719 0.0082348 0.00590609 0.0153542 0.0180525 0.104947 0.0270945 0.0361214 0.119181 0.183981	Less potent inhibitors include DRUG0 , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	1	0.0305667 0.0237667 0.0331844 0.0382645 0.0694335 0.0844638 0.0498134 0.0396282 0.0436988 0.099361 0.0756843 0.12342 0.0771317 0.0217239 0.0411525 0.0205674 0.0284084 0.0997308	Caution should be exercised when DRUG1 ( DRUG0 ) is used concurrently with other DRUG2 or DRUG0 .
1	1	0.0343079 0.0281297 0.0375115 0.0409215 0.0705396 0.0877793 0.0517256 0.0435937 0.0448956 0.109688 0.0735248 0.103055 0.0668969 0.0173162 0.0149788 0.0225627 0.0613998 0.0911734	Caution should be exercised when DRUG1 ( DRUG0 ) is used concurrently with other DRUG0 or DRUG2 .
1	1	0.0308323 0.0270662 0.0394526 0.0433368 0.0556969 0.0380182 0.0439298 0.140166 0.0387819 0.0865452 0.0612158 0.1071 0.0667468 0.020074 0.039899 0.0208168 0.03143 0.108892	Caution should be exercised when DRUG0 ( DRUG1 ) is used concurrently with other DRUG2 or DRUG0 .
1	4	0.0365353 0.0337636 0.0456333 0.0485355 0.0588808 0.0417816 0.0428877 0.136161 0.0356237 0.0945993 0.0588525 0.089832 0.0559205 0.0158525 0.015503 0.0229439 0.0659392 0.100755	Caution should be exercised when DRUG0 ( DRUG1 ) is used concurrently with other DRUG0 or DRUG2 .
4	4	0.0349542 0.0353934 0.0175152 0.0349759 0.0934327 0.0463516 0.0478683 0.0647175 0.0776943 0.0463564 0.0568625 0.0228825 0.0227227 0.0321429 0.0378101 0.0547064 0.0510775 0.0761921 0.0548087 0.0421716 0.0493635	We sought to evaluate whether initiation of an DRUG1 increases the risk of hospitalization for gastrointestinal bleeding in DRUG2 users .
2	2	0.0613986 0.0248634 0.0204355 0.0273866 0.0412517 0.0347148 0.0453723 0.0232028 0.0286969 0.0225686 0.0399427 0.0204803 0.0382204 0.0373628 0.0306045 0.0301691 0.0156198 0.0113472 0.00936706 0.00575818 0.00531041 0.00650317 0.00262322 0.0013178 0.00253769 0.00270248 0.0111616 0.0330205 0.0189222 0.00891221 0.00651772 0.00624244 0.00479171 0.00735772 0.00637352 0.00243148 0.00126202 0.00246194 0.00237666 0.0106726 0.0309728 0.0182716 0.00872212 0.00662204 0.00643624 0.00488378 0.0074823 0.00660545 0.00259565 0.00130636 0.00343039 0.00261954 0.0119887 0.0359577 0.0219583 0.0109794 0.00882972 0.00969148 0.00846162 0.0159309 0.013184 0.00596273 0.00351252 0.0153466 0.0259861	DRUG1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG2 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	2	0.05277 0.0172165 0.0129581 0.0182575 0.0269179 0.0250628 0.0297217 0.0121516 0.0144243 0.0140704 0.0275274 0.0196037 0.0230988 0.0207471 0.0383913 0.026112 0.0148267 0.0137712 0.0182848 0.0155442 0.0173227 0.0233313 0.0146582 0.00759489 0.0246579 0.0124016 0.0285402 0.0375037 0.0281058 0.0137495 0.00997792 0.0082901 0.00607271 0.00810503 0.00682416 0.00262486 0.00136797 0.002642 0.00256656 0.011104 0.0324412 0.0189561 0.00904291 0.00679515 0.00654374 0.00496652 0.0075649 0.00665708 0.00260783 0.00131267 0.0034451 0.00263109 0.0120527 0.0361538 0.0221035 0.0110714 0.00886821 0.00972339 0.00849723 0.015931 0.0131572 0.00594625 0.00349478 0.0153025 0.0258349	DRUG1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG2 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	2	0.0528014 0.0172933 0.0130406 0.0182664 0.0268133 0.0247673 0.0290027 0.0117395 0.0137034 0.0130425 0.0244281 0.01695 0.0195278 0.016955 0.0277026 0.0170747 0.00908207 0.00691894 0.00738845 0.00520076 0.00508879 0.00684532 0.0025665 0.00123735 0.00257729 0.00269852 0.0132504 0.0446822 0.0287802 0.0152613 0.0131449 0.0159783 0.0158046 0.0260508 0.0250776 0.016822 0.00809774 0.026013 0.0126215 0.0278863 0.0375507 0.0276446 0.0136717 0.0100539 0.00827778 0.00598284 0.007948 0.00692673 0.00276969 0.00139972 0.00356323 0.00281684 0.0123828 0.0368289 0.0222286 0.0111445 0.00893548 0.0097509 0.00851613 0.0159588 0.0131378 0.00594425 0.0034769 0.0152299 0.0256758	DRUG1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG2 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	2	0.0523491 0.0171412 0.0129217 0.0181001 0.0265681 0.0245416 0.0287225 0.0116314 0.0135788 0.0129113 0.0241639 0.0167648 0.0193865 0.0168501 0.0275556 0.0169865 0.00903125 0.00687286 0.00731489 0.00512423 0.00496287 0.00655759 0.00246814 0.00119121 0.00238963 0.00244374 0.0109234 0.0320677 0.0190304 0.00903814 0.00655243 0.00638505 0.00491624 0.00756413 0.00665098 0.00252703 0.00129583 0.00261168 0.00255268 0.0126041 0.0422784 0.0273103 0.0145494 0.0129988 0.0157025 0.0149861 0.0251801 0.0245192 0.0182287 0.0100907 0.0338971 0.0127157 0.0298148 0.0396603 0.0314048 0.0168431 0.013066 0.0127123 0.010519 0.0168696 0.0133217 0.00627707 0.00352784 0.0152154 0.0250617	DRUG1 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG2 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.0235826 0.0486602 0.0160773 0.0231342 0.0310435 0.0335358 0.0566593 0.0189455 0.0164874 0.0153911 0.033277 0.0172047 0.0164216 0.0223568 0.0175085 0.0160364 0.0167942 0.0207781 0.0241095 0.0198618 0.0175834 0.0193938 0.0132734 0.00627416 0.0204557 0.00973907 0.0221925 0.0339136 0.0250709 0.0127004 0.00935474 0.00762946 0.00556695 0.00743394 0.00640204 0.00249774 0.0012981 0.00249831 0.00243633 0.0104713 0.0305096 0.0177974 0.00847591 0.00640113 0.0061694 0.00468044 0.00716047 0.00631253 0.00247622 0.00124712 0.00327195 0.00250288 0.0114448 0.0343277 0.0209633 0.0104898 0.00842236 0.00923838 0.00806852 0.0151683 0.0125429 0.0056711 0.00333636 0.0145901 0.0246799	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG1 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG2 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.0229052 0.0470782 0.0154912 0.0222982 0.0298465 0.0322374 0.0538148 0.0178114 0.0154925 0.0144076 0.0306959 0.01565 0.0151289 0.0201913 0.0162966 0.0145628 0.0117964 0.0125277 0.0108292 0.00672495 0.00542947 0.00634705 0.0026322 0.00131952 0.00258659 0.00285452 0.0122188 0.0413303 0.0253368 0.013688 0.0121931 0.0146138 0.0143128 0.0235055 0.0223508 0.0151569 0.00723197 0.0229598 0.0111831 0.0246896 0.0335915 0.0249544 0.0124295 0.00918895 0.00755365 0.00545726 0.00727141 0.00638069 0.0025642 0.00129717 0.00329918 0.00261659 0.0114707 0.0341264 0.0205678 0.0103006 0.00828128 0.00904155 0.00789217 0.0148337 0.0122304 0.00553679 0.00324205 0.0141828 0.0239618	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG1 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG2 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.0227038 0.0466622 0.0153539 0.0220997 0.0295793 0.0319504 0.0533262 0.0176514 0.0153547 0.0142824 0.0304207 0.0155058 0.014987 0.0200061 0.0161286 0.0143989 0.0116762 0.0123906 0.0106728 0.00659339 0.00524286 0.00599376 0.00247853 0.0012539 0.00238129 0.00254704 0.0101295 0.0301201 0.0170234 0.00807108 0.00597273 0.00568237 0.00437675 0.00682604 0.0059946 0.00228833 0.00118206 0.00237711 0.00234243 0.0113694 0.0381603 0.0244967 0.0130239 0.0117308 0.0141778 0.013502 0.0228644 0.022335 0.016641 0.00921625 0.0308644 0.0116216 0.0272669 0.0362361 0.0288042 0.0154601 0.0120406 0.0117275 0.00970235 0.0156219 0.0123845 0.00584522 0.00329056 0.0141822 0.0234062	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG1 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG2 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.0228851 0.0423247 0.0129052 0.0177828 0.0229323 0.0210207 0.0311021 0.00856503 0.0109817 0.0094708 0.0184787 0.0123878 0.0142872 0.0160151 0.0307493 0.0205667 0.0116046 0.0107177 0.0135822 0.0102157 0.0120065 0.0187796 0.00927832 0.00441475 0.0137144 0.00660519 0.0303556 0.0169022 0.0143911 0.0132233 0.0162028 0.0185775 0.0184236 0.0232668 0.0214022 0.0151982 0.00692169 0.0231957 0.0107054 0.0237048 0.0374163 0.0270368 0.0137208 0.0101497 0.00828981 0.00599587 0.00802172 0.00715067 0.00288935 0.00145423 0.00367915 0.00292244 0.0127875 0.0379766 0.022927 0.011487 0.00922196 0.0100667 0.00879018 0.0164971 0.0135909 0.00615093 0.00359886 0.0157542 0.0265789	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG1 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG2 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG0 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.0216317 0.0400067 0.0121987 0.0168099 0.0216793 0.0198766 0.0294206 0.00810612 0.0103942 0.0089694 0.0175243 0.0117493 0.013577 0.0152161 0.0292241 0.0196012 0.0110946 0.0102941 0.0130662 0.00983143 0.0115289 0.017886 0.00874053 0.00406649 0.0121348 0.00596724 0.0269996 0.0147156 0.0113525 0.00829924 0.00908041 0.00825093 0.00658812 0.00832527 0.0071384 0.00282589 0.00147622 0.00287251 0.00288801 0.0128383 0.0429948 0.0267471 0.0145106 0.0131477 0.0156514 0.0148317 0.0246519 0.0237417 0.01776 0.00969378 0.0322191 0.0120922 0.0283137 0.0382691 0.030493 0.0164281 0.0127608 0.0124018 0.0102596 0.0164684 0.0130591 0.00616957 0.00347109 0.0149505 0.0246667	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG1 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG0 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG2 (OR   =   1.47 [95% CI , 1.02-2.11]) .
4	4	0.022858 0.0423115 0.0129646 0.0178012 0.0228191 0.0209434 0.0304436 0.00834564 0.0105058 0.00891311 0.0168493 0.0111088 0.01252 0.0135873 0.0234175 0.0149132 0.00802829 0.00643174 0.00694313 0.00488532 0.00484319 0.00657197 0.00247104 0.00119818 0.00245308 0.00252018 0.012272 0.0401713 0.0248298 0.0125289 0.0102061 0.0115755 0.01008 0.0182501 0.0189533 0.00970488 0.00425668 0.0135759 0.0064073 0.0298356 0.0168621 0.0145447 0.0133277 0.0164997 0.0187328 0.0182179 0.0234263 0.0217334 0.0170183 0.00891089 0.0307694 0.0109498 0.0256195 0.039028 0.0303952 0.0166951 0.0130086 0.0126208 0.010442 0.016784 0.0135284 0.00647454 0.00365258 0.0156343 0.0258287	DRUG0 users had an increased odds ratio of gastrointestinal bleeding upon initiation of DRUG0 (OR   =   1.73 [95% CI , 1.25-2.38]) , DRUG0 (OR   =   1.63 [95% CI , 1.11-2.38]) , DRUG1 (OR   =   1.64 [95% CI , 1.27-2.12]) , DRUG2 (OR   =   1.47 [95% CI , 1.02-2.11]) .
0	2	0.0580106 0.0752151 0.0225527 0.0278542 0.019816 0.0269342 0.0818633 0.0423222 0.0898017 0.0812037 0.0533743 0.0172253 0.0555834 0.078688 0.0330796 0.0134343 0.0121567 0.0302044 0.0345335 0.0183464 0.0115308 0.0105175 0.0109529 0.00975477 0.0179707 0.0152763 0.00697577 0.00354344 0.0131095 0.028169	Also DRUG1 , which is not believed to interact with DRUG2 , increased the risk of GI bleeding (OR   =   1.75 [95% CI , 1.30-2.35]) .
2	2	0.159126 0.0920217 0.0993241 0.107851 0.0236662 0.00515056 0.00456632 0.00273537 0.00345015 0.00259991 0.0042917 0.00281585 0.00366128 0.0120528 0.0215148 0.0666506 0.0833443 0.0629466 0.0314001 0.043341 0.0255853 0.0338806 0.0322553 0.0757682	DRUG1 users who initiated DRUG2 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 had an increased risk of hospitalization for gastrointestinal bleeding .
2	2	0.139823 0.0836708 0.0895447 0.0703211 0.0127021 0.00943271 0.0167174 0.00359413 0.00373093 0.00275402 0.00438777 0.0031573 0.00423509 0.0120269 0.0234668 0.0770908 0.0975795 0.0712453 0.0341076 0.0503295 0.0308935 0.0377149 0.036429 0.0850456	DRUG1 users who initiated DRUG0 , DRUG2 , DRUG0 , DRUG0 , or DRUG0 had an increased risk of hospitalization for gastrointestinal bleeding .
2	2	0.138588 0.0816272 0.0863059 0.062804 0.00956708 0.0047682 0.00703482 0.00767144 0.0154996 0.0035474 0.00459255 0.00339261 0.00471403 0.0121907 0.025216 0.0792521 0.100915 0.07173 0.0347655 0.0518447 0.0321138 0.0384264 0.0370611 0.0863724	DRUG1 users who initiated DRUG0 , DRUG0 , DRUG2 , DRUG0 , or DRUG0 had an increased risk of hospitalization for gastrointestinal bleeding .
2	2	0.139268 0.0817588 0.0859508 0.0615341 0.00910204 0.00414835 0.00507524 0.00382194 0.00625221 0.00667539 0.0167774 0.00458175 0.00590707 0.0117101 0.0251212 0.0762263 0.101173 0.0709711 0.0343747 0.052303 0.0330423 0.0388333 0.0375464 0.087846	DRUG1 users who initiated DRUG0 , DRUG0 , DRUG0 , DRUG2 , or DRUG0 had an increased risk of hospitalization for gastrointestinal bleeding .
2	2	0.127221 0.0751025 0.0785966 0.0573716 0.008584 0.0041014 0.00448653 0.00330849 0.00424425 0.00347238 0.00546883 0.0068677 0.0158225 0.0385255 0.0365543 0.085275 0.114632 0.0571026 0.0357726 0.0477531 0.0332273 0.0378498 0.0355241 0.0831358	DRUG1 users who initiated DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG2 had an increased risk of hospitalization for gastrointestinal bleeding .
4	4	0.0223811 0.0283636 0.0229117 0.0282288 0.0249154 0.0389672 0.0356449 0.0317743 0.0273306 0.0235415 0.0195921 0.0179858 0.0178818 0.0222344 0.0530562 0.0732322 0.0578275 0.0475042 0.0676715 0.0632102 0.0984055 0.0200819 0.0166746 0.00363591 0.00351087 0.00236608 0.00270564 0.00212121 0.00254636 0.00205217 0.00253498 0.00205516 0.00261131 0.00213134 0.002836 0.00243302 0.00357206 0.00292808 0.00526338 0.0192867 0.0759926	A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between DRUG1 and DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0215404 0.0273034 0.0220878 0.0271821 0.0240396 0.0377567 0.0349501 0.0312145 0.0267708 0.0229066 0.0195955 0.017953 0.0180179 0.0224264 0.0529178 0.0734864 0.058028 0.0508667 0.0728263 0.0627076 0.0858036 0.0234177 0.0112115 0.0103728 0.0157689 0.00317372 0.00313258 0.00219444 0.00255309 0.00202026 0.00247054 0.0019849 0.00251957 0.00203499 0.00271429 0.00229514 0.00339644 0.00275044 0.00499053 0.0179634 0.0726537	A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between DRUG1 and DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
4	4	0.0293325 0.036783 0.028951 0.0354376 0.0304933 0.0470249 0.0390032 0.0327777 0.0284577 0.0240759 0.0167143 0.0139402 0.0119167 0.013526 0.0374967 0.0434789 0.0366402 0.0407727 0.0434119 0.0345812 0.00701631 0.00283752 0.0036791 0.00207783 0.00371207 0.00202287 0.00375991 0.00201891 0.00389214 0.00215026 0.00437765 0.00265033 0.00586258 0.00422165 0.0104839 0.0124813 0.0637975 0.0189138 0.0247932 0.0769202 0.117516	A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0358885 0.0550131 0.0625194 0.0705637 0.0438789 0.0469452 0.0717159 0.0307018 0.0310436 0.0733086 0.0501108 0.0556613 0.0674886 0.0597262 0.0246495 0.00487893 0.00474119 0.00345528 0.00431432 0.00351092 0.00510446 0.00423232 0.0068822 0.0234879 0.0590562 0.101121	There was no effect of a single dose or multiple doses of DRUG1 on DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 pharmacokinetics .
4	4	0.0335553 0.0513552 0.0584673 0.0665294 0.0455542 0.0492688 0.072259 0.0347337 0.035511 0.0823542 0.0578587 0.0618953 0.0720045 0.0419669 0.0185389 0.0110744 0.0183493 0.00355124 0.0038231 0.00289491 0.00414448 0.00333687 0.00555337 0.0198917 0.0535917 0.0919365	There was no effect of a single dose or multiple doses of DRUG1 on DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 pharmacokinetics .
4	4	0.0332099 0.0510566 0.0581611 0.0662271 0.0465361 0.0500701 0.0724615 0.0351753 0.0352583 0.0804911 0.055691 0.0605705 0.0736372 0.0405225 0.0145174 0.00479821 0.00803236 0.00949605 0.0192999 0.00383574 0.00468866 0.00358514 0.00566852 0.0203087 0.0552493 0.0914518	There was no effect of a single dose or multiple doses of DRUG1 on DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 pharmacokinetics .
4	4	0.0333934 0.0513468 0.0585596 0.0666317 0.0463617 0.0498712 0.0721976 0.0348203 0.0348949 0.0798354 0.0545267 0.0608858 0.071338 0.0400558 0.0141777 0.00441248 0.00610142 0.00420536 0.00783225 0.00947627 0.0210466 0.0047637 0.0058692 0.0190295 0.0564911 0.0918754	There was no effect of a single dose or multiple doses of DRUG1 on DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 pharmacokinetics .
4	4	0.0304342 0.0463978 0.0527381 0.0599448 0.0403298 0.0433571 0.0636019 0.0304094 0.031392 0.0663574 0.0454287 0.0493667 0.056051 0.0294246 0.0105251 0.00370701 0.00489111 0.00378637 0.00539074 0.00507894 0.0082176 0.0131001 0.0276105 0.0626792 0.0875515 0.122228	There was no effect of a single dose or multiple doses of DRUG1 on DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 pharmacokinetics .
4	4	0.0335305 0.0491583 0.054428 0.055264 0.0297311 0.0301445 0.0540988 0.014452 0.0107106 0.0302001 0.0256061 0.0222779 0.0136509 0.011246 0.00864114 0.00298375 0.00651148 0.00470212 0.0133262 0.0157686 0.0763079 0.0263509 0.0352899 0.0763079 0.120168 0.179143	There was no effect of a single dose or multiple doses of DRUG0 on DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 pharmacokinetics .
4	3	0.05356 0.0814266 0.0454736 0.0516835 0.0337486 0.044735 0.0336545 0.0397473 0.0429372 0.0260434 0.0570369 0.0404214 0.0447111 0.0472529 0.0459996 0.0817036 0.0354758 0.023758 0.0260802 0.0266005 0.0318439 0.0861064	DRUG1 AUC was increased by 21% with no effect on Cmax in the presence of steady-state DRUG2 compared with DRUG0 alone .
3	4	0.0352301 0.0607342 0.0303204 0.0426456 0.0189477 0.0319956 0.0311046 0.0341027 0.0369062 0.0183779 0.0364317 0.0226455 0.0244592 0.0284934 0.0369482 0.063894 0.0606692 0.0724898 0.0791096 0.0590255 0.0676837 0.107785	DRUG0 AUC was increased by 21% with no effect on Cmax in the presence of steady-state DRUG1 compared with DRUG2 alone .
3	3	0.0792122 0.0572585 0.0219862 0.0443226 0.0413239 0.0542471 0.0252291 0.0256524 0.00846649 0.0349376 0.0232124 0.0594986 0.0182917 0.0336793 0.0432206 0.0498113 0.0509576 0.0907935 0.03931 0.0259717 0.0270206 0.0270874 0.0316426 0.0868667	DRUG1 AUC and Cmax were increased by 18% and 42% , respectively , in the presence of steady-state DRUG2 compared with DRUG0 alone .
3	4	0.0306764 0.0449082 0.0234039 0.0388574 0.0235959 0.0466114 0.0169265 0.0172336 0.00622759 0.0231586 0.0155587 0.0411259 0.0103067 0.0203534 0.0229955 0.0302481 0.0408758 0.0726361 0.0683739 0.0766908 0.082155 0.0632197 0.0714825 0.112378	DRUG0 AUC and Cmax were increased by 18% and 42% , respectively , in the presence of steady-state DRUG1 compared with DRUG2 alone .
1	1	0.0865135 0.0763699 0.058372 0.053014 0.0444421 0.10471 0.0842055 0.105287 0.0569005 0.0230912 0.0181841 0.0173368 0.0104968 0.00687756 0.00308362 0.00602687 0.0093904 0.00329393 0.00517459 0.00405393 0.0121227 0.0203164 0.0220625 0.0175138 0.0471099 0.0209812 0.0205576 0.0625112	Patients receiving DRUG1 or DRUG0 in combination with DRUG2 should be monitored for DRUG0 or DRUG0 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.0853918 0.0748455 0.0468954 0.0222316 0.022364 0.0267243 0.0238115 0.0252907 0.0432533 0.05217 0.0601981 0.0810125 0.0407648 0.01839 0.0113257 0.028139 0.0145533 0.00574938 0.00946967 0.00779784 0.0194644 0.0328071 0.029052 0.0243964 0.0639361 0.0308814 0.0258683 0.0732161	Patients receiving DRUG1 or DRUG0 in combination with DRUG0 should be monitored for DRUG0 or DRUG2 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.0926059 0.0803228 0.0504256 0.0232161 0.0220551 0.0247959 0.0207666 0.0218247 0.0392057 0.0416115 0.0449376 0.048465 0.0260452 0.0117963 0.00752367 0.0237126 0.041045 0.0121786 0.0144381 0.0202484 0.0386983 0.0240611 0.0208249 0.0260343 0.0758331 0.0404062 0.0314579 0.0754638	Patients receiving DRUG1 or DRUG0 in combination with DRUG0 should be monitored for DRUG0 or DRUG0 toxicity and DRUG0 or DRUG2 dosage should be reduced if necessary .
1	1	0.111622 0.0910659 0.0445764 0.0356626 0.0661644 0.106238 0.0713665 0.0859063 0.0464783 0.0224548 0.0197729 0.0189474 0.0111982 0.00735064 0.00323498 0.00630759 0.00974854 0.003404 0.00535556 0.00419093 0.0125217 0.0210247 0.0227493 0.0180987 0.0482812 0.0215877 0.0210727 0.0636181	Patients receiving DRUG0 or DRUG1 in combination with DRUG2 should be monitored for DRUG0 or DRUG0 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.116485 0.0842669 0.0332333 0.0159903 0.0314012 0.0262534 0.0214542 0.0230308 0.0381855 0.0536034 0.0632047 0.0927815 0.081338 0.0309652 0.010399 0.00813906 0.0107356 0.00365064 0.00562239 0.00490806 0.0126257 0.0240595 0.0236135 0.0211901 0.0544393 0.0263405 0.0215506 0.060533	Patients receiving DRUG0 or DRUG1 in combination with DRUG0 should be monitored for DRUG2 or DRUG0 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.136108 0.0963205 0.0386353 0.0182188 0.0344945 0.026194 0.019566 0.0194384 0.033225 0.0384003 0.0373257 0.0447971 0.0246695 0.0129774 0.00706885 0.025828 0.0461391 0.0187287 0.024321 0.00908292 0.0120375 0.0255643 0.0272149 0.0255357 0.0667698 0.0332558 0.0263265 0.0717563	Patients receiving DRUG0 or DRUG1 in combination with DRUG0 should be monitored for DRUG0 or DRUG0 toxicity and DRUG2 or DRUG0 dosage should be reduced if necessary .
4	4	0.0541511 0.043971 0.0187253 0.011336 0.0334514 0.0520945 0.065573 0.123089 0.144066 0.0349244 0.0466454 0.0601876 0.0620111 0.0220509 0.00802976 0.00668132 0.00884141 0.00305319 0.00469984 0.00401537 0.0100557 0.0184197 0.0185108 0.0163252 0.0422574 0.0206964 0.0172757 0.048862	Patients receiving DRUG0 or DRUG0 in combination with DRUG1 should be monitored for DRUG2 or DRUG0 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.0588245 0.0471652 0.0200154 0.0123485 0.0341795 0.0523565 0.0661764 0.128333 0.142968 0.0329211 0.0407928 0.0511716 0.0287944 0.0103767 0.00751115 0.0186109 0.0110696 0.00434521 0.00718525 0.00586192 0.0141095 0.0240182 0.020722 0.017863 0.0470583 0.023078 0.0190941 0.0530492	Patients receiving DRUG0 or DRUG0 in combination with DRUG1 should be monitored for DRUG0 or DRUG2 toxicity and DRUG0 or DRUG0 dosage should be reduced if necessary .
4	4	0.0598927 0.048351 0.0208728 0.0125911 0.0353384 0.0556201 0.0697622 0.132849 0.142729 0.0279223 0.0358429 0.0322704 0.0197521 0.00793666 0.00554177 0.0159772 0.0313715 0.0118601 0.0154192 0.00642397 0.00876831 0.01844 0.0197609 0.0187008 0.0485212 0.0244696 0.0195597 0.0534552	Patients receiving DRUG0 or DRUG0 in combination with DRUG1 should be monitored for DRUG0 or DRUG0 toxicity and DRUG2 or DRUG0 dosage should be reduced if necessary .
4	4	0.0617417 0.0495111 0.021279 0.0129011 0.0358055 0.0549376 0.0676702 0.13004 0.139092 0.0271448 0.0350013 0.030651 0.0189656 0.00694635 0.00515283 0.0139218 0.0264474 0.00732477 0.00857671 0.012172 0.0247753 0.0161449 0.0146466 0.018626 0.0551019 0.0292213 0.0227446 0.0534561	Patients receiving DRUG0 or DRUG0 in combination with DRUG1 should be monitored for DRUG0 or DRUG0 toxicity and DRUG0 or DRUG2 dosage should be reduced if necessary .
4	4	0.0471811 0.0317551 0.0115587 0.00519918 0.0126099 0.00993392 0.0109787 0.00998456 0.0297977 0.0379477 0.0392392 0.0610904 0.0653343 0.0553766 0.0337247 0.0453379 0.0952041 0.0201887 0.0155255 0.0258958 0.037995 0.0237425 0.0213733 0.0276132 0.082373 0.0418698 0.0313071 0.0698625	Patients receiving DRUG0 or DRUG0 in combination with DRUG0 should be monitored for DRUG1 or DRUG0 toxicity and DRUG0 or DRUG2 dosage should be reduced if necessary .
4	4	0.0412825 0.0280382 0.01023 0.00459299 0.0111657 0.00875721 0.00956565 0.00891091 0.0261337 0.0340144 0.0432395 0.0663967 0.061919 0.0362242 0.0315893 0.121473 0.120073 0.0180851 0.0210736 0.00941748 0.0130806 0.0301443 0.0291568 0.027644 0.067411 0.0325312 0.0244128 0.0634376	Patients receiving DRUG0 or DRUG0 in combination with DRUG0 should be monitored for DRUG0 or DRUG1 toxicity and DRUG2 or DRUG0 dosage should be reduced if necessary .
4	4	0.0967255 0.0950238 0.0736051 0.0835701 0.0811444 0.0654245 0.0605466 0.0557744 0.057776 0.0541292 0.0624088 0.0666661 0.147206	DRUG1 Reports suggest that DRUG2 may diminish the antihypertensive effect of DRUG0 .
4	4	0.110287 0.0334397 0.0227222 0.026353 0.0496411 0.087925 0.0704025 0.0738746 0.0835316 0.113843 0.11953 0.105973 0.102477	DRUG1 Reports suggest that DRUG0 may diminish the antihypertensive effect of DRUG2 .
2	2	0.0463007 0.0687865 0.0516067 0.0639864 0.140651 0.118857 0.0552579 0.0723327 0.0569574 0.0649132 0.0974191 0.091892 0.0710391	DRUG0 Reports suggest that DRUG1 may diminish the antihypertensive effect of DRUG2 .
1	1	0.0444258 0.040015 0.0397253 0.0483762 0.0533459 0.0828485 0.078628 0.0659017 0.0556648 0.0876823 0.0922645 0.113823 0.101651 0.0956475	This interaction should be given consideration in patients taking DRUG1 concomitantly with DRUG2 .
4	4	0.034245 0.0127814 0.0283998 0.0430667 0.0440877 0.0282069 0.0428191 0.0262661 0.0425273 0.0196604 0.0170275 0.0214949 0.0781846 0.0246986 0.0383214 0.032167 0.0403548 0.0265219 0.0187227 0.0731611 0.0623598 0.089198 0.0847518 0.0709754	DRUG1 : Concomitant administration of DRUG0 (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of DRUG2 .
3	3	0.013288 0.0163041 0.0237364 0.0323658 0.0331065 0.0393916 0.0308348 0.0203834 0.0230427 0.0158441 0.0186046 0.0236754 0.0663856 0.0277226 0.0543454 0.0422773 0.0521323 0.0455491 0.0229675 0.0803293 0.0646463 0.100475 0.0862854 0.0663065	DRUG0 : Concomitant administration of DRUG1 (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of DRUG2 .
4	4	0.0363493 0.0105759 0.0189208 0.0377811 0.0193869 0.0761143 0.0146172 0.0354895 0.0416045 0.052664 0.0216909 0.00599826 0.0142478 0.041101 0.0726029 0.096196 0.0200136 0.0197895 0.0302611 0.0430054 0.0535479 0.0343759 0.0652423 0.0330719 0.0373216 0.0680303	however , as with other DRUG1 , concomitant administration of DRUG2 and DRUG0 is not generally recommended because of the potential for increased adverse effects .
1	1	0.0280113 0.00773127 0.0130813 0.0256014 0.0148602 0.0588033 0.0113322 0.0280674 0.0429335 0.0335795 0.0171872 0.0196967 0.0570777 0.0636992 0.0941116 0.102468 0.021245 0.0237824 0.0325208 0.0485127 0.0514495 0.0342862 0.0556405 0.0283326 0.0312806 0.0547083	however , as with other DRUG1 , concomitant administration of DRUG0 and DRUG2 is not generally recommended because of the potential for increased adverse effects .
1	1	0.0104046 0.00281366 0.00377835 0.00750526 0.00363133 0.00581425 0.0115202 0.0478585 0.0533067 0.0585623 0.0869015 0.0367816 0.0603235 0.0579109 0.0864386 0.089768 0.0183317 0.0238266 0.0305509 0.0522817 0.050334 0.03794 0.0546793 0.0288096 0.0305442 0.0493828	however , as with other DRUG0 , concomitant administration of DRUG1 and DRUG2 is not generally recommended because of the potential for increased adverse effects .
2	2	0.0491394 0.0403234 0.0489703 0.0340434 0.0553365 0.0802144 0.0642446 0.0904352 0.0477637 0.0450983 0.0517592 0.0571145 0.0509229 0.0213134 0.0200811 0.0245894 0.00968405 0.0125637 0.0462682 0.00746886 0.0112733 0.00724313 0.0142554 0.0158472 0.0147977 0.0185564 0.0606923	Concomitant administration of low-dose DRUG1 with DRUG2 may result in an increased rate of GI ulceration or other complications , compared to use of DRUG0 alone .
4	4	0.0306422 0.0457383 0.0611226 0.0697928 0.0815662 0.0478905 0.0542408 0.0725424 0.0398115 0.0290236 0.0369508 0.0411575 0.0392521 0.0179506 0.0159381 0.0196745 0.00920142 0.0138972 0.0599994 0.0125443 0.0248544 0.0220033 0.0222349 0.0312982 0.0245939 0.0244894 0.0515892	Concomitant administration of low-dose DRUG1 with DRUG0 may result in an increased rate of GI ulceration or other complications , compared to use of DRUG2 alone .
4	4	0.0968544 0.0356964 0.0481724 0.0537454 0.124936 0.221897 0.103587 0.0683613 0.0754138 0.0688721 0.102464	DRUG1 is not a substitute for DRUG2 for cardiovascular prophylaxis .
4	4	0.0469533 0.0121331 0.0383388 0.02819 0.0276962 0.0221581 0.0278543 0.0525357 0.0826999 0.0839405 0.0813471 0.111034 0.0909745 0.0752467 0.0551935 0.0769321 0.0867718	DRUG1 : Pretreatment for four days with DRUG0 significantly increased the clearance of DRUG2 by 50% .
3	3	0.0179872 0.0197693 0.0560142 0.0679617 0.0653028 0.0508715 0.0518689 0.0454024 0.0811811 0.0866005 0.058362 0.0764911 0.0757895 0.0641818 0.0485198 0.0637522 0.0699441	DRUG0 : Pretreatment for four days with DRUG1 significantly increased the clearance of DRUG2 by 50% .
4	4	0.0487753 0.0123738 0.0225805 0.025249 0.0206419 0.0161268 0.0183932 0.0353055 0.043727 0.0369721 0.0546084 0.0507021 0.0664445 0.0728533 0.0745643 0.0662716 0.0799777 0.0758509 0.0820396 0.0965426	DRUG1 : Concomitant administration of 200 mg DRUG0 QID did not alter the single-dose pharmacokinetics of 30 mg DRUG2 .
4	4	0.0112263 0.0125409 0.0199539 0.0324033 0.0348769 0.0378978 0.0497372 0.065128 0.033488 0.0436276 0.0457999 0.0498191 0.0585734 0.067067 0.0644776 0.0581104 0.0694416 0.0836479 0.0825652 0.079618	DRUG0 : Concomitant administration of 200 mg DRUG1 QID did not alter the single-dose pharmacokinetics of 30 mg DRUG2 .
4	4	0.0654633 0.0247273 0.0374565 0.0224868 0.0241922 0.0471933 0.0521281 0.0394975 0.0356262 0.0373092 0.0395584 0.0474208 0.0378387 0.022195 0.0444798 0.028216 0.0254946 0.0180172 0.0273566 0.0411855 0.0389879 0.0304798 0.0292854 0.0273554 0.024172 0.0215911 0.0199914 0.0185017 0.0717925	DRUG1 : DRUG2 15 mg once daily for 7 days did not alter the plasma concentration profile of DRUG0 after b-acetyldigoxin administration for 7 days at clinical doses .
4	4	0.0177096 0.0194418 0.0452386 0.0125744 0.00737096 0.0106062 0.0132894 0.0161626 0.0203227 0.0220264 0.0278127 0.0324992 0.0395962 0.0371177 0.0769163 0.0732043 0.078585 0.0768809 0.0573069 0.0485048 0.0504705 0.0372115 0.0377862 0.0294279 0.0218764 0.0169505 0.0160684 0.0134692 0.0435727	DRUG0 : DRUG1 15 mg once daily for 7 days did not alter the plasma concentration profile of DRUG2 after b-acetyldigoxin administration for 7 days at clinical doses .
4	4	0.0279442 0.0205283 0.0485352 0.0445637 0.0587822 0.0679023 0.126124 0.0834462 0.0911867 0.0830431 0.133429 0.0394191 0.0865589 0.088537	In vitro testing found no protein binding drug interaction between DRUG1 and DRUG2 .
4	4	0.0624127 0.0163946 0.0257619 0.0135597 0.00522054 0.00885826 0.0239171 0.0100463 0.0273362 0.0490912 0.0189523 0.0450354 0.0886376 0.0756474 0.0767451 0.0721136 0.0369523 0.0328125 0.0556062 0.0301711 0.0181846 0.0134231 0.00712739 0.0210356 0.0191218 0.0257702 0.0316794 0.0883861	DRUG1 : Clinical studies , as well as post-marketing observations , have shown that DRUG2 can reduce the natriuretic effect of DRUG0 and DRUG0 in some patients .
4	4	0.0615446 0.0134916 0.0185979 0.0103262 0.00416018 0.00568631 0.0146242 0.00559731 0.0116008 0.0175317 0.00538871 0.0065194 0.0154157 0.0140332 0.05347 0.1167 0.0473045 0.0536897 0.112538 0.0764746 0.0363188 0.021796 0.0250166 0.0449224 0.0311511 0.0355317 0.0402413 0.100326	DRUG1 : Clinical studies , as well as post-marketing observations , have shown that DRUG0 can reduce the natriuretic effect of DRUG0 and DRUG2 in some patients .
2	2	0.0105085 0.0094342 0.0110067 0.00672015 0.00300576 0.00553815 0.0159366 0.00708037 0.0191896 0.0326401 0.0104519 0.0251298 0.0513755 0.0430623 0.0949647 0.0862254 0.0528389 0.0571334 0.0905344 0.0809455 0.0889412 0.0399741 0.00808822 0.0128775 0.0138183 0.0252535 0.0294508 0.0678743	DRUG0 : Clinical studies , as well as post-marketing observations , have shown that DRUG1 can reduce the natriuretic effect of DRUG2 and DRUG0 in some patients .
2	2	0.0103401 0.00939206 0.0110028 0.00666988 0.00297595 0.00552213 0.0158395 0.00703876 0.0190651 0.0319814 0.0103058 0.0238399 0.047844 0.0409071 0.0858203 0.0742347 0.0508805 0.0553163 0.0854733 0.0849292 0.0595842 0.0302821 0.0245787 0.039833 0.0289214 0.0295327 0.0343225 0.0735667	DRUG0 : Clinical studies , as well as post-marketing observations , have shown that DRUG1 can reduce the natriuretic effect of DRUG0 and DRUG2 in some patients .
4	4	0.0108767 0.00834588 0.00893073 0.00559513 0.0025666 0.00374861 0.00992323 0.0042124 0.00893201 0.0139045 0.00454733 0.00561757 0.0138415 0.0135966 0.0508744 0.106572 0.0478182 0.0475832 0.103868 0.088287 0.0636009 0.116776 0.031741 0.0553222 0.040648 0.0309932 0.0304721 0.0708055	DRUG0 : Clinical studies , as well as post-marketing observations , have shown that DRUG0 can reduce the natriuretic effect of DRUG1 and DRUG2 in some patients .
4	4	0.0648594 0.0685685 0.0835734 0.0739408 0.0350878 0.0607114 0.0377022 0.092394 0.0691606 0.0363151 0.0427944 0.0488014 0.130776 0.0694094 0.0859053	Studies with DRUG1 agents and DRUG2 have not demonstrated a reduction in natriuretic effect .
4	4	0.0674403 0.0220531 0.0552875 0.0153878 0.0247095 0.0193917 0.0677002 0.0263504 0.0440876 0.0239225 0.0583641 0.098136 0.066866 0.102913 0.0561956 0.0872866 0.0834124 0.0804951	DRUG1 : single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of DRUG2 .
1	1	0.0847389 0.0341848 0.0745406 0.0500532 0.0572776 0.0549215 0.100048 0.0338495 0.0372469 0.0110411 0.0236461 0.0225815 0.0256594 0.0421614 0.0171215 0.0146866 0.0141309 0.0154338 0.0311681 0.00827579 0.00728253 0.00363176 0.0067647 0.0213438 0.0075173 0.0110943 0.0321007 0.040816 0.0380198 0.0786612	Nevertheless , during concomitant therapy with DRUG1 and DRUG2 , patients should be observed closely for signs of declining renal function , as well as to assure diuretic efficacy .
4	4	0.0823349 0.0353788 0.0825182 0.0661198 0.0574699 0.0151023 0.0378125 0.0192603 0.0410859 0.073185 0.0785177 0.0310661 0.0422456 0.0332783 0.0221259 0.0108062 0.0103498 0.0143934 0.0143193 0.0148506 0.0392325 0.0831961 0.0953508	DRUG1 : In clinical trials , DRUG2 have produced an elevation of plasma DRUG0 levels and a reduction in renal DRUG0 clearance .
3	3	0.0200949 0.0201816 0.031268 0.0261536 0.0337444 0.0132395 0.0581717 0.0364356 0.0843024 0.0782617 0.080017 0.0629031 0.0847884 0.0499483 0.0357786 0.0122362 0.0113218 0.0136794 0.0148541 0.0142693 0.0397075 0.0849463 0.0936965	DRUG0 : In clinical trials , DRUG1 have produced an elevation of plasma DRUG2 levels and a reduction in renal DRUG0 clearance .
4	4	0.0166399 0.0158785 0.0246055 0.0204631 0.0273257 0.00920106 0.0391364 0.016704 0.0459248 0.05131 0.0485013 0.0265042 0.0312487 0.0367279 0.0355173 0.0242523 0.0367126 0.0664728 0.075186 0.0858909 0.0996044 0.0880953 0.0780973	DRUG0 : In clinical trials , DRUG1 have produced an elevation of plasma DRUG0 levels and a reduction in renal DRUG2 clearance .
4	4	0.0128565 0.00875608 0.0121648 0.0128019 0.0101963 0.00918241 0.00735193 0.00992567 0.0450802 0.0565384 0.0546895 0.0274062 0.0118246 0.0295403 0.0271839 0.0324726 0.0132752 0.0130353 0.0125762 0.014603 0.0209487 0.0147807 0.0153313 0.0417478 0.0184474 0.0204675 0.0196553 0.0289578 0.0312258 0.0763716 0.0647941 0.0359753 0.0134217 0.0128699 0.0203531 0.00877047 0.0117982 0.00875111 0.0135383 0.020065 0.0161799 0.0161549 0.0479329	In a study conducted in healthy subjects , mean pre-dose DRUG1 concentration and AUC were increased by 21% in subjects receiving DRUG0 doses ranging from 804 to 1072 mg BID with DRUG2 15 mg QD as compared to subjects receiving DRUG0 alone .
3	3	0.011455 0.00701384 0.00884357 0.00883646 0.00611438 0.00552257 0.00364285 0.00325129 0.0112383 0.013578 0.0253682 0.0270907 0.0169171 0.0416926 0.0267072 0.0541529 0.0249962 0.0307757 0.0270293 0.0319856 0.0287029 0.0297223 0.0193026 0.0266125 0.0172656 0.0221935 0.0214076 0.0245605 0.0234444 0.0415976 0.0481929 0.0321272 0.0196961 0.0187424 0.0294492 0.013114 0.0178399 0.0129054 0.0198428 0.0308643 0.0248977 0.0242972 0.0670096	In a study conducted in healthy subjects , mean pre-dose DRUG0 concentration and AUC were increased by 21% in subjects receiving DRUG1 doses ranging from 804 to 1072 mg BID with DRUG2 15 mg QD as compared to subjects receiving DRUG0 alone .
4	4	0.00964212 0.00586373 0.00725506 0.00723468 0.00498846 0.00451874 0.00300849 0.00271753 0.00926843 0.0110874 0.020669 0.0207892 0.0120788 0.0293934 0.0155245 0.0310153 0.0110831 0.0117706 0.00999663 0.0116013 0.0170662 0.0115985 0.0120592 0.0347939 0.0154843 0.0157944 0.0134302 0.0188782 0.0282159 0.092313 0.0850583 0.0743526 0.024019 0.0147761 0.017142 0.0103587 0.0264954 0.0284363 0.0482277 0.0510175 0.0299299 0.0315212 0.0595246	In a study conducted in healthy subjects , mean pre-dose DRUG0 concentration and AUC were increased by 21% in subjects receiving DRUG0 doses ranging from 804 to 1072 mg BID with DRUG1 15 mg QD as compared to subjects receiving DRUG2 alone .
1	1	0.0525302 0.0710243 0.102708 0.0527793 0.0282147 0.0316082 0.0300626 0.0596926 0.0893391 0.0812486 0.0726207 0.0796869 0.0426391 0.0836324 0.122213	Patients on DRUG1 treatment should be closely monitored when DRUG2 is introduced or withdrawn .
4	4	0.0598181 0.0175045 0.0499858 0.035367 0.0263142 0.0308565 0.0311192 0.0289369 0.0261335 0.0224256 0.0297356 0.0447433 0.0340484 0.028663 0.0383128 0.0264347 0.0426559 0.0325519 0.0249991 0.0279421 0.0524613 0.034461 0.0348518 0.0478205 0.0439805 0.0454976 0.0823791	DRUG1 : A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of DRUG2 on the pharmacokinetics of DRUG0 taken once weekly .
4	4	0.0137202 0.0124308 0.0276645 0.0206453 0.0167132 0.0222276 0.024049 0.0207042 0.0179214 0.0173143 0.0277839 0.035218 0.0245168 0.0213372 0.0292261 0.0272385 0.037327 0.040294 0.0438111 0.0635153 0.0711173 0.0721344 0.0583708 0.0602976 0.0564891 0.0538723 0.0840603	DRUG0 : A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of DRUG1 on the pharmacokinetics of DRUG2 taken once weekly .
4	4	0.0907578 0.0607081 0.0425809 0.0151271 0.0190983 0.0453569 0.0368 0.0475544 0.0620768 0.0705126 0.0635522 0.110283 0.0598689 0.0938778 0.0839595 0.0978852	DRUG1 did not have a significant effect on the pharmacokinetics of single doses of DRUG2 .
4	4	0.0267586 0.0150129 0.00881932 0.0388707 0.0419533 0.0623438 0.157933 0.0830812 0.057638 0.0822044 0.0738375 0.0638647 0.0975895 0.0992592 0.0908341	In vitro , DRUG1 did not displace DRUG2 from its human serum binding sites .
4	4	0.0398958 0.0100892 0.0210154 0.0127817 0.0118096 0.016125 0.021263 0.00890959 0.0268056 0.0170826 0.0209094 0.0310088 0.0232529 0.0230393 0.0358216 0.0331668 0.0244772 0.0625869 0.0417318 0.039161 0.0469459 0.0376667 0.0363666 0.00956443 0.00375553 0.00785859 0.00462709 0.00810904 0.0467477 0.0208754 0.0174562 0.00976591 0.00919389 0.0281592 0.0561237 0.0316787 0.0145256 0.0247694 0.0648775	DRUG1 : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUG2 therapy in patients receiving DRUG0 or similar agents , since these patients are at an increased risk of bleeding .
1	1	0.00704625 0.00688181 0.0107721 0.00611781 0.00765014 0.00986454 0.0141927 0.00720317 0.0253399 0.0211124 0.0261765 0.039417 0.0311077 0.0302836 0.0474458 0.0406234 0.02603 0.0548941 0.0716072 0.0361633 0.0377019 0.0331952 0.0467623 0.025783 0.00873571 0.0146108 0.0083731 0.0104761 0.0446324 0.0252319 0.0194888 0.0107992 0.00942208 0.0244313 0.0481613 0.0266042 0.0122342 0.0204956 0.0529312	DRUG0 : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUG1 therapy in patients receiving DRUG2 or similar agents , since these patients are at an increased risk of bleeding .
4	4	0.0449458 0.0387289 0.0357768 0.0307015 0.0200871 0.0360901 0.0257605 0.0354971 0.0505399 0.0415138 0.0422861 0.0506714 0.0204098 0.0164623 0.0222786 0.0143182 0.0134902 0.0127599 0.0166117 0.021501 0.0138657 0.0162053 0.0152207 0.0147331 0.0297337 0.0365018 0.0275286 0.0248639 0.0309617 0.0266599 0.0308212 0.0334881 0.0118845 0.0471701 0.0499313	The effect of DRUG1 on the anticoagulant effect of DRUG2 was studied in a group of healthy subjects receiving daily doses of DRUG0 that produced an INR (International Normalized Ratio) between 1.2 and 1.8 .
4	4	0.0369482 0.031081 0.0264714 0.0249054 0.0129596 0.0181495 0.0261379 0.0285633 0.0348672 0.0353393 0.0517233 0.055466 0.0216105 0.0224482 0.0358345 0.0261394 0.020575 0.0211477 0.0208338 0.0304139 0.0198273 0.0374461 0.0289546 0.014923 0.0259988 0.0478023 0.0356306 0.0252136 0.0297676 0.0255231 0.0253735 0.0253721 0.00922869 0.0322756 0.035048	The effect of DRUG1 on the anticoagulant effect of DRUG0 was studied in a group of healthy subjects receiving daily doses of DRUG2 that produced an INR (International Normalized Ratio) between 1.2 and 1.8 .
4	4	0.0291524 0.0179542 0.020629 0.0111118 0.0526901 0.0438708 0.07084 0.105563 0.0679239 0.0537569 0.0194761 0.0230559 0.0423633 0.0386011 0.0277243 0.0228755 0.0331209 0.035084 0.101375 0.0290601 0.0269761 0.0267184 0.100077	In these subjects , DRUG1 did not alter DRUG2 pharmacokinetics and the average anticoagulant effect of DRUG0 as determined by prothrombin time .
4	4	0.0215369 0.0113697 0.0113775 0.00543431 0.0300796 0.0256227 0.023962 0.025654 0.0215681 0.0370202 0.0238302 0.0480511 0.0863839 0.0853215 0.106236 0.0996894 0.0718987 0.0258016 0.0909104 0.0273636 0.0213458 0.0226226 0.0769205	In these subjects , DRUG1 did not alter DRUG0 pharmacokinetics and the average anticoagulant effect of DRUG2 as determined by prothrombin time .
1	1	0.0220385 0.0167311 0.0200446 0.0166464 0.0193447 0.0223717 0.0453152 0.0598741 0.0443876 0.0638088 0.0312052 0.0366892 0.0462775 0.0669741 0.033958 0.0458987 0.0195266 0.0217554 0.0124179 0.0318609 0.0531017 0.0311519 0.0204443 0.0413125 0.056166 0.0148373 0.0101485 0.0151487 0.00704698 0.0127164 0.0244181 0.0363813	Caution should be used when administering DRUG1 with DRUG2 since patients on DRUG0 may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced .
4	4	0.0125231 0.0102791 0.0142009 0.0140218 0.0219459 0.0364102 0.0485639 0.0367901 0.0345089 0.0716707 0.0703794 0.0599747 0.0595312 0.0527994 0.0368676 0.0428056 0.0269747 0.0281027 0.0119606 0.0275096 0.046808 0.02793 0.0184248 0.0359697 0.0479969 0.0130336 0.00885075 0.013109 0.00616918 0.0110984 0.0212943 0.0314954	Caution should be used when administering DRUG1 with DRUG0 since patients on DRUG2 may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced .
4	4	0.0623726 0.0215223 0.0204121 0.0238145 0.0495316 0.0316106 0.0102199 0.00906175 0.0158977 0.0222707 0.0300008 0.0643172 0.0228838 0.0371126 0.0349998 0.0337997 0.0241137 0.0160954 0.0203317 0.0113453 0.00788462 0.00533335 0.00725718 0.00685152 0.00886651 0.0317833 0.0890149 0.0663653 0.0368399 0.0339701 0.0346111 0.00679833 0.0138846 0.0144867 0.0239051 0.0504337	Because there is a theoretical basis that these effects may be additive , use of DRUG1 -containing or DRUG2 (like DRUG0 or DRUG0 ) and DRUG0 within 24 hours of each other should be avoided .
4	4	0.0559924 0.0190737 0.0180883 0.0209755 0.0439292 0.0284121 0.00917244 0.00814476 0.0143571 0.0208761 0.0285243 0.0617989 0.0227945 0.0404326 0.0365306 0.0346991 0.0199743 0.0173562 0.0195299 0.0556751 0.0247351 0.00850536 0.00698372 0.00607231 0.00682069 0.0235105 0.0757685 0.0645058 0.036831 0.0339331 0.0348343 0.00660298 0.0128061 0.0136668 0.0219802 0.0461066	Because there is a theoretical basis that these effects may be additive , use of DRUG1 -containing or DRUG0 (like DRUG2 or DRUG0 ) and DRUG0 within 24 hours of each other should be avoided .
4	4	0.0607066 0.0208494 0.0198014 0.0231624 0.0485499 0.0312666 0.0100434 0.00889676 0.0156467 0.0225675 0.0307056 0.0661159 0.0240821 0.0404603 0.0378975 0.0360027 0.0219059 0.0175288 0.0142012 0.0268508 0.0127679 0.00788383 0.0172383 0.00664885 0.00681435 0.0226747 0.078989 0.0643067 0.0345548 0.0302794 0.0323195 0.00654962 0.0140405 0.0146025 0.024092 0.0489965	Because there is a theoretical basis that these effects may be additive , use of DRUG1 -containing or DRUG0 (like DRUG0 or DRUG2 ) and DRUG0 within 24 hours of each other should be avoided .
1	1	0.0537691 0.0183682 0.0174234 0.0203038 0.0424553 0.0269071 0.008414 0.00739344 0.0127336 0.0180285 0.0239857 0.0491547 0.0171783 0.0275306 0.0253128 0.0242477 0.0180427 0.0148472 0.0111927 0.0229237 0.00806792 0.0102255 0.0153675 0.0331145 0.0213788 0.0524279 0.0599869 0.062082 0.0495574 0.0611731 0.0711951 0.0110702 0.0126146 0.0139149 0.0188282 0.0387827	Because there is a theoretical basis that these effects may be additive , use of DRUG1 -containing or DRUG0 (like DRUG0 or DRUG0 ) and DRUG2 within 24 hours of each other should be avoided .
4	4	0.0488529 0.0163305 0.0153362 0.0177201 0.0373095 0.0242348 0.00790008 0.00697586 0.0125639 0.020086 0.0259128 0.059884 0.0258079 0.0611268 0.047889 0.0318323 0.0305584 0.0227309 0.0649013 0.0513308 0.0173301 0.00683946 0.00545707 0.00499838 0.00576375 0.0208783 0.0679503 0.0584393 0.0321086 0.0285721 0.0297853 0.00574833 0.0116031 0.0124834 0.020298 0.0424604	Because there is a theoretical basis that these effects may be additive , use of DRUG0 -containing or DRUG1 (like DRUG2 or DRUG0 ) and DRUG0 within 24 hours of each other should be avoided .
4	4	0.053481 0.0179546 0.0168489 0.0194917 0.0407124 0.026073 0.00837192 0.00743088 0.0131653 0.0203666 0.0261773 0.0597058 0.0244229 0.0532256 0.0419884 0.0280866 0.0275508 0.0202144 0.0530305 0.0379253 0.0116456 0.00822328 0.0156425 0.00594206 0.00614471 0.0208518 0.0762785 0.0632816 0.0334637 0.0290123 0.0308428 0.00618059 0.013228 0.0138169 0.022798 0.0464235	Because there is a theoretical basis that these effects may be additive , use of DRUG0 -containing or DRUG1 (like DRUG0 or DRUG2 ) and DRUG0 within 24 hours of each other should be avoided .
1	1	0.0494408 0.0168224 0.0158871 0.0186114 0.0387338 0.0243718 0.00757773 0.00667611 0.0114937 0.0170022 0.0216523 0.0446586 0.018741 0.0347376 0.0278861 0.0183531 0.0195846 0.0142463 0.0394351 0.0275823 0.00904752 0.0124058 0.016383 0.0368101 0.0206923 0.051653 0.0576451 0.0595121 0.0461777 0.0580675 0.0686144 0.0107409 0.0120289 0.0131605 0.0176405 0.0359264	Because there is a theoretical basis that these effects may be additive , use of DRUG0 -containing or DRUG1 (like DRUG0 or DRUG0 ) and DRUG2 within 24 hours of each other should be avoided .
1	1	0.0497275 0.0161102 0.015026 0.0168672 0.0338815 0.0210868 0.00647653 0.00598335 0.0104497 0.0163653 0.0196151 0.039516 0.0151584 0.0315837 0.0204794 0.0100859 0.00883062 0.00638131 0.0120032 0.0230584 0.0132954 0.0148641 0.0644582 0.0435595 0.0238968 0.0572922 0.0560844 0.0580189 0.0463057 0.0599197 0.0780036 0.0132768 0.0141722 0.0158659 0.0206743 0.0416261	Because there is a theoretical basis that these effects may be additive , use of DRUG0 -containing or DRUG0 (like DRUG0 or DRUG1 ) and DRUG2 within 24 hours of each other should be avoided .
3	3	0.203894 0.16225 0.116314 0.0798578 0.0473267 0.0850961 0.067942 0.0424896 0.0794583 0.115372	DRUG1 reduce DRUG2 clearance , significantly increasing systemic exposure .
1	1	0.0382288 0.0214769 0.0551292 0.0392687 0.0487967 0.056849 0.0512803 0.0461339 0.0340897 0.0521688 0.0558161 0.0633687 0.0456487 0.0180368 0.00649865 0.00322044 0.00387678 0.00235656 0.00148326 0.00129717 0.00199525 0.00145405 0.00227279 0.00156885 0.00263714 0.00193434 0.00431634 0.00393567 0.00478536 0.00983061 0.0257788 0.00799625 0.0204592 0.00466624 0.00507415 0.0122985 0.0146389 0.00555983 0.0109737 0.00433726 0.00742964 0.0329449 0.0281374 0.0469302 0.0257032 0.0223845 0.0449317	Therefore , the use of DRUG1 tablets in patients receiving DRUG2 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0184003 0.0124967 0.0322509 0.0305553 0.0376685 0.0430002 0.0550719 0.0648243 0.0455553 0.0563479 0.0557433 0.0895381 0.0851894 0.0475105 0.0185924 0.00317071 0.00261043 0.00156575 0.00118258 0.00103259 0.00148212 0.00111878 0.00164722 0.00117346 0.00187586 0.00143539 0.00310345 0.00280348 0.00343045 0.00743456 0.0198454 0.00655993 0.0175744 0.00411791 0.00444034 0.0107589 0.0126037 0.00485668 0.00950234 0.00369269 0.00627208 0.028626 0.024494 0.0404427 0.0218217 0.0189297 0.0376498	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG2 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0202997 0.013549 0.0347626 0.0328109 0.0399851 0.0460582 0.0558312 0.0646217 0.0439072 0.0562397 0.0542351 0.0825453 0.0665509 0.0370544 0.0148978 0.0120162 0.0128042 0.00248803 0.00142487 0.00107732 0.00144331 0.00110601 0.00161026 0.00116857 0.00184243 0.00143125 0.00304755 0.00274999 0.0033651 0.00712207 0.0200193 0.00654753 0.0177096 0.00411594 0.00443783 0.010841 0.0126793 0.00494138 0.00975023 0.00385326 0.00656349 0.0295267 0.0254287 0.0423772 0.0231119 0.0199885 0.0400625	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG2 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0205287 0.0137158 0.0353358 0.033432 0.0409385 0.0471143 0.0572652 0.0665842 0.0451797 0.0582661 0.0561638 0.0868681 0.0679158 0.0357563 0.0100335 0.00674692 0.00520471 0.00380166 0.00257581 0.00269326 0.00627481 0.00118101 0.00139817 0.0010917 0.00155246 0.00127465 0.00236206 0.00248543 0.00324125 0.00573909 0.0194802 0.00630896 0.0151472 0.00376455 0.00414159 0.0106103 0.0123346 0.00499191 0.00938339 0.00388229 0.00668024 0.0292309 0.0253093 0.0421709 0.0231814 0.0201085 0.0405525	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0204969 0.0137329 0.035425 0.0335523 0.0410682 0.047283 0.0575289 0.0670384 0.0453871 0.0583058 0.0562387 0.0867862 0.0672869 0.0349855 0.0089976 0.00575375 0.00407009 0.00271301 0.00166553 0.00136191 0.00233579 0.00277031 0.00671534 0.00121163 0.00151327 0.00128915 0.00228912 0.00253146 0.00345429 0.00614058 0.0197773 0.00658546 0.0158842 0.00388182 0.00425245 0.0109609 0.0126158 0.00511939 0.00949367 0.00393707 0.00676408 0.0294997 0.02545 0.0421391 0.0231638 0.0200706 0.0404762	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.020353 0.0136487 0.0352601 0.033466 0.0409804 0.047234 0.0573941 0.0670474 0.0453847 0.0581596 0.0562922 0.0866246 0.0669549 0.0350351 0.00894505 0.00567428 0.00389792 0.00257375 0.00156536 0.00121082 0.00174476 0.0014036 0.00242249 0.00284541 0.00737086 0.00137462 0.00226499 0.00271052 0.00371997 0.00640918 0.0196691 0.00674522 0.0160286 0.00393361 0.00429979 0.0110577 0.0126532 0.0051558 0.00948852 0.00395106 0.00679059 0.0294681 0.0254048 0.0419884 0.0230786 0.0199933 0.0403252	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0204105 0.0136491 0.0351464 0.033341 0.0407266 0.0468358 0.0565744 0.0659149 0.0446357 0.0576214 0.0551498 0.0851429 0.065559 0.0330667 0.00842945 0.00517044 0.00366001 0.00240933 0.00144183 0.00112035 0.00161579 0.0012122 0.00179556 0.00139462 0.00248261 0.00333708 0.0124478 0.00407297 0.00467702 0.00811886 0.0188537 0.00714143 0.0183618 0.00429132 0.00465848 0.0112437 0.0127558 0.00514309 0.00962863 0.00394689 0.00676088 0.0295691 0.025401 0.0420391 0.0230137 0.019935 0.0400964	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0190342 0.0120673 0.0292203 0.0268908 0.0325061 0.0345364 0.0353382 0.0384021 0.0273431 0.0376091 0.0346608 0.0512365 0.0282508 0.00898015 0.00403424 0.00208307 0.00273597 0.00180107 0.00118471 0.00103754 0.00166148 0.00118322 0.00193858 0.00132301 0.0023623 0.00173477 0.00424036 0.00410091 0.00590023 0.0135953 0.0305818 0.00993683 0.0298815 0.00744145 0.00867666 0.0190909 0.0241596 0.0086417 0.0220882 0.00964984 0.0169644 0.0735313 0.052537 0.0605843 0.057217 0.051866 0.0501591	Therefore , the use of DRUG1 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	4	0.0184794 0.0114946 0.0367997 0.0401001 0.047036 0.0421849 0.0678007 0.0380198 0.0364128 0.0486375 0.0719964 0.068735 0.0583348 0.0411727 0.0148258 0.00412188 0.00366021 0.0022245 0.00166528 0.00142725 0.001975 0.00153348 0.00215768 0.00159116 0.00242049 0.00191145 0.00388811 0.00359905 0.00454051 0.00994089 0.0247358 0.00824749 0.0206682 0.00482658 0.00515894 0.0122858 0.014812 0.0055777 0.0107815 0.00420266 0.00712989 0.0321939 0.027565 0.0453624 0.0244152 0.0211528 0.0421967	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG2 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0191032 0.0116914 0.0363437 0.0393382 0.0456223 0.0406134 0.0654658 0.0360801 0.0335691 0.0480792 0.0670264 0.0630725 0.0404259 0.034696 0.0143744 0.0139627 0.0149824 0.00400464 0.00244801 0.00169366 0.00213389 0.00164575 0.0023166 0.00172746 0.00260079 0.0020687 0.00414508 0.00382901 0.00486203 0.0104169 0.027472 0.00901644 0.0222953 0.00514338 0.00548045 0.0131144 0.015583 0.0059511 0.011385 0.00451361 0.00769483 0.0340548 0.0289799 0.0475715 0.025934 0.0224525 0.0450186	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG2 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0184627 0.0112315 0.0350442 0.0381291 0.0442258 0.0392807 0.0661334 0.0368201 0.0346851 0.0510862 0.0723052 0.0672485 0.0413027 0.0343972 0.0125142 0.0117664 0.00749778 0.00508463 0.00371437 0.00399183 0.00872919 0.00186719 0.00214587 0.00163475 0.00232324 0.00191085 0.00345326 0.00355979 0.00471617 0.00864385 0.0276841 0.00911765 0.0200733 0.00486128 0.0052551 0.0130798 0.0153692 0.00605797 0.0110257 0.00452113 0.00776966 0.0335472 0.0285345 0.0466363 0.0255777 0.0222167 0.0447669	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0184812 0.0112691 0.0352053 0.0383098 0.0444198 0.0394095 0.0663781 0.0369516 0.0347991 0.0511514 0.07247 0.0676724 0.0413175 0.0339042 0.0114203 0.0103413 0.00596359 0.00362741 0.00237773 0.00221832 0.00351636 0.00388281 0.00924881 0.00183091 0.00222461 0.00188004 0.00325083 0.00357047 0.00498204 0.00906003 0.0280191 0.00950243 0.0210664 0.00505075 0.00541758 0.0135274 0.0156445 0.00620576 0.0110958 0.0045707 0.00784512 0.0336828 0.0285678 0.0464345 0.0254972 0.0221205 0.0446166	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0183901 0.0112157 0.0350418 0.0381415 0.0442382 0.0392498 0.0661355 0.0368027 0.0346419 0.0509574 0.0724548 0.0675929 0.041204 0.0338077 0.011364 0.0102153 0.00574035 0.00346026 0.00222334 0.00191314 0.00256134 0.00210436 0.00347515 0.00392807 0.0100752 0.00207089 0.00324137 0.00384738 0.00537196 0.00946019 0.0279274 0.00969829 0.0213702 0.00514237 0.00549246 0.0136491 0.0156282 0.00623929 0.0110961 0.00458818 0.00787301 0.0336308 0.0285175 0.0462888 0.0254292 0.0220426 0.0444602	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0183831 0.0111638 0.0347133 0.0377426 0.0438491 0.0390177 0.0651834 0.036149 0.0338108 0.0496806 0.070457 0.0654665 0.0399362 0.0323809 0.010967 0.00962658 0.00546381 0.00324997 0.00205977 0.00179599 0.00239399 0.00180183 0.00252972 0.00203357 0.00342114 0.00460353 0.0170953 0.00627536 0.00703345 0.012071 0.0260494 0.0098499 0.0237383 0.00544631 0.00580471 0.0135611 0.0152817 0.0061141 0.0111178 0.0045621 0.00782312 0.0336085 0.0285015 0.0464062 0.0254204 0.0220469 0.044312	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
2	4	0.0151374 0.00844618 0.0242944 0.0262967 0.0314036 0.0306869 0.0467487 0.0251286 0.0259619 0.0407969 0.0501855 0.0421629 0.0246135 0.013002 0.00462508 0.00268549 0.00308601 0.00188588 0.00133505 0.0012282 0.00180166 0.00137549 0.00205222 0.00153226 0.00245824 0.00201554 0.00420891 0.0049222 0.00788137 0.0162919 0.0359435 0.0126506 0.0355862 0.00794908 0.00936796 0.0214921 0.0261039 0.00936792 0.0226716 0.00997108 0.0173401 0.0718761 0.0511088 0.0565435 0.0536183 0.0482884 0.0458702	Therefore , the use of DRUG0 tablets in patients receiving DRUG1 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	4	0.014322 0.00646285 0.0146668 0.0159622 0.0172383 0.0236701 0.0349757 0.0185927 0.0199907 0.0356856 0.0539547 0.0869314 0.0784736 0.0746666 0.083255 0.0259985 0.0141545 0.00720349 0.00477657 0.00526768 0.0102993 0.00206667 0.00228445 0.00174339 0.00235833 0.0019636 0.00332324 0.0035473 0.00457847 0.00777348 0.0249546 0.00895006 0.0195088 0.00481673 0.00530106 0.0131527 0.0154489 0.00615299 0.0109562 0.00446098 0.00764474 0.0334736 0.0290721 0.0480451 0.0253264 0.0222376 0.0443099	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG1 ( DRUG0 ) (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0141904 0.00641121 0.0145488 0.0158278 0.017101 0.0234905 0.034738 0.0184922 0.019842 0.0353277 0.0532204 0.0864369 0.0786744 0.0760971 0.083755 0.0242214 0.011351 0.00530582 0.00319008 0.00308122 0.00454636 0.00492025 0.0106155 0.00202804 0.00237563 0.00198273 0.00325265 0.00369434 0.00496631 0.00843232 0.0258323 0.00953353 0.0207758 0.00507609 0.00552392 0.0137435 0.0158203 0.0063123 0.0110637 0.00450816 0.00771023 0.03366 0.0290953 0.0477151 0.0252391 0.0221311 0.0441424	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG1 ( DRUG0 ) (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0141015 0.00636987 0.0144261 0.0156873 0.0169614 0.023322 0.0344776 0.0183883 0.0197321 0.0351198 0.0527585 0.085743 0.0780512 0.075788 0.0833821 0.0240366 0.0110357 0.00509831 0.00301649 0.00274493 0.00344196 0.00274248 0.00426782 0.00468692 0.010872 0.00220347 0.00336239 0.00405026 0.00541839 0.00897868 0.0261996 0.00992188 0.0214564 0.0052472 0.00566604 0.0140225 0.0159577 0.00638184 0.0111074 0.00453463 0.00774758 0.033662 0.0290564 0.0475374 0.0251754 0.0220522 0.0440088	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG1 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0141802 0.006396 0.0145041 0.0157818 0.0169566 0.0232694 0.0343691 0.0181945 0.0195507 0.0349437 0.05338 0.0861807 0.0767949 0.0728792 0.078535 0.0227235 0.0101126 0.00464974 0.00277272 0.00261078 0.00319763 0.00235796 0.00318047 0.00247652 0.00391607 0.00507016 0.017407 0.00596274 0.00655913 0.010857 0.0244156 0.0101566 0.0236812 0.0055352 0.00599555 0.0139213 0.0157904 0.00627545 0.0111415 0.00450328 0.00767902 0.0335746 0.0289958 0.0476868 0.0251229 0.0220054 0.0437495	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG1 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	2	0.0123889 0.00550699 0.0124062 0.0135687 0.0139086 0.0191538 0.0278887 0.013905 0.0145273 0.0254188 0.0411665 0.0659363 0.0537993 0.039095 0.0374131 0.0104834 0.00451567 0.00248271 0.00169791 0.00156482 0.00208993 0.00158839 0.00224418 0.00172991 0.00266488 0.0022987 0.00427874 0.00598608 0.00915394 0.0157636 0.0337446 0.0130798 0.0350383 0.00717113 0.00919403 0.0241823 0.0269353 0.00989722 0.0235084 0.0101964 0.017299 0.0715498 0.0502442 0.0558954 0.0535663 0.0483539 0.045518	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG1 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	4	0.0165655 0.00735452 0.0164128 0.0177263 0.0188724 0.0270308 0.0397643 0.0202985 0.0209771 0.036757 0.0583277 0.0851029 0.0716193 0.0426579 0.0226411 0.0214251 0.0475218 0.00895254 0.00515451 0.00547507 0.00980093 0.00205901 0.00230202 0.00181313 0.00240506 0.00204436 0.00337542 0.00370225 0.00481771 0.00793842 0.0271292 0.00976048 0.0213643 0.00532538 0.00590804 0.0148168 0.0173699 0.00696284 0.0124384 0.00508297 0.00871931 0.0383636 0.033549 0.0557492 0.029335 0.0258146 0.0514155	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG1 ) (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0161272 0.00718035 0.0161202 0.0174109 0.0184913 0.0265164 0.0390977 0.0199561 0.0206203 0.0363833 0.0585573 0.0867092 0.0730972 0.0462712 0.0246561 0.0237787 0.0458104 0.00662768 0.00363357 0.00405077 0.00442666 0.00471197 0.0102807 0.00196043 0.00235655 0.00199884 0.00323539 0.00373076 0.00501598 0.00831324 0.0271167 0.0100458 0.0219057 0.00541128 0.00594416 0.0149047 0.0172198 0.00691668 0.0122122 0.00499389 0.00855321 0.0375473 0.0326978 0.0539832 0.0284791 0.0250335 0.0499082	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG1 ) (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0160508 0.00714523 0.0160309 0.0173149 0.018377 0.0263484 0.0388363 0.0198218 0.0205049 0.0362656 0.0584912 0.0862344 0.0723453 0.0459358 0.024505 0.0237242 0.0450081 0.00634427 0.00339728 0.00369144 0.00336844 0.0027236 0.00398753 0.00456711 0.0106003 0.00213868 0.0033443 0.00405932 0.00544368 0.00885712 0.0274612 0.0104342 0.0225579 0.00558988 0.00609038 0.0152041 0.0173744 0.00699606 0.0122642 0.00502314 0.00859495 0.037551 0.0326406 0.053737 0.0283853 0.0249205 0.0497121	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG1 ) (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	4	0.0160384 0.0071352 0.0159881 0.0172667 0.018286 0.0261426 0.0385135 0.0195846 0.0202086 0.035637 0.0578545 0.0858494 0.0715373 0.0446114 0.0235785 0.0222903 0.0421587 0.00581739 0.00317596 0.00355351 0.00313741 0.00236183 0.00297465 0.00244023 0.00378339 0.00511085 0.0168738 0.00567163 0.00639058 0.0105599 0.0257555 0.0107328 0.0249059 0.00592076 0.00646798 0.0151352 0.0172893 0.00690959 0.0123408 0.0050016 0.00853926 0.0374779 0.0325691 0.053903 0.0283159 0.0248502 0.0493534	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG1 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 .
4	2	0.0130735 0.00574883 0.0124569 0.0134369 0.013884 0.0190295 0.0273935 0.0133706 0.0133004 0.0220356 0.0385035 0.0604613 0.0503131 0.026864 0.0134774 0.00999734 0.0210126 0.00293282 0.00189737 0.00167601 0.00202507 0.00160156 0.00211079 0.0017366 0.00251292 0.00230876 0.00400983 0.00586049 0.00911221 0.0145165 0.0344568 0.0133362 0.0356689 0.00721357 0.00925832 0.0255566 0.027743 0.010449 0.024996 0.0110259 0.0189428 0.0782323 0.0546768 0.0608534 0.0585832 0.0528068 0.0495406	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG1 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	2	0.0137534 0.00609391 0.0132763 0.0143353 0.0146966 0.0197393 0.0285106 0.0138027 0.0135562 0.0222681 0.0382195 0.0582396 0.0469268 0.0237745 0.00832818 0.00541192 0.00552409 0.00387943 0.00298486 0.00331237 0.0159839 0.00274286 0.00261906 0.00248596 0.00303275 0.00347707 0.00456121 0.00781701 0.0103974 0.0145274 0.0355018 0.0123226 0.031453 0.00721743 0.00916088 0.0274132 0.0232186 0.010491 0.0265987 0.0123741 0.0205605 0.0799495 0.0521661 0.0598792 0.0620385 0.055731 0.0496453	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	2	0.0139394 0.00617988 0.0134528 0.0145027 0.0148567 0.0197204 0.0284996 0.0137854 0.0134478 0.0219491 0.0372114 0.0558208 0.0444637 0.0214786 0.00736727 0.00446576 0.00474998 0.00314189 0.00210593 0.00204775 0.00433601 0.00399216 0.0156507 0.00275726 0.00331742 0.00356454 0.00478484 0.00797591 0.0105159 0.0149366 0.0364782 0.0130591 0.0327349 0.00717288 0.00911488 0.0273677 0.0242111 0.0105258 0.0262489 0.0120744 0.0204784 0.0809384 0.0537759 0.0613462 0.0624985 0.0561967 0.0507602	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	2	0.0137552 0.00611153 0.013285 0.0142932 0.0146343 0.0190933 0.027582 0.0133108 0.0128549 0.0208843 0.0353925 0.0525675 0.0417312 0.0196557 0.00683577 0.00394188 0.00438874 0.00288554 0.00186936 0.00162187 0.00302601 0.00258724 0.0055937 0.00512305 0.0224021 0.00423134 0.00538903 0.00884425 0.0114581 0.0166373 0.0380429 0.0136481 0.0355767 0.00772337 0.0096275 0.0278748 0.0245989 0.0106449 0.0263043 0.0120634 0.0204648 0.0803515 0.0534694 0.0606141 0.0615327 0.0553625 0.0501134	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
4	2	0.0133695 0.00590024 0.0126227 0.0135435 0.013865 0.0179217 0.0256415 0.0123986 0.0119395 0.0188619 0.0308757 0.0443158 0.0351037 0.015178 0.00572046 0.00316463 0.00387579 0.00255287 0.0015905 0.00131803 0.0024294 0.00175588 0.00343088 0.00277801 0.00672517 0.00644398 0.0393643 0.0104665 0.0119367 0.0188866 0.0414229 0.015476 0.0411582 0.0087407 0.0105591 0.0287397 0.026832 0.0110883 0.0261682 0.0118831 0.0204271 0.0808943 0.0553517 0.0616123 0.0607006 0.054633 0.0503357	Therefore , the use of DRUG0 tablets in patients receiving DRUG0 is contraindicated . DRUG0 ( DRUG0 ) (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG2 .
1	1	0.0609441 0.0365159 0.0389678 0.0415888 0.0851987 0.0346715 0.108263 0.0653276 0.048508 0.0514049 0.082297 0.0437976 0.0703651 0.0389782 0.0300975 0.0286381 0.0192451 0.0251042 0.0259772 0.0641097	If concomitant treatment with DRUG1 and an DRUG2 is clinically warranted , appropriate observation of the patient is advised .
3	0	0.0597782 0.0468061 0.051708 0.0555824 0.0925066 0.0761908 0.125027 0.0764717 0.0658992 0.0845191 0.0537476 0.0569019 0.0576186 0.0972423	Concomitant use of DRUG1 with DRUG2 may result in an adverse drug interaction .
4	4	0.0065707 0.0152647 0.0137817 0.0241566 0.036231 0.0249771 0.0223006 0.0211956 0.0397868 0.045817 0.0762225 0.0165879 0.0434207 0.0313897 0.0159312 0.0184034 0.0403398 0.0653715 0.0563442 0.0422263 0.035072 0.0259547 0.0074107 0.0123095 0.00634606 0.0189636 0.00998126 0.0081907 0.0273216 0.0142929 0.00725101 0.00487703 0.00658638 0.0044032 0.00494617 0.00662903 0.00872529 0.0137022 0.00903709 0.00696772 0.00690012 0.00376603 0.00441426 0.00196282 0.00177785 0.0080672 0.0337587 0.0186029 0.0254633	Although this has not occurred in in vitro studies with DRUG1 , interactions with DRUG0 have been reported with DRUG2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG0 to patients on DRUG0 and other highly protein-bound drugs .
4	4	0.00846512 0.0200211 0.0183182 0.0326991 0.0473805 0.0310415 0.0285164 0.0273712 0.0528924 0.0673486 0.0891448 0.0123784 0.0333818 0.0158005 0.00684767 0.00280239 0.00394633 0.0121827 0.00480979 0.0106019 0.0172005 0.0137737 0.00546495 0.0115971 0.00648445 0.0237612 0.0158629 0.0130305 0.0472051 0.0269648 0.0163273 0.0124357 0.0159908 0.00957046 0.00904251 0.0131877 0.0125205 0.0241517 0.0159018 0.0123262 0.0135139 0.00920526 0.0077246 0.00259859 0.00242025 0.0104361 0.0459255 0.0253047 0.0341209	Although this has not occurred in in vitro studies with DRUG1 , interactions with DRUG0 have been reported with DRUG0 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG2 to patients on DRUG0 and other highly protein-bound drugs .
4	0	0.00556179 0.0105079 0.00779046 0.0129758 0.0161529 0.00772104 0.00695468 0.00536141 0.00842571 0.0108156 0.0121547 0.020415 0.0809231 0.0571114 0.0515612 0.036828 0.0550965 0.0602823 0.0699706 0.0540912 0.0441819 0.0337927 0.0100338 0.0157169 0.00807687 0.0224277 0.0117111 0.00960364 0.0317618 0.0166893 0.00851781 0.00569685 0.00766467 0.00512008 0.0057105 0.00764478 0.0100782 0.0158268 0.010417 0.0080393 0.00796138 0.00434369 0.00508859 0.00226112 0.00204731 0.00928948 0.0388719 0.0214155 0.0293084	Although this has not occurred in in vitro studies with DRUG0 , interactions with DRUG1 have been reported with DRUG2 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG0 to patients on DRUG0 and other highly protein-bound drugs .
4	4	0.00693516 0.0128365 0.00927348 0.0155624 0.0193425 0.00919484 0.0083448 0.00632672 0.00989839 0.0121255 0.0154457 0.0242117 0.0961974 0.0729284 0.0358038 0.00920315 0.011179 0.0265666 0.011772 0.0194972 0.031407 0.0183274 0.00658649 0.0138369 0.00807223 0.0287256 0.0188812 0.01544 0.0552695 0.0313264 0.0193407 0.0146972 0.0190436 0.0115738 0.0106382 0.0153891 0.0145774 0.0278652 0.0182866 0.0141675 0.0155848 0.0106257 0.00891033 0.00299212 0.00278086 0.0119904 0.052784 0.0290668 0.039168	Although this has not occurred in in vitro studies with DRUG0 , interactions with DRUG1 have been reported with DRUG0 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG2 to patients on DRUG0 and other highly protein-bound drugs .
4	4	0.00583805 0.0106137 0.00748045 0.0122932 0.0160558 0.00677454 0.00613605 0.00433886 0.0064846 0.00764559 0.00859506 0.00864704 0.0533136 0.0279268 0.0161414 0.0124018 0.0234049 0.0683395 0.0629003 0.0676177 0.036523 0.0180199 0.00665365 0.0110967 0.00737502 0.0223064 0.0138318 0.0105838 0.0354342 0.0190656 0.0109577 0.00780969 0.0115015 0.00868095 0.00990109 0.0155609 0.019511 0.0291767 0.0285909 0.0380742 0.0410578 0.034655 0.021447 0.00381674 0.00312459 0.00992397 0.0376977 0.0184902 0.0361834	Although this has not occurred in in vitro studies with DRUG0 , interactions with DRUG0 have been reported with DRUG1 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG0 to patients on DRUG2 and other highly protein-bound drugs .
1	1	0.00618279 0.010312 0.00693011 0.0105273 0.0135192 0.00602305 0.00550693 0.00374169 0.00492801 0.0060399 0.00664957 0.00473747 0.0253045 0.010204 0.00811632 0.00355038 0.00400808 0.0118686 0.00515248 0.0110311 0.0174788 0.0161078 0.00647432 0.0146592 0.00807883 0.0315234 0.0220114 0.0169273 0.0664298 0.044438 0.0324753 0.0321665 0.0466571 0.0335121 0.0265294 0.032139 0.0251107 0.0275551 0.0458241 0.0371706 0.0346352 0.0439333 0.0295861 0.00652868 0.00581245 0.0177069 0.0458475 0.0242493 0.044098	Although this has not occurred in in vitro studies with DRUG0 , interactions with DRUG0 have been reported with DRUG0 since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering DRUG1 to patients on DRUG2 and other highly protein-bound drugs .
4	4	0.0345974 0.0305206 0.0262608 0.0256553 0.0203698 0.0261689 0.0159521 0.0270817 0.0355832 0.0229356 0.0318012 0.0383208 0.0438774 0.0531715 0.0326376 0.0276599 0.0261453 0.0288638 0.0420747 0.02365 0.0193415 0.0223439 0.00934581 0.00268178 0.00453686 0.00661452 0.0132608 0.0114241 0.00998353 0.00970803 0.0137322 0.0143793 0.0062412 0.00718004 0.00814879 0.0066371 0.00314429 0.00223412 0.00129713 0.00182462 0.00315411 0.00267586 0.00699677 0.0176836 0.0331908 0.0098227 0.0154961 0.0152757 0.0103014 0.0195997 0.0229748 0.0193083 0.0361331	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG2 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0338699 0.0299779 0.0261963 0.0254844 0.0203386 0.0273487 0.0168675 0.0300877 0.034016 0.0140751 0.0138984 0.0132643 0.0124876 0.0168251 0.0278931 0.0458122 0.0416008 0.0320301 0.0658293 0.0687695 0.0433644 0.01947 0.0103642 0.00311442 0.00566244 0.00754531 0.0132955 0.0125388 0.00962159 0.00995807 0.0140846 0.0141373 0.00629748 0.00702962 0.00793198 0.00650886 0.00305703 0.00216886 0.00125647 0.00177002 0.00303539 0.00258119 0.00673227 0.0170246 0.0317385 0.00945956 0.0147373 0.0146663 0.00995023 0.0188948 0.0221133 0.0185887 0.0346283	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG2 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0436009 0.0384199 0.0333108 0.0324273 0.0245868 0.0314492 0.0185942 0.032481 0.0331069 0.0125687 0.0116173 0.00918446 0.0101058 0.0102193 0.0149578 0.0147432 0.0139851 0.0106643 0.0220111 0.0186081 0.0207095 0.0342767 0.0179085 0.00557476 0.0109352 0.0187881 0.0186183 0.0270631 0.0208724 0.0154519 0.0282266 0.0259498 0.0136359 0.011526 0.0136213 0.0103907 0.00427982 0.0030417 0.00170803 0.00235301 0.00389244 0.00329479 0.00856052 0.0213972 0.0398567 0.0119325 0.0183521 0.0184359 0.0126433 0.0239773 0.0281193 0.0237438 0.0442206	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG2 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0445577 0.0392302 0.0339695 0.033083 0.024883 0.0316196 0.0182627 0.0316838 0.0312574 0.0117782 0.0105852 0.00832709 0.0093707 0.00889 0.0120687 0.010938 0.0103112 0.00751903 0.0151029 0.0108441 0.0152579 0.0161928 0.00782056 0.00288359 0.00615495 0.00983164 0.0205623 0.0188229 0.0169329 0.0203426 0.0282108 0.0317408 0.0154707 0.0157932 0.0256516 0.0196399 0.0253802 0.0124798 0.00290437 0.0028857 0.00303934 0.00336058 0.00787327 0.0179248 0.0385765 0.0126486 0.0214899 0.0235968 0.0159034 0.0283657 0.0328923 0.0280489 0.0470385	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG2 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0468766 0.0412732 0.035735 0.0347885 0.0261654 0.0332548 0.0192345 0.0334492 0.0329308 0.0123236 0.011107 0.00868733 0.00981364 0.00935314 0.0126122 0.0115257 0.0108329 0.00794312 0.0159669 0.0114746 0.0160765 0.0174033 0.0083153 0.0030537 0.0065731 0.0105209 0.0216594 0.0191597 0.0162882 0.0192132 0.0269004 0.0271935 0.0123544 0.0121664 0.0175712 0.0125737 0.00935264 0.00360097 0.00336454 0.0065266 0.0127165 0.00354077 0.00813196 0.0192457 0.0411218 0.0141259 0.0230499 0.0246338 0.0166207 0.0292526 0.0342024 0.0294178 0.0487246	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG2 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0397536 0.0349988 0.0302971 0.0294778 0.0221056 0.0280972 0.0161521 0.0280805 0.0274488 0.0102828 0.00925194 0.00726571 0.00822717 0.00775505 0.010386 0.00936934 0.00881294 0.0064125 0.0127664 0.00903253 0.0128137 0.01307 0.00622816 0.00235437 0.00457773 0.00691629 0.0145034 0.0124547 0.0111669 0.0108092 0.0154565 0.0165444 0.00708501 0.00825223 0.00935707 0.00754691 0.003808 0.00267306 0.00157891 0.00229343 0.00413813 0.00353228 0.0107081 0.0264149 0.051517 0.0196671 0.0327942 0.0500164 0.0369353 0.0668801 0.0499758 0.05568 0.0662769	Plasma levels of DRUG1 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
3	3	0.013223 0.0178202 0.0157123 0.0225731 0.0195526 0.0397574 0.0223988 0.0366582 0.0536472 0.0270568 0.0265296 0.0293469 0.0344623 0.0294723 0.0417375 0.0269921 0.0211742 0.0245206 0.0263466 0.0401932 0.0332231 0.0216868 0.0166195 0.00478479 0.00792045 0.00977294 0.0167637 0.0166002 0.0114092 0.0127249 0.0168858 0.0160532 0.00725769 0.00769333 0.00868568 0.0069241 0.00316751 0.00223049 0.00128506 0.00181163 0.00311576 0.00263878 0.00688231 0.0173363 0.0324171 0.00959467 0.0150842 0.0149593 0.0100761 0.0190503 0.022382 0.0188141 0.034974	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG1 is administered in conjunction with DRUG2 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0117172 0.0157961 0.013849 0.0202054 0.01758 0.0359128 0.0200023 0.0326365 0.0470318 0.0181912 0.0157618 0.0188094 0.0259012 0.0292127 0.0370905 0.0250849 0.0237282 0.0334106 0.0444352 0.0378799 0.0295066 0.0544715 0.0307891 0.00657561 0.0107344 0.0169912 0.0164439 0.022084 0.0164436 0.0121734 0.021254 0.0196663 0.0104624 0.00851515 0.00990081 0.00731924 0.00296033 0.00209097 0.00116896 0.00160531 0.00265756 0.00225681 0.00590591 0.0149177 0.0274402 0.00824044 0.0125286 0.0124905 0.00850951 0.015975 0.01877 0.0157768 0.0291372	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG1 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG2 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0122722 0.0165536 0.0146381 0.0212488 0.0184359 0.0372093 0.020511 0.0333193 0.0473181 0.0177646 0.0148166 0.0177216 0.023638 0.0272041 0.0317923 0.0190243 0.0181116 0.0256664 0.0336948 0.0290621 0.0202527 0.028627 0.0131627 0.00315839 0.00679779 0.0109448 0.0211348 0.0186038 0.0150093 0.0207193 0.0280536 0.0417327 0.0304448 0.0302765 0.0180961 0.0124894 0.00585798 0.00307695 0.00152292 0.00190071 0.00318859 0.0026099 0.00653902 0.0168207 0.0293743 0.00879864 0.013689 0.0138054 0.00928575 0.0170226 0.0197624 0.0167528 0.0304857	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG1 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG2 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0129158 0.0174215 0.015396 0.0223626 0.0194127 0.03922 0.0216361 0.03515 0.0499542 0.0188402 0.0157337 0.0187948 0.0251005 0.0289224 0.0339488 0.0207737 0.01994 0.0284068 0.0373497 0.0328983 0.0226315 0.0320996 0.0141856 0.00326773 0.00575905 0.00885385 0.0173894 0.0163143 0.0136527 0.0177493 0.0227068 0.0251024 0.0122605 0.0123484 0.0196174 0.0145198 0.0183083 0.00890156 0.00205236 0.00202557 0.00212831 0.00236089 0.00557269 0.0127784 0.0273615 0.00897801 0.0151128 0.0165145 0.011065 0.0196267 0.0227855 0.0193963 0.0323956	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG1 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG2 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0120677 0.0162739 0.0143799 0.0208801 0.0181147 0.03654 0.0200897 0.0325745 0.0461889 0.0174047 0.0146219 0.0174969 0.0233814 0.0270569 0.0314939 0.018965 0.018139 0.0256939 0.033769 0.02969 0.0201962 0.0275253 0.0117871 0.00278574 0.00451104 0.00657516 0.0129264 0.0113851 0.00930932 0.00966258 0.0130229 0.0137662 0.00586075 0.00662054 0.00746424 0.00580807 0.00285047 0.00198065 0.00116516 0.00169211 0.0030595 0.0026121 0.00798438 0.0198369 0.0388115 0.0147602 0.0244959 0.0369283 0.0270355 0.0486952 0.0363065 0.0402984 0.0474587	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG1 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
4	4	0.012232 0.0159803 0.0138006 0.020044 0.0164957 0.0314627 0.0159969 0.0253808 0.0340546 0.0119671 0.00888852 0.00963982 0.00855923 0.00834892 0.0181566 0.0255579 0.0234761 0.0182167 0.0404476 0.0617491 0.0783801 0.043201 0.0263658 0.00808459 0.014385 0.0204264 0.0205635 0.0271373 0.0195751 0.013856 0.0250527 0.0238421 0.0130144 0.0104567 0.0117473 0.0086276 0.00348716 0.00246704 0.00138091 0.00188707 0.00309813 0.00264738 0.00687387 0.0171835 0.031595 0.00971831 0.0145537 0.0148927 0.0102642 0.0192433 0.0224621 0.0188521 0.0342225	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG1 (3900 mg/day) , but concomitant administration of DRUG2 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0115414 0.0150943 0.0130301 0.0189695 0.01562 0.0298619 0.0153058 0.0243431 0.0328194 0.011564 0.00864358 0.00942192 0.00835224 0.00803542 0.0170543 0.0237408 0.0221089 0.0182223 0.0418324 0.066575 0.0616296 0.0230444 0.0105132 0.00384668 0.00831226 0.0115805 0.0197589 0.0191351 0.014098 0.0234253 0.0327521 0.0450958 0.0342503 0.0333799 0.0202034 0.0139357 0.00662212 0.0033398 0.00163198 0.00201942 0.00339262 0.00276949 0.00685581 0.0178278 0.0309924 0.00942653 0.0143993 0.01467 0.00993794 0.0181639 0.0210308 0.0177664 0.032056	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG1 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG2 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0122883 0.0160677 0.0138738 0.0201937 0.0166251 0.0317677 0.0162668 0.0258669 0.0348483 0.012275 0.00915332 0.00998602 0.00885405 0.00851961 0.0181937 0.0253398 0.0235877 0.0193295 0.0444244 0.0717062 0.068681 0.0259868 0.0118698 0.00390157 0.00735963 0.00976399 0.0163615 0.0171112 0.0130405 0.0207339 0.0268032 0.0283993 0.0145713 0.0137414 0.0206281 0.0156632 0.019033 0.0093212 0.0021871 0.0021948 0.00230157 0.00256927 0.00603739 0.013747 0.0294721 0.0100013 0.0161412 0.0181851 0.012284 0.021685 0.0250188 0.0211651 0.0348723	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG1 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG2 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0127379 0.0166562 0.0143823 0.0209325 0.0172342 0.0329265 0.0168562 0.0268043 0.0360957 0.0127042 0.00946406 0.0103212 0.00915463 0.00880742 0.018883 0.0263465 0.0244918 0.0200089 0.0459404 0.0746559 0.0729759 0.0276195 0.0125656 0.0040452 0.00770567 0.0102442 0.0171631 0.01732 0.012363 0.0193845 0.0254757 0.0244723 0.011641 0.0105107 0.0143909 0.0103022 0.00717785 0.00271187 0.00251098 0.00491724 0.0095984 0.0027028 0.0061941 0.0145552 0.0311736 0.0111059 0.0172303 0.0188283 0.0126628 0.0220429 0.0256215 0.0218288 0.0355539	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG1 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG2 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0111925 0.0146358 0.0126372 0.0184049 0.0151572 0.0289827 0.0148691 0.0236592 0.0319004 0.0112567 0.00839928 0.00919699 0.00814659 0.00783852 0.0167435 0.0232888 0.0217538 0.0180692 0.0418053 0.0681265 0.0644634 0.0228525 0.00997041 0.0032388 0.00578746 0.00731895 0.0121817 0.0120364 0.00875921 0.0107913 0.0152486 0.0152717 0.00684887 0.00725987 0.00798448 0.00634722 0.00307334 0.00212768 0.00124755 0.00180657 0.00321006 0.00277494 0.00844203 0.0211989 0.0403522 0.0161502 0.0255769 0.0387722 0.0288846 0.0522476 0.0389622 0.0434335 0.0493142	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG1 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
4	4	0.0139851 0.0182976 0.0156017 0.0224396 0.018096 0.0324729 0.0148067 0.0216132 0.0263663 0.00835553 0.00673652 0.00652765 0.00665931 0.00577016 0.00917202 0.00929714 0.00892493 0.00716919 0.0154762 0.0116791 0.0151501 0.0217381 0.0129219 0.00523799 0.0144589 0.0217553 0.0247094 0.0300002 0.0427263 0.0273209 0.0347236 0.0431605 0.051829 0.0438527 0.0261594 0.0217328 0.0115815 0.0048977 0.00218169 0.00273265 0.00462075 0.00374887 0.00952674 0.0265578 0.0423496 0.0127068 0.0189835 0.0190692 0.0127058 0.0227388 0.0263259 0.0223291 0.0400198	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG1 has no effect on DRUG2 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
3	4	0.0149663 0.0195853 0.0167026 0.0240086 0.0193469 0.0346859 0.0158013 0.0230832 0.0281886 0.00897532 0.00722905 0.0070358 0.00718236 0.00620955 0.00992827 0.0099927 0.0096424 0.0076705 0.0166871 0.0126479 0.0161923 0.0229871 0.0132375 0.00512856 0.0142492 0.0226847 0.0290773 0.0375006 0.0502321 0.0287272 0.0308785 0.0394211 0.0307788 0.0247857 0.0294789 0.0229578 0.0251765 0.0112897 0.00263492 0.00251369 0.00245223 0.00280798 0.00677246 0.0155381 0.0342996 0.011291 0.0185826 0.0197105 0.0134359 0.0238826 0.0278535 0.0238271 0.0400444	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG1 has no effect on DRUG0 plasma levels . DRUG2 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
3	4	0.0158035 0.0206861 0.0176463 0.0253771 0.0204604 0.0367005 0.0167484 0.0244835 0.0299025 0.00952846 0.00765387 0.0074669 0.00761398 0.00657831 0.0105889 0.0106472 0.0102967 0.00818935 0.0179068 0.0137579 0.0175368 0.0254368 0.0143771 0.00544458 0.0147828 0.0231506 0.02855 0.0375238 0.0511791 0.028425 0.0305605 0.0371825 0.0264165 0.0198407 0.0234022 0.0179159 0.0110628 0.00355396 0.00290251 0.00547134 0.0104567 0.0029845 0.00663453 0.0157802 0.0356537 0.0121376 0.0197718 0.0203653 0.0139074 0.0244807 0.0287225 0.0248361 0.0415165	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG1 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG2 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0134739 0.0176591 0.015087 0.0216931 0.0174825 0.0313289 0.0143126 0.0209429 0.0255815 0.00815811 0.00652562 0.00637681 0.00649561 0.00561128 0.00901209 0.00899709 0.00867028 0.00687813 0.0149818 0.0113672 0.0142312 0.0196092 0.0108015 0.00398825 0.0107914 0.0180912 0.0248504 0.0329415 0.0421053 0.025461 0.024589 0.0302832 0.0189688 0.0144429 0.0133507 0.00928728 0.00409604 0.00265553 0.00145177 0.00206153 0.00361633 0.00309507 0.00955214 0.0234851 0.0448857 0.0170085 0.0283254 0.042428 0.0311088 0.0559048 0.0418163 0.0472233 0.0568574	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG1 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
4	4	0.0159233 0.021015 0.0180351 0.0261516 0.0209422 0.0369814 0.0167659 0.0242335 0.0293421 0.00931975 0.00704139 0.00688924 0.0070871 0.00594932 0.00930062 0.00847765 0.00818859 0.00625 0.0131644 0.00900125 0.0131565 0.0136096 0.00686724 0.00273045 0.00652059 0.0107463 0.0222625 0.020489 0.0165364 0.0211559 0.031831 0.0452179 0.0267422 0.0401529 0.0402816 0.0301044 0.0247446 0.0121236 0.00311611 0.00322717 0.00332852 0.0038659 0.00912837 0.0207777 0.0439553 0.0150802 0.0229996 0.0260633 0.017767 0.031154 0.0357276 0.030048 0.0484295	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG1 plasma levels . DRUG2 , including DRUG0 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0155839 0.0205305 0.0176095 0.0255724 0.020479 0.0362082 0.0164255 0.0236881 0.0287313 0.00911972 0.00688687 0.00674229 0.00690708 0.00580066 0.00911904 0.00833481 0.00803827 0.00610129 0.0128931 0.00886192 0.0129218 0.0135585 0.00679224 0.00265247 0.00626736 0.0104041 0.0216475 0.0195448 0.0158886 0.0199208 0.030269 0.0413577 0.0291526 0.0444492 0.0492052 0.0324261 0.0186824 0.00440534 0.00338203 0.00690926 0.0138197 0.00392214 0.00887418 0.0214351 0.0466834 0.0162739 0.0240985 0.0254695 0.0171034 0.0294737 0.034051 0.028912 0.046413	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG1 plasma levels . DRUG0 , including DRUG2 , have been reported to increase steady state plasma DRUG0 levels .
4	4	0.0124968 0.0164646 0.0141334 0.0205448 0.0164709 0.0291659 0.0132845 0.01924 0.0233731 0.00746222 0.00560346 0.00552294 0.00563006 0.00471723 0.00749096 0.006841 0.00661159 0.00498907 0.010577 0.00728923 0.0106883 0.0113726 0.00569829 0.00227643 0.00568028 0.00959483 0.0195962 0.0178246 0.0146013 0.0196412 0.0312416 0.0445931 0.0261773 0.0298156 0.0226042 0.0157102 0.00816213 0.00320208 0.00167011 0.00251937 0.00422767 0.00354443 0.0106727 0.0306976 0.0524887 0.0212976 0.0327753 0.048085 0.0351333 0.063207 0.0463958 0.0526911 0.0582053	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG1 plasma levels . DRUG0 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
4	4	0.0157588 0.0207921 0.0179255 0.0258924 0.0207292 0.0364834 0.0165126 0.023976 0.0289806 0.00933901 0.00699303 0.00697678 0.00708507 0.00592355 0.00958833 0.0086032 0.00831258 0.00621601 0.0132297 0.00937444 0.0129894 0.0134732 0.00659701 0.00248232 0.00481562 0.00753777 0.0170053 0.0165303 0.0181608 0.0200903 0.0263637 0.0351921 0.0190311 0.0213665 0.0324138 0.0251892 0.0272387 0.0415662 0.00811737 0.0162345 0.0172442 0.0051502 0.0107045 0.0262317 0.0462824 0.0173117 0.0253499 0.0254989 0.0169133 0.0285948 0.0338694 0.0292345 0.0465269	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG1 , including DRUG2 , have been reported to increase steady state plasma DRUG0 levels .
4	3	0.0153391 0.0202623 0.017435 0.0251647 0.020163 0.0355124 0.0160801 0.0233226 0.0281171 0.00899348 0.00679444 0.00673249 0.00688841 0.00577694 0.00924549 0.00839301 0.00809507 0.00612569 0.0130383 0.00922515 0.0128331 0.013647 0.0066711 0.00248296 0.00507059 0.00812169 0.0177491 0.0170077 0.0177949 0.0212115 0.0287823 0.0344697 0.016706 0.0170395 0.0248392 0.01767 0.0143025 0.0203501 0.00348179 0.00652156 0.00442592 0.00577292 0.0134981 0.0244693 0.0400242 0.0172651 0.035921 0.0386163 0.0284011 0.0455336 0.0361483 0.0518111 0.060656	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG1 , including DRUG0 , have been reported to increase steady state plasma DRUG2 levels .
4	3	0.0153826 0.0203344 0.0174534 0.0250863 0.0200937 0.035308 0.0158582 0.0229834 0.0275076 0.00874914 0.0067291 0.00661237 0.00685794 0.00577583 0.00906298 0.00832814 0.00801324 0.00617057 0.0130129 0.00903307 0.0124656 0.013129 0.00653682 0.00249511 0.00524943 0.00846478 0.0179295 0.0163015 0.0147741 0.0161095 0.0223787 0.0258536 0.0118085 0.0122625 0.017354 0.0129816 0.00931763 0.00561801 0.0049693 0.0147829 0.0515542 0.00881832 0.0150086 0.0234227 0.0394635 0.0175806 0.042119 0.0392966 0.0284094 0.0433737 0.0355567 0.0535028 0.0627589	Plasma levels of DRUG0 are depressed to approximately 80% of their normal values when DRUG0 is administered in conjunction with DRUG0 (3900 mg/day) , but concomitant administration of DRUG0 has no effect on DRUG0 plasma levels . DRUG0 , including DRUG1 , have been reported to increase steady state plasma DRUG2 levels .
1	1	0.0476269 0.0527253 0.0394746 0.0457435 0.0595551 0.0555614 0.0743532 0.0373261 0.053155 0.033163 0.0547854 0.0295644 0.0866199 0.0395035 0.107443 0.0933764 0.0900236	It is recommended that plasma DRUG1 levels be monitored when initiating , adjusting and discontinuing DRUG2 .
4	4	0.0513471 0.0457269 0.0518003 0.0653604 0.0685948 0.0158316 0.0248164 0.0358813 0.0320565 0.0674607 0.0673894 0.0215954 0.00388478 0.00320613 0.00190175 0.00312625 0.00150817 0.00300622 0.0024867 0.00793451 0.00321728 0.00145578 0.00148023 0.00269184 0.00271857 0.00850994 0.0622965 0.0477312 0.0667391 0.0234068 0.0185518 0.0265864 0.00807284 0.00562763 0.00756335 0.0103909 0.0153352 0.00566069 0.0147307 0.0339436 0.058374	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG2 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0568577 0.0505674 0.0551636 0.0708817 0.0784637 0.0163308 0.0218853 0.0302897 0.0394574 0.0646657 0.0542377 0.0156202 0.0146342 0.0143719 0.00245849 0.00273118 0.00169611 0.00269422 0.00274085 0.00703133 0.00313163 0.00162275 0.00159515 0.00274216 0.00272773 0.00717498 0.0480187 0.0394441 0.0574596 0.0203449 0.0172023 0.0266871 0.00828915 0.00574646 0.00769157 0.010765 0.0158217 0.00593705 0.0156372 0.0364995 0.062682	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG2 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0578973 0.0514633 0.0561558 0.0718162 0.0794466 0.0152486 0.0201532 0.0281951 0.03986 0.0579479 0.0440154 0.00926149 0.00518103 0.00557878 0.00601786 0.0166198 0.00590943 0.0106228 0.00266668 0.00581338 0.00324243 0.00169378 0.00168804 0.00290542 0.00284217 0.00709009 0.0480521 0.040666 0.0588071 0.0207456 0.017605 0.0280678 0.00874879 0.00598897 0.00797229 0.0112732 0.0164486 0.0061493 0.0163154 0.0384099 0.0654174	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG2 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0555289 0.0490576 0.0532783 0.0669624 0.0711883 0.01127 0.0138523 0.0186824 0.0251942 0.0353757 0.0266199 0.00628135 0.00299327 0.00462825 0.00311265 0.00626857 0.00282579 0.00868522 0.0175948 0.0773139 0.0225518 0.00365784 0.00251902 0.00307827 0.00334806 0.00858256 0.0536818 0.0424203 0.0599758 0.0211579 0.0174943 0.0284525 0.00902434 0.00608206 0.00796381 0.0114112 0.0163079 0.00605975 0.0161727 0.0384313 0.0649134	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG2 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0596111 0.0528243 0.0571886 0.0727486 0.080591 0.0138398 0.017919 0.0251489 0.0358132 0.0487267 0.0352394 0.00722706 0.0036781 0.00494395 0.00386733 0.0070204 0.00272087 0.00650534 0.00948515 0.0277604 0.00613912 0.00447325 0.00617921 0.0122197 0.00318992 0.00834396 0.0473866 0.0385514 0.0541458 0.0193826 0.0167765 0.0284833 0.00943988 0.00622956 0.00799155 0.011699 0.0164531 0.00619878 0.0166185 0.0398335 0.0674057	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0509773 0.0450857 0.0507675 0.0623803 0.061427 0.00931633 0.0110534 0.014084 0.0175039 0.0247427 0.0193566 0.0053852 0.0025148 0.00408855 0.00237919 0.00507674 0.00201644 0.00531646 0.00471184 0.022435 0.00645808 0.00277311 0.00361863 0.00812357 0.0135624 0.032298 0.119968 0.0693524 0.0545036 0.0243809 0.024674 0.0390721 0.0127674 0.00790509 0.00924744 0.013691 0.0174917 0.00599871 0.0157004 0.0373119 0.0604827	In clinical studies of DRUG1 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.0305213 0.0240563 0.0213462 0.0259652 0.0178031 0.0193129 0.0533004 0.0582723 0.056481 0.0785416 0.0569885 0.0181978 0.00448445 0.00406136 0.00236162 0.00371871 0.00177513 0.00341265 0.00295017 0.00909522 0.00378965 0.00166211 0.00168895 0.00306617 0.00315864 0.00994402 0.0733886 0.0588177 0.0826358 0.028854 0.0225218 0.0315788 0.00950496 0.00660901 0.00886908 0.0121138 0.0179026 0.00659694 0.0171491 0.0395094 0.0679927	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG2 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.0328952 0.0255923 0.0211993 0.026108 0.0177087 0.0202775 0.0527567 0.0553065 0.0673175 0.0724728 0.0610347 0.0237156 0.0188318 0.020508 0.00393802 0.0036134 0.00209091 0.00332365 0.00334888 0.008544 0.00380736 0.00190601 0.00185633 0.00322185 0.00320512 0.00849376 0.0562049 0.0479424 0.0695841 0.0246645 0.0203077 0.0303537 0.0093883 0.00649427 0.00865249 0.0119756 0.0175425 0.0065751 0.0173207 0.0405272 0.0693925	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG0 ( DRUG2 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.031279 0.0238883 0.0198423 0.0243079 0.0168743 0.0194555 0.049051 0.0539112 0.0675584 0.0762502 0.0556099 0.0160446 0.00945793 0.00976323 0.00808479 0.0214469 0.00821307 0.0141786 0.00368379 0.00665679 0.00380886 0.00196503 0.00194954 0.00332941 0.0033107 0.00827902 0.0549173 0.0477719 0.0692694 0.0246425 0.0204914 0.0315068 0.00982362 0.00670185 0.00885862 0.0124008 0.0179183 0.00667992 0.0177681 0.0420458 0.0710034	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG2 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.0249456 0.0177044 0.0155277 0.0180032 0.0141748 0.013395 0.0352417 0.045578 0.0636508 0.0653097 0.038022 0.0110999 0.00504336 0.00762903 0.00408512 0.00782791 0.00375477 0.0110496 0.0212034 0.0939819 0.0282771 0.00437138 0.00289341 0.00347935 0.0038009 0.00986244 0.0606884 0.0476301 0.0674098 0.0238464 0.0192054 0.0299748 0.00952042 0.0063971 0.0083195 0.0118507 0.0167382 0.00619164 0.0165722 0.039619 0.0661239	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG2 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.0297069 0.0218424 0.0181692 0.0220207 0.0160575 0.0179155 0.0442101 0.0525146 0.0708095 0.0779158 0.0484639 0.0130133 0.00662032 0.00871347 0.00530232 0.00884695 0.00357186 0.00856179 0.0121357 0.0357115 0.00804842 0.00538318 0.00749309 0.0141884 0.00379646 0.00968473 0.0534647 0.0449946 0.0626645 0.0227349 0.0192417 0.0314568 0.0103997 0.0068373 0.0087101 0.0126277 0.0175647 0.00659545 0.0177499 0.0427983 0.0714621	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	2	0.0211497 0.0145812 0.0137782 0.0143205 0.0123473 0.0099999 0.0324247 0.046201 0.066442 0.0638211 0.031289 0.00924419 0.00413973 0.00629984 0.00299768 0.00600053 0.00244021 0.00645394 0.00569645 0.0262435 0.00768434 0.00320772 0.0041356 0.00919628 0.0148794 0.0349298 0.12126 0.0709373 0.0594977 0.0268748 0.02697 0.0416972 0.0135477 0.00834734 0.00965561 0.0141084 0.0177254 0.00602909 0.015755 0.0374736 0.0602167	In clinical studies of DRUG0 , patients taking DRUG1 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0244895 0.0158663 0.018105 0.0136106 0.0142047 0.00854018 0.0304552 0.0408515 0.0622954 0.0756251 0.084106 0.0393653 0.0126972 0.00728339 0.00718275 0.0180991 0.00589995 0.0128798 0.00351668 0.00740058 0.00406634 0.00214398 0.00212395 0.00366538 0.00356088 0.00864761 0.0564443 0.0469576 0.0715119 0.025603 0.021954 0.035212 0.0110393 0.00750458 0.00997832 0.0140296 0.0198832 0.00735371 0.0198478 0.0477805 0.0782177	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG1 ( DRUG0 , Genentech) , DRUG2 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0216684 0.0140515 0.0155352 0.0119591 0.012463 0.00752592 0.0257896 0.0343754 0.0524826 0.0650614 0.0703397 0.0258253 0.00801651 0.00536412 0.00370458 0.00672604 0.00318088 0.00880513 0.0199904 0.0901407 0.0236373 0.00419456 0.00293088 0.00354195 0.00392148 0.0097719 0.0591031 0.0463753 0.0673186 0.024163 0.0202155 0.0330116 0.0105748 0.00705222 0.00918315 0.0131106 0.0181623 0.00669273 0.0181669 0.0441668 0.0717001	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG1 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG2 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0241975 0.0156044 0.0176075 0.013282 0.0138852 0.0083918 0.0293503 0.0394447 0.0607598 0.075233 0.082229 0.033432 0.00996915 0.00599622 0.00458618 0.00832441 0.00320579 0.00713174 0.010968 0.0304972 0.00639408 0.00479759 0.00633117 0.014292 0.00386208 0.0101639 0.0557721 0.0451666 0.0655265 0.023808 0.0206473 0.034893 0.0116649 0.00760869 0.00970087 0.0141302 0.019204 0.0071482 0.0195086 0.0478521 0.0774324	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG1 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0195865 0.0127885 0.0136784 0.0107279 0.0111113 0.00664416 0.021858 0.028628 0.0418805 0.0517827 0.0559304 0.0192911 0.00706428 0.00465024 0.00296105 0.00555976 0.00234962 0.00536828 0.00526597 0.0222737 0.00625632 0.00282926 0.00381868 0.00857675 0.0146229 0.0362766 0.14495 0.077992 0.0598763 0.0268334 0.0279615 0.0444914 0.014489 0.0089172 0.0102895 0.0150079 0.0186878 0.00640157 0.0169251 0.0408866 0.0645094	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG1 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0221977 0.0142571 0.0143196 0.0116096 0.0124328 0.0068941 0.0203931 0.0273694 0.0475689 0.0576777 0.0603139 0.0323215 0.0286788 0.0564601 0.0102812 0.0327013 0.00868355 0.0146596 0.00446082 0.0103878 0.00452893 0.0024574 0.00241308 0.00408017 0.00397429 0.00971127 0.0588101 0.046753 0.0721241 0.026004 0.0220899 0.0350582 0.0111825 0.00761463 0.0100811 0.0142474 0.0200728 0.00744553 0.020055 0.0483313 0.0792966	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG1 , Genentech) , DRUG2 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0197788 0.0126702 0.0126967 0.0102795 0.0109657 0.00612295 0.0180866 0.0237586 0.0399009 0.0480005 0.0503462 0.0271176 0.0238292 0.0425306 0.00592407 0.0126896 0.00690949 0.0121362 0.0298586 0.0942825 0.0171587 0.00359634 0.00280041 0.00353097 0.00402849 0.0101376 0.0600253 0.0481674 0.0680209 0.0245703 0.0203243 0.0326402 0.0105661 0.00700208 0.0090601 0.0130344 0.0180243 0.00664123 0.0180095 0.0437045 0.0710722	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG1 , Genentech) , DRUG0 , inhaled DRUG2 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0212616 0.0135499 0.0137704 0.0109976 0.0118776 0.0067096 0.019822 0.0262551 0.0447479 0.0531611 0.0571751 0.032219 0.0309769 0.0550423 0.00757918 0.0172146 0.00800317 0.0107564 0.0211698 0.0445041 0.00641833 0.00485351 0.007088 0.0144003 0.00414785 0.011124 0.0574904 0.0442844 0.0640579 0.0233054 0.0198745 0.0329631 0.0111367 0.00722919 0.0091416 0.0134669 0.0183044 0.0068026 0.0184691 0.0452098 0.0734386	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG1 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0188798 0.0121945 0.0119391 0.00983755 0.0102013 0.00562477 0.0166142 0.0214634 0.0351899 0.0424342 0.0440744 0.0228586 0.0180189 0.0341332 0.00490425 0.0113713 0.00600151 0.008004 0.0108296 0.0349726 0.00612833 0.00386095 0.00653457 0.0106858 0.0180726 0.0412657 0.120487 0.062873 0.0529258 0.0244355 0.0280602 0.0456955 0.0147423 0.00889499 0.0101556 0.0149765 0.0189445 0.00654728 0.0172436 0.0415042 0.0664195	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG1 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0180684 0.0115346 0.0103303 0.00854325 0.00913984 0.0043195 0.0104993 0.0123894 0.0167507 0.0199174 0.0196861 0.00960336 0.00542118 0.0108292 0.00945149 0.023444 0.0150944 0.0981937 0.0322352 0.106184 0.0183001 0.0040681 0.00319854 0.00404672 0.00465528 0.0120047 0.0695575 0.0540322 0.0758069 0.0272889 0.0224002 0.0355958 0.011611 0.00771574 0.00996675 0.0144226 0.0199379 0.00734292 0.019856 0.0480692 0.0784875	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG1 , inhaled DRUG2 , other DRUG0 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0201602 0.012797 0.0116096 0.00942941 0.0101595 0.00483746 0.011802 0.0138477 0.0190186 0.0222056 0.0225153 0.0107147 0.00612628 0.0120894 0.0110049 0.0259371 0.0158029 0.0981043 0.0241281 0.0589336 0.00876858 0.00614705 0.00967095 0.0171943 0.00518799 0.0141711 0.0710851 0.0512781 0.074017 0.0267426 0.0227847 0.0374832 0.0127389 0.00829447 0.0105009 0.0156153 0.0212855 0.00788189 0.0213127 0.051938 0.0846781	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG1 , inhaled DRUG0 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0179142 0.0115567 0.0100572 0.00868735 0.00863423 0.00425244 0.0108076 0.0127549 0.0174863 0.021504 0.0210124 0.00886405 0.00481131 0.00815182 0.00613556 0.0139676 0.00777128 0.0487222 0.0116384 0.0428246 0.00734963 0.00515624 0.00981692 0.0131789 0.0220428 0.0442368 0.12669 0.068588 0.060002 0.0286551 0.0336397 0.0541363 0.0173385 0.0103996 0.0117843 0.0172962 0.0218033 0.00750209 0.0196825 0.0472709 0.0758763	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG1 , inhaled DRUG0 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0173787 0.010949 0.00951985 0.00792908 0.00872328 0.00410718 0.00892764 0.0103078 0.0131653 0.0154735 0.0139595 0.00671955 0.00298522 0.00556379 0.00280941 0.00542655 0.00391233 0.0146177 0.0216274 0.0927556 0.0839118 0.0172948 0.0255925 0.0258152 0.00864689 0.0208389 0.0839958 0.0582918 0.0797843 0.0294681 0.0242771 0.0379615 0.0129458 0.00836578 0.0104517 0.0154915 0.0206753 0.00758043 0.0205748 0.0503337 0.0808441	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG1 , other DRUG2 , or parenteral DRUG0 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0155321 0.0098482 0.00840129 0.00717128 0.00743254 0.00355864 0.00818319 0.00937909 0.0118406 0.0142849 0.0126966 0.0056406 0.00256233 0.00444279 0.00239153 0.00435414 0.00269386 0.00913315 0.0138628 0.0777989 0.0528843 0.0114486 0.0176656 0.0163801 0.0286084 0.0438317 0.138258 0.0687872 0.0598884 0.0300598 0.0349613 0.0547486 0.0173527 0.0100648 0.0111159 0.0159828 0.0200706 0.0068467 0.0179251 0.0428466 0.0690647	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG1 , other DRUG0 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
4	4	0.0173636 0.0111053 0.00941251 0.00819411 0.00834835 0.0039522 0.00940622 0.0107991 0.0136938 0.0167423 0.0143318 0.00625998 0.00281286 0.00483164 0.00246952 0.00464345 0.00226976 0.00657999 0.006798 0.0299582 0.0117463 0.00776466 0.0151386 0.071611 0.0309046 0.0481022 0.153768 0.0684028 0.0580646 0.028741 0.0347436 0.0556992 0.01778 0.010369 0.0115465 0.0166459 0.0211197 0.00732625 0.0192015 0.0461801 0.0751722	In clinical studies of DRUG0 , patients taking DRUG0 concomitantly with DRUG0 ( DRUG0 , Genentech) , DRUG0 , inhaled DRUG0 , other DRUG1 , or parenteral DRUG2 demonstrated adverse experience profiles similar to the study population as a whole .
2	2	0.0514742 0.108704 0.116393 0.141097 0.0925157 0.0647927 0.0579196 0.0839152 0.047779 0.0401144 0.0171497 0.0151711 0.0159523 0.0725312 0.0744903	Some DRUG1 can enhance DRUG2 toxicity by altering DRUG0 concentrations in serum and tissue .
4	4	0.067504 0.105555 0.0991354 0.0734058 0.0818096 0.116702 0.081478 0.121697 0.0565106 0.0353192 0.0216864 0.0192536 0.0120127 0.0527915 0.0551391	Some DRUG1 can enhance DRUG0 toxicity by altering DRUG2 concentrations in serum and tissue .
4	4	0.0247183 0.0657399 0.135231 0.0974851 0.146273 0.092892 0.0747501 0.116757 0.056513 0.0345991 0.0206524 0.0179778 0.0115468 0.0514192 0.0534458	Some DRUG0 can enhance DRUG1 toxicity by altering DRUG2 concentrations in serum and tissue .
1	1	0.260721 0.0569294 0.0866106 0.0621761 0.0777529 0.114745 0.107988 0.0370595 0.00828169 0.00794393 0.0051747 0.00727293 0.0057825 0.0100993 0.0335788 0.117884	DRUG1 should not be administered concomitantly with DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
1	1	0.281683 0.0546443 0.0705161 0.0608023 0.0743626 0.117816 0.0983899 0.0252895 0.0142507 0.0243785 0.00542195 0.00657904 0.00550163 0.0104475 0.0307684 0.119149	DRUG1 should not be administered concomitantly with DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
1	1	0.282031 0.0547664 0.0716011 0.0612899 0.0761172 0.118024 0.0943373 0.0204349 0.00724089 0.0107619 0.0114613 0.0265802 0.00711908 0.012 0.0283241 0.117911	DRUG1 should not be administered concomitantly with DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
1	1	0.273167 0.0528771 0.0698015 0.0564833 0.0706762 0.103529 0.0838321 0.0188246 0.00654557 0.00775344 0.00557684 0.00905961 0.011403 0.025363 0.0772502 0.127857	DRUG1 should not be administered concomitantly with DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
2	2	0.00929956 0.0177946 0.0831936 0.0546525 0.026033 0.0277034 0.022472 0.0238249 0.00530668 0.0119381 0.0105727 0.0185112 0.0243949 0.0157008 0.0236239 0.0247557 0.104719 0.056135 0.0332671 0.034072 0.0294228 0.0344846 0.0371778 0.0530523 0.0394846 0.0154585 0.0582168 0.0310927 0.0149327 0.0132275 0.0454798	Although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with DRUG1 with and without DRUG2 or DRUG0 .
2	2	0.00980133 0.0185969 0.0871025 0.0570353 0.0273865 0.0289642 0.0234652 0.0247521 0.00543274 0.012096 0.0111482 0.0191438 0.024799 0.0167197 0.0251424 0.0262678 0.103904 0.0534171 0.0324585 0.0351349 0.029666 0.0356319 0.0386372 0.0539125 0.0453972 0.0159524 0.0356118 0.0164706 0.0140578 0.0295744 0.0423202	Although a causal relationship has not been established , there have been reports of bleeding and/or prolonged prothrombin time in patients treated with DRUG1 with and without DRUG0 or DRUG2 .
3	3	0.0845533 0.0754218 0.0732924 0.106806 0.0386361 0.0634048 0.0438525 0.0329921 0.0589541 0.0299859 0.0417414 0.0276218 0.0238306 0.0144323 0.0375441 0.057709 0.0221078 0.0238358 0.0380081 0.105271	Concomitant administration of DRUG1 and DRUG2 -containing drugs leads to increased DRUG0 levels and DRUG0 toxicity in some individuals .
4	4	0.0466922 0.0634494 0.0716564 0.0697622 0.0181184 0.0203254 0.0385572 0.038324 0.0867121 0.0819543 0.169866 0.0799478 0.032407 0.0154874 0.031055 0.0356987 0.013256 0.0129955 0.0195452 0.0541896	Concomitant administration of DRUG1 and DRUG0 -containing drugs leads to increased DRUG2 levels and DRUG0 toxicity in some individuals .
4	4	0.0521812 0.0707302 0.0796068 0.0781891 0.0187997 0.0210823 0.041627 0.0359935 0.0736399 0.0527506 0.0791093 0.0579136 0.0772018 0.0491237 0.0597701 0.0360021 0.019871 0.0160963 0.0256427 0.0546691	Concomitant administration of DRUG1 and DRUG0 -containing drugs leads to increased DRUG0 levels and DRUG2 toxicity in some individuals .
4	4	0.165916 0.0583208 0.0697619 0.047566 0.0999329 0.0816977 0.0267317 0.00539787 0.00510484 0.00345016 0.00439216 0.00335008 0.00447441 0.00344867 0.00511143 0.00336164 0.00501224 0.0128891 0.0164836 0.0765363 0.108395 0.0877927 0.104873	DRUG1 has been used concurrently with DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 , without observed problems .
4	4	0.170491 0.0527512 0.0550584 0.0440515 0.0966787 0.0741382 0.0187188 0.0124188 0.0191738 0.00370607 0.00429449 0.00318896 0.00439352 0.00333428 0.00517894 0.00332385 0.00478193 0.0125969 0.0150926 0.0711121 0.110198 0.094599 0.120719	DRUG1 has been used concurrently with DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 , without observed problems .
4	4	0.169344 0.0531472 0.0543836 0.0442944 0.091717 0.0694941 0.0149471 0.00525991 0.00910305 0.0108415 0.019611 0.00365791 0.00455469 0.00340683 0.00522923 0.003418 0.00477815 0.0126492 0.0153887 0.0741705 0.111688 0.095785 0.123131	DRUG1 has been used concurrently with DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 , without observed problems .
4	4	0.168624 0.0531151 0.0540268 0.0444159 0.0899588 0.0679084 0.0144099 0.00480893 0.0070555 0.0044814 0.00920934 0.0105892 0.0195041 0.00380457 0.00522159 0.00352167 0.00467233 0.0122742 0.01529 0.074714 0.111176 0.0962416 0.124977	DRUG1 has been used concurrently with DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 , without observed problems .
4	4	0.168872 0.0533314 0.0539334 0.0450113 0.0904947 0.0676036 0.0143037 0.00478596 0.00687331 0.00417344 0.007209 0.00448962 0.00937293 0.0103854 0.020872 0.00435082 0.0043578 0.0107771 0.0144116 0.0720946 0.107109 0.0978355 0.127352	DRUG1 has been used concurrently with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 , without observed problems .
4	4	0.161155 0.0494365 0.053265 0.0423882 0.0829371 0.0621432 0.013866 0.00466859 0.00619827 0.00403214 0.00635592 0.00423537 0.00693163 0.00504316 0.00922761 0.00985014 0.0223753 0.0347507 0.013253 0.065705 0.103649 0.102544 0.135989	DRUG1 has been used concurrently with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 , without observed problems .
4	4	0.0446828 0.039887 0.0392987 0.0462266 0.0839569 0.045274 0.0115044 0.00408803 0.00690225 0.00407851 0.00929865 0.00638068 0.0177073 0.018325 0.0779188 0.0216778 0.0282325 0.044732 0.0165346 0.0677741 0.118594 0.106055 0.14087	DRUG0 has been used concurrently with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 , without observed problems .
4	4	0.0742334 0.0202798 0.0320163 0.00603622 0.010825 0.00438907 0.00923242 0.0130166 0.0181378 0.0226578 0.0909657 0.142531 0.051787 0.0411241 0.0380356 0.0252574 0.139722 0.0679479 0.033208 0.0298276 0.0123696 0.0319457 0.0844534	DRUG1 : DRUG2 and probably other DRUG0 given concomitantly with DRUG0 can cause unusually large or prolonged losses of fluid and electrolytes .
4	4	0.0578755 0.0171688 0.0172885 0.0134788 0.0541287 0.0165067 0.0342017 0.024389 0.0399488 0.0458477 0.094427 0.148283 0.0551086 0.0399067 0.0340482 0.0215792 0.101578 0.04774 0.0237117 0.0213002 0.00876403 0.0227938 0.0599255	DRUG1 : DRUG0 and probably other DRUG2 given concomitantly with DRUG0 can cause unusually large or prolonged losses of fluid and electrolytes .
4	4	0.0371816 0.00888646 0.0102034 0.00444411 0.0135564 0.00496785 0.0217373 0.0575429 0.0989506 0.114883 0.100153 0.134532 0.0530989 0.0400493 0.0323483 0.0210513 0.0883097 0.0425889 0.0218052 0.0186642 0.00745071 0.0189046 0.04869	DRUG1 : DRUG0 and probably other DRUG0 given concomitantly with DRUG2 can cause unusually large or prolonged losses of fluid and electrolytes .
4	4	0.0205588 0.0278812 0.0719356 0.0115553 0.047435 0.0161075 0.0256202 0.0270609 0.0431565 0.0516776 0.10028 0.154398 0.0542936 0.0386038 0.0313416 0.0190666 0.0918822 0.0436826 0.0217647 0.0195807 0.00803685 0.0205754 0.0535052	DRUG0 : DRUG1 and probably other DRUG2 given concomitantly with DRUG0 can cause unusually large or prolonged losses of fluid and electrolytes .
2	2	0.0212329 0.0244503 0.0487446 0.00563289 0.0183083 0.0145092 0.0253791 0.072243 0.0591895 0.0805767 0.0793598 0.145008 0.0544874 0.038136 0.0333359 0.0225008 0.0942683 0.0407995 0.0229628 0.0197356 0.00809772 0.0200572 0.0509849	DRUG0 : DRUG1 and probably other DRUG0 given concomitantly with DRUG2 can cause unusually large or prolonged losses of fluid and electrolytes .
2	2	0.0122608 0.0157207 0.0127577 0.0125214 0.0426793 0.0182269 0.0534707 0.0629388 0.046424 0.0674532 0.070983 0.151999 0.0595186 0.040856 0.0356286 0.023689 0.101044 0.0428252 0.0243108 0.0208759 0.00858138 0.0213402 0.0538949	DRUG0 : DRUG0 and probably other DRUG1 given concomitantly with DRUG2 can cause unusually large or prolonged losses of fluid and electrolytes .
4	4	0.0467311 0.0723335 0.0515782 0.199346 0.0761298 0.0449315 0.0247492 0.0167134 0.0135814 0.00661077 0.0114141 0.0106129 0.0317101 0.0380887 0.0264675 0.0310575 0.00956593 0.0173061 0.0454541 0.0829854 0.0436503 0.0989826	Other DRUG1 : When DRUG2 Tablets are used with other DRUG0 , care must be taken , especially during initial therapy .
4	4	0.0351928 0.071704 0.0265723 0.0966952 0.100222 0.135736 0.0738089 0.0656744 0.0544728 0.015206 0.0318857 0.00621339 0.0155073 0.0212497 0.0160207 0.0160483 0.00587014 0.0128147 0.032442 0.0628296 0.0333442 0.0704899	Other DRUG1 : When DRUG0 Tablets are used with other DRUG2 , care must be taken , especially during initial therapy .
1	1	0.0238288 0.0208133 0.0397961 0.102022 0.109656 0.0814024 0.0611005 0.0799618 0.0626308 0.0224489 0.0362774 0.0101459 0.0252693 0.0294515 0.0214498 0.0200394 0.00734899 0.0153717 0.0369911 0.0712829 0.0385107 0.0842003	Other DRUG0 : When DRUG1 Tablets are used with other DRUG2 , care must be taken , especially during initial therapy .
4	4	0.0508158 0.00909376 0.00609829 0.00475741 0.00560579 0.00721292 0.0106901 0.0351454 0.0503554 0.0399929 0.0200169 0.0125318 0.0139625 0.0309873 0.0407802 0.0618146 0.0252526 0.0284144 0.0441039 0.0280947 0.0160711 0.054157 0.0551645 0.0722856 0.0719542 0.0602804 0.049976 0.0943844	DRUG1 , DRUG0 , and DRUG0 : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUG2 therapy .
4	4	0.0228532 0.013845 0.0682959 0.0140208 0.0191601 0.0469075 0.0264383 0.0538091 0.0669538 0.0499273 0.0237185 0.0154947 0.0175853 0.0364008 0.0422567 0.0664362 0.0249471 0.025597 0.0366616 0.0219671 0.0112237 0.0293592 0.0198944 0.0290318 0.0242395 0.0309313 0.0417713 0.120273	DRUG0 , DRUG1 , and DRUG2 : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUG0 therapy .
4	4	0.013284 0.00686928 0.0292839 0.00463939 0.00481428 0.0069685 0.0100619 0.0333609 0.0504646 0.0398335 0.0195538 0.0123431 0.0139246 0.0311462 0.0411042 0.0634315 0.0256962 0.0289723 0.0452139 0.0288378 0.0165452 0.0558522 0.0568489 0.0747364 0.0744052 0.0623863 0.0516573 0.0977647	DRUG0 , DRUG1 , and DRUG0 : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUG2 therapy .
4	4	0.00689269 0.00273283 0.00520596 0.00380479 0.00600557 0.0280924 0.01666 0.0363278 0.0481369 0.0380655 0.0192834 0.0123422 0.0139585 0.0311294 0.0413018 0.0642449 0.0260313 0.0294502 0.0458285 0.0291937 0.016767 0.0564928 0.0573916 0.0757993 0.0752505 0.0631201 0.0519344 0.0985561	DRUG0 , DRUG0 , and DRUG1 : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUG2 therapy .
4	4	0.122461 0.0659206 0.108642 0.117328 0.0973265 0.103337 0.0422905 0.0295634 0.0365832 0.021881 0.0230477 0.0249236 0.0261457 0.0471883 0.133361	DRUG1 : DRUG2 -induced hypokalemia can increase the sensitivity of the myocardium to DRUG0 .
4	4	0.0661454 0.0255897 0.0515215 0.0977648 0.0925198 0.109056 0.0351158 0.0328618 0.0480468 0.0383321 0.0654908 0.0692596 0.0810047 0.0845572 0.102733	DRUG1 : DRUG0 -induced hypokalemia can increase the sensitivity of the myocardium to DRUG2 .
2	2	0.0301347 0.0452503 0.117503 0.0799811 0.0580509 0.0857158 0.0474687 0.0494427 0.0595675 0.0521004 0.0760174 0.0561302 0.0852866 0.0753652 0.0819855	DRUG0 : DRUG1 -induced hypokalemia can increase the sensitivity of the myocardium to DRUG2 .
4	4	0.093265 0.0421395 0.0647033 0.0520834 0.028235 0.0464824 0.0279418 0.019583 0.0370613 0.0194143 0.0110364 0.0113647 0.00556654 0.00462978 0.0119415 0.0142257 0.0389555 0.026187 0.0534108 0.0291078 0.0233288 0.0131514 0.0164892 0.0199458 0.0207922 0.0435631 0.0476999 0.0330906 0.0637902 0.0808143	DRUG1 : DRUG2 -induced hypokalemia may enhance neuromuscular blocking effects of DRUG0 (such as DRUG0 ) the most serious effect would be respiratory depression which could proceed to apnea .
4	4	0.0635308 0.0240383 0.0454142 0.0802351 0.0527548 0.0711795 0.0425522 0.0278176 0.0749422 0.0475641 0.0219042 0.0130728 0.0123712 0.0132945 0.026762 0.0115897 0.0241523 0.0203476 0.0515326 0.0228037 0.0187749 0.0100569 0.0122876 0.0146481 0.0145648 0.0295863 0.0321855 0.0223181 0.0433235 0.0543951	DRUG1 : DRUG0 -induced hypokalemia may enhance neuromuscular blocking effects of DRUG0 (such as DRUG2 ) the most serious effect would be respiratory depression which could proceed to apnea .
2	2	0.0186114 0.0272252 0.0716668 0.0452841 0.0326197 0.0902009 0.0712329 0.0468958 0.0825317 0.0518637 0.0569201 0.0261078 0.00822862 0.00547283 0.00960444 0.0127816 0.0340269 0.0260777 0.0511673 0.0239775 0.0170617 0.00854354 0.00965086 0.0118099 0.0122404 0.0241987 0.0258896 0.0180491 0.0353902 0.0446689	DRUG0 : DRUG1 -induced hypokalemia may enhance neuromuscular blocking effects of DRUG2 (such as DRUG0 ) the most serious effect would be respiratory depression which could proceed to apnea .
2	2	0.0193537 0.0281004 0.074029 0.0416397 0.0304802 0.080708 0.0604051 0.0431473 0.079814 0.0564212 0.0377758 0.0170647 0.0141109 0.0136206 0.0271716 0.0133119 0.0284093 0.0239665 0.0568885 0.0245537 0.0187236 0.00970545 0.0112902 0.0135431 0.0137327 0.0269688 0.028589 0.0198448 0.0384799 0.0481503	DRUG0 : DRUG1 -induced hypokalemia may enhance neuromuscular blocking effects of DRUG0 (such as DRUG2 ) the most serious effect would be respiratory depression which could proceed to apnea .
4	4	0.0209963 0.0237705 0.0422052 0.0730776 0.0511125 0.0740072 0.0448527 0.0326937 0.0801566 0.0426263 0.0298167 0.0413864 0.0336441 0.018769 0.026988 0.012474 0.0242389 0.0223856 0.0538666 0.0240375 0.0177777 0.009036 0.0105082 0.0128986 0.0132562 0.0268257 0.0286015 0.01985 0.039022 0.0491188	DRUG0 : DRUG0 -induced hypokalemia may enhance neuromuscular blocking effects of DRUG1 (such as DRUG2 ) the most serious effect would be respiratory depression which could proceed to apnea .
4	4	0.157963 0.0314522 0.0741639 0.0571415 0.029831 0.0261627 0.075486 0.0505845 0.0550493 0.0517015 0.0604915 0.0710856 0.133812 0.125075	DRUG1 and Other DRUG2 : May decrease the antihypertensive effects of DRUG0 Tablets .
2	2	0.125998 0.0141767 0.0289691 0.0129501 0.018316 0.0311851 0.0834377 0.0828755 0.093114 0.0830319 0.117704 0.0989821 0.0812738 0.127985	DRUG1 and Other DRUG0 : May decrease the antihypertensive effects of DRUG2 Tablets .
2	2	0.0196629 0.0113945 0.0299554 0.0565371 0.0261023 0.0375992 0.104157 0.0945817 0.101736 0.0875564 0.121845 0.100762 0.0824379 0.125673	DRUG0 and Other DRUG1 : May decrease the antihypertensive effects of DRUG2 Tablets .
4	4	0.0502889 0.0277207 0.044968 0.0315075 0.0339079 0.0360579 0.0369946 0.0112017 0.00944055 0.004536 0.00652505 0.0169401 0.057724 0.0358806 0.0460602 0.0831955 0.0392385 0.073399 0.0415432 0.025037 0.0265542 0.0340597 0.0607332 0.0372371 0.0478825 0.0279758 0.0533906	DRUG1 : DRUG2 may decrease arterial responsiveness to DRUG0 , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
4	4	0.0529535 0.0258566 0.0376238 0.0471303 0.0365144 0.0630777 0.0792956 0.0544825 0.0249264 0.00552163 0.00620669 0.0117302 0.0602747 0.034325 0.0408162 0.0658812 0.0283557 0.0513121 0.0297829 0.0186002 0.0196786 0.0259966 0.0480006 0.0294515 0.0379254 0.0221791 0.0421009	DRUG1 : DRUG0 may decrease arterial responsiveness to DRUG2 , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
2	2	0.0214111 0.0337468 0.0864092 0.0602252 0.0490155 0.0454277 0.0496808 0.0443217 0.021461 0.00587316 0.00842644 0.018917 0.0668818 0.0359714 0.0410262 0.0629733 0.0279961 0.0510708 0.0292942 0.0183385 0.0193843 0.0256942 0.047245 0.0289589 0.0372032 0.0217748 0.0412717	DRUG0 : DRUG1 may decrease arterial responsiveness to DRUG2 , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
4	2	0.0570358 0.0222187 0.0674408 0.066348 0.0388247 0.0697234 0.048489 0.0397442 0.0971095 0.114702 0.100359 0.103716 0.0918968 0.0823928	DRUG1 : Efficacy may be decreased due to urinary alkalizing effect of DRUG2 .
4	4	0.155549 0.0380562 0.0525069 0.0100909 0.0108437 0.0250885 0.00898631 0.00766102 0.0139171 0.0150121 0.0964445 0.068935 0.069302 0.168846 0.113929 0.0462134 0.0473782 0.0512396	DRUG1 : DRUG2 , as well as other DRUG0 , may affect the hypoprothrombinemic response to DRUG0 ;
4	4	0.132735 0.0310586 0.0247066 0.014966 0.0268228 0.0759855 0.018589 0.0171581 0.049393 0.0101763 0.0753998 0.0711501 0.068653 0.161972 0.0986336 0.0402868 0.0388325 0.0434811	DRUG1 : DRUG0 , as well as other DRUG2 , may affect the hypoprothrombinemic response to DRUG0 ;
4	4	0.0461557 0.0554041 0.115085 0.0226905 0.0425039 0.0825756 0.0144786 0.0173762 0.0356817 0.00975124 0.0875832 0.0779404 0.0714609 0.138111 0.0820254 0.0343303 0.0318931 0.0349527	DRUG0 : DRUG1 , as well as other DRUG2 , may affect the hypoprothrombinemic response to DRUG0 ;
2	2	0.0401017 0.0403101 0.0688435 0.0105649 0.0118417 0.0296214 0.00847082 0.00990591 0.0178127 0.0271367 0.145396 0.0924761 0.087283 0.111394 0.0869689 0.102978 0.0786065 0.0302888	DRUG0 : DRUG1 , as well as other DRUG0 , may affect the hypoprothrombinemic response to DRUG2 ;
2	4	0.0253424 0.0301411 0.0233257 0.0119934 0.0269267 0.0605863 0.0236371 0.0296587 0.118455 0.0281171 0.118681 0.0700853 0.0749788 0.087628 0.0819183 0.0880518 0.072865 0.0276084	DRUG0 : DRUG0 , as well as other DRUG1 , may affect the hypoprothrombinemic response to DRUG2 ;
2	4	0.0554235 0.0545555 0.112126 0.0671518 0.0531834 0.0485591 0.0598034 0.0466861 0.0392185 0.0867181 0.0322789 0.0605873 0.0875733 0.0512934 0.0591941 0.0856474	Prevention of emergence agitation in seven children receiving low-dose DRUG1 and DRUG2 total intravenous anesthesia .
4	4	0.0478739 0.0474094 0.0278845 0.0455617 0.0327354 0.0144771 0.0161919 0.014054 0.0254889 0.0234791 0.0306365 0.0268196 0.0420294 0.0432376 0.0514939 0.0309764 0.0407878 0.0327617 0.0351721 0.064403 0.0296306 0.034647 0.040643 0.0547905 0.0470044 0.035479 0.0209625 0.0433692	We retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose DRUG1 in conjunction with DRUG2 for total intravenous anesthesia (TIVA) repeatedly for radiation therapy .
4	4	0.0222244 0.0289128 0.0275335 0.0327892 0.0122901 0.0118121 0.0193276 0.0177697 0.0171513 0.0375968 0.0319679 0.0319386 0.0165006 0.0157355 0.0210797 0.0313442 0.0497895 0.0375856 0.0327347 0.0368353 0.0302901 0.0505979 0.0360316 0.0339005 0.0292897 0.0378647 0.0601187 0.0254998 0.0170768 0.0212117 0.0160141 0.0275909 0.0815941	EA signs were observed in all 7 patients in association with DRUG1 TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose DRUG2 was added to DRUG0 .
4	4	0.0238357 0.0270912 0.0227215 0.0224065 0.00821385 0.00645816 0.00960286 0.00821067 0.00697362 0.0112896 0.00864969 0.011235 0.0137835 0.0110115 0.0230656 0.0329279 0.0426333 0.0297221 0.0330521 0.0360831 0.0436666 0.0640756 0.0403532 0.0315607 0.0258618 0.0306035 0.0383986 0.0553907 0.0524578 0.0397889 0.0646026 0.062845 0.0614276	EA signs were observed in all 7 patients in association with DRUG0 TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose DRUG1 was added to DRUG2 .
4	2	0.0288707 0.0174343 0.0239322 0.0226604 0.0214597 0.0723507 0.0210935 0.0229425 0.0429316 0.0872424 0.0569574 0.0610218 0.0464315 0.0410344 0.0296677 0.0309265 0.0291893 0.0262217 0.0161137 0.0187628 0.0233047 0.041816 0.0185854 0.0106142 0.0168494 0.0134457 0.0184245 0.0190355 0.0204081 0.0311932 0.0690787	Based on this experience , we suggest that low-dose DRUG1 added to DRUG2 may be associated with prevention of EA in children with a history of EA with DRUG0 TIVA .
4	4	0.0198733 0.01218 0.0169597 0.0156785 0.0151117 0.06131 0.0204933 0.0203154 0.049189 0.0410689 0.0228831 0.0168869 0.0219168 0.0357723 0.0239517 0.0227512 0.0295555 0.0330024 0.0244904 0.0313535 0.04226 0.079085 0.0375667 0.0248322 0.035379 0.0350608 0.0391536 0.052926 0.0354827 0.0273721 0.0561381	Based on this experience , we suggest that low-dose DRUG1 added to DRUG0 may be associated with prevention of EA in children with a history of EA with DRUG2 TIVA .
2	2	0.131669 0.104376 0.0618059 0.0699113 0.0715833 0.079124 0.0461617 0.116737 0.0633689 0.0978764 0.0848941 0.0724926	DRUG1 may accentuate the orthostatic hypotension that may occur with DRUG2 .
2	2	0.129896 0.0952195 0.0674329 0.081393 0.00973004 0.024856 0.0404361 0.0594776 0.0381313 0.0776936 0.0763095 0.0610189 0.0470918 0.0439274 0.0514992 0.0958865	Antihypertensive effects of DRUG1 and related compounds may be counteracted when DRUG2 are used concomitantly .
3	3	0.0711781 0.059377 0.0601912 0.0623538 0.0992966 0.0915015 0.113791 0.0717021 0.0646934 0.0596906 0.0621289 0.0532668 0.0500112 0.0278479 0.0529695	Concomitant administration of DRUG1 with DRUG2 results in increased plasma levels of both drugs .
4	4	0.0450227 0.0141478 0.0279391 0.0184228 0.0111884 0.00597054 0.00925746 0.0217678 0.0154424 0.0432549 0.04785 0.028258 0.060186 0.023552 0.0239227 0.0376154 0.101969 0.0388308 0.0320955 0.0216647 0.0268226 0.0433021 0.0337832 0.058679 0.0528389 0.0487626 0.0355135 0.0719403	DRUG1 : Patients on DRUG0 , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DRUG2 Tablets therapy .
2	2	0.0134767 0.0201418 0.0327186 0.0459035 0.0582705 0.0177595 0.0105832 0.0168706 0.0188916 0.0266095 0.0478861 0.0274725 0.0634318 0.0262524 0.0235368 0.0358081 0.0843681 0.0377224 0.0332801 0.0216385 0.0245408 0.0394476 0.0307436 0.0534788 0.0465072 0.0446214 0.0326105 0.0654277	DRUG0 : Patients on DRUG1 , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DRUG2 Tablets therapy .
2	2	0.0351059 0.0431612 0.0238701 0.0257834 0.0255961 0.0344819 0.0276289 0.077944 0.0306836 0.033448 0.0398271 0.039239 0.0373235 0.0196324 0.0506343 0.0445997 0.0344876 0.0323891 0.0518619 0.0329365 0.0275914 0.0437123 0.0317502 0.0589369 0.0465246 0.0508507	The possibility of hypotensive effects can be minimized by either discontinuing the DRUG1 or increasing the salt intake prior to initiation of treatment with DRUG2 .
1	1	0.059928 0.0612074 0.0588336 0.0319219 0.0547891 0.0181218 0.0452032 0.0289983 0.0282293 0.0186413 0.022005 0.0338926 0.0307038 0.0288915 0.039803 0.0237003 0.0520777 0.0474156 0.0291693 0.00672129 0.0122108 0.00915452 0.0189801 0.0158039 0.0163504 0.00739414 0.0214665 0.0144436 0.0185102 0.011573 0.0256238 0.0158094 0.0289793 0.0254693 0.0379768	If DRUG1 cannot be interrupted , close medical supervision should be provided with the first dose of DRUG2 Tablets , for at least two hours and until blood pressure has stabilized for another hour .
4	4	0.063354 0.0959687 0.0390117 0.0620261 0.0560464 0.0736772 0.0519377 0.0140901 0.0326439 0.0242375 0.0529567 0.103404 0.0942872 0.0701566 0.0773362 0.088866	The rate and extent of DRUG1 absorption and elimination are not affected by concomitant DRUG2 .
3	4	0.0605815 0.0848956 0.0531334 0.0783772 0.0507116 0.113945 0.101222 0.0382011 0.00798494 0.0119589 0.00585 0.00925013 0.0459947 0.0253222 0.0299375 0.0228629 0.01328 0.0388878 0.0215998 0.0384176 0.0392101 0.0587955 0.0495816	The bioavailability of DRUG1 was reduced by DRUG2 , however , and this was associated with a decrease in plasma ACE inhibition .
4	4	0.1211 0.115561 0.0245661 0.0481132 0.038339 0.0434065 0.0788763 0.0636473 0.0280318 0.0218198 0.0633361 0.020253 0.0200979 0.0346358 0.0303941 0.0155123 0.0353028 0.0480841 0.0745038 0.0744195	DRUG1 Supplements and DRUG2 : DRUG0 Tablets may increase serum potassium because of its potential to decrease aldosterone production .
4	4	0.105145 0.093664 0.0230839 0.0304625 0.0393511 0.0756579 0.0729245 0.0669618 0.0362613 0.0347661 0.0853055 0.0247398 0.0208771 0.0305384 0.0244331 0.0140648 0.0332569 0.0474433 0.0713401 0.069723	DRUG1 Supplements and DRUG0 : DRUG2 Tablets may increase serum potassium because of its potential to decrease aldosterone production .
4	4	0.0417313 0.0691352 0.0263484 0.0730331 0.0497645 0.0826747 0.0778849 0.0712692 0.0372935 0.0352479 0.0862627 0.0251261 0.0210789 0.0314528 0.0253069 0.0146112 0.0347609 0.049833 0.0745608 0.0726239	DRUG0 Supplements and DRUG1 : DRUG2 Tablets may increase serum potassium because of its potential to decrease aldosterone production .
4	4	0.0475339 0.0469851 0.0379565 0.0178396 0.0079681 0.00595646 0.00577995 0.00750405 0.0110364 0.0136516 0.0546485 0.016543 0.0292413 0.0133674 0.00726753 0.00871022 0.0360034 0.098995 0.0219384 0.0193974 0.00982035 0.0057895 0.00254638 0.00378027 0.00225028 0.00432618 0.0032854 0.010583 0.0112959 0.0544342 0.0999089 0.0343622 0.0583734 0.0451115 0.0245179 0.0316673 0.0896236	Use of DRUG1 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG2 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0383047 0.0370014 0.0289318 0.0134866 0.00496133 0.003183 0.00430322 0.00451205 0.00705797 0.0049852 0.0104108 0.00648542 0.0151892 0.0367435 0.0171555 0.024089 0.055687 0.0941149 0.0421908 0.0563237 0.0281877 0.0101623 0.00812547 0.0118729 0.0024901 0.0032813 0.00270493 0.00714857 0.0072992 0.0459824 0.104805 0.0437385 0.0536139 0.0349511 0.0199764 0.0306477 0.0798956	Use of DRUG1 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG2 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0400019 0.0386697 0.0301538 0.0140021 0.00515555 0.00330166 0.00446056 0.00465823 0.00733785 0.00515456 0.0106365 0.00671284 0.0157001 0.0368827 0.0169005 0.0243588 0.0574546 0.0925441 0.0391718 0.048573 0.0224783 0.00639043 0.00315208 0.00413788 0.00476721 0.011327 0.00278128 0.00656938 0.00719254 0.0449465 0.107104 0.0459757 0.0570885 0.0366073 0.0210033 0.0325143 0.0841336	Use of DRUG1 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG2 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0412034 0.0398435 0.0310041 0.0143844 0.00528783 0.00338681 0.00457157 0.00476284 0.00752724 0.00526289 0.0107521 0.00678771 0.0159253 0.0364464 0.0165118 0.024107 0.0579822 0.0910955 0.0384837 0.0467325 0.0216484 0.00619544 0.00276704 0.00329598 0.00222789 0.00459839 0.00575297 0.0223487 0.00758872 0.039757 0.100935 0.0463003 0.0573343 0.0357155 0.0207223 0.0334892 0.0872639	Use of DRUG1 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG2 and others) can increase the risk of hyperkalemia .
4	4	0.0531927 0.0413389 0.0224866 0.0201499 0.0362473 0.0108113 0.00701107 0.0091071 0.0108691 0.0128726 0.0579088 0.016414 0.025577 0.0119869 0.00657598 0.0084363 0.0355669 0.0937145 0.020663 0.018264 0.00932528 0.0055776 0.00246772 0.00367591 0.00219153 0.00420968 0.0031996 0.0102918 0.0110142 0.0530753 0.09785 0.0336791 0.0571417 0.0442691 0.0240741 0.0310373 0.0877266	Use of DRUG0 ( DRUG1 , DRUG0 , DRUG0 and others) , DRUG2 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0412548 0.034336 0.0198376 0.016199 0.0283588 0.00593342 0.00502973 0.00588426 0.00717316 0.00498472 0.012011 0.00711026 0.014382 0.0319352 0.0165895 0.0241058 0.0548409 0.0873767 0.0386961 0.0533723 0.0261233 0.00923395 0.0075909 0.0113924 0.00242193 0.00323444 0.00267628 0.00709465 0.00725675 0.0455979 0.104416 0.0437851 0.0536507 0.0351445 0.0200885 0.0307609 0.0801203	Use of DRUG0 ( DRUG1 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG2 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0429099 0.0358436 0.0207904 0.0169189 0.0295922 0.00610729 0.00519453 0.00604976 0.00742742 0.00514673 0.0122428 0.00732335 0.0147773 0.0316343 0.0160737 0.0240788 0.0562114 0.0849474 0.0357418 0.046339 0.0209705 0.00589197 0.00296016 0.00400798 0.00463203 0.0111568 0.00273451 0.00650673 0.00712305 0.044372 0.106583 0.0459289 0.057008 0.0367777 0.021107 0.0325877 0.0843013	Use of DRUG0 ( DRUG1 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG2 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0441264 0.0369068 0.0214375 0.0174006 0.0304334 0.00624053 0.00531403 0.00617697 0.00760186 0.0052523 0.0123908 0.00740478 0.0149452 0.0309201 0.0155026 0.0236409 0.0566045 0.083568 0.035241 0.0445019 0.0201714 0.00571759 0.00260192 0.00318657 0.00216623 0.00448313 0.00564513 0.0221506 0.00748876 0.039242 0.100458 0.0462691 0.0571895 0.0358445 0.0208079 0.0335491 0.0874188	Use of DRUG0 ( DRUG1 , DRUG0 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG2 and others) can increase the risk of hyperkalemia .
4	4	0.0347247 0.0240556 0.0103477 0.00623135 0.0099986 0.00875473 0.0340509 0.0102612 0.0122862 0.0133122 0.0574763 0.0145198 0.0259 0.012244 0.00662032 0.00876542 0.0369462 0.0995341 0.0218543 0.0197828 0.0101962 0.00613905 0.00271982 0.00406112 0.00241781 0.00464267 0.00352434 0.0113244 0.0121408 0.0585513 0.108323 0.0373831 0.0632512 0.0491769 0.0267655 0.03443 0.0972863	Use of DRUG0 ( DRUG0 , DRUG1 , DRUG0 and others) , DRUG2 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0287118 0.0205272 0.00947199 0.00500547 0.00869497 0.00649067 0.02412 0.00597327 0.00702658 0.00488862 0.0104536 0.0062314 0.0142198 0.0316011 0.0160839 0.0246241 0.0592629 0.0930612 0.0393984 0.054892 0.0266253 0.00990004 0.00813143 0.0121683 0.00257195 0.00343181 0.00283645 0.00750191 0.00769417 0.048615 0.112662 0.0474711 0.0584272 0.0383399 0.0219211 0.0335649 0.0873981	Use of DRUG0 ( DRUG0 , DRUG1 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG2 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0299629 0.0214123 0.00992972 0.00523883 0.00912945 0.00678465 0.0251927 0.00614979 0.00728506 0.00506431 0.0106668 0.00640313 0.0146292 0.0312501 0.0156356 0.0247109 0.0608348 0.0907267 0.0363053 0.0472901 0.0214713 0.00629207 0.00312306 0.00425416 0.00500128 0.0119363 0.00291814 0.00693586 0.00760275 0.047461 0.11524 0.0497221 0.0619957 0.0402946 0.0231314 0.0356551 0.0923624	Use of DRUG0 ( DRUG0 , DRUG1 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG2 , DRUG0 and others) can increase the risk of hyperkalemia .
2	4	0.0308447 0.022027 0.0102317 0.00539156 0.00941293 0.00697254 0.0258892 0.00627533 0.00746051 0.00518149 0.010795 0.00644712 0.0147839 0.0304547 0.0151289 0.0243171 0.06121 0.0892082 0.0357804 0.0454993 0.0206633 0.00611398 0.00275452 0.00339602 0.00230532 0.00478813 0.00609683 0.0238363 0.00802407 0.0420466 0.109029 0.0502045 0.0622666 0.0393664 0.0228831 0.0368022 0.0961111	Use of DRUG0 ( DRUG0 , DRUG1 , DRUG0 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG2 and others) can increase the risk of hyperkalemia .
4	4	0.0313317 0.0229482 0.0105696 0.00560271 0.00794738 0.00564003 0.0159684 0.0200673 0.0921228 0.0172607 0.0616021 0.0157323 0.028188 0.0123066 0.0065355 0.00847594 0.0346576 0.0874799 0.0190824 0.0173964 0.00903959 0.0054935 0.00245255 0.00365587 0.00218388 0.0041812 0.00318025 0.0101831 0.0109162 0.0525539 0.0975317 0.0336093 0.056901 0.0443205 0.0240886 0.0310601 0.0877334	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG1 and others) , DRUG2 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
4	4	0.0263037 0.0188551 0.00893866 0.00435739 0.00647579 0.0042736 0.0115652 0.013087 0.0598339 0.00663267 0.011275 0.00663031 0.0146856 0.0316622 0.0170822 0.0252158 0.0589158 0.0924797 0.0372041 0.0507205 0.0241388 0.00889863 0.00734629 0.0112 0.00237175 0.00318669 0.00263895 0.00698733 0.00717369 0.0451826 0.10512 0.0444401 0.0547971 0.0360718 0.0206115 0.0315487 0.0820921	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG1 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG2 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
4	4	0.0275068 0.0196994 0.00936419 0.00456182 0.00679035 0.00447491 0.0121089 0.0136842 0.0626298 0.00684982 0.0114743 0.00677477 0.0150361 0.0311227 0.016531 0.0251629 0.0603493 0.0895973 0.0339972 0.0433214 0.0193013 0.00565948 0.00281212 0.00389755 0.00455221 0.0110218 0.00269164 0.00645284 0.00706886 0.0440879 0.10745 0.0464669 0.0580201 0.0378312 0.021701 0.033418 0.08653	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG1 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG2 , DRUG0 and others) can increase the risk of hyperkalemia .
4	4	0.0283503 0.0202817 0.00964508 0.0046956 0.0069912 0.00460134 0.0124531 0.0140596 0.0643978 0.00698337 0.0115691 0.00680426 0.0151242 0.0300997 0.0158955 0.0246381 0.0606842 0.0879915 0.0334683 0.0416662 0.0185634 0.00547872 0.00247522 0.00309031 0.00210191 0.00437552 0.00558054 0.0219655 0.00740476 0.0391097 0.101699 0.0469385 0.0582063 0.0368745 0.0214237 0.0344329 0.0898795	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG1 and others) , DRUG0 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG2 and others) can increase the risk of hyperkalemia .
4	4	0.0201119 0.0143492 0.00708813 0.00318019 0.00450684 0.00230458 0.00561223 0.00425106 0.0139242 0.0122666 0.0377592 0.0192264 0.0888043 0.0324597 0.0208398 0.0257787 0.0542323 0.0921528 0.0374621 0.0508092 0.0241848 0.00768313 0.00642164 0.0100402 0.0021475 0.00289989 0.00240894 0.0064555 0.00664474 0.0416228 0.0962017 0.0406891 0.050121 0.0330249 0.0188348 0.0287914 0.0747084	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG1 supplements or other drugs capable of increasing serum DRUG0 ( DRUG2 , DRUG0 , DRUG0 and others) can increase the risk of hyperkalemia .
4	4	0.0210266 0.0150105 0.00743098 0.00333244 0.00472729 0.00241554 0.00589787 0.00446644 0.0146383 0.0128132 0.0391701 0.0198764 0.0912412 0.032166 0.0199442 0.0251156 0.0546834 0.0884356 0.0348262 0.0449138 0.01958 0.00501311 0.00254963 0.00351552 0.00397204 0.00999464 0.00243621 0.00589967 0.00647441 0.0404233 0.0985237 0.042813 0.0533976 0.0345381 0.0197714 0.0304742 0.0784917	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG1 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG2 , DRUG0 and others) can increase the risk of hyperkalemia .
4	4	0.0217494 0.0155159 0.00768031 0.00344538 0.00488443 0.00249442 0.00609459 0.0046183 0.0151389 0.0131868 0.040096 0.0202573 0.0925767 0.0316792 0.0191292 0.024289 0.0548484 0.0867281 0.0345383 0.0431577 0.0189325 0.00485703 0.00223805 0.002776 0.00189659 0.00391645 0.00494374 0.0199505 0.00674535 0.0357636 0.0931706 0.0432913 0.0535393 0.0335916 0.0194546 0.0313775 0.0814472	Use of DRUG0 ( DRUG0 , DRUG0 , DRUG0 and others) , DRUG1 supplements or other drugs capable of increasing serum DRUG0 ( DRUG0 , DRUG0 , DRUG2 and others) can increase the risk of hyperkalemia .
2	4	0.0443701 0.0622414 0.0703195 0.123336 0.0845086 0.0742569 0.0513611 0.100892 0.0424335 0.0971019 0.0783592 0.057974 0.112846	Use of a DRUG1 may further increase the risk of DRUG2 toxicity .
4	4	0.0370672 0.0109997 0.0353494 0.0333984 0.0255502 0.0189636 0.0172925 0.0278647 0.0385188 0.0383678 0.0217203 0.0440755 0.0497449 0.0548818 0.0529467 0.0737779 0.0708409 0.0513099 0.021641 0.0043898 0.00584179 0.0143884 0.0104209 0.00751748 0.0106964 0.00857619 0.00904026 0.0205844 0.0146717 0.00582628 0.00684443 0.00418477 0.014421 0.016344 0.0282587 0.0174435 0.0285565 0.0476824	DRUG1 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG2 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG0 / DRUG0 has not been excluded .
4	4	0.0401745 0.0109342 0.0316512 0.0274581 0.0209181 0.014887 0.0132849 0.0193338 0.0268472 0.0229998 0.0112411 0.0236481 0.0231914 0.0153219 0.0093458 0.0190282 0.010566 0.0136082 0.0123459 0.00363002 0.00511548 0.0152481 0.0130217 0.011124 0.0200404 0.0237365 0.0402627 0.0876672 0.0836931 0.0782711 0.0364937 0.0108463 0.0142745 0.0242848 0.0380053 0.0249791 0.0385198 0.0640007	DRUG1 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG2 / DRUG0 has not been excluded .
4	4	0.042947 0.0116752 0.0339046 0.0294309 0.022385 0.0159664 0.0142618 0.0207555 0.0288676 0.0249167 0.0122055 0.0258538 0.0251632 0.0169252 0.0104192 0.0213802 0.0121493 0.0152491 0.0146999 0.00431824 0.00612275 0.0183318 0.0155172 0.011668 0.0186545 0.0192424 0.026626 0.0537077 0.0456821 0.0226228 0.0269275 0.0357355 0.0550888 0.0377087 0.0526504 0.0326043 0.0444776 0.0731574	DRUG1 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG0 / DRUG2 has not been excluded .
4	4	0.0102351 0.00956101 0.0203143 0.0187865 0.0176265 0.0160217 0.0166226 0.0249104 0.032282 0.038029 0.0336717 0.0690518 0.0562781 0.0791356 0.0440859 0.0492814 0.0608306 0.0478896 0.0320444 0.00678664 0.00932395 0.0213777 0.014441 0.0105417 0.0135571 0.0104949 0.0107006 0.0232817 0.0159242 0.00637565 0.00757798 0.00465868 0.0160042 0.0180532 0.0309589 0.0190059 0.0313242 0.0529537	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG1 concentrations when coadministered with DRUG2 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG0 / DRUG0 has not been excluded .
4	4	0.00923755 0.00845248 0.0190446 0.0174508 0.0158969 0.0141325 0.0142328 0.0212306 0.0264049 0.0313299 0.0233999 0.0428736 0.035092 0.036161 0.0220683 0.0341917 0.0203909 0.0160318 0.0192615 0.00425528 0.00541333 0.0168122 0.0132613 0.0110749 0.0194154 0.0224713 0.0381679 0.081128 0.0751817 0.0694622 0.0324265 0.00955162 0.0124079 0.0208489 0.0323752 0.0212654 0.0329361 0.0546611	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG1 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG2 / DRUG0 has not been excluded .
4	4	0.00963716 0.00882028 0.019908 0.0182678 0.0166215 0.0147629 0.0148621 0.0222498 0.0277219 0.0329209 0.0247467 0.0457347 0.0376411 0.0407488 0.0253556 0.0392679 0.0236739 0.0184476 0.0231377 0.00518135 0.00655201 0.020284 0.0158355 0.0115945 0.0179909 0.0181695 0.0252453 0.0493375 0.0409898 0.0201389 0.0237355 0.031268 0.0478053 0.0320684 0.0439763 0.0272325 0.0371325 0.0609357	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG1 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG0 / DRUG2 has not been excluded .
4	4	0.00865612 0.00786488 0.0183002 0.0183001 0.0159294 0.0131625 0.0128601 0.0208785 0.0305529 0.0305366 0.0172487 0.0336662 0.0383021 0.0388193 0.03743 0.0585105 0.0581139 0.0679356 0.051986 0.0123914 0.0222605 0.0522472 0.0313868 0.0439994 0.0297288 0.0200123 0.0162594 0.0223352 0.0163418 0.00653459 0.00632374 0.00386842 0.0131101 0.0152574 0.0255044 0.0158209 0.0252259 0.0423383	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG1 Tablets , but an effect of DRUG2 on the plasma concentration of DRUG0 / DRUG0 has not been excluded .
4	4	0.00790925 0.00718522 0.0166653 0.0166106 0.014505 0.0119896 0.0117429 0.0189887 0.0278272 0.0275835 0.0155478 0.0303544 0.0349168 0.0355691 0.0351448 0.0570875 0.0590482 0.0718378 0.0298782 0.00534483 0.00725478 0.0178255 0.0108951 0.0109953 0.0160622 0.0229731 0.0357227 0.0621514 0.0584379 0.052055 0.0237545 0.00735934 0.00957104 0.0163333 0.0258414 0.0170537 0.0262698 0.0437073	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG1 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG2 / DRUG0 has not been excluded .
4	4	0.00833757 0.00757765 0.0175637 0.0175256 0.0153066 0.0126562 0.0124011 0.0200761 0.0294143 0.0291965 0.0164553 0.0321184 0.0371485 0.0378375 0.0372522 0.0597876 0.0611596 0.0765456 0.035123 0.00614181 0.00872604 0.0222833 0.0130417 0.0120834 0.0143432 0.0171717 0.0237293 0.0378602 0.0318469 0.0162348 0.0178481 0.0224903 0.0339352 0.0240428 0.0352545 0.0218645 0.0291264 0.0484928	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG1 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG0 / DRUG2 has not been excluded .
4	3	0.00869871 0.0077028 0.0167211 0.0153733 0.01294 0.0102836 0.0096892 0.014384 0.0202405 0.0183183 0.00994257 0.0204184 0.0197204 0.0140215 0.00961546 0.0194699 0.0129984 0.0146732 0.0177924 0.00552524 0.0149248 0.0484615 0.0363651 0.0354909 0.0413639 0.0352193 0.0576503 0.0839406 0.0719382 0.0733855 0.0315291 0.0104796 0.0124256 0.021966 0.0341393 0.0229245 0.0339104 0.0553565	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG1 on the plasma concentration of DRUG2 / DRUG0 has not been excluded .
4	3	0.00912976 0.00808875 0.0176014 0.0161978 0.0136281 0.010837 0.01021 0.0151916 0.0215057 0.0195357 0.0104487 0.0215651 0.0209187 0.0149123 0.0103598 0.0210515 0.0146325 0.0158493 0.0194766 0.00615898 0.016966 0.0537667 0.0395784 0.0400271 0.0473027 0.0315612 0.0422327 0.0480179 0.0460964 0.0308489 0.0269917 0.034877 0.0482641 0.0321143 0.0428008 0.0266749 0.035566 0.059014	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG1 on the plasma concentration of DRUG0 / DRUG2 has not been excluded .
4	4	0.00923287 0.00791901 0.0168528 0.01562 0.0131236 0.0102911 0.00964785 0.0142037 0.01995 0.0174636 0.00856607 0.017877 0.0181312 0.0116373 0.007212 0.0143816 0.00819299 0.0105142 0.00945697 0.00298075 0.00389497 0.0117293 0.0106775 0.00859825 0.0169154 0.0172001 0.0270571 0.0679571 0.0668242 0.0582099 0.0863773 0.0781295 0.0544131 0.0346454 0.0535918 0.0372771 0.0501375 0.0731098	DRUG0 : A controlled pharmacokinetic study has shown no effect on plasma DRUG0 concentrations when coadministered with DRUG0 Tablets , but an effect of DRUG0 on the plasma concentration of DRUG1 / DRUG2 has not been excluded .
4	4	0.090737 0.0379199 0.105072 0.0717526 0.0269958 0.031607 0.0484323 0.0889797 0.0886399 0.0923981 0.135694 0.0479002 0.0131836 0.0240666 0.0966216	DRUG1 : Animal data have suggested the possibility of interaction between DRUG2 and DRUG0 .
4	0	0.0246917 0.0332333 0.0712583 0.0576505 0.0299302 0.0393527 0.0520281 0.0881906 0.0693959 0.0874282 0.0717917 0.136655 0.0452463 0.0965973 0.0965497	DRUG0 : Animal data have suggested the possibility of interaction between DRUG1 and DRUG2 .
4	4	0.0375466 0.0225543 0.0167935 0.0227904 0.0340446 0.0344147 0.040393 0.0401505 0.0259857 0.0311822 0.0298988 0.0364846 0.0597367 0.0306778 0.0600584 0.0781042 0.0323167 0.0493153 0.0578206 0.0539809 0.0526927 0.0283681 0.0132955 0.0173721 0.0242873 0.0285374 0.0411972	Food Interaction : Oral administration of DRUG1 Tablets with food does not significantly lower the rate or extent of DRUG2 absorption relative to the fasted state .
3	4	0.0157725 0.0113983 0.030342 0.0336625 0.0257981 0.0400389 0.0383261 0.0444651 0.0205157 0.0315213 0.0281965 0.0298414 0.0145438 0.0221526 0.00816977 0.0292412 0.0614526 0.0233327 0.0230141 0.0173178 0.0361978 0.0153211 0.0111421 0.0182051 0.0204705 0.0187765 0.0386275 0.0358199 0.0519847 0.0297689 0.0116031 0.0106571 0.0140652 0.00628168 0.0254267 0.0179126 0.0395353 0.0491012	However , the extent of biotransformation of DRUG1 to the active metabolite , DRUG2 , is reduced approximately 43% , resulting in a reduction in the plasma ACE inhibition curve of approximately 20% , probably clinically insignificant .
2	2	0.173626 0.197135 0.082494 0.116036 0.0836074 0.109688 0.0466615 0.00933192 0.00885209 0.00612053 0.00899773 0.0324675 0.124983	DRUG1 may increase the effects of DRUG2 , DRUG0 , and DRUG0 .
2	2	0.169363 0.181594 0.0892626 0.124106 0.0887334 0.0775883 0.0267554 0.0156937 0.0365262 0.00850235 0.0095437 0.0336014 0.138729	DRUG1 may increase the effects of DRUG0 , DRUG2 , and DRUG0 .
2	2	0.157342 0.163178 0.0779582 0.10281 0.0723171 0.0699162 0.0209761 0.00939361 0.0126555 0.0167378 0.0421368 0.102995 0.151584	DRUG1 may increase the effects of DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0908714 0.127187 0.0926232 0.104845 0.0701105 0.0540301 0.0309032 0.0232498 0.0963106 0.0258557 0.0312848 0.099575 0.153153	DRUG0 may increase the effects of DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0358246 0.0721941 0.0475478 0.0711578 0.0503327 0.0438445 0.0586577 0.0485887 0.0162215 0.0280713 0.019598 0.016156 0.00765821 0.0221296 0.051419 0.0435412 0.0147156 0.00692147 0.0192662 0.0431551 0.025159 0.010227 0.00471428 0.0124498 0.0216373 0.0102644 0.0218733 0.00657668 0.00411533 0.00218596 0.00214039 0.0080109 0.0147277 0.0131376 0.0255073 0.01333 0.011318 0.0127883 0.0628359	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG2 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0381565 0.0756274 0.0521754 0.0777567 0.0563655 0.0385819 0.0232567 0.0141881 0.00824344 0.0216068 0.0672392 0.0600355 0.0187486 0.0375588 0.0386764 0.0379945 0.0155781 0.00788802 0.0207424 0.0415129 0.0241853 0.0100034 0.00440943 0.0115344 0.0196091 0.00909561 0.0188855 0.00566086 0.00352256 0.00188022 0.00183566 0.00685427 0.0126067 0.011208 0.0216795 0.0113213 0.00961708 0.0108835 0.0532749	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG2 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0348234 0.0687293 0.0496144 0.0743719 0.0562301 0.0360452 0.0154214 0.00721022 0.0034794 0.00801858 0.0171225 0.0140064 0.0082334 0.0307885 0.0850654 0.0665463 0.0697537 0.0273342 0.0488658 0.0485456 0.0253578 0.0132854 0.005611 0.0113206 0.0174054 0.00863399 0.0167102 0.00530883 0.00311808 0.00163087 0.0016195 0.00598354 0.0110778 0.00989899 0.0192012 0.0101181 0.00839032 0.00940071 0.0457219	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0370968 0.0729165 0.0532878 0.0792165 0.0599451 0.0379753 0.0151533 0.00720163 0.00357791 0.00806827 0.016551 0.0119596 0.00571709 0.0197894 0.0575945 0.0526699 0.0226118 0.0105671 0.0271281 0.0605566 0.0379782 0.0404827 0.0199406 0.0300693 0.0234587 0.0142726 0.0266656 0.00937647 0.00440873 0.00212211 0.00204909 0.00710847 0.0125387 0.0107424 0.0202829 0.0107353 0.00889494 0.0101219 0.0491666	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0366874 0.0722111 0.052313 0.0778375 0.0587266 0.0371693 0.0142536 0.00663243 0.00323652 0.00716823 0.0143367 0.0105121 0.00484481 0.0161218 0.044189 0.0374927 0.0134441 0.00574417 0.0176058 0.0454301 0.0280926 0.0143868 0.00791901 0.023981 0.0550097 0.0384309 0.0584726 0.0381856 0.0187271 0.00549762 0.00321805 0.00534669 0.0107825 0.0111391 0.0232762 0.0122659 0.00883655 0.0103801 0.0500951	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0361201 0.0710278 0.0516037 0.0767371 0.0579269 0.0366344 0.0142129 0.00665556 0.00325202 0.00720843 0.0144997 0.0106349 0.00499806 0.0168441 0.0467742 0.0398135 0.0150502 0.00700799 0.0220702 0.0590544 0.0348372 0.0170452 0.00805171 0.0218053 0.043347 0.0266102 0.0359222 0.0151198 0.00765236 0.00746005 0.00613901 0.0187636 0.0159346 0.0174139 0.0327 0.0178526 0.0105448 0.0124709 0.0522036	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0356161 0.070044 0.0508153 0.0755337 0.0570083 0.0359917 0.0137164 0.00638975 0.0031268 0.00690218 0.0137873 0.0100239 0.004532 0.0148327 0.0401646 0.0345769 0.0125476 0.00590443 0.0178319 0.0449681 0.0253435 0.0105133 0.0043027 0.0106405 0.0205807 0.00971595 0.0220659 0.00820582 0.00530391 0.00282934 0.00330152 0.0154831 0.0360428 0.039387 0.0715965 0.047183 0.0411979 0.0252643 0.0467284	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0224261 0.0479427 0.0330941 0.0369613 0.0225477 0.0223166 0.0258977 0.0324357 0.0132735 0.0541023 0.0729785 0.0653311 0.0225634 0.0432821 0.0462094 0.0470074 0.0189891 0.00950183 0.0244325 0.0484633 0.0281688 0.0115773 0.00520329 0.0134903 0.0228567 0.0107155 0.022197 0.00666825 0.00412933 0.00220041 0.00215246 0.00801629 0.0147482 0.0131243 0.0254089 0.0132782 0.0112648 0.0127364 0.0623074	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG2 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0264645 0.0551148 0.0401192 0.0394134 0.0219833 0.0200263 0.0236011 0.0260594 0.00855472 0.0363198 0.0236587 0.0194875 0.0126212 0.0340955 0.0747298 0.0542595 0.0646945 0.0287145 0.0495914 0.052269 0.0298731 0.0162661 0.00704219 0.0142565 0.0217513 0.0108181 0.0211085 0.00677488 0.00397468 0.00207171 0.00205974 0.00762616 0.0140906 0.0125841 0.0243918 0.0128576 0.0106472 0.0119261 0.0581015	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0243196 0.0508092 0.0362739 0.0368229 0.0209469 0.0198975 0.0234615 0.0270235 0.00880018 0.0361209 0.0208103 0.0134454 0.00781831 0.0222781 0.0551981 0.0557825 0.0263656 0.0126685 0.0328372 0.0721612 0.0440108 0.0480948 0.0241453 0.0351919 0.028061 0.0171069 0.0307565 0.0109116 0.00511153 0.00244735 0.00235249 0.00815108 0.0143844 0.0123089 0.0231825 0.0122848 0.0101516 0.0115341 0.055971	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0231247 0.0483162 0.0343363 0.034872 0.0196693 0.0186772 0.0218459 0.0250007 0.00805799 0.0332014 0.0178512 0.0112135 0.00627542 0.0171955 0.0395449 0.0360087 0.0148636 0.00702809 0.0228623 0.0591045 0.0369029 0.018966 0.0102051 0.0295751 0.0673703 0.046135 0.0679922 0.0442189 0.0213907 0.00631631 0.00369898 0.00608786 0.0122238 0.0125884 0.0261893 0.0138226 0.00990157 0.0115995 0.055766	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0228444 0.0477093 0.0339555 0.0344108 0.0194344 0.0184349 0.0215968 0.0247178 0.00796863 0.0328788 0.017926 0.0114238 0.00650299 0.017953 0.0414657 0.038282 0.0167031 0.00874232 0.0288237 0.0752078 0.0445873 0.0220549 0.0102832 0.0267901 0.0532705 0.0324182 0.0423077 0.0179336 0.00881328 0.00851823 0.00695741 0.0211421 0.0179575 0.0195308 0.0366527 0.0200296 0.0118218 0.0139323 0.0580173	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0224854 0.0469602 0.0333412 0.0338341 0.0190866 0.0181475 0.0212092 0.0242586 0.0078042 0.0321251 0.0172103 0.0106838 0.00583218 0.0158226 0.0360937 0.0333121 0.0140634 0.0073931 0.0238781 0.0592307 0.033469 0.0141025 0.00564005 0.0134297 0.0256726 0.0121331 0.0260046 0.00975638 0.00614121 0.00327573 0.00381434 0.017654 0.041024 0.0446003 0.0806862 0.0529809 0.0462564 0.02839 0.0521971	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0162639 0.0328132 0.018349 0.0193206 0.00989369 0.00933663 0.0070681 0.00615311 0.00444768 0.0193173 0.0737558 0.0760363 0.0222212 0.0648426 0.0854376 0.0537902 0.065033 0.0283021 0.0504465 0.05361 0.0308868 0.0161392 0.00689748 0.0139121 0.021354 0.0106427 0.0207489 0.00666924 0.00389612 0.00202783 0.0020176 0.00744807 0.0137284 0.0122589 0.0237916 0.0125467 0.0103891 0.0116264 0.0565805	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0161255 0.0324078 0.0185537 0.0194161 0.00952254 0.0089175 0.0068446 0.00570392 0.00409766 0.0184731 0.0751628 0.0820615 0.0190049 0.0634791 0.0672904 0.0526297 0.0248537 0.0123019 0.0304251 0.0652803 0.0385275 0.043712 0.02256 0.0319963 0.0262442 0.0160865 0.0287606 0.0104246 0.00489921 0.00233419 0.00223045 0.00770819 0.0136302 0.0116472 0.0219223 0.0116275 0.00957587 0.0108656 0.0526957	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0148001 0.0297686 0.0170263 0.0178215 0.00876174 0.00822727 0.00628394 0.0052802 0.00382253 0.0170331 0.0695095 0.0755897 0.0167428 0.0533925 0.0456036 0.0305004 0.0131737 0.00715453 0.0220772 0.0586769 0.037925 0.0203256 0.0107466 0.028775 0.0656382 0.0444581 0.0640521 0.0416725 0.0198516 0.00587991 0.00343183 0.00560774 0.0112933 0.0116422 0.0242165 0.012851 0.00911436 0.0106027 0.0506695	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0146261 0.0294201 0.0168014 0.017607 0.00866623 0.00813964 0.00621336 0.00522516 0.00377762 0.0168871 0.069244 0.0754225 0.0168309 0.0542478 0.0477862 0.032745 0.0154289 0.00918501 0.028338 0.0719228 0.0435262 0.0227732 0.0106024 0.0259125 0.052259 0.0317622 0.0405562 0.0173496 0.00827766 0.00791523 0.00640068 0.0193172 0.0165303 0.0179691 0.0340501 0.0187037 0.011027 0.0129396 0.0536132	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0145645 0.0292861 0.0167788 0.0175217 0.00860351 0.00807462 0.00617491 0.00517392 0.00375112 0.0166568 0.06768 0.0736082 0.0161272 0.0516875 0.0419658 0.0280476 0.0128233 0.00780945 0.023784 0.0583626 0.033993 0.0154325 0.00618329 0.0135192 0.0258415 0.0122907 0.0248007 0.00945759 0.0057611 0.00306303 0.00356764 0.0163676 0.0383135 0.0416082 0.0752448 0.0490489 0.0428332 0.0263186 0.0478729	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0177724 0.0348815 0.0187219 0.0187303 0.00858259 0.00838279 0.00606187 0.00455995 0.00224596 0.00766409 0.0164806 0.0152861 0.00719669 0.0288526 0.104103 0.102461 0.0687788 0.0200442 0.0569781 0.0767658 0.0357154 0.0429022 0.021412 0.0306797 0.0253218 0.0151627 0.0295176 0.0106915 0.0050529 0.00244219 0.00237585 0.00827981 0.0148251 0.0127325 0.0244541 0.0129936 0.010639 0.012034 0.0582172	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0162661 0.0319145 0.0172945 0.0172382 0.00788355 0.00762833 0.0055575 0.00417379 0.00205802 0.00717878 0.0158799 0.0145932 0.00698428 0.0276447 0.101509 0.102915 0.0760458 0.019034 0.0514098 0.0479338 0.0216199 0.0173418 0.00932161 0.0218862 0.0551855 0.0353851 0.0548306 0.0361483 0.0160108 0.00495867 0.00298123 0.00531315 0.0114587 0.012151 0.026211 0.0141918 0.00981815 0.0111942 0.0528494	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0161242 0.0316365 0.0170854 0.0170662 0.00781244 0.00757247 0.00550553 0.00413357 0.00202993 0.00699234 0.0152943 0.0140648 0.00667853 0.0267948 0.100566 0.102396 0.0758317 0.0193667 0.051432 0.0530319 0.0228173 0.0183056 0.00852321 0.0202262 0.0472752 0.0279653 0.0401976 0.0180665 0.00785911 0.00691565 0.00562742 0.0172849 0.0160907 0.0180482 0.0364562 0.0204339 0.0124238 0.0144996 0.0595684	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0148175 0.0290703 0.0157017 0.0156821 0.0071826 0.00696305 0.00505988 0.00379866 0.0018671 0.00642199 0.014047 0.0129462 0.00615807 0.0246328 0.0924919 0.0937636 0.0688311 0.0173372 0.0447192 0.0420166 0.0177471 0.0121021 0.00513777 0.00985985 0.0214982 0.0118423 0.0252387 0.0109511 0.00604243 0.00317259 0.00378147 0.0168091 0.0405241 0.0433324 0.0782449 0.0504387 0.0439699 0.0272031 0.0485955	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0170146 0.0329265 0.0174708 0.0169695 0.00804605 0.00782944 0.00557579 0.00420683 0.00216433 0.00691071 0.0142834 0.0124637 0.0046144 0.0145843 0.0435666 0.045161 0.0194101 0.00881545 0.0281397 0.0756228 0.0540206 0.0512782 0.0238272 0.0674351 0.073951 0.0291615 0.0459166 0.0214552 0.00935305 0.00851343 0.00708613 0.0201773 0.0197531 0.0206313 0.0413393 0.0234538 0.0140734 0.0161987 0.0665991	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG1 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0147333 0.028531 0.0152084 0.0147671 0.00697298 0.00676818 0.00483788 0.00364668 0.00187102 0.00603367 0.0126175 0.0110916 0.00418295 0.0135229 0.0410603 0.041504 0.0175704 0.00809828 0.0248468 0.0644948 0.0451215 0.04105 0.0170953 0.0530403 0.0476975 0.0182447 0.0292809 0.0151582 0.00645424 0.00402917 0.00474491 0.018548 0.0503178 0.0472769 0.0829934 0.0534454 0.0461753 0.0286983 0.0482688	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG1 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0166533 0.0322113 0.0167989 0.0164593 0.00758712 0.00748297 0.00525406 0.00393332 0.00198597 0.00637396 0.0128832 0.0116197 0.0045356 0.0147364 0.0431111 0.0399239 0.0148714 0.00653641 0.0206375 0.0585155 0.0361019 0.0175517 0.00780314 0.0228771 0.0465763 0.0318088 0.0556865 0.0375776 0.0334708 0.00931173 0.00824582 0.0189243 0.055692 0.0346086 0.0635361 0.0537206 0.046826 0.0289453 0.0486247	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG1 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
2	2	0.115023 0.0296467 0.0146308 0.015026 0.0719339 0.0288002 0.107274 0.0377436 0.0683043 0.084457 0.0830956 0.0564519 0.0606742 0.0900603 0.076349 0.0605294	Catecholamine-depleting drugs (e.g. , DRUG1 ) may have an additive effect when given with DRUG2 .
3	4	0.123035 0.0513562 0.0471392 0.0384922 0.0555518 0.0536854 0.112605 0.0659311 0.0234363 0.00527446 0.00469655 0.0035111 0.00306991 0.00452582 0.00319867 0.00500731 0.0199024 0.0564598 0.136195 0.0570206 0.0593092 0.0705966	DRUG1 has been used with a variety of DRUG2 , including DRUG0 , DRUG0 , and DRUG0 without unexpected adverse interactions .
3	4	0.128599 0.0509301 0.0440208 0.0408096 0.0465569 0.0531598 0.10767 0.0328012 0.00973764 0.0060887 0.0091642 0.0141209 0.00303536 0.00417326 0.00297846 0.00468177 0.0197877 0.0629338 0.151173 0.0637087 0.0655966 0.0782721	DRUG1 has been used with a variety of DRUG0 , including DRUG2 , DRUG0 , and DRUG0 without unexpected adverse interactions .
3	4	0.130236 0.0516807 0.046007 0.0413987 0.0483528 0.0561579 0.113266 0.0335701 0.00894291 0.00411541 0.00460709 0.00518602 0.00479458 0.0130607 0.00310537 0.004047 0.0171976 0.0575816 0.150317 0.0644784 0.0639742 0.0779236	DRUG1 has been used with a variety of DRUG0 , including DRUG0 , DRUG2 , and DRUG0 without unexpected adverse interactions .
3	4	0.114439 0.0461247 0.0420423 0.035905 0.0436624 0.0525668 0.0909699 0.0289066 0.0073398 0.00331807 0.00413491 0.00360559 0.00220383 0.00459751 0.00540823 0.0153136 0.0403593 0.0766775 0.171908 0.0762489 0.0622307 0.0720368	DRUG1 has been used with a variety of DRUG0 , including DRUG0 , DRUG0 , and DRUG2 without unexpected adverse interactions .
4	4	0.037673 0.0562278 0.0625065 0.0566306 0.0774141 0.0584578 0.0895277 0.0596283 0.0491745 0.00739676 0.0116646 0.0113314 0.00306657 0.00384154 0.00293677 0.00442789 0.016769 0.0605264 0.150464 0.0603027 0.0563053 0.0637269	DRUG0 has been used with a variety of DRUG1 , including DRUG2 , DRUG0 , and DRUG0 without unexpected adverse interactions .
4	4	0.0387526 0.0605307 0.0667811 0.0603068 0.0826153 0.0630613 0.089583 0.0628934 0.048237 0.00586607 0.0144181 0.00593075 0.00706847 0.0138212 0.00348504 0.00434145 0.0153622 0.0590625 0.136617 0.0547867 0.050426 0.0560537	DRUG0 has been used with a variety of DRUG1 , including DRUG0 , DRUG2 , and DRUG0 without unexpected adverse interactions .
4	4	0.0389522 0.0604606 0.0661774 0.0593363 0.0802436 0.0602881 0.0689844 0.0453377 0.0374995 0.00527852 0.0140142 0.00448709 0.00544903 0.00553696 0.0113302 0.0157092 0.041695 0.0689031 0.148206 0.0616914 0.0485682 0.0518513	DRUG0 has been used with a variety of DRUG1 , including DRUG0 , DRUG0 , and DRUG2 without unexpected adverse interactions .
4	4	0.0394233 0.056829 0.0632767 0.0584046 0.0676074 0.0376584 0.0501192 0.0174261 0.0074538 0.00342809 0.00586994 0.0078165 0.0093557 0.0537031 0.0143924 0.0192955 0.04864 0.0772878 0.173763 0.0702639 0.056539 0.0614463	DRUG0 has been used with a variety of DRUG0 , including DRUG0 , DRUG1 , and DRUG2 without unexpected adverse interactions .
3	3	0.0949333 0.0419596 0.0430119 0.0575702 0.0466906 0.105972 0.156997 0.088213 0.0766086 0.0514056 0.0499543 0.0363718 0.0299367 0.0358432 0.0845329	DRUG1 has been shown to increase serum DRUG2 levels when both drugs are co-administered .
4	4	0.0509085 0.00952787 0.0064861 0.00572498 0.00848473 0.00978013 0.0153611 0.0766997 0.0847942 0.0969437 0.0746414 0.0385318 0.0341866 0.0219517 0.0237028 0.00728176 0.00275454 0.00400993 0.00365513 0.0108234 0.00213828 0.00198994 0.00340293 0.00361333 0.00495768 0.0150813 0.0292969 0.0133764 0.0153471 0.00998361 0.0237299 0.0176345 0.0065505 0.0195741 0.0353519 0.0444331 0.0283784 0.0639811 0.0749288	DRUG1 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG2 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.049807 0.0093352 0.00634298 0.00560753 0.00831534 0.00956659 0.0150587 0.0750832 0.0828311 0.094611 0.0723474 0.0370031 0.0322499 0.0202097 0.0225809 0.00659862 0.0023959 0.0031396 0.00198764 0.00383832 0.00324395 0.00668521 0.0143857 0.00532256 0.00576974 0.01648 0.0330334 0.0139688 0.0151608 0.0106183 0.0244389 0.018638 0.00679289 0.0201555 0.0363545 0.0450596 0.0285577 0.0627538 0.0736711	DRUG1 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG2 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.035557 0.00659348 0.00434609 0.00387392 0.00563872 0.00614438 0.00942056 0.0452742 0.0500734 0.0653999 0.0440744 0.0184979 0.0136567 0.00818732 0.0116534 0.00304699 0.00156527 0.00202718 0.0014307 0.00237921 0.00172775 0.00252325 0.00545845 0.011346 0.0208501 0.0844111 0.124858 0.0930409 0.0457061 0.0205176 0.0262284 0.0194081 0.00669794 0.0172563 0.0299767 0.0330148 0.0214753 0.045106 0.0515565	DRUG1 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.0351917 0.00647219 0.00429614 0.00380558 0.00541976 0.00600035 0.00912354 0.0433791 0.0481291 0.0656866 0.0407912 0.016247 0.0114685 0.00664116 0.0105915 0.00268315 0.00144289 0.00197048 0.00130213 0.00233013 0.00147144 0.00183632 0.00382479 0.00388715 0.00659099 0.0254792 0.0439708 0.0228756 0.0343092 0.0395921 0.0996965 0.0810841 0.0289973 0.0567689 0.0314169 0.0486588 0.0326221 0.0543478 0.0595978	DRUG1 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
4	4	0.0199517 0.0127453 0.0628505 0.0153306 0.0196132 0.0475703 0.0256486 0.054072 0.0540037 0.0786494 0.0397246 0.0156555 0.0124457 0.00882296 0.015238 0.00376354 0.00236279 0.00294001 0.00214621 0.00342678 0.00227743 0.00273112 0.00520091 0.00488469 0.00814751 0.0223234 0.039285 0.0162933 0.0198079 0.0132869 0.0275407 0.022094 0.00812932 0.0243924 0.0421202 0.0500092 0.0319529 0.0743117 0.08825	DRUG0 , DRUG1 , and DRUG2 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.0135403 0.00742481 0.0319063 0.00540767 0.00694907 0.00883263 0.0131193 0.072431 0.0822896 0.10143 0.0762089 0.0392973 0.036548 0.0274301 0.0315036 0.0117533 0.00519377 0.0107978 0.00219351 0.00265763 0.00191555 0.00200357 0.0035868 0.00364396 0.00516978 0.015923 0.0293891 0.0131014 0.0151309 0.00987417 0.0233651 0.0176196 0.0065663 0.0195872 0.035328 0.0443186 0.0282794 0.0637256 0.0745574	DRUG0 , DRUG1 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG2 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.0135623 0.00742445 0.0319746 0.00543351 0.00698079 0.00898591 0.0135932 0.0754063 0.084991 0.10174 0.0747966 0.037353 0.0313993 0.0201135 0.0225332 0.00662882 0.00239855 0.00315068 0.00200848 0.00386487 0.00327195 0.00674837 0.0144896 0.00534683 0.00582758 0.0165478 0.0333555 0.0140541 0.0152935 0.0107301 0.024708 0.0188591 0.00688585 0.0204597 0.0368261 0.0455605 0.0287749 0.0634591 0.0744627	DRUG0 , DRUG1 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG2 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.00955217 0.00524005 0.0225268 0.00377869 0.0048058 0.00580488 0.00844871 0.0453902 0.0516236 0.0694763 0.0445933 0.0185671 0.0131697 0.00791774 0.0115631 0.00300928 0.00154418 0.00200826 0.00142304 0.00237209 0.0017204 0.00251167 0.00544718 0.0113246 0.0210452 0.0852505 0.126217 0.0941427 0.0462266 0.0206062 0.02629 0.0195344 0.00673722 0.0174028 0.0302264 0.0332872 0.0216383 0.0455334 0.0520426	DRUG0 , DRUG1 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.00953149 0.00519157 0.0223894 0.00371556 0.00463044 0.0056998 0.00824005 0.0432444 0.0491818 0.0690884 0.041176 0.0164316 0.0111659 0.00645546 0.0104793 0.00265548 0.00142266 0.00194895 0.00129277 0.00232127 0.00146459 0.00182801 0.00382176 0.00389058 0.00661183 0.0254657 0.0441573 0.022853 0.0344688 0.0398764 0.100756 0.082086 0.029359 0.0575219 0.0317883 0.0492649 0.0329822 0.0550896 0.0604525	DRUG0 , DRUG1 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
4	4	0.00787878 0.00312477 0.00632503 0.00508025 0.00959563 0.0487761 0.0247399 0.0657863 0.0704815 0.0888981 0.0637022 0.0360802 0.0368336 0.0270859 0.0325534 0.0119379 0.00534041 0.0110466 0.00235438 0.00286025 0.00206593 0.00215886 0.00385925 0.00391876 0.00555208 0.0171995 0.0313293 0.0140183 0.0160824 0.0104874 0.0248229 0.018735 0.00696134 0.020685 0.037448 0.0470305 0.0301408 0.0677052 0.0793181	DRUG0 , DRUG0 , and DRUG1 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG2 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.00807499 0.00319577 0.00647612 0.00519423 0.00986179 0.0503889 0.0261731 0.0699085 0.0746243 0.0909503 0.0643748 0.0358231 0.0336297 0.0218587 0.0248548 0.00762618 0.00294493 0.00435372 0.00397103 0.0117196 0.00232261 0.00215917 0.00368451 0.00390863 0.00535873 0.0163058 0.0313686 0.0143405 0.016399 0.0106749 0.0254331 0.0189352 0.00702698 0.0209437 0.0378874 0.0475976 0.0304347 0.0686772 0.080537	DRUG0 , DRUG0 , and DRUG1 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG2 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.00534212 0.00213703 0.00429093 0.00345691 0.00637521 0.0316436 0.0150941 0.0393105 0.0424552 0.0588602 0.0358744 0.0164979 0.0132629 0.00819633 0.0121129 0.003176 0.00165807 0.00215294 0.00151496 0.00251917 0.00182876 0.00267143 0.00577493 0.0119827 0.0220766 0.0893728 0.130917 0.0975859 0.0478195 0.0214043 0.0273985 0.0203365 0.00700565 0.0180452 0.0313756 0.0345356 0.0224821 0.0473203 0.0541355	DRUG0 , DRUG0 , and DRUG1 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	4	0.00532593 0.00212476 0.00427679 0.00341038 0.00623879 0.031048 0.0147114 0.0378319 0.0408077 0.058659 0.033309 0.0145361 0.0112121 0.00671349 0.011064 0.00280594 0.00153109 0.00209408 0.00138038 0.00246773 0.0015599 0.00194802 0.00405533 0.00410787 0.00695544 0.0267628 0.0458739 0.0237737 0.0356526 0.0412503 0.104193 0.0849195 0.0303635 0.0594116 0.0327988 0.0508446 0.0341496 0.057031 0.0627998	DRUG0 , DRUG0 , and DRUG1 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
3	3	0.0052285 0.00214392 0.00334914 0.0022719 0.00282612 0.00694308 0.0118017 0.04426 0.0495661 0.0683914 0.0474173 0.0248738 0.0229136 0.0153213 0.0220282 0.00921817 0.00551681 0.0255906 0.00576073 0.00463991 0.00520324 0.00611424 0.00735106 0.0197601 0.0225323 0.0422495 0.0564013 0.0668789 0.0390838 0.0219164 0.0358653 0.0249729 0.0101208 0.0246374 0.0424721 0.0432076 0.0285826 0.0568671 0.0657211	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG1 , DRUG0 , and DRUG0 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	3	0.0038045 0.00156029 0.00243939 0.00165434 0.00206491 0.00506913 0.00868379 0.0327621 0.0364613 0.0506361 0.0356126 0.0191184 0.0176647 0.0109648 0.0172999 0.00698386 0.00386735 0.0177889 0.00357746 0.0030317 0.00288638 0.0036844 0.0043221 0.00874007 0.00887037 0.0173849 0.0254395 0.0279025 0.0372685 0.0590772 0.128141 0.091313 0.032241 0.0589611 0.0321378 0.0436769 0.031558 0.0494266 0.0559233	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG1 , DRUG0 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
4	4	0.00650067 0.00266411 0.00414242 0.0028146 0.00347705 0.00843679 0.0143647 0.0543103 0.060477 0.0848816 0.059399 0.0313567 0.0287968 0.016791 0.0246417 0.00839816 0.00465159 0.00775214 0.00754235 0.0453921 0.00972017 0.0116607 0.0213308 0.00754651 0.00849525 0.0208533 0.0358256 0.0174099 0.0186848 0.0121143 0.0273766 0.0205472 0.00761294 0.0223626 0.0405481 0.0516055 0.0326772 0.0726043 0.0842334	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG1 , and DRUG2 ) , the clearance of DRUG0 was significantly increased and DRUG0 blood concentrations were decreased .
3	3	0.00546129 0.00223834 0.00347821 0.00235769 0.00287477 0.00690904 0.0115509 0.043177 0.0481249 0.0676299 0.0450578 0.0220476 0.0193839 0.0118555 0.0162659 0.00557272 0.00335074 0.00498303 0.00476047 0.0285082 0.0057367 0.00613067 0.00743597 0.0191506 0.022017 0.0466006 0.0607528 0.0689728 0.040074 0.0223298 0.0368589 0.0258367 0.0104075 0.0253382 0.043543 0.0450153 0.0297131 0.0595451 0.0689532	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG1 , and DRUG0 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	3	0.00393635 0.00161573 0.00251278 0.00170782 0.00211182 0.00511146 0.00869392 0.0328338 0.0365641 0.0519493 0.0354569 0.0178319 0.0156708 0.00863273 0.0130065 0.0040843 0.00217107 0.00395419 0.00316333 0.0187357 0.00308027 0.00352335 0.00420787 0.00821183 0.00899178 0.0176103 0.0271041 0.026843 0.0378454 0.0592045 0.130017 0.0922301 0.032236 0.0598412 0.0326513 0.0451682 0.0324094 0.0512114 0.0578681	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG1 , and DRUG0 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
3	3	0.00519743 0.00213511 0.00329908 0.00224269 0.00272281 0.00645852 0.0107301 0.040007 0.044561 0.0638133 0.0418855 0.0203251 0.0176936 0.0107325 0.0146793 0.00448201 0.00226729 0.00288745 0.00225247 0.0042584 0.00376127 0.00638284 0.0309373 0.0230523 0.0206246 0.0560973 0.075728 0.0758829 0.0433068 0.0235324 0.0364327 0.0259601 0.0103456 0.0246559 0.0423544 0.0441116 0.0289884 0.0582421 0.0669732	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG1 ) , the clearance of DRUG2 was significantly increased and DRUG0 blood concentrations were decreased .
4	3	0.00374766 0.00153966 0.00238396 0.00162083 0.00198511 0.00473713 0.00797794 0.0300035 0.0334514 0.0486277 0.0323219 0.0160378 0.0142418 0.00814568 0.0124275 0.00368034 0.00170664 0.0024252 0.00175518 0.00402407 0.00320128 0.00592872 0.0321283 0.0122679 0.0101691 0.0243074 0.039755 0.0337664 0.0429022 0.0566128 0.121761 0.0867121 0.0301733 0.056511 0.0304542 0.0438061 0.0311363 0.049608 0.0559578	DRUG0 , DRUG0 , and DRUG0 : In patients treated with potent inducers of CYP3A4 (i.e. , DRUG0 , DRUG0 , and DRUG1 ) , the clearance of DRUG0 was significantly increased and DRUG2 blood concentrations were decreased .
4	4	0.00649874 0.00242976 0.00765715 0.0157129 0.0157572 0.0123396 0.017696 0.00976647 0.00233692 0.011428 0.0219689 0.0292981 0.037854 0.0462906 0.0334761 0.0174503 0.0357151 0.0236677 0.0226232 0.0250479 0.0422451 0.0143399 0.00644994 0.00527072 0.0102835 0.00932037 0.00893734 0.00766969 0.00730833 0.0038918 0.0021128 0.00579342 0.00572384 0.00605761 0.00897078 0.00346257 0.00630862 0.00343383 0.00336289 0.00572181 0.00352051 0.00367973 0.00267227 0.00740091 0.0107799 0.00609688 0.00936737 0.00781083 0.00541427 0.00826795 0.00498671 0.00532793 0.0106213 0.00966441 0.0114228 0.0133662 0.0252806 0.0187735 0.00976664 0.0110638 0.0346248 0.0159163 0.00773549 0.00659631 0.0061798 0.00734147 0.00938388 0.00696466 0.0131534 0.0211045 0.0261668 0.0138832 0.0139557 0.0158094 0.0104178 0.0127381 0.0310645	However , on the basis of available data , no dosage adjustment for DRUG1 is recommended for patients on these drugs.1,3 DRUG2 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00731397 0.00267566 0.00822333 0.0168111 0.0170729 0.0132548 0.0198191 0.0105773 0.00249828 0.010678 0.0199588 0.0242746 0.0343599 0.0351583 0.0138988 0.00951698 0.0177304 0.0109872 0.00718505 0.00659232 0.00823437 0.00456293 0.00423206 0.00719326 0.0179383 0.0179175 0.0180121 0.020405 0.0208787 0.00858019 0.010747 0.0152618 0.00760762 0.00734982 0.0121977 0.00429101 0.0101493 0.00504466 0.00487151 0.00757661 0.00403636 0.00418031 0.00322789 0.00855139 0.0128681 0.00748369 0.0107476 0.00882138 0.0061923 0.00937751 0.00587584 0.00625192 0.0125437 0.0113796 0.0134182 0.0151272 0.0285365 0.021164 0.0110011 0.0124525 0.0387163 0.0177797 0.00863444 0.00737466 0.00692463 0.00822071 0.0105403 0.00783372 0.014793 0.0237965 0.0295901 0.0157303 0.0158142 0.0179247 0.0118106 0.0144323 0.0352087	However , on the basis of available data , no dosage adjustment for DRUG1 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG2 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00683257 0.00248458 0.00755665 0.0154423 0.0158479 0.0121761 0.0186264 0.00985872 0.00237038 0.0101936 0.0193795 0.023806 0.0341585 0.0342804 0.0124262 0.0080126 0.014549 0.00898677 0.00577615 0.00531299 0.00693687 0.003739 0.00299916 0.00395912 0.00855982 0.00726366 0.00735747 0.00659519 0.00648941 0.00352204 0.00200183 0.00562006 0.00581397 0.00639042 0.00955761 0.00377197 0.00731809 0.00398404 0.0039708 0.00739086 0.00484328 0.00520729 0.00369718 0.0101366 0.0168707 0.00986991 0.0175371 0.0188371 0.0134339 0.0191586 0.0117496 0.0115448 0.0240483 0.0186195 0.029545 0.0305312 0.0247254 0.0323535 0.014329 0.0146252 0.0469788 0.0204356 0.00961227 0.00760295 0.00674996 0.00813521 0.0101441 0.00750978 0.0141565 0.0227137 0.0281274 0.0149065 0.0149864 0.0169416 0.0111605 0.0136383 0.0332184	However , on the basis of available data , no dosage adjustment for DRUG1 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG2 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00653787 0.00229645 0.00653611 0.0129782 0.0129144 0.00835495 0.0129156 0.00681493 0.00189457 0.00711596 0.00891308 0.0074033 0.00581378 0.0103043 0.0138553 0.0163871 0.0337704 0.0198932 0.0143066 0.015016 0.0231456 0.0191154 0.00409745 0.00811853 0.0219966 0.0260037 0.0258041 0.0295331 0.0561385 0.018819 0.00293991 0.0042157 0.0047084 0.00531147 0.0124086 0.0039576 0.00912669 0.00447106 0.00420872 0.00714208 0.00390442 0.00402753 0.00308928 0.00840077 0.0124545 0.00726328 0.0105091 0.00886055 0.00617277 0.00929589 0.00576642 0.00613974 0.0124429 0.0111462 0.0131517 0.0151927 0.0284047 0.0210577 0.0107333 0.0120839 0.0381009 0.0174678 0.00852636 0.00720764 0.00677655 0.00809961 0.0102588 0.00760898 0.0143803 0.0229143 0.0285999 0.0150366 0.0150245 0.016945 0.0111345 0.0135847 0.0329521	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG1 : Although no pharmacokinetic drug interaction between DRUG2 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00575556 0.00201586 0.00571393 0.0113375 0.0113287 0.00726422 0.0113155 0.00594503 0.0016636 0.00620818 0.00775229 0.00643715 0.00510664 0.00911773 0.0121716 0.0146645 0.029525 0.0173308 0.0121201 0.0127574 0.0207633 0.0169141 0.00292986 0.0044688 0.0101097 0.00960743 0.00930197 0.00821167 0.00815378 0.00434142 0.00237727 0.00758875 0.00966312 0.0121863 0.0173776 0.00772207 0.0222923 0.0120152 0.0128982 0.0275172 0.0312759 0.0449107 0.034449 0.0322526 0.0144841 0.0122747 0.0138003 0.00868964 0.00646515 0.00983343 0.00748734 0.00784061 0.0132662 0.0115647 0.013348 0.0130635 0.0249157 0.0186279 0.00946105 0.0105289 0.0327895 0.014975 0.00734564 0.00622807 0.00588327 0.00703836 0.00893089 0.00663164 0.0125345 0.0200249 0.025128 0.0132308 0.0132107 0.0148994 0.00978683 0.0119257 0.0289261	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG1 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG2 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00608417 0.00212915 0.00602625 0.0119515 0.0119455 0.00764955 0.0119302 0.00626089 0.0017558 0.00654657 0.00816783 0.00678028 0.00539537 0.0096476 0.012821 0.0155175 0.0308997 0.0178764 0.0123583 0.012898 0.0208488 0.0169531 0.00288475 0.00415488 0.00905921 0.00836612 0.00799907 0.0068702 0.00666353 0.00380642 0.00210769 0.00581854 0.00575968 0.0061089 0.0089821 0.00341901 0.00626447 0.00346513 0.00338107 0.00579473 0.0035268 0.00375047 0.00269576 0.00760404 0.0109359 0.00621392 0.00935622 0.00801375 0.00559313 0.00834852 0.00508525 0.00543771 0.0109872 0.0100248 0.0118946 0.0142414 0.0274665 0.0206226 0.0104085 0.0119272 0.0386769 0.0183342 0.00995561 0.00872139 0.0086696 0.0112745 0.0148904 0.0118027 0.0213439 0.0313552 0.0416633 0.0236684 0.0348008 0.0517551 0.0492494 0.0421107 0.0442448	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG1 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG2 .
4	4	0.00737213 0.002513 0.00682971 0.0133911 0.0137596 0.00834229 0.0134679 0.00679846 0.00206123 0.00758957 0.00899657 0.00736831 0.00615247 0.0102654 0.0115941 0.0145339 0.0192067 0.00955782 0.00581471 0.00434973 0.00555562 0.00391775 0.00411048 0.00747029 0.0212835 0.0240386 0.0208484 0.0269649 0.0255351 0.0508909 0.0152408 0.0261779 0.0147438 0.0170447 0.0229237 0.00655261 0.0146062 0.00695272 0.00567218 0.00755834 0.00390856 0.00417064 0.00323955 0.00851063 0.0130146 0.00730425 0.0102554 0.00844834 0.00588756 0.00894309 0.00544779 0.00574689 0.0116699 0.0106868 0.0125739 0.0143957 0.0272582 0.0202452 0.0107142 0.0122281 0.037862 0.0175479 0.00846405 0.00729453 0.00684352 0.00807883 0.0104806 0.00780471 0.0147253 0.0239733 0.0298866 0.0160516 0.0162214 0.0184624 0.01219 0.0149006 0.0365101	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG1 and DRUG2 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00576279 0.00195611 0.0052802 0.0103315 0.0106572 0.00643611 0.0104703 0.00527653 0.00161001 0.00588638 0.0069688 0.00570102 0.00477407 0.00795837 0.00867847 0.0109725 0.0144344 0.00723096 0.00440071 0.00318797 0.0040988 0.00296823 0.00273718 0.00576304 0.0174919 0.0209775 0.0234236 0.0333451 0.0460377 0.0418366 0.00798528 0.0101704 0.0185557 0.0221369 0.0265727 0.00722504 0.0169478 0.00763268 0.00615541 0.00828123 0.00438674 0.00493952 0.0037705 0.00963832 0.016587 0.00963697 0.0151321 0.015951 0.0113267 0.0160931 0.00965828 0.00941996 0.01992 0.0154479 0.0246456 0.0254092 0.0205431 0.0267593 0.0122134 0.0125157 0.039755 0.0173596 0.00817993 0.00651193 0.00578512 0.0069657 0.00873835 0.00647751 0.0122134 0.0196855 0.0243589 0.0129658 0.013067 0.0148008 0.00976048 0.0119346 0.0291289	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG1 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG2 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00568216 0.00192274 0.00516537 0.0101034 0.0105228 0.006316 0.0104026 0.00523732 0.0016084 0.00585663 0.00698549 0.00573605 0.00479783 0.00806689 0.00861951 0.0109801 0.0143137 0.0072751 0.00440575 0.00320732 0.0042667 0.00291209 0.00252963 0.00485271 0.0135752 0.0148607 0.0172474 0.019439 0.0233 0.0139201 0.0106962 0.0310385 0.0234188 0.0266746 0.0348947 0.00938306 0.0300156 0.0193073 0.0170469 0.0246443 0.0230883 0.0332226 0.0287898 0.024256 0.0125552 0.0112737 0.0126677 0.00787537 0.00565696 0.00890589 0.00668671 0.00735249 0.012564 0.0110625 0.0126674 0.0122692 0.02297 0.0171687 0.00892685 0.0100249 0.0306554 0.014094 0.00685115 0.00588792 0.00553435 0.00657833 0.00845873 0.00628631 0.0118786 0.0191444 0.0237803 0.0126725 0.0127607 0.0144748 0.00954567 0.0116705 0.0285133	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG1 has been observed , data from 2 small studies indicate that DRUG2 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00601653 0.00203617 0.00546824 0.0106923 0.0111276 0.00668357 0.0109973 0.00553612 0.00170058 0.00619221 0.00737684 0.00606044 0.00507114 0.00851778 0.00909287 0.0115723 0.0150485 0.00763984 0.00461654 0.00337349 0.00447237 0.00302318 0.00262901 0.0050572 0.0141363 0.0154401 0.0178322 0.0201104 0.0236029 0.0128937 0.00905995 0.0248847 0.0146494 0.0162717 0.022239 0.0052322 0.0129292 0.00591527 0.00487536 0.00660603 0.00344797 0.00367621 0.00281187 0.00743775 0.0113491 0.00622636 0.00895535 0.00741516 0.00517106 0.00789179 0.00476967 0.00506012 0.0101507 0.00925712 0.0109161 0.0125929 0.0241884 0.0182187 0.00948165 0.0109807 0.0347648 0.0165941 0.00891124 0.0079567 0.00786028 0.0101564 0.0136883 0.0108228 0.0196219 0.0292525 0.0386899 0.0222136 0.0327955 0.0493645 0.0470585 0.0400321 0.0435378	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG1 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG0 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG2 .
4	2	0.00572822 0.0019365 0.00519521 0.0101513 0.0105707 0.00629206 0.0103263 0.00517706 0.00159772 0.00578602 0.00682795 0.00560677 0.00466897 0.00786572 0.00816795 0.0104408 0.0130926 0.00670731 0.0040424 0.00292232 0.00396993 0.00254174 0.0020943 0.00323532 0.00751695 0.00671176 0.00700596 0.00637715 0.00648848 0.00336006 0.00187129 0.00600091 0.00724819 0.00914015 0.0145085 0.00631895 0.0169648 0.00846048 0.00965349 0.0260418 0.0279562 0.0339867 0.0229698 0.0505618 0.0314703 0.0175756 0.0294844 0.0183755 0.0156205 0.0184183 0.0143291 0.01077 0.0190728 0.0173097 0.0268009 0.0256512 0.0221231 0.0286515 0.0126702 0.0130504 0.0418814 0.0184581 0.00861087 0.00676543 0.00598438 0.00722374 0.00898446 0.00665154 0.0125549 0.0201168 0.0248687 0.0131527 0.0132182 0.0149313 0.00983586 0.0120259 0.0292734	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG1 may be associated with an increase in patient controlled administration of DRUG2 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG0 .
4	4	0.00581879 0.00197262 0.00526348 0.0102465 0.0106162 0.00637972 0.0103889 0.00518094 0.00160698 0.00582322 0.00683256 0.00563591 0.00468641 0.00780404 0.00806004 0.01025 0.0126233 0.00638406 0.00389693 0.00287772 0.00384292 0.00239796 0.00200358 0.0029605 0.00666672 0.00584778 0.00593753 0.00533584 0.00530642 0.00288753 0.00165109 0.00464492 0.00479701 0.0052787 0.0079917 0.00318002 0.00615365 0.0033597 0.00337539 0.00625815 0.00399352 0.00433275 0.00304347 0.00847324 0.0142338 0.00813933 0.0142941 0.0146822 0.0101522 0.0152603 0.00895319 0.0109442 0.0202175 0.0169761 0.0201413 0.0401615 0.0305926 0.0323235 0.0147848 0.0156939 0.0519303 0.0247938 0.0128516 0.0095773 0.00860672 0.0113283 0.0144092 0.0112345 0.0202697 0.0299545 0.0393967 0.0225101 0.0332287 0.0496506 0.0473145 0.0402841 0.0430407	However , on the basis of available data , no dosage adjustment for DRUG0 is recommended for patients on these drugs.1,3 DRUG0 : Although no pharmacokinetic drug interaction between DRUG0 and DRUG0 has been observed , data from 2 small studies indicate that DRUG0 may be associated with an increase in patient controlled administration of DRUG1 .4,5  Chemotherapy : Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by DRUG2 .
4	4	0.0559583 0.0746614 0.0135796 0.0379984 0.00690113 0.00690681 0.00639912 0.00908658 0.0168621 0.0437766 0.0463842 0.0630289 0.116457 0.128622 0.136722 0.11647 0.120186	In humans , DRUG1 , DRUG0 , and DRUG0 do not affect the pharmacokinetics of DRUG2 .
4	4	0.0598449 0.0574024 0.0130261 0.0160964 0.0151304 0.0825028 0.0210193 0.0294003 0.071823 0.0724911 0.0807261 0.0623941 0.0689485 0.0994459 0.0746601 0.0635348 0.111554	In humans , DRUG0 , DRUG1 , and DRUG2 do not affect the pharmacokinetics of DRUG0 .
4	4	0.0395915 0.045565 0.00842385 0.0118062 0.00779014 0.0389809 0.00705424 0.00906505 0.0177376 0.0438527 0.0481668 0.0647132 0.12412 0.138248 0.142504 0.122859 0.129521	In humans , DRUG0 , DRUG1 , and DRUG0 do not affect the pharmacokinetics of DRUG2 .
4	4	0.0310384 0.0351552 0.00574354 0.00676382 0.00401139 0.00938045 0.00677884 0.0130243 0.073287 0.0524089 0.062832 0.075014 0.121453 0.135211 0.136849 0.114968 0.116082	In humans , DRUG0 , DRUG0 , and DRUG1 do not affect the pharmacokinetics of DRUG2 .
4	4	0.0884825 0.0705999 0.0778807 0.110284 0.0893337 0.100073 0.10431 0.121673 0.123797 0.113567	DRUG1 did not increase blood levels of high-dose DRUG2 .
4	4	0.0912716 0.0525477 0.0447243 0.054084 0.0655331 0.0594071 0.117332 0.0313343 0.10363 0.0473369 0.0319794 0.0365991 0.047859 0.0236965 0.019597 0.0246941 0.0364676 0.0333632 0.0276383 0.0509047	No pharmacokinetic interaction between 85 mg/m2 DRUG1 and infusional DRUG2 has been observed in patients treated every 2 weeks .
3	3	0.136387 0.0808286 0.0723283 0.06877 0.0423782 0.0292412 0.0319628 0.041548 0.021548 0.0294188 0.0433871 0.0264832 0.0167555 0.0270168 0.0306973 0.0545579 0.0377639 0.0340727 0.0392727 0.0482466 0.0325475 0.0547875	Increases of DRUG1 plasma concentrations by approximately 20% have been observed with doses of 130 mg/m2 DRUG2 dosed every 3 weeks .
4	2	0.0241333 0.0281969 0.0474661 0.102096 0.158836 0.0949352 0.0582264 0.0264377 0.0168354 0.0227939 0.0194134 0.0476992 0.154885 0.10656 0.0914853	There is usually complete cross-resistance between DRUG1 ( DRUG0 ) and DRUG0 brand DRUG2 .
2	2	0.0289366 0.0394712 0.064601 0.116745 0.15693 0.0843426 0.0323378 0.0289429 0.0628662 0.0351385 0.0227138 0.052672 0.0601999 0.0651376 0.148964	There is usually complete cross-resistance between DRUG0 ( DRUG1 ) and DRUG2 brand DRUG0 .
4	2	0.021201 0.0286067 0.0508141 0.107927 0.153794 0.0832071 0.0302622 0.0221342 0.0438949 0.0245683 0.0185945 0.0540783 0.168311 0.104183 0.0884235	There is usually complete cross-resistance between DRUG0 ( DRUG1 ) and DRUG0 brand DRUG2 .
4	4	0.0202282 0.0244296 0.0423609 0.085012 0.127588 0.0714625 0.021001 0.0151251 0.0240285 0.028303 0.029767 0.0909285 0.207448 0.113413 0.0989053	There is usually complete cross-resistance between DRUG0 ( DRUG0 ) and DRUG1 brand DRUG2 .
4	4	0.0612987 0.0596433 0.0613751 0.0567026 0.0494113 0.0754138 0.0437391 0.0338543 0.0090173 0.00974601 0.014105 0.00336158 0.00377362 0.00331535 0.00495687 0.00899893 0.0211757 0.10289 0.0294496 0.0132907 0.00539896 0.00413116 0.0143126 0.0113391 0.012971 0.0121776 0.0109343 0.0112894 0.0146409 0.0152294 0.0249558 0.0467898 0.0373886 0.0414272 0.0714952	As there is in vitro evidence that DRUG1 (e.g. , DRUG2 , DRUG0 , or DRUG0 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG0 therapy .
4	4	0.06131 0.0592678 0.0607582 0.0570723 0.0498083 0.0749367 0.0443827 0.0351803 0.0069959 0.00840741 0.00690298 0.00880828 0.0176724 0.00445238 0.0063762 0.00916232 0.0206165 0.0985009 0.0276002 0.0126909 0.00530695 0.00407208 0.0141086 0.0111797 0.0127288 0.0119311 0.0107126 0.0110783 0.0143734 0.0149609 0.024551 0.0460548 0.03679 0.0407434 0.0705059	As there is in vitro evidence that DRUG1 (e.g. , DRUG0 , DRUG2 , or DRUG0 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG0 therapy .
4	4	0.0569457 0.0551322 0.0558807 0.0525094 0.0457969 0.067124 0.0393881 0.0331668 0.0080642 0.00941755 0.00582451 0.00658914 0.00690659 0.0108306 0.0210647 0.0323673 0.0190569 0.0924463 0.0304045 0.0129523 0.00548211 0.00432571 0.0157461 0.0119562 0.0137083 0.012762 0.0112852 0.0114923 0.0148554 0.0153621 0.024988 0.046733 0.037282 0.0412643 0.0708889	As there is in vitro evidence that DRUG1 (e.g. , DRUG0 , DRUG0 , or DRUG2 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG0 therapy .
1	3	0.0419545 0.0414484 0.0441569 0.0387802 0.032748 0.0494736 0.0263627 0.0184778 0.00380925 0.00360868 0.00364823 0.00333181 0.00385514 0.00375044 0.00632179 0.0108906 0.0220961 0.0925543 0.0269532 0.0158056 0.00867769 0.00818594 0.0359957 0.0282968 0.0319664 0.033981 0.0310046 0.0240726 0.0242993 0.0246443 0.0270206 0.0659216 0.0448762 0.0384847 0.0825454	As there is in vitro evidence that DRUG1 (e.g. , DRUG0 , DRUG0 , or DRUG0 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG2 therapy .
1	3	0.04301 0.0399802 0.0398489 0.034093 0.0277441 0.0447495 0.018048 0.010652 0.00402021 0.00418124 0.0217087 0.00380828 0.00392828 0.00359718 0.00600096 0.0107006 0.0210727 0.089927 0.0252034 0.0155108 0.00900021 0.00821154 0.0369163 0.0290193 0.0326021 0.0350637 0.0323578 0.0251667 0.0255258 0.0261866 0.0285023 0.069513 0.0472661 0.0404299 0.0864533	As there is in vitro evidence that DRUG0 (e.g. , DRUG1 , DRUG0 , or DRUG0 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG2 therapy .
1	3	0.0405597 0.0361866 0.0355219 0.0291402 0.0230456 0.0379651 0.0145135 0.00833979 0.00274851 0.00226575 0.00511411 0.00476027 0.022017 0.00434152 0.00698017 0.0120729 0.0231891 0.105993 0.027872 0.0161119 0.00874694 0.00823425 0.0369845 0.0301942 0.0340179 0.0361887 0.0330368 0.0256051 0.0258284 0.0261419 0.02872 0.0703257 0.0479051 0.0410908 0.088241	As there is in vitro evidence that DRUG0 (e.g. , DRUG0 , DRUG1 , or DRUG0 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG2 therapy .
1	3	0.0396804 0.0378577 0.0389141 0.0340858 0.0284161 0.0426333 0.0165693 0.00833635 0.00274834 0.00214301 0.00377677 0.0032219 0.00649375 0.00635003 0.0130321 0.0633721 0.0219224 0.0888953 0.0285079 0.0154979 0.00863723 0.00893255 0.0365913 0.028353 0.0316553 0.0334437 0.0304226 0.0234753 0.0236523 0.023963 0.0260802 0.0632198 0.0430481 0.0369193 0.079152	As there is in vitro evidence that DRUG0 (e.g. , DRUG0 , DRUG0 , or DRUG1 ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUG2 therapy .
4	4	0.0177501 0.0104873 0.0113869 0.00717596 0.0072202 0.0209127 0.0344839 0.0140059 0.0140488 0.026666 0.0244917 0.114855 0.0679772 0.0574869 0.0404472 0.0411851 0.0111928 0.016418 0.0236841 0.0546032 0.0659271 0.0502207 0.0447911 0.0271529 0.0414585 0.0238393 0.0115788 0.00529646 0.00620755 0.0126249 0.00804485 0.0218616 0.0250986 0.0394181	In a study in which 34 different drugs were tested , therapeutically relevant concentrations of DRUG1 , DRUG0 and DRUG2 displaced protein-bound DRUG0 in fresh human serum to a small but significant extent .
3	3	0.0179012 0.0105246 0.0114481 0.0071823 0.00708997 0.0200565 0.0330511 0.0130933 0.0131646 0.024263 0.01762 0.0986293 0.05391 0.0524619 0.0453073 0.0415609 0.00939589 0.0150991 0.0174567 0.0354403 0.0603611 0.0873234 0.0491984 0.0410452 0.0452262 0.0360197 0.0196815 0.00773415 0.00686089 0.0125082 0.0087571 0.0196368 0.0241171 0.0368741	In a study in which 34 different drugs were tested , therapeutically relevant concentrations of DRUG1 , DRUG0 and DRUG0 displaced protein-bound DRUG2 in fresh human serum to a small but significant extent .
4	4	0.0193567 0.0113939 0.0123962 0.00775783 0.00767351 0.0218446 0.0356981 0.0144788 0.0151888 0.0285954 0.0193584 0.0919498 0.0406797 0.0404721 0.0261677 0.0142816 0.0138882 0.0825492 0.0269816 0.0548407 0.0784981 0.0529353 0.0466649 0.026332 0.0426004 0.0246408 0.0121371 0.00563743 0.00670917 0.01363 0.00858234 0.024154 0.0282821 0.0436435	In a study in which 34 different drugs were tested , therapeutically relevant concentrations of DRUG0 , DRUG1 and DRUG2 displaced protein-bound DRUG0 in fresh human serum to a small but significant extent .
3	3	0.0198156 0.0116381 0.01266 0.00792977 0.00780072 0.0220824 0.0362437 0.0146985 0.0155505 0.0278802 0.0176708 0.0841488 0.0366432 0.0309937 0.022425 0.0127265 0.00933407 0.0490005 0.016355 0.0437489 0.073235 0.0955207 0.0505589 0.0440359 0.0493581 0.0387364 0.0211725 0.00837339 0.00745411 0.0136805 0.00960749 0.0216092 0.0266196 0.0406922	In a study in which 34 different drugs were tested , therapeutically relevant concentrations of DRUG0 , DRUG1 and DRUG0 displaced protein-bound DRUG2 in fresh human serum to a small but significant extent .
3	3	0.0190165 0.0109635 0.011896 0.00758086 0.00722457 0.0198637 0.0327199 0.0118881 0.0116832 0.0191 0.0107314 0.0576397 0.0312223 0.0270376 0.017479 0.00875556 0.00682573 0.0152189 0.0214453 0.0867514 0.0800153 0.112446 0.0594696 0.0502116 0.0578884 0.044628 0.0240463 0.00944552 0.00827898 0.0146679 0.0101743 0.0229741 0.0279007 0.0428099	In a study in which 34 different drugs were tested , therapeutically relevant concentrations of DRUG0 , DRUG0 and DRUG1 displaced protein-bound DRUG2 in fresh human serum to a small but significant extent .
3	4	0.0257545 0.0388638 0.0419735 0.0452024 0.0396744 0.039811 0.0938367 0.11878 0.0639456 0.137428 0.0536269 0.0614907 0.0910842 0.0802248 0.0683031	There was no change in the plasma kinetics of DRUG1 when coadministered with DRUG2 .
3	3	0.0469907 0.0604684 0.0532558 0.0848929 0.062628 0.0546529 0.0505445 0.0553363 0.0647982 0.0601204 0.0410459 0.0391177 0.0620336 0.0450488 0.0802206 0.0707628 0.0680825	An increase in intracellular levels of DRUG1 was observed in vitro in the presence of DRUG2 .
2	2	0.0635239 0.0855511 0.0348471 0.0478549 0.03595 0.0304606 0.0455881 0.0107307 0.0179437 0.0161234 0.0176505 0.0268893 0.0192243 0.00772273 0.0191916 0.0102616 0.0236159 0.0115462 0.0296915 0.0285131 0.03066 0.052474 0.0181919 0.0608958 0.0400007 0.0125263 0.0162473 0.00784262 0.0222289 0.0105118 0.0150374 0.0139969 0.0153778 0.0150228 0.0115826 0.0163447 0.0581782	When DRUG1 and DRUG2 are used together , the signs of atropinization (flushing , mydriasis , tachycardia , dryness of the mouth and nose) may occur earlier than might be expected when DRUG0 is used alone .
4	4	0.0612621 0.0353043 0.0212977 0.0384067 0.0298506 0.0193155 0.0330449 0.00747295 0.0142055 0.0133574 0.0157403 0.0224119 0.0150111 0.00590986 0.0152531 0.00811721 0.0196181 0.00971526 0.0267523 0.0261974 0.0284297 0.0498331 0.0189811 0.0698471 0.0452698 0.0174899 0.0229002 0.0131632 0.0416625 0.026809 0.0361796 0.039789 0.0312213 0.0229303 0.0160038 0.0229497 0.0582963	When DRUG0 and DRUG1 are used together , the signs of atropinization (flushing , mydriasis , tachycardia , dryness of the mouth and nose) may occur earlier than might be expected when DRUG2 is used alone .
3	4	0.0297032 0.0179443 0.01263 0.0376653 0.0245485 0.0296612 0.0347466 0.01819 0.0315143 0.0396313 0.0280519 0.0218776 0.0484669 0.0146194 0.0491894 0.0414493 0.0807442 0.0705905 0.0491254 0.0598827 0.153601 0.106167	This is especially true if the total dose of DRUG1 has been large and the administration of DRUG2 has been delayed .
4	4	0.0142461 0.0103349 0.0372041 0.0265167 0.0147147 0.0136779 0.00969924 0.0123268 0.0196339 0.0105654 0.0115587 0.0102487 0.00995415 0.0082713 0.00819288 0.0155629 0.0252717 0.0177901 0.049136 0.0176222 0.011887 0.0157038 0.0340046 0.0563098 0.0383789 0.0425851 0.0357368 0.0357777 0.0238183 0.018847 0.0886521 0.0237119 0.0129986 0.0169264 0.00916694 0.00717533 0.00749107 0.00514841 0.0183238 0.0125931 0.0113419 0.0115828 0.0261456 0.0205149 0.0212133 0.0119062 0.0143695 0.0251605	2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of DRUG1 : since DRUG2 are potentiated by the DRUG0 , they should be used cautiously in the treatment of convulsions;
4	4	0.0130946 0.00948028 0.0341295 0.0242897 0.0134675 0.0125441 0.00889182 0.0112655 0.0178788 0.00958169 0.0104489 0.00924301 0.0089748 0.00745321 0.00738442 0.0141027 0.0226135 0.0160342 0.0444443 0.0156867 0.0107477 0.0143459 0.0313361 0.0510101 0.0323188 0.0366752 0.0317799 0.0305067 0.0213604 0.00953426 0.0370989 0.0299669 0.0327098 0.0543646 0.0425349 0.0486838 0.0247959 0.00509918 0.0131287 0.0094233 0.00940499 0.00893782 0.0201477 0.0172266 0.0189491 0.0108464 0.0128421 0.0232148	2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of DRUG1 : since DRUG0 are potentiated by the DRUG2 , they should be used cautiously in the treatment of convulsions;
1	2	0.0163914 0.0117699 0.0423516 0.0299607 0.0165572 0.0155343 0.0109685 0.0136762 0.021272 0.0112015 0.0119967 0.0104487 0.0100755 0.00827506 0.00811825 0.015747 0.0232843 0.0168331 0.0482169 0.0147847 0.0105642 0.0136032 0.028422 0.034897 0.0171102 0.0176752 0.0173928 0.0178691 0.0110149 0.0162514 0.048445 0.0344411 0.0338418 0.0347557 0.0320886 0.0558845 0.0285315 0.00747363 0.0216635 0.0144152 0.0131942 0.011861 0.0243894 0.0206376 0.0220991 0.0125981 0.0147624 0.0266542	2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of DRUG0 : since DRUG1 are potentiated by the DRUG2 , they should be used cautiously in the treatment of convulsions;
4	4	0.0100101 0.00388659 0.00613901 0.00448254 0.00813785 0.00726215 0.0143507 0.0181526 0.111983 0.0475723 0.0580532 0.096486 0.049178 0.0625805 0.0747828 0.0731027 0.0609201 0.0504001 0.0396463 0.0774132 0.125461	DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 should be avoided in patients with organophosphate poisoning .
4	4	0.0339518 0.023233 0.0162882 0.0117604 0.034322 0.0331121 0.0534256 0.0414932 0.050965 0.0381102 0.033833 0.0150516 0.0171972 0.0643992 0.0300036 0.0127799 0.0100957 0.0148015 0.00549049 0.0209306 0.0523375 0.0288204 0.0135699 0.00907344 0.0339185 0.0543416 0.0243342 0.00551471 0.00911875 0.0122381 0.0116308 0.0201257 0.0452281 0.0414089 0.0394768 0.0376183	We also found that Bcl-2 was overexpressed in DRUG1 insensitive cells , and cotreatment with DRUG0 and DRUG2 , a Bcl-2 family inhibitor , synergistically inhibited growth and induced apoptosis of DRUG0 insensitive MM cells .
4	2	0.0325255 0.0195058 0.0125786 0.00666772 0.0149105 0.00904907 0.0161683 0.0145832 0.0216874 0.0464549 0.0304473 0.0094132 0.012497 0.046879 0.0352082 0.0681511 0.0194785 0.022168 0.00831247 0.0274769 0.0545281 0.0301841 0.0142636 0.00959305 0.0379904 0.0659371 0.0302161 0.00690627 0.0116417 0.0156314 0.0148697 0.0257142 0.0574769 0.0526677 0.0502451 0.0479718	We also found that Bcl-2 was overexpressed in DRUG0 insensitive cells , and cotreatment with DRUG1 and DRUG2 , a Bcl-2 family inhibitor , synergistically inhibited growth and induced apoptosis of DRUG0 insensitive MM cells .
4	4	0.0260028 0.0152532 0.00970916 0.00462734 0.0101856 0.00561719 0.00951977 0.00739066 0.0120511 0.0209776 0.0145601 0.00390886 0.00714521 0.0439577 0.032731 0.0143715 0.00985718 0.0301159 0.00847081 0.0310485 0.0415006 0.0241079 0.0145819 0.0113945 0.0458884 0.0720185 0.0476915 0.0192405 0.0383987 0.0507049 0.0632659 0.0544039 0.0511755 0.0471831 0.0540208 0.046922	We also found that Bcl-2 was overexpressed in DRUG0 insensitive cells , and cotreatment with DRUG0 and DRUG1 , a Bcl-2 family inhibitor , synergistically inhibited growth and induced apoptosis of DRUG2 insensitive MM cells .
4	4	0.0462993 0.0455586 0.0130548 0.0565551 0.0614939 0.0371611 0.0223304 0.0376116 0.0231541 0.030867 0.0156317 0.0163873 0.00623788 0.0129321 0.078209 0.0578303 0.0585667 0.0346412 0.00788533 0.0173348 0.0533037 0.0591832 0.0595158 0.0789086 0.0693467	In addition , DRUG1 insensitivity might be associated with overexpression of Bcl-2 , and the combination of DRUG2 and DRUG0 could synergistically induced apoptosis .
2	2	0.0105974 0.0075766 0.00459477 0.0141359 0.036126 0.0344057 0.0171846 0.0250655 0.020751 0.0272179 0.0120969 0.0144379 0.00645255 0.0150934 0.0879719 0.056074 0.0534751 0.0915469 0.0292168 0.0591237 0.076503 0.0664213 0.0829405 0.0826527 0.068338	In addition , DRUG0 insensitivity might be associated with overexpression of Bcl-2 , and the combination of DRUG1 and DRUG2 could synergistically induced apoptosis .
1	1	0.027 0.0274221 0.0228385 0.0374966 0.0355305 0.083798 0.0380017 0.0437984 0.0279237 0.0329796 0.0582699 0.051267 0.0436327 0.0504818 0.0605773 0.0836173 0.0403588 0.0596097 0.0579027 0.035405 0.0820886	Caution is recommended when administering DRUG1 with compounds that are metabolized/eliminated predominantly by the UGT1A1 pathway (e.g . DRUG2 ) .
3	3	0.0371064 0.0300365 0.0449143 0.058744 0.105984 0.0641324 0.0429206 0.0551089 0.0920222 0.0695673 0.0764434 0.102418 0.0825755 0.0712299 0.0667967	Concomitant treatment with DRUG1 resulted in a 21% increase in the AUC of DRUG2 .
1	1	0.075717 0.080986 0.0673805 0.0821026 0.0768964 0.145127 0.20033 0.153849 0.117611	Caution is recommended when administering DRUG1 with DRUG2 .
4	4	0.0664759 0.079464 0.0586689 0.0557291 0.037781 0.0528969 0.0880535 0.052351 0.0579154 0.0440718 0.0590203 0.075806 0.0273409 0.00944119 0.00748114 0.00758195 0.0294112 0.026396 0.0193126 0.0123352 0.00690341 0.027926 0.0976366	Pharmacokinetic properties of DRUG1 were not altered by the addition of either DRUG2 or DRUG0 or the combination of DRUG0 and DRUG0 .
4	4	0.0751184 0.0896225 0.0660596 0.0620639 0.0411965 0.0590197 0.0937161 0.0517824 0.0588895 0.0380448 0.0514791 0.0393262 0.0148217 0.00875666 0.0181646 0.00918236 0.0252541 0.0272571 0.0199315 0.0128389 0.00719545 0.0289742 0.101305	Pharmacokinetic properties of DRUG1 were not altered by the addition of either DRUG0 or DRUG2 or the combination of DRUG0 and DRUG0 .
4	4	0.0681904 0.082231 0.060424 0.0567497 0.0371123 0.0486276 0.0789783 0.0393235 0.0390753 0.0300098 0.0297296 0.0277271 0.0112544 0.00626565 0.0148718 0.0177042 0.0943982 0.0666308 0.0649578 0.036306 0.00805235 0.0148793 0.066501	Pharmacokinetic properties of DRUG1 were not altered by the addition of either DRUG0 or DRUG0 or the combination of DRUG2 and DRUG0 .
4	4	0.0652336 0.0787633 0.0574856 0.0539106 0.0355755 0.0467263 0.0755382 0.0391059 0.0391182 0.0299279 0.0283653 0.0259354 0.0106187 0.00637442 0.0160563 0.0210856 0.0849147 0.0580556 0.0357923 0.0241421 0.0252417 0.057843 0.0841896	Pharmacokinetic properties of DRUG1 were not altered by the addition of either DRUG0 or DRUG0 or the combination of DRUG0 and DRUG2 .
4	4	0.0331521 0.0347448 0.0226858 0.0249349 0.0331869 0.0702276 0.094548 0.0339238 0.0418001 0.0418284 0.0372102 0.0464264 0.0319401 0.0168444 0.0183099 0.0296502 0.0753053 0.0477637 0.0486715 0.0274879 0.0267067 0.0693362 0.093315	Pharmacokinetic properties of DRUG0 were not altered by the addition of either DRUG1 or DRUG0 or the combination of DRUG0 and DRUG2 .
4	4	0.0360616 0.0373354 0.0237886 0.0255698 0.0336979 0.0726387 0.0987721 0.0384429 0.0478726 0.0462479 0.0462164 0.0447307 0.022814 0.015432 0.0380349 0.0243863 0.0771666 0.0398553 0.0623436 0.0374684 0.0102251 0.0253179 0.0955811	Pharmacokinetic properties of DRUG0 were not altered by the addition of either DRUG0 or DRUG1 or the combination of DRUG2 and DRUG0 .
4	4	0.0308836 0.0310399 0.0193121 0.0195693 0.0254094 0.0528368 0.0668132 0.0221513 0.0251143 0.0305283 0.0244363 0.0246322 0.015071 0.00969149 0.019629 0.0218141 0.0962633 0.065821 0.0686132 0.115711 0.0361293 0.0853483 0.0931818	Pharmacokinetic properties of DRUG0 were not altered by the addition of either DRUG0 or DRUG0 or the combination of DRUG1 and DRUG2 .
4	4	0.0802274 0.0494136 0.0695748 0.0974975 0.0459106 0.0411646 0.0237581 0.040275 0.0773765 0.0573519 0.0766882 0.0584338 0.041739 0.0459124 0.0647301 0.0649431 0.0650033	No clinically significant changes to DRUG1 or DRUG0 pharmacokinetics were observed following concomitant administration of DRUG2 .
4	4	0.0739302 0.0458934 0.0578335 0.0709137 0.0349116 0.0228387 0.0225381 0.0600705 0.0742463 0.0613584 0.0926282 0.069018 0.0483498 0.0521006 0.0757034 0.0713592 0.0663065	No clinically significant changes to DRUG0 or DRUG1 pharmacokinetics were observed following concomitant administration of DRUG2 .
4	4	0.0910085 0.0482056 0.0526753 0.0655339 0.0714856 0.0878745 0.0887105 0.138271 0.132366 0.109464 0.114405	DRUG1 has no effect on the pharmacokinetic properties of DRUG2 .
3	3	0.0782216 0.0914033 0.051203 0.0500763 0.0776902 0.0574355 0.0399248 0.0392231 0.0345482 0.0283794 0.0382026 0.024981 0.0216747 0.0216291 0.0169605 0.0160012 0.0154585 0.016678 0.0253772 0.0214228 0.0359106 0.0275361 0.0146537 0.0152748 0.0161424 0.0271587 0.0199676 0.0234627 0.0534027	DRUG1 decreases the elimination of DRUG2 causing an increase in overall exposure . The addition of DRUG0 has no clinically significant effect on the pharmacokinetic properties of DRUG0 .
4	4	0.0631741 0.0811061 0.0295675 0.0290673 0.0370161 0.0398639 0.0648675 0.0458074 0.0408386 0.0288118 0.0563392 0.0298706 0.0286443 0.0290345 0.0257529 0.0372333 0.0345843 0.0211916 0.0339365 0.0265297 0.0331455 0.0223989 0.0149075 0.0155764 0.0165794 0.0259558 0.0192074 0.0206684 0.0483235	DRUG1 decreases the elimination of DRUG0 causing an increase in overall exposure . The addition of DRUG2 has no clinically significant effect on the pharmacokinetic properties of DRUG0 .
4	4	0.0626713 0.0766814 0.0261427 0.0249199 0.0310321 0.0352392 0.053493 0.0342443 0.027961 0.0175316 0.0313558 0.0182384 0.0160147 0.0142772 0.0120326 0.0122984 0.0143489 0.0154253 0.0242932 0.0214598 0.037105 0.0276993 0.0227523 0.037898 0.0372488 0.0736258 0.0664853 0.0589305 0.0685945	DRUG1 decreases the elimination of DRUG0 causing an increase in overall exposure . The addition of DRUG0 has no clinically significant effect on the pharmacokinetic properties of DRUG2 .
4	4	0.0533756 0.0997731 0.0600045 0.0521059 0.0501177 0.0630194 0.0502449 0.0346416 0.0351285 0.0304955 0.0419685 0.0255538 0.0234821 0.0273588 0.0221514 0.0311176 0.0264667 0.0187147 0.0309465 0.0250287 0.0314845 0.0210296 0.013964 0.0144113 0.014893 0.0233725 0.0172497 0.018716 0.0431837	DRUG0 decreases the elimination of DRUG1 causing an increase in overall exposure . The addition of DRUG2 has no clinically significant effect on the pharmacokinetic properties of DRUG0 .
4	4	0.032201 0.0527107 0.0166047 0.0162766 0.0115652 0.0199827 0.0390387 0.0318398 0.0301715 0.0218221 0.0457514 0.0266019 0.0246872 0.0283768 0.0248698 0.0321684 0.0409754 0.0234785 0.0283872 0.0253816 0.0306801 0.0262147 0.0310409 0.0426073 0.0433859 0.0706415 0.0678597 0.0559009 0.0587779	DRUG0 decreases the elimination of DRUG0 causing an increase in overall exposure . The addition of DRUG1 has no clinically significant effect on the pharmacokinetic properties of DRUG2 .
3	3	0.0240913 0.015223 0.0154229 0.0168121 0.0271664 0.0442384 0.0262908 0.0228216 0.0352482 0.0369586 0.0187008 0.0265526 0.0214294 0.0111002 0.0247159 0.0180639 0.0328589 0.0289571 0.02221 0.0184418 0.0364432 0.0231817 0.0110291 0.0131665 0.0170893 0.0170575 0.0142383 0.00694863 0.00670688 0.0033792 0.00855745 0.0253921 0.0461015 0.0463603 0.0347648 0.0327962 0.029677 0.0391806 0.01954 0.0291065 0.0519795	In a study of 11 HIV-infected patients receiving DRUG1 -maintenance therapy (40 mg and 90 mg daily) with 600 mg of DRUG2 twice daily (twice the currently recommended dose) , oral DRUG0 clearance increased 22% (90% CI 6% to 42%) .
4	4	0.0110258 0.0063884 0.00667702 0.00695209 0.0123051 0.0204501 0.011269 0.0145901 0.018663 0.0291943 0.0139454 0.0132018 0.00709697 0.00846491 0.0190345 0.018087 0.0510836 0.0548665 0.0374342 0.0249356 0.0343393 0.0388878 0.0181722 0.0142598 0.0169834 0.0194796 0.0210673 0.0139469 0.0252103 0.0153293 0.0332308 0.0439961 0.055968 0.0471995 0.0392397 0.038926 0.0321253 0.0318075 0.0171916 0.0214858 0.0354886	In a study of 11 HIV-infected patients receiving DRUG0 -maintenance therapy (40 mg and 90 mg daily) with 600 mg of DRUG1 twice daily (twice the currently recommended dose) , oral DRUG2 clearance increased 22% (90% CI 6% to 42%) .
4	4	0.265962 0.0915492 0.0832116 0.216489 0.102893 0.0999076 0.0298925 0.0392451 0.0708504	DRUG1 ( DRUG0 )--better than DRUG2 ( DRUG0 )
4	4	0.231519 0.0699702 0.0709872 0.177013 0.0712055 0.0430038 0.0994043 0.146772 0.0901244	DRUG1 ( DRUG0 )--better than DRUG0 ( DRUG2 )
4	4	0.116106 0.10693 0.256955 0.202771 0.108979 0.0823324 0.0264875 0.0340771 0.0653613	DRUG0 ( DRUG1 )--better than DRUG2 ( DRUG0 )
4	4	0.0987027 0.0937914 0.202618 0.174827 0.0940988 0.0399764 0.0909312 0.128914 0.0761399	DRUG0 ( DRUG1 )--better than DRUG0 ( DRUG2 )
4	4	0.0222509 0.0284784 0.0263833 0.0402833 0.0241974 0.011568 0.016017 0.0558773 0.0167722 0.0712128 0.0530406 0.0302935 0.0069073 0.0109958 0.0132135 0.010022 0.00984743 0.015467 0.0129986 0.0279904 0.0346961 0.0471389 0.0220677 0.0308537 0.040465 0.0475565 0.0277384 0.0226267 0.0229502 0.0160073 0.0291928 0.0835005 0.030081 0.0413084	The FDA has approved DRUG1 ( DRUG0 -AstraZeneca) , an oral DRUG2 , for use with low-dose DRUG0 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) .
4	2	0.0190271 0.0263099 0.0245293 0.0398046 0.0178278 0.00736405 0.0083471 0.0187633 0.00698471 0.0261689 0.0177995 0.0120906 0.0107725 0.0373391 0.0373865 0.0549507 0.048567 0.0270488 0.0168478 0.0305861 0.0430832 0.0531827 0.0314663 0.0392161 0.0472074 0.0483 0.0323892 0.0248122 0.0209417 0.0142427 0.0250537 0.0717266 0.0254747 0.0343881	The FDA has approved DRUG1 ( DRUG0 -AstraZeneca) , an oral DRUG0 , for use with low-dose DRUG2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) .
4	4	0.0208392 0.0327396 0.0338447 0.0366194 0.0198423 0.0208233 0.0517812 0.0650489 0.0211457 0.0682707 0.0421346 0.021031 0.00530637 0.00973806 0.0120536 0.00894013 0.00869786 0.014394 0.0120033 0.0263302 0.0326026 0.0447963 0.0210173 0.0295805 0.0386803 0.0450144 0.0265117 0.0214705 0.0215181 0.0150717 0.0275161 0.0784017 0.0279905 0.0382443	The FDA has approved DRUG0 ( DRUG1 -AstraZeneca) , an oral DRUG2 , for use with low-dose DRUG0 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) .
2	2	0.0203909 0.0317537 0.0317542 0.0300127 0.0140895 0.0128682 0.0362971 0.0279138 0.00917336 0.0297575 0.020633 0.00998474 0.0109064 0.037142 0.0297451 0.042401 0.040703 0.0232028 0.015821 0.0320284 0.0426731 0.051142 0.0303641 0.0381471 0.0454246 0.0460778 0.0309612 0.0239683 0.0201021 0.013615 0.0240178 0.0691435 0.0245545 0.0332306	The FDA has approved DRUG0 ( DRUG1 -AstraZeneca) , an oral DRUG0 , for use with low-dose DRUG2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) .
4	4	0.0108612 0.0142089 0.0126423 0.0159794 0.00665312 0.00539603 0.0177736 0.047743 0.0240253 0.0738966 0.0517419 0.0790497 0.0139326 0.0334618 0.0143449 0.0209015 0.0271799 0.0218965 0.0157936 0.0351037 0.0450231 0.0483393 0.0294055 0.0359464 0.0418824 0.0417957 0.028144 0.0218989 0.0180515 0.0121794 0.0214087 0.0616942 0.0219323 0.0297127	The FDA has approved DRUG0 ( DRUG0 -AstraZeneca) , an oral DRUG1 , for use with low-dose DRUG2 to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) .
4	4	0.0944943 0.114756 0.177689 0.102781 0.0460486 0.0393347 0.0815682 0.0385676 0.0199702 0.0258744 0.00742899 0.00750591 0.0103156 0.0229307 0.0175731 0.050135 0.143026	It will compete with DRUG0 ( DRUG1 ) and DRUG2 ( DRUG0 ) for such use .
2	4	0.129517 0.0942483 0.0804369 0.121425 0.0360492 0.0708166 0.0504825 0.0539452 0.0534869 0.0581063 0.0374841 0.0365711 0.0216584 0.0420646 0.0397806 0.0739272	Protective effect of DRUG1 and DRUG2 against the acute toxicity of diepoxybutane to human lymphocytes .
2	2	0.0671202 0.0894439 0.106129 0.0528464 0.0451153 0.109017 0.0613935 0.0311868 0.0249499 0.0303242 0.0325566 0.0219019 0.0455629 0.0481451 0.0465939 0.0705576 0.0609895 0.0561666	(ii) DRUG1 elicits a significant protective effect on DEB induced toxicity , which was potentiated by DRUG2 .
2	2	0.07929 0.127931 0.0814854 0.0873321 0.0721183 0.0935743 0.0838248 0.0458793 0.0674409 0.0340969 0.0436357 0.0486022 0.0410821 0.0426775 0.0510295	DRUG1 enhances DRUG2 -mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression .
2	2	0.0100063 0.0178865 0.0207355 0.0336972 0.0381503 0.0210228 0.0729849 0.0416352 0.0520356 0.0490713 0.0591011 0.0419643 0.0263066 0.0177895 0.013378 0.00688283 0.00567955 0.00745284 0.00584599 0.00754947 0.0065338 0.00619165 0.0105478 0.0157664 0.0161463 0.0169209 0.0186253 0.0119344 0.00505333 0.0129974 0.0367658 0.0137595 0.0167247 0.00918218 0.0114259 0.0226336 0.0364412 0.0220029 0.0208438 0.0137615 0.0219683 0.0344615 0.0159866 0.00921526 0.0090576 0.00732808 0.0285486	Although it was previously reported that DRUG1 combined with DRUG2 improved the progression-free survival rate compared with DRUG0 alone for patients with DRUG0 -refractory HER2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .
4	4	0.00897232 0.0146313 0.0199954 0.0420699 0.0455365 0.0236493 0.0327666 0.0203376 0.0155186 0.0226621 0.0544808 0.0347306 0.0257358 0.0243475 0.020437 0.0097931 0.00761112 0.0119369 0.017214 0.0366464 0.034568 0.039075 0.0268886 0.022119 0.0241116 0.0240747 0.0252571 0.0161549 0.00612614 0.0144898 0.0312977 0.0124113 0.0137316 0.0078281 0.00964477 0.0193008 0.0309289 0.0186109 0.0175978 0.0116169 0.0182935 0.0285607 0.0132739 0.00767947 0.00756706 0.00610743 0.0236115	Although it was previously reported that DRUG1 combined with DRUG0 improved the progression-free survival rate compared with DRUG0 alone for patients with DRUG2 -refractory HER2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .
4	4	0.0041687 0.00491435 0.00434045 0.00606095 0.00934577 0.00706149 0.0221695 0.046346 0.0579899 0.0654002 0.0516461 0.0356054 0.0305208 0.0515252 0.0751869 0.0468633 0.0477226 0.0224528 0.0181147 0.017467 0.0122585 0.0103447 0.0123451 0.0192908 0.0177941 0.0158493 0.0154678 0.00974471 0.00402783 0.010836 0.0303056 0.0108234 0.0125748 0.00687107 0.00847783 0.0168004 0.0268415 0.016193 0.0153097 0.0101138 0.0161027 0.0252693 0.0117102 0.00675163 0.00664581 0.00538158 0.0209667	Although it was previously reported that DRUG0 combined with DRUG1 improved the progression-free survival rate compared with DRUG2 alone for patients with DRUG0 -refractory HER2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .
2	4	0.00379487 0.00399489 0.0032556 0.00483273 0.00737893 0.00298554 0.00594569 0.00799023 0.00555806 0.0186486 0.0297644 0.018094 0.0209142 0.0431821 0.06695 0.0375641 0.0361946 0.0546726 0.034854 0.0420576 0.0286849 0.0386366 0.0278071 0.0247103 0.0263594 0.0264905 0.0284991 0.0194717 0.00740597 0.0180447 0.0355214 0.0139224 0.0153112 0.00879375 0.0106979 0.0213297 0.0338226 0.0203838 0.0191832 0.0126637 0.019748 0.0308705 0.0143825 0.00833037 0.00821623 0.00661858 0.025461	Although it was previously reported that DRUG0 combined with DRUG0 improved the progression-free survival rate compared with DRUG1 alone for patients with DRUG2 -refractory HER2-positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .
2	4	0.0397116 0.0324142 0.0544314 0.062927 0.0820512 0.070663 0.0548932 0.0464134 0.054352 0.069809 0.0378882 0.00757824 0.0165509 0.00863091 0.0157599 0.00958611 0.0125696 0.0287616 0.0519317 0.0435708 0.0526125 0.0458677 0.0371348 0.0638915	We evaluated how DRUG1 interacts with DRUG2 in HER2-positive breast cancer , with a particular focus on DRUG0 -mediated antibody-dependent cellular cytotoxicity (ADCC) .
4	4	0.0300816 0.0350163 0.0633971 0.0499401 0.0730269 0.0417653 0.0326362 0.0276396 0.0415986 0.0567546 0.0368406 0.00854299 0.0223031 0.0161535 0.0299004 0.0275743 0.0348819 0.0441183 0.071962 0.0552399 0.0585899 0.0506222 0.0398713 0.0515432	We evaluated how DRUG1 interacts with DRUG0 in HER2-positive breast cancer , with a particular focus on DRUG2 -mediated antibody-dependent cellular cytotoxicity (ADCC) .
2	2	0.0267971 0.0310928 0.0200833 0.0199834 0.0361665 0.00971235 0.0246863 0.0433002 0.0203001 0.0198302 0.0135249 0.0231346 0.0286393 0.0326435 0.0268088 0.0311751 0.0330363 0.0272375 0.0368496 0.0258415 0.00865163 0.0329207 0.0229771 0.0498506 0.0586852 0.0715203 0.0581396 0.0589314 0.0483091 0.0591711	In an in vitro assay , DRUG1 induced HER2 expression at the cell surface of HER2-positive breast cancer cell lines , leading to the enhancement of DRUG2 -mediated ADCC .
2	2	0.0518065 0.0259868 0.0670423 0.0372548 0.025617 0.0324212 0.0260604 0.0228292 0.0199276 0.0221264 0.0399543 0.0537706 0.0233853 0.0430419 0.0430229 0.044495 0.0281934 0.0235092 0.0205581 0.0472778 0.0276782 0.0365581 0.0448647 0.0401214 0.0248735 0.034381 0.0354648 0.0262507 0.0315272	Furthermore , we present a case report in which a second DRUG1 treatment following DRUG2 resulted in the marked shrinkage of multiple metastatic tumors in HER2-positive breast cancer .
2	4	0.060501 0.0527514 0.018036 0.0383237 0.0261646 0.0308998 0.0897901 0.0344648 0.0299554 0.0278903 0.0431162 0.0767706 0.0597272 0.0337149 0.0462845 0.0618366 0.0354093 0.0158248 0.0314085 0.0198507 0.0205433 0.0211435 0.0259594 0.025867 0.0193775 0.0254576 0.0289312	DRUG1 may have the potential to convert DRUG2 -refractory to DRUG0 -sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2 .
4	4	0.0427934 0.0250078 0.0112883 0.0198189 0.0180489 0.0156499 0.035858 0.0549353 0.101286 0.0884275 0.0726745 0.063653 0.0597779 0.0452429 0.0482789 0.05079 0.0304138 0.0157076 0.0290724 0.019142 0.0191493 0.0187793 0.0231531 0.0234066 0.0177196 0.0234363 0.0264888	DRUG1 may have the potential to convert DRUG0 -refractory to DRUG2 -sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2 .
2	2	0.0639833 0.0567465 0.0790924 0.0778956 0.0665445 0.0896578 0.073367 0.0537385 0.075372 0.0447155 0.0303213 0.0436071 0.0210985 0.0645193 0.073836 0.0855047	The CNS depressant effects of DRUG1 may be additive with that of other DRUG2 . .
1	1	0.0427012 0.183742 0.0411921 0.0537459 0.051795 0.047313 0.0811735 0.0900512 0.0313894 0.0126899 0.024628 0.0707602 0.0494159 0.0347253 0.0380127 0.0188433 0.0410386 0.0328959 0.0538869	Other DRUG1 should not be used concomitantly with DRUG2 ( DRUG0 USP) because they may have additive effects .
1	1	0.0400002 0.173751 0.0334258 0.0400565 0.0413675 0.038044 0.0635417 0.059727 0.0439025 0.0675187 0.068534 0.0736206 0.0501433 0.0313762 0.0352813 0.0203003 0.0398923 0.0305983 0.0489183	Other DRUG1 should not be used concomitantly with DRUG0 ( DRUG2 USP) because they may have additive effects .
1	1	0.179261 0.0402705 0.0464648 0.0484476 0.046667 0.0278596 0.0388859 0.0347482 0.0478456 0.078636 0.0796897 0.0266453 0.0102873 0.0103405 0.00812392 0.0275062 0.0117446 0.0118181 0.00882809 0.0129736 0.0124163 0.0179867 0.0147614 0.0100995 0.0283306 0.0272727 0.0396319 0.0524577	DRUG1 should be administered with caution to patients being treated with DRUG2 or DRUG0 , since the action of DRUG0 on the vascular system may be potentiated .
1	1	0.197632 0.0472438 0.0536202 0.0553966 0.0510025 0.0275475 0.032342 0.0311109 0.0367799 0.0766154 0.0656387 0.017583 0.00994685 0.025174 0.00615547 0.0210321 0.009749 0.0110072 0.0074372 0.0109223 0.0105431 0.015499 0.0137311 0.00974569 0.0283687 0.0283143 0.0428807 0.0569813	DRUG1 should be administered with caution to patients being treated with DRUG0 or DRUG2 , since the action of DRUG0 on the vascular system may be potentiated .
4	4	0.0197531 0.0197158 0.0147209 0.0133462 0.0188812 0.0141921 0.0162753 0.0196173 0.0519387 0.0605757 0.059988 0.0276036 0.0157233 0.0220429 0.0291646 0.0925773 0.0639379 0.0425219 0.08169 0.0521193 0.0403952 0.0385387 0.0207242 0.0115175 0.0328635 0.0327075 0.0394583 0.0474097	DRUG0 should be administered with caution to patients being treated with DRUG1 or DRUG0 , since the action of DRUG2 on the vascular system may be potentiated .
4	4	0.0184342 0.0196192 0.0156557 0.0160605 0.0209401 0.0147427 0.0209389 0.0221812 0.0550407 0.073999 0.0598625 0.0250565 0.0220461 0.0930159 0.0214367 0.0500565 0.0557382 0.0357306 0.0704145 0.0441729 0.0374191 0.0377554 0.0204941 0.0111106 0.030387 0.0296276 0.0354075 0.0426562	DRUG0 should be administered with caution to patients being treated with DRUG0 or DRUG1 , since the action of DRUG2 on the vascular system may be potentiated .
4	4	0.0265602 0.033407 0.0278854 0.0130818 0.014989 0.0253744 0.0568938 0.0443988 0.0627188 0.0518602 0.0296836 0.0529602 0.0364352 0.0392149 0.0301229 0.0202319 0.0240234 0.0132973 0.0115028 0.0120188 0.00941035 0.0145207 0.0158939 0.0138673 0.00697883 0.00732065 0.0156004 0.0170993 0.050253 0.030594 0.0150205 0.0297868 0.0264291 0.0121279 0.0252787 0.0368337 0.0463247	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG1 Vaccinations with DRUG2 are not recommended in immunocompromised individuals DRUG0 together with high-dose intravenous DRUG0 has caused deaths in children due to haemorrhagic enterocolitis .
4	4	0.0222382 0.0284139 0.0227798 0.00960786 0.0105088 0.0203871 0.0482725 0.0547317 0.0530924 0.0442086 0.0308303 0.0264408 0.0108333 0.0106035 0.0122048 0.0172256 0.0272867 0.0148704 0.025856 0.040794 0.0481439 0.0264251 0.0304718 0.0213413 0.0150585 0.0175823 0.0190753 0.02236 0.0566225 0.0326253 0.0157312 0.027977 0.0253878 0.0116027 0.0231874 0.0337076 0.041514	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG1 Vaccinations with DRUG0 are not recommended in immunocompromised individuals DRUG2 together with high-dose intravenous DRUG0 has caused deaths in children due to haemorrhagic enterocolitis .
4	4	0.0205989 0.0262165 0.0208529 0.00877709 0.00954866 0.018622 0.043826 0.050662 0.0473464 0.0383416 0.0270011 0.0222323 0.00807692 0.00717743 0.0076695 0.0098656 0.0155899 0.0103418 0.0101931 0.0130824 0.0141735 0.0289503 0.0603031 0.0604292 0.0361929 0.0553064 0.0511344 0.0337069 0.0473751 0.0342015 0.0254916 0.0292082 0.0189563 0.0103247 0.0174713 0.0263433 0.0344089	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG1 Vaccinations with DRUG0 are not recommended in immunocompromised individuals DRUG0 together with high-dose intravenous DRUG2 has caused deaths in children due to haemorrhagic enterocolitis .
4	4	0.0209319 0.0261455 0.0206986 0.00879095 0.00924519 0.0164512 0.0351057 0.0380004 0.0305168 0.0158587 0.0154374 0.0211207 0.0388375 0.0616398 0.0451313 0.0232925 0.0260898 0.0125328 0.0203597 0.0318133 0.0442119 0.0265759 0.0346016 0.0238074 0.0159982 0.0183608 0.0205368 0.0236032 0.0583636 0.0333753 0.0161102 0.0287236 0.0259593 0.0118352 0.0235519 0.0342255 0.04216	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG0 Vaccinations with DRUG1 are not recommended in immunocompromised individuals DRUG2 together with high-dose intravenous DRUG0 has caused deaths in children due to haemorrhagic enterocolitis .
4	4	0.0184664 0.0231021 0.0182546 0.00771154 0.00805621 0.0145151 0.0310811 0.0337216 0.0269292 0.0138097 0.0131457 0.0177663 0.0333919 0.0558804 0.0383979 0.0189166 0.0163558 0.0101105 0.011774 0.0166072 0.017529 0.0306875 0.0580428 0.0599091 0.0355915 0.0538098 0.0490653 0.0326692 0.0461569 0.033074 0.0243328 0.0280482 0.018183 0.00986326 0.0167451 0.0252828 0.0330162	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG0 Vaccinations with DRUG1 are not recommended in immunocompromised individuals DRUG0 together with high-dose intravenous DRUG2 has caused deaths in children due to haemorrhagic enterocolitis .
2	2	0.024895 0.0300372 0.0225841 0.0092775 0.00933069 0.0167372 0.0339198 0.0314139 0.0204393 0.00881264 0.00569371 0.00637381 0.00527049 0.00525711 0.0109836 0.0113641 0.0231428 0.0139591 0.0173332 0.0318237 0.0250113 0.0628239 0.0333446 0.0349531 0.0251696 0.0555639 0.0534813 0.0417323 0.0709334 0.046278 0.0338364 0.0385719 0.0251399 0.0141424 0.0225913 0.0336723 0.0441057	DRUG INTERACTIONS  There are no known drug/drug interactions with oral DRUG0 Vaccinations with DRUG0 are not recommended in immunocompromised individuals DRUG1 together with high-dose intravenous DRUG2 has caused deaths in children due to haemorrhagic enterocolitis .
2	2	0.0437375 0.0144908 0.0165637 0.0121104 0.010799 0.0108972 0.011091 0.0193634 0.0151831 0.0192964 0.0172345 0.0229853 0.0281596 0.0748463 0.0359346 0.0320791 0.0381808 0.0802243 0.0181009 0.027724 0.0520975 0.0796915 0.0682247 0.0481249 0.104477 0.053353 0.0450292	Impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous DRUG1 and who subsequently received DRUG2 to prevent graft-versus-host disease
2	3	0.12501 0.13706 0.0498804 0.059016 0.0756667 0.0672011 0.111937 0.0577736 0.060185 0.0249169 0.0134839 0.0221848 0.0186664 0.0187202 0.00400329 0.00410753 0.00303367 0.00425446 0.00334244 0.00529357 0.00377827 0.00638493 0.0249833 0.0991159	DRUG1 inhibits some of the liver's ability to metabolize some other drugs - DRUG2 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.12749 0.140827 0.0512771 0.0613746 0.078325 0.0687698 0.113724 0.059404 0.0619816 0.0252053 0.0132138 0.0194707 0.0142422 0.00582465 0.00514473 0.0133689 0.00292753 0.00380748 0.00305648 0.00481655 0.00351846 0.00586547 0.0229077 0.0934576	DRUG1 inhibits some of the liver's ability to metabolize some other drugs - DRUG0 , DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
3	3	0.128105 0.14147 0.0514671 0.0618764 0.0789599 0.0690689 0.113156 0.0592697 0.0613525 0.0239871 0.0119289 0.0171527 0.0119593 0.00452598 0.00276671 0.00513812 0.00552992 0.01486 0.00334217 0.00491626 0.00372881 0.00588704 0.0230822 0.0964694	DRUG1 inhibits some of the liver's ability to metabolize some other drugs - DRUG0 , DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
3	3	0.128468 0.141848 0.05149 0.0621184 0.0793966 0.0693206 0.112871 0.0594899 0.0615955 0.0240789 0.0117394 0.0167205 0.0117687 0.00436316 0.00252747 0.00402326 0.00302624 0.00549891 0.00584547 0.0176179 0.0043001 0.00566255 0.0218729 0.0943559	DRUG1 inhibits some of the liver's ability to metabolize some other drugs - DRUG0 , DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
3	3	0.122258 0.132775 0.0473321 0.057658 0.0731443 0.0657764 0.105612 0.0557076 0.0566815 0.023923 0.012093 0.0158078 0.0115112 0.0040152 0.00234915 0.00340778 0.00258684 0.00381308 0.00299648 0.00510966 0.00637861 0.0174395 0.06202 0.109604	DRUG1 inhibits some of the liver's ability to metabolize some other drugs - DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0521136 0.0976819 0.0433302 0.0631621 0.0707789 0.091522 0.128921 0.0316773 0.0259884 0.0101616 0.00465899 0.00939486 0.00720573 0.00401703 0.00248586 0.0051369 0.00424575 0.0100836 0.0124613 0.0732946 0.0190175 0.025432 0.0815018 0.125727	DRUG0 inhibits some of the liver's ability to metabolize some other drugs - DRUG0 , DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
0	0	0.0407781 0.0384827 0.0217494 0.03331 0.023836 0.0231835 0.0395496 0.0429316 0.0297976 0.0320766 0.048065 0.0360101 0.0445643 0.075103 0.0371925 0.0602938 0.0459881 0.0516882 0.0431512 0.0566491 0.0663086 0.0633434 0.0459477	The authors report the case of an infant with confirmed congenital hypothyroidism on DRUG1 who experienced a possible drug interaction with DRUG2 .
2	4	0.053247 0.0582588 0.0842744 0.0816354 0.0735799 0.0526249 0.079475 0.0790729 0.0341728 0.0695014 0.0554494 0.0910896 0.0948352 0.0927833	Questioning revealed the child was taking DRUG1 drops before feeds while on DRUG2 .
4	4	0.0733139 0.0630504 0.0602082 0.0608303 0.08267 0.0695456 0.0402732 0.0584476 0.061404 0.0699874 0.0523194 0.012971 0.0276714 0.0272565 0.018612 0.0178784 0.0192595 0.0208244 0.0351332 0.0240387 0.0268083 0.0261956 0.0513009	Drug interaction of DRUG1 with DRUG2 has not been reported previously and is not listed in the British National Formulary for Children .
4	4	0.0521405 0.0465548 0.0398819 0.0405613 0.071996 0.0269308 0.0592188 0.085062 0.0568586 0.0456189 0.0321332 0.0617476 0.0319734 0.0174286 0.0313885 0.0145563 0.0135413 0.00728154 0.0198908 0.0416809 0.0603821 0.078512 0.06466	Phase I trial of DRUG1 and DRUG2 in patients with relapsed multiple myeloma : evidence for DRUG0 - DRUG0 interaction via P-glycoprotein .
4	4	0.03503 0.044732 0.055644 0.0582845 0.0612768 0.0166005 0.0198525 0.0563846 0.0375503 0.0408835 0.0290606 0.0630071 0.0318421 0.0311914 0.0626386 0.039135 0.0292685 0.0317454 0.0406451 0.0367953 0.0449515 0.0710647 0.062416	Phase I trial of DRUG1 and DRUG0 in patients with relapsed multiple myeloma : evidence for DRUG0 - DRUG2 interaction via P-glycoprotein .
4	4	0.0399082 0.0532229 0.0622247 0.0462588 0.0238196 0.0161872 0.0468273 0.0635482 0.0377307 0.0353663 0.0252023 0.0550677 0.0297218 0.024825 0.0664727 0.0616815 0.0251605 0.0104818 0.0128397 0.0402557 0.0717998 0.0838428 0.0675547	Phase I trial of DRUG0 and DRUG1 in patients with relapsed multiple myeloma : evidence for DRUG2 - DRUG0 interaction via P-glycoprotein .
4	2	0.0318526 0.0586117 0.0375618 0.0384113 0.0500307 0.0168314 0.0343931 0.0532845 0.100562 0.0624851 0.0487229 0.0688959 0.0908875 0.0304284 0.0189631 0.0105994 0.0296187 0.0334598 0.0795823 0.0265066 0.0172546 0.0243919 0.0366644	The preclinical combination of DRUG1 with the mTOR inhibitor DRUG2 has displayed synergy in vitro and represents a novel combination in MM .
4	4	0.15397 0.108312 0.0997231 0.126267 0.0974146 0.10938 0.090554 0.0323257 0.0630792 0.045041 0.0739335	Influence of DRUG1 on DRUG2 induced antinociception and its pharmacokinetics .
2	2	0.026389 0.0309658 0.0379593 0.052864 0.0605042 0.030811 0.0284609 0.0507386 0.0587589 0.0501807 0.0647029 0.074979 0.0341515 0.0745994 0.046797 0.0343327 0.0148001 0.0101536 0.0125241 0.0133427 0.0044974 0.010697 0.00408375 0.00378131 0.0157495 0.0208298 0.0191159 0.0204949 0.0197872 0.0213415 0.0516063	In the present study DRUG1 (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of DRUG2 evaluated by both DRUG0 writhing and formalin test , when it was administered with DRUG0 .
4	4	0.0224181 0.0264057 0.0308963 0.0413643 0.0462973 0.0199145 0.0168884 0.0266696 0.0326304 0.023772 0.0396508 0.0336664 0.022943 0.039803 0.0621781 0.108476 0.0744022 0.0895981 0.0462221 0.0168862 0.00559299 0.0115197 0.00437813 0.00388921 0.0141741 0.0188217 0.018721 0.0188628 0.0185428 0.0189036 0.0455114	In the present study DRUG1 (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of DRUG0 evaluated by both DRUG2 writhing and formalin test , when it was administered with DRUG0 .
4	4	0.0280255 0.033848 0.0399264 0.0532188 0.0595073 0.0235818 0.018871 0.0265561 0.0307444 0.0209402 0.0325703 0.0219138 0.0115927 0.0156261 0.0232118 0.0308597 0.0126054 0.0103687 0.0196758 0.0195759 0.00847586 0.0236632 0.0119245 0.0119676 0.0439788 0.0560836 0.0628193 0.0644785 0.0676738 0.0552385 0.0604767	In the present study DRUG1 (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of DRUG0 evaluated by both DRUG0 writhing and formalin test , when it was administered with DRUG2 .
4	4	0.0139778 0.0126298 0.0162732 0.0195352 0.0337869 0.0523726 0.059207 0.0470215 0.0440465 0.0285789 0.0449166 0.0479141 0.0271044 0.0404345 0.0581002 0.0455252 0.0481965 0.0648462 0.0434513 0.0209664 0.00896948 0.0165089 0.00688707 0.00595844 0.0194441 0.0236247 0.0236913 0.0227967 0.0238896 0.0229413 0.0564035	In the present study DRUG0 (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of DRUG1 evaluated by both DRUG2 writhing and formalin test , when it was administered with DRUG0 .
4	4	0.0116544 0.0102825 0.0130274 0.0138907 0.0223156 0.0309146 0.0331088 0.0262751 0.0261895 0.0136645 0.0217645 0.0190546 0.0108858 0.0203181 0.0381171 0.0713908 0.0519168 0.0725192 0.0815024 0.0502736 0.0114954 0.0374227 0.0198547 0.0155615 0.0347038 0.0332806 0.0390903 0.0406164 0.0486221 0.0392214 0.0410652	In the present study DRUG0 (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of DRUG0 evaluated by both DRUG1 writhing and formalin test , when it was administered with DRUG2 .
3	3	0.06969 0.112826 0.0653905 0.0608091 0.0591519 0.115858 0.0682745 0.0636854 0.0796827 0.0766603 0.0892598 0.0702271 0.0684851	DRUG1 plasma concentration was also increased when it was administered with DRUG2 .
2	3	0.0455838 0.0875391 0.0551 0.0325344 0.0334535 0.0637005 0.0376741 0.0399268 0.0606604 0.0650526 0.0801515 0.0521231 0.108036 0.0361633 0.0380369 0.0316334 0.0324504 0.0280914 0.024857 0.0472321	The synergistic antinociception activity of DRUG1 when administered with DRUG2 can be attributed to increased plasma concentration of DRUG0 .
4	4	0.0226573 0.0482515 0.0229179 0.0173149 0.0267715 0.0300296 0.0555114 0.0617114 0.0793943 0.0762941 0.0612794 0.0350758 0.0903046 0.0417603 0.0630106 0.0529454 0.0520439 0.0581109 0.0553573 0.0492578	The synergistic antinociception activity of DRUG0 when administered with DRUG1 can be attributed to increased plasma concentration of DRUG2 .
4	2	0.0265924 0.0271469 0.0172238 0.0179234 0.0370484 0.0314332 0.0991104 0.048668 0.101388 0.0745288 0.0335024 0.023563 0.0155847 0.0422063 0.0905868 0.100161 0.0873577 0.0693205 0.0566541	From this study it can be concluded that DRUG1 can be used as a bioenhancer along with DRUG2 .
2	2	0.173626 0.197135 0.082494 0.116036 0.0836074 0.109688 0.0466615 0.00933192 0.00885209 0.00612053 0.00899773 0.0324675 0.124983	DRUG1 may increase the effects of DRUG2 , DRUG0 , and DRUG0 .
2	2	0.169363 0.181594 0.0892626 0.124106 0.0887334 0.0775883 0.0267554 0.0156937 0.0365262 0.00850235 0.0095437 0.0336014 0.138729	DRUG1 may increase the effects of DRUG0 , DRUG2 , and DRUG0 .
2	2	0.157342 0.163178 0.0779582 0.10281 0.0723171 0.0699162 0.0209761 0.00939361 0.0126555 0.0167378 0.0421368 0.102995 0.151584	DRUG1 may increase the effects of DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0908714 0.127187 0.0926232 0.104845 0.0701105 0.0540301 0.0309032 0.0232498 0.0963106 0.0258557 0.0312848 0.099575 0.153153	DRUG0 may increase the effects of DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0358246 0.0721941 0.0475478 0.0711578 0.0503327 0.0438445 0.0586577 0.0485887 0.0162215 0.0280713 0.019598 0.016156 0.00765821 0.0221296 0.051419 0.0435412 0.0147156 0.00692147 0.0192662 0.0431551 0.025159 0.010227 0.00471428 0.0124498 0.0216373 0.0102644 0.0218733 0.00657668 0.00411533 0.00218596 0.00214039 0.0080109 0.0147277 0.0131376 0.0255073 0.01333 0.011318 0.0127883 0.0628359	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG2 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0381565 0.0756274 0.0521754 0.0777567 0.0563655 0.0385819 0.0232567 0.0141881 0.00824344 0.0216068 0.0672392 0.0600355 0.0187486 0.0375588 0.0386764 0.0379945 0.0155781 0.00788802 0.0207424 0.0415129 0.0241853 0.0100034 0.00440943 0.0115344 0.0196091 0.00909561 0.0188855 0.00566086 0.00352256 0.00188022 0.00183566 0.00685427 0.0126067 0.011208 0.0216795 0.0113213 0.00961708 0.0108835 0.0532749	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG2 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0348234 0.0687293 0.0496144 0.0743719 0.0562301 0.0360452 0.0154214 0.00721022 0.0034794 0.00801858 0.0171225 0.0140064 0.0082334 0.0307885 0.0850654 0.0665463 0.0697537 0.0273342 0.0488658 0.0485456 0.0253578 0.0132854 0.005611 0.0113206 0.0174054 0.00863399 0.0167102 0.00530883 0.00311808 0.00163087 0.0016195 0.00598354 0.0110778 0.00989899 0.0192012 0.0101181 0.00839032 0.00940071 0.0457219	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0370968 0.0729165 0.0532878 0.0792165 0.0599451 0.0379753 0.0151533 0.00720163 0.00357791 0.00806827 0.016551 0.0119596 0.00571709 0.0197894 0.0575945 0.0526699 0.0226118 0.0105671 0.0271281 0.0605566 0.0379782 0.0404827 0.0199406 0.0300693 0.0234587 0.0142726 0.0266656 0.00937647 0.00440873 0.00212211 0.00204909 0.00710847 0.0125387 0.0107424 0.0202829 0.0107353 0.00889494 0.0101219 0.0491666	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0366874 0.0722111 0.052313 0.0778375 0.0587266 0.0371693 0.0142536 0.00663243 0.00323652 0.00716823 0.0143367 0.0105121 0.00484481 0.0161218 0.044189 0.0374927 0.0134441 0.00574417 0.0176058 0.0454301 0.0280926 0.0143868 0.00791901 0.023981 0.0550097 0.0384309 0.0584726 0.0381856 0.0187271 0.00549762 0.00321805 0.00534669 0.0107825 0.0111391 0.0232762 0.0122659 0.00883655 0.0103801 0.0500951	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0361201 0.0710278 0.0516037 0.0767371 0.0579269 0.0366344 0.0142129 0.00665556 0.00325202 0.00720843 0.0144997 0.0106349 0.00499806 0.0168441 0.0467742 0.0398135 0.0150502 0.00700799 0.0220702 0.0590544 0.0348372 0.0170452 0.00805171 0.0218053 0.043347 0.0266102 0.0359222 0.0151198 0.00765236 0.00746005 0.00613901 0.0187636 0.0159346 0.0174139 0.0327 0.0178526 0.0105448 0.0124709 0.0522036	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0356161 0.070044 0.0508153 0.0755337 0.0570083 0.0359917 0.0137164 0.00638975 0.0031268 0.00690218 0.0137873 0.0100239 0.004532 0.0148327 0.0401646 0.0345769 0.0125476 0.00590443 0.0178319 0.0449681 0.0253435 0.0105133 0.0043027 0.0106405 0.0205807 0.00971595 0.0220659 0.00820582 0.00530391 0.00282934 0.00330152 0.0154831 0.0360428 0.039387 0.0715965 0.047183 0.0411979 0.0252643 0.0467284	It may also interact with DRUG1 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0224261 0.0479427 0.0330941 0.0369613 0.0225477 0.0223166 0.0258977 0.0324357 0.0132735 0.0541023 0.0729785 0.0653311 0.0225634 0.0432821 0.0462094 0.0470074 0.0189891 0.00950183 0.0244325 0.0484633 0.0281688 0.0115773 0.00520329 0.0134903 0.0228567 0.0107155 0.022197 0.00666825 0.00412933 0.00220041 0.00215246 0.00801629 0.0147482 0.0131243 0.0254089 0.0132782 0.0112648 0.0127364 0.0623074	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG2 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0264645 0.0551148 0.0401192 0.0394134 0.0219833 0.0200263 0.0236011 0.0260594 0.00855472 0.0363198 0.0236587 0.0194875 0.0126212 0.0340955 0.0747298 0.0542595 0.0646945 0.0287145 0.0495914 0.052269 0.0298731 0.0162661 0.00704219 0.0142565 0.0217513 0.0108181 0.0211085 0.00677488 0.00397468 0.00207171 0.00205974 0.00762616 0.0140906 0.0125841 0.0243918 0.0128576 0.0106472 0.0119261 0.0581015	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0243196 0.0508092 0.0362739 0.0368229 0.0209469 0.0198975 0.0234615 0.0270235 0.00880018 0.0361209 0.0208103 0.0134454 0.00781831 0.0222781 0.0551981 0.0557825 0.0263656 0.0126685 0.0328372 0.0721612 0.0440108 0.0480948 0.0241453 0.0351919 0.028061 0.0171069 0.0307565 0.0109116 0.00511153 0.00244735 0.00235249 0.00815108 0.0143844 0.0123089 0.0231825 0.0122848 0.0101516 0.0115341 0.055971	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0231247 0.0483162 0.0343363 0.034872 0.0196693 0.0186772 0.0218459 0.0250007 0.00805799 0.0332014 0.0178512 0.0112135 0.00627542 0.0171955 0.0395449 0.0360087 0.0148636 0.00702809 0.0228623 0.0591045 0.0369029 0.018966 0.0102051 0.0295751 0.0673703 0.046135 0.0679922 0.0442189 0.0213907 0.00631631 0.00369898 0.00608786 0.0122238 0.0125884 0.0261893 0.0138226 0.00990157 0.0115995 0.055766	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0228444 0.0477093 0.0339555 0.0344108 0.0194344 0.0184349 0.0215968 0.0247178 0.00796863 0.0328788 0.017926 0.0114238 0.00650299 0.017953 0.0414657 0.038282 0.0167031 0.00874232 0.0288237 0.0752078 0.0445873 0.0220549 0.0102832 0.0267901 0.0532705 0.0324182 0.0423077 0.0179336 0.00881328 0.00851823 0.00695741 0.0211421 0.0179575 0.0195308 0.0366527 0.0200296 0.0118218 0.0139323 0.0580173	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0224854 0.0469602 0.0333412 0.0338341 0.0190866 0.0181475 0.0212092 0.0242586 0.0078042 0.0321251 0.0172103 0.0106838 0.00583218 0.0158226 0.0360937 0.0333121 0.0140634 0.0073931 0.0238781 0.0592307 0.033469 0.0141025 0.00564005 0.0134297 0.0256726 0.0121331 0.0260046 0.00975638 0.00614121 0.00327573 0.00381434 0.017654 0.041024 0.0446003 0.0806862 0.0529809 0.0462564 0.02839 0.0521971	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG1 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0162639 0.0328132 0.018349 0.0193206 0.00989369 0.00933663 0.0070681 0.00615311 0.00444768 0.0193173 0.0737558 0.0760363 0.0222212 0.0648426 0.0854376 0.0537902 0.065033 0.0283021 0.0504465 0.05361 0.0308868 0.0161392 0.00689748 0.0139121 0.021354 0.0106427 0.0207489 0.00666924 0.00389612 0.00202783 0.0020176 0.00744807 0.0137284 0.0122589 0.0237916 0.0125467 0.0103891 0.0116264 0.0565805	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG2 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0161255 0.0324078 0.0185537 0.0194161 0.00952254 0.0089175 0.0068446 0.00570392 0.00409766 0.0184731 0.0751628 0.0820615 0.0190049 0.0634791 0.0672904 0.0526297 0.0248537 0.0123019 0.0304251 0.0652803 0.0385275 0.043712 0.02256 0.0319963 0.0262442 0.0160865 0.0287606 0.0104246 0.00489921 0.00233419 0.00223045 0.00770819 0.0136302 0.0116472 0.0219223 0.0116275 0.00957587 0.0108656 0.0526957	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0148001 0.0297686 0.0170263 0.0178215 0.00876174 0.00822727 0.00628394 0.0052802 0.00382253 0.0170331 0.0695095 0.0755897 0.0167428 0.0533925 0.0456036 0.0305004 0.0131737 0.00715453 0.0220772 0.0586769 0.037925 0.0203256 0.0107466 0.028775 0.0656382 0.0444581 0.0640521 0.0416725 0.0198516 0.00587991 0.00343183 0.00560774 0.0112933 0.0116422 0.0242165 0.012851 0.00911436 0.0106027 0.0506695	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0146261 0.0294201 0.0168014 0.017607 0.00866623 0.00813964 0.00621336 0.00522516 0.00377762 0.0168871 0.069244 0.0754225 0.0168309 0.0542478 0.0477862 0.032745 0.0154289 0.00918501 0.028338 0.0719228 0.0435262 0.0227732 0.0106024 0.0259125 0.052259 0.0317622 0.0405562 0.0173496 0.00827766 0.00791523 0.00640068 0.0193172 0.0165303 0.0179691 0.0340501 0.0187037 0.011027 0.0129396 0.0536132	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0145645 0.0292861 0.0167788 0.0175217 0.00860351 0.00807462 0.00617491 0.00517392 0.00375112 0.0166568 0.06768 0.0736082 0.0161272 0.0516875 0.0419658 0.0280476 0.0128233 0.00780945 0.023784 0.0583626 0.033993 0.0154325 0.00618329 0.0135192 0.0258415 0.0122907 0.0248007 0.00945759 0.0057611 0.00306303 0.00356764 0.0163676 0.0383135 0.0416082 0.0752448 0.0490489 0.0428332 0.0263186 0.0478729	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG1 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0177724 0.0348815 0.0187219 0.0187303 0.00858259 0.00838279 0.00606187 0.00455995 0.00224596 0.00766409 0.0164806 0.0152861 0.00719669 0.0288526 0.104103 0.102461 0.0687788 0.0200442 0.0569781 0.0767658 0.0357154 0.0429022 0.021412 0.0306797 0.0253218 0.0151627 0.0295176 0.0106915 0.0050529 0.00244219 0.00237585 0.00827981 0.0148251 0.0127325 0.0244541 0.0129936 0.010639 0.012034 0.0582172	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG2 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0162661 0.0319145 0.0172945 0.0172382 0.00788355 0.00762833 0.0055575 0.00417379 0.00205802 0.00717878 0.0158799 0.0145932 0.00698428 0.0276447 0.101509 0.102915 0.0760458 0.019034 0.0514098 0.0479338 0.0216199 0.0173418 0.00932161 0.0218862 0.0551855 0.0353851 0.0548306 0.0361483 0.0160108 0.00495867 0.00298123 0.00531315 0.0114587 0.012151 0.026211 0.0141918 0.00981815 0.0111942 0.0528494	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG2 ) , DRUG0 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0161242 0.0316365 0.0170854 0.0170662 0.00781244 0.00757247 0.00550553 0.00413357 0.00202993 0.00699234 0.0152943 0.0140648 0.00667853 0.0267948 0.100566 0.102396 0.0758317 0.0193667 0.051432 0.0530319 0.0228173 0.0183056 0.00852321 0.0202262 0.0472752 0.0279653 0.0401976 0.0180665 0.00785911 0.00691565 0.00562742 0.0172849 0.0160907 0.0180482 0.0364562 0.0204339 0.0124238 0.0144996 0.0595684	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0148175 0.0290703 0.0157017 0.0156821 0.0071826 0.00696305 0.00505988 0.00379866 0.0018671 0.00642199 0.014047 0.0129462 0.00615807 0.0246328 0.0924919 0.0937636 0.0688311 0.0173372 0.0447192 0.0420166 0.0177471 0.0121021 0.00513777 0.00985985 0.0214982 0.0118423 0.0252387 0.0109511 0.00604243 0.00317259 0.00378147 0.0168091 0.0405241 0.0433324 0.0782449 0.0504387 0.0439699 0.0272031 0.0485955	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG1 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0170146 0.0329265 0.0174708 0.0169695 0.00804605 0.00782944 0.00557579 0.00420683 0.00216433 0.00691071 0.0142834 0.0124637 0.0046144 0.0145843 0.0435666 0.045161 0.0194101 0.00881545 0.0281397 0.0756228 0.0540206 0.0512782 0.0238272 0.0674351 0.073951 0.0291615 0.0459166 0.0214552 0.00935305 0.00851343 0.00708613 0.0201773 0.0197531 0.0206313 0.0413393 0.0234538 0.0140734 0.0161987 0.0665991	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG1 (decreased renal excretion of DRUG0 ) , DRUG2 (decreased hepatic clearance of DRUG0 ) .
4	4	0.0147333 0.028531 0.0152084 0.0147671 0.00697298 0.00676818 0.00483788 0.00364668 0.00187102 0.00603367 0.0126175 0.0110916 0.00418295 0.0135229 0.0410603 0.041504 0.0175704 0.00809828 0.0248468 0.0644948 0.0451215 0.04105 0.0170953 0.0530403 0.0476975 0.0182447 0.0292809 0.0151582 0.00645424 0.00402917 0.00474491 0.018548 0.0503178 0.0472769 0.0829934 0.0534454 0.0461753 0.0286983 0.0482688	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG1 (decreased renal excretion of DRUG0 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	4	0.0166533 0.0322113 0.0167989 0.0164593 0.00758712 0.00748297 0.00525406 0.00393332 0.00198597 0.00637396 0.0128832 0.0116197 0.0045356 0.0147364 0.0431111 0.0399239 0.0148714 0.00653641 0.0206375 0.0585155 0.0361019 0.0175517 0.00780314 0.0228771 0.0465763 0.0318088 0.0556865 0.0375776 0.0334708 0.00931173 0.00824582 0.0189243 0.055692 0.0346086 0.0635361 0.0537206 0.046826 0.0289453 0.0486247	It may also interact with DRUG0 (increased thrombocytopenia) , DRUG0 (increased nephrotoxicity) , DRUG0 (increased hypoglycemic response) , DRUG0 (increased anticoagulant effect) , DRUG0 (decreased renal excretion of DRUG1 ) , DRUG0 (decreased hepatic clearance of DRUG2 ) .
4	3	0.0241965 0.0146708 0.0191124 0.0523613 0.00967454 0.0254683 0.0140296 0.0138203 0.0132089 0.0126369 0.0239553 0.0135582 0.0200962 0.0174511 0.0669239 0.0504162 0.0430289 0.0428376 0.0532416 0.0375557 0.0237949 0.0426644 0.0276731 0.0287407 0.0309284 0.0291163 0.0277295 0.0134912 0.0207673 0.020071 0.0157334 0.00724677 0.0221278 0.0160998 0.0169568 0.0076395 0.0240168 0.0232907 0.0336675	CYP3A4 Inhibitors : DRUG1 , an inhibitor of the drug metabolizing enzyme CYP3A4 , significantly increased plasma concentrations of DRUG2 when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY , Variability in Metabolism and Drug-Drug Interactions) .
4	4	0.117479 0.0831313 0.0729774 0.0706752 0.0407175 0.040267 0.0648844 0.0390117 0.00964426 0.00691387 0.00515158 0.00663782 0.0130405 0.00449644 0.00265745 0.00336883 0.00275252 0.00399937 0.00305083 0.00311369 0.00500808 0.00381386 0.00223363 0.00303089 0.00252561 0.00391211 0.00279428 0.00287792 0.00487544 0.00332556 0.00797993 0.00644158 0.0140366 0.0151834 0.00840858 0.0143133 0.0265486 0.0360049 0.0345488 0.0245919 0.054041 0.129533	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG2 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123519 0.088447 0.0774776 0.0750129 0.040165 0.0405598 0.0589987 0.0321472 0.00774861 0.00495223 0.00350383 0.00288091 0.00539921 0.00685003 0.00455533 0.011464 0.0024732 0.00323655 0.00274707 0.00292768 0.00440882 0.00356342 0.00215231 0.00288496 0.00240763 0.00374686 0.0026813 0.00278864 0.00474697 0.0031961 0.00771334 0.00616085 0.013476 0.0150222 0.00831613 0.0143465 0.0264589 0.0357129 0.0343503 0.0245927 0.0544993 0.131708	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG2 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123053 0.0886218 0.077775 0.0749422 0.040103 0.0396529 0.0550606 0.0297919 0.00707837 0.00448632 0.00313312 0.00259006 0.00464962 0.00445851 0.00226201 0.00404249 0.00435077 0.0122241 0.00347179 0.00342879 0.00490124 0.0036393 0.00216806 0.00307605 0.00246766 0.00408116 0.00265825 0.00285903 0.00505272 0.00317776 0.00865149 0.00640038 0.0135604 0.0153925 0.00842915 0.0145811 0.0285676 0.0380844 0.0365037 0.025022 0.0544903 0.131059	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG2 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.121068 0.0867156 0.0760796 0.0738079 0.0393464 0.0395604 0.0572154 0.0310683 0.00727604 0.00459351 0.00313948 0.00259745 0.00443161 0.00437545 0.00205522 0.00308136 0.00242007 0.00504507 0.00551276 0.00568417 0.013859 0.00456348 0.00271602 0.00351582 0.00289056 0.00424287 0.00331353 0.00323062 0.00506644 0.00366637 0.0082749 0.00693371 0.0150562 0.0157421 0.00893318 0.0150024 0.0267594 0.0363029 0.0350303 0.0248123 0.0542365 0.130777	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG2 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123608 0.0888915 0.0776791 0.0742857 0.0392635 0.0395425 0.0546105 0.0290312 0.00686091 0.00432056 0.0029957 0.00249698 0.0043214 0.0042178 0.0020525 0.00309193 0.00236258 0.00404691 0.0032741 0.00311238 0.00622988 0.00701157 0.00488386 0.0123322 0.00262714 0.00353663 0.0030045 0.00305544 0.00452015 0.00326436 0.00691597 0.00576992 0.0128825 0.0154144 0.00872327 0.0150826 0.0268002 0.0362219 0.0349919 0.0252772 0.0559453 0.135444	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG2 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.122631 0.0884694 0.0771944 0.0734593 0.0390299 0.0386209 0.0513777 0.0272426 0.00643856 0.00404311 0.00282703 0.00234719 0.00413534 0.00394027 0.00197191 0.00297433 0.00225187 0.00374735 0.00297001 0.00278063 0.00537844 0.00460732 0.00224686 0.00423728 0.00446072 0.0125421 0.00374579 0.00350944 0.00505449 0.00336522 0.00841202 0.00630792 0.0134072 0.0161364 0.00896545 0.0153859 0.0298326 0.039571 0.0379125 0.0258791 0.0559747 0.134615	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG2 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123158 0.0889119 0.0775576 0.0735714 0.039058 0.0389097 0.052036 0.0275221 0.00655029 0.00410955 0.0028629 0.00237972 0.00418895 0.00405513 0.00197712 0.00300523 0.00225214 0.00373617 0.00296886 0.00270088 0.00522596 0.00464757 0.00208089 0.00342267 0.00246478 0.00551505 0.00529628 0.0056306 0.014731 0.0052781 0.00678698 0.00620043 0.0141272 0.0160035 0.00939501 0.0160432 0.0270929 0.0361971 0.0350245 0.0256877 0.05605 0.135587	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG2 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.122639 0.0877016 0.0760251 0.0724941 0.0388018 0.039563 0.055986 0.0299124 0.00700123 0.00447603 0.00302818 0.00252164 0.00406744 0.00427882 0.00198045 0.0029109 0.00224871 0.00364629 0.00301679 0.00273814 0.00481662 0.00471115 0.00205146 0.00319917 0.00239569 0.0047039 0.00391566 0.00331505 0.00683735 0.00717233 0.0232683 0.00505863 0.0141026 0.0160772 0.00939318 0.0161215 0.0255573 0.0342883 0.0331055 0.0256224 0.0559978 0.133252	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG2 , the recommended dose of DRUG0 is 2 mg daily .
1	1	0.0942833 0.0678377 0.0589497 0.0508053 0.026125 0.0229255 0.0291449 0.0162587 0.00414069 0.00271419 0.00204935 0.00180246 0.00300855 0.00257058 0.00152492 0.00205817 0.0016783 0.00258432 0.0019619 0.0021945 0.00368053 0.00266022 0.00159984 0.00229619 0.00191813 0.0032112 0.00239242 0.00273422 0.00475225 0.00422999 0.0108198 0.0155133 0.0687994 0.0499156 0.0318567 0.0654373 0.055531 0.0446829 0.0392506 0.0316461 0.0512366 0.111217	For patients receiving DRUG1 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
4	4	0.125671 0.10449 0.108335 0.0301982 0.0141413 0.0180791 0.0409793 0.0322937 0.0110774 0.00800344 0.0075848 0.0118101 0.042213 0.0179048 0.00837517 0.0118068 0.00277857 0.00350922 0.00320641 0.00330387 0.00447038 0.00383369 0.00225274 0.00291997 0.0024372 0.0036364 0.00277039 0.00279043 0.0044407 0.00313031 0.00708827 0.00599553 0.013749 0.0147837 0.00837395 0.0141399 0.0259399 0.0356993 0.0344405 0.0242198 0.0526377 0.124489	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG2 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123674 0.103423 0.107357 0.0301308 0.0142164 0.0181901 0.0413047 0.0325043 0.0110622 0.00797626 0.00740687 0.0111634 0.0383229 0.0121193 0.00738469 0.00645324 0.00691869 0.0134512 0.00400092 0.00386869 0.00484461 0.0037095 0.00220277 0.00297766 0.0024208 0.00377243 0.00266663 0.00275867 0.00463066 0.00307297 0.00774967 0.00608779 0.0138181 0.0148571 0.00837263 0.0142204 0.0274036 0.0373788 0.0357885 0.0244662 0.0524889 0.123383	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG2 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.121697 0.101569 0.10563 0.0297836 0.0141265 0.0180426 0.0407818 0.0319674 0.0109415 0.00799223 0.00744542 0.0113383 0.0395802 0.0131529 0.00777153 0.00561573 0.00644143 0.00713947 0.00745303 0.00752561 0.0115364 0.00435097 0.00261501 0.00341129 0.00285848 0.00408668 0.00329831 0.00315786 0.00480321 0.00354814 0.00759105 0.00677665 0.015286 0.015075 0.00864361 0.01441 0.0253439 0.0351911 0.0341794 0.0239766 0.0517555 0.12211	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG2 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.121406 0.101079 0.104744 0.029528 0.0139618 0.0180556 0.0406002 0.0316068 0.0108403 0.00786369 0.00731288 0.0109563 0.0371442 0.0118513 0.00709918 0.00532293 0.00588627 0.00538189 0.00504229 0.00696628 0.00765156 0.0107779 0.00587539 0.0125194 0.00273877 0.00354566 0.00318663 0.003144 0.00441717 0.00330642 0.00652536 0.00582141 0.013617 0.0151127 0.00868279 0.014714 0.025692 0.0350712 0.0338958 0.0242037 0.0525808 0.124272	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG2 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.120305 0.10036 0.10362 0.0290146 0.0136859 0.0177038 0.0397745 0.0310046 0.0105682 0.00755777 0.0069617 0.0102404 0.0340028 0.0106307 0.00650488 0.00505458 0.00536756 0.00498958 0.00469056 0.00633921 0.00643459 0.00659722 0.00300205 0.00516802 0.00512712 0.0132718 0.00396168 0.00359768 0.00481898 0.0033078 0.00769732 0.00610812 0.0136763 0.0156281 0.00885459 0.015019 0.0291198 0.0390717 0.0372629 0.0251933 0.0534935 0.125212	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG2 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.12132 0.100946 0.104256 0.0292413 0.013791 0.0178877 0.0402156 0.0311626 0.0106746 0.00764289 0.00707662 0.0104459 0.0349331 0.0111377 0.00664333 0.00508207 0.00544496 0.00496617 0.00460263 0.00615455 0.0062512 0.00643095 0.00269802 0.00401636 0.00299523 0.00585066 0.0055303 0.00585415 0.0131883 0.00540278 0.00676716 0.00622006 0.0150282 0.0155976 0.00922968 0.0155703 0.0261977 0.0357998 0.0347626 0.0248199 0.0530244 0.12514	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG2 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.123224 0.10237 0.105173 0.0294258 0.0139601 0.0179347 0.0396909 0.0309769 0.0104066 0.00766069 0.00713567 0.0109078 0.0372457 0.0126183 0.00719955 0.00497123 0.00560318 0.00485825 0.00459647 0.00646885 0.00598624 0.00691368 0.00270001 0.00371623 0.00292454 0.00495787 0.00448955 0.00433952 0.00640636 0.00709865 0.022098 0.00517766 0.0147658 0.0153577 0.00898747 0.015377 0.0239851 0.0328513 0.0318053 0.0241901 0.0521272 0.121318	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG2 , the recommended dose of DRUG0 is 2 mg daily .
1	1	0.0947677 0.0788137 0.0784191 0.0199662 0.00914626 0.0108407 0.0249892 0.0212996 0.00720532 0.00496385 0.0043053 0.00574892 0.0184833 0.0049479 0.00308488 0.0028942 0.00266249 0.00299085 0.00288042 0.00317899 0.00346244 0.00323933 0.00187208 0.00244382 0.00210408 0.00309815 0.00316876 0.00357645 0.0049691 0.00511486 0.0106148 0.015044 0.0707145 0.0456629 0.0292358 0.0615849 0.055047 0.0479795 0.0424064 0.0329828 0.0499696 0.10412	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
4	4	0.119644 0.0954633 0.0954753 0.0242615 0.0111057 0.0138949 0.0301108 0.0228481 0.00730819 0.00492522 0.00386469 0.00405651 0.0118315 0.0149344 0.00946417 0.0457399 0.00924748 0.00693477 0.00601894 0.00828937 0.00859346 0.0129931 0.00679302 0.0133933 0.00300687 0.00385454 0.00353129 0.00347726 0.00478925 0.00365062 0.00704242 0.0063708 0.0148519 0.0164445 0.00955763 0.0160531 0.0277692 0.038203 0.0369835 0.0262523 0.0568198 0.13415	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 (eg , DRUG2 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.118597 0.0949955 0.0948037 0.0240498 0.0109792 0.0137754 0.0298211 0.0225781 0.0071921 0.00481766 0.00378085 0.00395537 0.0117374 0.0143811 0.00884641 0.0423681 0.00852725 0.00638109 0.00560804 0.00758625 0.0071263 0.0079601 0.00368026 0.00577037 0.00586286 0.0140879 0.00428725 0.00391234 0.00517779 0.00361842 0.00818676 0.0065631 0.0147513 0.0167668 0.00953967 0.0161052 0.0309862 0.0419122 0.0400127 0.0270487 0.0574409 0.134421	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG2 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.119144 0.0950871 0.0947272 0.0239242 0.0108948 0.0136533 0.0295962 0.0223826 0.00716896 0.00480866 0.00378915 0.00400089 0.0120571 0.0149011 0.00910053 0.0436524 0.0086698 0.00638343 0.00553339 0.00738187 0.00696109 0.00785373 0.00347322 0.00466589 0.0037177 0.0064469 0.00594121 0.00630237 0.0135514 0.00587096 0.00731921 0.00676386 0.0164702 0.0168741 0.0100759 0.0169123 0.0282197 0.0388663 0.0378214 0.0268762 0.0572207 0.134939	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG2 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.121686 0.0969115 0.0963075 0.0243285 0.0112184 0.0138949 0.0297994 0.022702 0.00723654 0.00486108 0.00379929 0.0040779 0.0113793 0.0149155 0.00949743 0.0450543 0.00891463 0.00633674 0.00551681 0.00758664 0.00667484 0.00862802 0.00359799 0.00437629 0.00374626 0.00547561 0.00503422 0.00518867 0.00665265 0.00773985 0.0239936 0.00564993 0.0161939 0.0165765 0.00973532 0.0165933 0.025813 0.0353963 0.0342512 0.0260015 0.0560405 0.130617	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG2 , the recommended dose of DRUG0 is 2 mg daily .
1	1	0.0941019 0.0751905 0.0717779 0.0168632 0.00756123 0.0090401 0.0198487 0.0158099 0.00480165 0.00322681 0.00250798 0.00245745 0.00597211 0.00626631 0.00405284 0.020079 0.00421077 0.00346407 0.00323029 0.00357195 0.00359978 0.00360774 0.0020875 0.00261834 0.00233088 0.00321331 0.00353385 0.00411712 0.00514971 0.00548687 0.0109195 0.0154929 0.0687974 0.0431495 0.0298206 0.0642994 0.0585934 0.0515661 0.0460049 0.0354024 0.0536612 0.112513	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
4	4	0.122162 0.0951015 0.0948647 0.0233356 0.0106308 0.0131131 0.0283328 0.0217752 0.00638451 0.00421738 0.00318035 0.00285365 0.00645916 0.00507839 0.00313507 0.00798017 0.00873253 0.0463686 0.00795206 0.00937204 0.00928283 0.0126694 0.00679335 0.0142372 0.00314895 0.00401238 0.00360485 0.00358047 0.00500366 0.00375463 0.00742302 0.00656835 0.015287 0.017107 0.00984761 0.0166949 0.0293031 0.0402536 0.0389474 0.027781 0.0605003 0.143169	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 (eg , DRUG2 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.12032 0.094289 0.0936288 0.0229111 0.0103609 0.0127111 0.0274896 0.0213605 0.00625204 0.00412936 0.00313191 0.00282667 0.00648348 0.00500377 0.00307225 0.00792708 0.00817379 0.0424805 0.00732682 0.00836277 0.00770299 0.00772939 0.00351384 0.0059055 0.00582935 0.0147742 0.00448534 0.00410599 0.00548299 0.00377438 0.00873645 0.00691764 0.0153659 0.0176085 0.00994984 0.0169262 0.0329078 0.0445061 0.0424773 0.0287326 0.0611486 0.143177	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 (eg , DRUG0 , DRUG2 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.1211 0.0945905 0.0938426 0.0228958 0.0103501 0.0127128 0.0275351 0.0212616 0.00625451 0.00412807 0.00313025 0.00281361 0.00648014 0.00500697 0.00307886 0.00800466 0.00832003 0.0433124 0.00726797 0.00820238 0.00747964 0.00755975 0.00321176 0.00467125 0.00359527 0.0067215 0.00612667 0.00644337 0.0148985 0.00621759 0.00774002 0.00712408 0.017273 0.0177873 0.0105553 0.0177822 0.0298724 0.0411726 0.0400472 0.0285595 0.060965 0.143908	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG2 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.12448 0.096491 0.0958782 0.0234678 0.0108183 0.0133511 0.0285261 0.0214852 0.00632149 0.00416439 0.00310764 0.00277803 0.0060284 0.00484059 0.00302676 0.0071858 0.00869261 0.0434729 0.00748031 0.0086898 0.00722493 0.00813545 0.00324564 0.00434453 0.00356073 0.00569144 0.00509702 0.00515202 0.00708241 0.00796155 0.0255842 0.00594587 0.0170381 0.0175179 0.0102772 0.0175447 0.0273839 0.037515 0.036373 0.0276624 0.0597505 0.139625	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG2 , the recommended dose of DRUG0 is 2 mg daily .
1	1	0.0915943 0.0719234 0.0680279 0.0154817 0.00682239 0.00791641 0.0175339 0.0147144 0.00430897 0.0028939 0.00225633 0.00210384 0.00440584 0.00340191 0.00206078 0.00430488 0.00356451 0.0169149 0.00393632 0.00368476 0.00384489 0.00353229 0.00203908 0.00262926 0.00230519 0.00333194 0.00349008 0.00401422 0.00540752 0.00560925 0.0118105 0.0165755 0.0762215 0.0483717 0.0315602 0.067375 0.0603834 0.0522282 0.0463051 0.0357391 0.0544963 0.114879	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
4	4	0.116458 0.0938018 0.0953389 0.0246541 0.0111427 0.0136557 0.0290616 0.0223767 0.0066768 0.00442343 0.00326367 0.00302454 0.00687667 0.00542267 0.00282603 0.00537168 0.00444208 0.0106985 0.0120882 0.0150054 0.0505555 0.0235502 0.0108586 0.0151482 0.00351072 0.00417828 0.00402771 0.00390611 0.0049721 0.00404096 0.007291 0.0069242 0.0163709 0.016902 0.0100169 0.0164461 0.0273888 0.0378697 0.0367308 0.0259432 0.0556903 0.131069	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 (eg , DRUG2 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.114129 0.0921967 0.0932609 0.0240544 0.0109375 0.0134427 0.0287313 0.0218073 0.00653735 0.00430958 0.00317011 0.0029207 0.0066668 0.00529504 0.00269837 0.00507896 0.00425854 0.0100725 0.0116508 0.0143795 0.0467018 0.016007 0.00916441 0.00756464 0.00835369 0.0163561 0.0049342 0.00443298 0.00537036 0.00398083 0.00823571 0.00691833 0.0159631 0.0171938 0.0100241 0.016561 0.0305676 0.0417602 0.0396614 0.0268254 0.0564437 0.131382	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 (eg , DRUG0 , DRUG2 ) or DRUG0 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.114784 0.0925008 0.0934992 0.0240542 0.0109393 0.0134598 0.0287361 0.02158 0.00653752 0.00430872 0.00316799 0.00291768 0.0067114 0.00529187 0.00269324 0.00509499 0.0042553 0.0101309 0.0117986 0.014541 0.0472302 0.0170594 0.00969193 0.00666883 0.00759814 0.00839129 0.00751024 0.00802411 0.0137943 0.00624669 0.00726642 0.00699251 0.0172652 0.0169216 0.0102188 0.017035 0.0276313 0.0379321 0.0368002 0.0262534 0.0556814 0.130785	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG2 or DRUG0 , the recommended dose of DRUG0 is 2 mg daily .
4	4	0.116675 0.0937978 0.0946411 0.024446 0.0112489 0.0137603 0.0289291 0.0218217 0.00657186 0.00434831 0.00317417 0.0029224 0.00625882 0.00511226 0.00267583 0.00481093 0.00427018 0.00963649 0.0123969 0.0153132 0.0491113 0.0198859 0.0101297 0.00621409 0.00732174 0.00690061 0.00656861 0.00718463 0.00772396 0.00982144 0.0252167 0.00597056 0.0171037 0.0164867 0.00964207 0.0162544 0.0249827 0.0340562 0.032819 0.0249651 0.0538008 0.125028	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG2 , the recommended dose of DRUG0 is 2 mg daily .
1	1	0.0902753 0.0722649 0.0688587 0.0162767 0.00718851 0.00826618 0.0184045 0.0155911 0.00466669 0.00312755 0.00236215 0.00226362 0.00466837 0.00367718 0.00192646 0.00323509 0.00267128 0.0057511 0.00597309 0.00737851 0.0209947 0.005955 0.00328338 0.00323168 0.00313465 0.00356201 0.00389877 0.00494999 0.00533568 0.00622881 0.0112636 0.0176375 0.0717636 0.0401759 0.030186 0.065219 0.0596775 0.0526099 0.0468636 0.0358555 0.0531094 0.110237	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
1	1	0.090655 0.0704223 0.065378 0.0147641 0.00644802 0.0075834 0.016674 0.0136306 0.00387804 0.00262895 0.00199989 0.00183722 0.00364025 0.00299272 0.00156721 0.00249289 0.00193108 0.00353557 0.00276903 0.00322041 0.00686373 0.00661389 0.00398056 0.0186268 0.00387048 0.0039106 0.0042372 0.0053165 0.00564491 0.00673864 0.0119026 0.0182966 0.0669625 0.0387615 0.0314072 0.0680291 0.0627123 0.0557542 0.0502131 0.0383037 0.0566024 0.117203	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG1 , DRUG0 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
1	1	0.0892591 0.0684305 0.0633112 0.0140753 0.00610631 0.007112 0.0155978 0.0130192 0.00361682 0.00245906 0.00187908 0.00172541 0.00334084 0.00271678 0.00145494 0.00224011 0.00173155 0.00308148 0.00234991 0.00270579 0.00523272 0.0036341 0.00218302 0.00464624 0.0036717 0.0164608 0.00510877 0.00555283 0.00603839 0.00674626 0.0125769 0.0191882 0.0751007 0.0433426 0.0321096 0.0699343 0.0633937 0.0557325 0.049848 0.0380898 0.0568333 0.118363	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG1 ) or DRUG0 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
1	1	0.0910499 0.069589 0.0647981 0.0146014 0.00637031 0.00754898 0.0164675 0.0133476 0.00365309 0.00252389 0.0018918 0.00173096 0.00323649 0.00270022 0.00145043 0.00213846 0.00168388 0.0028601 0.00219009 0.00244355 0.00462816 0.00336038 0.00179149 0.0029629 0.00234554 0.00499954 0.005042 0.00747889 0.0234426 0.0125466 0.0153601 0.0220652 0.0595071 0.0336384 0.0312848 0.0672516 0.0643824 0.0573242 0.0523303 0.0403962 0.0576061 0.117979	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG1 or DRUG0 , the recommended dose of DRUG2 is 2 mg daily .
1	1	0.0828295 0.0659785 0.0612714 0.0141463 0.00618047 0.00711563 0.015394 0.0128857 0.00371817 0.00254732 0.00188786 0.00180966 0.00356633 0.00292203 0.00150955 0.00233602 0.0018428 0.00333048 0.00287778 0.00311762 0.00567921 0.00465796 0.00236642 0.00407174 0.0035779 0.00721556 0.00746308 0.0076049 0.0134721 0.0170733 0.0999222 0.0195742 0.0496192 0.0300802 0.0282405 0.0607176 0.0563596 0.0502829 0.0462203 0.0360468 0.0504175 0.10207	For patients receiving DRUG0 or other potent CYP3A4 inhibitors such as other DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 (eg , DRUG0 , DRUG0 ) or DRUG0 or DRUG1 , the recommended dose of DRUG2 is 2 mg daily .
2	2	0.149478 0.0525554 0.0527032 0.0755863 0.046979 0.0912827 0.0668234 0.0910796 0.0574746 0.0788367 0.0280615 0.00631767 0.0067946 0.00493861 0.00762748 0.00544458 0.00886622 0.0358504 0.1333	DRUG1 has been reported to enhance the sedative activity of DRUG2 , DRUG0 , DRUG0 , and DRUG0 .
2	4	0.166075 0.0571122 0.0564351 0.0801925 0.0468369 0.0870078 0.0630627 0.0805538 0.0581023 0.0446702 0.0152435 0.0109295 0.0254287 0.00553846 0.00787412 0.00597707 0.00935709 0.0353248 0.144279	DRUG1 has been reported to enhance the sedative activity of DRUG0 , DRUG2 , DRUG0 , and DRUG0 .
2	4	0.167067 0.0574077 0.0567002 0.0807539 0.0465247 0.0854448 0.0615787 0.0782535 0.0560121 0.0410709 0.0117896 0.00568083 0.0110814 0.0121968 0.0318356 0.00734457 0.00922975 0.034164 0.145865	DRUG1 has been reported to enhance the sedative activity of DRUG0 , DRUG0 , DRUG2 , and DRUG0 .
2	4	0.155244 0.0533663 0.0524349 0.0764088 0.0453928 0.0809141 0.0557595 0.065821 0.0460949 0.0349709 0.0103155 0.00490317 0.00729544 0.00611282 0.0102187 0.0131446 0.0334607 0.0951299 0.153012	DRUG1 has been reported to enhance the sedative activity of DRUG0 , DRUG0 , DRUG0 , and DRUG2 .
4	4	0.0455303 0.0406344 0.0451787 0.0862964 0.0498945 0.0787416 0.042697 0.0596268 0.0379703 0.0333162 0.0119422 0.00719403 0.0169056 0.0211741 0.095827 0.0262605 0.033754 0.106355 0.160701	DRUG0 has been reported to enhance the sedative activity of DRUG0 , DRUG0 , DRUG1 , and DRUG2 .
4	4	0.0360295 0.0444081 0.013214 0.0318784 0.0379789 0.0386435 0.0529288 0.0167694 0.0490978 0.0494515 0.0791744 0.0599059 0.0281414 0.00504498 0.00787993 0.014156 0.0139646 0.0134455 0.0151193 0.0342769 0.00895797 0.00986992 0.0141744 0.0101688 0.0128166 0.0177749 0.0152286 0.0511533 0.030356 0.0173885 0.0120258 0.0131589 0.0134973 0.0193725 0.0217903 0.0365085 0.0542493	Oral DRUG1 : In 10 healthy women , the pharmacokinetic profiles of DRUG2 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG0 and 75    g of DRUG0 were studied .
4	4	0.0358467 0.04405 0.0130873 0.031252 0.0368279 0.0352266 0.046844 0.0165022 0.0421766 0.039844 0.0574076 0.0260467 0.0173933 0.018555 0.0334737 0.020208 0.0219103 0.0213045 0.0182402 0.039404 0.0108306 0.0122551 0.0165272 0.0119177 0.0149514 0.0193259 0.0167587 0.0555782 0.0332099 0.0188064 0.0127626 0.0136608 0.0138888 0.0197738 0.0222345 0.0370469 0.0548708	Oral DRUG1 : In 10 healthy women , the pharmacokinetic profiles of DRUG0 and DRUG2 following administration of a single dose containing 1.0 mg of DRUG0 and 75    g of DRUG0 were studied .
4	4	0.0305335 0.0377515 0.00948574 0.021662 0.0217425 0.0202054 0.0233985 0.00655613 0.0199546 0.0207031 0.0353421 0.0153453 0.0105873 0.00618866 0.0237161 0.0527615 0.0369527 0.0435038 0.039072 0.0572527 0.0227109 0.026256 0.0379443 0.0318829 0.060107 0.0430682 0.00953394 0.0381927 0.0249827 0.015302 0.0109778 0.013341 0.0131534 0.0179629 0.0214962 0.0328091 0.0475639	Oral DRUG1 : In 10 healthy women , the pharmacokinetic profiles of DRUG0 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG2 and 75    g of DRUG0 were studied .
4	4	0.0286714 0.0351241 0.00786983 0.017919 0.0167055 0.0151012 0.0169957 0.004709 0.0131279 0.0133607 0.0224938 0.00823398 0.00652443 0.00363868 0.0127943 0.0242943 0.0180771 0.0154492 0.0122706 0.0252993 0.00743868 0.00748151 0.0113284 0.008286 0.0111264 0.0175516 0.019232 0.0723528 0.0536706 0.0516741 0.046555 0.0540764 0.0802362 0.0626063 0.0601755 0.0525724 0.0649759	Oral DRUG1 : In 10 healthy women , the pharmacokinetic profiles of DRUG0 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG0 and 75    g of DRUG2 were studied .
4	4	0.0117511 0.00771219 0.00670429 0.0128261 0.0187016 0.022775 0.0331949 0.0112216 0.0343562 0.0376937 0.0619537 0.0453064 0.086797 0.0242575 0.0344148 0.0184576 0.0218166 0.0272845 0.031745 0.053129 0.0146476 0.0175673 0.0223389 0.0161633 0.0203439 0.0224655 0.0179858 0.0568893 0.0328301 0.0181142 0.011931 0.0124286 0.0125383 0.0179204 0.0199661 0.033404 0.050367	Oral DRUG0 : In 10 healthy women , the pharmacokinetic profiles of DRUG1 and DRUG2 following administration of a single dose containing 1.0 mg of DRUG0 and 75    g of DRUG0 were studied .
4	4	0.0107407 0.00710289 0.00640074 0.0121805 0.0180498 0.0204512 0.0302781 0.010718 0.037825 0.0452367 0.0806156 0.052031 0.0497278 0.0109358 0.0190061 0.0240146 0.0218965 0.032147 0.0216605 0.0402345 0.0211972 0.0292441 0.0368066 0.0285644 0.0530721 0.035758 0.0106302 0.0479204 0.0284736 0.0159628 0.0103356 0.0116854 0.0117501 0.0161213 0.0189199 0.0289859 0.0433195	Oral DRUG0 : In 10 healthy women , the pharmacokinetic profiles of DRUG1 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG2 and 75    g of DRUG0 were studied .
4	4	0.00795529 0.00520538 0.00465714 0.00885558 0.0129599 0.0147388 0.0217283 0.00774808 0.0284254 0.0348717 0.0617839 0.0386019 0.0361085 0.00596089 0.0103301 0.0133928 0.0122613 0.0160979 0.0167984 0.0297029 0.00940138 0.0137914 0.019855 0.0176356 0.0245673 0.0208668 0.0185007 0.0692696 0.0517521 0.0483838 0.0405692 0.0428155 0.060759 0.0459473 0.043848 0.037272 0.0465813	Oral DRUG0 : In 10 healthy women , the pharmacokinetic profiles of DRUG1 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG0 and 75    g of DRUG2 were studied .
4	4	0.0106569 0.00697723 0.00614976 0.0116038 0.0169057 0.0188635 0.0264698 0.00966103 0.0327487 0.0388287 0.0577734 0.0412013 0.0295568 0.0211183 0.08882 0.0250653 0.0221139 0.0304612 0.0217678 0.0385078 0.0210312 0.0281765 0.0364942 0.0287052 0.0529841 0.0354912 0.0105144 0.0472054 0.0277888 0.015642 0.0101841 0.0115497 0.0116539 0.0160824 0.0188027 0.0289555 0.0434877	Oral DRUG0 : In 10 healthy women , the pharmacokinetic profiles of DRUG0 and DRUG1 following administration of a single dose containing 1.0 mg of DRUG2 and 75    g of DRUG0 were studied .
4	4	0.00769828 0.00470274 0.00396407 0.00717085 0.00918172 0.00982262 0.0122557 0.00382585 0.0122559 0.0132977 0.0235987 0.00967558 0.00706431 0.00395124 0.0170983 0.0396444 0.0278391 0.0321997 0.0337748 0.0462548 0.0165285 0.0203146 0.0392358 0.0362065 0.0430554 0.0740294 0.0127046 0.039002 0.038134 0.044592 0.046372 0.0390285 0.0602588 0.0417194 0.0421997 0.0377901 0.0435523	Oral DRUG0 : In 10 healthy women , the pharmacokinetic profiles of DRUG0 and DRUG0 following administration of a single dose containing 1.0 mg of DRUG1 and 75    g of DRUG2 were studied .
4	4	0.0688714 0.0935205 0.134413 0.0972612 0.0602448 0.0453319 0.0611617 0.0951396 0.0612753 0.0310513 0.0147983 0.0227929 0.0296935 0.016083 0.00664374 0.00222218 0.00297235 0.00164001 0.00282424 0.00148577 0.00272103 0.00140786 0.00269215 0.00139417 0.00277167 0.00145623 0.00303579 0.00172194 0.00402139 0.00251078 0.00253554 0.0132826 0.0204019 0.00831201 0.00323156 0.00452661 0.0244802 0.0500696	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG2 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0627231 0.0911822 0.12359 0.083164 0.0356638 0.0465472 0.0760508 0.093462 0.0392311 0.0197032 0.0226756 0.0367308 0.0387741 0.0364271 0.0149245 0.00243059 0.00247195 0.00159487 0.00225532 0.0015295 0.00222518 0.00146776 0.00221393 0.00145039 0.00227829 0.00149524 0.00247409 0.00172736 0.00335949 0.00240697 0.00281193 0.0132952 0.0259842 0.00986406 0.00474464 0.00527341 0.026254 0.0595421	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0653152 0.0942519 0.128157 0.0859598 0.0381774 0.0479861 0.0781712 0.0949681 0.0367862 0.0177644 0.0196776 0.0320543 0.0335533 0.0238009 0.00831409 0.00551347 0.0101598 0.00171826 0.00207396 0.00150722 0.0021773 0.00148236 0.00222296 0.00148793 0.00232267 0.00154724 0.00253578 0.00177635 0.00341063 0.00246018 0.00289611 0.0121494 0.0240291 0.00963635 0.0049995 0.00562775 0.0283345 0.0649932	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0659662 0.0952642 0.129707 0.0867152 0.0381063 0.0481027 0.0784225 0.094679 0.0363129 0.0173149 0.0188123 0.0301982 0.0308189 0.0207409 0.00676498 0.00276111 0.00402778 0.00493862 0.00985958 0.00169636 0.00212121 0.00152579 0.00226161 0.00153078 0.00237942 0.00158924 0.00260527 0.00181816 0.0035006 0.00256695 0.00300544 0.0124039 0.0249085 0.00994458 0.00522634 0.00580131 0.0290257 0.0665755	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0660149 0.0953238 0.129826 0.0867432 0.038114 0.048041 0.0783572 0.094757 0.0362571 0.0172609 0.0186653 0.0298159 0.0301189 0.0197565 0.00641704 0.00251813 0.00332166 0.00231476 0.00404604 0.00486618 0.00989528 0.00169796 0.00218213 0.00155575 0.00238876 0.00160788 0.00262344 0.00181713 0.00349715 0.00258424 0.00300416 0.0123284 0.0247885 0.0100032 0.00529844 0.00586118 0.0292684 0.0670625	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.065948 0.0952434 0.129775 0.0866917 0.0380225 0.0479406 0.0782662 0.0947117 0.0362611 0.0173262 0.0187152 0.0298364 0.0300426 0.0195054 0.0063366 0.0024797 0.00319943 0.00213814 0.00332341 0.00225542 0.00401707 0.00476822 0.00999554 0.00172398 0.00230398 0.0016364 0.00263372 0.00182581 0.0034761 0.00259966 0.00300671 0.0120007 0.0242726 0.00994057 0.00535322 0.00589136 0.0293115 0.0672242	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0658517 0.0951102 0.129655 0.0866435 0.0379669 0.0478541 0.0781759 0.0947293 0.0363222 0.0174263 0.0188341 0.0299609 0.0301237 0.0195021 0.00632939 0.00248065 0.00317608 0.00211156 0.00319668 0.00208108 0.00328918 0.0022006 0.0039986 0.00477368 0.0102968 0.00180157 0.00253959 0.00184529 0.00344299 0.00262896 0.00303546 0.0114933 0.0235094 0.00980888 0.00541601 0.00591694 0.0292541 0.0672176	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0657424 0.0949246 0.129442 0.0866056 0.0380096 0.0477913 0.0780645 0.0948576 0.0364322 0.0175289 0.0189923 0.0300954 0.0301822 0.0196308 0.00634957 0.00249437 0.00317232 0.0021115 0.00316567 0.00205267 0.00314831 0.0020273 0.00327139 0.00219479 0.00405241 0.00494132 0.0110424 0.00198811 0.00330626 0.00266911 0.00316596 0.0107765 0.0224022 0.00961065 0.00552208 0.00596039 0.0291342 0.0671409	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0652925 0.0943686 0.128612 0.0861527 0.0377332 0.0474721 0.0774831 0.0942257 0.0364287 0.0177349 0.0194083 0.0304243 0.0303481 0.0201069 0.00646825 0.00251395 0.00314785 0.00210364 0.00312162 0.00203809 0.00307457 0.00198083 0.00306906 0.00199016 0.00325065 0.00220038 0.00402089 0.00506425 0.0136734 0.00307685 0.00368621 0.0101857 0.0217609 0.00955619 0.0057475 0.00608927 0.0291199 0.067269	Important Non- DRUG1 Drug Interactions Drugs That Interfere with DRUG0 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or certain herbal supplements such as St .
4	4	0.0376852 0.0379457 0.0498842 0.103037 0.0502214 0.0458116 0.0825573 0.10334 0.0589562 0.0509824 0.0288547 0.0523928 0.0527378 0.0450669 0.0183289 0.00289739 0.00275599 0.0017274 0.00237466 0.00160256 0.00229768 0.00150976 0.00225922 0.00147575 0.00231058 0.00151364 0.00250556 0.0017469 0.00338919 0.00246839 0.00284173 0.01358 0.0270015 0.0102757 0.0048518 0.00526438 0.0261161 0.0594315	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0391622 0.0391762 0.0515722 0.104957 0.0503984 0.0450925 0.0819112 0.103432 0.0595156 0.0516431 0.0263793 0.0492226 0.0516017 0.0349572 0.0116361 0.00728675 0.0127108 0.0019623 0.00219805 0.00157694 0.00222234 0.00151124 0.00223926 0.00149611 0.00231982 0.00154259 0.00251562 0.0017607 0.00336088 0.00244268 0.00285434 0.0120193 0.0243202 0.00980862 0.0049998 0.00552211 0.028 0.0646725	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0397806 0.0397937 0.052423 0.106164 0.0508784 0.0453646 0.0825948 0.104384 0.0601457 0.0519197 0.0252955 0.0465601 0.0479612 0.0311147 0.00954558 0.00363296 0.00470188 0.00563488 0.0109774 0.00184399 0.00219397 0.00156624 0.00227732 0.00154302 0.00237854 0.00158946 0.00259253 0.00181138 0.00346681 0.00256932 0.00298476 0.0123399 0.0253453 0.0101735 0.00526466 0.00573034 0.0288556 0.0666007	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0398615 0.0398657 0.0525056 0.106074 0.0507711 0.0452198 0.0824614 0.104306 0.0601875 0.0519742 0.0251701 0.0461252 0.0472008 0.0298744 0.00905689 0.00328658 0.00389254 0.00266399 0.00449586 0.00541747 0.0107889 0.0018175 0.00222985 0.00158405 0.00239441 0.00161629 0.00261934 0.00181813 0.00347728 0.00260031 0.0029961 0.0122944 0.0252867 0.010261 0.0053597 0.00581565 0.0292318 0.0673987	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0398068 0.039807 0.0524103 0.105784 0.0505869 0.0450839 0.0823062 0.10416 0.0601609 0.0519386 0.0252767 0.0462415 0.0472567 0.0296208 0.00895045 0.00323289 0.00373909 0.00245101 0.00371033 0.00252304 0.00440316 0.00523462 0.0107627 0.00182463 0.00233662 0.00165667 0.00263332 0.00183181 0.00346338 0.00262244 0.00300404 0.0119751 0.0247588 0.010192 0.00541914 0.00585314 0.0293209 0.0676601	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0397238 0.0397222 0.0522851 0.105544 0.0504435 0.0449758 0.0821526 0.104019 0.0601526 0.0518635 0.0254519 0.0464756 0.0474692 0.0296781 0.00894705 0.00323525 0.00371057 0.00241958 0.00356195 0.00232394 0.00362235 0.00242435 0.00433731 0.00519222 0.011 0.00189325 0.00256543 0.00186192 0.00343786 0.00265892 0.00303833 0.0114759 0.023954 0.0100394 0.00548132 0.00588102 0.0292867 0.0676945	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0396404 0.0396355 0.0521656 0.105414 0.050378 0.0448866 0.0819702 0.103863 0.0601718 0.0517766 0.0256426 0.0466698 0.0475355 0.0298777 0.00897737 0.00325544 0.00371054 0.00242162 0.00352772 0.0022921 0.00346288 0.00223287 0.00356842 0.00239597 0.00436936 0.00534611 0.0117483 0.00207883 0.00332832 0.00271014 0.00318468 0.0107756 0.0227977 0.00981322 0.00558789 0.00592842 0.0291993 0.0676606	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , or certain herbal supplements such as St .
4	4	0.0394464 0.039428 0.0518424 0.104917 0.0502094 0.0446824 0.0814519 0.103061 0.0600197 0.0512856 0.0259529 0.0467991 0.0473269 0.0303315 0.00911669 0.00328655 0.00369846 0.00241293 0.00348046 0.00227333 0.00337941 0.00217592 0.00333897 0.00216772 0.00351786 0.00237848 0.00431241 0.00544302 0.0144899 0.00321986 0.00372103 0.01018 0.0221123 0.0097434 0.00582576 0.00606613 0.0291963 0.0677098	Important Non- DRUG0 Drug Interactions Drugs That Interfere with DRUG1 : Concomitant use of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , or certain herbal supplements such as St .
2	2	0.0964522 0.0818799 0.0760592 0.0792425 0.0748807 0.0667886 0.0450098 0.0480389 0.0497168 0.0454644 0.012626 0.0336959 0.0139735 0.019217 0.0319713 0.0407523 0.0317173 0.025149 0.0138291 0.0137102 0.0402428 0.0595825	DRUG1 with DRUG2 may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .
2	2	0.135025 0.107643 0.0824416 0.0569765 0.058973 0.0720979 0.059681 0.052021 0.0492581 0.0612965 0.0615295 0.073572 0.0666978 0.062787	Decreased seizure threshold has been reported in patients receiving DRUG1 concomitantly with DRUG2 .
4	4	0.205328 0.0494156 0.086661 0.0965601 0.0969055 0.0704948 0.08953 0.0919307 0.213174	DRUG1 and DRUG2 increase the effects of DRUG0 .
2	2	0.138863 0.0315648 0.0513506 0.132794 0.117902 0.079032 0.177218 0.15952 0.111756	DRUG1 and DRUG0 increase the effects of DRUG2 .
2	2	0.0472085 0.0297925 0.132797 0.127492 0.134415 0.0814287 0.178211 0.158405 0.110251	DRUG0 and DRUG1 increase the effects of DRUG2 .
2	2	0.151187 0.151893 0.0756871 0.0798492 0.0814076 0.0991283 0.102122 0.0410157 0.00837776 0.00828884 0.00594244 0.0107588 0.00996161 0.0377859 0.136594	DRUG1 may reduce the antihypertensive effects of DRUG2 , DRUG0 , DRUG0 and DRUG0 .
2	2	0.145916 0.149652 0.0760617 0.0801905 0.0878225 0.116246 0.0725233 0.0240848 0.0137568 0.0311204 0.00706875 0.0104044 0.00957903 0.0354505 0.140124	DRUG1 may reduce the antihypertensive effects of DRUG0 , DRUG2 , DRUG0 and DRUG0 .
2	2	0.144232 0.143573 0.0742062 0.0779516 0.0863077 0.112602 0.0677564 0.0188533 0.00750968 0.0126863 0.0137307 0.0423843 0.0120754 0.037258 0.148874	DRUG1 may reduce the antihypertensive effects of DRUG0 , DRUG0 , DRUG2 and DRUG0 .
2	2	0.136018 0.130423 0.0665102 0.0659612 0.0702782 0.0887418 0.0604125 0.0177248 0.00712442 0.00947324 0.00945446 0.0251441 0.043347 0.109275 0.160112	DRUG1 may reduce the antihypertensive effects of DRUG0 , DRUG0 , DRUG0 and DRUG2 .
4	4	0.0798889 0.11715 0.0846667 0.0712882 0.0964308 0.0970079 0.0574023 0.0238339 0.015789 0.0511013 0.0149505 0.0212518 0.0292925 0.100252 0.139694	DRUG0 may reduce the antihypertensive effects of DRUG0 , DRUG1 , DRUG0 and DRUG2 .
4	4	0.0599498 0.085442 0.064116 0.0497197 0.0726449 0.0787139 0.0467796 0.0197766 0.011108 0.0238775 0.0359386 0.165466 0.0377973 0.107175 0.141495	DRUG0 may reduce the antihypertensive effects of DRUG0 , DRUG0 , DRUG1 and DRUG2 .
1	1	0.0623698 0.045252 0.0436214 0.037166 0.0548992 0.0639208 0.12573 0.0649568 0.0681638 0.0839242 0.0900399 0.0412777 0.099239 0.119439	Caution should be exercised when administering DRUG1 therapy in combination with other DRUG2 .
4	3	0.0173169 0.0232761 0.014625 0.0323055 0.032837 0.0367076 0.0314394 0.0278847 0.0454069 0.0427019 0.0703715 0.034795 0.028766 0.0301937 0.0295306 0.0651943 0.0423651 0.0211044 0.0153288 0.0205517 0.00606331 0.00428866 0.0072273 0.00277774 0.00885497 0.018621 0.018998 0.0289315 0.00875208 0.0093561 0.0103442 0.0159633 0.0220862 0.00805027 0.00941468 0.00594929 0.00483648 0.00196777 0.0018319 0.00795809 0.00531595 0.00430734 0.00800808 0.01366 0.0101047 0.00810467 0.00482613 0.00314703 0.00175395 0.00134944 0.00333418 0.00309876 0.00273423 0.00119098 0.00105589 0.000973136 0.000666158 0.000986899 0.000687493 0.00105528 0.000694369 0.00108557 0.000709574 0.00112045 0.000735067 0.00117537 0.000778339 0.00127839 0.000870046 0.00152436 0.00116194 0.00283122 0.00244521 0.00992395 0.0323309	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG2 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
3	4	0.0199675 0.0279045 0.0161312 0.0327836 0.0348262 0.0422138 0.0405649 0.0276722 0.0260761 0.0203843 0.0297502 0.0163704 0.0241127 0.0251105 0.0238788 0.0652574 0.0517018 0.0351793 0.0274098 0.0349487 0.0116972 0.00856004 0.0110512 0.00413096 0.012852 0.0248736 0.0237791 0.0334405 0.00977723 0.0106116 0.0110284 0.0171272 0.0232898 0.00860547 0.00997083 0.00620789 0.00483925 0.00193586 0.00179611 0.00798928 0.00539341 0.00439536 0.00813733 0.0139022 0.0101139 0.00801659 0.00482453 0.00312724 0.00173452 0.00133333 0.00327833 0.00305907 0.00269175 0.00116595 0.00103018 0.000951559 0.000651924 0.00096776 0.00067322 0.00103544 0.000680208 0.00106544 0.000695315 0.00109982 0.000720499 0.00115382 0.000763117 0.001255 0.000853267 0.00149636 0.00113995 0.00277751 0.00239734 0.00971153 0.0318997	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG2 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0217976 0.0303963 0.0177229 0.0360543 0.0379553 0.0459079 0.0446253 0.0312796 0.0260845 0.0176811 0.023546 0.0159424 0.0188725 0.0166265 0.018829 0.048734 0.0345735 0.0193061 0.0145216 0.0199448 0.00606362 0.00428444 0.00732677 0.00283263 0.00909119 0.0191735 0.0196665 0.0306221 0.00945088 0.0100635 0.011405 0.0179439 0.0260509 0.0100838 0.0121008 0.00808488 0.00655331 0.00257469 0.00260316 0.0103921 0.00981467 0.0111133 0.0267045 0.0332434 0.0381274 0.0190474 0.0080252 0.00407439 0.00180959 0.00126702 0.00341525 0.00367736 0.00322953 0.00133765 0.0011464 0.00104576 0.000716303 0.00105198 0.000736807 0.00112173 0.000739963 0.00114874 0.000753137 0.00118155 0.000777929 0.00123596 0.000821664 0.00134037 0.000916132 0.00159493 0.00121932 0.00296522 0.00257759 0.0104472 0.0348054	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG2 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0229804 0.0320455 0.0186843 0.03801 0.040014 0.0483973 0.0470429 0.0329757 0.027503 0.0186406 0.0248254 0.0168112 0.01991 0.0175456 0.0198699 0.0514284 0.0364664 0.0203587 0.015315 0.0210088 0.00638725 0.00451147 0.0077163 0.00298622 0.00957066 0.0201016 0.0205793 0.0317052 0.0097156 0.0103533 0.0115905 0.0179439 0.0251904 0.00930502 0.0109399 0.00700219 0.00571938 0.00231193 0.00220118 0.00960903 0.0067686 0.00594384 0.0117766 0.0214841 0.0167742 0.0122785 0.00814448 0.00442589 0.00308036 0.00342445 0.0119809 0.0112435 0.00886572 0.00342018 0.00302879 0.00469657 0.000963545 0.00107212 0.000803546 0.00105646 0.000788308 0.00105525 0.000786107 0.00107199 0.000800109 0.00111257 0.000835207 0.00120264 0.00091662 0.00142889 0.00121517 0.0028863 0.00273571 0.00999552 0.0366639	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230236 0.0321058 0.0187194 0.0380815 0.0400892 0.0484884 0.0471315 0.0330379 0.0275548 0.0186757 0.0248724 0.0168436 0.0199489 0.0175803 0.0199095 0.0515304 0.0365406 0.0204005 0.015347 0.0210523 0.00640022 0.00452073 0.00773155 0.00299277 0.00959132 0.0201442 0.0206259 0.0317602 0.00973085 0.0103662 0.0115997 0.0179405 0.0251515 0.00926873 0.0108825 0.00694883 0.00566874 0.00228611 0.00216464 0.00937728 0.00665312 0.00589863 0.0120531 0.0218466 0.0170996 0.0125292 0.00839323 0.00477447 0.00355908 0.00406706 0.0136911 0.011209 0.00668311 0.00255927 0.00188851 0.00165139 0.00161761 0.00411477 0.000803396 0.000985901 0.000765885 0.00101525 0.000760625 0.00103813 0.000776854 0.00108553 0.000814724 0.00118352 0.000899651 0.00141687 0.00118964 0.00283918 0.00266565 0.00972234 0.0356622	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230739 0.0321759 0.0187603 0.0381647 0.0401768 0.0485943 0.0472345 0.0331101 0.0276151 0.0187165 0.0249268 0.0168804 0.0199926 0.0176188 0.0199531 0.0516431 0.0366205 0.0204452 0.0153806 0.0210981 0.00641416 0.00453056 0.00774829 0.00299929 0.0096118 0.0201856 0.0206673 0.0318195 0.00974735 0.0103836 0.0116163 0.0179619 0.0251709 0.00927119 0.0108834 0.00694558 0.00566433 0.00228394 0.00215987 0.00934236 0.00661025 0.00584893 0.0119831 0.0216462 0.0169119 0.0123809 0.00824875 0.00480029 0.00358244 0.00406406 0.0134377 0.0105557 0.00608406 0.00225838 0.00158198 0.00128582 0.000808047 0.00146976 0.00161763 0.00391064 0.000809077 0.00102767 0.000794597 0.00106539 0.00079769 0.00110788 0.000830621 0.00120309 0.000911922 0.00143444 0.00119929 0.00287151 0.00268839 0.00992335 0.0366604	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230934 0.0322032 0.0187762 0.038197 0.0402108 0.0486354 0.0472744 0.0331381 0.0276385 0.0187324 0.0249479 0.0168947 0.0200096 0.0176339 0.0199701 0.0516871 0.0366516 0.0204625 0.0153936 0.0211158 0.00641952 0.00453433 0.0077547 0.00300182 0.00961949 0.0202002 0.0206813 0.0318371 0.0097514 0.010388 0.0116187 0.017962 0.0251608 0.00926269 0.0108712 0.00693393 0.00565393 0.00227989 0.00215381 0.00930807 0.006567 0.00579344 0.0118736 0.021412 0.0167034 0.0122451 0.00813081 0.00482067 0.00360517 0.00407839 0.0134445 0.0103932 0.00591336 0.00215695 0.00148554 0.00122088 0.000747685 0.00115 0.000828832 0.00153415 0.00163541 0.00395404 0.000827256 0.00107041 0.000825933 0.00112582 0.000845767 0.00121622 0.000921375 0.0014444 0.00120069 0.00288443 0.00269806 0.0100101 0.037176	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230949 0.0322053 0.0187774 0.0381995 0.0402134 0.0486386 0.0472774 0.0331402 0.0276403 0.0187336 0.0249495 0.0168959 0.020011 0.0176351 0.0199715 0.0516906 0.036654 0.0204638 0.0153946 0.021117 0.00641988 0.00453457 0.00775509 0.00300199 0.00961981 0.0201999 0.0206804 0.0318332 0.00974946 0.010386 0.0116148 0.0179538 0.025143 0.00925331 0.0108589 0.00692378 0.00564536 0.00227663 0.00214946 0.00928481 0.00653718 0.00575505 0.0117964 0.0212559 0.0165716 0.0121642 0.00806058 0.00483791 0.00362802 0.0040971 0.013473 0.0103192 0.00583821 0.00211565 0.0014471 0.00119257 0.000729697 0.0011089 0.000768194 0.00120789 0.000834277 0.00155693 0.00164448 0.00405347 0.000856266 0.00113163 0.000875808 0.00123372 0.000937263 0.00145776 0.00120489 0.0028995 0.00271513 0.0100852 0.0376217	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230827 0.0321882 0.0187675 0.0381793 0.0401921 0.0486128 0.0472524 0.0331227 0.0276257 0.0187237 0.0249364 0.0168869 0.0200005 0.0176259 0.019961 0.0516635 0.0366347 0.020453 0.0153865 0.0211058 0.00641646 0.00453215 0.00775092 0.00300041 0.00961456 0.0201883 0.0206681 0.0318127 0.00974277 0.0103788 0.0116057 0.0179383 0.0251167 0.00924162 0.0108441 0.0069127 0.00563632 0.0022731 0.00214529 0.00926352 0.00651368 0.00572635 0.011743 0.0211533 0.0164947 0.0121228 0.0080254 0.00485776 0.00365506 0.00412625 0.0135406 0.0103061 0.00580971 0.00210203 0.00143437 0.00118331 0.000722179 0.00109433 0.000753812 0.00116441 0.000771714 0.00122489 0.000843182 0.0015796 0.00165805 0.00420749 0.000907056 0.0012449 0.00097152 0.00147963 0.00121501 0.00291634 0.00274775 0.0101497 0.0380702	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230577 0.0321534 0.0187472 0.0381379 0.0401486 0.0485602 0.0472013 0.0330868 0.0275958 0.0187034 0.0249094 0.0168687 0.019979 0.0176069 0.0199396 0.051608 0.0365954 0.0204311 0.01537 0.021083 0.00640954 0.00452725 0.00774252 0.00299719 0.00960415 0.020166 0.0206453 0.0317762 0.00973142 0.0103667 0.0115914 0.0179148 0.02508 0.00922628 0.0108249 0.00689891 0.00562524 0.00226865 0.0021404 0.00923971 0.00649256 0.00570259 0.0117058 0.0210886 0.0164602 0.0121139 0.00802023 0.00488393 0.00368975 0.00417088 0.0136725 0.0103604 0.00582169 0.00210637 0.00143492 0.00118254 0.000719477 0.00109254 0.000748679 0.00115125 0.000758653 0.00118386 0.000779974 0.00124373 0.000859989 0.00160978 0.00168756 0.00448213 0.00101011 0.00151179 0.00124445 0.0029267 0.00281249 0.0101783 0.0385316	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0230128 0.0320907 0.0187106 0.0380636 0.0400704 0.0484656 0.0471093 0.0330224 0.0275421 0.018667 0.0248609 0.0168359 0.0199402 0.0175728 0.019901 0.0515081 0.0365247 0.0203916 0.0153404 0.0210423 0.00639713 0.00451848 0.00772748 0.00299143 0.00958563 0.020127 0.0206055 0.0317135 0.00971241 0.0103463 0.011568 0.0178773 0.0250237 0.00920346 0.0107963 0.00687888 0.0056093 0.00226213 0.00213356 0.0092084 0.00647097 0.00568039 0.0116817 0.0210557 0.0164649 0.0121359 0.00804584 0.00491971 0.00373685 0.00424057 0.0139198 0.0105216 0.00589055 0.0021316 0.00144747 0.00118685 0.000719332 0.00109548 0.000747367 0.00114945 0.000754556 0.00117192 0.000768263 0.00120542 0.000796665 0.00127306 0.000887228 0.00165422 0.00179925 0.00526995 0.00129082 0.00292858 0.00303242 0.0100867 0.0388805	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	4	0.0229929 0.032063 0.0186945 0.0380307 0.0400358 0.0484237 0.0470686 0.0329938 0.0275184 0.0186509 0.0248396 0.0168216 0.0199234 0.0175581 0.0198843 0.0514644 0.0364941 0.0203746 0.0153277 0.0210246 0.00639174 0.00451466 0.00772082 0.00298892 0.00957729 0.0201086 0.0205865 0.0316782 0.00970033 0.0103328 0.0115495 0.0178458 0.024967 0.00917844 0.0107637 0.00685373 0.00558834 0.00225296 0.00212302 0.00917795 0.00645476 0.00565678 0.011684 0.0210532 0.016535 0.0121543 0.00804668 0.00494029 0.00374381 0.00423213 0.0136391 0.0101781 0.0058064 0.00213422 0.00145924 0.0012079 0.000724749 0.00112293 0.000757124 0.00118039 0.000765553 0.00120327 0.000779436 0.00123128 0.00080385 0.00127563 0.00084531 0.00135917 0.00095013 0.00181655 0.00225888 0.00735964 0.00370498 0.00988657 0.0389641	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	4	0.0226262 0.0315517 0.0183963 0.0374242 0.0393973 0.0476515 0.0463181 0.0324678 0.0270795 0.0183535 0.0244436 0.0165535 0.0196059 0.0172783 0.0195675 0.0506448 0.0359132 0.0200501 0.0150836 0.0206901 0.00628995 0.00444277 0.00759784 0.00294135 0.00942589 0.0197939 0.0202676 0.0311895 0.00955144 0.0101722 0.011373 0.0175746 0.0246026 0.00904787 0.0106123 0.006763 0.00551725 0.00222414 0.00209997 0.00909274 0.00647791 0.00573454 0.0119582 0.0216557 0.0170615 0.0124456 0.00836411 0.00488177 0.00366747 0.00420378 0.0138433 0.0107875 0.00567108 0.00213595 0.00145985 0.00109127 0.00066641 0.000976833 0.000683687 0.00100703 0.000685019 0.00101438 0.000690516 0.00102542 0.000704572 0.00104804 0.000734915 0.0011011 0.000808454 0.00127825 0.00119215 0.0030804 0.00553474 0.0221749 0.0424772	A multiple dose drug-drug interaction study demonstrated that DRUG1 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
4	4	0.0116163 0.0152371 0.00773449 0.0178403 0.0113973 0.0118392 0.0102976 0.00878866 0.0182445 0.0331702 0.0680706 0.0552547 0.0296449 0.0222848 0.0238958 0.0443145 0.0450927 0.0287897 0.0306985 0.0527944 0.0255961 0.034625 0.0425293 0.0212974 0.0275108 0.0159743 0.0195966 0.0322641 0.00988123 0.0113173 0.0103386 0.0161381 0.0224197 0.00851285 0.00978409 0.00609523 0.00447909 0.00175987 0.00160042 0.00730662 0.00498654 0.00406371 0.0075121 0.0128259 0.00935142 0.00738577 0.00445257 0.00288691 0.00160005 0.00123049 0.00302901 0.00282437 0.00248985 0.00107895 0.000953185 0.000880566 0.000603659 0.000894953 0.000623224 0.000957232 0.000629556 0.000984761 0.00064341 0.0010164 0.000666608 0.00106618 0.000705944 0.00115957 0.000789228 0.00138246 0.00105421 0.00256674 0.00221684 0.00897704 0.029478	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG2 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0131798 0.0172106 0.00864106 0.0199355 0.0126948 0.0132386 0.0115607 0.0098634 0.0203788 0.0365311 0.0737773 0.0598058 0.0325393 0.0256605 0.0279411 0.0554493 0.0427434 0.0211518 0.0162838 0.0215842 0.00645078 0.00462948 0.00762602 0.0028698 0.00914371 0.0191747 0.0194552 0.0296583 0.00905179 0.00969994 0.0107903 0.0168545 0.0238833 0.00878101 0.0102311 0.0065432 0.00538192 0.00218232 0.00207042 0.0088964 0.00799131 0.0103481 0.0219956 0.0352674 0.0241302 0.0290704 0.0287765 0.0125405 0.00232741 0.00156183 0.00310524 0.0032467 0.00274898 0.00127391 0.00107634 0.000965239 0.00069425 0.00097804 0.000709315 0.00103325 0.000706473 0.00105231 0.000714336 0.00107807 0.000734226 0.00112452 0.000772287 0.0012177 0.000855609 0.00144394 0.00113521 0.00277087 0.00242757 0.00931661 0.0312648	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG2 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0140947 0.018405 0.00924049 0.0213189 0.0135759 0.0141573 0.0123636 0.010548 0.0217953 0.0390749 0.0789123 0.0639826 0.0348168 0.0274627 0.0299003 0.0593311 0.0457388 0.0226332 0.0174194 0.0230808 0.00690039 0.00495163 0.00815787 0.00306642 0.00977211 0.0204934 0.0207784 0.0315608 0.00960578 0.010263 0.0113334 0.017587 0.0245468 0.00906395 0.0106629 0.00681265 0.00552701 0.0022282 0.00212117 0.00927605 0.00653981 0.00574403 0.0113728 0.0207448 0.0161828 0.0118361 0.00785439 0.00426796 0.00296977 0.00330121 0.0115467 0.01084 0.00854573 0.00329631 0.00291858 0.00452633 0.000928663 0.00103329 0.000774375 0.00101825 0.000759677 0.00101711 0.000757547 0.00103324 0.000771034 0.00107233 0.000804857 0.00115914 0.000883321 0.00137721 0.00117105 0.00278178 0.00263639 0.00963217 0.0353402	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141204 0.0184385 0.00925729 0.0213577 0.0136006 0.0141831 0.0123861 0.0105672 0.0218352 0.0391468 0.0790575 0.0641017 0.0348822 0.0275149 0.0299575 0.0594446 0.0458288 0.0226784 0.0174548 0.0231272 0.00691398 0.0049615 0.00817355 0.00307296 0.00979268 0.0205356 0.0208244 0.0316138 0.00962018 0.010275 0.0113416 0.0175826 0.0245077 0.00902822 0.010606 0.00676015 0.00547773 0.00220318 0.00208588 0.00905159 0.00642802 0.00570005 0.0116391 0.0210925 0.016494 0.0120762 0.00809317 0.00460356 0.00343089 0.0039201 0.0131938 0.0108056 0.0064411 0.00246611 0.00181957 0.0015911 0.00155861 0.00396488 0.000774129 0.000950071 0.000737936 0.000978373 0.000732855 0.00100042 0.000748486 0.00104609 0.000784976 0.00114051 0.000866815 0.00136538 0.00114624 0.00273586 0.00256841 0.00936711 0.0343692	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141502 0.0184774 0.00927683 0.0214028 0.0136294 0.0142131 0.0124123 0.0105895 0.0218813 0.0392295 0.0792245 0.0642372 0.034956 0.0275732 0.0300209 0.0595701 0.0459256 0.0227264 0.0174917 0.0231758 0.00692852 0.00497193 0.00819065 0.00307943 0.00981286 0.0205763 0.0208646 0.0316705 0.00963573 0.0102915 0.0113569 0.0176024 0.0245248 0.00903002 0.010606 0.00675643 0.00547306 0.00220093 0.00208114 0.00901722 0.00638612 0.00565158 0.0115707 0.0208973 0.0163114 0.0119323 0.00795321 0.00462806 0.00345312 0.00391687 0.0129485 0.010175 0.00586322 0.00217594 0.00152407 0.00123874 0.000778438 0.0014161 0.0015585 0.00376786 0.000779545 0.000990272 0.000765543 0.00102661 0.000768513 0.00106755 0.000800236 0.00115928 0.00087857 0.0013822 0.00115545 0.00276675 0.0025901 0.00955984 0.0353279	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141618 0.0184926 0.00928445 0.0214204 0.0136406 0.0142248 0.0124225 0.0105982 0.0218993 0.0392618 0.0792896 0.0642902 0.0349849 0.027596 0.0300457 0.0596193 0.0459634 0.0227451 0.0175061 0.0231947 0.00693414 0.00497594 0.00819721 0.00308194 0.00982045 0.0205906 0.0208782 0.0316872 0.00963944 0.0102956 0.0113589 0.017602 0.0245144 0.00902157 0.0105937 0.00674487 0.00546285 0.00219697 0.00207527 0.00898388 0.00634416 0.0055978 0.0114646 0.0206706 0.0161098 0.0118011 0.00783927 0.00464755 0.00347492 0.00393054 0.0129548 0.0100181 0.00569852 0.00207813 0.0014311 0.00117612 0.000720256 0.00110799 0.000798434 0.00147808 0.00157558 0.00380952 0.000797033 0.00103144 0.000795712 0.00108482 0.000814816 0.00117191 0.000887657 0.00139176 0.00115676 0.00277913 0.00259933 0.00964303 0.0358233	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141628 0.0184938 0.00928505 0.0214217 0.0136414 0.0142257 0.0124233 0.0105989 0.0219008 0.0392643 0.0792948 0.0642945 0.0349873 0.0275979 0.0300478 0.0596233 0.0459664 0.0227466 0.0175072 0.023196 0.00693453 0.0049762 0.00819762 0.00308212 0.00982078 0.0205903 0.0208772 0.0316834 0.00963749 0.0102935 0.011355 0.017594 0.024497 0.00901247 0.0105817 0.00673496 0.00545456 0.00219383 0.0020711 0.00896144 0.00631535 0.00556069 0.01139 0.0205198 0.0159826 0.0117231 0.00777154 0.00466414 0.00349693 0.00394856 0.0129822 0.0099468 0.00562608 0.00203834 0.00139406 0.00114883 0.000702921 0.00106839 0.000740011 0.00116377 0.000803671 0.00149999 0.00158431 0.00390528 0.000824978 0.00109044 0.000843765 0.00118879 0.000902973 0.00140465 0.00116081 0.00279368 0.00261577 0.00971536 0.0362523	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141556 0.0184844 0.00928033 0.0214108 0.0136345 0.0142184 0.012417 0.0105935 0.0218896 0.0392445 0.0792545 0.064262 0.0349697 0.0275841 0.0300327 0.0595933 0.0459433 0.0227351 0.0174984 0.0231842 0.00693098 0.00497365 0.00819339 0.00308055 0.00981563 0.0205789 0.0208653 0.0316636 0.00963106 0.0102867 0.0113464 0.0175792 0.024472 0.00900132 0.0105674 0.0067243 0.00544595 0.00219048 0.00206713 0.00894109 0.00629278 0.00553308 0.0113387 0.0204212 0.0159086 0.0116834 0.00773777 0.00468337 0.00352306 0.00397672 0.0130475 0.00993432 0.00559871 0.00202524 0.00138183 0.00113993 0.000695687 0.00105436 0.000726167 0.00112189 0.00074341 0.00118014 0.000812264 0.00152184 0.00159743 0.00405372 0.000873931 0.00119961 0.000936001 0.00142577 0.0011706 0.00281001 0.00264725 0.00977767 0.0366848	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141408 0.0184652 0.00927067 0.0213886 0.0136203 0.0142036 0.0124041 0.0105825 0.0218669 0.0392037 0.0791721 0.0641954 0.0349335 0.0275556 0.0300016 0.0595317 0.0458958 0.0227116 0.0174804 0.0231602 0.00692379 0.00496848 0.00818484 0.00307737 0.0098054 0.0205571 0.0208431 0.0316286 0.00962022 0.0102751 0.0113328 0.0175568 0.0244373 0.00898677 0.0105491 0.00671115 0.00543547 0.00218628 0.00206251 0.00891848 0.00627265 0.00551035 0.0113033 0.0203594 0.0158759 0.0116752 0.00773307 0.00470876 0.00355662 0.00401987 0.0131752 0.00998704 0.00561047 0.0020295 0.0013824 0.00113923 0.000693109 0.00105268 0.000721246 0.00110926 0.000730853 0.00114065 0.000751395 0.00119832 0.00082849 0.00155095 0.00162593 0.00431847 0.000973255 0.00145685 0.00119901 0.00282017 0.00270974 0.00980571 0.0371301	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0141143 0.0184305 0.00925327 0.0213484 0.0135948 0.014177 0.0123808 0.0105627 0.0218259 0.0391302 0.0790238 0.0640752 0.0348682 0.0275042 0.0299457 0.0594208 0.0458104 0.0226694 0.017448 0.0231171 0.00691089 0.00495922 0.00816954 0.00307168 0.0097872 0.0205188 0.0208045 0.0315686 0.00960212 0.0102556 0.0113107 0.0175214 0.0243843 0.00896522 0.010522 0.00669212 0.00542047 0.00218016 0.00205608 0.0088889 0.00625225 0.0054893 0.0112808 0.0203291 0.0158813 0.0116972 0.00775825 0.00474356 0.00360225 0.0040873 0.0134143 0.0101431 0.00567719 0.00205395 0.00139458 0.00114345 0.000693013 0.00105558 0.000720029 0.0011076 0.000726952 0.00112923 0.00074016 0.00116148 0.000767529 0.00122664 0.000854793 0.00159386 0.00173367 0.00507784 0.00124381 0.00282218 0.00292174 0.00971814 0.0374679	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	4	0.0141027 0.0184154 0.00924566 0.0213309 0.0135836 0.0141653 0.0123706 0.010554 0.021808 0.0390982 0.0789592 0.0640234 0.0348402 0.0274823 0.0299218 0.0593729 0.0457741 0.0226515 0.0174343 0.0230988 0.00690536 0.00495525 0.00816286 0.00306924 0.00977914 0.0205009 0.0207862 0.0315348 0.00959057 0.0102426 0.0112931 0.0174914 0.0243302 0.00894133 0.0104905 0.00666792 0.00540049 0.00217143 0.00204603 0.00885986 0.00623684 0.00546669 0.0112835 0.0203271 0.015949 0.011715 0.00775913 0.00476344 0.003609 0.00407919 0.013144 0.0098121 0.00559613 0.00205646 0.00140591 0.00116372 0.000698229 0.00108201 0.000729426 0.00113739 0.000737546 0.00115942 0.000750923 0.00118638 0.000774451 0.00122909 0.000814405 0.00130957 0.000915408 0.00175023 0.00217655 0.00709143 0.00357006 0.00952587 0.0375424	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	4	0.0138858 0.0181322 0.00910347 0.0210028 0.0133747 0.0139475 0.0121804 0.0103917 0.0214727 0.0384971 0.0777452 0.063039 0.0343049 0.02706 0.0294623 0.0584614 0.0450716 0.0223036 0.0171666 0.0227444 0.00679934 0.00487918 0.00803754 0.00302215 0.00963015 0.0201919 0.0204761 0.0310663 0.00944892 0.0100893 0.0111271 0.0172355 0.0239888 0.00881913 0.0103492 0.00658353 0.0053349 0.00214491 0.00202496 0.00878257 0.00626291 0.00554514 0.0115552 0.0209209 0.0164662 0.0120024 0.00806959 0.00470964 0.00353738 0.00405414 0.0133483 0.0104052 0.00546875 0.00205936 0.00140734 0.001052 0.000642413 0.00094182 0.000659071 0.000970937 0.00066035 0.000978007 0.000665651 0.000988635 0.000679206 0.00101042 0.000708465 0.00106155 0.000779371 0.0012323 0.00114934 0.0029694 0.00533535 0.0213758 0.0409488	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG1 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
3	4	0.0113181 0.013638 0.00705955 0.0156133 0.0082634 0.00780628 0.00653501 0.00393964 0.00774508 0.00756896 0.017131 0.0174941 0.0254565 0.0219403 0.0238648 0.0794934 0.0449116 0.0488083 0.0341503 0.040936 0.0294039 0.0358181 0.0558101 0.0289303 0.0356069 0.0227341 0.0274789 0.0432922 0.0139351 0.0152658 0.0134341 0.0188209 0.0259679 0.0100404 0.0112583 0.00705404 0.00515027 0.00201822 0.00181559 0.00843541 0.00580736 0.00472827 0.00874201 0.0149449 0.0108525 0.0085899 0.00518689 0.00335653 0.00185905 0.00143005 0.00351721 0.00328304 0.00288956 0.00125075 0.00110457 0.00102057 0.00069949 0.00103823 0.000722341 0.00111083 0.000729815 0.00114296 0.000745991 0.0011798 0.000772983 0.00123767 0.000818682 0.00134615 0.000915359 0.00160497 0.0012229 0.00297948 0.00257139 0.0104109 0.0342426	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG2 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0118852 0.0145468 0.00765336 0.0171126 0.00898786 0.00844858 0.00716044 0.00397573 0.00787395 0.00750099 0.0174251 0.0174771 0.0250853 0.0205943 0.0251239 0.0901551 0.0449423 0.0391057 0.0274158 0.0287719 0.0120444 0.010049 0.0129103 0.00598875 0.0172038 0.0354507 0.0317889 0.0423315 0.0126112 0.0140785 0.0139241 0.0211278 0.0281133 0.0105096 0.0120744 0.00755486 0.00578892 0.00228129 0.00214352 0.00949641 0.008659 0.0112822 0.0238265 0.038091 0.025732 0.0305783 0.0302729 0.0131947 0.00245182 0.0016435 0.00325205 0.00339765 0.0028659 0.00132109 0.00111412 0.000999335 0.000719283 0.00101582 0.000735187 0.00107409 0.000732669 0.00109432 0.000741139 0.00112136 0.00076206 0.00116987 0.000801838 0.00126691 0.000888632 0.0015022 0.00117942 0.00287972 0.00252115 0.00967097 0.0327281	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG2 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0127679 0.0156272 0.00822181 0.0183837 0.00965548 0.00907619 0.00769253 0.00427115 0.00845926 0.00805863 0.0187207 0.0187768 0.0269526 0.0221277 0.0269963 0.0968516 0.0482798 0.0420195 0.029463 0.0309141 0.0129477 0.0108041 0.0138791 0.00643194 0.0185041 0.0381272 0.0341931 0.045415 0.0134551 0.0149948 0.0146977 0.0221753 0.029065 0.0109204 0.0126417 0.00790211 0.00597574 0.0023405 0.00221193 0.00999027 0.00713277 0.00629379 0.0123722 0.0225504 0.0173267 0.012494 0.00836688 0.00453908 0.00314451 0.00348541 0.0121333 0.0114699 0.00901641 0.00346996 0.00306297 0.00476228 0.000977901 0.00108751 0.00081387 0.00107255 0.000798175 0.00107164 0.000795778 0.00108845 0.000809837 0.00112939 0.000845368 0.00122068 0.000927946 0.00145026 0.00123063 0.00292618 0.00277004 0.0101078 0.0372665	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0127965 0.0156622 0.0082402 0.0184249 0.00967709 0.00909651 0.00770977 0.00428072 0.00847826 0.00807673 0.0187628 0.0188191 0.0270136 0.0221778 0.0270576 0.0970691 0.048388 0.0421151 0.0295312 0.0309858 0.0129777 0.0108293 0.0139114 0.00644765 0.0185498 0.0382184 0.0342802 0.0455119 0.0134796 0.0150169 0.0147126 0.0221792 0.029034 0.0108841 0.0125758 0.00784202 0.00592426 0.0023149 0.00217638 0.00974945 0.00701549 0.00624877 0.0126681 0.0229205 0.0176382 0.0127387 0.00861273 0.0048935 0.00363084 0.00413408 0.0138643 0.0114291 0.00679317 0.00259115 0.00190816 0.00166879 0.0016362 0.00416423 0.000813259 0.00099931 0.000774192 0.0010292 0.000768577 0.00105226 0.000784866 0.00110007 0.000823185 0.00119922 0.000909217 0.00143556 0.00120277 0.00287304 0.00269436 0.00981148 0.0361948	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0128262 0.0156987 0.00825938 0.0184677 0.00969961 0.00911768 0.00772772 0.00429068 0.00849798 0.00809553 0.0188065 0.0188628 0.0270764 0.0222293 0.0271203 0.0972939 0.0484999 0.0422127 0.0295996 0.0310574 0.0130078 0.0108543 0.0139435 0.0064625 0.018592 0.0383023 0.0343543 0.0456042 0.0135042 0.015044 0.0147352 0.0222093 0.029061 0.0108893 0.0125775 0.00783868 0.00592033 0.00231299 0.00217206 0.00971411 0.00697121 0.00619679 0.0125961 0.022711 0.0174424 0.0125881 0.00846461 0.00491968 0.00365452 0.0041304 0.0136072 0.010763 0.00618353 0.00228559 0.00159773 0.00129864 0.000815795 0.00148727 0.00163629 0.00395798 0.000819059 0.0010421 0.000803214 0.00108004 0.000806145 0.00112288 0.00083938 0.00121908 0.000921663 0.00145323 0.00121248 0.00290526 0.00271716 0.0100114 0.0371999	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0128384 0.0157136 0.00826723 0.0184853 0.00970883 0.00912635 0.00773506 0.00429476 0.00850606 0.00810322 0.0188243 0.0188807 0.027102 0.0222503 0.0271459 0.0973853 0.0485452 0.0422524 0.0296273 0.0310862 0.0130199 0.0108644 0.0139563 0.00646847 0.0186085 0.0383339 0.0343816 0.0456349 0.0135109 0.0150517 0.0147391 0.0222119 0.0290529 0.0108811 0.0125635 0.00782549 0.00590988 0.00230912 0.00216637 0.00967908 0.0069261 0.00613839 0.012482 0.0224664 0.0172262 0.0124502 0.00834398 0.00494035 0.00367762 0.00414461 0.0136147 0.0105984 0.00601003 0.00218272 0.00150015 0.00123273 0.000754685 0.00116398 0.000836853 0.00155227 0.00165408 0.0040008 0.000837306 0.00108558 0.000834915 0.00114132 0.00085487 0.00123271 0.000931318 0.00146355 0.00121392 0.00291858 0.00272686 0.0100978 0.0377163	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.01284 0.0157156 0.00826827 0.0184876 0.00971004 0.00912749 0.00773603 0.0042953 0.00850712 0.00810423 0.0188267 0.018883 0.0271053 0.0222529 0.0271492 0.0973968 0.0485508 0.0422574 0.0296308 0.0310896 0.0130214 0.0108656 0.0139578 0.00646914 0.0186102 0.0383357 0.0343825 0.0456328 0.0135088 0.0150496 0.0147347 0.0222033 0.0290344 0.0108712 0.0125493 0.00781398 0.00590118 0.00230596 0.00216226 0.00965531 0.00689494 0.00609792 0.0124013 0.0223032 0.0170895 0.012368 0.00827215 0.00495787 0.00370086 0.00416343 0.0136437 0.0105236 0.00593363 0.00214081 0.0014612 0.00120395 0.000736449 0.00112228 0.000775497 0.00122248 0.000842178 0.00157453 0.00166315 0.00410053 0.000866595 0.00114775 0.000885395 0.00125074 0.000947539 0.00147749 0.00121826 0.00293456 0.00274419 0.0101732 0.0381619	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0128338 0.0157079 0.00826422 0.0184786 0.00970528 0.00912302 0.00773224 0.00429319 0.00850295 0.00810026 0.0188175 0.0188738 0.027092 0.022242 0.0271359 0.0973487 0.0485268 0.0422366 0.0296162 0.0310741 0.0130149 0.0108601 0.0139508 0.00646589 0.0186007 0.0383151 0.0343638 0.0456058 0.0134999 0.0150398 0.0147235 0.0221852 0.0290055 0.0108582 0.0125322 0.00780141 0.00589193 0.00230249 0.00215824 0.00963347 0.00687039 0.00606767 0.0123456 0.0221955 0.0170092 0.0123257 0.00823597 0.004978 0.00372831 0.0041928 0.0137118 0.0105101 0.00590449 0.00212691 0.00144824 0.00119447 0.000728793 0.00110745 0.000760896 0.00117841 0.000778875 0.00123907 0.000851094 0.00159689 0.00167686 0.00425567 0.000917972 0.00126264 0.000982228 0.00149998 0.00122859 0.00295265 0.00277725 0.0102381 0.0386076	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0128203 0.0156913 0.00825553 0.0184591 0.00969508 0.00911343 0.00772412 0.00428868 0.00849401 0.00809174 0.0187977 0.0188539 0.0270635 0.0222186 0.0271074 0.0972461 0.0484756 0.0421922 0.0295851 0.0310413 0.0130012 0.0108487 0.013936 0.00645908 0.018581 0.0382741 0.0343271 0.0455554 0.0134845 0.0150227 0.0147055 0.0221569 0.0289645 0.0108408 0.0125098 0.00778578 0.00588053 0.00229808 0.00215347 0.00960893 0.00684835 0.00604265 0.0123069 0.0221271 0.016972 0.0123159 0.00823021 0.00500445 0.00376346 0.00423777 0.0138448 0.010565 0.00591634 0.00213117 0.00144868 0.00119356 0.000725995 0.00110556 0.000755631 0.00116502 0.000765596 0.0011975 0.000787119 0.00125763 0.000868068 0.00162697 0.00170671 0.00453281 0.00102224 0.00153317 0.00125823 0.00296428 0.00284264 0.010267 0.0390607	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0127956 0.0156612 0.00823966 0.0184237 0.00967645 0.00909592 0.00770927 0.00428044 0.00847769 0.0080762 0.0187616 0.0188177 0.0270116 0.022176 0.0270553 0.0970592 0.0483824 0.0421113 0.0295284 0.0309818 0.0129762 0.0108278 0.0139093 0.00644673 0.0185455 0.0382008 0.0342621 0.0454675 0.0134584 0.0149936 0.0146761 0.0221114 0.0289011 0.0108145 0.0124767 0.00776305 0.00586407 0.00229156 0.00214674 0.00957648 0.00682585 0.0060193 0.0122819 0.0220914 0.0169739 0.0123369 0.00825535 0.0050404 0.00381104 0.00430791 0.0140938 0.010728 0.00598569 0.00215653 0.00146122 0.00119777 0.000725752 0.00110841 0.000754206 0.00116308 0.000761347 0.00118533 0.00077517 0.00121877 0.000803928 0.00128682 0.00089558 0.00167146 0.00181961 0.00532849 0.00130616 0.00296616 0.00306287 0.0101742 0.0393948	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	4	0.0127877 0.0156515 0.00823456 0.0184123 0.00967046 0.00909029 0.0077045 0.00427779 0.00847245 0.00807121 0.01875 0.0188061 0.0269949 0.0221622 0.0270386 0.0969983 0.0483518 0.0420854 0.0295106 0.030963 0.0129685 0.0108214 0.0139008 0.00644283 0.0185343 0.0381755 0.0342399 0.0454308 0.0134452 0.0149784 0.0146563 0.0220792 0.0288444 0.0107889 0.0124413 0.00773606 0.00584404 0.00228293 0.00213685 0.00954675 0.00681015 0.00599547 0.0122874 0.0220878 0.0170384 0.012351 0.0082527 0.00505923 0.00381667 0.00429741 0.013804 0.0103746 0.00589741 0.00215773 0.00147194 0.0012181 0.00073077 0.00113521 0.00076358 0.00119337 0.000771988 0.00121603 0.000785994 0.00124389 0.000810724 0.00128834 0.000852722 0.00137248 0.000958764 0.00183389 0.00228316 0.00743821 0.00374702 0.0099763 0.03935	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	4	0.0125818 0.0153994 0.00810195 0.0181158 0.00951473 0.00894391 0.00758045 0.00420891 0.00833606 0.00794127 0.0184482 0.0185034 0.0265606 0.0218058 0.0266039 0.0954384 0.0475745 0.0414086 0.0290366 0.030466 0.0127601 0.0106476 0.0136777 0.00633945 0.0182386 0.0375703 0.0337008 0.0447196 0.0132367 0.0147424 0.0144303 0.0217387 0.0284172 0.0106327 0.0122661 0.00763341 0.00576906 0.00225352 0.00211307 0.00945588 0.00683441 0.00607781 0.0125759 0.0227129 0.0175719 0.0126389 0.00857102 0.00499673 0.00373709 0.00426682 0.0140058 0.010987 0.00575565 0.00215924 0.00147276 0.00110072 0.000672057 0.000988038 0.00068963 0.00101858 0.000690825 0.00102557 0.000696344 0.00103631 0.000710597 0.00105876 0.000741363 0.00111194 0.000815843 0.00129032 0.00120441 0.00310402 0.00557887 0.022343 0.0428453	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG1 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
4	4	0.0115332 0.0138586 0.00696488 0.0156183 0.00803109 0.00751607 0.00619326 0.00374291 0.0074425 0.00650112 0.0149947 0.0181056 0.0235052 0.0169285 0.012545 0.0367288 0.0397863 0.0290248 0.0309158 0.0508745 0.0195485 0.0252423 0.0402314 0.0159419 0.0499436 0.0218 0.0173654 0.0358066 0.0120723 0.0136157 0.0165168 0.0228382 0.0310644 0.013037 0.0149171 0.00992766 0.00723263 0.00269658 0.00260054 0.0115016 0.0112947 0.0128096 0.0302508 0.036925 0.0415856 0.0203493 0.00873914 0.00448 0.00197691 0.00137062 0.00366125 0.00396332 0.00346216 0.00142286 0.00121315 0.00110907 0.000760132 0.00111992 0.000782487 0.00119513 0.000786312 0.00122415 0.00080062 0.00125916 0.000827236 0.0013171 0.000873996 0.00142819 0.000974774 0.00169894 0.00129783 0.00315408 0.00274056 0.0110851 0.0373497	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG2 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0122558 0.014727 0.00740123 0.0165967 0.00853406 0.00798684 0.00658102 0.00397737 0.00790833 0.00690813 0.0159335 0.0192387 0.0249754 0.0179873 0.0133298 0.039029 0.0422762 0.0308448 0.0328465 0.0540378 0.0207597 0.0268039 0.04272 0.0169278 0.0529502 0.0229914 0.0183274 0.0374797 0.0124825 0.0139634 0.0168097 0.0229985 0.0303538 0.0122377 0.0133954 0.00859339 0.00635258 0.00244666 0.00224493 0.0105875 0.00774512 0.00682589 0.0133755 0.0244159 0.018601 0.0133196 0.00897623 0.00486559 0.00336069 0.00372455 0.0129438 0.012289 0.00964336 0.00370615 0.00326481 0.00508341 0.00104456 0.00116169 0.000868716 0.00114618 0.000851801 0.00114531 0.000849139 0.00116313 0.000864075 0.00120671 0.000901991 0.00130417 0.0009902 0.00154942 0.00131345 0.00312456 0.00295632 0.0107782 0.0398382	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0122867 0.014764 0.00741987 0.0166385 0.00855556 0.00800696 0.00659759 0.00398739 0.00792826 0.00692555 0.0159737 0.0192873 0.0250385 0.0180328 0.0133635 0.0391277 0.0423836 0.0309234 0.0329304 0.0541764 0.0208129 0.0268729 0.0428302 0.0169728 0.0530864 0.023048 0.0183739 0.0375688 0.0125073 0.0139867 0.0168327 0.0230155 0.0303355 0.0122051 0.013327 0.00853101 0.00629996 0.00242065 0.00220978 0.0103329 0.00762172 0.00677962 0.0137009 0.0248163 0.0189264 0.0135756 0.00923565 0.00524479 0.00387966 0.00441543 0.0147958 0.0122463 0.00726488 0.00276509 0.00203416 0.00177859 0.00174447 0.00444177 0.00086772 0.00106711 0.000825544 0.00109905 0.000819401 0.00112356 0.000836714 0.00117446 0.000877608 0.00128023 0.000969467 0.0015325 0.00128277 0.00306522 0.00287323 0.0104531 0.0386675	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0123174 0.0148009 0.00743841 0.0166801 0.00857693 0.00802696 0.00661408 0.00399736 0.00794806 0.00694285 0.0160136 0.0193355 0.025101 0.0180778 0.0133969 0.0392255 0.0424894 0.0310006 0.0330125 0.0543112 0.0208645 0.0269395 0.0429362 0.0170149 0.0532164 0.0231026 0.0184176 0.037654 0.0125332 0.014015 0.016863 0.0230543 0.0303709 0.0122143 0.0133305 0.00852887 0.00629706 0.00241913 0.0022059 0.0102968 0.00757466 0.00672416 0.0136252 0.0245926 0.0187171 0.0134162 0.00907742 0.00527315 0.00390518 0.00441144 0.0145226 0.0115335 0.00661299 0.00243864 0.00170296 0.0013839 0.000869173 0.00158648 0.0017453 0.00422318 0.000874112 0.00111316 0.000856585 0.00115344 0.000859605 0.00119902 0.000895027 0.00130155 0.000982846 0.0015514 0.00129322 0.00309958 0.00289767 0.0106655 0.03974	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.01233 0.014816 0.00744601 0.0166971 0.0085857 0.00803517 0.00662083 0.00400144 0.00795618 0.00694995 0.0160299 0.0193552 0.0251267 0.0180963 0.0134106 0.0392655 0.0425327 0.0310323 0.0330461 0.0543661 0.0208854 0.0269665 0.042979 0.017032 0.0532685 0.0231235 0.0184344 0.0376844 0.0125412 0.0140235 0.01687 0.0230618 0.030366 0.0122072 0.0133158 0.00851511 0.00628653 0.00241535 0.00220042 0.01026 0.00752578 0.00666097 0.0135025 0.0243289 0.0184848 0.0132693 0.0089481 0.00529518 0.00392982 0.00442639 0.0145309 0.0113577 0.00642741 0.00232874 0.00159887 0.00131356 0.00080401 0.00124179 0.000891835 0.00165584 0.00176431 0.00426844 0.000893531 0.00115969 0.000890423 0.00121892 0.000911653 0.00131632 0.000993203 0.00156257 0.00129476 0.00311395 0.00290799 0.0107569 0.0402882	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0123317 0.0148181 0.00744704 0.0166995 0.00858689 0.00803628 0.00662174 0.00400199 0.00795728 0.00695091 0.0160322 0.0193579 0.0251301 0.0180988 0.0134124 0.0392709 0.0425386 0.0310366 0.0330505 0.0543734 0.0208881 0.0269698 0.0429843 0.0170342 0.0532745 0.023125 0.0184359 0.0376848 0.01254 0.014022 0.0168662 0.0230554 0.0303483 0.0121968 0.0133003 0.00850268 0.0062775 0.00241215 0.00219637 0.0102347 0.00749178 0.00661699 0.0134152 0.024152 0.0183374 0.0131813 0.00887081 0.00531372 0.00395448 0.00444621 0.0145615 0.0112775 0.0063455 0.00228389 0.00155725 0.00128278 0.000784532 0.00119727 0.000826374 0.00130416 0.000897434 0.00167913 0.00177395 0.00437436 0.000924742 0.00122611 0.000944281 0.00133575 0.00101057 0.00157767 0.00129942 0.00313133 0.00292646 0.0108368 0.0407595	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0123253 0.0148104 0.0074432 0.0166908 0.00858245 0.00803213 0.00661833 0.00399993 0.00795317 0.00694732 0.0160239 0.0193479 0.0251171 0.0180894 0.0134055 0.0392507 0.0425166 0.0310206 0.0330335 0.0543452 0.0208772 0.0269557 0.0429618 0.0170254 0.0532463 0.0231121 0.0184258 0.0376625 0.0125318 0.0140127 0.0168537 0.0230375 0.0303183 0.0121824 0.0132814 0.00848877 0.00626763 0.00240853 0.00219232 0.0102112 0.00746481 0.00658393 0.0133546 0.0240344 0.0182497 0.0131354 0.00883144 0.00533488 0.00398351 0.00447719 0.0146335 0.0112626 0.00631391 0.00226889 0.00154329 0.00127255 0.000776306 0.00118138 0.000810739 0.00125709 0.00082987 0.00132146 0.000906871 0.0017026 0.0017885 0.00453933 0.00097951 0.00134878 0.00104755 0.00160184 0.00131043 0.00315109 0.00296164 0.0109053 0.0412284	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0123116 0.014794 0.00743493 0.0166723 0.00857292 0.00802321 0.00661098 0.00399549 0.00794433 0.0069396 0.0160061 0.0193264 0.0250892 0.0180693 0.0133906 0.0392071 0.0424695 0.0309862 0.0329968 0.0542849 0.020854 0.0269257 0.042914 0.0170065 0.053187 0.0230859 0.0184053 0.0376193 0.012517 0.0139961 0.0168327 0.0230082 0.0302746 0.0121625 0.0132565 0.00847126 0.0062553 0.00240384 0.00218742 0.0101846 0.00744044 0.00655641 0.013312 0.0239585 0.0182077 0.0131235 0.00882427 0.00536259 0.00402061 0.00452464 0.014774 0.0113202 0.00632593 0.00227321 0.00154359 0.00127143 0.00077323 0.00117924 0.000805026 0.00124271 0.000815616 0.00127703 0.000838558 0.00134086 0.000924905 0.0017343 0.00182023 0.00483431 0.00109068 0.00163754 0.00134187 0.00316394 0.00303111 0.0109353 0.041701	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0122866 0.0147639 0.00741981 0.0166384 0.00855549 0.0080069 0.00659753 0.00398736 0.00792818 0.0069255 0.0159736 0.0192871 0.0250382 0.0180326 0.0133634 0.0391275 0.0423832 0.0309233 0.0329299 0.0541749 0.0208117 0.0268711 0.042827 0.0169722 0.0530794 0.023039 0.0183683 0.0375431 0.0124915 0.0139676 0.0167978 0.0229598 0.0302061 0.0121321 0.0132194 0.00844564 0.00623735 0.00239687 0.00218043 0.0101491 0.00741531 0.00653046 0.0132838 0.0239166 0.0182061 0.0131434 0.0088495 0.00540007 0.0040707 0.00459862 0.0150375 0.0114929 0.006399 0.00229993 0.0015567 0.00127568 0.000772825 0.00118208 0.000803357 0.00124044 0.000810934 0.00126386 0.000825664 0.00129923 0.000856351 0.00137155 0.000954114 0.00178123 0.00194044 0.00568185 0.00139337 0.00316556 0.00326444 0.0108346 0.0420425	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	4	0.0122795 0.0147554 0.00741551 0.0166288 0.00855053 0.00800225 0.00659371 0.00398505 0.00792358 0.00692148 0.0159643 0.0192759 0.0250238 0.0180222 0.0133557 0.039105 0.0423589 0.0309056 0.032911 0.054144 0.0207998 0.0268556 0.0428024 0.0169626 0.0530481 0.0230245 0.0183579 0.0375193 0.0124814 0.0139556 0.0167793 0.0229335 0.0301544 0.0121059 0.0131826 0.00841709 0.00621759 0.00238833 0.00217072 0.0101179 0.00739854 0.00650496 0.0132909 0.0239113 0.0182704 0.0131553 0.00884441 0.00541889 0.00407583 0.00458623 0.014725 0.0111126 0.00630332 0.00230047 0.00156747 0.00129683 0.000777915 0.00121011 0.000813068 0.00127216 0.000821997 0.00129601 0.000836925 0.00132544 0.000863318 0.00137256 0.000908132 0.00146202 0.00102121 0.00195339 0.00243404 0.00792973 0.00399596 0.010625 0.0419219	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	4	0.0120699 0.0145035 0.00728895 0.0163449 0.0084046 0.00786568 0.00648118 0.00391704 0.00778835 0.00680336 0.0156919 0.018947 0.0245968 0.0177147 0.0131279 0.0384378 0.0416364 0.0303782 0.0323496 0.0532203 0.0204451 0.0263977 0.0420722 0.0166729 0.0521434 0.0226345 0.0180463 0.0368869 0.0122727 0.0137196 0.0165005 0.0225505 0.0296754 0.0119174 0.0129859 0.00829733 0.00613175 0.00235545 0.00214438 0.0100116 0.00741904 0.00658889 0.0135917 0.0245631 0.0188222 0.0134455 0.00917407 0.00534599 0.00398654 0.00454928 0.0149273 0.0117548 0.00614397 0.00230011 0.00156713 0.00117089 0.000714818 0.00105258 0.000733716 0.00108515 0.000734939 0.00109232 0.000740811 0.0011035 0.000756025 0.00112715 0.000788843 0.0011835 0.000868247 0.00137314 0.00128252 0.00330088 0.00593342 0.0237617 0.0455867	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG1 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
3	1	0.0131307 0.0157116 0.00782034 0.0174087 0.00883415 0.00828812 0.00682172 0.00418045 0.00811152 0.00703281 0.0161666 0.0194448 0.0247486 0.0185022 0.0147267 0.0476432 0.0370512 0.0193443 0.01497 0.0214444 0.00663618 0.00457301 0.00800034 0.00308598 0.0101114 0.0215668 0.022286 0.03526 0.0110284 0.0116084 0.0133629 0.0208807 0.0304419 0.0120929 0.0146301 0.0101364 0.00867395 0.00402885 0.00474974 0.0226913 0.0183862 0.0165798 0.0265927 0.0443547 0.0321324 0.0714481 0.0512808 0.0223906 0.00504015 0.00371415 0.00706695 0.00575728 0.00429596 0.0018559 0.00149285 0.00133917 0.000966546 0.00134343 0.000993363 0.00141682 0.000981819 0.00142728 0.000980793 0.00144592 0.000996007 0.00149209 0.00103639 0.00159982 0.00113724 0.00187922 0.00149466 0.0035438 0.00316143 0.0120705 0.0410781	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG2 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0107966 0.0129181 0.00642904 0.0143131 0.00726272 0.00681403 0.00560839 0.00343689 0.00666864 0.00578186 0.0132903 0.0159855 0.0203471 0.0152111 0.0121044 0.0391591 0.0304517 0.015893 0.0122932 0.0176065 0.00545051 0.0037554 0.00656937 0.00252645 0.00826923 0.0175803 0.0180903 0.0284297 0.00877285 0.00923327 0.0105568 0.0165092 0.0241462 0.00923939 0.0109676 0.00728683 0.0060942 0.00239759 0.00255118 0.0125573 0.0121439 0.0142037 0.0330081 0.0549083 0.068838 0.110965 0.0417997 0.0172529 0.00938591 0.00845428 0.0235262 0.0200745 0.0128361 0.00505203 0.00428532 0.00589357 0.00123223 0.00133459 0.0010078 0.00130885 0.000988099 0.0013011 0.000973663 0.00130455 0.000973764 0.00133241 0.000998292 0.00141766 0.00107774 0.00165868 0.00140464 0.00327766 0.0031033 0.0110432 0.0382797	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0107789 0.0128967 0.00641829 0.0142893 0.00725061 0.00680269 0.00559906 0.00343121 0.0066576 0.00577229 0.0132683 0.0159591 0.0203133 0.0151858 0.0120839 0.0390922 0.0303992 0.015865 0.0122707 0.0175734 0.00544045 0.00374828 0.00655683 0.00252118 0.00825062 0.0175326 0.0180342 0.0283157 0.00872558 0.0091817 0.0104869 0.0163864 0.0239372 0.00912844 0.0108114 0.0071509 0.00596579 0.002328 0.00243522 0.0119496 0.0117524 0.0139753 0.0327606 0.0551502 0.0704938 0.113075 0.0433633 0.0198111 0.0110165 0.00983242 0.0266164 0.0193789 0.00958402 0.00376482 0.00284479 0.00194729 0.00177916 0.00445002 0.000937565 0.00113297 0.000898159 0.00117888 0.000891961 0.00120229 0.000903346 0.00124785 0.000937387 0.00134884 0.00102468 0.00160051 0.00134119 0.0031492 0.00294814 0.0104969 0.0363695	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.010806 0.0129291 0.00643435 0.0143251 0.00726876 0.00681972 0.00561308 0.00343982 0.00667427 0.00578677 0.0133015 0.015999 0.0203641 0.0152239 0.0121142 0.0391897 0.0304749 0.0159041 0.0123007 0.017616 0.0054537 0.00375734 0.00657263 0.00252713 0.00826959 0.0175701 0.0180702 0.0283614 0.00873541 0.00919136 0.0104932 0.016389 0.0239222 0.0091115 0.010784 0.00712177 0.00593476 0.00230979 0.00240254 0.0117578 0.0116267 0.0139139 0.0327477 0.0552632 0.0710564 0.113633 0.0434306 0.0200906 0.0112125 0.00991182 0.0263778 0.0182986 0.00872484 0.00327711 0.00227962 0.00149896 0.000925246 0.00167978 0.00183233 0.00434949 0.000932389 0.00116079 0.000913965 0.00121305 0.000916918 0.00125866 0.000948037 0.00135859 0.00103166 0.0016073 0.00134334 0.00316421 0.00295399 0.0106474 0.0370984	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0108166 0.0129417 0.00644059 0.014339 0.0072758 0.00682634 0.00561852 0.00344318 0.00668075 0.00579242 0.0133145 0.0160146 0.0203839 0.0152388 0.012126 0.0392277 0.0305042 0.0159191 0.0123121 0.0176319 0.00545867 0.00376071 0.00657846 0.00252929 0.00827618 0.0175815 0.0180798 0.0283661 0.00873319 0.00918848 0.0104856 0.01637 0.0238748 0.00908253 0.0107423 0.00708364 0.00589715 0.00228997 0.00236966 0.0115661 0.0114963 0.0138374 0.032687 0.0552569 0.0713765 0.113828 0.0433672 0.0202243 0.0113312 0.00995811 0.0264354 0.0179812 0.0084519 0.00310062 0.00210355 0.0014148 0.000851495 0.00131264 0.000965466 0.00175411 0.00183699 0.00434904 0.000939225 0.00119389 0.000936769 0.00126494 0.000959121 0.00136489 0.00103891 0.00161209 0.00134174 0.00317017 0.00295703 0.0106973 0.037443	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0108193 0.0129449 0.00644215 0.0143424 0.00727757 0.006828 0.00561988 0.00344404 0.00668239 0.00579385 0.0133177 0.0160185 0.0203889 0.0152426 0.012129 0.0392372 0.0305115 0.0159227 0.0123148 0.0176355 0.00545979 0.00376144 0.00657971 0.00252973 0.00827731 0.0175822 0.0180793 0.0283586 0.00872864 0.00918335 0.0104769 0.0163516 0.0238345 0.00906037 0.0107116 0.00705684 0.00587131 0.0022769 0.00234884 0.0114453 0.0114106 0.0137798 0.0326289 0.0552093 0.0715135 0.113913 0.043313 0.0202989 0.0114088 0.00998676 0.0264731 0.0178099 0.00832045 0.0030225 0.00203107 0.00137727 0.000829405 0.00126181 0.000888291 0.00138003 0.000964708 0.00176829 0.00183246 0.0044294 0.00096279 0.00125083 0.000984157 0.00137412 0.00105359 0.00162192 0.00134585 0.00318557 0.00297744 0.0107445 0.0377612	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0108158 0.0129407 0.00644006 0.0143378 0.00727521 0.0068258 0.00561806 0.00344293 0.00668023 0.005792 0.0133135 0.0160134 0.0203824 0.0152377 0.0121251 0.0392246 0.0305015 0.0159173 0.0123106 0.0176293 0.00545789 0.0037601 0.00657734 0.00252879 0.00827404 0.0175741 0.0180701 0.0283394 0.00872125 0.00917535 0.0104657 0.0163307 0.0237941 0.00904031 0.0106847 0.00703466 0.00585056 0.00226691 0.00233369 0.0113592 0.0113474 0.0137321 0.0325713 0.0551431 0.0715631 0.113935 0.0432756 0.0203634 0.0114752 0.0100214 0.0265505 0.0177335 0.00825751 0.00299009 0.00200362 0.00136293 0.000819613 0.00124257 0.00086971 0.00132723 0.000886845 0.00139223 0.000966167 0.00178215 0.00183668 0.00457584 0.00101257 0.00136589 0.00108369 0.00163577 0.00135389 0.00320061 0.003015 0.0107711 0.0380744	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0108061 0.0129291 0.00643428 0.0143249 0.00726867 0.00681967 0.00561301 0.00343985 0.00667423 0.00578681 0.0133015 0.015999 0.0203641 0.0152241 0.0121143 0.0391894 0.0304741 0.0159029 0.0122994 0.0176131 0.00545288 0.00375663 0.00657125 0.00252643 0.00826615 0.0175564 0.0180513 0.0283061 0.00870987 0.00916319 0.0104502 0.0163037 0.0237464 0.00901834 0.0106561 0.00701211 0.00583015 0.00225759 0.00232029 0.0112857 0.0112924 0.0136868 0.0325077 0.0550612 0.0715628 0.113914 0.0432584 0.0204385 0.0115457 0.0100755 0.0267249 0.0177623 0.00825435 0.00298847 0.00200081 0.00135917 0.000815273 0.0012381 0.000862102 0.00130943 0.000869914 0.00134264 0.000888706 0.00140545 0.000977817 0.00180673 0.00186121 0.00485629 0.00112117 0.0016466 0.00137627 0.00319564 0.00307984 0.0107263 0.0383682	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	1	0.0107855 0.0129044 0.00642196 0.0142975 0.00725476 0.00680661 0.00560226 0.00343328 0.00666146 0.00577576 0.0132761 0.0159684 0.0203252 0.0151951 0.0120911 0.0391145 0.0304159 0.0158724 0.0122757 0.017579 0.00544235 0.00374936 0.0065585 0.00252152 0.00824992 0.0175211 0.0180143 0.0282443 0.00868982 0.00914195 0.0104244 0.0162606 0.0236751 0.00898729 0.0106164 0.00698212 0.0058038 0.00224615 0.0023048 0.0112041 0.0112311 0.0136326 0.0324198 0.054943 0.0715091 0.113829 0.0432579 0.0205404 0.0116336 0.0101665 0.0270902 0.0179566 0.00833646 0.00302365 0.00202305 0.00136244 0.000813628 0.00123885 0.000858612 0.00130431 0.000863229 0.00132594 0.000873188 0.00135896 0.00090077 0.00143174 0.00100184 0.00184622 0.00197359 0.00568498 0.00142399 0.00314487 0.00329078 0.0104806 0.0385338	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	1	0.0108118 0.0129358 0.00643757 0.0143322 0.0072724 0.00682317 0.00561589 0.00344165 0.00667768 0.00578984 0.0133085 0.0160074 0.0203748 0.0152322 0.0121207 0.03921 0.0304901 0.0159109 0.0123054 0.0176212 0.00545542 0.00375832 0.0065741 0.00252752 0.00826919 0.0175601 0.0180532 0.0282959 0.00870332 0.00915563 0.0104364 0.016272 0.02367 0.00897543 0.0105953 0.0069586 0.00577871 0.0022325 0.00228099 0.0110638 0.0111244 0.0135543 0.0323356 0.0548671 0.0715799 0.114103 0.0433947 0.02069 0.0116857 0.0101755 0.0267304 0.0172909 0.00820755 0.00301019 0.00201244 0.00137878 0.000817616 0.00126608 0.000867071 0.00133531 0.000872781 0.00135737 0.000882663 0.00138406 0.000905291 0.00143065 0.000948151 0.00152073 0.00106397 0.00200563 0.00246578 0.0079183 0.00405825 0.00990155 0.0375232	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	1	0.0106129 0.0126979 0.0063192 0.0140687 0.0071387 0.00669772 0.00551264 0.00337836 0.00655493 0.00568339 0.0130638 0.0157132 0.0200003 0.0149522 0.0118979 0.0384892 0.02993 0.0156191 0.01208 0.0172988 0.00535552 0.00368955 0.00645386 0.00248143 0.00811887 0.0172434 0.01773 0.027801 0.00855515 0.00900072 0.0102649 0.0160129 0.0233154 0.00885081 0.0104525 0.00687479 0.00571917 0.0022174 0.00227851 0.0111165 0.0111415 0.01347 0.0319773 0.0543219 0.0703742 0.112067 0.0428848 0.0205346 0.0112677 0.00994107 0.0267728 0.01844 0.00837521 0.00317235 0.00215659 0.00128013 0.00076616 0.00111746 0.000794538 0.00115371 0.000792698 0.00115968 0.000794375 0.00116902 0.000806167 0.00119231 0.000836881 0.00124992 0.000916825 0.00144482 0.00133626 0.00338895 0.00605541 0.02347 0.0421367	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG1 with DRUG0 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
4	4	0.0121855 0.0145798 0.00725557 0.0161504 0.0081941 0.00768849 0.00632778 0.00387943 0.00752771 0.00652704 0.0150079 0.0180547 0.0229787 0.017186 0.0136813 0.04427 0.0344101 0.0179561 0.0138921 0.0198609 0.00614559 0.00423176 0.00740371 0.00285617 0.00932394 0.0196757 0.0201953 0.0313087 0.00966788 0.0101926 0.0114645 0.0174078 0.024093 0.00864849 0.00992146 0.00614752 0.00513901 0.00209754 0.00196636 0.00936007 0.00874857 0.00986988 0.0215277 0.0397691 0.0539398 0.0665658 0.070729 0.04795 0.00686469 0.00732215 0.0178165 0.016341 0.0106599 0.00368257 0.00328249 0.0048371 0.00111743 0.00134548 0.00103966 0.00136116 0.00102195 0.00135959 0.00101241 0.00137419 0.0010254 0.00142009 0.00106747 0.00153252 0.00117112 0.00182322 0.00155531 0.00372689 0.00352993 0.0126972 0.0460518	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120865 0.0144614 0.00719659 0.0160192 0.00812757 0.00762606 0.00627642 0.00384794 0.00746664 0.00647407 0.0148861 0.0179084 0.0227925 0.0170468 0.0135704 0.0439105 0.0341317 0.0178113 0.0137803 0.0197014 0.00609606 0.00419762 0.00734369 0.00283323 0.00924811 0.0195139 0.0200293 0.0310535 0.00958922 0.0101099 0.0113691 0.0172615 0.0238908 0.0085725 0.00982995 0.00608454 0.00508791 0.00207574 0.0019445 0.00927016 0.00876178 0.00997586 0.0218966 0.040483 0.0550498 0.0681878 0.073371 0.051921 0.00749909 0.00836345 0.0201037 0.0153329 0.00764449 0.00287284 0.00238431 0.00168689 0.00166157 0.00442215 0.000934155 0.00118491 0.000920423 0.00123209 0.00091758 0.00126282 0.000937266 0.00132037 0.00098408 0.00144107 0.00108981 0.00173208 0.00145449 0.00352114 0.00327618 0.0120598 0.0435904	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120805 0.0144541 0.00719298 0.0160112 0.0081235 0.00762223 0.00627327 0.00384602 0.0074629 0.00647084 0.0148787 0.0178995 0.0227811 0.0170382 0.0135635 0.0438883 0.0341145 0.0178024 0.0137735 0.0196916 0.00609301 0.0041955 0.00733996 0.00283178 0.00924318 0.0195029 0.0200176 0.0310355 0.00958335 0.0101038 0.0113614 0.0172495 0.0238739 0.00856626 0.00982269 0.0060794 0.00508374 0.00207393 0.00194268 0.00926641 0.00877113 0.00999675 0.0219587 0.0406028 0.0552964 0.0685741 0.0739617 0.052429 0.00749703 0.0083355 0.0197993 0.014336 0.00698383 0.00253072 0.00196319 0.00132182 0.000874233 0.00162036 0.00179729 0.00442741 0.000958496 0.00122944 0.000943251 0.00127612 0.000949989 0.00132922 0.000990589 0.00144506 0.00109059 0.00172929 0.00144759 0.00352016 0.00326356 0.0121887 0.0443252	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120729 0.014445 0.00718844 0.0160011 0.00811837 0.00761743 0.00626931 0.0038436 0.00745819 0.00646677 0.0148693 0.0178882 0.0227667 0.0170275 0.013555 0.0438604 0.0340929 0.0177912 0.0137647 0.0196791 0.00608916 0.00419284 0.00733531 0.00282997 0.00923707 0.0194896 0.0200036 0.031014 0.00957651 0.0100968 0.011353 0.0172369 0.0238563 0.00855999 0.00981576 0.00607477 0.0050797 0.00207218 0.00194091 0.00925976 0.00877059 0.00999848 0.0219685 0.0406269 0.0554109 0.0687437 0.0742363 0.0525398 0.00747557 0.00832857 0.0197653 0.0140122 0.00676572 0.00240606 0.00183711 0.00126631 0.00081123 0.00127004 0.000952939 0.00173658 0.00184346 0.00450224 0.000979807 0.00127461 0.000974053 0.00133908 0.00100069 0.00144933 0.00109295 0.00172683 0.00143639 0.00350353 0.00324443 0.0121965 0.0446231	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120623 0.0144323 0.0071821 0.015987 0.00811121 0.00761071 0.00626378 0.00384022 0.00745162 0.00646107 0.0148562 0.0178724 0.0227467 0.0170125 0.013543 0.0438216 0.0340627 0.0177755 0.0137526 0.0196617 0.0060838 0.00418913 0.00732882 0.00282745 0.00922875 0.0194718 0.019985 0.0309854 0.00956758 0.0100875 0.0113422 0.0172205 0.0238334 0.00855176 0.00980651 0.00606875 0.00507463 0.00207 0.00193876 0.00925081 0.00876455 0.00999064 0.0219532 0.0406082 0.0554663 0.0688455 0.0744156 0.052594 0.00745552 0.00831434 0.0197252 0.0138246 0.00665648 0.00235035 0.00178498 0.00124267 0.000795393 0.00123447 0.000882799 0.00136654 0.000968045 0.00177085 0.00186635 0.00464151 0.00101448 0.00134644 0.00103199 0.00146483 0.00110826 0.00173583 0.00143506 0.00350394 0.0032503 0.0122249 0.0449465	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120494 0.0144169 0.00717443 0.0159699 0.00810255 0.00760258 0.00625709 0.00383612 0.00744366 0.00645418 0.0148403 0.0178533 0.0227224 0.0169943 0.0135286 0.0437747 0.0340263 0.0177565 0.0137379 0.0196407 0.00607731 0.00418465 0.00732099 0.00282442 0.00921878 0.0194505 0.019963 0.0309515 0.00955706 0.0100765 0.0113295 0.0172013 0.0238066 0.00854218 0.00979565 0.00606181 0.00506882 0.0020675 0.00193634 0.00924023 0.00875631 0.00997956 0.0219309 0.0405755 0.0554877 0.0688988 0.0745277 0.0526294 0.00744467 0.00831089 0.0197234 0.0137135 0.00659939 0.00232513 0.001765 0.001234 0.000787686 0.00122166 0.000869031 0.00132827 0.000894799 0.00139102 0.000978916 0.00179653 0.00189376 0.00484468 0.00107514 0.0014805 0.00114525 0.00175696 0.00144258 0.00351073 0.00327834 0.012249 0.0452967	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120332 0.0143975 0.00716478 0.0159484 0.00809166 0.00759237 0.00624867 0.00383097 0.00743366 0.00644551 0.0148204 0.0178293 0.0226918 0.0169715 0.0135104 0.0437158 0.0339806 0.0177326 0.0137194 0.0196144 0.00606915 0.00417903 0.00731115 0.00282062 0.00920631 0.0194241 0.0199358 0.0309095 0.00954405 0.0100628 0.011314 0.0171778 0.0237742 0.00853063 0.0097825 0.00605353 0.00506189 0.00206451 0.00193349 0.00922735 0.00874614 0.00996622 0.0219056 0.0405359 0.05548 0.0689032 0.0745745 0.0526493 0.00744538 0.0083284 0.0198033 0.0136834 0.00658997 0.00232076 0.00176299 0.00123161 0.000783285 0.00121893 0.000862696 0.00131649 0.000881829 0.00135412 0.000904256 0.00141009 0.000996653 0.00182555 0.00194205 0.00519182 0.00119848 0.00179831 0.00147259 0.00351245 0.00334742 0.0122345 0.0456662	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 or DRUG0 .
4	4	0.0120082 0.0143676 0.00714988 0.0159153 0.00807483 0.00757658 0.00623568 0.00382301 0.0074182 0.00643211 0.0147896 0.0177922 0.0226446 0.0169362 0.0134823 0.0436249 0.0339099 0.0176958 0.0136909 0.0195736 0.00605655 0.00417035 0.00729595 0.00281475 0.00918712 0.0193836 0.0198942 0.0308452 0.00952422 0.010042 0.0112904 0.0171425 0.0237258 0.00851353 0.00976304 0.00604148 0.00505177 0.00206019 0.00192941 0.00920849 0.00873125 0.0099476 0.0218726 0.0404809 0.0554243 0.0688227 0.0745134 0.0526292 0.00746145 0.00838297 0.02004 0.0137765 0.00665024 0.00234153 0.00178011 0.00123274 0.000779884 0.00121889 0.000858724 0.00131353 0.000875998 0.00134318 0.000891845 0.00137378 0.000920665 0.00143671 0.00102289 0.00186044 0.00208825 0.00615539 0.00153806 0.00350992 0.00359935 0.0120953 0.0459477	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 or DRUG0 .
4	4	0.0120272 0.0143903 0.00716116 0.0159404 0.00808758 0.00758854 0.00624552 0.00382904 0.00742989 0.00644227 0.0148129 0.0178203 0.0226803 0.0169629 0.0135035 0.0436934 0.0339632 0.0177236 0.0137124 0.0196043 0.00606608 0.00417691 0.00730742 0.00281912 0.00920134 0.0194136 0.0199247 0.0308926 0.00953831 0.0100567 0.0113067 0.0171678 0.0237621 0.00852766 0.00978007 0.00605295 0.00506102 0.00206331 0.00193248 0.00922807 0.00874972 0.00995835 0.0219098 0.0405546 0.0554728 0.068863 0.0745406 0.0525162 0.00740759 0.00835148 0.019514 0.0132473 0.00659336 0.00233614 0.00177433 0.00124848 0.000782511 0.00123971 0.000864653 0.00133815 0.000882993 0.00136919 0.000899272 0.00139534 0.000924176 0.00143239 0.000966139 0.00151453 0.00108184 0.00201606 0.0026178 0.00866085 0.0043892 0.0116169 0.045073	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 or DRUG0 .
4	4	0.0118633 0.0141942 0.00706359 0.0157232 0.00797741 0.00748516 0.00616046 0.00377686 0.00732867 0.00635447 0.014611 0.0175774 0.0223713 0.0167316 0.0133194 0.0430978 0.0335003 0.0174818 0.0135252 0.0193369 0.00598333 0.00411996 0.00720779 0.00278062 0.0090761 0.0191503 0.0196551 0.0304743 0.00940838 0.00991904 0.011153 0.0169358 0.0234466 0.00841685 0.00965386 0.00597784 0.00499829 0.00203792 0.00190936 0.00911096 0.00864344 0.0098565 0.0217086 0.0401595 0.0543162 0.0668288 0.0714454 0.0502797 0.00728102 0.00849683 0.0202787 0.0142102 0.00671246 0.00243842 0.00187761 0.00111359 0.000712625 0.00106829 0.00077638 0.0011376 0.00078999 0.00115445 0.000798862 0.00116621 0.000814225 0.00118531 0.000845506 0.00123672 0.00092887 0.00145876 0.00138329 0.00354206 0.00645541 0.0268699 0.0511331	A multiple dose drug-drug interaction study demonstrated that DRUG0 approximately doubled DRUG0 AUC0-   . Since DRUG0 is partially metabolized by CYP3A and DRUG0 le is known to be a strong inhibitor of cytochrome P450 3A enzyme , care should be taken while dosing DRUG0 with DRUG1 and other strong P450 3A inhibitors including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG2 .
1	1	0.0349195 0.0322576 0.0336124 0.0293146 0.0250505 0.0252346 0.0141741 0.00871565 0.00360899 0.00488812 0.0143614 0.00766991 0.017547 0.0492955 0.0279465 0.0160093 0.0141593 0.0142395 0.0314799 0.0225914 0.026901 0.01876 0.0699553 0.0335976 0.0674941 0.0569068 0.0598765 0.0391652 0.0272703 0.0339136 0.0218342 0.00968728 0.0130458 0.0373116 0.0572052	Dose adjustment of DRUG1 Capsules may be required , and iPTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor such as DRUG2 .
4	3	0.0270533 0.0399118 0.188822 0.0831983 0.0756011 0.0490506 0.0572954 0.00961011 0.0178185 0.0180593 0.0349516 0.0135303 0.0907071 0.0804205 0.0451754 0.023993 0.0256793 0.0158038 0.0168462 0.0272031 0.0592689	Drugs that impair intestinal absorption of DRUG1 , such as DRUG2 , may interfere with the absorption of DRUG0 Capsules .
3	4	0.0271611 0.033737 0.179524 0.0693765 0.0644219 0.0377419 0.0356595 0.00478324 0.00702149 0.00672962 0.0119131 0.0162939 0.0720031 0.0425058 0.0416065 0.0456048 0.0602381 0.0673431 0.0527809 0.0489706 0.0745842	Drugs that impair intestinal absorption of DRUG1 , such as DRUG0 , may interfere with the absorption of DRUG2 Capsules .
3	3	0.0257742 0.0286868 0.132688 0.0488342 0.0424682 0.0253842 0.0133344 0.0064677 0.0144961 0.0188914 0.0683101 0.015818 0.0865863 0.05419 0.0467468 0.0498428 0.0639668 0.0728154 0.0563934 0.0518609 0.0764447	Drugs that impair intestinal absorption of DRUG0 , such as DRUG1 , may interfere with the absorption of DRUG2 Capsules .
1	4	0.102341 0.0679222 0.137696 0.0477909 0.0930683 0.107908 0.0537094 0.0388792 0.0393533 0.0540716 0.0641408 0.0583966 0.134723	Patients receiving DRUG1 and DRUG2 generally should not be treated with DRUG0 .
1	1	0.0974564 0.0976401 0.0940333 0.0420047 0.0391675 0.0999286 0.0411959 0.0537955 0.0499362 0.0886856 0.110593 0.100617 0.0849456	Patients receiving DRUG1 and DRUG0 generally should not be treated with DRUG2 .
1	1	0.108303 0.0883611 0.0547979 0.0317069 0.12045 0.128856 0.0427791 0.0423351 0.0398841 0.0727613 0.0953053 0.0880726 0.0863876	Patients receiving DRUG0 and DRUG1 generally should not be treated with DRUG2 .
2	2	0.0863592 0.075903 0.0840776 0.138607 0.107498 0.0646673 0.0749662 0.0688724 0.0618403 0.0149079 0.0179751 0.0360691 0.0138945 0.0331373 0.121225	The action of DRUG1 may be potentiated by anesthesia , other DRUG2 and DRUG0 .
2	2	0.0863239 0.0741025 0.0796341 0.131403 0.0997261 0.05792 0.0662023 0.0573146 0.0450319 0.012063 0.0163538 0.0210634 0.0312707 0.0948524 0.126738	The action of DRUG1 may be potentiated by anesthesia , other DRUG0 and DRUG2 .
4	4	0.0372409 0.0297311 0.0358644 0.0465809 0.0875528 0.0863772 0.109665 0.0691899 0.0637755 0.0262688 0.0289677 0.135583 0.0356241 0.0952682 0.11231	The action of DRUG0 may be potentiated by anesthesia , other DRUG1 and DRUG2 .
4	4	0.0479005 0.0161319 0.0729449 0.0227055 0.0136536 0.0139094 0.0109249 0.013508 0.0204567 0.020393 0.0369318 0.0580944 0.0387054 0.0357224 0.0675162 0.0723222 0.0762159 0.0380949 0.0298922 0.0435639 0.0147599 0.038676 0.0588957 0.0310452 0.0299289 0.00712687 0.0199352 0.0500443	DRUG1 : Spontaneous adverse reaction reports of patients taking concomitant DRUG0 with recommended doses of DRUG2 demonstrate QT interval prolongation and rare serious cardiac events , e.g .
2	2	0.0162234 0.0223337 0.0809225 0.0310774 0.0221523 0.0224611 0.0234026 0.0191705 0.0237719 0.0169471 0.0594937 0.0319613 0.0230904 0.0229705 0.0481163 0.0518138 0.0838454 0.0464703 0.0412419 0.0584393 0.0190015 0.0410905 0.0566138 0.0313226 0.0299476 0.0072295 0.0199677 0.0489213	DRUG0 : Spontaneous adverse reaction reports of patients taking concomitant DRUG1 with recommended doses of DRUG2 demonstrate QT interval prolongation and rare serious cardiac events , e.g .
3	3	0.0656334 0.06444 0.0618081 0.0431271 0.0863519 0.0793588 0.0821218 0.050653 0.0568437 0.0732956 0.0466534 0.0178924 0.0491281 0.0292083 0.0370579 0.0323 0.0377471 0.0340448 0.0523345	Pharmacokinetic data indicate that DRUG1 markedly inhibits the metabolism of DRUG2 , resulting in elevated plasma DRUG0 levels .
4	4	0.0446135 0.0426406 0.0401289 0.0280745 0.0456225 0.0580667 0.0539826 0.0265757 0.0365913 0.0370265 0.0374107 0.0354312 0.114663 0.0566161 0.0972858 0.0780894 0.0530557 0.052916 0.0612095	Pharmacokinetic data indicate that DRUG1 markedly inhibits the metabolism of DRUG0 , resulting in elevated plasma DRUG2 levels .
1	1	0.0995078 0.0969336 0.0971932 0.127337 0.0533096 0.111011 0.145996 0.10603 0.162682	Concomitant administration of DRUG1 and DRUG2 is contraindicated .
4	4	0.0553445 0.0201943 0.0526736 0.0462464 0.056868 0.0417371 0.16421 0.122865 0.0523739 0.0302502 0.0124535 0.0115781 0.0177013 0.0105221 0.00951078 0.0157115 0.00983768 0.00694597 0.00402744 0.0107445 0.00821434 0.0077591 0.0126438 0.00817945 0.0120702 0.0126712 0.0222414 0.030414 0.0230095 0.0443831 0.0666174	DRUG1 : Torsades de pointes and elevated parent DRUG2 levels have been reported during concomitant use of DRUG0 and DRUG0 in clinical trials of DRUG0 and from foreign post-marketing sources .
4	4	0.0619222 0.0227558 0.0612885 0.0533855 0.0414634 0.0161242 0.0567958 0.0285078 0.0233728 0.0214452 0.0113979 0.0163162 0.0481333 0.0359024 0.0286943 0.0332552 0.0578059 0.0282126 0.00550224 0.00923413 0.0107393 0.0118016 0.0208731 0.012928 0.0166293 0.0150143 0.0304927 0.0441349 0.0329184 0.0591296 0.0838234	DRUG1 : Torsades de pointes and elevated parent DRUG0 levels have been reported during concomitant use of DRUG2 and DRUG0 in clinical trials of DRUG0 and from foreign post-marketing sources .
4	4	0.013399 0.0139259 0.0253415 0.0211606 0.0295005 0.0210216 0.102892 0.0782939 0.0524256 0.0357003 0.0187612 0.0224387 0.044372 0.0299545 0.0272857 0.0393216 0.0320701 0.0187789 0.018614 0.0246919 0.015815 0.0155186 0.0257815 0.0157579 0.0178174 0.0158653 0.0295948 0.0401182 0.0292536 0.0518339 0.0726938	DRUG0 : Torsades de pointes and elevated parent DRUG1 levels have been reported during concomitant use of DRUG0 and DRUG2 in clinical trials of DRUG0 and from foreign post-marketing sources .
4	4	0.0128016 0.0134298 0.0244093 0.0207805 0.0281149 0.0201907 0.110913 0.086255 0.0486233 0.0241682 0.0111484 0.0111797 0.0269691 0.0165029 0.0154568 0.0277955 0.0190697 0.0118174 0.00719327 0.0262665 0.0314746 0.040342 0.0595255 0.0624848 0.0390489 0.00899061 0.0177496 0.0312297 0.0270269 0.049731 0.0693104	DRUG0 : Torsades de pointes and elevated parent DRUG1 levels have been reported during concomitant use of DRUG0 and DRUG0 in clinical trials of DRUG2 and from foreign post-marketing sources .
3	3	0.0117477 0.0136564 0.0274741 0.0269789 0.0258692 0.0111337 0.0479531 0.0304691 0.0260402 0.0228604 0.0167586 0.0250839 0.0585651 0.0477906 0.0317539 0.0316001 0.0365086 0.0751815 0.0280377 0.0398351 0.030568 0.0259756 0.0415564 0.0270751 0.0232123 0.0166406 0.0310038 0.0370911 0.0253277 0.0440692 0.0621825	DRUG0 : Torsades de pointes and elevated parent DRUG0 levels have been reported during concomitant use of DRUG1 and DRUG2 in clinical trials of DRUG0 and from foreign post-marketing sources .
4	4	0.0108885 0.0119578 0.0234152 0.0223519 0.0213413 0.00926675 0.039334 0.0220772 0.0189053 0.0163999 0.00863997 0.0111564 0.0363877 0.0404445 0.0307753 0.0539565 0.068507 0.0855551 0.0181082 0.0293696 0.0429587 0.0393168 0.0602563 0.0678759 0.0375805 0.00876451 0.0168998 0.0276567 0.0221796 0.0403075 0.0573658	DRUG0 : Torsades de pointes and elevated parent DRUG0 levels have been reported during concomitant use of DRUG1 and DRUG0 in clinical trials of DRUG2 and from foreign post-marketing sources .
1	1	0.0995078 0.0969336 0.0971932 0.127337 0.0533096 0.111011 0.145996 0.10603 0.162682	Concomitant administration of DRUG1 and DRUG2 is contraindicated .
4	4	0.0753673 0.043561 0.0513249 0.0659782 0.0681588 0.042295 0.0224877 0.0716591 0.0409677 0.0137186 0.00292714 0.00294661 0.00224115 0.00214027 0.00359742 0.00351662 0.0037625 0.0032796 0.00203457 0.0022971 0.00482465 0.00372987 0.00990323 0.0148161 0.00923428 0.00621373 0.00899461 0.0100465 0.0193457 0.0215713 0.0306094 0.0233016 0.0317268 0.061547 0.0317875 0.0460174 0.0410654 0.0462244 0.054779	Due to the chemical similarity of other DRUG1 (including DRUG2 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0778086 0.0460725 0.0534105 0.0652536 0.0618919 0.0420956 0.0229169 0.0646417 0.0331292 0.00809912 0.00676518 0.0136552 0.00255514 0.00216456 0.00327929 0.00357717 0.0035693 0.00315712 0.00202068 0.00226419 0.00465971 0.00374233 0.00982704 0.0142019 0.00879878 0.00619665 0.00900435 0.0102325 0.0195368 0.021832 0.0311125 0.0237166 0.0322599 0.0625782 0.0323444 0.0468015 0.0418103 0.0471062 0.0559108	Due to the chemical similarity of other DRUG1 (including DRUG0 , DRUG2 , and DRUG0 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0771911 0.0454076 0.0526761 0.0638077 0.0610264 0.040553 0.0221728 0.0618949 0.0302839 0.0063225 0.00449419 0.00545091 0.00452628 0.00726612 0.0128826 0.00452379 0.00460051 0.00395268 0.00205243 0.00242113 0.00531701 0.00374683 0.0111321 0.0161977 0.0110774 0.00705969 0.0098826 0.0107374 0.020238 0.0223651 0.0317118 0.0238194 0.0317824 0.0619741 0.0316887 0.0460087 0.0409979 0.0460824 0.0546741	Due to the chemical similarity of other DRUG1 (including DRUG0 , DRUG0 , and DRUG2 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.073735 0.0421456 0.0477865 0.0578598 0.0537644 0.034683 0.018946 0.0519298 0.0250657 0.00576416 0.0047614 0.00510296 0.00654317 0.0104029 0.0112252 0.0299321 0.0481912 0.0190161 0.00341951 0.00258513 0.0039728 0.00407388 0.00940241 0.0126219 0.00810895 0.0058468 0.00851239 0.00988923 0.0187621 0.0212038 0.0289723 0.0218068 0.030269 0.0574348 0.0297457 0.0429295 0.0384386 0.0433483 0.051801	Due to the chemical similarity of other DRUG1 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG2 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0762652 0.0438317 0.0500979 0.0595463 0.0547018 0.0367008 0.020101 0.0549732 0.0262265 0.00599556 0.00504402 0.00525119 0.00793892 0.0114198 0.0105527 0.0207775 0.0247264 0.00683945 0.00489853 0.00909399 0.017028 0.00417197 0.00875472 0.0112589 0.00779593 0.00545031 0.00776687 0.0093206 0.0181047 0.0207325 0.0284362 0.021818 0.0309608 0.0583165 0.0308622 0.0442544 0.0401559 0.0453335 0.0544956	Due to the chemical similarity of other DRUG1 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG2 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
1	1	0.0568575 0.0287435 0.0299851 0.0373248 0.0341519 0.0178958 0.0090491 0.0220687 0.0107396 0.00324065 0.00233912 0.00290719 0.00237704 0.00262257 0.00358944 0.00481974 0.00617741 0.00349617 0.00238748 0.00383158 0.00700705 0.00956775 0.0470231 0.0424236 0.0426136 0.0329672 0.0383165 0.0527852 0.0429638 0.0359903 0.0417806 0.0279442 0.0345831 0.0661565 0.0306666 0.0451376 0.0359673 0.0384762 0.0430255	Due to the chemical similarity of other DRUG1 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
4	4	0.0711728 0.0369578 0.0391514 0.0469756 0.0375095 0.018153 0.0106398 0.0218147 0.0407056 0.0526843 0.0113537 0.00738613 0.00896704 0.0127803 0.0125093 0.0309633 0.0468385 0.0186341 0.00353804 0.00273129 0.00423622 0.00438162 0.0101065 0.0130356 0.00830202 0.00600845 0.00885506 0.0103497 0.0196227 0.0220783 0.0301166 0.0227937 0.031607 0.0598339 0.0310759 0.0449968 0.0404411 0.0456953 0.0549975	Due to the chemical similarity of other DRUG0 (including DRUG1 , DRUG0 , and DRUG0 ) to DRUG2 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0733645 0.0385576 0.0412102 0.0495131 0.038543 0.018988 0.0111363 0.022587 0.041793 0.0561539 0.0118019 0.00838142 0.0113859 0.0142027 0.0121539 0.0225542 0.0262806 0.00771437 0.00638804 0.0109676 0.0184859 0.00466305 0.00966472 0.0113131 0.0077391 0.00539823 0.00779335 0.00947907 0.0183914 0.0209037 0.0286765 0.0221567 0.0313995 0.0591459 0.0314378 0.0452213 0.0412322 0.0466555 0.0565657	Due to the chemical similarity of other DRUG0 (including DRUG1 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG2 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
1	1	0.0519716 0.0224469 0.0220345 0.0260984 0.0214529 0.00967543 0.00574626 0.0148856 0.0258946 0.0258851 0.00419036 0.0033159 0.00283152 0.00318095 0.00341233 0.00507766 0.00667624 0.00315631 0.00264275 0.00406289 0.00652485 0.00892658 0.0451748 0.0366091 0.036975 0.0293221 0.0347695 0.0511321 0.0434215 0.0388523 0.0467019 0.0313314 0.0390005 0.0740467 0.0338779 0.0505328 0.0396298 0.0419329 0.0466	Due to the chemical similarity of other DRUG0 (including DRUG1 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
4	4	0.0833778 0.0392098 0.0401163 0.0473855 0.0335748 0.0142601 0.0057783 0.0100036 0.0110527 0.00973791 0.00806568 0.0431213 0.00744178 0.00942364 0.016403 0.00525388 0.00517776 0.00446119 0.00251906 0.00298834 0.0063539 0.00457747 0.0128163 0.0177954 0.0118263 0.00791987 0.0114998 0.0126399 0.024028 0.0266574 0.0381467 0.0294599 0.0395956 0.0772611 0.0400179 0.0582256 0.0523037 0.0590248 0.0704977	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG1 , and DRUG2 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0778986 0.0361595 0.036528 0.0419915 0.0292928 0.0126811 0.00530898 0.00865785 0.0101015 0.00980116 0.0084321 0.0447331 0.00827853 0.0111519 0.0110907 0.0303197 0.0449399 0.0184093 0.00353039 0.0028903 0.00460055 0.00473565 0.0109078 0.0143202 0.00914842 0.00666077 0.0100009 0.0117278 0.0224566 0.0254965 0.0350398 0.0268339 0.0373143 0.070706 0.036853 0.0533415 0.0480101 0.0542677 0.0653815	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG1 , and DRUG0 ) to DRUG2 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.0790532 0.0376063 0.0385523 0.0445996 0.0307256 0.0134809 0.00569851 0.0091516 0.011069 0.0106244 0.00985997 0.0528294 0.0109118 0.0141916 0.0121098 0.0234781 0.0249614 0.00713199 0.00592716 0.0100234 0.0183865 0.00474695 0.0102185 0.0124284 0.0085732 0.00598493 0.0087945 0.0107584 0.0210284 0.0239981 0.0330892 0.0257304 0.0365703 0.0690177 0.0367531 0.0528361 0.0482509 0.0545958 0.0662529	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG1 , and DRUG0 ) to DRUG0 , and DRUG2 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
1	1	0.0555828 0.0232504 0.0222323 0.0252928 0.0184089 0.00807339 0.0035046 0.00550139 0.00622464 0.00542596 0.00385313 0.0169781 0.0027685 0.00294906 0.00333424 0.00456911 0.00592041 0.00296595 0.00270243 0.00412179 0.00681279 0.00925398 0.0446493 0.0373366 0.0369575 0.0295069 0.0361028 0.0529551 0.0461223 0.0425432 0.0512224 0.0338584 0.0418666 0.0792525 0.0362709 0.0542585 0.0425476 0.0449478 0.0498749	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG1 , and DRUG0 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
4	4	0.0717258 0.0310492 0.0305484 0.0349434 0.0250286 0.0113732 0.00465861 0.00673565 0.00756039 0.00526498 0.00338658 0.00761167 0.00733671 0.0144181 0.0767105 0.0397861 0.0570667 0.0231452 0.00387497 0.0030174 0.00460626 0.00477645 0.010757 0.0136509 0.00880766 0.00641346 0.00967596 0.0114123 0.0218308 0.0248855 0.034072 0.0261276 0.0363535 0.0688333 0.0360044 0.052115 0.0470391 0.0532061 0.0641903	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG1 ) to DRUG2 , and DRUG0 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
4	4	0.073917 0.0336113 0.0341515 0.0390975 0.0266988 0.0124255 0.00491129 0.00679654 0.00781718 0.00526954 0.00356918 0.00755652 0.00831411 0.0160521 0.0764776 0.0327327 0.0297691 0.00924917 0.00674941 0.0117238 0.0201033 0.0049062 0.0100178 0.0125625 0.00863118 0.00603465 0.00886016 0.0107104 0.020956 0.0241438 0.0333175 0.0259624 0.0368993 0.0694864 0.0369688 0.0532594 0.0485914 0.0549986 0.0667004	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG1 ) to DRUG0 , and DRUG2 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
1	1	0.0507057 0.0197213 0.0187472 0.0209661 0.0149549 0.00679335 0.00280738 0.00409933 0.00428587 0.00307873 0.00170372 0.00355486 0.00226724 0.00380837 0.0158609 0.00553424 0.0060271 0.00344384 0.00257658 0.00397019 0.00700792 0.00991812 0.0491325 0.0449928 0.0442774 0.0340908 0.0415201 0.0583798 0.0483605 0.0408811 0.0482047 0.0325279 0.0404581 0.0776905 0.0359445 0.0532624 0.0424593 0.0453605 0.0506241	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG1 ) to DRUG0 , and DRUG0 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
4	4	0.062559 0.0255439 0.0244332 0.0272246 0.0193774 0.0091769 0.00412561 0.00568744 0.00653193 0.00467595 0.00278027 0.00578961 0.00419459 0.00654434 0.0191671 0.0358425 0.0702806 0.0823129 0.0242988 0.0272214 0.034478 0.00798245 0.012738 0.0118495 0.00786849 0.00560133 0.00804636 0.0103158 0.0198888 0.0220599 0.029931 0.0232853 0.0333047 0.0631401 0.034262 0.0487437 0.0452087 0.0512292 0.0622988	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG1 , and DRUG2 , concomitant use of these products with DRUG0 is not recommended pending full examination of potential interactions .
1	4	0.0475155 0.0174865 0.0161626 0.0179345 0.0129573 0.00591299 0.00263987 0.00372527 0.00395698 0.00289143 0.00153585 0.00325061 0.00196917 0.00291924 0.00922539 0.0170387 0.0376372 0.0299083 0.00533313 0.00638301 0.00875736 0.0117499 0.0378568 0.0323548 0.0336624 0.0262226 0.0341492 0.0509236 0.043981 0.0434334 0.0520301 0.0340052 0.0419471 0.0776377 0.0360206 0.053123 0.0420722 0.0444259 0.0492634	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG1 , and DRUG0 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
1	4	0.0498847 0.0188833 0.0174374 0.0197625 0.0146575 0.0067014 0.00300092 0.00413328 0.00444299 0.00298931 0.00154691 0.00310798 0.0018294 0.00236228 0.00582517 0.0079075 0.0100676 0.00674852 0.00458215 0.00888097 0.0490521 0.0111795 0.0390509 0.0388295 0.0370017 0.0279529 0.0358896 0.0505622 0.0440644 0.0431793 0.051936 0.0336658 0.0415428 0.0768442 0.0359204 0.0526311 0.0419614 0.0445161 0.0494683	Due to the chemical similarity of other DRUG0 (including DRUG0 , DRUG0 , and DRUG0 ) to DRUG0 , and DRUG1 , concomitant use of these products with DRUG2 is not recommended pending full examination of potential interactions .
4	4	0.0500258 0.0232215 0.0561634 0.0576369 0.057595 0.052247 0.064904 0.0487721 0.0408274 0.00821421 0.0168612 0.0549212 0.0278952 0.0224346 0.0170294 0.0145797 0.0239522 0.0371261 0.0130756 0.00926055 0.0339526 0.0110191 0.0184372 0.00888332 0.00648563 0.00419906 0.00363762 0.00557347 0.00647851 0.00353221 0.00584905 0.00813944 0.0149835 0.0609759 0.0482983 0.0628119	DRUG1 : Clinical drug interaction studies indicate that DRUG2 and DRUG0 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	4	0.0435223 0.019839 0.0447481 0.0432598 0.0423052 0.0362582 0.0432093 0.0220415 0.019708 0.0244341 0.0619546 0.0832441 0.0358244 0.0334901 0.0227704 0.0199196 0.0285938 0.0429734 0.0150027 0.0103499 0.0352476 0.011207 0.0187732 0.00903695 0.0066203 0.0042581 0.00370877 0.00571023 0.00654826 0.00357079 0.00590095 0.0082083 0.0151174 0.0615132 0.0483112 0.0628192	DRUG1 : Clinical drug interaction studies indicate that DRUG0 and DRUG2 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	4	0.0370108 0.0111332 0.0198628 0.0170988 0.0131135 0.0106088 0.013203 0.00802383 0.0137472 0.00977646 0.0400205 0.0877641 0.0466184 0.0618354 0.0737432 0.0595958 0.0786011 0.079316 0.0317932 0.0194801 0.0352179 0.0099098 0.0177586 0.00869309 0.00635829 0.00372294 0.0032589 0.00495837 0.00551462 0.00291082 0.00490295 0.00682647 0.0126177 0.0519815 0.0401422 0.0528799	DRUG1 : Clinical drug interaction studies indicate that DRUG0 and DRUG0 can exert an effect on DRUG2 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	4	0.0410586 0.0112816 0.0188619 0.0160562 0.0121154 0.00981527 0.0119466 0.00792895 0.0118776 0.00856987 0.0275528 0.0528412 0.0257926 0.0238222 0.0216503 0.0174857 0.0337249 0.0546356 0.0227345 0.0175161 0.0663048 0.027941 0.041097 0.0272605 0.0276865 0.0229288 0.0294055 0.0507152 0.0252853 0.00534636 0.00859127 0.00821545 0.015681 0.0742908 0.0583499 0.0636325	DRUG1 : Clinical drug interaction studies indicate that DRUG0 and DRUG0 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG2 , but to a lesser extent .
4	4	0.0142588 0.0235835 0.0436725 0.0463707 0.0503051 0.0478539 0.0552996 0.0435118 0.0933039 0.0296796 0.0662388 0.086811 0.0397944 0.0313152 0.0213615 0.0190812 0.0238834 0.0329847 0.0120727 0.00797753 0.02532 0.00822512 0.0133478 0.00617501 0.00450115 0.00287877 0.00251769 0.00380449 0.00446663 0.00246395 0.00409444 0.00557666 0.0101669 0.0408581 0.0320167 0.044227	DRUG0 : Clinical drug interaction studies indicate that DRUG1 and DRUG2 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	3	0.00970969 0.0114868 0.0255704 0.0348987 0.0382879 0.0411696 0.0500503 0.0372381 0.0540959 0.0138792 0.0360887 0.0746507 0.0389269 0.0547618 0.0575746 0.0645803 0.0673556 0.0539155 0.0227565 0.0142309 0.0246824 0.00731046 0.013943 0.00682867 0.00514772 0.00288474 0.00250136 0.0037383 0.00415368 0.0021718 0.00368726 0.00506277 0.00927707 0.0381518 0.0293691 0.0398617	DRUG0 : Clinical drug interaction studies indicate that DRUG1 and DRUG0 can exert an effect on DRUG2 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	4	0.00968534 0.011375 0.0250903 0.0333809 0.0365653 0.0399445 0.0490693 0.0379329 0.0570616 0.013649 0.0331828 0.074674 0.0231473 0.0187739 0.018129 0.0214796 0.0324035 0.0545037 0.0240074 0.0171705 0.05218 0.0205973 0.0314373 0.0197554 0.0189319 0.0152416 0.0190989 0.0312864 0.0153883 0.00329685 0.00527741 0.0050906 0.0095517 0.0442215 0.0349342 0.0424849	DRUG0 : Clinical drug interaction studies indicate that DRUG1 and DRUG0 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG2 , but to a lesser extent .
4	3	0.00885441 0.00991027 0.0187678 0.0222152 0.0217665 0.020157 0.0216366 0.0159234 0.0174912 0.0194284 0.0747255 0.0980657 0.0549254 0.0677994 0.0673474 0.0701522 0.0713874 0.0611792 0.0254158 0.0157168 0.0269656 0.00796662 0.0147814 0.00727719 0.00550948 0.00312442 0.00271946 0.00408442 0.00455967 0.00238445 0.0040487 0.00555961 0.0101782 0.0419076 0.0322672 0.0438003	DRUG0 : Clinical drug interaction studies indicate that DRUG0 and DRUG1 can exert an effect on DRUG2 metabolism by a mechanism which may be similar to that of DRUG0 , but to a lesser extent .
4	4	0.0087748 0.0100907 0.0190623 0.0219754 0.0218823 0.0202637 0.0217366 0.0168823 0.0179414 0.0204844 0.0957673 0.0964459 0.0316254 0.0266056 0.0230047 0.0251494 0.0351724 0.054847 0.0233436 0.0164746 0.0534335 0.0214517 0.031932 0.0202833 0.0197403 0.0160871 0.0202704 0.0336355 0.016524 0.00354544 0.00573848 0.0055511 0.0104275 0.0487702 0.0385206 0.046559	DRUG0 : Clinical drug interaction studies indicate that DRUG0 and DRUG1 can exert an effect on DRUG0 metabolism by a mechanism which may be similar to that of DRUG2 , but to a lesser extent .
4	4	0.00811403 0.00751627 0.00978754 0.00994424 0.00792611 0.00666047 0.00843075 0.00563049 0.00962618 0.00686608 0.0277678 0.0589337 0.0303435 0.0450595 0.0417717 0.0347697 0.0737374 0.0791606 0.0364846 0.0273829 0.0676611 0.0238032 0.0460797 0.0315408 0.029443 0.0211071 0.0242065 0.0371998 0.0179646 0.00393863 0.00624547 0.0059577 0.011118 0.0498527 0.0406315 0.0473368	DRUG0 : Clinical drug interaction studies indicate that DRUG0 and DRUG0 can exert an effect on DRUG1 metabolism by a mechanism which may be similar to that of DRUG2 , but to a lesser extent .
1	1	0.0619178 0.0617545 0.0537978 0.0662355 0.0646511 0.0277922 0.00752602 0.0106231 0.0103781 0.0210912 0.063786 0.147967 0.0648825 0.0224875 0.0434801 0.0329468 0.0243497 0.0204275 0.0158381 0.00939937 0.00227313 0.00315087 0.00723089 0.0066689 0.00562222 0.00469022 0.00162341 0.00269749 0.00125454 0.00205076 0.00559021 0.00475104 0.0176876 0.0220171 0.0173923 0.0639669	Concomitant administration of DRUG1 with DRUG2 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG0 , is not recommended .
4	1	0.0690802 0.0753572 0.070152 0.0775398 0.0748427 0.0255181 0.014869 0.0312155 0.0111224 0.0244021 0.0553812 0.112665 0.0518368 0.0174981 0.0357188 0.0290066 0.0218125 0.0181364 0.0145219 0.00875544 0.00214004 0.00298208 0.00686048 0.00629931 0.00530963 0.00442938 0.00153899 0.00255771 0.00119071 0.00194697 0.00529449 0.00450076 0.0167517 0.0208486 0.0166348 0.0612827	Concomitant administration of DRUG1 with DRUG0 , DRUG2 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG0 , is not recommended .
1	1	0.063521 0.0689742 0.0609708 0.0675395 0.0607094 0.0230307 0.013963 0.0139398 0.0192782 0.0408529 0.0773406 0.097419 0.0551077 0.0204857 0.040658 0.0337864 0.0260165 0.0214873 0.0166613 0.00977955 0.00233269 0.00320301 0.00729525 0.00669113 0.00563212 0.00472206 0.00162431 0.00269683 0.0012517 0.00204814 0.00556991 0.00473897 0.0176287 0.0219411 0.0173528 0.0637498	Concomitant administration of DRUG1 with DRUG0 , DRUG0 , or DRUG2 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG0 , is not recommended .
4	4	0.0479917 0.070436 0.0710965 0.0778419 0.0403196 0.0126682 0.00654336 0.00925031 0.0083411 0.0152788 0.0429116 0.108248 0.0475914 0.0235216 0.0451174 0.0424031 0.0352738 0.0330854 0.0275368 0.0194461 0.00426739 0.00869063 0.0179159 0.0208331 0.0162616 0.0159255 0.00451769 0.00802899 0.00175464 0.00223323 0.00340237 0.00342939 0.0163619 0.018867 0.0134971 0.0591107	Concomitant administration of DRUG1 with DRUG0 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG2 , including DRUG0 , is not recommended .
4	4	0.0483703 0.0709981 0.071655 0.0784782 0.040689 0.0127987 0.00662421 0.00936018 0.00844923 0.0154652 0.0433243 0.10922 0.0480433 0.0234339 0.0449671 0.0418565 0.0345391 0.032172 0.0268285 0.0187387 0.00393975 0.00744903 0.0156894 0.0184839 0.014524 0.0119092 0.00239033 0.00281379 0.00311834 0.00563371 0.0114301 0.00268323 0.0168738 0.0203969 0.0138649 0.0627886	Concomitant administration of DRUG1 with DRUG0 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG2 , is not recommended .
4	4	0.0585272 0.086107 0.0990338 0.0604616 0.0550215 0.0151637 0.00341749 0.0051383 0.00493689 0.0101581 0.028543 0.0826012 0.0411176 0.019286 0.0378022 0.0390214 0.0336724 0.0324802 0.0293022 0.0240872 0.00522445 0.0114804 0.0174842 0.0327583 0.0164919 0.00607633 0.00194881 0.00229124 0.00136613 0.00240536 0.00505608 0.00453704 0.0194132 0.0231234 0.0167584 0.0677057	Concomitant administration of DRUG0 with DRUG1 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG2 with other DRUG0 , including DRUG0 , is not recommended .
4	4	0.0594697 0.0874096 0.100633 0.0614391 0.0559487 0.0154486 0.00347834 0.00522353 0.00500599 0.0102543 0.0288746 0.0838556 0.0422565 0.0193498 0.0373974 0.0373816 0.0321166 0.0301474 0.0265893 0.0196336 0.00444079 0.00925323 0.0196735 0.0226326 0.0176231 0.0173647 0.00491955 0.00880543 0.00193261 0.00247549 0.00376496 0.00379852 0.0180879 0.0209753 0.0152924 0.0670464	Concomitant administration of DRUG0 with DRUG1 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG2 , including DRUG0 , is not recommended .
4	4	0.0598418 0.0879035 0.10125 0.0617983 0.056328 0.0156011 0.00352247 0.00529081 0.00507766 0.0103729 0.0291344 0.0845845 0.0426507 0.0192922 0.0372718 0.036953 0.0314977 0.0294018 0.0259483 0.018949 0.00410756 0.00795216 0.0172635 0.0201002 0.0157537 0.0129707 0.00259759 0.0030826 0.00342819 0.00620559 0.0126737 0.00297493 0.0187223 0.0226787 0.0156893 0.0711288	Concomitant administration of DRUG0 with DRUG1 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG2 , is not recommended .
4	4	0.047426 0.0727855 0.0748777 0.0432347 0.0331452 0.0141682 0.00742239 0.0232589 0.00653502 0.0150468 0.0315045 0.0783462 0.0383384 0.0193028 0.0423497 0.0450008 0.039605 0.0381525 0.0340988 0.0281232 0.00605067 0.0131351 0.0199847 0.0374773 0.0188704 0.00694758 0.00222085 0.00261246 0.00155757 0.00274376 0.00578015 0.00518409 0.0221556 0.0263425 0.0190786 0.0771363	Concomitant administration of DRUG0 with DRUG0 , DRUG1 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG2 with other DRUG0 , including DRUG0 , is not recommended .
4	4	0.0484933 0.074335 0.0764844 0.0441366 0.033776 0.0144664 0.00755822 0.0236823 0.00662056 0.0152137 0.0318934 0.0796258 0.0392912 0.0193181 0.0418056 0.043197 0.0378656 0.0356085 0.03112 0.0229961 0.00513999 0.010595 0.0224362 0.0259847 0.0202549 0.0199398 0.00565294 0.0100779 0.00221029 0.00282962 0.0043059 0.00433771 0.0206486 0.0239016 0.0174677 0.0767296	Concomitant administration of DRUG0 with DRUG0 , DRUG1 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG2 , including DRUG0 , is not recommended .
4	4	0.0489662 0.0749918 0.0771855 0.0445394 0.0340474 0.0145814 0.00762597 0.024009 0.00671299 0.0153989 0.0321767 0.0803746 0.0397123 0.0192446 0.0416595 0.0427146 0.0371434 0.0347138 0.0303717 0.0222051 0.00475853 0.00910774 0.019694 0.0230957 0.0181242 0.0149036 0.00299327 0.00354008 0.00393229 0.00711661 0.0145007 0.00339629 0.0213551 0.0258608 0.0179051 0.0813413	Concomitant administration of DRUG0 with DRUG0 , DRUG1 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG2 , is not recommended .
4	4	0.0415699 0.0602877 0.0571954 0.0290128 0.0217109 0.00973714 0.00480217 0.00866963 0.010994 0.0191598 0.0836966 0.0849406 0.032812 0.0199252 0.0476857 0.0526676 0.0458405 0.0433416 0.0371866 0.0297209 0.00633311 0.0131907 0.0195738 0.0369055 0.01863 0.00674535 0.00215299 0.00251409 0.00149584 0.00263259 0.005575 0.00499706 0.0213232 0.025375 0.0182008 0.0733983	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG1 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG2 with other DRUG0 , including DRUG0 , is not recommended .
4	4	0.0428207 0.0620938 0.0588942 0.0298681 0.0223542 0.0100345 0.00491948 0.00887233 0.0111371 0.0193979 0.0851775 0.0861725 0.0334134 0.0200112 0.0471669 0.0507268 0.0437977 0.0405427 0.0342561 0.0242162 0.00534475 0.0104919 0.0215287 0.0253844 0.0199462 0.0195112 0.00554791 0.00983162 0.00215361 0.00274474 0.00418063 0.00420792 0.0200235 0.023129 0.016732 0.0733685	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG1 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG2 , including DRUG0 , is not recommended .
4	4	0.0432744 0.0627308 0.05953 0.0302069 0.0226041 0.0101387 0.00497972 0.00897228 0.0112736 0.0195958 0.0858484 0.0870663 0.0338009 0.0199633 0.0470663 0.0501928 0.0429993 0.039527 0.0334711 0.0233974 0.00494309 0.00899577 0.0188712 0.0225567 0.0178466 0.0145912 0.00294281 0.00345917 0.00384459 0.00695247 0.0141145 0.00329961 0.020691 0.0250456 0.0172018 0.0780047	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG1 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG0 , including DRUG2 , is not recommended .
4	1	0.0199192 0.0264581 0.0222246 0.0116011 0.00895693 0.00593987 0.00233049 0.00506189 0.00283877 0.0064936 0.031358 0.0667425 0.0487032 0.0223888 0.0402799 0.0535818 0.0474153 0.0492127 0.0416194 0.0409408 0.0157508 0.0283169 0.0347746 0.0402832 0.0608348 0.0349415 0.0150897 0.0155025 0.00540333 0.00649247 0.00812313 0.00932061 0.0408887 0.0382009 0.019546 0.0724639	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG1 with other DRUG2 , including DRUG0 , is not recommended .
4	1	0.0194077 0.0258128 0.0216861 0.0113399 0.0087505 0.00580326 0.00227998 0.00496196 0.00278302 0.00637121 0.0308763 0.0660324 0.0485105 0.0231012 0.0414347 0.0558577 0.0484803 0.0505657 0.0415218 0.0411975 0.015313 0.0263189 0.0329068 0.0378757 0.0613851 0.0289654 0.0163678 0.00951423 0.00882739 0.0219696 0.0258894 0.00693328 0.0308704 0.032136 0.0176815 0.070271	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG1 with other DRUG0 , including DRUG2 , is not recommended .
4	4	0.0235235 0.031189 0.0262247 0.0136798 0.0105602 0.00698407 0.00274566 0.00602399 0.00337226 0.00790745 0.037445 0.0777643 0.0545701 0.0227607 0.0366907 0.0395924 0.0334444 0.0327787 0.0319365 0.025872 0.0066594 0.0165267 0.0445766 0.0530046 0.0455071 0.0433458 0.0133214 0.0352976 0.00776978 0.0193053 0.0200147 0.00521121 0.0279049 0.0311959 0.0202979 0.0849957	Concomitant administration of DRUG0 with DRUG0 , DRUG0 , or DRUG0 is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUG0 with other DRUG1 , including DRUG2 , is not recommended .
1	4	0.0356423 0.0258702 0.0747553 0.0496919 0.0730374 0.0617941 0.0812679 0.13012 0.0963625 0.0777696 0.0839219 0.0884702 0.121297	Studies to evaluate potential interactions of DRUG1 with DRUG2 are in progress .
4	4	0.135547 0.0206837 0.0326768 0.0359071 0.135957 0.0412297 0.00945441 0.00670153 0.00509812 0.00667594 0.00581578 0.00865295 0.00663633 0.00811151 0.0139006 0.0152903 0.0881381 0.0571729 0.0293698 0.0292435 0.0305322 0.0463295 0.0364413 0.0427375 0.0435961 0.0531225 0.0549776	DRUG1 , such as the DRUG2 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG0 );
4	4	0.161322 0.0222907 0.0403032 0.0406026 0.0858744 0.0220066 0.0209446 0.0261839 0.00571421 0.00603448 0.0053499 0.00725479 0.00713656 0.00787782 0.0130249 0.0147307 0.0953673 0.056744 0.0301156 0.0322817 0.0321312 0.047332 0.0356809 0.0399144 0.0405076 0.0505868 0.0526869	DRUG1 , such as the DRUG0 ( DRUG2 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG0 );
4	4	0.163417 0.0223468 0.0420375 0.041883 0.0760741 0.0188085 0.0193472 0.0119668 0.0113743 0.0269084 0.00577798 0.00688201 0.00742881 0.00818078 0.0126032 0.0146209 0.0982697 0.0555923 0.0302757 0.0332931 0.032973 0.0477185 0.0352195 0.038175 0.0388502 0.0487636 0.0512117	DRUG1 , such as the DRUG0 ( DRUG0 , DRUG2 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG0 );
4	4	0.15845 0.021547 0.0403893 0.0407218 0.0711555 0.0172555 0.0174508 0.00959152 0.0067604 0.0105616 0.0109892 0.0287321 0.0101765 0.00976353 0.01338 0.0148779 0.0957457 0.0565101 0.0298386 0.0297579 0.031541 0.0471534 0.0366705 0.0418013 0.0428188 0.0520775 0.0542825	DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG2 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG0 );
4	4	0.161572 0.0227949 0.0445012 0.0415726 0.0641197 0.0168503 0.0164131 0.00857532 0.0062126 0.00784092 0.00746479 0.0126957 0.0185305 0.0187516 0.0430735 0.0134005 0.0863479 0.0551034 0.0307342 0.035295 0.0354192 0.049826 0.034699 0.0359062 0.0357638 0.047024 0.0495121	DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG2 , ordinarily should not be administered concurrently with DRUG0 (a DRUG0 );
1	1	0.0428843 0.00526725 0.00783673 0.00676828 0.0113825 0.00454119 0.00382247 0.0036273 0.00279007 0.00369126 0.00357787 0.00514339 0.00649883 0.00925674 0.0128968 0.0186803 0.12328 0.0494841 0.0492104 0.0468332 0.0798514 0.108765 0.132652 0.0799501 0.0638942 0.0547618 0.0626531	DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.0537226 0.00669365 0.0099231 0.00807674 0.0124998 0.00521205 0.00457953 0.00431092 0.0035267 0.00441745 0.00409924 0.00546001 0.00570794 0.00823175 0.0115836 0.0140331 0.103333 0.0436499 0.041685 0.0407407 0.0481746 0.0723193 0.0801203 0.104057 0.166542 0.0957328 0.0415674	DRUG1 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	1	0.0101793 0.00424925 0.00620975 0.00949292 0.0350937 0.020016 0.00647969 0.00364024 0.00294466 0.00366393 0.00351643 0.00478479 0.00555229 0.00911436 0.0124204 0.0183993 0.133691 0.0485969 0.0487424 0.0452485 0.0772309 0.104857 0.128259 0.0781321 0.0629853 0.054457 0.0620425	DRUG0 , such as the DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.0131037 0.00521698 0.00807119 0.0113836 0.0401005 0.0245664 0.00715359 0.00440614 0.0037866 0.00451275 0.00423861 0.00520189 0.0051219 0.00788771 0.0109586 0.0136356 0.108644 0.0434475 0.0420404 0.0408326 0.0470239 0.0706209 0.079395 0.101421 0.16253 0.0939432 0.0407559	DRUG0 , such as the DRUG1 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	1	0.00917374 0.00390972 0.00585047 0.00673469 0.0172674 0.0146984 0.0112032 0.0243767 0.00426067 0.00441777 0.00431775 0.00547371 0.00653052 0.0110338 0.0136039 0.0206238 0.139629 0.0445539 0.0474648 0.0421037 0.0713259 0.0995055 0.122564 0.0773712 0.0668944 0.058712 0.0663992	DRUG0 , such as the DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.011498 0.00475462 0.0075228 0.00848153 0.0209972 0.0170869 0.0136036 0.031036 0.00507331 0.00512938 0.00485831 0.0055019 0.00590135 0.00886379 0.011294 0.0150866 0.111878 0.0398343 0.0410372 0.0412704 0.0466001 0.0722928 0.0831267 0.0992388 0.156197 0.0917291 0.0401069	DRUG0 , such as the DRUG0 ( DRUG1 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	1	0.00901971 0.00373548 0.00509434 0.0051797 0.0105346 0.00732923 0.00485856 0.00705728 0.00482432 0.0197572 0.00438421 0.00596333 0.00714532 0.0114909 0.0150599 0.0215497 0.139183 0.0482967 0.0482371 0.0429832 0.0732824 0.102472 0.12695 0.0793878 0.0680108 0.0601148 0.0680988	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.011175 0.00448462 0.00642303 0.00641614 0.0124381 0.00844816 0.00581793 0.00855147 0.0058226 0.0247588 0.00490617 0.00589914 0.00633007 0.00917145 0.0125736 0.015749 0.111556 0.0428383 0.0428651 0.0419335 0.0478552 0.0733799 0.0841137 0.103379 0.164575 0.096437 0.0421025	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG1 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	1	0.00817219 0.0034184 0.00440605 0.00428517 0.00810715 0.0056905 0.00338161 0.00420845 0.00269109 0.00632895 0.00512047 0.0222663 0.00801507 0.0107613 0.0143638 0.0220426 0.148575 0.0504363 0.0493679 0.0444514 0.075431 0.104024 0.127421 0.0781023 0.0656335 0.0578562 0.0654425	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.0103809 0.00416573 0.0056242 0.00540658 0.00964394 0.00663217 0.0040094 0.00504647 0.00321845 0.0073685 0.00588649 0.0248763 0.00771329 0.00953414 0.0127441 0.0158318 0.120121 0.0443688 0.0437382 0.0427057 0.0489148 0.0736892 0.0829088 0.103731 0.164412 0.0956539 0.0416733	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG1 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	1	0.00765787 0.0031146 0.00481509 0.0049074 0.0102235 0.00526693 0.00369919 0.00381853 0.00264836 0.00520008 0.00573552 0.0136117 0.022582 0.0223285 0.128898 0.0252659 0.106295 0.0378199 0.0440101 0.0372866 0.0647577 0.0888662 0.106886 0.0694534 0.0609698 0.0534788 0.0604027	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG1 , ordinarily should not be administered concurrently with DRUG2 (a DRUG0 );
4	4	0.00913464 0.00375888 0.00576442 0.00575093 0.0114299 0.00589481 0.00415448 0.00425323 0.00282934 0.00539232 0.00544778 0.0126535 0.0195664 0.0238022 0.119143 0.0209078 0.0948771 0.0338462 0.035816 0.03997 0.044746 0.0697549 0.0799686 0.0870578 0.138337 0.0803478 0.0353949	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG1 , ordinarily should not be administered concurrently with DRUG0 (a DRUG2 );
1	4	0.00850121 0.00333747 0.00426325 0.0038609 0.0058737 0.00449077 0.00277599 0.00352921 0.00209569 0.00329647 0.00271802 0.00468819 0.003459 0.00458784 0.00877237 0.0123871 0.0760106 0.0537313 0.0444167 0.0464053 0.0597202 0.0602234 0.0764423 0.117991 0.237358 0.104464 0.0446004	DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , ordinarily should not be administered concurrently with DRUG1 (a DRUG2 );
2	4	0.0377096 0.0467464 0.0346491 0.0408888 0.033896 0.020267 0.0742469 0.0294885 0.080254 0.0338723 0.0111186 0.0510093 0.0750308 0.0646825 0.0584504 0.0891037 0.0553744 0.0276742 0.0203105 0.0244861 0.0431286 0.0476123	In elderly patients concurrently receiving certain DRUG1 , primarily DRUG2 , an increased incidence of thrombopenia with purpura has been reported .
2	4	0.0445278 0.038826 0.0421466 0.0487697 0.0391792 0.0991671 0.0612176 0.0392772 0.0484202 0.0298079 0.0277009 0.0345394 0.0318359 0.0344548 0.0402586 0.0583972 0.0761898 0.0596332 0.0363357 0.109315	It has been reported that DRUG1 may prolong the prothrombin time in patients who are receiving the DRUG2 DRUG0 .
2	2	0.0482179 0.0421615 0.0459323 0.0526059 0.0417804 0.110083 0.0667905 0.040949 0.0559547 0.0342811 0.0304623 0.0364935 0.033285 0.0411497 0.047643 0.0672008 0.0545685 0.0350745 0.0478845 0.0674815	It has been reported that DRUG1 may prolong the prothrombin time in patients who are receiving the DRUG0 DRUG2 .
3	3	0.137369 0.131914 0.0941744 0.100017 0.0569049 0.151284 0.136094 0.109183 0.0830591	DRUG1 may inhibit the hepatic metabolism of DRUG2 .
3	3	0.0359067 0.0304531 0.037299 0.0178066 0.013788 0.0570276 0.0493975 0.0263906 0.0436639 0.0287678 0.0340255 0.0499181 0.0329116 0.0349032 0.0435905 0.0479409 0.0243669 0.0170853 0.0318242 0.0404236 0.0475322 0.024466 0.0226098 0.0327205 0.0162372 0.0152382 0.0197778 0.0414511 0.0392002 0.043276	At a 1.6-g dose , DRUG1 produced a slight but significant increase in the half-life of DRUG2 but did not produce a corresponding decrease in the metabolic clearance rate .
3	3	0.104474 0.10555 0.0625373 0.132191 0.094673 0.0594834 0.0875493 0.0823895 0.0656383 0.0171583 0.0219674 0.0228665 0.0274574 0.0283329 0.0329605 0.0547718	DRUG1 can also displace DRUG2 from plasma protein-binding sites , thus increasing free DRUG0 concentrations .
3	4	0.108424 0.0985208 0.0511419 0.0724794 0.0423344 0.0339633 0.0392202 0.0386058 0.0327039 0.0182623 0.0555848 0.0787718 0.114754 0.0731669 0.0643139 0.0777525	DRUG1 can also displace DRUG0 from plasma protein-binding sites , thus increasing free DRUG2 concentrations .
1	4	0.140203 0.0221784 0.0256263 0.0220134 0.0204095 0.0155315 0.0228787 0.0330716 0.0245244 0.0169682 0.0758619 0.108124 0.0646969 0.0615641 0.0409003 0.0087925 0.0198324 0.0514723 0.0361852 0.0631301 0.0418666 0.0841678	DRUG1 should be used with caution in digitalized patients , since the combination of DRUG2 and DRUG0 may cause ectopic arrhythmias .
4	4	0.140424 0.0215651 0.0249453 0.0206385 0.0183709 0.0128819 0.0182139 0.0256425 0.019365 0.0172778 0.0746994 0.0831817 0.0482117 0.0396436 0.0264584 0.0270247 0.0646708 0.0671147 0.0461779 0.0742382 0.0441877 0.0850669	DRUG1 should be used with caution in digitalized patients , since the combination of DRUG0 and DRUG2 may cause ectopic arrhythmias .
2	2	0.0203886 0.0207844 0.0165183 0.0118682 0.0227737 0.0140466 0.0166672 0.0289635 0.0176036 0.0113792 0.0669289 0.0847635 0.052363 0.0510958 0.0945464 0.0267642 0.0680183 0.0978019 0.0668082 0.0847976 0.0461335 0.0789854	DRUG0 should be used with caution in digitalized patients , since the combination of DRUG1 and DRUG2 may cause ectopic arrhythmias .
2	2	0.0775956 0.0471598 0.0638182 0.166544 0.070772 0.106805 0.0720001 0.151544 0.145663 0.0980986	DRUG1 or DRUG0 may potentiate the action of DRUG2 .
2	2	0.0328758 0.0309585 0.148805 0.180463 0.0687404 0.101438 0.0667526 0.14507 0.131366 0.0935305	DRUG0 or DRUG1 may potentiate the action of DRUG2 .
4	0	0.170332 0.245159 0.18556 0.0691095 0.0465243 0.0555026 0.0320125 0.0543645 0.0124705 0.0144666 0.0118644 0.00808989 0.0159572 0.0167843 0.0618032	Interactions for DRUG1 ( DRUG0 ) : DRUG2 , Oral DRUG0 , DRUG0 , DRUG0
4	0	0.152336 0.222049 0.16544 0.0618863 0.0385337 0.0409737 0.0304924 0.0220502 0.0205953 0.0982963 0.0532971 0.0102024 0.0149509 0.0138642 0.055033	Interactions for DRUG1 ( DRUG0 ) : DRUG0 , Oral DRUG2 , DRUG0 , DRUG0
4	0	0.176418 0.253248 0.190169 0.0672697 0.0433619 0.0460476 0.0308491 0.0194546 0.0119402 0.0328632 0.0177372 0.0141917 0.0426004 0.0112648 0.0425845	Interactions for DRUG1 ( DRUG0 ) : DRUG0 , Oral DRUG0 , DRUG2 , DRUG0
4	0	0.16622 0.224969 0.170888 0.063315 0.0422034 0.0468615 0.0308873 0.0180087 0.0115225 0.0300672 0.0149715 0.00817485 0.0164594 0.030042 0.125411	Interactions for DRUG1 ( DRUG0 ) : DRUG0 , Oral DRUG0 , DRUG0 , DRUG2
4	0	0.171406 0.150509 0.0814225 0.0765086 0.207469 0.0790541 0.0368691 0.0534711 0.0119607 0.0140755 0.0119372 0.00822465 0.0162534 0.017123 0.063716	Interactions for DRUG0 ( DRUG1 ) : DRUG2 , Oral DRUG0 , DRUG0 , DRUG0
4	0	0.141197 0.12421 0.0681052 0.0690156 0.174656 0.0708185 0.0383351 0.0260524 0.0235327 0.108406 0.0567979 0.0104223 0.0152898 0.0142456 0.0589154	Interactions for DRUG0 ( DRUG1 ) : DRUG0 , Oral DRUG2 , DRUG0 , DRUG0
4	0	0.165528 0.145917 0.0816178 0.0828445 0.207327 0.0773902 0.0380743 0.0224326 0.0133331 0.0349656 0.0185337 0.0146774 0.0420929 0.011071 0.0441944	Interactions for DRUG0 ( DRUG1 ) : DRUG0 , Oral DRUG0 , DRUG2 , DRUG0
4	0	0.156948 0.135913 0.0742002 0.0742109 0.187303 0.0743496 0.0368958 0.0204815 0.012668 0.0316632 0.0153507 0.00830651 0.0167182 0.0309667 0.124025	Interactions for DRUG0 ( DRUG1 ) : DRUG0 , Oral DRUG0 , DRUG0 , DRUG2
4	4	0.0878718 0.0755512 0.0389412 0.0249954 0.0423151 0.0478062 0.0733932 0.228851 0.0531708 0.147278 0.0577854 0.0136638 0.0190024 0.0193138 0.0700607	Interactions for DRUG0 ( DRUG0 ) : DRUG1 , Oral DRUG2 , DRUG0 , DRUG0
4	4	0.0939228 0.0793467 0.04021 0.0261275 0.0422772 0.0509613 0.0795352 0.222354 0.0428092 0.105702 0.0272858 0.0281335 0.074514 0.0190883 0.0677321	Interactions for DRUG0 ( DRUG0 ) : DRUG1 , Oral DRUG0 , DRUG2 , DRUG0
4	4	0.0881447 0.0726742 0.0355594 0.0231271 0.0361446 0.0434004 0.0676819 0.177066 0.0384905 0.085814 0.0225757 0.0196222 0.0257196 0.0644507 0.199529	Interactions for DRUG0 ( DRUG0 ) : DRUG1 , Oral DRUG0 , DRUG0 , DRUG2
0	4	0.238722 0.193064 0.099237 0.102279 0.109529 0.0418023 0.00878692 0.00844345 0.00531298 0.00522954 0.0063994 0.00503012 0.00711034 0.0115343 0.00837865 0.0278706 0.12127	DRUG1 may be used with DRUG2 , DRUG0 and other DRUG0 , and with other DRUG0 .
1	4	0.215333 0.191969 0.0962966 0.102442 0.0938717 0.0225265 0.0130143 0.0344834 0.00783215 0.00579028 0.00698709 0.00541591 0.00778233 0.0128793 0.0100728 0.0325137 0.14079	DRUG1 may be used with DRUG0 , DRUG2 and other DRUG0 , and with other DRUG0 .
2	4	0.221189 0.190336 0.0943871 0.0919688 0.0864894 0.0187565 0.00738367 0.0135465 0.0101586 0.0152602 0.0319837 0.00672685 0.00797298 0.0133874 0.0107634 0.0342781 0.145411	DRUG1 may be used with DRUG0 , DRUG0 and other DRUG2 , and with other DRUG0 .
1	4	0.156598 0.154 0.0797804 0.0692178 0.0595413 0.0145601 0.00558113 0.0102811 0.00612195 0.0069705 0.0123535 0.0131538 0.0342631 0.087823 0.0310438 0.112286 0.146424	DRUG1 may be used with DRUG0 , DRUG0 and other DRUG0 , and with other DRUG2 .
4	4	0.0992498 0.173689 0.137613 0.105322 0.115506 0.10014 0.0218 0.0169886 0.0105156 0.0160314 0.026555 0.00574708 0.0065222 0.00945294 0.00795786 0.0275266 0.119384	DRUG0 may be used with DRUG1 , DRUG0 and other DRUG2 , and with other DRUG0 .
4	4	0.0885009 0.152031 0.118997 0.0898356 0.0944377 0.0756336 0.0165319 0.0121289 0.00691445 0.0127551 0.0115095 0.0204994 0.0252075 0.0591628 0.0224483 0.0743467 0.11906	DRUG0 may be used with DRUG1 , DRUG0 and other DRUG0 , and with other DRUG2 .
4	4	0.0897384 0.140167 0.111868 0.0854892 0.074551 0.0316569 0.0258093 0.117279 0.0157236 0.0188936 0.0327721 0.0073477 0.00903972 0.0129737 0.0114437 0.0398131 0.175434	DRUG0 may be used with DRUG0 , DRUG1 and other DRUG2 , and with other DRUG0 .
4	4	0.0783466 0.122702 0.0980324 0.0735351 0.0576776 0.0227718 0.0174832 0.0760857 0.0100401 0.0151159 0.0138288 0.0256138 0.032216 0.0708335 0.0268226 0.0924795 0.166415	DRUG0 may be used with DRUG0 , DRUG1 and other DRUG0 , and with other DRUG2 .
4	4	0.0623348 0.0948637 0.0787596 0.0589436 0.0450789 0.0151594 0.00783933 0.0174715 0.0138399 0.0276325 0.116419 0.03997 0.0451496 0.0874328 0.0321744 0.0971026 0.159828	DRUG0 may be used with DRUG0 , DRUG0 and other DRUG1 , and with other DRUG2 .
2	2	0.092552 0.0996695 0.0736949 0.077512 0.0763383 0.0502757 0.0443174 0.0569753 0.0445592 0.0902936 0.0252027 0.0446899 0.0556597 0.0479404 0.0431784 0.0771407	Mild hepatotoxicity has been reported in some patients when DRUG1 and DRUG2 were administered concomitantly .
2	2	0.0669094 0.0628361 0.0585026 0.0825744 0.0353901 0.0692961 0.0506484 0.0477995 0.0496865 0.039541 0.0270756 0.0140886 0.0636248 0.0762249 0.0271934 0.0778605 0.0843985 0.0663496	Concomitant administration of DRUG1 and DRUG2 has been associated with erythema and histamine-like flushing and anaphylactoid reactions .
2	2	0.0610324 0.0777384 0.0389697 0.0388293 0.0105694 0.0253226 0.0395966 0.0253116 0.0406509 0.0136771 0.00724979 0.012379 0.0597777 0.0229255 0.0215226 0.02723 0.0477692 0.0252617 0.0234142 0.0292195 0.0330041 0.0641743 0.0378168 0.038333 0.0580315 0.0189432 0.0463552 0.054895	The occurrence of stupor , muscular rigidity , severe agitation , and elevated temperature has been reported in some patients receiving the combination of DRUG1 and DRUG2 .
0	0	0.074654 0.0678466 0.115495 0.0912935 0.0930955 0.107276 0.0955771 0.127707 0.0419307 0.0954082 0.0897168	This is typical of the interaction of DRUG1 and DRUG2 .
2	2	0.089736 0.0709639 0.0436568 0.0496517 0.0441006 0.0636628 0.0486911 0.0447778 0.0540239 0.108358 0.0616422 0.0568679 0.0636425 0.0160742 0.0237052 0.00641657 0.00891463 0.00837601 0.0272075 0.109531	Severe toxicity has also been reported in patients receiving the combination of DRUG1 and DRUG2 and DRUG0 and DRUG0 .
2	4	0.0854229 0.0667047 0.0407767 0.0460766 0.0403903 0.0578119 0.0447077 0.0415861 0.0548007 0.10575 0.0656535 0.0641408 0.0673322 0.0203721 0.0200539 0.0137079 0.028474 0.00923729 0.0243336 0.102667	Severe toxicity has also been reported in patients receiving the combination of DRUG1 and DRUG0 and DRUG2 and DRUG0 .
4	4	0.0704531 0.0571329 0.0318549 0.0355999 0.0281338 0.0484144 0.029378 0.0303648 0.0564945 0.1138 0.0924727 0.0777987 0.052472 0.0286733 0.0722876 0.0148679 0.029082 0.0083138 0.0232736 0.0991319	Severe toxicity has also been reported in patients receiving the combination of DRUG0 and DRUG1 and DRUG2 and DRUG0 .
4	2	0.0550908 0.0458714 0.0263614 0.0288155 0.0231423 0.0398075 0.0256852 0.0268481 0.0509599 0.0908053 0.068765 0.0580266 0.0296795 0.0143958 0.0296206 0.0338924 0.111883 0.0346967 0.0892106 0.116443	Severe toxicity has also been reported in patients receiving the combination of DRUG0 and DRUG0 and DRUG1 and DRUG2 .
2	2	0.107677 0.0542538 0.033188 0.0336116 0.0539356 0.0363342 0.0421949 0.0540891 0.0235604 0.0207879 0.0287596 0.0293162 0.0391361 0.0309088 0.0223754 0.0353321 0.0677425 0.025819 0.0663459 0.0354706 0.0133852 0.0153813 0.0225363 0.107858	One case of hypertensive crisis has been reported in a patient taking the recommended doses of DRUG1 and a DRUG2 ( DRUG0 ) .
2	2	0.104429 0.0530398 0.0330373 0.0330384 0.0527194 0.0360423 0.0417791 0.0533115 0.0253488 0.0221787 0.0301251 0.0292104 0.0390988 0.031886 0.0223012 0.0346498 0.0666906 0.0205364 0.0491295 0.0218354 0.0349535 0.0486298 0.0311159 0.0849133	One case of hypertensive crisis has been reported in a patient taking the recommended doses of DRUG1 and a DRUG0 ( DRUG2 ) .
4	4	0.0426026 0.0344326 0.0303407 0.0659612 0.0457504 0.0589015 0.0268838 0.0312313 0.0625898 0.0720276 0.0560978 0.108154 0.0844396 0.0307628 0.00505934 0.00341212 0.00747763 0.0178779 0.0253613 0.0268105 0.0211901 0.0176071 0.0128385 0.0144064 0.0204844 0.0181025 0.0591967	The in vitro binding of DRUG1 to human plasma proteins is unaffected by DRUG2 , and DRUG0 does not alter the prothrombin time of normal volunteers .
4	4	0.045056 0.0358133 0.0316848 0.0690838 0.0473371 0.060173 0.0276483 0.031523 0.0649832 0.0678795 0.0468973 0.0738986 0.0307216 0.00940009 0.00502469 0.0107417 0.0307038 0.0377206 0.0416747 0.0348836 0.0296673 0.0222234 0.0158925 0.0177201 0.0238691 0.0211364 0.0666426	The in vitro binding of DRUG1 to human plasma proteins is unaffected by DRUG0 , and DRUG2 does not alter the prothrombin time of normal volunteers .
2	2	0.0310003 0.024087 0.0659556 0.037605 0.0188061 0.00990527 0.0253711 0.0232901 0.0428051 0.0807834 0.0652578 0.0473237 0.048321 0.0536226 0.148278 0.0381239 0.0663536 0.055709 0.117402	However , increased prothrombin time and bleeding have been reported in patients on concomitant DRUG1 and DRUG2 therapy .
1	1	0.0426724 0.0169801 0.0389557 0.0425408 0.0447459 0.0376536 0.0550666 0.0671312 0.110203 0.101714 0.0852459 0.121598 0.125642 0.109851	Therefore , caution should be exercised when administering DRUG1 to patients on DRUG2 .
4	4	0.0336594 0.0394746 0.0252395 0.0219523 0.0460311 0.0310987 0.0341692 0.043515 0.0281625 0.0125607 0.0151901 0.0320895 0.0346555 0.0406067 0.0568357 0.039677 0.0388283 0.0412944 0.0575163 0.0483508 0.0640216 0.0350386 0.0180039 0.0253226 0.0261257 0.11058	In adult diabetic patients under treatment with either DRUG1 or DRUG0 there is no change in the clinical effects of either DRUG2 or the DRUG0 .
4	4	0.0367228 0.042719 0.0270498 0.0235147 0.0488686 0.0328271 0.0360062 0.0461324 0.0304685 0.0135888 0.0159368 0.0326902 0.0346284 0.040001 0.053964 0.0380582 0.0365599 0.035825 0.0424978 0.0340781 0.0345054 0.0177463 0.0217738 0.0748373 0.065034 0.0839658	In adult diabetic patients under treatment with either DRUG1 or DRUG0 there is no change in the clinical effects of either DRUG0 or the DRUG2 .
4	4	0.0362538 0.0439727 0.0293245 0.0257411 0.0520604 0.037744 0.045617 0.0368431 0.0204542 0.0155582 0.0533555 0.0264502 0.0257761 0.0346971 0.0528192 0.03842 0.0364298 0.0383195 0.0528185 0.04451 0.0587751 0.0320304 0.0165693 0.0229418 0.023327 0.0991917	In adult diabetic patients under treatment with either DRUG0 or DRUG1 there is no change in the clinical effects of either DRUG2 or the DRUG0 .
4	4	0.0399859 0.0482741 0.0319292 0.0278038 0.0554176 0.0398636 0.0478859 0.0390174 0.0216415 0.0160295 0.0549546 0.0265516 0.0255789 0.0338042 0.0494774 0.036458 0.0341251 0.0328947 0.038819 0.0311951 0.0314685 0.015922 0.0197189 0.0672595 0.0583263 0.0755977	In adult diabetic patients under treatment with either DRUG0 or DRUG1 there is no change in the clinical effects of either DRUG0 or the DRUG2 .
4	4	0.0224109 0.0243579 0.0155165 0.0124578 0.0186743 0.013678 0.0128035 0.0101641 0.0103422 0.00540249 0.0180535 0.0281873 0.0430877 0.0462642 0.0488546 0.0230185 0.0281123 0.0307471 0.0678775 0.0540039 0.0637498 0.0712403 0.0346127 0.114964 0.0854801 0.0959383	In adult diabetic patients under treatment with either DRUG0 or DRUG0 there is no change in the clinical effects of either DRUG1 or the DRUG2 .
1	1	0.0600894 0.0411563 0.0488794 0.0499838 0.0523754 0.11957 0.0695477 0.0923904 0.0928353 0.14201 0.123009 0.108154	Caution should be used if DRUG1 is administered concomitantly with DRUG2 .
4	4	0.112432 0.022317 0.0375706 0.0464278 0.0244745 0.0364336 0.0687747 0.0367212 0.0495083 0.0199211 0.0183715 0.0172984 0.0133865 0.0206156 0.0155387 0.0248027 0.0177531 0.0254527 0.00797695 0.0234212 0.114812 0.0437237 0.0382656 0.0336724 0.0375253 0.0928028	DRUG1 and other DRUG2 have been reported to reduce the tubular secretion of DRUG0 in an animal model , possibly enhancing the toxicity of DRUG0 .
3	3	0.0658031 0.00623197 0.00699922 0.00949579 0.0177369 0.0297612 0.0526757 0.026005 0.0559582 0.0378217 0.0416371 0.0495567 0.0690056 0.051915 0.0348124 0.0379547 0.0291892 0.0318403 0.007531 0.0196671 0.0885106 0.0391144 0.036479 0.0336142 0.0348087 0.0858753	DRUG1 and other DRUG0 have been reported to reduce the tubular secretion of DRUG2 in an animal model , possibly enhancing the toxicity of DRUG0 .
4	4	0.0477407 0.00418596 0.00434387 0.00591418 0.0100223 0.0165365 0.0316991 0.0147105 0.0347444 0.0178712 0.014276 0.014527 0.0154979 0.0220556 0.0199171 0.0320665 0.0216679 0.0285951 0.010463 0.0365702 0.163182 0.108861 0.0691136 0.0926099 0.0864714 0.0763574	DRUG1 and other DRUG0 have been reported to reduce the tubular secretion of DRUG0 in an animal model , possibly enhancing the toxicity of DRUG2 .
3	3	0.0159977 0.00719562 0.0135048 0.0546967 0.0244672 0.0340491 0.0600648 0.0270055 0.0578958 0.0381647 0.0396257 0.0476077 0.0666575 0.0504219 0.0345141 0.0381415 0.0290224 0.0311731 0.00728644 0.0188785 0.084453 0.0372784 0.0347607 0.032041 0.0331949 0.0819008	DRUG0 and other DRUG1 have been reported to reduce the tubular secretion of DRUG2 in an animal model , possibly enhancing the toxicity of DRUG0 .
4	4	0.0120732 0.00532259 0.00951232 0.0370062 0.0141503 0.0177371 0.0359374 0.0152371 0.0362966 0.0185204 0.0147153 0.0153766 0.0166054 0.0228739 0.020574 0.0326793 0.0218491 0.0284655 0.0102474 0.036042 0.159407 0.105524 0.0669841 0.0896494 0.0837119 0.0735014	DRUG0 and other DRUG1 have been reported to reduce the tubular secretion of DRUG0 in an animal model , possibly enhancing the toxicity of DRUG2 .
2	2	0.0433379 0.031759 0.0318079 0.0372957 0.0509095 0.0411133 0.0295526 0.0431855 0.0257085 0.0527437 0.0605463 0.0715516 0.0182432 0.020593 0.00621626 0.00642598 0.00960319 0.0491602 0.044588 0.0306648 0.0264234 0.0186172 0.0217794 0.0343091 0.0234488 0.0679946 0.01781 0.0134226 0.0215227 0.0496658	The concomitant use of DRUG1 with other DRUG2 that produce dry mouth , constipation , and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects .
4	4	0.0215038 0.0354246 0.0345937 0.0338507 0.0190465 0.0113538 0.00456796 0.00353068 0.0066886 0.0119865 0.045738 0.0446053 0.0626357 0.055403 0.040316 0.0114774 0.015084 0.00713202 0.00581534 0.0037474 0.00905737 0.0198317 0.0436851 0.0396009 0.0355321 0.0320859 0.0316415 0.0141666 0.00374558 0.00659073 0.00611089 0.0118436 0.049355 0.0338798 0.0265097 0.0271177 0.0247011 0.016585 0.0185061 0.008278 0.00154812 0.0013075 0.000940387 0.00117244 0.000910039 0.00119826 0.00093438 0.00132254 0.00108172 0.00188055 0.00167573 0.00389127 0.00664804 0.0421638	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	4	0.0219085 0.0360911 0.0352428 0.0344847 0.0194028 0.0115656 0.00465286 0.00359587 0.00681044 0.0122023 0.0465697 0.0454213 0.0637623 0.0563839 0.0410265 0.0116757 0.0153443 0.00725419 0.00591165 0.00380785 0.00918794 0.0200948 0.0442901 0.0401564 0.0358784 0.0322774 0.03186 0.0141957 0.00373351 0.00649248 0.00632931 0.0125379 0.0514443 0.0340291 0.027453 0.0284877 0.024103 0.0141479 0.00971953 0.0025909 0.00208128 0.00482129 0.000965435 0.00107575 0.000841109 0.00109677 0.000865221 0.00122327 0.0010155 0.00174635 0.0015812 0.00364913 0.00641339 0.0405003	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	4	0.0219913 0.0362276 0.0353758 0.0346146 0.0194755 0.0116087 0.00467026 0.00360921 0.00683521 0.0122463 0.0467386 0.0455884 0.0639933 0.0565847 0.0411669 0.0117142 0.0153966 0.00727813 0.00593092 0.00382002 0.00921447 0.0201518 0.0444412 0.0403159 0.0360019 0.0323849 0.0320179 0.014302 0.00376801 0.00653809 0.00637882 0.01263 0.0515822 0.0334526 0.0269048 0.0278014 0.0233357 0.013297 0.00868346 0.00194111 0.00110616 0.00182129 0.00199045 0.00477566 0.00096484 0.00114828 0.000909884 0.0012653 0.00104789 0.0017765 0.00159512 0.0036871 0.00660411 0.0412979	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	4	0.0219665 0.0361868 0.0353358 0.0345754 0.0194532 0.0115953 0.00466489 0.00360501 0.00682702 0.0122314 0.0466826 0.0455348 0.0639165 0.0565161 0.0411131 0.0116985 0.0153762 0.00726803 0.00592278 0.00381425 0.00919978 0.0201173 0.0443695 0.04026 0.0359084 0.0322868 0.0319492 0.0142885 0.00376749 0.00653455 0.00639485 0.0126918 0.0517999 0.0335273 0.0270041 0.0278953 0.0233426 0.0131555 0.00848676 0.00185902 0.000983063 0.00139493 0.00108833 0.00180177 0.00195732 0.0048719 0.0010143 0.0013201 0.00109014 0.00179459 0.00158963 0.00367571 0.00670277 0.0415927	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 and DRUG0 ) .
4	4	0.0219232 0.0361155 0.0352661 0.0345072 0.0194148 0.0115723 0.00465566 0.00359786 0.0068134 0.012207 0.0465895 0.0454444 0.063789 0.0564031 0.041029 0.0116744 0.0153443 0.00725276 0.00591044 0.00380621 0.00918063 0.0200755 0.0442809 0.0401862 0.0358293 0.0322147 0.0319013 0.0142786 0.00376692 0.00653434 0.00640505 0.0127196 0.0518863 0.0336259 0.027137 0.0280445 0.0234278 0.0131463 0.00845288 0.0018363 0.000974532 0.00136454 0.000973001 0.00139398 0.00107493 0.00180866 0.00197328 0.00537718 0.00118474 0.00183059 0.00159272 0.00366409 0.00684674 0.0416946	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 and DRUG0 ) .
4	4	0.0220756 0.0363666 0.0355113 0.0347472 0.01955 0.011653 0.00468805 0.00362289 0.00686097 0.0122923 0.0469148 0.0457606 0.0642339 0.0567972 0.0413202 0.0117562 0.0154559 0.00730611 0.00595358 0.00383408 0.00924549 0.0202214 0.0445939 0.0404612 0.0360924 0.0324222 0.0319784 0.0142663 0.00375686 0.00652118 0.00634872 0.0125892 0.0514192 0.0330367 0.026324 0.0269348 0.022391 0.0126544 0.00811167 0.00180881 0.000957727 0.00134074 0.000954126 0.0013483 0.000947953 0.00137465 0.00105119 0.00181692 0.00201382 0.00727085 0.00173584 0.00368581 0.0070443 0.0405795	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 and DRUG0 ) .
4	4	0.0217311 0.035799 0.0349565 0.034204 0.0192441 0.0114704 0.00461446 0.00356588 0.00675236 0.0120968 0.0461725 0.0450392 0.0632157 0.0558957 0.040662 0.011569 0.0152065 0.0071887 0.00585756 0.00377114 0.00909216 0.0198796 0.0438356 0.0397841 0.0353909 0.0317809 0.0314289 0.0140327 0.00369781 0.0063936 0.00624092 0.0123607 0.0502314 0.0323396 0.0260292 0.0266422 0.0220679 0.012388 0.00803898 0.00176157 0.000940019 0.00128429 0.000931405 0.00128496 0.000926557 0.00130754 0.000964053 0.00145385 0.00123643 0.00286864 0.0048972 0.0152929 0.0102585 0.0439242	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG1 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG2 ) .
4	3	0.0221827 0.0370648 0.0349903 0.0335194 0.0181576 0.0107147 0.00454194 0.00340158 0.00576383 0.00925803 0.0296471 0.0227737 0.0302644 0.0141309 0.0106465 0.00892153 0.0229515 0.0179066 0.0182125 0.00883307 0.0487065 0.0196642 0.0435351 0.0289029 0.0413946 0.0465659 0.0409775 0.0179408 0.00448981 0.00745332 0.00766443 0.015529 0.0594845 0.0409888 0.0318539 0.0308894 0.0286819 0.0184932 0.0198052 0.0089438 0.0017165 0.00145266 0.00103997 0.00130038 0.00100864 0.00133247 0.00103729 0.00147318 0.00120267 0.00209729 0.00186627 0.00433878 0.00741828 0.046868	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	3	0.0226209 0.0377956 0.0356834 0.034185 0.0185202 0.0109292 0.0046326 0.0034696 0.00587978 0.00944535 0.0302457 0.0232391 0.0308735 0.0143938 0.0108486 0.00906159 0.0233091 0.0181465 0.0184489 0.0089456 0.0492431 0.0199565 0.044019 0.0292333 0.0419237 0.0469946 0.0412025 0.0179778 0.00446386 0.00729355 0.00790584 0.0163462 0.062131 0.0413418 0.0331819 0.0326834 0.0281592 0.015889 0.0108091 0.00290092 0.00231812 0.00536694 0.00108044 0.00120036 0.000936612 0.00122328 0.000963626 0.00136613 0.0011315 0.00195116 0.00176365 0.00407582 0.00717488 0.0451171	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	3	0.0227246 0.0379684 0.0358471 0.0343422 0.0186057 0.0109796 0.00465392 0.00348555 0.00590681 0.00948884 0.0303847 0.0233458 0.0310134 0.0144559 0.0108951 0.00909612 0.0233957 0.018208 0.018513 0.00897613 0.049408 0.0200302 0.044195 0.0293456 0.042071 0.0471866 0.0414082 0.0180988 0.00450114 0.00734343 0.00796167 0.0164582 0.062378 0.0407516 0.0325744 0.0319621 0.0273054 0.0149441 0.00968093 0.0021701 0.0012296 0.00202627 0.00221921 0.00534035 0.00108079 0.00128106 0.00101238 0.00141024 0.0011658 0.00198102 0.00177586 0.00411165 0.0073751 0.0459295	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) .
4	3	0.0226942 0.0379171 0.0357998 0.0342975 0.0185821 0.0109659 0.00464794 0.00348107 0.00589941 0.00947715 0.0303475 0.0233176 0.0309739 0.0144334 0.0108788 0.00907669 0.0233459 0.0181616 0.0184658 0.0089533 0.04927 0.0199922 0.0440832 0.029278 0.0419905 0.0470862 0.0413158 0.0180668 0.00449582 0.0073355 0.00798592 0.016547 0.0626854 0.0408779 0.0327158 0.0320753 0.0273118 0.0147862 0.00946534 0.00207711 0.0010918 0.0015485 0.00120916 0.00201111 0.00218495 0.00545894 0.00113548 0.00147161 0.0012117 0.00199792 0.00176693 0.00409325 0.00747332 0.0461871	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 and DRUG0 ) .
4	3	0.0226461 0.0378364 0.0357243 0.0342255 0.0185434 0.0109431 0.00463821 0.00347378 0.00588718 0.0094576 0.0302851 0.0232699 0.0309097 0.0144013 0.0108552 0.00905407 0.0232883 0.0181133 0.0184169 0.00893014 0.0491372 0.0199479 0.0439739 0.0292118 0.0419044 0.0469885 0.0412461 0.0180482 0.00449331 0.00733311 0.00799758 0.016581 0.0627828 0.0409777 0.032864 0.0322268 0.0273922 0.0147666 0.00942366 0.00205103 0.00108196 0.00151404 0.00108047 0.00155262 0.00119515 0.00201984 0.00220224 0.00602532 0.00132524 0.00203833 0.00176863 0.00407738 0.00762634 0.0462448	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 and DRUG0 ) .
4	3	0.0228278 0.0381407 0.0360097 0.0344976 0.0186898 0.0110293 0.00467504 0.00350134 0.0059335 0.00953187 0.0305219 0.0234502 0.0311519 0.0145225 0.0109442 0.00913822 0.0234998 0.0182887 0.0185935 0.00901191 0.0496061 0.0200981 0.0443473 0.0294285 0.0421924 0.0472979 0.0413856 0.0180389 0.00448267 0.00730977 0.00791962 0.0164121 0.0622493 0.0403999 0.0319686 0.0310426 0.0262913 0.0142801 0.00906554 0.00202301 0.00106459 0.00148979 0.00106087 0.00150359 0.00105497 0.00153479 0.00116943 0.00203124 0.00224929 0.00815803 0.00194116 0.00410755 0.00784195 0.0449939	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 and DRUG0 ) .
4	3	0.0224379 0.0374876 0.0353965 0.0339123 0.0183746 0.0108438 0.00459589 0.00344207 0.00583372 0.00937202 0.0300115 0.0230596 0.0306273 0.0142646 0.0107529 0.00896115 0.0230477 0.0179141 0.0182099 0.00882754 0.0485454 0.0197304 0.0434261 0.0288635 0.0414051 0.0463486 0.0405831 0.0177292 0.00440759 0.00716366 0.00778465 0.0161239 0.0608298 0.0394446 0.0315377 0.030615 0.025818 0.0139319 0.00895417 0.00196566 0.0010425 0.00142322 0.00103299 0.00142931 0.0010287 0.00145621 0.00107013 0.00161984 0.00137404 0.00320968 0.00546207 0.0171149 0.0115386 0.0486168	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG1 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG2 ) .
4	4	0.029341 0.0486132 0.0456389 0.0439005 0.023835 0.0142341 0.00571138 0.00411029 0.00651664 0.00962938 0.030872 0.0183611 0.0245849 0.00980259 0.00818954 0.00375336 0.00883514 0.00448813 0.00479115 0.00271814 0.00877231 0.0133708 0.0323678 0.0351869 0.0278527 0.0276568 0.0359745 0.01675 0.00472056 0.00941538 0.00828995 0.0169383 0.0773834 0.0467056 0.0342362 0.0254177 0.0178897 0.0116959 0.00951177 0.00285545 0.00156124 0.00254516 0.00190928 0.00322129 0.00280364 0.00526473 0.00552309 0.0252938 0.00687945 0.00871698 0.0121388 0.0316524 0.0174079 0.0641642	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 and DRUG2 ) .
4	4	0.0268629 0.0444951 0.0417782 0.0401923 0.0218251 0.0130482 0.00523693 0.00376849 0.00597865 0.00883458 0.0283187 0.0168528 0.0225816 0.00899949 0.00752088 0.00344691 0.00811554 0.00412184 0.00439811 0.00249303 0.00804738 0.0122868 0.0298216 0.0325298 0.026001 0.0260813 0.0338586 0.0156088 0.00434339 0.00869402 0.00758954 0.0154613 0.0717064 0.0426247 0.0307297 0.0228218 0.0167211 0.0114195 0.0097266 0.00310999 0.00169412 0.00279822 0.00204357 0.00337898 0.00255314 0.00462647 0.00433894 0.00912571 0.0128316 0.0716397 0.0157949 0.0340597 0.0197444 0.0673178	Drugs Eliminated by Active Tubular Secretion : Although studies to assess drug-drug interactions with DRUG0 have not been conducted , DRUG0 has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g . DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 and DRUG2 ) .
2	0	0.0702547 0.0390754 0.038313 0.029042 0.0307866 0.013485 0.0190773 0.0226332 0.0165692 0.0139497 0.00588855 0.0112845 0.00422122 0.0072069 0.00590105 0.00842795 0.0362468 0.0115088 0.0128364 0.0117572 0.00468336 0.00928644 0.00861628 0.0081599 0.00855434 0.034951 0.00959445 0.00666712 0.013529 0.0195013 0.0115182 0.00564997 0.0110295 0.00779977 0.00590067 0.0128795 0.00746441 0.00563147 0.00424377 0.00484848 0.012929 0.00503986 0.00757318 0.0368441 0.0132886 0.0130114 0.0150097 0.00941714 0.0126618 0.00864985 0.0142679 0.00449798 0.00438915 0.0018293 0.00177558 0.00240437 0.00277091 0.00683846 0.00593196 0.00370739 0.00429206 0.00363352 0.00371245 0.00514358 0.00684847 0.003169 0.0116133 0.00615102 0.00401114 0.00401805 0.00510738 0.00271695 0.00228465 0.00269175 0.00100917 0.00172022 0.0128224 0.0132412 0.00610423 0.0026753 0.00235268 0.00193298 0.00146074 0.00273072 0.0034575 0.00982737 0.00570494 0.00554392 0.00392947 0.00374206 0.00223548 0.00521969 0.0019319 0.002525 0.00285397 0.006147 0.00798905 0.00880148 0.00676758 0.00482433 0.00647532 0.00876899	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG2 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
2	0	0.0704959 0.0392091 0.0384432 0.0291393 0.0308896 0.0135296 0.0191397 0.0227072 0.0166226 0.0139942 0.00590685 0.0113193 0.00423429 0.00722917 0.00591808 0.00844907 0.0363458 0.0115351 0.0128613 0.0117678 0.00468472 0.00928633 0.00861568 0.00815662 0.00849632 0.0347655 0.00950304 0.00658095 0.0133485 0.0190854 0.0112044 0.00548538 0.0106659 0.00755998 0.00553713 0.011939 0.00683233 0.00502131 0.00391713 0.00458625 0.0121806 0.00426624 0.00517086 0.0242264 0.00743752 0.00577546 0.00644809 0.00336624 0.00519933 0.00768795 0.0278531 0.0112844 0.01268 0.00671813 0.00714323 0.00984196 0.00594125 0.00807903 0.006587 0.00436043 0.0048972 0.00419346 0.00423429 0.00561375 0.00742544 0.00332767 0.0118936 0.00636041 0.00411813 0.004092 0.0051799 0.0027526 0.00231323 0.00271005 0.00101463 0.00173099 0.0129945 0.0133896 0.00616211 0.00270154 0.00236896 0.00194109 0.00146691 0.00274033 0.00347126 0.00986679 0.00572992 0.00556666 0.00394306 0.00375296 0.00224179 0.00523541 0.0019367 0.00253055 0.00286153 0.00617544 0.00803251 0.00883728 0.00679599 0.00484432 0.00650114 0.00879792	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG2 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
2	4	0.066856 0.0371844 0.0364569 0.0276333 0.0292926 0.01283 0.0181498 0.0215323 0.0157622 0.0132698 0.00560128 0.0107331 0.00401522 0.00685482 0.0056116 0.00801027 0.0344617 0.0109353 0.0121912 0.0111511 0.00443907 0.0087973 0.00816083 0.00772837 0.00803424 0.0329082 0.008972 0.00621588 0.0126001 0.0179728 0.0105375 0.0051771 0.0100329 0.00712966 0.00519724 0.0111375 0.00636343 0.0046564 0.00366204 0.00428713 0.0113466 0.00396152 0.00472719 0.0214283 0.00638122 0.00483114 0.00542944 0.0027333 0.003889 0.00533685 0.017967 0.00548164 0.00533326 0.00239756 0.00255492 0.00333495 0.00469717 0.0141653 0.0145029 0.0131087 0.0139329 0.0184415 0.0235888 0.0167519 0.00851805 0.0031832 0.0147868 0.00924425 0.00670909 0.00566599 0.00564323 0.00337732 0.00274886 0.00278056 0.00101642 0.00173761 0.013695 0.0136891 0.00620504 0.00271385 0.00234381 0.00186246 0.00140465 0.00260992 0.00331033 0.00924278 0.00537559 0.00523194 0.00371547 0.00353228 0.00211187 0.00492766 0.00182837 0.00238692 0.00270013 0.00579435 0.00751713 0.00828509 0.0063643 0.00453425 0.00609116 0.00824952	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG2 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
2	0	0.069665 0.0387465 0.0379866 0.028792 0.0305198 0.0133673 0.0189099 0.0224331 0.0164215 0.0138244 0.00583583 0.0111816 0.00418334 0.00714196 0.00584664 0.00834396 0.035896 0.0113909 0.012697 0.0116097 0.00462136 0.00915497 0.00848943 0.00804022 0.00833559 0.0341729 0.00928951 0.00644752 0.0130327 0.0185662 0.0108814 0.00535556 0.01033 0.007316 0.00533244 0.0113268 0.00648883 0.00474537 0.00374868 0.00442365 0.0116547 0.00399672 0.0046376 0.0206001 0.0060336 0.0045215 0.00501337 0.00251172 0.00342385 0.00452538 0.0143321 0.0042091 0.00388584 0.00160961 0.00159631 0.00219384 0.00259492 0.00659954 0.00572608 0.00366608 0.00431275 0.00367248 0.0037689 0.00521725 0.00732663 0.00344236 0.0128609 0.00690149 0.00477945 0.00492336 0.00653093 0.00335883 0.00290334 0.0034991 0.00149263 0.00294011 0.0223083 0.0289083 0.0139061 0.00949506 0.00813185 0.00493581 0.00699337 0.0107073 0.00734569 0.0112555 0.00688786 0.00670861 0.00483598 0.00433067 0.00251326 0.00568488 0.00208373 0.00269047 0.00301479 0.00639154 0.0082304 0.00906176 0.00692976 0.00492054 0.00661308 0.00896121	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG2 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
2	0	0.0687112 0.0382161 0.0374671 0.0283984 0.030103 0.0131847 0.0186516 0.022127 0.0161975 0.0136359 0.00575607 0.0110291 0.00412617 0.00704443 0.00576674 0.00823048 0.0354073 0.0112359 0.0125247 0.0114529 0.00455882 0.00903206 0.00837626 0.00793178 0.00822903 0.0337225 0.00917626 0.00636492 0.0128723 0.0183429 0.010752 0.00528713 0.0102135 0.00723689 0.00526831 0.011216 0.00641676 0.00469536 0.00370257 0.00436614 0.0115208 0.0039522 0.00458514 0.020382 0.00597287 0.00447385 0.00495237 0.0024786 0.0033993 0.00447138 0.0142383 0.00415855 0.0038455 0.00158605 0.00156896 0.00216339 0.00254157 0.00642707 0.00552987 0.00349803 0.00409438 0.00346486 0.0035543 0.00493205 0.00666064 0.00308854 0.0114055 0.00608086 0.00401531 0.00405067 0.00514681 0.00275374 0.00232128 0.00273916 0.00104364 0.00183789 0.0143005 0.0155615 0.00710161 0.00323841 0.00298396 0.00229139 0.00198111 0.00364127 0.00541971 0.0169889 0.0116651 0.0127258 0.0115244 0.0133037 0.00638558 0.017144 0.00886764 0.0114898 0.00690476 0.00842115 0.0101836 0.0109243 0.00815147 0.00583717 0.00749435 0.00950555	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG2 : may decrease patient's response to the DRUG0
2	4	0.0713213 0.0396677 0.0388896 0.0294764 0.0312453 0.013685 0.0193593 0.0229662 0.0168117 0.0141529 0.00597455 0.0114474 0.00428277 0.00731174 0.00598561 0.00854214 0.0367487 0.0116615 0.0129986 0.0118853 0.00473104 0.00937212 0.00869066 0.00823086 0.00853136 0.0349792 0.00950688 0.00659837 0.0133354 0.0189932 0.0111312 0.0054785 0.0105652 0.00748276 0.00545313 0.0115804 0.00663398 0.00485081 0.00383178 0.00452074 0.0119045 0.00408344 0.00473549 0.0210192 0.00614565 0.00459972 0.00509838 0.00255644 0.00348161 0.0045989 0.0145357 0.004257 0.003928 0.00162822 0.00160938 0.00221134 0.00260084 0.00655877 0.00561983 0.00356205 0.00415362 0.00353525 0.00360417 0.00495577 0.00665452 0.00307361 0.0112912 0.00608004 0.00395581 0.00399271 0.00502701 0.0027292 0.00228682 0.00267887 0.00101324 0.00172605 0.0130046 0.0135956 0.00616478 0.00277128 0.00242169 0.00195463 0.00153707 0.0028582 0.00379914 0.0111216 0.00682024 0.00678605 0.00504782 0.00486967 0.00277316 0.00720222 0.00286232 0.00349925 0.0045786 0.0115754 0.014892 0.0167892 0.0128826 0.0124037 0.0189973 0.0183883	DRUG1 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG2
4	4	0.0330652 0.066935 0.0356513 0.0183306 0.0125107 0.0079858 0.0104717 0.0126573 0.01055 0.00971713 0.00462705 0.00952282 0.00366416 0.00713975 0.00581123 0.00805279 0.0340874 0.0108361 0.011973 0.0109013 0.0043113 0.008424 0.00781313 0.00747924 0.00779889 0.032045 0.00881014 0.00616814 0.0125576 0.0180279 0.0106714 0.00528265 0.0102655 0.00737543 0.00567716 0.0123667 0.00719616 0.00543573 0.00415557 0.0047453 0.0126276 0.00516959 0.00776069 0.0382745 0.0133868 0.0151149 0.0172066 0.0147328 0.0252483 0.00969518 0.0380992 0.0132846 0.0138118 0.00720609 0.00765921 0.0105995 0.00638516 0.00869817 0.00707744 0.0047269 0.00507886 0.00433602 0.00435346 0.00569794 0.00749076 0.00331254 0.011725 0.00637288 0.00409062 0.00404121 0.0051557 0.00276857 0.00233698 0.00265492 0.000989803 0.00169101 0.0129527 0.0133887 0.0061892 0.00274244 0.00239014 0.0019321 0.00145637 0.0027166 0.003442 0.00998287 0.00574957 0.00552977 0.00391169 0.00368159 0.00219627 0.00513443 0.00187897 0.00245365 0.00278052 0.00614308 0.00803151 0.00876053 0.00673424 0.00479341 0.00641782 0.00865163	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG1 : can increase seizure activity - DRUG2 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0316652 0.0641007 0.0341414 0.0175542 0.0119808 0.00764755 0.0100281 0.0121211 0.0101031 0.00930547 0.00443099 0.00911931 0.00350889 0.00683739 0.00556497 0.0077115 0.0326425 0.0103769 0.0114655 0.0104383 0.00412771 0.00806525 0.00748021 0.00715918 0.00746148 0.0306607 0.00842713 0.00589814 0.0120035 0.0172271 0.0101943 0.00504181 0.00979598 0.007032 0.00539897 0.0117517 0.00682789 0.00514304 0.00393188 0.00450572 0.011984 0.00484218 0.0071863 0.0356706 0.0121381 0.0136329 0.0152487 0.0128354 0.0213088 0.00703899 0.0262445 0.00694774 0.00584687 0.00258187 0.00263967 0.00345869 0.00481955 0.0148439 0.0157905 0.0137661 0.0142751 0.0187354 0.023712 0.0170323 0.00872897 0.00323798 0.0149149 0.00946081 0.0069028 0.00578211 0.00571792 0.00343321 0.00280587 0.00272161 0.000989761 0.00168873 0.0134963 0.0134136 0.00607484 0.00267176 0.00230046 0.0018153 0.00136618 0.00253579 0.00321854 0.0090815 0.00525871 0.0050854 0.00360821 0.0034077 0.00203653 0.0047537 0.00175401 0.00228898 0.00259305 0.0056325 0.00732758 0.00803351 0.00616677 0.00438913 0.00588852 0.00795883	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG1 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG2 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0328729 0.0665451 0.0354428 0.0182232 0.0124374 0.00793901 0.0104103 0.012583 0.0104881 0.00966008 0.00459991 0.00946683 0.00364266 0.00709806 0.00577713 0.00800526 0.0338861 0.0107722 0.011902 0.0108352 0.00428463 0.00837148 0.00776382 0.00743063 0.0077418 0.0318161 0.00873917 0.00611805 0.012443 0.0178488 0.010561 0.00522439 0.0101415 0.0072821 0.00559718 0.0121683 0.00706952 0.0053239 0.00407088 0.00467893 0.0124386 0.00502677 0.00741943 0.036816 0.0124367 0.0140069 0.0154841 0.0127494 0.0211771 0.00607719 0.0212391 0.00539574 0.00430705 0.0017406 0.00165989 0.00227697 0.00266751 0.00701497 0.00628295 0.0039906 0.00450386 0.00383688 0.00390655 0.00533167 0.00746071 0.00346305 0.0127391 0.00696701 0.00475056 0.00485883 0.00650315 0.00338795 0.00294277 0.00341826 0.00145069 0.00285402 0.0222106 0.0286335 0.0141154 0.00970528 0.00826302 0.00500456 0.00703774 0.0108479 0.00747121 0.0115074 0.00698512 0.00672705 0.00485459 0.00430405 0.00248834 0.00560778 0.00203498 0.00262285 0.00294324 0.00637555 0.00824628 0.00900401 0.00688646 0.00488409 0.00654898 0.00884473	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG1 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG2 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0324427 0.0656744 0.0349792 0.0179849 0.0122748 0.00783519 0.0102742 0.0124185 0.0103509 0.00953376 0.00453974 0.00934303 0.003595 0.00700521 0.00570155 0.00790063 0.0334432 0.0106314 0.0117465 0.0106938 0.0042287 0.00826236 0.00766277 0.00733371 0.00764205 0.0314032 0.00862767 0.00603929 0.0122844 0.0176229 0.0104277 0.00515782 0.0100155 0.00719192 0.00552634 0.0120203 0.00698166 0.00525873 0.00401957 0.00461758 0.0122809 0.00496331 0.00733281 0.0363625 0.0123086 0.0138393 0.0153035 0.0125684 0.0209164 0.00601137 0.0211077 0.00533969 0.00426629 0.00171604 0.00163239 0.00224682 0.002614 0.00683792 0.00607157 0.00381123 0.00427924 0.00362186 0.00368593 0.00504229 0.00678969 0.00311164 0.0113053 0.00613495 0.0039975 0.00400191 0.00513103 0.00278213 0.00235795 0.0026809 0.00101818 0.00179336 0.0143291 0.0156791 0.00724272 0.00334591 0.0030619 0.00230895 0.00198685 0.00363744 0.00542483 0.0173705 0.0117847 0.0127775 0.0115128 0.013227 0.00629609 0.016822 0.0087147 0.0113451 0.00681964 0.00844085 0.0102617 0.0108511 0.00811599 0.00581562 0.00745167 0.00941881	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG1 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG2 : may decrease patient's response to the DRUG0
4	4	0.033656 0.0681304 0.0362871 0.0186573 0.0127337 0.00812812 0.0106583 0.0128828 0.0107379 0.0098902 0.00470949 0.00969234 0.00372943 0.00726715 0.00591475 0.00819595 0.0346933 0.0110289 0.0121856 0.0110933 0.00438667 0.00857085 0.0079487 0.00760756 0.00792593 0.0325731 0.00894689 0.00626347 0.0127385 0.0182723 0.0108116 0.00534829 0.0103817 0.00745446 0.0057295 0.0124555 0.0072362 0.00544896 0.00416657 0.00478927 0.0127307 0.00514327 0.00759007 0.037687 0.0127175 0.0143055 0.0157998 0.0130073 0.0215993 0.00617445 0.0215554 0.00546135 0.00435667 0.0017613 0.00167394 0.00229545 0.00267368 0.00697518 0.00616742 0.00387887 0.00433841 0.0036928 0.00373485 0.00506269 0.00677984 0.00309534 0.0111852 0.00612824 0.00393701 0.00394332 0.00501005 0.00275649 0.00232233 0.00262141 0.000988614 0.00168548 0.0130458 0.0137087 0.00627836 0.00285997 0.00247707 0.00196366 0.00153963 0.00285474 0.0038022 0.0114015 0.00692433 0.00681695 0.00506178 0.00482559 0.0027456 0.00712109 0.00279934 0.00341383 0.00447934 0.0116332 0.0150645 0.0167965 0.0127928 0.01238 0.0188094 0.01824	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG1 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG2
4	4	0.0319383 0.0646533 0.0344353 0.0177048 0.0120836 0.00771308 0.0101134 0.0122242 0.0101886 0.009384 0.00446778 0.00919501 0.00353794 0.00689446 0.00560996 0.00777179 0.0329007 0.0104558 0.0115489 0.0105033 0.00415007 0.00810686 0.0075182 0.0071867 0.00744574 0.0306048 0.00839244 0.00584866 0.0118884 0.0169229 0.00994931 0.00488227 0.0094552 0.00674471 0.00496419 0.0106896 0.00613447 0.0045013 0.00353991 0.00412447 0.0109174 0.00392838 0.00486011 0.0223992 0.00673999 0.00521863 0.00581887 0.00318268 0.00471447 0.00674564 0.0256193 0.010107 0.0116893 0.00589452 0.00596467 0.0115724 0.00710134 0.0276724 0.0245089 0.0212969 0.0181363 0.0229014 0.027592 0.0189818 0.0090822 0.00337261 0.0152865 0.00956466 0.00694295 0.00580997 0.00575037 0.00344157 0.00280493 0.00273073 0.000994441 0.00169657 0.0135323 0.0134494 0.00609247 0.00267653 0.00230473 0.00182072 0.00137065 0.00254444 0.00322913 0.00909562 0.00527046 0.00510176 0.00362015 0.0034226 0.00204553 0.00477446 0.00176328 0.00230124 0.00260637 0.00565048 0.00734806 0.00806228 0.00618951 0.00440602 0.00591236 0.00799356	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG1 : may potentiate the replication of the DRUG2 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0337235 0.068267 0.0363591 0.0186939 0.0127585 0.00814389 0.0106782 0.0129068 0.0107576 0.00990811 0.00471744 0.00970859 0.00373563 0.00727964 0.00592338 0.00820529 0.0347372 0.0110391 0.0121928 0.0110881 0.00438113 0.00855749 0.00793555 0.00758702 0.00785404 0.0322999 0.0088482 0.00616944 0.0125349 0.0178338 0.0104826 0.00515093 0.00996178 0.00710655 0.00523276 0.0112443 0.00645849 0.00473652 0.00373494 0.0043544 0.0115001 0.00414861 0.0051274 0.0234989 0.0070278 0.00543533 0.00609159 0.00332974 0.00482463 0.00687488 0.0258362 0.0099474 0.0118098 0.00615073 0.00608135 0.0124804 0.0041356 0.0140937 0.0109469 0.00654549 0.00594875 0.0048409 0.00467665 0.00618303 0.00823398 0.00372693 0.0131726 0.00711559 0.00485271 0.00495739 0.00660663 0.0033977 0.00294579 0.00341206 0.00146738 0.00289607 0.0224487 0.0288859 0.014255 0.00976339 0.00830893 0.00504044 0.00709784 0.0109338 0.00752485 0.0115917 0.00704935 0.00680364 0.00490638 0.00435774 0.00252132 0.00568669 0.00206701 0.00266443 0.00299043 0.0064607 0.00835589 0.00912707 0.00698169 0.00495274 0.00664311 0.00897236	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG1 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG2 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0332967 0.0674029 0.0358992 0.0184574 0.0125972 0.00804092 0.0105432 0.0127437 0.0106216 0.00978283 0.00465774 0.00958582 0.00368836 0.00718755 0.00584843 0.00810162 0.0342983 0.0108996 0.0120389 0.0109484 0.00432589 0.00844987 0.00783598 0.00749148 0.00775694 0.0318963 0.0087404 0.00609314 0.0123821 0.0176182 0.0103563 0.00508758 0.00984388 0.00702343 0.00516945 0.0111165 0.00638238 0.00468154 0.00368933 0.00429936 0.0113596 0.00409678 0.00506288 0.0232072 0.00694662 0.00536987 0.00601473 0.00328638 0.0047723 0.00679723 0.0255743 0.00982396 0.0116743 0.00606499 0.00597779 0.0123234 0.00404638 0.0137399 0.0105851 0.00626468 0.00565811 0.00456871 0.00441129 0.00584928 0.00749774 0.00334896 0.0116901 0.00626822 0.00408231 0.00408253 0.00520343 0.00278673 0.00235664 0.00267578 0.00103064 0.00182209 0.0144772 0.0157703 0.00729243 0.0033602 0.00307336 0.00232784 0.00200548 0.00367459 0.00548351 0.0175081 0.0119134 0.0129446 0.0116564 0.0133986 0.00638609 0.0170706 0.00884671 0.0115107 0.00692005 0.00854344 0.0103861 0.0110055 0.00823158 0.00589769 0.00755845 0.00955582	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG1 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG2 : may decrease patient's response to the DRUG0
4	4	0.0345521 0.0699441 0.0372523 0.0191531 0.013072 0.00834397 0.0109406 0.0132239 0.0110219 0.0101515 0.00483333 0.0099471 0.0038274 0.00745848 0.0060689 0.00840685 0.0355906 0.0113103 0.0124924 0.0113605 0.00448875 0.00876769 0.00813046 0.00777339 0.00804669 0.0330929 0.00906516 0.00632063 0.0128419 0.0182699 0.0107389 0.00527691 0.0102053 0.00728078 0.00536118 0.0115202 0.00661686 0.00485258 0.00382632 0.00446095 0.0117811 0.00425102 0.00525489 0.0240814 0.00719832 0.00556575 0.00623934 0.00340986 0.00494209 0.00703737 0.0264506 0.010147 0.0120549 0.00626374 0.00617643 0.0127004 0.00413829 0.0140145 0.0107555 0.00637393 0.0057349 0.00465991 0.00447105 0.00587411 0.00748971 0.00333181 0.0115674 0.0062631 0.00402114 0.00402362 0.00507912 0.00276151 0.00232144 0.00261762 0.00100107 0.00171307 0.013186 0.0137925 0.00632302 0.00287341 0.0024887 0.00198123 0.00155492 0.0028848 0.00384455 0.011497 0.00699932 0.00690316 0.00512081 0.0048899 0.00278326 0.00722063 0.00284321 0.00346726 0.0045505 0.0117767 0.0152521 0.0170216 0.0129739 0.0125431 0.019071 0.0185016	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG1 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG2
4	4	0.0324012 0.0655901 0.0349334 0.0179608 0.0122583 0.00782451 0.0102594 0.0124006 0.0103355 0.00951926 0.00453215 0.00932719 0.00358887 0.00699364 0.00569059 0.00788339 0.033372 0.0106048 0.0117121 0.0106484 0.00420707 0.00821658 0.00761893 0.00728134 0.00753679 0.0309746 0.00848452 0.00591144 0.0120061 0.0170626 0.0100203 0.00491798 0.00950712 0.0067786 0.00495297 0.0106114 0.00607132 0.00443668 0.00349755 0.00408295 0.0108122 0.00381313 0.00460158 0.0206935 0.00610978 0.00461326 0.00511861 0.00263361 0.00365584 0.00505023 0.0169573 0.00505952 0.00505065 0.00224033 0.00254701 0.00336535 0.00468423 0.01483 0.0146777 0.0116112 0.0130686 0.0155307 0.019182 0.0189419 0.0123384 0.00427647 0.020215 0.00879303 0.00694328 0.0068073 0.00702582 0.00505056 0.00481062 0.0046725 0.00178523 0.00347277 0.0242773 0.0269356 0.0133918 0.010294 0.00899902 0.00507917 0.00711952 0.0105904 0.0072969 0.0103829 0.00628736 0.00605803 0.00439927 0.00396555 0.00232162 0.00525955 0.00193218 0.0024951 0.00280098 0.00591181 0.00757137 0.00836204 0.00637454 0.00451716 0.00607819 0.00824607	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG1 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG2 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG0
4	4	0.0321797 0.0651418 0.0346946 0.0178381 0.0121745 0.00777103 0.0101893 0.0123159 0.0102649 0.00945421 0.00450118 0.00926344 0.00356435 0.00694585 0.0056517 0.00782952 0.0331439 0.0105323 0.011632 0.0105756 0.00417831 0.00816039 0.00756682 0.00723154 0.00748522 0.0307628 0.00842637 0.00587099 0.011924 0.0169459 0.00995169 0.00488431 0.00944179 0.00673198 0.00491908 0.0105383 0.00602967 0.00440608 0.00347354 0.004055 0.0107382 0.00378722 0.00457127 0.0205578 0.00606961 0.00458315 0.00508543 0.00261727 0.00363306 0.0050203 0.0168612 0.00503393 0.00502429 0.00223085 0.00253856 0.00334949 0.00466254 0.0147625 0.0145691 0.0114964 0.0129422 0.0153415 0.0188394 0.0186395 0.0113842 0.00390294 0.0183994 0.00800858 0.00593826 0.00569259 0.00593949 0.00413276 0.00378602 0.00355114 0.00124012 0.00217661 0.0167701 0.0166647 0.00749361 0.00347711 0.00317418 0.00227238 0.00194611 0.0035304 0.00524161 0.0156917 0.0107697 0.0117046 0.0106506 0.0122846 0.00590551 0.015923 0.00821813 0.0106062 0.00637527 0.00773895 0.00930973 0.0100549 0.00748394 0.0053496 0.00687615 0.00873257	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG1 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG2 : may decrease patient's response to the DRUG0
4	4	0.0330611 0.0669243 0.0356409 0.0183242 0.0125063 0.00798273 0.0104668 0.012651 0.0105443 0.00971169 0.00462406 0.00951576 0.00366164 0.00713603 0.00580605 0.00804095 0.0340398 0.0108181 0.0119466 0.0108584 0.00428906 0.0083748 0.00776349 0.00741957 0.00765313 0.0314976 0.00860689 0.00600465 0.0121627 0.0172671 0.0101393 0.00498639 0.00961626 0.00682388 0.00496995 0.0105869 0.00607171 0.00444571 0.00351113 0.00413821 0.0108933 0.00373541 0.00433487 0.0193011 0.00565149 0.00424025 0.00469979 0.00235299 0.00321429 0.0042421 0.0134679 0.00394604 0.00364829 0.00150855 0.00149698 0.00205623 0.00243265 0.00616773 0.0053599 0.00341269 0.00402609 0.00342156 0.00351397 0.00488373 0.00684508 0.00319738 0.011885 0.00628122 0.00426674 0.00432856 0.00554592 0.0029542 0.00251368 0.0030744 0.00108878 0.00194666 0.0168226 0.0266269 0.013384 0.00894154 0.0079004 0.00502972 0.00681436 0.0123409 0.00872862 0.0324935 0.0189078 0.0166004 0.0145097 0.0167459 0.00735453 0.0179023 0.00936038 0.0121656 0.00734115 0.0089456 0.0108821 0.0113255 0.00853183 0.00612557 0.00783416 0.00986016	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG1 : may cause shortness of breath and bronchospasm - DRUG2 : may decrease patient's response to the DRUG0
4	4	0.0344521 0.0697401 0.0371404 0.0190952 0.0130325 0.00831859 0.0109072 0.0131832 0.0109879 0.0101203 0.00481861 0.00991613 0.0038157 0.00743628 0.00605033 0.0083792 0.0354718 0.0112733 0.0124492 0.0113153 0.00446948 0.00872712 0.0080901 0.00773174 0.00797462 0.032822 0.0089686 0.006257 0.0126737 0.0179921 0.0105649 0.005196 0.0100208 0.00711046 0.00517793 0.0110303 0.00632603 0.00463217 0.00365826 0.00431159 0.0113479 0.0038903 0.00451247 0.0200948 0.00588546 0.00441577 0.00489626 0.0024493 0.00334741 0.00441551 0.0140196 0.00410916 0.00379919 0.00157087 0.00155676 0.00214084 0.00253107 0.0064159 0.0055752 0.00354657 0.0041861 0.00355638 0.00364653 0.00507452 0.00709963 0.00332059 0.0123529 0.00653114 0.00442896 0.00448771 0.00575007 0.00306421 0.00260667 0.00320052 0.00113447 0.00201747 0.0175686 0.0279273 0.0141023 0.00941545 0.00820498 0.00519058 0.00679714 0.0125233 0.00631521 0.0221693 0.01111 0.00880701 0.00644626 0.00588688 0.00316692 0.00786164 0.00306723 0.00370209 0.00476792 0.0122 0.0158 0.0174509 0.0133162 0.0129815 0.0195891 0.0190159	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG1 : may cause shortness of breath and bronchospasm - DRUG0 : may decrease patient's response to the DRUG2
4	4	0.0342169 0.0692639 0.0368863 0.0189645 0.0129433 0.00826163 0.0108325 0.0130929 0.0109127 0.010051 0.00478568 0.00984821 0.00378961 0.00738539 0.00600897 0.00832174 0.0352285 0.0111959 0.0123635 0.0112369 0.00443861 0.00866632 0.00803332 0.00767788 0.0079167 0.0325882 0.00890036 0.00621098 0.0125767 0.0178505 0.0104809 0.00515594 0.00993535 0.00704975 0.00513702 0.0109299 0.0062715 0.00459043 0.00362805 0.00427657 0.0112489 0.00385905 0.00447966 0.0199106 0.0058177 0.00436166 0.00483375 0.00242549 0.00330005 0.00436216 0.0137878 0.00403879 0.00372707 0.001545 0.00153087 0.00209856 0.00247331 0.0062359 0.00535832 0.00340501 0.00397637 0.00338473 0.00346459 0.0047577 0.00644324 0.00297656 0.0109388 0.00587267 0.00385738 0.00390834 0.00493967 0.00267024 0.00224556 0.00263994 0.00100719 0.00176052 0.0136994 0.0149041 0.00680195 0.00310389 0.00283685 0.00219678 0.00186767 0.00347747 0.0051001 0.0165003 0.0110035 0.0122958 0.0109933 0.0124769 0.00537308 0.0127667 0.00706149 0.0157933 0.00698659 0.0227782 0.0213114 0.021234 0.0163546 0.0159533 0.0235629 0.0220185	DRUG0 can interact with the drugs of the following categories :  - Blood dyscrasia : can cause unpredictable myelotoxicity - Bone marrow depressants : can cause a predictable dose-related myelotoxicity - Radiation therapy : may cause marrow depression - Neurotoxic medications : can cause neurologic toxicity - DRUG0 : can increase seizure activity - DRUG0 : may potentiate the replication of the DRUG0 virus , may increase the side effects of the vaccination , and decrease patient's response to the DRUG0 - DRUG0 : may cause shortness of breath and bronchospasm - DRUG1 : may decrease patient's response to the DRUG2
2	2	0.0556428 0.0830644 0.0596022 0.0763437 0.0633396 0.0802288 0.112212 0.0702777 0.0760082 0.0471734 0.0479988 0.0517764 0.0503949 0.0662287 0.0597085	The role of p27(Kip1) in DRUG1 -enhanced DRUG2 cytotoxicity in human ovarian cancer cells .
2	4	0.0523744 0.0547463 0.0413697 0.0616324 0.0167018 0.0440425 0.0261268 0.0245671 0.0253257 0.00902898 0.0343442 0.0350886 0.0130993 0.0506224 0.0536913 0.0947908 0.0571446 0.0369364 0.0261319 0.0350976 0.0442843 0.0436646 0.0109983 0.0264355 0.039596 0.0421586	The effect of DRUG1 , an inhibitor of Src and Abl kinases , on DRUG2 sensitivity was measured in ovarian cancer cells and HEY xenografts .
4	4	0.0327603 0.034035 0.0135289 0.0122003 0.0049967 0.015563 0.00396933 0.00610109 0.0321186 0.0297854 0.0536911 0.0545178 0.05257 0.059717 0.0135192 0.0218692 0.0265193 0.0259933 0.0131054 0.0102801 0.0216352 0.0199918 0.0188156 0.0190701 0.0172928 0.0200237 0.0152014 0.016707 0.0066328 0.0216436 0.0251087 0.0130459 0.0195202 0.0247005 0.0136862 0.0403867 0.0183493 0.0096161 0.00318208 0.00844763 0.0186731 0.0106389 0.00302177 0.0046895 0.0271202 0.0318862 0.0340718	The roles of p27(Kip1) , Bcl-2 , and Cdk1 in apoptosis induced by DRUG1 and DRUG2 were assessed using a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay , siRNA knockdown of gene expression , transfection with Bcl-2 and Cdk1 expression vectors , and flow cytometry .
2	2	0.0670776 0.104968 0.0565173 0.0456259 0.0745306 0.109515 0.0648137 0.0458049 0.0424176 0.0273536 0.0181663 0.0214547 0.0953633 0.0469553 0.0313032 0.0197455 0.0375976 0.033317 0.0574725	HEY cells treated with DRUG1 plus DRUG2 formed fewer colonies than did cells treated with either agent alone .
2	2	0.023375 0.022625 0.0289674 0.0365649 0.0386766 0.034573 0.0531136 0.0720841 0.0568721 0.0761531 0.0709113 0.0656815 0.0200792 0.0108916 0.00904928 0.00929762 0.00757268 0.014947 0.0099797 0.00957295 0.0127596 0.0112164 0.00503457 0.00214008 0.000983419 0.00246599 0.00339068 0.00693085 0.00669662 0.00436149 0.00437495 0.01412 0.01452 0.0186313 0.0151959 0.00998927 0.00538284 0.0136409 0.00937029 0.0138687 0.00895146 0.00511739 0.018444 0.0164873 0.00565671 0.00629925 0.00714369 0.00952591 0.00451958 0.00793946 0.00537845 0.00329829 0.0144229 0.0171811 0.023573	Treatment of HEY xenograft-bearing mice with DRUG1 plus DRUG2 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG0 + DRUG0 vs DRUG0 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.0148991 0.0175379 0.0316326 0.053025 0.0633692 0.0487993 0.0352019 0.0340274 0.0370209 0.089737 0.0581812 0.0470028 0.0169045 0.00937573 0.00921205 0.00971349 0.0082423 0.0147488 0.0116743 0.0132932 0.0190169 0.0207699 0.0129139 0.00536351 0.00287285 0.0130179 0.0315262 0.0192638 0.00890703 0.00528981 0.0057449 0.0137821 0.0127042 0.0169215 0.0135187 0.00903814 0.0047448 0.0119013 0.00813617 0.0117894 0.00760345 0.00432564 0.0156817 0.0139635 0.00477063 0.00529488 0.00599282 0.00796301 0.00377795 0.00662808 0.00448496 0.00274927 0.0120238 0.0143118 0.0196068	Treatment of HEY xenograft-bearing mice with DRUG1 plus DRUG0 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG0 + DRUG2 vs DRUG0 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.0148886 0.0175215 0.0315996 0.0529645 0.0633 0.0487327 0.0352397 0.034029 0.0369404 0.0891927 0.0575878 0.0464056 0.0162993 0.00883176 0.00852881 0.00899976 0.00758951 0.0138444 0.0101545 0.0109682 0.0154773 0.0160812 0.00851902 0.00341061 0.00121948 0.00381333 0.0070554 0.0196573 0.0376896 0.0206879 0.0127508 0.0156594 0.0147773 0.0201978 0.0148391 0.00941816 0.0048798 0.011787 0.00793599 0.0115873 0.00748151 0.00429195 0.0156115 0.0139713 0.00475667 0.00529647 0.00599266 0.00796457 0.0037747 0.00662889 0.00448534 0.00275015 0.0120218 0.0143053 0.019605	Treatment of HEY xenograft-bearing mice with DRUG1 plus DRUG0 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG0 + DRUG0 vs DRUG2 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.0116443 0.0113304 0.0165357 0.0233273 0.0255948 0.0266362 0.0423798 0.0555398 0.0752311 0.0783163 0.0513245 0.0516625 0.0175105 0.011774 0.0111458 0.0110804 0.0107927 0.0185485 0.0155603 0.0171915 0.0268741 0.0258178 0.0246668 0.0155543 0.00505732 0.00972234 0.00658253 0.00902192 0.00869749 0.00587808 0.00578697 0.0160854 0.0153239 0.0204641 0.0160346 0.0104373 0.00554457 0.0140604 0.00962051 0.0139562 0.00896943 0.00510351 0.0183681 0.0163601 0.00559417 0.00621717 0.00703809 0.00935659 0.00444025 0.00779502 0.00527177 0.00323201 0.0141382 0.0168095 0.0229932	Treatment of HEY xenograft-bearing mice with DRUG0 plus DRUG1 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG2 + DRUG0 vs DRUG0 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.0105844 0.00836361 0.010015 0.0117195 0.0114044 0.00856655 0.0110277 0.0110986 0.0274059 0.0559863 0.0427026 0.0391009 0.0140302 0.00951435 0.0134985 0.014909 0.0127549 0.0279734 0.0182263 0.0220512 0.0337963 0.0346346 0.0273246 0.0218774 0.0105144 0.0472508 0.0586411 0.0224503 0.0123654 0.00861657 0.00982626 0.0222186 0.0199428 0.024662 0.019439 0.0126667 0.00665974 0.0167097 0.011434 0.0163961 0.0105812 0.00600663 0.0219059 0.0196391 0.00673503 0.00743815 0.00843089 0.0112193 0.00533769 0.00935846 0.00631886 0.00386525 0.0169886 0.0202497 0.0275655	Treatment of HEY xenograft-bearing mice with DRUG0 plus DRUG0 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG1 + DRUG2 vs DRUG0 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.01032 0.00816088 0.0097785 0.0114459 0.011137 0.00837515 0.0107637 0.0108596 0.0268892 0.0550095 0.0421006 0.0386858 0.013992 0.00955189 0.0133574 0.0144133 0.0118477 0.0246112 0.0166832 0.0206277 0.0322915 0.0330754 0.0282254 0.0180079 0.00690402 0.028342 0.0294683 0.0231354 0.056413 0.0271819 0.0172095 0.0234396 0.0225387 0.0277848 0.0205058 0.0133006 0.00685956 0.0160641 0.0106747 0.0155948 0.0100844 0.0057948 0.0211725 0.0189199 0.00644769 0.00717041 0.00810958 0.010771 0.00510963 0.00896768 0.00606493 0.00371888 0.0162671 0.0193358 0.0264388	Treatment of HEY xenograft-bearing mice with DRUG0 plus DRUG0 inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse , DRUG1 + DRUG0 vs DRUG2 : 0.28 vs . 0.81 cm3 , difference = 0.53 cm3 , 95% confidence interval [CI] = 0.44 to 0.62 cm3 , P = .014);
4	4	0.211295 0.257012 0.17138 0.167141 0.193173	DRUG1 + DRUG2 vs .
2	4	0.0195812 0.0301708 0.0338015 0.0243403 0.032372 0.04662 0.0400255 0.029198 0.0158812 0.0317597 0.0462895 0.0472441 0.0252192 0.0190361 0.00908837 0.0185238 0.0167818 0.0256298 0.0231219 0.0243423 0.00836607 0.0153636 0.0200965 0.0183879 0.0210566 0.0212805 0.0110885 0.00995508 0.0218279 0.0258448 0.0312358 0.0224444 0.00734654 0.0199376 0.012424 0.0094072 0.00364462 0.0132436 0.0139501 0.0187525 0.0172534 0.00804277 0.00844694 0.00280016 0.0124076 0.0164584 0.0216356 0.0282743	The siRNA knockdown of p27(Kip1) decreased DRUG1 - and DRUG2 -induced apoptosis compared with a negative control siRNA (sub-G1 fraction , control siRNA vs . p27(Kip1) siRNA : 42.5% vs . 20.1% , difference = 22.4% , 95% CI = 20.1% to 24.7% , P = .017) .
2	2	0.0138187 0.0117735 0.0100948 0.0107717 0.00575204 0.0292166 0.0416206 0.0244463 0.0286576 0.00902588 0.0235579 0.0251418 0.0301054 0.0539971 0.0457588 0.0353184 0.0303466 0.0404054 0.0591515 0.0548299 0.0526313 0.0511655 0.0403923 0.0660342 0.0749203 0.0307421 0.00737472 0.0200902 0.033753 0.0391057	Studies with forced expression and siRNA knockdown of Bcl-2 and Cdk1 suggest that DRUG1 -mediated induction of p27(Kip1) enhanced DRUG2 -induced apoptosis by negatively regulating Bcl-2 and Cdk1 expression .
2	2	0.0445158 0.0339123 0.0509771 0.0433498 0.0111321 0.039495 0.0574682 0.0356925 0.0263745 0.0372156 0.0197136 0.0497452 0.0916411 0.049925 0.059488 0.0407703 0.0359151 0.0324998 0.0389816 0.0295767 0.0272465 0.0282886 0.015288 0.0147971 0.00454681 0.0179003 0.030175 0.0333684	Inhibition of Src family and Abl kinases with either siRNAs or DRUG1 enhances DRUG2 sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression .
3	3	0.0799231 0.0825659 0.108392 0.0553936 0.0473607 0.0324972 0.0756871 0.0672771 0.0692112 0.0364159 0.00626056 0.00538667 0.0102056 0.00225194 0.00232081 0.00179959 0.00225126 0.00174793 0.00221087 0.00169819 0.00218261 0.00166826 0.00217673 0.00166137 0.00220038 0.0016804 0.00226637 0.00173655 0.00241382 0.00186885 0.00286389 0.00247594 0.00648393 0.00815184 0.0526342 0.0481904 0.0469793 0.0438129 0.0776956	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0827652 0.0854539 0.112778 0.0582613 0.0503038 0.0329705 0.0708866 0.0606171 0.060133 0.0258836 0.0042319 0.00314363 0.00427521 0.00374392 0.00929636 0.00195146 0.00218605 0.00173263 0.00218187 0.00169145 0.0021702 0.00166747 0.0021769 0.00166434 0.00221002 0.00168683 0.00228466 0.00174677 0.00244224 0.00188457 0.0029093 0.00249754 0.00665059 0.00836512 0.0555772 0.0516494 0.0503585 0.0466221 0.0809493	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0827527 0.0854648 0.112638 0.0585522 0.0506 0.0325934 0.0683976 0.0582798 0.0575349 0.0243814 0.00393909 0.00276643 0.00324498 0.00211713 0.00367969 0.00386917 0.00923539 0.00195857 0.00223725 0.0017544 0.00223395 0.00172013 0.00223547 0.00170907 0.00226389 0.00172471 0.00233395 0.00178026 0.00248994 0.00191674 0.00296009 0.00253481 0.00678586 0.0085961 0.0572693 0.0533105 0.0519584 0.0478514 0.0823281	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0825273 0.0852064 0.112366 0.0583303 0.050377 0.0323637 0.0675283 0.0574949 0.0566525 0.0239179 0.00383825 0.00267494 0.00308597 0.00194701 0.00283912 0.00217695 0.00381451 0.00393302 0.00927037 0.00195707 0.00226815 0.00176627 0.00227251 0.00174201 0.00229249 0.00174822 0.00235623 0.00179557 0.00250593 0.00192567 0.00296897 0.0025333 0.00678621 0.00865884 0.0579644 0.0540309 0.0527441 0.0485322 0.0828069	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0822581 0.0849066 0.11204 0.0580936 0.0501457 0.0322 0.0669934 0.0569978 0.0561067 0.0236231 0.00378533 0.00263551 0.00302202 0.00191049 0.00274114 0.00200336 0.00294811 0.00218493 0.00382461 0.00392095 0.00936238 0.00196627 0.00231253 0.00179285 0.00233281 0.00178382 0.00238491 0.00182017 0.0025261 0.00194048 0.00297792 0.00253292 0.00677127 0.00870245 0.058453 0.0544372 0.0533446 0.0490864 0.0831307	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0819346 0.0845546 0.111639 0.0578387 0.0499085 0.0320453 0.0665331 0.0565706 0.0556438 0.0233871 0.0037474 0.00261108 0.00299166 0.00189208 0.00270546 0.00197358 0.00284799 0.00201208 0.00295633 0.00216873 0.00381279 0.0039091 0.00951348 0.00198834 0.00237433 0.00183552 0.00242473 0.00185519 0.00255228 0.00196363 0.00299108 0.00253561 0.0067488 0.00874018 0.0588838 0.0547674 0.0539745 0.0496937 0.0834745	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0815499 0.084141 0.111154 0.0575491 0.0496496 0.0318806 0.0660874 0.0561652 0.0552127 0.0231861 0.00371651 0.00259114 0.0029701 0.001878 0.00268796 0.00195745 0.00281215 0.00198356 0.00285831 0.00199621 0.0029464 0.00215512 0.00381086 0.00390932 0.00974064 0.00202795 0.00246787 0.00190788 0.00259129 0.00199827 0.00301145 0.00254586 0.00672092 0.00878472 0.0593103 0.0550633 0.0546919 0.050412 0.0838772	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0810945 0.0836553 0.110574 0.0572115 0.0493567 0.0316978 0.0656365 0.0557633 0.0547955 0.0230104 0.00369083 0.00257365 0.00295256 0.00186528 0.00267473 0.00194418 0.00279368 0.00196769 0.00282382 0.00196867 0.00285159 0.00198254 0.00294413 0.00215042 0.00382855 0.00392399 0.0100757 0.00209899 0.00263628 0.00205401 0.00304549 0.00256568 0.00667825 0.00884769 0.0597398 0.0553282 0.0555352 0.0513064 0.084357	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0805407 0.0830683 0.109863 0.0568036 0.0490163 0.0314928 0.0651846 0.0553644 0.0543811 0.0228647 0.00367162 0.00255966 0.00293845 0.00185342 0.00266266 0.00193184 0.00277864 0.00195466 0.00280517 0.00195331 0.00281834 0.00195596 0.00285145 0.00197668 0.0029554 0.00215626 0.00386483 0.00395453 0.0105767 0.00224876 0.0030895 0.00261152 0.00658845 0.00894936 0.0601823 0.0555801 0.0565694 0.0524753 0.0849064	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0795557 0.0820327 0.10857 0.0560306 0.0483652 0.0311321 0.0645383 0.0547822 0.0537396 0.0226406 0.00363555 0.00253619 0.00290244 0.00183037 0.00262398 0.00190605 0.00273434 0.00192809 0.00275834 0.00192573 0.00276736 0.001926 0.00278577 0.00193584 0.00283046 0.00196698 0.002952 0.00216833 0.00389117 0.00408513 0.0121202 0.00277501 0.00643553 0.00934945 0.0610457 0.0563557 0.0584891 0.0545184 0.0854332	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 ) may increases DRUG0 concentrations .
3	3	0.0788631 0.0813775 0.10728 0.055647 0.0478729 0.0305706 0.0627158 0.0528915 0.0519156 0.0219155 0.0035625 0.00247092 0.0028247 0.00178277 0.002566 0.00186059 0.00267992 0.00188211 0.00270535 0.00188044 0.00271612 0.00188156 0.00273488 0.00189109 0.00277051 0.0019128 0.00283792 0.00196573 0.00301526 0.00220561 0.0039999 0.0051392 0.0222038 0.0114623 0.0576738 0.0592992 0.0596636 0.055021 0.0863411	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 ) may increases DRUG0 concentrations .
1	4	0.0593397 0.0614514 0.0799149 0.0409716 0.0321193 0.0199359 0.035104 0.0281019 0.0309125 0.0128292 0.0023584 0.00165938 0.00198061 0.00142328 0.00194444 0.00149526 0.00206636 0.00151227 0.00209652 0.00152211 0.00211056 0.00153904 0.00213312 0.0015716 0.00218847 0.00164124 0.00233194 0.00180819 0.00269778 0.0022378 0.003973 0.0043809 0.0132645 0.030145 0.128791 0.127247 0.0950665 0.0779928 0.0801398	Co-administration of DRUG1 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0750522 0.0707401 0.0544925 0.0715928 0.0318341 0.0144958 0.035181 0.0317704 0.0424907 0.0275536 0.00782509 0.0062842 0.0265953 0.00517519 0.0037812 0.0036468 0.00334478 0.00334591 0.00319297 0.00312371 0.00312857 0.00299802 0.00311031 0.00294832 0.00314637 0.00298659 0.00328678 0.00320869 0.00372632 0.00402873 0.00540919 0.00685335 0.0135424 0.0285557 0.0929914 0.0717125 0.0720469 0.0732212 0.0815803	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.078523 0.0723792 0.0555425 0.0725081 0.0321256 0.0140043 0.0308691 0.0261377 0.0348004 0.0192053 0.00498674 0.00346054 0.00527049 0.00480899 0.0212409 0.00402996 0.00362286 0.00327123 0.00332085 0.00311232 0.00322909 0.00298261 0.00321063 0.00293608 0.00325095 0.00298255 0.0033971 0.00321129 0.00384728 0.00402826 0.00557308 0.00685547 0.0139278 0.0293551 0.100763 0.0766682 0.0770125 0.076581 0.0869683	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0790762 0.0720272 0.0550104 0.0715909 0.0315648 0.0134343 0.028304 0.0232608 0.0312116 0.0169324 0.00434257 0.00276268 0.00358244 0.00286283 0.00596733 0.00526069 0.0212826 0.00398672 0.00378953 0.00338567 0.00351245 0.00326213 0.00342841 0.00316231 0.0034382 0.00317203 0.00356613 0.00338015 0.00400967 0.00419837 0.00577786 0.0071152 0.0144557 0.030311 0.102996 0.0786638 0.0791657 0.0780929 0.0886566	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0792033 0.071658 0.054548 0.0708255 0.0310822 0.0131077 0.0271688 0.0220711 0.0296558 0.0158781 0.00403078 0.00251959 0.00316401 0.00233261 0.00394422 0.00318125 0.00651495 0.00542074 0.0214059 0.00402305 0.00394196 0.00350359 0.00367542 0.00341047 0.00361911 0.00336947 0.00371757 0.00354273 0.00414667 0.00434819 0.00593766 0.0073261 0.0148902 0.030986 0.103773 0.0796581 0.0801585 0.0788841 0.0893756	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0791724 0.0713449 0.0542018 0.0702721 0.030738 0.0129078 0.0265799 0.0214839 0.0288395 0.0152926 0.00384512 0.00238122 0.002914 0.00215368 0.00345595 0.00251095 0.00429353 0.00335104 0.00674418 0.00550998 0.0216226 0.00408713 0.00409202 0.00364838 0.00385641 0.00361566 0.00388834 0.00373862 0.00428903 0.00451739 0.00609304 0.00755021 0.0153151 0.0315839 0.104007 0.0803841 0.0807374 0.079374 0.0896068	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0790403 0.071055 0.0539354 0.0698789 0.0305087 0.012788 0.0262609 0.0211754 0.0283715 0.0149517 0.00373723 0.00230692 0.00277704 0.00205187 0.00316535 0.00230192 0.00374915 0.00261134 0.00445158 0.00345219 0.00682615 0.00556914 0.0218744 0.00418264 0.00427349 0.00385456 0.00412409 0.00398643 0.00445686 0.00472325 0.00625947 0.00780102 0.015757 0.0321748 0.104072 0.0811403 0.0811609 0.0796767 0.0895168	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.07879 0.0707302 0.0536864 0.0695496 0.0303417 0.0127117 0.0260745 0.0209977 0.0280645 0.0147347 0.00367332 0.00226678 0.002703 0.00199817 0.00300977 0.00218387 0.00341972 0.00238659 0.0038787 0.00268087 0.00452332 0.00350932 0.00682758 0.0056428 0.0222966 0.00435344 0.0045597 0.00423512 0.0047008 0.00499088 0.0064653 0.00811147 0.0162448 0.0328472 0.104221 0.0821019 0.0815448 0.0797897 0.0891524	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.078367 0.0702905 0.0533732 0.0691586 0.0301708 0.0126467 0.0259312 0.0208646 0.0278073 0.0145672 0.00363028 0.00224126 0.00265817 0.00196675 0.00292103 0.00212007 0.00323945 0.00225794 0.00352649 0.00244423 0.00393094 0.00273222 0.00455257 0.00353451 0.00677706 0.00578417 0.0231531 0.00471087 0.00516116 0.00524564 0.00676486 0.0085069 0.0168387 0.033748 0.104824 0.0834807 0.0819467 0.0796212 0.088504	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0775435 0.069511 0.0528005 0.06844 0.0298709 0.0125383 0.0257065 0.020671 0.0274669 0.0143733 0.00358657 0.00221295 0.00261565 0.00193733 0.00285369 0.00207393 0.00312377 0.00218102 0.00332218 0.00230318 0.00356054 0.00248123 0.00393837 0.00277176 0.00455865 0.00353285 0.00670016 0.00614469 0.0254577 0.00574023 0.00724126 0.00880812 0.0176446 0.0352182 0.106678 0.0857823 0.0823856 0.0788433 0.0873804	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0749649 0.0670906 0.0508846 0.0659987 0.028833 0.0121375 0.0248706 0.0200212 0.0266281 0.0139548 0.00349804 0.00214913 0.00253377 0.00187864 0.00275687 0.0020072 0.00300059 0.00210194 0.00315953 0.00219921 0.00332445 0.00232359 0.00356325 0.00251364 0.00395897 0.0028401 0.00463799 0.00360958 0.00688549 0.00768568 0.0352616 0.00921391 0.0190204 0.037437 0.111648 0.0913158 0.0830656 0.0762048 0.084821	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 ) may increases DRUG2 concentrations .
4	4	0.0671945 0.0593779 0.0446032 0.0580072 0.025408 0.0107286 0.0221894 0.0179765 0.0243362 0.0130235 0.00326104 0.00196237 0.0023338 0.00171177 0.00252773 0.00182516 0.00273116 0.00190399 0.00284855 0.00197952 0.00295714 0.00206979 0.00310903 0.00220378 0.00337505 0.00244476 0.00387429 0.00290027 0.00487538 0.00430166 0.00851298 0.01165 0.0634542 0.0345858 0.122751 0.112665 0.0913541 0.0748642 0.0821212	Co-administration of DRUG0 with strong inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 ) may increases DRUG2 concentrations .
3	3	0.0600384 0.0611104 0.0886506 0.0540354 0.0539437 0.0632337 0.0649635 0.0789731 0.0474642 0.00776983 0.00679212 0.0113532 0.00259211 0.00263415 0.00201708 0.00256793 0.00199721 0.00259502 0.0019965 0.00270646 0.00208217 0.00316053 0.00274252 0.0061539 0.0061429 0.0281799 0.0280653 0.0246104 0.0445269 0.0514741 0.0397392 0.0418238 0.0428295 0.0610343	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0615161 0.062403 0.091181 0.054476 0.0531222 0.0617512 0.061794 0.0724642 0.0351726 0.00541438 0.00428825 0.00531988 0.00445463 0.0106182 0.00226197 0.00253962 0.00200468 0.00258366 0.00201257 0.00272127 0.00210837 0.00320754 0.00275834 0.00618267 0.00612881 0.0291146 0.0295564 0.025797 0.0467352 0.0547177 0.0423797 0.0447174 0.0455049 0.062992	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0615453 0.0623508 0.0911102 0.054215 0.0523321 0.0603659 0.0603384 0.0702703 0.0332392 0.00497582 0.00365038 0.00393326 0.00256452 0.00430467 0.00445765 0.0105346 0.00228004 0.00266875 0.00208 0.00279691 0.00217265 0.00329718 0.00281764 0.00628726 0.0062828 0.0306061 0.0308575 0.0264133 0.0473553 0.0555747 0.0431085 0.0455198 0.046342 0.0633513	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0613849 0.0621821 0.0908986 0.0539765 0.0519736 0.0599373 0.0598822 0.0695553 0.0326232 0.00484114 0.00354242 0.00374952 0.00230252 0.0032582 0.00262076 0.00449888 0.00456162 0.0107847 0.00233971 0.00286857 0.00222489 0.0033446 0.00282882 0.00620412 0.00624393 0.0308262 0.0315107 0.0264958 0.0472267 0.0557946 0.0434625 0.0459525 0.0468959 0.0632071	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0612526 0.0620486 0.0907367 0.0538435 0.0517895 0.0597388 0.0596084 0.069106 0.0322933 0.00478127 0.00349908 0.00368105 0.00226483 0.00316057 0.00236372 0.00343838 0.00265572 0.00457974 0.00463165 0.0112142 0.0025074 0.0034502 0.00286638 0.00600315 0.00613415 0.0303919 0.0321128 0.0264152 0.0467621 0.0558983 0.0438006 0.0464368 0.0475344 0.062999	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0610673 0.0618895 0.0905073 0.0537032 0.0516814 0.0596944 0.0595202 0.068879 0.0322028 0.00477178 0.00350204 0.00367633 0.00225366 0.00313476 0.00233994 0.00334539 0.00240555 0.00352684 0.0026853 0.00470176 0.00484412 0.0125978 0.00309943 0.0055421 0.00594523 0.0289809 0.0326306 0.0260695 0.045923 0.0561984 0.0442697 0.0471503 0.0484489 0.0628117	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , DRUG0 , St . Johns Wort) may decrease DRUG0 concentrations .
3	3	0.0598154 0.0608685 0.088688 0.0526807 0.0516183 0.0601632 0.0595579 0.0677209 0.0320667 0.00487485 0.0036044 0.00359094 0.0022584 0.00301916 0.00232755 0.00318867 0.00238739 0.00330975 0.00247331 0.0035633 0.00284366 0.00477609 0.00577778 0.0214535 0.00556904 0.0228904 0.0343942 0.0264478 0.0452778 0.0562676 0.0455268 0.0484095 0.0499585 0.0626298	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG2 , St . Johns Wort) may decrease DRUG0 concentrations .
1	4	0.0428685 0.0439035 0.0647627 0.0338947 0.0317277 0.0281913 0.0262919 0.0340885 0.0149596 0.00269081 0.00196506 0.00224373 0.00162826 0.00216292 0.00170116 0.00230773 0.00173831 0.00241315 0.00181878 0.00262606 0.00202569 0.00323016 0.00306931 0.0065677 0.00800482 0.0464406 0.0475003 0.048417 0.0807015 0.0938624 0.0950977 0.081902 0.0683269 0.0708694	Co-administration of DRUG1 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0631147 0.0788357 0.0705237 0.0878253 0.0302843 0.0275334 0.021227 0.026654 0.0200436 0.00628036 0.00479086 0.0187 0.00358203 0.00311201 0.00284044 0.00288153 0.00276172 0.00285536 0.00272935 0.00297469 0.00292141 0.00366982 0.00449471 0.00736621 0.00979586 0.0340322 0.0442987 0.036146 0.0507176 0.0616853 0.0700254 0.0656276 0.0622315 0.0674375	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0654386 0.0797783 0.0703784 0.0848874 0.0284898 0.0246556 0.0180725 0.0233316 0.0153945 0.00436931 0.00288584 0.00464676 0.00383846 0.0155631 0.00298129 0.00308808 0.00270576 0.00294721 0.00272339 0.00304245 0.00289852 0.00372681 0.00441191 0.00747789 0.00984661 0.0365021 0.0446072 0.0368723 0.0534091 0.064403 0.0727847 0.068482 0.0645172 0.0708423	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0656979 0.0790923 0.0692137 0.0823953 0.0272784 0.0228768 0.0162269 0.0212166 0.0136723 0.00379185 0.0023096 0.00311014 0.0024207 0.0053364 0.00423781 0.0161433 0.00307886 0.00330776 0.00292496 0.00327263 0.00312468 0.00393361 0.00464878 0.00779904 0.010414 0.0371618 0.0458956 0.0378924 0.0546986 0.0656884 0.0744487 0.0695135 0.0653309 0.0718456	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0656475 0.0784678 0.0683404 0.080881 0.026619 0.0220363 0.0153989 0.0201995 0.0128327 0.00349989 0.00209938 0.00274013 0.00195883 0.00347114 0.0026981 0.00586707 0.00445829 0.0168423 0.00327427 0.0036326 0.00331654 0.00416134 0.00487187 0.0081072 0.0110199 0.0373614 0.0469707 0.038709 0.0553934 0.0663535 0.075491 0.0697366 0.0655253 0.0720171	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0652586 0.0776902 0.0674487 0.0795843 0.0261275 0.0215249 0.0149251 0.0195702 0.0123527 0.00332396 0.00197105 0.0025089 0.00179203 0.0030377 0.0020973 0.00377378 0.00284352 0.0061675 0.00469038 0.0179739 0.00370407 0.00451966 0.00498584 0.00851401 0.011892 0.0384326 0.0483932 0.0397502 0.0560168 0.066687 0.0761856 0.0694814 0.0652106 0.0715648	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0641016 0.0760854 0.0658615 0.0774759 0.0254498 0.0209692 0.0144934 0.0189997 0.0120084 0.00320561 0.00187574 0.00236863 0.00167329 0.00275832 0.00188646 0.00328247 0.00216071 0.0039432 0.00293253 0.00650461 0.00531636 0.0220758 0.00546755 0.00907985 0.0128631 0.0415653 0.0504525 0.0415154 0.0571705 0.0667163 0.076504 0.068734 0.0641622 0.0703409	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , DRUG0 , St . Johns Wort) may decrease DRUG2 concentrations .
4	4	0.0579657 0.0687693 0.0586976 0.0682139 0.0223785 0.0186464 0.0131182 0.0176578 0.0113628 0.00310233 0.00177005 0.00230554 0.00157837 0.00269022 0.00178173 0.00318261 0.00206862 0.00390995 0.00263174 0.00524418 0.00428391 0.00953859 0.0126763 0.0720045 0.01316 0.0375033 0.0554528 0.0441745 0.0563625 0.0651205 0.0747841 0.0642612 0.0592485 0.0643539	Co-administration of DRUG0 with inducers of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG1 , St . Johns Wort) may decrease DRUG2 concentrations .
3	3	0.121433 0.0755385 0.0816273 0.0402076 0.0147838 0.0123047 0.00441596 0.00619152 0.00803495 0.0189451 0.00720521 0.0299554 0.0832966 0.0356208 0.0496641 0.0256787 0.0168315 0.0153067 0.00610445 0.0266244 0.089093 0.0314985 0.0179657 0.0179539 0.00952438 0.00643234 0.0206623 0.0104126 0.024374 0.0307512 0.0241126 0.0374493	DRUG1 may compete with other drugs , such as DRUG2 , for sites of metabolism in the liver , thus elevating the serum levels of such compounds to potentially toxic levels .
1	1	0.0458858 0.0280885 0.0423654 0.0382633 0.0387746 0.0415781 0.0763212 0.0312654 0.054591 0.0356919 0.0525877 0.0157172 0.0248421 0.0625547 0.0389952 0.0258989 0.0239161 0.0512968 0.0210975 0.0144654 0.0098959 0.0267197 0.0238546 0.0212189 0.0126251 0.0125524 0.0580288 0.070908	Therefore , when concomitant use of DRUG1 and DRUG2 is anticipated , it may be necessary to monitor blood levels and/or reduce the dosage of such compounds .
3	3	0.0390513 0.0202309 0.0683968 0.0261406 0.0472769 0.0466764 0.0510321 0.0323401 0.0392729 0.0342979 0.0363676 0.0188611 0.0859254 0.052281 0.0558794 0.0530241 0.06028 0.0529263 0.0355142 0.0258833 0.0445271 0.0738147	However , DRUG1 , a potent inhibitor of cytochrome P450 3A4 , may increase plasma levels of DRUG2 during concomitant dosing .
3	3	0.0596696 0.0472116 0.0337459 0.040547 0.0266798 0.0175369 0.0553627 0.0278158 0.107529 0.0503657 0.045288 0.0500233 0.0524158 0.0325249 0.0082875 0.0191358 0.015652 0.00784334 0.00722679 0.00374041 0.00307408 0.00812702 0.0146229 0.0653412 0.0359821 0.0247209 0.0333265 0.0228627 0.0227276 0.0606132	An inhibitor of CYP2C8 (such as DRUG1 ) may increase the AUC of DRUG2 and an inducer of CYP2C8 (such as DRUG0 ) may decrease the AUC of DRUG0 .
4	4	0.0534572 0.0436176 0.0301235 0.0382828 0.0268828 0.0182514 0.0587696 0.0202131 0.0685133 0.0351296 0.0267996 0.0337685 0.0344045 0.0266338 0.0215733 0.0657993 0.0563105 0.0386243 0.0308561 0.0150959 0.0135524 0.0273323 0.0152773 0.0395326 0.0316182 0.0193064 0.0278957 0.01766 0.017286 0.0474324	An inhibitor of CYP2C8 (such as DRUG1 ) may increase the AUC of DRUG0 and an inducer of CYP2C8 (such as DRUG2 ) may decrease the AUC of DRUG0 .
4	4	0.0495521 0.0397724 0.0265928 0.0325008 0.0216236 0.0150069 0.0478711 0.0141483 0.0538878 0.0234851 0.0164444 0.0204286 0.0158163 0.0147243 0.00939615 0.0311729 0.0272393 0.012341 0.00928817 0.00424535 0.00372029 0.00974961 0.0186121 0.0902891 0.0606935 0.0674369 0.0829277 0.0656971 0.0615254 0.0538111	An inhibitor of CYP2C8 (such as DRUG1 ) may increase the AUC of DRUG0 and an inducer of CYP2C8 (such as DRUG0 ) may decrease the AUC of DRUG2 .
4	4	0.0234718 0.0173007 0.00960897 0.00908795 0.00474121 0.00411628 0.0106575 0.0193269 0.0937076 0.0547102 0.0605047 0.0772839 0.0571598 0.101022 0.0165573 0.0620275 0.0348283 0.0264386 0.0243646 0.0156693 0.0117885 0.024806 0.0153675 0.046522 0.0330773 0.0218765 0.0312896 0.0198696 0.0196741 0.0531439	An inhibitor of CYP2C8 (such as DRUG0 ) may increase the AUC of DRUG1 and an inducer of CYP2C8 (such as DRUG2 ) may decrease the AUC of DRUG0 .
3	3	0.0238231 0.0165667 0.00894379 0.00811004 0.00385237 0.00318926 0.00896218 0.0169722 0.059186 0.0242165 0.0200477 0.0304042 0.0172353 0.0183758 0.0194203 0.0539512 0.0415009 0.0229175 0.024323 0.0162093 0.0140135 0.0490136 0.0196013 0.10023 0.0625886 0.0606782 0.069806 0.0710857 0.0615979 0.0531783	An inhibitor of CYP2C8 (such as DRUG0 ) may increase the AUC of DRUG0 and an inducer of CYP2C8 (such as DRUG1 ) may decrease the AUC of DRUG2 .
3	3	0.0605533 0.0244518 0.0256796 0.0397641 0.0251006 0.086403 0.0645926 0.0777888 0.0794005 0.0731009 0.0463419 0.0453133 0.0756091 0.0357088 0.0209543 0.0155974 0.00757497 0.0224631 0.0071573 0.0154108 0.00648266 0.0101352 0.0150146 0.0108305 0.011343 0.0166941 0.0172309 0.0214732 0.0418293	DRUG1 has been reported to accelerate the metabolism of DRUG2 by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for DRUG0 .
3	4	0.0503118 0.0188508 0.0182671 0.0300814 0.0178419 0.0569748 0.0329494 0.0402995 0.0386151 0.0306534 0.0353374 0.0530546 0.0852956 0.0409909 0.0208839 0.0178819 0.00849236 0.0314457 0.0107126 0.028883 0.0163827 0.0280779 0.0356343 0.0265842 0.0234836 0.0353818 0.0606817 0.0521768 0.0537742	DRUG1 has been reported to accelerate the metabolism of DRUG0 by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for DRUG2 .
4	4	0.0249038 0.0136878 0.039078 0.0245245 0.0226119 0.0846303 0.0684903 0.0568035 0.0563268 0.0758198 0.0644191 0.0710338 0.0170336 0.0235772 0.027183 0.0417743 0.0331529 0.0294587 0.0370299 0.0413965 0.0523795 0.0946844	Therefore , physicians should closely monitor patients for a change in DRUG1 dosage requirements when administering DRUG2 to patients on DRUG0 .
4	4	0.0200533 0.0110907 0.0322988 0.0196529 0.0195122 0.0718949 0.0567034 0.0473149 0.044245 0.06262 0.0542577 0.0601574 0.0151716 0.0231625 0.0318586 0.0371162 0.0322576 0.0553605 0.0632517 0.0745188 0.079357 0.0881443	Therefore , physicians should closely monitor patients for a change in DRUG1 dosage requirements when administering DRUG0 to patients on DRUG2 .
1	1	0.0273113 0.015532 0.0458661 0.026984 0.0276254 0.092818 0.0549782 0.031313 0.0210195 0.0236952 0.0165648 0.0226561 0.0342794 0.0419094 0.0391855 0.0397086 0.0761621 0.0687845 0.0568153 0.079721 0.082463 0.0746076	Therefore , physicians should closely monitor patients for a change in DRUG0 dosage requirements when administering DRUG1 to patients on DRUG2 .
4	4	0.0658764 0.0581027 0.0538673 0.0657529 0.0599181 0.100684 0.117527 0.0589578 0.0314713 0.0849852 0.0869176 0.0511959 0.0518627 0.112882	Exposure to oral DRUG1 is unaffected by DRUG2 but greatly increased by DRUG0 .
4	2	0.0606214 0.047337 0.0523857 0.0487092 0.0213369 0.029153 0.0269378 0.0290511 0.0459974 0.162787 0.134889 0.143584 0.115215 0.0819956	Exposure to oral DRUG1 is unaffected by DRUG0 but greatly increased by DRUG2 .
4	4	0.0292862 0.0185206 0.0276549 0.0535137 0.0858638 0.109319 0.0824884 0.0943528 0.0400461 0.103842 0.090833 0.115264 0.0892412 0.0597748	Exposure to oral DRUG0 is unaffected by DRUG1 but greatly increased by DRUG2 .
4	4	0.0253426 0.028271 0.0649423 0.040892 0.0462497 0.0443205 0.0372034 0.0612403 0.0270383 0.0373441 0.0441658 0.0425265 0.0654025 0.080201 0.102766 0.0414502 0.0100543 0.0220715 0.0310127 0.0302397 0.0388372 0.0784288	This study examined drug-drug interactions of oral DRUG1 with the cytochrome P450 (CYP) 2B6 inhibitor DRUG2 and the CYP3A inhibitor DRUG0 .
4	4	0.0222874 0.0251108 0.0578859 0.0372649 0.0430211 0.042672 0.0342167 0.0572781 0.0274893 0.0342837 0.0305071 0.0229621 0.0277763 0.030827 0.0292188 0.0308352 0.0241307 0.0757123 0.0973274 0.106588 0.0780701 0.0645354	This study examined drug-drug interactions of oral DRUG1 with the cytochrome P450 (CYP) 2B6 inhibitor DRUG0 and the CYP3A inhibitor DRUG2 .
4	4	0.0153104 0.0192775 0.041367 0.0268661 0.0252706 0.0129354 0.0154842 0.0259911 0.0378908 0.0205491 0.0172725 0.0246291 0.0670044 0.0803442 0.102192 0.112731 0.0149348 0.0457848 0.0680132 0.107098 0.06685 0.0522042	This study examined drug-drug interactions of oral DRUG0 with the cytochrome P450 (CYP) 2B6 inhibitor DRUG1 and the CYP3A inhibitor DRUG2 .
2	4	0.0124012 0.0112078 0.0138453 0.0044928 0.0113619 0.00373548 0.0111847 0.00738264 0.00675556 0.0278788 0.0188766 0.0158126 0.0356803 0.0408693 0.0308128 0.0498414 0.0429884 0.028522 0.0300597 0.0343011 0.03478 0.0202948 0.014349 0.0182371 0.0164713 0.00921552 0.0247721 0.048332 0.0291078 0.0433445 0.0208975 0.00543397 0.0080884 0.0287861 0.0219777 0.0256428 0.0118108 0.0227219 0.0162165 0.0318164 0.0205479 0.0246005 0.021428 0.0431173	In this randomized , blinded , crossover study , 11 healthy volunteers ingested 0.2 mg/kg DRUG1 after pretreatments with oral DRUG2 (250 mg twice daily) , DRUG0 (200 mg once daily) , or placebo in 6-day treatment periods at intervals of 4 weeks .
4	4	0.0102249 0.00925442 0.0114941 0.00371772 0.0095022 0.00315667 0.00966813 0.00620854 0.0052916 0.0215625 0.0135622 0.0120662 0.0318654 0.0413369 0.0386303 0.0482628 0.0523599 0.0502732 0.033624 0.0345885 0.0326701 0.0403133 0.0241223 0.0254647 0.0326275 0.0151515 0.0328062 0.036661 0.0263154 0.0273283 0.0184074 0.00453278 0.00790896 0.023484 0.0201012 0.0218757 0.0109364 0.0201255 0.0142895 0.0262711 0.0175913 0.0210374 0.0180177 0.0353108	In this randomized , blinded , crossover study , 11 healthy volunteers ingested 0.2 mg/kg DRUG1 after pretreatments with oral DRUG0 (250 mg twice daily) , DRUG2 (200 mg once daily) , or placebo in 6-day treatment periods at intervals of 4 weeks .
4	4	0.010493 0.00929643 0.0115031 0.00364262 0.00912565 0.00301424 0.00857323 0.00533379 0.00458063 0.0186668 0.0106976 0.00752562 0.0182942 0.020625 0.0205809 0.0355076 0.048478 0.0566528 0.0676701 0.0377891 0.0767712 0.0369601 0.0224476 0.0212439 0.0284984 0.0141141 0.0309645 0.0389834 0.0262109 0.0280508 0.0189943 0.00469061 0.00821176 0.0235814 0.0203621 0.022164 0.0112711 0.0208703 0.0148284 0.0271126 0.0183023 0.0218799 0.0187426 0.0366931	In this randomized , blinded , crossover study , 11 healthy volunteers ingested 0.2 mg/kg DRUG0 after pretreatments with oral DRUG1 (250 mg twice daily) , DRUG2 (200 mg once daily) , or placebo in 6-day treatment periods at intervals of 4 weeks .
3	3	0.0592463 0.0140223 0.0479592 0.0272924 0.0289635 0.0265678 0.0177909 0.0163041 0.0277939 0.0337064 0.0413807 0.0271419 0.0151806 0.0301939 0.0597391 0.0518578 0.0533352 0.0411711 0.0577223 0.0483913 0.0360353 0.0133842 0.0155357 0.00657889 0.0209387 0.0244302 0.020517 0.0149452 0.017269 0.0171025 0.00890005 0.0156668 0.00984782 0.0151697 0.0379183	DRUG1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG2 by 2.4-fold , whereas DRUG0 treatment did not increase the exposure to DRUG0 .
4	4	0.0473739 0.0111485 0.0383127 0.0219139 0.0232275 0.0214026 0.0142892 0.0129592 0.0220634 0.0269864 0.0324794 0.0227505 0.0125826 0.0285442 0.0515644 0.0336473 0.0253591 0.0175875 0.0189496 0.0223354 0.022308 0.0242887 0.0555522 0.0358334 0.108322 0.0564977 0.0291654 0.0276515 0.0256007 0.0188277 0.0111149 0.0181069 0.0110398 0.0144248 0.0357887	DRUG1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG0 by 2.4-fold , whereas DRUG2 treatment did not increase the exposure to DRUG0 .
4	4	0.0596047 0.01398 0.0479674 0.027427 0.0290146 0.0265621 0.0174923 0.0157068 0.0263649 0.0322807 0.0379383 0.0249883 0.0126328 0.0275928 0.0438265 0.0233448 0.0156183 0.00889098 0.0072767 0.00698772 0.011375 0.00589348 0.0114575 0.00404705 0.0166327 0.0222128 0.0205085 0.0170698 0.0278133 0.0392605 0.0492725 0.0729962 0.0599743 0.0656094 0.0703794	DRUG1 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG0 by 2.4-fold , whereas DRUG0 treatment did not increase the exposure to DRUG2 .
4	4	0.014948 0.0139876 0.032408 0.0186411 0.022218 0.0287564 0.0224854 0.0126579 0.0251067 0.0276631 0.0312467 0.0222151 0.0108778 0.0252608 0.0525929 0.0403015 0.0356367 0.0324334 0.0389366 0.0351546 0.0388843 0.026056 0.0422641 0.0270977 0.0727633 0.0364539 0.0299226 0.0333519 0.0332599 0.0225582 0.0133459 0.0192689 0.0115034 0.0145218 0.03522	DRUG0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG1 by 2.4-fold , whereas DRUG2 treatment did not increase the exposure to DRUG0 .
4	4	0.0156278 0.014598 0.0338849 0.0195636 0.0232296 0.0301185 0.023575 0.0132048 0.026287 0.0290769 0.032685 0.022934 0.010925 0.0248603 0.0493134 0.0354031 0.0306012 0.0278304 0.0328974 0.0316628 0.0298327 0.0121126 0.0113134 0.00588938 0.0187653 0.0191342 0.020731 0.0200456 0.0287454 0.0441392 0.0437914 0.0645058 0.0505624 0.0506071 0.0515458	DRUG0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG1 by 2.4-fold , whereas DRUG0 treatment did not increase the exposure to DRUG2 .
4	4	0.0146916 0.0137073 0.0316057 0.0181803 0.0214629 0.0275599 0.0212991 0.011695 0.0231563 0.0247831 0.0265726 0.0186131 0.00935468 0.0225057 0.0411194 0.0239837 0.0172276 0.0113737 0.0113566 0.0130464 0.0149314 0.011436 0.0320306 0.0193999 0.0710099 0.0758545 0.0230848 0.0256815 0.0272373 0.0407312 0.0413402 0.059393 0.052556 0.0511589 0.0508604	DRUG0 treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral DRUG0 by 2.4-fold , whereas DRUG1 treatment did not increase the exposure to DRUG2 .
3	4	0.0383759 0.0696674 0.0448823 0.0692419 0.0462535 0.0437923 0.0483441 0.0371992 0.0525024 0.0483755 0.0551521 0.0615729 0.0315501 0.0128421 0.0161314 0.019787 0.0144854 0.00848315 0.00673014 0.0100224 0.0118017 0.0124516 0.0076957 0.0061278 0.023889 0.0703836 0.0255673 0.0108084 0.0064406 0.00498216 0.0101775 0.0082995 0.0180384 0.0479456	The ratio of DRUG1 AUC(0-   ) to DRUG2 AUC(0-   ) was significantly decreased in the DRUG0 (P &lt; 0.001) and DRUG0 phases (P = 0.006) as compared to placebo .
4	4	0.0334192 0.0691074 0.0461581 0.0449456 0.0259521 0.0195445 0.012196 0.00731157 0.0104814 0.0192387 0.0460225 0.0391455 0.0253217 0.0154724 0.0293613 0.0628953 0.0733561 0.0465006 0.0566034 0.0407447 0.0216605 0.0202668 0.0133281 0.00932762 0.027113 0.0687028 0.0242996 0.00946967 0.00554294 0.00423896 0.00903619 0.00728667 0.0158288 0.0401202	The ratio of DRUG1 AUC(0-   ) to DRUG0 AUC(0-   ) was significantly decreased in the DRUG2 (P &lt; 0.001) and DRUG0 phases (P = 0.006) as compared to placebo .
4	4	0.0357628 0.0740427 0.0497047 0.0480983 0.026807 0.0202288 0.012769 0.00810739 0.0114344 0.0201289 0.0458925 0.041147 0.0244232 0.0117412 0.0167738 0.0297799 0.0225013 0.0160814 0.0148469 0.0192534 0.0410116 0.0460831 0.0511218 0.037007 0.0550669 0.0707859 0.0318588 0.0196246 0.0120034 0.00734705 0.0111036 0.00849578 0.0170916 0.0418744	The ratio of DRUG1 AUC(0-   ) to DRUG0 AUC(0-   ) was significantly decreased in the DRUG0 (P &lt; 0.001) and DRUG2 phases (P = 0.006) as compared to placebo .
4	4	0.0151043 0.0249239 0.0199183 0.0309203 0.0591714 0.0519314 0.0361199 0.0269491 0.0372614 0.0457234 0.0392671 0.0324001 0.0258757 0.017164 0.0323242 0.0615922 0.0605769 0.0428921 0.0480871 0.0326855 0.0195912 0.0190886 0.0131257 0.00940839 0.0257294 0.0646927 0.0227813 0.00885335 0.00519998 0.00394146 0.00838285 0.00675009 0.0146143 0.0369522	The ratio of DRUG0 AUC(0-   ) to DRUG1 AUC(0-   ) was significantly decreased in the DRUG2 (P &lt; 0.001) and DRUG0 phases (P = 0.006) as compared to placebo .
4	4	0.0158505 0.0260465 0.0210069 0.0327456 0.0618241 0.0535455 0.0370427 0.0273361 0.0365188 0.044386 0.0371813 0.0344709 0.0252189 0.0130656 0.0195306 0.0302049 0.0220608 0.0177047 0.0162344 0.0179836 0.0381355 0.0423451 0.0468504 0.0326764 0.0482912 0.0645648 0.0292834 0.0182042 0.0112096 0.00687273 0.0101631 0.00775496 0.0155527 0.0381374	The ratio of DRUG0 AUC(0-   ) to DRUG1 AUC(0-   ) was significantly decreased in the DRUG0 (P &lt; 0.001) and DRUG2 phases (P = 0.006) as compared to placebo .
4	4	0.0139452 0.0207036 0.0125132 0.0171596 0.0241246 0.0158909 0.00866545 0.00444133 0.00688547 0.0151292 0.0317004 0.0293739 0.0189057 0.0120444 0.0229556 0.0575578 0.0626542 0.0427582 0.0464446 0.0749186 0.0449437 0.0450944 0.0613107 0.0271072 0.0535689 0.0814428 0.0314686 0.0191577 0.011978 0.00735885 0.011061 0.00837415 0.0169225 0.0414395	The ratio of DRUG0 AUC(0-   ) to DRUG0 AUC(0-   ) was significantly decreased in the DRUG1 (P &lt; 0.001) and DRUG2 phases (P = 0.006) as compared to placebo .
4	4	0.0550803 0.0639339 0.0948412 0.0295751 0.0677364 0.0785902 0.0179647 0.0377449 0.0375383 0.0273823 0.0257309 0.0346281 0.0365197 0.0229911 0.0281128 0.00872496 0.0244588 0.0206008 0.0256769 0.0200154 0.008 0.00813029 0.0114252 0.0128023 0.0195647 0.0482175 0.0274238 0.0270009 0.0348448 0.0447438	In the DRUG1 and DRUG2 phases , the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (P < 0.05) .
1	1	0.0479342 0.0425693 0.0230605 0.0325151 0.0718614 0.0556532 0.0586506 0.0903468 0.0282029 0.0390587 0.109836 0.0818332 0.0673938 0.0886958 0.0929917 0.0693968	The findings suggest that the dosage of DRUG1 should be reduced in patients receiving DRUG2 .
3	3	0.0415062 0.0423255 0.0429191 0.0605113 0.0546747 0.0339807 0.047907 0.0386605 0.0471803 0.0561879 0.0372599 0.0183647 0.0194645 0.0065648 0.0175367 0.068086 0.020761 0.0192536 0.0160694 0.0106444 0.0114368 0.0131979 0.0172711 0.0144687 0.0123168 0.0169628 0.0208499 0.00478252 0.00930779 0.0078593 0.0220165 0.0320943 0.0195621 0.0251966 0.0231003 0.0497187	While co-administration of DRUG1 appeared to increase the clearance of DRUG2 by 70% , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of DRUG0 .
4	4	0.0319287 0.0322753 0.0345644 0.04251 0.039955 0.0174094 0.0326235 0.0201584 0.023823 0.019585 0.0203803 0.0170336 0.0193919 0.00640232 0.0176526 0.0631322 0.0184656 0.0179011 0.0178803 0.0127331 0.0147202 0.0171386 0.0232156 0.0215076 0.0214763 0.027247 0.0309374 0.00798559 0.0145602 0.0142557 0.0475449 0.0601568 0.0287286 0.0554016 0.0546087 0.0547098	While co-administration of DRUG1 appeared to increase the clearance of DRUG0 by 70% , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of DRUG2 .
4	1	0.114302 0.0913966 0.0720224 0.0386162 0.0372518 0.0748529 0.0553665 0.0348816 0.0756993 0.0727576 0.0941023 0.107748 0.131003	Combination therapy with DRUG0 ( DRUG1 ) and DRUG2 is not indicated .
4	2	0.049371 0.0576488 0.0476068 0.0409801 0.0777253 0.0190129 0.0331469 0.0716908 0.0373733 0.0352148 0.0535064 0.0362107 0.0567913 0.054719 0.0697688 0.0328066 0.0363854 0.017894 0.0106533 0.0386026 0.0255606 0.0290791 0.0682513	Dosages of concomitantly administered DRUG1 should be reduced by approximately half , because DRUG2 amplifies the therapeutic actions and side-effects of DRUG0 .
2	2	0.0145234 0.0116237 0.0188653 0.0175168 0.0220241 0.0260763 0.0332005 0.0787648 0.0231735 0.01399 0.0191623 0.0141192 0.0352511 0.0704298 0.0869525 0.0546554 0.0644889 0.074455 0.0321375 0.0595346 0.0874554 0.072792 0.0688079	Dosages of concomitantly administered DRUG0 should be reduced by approximately half , because DRUG1 amplifies the therapeutic actions and side-effects of DRUG2 .
2	2	0.0760469 0.128548 0.0793005 0.019043 0.0397912 0.0651917 0.0666698 0.0624192 0.0561154 0.0827144 0.0575992 0.060525 0.0646326 0.0346014 0.0166894 0.0200419 0.070071	Additive sedative effects and confusional states may emerge if DRUG1 is given with DRUG2 or DRUG0 .
2	2	0.0908438 0.153543 0.0954407 0.0233181 0.0469379 0.0697408 0.07149 0.0532397 0.0405596 0.0786398 0.0376909 0.0457393 0.0429866 0.0186466 0.0187142 0.0484628 0.064006	Additive sedative effects and confusional states may emerge if DRUG1 is given with DRUG0 or DRUG2 .
1	1	0.0656684 0.0868162 0.0373879 0.0530134 0.0756728 0.108363 0.0432685 0.0139558 0.017378 0.0051614 0.00516806 0.00362422 0.00575808 0.00840524 0.0120743 0.0426577 0.0386132 0.0241758 0.03495 0.0233587 0.00997031 0.00500354 0.0117446 0.013835 0.0183616 0.0476244 0.0218628 0.0125781 0.0354856 0.0328811 0.0101489 0.0232927 0.0517407	Exert particular caution in combining DRUG1 with other DRUG2 ( DRUG0 and DRUG0 ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
1	1	0.0656062 0.0828709 0.0353598 0.0502354 0.0740579 0.104136 0.0413514 0.0175069 0.012921 0.0153939 0.0214172 0.00468658 0.00677226 0.010629 0.0143607 0.0395141 0.0361326 0.0229464 0.0338299 0.0226451 0.00967203 0.00484842 0.0112883 0.0133491 0.01779 0.0461122 0.0213235 0.0122966 0.0348396 0.032342 0.00998469 0.0228938 0.0508863	Exert particular caution in combining DRUG1 with other DRUG0 ( DRUG2 and DRUG0 ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
1	1	0.0575243 0.0732902 0.032216 0.0482121 0.0748494 0.101877 0.0380574 0.0160587 0.0120786 0.0142047 0.0138124 0.0148812 0.0326482 0.0188415 0.0219048 0.0395726 0.0366126 0.0225859 0.0329842 0.0226341 0.00955892 0.00473566 0.0109557 0.0129376 0.0171542 0.0441427 0.020465 0.0117826 0.0331426 0.0307442 0.00949095 0.0217368 0.048307	Exert particular caution in combining DRUG1 with other DRUG0 ( DRUG0 and DRUG2 ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
4	4	0.042586 0.0641088 0.0379013 0.0698493 0.090585 0.0563349 0.0499567 0.0136564 0.0345178 0.0153653 0.011467 0.0118661 0.029381 0.0133825 0.0164025 0.0377192 0.0338905 0.0214391 0.0312102 0.0231407 0.00992401 0.00488364 0.0112866 0.0135826 0.0178526 0.0488103 0.0222982 0.012558 0.0353447 0.0329395 0.0101796 0.0234233 0.0521565	Exert particular caution in combining DRUG0 with other DRUG1 ( DRUG0 and DRUG2 ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
4	4	0.0331583 0.0495361 0.0316313 0.0587758 0.0789315 0.0470917 0.0350171 0.0106484 0.0171526 0.0301531 0.10648 0.0251422 0.0361814 0.0162239 0.0187216 0.0382746 0.0330611 0.0203962 0.0292567 0.0208736 0.00887 0.00436007 0.0100601 0.0120615 0.0159106 0.0432069 0.0198699 0.0112191 0.0315529 0.0294197 0.00910832 0.0209602 0.046693	Exert particular caution in combining DRUG0 with other DRUG0 ( DRUG1 and DRUG2 ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
4	4	0.120199 0.0600662 0.073045 0.0739149 0.0883706 0.0537819 0.0208147 0.0403473 0.0889566 0.0648018 0.0696122 0.0255648 0.0283459 0.0298891 0.027945 0.0357186 0.0986261	DRUG1 and/or stimulantes of the DRUG2 / DRUG0 type may counteract the specific actions of DRUG0 .
4	4	0.100075 0.0512576 0.0612483 0.062263 0.0562218 0.0317258 0.0611538 0.086273 0.0714704 0.0694028 0.082676 0.0373648 0.0327495 0.0328244 0.0325387 0.037801 0.092954	DRUG1 and/or stimulantes of the DRUG0 / DRUG2 type may counteract the specific actions of DRUG0 .
4	2	0.0657738 0.0182498 0.0203412 0.0182363 0.0206461 0.0168241 0.0194327 0.0496638 0.124027 0.0878792 0.0902689 0.0549252 0.0511006 0.0651133 0.106851 0.0979877 0.0926795	DRUG1 and/or stimulantes of the DRUG0 / DRUG0 type may counteract the specific actions of DRUG2 .
4	4	0.0269614 0.0326036 0.0621349 0.0639272 0.0858218 0.111823 0.116336 0.083097 0.0700597 0.0688474 0.07219 0.0279898 0.025446 0.0255432 0.0243505 0.028944 0.073924	DRUG0 and/or stimulantes of the DRUG1 / DRUG2 type may counteract the specific actions of DRUG0 .
2	2	0.0317872 0.0393105 0.0701199 0.0588703 0.0585954 0.037239 0.0224435 0.03467 0.0860669 0.0713473 0.0760458 0.0510329 0.0454834 0.0519548 0.0957588 0.0866032 0.082671	DRUG0 and/or stimulantes of the DRUG1 / DRUG0 type may counteract the specific actions of DRUG2 .
2	2	0.0245238 0.0308847 0.0532794 0.0450638 0.041435 0.035604 0.0616616 0.160511 0.0569373 0.0686023 0.0705452 0.0476267 0.0393998 0.0452946 0.0806105 0.0717491 0.0662711	DRUG0 and/or stimulantes of the DRUG0 / DRUG1 type may counteract the specific actions of DRUG2 .
4	2	0.066276 0.171285 0.169128 0.0796692 0.109157 0.0809003 0.105104 0.130961 0.0875207	DRUG0 DRUG1 may increase sensitivity to oral DRUG2 .
4	4	0.0441855 0.0194175 0.0517105 0.0490634 0.0461242 0.0509554 0.024019 0.00493283 0.00626888 0.00347489 0.00925697 0.00508381 0.0198138 0.0102068 0.0166686 0.00934075 0.00771675 0.00701325 0.00694168 0.0118514 0.011933 0.0104172 0.0121213 0.0133468 0.0228502 0.00645027 0.00717152 0.0133936 0.0115377 0.00728286 0.0109849 0.0216873 0.0114485 0.0150468 0.0145346 0.0320299 0.0188943 0.015166 0.0254321 0.0105575 0.0130401 0.00739868 0.0132351 0.0108386 0.00561558 0.00801471 0.0187672 0.0110943 0.016247 0.0266579 0.01823 0.0362627 0.0159094 0.0188875 0.0314057 0.0520637	DRUG1 : A multidose study of DRUG2 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG0 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG0 half-life and AUC were also detected .
4	4	0.0306315 0.00687921 0.0160239 0.0181277 0.0179985 0.00812311 0.00637606 0.00278413 0.00475245 0.00302087 0.00729816 0.0031899 0.0195359 0.00729439 0.0137505 0.00595268 0.00697083 0.00670704 0.0067506 0.0121412 0.0143479 0.0118804 0.0121173 0.0195842 0.0518537 0.017893 0.0241791 0.057262 0.0574732 0.0483304 0.0551599 0.038615 0.019973 0.0183758 0.0162192 0.0282858 0.0204059 0.0123327 0.0229289 0.00908219 0.0103222 0.00548533 0.010222 0.00814644 0.00413216 0.0064804 0.0155952 0.00909798 0.0132328 0.0213184 0.014389 0.0285352 0.0125977 0.0147943 0.0245391 0.0405035	DRUG1 : A multidose study of DRUG0 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG2 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG0 half-life and AUC were also detected .
4	4	0.033324 0.00734337 0.0165708 0.0182694 0.0179911 0.00816197 0.00664185 0.00284601 0.00475264 0.00291181 0.00664284 0.00298295 0.0168513 0.0061137 0.0119632 0.00519999 0.00595617 0.00561374 0.00545595 0.00954745 0.010081 0.00851231 0.0103479 0.0123357 0.0212621 0.00610396 0.0069107 0.0128673 0.0109378 0.00687466 0.0105387 0.0211904 0.0115239 0.0156233 0.0153627 0.0340557 0.020794 0.0174035 0.0318392 0.0145703 0.0192116 0.0102099 0.0154604 0.0124642 0.0109716 0.0275683 0.0898001 0.0577153 0.0549716 0.0391613 0.0203984 0.0413969 0.0215935 0.0171729 0.0269655 0.040663	DRUG1 : A multidose study of DRUG0 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG0 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG2 half-life and AUC were also detected .
3	3	0.0108498 0.0129551 0.0332792 0.0469814 0.0409904 0.033554 0.0396305 0.00771047 0.018586 0.00954013 0.028299 0.0184802 0.037891 0.0176033 0.0250961 0.0234929 0.0195314 0.0201753 0.0222109 0.0250329 0.0273127 0.0351743 0.0211889 0.00702464 0.024007 0.00913843 0.00694188 0.012154 0.0102711 0.00799924 0.010149 0.0196156 0.00957248 0.0111836 0.0107055 0.0240052 0.0143752 0.0105385 0.0182694 0.00745397 0.00890381 0.00484005 0.00881636 0.00703744 0.00363025 0.00533946 0.0131356 0.00781934 0.0116756 0.0189264 0.0129168 0.0253916 0.0112157 0.0131307 0.0219645 0.0362859	DRUG0 : A multidose study of DRUG1 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG2 , resulted in a mean increase in DRUG0 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG0 half-life and AUC were also detected .
4	4	0.00997657 0.0112239 0.0295477 0.0421694 0.0360933 0.0290781 0.032053 0.00598545 0.00920816 0.00398884 0.00987202 0.00615035 0.0144112 0.00718066 0.00967974 0.00834941 0.0082645 0.00816244 0.0094612 0.0147343 0.015467 0.0148356 0.0137692 0.0183741 0.0526427 0.0171319 0.0218552 0.0507989 0.0503792 0.0414055 0.046338 0.0312626 0.0160142 0.0149084 0.0132033 0.0232989 0.0167483 0.0101369 0.0189799 0.00744677 0.00855284 0.00456527 0.00853544 0.00684184 0.00347228 0.00540394 0.0128772 0.00754235 0.01093 0.0177116 0.0119359 0.0236862 0.0104803 0.0123489 0.0205798 0.0339496	DRUG0 : A multidose study of DRUG1 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG2 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG0 half-life and AUC were also detected .
4	4	0.0111007 0.0125324 0.0332093 0.0474069 0.040571 0.0326299 0.0357382 0.00644384 0.00939091 0.00404371 0.00955764 0.00596287 0.0136862 0.00672058 0.00896302 0.00748325 0.00684948 0.00650004 0.00713464 0.0108356 0.0105082 0.0106532 0.011793 0.0118075 0.0217456 0.00581736 0.00620364 0.0110061 0.00932474 0.00572871 0.00874711 0.0176332 0.00935123 0.0128375 0.0125815 0.0283204 0.0170438 0.014282 0.0263358 0.0119077 0.0157554 0.00837426 0.0127166 0.0104352 0.0091979 0.0225356 0.0742253 0.0476877 0.0459363 0.0321968 0.0168771 0.0338118 0.0180303 0.0144249 0.0227998 0.0346067	DRUG0 : A multidose study of DRUG1 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG0 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG2 half-life and AUC were also detected .
4	4	0.00612203 0.00519908 0.00937324 0.0124199 0.01441 0.00696258 0.00515151 0.00266917 0.00526833 0.0040989 0.0120893 0.00573868 0.0334163 0.0173286 0.0313753 0.0173021 0.021847 0.0237228 0.0214617 0.0297054 0.0344837 0.0284933 0.0478354 0.014219 0.0476048 0.0281883 0.0229615 0.050715 0.0423674 0.0410781 0.0384997 0.0262129 0.0156655 0.0151733 0.0124585 0.0199939 0.0150581 0.00907727 0.0169039 0.00668116 0.00757449 0.00402912 0.00753504 0.00612792 0.00313384 0.00483256 0.0114872 0.00678251 0.00987396 0.0160744 0.010857 0.0214435 0.0095269 0.0112527 0.0189022 0.031234	DRUG0 : A multidose study of DRUG0 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG1 , resulted in a mean increase in DRUG2 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG0 half-life and AUC were also detected .
4	4	0.00664248 0.00564489 0.0101809 0.0134906 0.0156746 0.00759074 0.00562599 0.00291979 0.00576865 0.00451518 0.0132822 0.00627102 0.0368926 0.0193426 0.0351636 0.0200243 0.0253071 0.0266845 0.0238012 0.0330283 0.0384817 0.0304147 0.0492975 0.0113109 0.0286 0.0102892 0.00660435 0.0101082 0.00899573 0.00739323 0.00990639 0.0176544 0.00869943 0.0103837 0.0100321 0.0226435 0.0137545 0.0110304 0.0208998 0.00944428 0.0124002 0.00653833 0.0097773 0.00795215 0.00708457 0.0172465 0.0602936 0.0387051 0.0370914 0.0268193 0.014307 0.0282812 0.0157003 0.0126719 0.02018 0.0311559	DRUG0 : A multidose study of DRUG0 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG1 , resulted in a mean increase in DRUG0 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG2 half-life and AUC were also detected .
4	4	0.00648369 0.00520212 0.00853127 0.0108591 0.0118744 0.00561051 0.00469662 0.00206511 0.00374557 0.00238036 0.00616797 0.00276232 0.0173291 0.00650812 0.0120674 0.00529882 0.00629643 0.00613475 0.00618807 0.0112131 0.0136806 0.0118467 0.0111665 0.0170586 0.0358402 0.0135153 0.0174698 0.0458298 0.0451626 0.0380925 0.0525813 0.0298323 0.0157325 0.0170182 0.0138239 0.026841 0.0233451 0.0127116 0.027625 0.0157357 0.0182845 0.00850146 0.0115483 0.00834602 0.00741675 0.0190758 0.0644731 0.0402389 0.037596 0.0280771 0.0151114 0.0299597 0.0166426 0.0135424 0.0215192 0.0333429	DRUG0 : A multidose study of DRUG0 , given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with DRUG0 , resulted in a mean increase in DRUG1 half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL : similar increases in DRUG2 half-life and AUC were also detected .
1	1	0.0762524 0.0901598 0.030829 0.036895 0.0418912 0.0399302 0.0357735 0.0248904 0.0362887 0.0323505 0.0361364 0.0471503 0.0221333 0.00557855 0.012867 0.0100476 0.00443318 0.0100604 0.00786196 0.0128409 0.008392 0.00737465 0.0067911 0.00282308 0.00182635 0.00258846 0.00202334 0.00446237 0.0112145 0.0170874 0.00715597 0.0201911 0.0389567 0.0225442 0.0351912 0.0457486 0.0143614 0.00670385 0.0211741 0.0153403 0.0169352 0.0358408 0.0409027	When DRUG1 therapy is initiated in a patient already receiving treatment with DRUG2 , the INR or prothrombin time (PT) should be monitored closely and the dose of DRUG0 adjusted as necessary until a stable target INR or PT has been achieved .
4	4	0.0657907 0.0564007 0.0196689 0.019954 0.0184352 0.010246 0.00856424 0.00869933 0.0159677 0.0235051 0.0280254 0.0158378 0.011241 0.0100154 0.0174977 0.0128785 0.00580936 0.0221132 0.0149196 0.0289857 0.0207464 0.0239205 0.0324054 0.0216687 0.0120007 0.0244499 0.0186542 0.0421097 0.0363169 0.0256066 0.00653541 0.0158275 0.0319242 0.0235194 0.0388156 0.0496148 0.0170325 0.00897559 0.0240176 0.0176736 0.0188981 0.0345854 0.0401458	When DRUG1 therapy is initiated in a patient already receiving treatment with DRUG0 , the INR or prothrombin time (PT) should be monitored closely and the dose of DRUG2 adjusted as necessary until a stable target INR or PT has been achieved .
1	1	0.0388842 0.0092731 0.0209668 0.0190478 0.0273767 0.0385025 0.0224363 0.00892354 0.0227042 0.0433286 0.0206146 0.0146584 0.0086437 0.00379664 0.00917024 0.0029547 0.00565281 0.030798 0.0390746 0.0464726 0.0463871 0.0162137 0.0185346 0.0289094 0.0225133 0.0233919 0.0215545 0.0443312 0.0351951 0.0198087 0.0433456 0.095993 0.0358611 0.0464698 0.068211	Furthermore , in patients receiving both drugs , careful monitoring of the INR or PT , and adjustment of the DRUG1 dosage if indicated are recommended when the DRUG2 dose is changed or discontinued .
3	3	0.0424537 0.0463213 0.120883 0.133974 0.0977559 0.0933783 0.110507 0.0873362 0.0962376 0.096645 0.0745082	Oral DRUG0 DRUG1 may inhibit the metabolism of oral DRUG2 .
2	4	0.063361 0.0366623 0.0375657 0.0900888 0.0709272 0.057148 0.0339559 0.0167524 0.0645005 0.0707061 0.0781771 0.0309557 0.0156493 0.0299865 0.0501019 0.0417168 0.0393174 0.059877 0.112551	DRUG1 or DRUG0 In patients with edema , concomitant administration with DRUG2 or DRUG0 may increase the edema .
2	4	0.069977 0.0388099 0.0428422 0.091112 0.0660741 0.0517271 0.0310845 0.0128449 0.0419227 0.052956 0.0472669 0.0202447 0.0185063 0.0614918 0.0655169 0.0518631 0.0513975 0.0602974 0.124065	DRUG1 or DRUG0 In patients with edema , concomitant administration with DRUG0 or DRUG2 may increase the edema .
4	4	0.0289628 0.0294696 0.120841 0.0885954 0.0656917 0.055401 0.040195 0.0178345 0.0625627 0.068065 0.0727804 0.0288735 0.0144892 0.0280565 0.0465533 0.0380568 0.0363196 0.0550185 0.102233	DRUG0 or DRUG1 In patients with edema , concomitant administration with DRUG2 or DRUG0 may increase the edema .
4	4	0.0680299 0.0745341 0.104931 0.0291855 0.0410148 0.0216904 0.00777857 0.00425406 0.00792478 0.00650393 0.0168699 0.00876967 0.0207094 0.0270134 0.020003 0.0135959 0.00695246 0.0196237 0.0241084 0.113292 0.055087 0.0730448 0.136853 0.098231	Use of DRUG1 and DRUG2 -- DRUG0 , DRUG0 , alone or in combination with DRUG0 and DRUG0 , may cause bleeding complications .
4	4	0.0724534 0.0787139 0.0745869 0.0184091 0.03877 0.119817 0.02725 0.00510747 0.00472332 0.00404254 0.010556 0.00660314 0.0157854 0.0204598 0.0157924 0.011428 0.00593818 0.0165942 0.0207904 0.100874 0.0495448 0.0696919 0.122036 0.0900323	Use of DRUG1 and DRUG0 -- DRUG2 , DRUG0 , alone or in combination with DRUG0 and DRUG0 , may cause bleeding complications .
4	4	0.0748803 0.0825219 0.0854141 0.0196344 0.0267076 0.0690066 0.0130436 0.00967426 0.0194658 0.00534389 0.0125659 0.00745759 0.0171347 0.0218475 0.0169908 0.0118082 0.00621117 0.0171066 0.0217978 0.108558 0.0522637 0.0740445 0.131504 0.0950172	Use of DRUG1 and DRUG0 -- DRUG0 , DRUG2 , alone or in combination with DRUG0 and DRUG0 , may cause bleeding complications .
4	4	0.0555915 0.062118 0.0497224 0.00962104 0.0139823 0.0324436 0.00877241 0.00466255 0.010032 0.0119902 0.0596175 0.0426887 0.0752097 0.067796 0.0655488 0.0240536 0.00517983 0.00879004 0.0101167 0.0766875 0.0488847 0.0692112 0.10711 0.0801693	Use of DRUG1 and DRUG0 -- DRUG0 , DRUG0 , alone or in combination with DRUG2 and DRUG0 , may cause bleeding complications .
4	4	0.0670121 0.0660187 0.0438123 0.0312025 0.121559 0.112423 0.0246634 0.00443335 0.00447846 0.00405736 0.0104703 0.00664988 0.0157847 0.0191932 0.0146941 0.0108609 0.00569177 0.0158004 0.0196389 0.0954652 0.0469063 0.065259 0.112104 0.0818209	Use of DRUG0 and DRUG1 -- DRUG2 , DRUG0 , alone or in combination with DRUG0 and DRUG0 , may cause bleeding complications .
4	4	0.0724638 0.0664422 0.0418316 0.0267746 0.0903968 0.0663382 0.0106343 0.00778525 0.0173621 0.00467563 0.0117554 0.00730811 0.0177251 0.0214475 0.0164707 0.0118444 0.00630392 0.0173692 0.0219595 0.109747 0.0535378 0.0754001 0.130433 0.0939941	Use of DRUG0 and DRUG1 -- DRUG0 , DRUG2 , alone or in combination with DRUG0 and DRUG0 , may cause bleeding complications .
4	4	0.0571569 0.0507786 0.0262329 0.0128105 0.0381398 0.0231369 0.00638505 0.0043592 0.00884763 0.011488 0.0494487 0.0333769 0.0732139 0.0723756 0.0390277 0.0179444 0.0199571 0.030943 0.00894137 0.066614 0.0496535 0.0888345 0.119808 0.090526	Use of DRUG0 and DRUG1 -- DRUG0 , DRUG0 , alone or in combination with DRUG0 and DRUG2 , may cause bleeding complications .
4	2	0.0245591 0.0237276 0.0161214 0.00786499 0.0350583 0.0953868 0.0550805 0.0112488 0.01378 0.0141901 0.0580922 0.0447348 0.0786642 0.0625605 0.0566406 0.0207565 0.00468818 0.00798541 0.00917614 0.0723945 0.0463651 0.0678267 0.100029 0.0730682	Use of DRUG0 and DRUG0 -- DRUG1 , DRUG0 , alone or in combination with DRUG2 and DRUG0 , may cause bleeding complications .
4	2	0.0276011 0.0273228 0.0177915 0.00902194 0.0384117 0.104663 0.061458 0.0103793 0.0127282 0.0124848 0.0477588 0.0346681 0.0629836 0.0512226 0.0323924 0.0150244 0.0156967 0.0261456 0.0080323 0.0631326 0.0459356 0.0819081 0.110939 0.082297	Use of DRUG0 and DRUG0 -- DRUG1 , DRUG0 , alone or in combination with DRUG0 and DRUG2 , may cause bleeding complications .
4	2	0.0255446 0.0204715 0.0125124 0.00510046 0.0160058 0.0388934 0.0152632 0.0104271 0.0445409 0.0120025 0.0522096 0.0447551 0.0912597 0.0738352 0.0635408 0.0229931 0.00533865 0.00933175 0.0107111 0.0841204 0.0545272 0.081805 0.11827 0.0865403	Use of DRUG0 and DRUG0 -- DRUG0 , DRUG1 , alone or in combination with DRUG2 and DRUG0 , may cause bleeding complications .
4	2	0.0283021 0.0228439 0.0131698 0.00559169 0.0171811 0.0418778 0.0168086 0.0121872 0.0514537 0.0107077 0.0460337 0.0360542 0.0775691 0.0624055 0.0373674 0.017298 0.017266 0.0301878 0.00957541 0.0734587 0.053192 0.0958066 0.128267 0.0953948	Use of DRUG0 and DRUG0 -- DRUG0 , DRUG1 , alone or in combination with DRUG0 and DRUG2 , may cause bleeding complications .
4	4	0.0162798 0.0119192 0.00893338 0.00385603 0.00946404 0.0188826 0.00714305 0.00376573 0.0103582 0.0113338 0.0359766 0.0221361 0.0537472 0.0720222 0.0613208 0.103939 0.0307595 0.0443185 0.0136283 0.0984747 0.0677759 0.0888259 0.114632 0.0905082	Use of DRUG0 and DRUG0 -- DRUG0 , DRUG0 , alone or in combination with DRUG1 and DRUG2 , may cause bleeding complications .
1	4	0.0342783 0.0359095 0.0267517 0.0415637 0.062161 0.04724 0.0148265 0.0707685 0.018368 0.0272771 0.0412271 0.049245 0.0666735 0.0352923 0.0433029 0.0396144 0.0634977 0.0674661 0.0371318 0.0174589 0.0331153 0.0294119 0.0216502 0.0757686	In the treatment of acute MI , DRUG1 , when not otherwise contraindicated , should be administered with DRUG2 ( see below ) .
4	4	0.0441558 0.0212978 0.070478 0.0503336 0.026846 0.0292292 0.0308487 0.0361539 0.0312929 0.0189092 0.022515 0.0162411 0.0257384 0.0393959 0.0318332 0.0212054 0.011572 0.0391247 0.029607 0.0479739 0.031036 0.0196737 0.0204821 0.0221635 0.0143933 0.0306577 0.0279217 0.0341475 0.0302543 0.0323977 0.00925304 0.0289575 0.0539103	Anticoagulation and DRUG1 After Treatment for Myocardial Infarction -- In the treatment of acute myocardial infarction , the use of DRUG2 has been shown to reduce the incidence of reinfarction and stroke .
2	2	0.0401565 0.02628 0.0382622 0.0344777 0.0557783 0.0492625 0.0990586 0.0352558 0.0461645 0.0479039 0.0396692 0.0473396 0.0255336 0.0102659 0.0134647 0.0154364 0.0188692 0.0171169 0.0205278 0.0121879 0.00374598 0.00848384 0.0149042 0.0250895 0.0414115 0.0164338 0.0290234 0.039906 0.0311433 0.01548 0.0187053 0.031539 0.0311226	The addition of DRUG1 to DRUG2 causes a minimal increase in the risk of minor bleeding (3.9% vs . 3.1%) , but does not appear to increase the incidence of major bleeding (see
4	4	0.0752601 0.0876917 0.0581054 0.0499821 0.0644276 0.0635647 0.0527745 0.0726795 0.0720279 0.0866466 0.101518 0.0440333 0.0135417 0.0323336 0.125413	Patients studied in clinical trials of DRUG1 were routinely treated with DRUG2 and DRUG0 .
4	4	0.0816657 0.0924871 0.0638217 0.0545957 0.0642279 0.0646041 0.0495327 0.0587653 0.0464232 0.0893307 0.0590545 0.0283571 0.0308268 0.0864396 0.129868	Patients studied in clinical trials of DRUG1 were routinely treated with DRUG0 and DRUG2 .
4	4	0.0752529 0.081127 0.0453775 0.0348064 0.0440239 0.0355439 0.0347879 0.0428041 0.076703 0.0924166 0.0804088 0.130159 0.0351531 0.0865256 0.104911	Patients studied in clinical trials of DRUG0 were routinely treated with DRUG1 and DRUG2 .
4	4	0.0697871 0.0383944 0.0212176 0.026937 0.00492422 0.00655717 0.00663301 0.00639145 0.0107859 0.00569846 0.0131132 0.00705372 0.00708836 0.00424392 0.00339861 0.00494353 0.00379643 0.00833913 0.00647632 0.010054 0.0558998 0.0568024 0.0454164 0.051424 0.0411331 0.0553117 0.0289982 0.0107685 0.0144252 0.0193082 0.0229512 0.0373519 0.00974062 0.00466574 0.00795673 0.00390047 0.00988549 0.0442201 0.0472546 0.0535153 0.113237	DRUG1 (such as DRUG2 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.079867 0.0321956 0.0190058 0.0200344 0.0210748 0.0338053 0.0107349 0.00756315 0.0121561 0.00617679 0.014389 0.00738938 0.00715681 0.00411917 0.00326531 0.00473206 0.003614 0.00801712 0.00622219 0.00977332 0.0553507 0.0553342 0.0440109 0.0476871 0.0380567 0.0510582 0.0266923 0.0099595 0.0133131 0.0178492 0.0211292 0.0345017 0.00901764 0.00433733 0.0074004 0.00363206 0.00920604 0.0410921 0.0439003 0.049706 0.105473	DRUG1 (such as DRUG0 and DRUG2 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.0535547 0.0185459 0.0116505 0.0113123 0.011126 0.0127165 0.0300079 0.0177197 0.029281 0.0214577 0.0413558 0.0191704 0.0245592 0.0140123 0.0113612 0.0162055 0.0037071 0.00572724 0.00516718 0.00741028 0.04065 0.0480715 0.0390868 0.0508509 0.039681 0.0506934 0.0247346 0.00902952 0.0124087 0.0166174 0.0198622 0.0316942 0.0082466 0.00394397 0.00672823 0.00331288 0.00838738 0.0374485 0.0400598 0.0453495 0.0970949	DRUG1 (such as DRUG0 and DRUG0 ) and drugs that alter platelet function (such as DRUG2 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.0545213 0.0188229 0.011769 0.0113998 0.0113305 0.0130106 0.0307952 0.0184962 0.0305048 0.0220887 0.0374938 0.0152665 0.014333 0.00727741 0.00475314 0.00651366 0.00711717 0.0191754 0.00432159 0.00675314 0.0383569 0.0487908 0.0402152 0.0541431 0.0425852 0.0551437 0.0259931 0.00932966 0.012693 0.0169527 0.0203181 0.0324593 0.00844922 0.00404499 0.00689338 0.00340269 0.00861274 0.0383785 0.0410784 0.0464886 0.0999269	DRUG1 (such as DRUG0 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG2 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
2	2	0.0408817 0.0112256 0.00706406 0.00665985 0.00572154 0.00707772 0.0141081 0.00877739 0.010369 0.0059174 0.0111234 0.00613059 0.00611894 0.00378454 0.00306428 0.00415182 0.00347918 0.00716637 0.00621809 0.00937485 0.0542693 0.052082 0.0435666 0.0491772 0.038972 0.0586155 0.0282832 0.0171279 0.0243787 0.0284766 0.0237451 0.0385629 0.0234814 0.0109091 0.0244345 0.0121447 0.026072 0.0846427 0.0507164 0.0439777 0.08795	DRUG1 (such as DRUG0 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG2 therapy .
4	4	0.0453686 0.0418514 0.0290712 0.112243 0.0201633 0.0289404 0.00921861 0.00681479 0.0111601 0.00532247 0.0116888 0.0062346 0.0062878 0.00368865 0.00293021 0.0042665 0.00325192 0.00725255 0.00561936 0.00892875 0.0498775 0.0504523 0.040055 0.0430047 0.0343767 0.0462332 0.0244818 0.00913487 0.0122708 0.0164225 0.0193542 0.0316724 0.00828497 0.00399416 0.00681655 0.00335028 0.00849219 0.0378491 0.0404271 0.0457702 0.0973764	DRUG0 (such as DRUG1 and DRUG2 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.0339945 0.0305794 0.0230199 0.0712158 0.0126051 0.011574 0.024112 0.0140523 0.0243734 0.016892 0.03524 0.0165494 0.0222762 0.0133818 0.0102996 0.0146155 0.003356 0.0053698 0.00482082 0.00702534 0.0386591 0.0457435 0.0370523 0.0479681 0.0375632 0.048242 0.0235503 0.00861901 0.0118733 0.0159117 0.0190072 0.0303397 0.00789817 0.00377895 0.00644815 0.00317466 0.0080382 0.035887 0.038386 0.043455 0.0930516	DRUG0 (such as DRUG1 and DRUG0 ) and drugs that alter platelet function (such as DRUG2 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.0348228 0.0313697 0.0236322 0.0727528 0.0126515 0.0116312 0.0243383 0.014589 0.0251242 0.0171429 0.0317724 0.0130465 0.0128445 0.00693286 0.00441848 0.00590477 0.00663617 0.0178083 0.00398298 0.00640468 0.0363593 0.0463009 0.0378218 0.0508219 0.0399945 0.0522613 0.0246769 0.00887573 0.0121103 0.0161889 0.019415 0.0310325 0.00808285 0.00387168 0.00659938 0.00325789 0.00824707 0.0367422 0.0393252 0.0445045 0.0957039	DRUG0 (such as DRUG1 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG2 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
2	2	0.0260276 0.0202735 0.0156401 0.0471419 0.00787759 0.00697754 0.012103 0.00754036 0.00917744 0.0050892 0.0092881 0.00532133 0.00540657 0.00344062 0.00275947 0.00372778 0.00319098 0.00657137 0.00583588 0.00882783 0.0511781 0.0495732 0.0417473 0.0474499 0.0373711 0.0571221 0.0272648 0.01661 0.0234861 0.0273494 0.0227598 0.0369569 0.022542 0.0104692 0.0234325 0.0116402 0.0249748 0.0810224 0.0485517 0.0420922 0.0841881	DRUG0 (such as DRUG1 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG2 therapy .
4	4	0.02033 0.0121859 0.00782272 0.016299 0.0177115 0.0787973 0.0317622 0.0168758 0.0283638 0.0200444 0.0429579 0.016762 0.0221018 0.0123478 0.010264 0.0144627 0.00328729 0.00527158 0.00471967 0.0069294 0.0380183 0.0453665 0.0365965 0.047687 0.0375202 0.0485322 0.0238424 0.00871018 0.0120655 0.0161873 0.0193641 0.0309632 0.0080643 0.00386378 0.00659586 0.0032509 0.00823243 0.0367222 0.0392772 0.0444655 0.0953778	DRUG0 (such as DRUG0 and DRUG1 ) and drugs that alter platelet function (such as DRUG2 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
4	4	0.0207414 0.0124741 0.00798735 0.0166007 0.0181394 0.080691 0.0323998 0.0176205 0.0293693 0.0205684 0.0385803 0.0130609 0.0126183 0.00629141 0.00397751 0.00573715 0.00634964 0.0173945 0.00388372 0.00637691 0.03616 0.0462824 0.0376754 0.0505928 0.0399126 0.0525102 0.0249549 0.00896713 0.0123024 0.0164619 0.0197751 0.0316497 0.00824731 0.00395461 0.00674388 0.00333159 0.00843477 0.0375595 0.0401982 0.0454951 0.0979281	DRUG0 (such as DRUG0 and DRUG1 ) and drugs that alter platelet function (such as DRUG0 , DRUG2 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG0 therapy .
2	2	0.0168379 0.00938514 0.00583218 0.0120072 0.0111753 0.0479752 0.0159298 0.00843398 0.00977116 0.00512814 0.010517 0.00548687 0.0056239 0.00340943 0.00272007 0.00375695 0.00312733 0.00662325 0.00566282 0.00877174 0.0506766 0.049849 0.0416843 0.0460425 0.037314 0.0558423 0.0275837 0.016559 0.0239347 0.0281123 0.023492 0.0382553 0.0232415 0.0108304 0.0242555 0.0120736 0.0259412 0.0842061 0.0504892 0.0437963 0.0876449	DRUG0 (such as DRUG0 and DRUG1 ) and drugs that alter platelet function (such as DRUG0 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG2 therapy .
2	2	0.010856 0.00554098 0.00264697 0.00496514 0.00343108 0.00817069 0.0116267 0.0115464 0.0251267 0.014973 0.0285347 0.0131384 0.0175463 0.0101125 0.00877068 0.0275392 0.00549132 0.00754006 0.00886282 0.00973728 0.0379351 0.0340249 0.0306942 0.0535832 0.0380512 0.0632714 0.0245696 0.0182001 0.02405 0.0257454 0.022529 0.0374019 0.0246251 0.011174 0.0249664 0.0121309 0.0253263 0.0825517 0.0486547 0.0418861 0.0824716	DRUG0 (such as DRUG0 and DRUG0 ) and drugs that alter platelet function (such as DRUG1 , DRUG0 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG2 therapy .
2	2	0.0108019 0.00555908 0.00260571 0.00489286 0.00337769 0.00809567 0.0114309 0.0114133 0.0232596 0.0121547 0.0211056 0.00952867 0.0109537 0.00624333 0.00469193 0.00895552 0.00857498 0.0468102 0.00828738 0.00942313 0.0392261 0.0373255 0.0338137 0.0565212 0.0403974 0.0664245 0.0252857 0.0182155 0.0239298 0.0256699 0.0222094 0.0366963 0.0238771 0.0108218 0.0241775 0.0117765 0.0247152 0.080653 0.0477555 0.0411226 0.0812198	DRUG0 (such as DRUG0 and DRUG0 ) and drugs that alter platelet function (such as DRUG0 , DRUG1 , and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to , during , or after DRUG2 therapy .
4	4	0.0888261 0.0629359 0.0550182 0.0247343 0.0629637 0.021214 0.0227135 0.0183105 0.00974289 0.0210681 0.0125808 0.0134741 0.00854929 0.0056125 0.0175597 0.0273393 0.0172456 0.0153625 0.0357255 0.0273024 0.0269737 0.0287038 0.0377985 0.0327699 0.0776481 0.07172 0.0698547 0.0862523	Usage with DRUG1 : Due to the potential for increased CNS depressants effects , DRUG0 should be used with caution in patients who are currently receiving DRUG2 .
2	1	0.0207772 0.0135595 0.00884901 0.0143497 0.042932 0.0210219 0.03142 0.0293277 0.0234174 0.0618064 0.0529373 0.0979868 0.0663297 0.0218204 0.0928132 0.0176244 0.0193305 0.0192324 0.0226258 0.0183926 0.0232247 0.022217 0.0265053 0.0211457 0.0472526 0.0549807 0.0514734 0.0566467	Usage with DRUG0 : Due to the potential for increased CNS depressants effects , DRUG1 should be used with caution in patients who are currently receiving DRUG2 .
3	3	0.0609158 0.0600762 0.0768721 0.167371 0.0620886 0.0919251 0.101948 0.0816176 0.0481587 0.0607 0.0758722 0.112455	Administration of DRUG1 decreases oral clearance of DRUG2 by about 5% .
2	1	0.152248 0.0263844 0.0312194 0.0269089 0.0308841 0.021399 0.0195619 0.0170576 0.0153911 0.00603866 0.0135145 0.0165069 0.0423828 0.159993 0.0530135 0.0767636 0.0654173 0.0390436 0.0111392 0.0111336 0.0217006 0.00440668 0.00517289 0.00479227 0.00927751 0.0264884 0.0921605	DRUG1 should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUG2 , DRUG0 , or DRUG0 .
2	1	0.155842 0.0268262 0.0317372 0.0273027 0.0314582 0.0219279 0.0201218 0.0176019 0.015795 0.00623757 0.013991 0.0173973 0.0449583 0.169776 0.0564641 0.0794236 0.0602509 0.0302214 0.00741531 0.00435229 0.00570813 0.00604606 0.0180738 0.00495317 0.00963044 0.0250919 0.0913965	DRUG1 should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUG0 , DRUG2 , or DRUG0 .
2	1	0.156741 0.0270093 0.0320244 0.0275814 0.0316318 0.0219288 0.0199148 0.0173734 0.0155568 0.0061314 0.013736 0.0168706 0.0433365 0.166209 0.0547961 0.072575 0.0546274 0.0265589 0.00694634 0.00396097 0.00397565 0.00291937 0.00470364 0.00728045 0.0182309 0.0511978 0.0961822	DRUG1 should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUG0 , DRUG0 , or DRUG2 .
4	4	0.058136 0.0276861 0.0391012 0.137754 0.0319443 0.052249 0.128947 0.0646947 0.0205504 0.0121987 0.0178621 0.0125652 0.0214119 0.0797135 0.295186	e.g. , other DRUG1 , DRUG0 (including DRUG2 ) , DRUG0 , and DRUG0 .
4	4	0.0621912 0.0321714 0.0457117 0.158753 0.035371 0.0438411 0.113754 0.0292343 0.0253188 0.0244792 0.0556647 0.0151707 0.0191368 0.0647706 0.274431	e.g. , other DRUG1 , DRUG0 (including DRUG0 ) , DRUG2 , and DRUG0 .
4	4	0.0501551 0.0256551 0.0361641 0.125459 0.029433 0.0322486 0.0890279 0.0238582 0.0219577 0.018134 0.0199156 0.0276075 0.0488532 0.172527 0.279005	e.g. , other DRUG1 , DRUG0 (including DRUG0 ) , DRUG0 , and DRUG2 .
4	4	0.0463684 0.0206415 0.0224879 0.0320221 0.0354225 0.179004 0.104453 0.0691312 0.0216822 0.0129058 0.0194174 0.0136858 0.0233826 0.0855094 0.313886	e.g. , other DRUG0 , DRUG1 (including DRUG2 ) , DRUG0 , and DRUG0 .
4	4	0.0453773 0.0203315 0.0239491 0.0317106 0.0417761 0.196449 0.100244 0.0313273 0.0254495 0.0253423 0.0609602 0.0159521 0.0200964 0.0691148 0.291919	e.g. , other DRUG0 , DRUG1 (including DRUG0 ) , DRUG2 , and DRUG0 .
4	4	0.03688 0.0162297 0.0185042 0.0234613 0.034387 0.158096 0.0762915 0.023293 0.0191912 0.0150617 0.0200139 0.0260635 0.0510955 0.179339 0.302092	e.g. , other DRUG0 , DRUG1 (including DRUG0 ) , DRUG0 , and DRUG2 .
4	4	0.0243542 0.00952642 0.00845043 0.0102468 0.00938248 0.0317737 0.0444911 0.0274007 0.0275906 0.0290705 0.181366 0.0497576 0.0614252 0.195949 0.289215	e.g. , other DRUG0 , DRUG0 (including DRUG0 ) , DRUG1 , and DRUG2 .
4	3	0.0578574 0.0855258 0.0541385 0.0763883 0.0536955 0.123106 0.12557 0.0941666 0.0299979 0.0071367 0.0085657 0.00687586 0.00420422 0.0127112 0.0113985 0.0094785 0.0063456 0.00775231 0.0100819 0.00415654 0.00182528 0.00226669 0.00809082 0.00425327 0.00327309 0.00324438 0.00203377 0.00168248 0.00288952 0.00359036 0.0060096 0.00325787 0.0102137 0.0101177 0.0142923 0.0328701 0.0239989 0.0296982 0.0472392	The bioavailability of DRUG1 is decreased 80% by DRUG2 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0539238 0.0835379 0.0572328 0.0811055 0.0402998 0.108515 0.063577 0.0352251 0.0193359 0.0265602 0.102088 0.0396044 0.00705652 0.0120888 0.01171 0.0107976 0.00785883 0.00974761 0.0120682 0.00474319 0.00197501 0.00242843 0.00838375 0.0043704 0.00337563 0.00336149 0.00211149 0.00174245 0.00299041 0.0037272 0.00612628 0.0033328 0.0102908 0.0102243 0.014432 0.0330289 0.0241949 0.0296696 0.0471585	The bioavailability of DRUG1 is decreased 80% by DRUG0 , when DRUG2 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0584301 0.0846181 0.0590865 0.0652837 0.0226689 0.0479024 0.0266727 0.0127516 0.0101481 0.00431817 0.0159121 0.0131923 0.00759113 0.0289516 0.0319944 0.0271704 0.0185317 0.0268416 0.028503 0.0147026 0.00605685 0.0115151 0.0573651 0.0245659 0.0222958 0.0157163 0.00483023 0.00372387 0.00416784 0.00471125 0.00746684 0.00422201 0.0133781 0.0138874 0.0215254 0.0470707 0.0335418 0.0379369 0.0607516	The bioavailability of DRUG1 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG2 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0586078 0.0850904 0.0594942 0.0664383 0.0234552 0.0497638 0.0277464 0.0131199 0.010273 0.00438419 0.0163656 0.0134489 0.00779913 0.0297832 0.0331928 0.0280824 0.0189925 0.027384 0.0291085 0.0146496 0.00582951 0.00957208 0.0368558 0.0160802 0.00716601 0.00607753 0.00661301 0.00545776 0.0112774 0.00504697 0.006971 0.00446812 0.0166812 0.0167679 0.0272294 0.0534737 0.0398732 0.0416561 0.0657234	The bioavailability of DRUG1 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG2 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0564788 0.0818939 0.0571995 0.063217 0.0218833 0.045938 0.025376 0.0120602 0.00968024 0.00412329 0.0150851 0.0125966 0.00726116 0.0276865 0.0306521 0.0257753 0.0175436 0.0253507 0.0268177 0.0138451 0.00550744 0.00875339 0.0302391 0.011282 0.00503591 0.00415975 0.00275817 0.00267469 0.00728131 0.0232631 0.01726 0.0040182 0.0174536 0.0198216 0.0377026 0.0649959 0.0481811 0.04119 0.067958	The bioavailability of DRUG1 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	4	0.0384523 0.0520974 0.0345139 0.0396774 0.0533575 0.103829 0.102419 0.0706441 0.0817142 0.0172598 0.0361354 0.0210377 0.0266695 0.0399057 0.0223559 0.0191879 0.0127377 0.0147887 0.0162115 0.00512297 0.0019537 0.00241322 0.00810345 0.00426986 0.00313035 0.00310691 0.00198669 0.00165126 0.00275421 0.00338757 0.0055837 0.00299249 0.00925667 0.00903125 0.0126838 0.0289485 0.0215662 0.0263363 0.042726	The bioavailability of DRUG0 is decreased 80% by DRUG1 , when DRUG0 and DRUG2 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0331126 0.0445623 0.0266952 0.0302301 0.0409584 0.0933432 0.0941048 0.0625495 0.059304 0.00896978 0.028112 0.0107489 0.00915673 0.0230078 0.0311656 0.0178657 0.0129947 0.0242915 0.0331719 0.0148803 0.00584818 0.0104042 0.0494996 0.022792 0.017489 0.0111785 0.00374159 0.00291609 0.00317356 0.00359043 0.00548976 0.00302889 0.00959221 0.00972643 0.0149536 0.0327051 0.0239464 0.0269022 0.0437972	The bioavailability of DRUG0 is decreased 80% by DRUG1 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG2 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0329727 0.044359 0.0266765 0.0302335 0.0410781 0.0934629 0.0944828 0.0631386 0.0601019 0.00918418 0.0289051 0.0109652 0.00934367 0.0237191 0.0321906 0.0183873 0.0132602 0.0245955 0.0338299 0.0150294 0.00562548 0.00888837 0.0339253 0.0154807 0.00633032 0.00453222 0.00495109 0.00431787 0.00842905 0.00394012 0.00500363 0.00328428 0.0124061 0.0122242 0.0194629 0.0376709 0.0293434 0.0301757 0.0480921	The bioavailability of DRUG0 is decreased 80% by DRUG1 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG2 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0320601 0.0431466 0.0258765 0.0293089 0.0397428 0.0905062 0.0913547 0.060801 0.0575685 0.00857828 0.0269697 0.0103495 0.0088088 0.0220941 0.0305715 0.0173225 0.0124261 0.0229166 0.0315064 0.014325 0.00519335 0.00789532 0.0284571 0.0110935 0.00442264 0.00315964 0.0022466 0.0023 0.00594697 0.018084 0.01335 0.003196 0.0136258 0.0147681 0.0268885 0.0462537 0.0361342 0.0302776 0.0504731	The bioavailability of DRUG0 is decreased 80% by DRUG1 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	4	0.0342907 0.0462696 0.0272656 0.0308382 0.0412237 0.0939784 0.0938502 0.060984 0.0562205 0.00758282 0.0223976 0.00856647 0.00698314 0.0156659 0.0212763 0.0119856 0.00818501 0.0134547 0.016218 0.0058395 0.00204453 0.00290394 0.0106512 0.00524622 0.00364368 0.00367806 0.00238878 0.00186887 0.00352273 0.00472258 0.0091961 0.00978121 0.0355602 0.0275434 0.0319541 0.0529426 0.0628361 0.0513752 0.0550646	The bioavailability of DRUG0 is decreased 80% by DRUG1 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG2 .
3	4	0.0425024 0.052448 0.0276803 0.0222037 0.0210906 0.045526 0.0396391 0.027093 0.0279509 0.0412024 0.0688196 0.12019 0.0466477 0.0544036 0.0300752 0.0231312 0.0171488 0.0217733 0.0226804 0.00715502 0.0026036 0.00315043 0.0103277 0.00537802 0.00390805 0.00386581 0.00251427 0.00211658 0.00344402 0.00425779 0.00696019 0.00370476 0.0114991 0.0111277 0.0157227 0.035702 0.0271181 0.0329108 0.0543273	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG1 and DRUG2 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0293726 0.0387343 0.0177491 0.0173081 0.0164591 0.0380283 0.0301985 0.0191479 0.0227587 0.0252301 0.105953 0.115274 0.0205183 0.0329134 0.036999 0.0211732 0.0154491 0.0289563 0.0359567 0.0171498 0.00665988 0.0115993 0.0532348 0.0239975 0.0185071 0.0115035 0.00381661 0.00295334 0.00327797 0.00368016 0.00572426 0.00316661 0.0101066 0.0100894 0.0154254 0.0337415 0.0246039 0.0276235 0.0449592	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG1 and DRUG0 are administered at the same time , and 60% by some DRUG2 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0293774 0.0387363 0.0177797 0.0173128 0.0164735 0.0380745 0.0302563 0.0192372 0.0228044 0.0254767 0.106478 0.11631 0.0209219 0.0334572 0.0382806 0.0219527 0.0159229 0.0294421 0.0370008 0.0175211 0.00650374 0.0101177 0.0369608 0.0165302 0.00683414 0.00469311 0.00517799 0.00448433 0.00871178 0.00403447 0.0052402 0.00343446 0.0130344 0.0125927 0.0199322 0.0386938 0.0300176 0.0309005 0.0492898	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG1 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG2 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0285109 0.037569 0.0172259 0.0167708 0.015951 0.036839 0.0292722 0.0185766 0.0220571 0.0245764 0.102945 0.111972 0.0198584 0.0316755 0.0363107 0.0206175 0.0148336 0.027225 0.034331 0.0166403 0.00595389 0.00892754 0.0308191 0.0118002 0.00475726 0.00326439 0.00234095 0.00240137 0.00621441 0.0188166 0.0136836 0.00329325 0.0142594 0.015209 0.027639 0.047426 0.0368419 0.0309479 0.0516463	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG1 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	4	0.0305828 0.0401498 0.0183491 0.0177931 0.0168829 0.0386194 0.0309128 0.019704 0.0234555 0.0255125 0.106374 0.109018 0.0163666 0.0274555 0.0270204 0.0144076 0.00960706 0.0162596 0.0175964 0.00653781 0.0022139 0.00314271 0.0112097 0.00548074 0.00380544 0.00379364 0.00246936 0.00193535 0.00364479 0.00486168 0.00960132 0.0102333 0.0370661 0.0280028 0.0326091 0.0541429 0.0641562 0.0526122 0.0564146	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG1 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG2 .
4	4	0.0362407 0.0485345 0.0208107 0.0196632 0.0185266 0.0411961 0.0340556 0.0144406 0.014292 0.00783067 0.0408882 0.034949 0.0325916 0.0708225 0.0431257 0.0233525 0.0174361 0.0297756 0.0417547 0.0195528 0.00766683 0.0133861 0.0621124 0.0297078 0.0225398 0.0142925 0.00484516 0.00380364 0.00404073 0.00458424 0.0070727 0.00386106 0.0123528 0.0125892 0.0193434 0.0427222 0.0316248 0.0356375 0.0579776	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG1 are administered at the same time , and 60% by some DRUG2 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0359105 0.0481168 0.0206472 0.0195084 0.0183929 0.040956 0.0339331 0.0144229 0.0142673 0.00781866 0.041018 0.0351044 0.0331032 0.0723127 0.0440171 0.0237172 0.0175464 0.0299538 0.0423045 0.0199344 0.00745175 0.0115199 0.0435007 0.020557 0.00825482 0.00578511 0.00633246 0.00550029 0.0107474 0.00508246 0.00640012 0.00421287 0.0160891 0.0160953 0.0256086 0.0500901 0.0392597 0.0403283 0.0641988	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG1 are administered at the same time , and 60% by some DRUG0 - or DRUG2 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0343474 0.0459813 0.0197419 0.0186465 0.0175824 0.0391154 0.0323829 0.0137586 0.0136168 0.00747693 0.038982 0.0331674 0.0311162 0.0683592 0.0414326 0.0221544 0.0163111 0.0274831 0.0388104 0.0186697 0.00671819 0.00995308 0.0359508 0.0145596 0.00561918 0.0039456 0.00280188 0.0028816 0.00758306 0.0235872 0.0171775 0.00408664 0.0173755 0.0190677 0.0347817 0.0609292 0.0477455 0.0398276 0.066272	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG1 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	4	0.0371238 0.0478415 0.0183812 0.0190862 0.0155757 0.0328647 0.0225121 0.00790822 0.00872631 0.00388617 0.0126171 0.0107291 0.00617119 0.0236949 0.026224 0.023028 0.0173272 0.0241783 0.0243038 0.0133869 0.00601216 0.0111372 0.0511708 0.0261817 0.0242975 0.0450256 0.0154998 0.0128967 0.0185983 0.00919067 0.00852344 0.00670083 0.0253866 0.0274089 0.0461017 0.0787209 0.0563091 0.0522701 0.0830017	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG1 - or DRUG2 -containing DRUG0 , when administered 1 hour before DRUG0 .
4	4	0.0342537 0.044365 0.0168818 0.0175605 0.0143245 0.0303667 0.020807 0.00729021 0.00808534 0.00359666 0.0116812 0.0100166 0.00575448 0.0223649 0.0250295 0.0221624 0.0165817 0.0232171 0.0231813 0.012916 0.0059034 0.0116155 0.0498264 0.0260562 0.0225555 0.036035 0.00951207 0.00876556 0.0100381 0.0388884 0.0244039 0.00593562 0.0234582 0.0271774 0.0511933 0.0869972 0.062591 0.0483583 0.0802522	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG1 - or DRUG0 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	3	0.0332989 0.0431033 0.0162637 0.0169686 0.0137765 0.0291729 0.0200026 0.00703736 0.00790639 0.00348166 0.0110253 0.00947214 0.00543079 0.020183 0.0216606 0.0189237 0.0145669 0.0200932 0.0198925 0.0112645 0.00499469 0.00808104 0.0340953 0.0156421 0.0180623 0.0256934 0.00637369 0.00540201 0.00525479 0.0101089 0.0148737 0.014662 0.068096 0.0480938 0.0457252 0.0745553 0.0993047 0.0822885 0.0751681	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG1 - or DRUG0 -containing DRUG0 , when administered 1 hour before DRUG2 .
4	4	0.0333541 0.0434535 0.0164806 0.0170304 0.0139669 0.0299409 0.0207249 0.00723107 0.00801353 0.00355335 0.0114088 0.00967837 0.00546512 0.0210465 0.0231393 0.0204852 0.0155677 0.022719 0.0230708 0.0135125 0.00624903 0.0118895 0.0445058 0.0199522 0.014974 0.0138161 0.0132449 0.0143695 0.0455943 0.0502079 0.0203158 0.00550988 0.0218562 0.0262092 0.0505332 0.0869214 0.0631161 0.0488503 0.0820423	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG1 -containing DRUG2 , when administered 1 hour before DRUG0 .
4	3	0.0365616 0.0473141 0.0179621 0.0184393 0.0151944 0.0324209 0.0224143 0.00784608 0.00865007 0.00383853 0.0122131 0.0102657 0.00585325 0.0216928 0.0236055 0.0205889 0.0156399 0.0217336 0.0218119 0.0122571 0.00526417 0.00794792 0.0289898 0.0133719 0.00955443 0.0114371 0.0101801 0.011687 0.0363233 0.0322084 0.0163609 0.0191683 0.0600393 0.0357896 0.0369206 0.0570011 0.0828422 0.0793128 0.0692981	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG1 -containing DRUG0 , when administered 1 hour before DRUG2 .
4	4	0.0315137 0.040574 0.0152464 0.0158293 0.0127898 0.0270113 0.01888 0.00663366 0.00755507 0.00329966 0.0101418 0.00867293 0.00480389 0.0173178 0.0172472 0.01486 0.0114864 0.0156708 0.0154542 0.00896626 0.00386235 0.00609933 0.0218386 0.0102797 0.0101902 0.0102083 0.00887888 0.0108611 0.034922 0.0800997 0.13259 0.031097 0.0421364 0.0249401 0.0328139 0.0443326 0.0630236 0.0680588 0.0598127	The bioavailability of DRUG0 is decreased 80% by DRUG0 , when DRUG0 and DRUG0 are administered at the same time , and 60% by some DRUG0 - or DRUG0 -containing DRUG1 , when administered 1 hour before DRUG2 .
3	3	0.106434 0.105224 0.0824244 0.0723058 0.0781254 0.0554498 0.0281738 0.0327138 0.0163978 0.0329826 0.0239656 0.0526162 0.0406532 0.0518012 0.0616897 0.0595974 0.0994443	DRUG1 may decrease bioavailability of DRUG2 by up to 50% when taken 2 hours after DRUG0 .
4	4	0.113213 0.0687586 0.052075 0.0497359 0.0439794 0.0388227 0.0376764 0.0526894 0.0333567 0.0642898 0.0321294 0.0537875 0.0474398 0.0680651 0.0901763 0.0757508 0.078054	DRUG1 may decrease bioavailability of DRUG0 by up to 50% when taken 2 hours after DRUG2 .
4	3	0.0548957 0.07635 0.048106 0.0678792 0.0400173 0.118094 0.0577814 0.0832679 0.0854108 0.0335926 0.0158453 0.0205624 0.0293114 0.0496618 0.0433543 0.0203739 0.0280969 0.0335294 0.0285675 0.0653024	The bioavailability of DRUG1 is increased 2-4 fold by DRUG2 but is not significantly altered by coadministration of DRUG0 .
4	4	0.0523784 0.0737217 0.0500943 0.0522973 0.0165038 0.038964 0.0157504 0.0168637 0.0100412 0.0124063 0.0131285 0.0301392 0.0494403 0.101127 0.110997 0.0646881 0.0554863 0.0807286 0.0794794 0.0757649	The bioavailability of DRUG1 is increased 2-4 fold by DRUG0 but is not significantly altered by coadministration of DRUG2 .
4	4	0.032157 0.0436671 0.0216088 0.0285417 0.0381131 0.0754005 0.0519376 0.0798 0.0557759 0.0569851 0.0165729 0.0160328 0.0232386 0.0637169 0.0642244 0.0669733 0.0518316 0.0827452 0.0719436 0.0587337	The bioavailability of DRUG0 is increased 2-4 fold by DRUG1 but is not significantly altered by coadministration of DRUG2 .
4	4	0.0480544 0.0386628 0.0412011 0.0406358 0.0425521 0.0194413 0.0342186 0.110419 0.135837 0.169519 0.107563 0.0828106 0.129085	The pharmacokinetic parameters of DRUG1 are not significantly modified by DRUG2 coadministration .
4	4	0.0329869 0.0252551 0.0472228 0.0839549 0.045035 0.0527602 0.0374712 0.0554913 0.120838 0.0695884 0.055112 0.0670099 0.105212 0.0702319 0.0349492 0.0375892 0.0592919	In vitro studies show that DRUG1 does not displace DRUG2 from its binding site on protein .
2	4	0.0368549 0.0218461 0.0190959 0.029563 0.0522157 0.0519751 0.0585644 0.0442825 0.0373055 0.029891 0.0522866 0.072233 0.0851227 0.1498 0.0967746 0.0825098 0.0796792	In vitro activity of DRUG1 combined with DRUG2 against clinical isolates of DRUG0 -resistant Staphylococcus aureus .
4	4	0.0214623 0.012141 0.0135043 0.0255189 0.0370742 0.0376707 0.0283331 0.0389709 0.0671759 0.0484323 0.10584 0.112562 0.0948295 0.0982632 0.0985363 0.0836255 0.0760599	In vitro activity of DRUG1 combined with DRUG0 against clinical isolates of DRUG2 -resistant Staphylococcus aureus .
4	4	0.0122325 0.00761869 0.00662541 0.01361 0.0327598 0.069191 0.0854202 0.0963532 0.0552986 0.0416389 0.0663612 0.0980551 0.0897479 0.0886939 0.0887034 0.0774844 0.0702058	In vitro activity of DRUG0 combined with DRUG1 against clinical isolates of DRUG2 -resistant Staphylococcus aureus .
2	4	0.0220902 0.0223513 0.0364646 0.0249824 0.0404305 0.0283112 0.0209906 0.0154578 0.0167217 0.025713 0.0456559 0.0493023 0.0541817 0.0380615 0.0282752 0.0427185 0.0573215 0.0748185 0.116675 0.0711808 0.0627179 0.0453331 0.0602451	This study aimed to evaluate the in vitro activity of DRUG1 combined with DRUG2 against isolates of DRUG0 -resistant Staphylococcus aureus (MRSA) .
4	4	0.0147293 0.0154548 0.0274806 0.0214169 0.0368124 0.0190638 0.0107389 0.00874633 0.0120229 0.0232873 0.0319214 0.0362574 0.0277742 0.0370711 0.0635495 0.0973884 0.109735 0.0868238 0.0770866 0.077901 0.0710888 0.0431013 0.0505485	This study aimed to evaluate the in vitro activity of DRUG1 combined with DRUG0 against isolates of DRUG2 -resistant Staphylococcus aureus (MRSA) .
4	4	0.0104923 0.0110778 0.0187767 0.0109137 0.020651 0.0104716 0.00513288 0.00468942 0.00609772 0.0139573 0.0296381 0.0602322 0.0647971 0.0816732 0.0662683 0.0702647 0.112613 0.094356 0.0760372 0.0723266 0.0679327 0.0418911 0.0497094	This study aimed to evaluate the in vitro activity of DRUG0 combined with DRUG1 against isolates of DRUG2 -resistant Staphylococcus aureus (MRSA) .
4	4	0.064945 0.107787 0.118393 0.122278 0.140079 0.0264348 0.0546207 0.0720288 0.0828005 0.0317395 0.0117077 0.0155673 0.0162869 0.0453711 0.0283541 0.0616079	The susceptibility results for DRUG1 and DRUG2 were interpreted according to the most relevant criteria .
2	2	0.0677439 0.0614197 0.0632382 0.0890774 0.0335608 0.0756927 0.109058 0.0821557 0.178479 0.0883706 0.0694141 0.0817901	The combination of DRUG1 and DRUG2 can be synergistic against MRSA .
4	4	0.114697 0.0756263 0.027626 0.0677438 0.0235245 0.0552377 0.0710088 0.0744815 0.0702227 0.0517408 0.0368852 0.0509087 0.0173618 0.0125003 0.0114991 0.0100671 0.00440698 0.00678627 0.00396915 0.00277328 0.00395561 0.00290334 0.00488803 0.00366191 0.00731252 0.00474395 0.00977519 0.0400868 0.133606	Use with Other DRUG1 : The depressant effects of DRUG2 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0887371 0.0602089 0.0226431 0.0530425 0.0165445 0.0397255 0.0340501 0.0294215 0.0320541 0.0485168 0.0627887 0.097982 0.0525076 0.050859 0.0426044 0.0272295 0.0142363 0.0239913 0.00757677 0.00412229 0.00432733 0.00334654 0.0046136 0.00365011 0.00626519 0.00495824 0.00967502 0.0352333 0.119089	Use with Other DRUG1 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG2 such as DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0955153 0.0650234 0.0246895 0.058405 0.0176281 0.0423748 0.0362564 0.0311743 0.0335356 0.0507184 0.0659096 0.100523 0.0518184 0.0474931 0.0328427 0.0194032 0.0059755 0.00765867 0.00617042 0.00771007 0.0161174 0.00324398 0.00414501 0.00327971 0.0054757 0.00451577 0.00870433 0.030851 0.122842	Use with Other DRUG1 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG0 such as DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
4	4	0.0950304 0.0647541 0.0245524 0.0580274 0.0175841 0.0422217 0.036149 0.0310717 0.0333853 0.0507508 0.0662831 0.101694 0.0528721 0.0488545 0.0335175 0.0188381 0.00560931 0.00687394 0.00426193 0.00277444 0.00502729 0.0057219 0.0163646 0.0036308 0.00562867 0.00482008 0.00935765 0.0304085 0.123935	Use with Other DRUG1 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0951427 0.0648568 0.0245478 0.0578834 0.0175713 0.0421226 0.0360379 0.030935 0.0332733 0.0507526 0.0660661 0.101787 0.0530058 0.0491787 0.0334952 0.0184246 0.00546386 0.00652318 0.00410106 0.00263434 0.00398384 0.00287618 0.00555491 0.00645131 0.0208126 0.00559862 0.0107588 0.0296101 0.12055	Use with Other DRUG1 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0900696 0.0613477 0.0231804 0.0544376 0.0164053 0.0393121 0.0336281 0.0289933 0.031155 0.0462997 0.0608744 0.0965844 0.0522536 0.0489797 0.0335585 0.0187927 0.005436 0.00561915 0.0037018 0.00231832 0.0033057 0.00241568 0.00377234 0.00294015 0.00511865 0.00785346 0.0192829 0.0662079 0.136156	Use with Other DRUG1 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
2	2	0.0399748 0.0290706 0.00908824 0.0126909 0.0206031 0.0427856 0.0585511 0.0678479 0.0648998 0.0636331 0.0638049 0.0729341 0.043894 0.0512418 0.0464019 0.0433966 0.0184713 0.0246095 0.00951138 0.00509266 0.00515332 0.00401808 0.00543665 0.00434581 0.00718695 0.00580597 0.0108665 0.0422461 0.126437	Use with Other DRUG0 : The depressant effects of DRUG1 are potentiated by the presence of other DRUG2 such as DRUG0 , DRUG0 , DRUG0 , or DRUG0 .
2	2	0.0434598 0.0311791 0.00997524 0.0134701 0.0219554 0.0448143 0.0599673 0.0685662 0.0669883 0.0673004 0.0658412 0.0756791 0.0428417 0.0511429 0.0379351 0.0359577 0.015305 0.0111868 0.00848612 0.0100648 0.0191222 0.00411472 0.00472848 0.00375379 0.00615491 0.00522447 0.0099813 0.0364581 0.128345	Use with Other DRUG0 : The depressant effects of DRUG1 are potentiated by the presence of other DRUG0 such as DRUG2 , DRUG0 , DRUG0 , or DRUG0 .
2	2	0.0434142 0.0311295 0.00998623 0.0134442 0.0219829 0.0447417 0.0596361 0.0682171 0.0668428 0.0674043 0.0661207 0.0764029 0.043006 0.052089 0.0381139 0.0362741 0.0147529 0.0105212 0.00625978 0.00406394 0.00653704 0.00722573 0.0198273 0.00449069 0.00628519 0.00555826 0.0108386 0.0354561 0.129377	Use with Other DRUG0 : The depressant effects of DRUG1 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
2	2	0.0430159 0.030868 0.00989219 0.0133392 0.0217994 0.0443912 0.0591296 0.0678627 0.0670172 0.0674536 0.0663006 0.0766202 0.0432923 0.0524384 0.0383995 0.0356834 0.0143167 0.0100228 0.00597744 0.00366762 0.00497711 0.00396468 0.00712554 0.00805957 0.025504 0.00709236 0.0128941 0.0329118 0.125983	Use with Other DRUG0 : The depressant effects of DRUG1 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
2	2	0.0418628 0.029876 0.00957146 0.0127925 0.0208289 0.0423768 0.057006 0.0649054 0.0638646 0.0643039 0.0628007 0.0740926 0.0415494 0.0499617 0.0362181 0.0356624 0.013894 0.0089965 0.00545872 0.00339649 0.00422478 0.00328264 0.00470448 0.00401276 0.00695908 0.0100565 0.0254289 0.0758443 0.126067	Use with Other DRUG0 : The depressant effects of DRUG1 are potentiated by the presence of other DRUG0 such as DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
4	4	0.0289418 0.0233933 0.00741923 0.0109771 0.0130846 0.0277978 0.0312289 0.0279317 0.0306231 0.0491861 0.0702409 0.128603 0.0665706 0.0629899 0.0584872 0.0420839 0.0167543 0.04036 0.0149975 0.0114278 0.00932228 0.0111836 0.0217435 0.00491311 0.00664594 0.00622803 0.0126426 0.0342936 0.129928	Use with Other DRUG0 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG1 such as DRUG0 , DRUG2 , DRUG0 , or DRUG0 .
4	4	0.0285642 0.0231151 0.00733448 0.0108599 0.0129394 0.027487 0.0308944 0.0276612 0.0303365 0.0488345 0.0698612 0.127906 0.0668124 0.0634904 0.0584748 0.0422367 0.016864 0.0396502 0.0147635 0.0112499 0.00738061 0.00777599 0.00815028 0.0109961 0.0260116 0.0073861 0.0145664 0.0323564 0.126041	Use with Other DRUG0 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG1 such as DRUG0 , DRUG0 , DRUG2 , or DRUG0 .
4	4	0.0285298 0.0229639 0.00730905 0.0107111 0.0128267 0.0273609 0.0306539 0.0275186 0.0298837 0.0474147 0.0677164 0.124048 0.0654504 0.0598274 0.0517333 0.0381186 0.0152095 0.0374326 0.016092 0.0120224 0.00679966 0.00827072 0.00624917 0.00788064 0.00872517 0.0138081 0.0282125 0.0671398 0.120091	Use with Other DRUG0 : The depressant effects of DRUG0 are potentiated by the presence of other DRUG1 such as DRUG0 , DRUG0 , DRUG0 , or DRUG2 .
2	2	0.0392669 0.0539161 0.0410683 0.0728294 0.0446793 0.0558048 0.0606005 0.0761112 0.0856877 0.0761317 0.0881067 0.0390257 0.0153066 0.0122552 0.0129185 0.0138507 0.0382203 0.011702 0.0257539 0.0151341 0.0111917 0.0467014 0.0637376	Use of DRUG1 in conjunction with oral DRUG2 may increase the risk of respiratory depression , hypotension and profound sedation or coma .
4	4	0.111151 0.0688321 0.0474526 0.0179634 0.0235334 0.00558365 0.00315787 0.00331614 0.00258069 0.00322463 0.00281854 0.00416745 0.0030688 0.00443724 0.0103234 0.0242452 0.0491669 0.037534 0.0348024 0.030018 0.0257195 0.02945 0.0292455 0.0101299 0.0151504 0.00784108 0.0145576 0.0222314 0.0193018 0.0286028 0.0278379 0.0328841 0.0269989 0.0181541 0.044638 0.0493104 0.110569	Interaction with DRUG1 : DRUG2 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.119302 0.0735605 0.0580849 0.0215402 0.012744 0.0146814 0.00645454 0.01283 0.0027679 0.0029187 0.00249214 0.00340871 0.00277389 0.00392137 0.00809317 0.0187634 0.0474668 0.0308596 0.0312136 0.0259291 0.0209816 0.0241518 0.0258127 0.00938916 0.0144846 0.00772061 0.0144809 0.0222233 0.0195026 0.0289611 0.0282219 0.0332551 0.0272538 0.0182981 0.0448835 0.049578 0.110995	Interaction with DRUG1 : DRUG0 (i.e. , DRUG2 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.118641 0.0747884 0.0588241 0.0208022 0.0116286 0.0105886 0.00337989 0.00482289 0.00527618 0.0122266 0.00270594 0.00332322 0.00286389 0.00416868 0.00774111 0.0192063 0.0475406 0.0314045 0.0323491 0.0268911 0.02167 0.0246017 0.0258553 0.00943604 0.0145069 0.00774003 0.0144902 0.0221725 0.0195473 0.0289816 0.0282204 0.0332005 0.0271787 0.0182471 0.0447551 0.0494411 0.110782	Interaction with DRUG1 : DRUG0 (i.e. , DRUG0 , DRUG2 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.117659 0.0746851 0.0589936 0.0202382 0.0110913 0.00994468 0.00300549 0.00375296 0.00267168 0.00469406 0.00519 0.0136447 0.00360499 0.0049003 0.00731688 0.018375 0.0466165 0.0306898 0.0326066 0.0272539 0.0217205 0.0241468 0.0251157 0.00930566 0.0144195 0.00776503 0.0145532 0.0222856 0.0197626 0.0292388 0.0284788 0.0335065 0.0274038 0.0183988 0.0451806 0.0498938 0.111889	Interaction with DRUG1 : DRUG0 (i.e. , DRUG0 , DRUG0 , DRUG2 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.108593 0.0685369 0.0535452 0.0188785 0.0100301 0.00951584 0.00271657 0.00323273 0.00233821 0.00340391 0.0026309 0.00439712 0.00540923 0.0112161 0.0309816 0.0228046 0.040249 0.02973 0.0349331 0.0299608 0.0239298 0.0271137 0.0271629 0.00994687 0.015063 0.00801149 0.0147874 0.0222807 0.0196054 0.0289248 0.0281089 0.0330668 0.0270374 0.0181701 0.0445329 0.0490894 0.110065	Interaction with DRUG1 : DRUG0 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG2 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.0631537 0.0392939 0.0226178 0.00655675 0.00441112 0.00319999 0.00143184 0.00181698 0.00136347 0.00198537 0.00155017 0.00271786 0.00179222 0.00308227 0.00936345 0.0244117 0.041 0.0310956 0.0306993 0.0360584 0.033157 0.0447407 0.0457824 0.0179878 0.0258047 0.0140562 0.0268243 0.0341852 0.0315132 0.0369218 0.0437413 0.044512 0.0499007 0.039188 0.0712314 0.0517429 0.0611085	Interaction with DRUG1 : DRUG0 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
4	4	0.0968003 0.062344 0.0308507 0.0290527 0.0467547 0.0199374 0.00765537 0.0127221 0.00311568 0.00314168 0.00287577 0.00352168 0.00333153 0.00488812 0.0089763 0.0227276 0.049768 0.0342157 0.0344302 0.0289424 0.0236488 0.0257182 0.0252681 0.00930202 0.0142372 0.00760576 0.0141477 0.0215456 0.0192502 0.0282756 0.0274926 0.0323549 0.0264129 0.0177588 0.0437936 0.0483394 0.108797	Interaction with DRUG0 : DRUG1 (i.e. , DRUG2 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.0959968 0.0616358 0.0323984 0.0347696 0.0547024 0.0194892 0.00864168 0.00606014 0.00616619 0.0149791 0.00334974 0.00366337 0.00349429 0.00533013 0.00893906 0.0235473 0.0481755 0.0334578 0.0337226 0.0287509 0.0236923 0.0253603 0.0242256 0.00891217 0.0135303 0.00722972 0.0133882 0.0204328 0.0183414 0.0268772 0.0261209 0.0307677 0.0250999 0.0168844 0.0417491 0.0461032 0.104015	Interaction with DRUG0 : DRUG1 (i.e. , DRUG0 , DRUG2 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.0953198 0.0612656 0.0323697 0.0353403 0.0555392 0.020051 0.0088604 0.00510869 0.00468809 0.00508275 0.00630294 0.0164234 0.00448236 0.00660892 0.00871233 0.0232086 0.0472479 0.0317587 0.0328292 0.0279764 0.0230651 0.0247786 0.0238603 0.00891221 0.0134823 0.00724146 0.0133604 0.0203932 0.0183927 0.0268821 0.0261286 0.030748 0.0250625 0.0168536 0.0416782 0.0460355 0.103949	Interaction with DRUG0 : DRUG1 (i.e. , DRUG0 , DRUG0 , DRUG2 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
4	4	0.0888196 0.0564174 0.0296193 0.0324125 0.0486696 0.0202886 0.00912543 0.00479031 0.00506887 0.00416848 0.00514541 0.00573643 0.00849332 0.0177678 0.0331912 0.0199636 0.0391875 0.0305631 0.0349334 0.0299623 0.0237984 0.0263222 0.0253009 0.00932828 0.0138965 0.00741165 0.0135813 0.020639 0.0184641 0.0270617 0.0262734 0.0308178 0.0251163 0.0168799 0.0415276 0.0458638 0.103393	Interaction with DRUG0 : DRUG1 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG2 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG0 .
1	1	0.0497274 0.033804 0.0159456 0.0142437 0.0162015 0.00401549 0.00228947 0.0021566 0.0019248 0.00210779 0.00221907 0.00295236 0.0031153 0.00593752 0.00967124 0.0314787 0.0374864 0.031895 0.0273407 0.027197 0.0283963 0.032087 0.0407562 0.0211756 0.0301391 0.0190013 0.0318452 0.0370927 0.0364872 0.0380163 0.0458102 0.0454834 0.0504447 0.0392564 0.0719922 0.0507875 0.0595191	Interaction with DRUG0 : DRUG1 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
1	1	0.0503346 0.0304286 0.0115035 0.0132699 0.00878969 0.0063575 0.00275806 0.0101217 0.00219051 0.00236654 0.00217414 0.00295705 0.00292165 0.00525966 0.0094596 0.0295366 0.0329688 0.027034 0.0240512 0.0247796 0.0265575 0.0295261 0.039312 0.0213544 0.0308741 0.0196572 0.0335977 0.0391738 0.0384107 0.0399563 0.0483473 0.0478132 0.0531118 0.0413858 0.0758799 0.0533949 0.0623846	Interaction with DRUG0 : DRUG0 (i.e. , DRUG1 , DRUG0 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
1	1	0.0490328 0.0290969 0.0109334 0.0115483 0.00747609 0.00443737 0.00194384 0.00352872 0.00282004 0.0102238 0.00238617 0.00323232 0.00302794 0.00553491 0.0104055 0.0319596 0.0345872 0.0283365 0.0247199 0.0256402 0.0271301 0.0308808 0.0401534 0.0210514 0.030565 0.0192713 0.0328443 0.0385798 0.0376835 0.0395127 0.0477064 0.0475039 0.0528719 0.0411987 0.0758518 0.0534976 0.062826	Interaction with DRUG0 : DRUG0 (i.e. , DRUG0 , DRUG1 , DRUG0 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
1	1	0.047097 0.0272978 0.0100594 0.0101212 0.00657343 0.00382981 0.0016023 0.00250113 0.00185995 0.00385567 0.00325027 0.0131397 0.00349688 0.00677768 0.0109269 0.0319035 0.0342623 0.0283375 0.0245455 0.0251599 0.026937 0.0304884 0.0398716 0.0210617 0.030662 0.0194257 0.0331484 0.0390111 0.0382639 0.0400443 0.0483246 0.0480163 0.05331 0.0415463 0.0763781 0.0538349 0.0630779	Interaction with DRUG0 : DRUG0 (i.e. , DRUG0 , DRUG0 , DRUG1 , or DRUG0 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
1	1	0.0405528 0.0244734 0.00952274 0.0099443 0.00616608 0.00366147 0.00150469 0.00220457 0.00170756 0.00283339 0.00244977 0.00451285 0.0052635 0.0110086 0.0720132 0.0283985 0.0237547 0.0271525 0.0259251 0.0244767 0.0271718 0.0299647 0.0402518 0.0224803 0.0306988 0.019762 0.0331741 0.038 0.0379287 0.0385944 0.0464158 0.0452205 0.0494587 0.0384606 0.069674 0.0488802 0.0563373	Interaction with DRUG0 : DRUG0 (i.e. , DRUG0 , DRUG0 , DRUG0 , or DRUG1 ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUG2 .
4	4	0.0367433 0.0428106 0.0484739 0.032497 0.034017 0.0737113 0.0455903 0.0888359 0.0204065 0.0336626 0.0182855 0.021991 0.0322721 0.0518156 0.0194261 0.0143583 0.00712112 0.0249657 0.0655995 0.0450643 0.073291 0.0256752 0.0243294 0.0170674 0.0168708 0.0232645 0.0618542	Concomitant administrations not recommended :  - DRUG1 and DRUG2 : Certain DRUG0 interact with DRUG0 and DRUG0 leading to increased serum concentrations of the latter .
4	4	0.0333945 0.0396111 0.044117 0.0312175 0.030426 0.0630887 0.0403546 0.0679468 0.0176875 0.0142122 0.0196738 0.116833 0.0576089 0.0415737 0.0193546 0.0134787 0.00676218 0.0246965 0.0562603 0.0413363 0.061244 0.0219974 0.0228471 0.0159305 0.015616 0.0224622 0.0602695	Concomitant administrations not recommended :  - DRUG1 and DRUG0 : Certain DRUG2 interact with DRUG0 and DRUG0 leading to increased serum concentrations of the latter .
4	4	0.0267544 0.0317365 0.0348946 0.0246916 0.0230726 0.0495342 0.0311281 0.0518731 0.0129661 0.00987071 0.0122709 0.0346934 0.0582455 0.122374 0.0565508 0.0243292 0.0268424 0.0438916 0.0682526 0.0471011 0.0655636 0.0246028 0.0240769 0.0184877 0.016557 0.0183682 0.0412704	Concomitant administrations not recommended :  - DRUG1 and DRUG0 : Certain DRUG0 interact with DRUG0 and DRUG2 leading to increased serum concentrations of the latter .
4	4	0.0437924 0.0486483 0.0517942 0.0424782 0.0234687 0.0469274 0.0164452 0.0121978 0.00830344 0.0288573 0.0261569 0.119417 0.0561317 0.0421015 0.0201204 0.0144524 0.00732989 0.026753 0.0612183 0.0460285 0.0693775 0.0251577 0.0269628 0.0188409 0.0185326 0.0265937 0.0719121	Concomitant administrations not recommended :  - DRUG0 and DRUG1 : Certain DRUG2 interact with DRUG0 and DRUG0 leading to increased serum concentrations of the latter .
4	4	0.0336972 0.0381263 0.0403429 0.0325403 0.0166704 0.0343937 0.0118606 0.00871957 0.0052576 0.0200167 0.0163779 0.0341902 0.0776896 0.167855 0.112762 0.0418099 0.009053 0.0136298 0.0504132 0.0338168 0.0539817 0.0228833 0.022189 0.0160864 0.015009 0.0203247 0.050303	Concomitant administrations not recommended :  - DRUG0 and DRUG1 : Certain DRUG0 interact with DRUG2 and DRUG0 leading to increased serum concentrations of the latter .
3	0	0.0292418 0.0326583 0.0337697 0.0252577 0.0109009 0.0199114 0.0080241 0.00507194 0.00395001 0.0083911 0.01771 0.110878 0.141 0.107996 0.0927673 0.0387559 0.00974351 0.0192459 0.0579037 0.0373669 0.0551538 0.0213503 0.0198878 0.0147857 0.0139936 0.0184187 0.0458671	Concomitant administrations not recommended :  - DRUG0 and DRUG0 : Certain DRUG1 interact with DRUG2 and DRUG0 leading to increased serum concentrations of the latter .
3	0	0.0298109 0.0334526 0.0344092 0.0259067 0.0107836 0.0195287 0.00778932 0.00510557 0.00386651 0.00757314 0.0144867 0.0825153 0.117601 0.0906932 0.0534871 0.0276174 0.0260482 0.0524221 0.0649204 0.0487263 0.0727857 0.0286246 0.028719 0.0225836 0.0204153 0.0218535 0.0482742	Concomitant administrations not recommended :  - DRUG0 and DRUG0 : Certain DRUG1 interact with DRUG0 and DRUG2 leading to increased serum concentrations of the latter .
4	4	0.0276841 0.0319537 0.0329813 0.0251508 0.0104954 0.019912 0.00690986 0.00448509 0.00265089 0.00591152 0.00965764 0.0292144 0.0680866 0.125942 0.0875437 0.0937359 0.0315525 0.0713553 0.0716676 0.0423627 0.0617177 0.0221539 0.0224078 0.0171235 0.0158515 0.0183613 0.0431315	Concomitant administrations not recommended :  - DRUG0 and DRUG0 : Certain DRUG0 interact with DRUG1 and DRUG2 leading to increased serum concentrations of the latter .
4	4	0.0104877 0.00734965 0.0199113 0.0299694 0.0363102 0.0684024 0.0546809 0.0733088 0.103909 0.0671473 0.0104171 0.0323472 0.0524808 0.0605487 0.0536686 0.0582388 0.0251441 0.0105766 0.0140349 0.0355175 0.0448435 0.0268736 0.103832	Although such a reaction has not been demonstrated with DRUG1 , concomitant administration of DRUG0 with DRUG2 or DRUG0 is not recommended .
4	4	0.0111185 0.00772143 0.0205793 0.0302365 0.0360339 0.0686654 0.0542097 0.0726175 0.0999536 0.0639791 0.00904833 0.0258781 0.0455507 0.0434885 0.0370444 0.0357972 0.0136173 0.018873 0.047025 0.0559497 0.0632742 0.031481 0.107858	Although such a reaction has not been demonstrated with DRUG1 , concomitant administration of DRUG0 with DRUG0 or DRUG2 is not recommended .
1	1	0.00884332 0.00674225 0.0172358 0.0256489 0.0311617 0.0485301 0.0256039 0.0262859 0.0280741 0.015647 0.0166391 0.0496536 0.0556318 0.0526722 0.0872749 0.0862386 0.0372374 0.0191043 0.0328897 0.0788504 0.0805351 0.0365411 0.132959	Although such a reaction has not been demonstrated with DRUG0 , concomitant administration of DRUG1 with DRUG2 or DRUG0 is not recommended .
1	1	0.00889288 0.00660304 0.0163669 0.024045 0.0289236 0.0451155 0.0231206 0.0223456 0.0226223 0.0127186 0.0142233 0.0463266 0.0603247 0.059976 0.0924749 0.077155 0.0312267 0.0400501 0.0717881 0.06739 0.0718886 0.0350221 0.1214	Although such a reaction has not been demonstrated with DRUG0 , concomitant administration of DRUG1 with DRUG0 or DRUG2 is not recommended .
4	4	0.0266334 0.0468212 0.0159541 0.0105199 0.00810563 0.0122926 0.00756625 0.00323183 0.00247821 0.00563285 0.00621439 0.0161038 0.00529172 0.0275728 0.0300874 0.0648295 0.0328626 0.0257887 0.0477355 0.0260462 0.0115377 0.0155431 0.0191036 0.0162251 0.00885465 0.00860311 0.0169302 0.00779036 0.0100214 0.0206989 0.0230412 0.0198587 0.0145407 0.010496 0.00447132 0.00913456 0.016762 0.01694 0.0212002 0.0181693 0.0199648 0.0239336 0.0439847 0.0386313 0.0226945 0.0274821 0.0222692 0.0132973 0.00253054 0.00317659 0.00315401 0.00231912 0.00145545 0.00237029 0.00491094 0.0114138 0.0447215	- DRUG1 , DRUG0 : Other drugs such as DRUG0 or DRUG2 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG0 .
4	4	0.0175412 0.0247059 0.00658854 0.00486575 0.00273082 0.00299394 0.00330671 0.00211168 0.00170016 0.0031929 0.00302151 0.00776519 0.00927546 0.0385724 0.0259287 0.0517166 0.0312058 0.0229099 0.0431164 0.0262607 0.0114739 0.0148848 0.0190223 0.0160971 0.00914509 0.00874867 0.0163243 0.0073575 0.00933591 0.019083 0.0214089 0.0183917 0.0139437 0.0104594 0.00444707 0.0094694 0.017444 0.0183864 0.0232381 0.0217561 0.0234891 0.0251776 0.040762 0.0418478 0.0267731 0.0348541 0.032513 0.022376 0.00506524 0.0105215 0.0110655 0.00585481 0.00321929 0.00774972 0.0215609 0.0285672 0.0386758	- DRUG1 , DRUG0 : Other drugs such as DRUG0 or DRUG0 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG2 .
4	4	0.0124817 0.00613331 0.00446013 0.0228263 0.00765096 0.00859786 0.00775916 0.00391027 0.00546898 0.010743 0.00487473 0.00706036 0.00731424 0.0369412 0.0281681 0.0641623 0.036219 0.0295998 0.057693 0.0317501 0.0135677 0.0176692 0.0217683 0.0181712 0.0100533 0.00968598 0.0184361 0.00837101 0.0106109 0.0216358 0.0240396 0.0205765 0.0150449 0.0108268 0.00460577 0.00940903 0.0172674 0.0174495 0.0218338 0.0187166 0.0205688 0.024645 0.0452641 0.0397357 0.0233343 0.0282458 0.0229055 0.0136868 0.00260345 0.00326688 0.003242 0.00238066 0.00149351 0.00243195 0.0050376 0.0117073 0.0458968	- DRUG0 , DRUG1 : Other drugs such as DRUG2 or DRUG0 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG0 .
4	3	0.00829594 0.00458297 0.0027858 0.0131496 0.00368033 0.00325369 0.00341001 0.00214513 0.0017351 0.00329221 0.00286803 0.0076771 0.00866343 0.0357665 0.0222347 0.0500464 0.0301238 0.0218584 0.0434199 0.0272174 0.0119491 0.0153488 0.0200014 0.0170474 0.00971333 0.00927403 0.0173305 0.0078082 0.00989866 0.0201733 0.0226252 0.0193677 0.0146704 0.0109855 0.00466551 0.00992741 0.0183014 0.0192876 0.0243768 0.022836 0.0246601 0.0264258 0.042761 0.0438498 0.0280486 0.0365197 0.0340677 0.0234445 0.00530561 0.0110283 0.0115963 0.00613392 0.0033703 0.00811767 0.0225652 0.0298802 0.0404306	- DRUG0 , DRUG1 : Other drugs such as DRUG0 or DRUG0 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG2 .
3	3	0.00738538 0.00312736 0.00158743 0.00408063 0.00360281 0.00481115 0.00497787 0.00327686 0.00373194 0.0129694 0.00685607 0.00789234 0.0113033 0.0296409 0.0209902 0.0350724 0.0273915 0.0207194 0.0386572 0.0236169 0.0115099 0.0169169 0.0206094 0.0177201 0.00966371 0.00883304 0.0166546 0.00760079 0.00973323 0.0200235 0.0225268 0.0197704 0.0150245 0.0113712 0.00485545 0.0103682 0.0190714 0.020109 0.025408 0.0237423 0.0256045 0.0274771 0.0445647 0.0459247 0.0293785 0.0381992 0.0356263 0.0245193 0.00555385 0.0115092 0.0121119 0.00641551 0.00353649 0.00849583 0.0237084 0.0314782 0.0426932	- DRUG0 , DRUG0 : Other drugs such as DRUG1 or DRUG0 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG2 .
4	4	0.00907892 0.00367587 0.00189037 0.00524931 0.00530431 0.00874509 0.007175 0.0057104 0.00502813 0.0103268 0.0137343 0.0609608 0.0110508 0.0197995 0.0184417 0.0317097 0.0251752 0.0191683 0.0356126 0.0219776 0.0110746 0.0161559 0.0198582 0.0169362 0.00928123 0.0083643 0.015646 0.00714872 0.00912196 0.0187242 0.0210277 0.018425 0.013978 0.0105689 0.00451321 0.00965567 0.0177698 0.0187373 0.0236662 0.0221408 0.0238692 0.0255983 0.0414492 0.0426887 0.027301 0.0354924 0.0330955 0.0227811 0.00515868 0.0106938 0.0112531 0.00596004 0.00328454 0.00789225 0.0220178 0.0292268 0.039629	- DRUG0 , DRUG0 : Other drugs such as DRUG0 or DRUG1 , which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some DRUG2 .
3	3	0.10037 0.109666 0.103863 0.0862687 0.0886272 0.0801796 0.0400252 0.0278192 0.0169514 0.0420617 0.0780817 0.0327387 0.0171964 0.0346346 0.0282304 0.0337031 0.0795833	DRUG1 competes with DRUG2 for active tubular secretion and thus inhibits the renal excretion of DRUG0 .
4	4	0.0745216 0.0861521 0.0566325 0.0486434 0.0610319 0.0571463 0.0240879 0.0144454 0.0119419 0.0418838 0.102915 0.0661402 0.0447221 0.0867861 0.0815322 0.0767294 0.0646882	DRUG1 competes with DRUG0 for active tubular secretion and thus inhibits the renal excretion of DRUG2 .
1	1	0.06399 0.0328222 0.0626563 0.0587686 0.0752402 0.0883444 0.128703 0.0877669 0.0809466 0.10187 0.0540376 0.164854	Therefore , the coadministration of DRUG1 with DRUG2 is not recommended .
3	3	0.0307039 0.0425723 0.0452479 0.0308756 0.0613074 0.0656143 0.0425627 0.0366912 0.0372493 0.0466342 0.0382218 0.0224072 0.0493713 0.0417541 0.0535811 0.0261717 0.0156247 0.0106691 0.014725 0.0317821 0.0241734 0.0439092 0.0292244 0.0183245 0.0166387 0.019733 0.021418 0.0121456 0.0120206 0.0586454	There is evidence that DRUG1 may reduce serum levels of DRUG2 to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total DRUG0 ) .
4	4	0.0240553 0.0334154 0.0391188 0.0271133 0.0473563 0.0546733 0.027472 0.0198278 0.022814 0.0200222 0.0196912 0.0214933 0.041888 0.0261039 0.0340064 0.0243003 0.0167646 0.0105484 0.0157515 0.037983 0.0277163 0.0520939 0.0409443 0.032491 0.0334578 0.0503144 0.0713481 0.046334 0.0298241 0.0510774	There is evidence that DRUG1 may reduce serum levels of DRUG0 to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total DRUG2 ) .
4	4	0.0102433 0.0103457 0.0141864 0.0103283 0.0311693 0.0613714 0.039592 0.0315699 0.0386418 0.0315056 0.0434501 0.0221358 0.0243147 0.0250025 0.0283137 0.0202044 0.0178874 0.0132411 0.0151934 0.0305659 0.0259685 0.046608 0.0486242 0.0440488 0.0456567 0.0548336 0.0810685 0.0494415 0.0317189 0.0527685	There is evidence that DRUG0 may reduce serum levels of DRUG1 to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total DRUG2 ) .
4	4	0.058221 0.0441337 0.0443142 0.0432285 0.041596 0.0505964 0.0356192 0.0684069 0.0394882 0.0490684 0.0827728 0.0760918 0.100525 0.0760381 0.0529597 0.0409461 0.0161051 0.0109216 0.0248023 0.0441646	Improved parathyroid hormone control by DRUG1 is associated with reduction in DRUG2 requirement in patients with end-stage renal disease .
1	4	0.040358 0.0287637 0.0465991 0.047292 0.0520686 0.0378298 0.0373835 0.0413732 0.0458386 0.0495353 0.0300187 0.0199112 0.0214994 0.0108994 0.0225491 0.0537144 0.0548321 0.0677245 0.0632023 0.0634534 0.0434331 0.0419883 0.0797321	Medical treatment with DRUG1 is effective in reducing plasma parathyroid hormone (PTH) levels , but its effect on DRUG2 dosing is unknown .
4	4	0.0309106 0.0367472 0.0284252 0.0192912 0.0182111 0.0172816 0.0147797 0.0146514 0.0522301 0.0749751 0.0658908 0.0487888 0.11178 0.0576489 0.0487379 0.0163046 0.0348709 0.0292334 0.0424625 0.0708397 0.0532029 0.0429507 0.0697859	The primary objective of the study was to ascertain the difference in DRUG1 responsiveness before and after 12 months of DRUG2 therapy .
4	2	0.0592464 0.0504749 0.0650043 0.0726496 0.0726208 0.0549967 0.0959821 0.0661125 0.0475912 0.097319 0.0929251 0.0842437 0.059146 0.0816879	Reduction of PTH by DRUG1 is associated with a decrease in DRUG2 requirement .
